data_6twe_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6twe _Structure_validation_residue.Date_analyzed 2020-07-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.1 m80 . . . . . 0 N--CA 1.506 2.352 0 CA-C-O 123.733 1.73 . . . . 25.0 109.608 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.7 173.62 42.44 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 127.244 2.355 . . . . 25.0 116.754 -173.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -151.55 164.39 36.94 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-N 119.814 1.807 . . . . 50.0 113.357 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.67 135.24 27.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.647 -1.242 . . . . 25.0 107.647 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -107.89 -36.08 6.47 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 113.378 0.881 . . . . 25.0 113.378 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -148.7 158.84 39.41 Favored Pre-proline 0 C--O 1.286 3.011 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.17 145.26 77.58 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 C-N-CA 133.005 2.502 . . . . 25.0 111.966 -3.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.39 -169.61 52.76 Favored Glycine 0 C--O 1.214 -1.15 0 CA-C-N 113.107 -1.86 . . . . 25.0 111.767 162.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 t -140.89 121.7 14.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.598 1.959 . . . . 25.0 107.025 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.12 -16.8 36.82 Favored 'General case' 0 C--O 1.259 1.59 0 C-N-CA 116.975 -1.89 . . . . 25.0 107.724 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.66 -35.38 70.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 123.453 1.597 . . . . 25.0 110.783 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.28 92.64 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 112.875 -1.966 . . . . 25.0 111.965 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.257 1.456 0 CA-C-N 113.228 -1.806 . . . . 75.0 114.956 175.726 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 117.643 2.46 . . . . 25.0 117.643 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -63.61 -50.17 70.43 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 120.674 1.579 . . . . 50.0 113.538 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -135.69 42.8 0.78 Allowed Pre-proline 0 N--CA 1.517 2.911 0 N-CA-C 117.347 2.351 . . . . 25.0 117.347 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.43 -15.72 12.36 Favored 'Trans proline' 0 C--N 1.375 1.941 1 C-N-CA 108.82 -6.987 . . . . 25.0 118.324 -170.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -71.7 -39.17 70.38 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -83.86 51.76 2.12 Favored 'General case' 0 C--O 1.266 1.921 0 CA-C-N 113.265 -1.788 . . . . 25.0 112.408 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.4 tp -87.18 111.45 20.99 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.29 1.043 . . . . 50.0 108.325 170.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -78.45 161.78 26.86 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-O 124.869 2.271 . . . . 25.0 110.558 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.69 144.67 50.47 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 104.89 -2.263 . . . . 25.0 104.89 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -135.69 146.25 47.56 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 106.314 -1.735 . . . . 25.0 106.314 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.2 mttt . . . . . 0 N--CA 1.428 -1.528 0 N-CA-C 104.63 -2.359 . . . . 25.0 104.63 175.576 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.6 mt . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 116.222 -1.847 . . . . 50.0 111.714 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.75 -32.75 73.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 125.982 2.051 . . . . 50.0 108.726 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.85 -13.28 69.86 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 125.079 2.489 . . . . 25.0 112.094 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.03 0.11 87.88 Favored Glycine 0 CA--C 1.488 -1.644 0 CA-C-N 112.921 -1.639 . . . . 25.0 112.082 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.9 -28.03 39.88 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 O-C-N 121.578 -0.954 . . . . 25.0 110.827 168.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.45 -22.99 61.0 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 117.611 -1.185 . . . . 75.0 112.097 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.17 -23.95 51.52 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.54 1.063 . . . . 50.0 110.116 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -87.02 11.78 12.86 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 125.324 1.64 . . . . 25.0 110.168 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -132.56 23.45 4.36 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.212 1.958 . . . . 25.0 110.636 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.7 t -87.94 155.97 19.58 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 114.496 -1.229 . . . . 25.0 109.487 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.57 -35.73 66.08 Favored 'General case' 0 CA--C 1.484 -1.561 0 O-C-N 120.334 -1.479 . . . . 25.0 112.115 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -79.45 -4.39 50.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.851 2.537 . . . . 25.0 117.851 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -74.95 86.1 2.28 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 111.742 -2.481 . . . . 25.0 113.081 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -76.52 175.77 8.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 109.194 -3.639 . . . . 25.0 111.391 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -75.98 152.81 36.91 Favored 'General case' 0 C--O 1.192 -1.95 0 CA-C-N 112.129 -2.305 . . . . 50.0 115.431 -144.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -75.28 128.48 35.53 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.843 -1.143 . . . . 25.0 109.913 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -84.5 130.55 34.74 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.394 -2.066 . . . . 25.0 108.501 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.17 125.9 44.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mmt -131.01 129.03 41.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 115.651 -2.119 . . . . 25.0 107.559 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.7 p -80.57 173.88 12.16 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 127.713 3.133 . . . . 25.0 107.685 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.91 159.69 46.04 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 117.693 1.837 . . . . 25.0 117.693 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 174.05 25.21 Favored Glycine 0 C--O 1.216 -1.001 0 CA-C-N 112.161 -2.019 . . . . 25.0 112.067 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.51 148.42 31.83 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 118.045 -3.032 . . . . 25.0 108.845 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.08 154.05 49.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.287 -1.746 . . . . 25.0 106.287 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.9 m -83.64 138.54 33.29 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.597 -1.241 . . . . 25.0 111.761 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . 0.294 71.0 m-85 -124.88 123.85 40.81 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 102.363 -3.199 . . . . 50.0 102.363 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.9 m -139.37 137.78 36.02 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.984 -1.858 . . . . 25.0 105.984 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -120.52 147.07 45.64 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 116.288 -1.815 . . . . 25.0 106.612 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 t -122.26 137.19 54.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.932 1.395 . . . . 25.0 107.368 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.22 158.15 36.4 Favored 'General case' 0 C--O 1.188 -2.132 0 CA-C-O 124.28 1.991 . . . . 50.0 113.311 -172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 p -120.04 16.14 12.46 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 102.964 -2.976 . . . . 25.0 102.964 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.42 125.29 79.18 Favored Pre-proline 0 C--O 1.255 1.366 0 CA-C-O 113.456 -3.164 . . . . 25.0 111.847 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -88.47 -6.5 6.06 Favored 'Trans proline' 0 C--N 1.292 -2.395 0 N-CA-C 108.954 -1.21 . . . . 25.0 108.954 156.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -56.03 139.01 48.16 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.165 -1.38 . . . . 25.0 114.526 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.44 109.28 20.41 Favored 'General case' 0 C--O 1.202 -1.437 0 N-CA-C 114.63 1.344 . . . . 25.0 114.63 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.7 m -66.21 148.44 51.84 Favored 'General case' 0 C--O 1.192 -1.946 0 N-CA-C 106.231 -1.766 . . . . 25.0 106.231 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 p -100.49 -42.06 6.74 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 124.258 1.98 . . . . 25.0 110.09 166.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -164.99 144.2 6.77 Favored 'General case' 0 C--O 1.191 -1.995 0 O-C-N 118.788 -2.445 . . . . 25.0 113.062 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.42 139.64 38.99 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 115.085 -2.646 . . . . 25.0 109.716 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -148.4 152.08 36.38 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.014 -1.678 . . . . 25.0 110.195 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.19 143.56 40.27 Favored 'General case' 0 C--O 1.197 -1.702 0 O-C-N 127.68 3.113 . . . . 50.0 110.9 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.87 166.63 17.12 Favored 'General case' 0 C--O 1.258 1.527 0 N-CA-C 106.39 -1.707 . . . . 50.0 106.39 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 pt -120.99 154.88 24.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 102.694 -3.076 . . . . 25.0 102.694 161.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.5 p -74.97 151.82 38.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.798 -1.189 . . . . 25.0 111.124 163.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -122.29 133.42 54.68 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.216 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.0 157.87 32.36 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 126.429 1.892 . . . . 25.0 108.734 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.87 38.56 7.94 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 118.121 -2.862 . . . . 25.0 118.333 165.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 168.5 9.7 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -144.08 124.29 7.58 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 114.814 -1.085 . . . . 25.0 109.96 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 108' ' ' LYS . 27.3 Cg_exo -58.26 -30.08 89.77 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 114.289 -3.341 . . . . 25.0 118.297 172.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.23 1.02 5.27 Favored 'General case' 0 C--O 1.198 -1.634 0 C-N-CA 116.542 -2.063 . . . . 75.0 115.403 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.412 ' H ' ' C ' ' A' ' 106' ' ' PRO . 55.1 mttp -132.84 173.13 6.25 Favored Pre-proline 0 C--O 1.199 -1.589 0 N-CA-C 104.849 -2.278 . . . . 25.0 104.849 -167.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -50.65 20.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.398 2 C-N-CA 129.738 6.959 . . . . 25.0 124.732 173.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -16.71 -49.82 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.017 1 N-CA-C 121.959 4.059 . . . . 50.0 121.959 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -77.58 -8.56 58.03 Favored 'General case' 0 CA--C 1.479 -1.76 1 O-C-N 114.005 -5.434 . . . . 25.0 113.306 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -108.85 -40.73 4.95 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 126.728 2.011 . . . . 25.0 114.76 164.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.27 13.97 1.69 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 127.791 3.182 . . . . 25.0 114.358 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -26.88 67.87 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.481 -0.933 . . . . 25.0 108.481 168.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -137.31 174.14 10.93 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 119.391 3.108 . . . . 50.0 119.391 -171.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -127.8 128.93 46.14 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.566 -1.197 . . . . 25.0 108.265 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 tp -70.16 123.35 21.41 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 103.46 -2.793 . . . . 50.0 103.46 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.9 pt -105.68 -12.93 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.54 1.162 . . . . 25.0 107.937 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.96 154.19 11.68 Favored Glycine 0 CA--C 1.501 -0.81 0 O-C-N 119.117 -2.239 . . . . 25.0 116.791 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.39 139.95 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 126.362 1.86 . . . . 25.0 109.944 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 t -134.69 103.64 11.05 Favored Pre-proline 0 CA--C 1.572 1.8 0 CA-C-O 125.727 2.68 . . . . 50.0 116.863 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.15 157.44 37.97 Favored 'Trans proline' 0 C--O 1.252 1.211 0 O-C-N 115.971 -2.7 . . . . 25.0 108.656 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -82.55 106.48 14.44 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-O 123.917 1.818 . . . . 25.0 110.37 171.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.466 ' H ' ' HG ' ' A' ' 129' ' ' SER . 19.3 t70 -140.12 -46.53 0.43 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 120.276 3.435 . . . . 50.0 120.276 -174.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 156.17 175.57 27.3 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 105.581 -3.008 . . . . 25.0 105.581 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 p 59.46 162.4 0.1 OUTLIER Pre-proline 0 C--O 1.251 1.176 0 N-CA-C 119.491 3.145 . . . . 25.0 119.491 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.63 1.98 3.87 Favored 'Trans proline' 0 C--N 1.371 1.716 1 C-N-CA 113.147 -4.102 . . . . 25.0 118.591 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -43.12 57.18 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 123.642 1.687 . . . . 25.0 109.877 172.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.466 ' HG ' ' H ' ' A' ' 124' ' ' ASP . 30.1 t -77.46 -26.67 51.65 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.819 -4.301 . . . . 25.0 111.576 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -67.26 -20.86 65.72 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 125.197 2.427 . . . . 25.0 115.614 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -62.31 127.69 32.51 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 112.071 -2.331 . . . . 25.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.5 tp -122.21 4.12 9.78 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.403 -1.702 . . . . 75.0 106.403 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.5 t -128.85 136.36 50.35 Favored 'General case' 0 CA--C 1.47 -2.131 0 N-CA-C 102.442 -3.17 . . . . 25.0 102.442 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -147.88 153.24 38.85 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 106.053 -1.832 . . . . 25.0 106.053 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.823 -1.561 . . . . 25.0 107.925 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.23 129.65 75.43 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-O 113.113 -3.327 . . . . 25.0 108.852 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -73.9 135.51 43.31 Favored 'General case' 0 C--O 1.187 -2.189 0 O-C-N 128.725 3.766 . . . . 50.0 114.173 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.4 mm -113.07 121.67 37.62 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 115.833 -2.032 . . . . 25.0 108.095 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -58.12 147.38 83.65 Favored 'Trans proline' 0 CA--C 1.483 -2.054 1 C-N-CA 112.099 -4.801 . . . . 25.0 114.946 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.08 -11.24 47.68 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 111.557 -2.565 . . . . 25.0 112.555 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -112.19 -9.26 13.94 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 118.818 -1.153 . . . . 50.0 111.464 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -108.99 160.91 15.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 118.921 -2.362 . . . . 25.0 112.387 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . 0.304 2.6 mp -138.95 132.92 31.09 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 128.191 2.596 . . . . 50.0 106.572 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.3 148.89 5.25 Favored Glycine 0 C--O 1.272 2.498 0 CA-C-O 127.078 3.599 . . . . 25.0 118.575 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.88 143.78 57.58 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 108.671 -3.765 . . . . 50.0 109.364 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -151.02 165.5 33.59 Favored 'General case' 0 C--O 1.269 2.094 0 N-CA-C 101.561 -3.496 . . . . 25.0 101.561 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.42 136.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 104.243 -2.503 . . . . 50.0 104.243 166.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -78.48 125.96 38.3 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 CA-C-O 114.711 -2.566 . . . . 25.0 106.031 164.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.36 131.62 53.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 103.104 -2.925 . . . . 50.0 103.104 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.29 146.15 44.32 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-O 126.345 2.974 . . . . 25.0 107.003 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -128.27 138.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 119.961 -1.712 . . . . 50.0 107.985 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -138.47 94.56 2.87 Favored 'General case' 0 C--O 1.196 -1.729 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -96.58 146.33 24.92 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-O 126.113 2.863 . . . . 25.0 105.184 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . 0.25 41.3 t -116.82 128.29 74.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 111.16 -2.745 . . . . 50.0 109.196 -169.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.56 -29.63 62.55 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.616 1.966 . . . . 25.0 110.579 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.05 -20.8 60.91 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 114.787 1.402 . . . . 25.0 114.787 -169.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.1 t -151.55 159.15 44.24 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 116.791 -1.576 . . . . 25.0 107.951 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.07 -1.36 28.6 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 117.765 -1.112 . . . . 25.0 112.596 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -103.34 160.57 14.58 Favored 'General case' 0 CA--C 1.569 1.695 0 O-C-N 124.91 1.381 . . . . 25.0 108.463 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.4 -173.89 4.52 Favored 'General case' 0 C--O 1.189 -2.093 0 O-C-N 120.304 -1.497 . . . . 25.0 109.545 -167.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -113.42 148.22 36.28 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.516 -1.661 . . . . 50.0 106.516 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -146.48 118.48 8.22 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.356 -2.461 . . . . 50.0 104.356 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.99 153.29 49.42 Favored 'General case' 0 C--O 1.265 1.899 0 O-C-N 120.734 -1.229 . . . . 25.0 110.063 -164.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.17 152.05 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 125.558 1.786 . . . . 75.0 108.367 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.2 mt -140.57 121.82 14.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.675 0 N-CA-C 105.046 -2.205 . . . . 25.0 105.046 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.47 142.67 44.85 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.522 -1.361 . . . . 25.0 108.632 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.2 163.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 124.903 1.377 . . . . 50.0 109.715 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -133.88 103.56 5.89 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.8 mt -99.73 133.51 43.98 Favored 'General case' 0 C--O 1.16 -3.611 0 N-CA-C 103.289 -2.856 . . . . 50.0 103.289 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.17 179.03 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-O 123.743 1.735 . . . . 50.0 111.908 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -64.94 172.21 3.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.748 -2.478 . . . . 25.0 115.969 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 114.784 -2.531 . . . . 25.0 107.985 -177.409 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.511 2.612 0 CA-C-O 123.853 1.787 . . . . 25.0 111.216 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.87 -160.92 30.3 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 111.829 -2.441 . . . . 25.0 118.642 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -156.06 157.34 35.92 Favored 'General case' 0 C--O 1.261 1.683 0 N-CA-C 105.123 -2.177 . . . . 50.0 105.123 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.2 mm -84.09 110.26 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 O-C-N 119.47 -2.018 . . . . 25.0 107.286 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.96 -38.78 20.57 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 123.044 2.657 . . . . 25.0 109.946 170.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.82 149.25 63.82 Favored Pre-proline 0 N--CA 1.518 2.974 0 N-CA-C 104.004 -2.591 . . . . 25.0 104.004 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.07 160.69 93.42 Favored 'Cis proline' 0 C--O 1.252 1.213 0 C-N-CA 129.47 1.029 . . . . 25.0 113.159 -9.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.0 -173.09 52.09 Favored Glycine 0 C--N 1.286 -2.23 0 N-CA-C 117.84 1.896 . . . . 25.0 117.84 155.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 t -153.59 75.96 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 103.009 -2.96 . . . . 25.0 103.009 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -70.55 -7.91 47.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.436 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.28 -40.74 49.16 Favored 'General case' 0 C--O 1.255 1.369 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 161.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.4 67.6 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 114.359 1.244 . . . . 25.0 114.359 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 mt . . . . . 0 C--O 1.21 -1.005 0 CA-C-O 122.743 1.259 . . . . 75.0 113.73 175.502 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.205 -1.284 0 N-CA-C 121.0 3.704 . . . . 25.0 121.0 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.3 -34.1 73.31 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-N 114.983 -1.008 . . . . 50.0 109.15 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.02 47.02 0.54 Allowed Pre-proline 0 C--O 1.294 3.447 0 N-CA-C 118.172 2.656 . . . . 25.0 118.172 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.75 -11.37 31.72 Favored 'Trans proline' 0 CA--C 1.487 -1.874 0 C-N-CA 121.372 1.381 . . . . 25.0 111.966 -159.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -116.98 6.75 13.02 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.74 0.7 . . . . 25.0 112.363 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -89.83 55.73 3.26 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 117.906 -2.996 . . . . 25.0 112.17 -171.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.3 mt -103.67 96.08 6.48 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 118.009 -0.996 . . . . 50.0 112.964 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -123.87 157.4 34.28 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 103.721 -2.696 . . . . 25.0 103.721 166.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.84 42.2 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.713 -2.039 . . . . 25.0 110.225 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.02 150.07 47.03 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 121.992 2.178 . . . . 25.0 108.693 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.9 mttt . . . . . 0 N--CA 1.441 -0.908 0 C-N-CA 123.808 0.843 . . . . 25.0 111.605 171.302 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.4 mt . . . . . 0 C--O 1.27 2.184 0 CA-C-O 126.574 3.083 . . . . 50.0 104.696 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -73.69 -24.48 59.96 Favored 'General case' 0 CA--C 1.481 -1.678 1 O-C-N 116.272 -4.018 . . . . 50.0 113.975 -174.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -36.84 80.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-O 124.374 2.097 . . . . 25.0 108.239 167.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.85 -31.28 72.7 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 119.992 -1.887 . . . . 25.0 113.809 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.17 -50.23 65.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 117.582 -3.305 . . . . 25.0 110.432 167.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.98 -26.9 67.04 Favored 'General case' 1 C--O 1.319 4.725 0 CA-C-N 121.593 1.997 . . . . 75.0 107.418 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.11 -29.53 67.61 Favored 'General case' 0 C--O 1.27 2.133 0 C-N-CA 119.997 -0.681 . . . . 50.0 110.121 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -79.11 56.81 2.09 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-O 123.444 1.592 . . . . 25.0 109.391 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -91.94 60.41 3.84 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 118.644 -2.535 . . . . 25.0 106.39 167.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.0 p -146.97 -164.2 1.94 Allowed 'General case' 0 C--O 1.273 2.342 0 CA-C-N 111.303 -2.681 . . . . 25.0 116.633 -164.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.44 -26.92 68.76 Favored 'General case' 0 C--O 1.267 1.981 0 O-C-N 119.604 -1.935 . . . . 25.0 111.17 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -87.35 16.01 5.81 Favored 'General case' 0 C--O 1.264 1.845 0 N-CA-C 116.01 1.856 . . . . 25.0 116.01 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -75.21 89.39 2.53 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 123.879 1.799 . . . . 25.0 108.676 173.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -18.49 142.79 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 108.596 -3.911 . . . . 25.0 121.148 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.13 125.79 26.07 Favored 'General case' 0 N--CA 1.42 -1.949 0 O-C-N 125.459 1.724 . . . . 50.0 111.546 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -117.78 149.74 40.29 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 119.213 3.042 . . . . 25.0 119.213 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -142.61 126.07 16.73 Favored 'General case' 0 CA--C 1.591 2.538 0 N-CA-C 117.276 2.324 . . . . 25.0 117.276 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.54 125.37 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 O-C-N 117.735 -3.103 . . . . 25.0 106.919 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttt -148.06 161.84 40.59 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 102.539 -3.134 . . . . 25.0 102.539 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 64.6 p -88.71 166.67 13.91 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 119.672 -1.893 . . . . 25.0 112.209 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.87 176.41 51.1 Favored Glycine 0 C--O 1.256 1.499 0 C-N-CA 116.792 -2.623 . . . . 25.0 115.704 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.89 -171.79 19.12 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 105.118 -3.193 . . . . 25.0 105.118 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.64 141.1 58.89 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 103.792 -2.67 . . . . 25.0 103.792 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -111.26 144.34 40.59 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 101.814 -3.402 . . . . 25.0 101.814 158.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -126.15 120.83 31.13 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 100.996 -3.705 . . . . 25.0 100.996 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -114.59 119.33 36.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 118.73 -2.481 . . . . 50.0 109.61 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 m -131.61 97.26 4.17 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 100.019 -4.067 . . . . 25.0 100.019 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -112.53 116.28 29.99 Favored 'General case' 1 N--CA 1.539 4.01 0 O-C-N 126.614 2.446 . . . . 25.0 106.657 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.251 2.1 p -127.07 157.33 39.91 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 125.56 1.788 . . . . 25.0 106.228 -162.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -113.52 140.43 48.14 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 127.503 2.321 . . . . 50.0 107.097 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -88.1 -9.59 52.79 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 123.807 1.765 . . . . 25.0 108.773 -169.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.94 149.1 38.05 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 101.639 -3.467 . . . . 25.0 101.639 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.68 147.36 75.72 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 118.167 -0.755 . . . . 25.0 113.558 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -141.85 141.83 33.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 117.647 -1.168 . . . . 25.0 110.935 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -80.75 159.58 25.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 117.99 -1.484 . . . . 25.0 113.776 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.9 m -150.48 148.23 28.47 Favored 'General case' 0 C--O 1.208 -1.122 0 C-N-CA 125.903 1.681 . . . . 25.0 109.695 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.7 p -111.21 -29.39 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.583 1.953 . . . . 25.0 112.486 170.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -166.96 158.87 12.84 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.405 1.482 . . . . 25.0 107.777 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -143.74 146.35 33.08 Favored 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -144.48 149.37 35.85 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 120.329 -1.482 . . . . 25.0 110.59 -167.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.433 ' HH ' ' HZ3' ' A' ' 152' ' ' TRP . 97.6 m-85 -130.59 134.7 47.21 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 113.097 -1.865 . . . . 50.0 110.776 172.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.33 171.09 11.81 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 103.493 -2.78 . . . . 50.0 103.493 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.39 155.95 41.17 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 N-CA-C 103.321 -2.844 . . . . 25.0 103.321 167.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.295 33.5 p -81.52 153.91 26.55 Favored 'General case' 0 CA--C 1.469 -2.173 0 CA-C-O 124.096 1.903 . . . . 25.0 106.925 165.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -87.85 107.99 18.95 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 112.392 -2.185 . . . . 25.0 110.884 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -49.57 117.7 2.37 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 105.696 -1.965 . . . . 25.0 105.696 155.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.66 33.28 34.77 Favored Glycine 0 C--O 1.192 -2.515 0 CA-C-O 117.693 -1.615 . . . . 25.0 115.726 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -51.02 159.83 0.55 Allowed 'General case' 0 C--O 1.259 1.576 0 CA-C-O 122.267 1.032 . . . . 25.0 108.446 169.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -102.9 107.49 55.06 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 102.075 -3.306 . . . . 25.0 102.075 167.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -72.54 -16.34 27.24 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.552 2.168 . . . . 25.0 116.28 -173.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -84.2 -2.61 57.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.392 -1.731 . . . . 75.0 106.873 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -132.48 154.54 81.58 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 103.513 -2.773 . . . . 25.0 103.513 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.381 72.4 Cg_exo -25.64 91.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.285 3 C-N-CA 125.506 4.138 . . . . 25.0 122.529 -167.468 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.42 -15.34 61.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 110.883 -2.871 . . . . 50.0 112.928 -171.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 6.36 11.21 Favored 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 120.027 -1.671 . . . . 25.0 111.866 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -136.62 -46.11 0.6 Allowed 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 118.166 2.654 . . . . 25.0 118.166 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.35 -4.48 53.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.44 1.644 . . . . 25.0 115.44 165.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.61 7.8 16.22 Favored 'General case' 0 C--O 1.274 2.346 0 C-N-CA 125.645 1.578 . . . . 25.0 114.917 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -141.69 166.95 23.34 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 126.041 2.088 . . . . 50.0 106.95 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -134.27 154.41 51.3 Favored 'General case' 0 C--O 1.176 -2.796 0 N-CA-C 105.954 -1.869 . . . . 25.0 105.954 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.32 120.72 38.21 Favored 'General case' 0 CA--C 1.58 2.097 0 O-C-N 120.507 -1.371 . . . . 50.0 112.647 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.292 4.8 tp -98.13 -19.51 5.94 Favored 'Isoleucine or valine' 0 C--O 1.274 2.352 0 C-N-CA 126.738 2.015 . . . . 25.0 106.416 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.77 164.93 26.31 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 113.331 -1.759 . . . . 25.0 117.149 162.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.84 157.65 45.66 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 101.531 -3.507 . . . . 25.0 101.531 166.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.9 130.44 13.01 Favored Pre-proline 0 C--O 1.245 0.866 0 N-CA-C 102.832 -3.025 . . . . 50.0 102.832 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.01 168.86 11.92 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 116.847 -1.636 . . . . 25.0 111.898 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -129.76 56.3 1.73 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.9 0.75 . . . . 25.0 109.57 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -123.93 -0.1 8.5 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 124.474 2.083 . . . . 50.0 113.316 -164.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -167.7 -165.72 25.58 Favored Glycine 0 C--O 1.258 1.608 0 N-CA-C 103.919 -3.673 . . . . 25.0 103.919 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.654 ' HG ' HH11 ' A' ' 130' ' ' ARG . 12.1 t -120.68 69.67 16.9 Favored Pre-proline 0 CA--C 1.556 1.19 0 O-C-N 126.411 1.889 . . . . 25.0 115.318 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.3 178.79 7.2 Favored 'Trans proline' 0 CA--C 1.578 2.682 0 C-N-CA 121.613 1.542 . . . . 25.0 112.618 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.67 71.31 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.36 2.14 2.5 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.992 1.317 . . . . 25.0 114.312 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.654 HH11 ' HG ' ' A' ' 126' ' ' SER . 50.4 ttt180 -70.94 -16.8 62.68 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 124.162 1.934 . . . . 25.0 111.04 170.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -68.24 125.77 27.45 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 103.906 -2.627 . . . . 25.0 103.906 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.8 tp -75.81 -7.14 53.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 118.25 -1.38 . . . . 75.0 113.997 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.9 t -85.23 144.53 28.07 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 104.705 -2.331 . . . . 25.0 104.705 173.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -137.79 135.78 36.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.178 0.806 . . . . 25.0 113.178 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -101.47 128.42 47.69 Favored 'General case' 0 C--O 1.301 3.807 0 CA-C-O 123.272 1.51 . . . . 25.0 108.912 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 46.3 mt -118.32 120.98 66.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 116.089 -2.244 . . . . 25.0 108.166 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -83.33 117.64 23.14 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 115.255 -2.578 . . . . 50.0 110.019 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.77 97.25 27.59 Favored Pre-proline 0 C--O 1.275 2.424 0 CA-C-O 123.321 1.534 . . . . 25.0 108.686 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 132.96 20.84 Favored 'Trans proline' 0 C--N 1.372 1.771 1 C-N-CA 113.121 -4.119 . . . . 25.0 110.298 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.43 97.06 3.14 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 117.321 -3.362 . . . . 25.0 109.979 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.69 -13.02 30.0 Favored 'General case' 0 C--O 1.267 1.977 0 N-CA-C 104.87 -2.27 . . . . 50.0 104.87 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -106.83 -173.68 2.35 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.643 -1.91 . . . . 25.0 112.82 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.53 129.87 45.05 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.169 -1.582 . . . . 50.0 111.609 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 152.9 -179.95 28.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 124.707 2.282 . . . . 25.0 116.113 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.14 158.84 38.58 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 117.113 -3.581 . . . . 50.0 117.192 -153.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -158.99 168.6 26.32 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 120.579 -1.325 . . . . 25.0 110.292 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.16 135.31 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.065 0 N-CA-C 103.775 -2.676 . . . . 50.0 103.775 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 mt -85.08 134.98 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 100.758 -3.793 . . . . 25.0 100.758 167.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.4 mt -116.5 135.18 54.05 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.387 -2.079 . . . . 50.0 105.387 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.7 136.59 54.94 Favored 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 97.282 -5.081 . . . . 25.0 97.282 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.5 120.44 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 O-C-N 125.491 1.744 . . . . 50.0 108.481 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.433 ' HZ3' ' HH ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -124.89 121.86 35.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.071 1.76 . . . . 25.0 107.881 -175.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -102.77 134.53 46.02 Favored 'General case' 0 N--CA 1.407 -2.625 0 O-C-N 120.413 -1.43 . . . . 25.0 110.346 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.59 99.11 3.65 Favored 'Isoleucine or valine' 0 C--O 1.262 1.747 0 N-CA-C 105.93 -1.878 . . . . 50.0 105.93 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.34 66.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 117.138 -1.825 . . . . 25.0 113.167 -167.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.3 -16.69 55.98 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.379 -1.282 . . . . 25.0 113.13 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.9 p -109.68 164.64 12.35 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 120.15 1.341 . . . . 25.0 109.621 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -81.75 -36.88 28.04 Favored 'General case' 0 C--O 1.285 2.933 0 CA-C-O 123.699 1.714 . . . . 25.0 110.38 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.61 154.38 20.02 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 112.369 -2.196 . . . . 25.0 108.378 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -111.0 158.15 19.12 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 124.941 1.297 . . . . 25.0 111.411 168.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -109.94 142.71 40.91 Favored 'General case' 0 C--O 1.269 2.104 0 O-C-N 119.391 -2.068 . . . . 50.0 109.032 -165.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.16 162.34 41.06 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-O 123.459 1.599 . . . . 50.0 111.872 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -138.86 157.6 45.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.921 -1.112 . . . . 25.0 108.047 166.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.1 133.04 63.2 Favored 'Isoleucine or valine' 0 C--O 1.258 1.53 0 O-C-N 120.117 -1.614 . . . . 75.0 109.363 165.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.2 mt -136.1 119.64 23.71 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 N-CA-C 102.421 -3.177 . . . . 25.0 102.421 -169.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -83.42 133.42 34.92 Favored 'General case' 0 CA--C 1.613 3.376 0 CA-C-O 123.094 1.426 . . . . 25.0 111.241 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.53 144.33 38.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 O-C-N 119.76 -1.838 . . . . 50.0 111.577 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.78 135.14 54.97 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 100.626 -3.842 . . . . 25.0 100.626 167.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 mt -126.36 129.34 48.61 Favored 'General case' 0 C--O 1.294 3.431 0 N-CA-C 104.75 -2.315 . . . . 50.0 104.75 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.01 163.9 30.78 Favored 'Isoleucine or valine' 0 C--O 1.277 2.523 0 N-CA-C 115.714 1.746 . . . . 50.0 115.714 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -71.01 134.36 47.07 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.161 -0.962 . . . . 25.0 111.638 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.657 -1.163 . . . . 25.0 112.826 -173.622 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . 0.259 47.0 p-80 . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 122.897 1.332 . . . . 25.0 109.553 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.52 -165.02 38.85 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-O 116.546 -2.252 . . . . 25.0 114.783 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.71 151.58 33.89 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-N 122.18 2.99 . . . . 50.0 116.056 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.445 HG23 ' H ' ' A' ' 6' ' ' LYS . 43.9 mm -66.78 132.09 32.26 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.722 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.11 39.98 3.42 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 126.4 3.0 . . . . 25.0 107.454 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.445 ' H ' HG23 ' A' ' 4' ' ' ILE . 96.2 mttt 72.09 163.53 0.14 Allowed Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 108.512 -3.949 . . . . 25.0 115.078 169.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.78 122.05 0.42 Allowed 'Cis proline' 0 C--N 1.357 0.98 0 C-N-CA 133.055 2.523 . . . . 25.0 114.14 3.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.47 147.93 13.28 Favored Glycine 0 C--O 1.252 1.238 0 CA-C-N 114.019 -1.446 . . . . 25.0 111.239 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -145.92 134.58 22.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.406 -1.643 . . . . 25.0 108.45 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -75.16 -17.1 60.46 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 117.086 -3.509 . . . . 25.0 111.88 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.78 56.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 116.374 -1.774 . . . . 25.0 107.65 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.72 63.32 Favored 'General case' 1 C--O 1.306 4.054 0 CA-C-N 122.002 2.183 . . . . 25.0 109.642 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--N 1.301 -1.52 0 O-C-N 121.142 -0.974 . . . . 75.0 110.021 -178.253 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 ptm . . . . . 0 C--O 1.278 2.578 1 N-CA-C 122.734 4.346 . . . . 25.0 122.734 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -57.48 -47.83 80.82 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 120.242 -1.536 . . . . 50.0 113.717 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -149.35 44.66 0.34 Allowed Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 119.733 3.234 . . . . 25.0 119.733 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -79.34 -17.32 11.63 Favored 'Trans proline' 0 C--O 1.272 2.206 0 C-N-CA 115.112 -2.792 . . . . 25.0 114.413 -167.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -92.66 5.77 49.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 116.85 -1.547 . . . . 25.0 112.253 170.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -119.29 16.66 13.11 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 124.983 1.427 . . . . 25.0 111.597 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 mt -73.19 124.85 26.42 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 126.115 1.766 . . . . 50.0 108.361 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.41 164.86 20.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 118.955 -2.341 . . . . 25.0 112.334 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.26 139.02 26.83 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.188 -1.824 . . . . 25.0 111.882 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -59.8 137.55 58.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 118.206 -2.809 . . . . 25.0 112.552 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 117.559 -3.213 . . . . 25.0 103.336 178.191 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 117.797 -1.097 . . . . 50.0 112.053 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -68.78 -22.96 64.25 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.547 -0.909 . . . . 50.0 108.547 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -26.43 62.84 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 117.049 -1.973 . . . . 25.0 116.058 166.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.63 -21.22 64.72 Favored Glycine 0 C--O 1.186 -2.855 0 CA-C-O 114.435 -3.425 . . . . 25.0 112.829 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.68 -34.39 23.46 Favored 'Isoleucine or valine' 0 C--O 1.293 3.361 0 CA-C-N 124.147 3.973 . . . . 25.0 112.402 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.72 -18.85 56.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 125.794 1.934 . . . . 75.0 107.51 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.266 4.8 t70 -43.19 -39.77 3.05 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 115.35 1.611 . . . . 50.0 115.35 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -78.05 10.63 2.76 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 116.442 2.015 . . . . 25.0 116.442 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -147.97 47.11 1.08 Allowed 'General case' 0 C--O 1.255 1.395 0 C-N-CA 128.179 2.591 . . . . 25.0 110.269 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 t -144.52 161.19 39.71 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 119.254 3.057 . . . . 25.0 119.254 -166.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -68.21 -17.4 64.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 122.151 2.251 . . . . 25.0 108.907 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -96.54 26.25 4.56 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.322 36.5 ttp180 -78.56 67.79 4.4 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-O 123.491 1.615 . . . . 25.0 110.418 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -61.84 145.39 52.83 Favored 'General case' 0 CA--C 1.454 -2.715 1 CA-C-N 107.191 -4.549 . . . . 25.0 111.745 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -77.17 144.48 38.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.38 -1.736 . . . . 50.0 113.354 -166.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -107.76 165.53 11.37 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-O 118.311 -0.852 . . . . 25.0 111.541 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.409 ' H ' ' HA ' ' A' ' 167' ' ' VAL . 3.6 m80 -127.72 122.16 32.17 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 126.204 1.802 . . . . 25.0 107.023 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.3 mt -83.7 126.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 103.511 -2.774 . . . . 25.0 103.511 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.8 mtp -138.15 156.4 47.77 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 126.051 2.834 . . . . 25.0 105.013 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.7 p -91.88 166.05 12.93 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.786 -2.302 . . . . 25.0 104.786 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.74 167.85 52.05 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-O 116.793 -2.115 . . . . 25.0 115.213 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.4 171.01 12.95 Favored Glycine 0 CA--C 1.555 2.559 1 N-CA-C 102.906 -4.077 . . . . 25.0 102.906 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -62.92 144.9 56.32 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.572 -1.546 . . . . 25.0 111.258 168.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -136.11 146.75 47.33 Favored 'General case' 0 CA--C 1.445 -3.082 0 O-C-N 119.802 -1.811 . . . . 25.0 107.907 162.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.1 m -101.91 137.27 40.43 Favored 'General case' 0 CA--C 1.468 -2.198 0 C-N-CA 124.907 1.283 . . . . 25.0 109.216 167.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -114.79 140.93 48.52 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.856 -1.778 . . . . 50.0 106.669 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -127.32 136.16 51.54 Favored 'General case' 0 C--O 1.19 -2.059 0 CA-C-O 125.014 2.34 . . . . 25.0 111.109 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -129.99 158.85 38.43 Favored 'General case' 0 C--O 1.28 2.676 1 N-CA-C 97.988 -4.819 . . . . 25.0 97.988 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 t -147.23 155.04 41.73 Favored 'General case' 0 CA--C 1.476 -1.886 0 CA-C-N 119.68 1.127 . . . . 25.0 111.108 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.22 162.26 28.27 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 105.162 -2.162 . . . . 50.0 105.162 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 t -116.51 -9.2 11.45 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-N 120.244 1.383 . . . . 25.0 113.107 167.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.6 31.29 Favored Pre-proline 0 CA--C 1.481 -1.687 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 168.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.01 155.88 61.03 Favored 'Trans proline' 0 CA--C 1.486 -1.887 1 C-N-CA 113.032 -4.179 . . . . 25.0 116.586 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -86.02 156.56 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 104.601 -2.37 . . . . 25.0 104.601 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -80.16 132.22 35.87 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.762 -2.31 . . . . 25.0 104.762 166.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 m -152.48 153.59 33.8 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 116.039 -1.934 . . . . 25.0 109.542 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 p -114.66 -43.27 3.17 Favored 'General case' 0 C--O 1.275 2.43 0 C-N-CA 125.201 1.401 . . . . 25.0 108.76 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -151.16 144.6 24.87 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 117.911 -2.993 . . . . 25.0 110.766 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . 0.262 51.5 p-90 -114.45 150.01 35.4 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 117.902 -1.519 . . . . 25.0 112.403 166.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -136.17 150.28 48.97 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 103.885 -2.635 . . . . 25.0 103.885 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . 0.252 7.1 p90 -147.23 149.4 32.83 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 106.12 -1.808 . . . . 50.0 106.12 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -152.98 163.54 39.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.42 -1.696 . . . . 50.0 106.42 -157.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.02 167.3 20.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 115.529 -2.177 . . . . 25.0 107.657 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.4 p -96.69 157.95 15.66 Favored 'General case' 0 C--O 1.203 -1.373 0 O-C-N 125.718 1.886 . . . . 25.0 109.298 170.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -74.03 92.02 2.11 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 111.292 -2.685 . . . . 25.0 114.274 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.99 113.93 2.11 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 126.457 2.348 . . . . 25.0 114.323 165.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.13 35.47 9.7 Favored Glycine 0 C--O 1.25 1.131 0 CA-C-N 115.05 -0.977 . . . . 25.0 114.097 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 162.4 28.81 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 113.603 -1.299 . . . . 25.0 112.75 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.15 143.83 40.02 Favored Pre-proline 0 C--O 1.194 -1.867 0 CA-C-N 115.518 -0.764 . . . . 25.0 109.394 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 108' ' ' LYS . 72.4 Cg_endo -75.62 -18.18 17.64 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 114.85 -2.967 . . . . 25.0 118.82 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -83.69 9.2 12.26 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 118.779 -2.451 . . . . 75.0 109.172 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 106' ' ' PRO . 84.9 mttt -128.0 169.74 11.9 Favored Pre-proline 0 C--O 1.285 2.954 0 N-CA-C 101.74 -3.43 . . . . 25.0 101.74 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -55.66 28.21 0.02 OUTLIER 'Trans proline' 0 C--O 1.243 0.753 1 C-N-CA 129.121 6.547 . . . . 25.0 122.359 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.95 -40.15 66.56 Favored 'General case' 0 C--O 1.197 -1.659 0 CA-C-N 119.773 1.17 . . . . 50.0 112.939 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -85.34 -5.7 59.29 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 115.938 1.829 . . . . 25.0 115.938 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -111.37 -66.54 1.07 Allowed 'General case' 0 CA--C 1.475 -1.937 0 O-C-N 119.978 -1.701 . . . . 25.0 107.927 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.24 54.02 1.2 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.516 2.326 . . . . 25.0 109.251 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . 0.251 9.9 t0 -60.68 -42.24 96.73 Favored 'General case' 0 CA--C 1.596 2.746 0 CA-C-N 110.099 -3.228 . . . . 25.0 110.267 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 126.172 2.17 . . . . 50.0 112.428 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -141.8 129.52 21.62 Favored 'General case' 0 C--O 1.195 -1.774 0 O-C-N 126.364 2.29 . . . . 25.0 112.057 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.06 129.94 41.52 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 115.192 -2.337 . . . . 50.0 110.685 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.4 tt -105.59 -20.5 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 122.114 2.233 . . . . 25.0 106.797 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.65 161.36 27.22 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 120.567 -0.825 . . . . 25.0 114.566 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.5 133.4 14.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 123.0 1.381 . . . . 25.0 111.064 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.76 97.61 38.46 Favored Pre-proline 0 N--CA 1.499 1.982 0 CA-C-N 112.552 -2.113 . . . . 50.0 111.228 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.99 152.73 76.53 Favored 'Trans proline' 0 C--N 1.347 0.479 0 N-CA-C 116.79 1.804 . . . . 25.0 116.79 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -79.09 69.31 5.25 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.702 1.251 . . . . 25.0 111.222 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.588 ' N ' ' HG ' ' A' ' 129' ' ' SER . 65.3 m-20 -74.95 -31.32 61.46 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 119.341 -2.099 . . . . 50.0 113.089 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.17 -5.26 71.53 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-O 117.94 -1.478 . . . . 25.0 113.89 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.0 p -71.7 166.19 42.24 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 126.429 1.899 . . . . 25.0 109.054 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.29 -10.94 26.36 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 116.23 -2.046 . . . . 25.0 117.039 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.4 -30.8 42.56 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 121.616 -0.677 . . . . 25.0 109.21 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.588 ' HG ' ' N ' ' A' ' 124' ' ' ASP . 48.0 t -74.87 -44.86 46.7 Favored 'General case' 0 C--O 1.285 2.936 0 CA-C-O 124.141 1.924 . . . . 25.0 108.086 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -64.01 -23.96 67.53 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 111.941 -2.39 . . . . 25.0 113.799 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.25 109.19 12.16 Favored 'General case' 0 CA--C 1.58 2.115 0 O-C-N 124.99 1.431 . . . . 25.0 110.38 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.1 tp -83.35 -33.78 25.76 Favored 'General case' 0 C--O 1.193 -1.901 0 C-N-CA 127.214 2.206 . . . . 75.0 108.17 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -80.36 128.27 33.37 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 115.987 -2.285 . . . . 25.0 108.45 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -124.44 153.86 41.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 125.314 1.634 . . . . 25.0 114.327 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -98.59 148.55 23.67 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.6 mt -142.27 129.2 19.38 Favored 'Isoleucine or valine' 0 C--O 1.264 1.818 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -75.95 120.11 20.84 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 120.401 -1.437 . . . . 50.0 113.135 169.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.53 122.81 44.96 Favored Pre-proline 0 C--O 1.206 -1.227 0 N-CA-C 101.918 -3.364 . . . . 25.0 101.918 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -61.43 153.2 67.73 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 123.775 1.408 . . . . 25.0 109.805 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -110.35 -0.09 17.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 119.566 -1.959 . . . . 25.0 112.493 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.91 -8.36 57.33 Favored 'General case' 0 C--O 1.265 1.896 0 N-CA-C 116.583 2.068 . . . . 50.0 116.583 -172.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -133.92 151.38 51.47 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 116.798 2.147 . . . . 25.0 116.798 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.0 155.73 17.54 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.56 1.544 . . . . 50.0 107.676 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.17 157.01 10.08 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 123.371 4.108 . . . . 25.0 123.371 172.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.68 146.0 31.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 123.09 1.424 . . . . 50.0 113.494 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.11 159.14 43.72 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.12 -1.4 . . . . 25.0 109.913 162.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.71 142.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 O-C-N 125.233 1.583 . . . . 50.0 108.156 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 mt -109.85 134.66 51.27 Favored 'Isoleucine or valine' 0 C--O 1.25 1.105 0 CA-C-O 118.201 -0.904 . . . . 25.0 109.76 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.24 155.39 35.96 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 124.913 2.292 . . . . 50.0 108.27 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.6 153.77 48.66 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 118.998 -2.313 . . . . 25.0 109.277 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.86 118.52 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 128.707 2.803 . . . . 50.0 106.29 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -107.63 88.25 2.69 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 126.36 2.287 . . . . 25.0 107.106 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.36 141.69 39.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.158 -1.589 . . . . 25.0 111.832 -163.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.02 123.77 59.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-O 116.991 -1.48 . . . . 50.0 112.464 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.94 20.07 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 120.231 1.378 . . . . 25.0 111.671 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.52 -20.84 65.49 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -124.51 159.88 29.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.932 1.456 . . . . 25.0 114.932 -173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.04 -39.7 87.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 116.61 2.078 . . . . 25.0 116.61 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -91.87 160.55 15.24 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 118.508 -0.758 . . . . 25.0 112.299 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.57 159.9 40.93 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 101.221 -3.622 . . . . 25.0 101.221 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -90.99 153.36 20.21 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 124.379 1.071 . . . . 50.0 108.538 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -136.95 164.71 27.7 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.849 -1.94 . . . . 50.0 111.021 164.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.54 133.38 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 111.991 -2.368 . . . . 75.0 115.557 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -135.33 136.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 124.091 1.901 . . . . 25.0 106.413 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . 0.284 22.3 t0 -102.92 150.43 23.53 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 101.246 -3.613 . . . . 25.0 101.246 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.409 ' HA ' ' H ' ' A' ' 73' ' ' HIS . 27.2 m -144.83 167.07 11.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 116.631 -1.652 . . . . 50.0 107.662 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -133.52 132.97 41.59 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.3 mt -126.12 117.12 22.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 107.813 -1.18 . . . . 50.0 107.813 -164.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.0 162.31 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 117.926 2.565 . . . . 50.0 117.926 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -69.84 160.93 30.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.235 1.814 . . . . 25.0 107.835 166.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.1 mttt . . . . . 0 C--O 1.266 1.953 0 N-CA-C 118.318 2.71 . . . . 25.0 118.318 -176.855 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 51.5 m80 . . . . . 1 N--CA 1.572 5.642 0 CA-C-O 120.832 0.349 . . . . 25.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.01 174.15 36.76 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-O 117.409 -1.773 . . . . 25.0 116.865 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -126.29 171.45 10.93 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 123.436 1.589 . . . . 50.0 107.703 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm -81.73 116.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 O-C-N 120.024 -1.672 . . . . 25.0 108.539 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.05 -40.92 30.06 Favored 'General case' 0 C--O 1.268 2.058 0 CA-C-N 115.424 -0.807 . . . . 25.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -154.55 136.34 9.36 Favored Pre-proline 0 C--O 1.199 -1.599 0 N-CA-C 105.183 -2.154 . . . . 25.0 105.183 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.03 145.61 65.66 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 C-N-CA 130.698 1.541 . . . . 25.0 115.226 -1.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.32 170.31 50.47 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 120.916 -0.659 . . . . 25.0 111.758 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 84.7 p -70.28 162.18 28.96 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.314 2.339 . . . . 25.0 117.314 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -68.71 -3.45 12.16 Favored 'General case' 0 CA--C 1.581 2.16 0 CA-C-N 118.916 0.78 . . . . 25.0 110.471 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.23 -27.71 68.18 Favored 'General case' 0 C--O 1.197 -1.666 0 C-N-CA 118.949 -1.1 . . . . 25.0 110.911 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.82 91.84 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-O 122.962 1.363 . . . . 25.0 108.436 171.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 124.215 1.959 . . . . 75.0 115.634 -178.255 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.51 -0.562 0 CA-C-O 120.863 0.364 . . . . 25.0 111.905 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -74.55 -50.17 19.07 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.818 -1.537 . . . . 50.0 111.086 -162.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -143.41 63.39 12.49 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.742 -1.224 . . . . 25.0 112.38 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.74 -26.47 38.91 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 115.869 -2.287 . . . . 25.0 114.203 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -60.01 -9.81 3.53 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.024 2.602 . . . . 25.0 118.024 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -74.91 -5.47 43.91 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 116.633 -1.651 . . . . 25.0 113.236 -168.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.0 122.58 25.11 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 120.6 1.545 . . . . 50.0 112.807 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -136.2 165.17 26.36 Favored 'General case' 0 C--O 1.261 1.691 0 N-CA-C 114.87 1.433 . . . . 25.0 114.87 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.92 143.96 30.83 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 160.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -87.92 158.58 18.65 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 103.514 -2.772 . . . . 25.0 103.514 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.2 mttp . . . . . 0 C--O 1.29 3.186 0 CA-C-O 123.316 1.531 . . . . 25.0 106.982 170.341 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 60' ' ' GLY . 29.6 mt . . . . . 0 C--O 1.199 -1.604 0 CA-C-O 118.163 -0.923 . . . . 50.0 112.992 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -69.82 -25.59 63.84 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 101.253 -3.61 . . . . 50.0 101.253 157.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.43 -15.45 80.33 Favored Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.804 -1.553 . . . . 25.0 110.433 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 57' ' ' LEU . . . -66.48 -29.85 75.51 Favored Glycine 0 CA--C 1.493 -1.342 0 O-C-N 126.954 2.208 . . . . 25.0 113.081 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.51 -42.08 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 O-C-N 119.805 -1.997 . . . . 25.0 111.985 174.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.44 -23.94 50.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.83 -1.174 . . . . 75.0 107.83 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.7 -31.2 64.84 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.73 1.252 . . . . 50.0 113.216 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -89.93 35.48 0.85 Allowed 'General case' 0 C--O 1.161 -3.556 0 CA-C-N 114.167 -1.379 . . . . 25.0 111.059 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -159.7 50.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 100.432 -3.914 . . . . 25.0 100.432 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.8 t -140.69 179.58 6.61 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 102.081 -3.303 . . . . 25.0 102.081 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.55 -31.55 65.36 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 123.677 2.944 . . . . 25.0 111.478 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.89 21.59 0.84 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 116.945 -1.503 . . . . 25.0 114.549 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -60.8 90.25 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.809 2.444 . . . . 25.0 106.014 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -17.25 131.03 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.5 2 CA-C-N 106.614 -4.812 . . . . 25.0 118.806 171.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -68.93 142.86 54.61 Favored 'General case' 0 CA--C 1.476 -1.901 0 N-CA-C 117.733 2.494 . . . . 50.0 117.733 -160.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -112.76 147.2 37.37 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.046 1.748 . . . . 25.0 108.496 -166.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -122.84 137.61 54.88 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-O 116.493 -1.718 . . . . 25.0 108.451 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.0 mt -96.47 119.49 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 105.585 -2.006 . . . . 25.0 105.585 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.8 mtp -128.1 174.63 9.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.824 1.249 . . . . 25.0 111.718 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -112.54 171.16 7.69 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.434 1.493 . . . . 25.0 110.147 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.67 170.42 53.21 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 105.997 -2.841 . . . . 25.0 105.997 171.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.14 178.21 15.4 Favored Glycine 0 C--N 1.285 -2.302 2 O-C-N 115.882 -4.305 . . . . 25.0 109.614 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.81 137.32 51.72 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 127.645 2.615 . . . . 25.0 113.651 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -110.74 134.93 52.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 111.765 -2.47 . . . . 25.0 106.189 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -92.18 134.03 35.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 117.56 -3.212 . . . . 25.0 112.948 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.85 127.0 50.03 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 118.829 -2.419 . . . . 50.0 109.371 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.0 m -140.22 126.93 20.43 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.415 -1.328 . . . . 25.0 107.415 -167.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -104.05 162.95 12.72 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 128.938 3.899 . . . . 25.0 109.014 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 t -149.29 146.47 27.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 103.331 -2.84 . . . . 25.0 103.331 165.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.48 143.07 49.46 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 127.123 2.169 . . . . 50.0 111.42 173.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -96.77 -5.16 39.2 Favored 'General case' 0 C--O 1.27 2.169 0 C-N-CA 127.072 2.149 . . . . 25.0 115.173 -168.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.87 137.57 12.59 Favored Pre-proline 0 N--CA 1.481 1.112 0 N-CA-C 103.529 -2.767 . . . . 25.0 103.529 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.5 137.78 61.7 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 115.404 -2.597 . . . . 25.0 116.167 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -148.03 169.2 20.45 Favored 'General case' 0 CA--C 1.557 1.222 1 N-CA-C 99.761 -4.163 . . . . 25.0 99.761 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -111.57 113.11 25.3 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 123.744 1.735 . . . . 25.0 108.402 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.673 ' HG1' ' HE1' ' A' ' 152' ' ' TRP . 15.9 m -71.98 136.02 46.62 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 113.094 -1.866 . . . . 25.0 111.847 172.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 -47.13 5.44 Favored 'General case' 0 C--O 1.274 2.376 0 CA-C-O 122.722 1.248 . . . . 25.0 112.624 167.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.24 159.01 44.75 Favored 'General case' 0 C--O 1.219 -0.547 1 O-C-N 116.011 -4.18 . . . . 25.0 102.242 175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -142.06 152.03 42.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 116.821 -1.952 . . . . 25.0 112.604 160.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -129.1 151.58 49.62 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 126.425 1.89 . . . . 25.0 109.771 -156.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.68 147.17 50.05 Favored 'General case' 0 C--O 1.194 -1.834 0 O-C-N 123.498 0.499 . . . . 50.0 111.311 156.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.31 163.02 28.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 104.286 -2.487 . . . . 50.0 104.286 172.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.79 133.55 67.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 163.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -73.48 131.94 42.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 101.88 -3.378 . . . . 25.0 101.88 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -87.27 104.41 16.37 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 125.8 2.714 . . . . 25.0 105.753 -169.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.08 113.25 1.46 Allowed 'General case' 0 C--O 1.279 2.607 0 O-C-N 119.233 -2.167 . . . . 25.0 110.341 153.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.88 40.21 7.72 Favored Glycine 0 C--O 1.181 -3.162 0 C-N-CA 116.912 -2.566 . . . . 25.0 108.837 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -55.87 160.63 2.59 Favored 'General case' 0 CA--C 1.579 2.063 0 O-C-N 120.376 -1.661 . . . . 25.0 109.851 168.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -80.71 117.12 66.46 Favored Pre-proline 0 C--O 1.266 1.933 0 N-CA-C 102.596 -3.113 . . . . 25.0 102.596 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.11 -25.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 N-CA-C 116.36 1.638 . . . . 25.0 116.36 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.33 -6.19 57.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 112.217 -2.265 . . . . 75.0 106.111 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.55 150.9 46.36 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 114.847 -2.501 . . . . 25.0 110.027 -171.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.294 0.0 OUTLIER -2.52 87.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.264 1.794 2 C-N-CA 125.642 4.228 . . . . 25.0 122.698 176.045 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.57 -34.12 72.3 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 110.301 -3.136 . . . . 50.0 109.595 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -87.81 -10.05 52.04 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.695 2.109 . . . . 25.0 116.695 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.84 -38.41 0.64 Allowed 'General case' 0 C--O 1.185 -2.308 0 N-CA-C 121.468 3.877 . . . . 25.0 121.468 -170.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.6 -9.63 59.44 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 117.18 -3.45 . . . . 25.0 111.871 171.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.63 4.98 10.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.378 -0.929 . . . . 25.0 112.849 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.62 167.33 22.18 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.755 0.788 . . . . 50.0 112.782 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -117.73 141.83 47.95 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.193 160.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 tp -67.33 132.09 47.01 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.319 -2.104 . . . . 50.0 105.319 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 tt -110.97 -14.2 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 118.928 2.936 . . . . 25.0 118.928 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.82 165.69 30.9 Favored Glycine 0 C--O 1.212 -1.269 0 CA-C-O 115.217 -2.991 . . . . 25.0 112.43 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.36 21.88 Favored 'General case' 0 N--CA 1.418 -2.054 0 O-C-N 126.025 1.662 . . . . 25.0 108.329 168.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.38 101.02 28.42 Favored Pre-proline 0 C--N 1.312 -1.059 0 C-N-CA 125.473 1.509 . . . . 50.0 111.892 -170.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.64 170.47 8.94 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 115.752 -2.365 . . . . 25.0 113.607 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -97.31 78.27 2.71 Favored 'General case' 0 C--O 1.175 -2.851 0 CA-C-O 115.959 -1.972 . . . . 25.0 108.546 167.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.47 37.47 1.22 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.21 1.481 . . . . 50.0 110.596 -158.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.59 35.01 17.86 Favored Glycine 0 C--O 1.263 1.92 0 N-CA-C 108.834 -1.706 . . . . 25.0 108.834 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.4 m -75.3 147.01 82.27 Favored Pre-proline 0 C--O 1.263 1.796 0 N-CA-C 117.558 2.429 . . . . 25.0 117.558 -154.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HG2' ' HG ' ' A' ' 129' ' ' SER . 72.7 Cg_endo -72.28 177.28 7.48 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 115.564 -2.491 . . . . 25.0 109.267 170.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.06 6.2 0.99 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.836 2.162 . . . . 25.0 116.836 -167.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.429 ' HG ' ' HG2' ' A' ' 127' ' ' PRO . 89.4 p -68.05 -4.44 13.45 Favored 'General case' 0 C--O 1.182 -2.494 0 CA-C-N 114.299 -1.318 . . . . 25.0 109.29 163.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.2 ttp85 -69.88 -16.52 63.25 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 114.154 1.168 . . . . 25.0 114.154 167.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -52.44 133.25 35.35 Favored 'General case' 0 C--O 1.191 -1.995 0 CA-C-O 121.905 0.859 . . . . 25.0 108.732 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -70.66 -13.12 61.95 Favored 'General case' 0 C--O 1.187 -2.197 0 CA-C-O 123.466 1.603 . . . . 75.0 111.504 -161.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.8 t -98.0 141.62 30.74 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 118.487 -2.633 . . . . 25.0 110.405 163.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -132.59 157.16 45.44 Favored 'General case' 0 C--O 1.161 -3.559 0 N-CA-C 103.376 -2.824 . . . . 25.0 103.376 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -120.9 148.45 44.03 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 100.863 -3.754 . . . . 25.0 100.863 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 50.6 mm -129.78 125.69 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -79.76 136.77 36.83 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.94 -0.475 . . . . 50.0 109.853 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.2 mm -125.96 119.76 23.99 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 126.623 2.452 . . . . 25.0 109.403 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.25 159.83 33.02 Favored 'Trans proline' 0 C--N 1.359 1.131 1 C-N-CA 113.288 -4.008 . . . . 25.0 115.353 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.51 43.45 1.1 Allowed 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 122.906 1.336 . . . . 25.0 110.833 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.23 -42.51 99.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 111.089 -2.778 . . . . 50.0 114.351 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -149.47 154.2 38.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.897 1.679 . . . . 25.0 108.742 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.25 154.81 34.9 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.859 -1.534 . . . . 50.0 106.859 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.25 168.02 11.95 Favored Glycine 0 C--N 1.364 2.104 0 O-C-N 126.224 2.202 . . . . 25.0 118.177 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.26 153.52 41.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 117.697 2.48 . . . . 50.0 117.697 -165.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.96 147.09 39.99 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 120.879 -1.138 . . . . 25.0 109.392 160.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.48 133.81 46.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 N-CA-C 103.852 -2.647 . . . . 50.0 103.852 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.81 137.92 31.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 103.962 -2.607 . . . . 25.0 103.962 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.6 mt -122.82 145.77 48.13 Favored 'General case' 0 C--O 1.184 -2.351 0 N-CA-C 104.681 -2.34 . . . . 50.0 104.681 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.22 156.48 44.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 117.983 -1.008 . . . . 25.0 110.344 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.5 132.63 31.63 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 O-C-N 127.715 3.134 . . . . 50.0 105.793 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.673 ' HE1' ' HG1' ' A' ' 92' ' ' THR . 14.8 t90 -105.4 130.69 53.45 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 104.131 -2.544 . . . . 25.0 104.131 170.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -103.71 126.8 51.08 Favored 'General case' 0 C--O 1.264 1.835 0 O-C-N 118.751 -2.468 . . . . 25.0 104.962 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.06 133.06 64.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 O-C-N 116.656 -3.778 . . . . 50.0 107.823 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.25 -11.73 59.7 Favored 'General case' 0 C--O 1.178 -2.698 0 O-C-N 121.337 -0.852 . . . . 25.0 110.791 -171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -35.53 81.41 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.078 1.894 . . . . 25.0 114.077 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.2 p -143.79 159.82 41.84 Favored 'General case' 0 C--O 1.274 2.393 0 O-C-N 120.924 -1.11 . . . . 25.0 112.089 -164.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -76.98 -23.98 52.28 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.999 -1.111 . . . . 25.0 107.999 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.49 151.85 45.54 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.041 -0.981 . . . . 25.0 110.85 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -123.9 159.0 30.65 Favored 'General case' 0 C--O 1.27 2.182 0 N-CA-C 102.039 -3.319 . . . . 25.0 102.039 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -111.72 154.41 25.04 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 104.31 -2.478 . . . . 50.0 104.31 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.36 149.48 50.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 110.971 -2.831 . . . . 50.0 106.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -133.74 129.85 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.253 33.9 m -121.73 135.37 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 117.576 -3.203 . . . . 75.0 112.99 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 95.8 mt -135.64 132.59 51.47 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 105.07 -2.196 . . . . 25.0 105.07 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -104.7 141.4 36.53 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 106.118 -1.808 . . . . 25.0 106.118 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.92 149.25 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 107.725 -1.213 . . . . 50.0 107.725 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.42 94.43 4.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 118.26 20.96 Favored 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 125.161 1.384 . . . . 50.0 108.333 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.1 m -117.5 157.84 18.47 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-O 124.448 2.071 . . . . 50.0 108.501 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -91.64 162.55 14.45 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 111.252 -2.703 . . . . 25.0 106.401 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 CA--C 1.565 1.548 0 O-C-N 118.742 -2.474 . . . . 25.0 108.166 166.94 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 N--CA 1.517 2.9 0 CA-C-O 123.532 1.634 . . . . 25.0 113.724 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.46 -174.81 24.92 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 125.074 2.486 . . . . 25.0 111.921 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.59 161.95 39.43 Favored 'General case' 0 CA--C 1.47 -2.113 0 CA-C-N 110.77 -2.715 . . . . 50.0 108.891 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 mt -97.8 123.52 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 N-CA-C 103.805 -2.665 . . . . 25.0 103.805 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.35 -38.93 18.22 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 119.609 -1.932 . . . . 25.0 111.383 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -136.45 160.01 68.4 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 118.005 -0.998 . . . . 25.0 110.169 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.13 141.4 62.24 Favored 'Cis proline' 0 CA--C 1.477 -2.327 0 C-N-CA 133.479 2.7 . . . . 25.0 114.386 -1.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.36 -168.66 45.16 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 119.253 2.461 . . . . 25.0 119.253 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t -145.92 156.17 43.35 Favored 'General case' 0 C--O 1.266 1.944 0 CA-C-N 119.196 1.498 . . . . 25.0 107.7 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -79.25 -8.46 59.06 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.87 1.319 . . . . 25.0 109.917 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.47 -29.47 64.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.428 -0.795 . . . . 25.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.13 -27.84 67.65 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 118.686 2.847 . . . . 25.0 118.686 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--N 1.306 -1.288 0 O-C-N 125.903 2.002 . . . . 75.0 111.554 -178.382 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.0 ptp . . . . . 0 N--CA 1.439 -1.01 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -101.47 -46.08 5.1 Favored 'General case' 0 CA--C 1.485 -1.529 0 O-C-N 120.908 -1.12 . . . . 50.0 110.452 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -114.3 79.06 4.93 Favored Pre-proline 0 C--O 1.264 1.826 0 N-CA-C 115.654 1.724 . . . . 25.0 115.654 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.18 -20.77 8.35 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 114.958 1.099 . . . . 25.0 114.958 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -127.5 2.36 6.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 120.25 3.426 . . . . 25.0 120.25 -161.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 49.55 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.006 -1.059 . . . . 25.0 108.163 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.59 79.92 8.16 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.42 0.628 . . . . 50.0 111.679 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -135.76 150.98 49.68 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 116.819 -1.563 . . . . 25.0 110.71 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.02 166.52 25.83 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.414 -3.18 . . . . 25.0 102.414 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -93.23 142.56 27.18 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 117.345 -1.742 . . . . 25.0 111.714 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mttt . . . . . 0 C--O 1.205 -1.272 0 C-N-CA 119.472 -0.891 . . . . 25.0 109.112 175.89 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 CA--C 1.475 -1.91 0 N-CA-C 114.715 1.376 . . . . 50.0 114.715 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.09 -34.99 69.09 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.775 -1.935 . . . . 50.0 105.775 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -11.3 85.26 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-O 122.805 1.225 . . . . 25.0 110.245 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.6 -29.9 76.21 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 123.85 1.805 . . . . 25.0 114.599 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -74.92 -39.19 44.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 O-C-N 119.986 -1.89 . . . . 25.0 107.111 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -68.88 -27.8 66.12 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 119.269 -2.144 . . . . 75.0 109.783 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 -27.6 67.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.521 -1.362 . . . . 50.0 110.843 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -80.09 3.7 19.53 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 120.574 -1.329 . . . . 25.0 107.641 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -128.45 43.85 3.06 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.122 -2.918 . . . . 25.0 103.122 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 t -134.9 161.14 36.08 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.563 -1.336 . . . . 25.0 109.799 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.17 -29.02 68.41 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-N 114.45 -1.25 . . . . 25.0 111.553 161.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -72.65 0.39 10.77 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.911 1.449 . . . . 25.0 114.911 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -76.13 93.33 3.32 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 103.755 -2.683 . . . . 25.0 103.755 169.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -45.29 153.83 0.2 Allowed 'General case' 0 C--O 1.263 1.791 0 CA-C-N 111.411 -2.631 . . . . 25.0 107.972 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -56.19 136.17 52.93 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 115.247 1.573 . . . . 50.0 115.247 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -94.32 156.24 16.61 Favored 'General case' 0 N--CA 1.528 3.444 0 CA-C-O 117.399 -1.286 . . . . 25.0 112.886 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -153.8 151.95 30.14 Favored 'General case' 0 C--O 1.26 1.65 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 tt -87.43 135.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtp -144.56 -172.76 3.87 Favored 'General case' 0 C--O 1.186 -2.255 0 CA-C-O 123.06 1.409 . . . . 25.0 109.029 -171.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 p -127.37 172.65 10.45 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 104.61 -2.367 . . . . 25.0 104.61 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.61 -178.26 25.2 Favored Glycine 0 CA--C 1.542 1.754 0 O-C-N 124.692 1.245 . . . . 25.0 112.754 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.54 -156.3 30.29 Favored Glycine 0 CA--C 1.559 2.83 0 CA-C-O 115.697 -2.724 . . . . 25.0 111.032 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -72.64 143.33 48.2 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 120.472 3.508 . . . . 25.0 120.472 -171.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -125.5 143.51 50.97 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 101.51 -3.515 . . . . 25.0 101.51 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.7 m -99.11 127.21 45.03 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 105.331 -2.1 . . . . 25.0 105.331 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.61 128.44 55.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 104.191 -2.522 . . . . 50.0 104.191 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.2 m -134.2 109.13 8.67 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 105.4 -2.074 . . . . 25.0 105.4 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -83.31 149.75 26.56 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.641 -1.163 . . . . 25.0 107.896 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.3 t -142.54 122.68 13.76 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 120.922 1.692 . . . . 25.0 109.652 173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.73 143.27 39.76 Favored 'General case' 0 N--CA 1.423 -1.782 0 O-C-N 119.503 -1.998 . . . . 50.0 113.987 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -91.43 -12.67 34.05 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.487 -2.142 . . . . 25.0 110.433 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.18 143.76 25.9 Favored Pre-proline 0 C--O 1.273 2.315 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 168.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.08 140.88 25.75 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 124.078 3.185 . . . . 25.0 117.732 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -138.6 151.4 47.23 Favored 'General case' 0 CA--C 1.55 0.958 1 N-CA-C 97.77 -4.9 . . . . 25.0 97.77 172.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . 0.254 67.2 m-80 -78.68 109.69 13.14 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 121.998 2.181 . . . . 25.0 113.772 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.406 HG21 ' CE3' ' A' ' 95' ' ' TRP . 7.9 m -79.38 135.69 36.77 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 123.684 1.707 . . . . 25.0 109.729 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.3 p -80.59 -50.11 10.41 Favored 'General case' 0 CA--C 1.571 1.759 0 O-C-N 116.632 -3.792 . . . . 25.0 106.706 171.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -164.27 173.88 11.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 127.084 2.154 . . . . 25.0 113.513 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.406 ' CE3' HG21 ' A' ' 92' ' ' THR . 37.6 p90 -143.32 158.36 43.7 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.098 -1.002 . . . . 25.0 112.767 164.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -133.84 155.25 50.18 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -150.14 149.93 30.95 Favored 'General case' 0 C--O 1.283 2.867 0 CA-C-N 120.789 1.631 . . . . 50.0 114.137 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.64 158.35 44.26 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.632 1.573 . . . . 50.0 109.929 -157.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.22 159.88 13.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 164.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 p -71.82 155.71 40.12 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.648 1.217 . . . . 25.0 110.783 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -124.04 113.07 17.91 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.653 -1.279 . . . . 25.0 113.821 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.08 161.23 8.84 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 114.461 -2.685 . . . . 25.0 110.384 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.1 -0.16 47.74 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 122.827 2.558 . . . . 25.0 115.427 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -59.51 159.05 8.74 Favored 'General case' 0 C--O 1.271 2.199 0 N-CA-C 113.892 1.071 . . . . 25.0 113.892 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -160.77 144.02 9.86 Favored Pre-proline 0 C--O 1.193 -1.916 0 N-CA-C 104.486 -2.412 . . . . 25.0 104.486 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -69.87 -15.94 36.89 Favored 'Trans proline' 0 C--O 1.177 -2.528 0 C-N-CA 114.003 -3.532 . . . . 25.0 119.594 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.84 -21.19 65.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.918 1.818 . . . . 75.0 109.131 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -99.47 163.54 18.36 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 103.384 -2.821 . . . . 25.0 103.384 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -32.37 30.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.249 1 C-N-CA 129.759 6.973 . . . . 25.0 121.64 154.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -40.39 60.26 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 115.922 -1.989 . . . . 50.0 114.794 -175.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -75.59 -7.93 55.48 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 116.636 2.087 . . . . 25.0 116.636 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.413 ' C ' ' H ' ' A' ' 114' ' ' ASP . 51.8 mtp180 -120.08 -62.55 1.47 Allowed 'General case' 0 C--O 1.198 -1.621 0 O-C-N 121.25 -0.906 . . . . 25.0 112.441 -166.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.51 18.25 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 118.014 2.598 . . . . 25.0 118.014 163.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 112' ' ' ARG . 35.9 t0 -65.37 -26.51 68.04 Favored 'General case' 0 CA--C 1.483 -1.602 0 O-C-N 127.116 2.76 . . . . 25.0 109.65 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -141.07 160.52 39.9 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 103.586 -2.746 . . . . 50.0 103.586 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -129.95 135.15 47.99 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 106.65 -1.611 . . . . 25.0 106.65 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.64 145.48 54.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 104.173 -2.528 . . . . 50.0 104.173 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.7 tt -128.71 -12.52 2.94 Favored 'Isoleucine or valine' 0 C--O 1.263 1.783 0 CA-C-O 125.848 2.737 . . . . 25.0 112.252 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.75 167.12 37.85 Favored Glycine 0 C--O 1.268 2.234 0 CA-C-O 124.142 1.968 . . . . 25.0 112.266 168.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.84 161.29 40.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 112.991 -1.605 . . . . 25.0 107.968 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.49 111.68 15.16 Favored Pre-proline 0 C--O 1.207 -1.177 0 N-CA-C 104.124 -2.546 . . . . 50.0 104.124 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.4 162.05 36.67 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 117.144 -1.438 . . . . 25.0 110.885 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -120.11 49.6 1.39 Allowed 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.229 -1.767 . . . . 25.0 106.229 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -76.06 -32.34 59.24 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 112.38 -2.191 . . . . 50.0 110.133 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 172.04 -175.6 45.3 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 119.98 -1.7 . . . . 25.0 115.341 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 57.8 m 72.19 155.72 0.16 Allowed Pre-proline 0 CA--C 1.569 1.698 0 N-CA-C 117.658 2.466 . . . . 25.0 117.658 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.23 -3.33 13.64 Favored 'Trans proline' 0 CA--C 1.572 2.415 0 C-N-CA 115.642 -2.439 . . . . 25.0 113.38 -166.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.25 76.52 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 116.84 2.163 . . . . 25.0 116.84 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 83.8 p -80.81 -21.95 40.44 Favored 'General case' 0 C--O 1.273 2.314 0 CA-C-O 124.259 1.981 . . . . 25.0 110.894 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -72.81 -28.55 62.63 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.111 -1.859 . . . . 25.0 111.918 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.55 140.59 39.75 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.709 -3.071 . . . . 25.0 102.709 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mt -103.67 -38.63 7.02 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 124.346 2.022 . . . . 75.0 109.934 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 t -77.36 127.05 31.9 Favored 'General case' 0 N--CA 1.411 -2.421 0 O-C-N 120.361 -1.462 . . . . 25.0 108.392 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -140.04 156.43 46.61 Favored 'General case' 0 CA--C 1.488 -1.442 0 O-C-N 118.937 -2.352 . . . . 25.0 110.607 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -106.1 141.25 37.78 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 125.308 1.63 . . . . 25.0 107.893 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.91 121.13 46.38 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.187 0 C-N-CA 125.944 1.698 . . . . 25.0 109.995 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -82.47 126.14 31.9 Favored 'General case' 0 C--O 1.175 -2.82 0 CA-C-N 121.103 1.774 . . . . 50.0 106.667 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -110.79 123.56 35.22 Favored Pre-proline 0 C--O 1.265 1.879 0 N-CA-C 103.584 -2.747 . . . . 25.0 103.584 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.41 146.17 55.44 Favored 'Trans proline' 0 CA--C 1.585 3.037 0 C-N-CA 116.847 -1.635 . . . . 25.0 115.351 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.1 67.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 125.828 2.727 . . . . 25.0 104.879 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -62.92 -28.6 70.18 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 119.729 -1.857 . . . . 50.0 113.238 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -143.63 158.85 43.36 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.368 -1.716 . . . . 25.0 106.368 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.95 138.56 39.74 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 102.028 -3.323 . . . . 50.0 102.028 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 147.14 177.49 21.71 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 124.992 2.44 . . . . 25.0 116.18 -173.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 137.88 56.6 Favored 'General case' 0 C--O 1.192 -1.953 0 C-N-CA 126.287 1.835 . . . . 50.0 113.443 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -145.96 167.22 23.84 Favored 'General case' 0 C--O 1.255 1.355 0 C-N-CA 126.684 1.994 . . . . 25.0 109.017 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 t -124.16 144.47 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.425 -1.324 . . . . 50.0 107.425 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.16 113.05 43.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.303 -2.851 . . . . 25.0 103.303 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.56 153.06 21.66 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-N 119.029 0.831 . . . . 50.0 110.55 -170.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.52 136.95 23.86 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 120.515 -1.365 . . . . 25.0 109.416 -173.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.56 136.12 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.403 -0.919 . . . . 50.0 112.0 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -118.65 125.62 50.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.181 2.592 . . . . 25.0 104.893 -170.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -113.69 140.98 47.79 Favored 'General case' 0 C--O 1.269 2.109 0 O-C-N 125.679 1.862 . . . . 25.0 108.996 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.3 139.74 26.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 N-CA-C 104.914 -2.254 . . . . 50.0 104.914 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.6 -20.44 20.89 Favored 'General case' 0 C--O 1.196 -1.753 0 CA-C-N 112.324 -2.216 . . . . 25.0 112.149 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.27 -23.75 54.44 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.905 1.817 . . . . 25.0 115.905 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.2 p -145.3 -179.79 6.88 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 115.6 -2.143 . . . . 25.0 113.245 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -89.01 1.1 56.04 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-O 126.379 2.99 . . . . 25.0 113.014 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.43 158.54 31.26 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 119.781 -1.824 . . . . 25.0 112.739 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.75 159.35 29.99 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -145.42 158.24 43.87 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 124.648 2.166 . . . . 50.0 109.643 172.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -118.47 144.38 46.04 Favored 'General case' 0 C--O 1.193 -1.909 0 CA-C-N 110.824 -2.898 . . . . 50.0 104.101 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -141.51 138.04 32.49 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.312 -1.328 . . . . 25.0 107.886 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.61 156.49 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 120.596 1.543 . . . . 75.0 109.715 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.46 115.16 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.444 1.592 . . . . 25.0 108.322 172.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.18 118.65 22.06 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 117.155 -1.402 . . . . 25.0 108.618 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.88 156.48 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 120.466 1.484 . . . . 50.0 113.45 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -111.7 98.63 7.55 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 103.173 -2.899 . . . . 25.0 103.173 171.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.17 135.02 34.07 Favored 'General case' 0 N--CA 1.499 2.009 1 N-CA-C 99.734 -4.173 . . . . 50.0 99.734 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.01 169.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 119.564 -1.96 . . . . 50.0 113.67 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -59.8 139.42 57.32 Favored 'General case' 0 C--O 1.282 2.791 0 C-N-CA 119.23 -0.988 . . . . 25.0 109.814 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 CA--C 1.577 1.983 0 N-CA-C 115.756 1.762 . . . . 25.0 115.756 177.227 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.882 -1.056 . . . . 25.0 109.245 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.99 170.45 37.66 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 120.764 3.066 . . . . 25.0 120.764 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -136.49 151.79 49.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.818 1.784 . . . . 50.0 115.818 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.28 139.17 20.32 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 101.181 -3.636 . . . . 25.0 101.181 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -112.08 -28.14 8.11 Favored 'General case' 0 C--N 1.362 1.112 0 N-CA-C 113.519 0.933 . . . . 25.0 113.519 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -151.5 140.53 13.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 104.597 -2.371 . . . . 25.0 104.597 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.97 147.27 86.85 Favored 'Cis proline' 0 N--CA 1.499 1.834 0 CA-C-N 119.844 0.98 . . . . 25.0 114.53 -5.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.25 174.25 47.54 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.939 1.936 . . . . 25.0 117.939 161.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -131.62 141.45 49.64 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.472 1.909 . . . . 25.0 107.663 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -58.07 -31.5 67.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 115.105 1.52 . . . . 25.0 115.105 167.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.51 -35.05 70.62 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 125.961 2.038 . . . . 25.0 112.175 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.02 94.66 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.399 -0.813 . . . . 25.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.246 0.87 0 N-CA-C 108.302 -0.999 . . . . 75.0 108.302 -176.231 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.281 2.72 0 N-CA-C 117.563 2.431 . . . . 25.0 117.563 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -65.95 -46.75 77.0 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 123.304 2.775 . . . . 50.0 104.784 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.37 73.04 31.25 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 117.529 2.418 . . . . 25.0 117.529 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -71.57 -21.18 26.05 Favored 'Trans proline' 0 C--N 1.393 2.882 0 CA-C-O 122.863 1.11 . . . . 25.0 112.066 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -82.87 -1.22 51.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.345 1.545 . . . . 25.0 112.11 -171.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 t -76.33 -18.0 59.14 Favored 'General case' 0 C--O 1.285 2.961 0 CA-C-N 111.317 -2.674 . . . . 25.0 109.148 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.52 119.22 15.36 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.731 1.605 . . . . 50.0 108.486 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -152.68 176.34 11.86 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 105.151 -2.166 . . . . 25.0 105.151 -172.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.25 144.58 30.87 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 166.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -129.3 145.88 51.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.459 1.481 . . . . 25.0 109.616 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 C--O 1.199 -1.595 0 CA-C-N 113.435 -1.712 . . . . 25.0 109.738 169.519 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.505 2.279 0 N-CA-C 115.631 1.715 . . . . 50.0 115.631 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -78.26 -22.77 47.82 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 104.198 -2.519 . . . . 50.0 104.198 152.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.58 -18.6 77.38 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.356 -0.838 . . . . 25.0 111.385 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.3 -34.46 80.36 Favored Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 109.972 -1.251 . . . . 25.0 109.972 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 40.5 mt -61.93 -40.18 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 O-C-N 119.925 -1.926 . . . . 25.0 113.326 -175.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.04 -29.8 68.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 122.585 1.183 . . . . 75.0 109.576 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.66 -36.35 62.82 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 120.287 -1.508 . . . . 50.0 110.118 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -77.92 20.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 114.684 1.365 . . . . 25.0 114.684 166.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -147.12 40.99 1.07 Allowed 'General case' 0 C--O 1.264 1.822 0 CA-C-O 125.691 2.662 . . . . 25.0 110.097 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -137.63 -177.78 4.95 Favored 'General case' 0 CA--C 1.58 2.119 0 CA-C-N 112.325 -2.216 . . . . 25.0 115.064 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -60.09 -23.69 64.01 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 125.652 2.644 . . . . 25.0 114.789 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -93.03 18.26 9.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 118.894 -2.379 . . . . 25.0 109.599 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -70.12 90.05 0.65 Allowed 'General case' 0 C--O 1.287 3.044 0 CA-C-O 127.681 3.61 . . . . 25.0 108.581 170.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -52.48 160.91 0.76 Allowed 'General case' 0 C--O 1.272 2.241 0 CA-C-N 109.288 -3.596 . . . . 25.0 110.072 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -62.34 142.75 57.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.451 1.1 . . . . 50.0 113.755 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.8 143.58 26.58 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -117.56 125.36 50.69 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-N 123.005 2.639 . . . . 25.0 108.737 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mt -83.49 123.9 39.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 116.332 -0.395 . . . . 25.0 110.864 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.7 mtp -138.84 157.44 46.06 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.446 1.117 . . . . 25.0 110.217 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.4 p -89.28 179.25 6.15 Favored 'General case' 0 C--O 1.273 2.32 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.13 -170.1 29.58 Favored Glycine 0 C--O 1.194 -2.364 0 N-CA-C 110.195 -1.162 . . . . 25.0 110.195 163.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.76 179.12 46.22 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 118.736 -1.697 . . . . 25.0 115.978 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.45 149.17 36.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 119.228 -2.336 . . . . 25.0 108.549 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -129.12 157.09 42.74 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.208 -1.814 . . . . 25.0 107.93 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -120.89 157.84 28.96 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 127.078 2.736 . . . . 25.0 110.19 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -143.15 152.45 41.81 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.509 1.124 . . . . 50.0 108.534 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.0 m -137.93 141.93 40.58 Favored 'General case' 0 CA--C 1.426 -3.812 0 C-N-CA 125.304 1.442 . . . . 25.0 107.684 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -135.52 167.92 20.2 Favored 'General case' 0 C--O 1.262 1.741 1 N-CA-C 99.058 -4.423 . . . . 25.0 99.058 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -131.29 146.46 52.31 Favored 'General case' 0 C--O 1.278 2.587 0 N-CA-C 105.24 -2.133 . . . . 25.0 105.24 162.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -95.87 148.01 23.05 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-O 116.834 -1.555 . . . . 50.0 108.706 159.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -103.96 -24.5 13.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.521 1.964 . . . . 25.0 113.809 173.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 137.6 52.59 Favored Pre-proline 0 N--CA 1.425 -1.677 0 O-C-N 120.218 -1.551 . . . . 25.0 109.836 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -67.86 135.32 34.95 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 116.661 -1.759 . . . . 25.0 112.684 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -152.39 169.49 22.43 Favored 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.538 -2.023 . . . . 25.0 105.538 -163.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -127.58 96.21 4.47 Favored 'General case' 0 C--O 1.273 2.291 0 CA-C-O 118.186 -0.912 . . . . 25.0 108.961 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.2 m -65.4 143.22 57.87 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 120.943 1.701 . . . . 25.0 108.99 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 p -105.76 -48.79 3.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 116.46 2.022 . . . . 25.0 116.46 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -162.93 172.42 15.11 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 120.703 1.592 . . . . 25.0 110.748 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.28 149.05 32.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.442 1.019 . . . . 25.0 113.445 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -122.73 157.68 31.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 114.388 -2.72 . . . . 25.0 110.884 -170.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.638 ' HH ' ' CE1' ' A' ' 134' ' ' HIS . 0.7 OUTLIER -155.06 128.84 8.64 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 125.32 2.486 . . . . 50.0 109.339 178.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -142.02 147.17 36.44 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 112.66 -2.064 . . . . 50.0 110.067 -168.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.1 163.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 124.071 0.948 . . . . 25.0 110.387 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 p -62.61 156.51 23.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 116.964 -1.493 . . . . 25.0 111.819 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -91.5 97.95 11.38 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 124.373 2.035 . . . . 25.0 111.404 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -56.86 154.04 9.97 Favored 'General case' 0 C--O 1.187 -2.198 0 O-C-N 117.213 -3.43 . . . . 25.0 113.782 159.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 3.03 50.34 Favored Glycine 0 CA--C 1.545 1.963 0 N-CA-C 120.454 2.941 . . . . 25.0 120.454 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.8 169.17 0.1 Allowed 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.02 1.41 . . . . 25.0 112.611 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.08 130.62 9.4 Favored Pre-proline 0 C--N 1.31 -1.114 0 N-CA-C 102.996 -2.965 . . . . 25.0 102.996 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -59.3 -31.53 95.23 Favored 'Trans proline' 0 C--N 1.373 1.848 0 N-CA-C 116.037 1.514 . . . . 25.0 116.037 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -76.81 -1.74 29.76 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 125.051 1.469 . . . . 75.0 112.186 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -121.15 -176.83 0.43 Allowed Pre-proline 0 CA--C 1.584 2.288 1 N-CA-C 100.053 -4.054 . . . . 25.0 100.053 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -55.49 16.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.477 -2.362 2 C-N-CA 126.754 4.969 . . . . 25.0 123.235 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.97 -39.91 20.79 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 124.828 3.467 . . . . 50.0 119.171 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -77.22 -20.02 55.86 Favored 'General case' 0 C--O 1.194 -1.823 0 O-C-N 120.242 -1.536 . . . . 25.0 110.867 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -91.73 -53.53 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.424 -1.423 . . . . 25.0 112.033 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.4 42.98 0.85 Allowed 'General case' 0 C--N 1.319 -0.76 0 O-C-N 119.343 -2.098 . . . . 25.0 110.527 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.92 -31.37 70.89 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 125.613 1.565 . . . . 25.0 112.434 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 146.13 47.77 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 125.318 2.485 . . . . 50.0 109.46 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -129.89 132.47 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.138 -1.601 . . . . 25.0 107.249 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.1 tp -73.56 141.04 46.67 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 100.309 -3.96 . . . . 50.0 100.309 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.12 -14.43 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 25.0 112.035 166.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.42 -173.82 43.16 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 125.893 1.996 . . . . 25.0 114.793 159.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.35 153.7 30.88 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.164 -2.902 . . . . 25.0 103.164 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.17 122.01 5.67 Favored Pre-proline 0 C--O 1.259 1.598 0 CA-C-N 119.777 1.171 . . . . 50.0 108.292 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -75.57 164.06 32.99 Favored 'Trans proline' 0 CA--C 1.494 -1.509 0 C-N-CA 115.991 -2.206 . . . . 25.0 115.312 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -133.82 72.95 1.48 Allowed 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 128.353 2.661 . . . . 25.0 109.941 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -74.76 -24.26 58.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 118.643 2.831 . . . . 50.0 118.643 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -170.58 -92.44 0.08 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 127.723 3.14 . . . . 25.0 109.889 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 t -122.0 61.07 12.95 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 114.237 1.199 . . . . 25.0 114.237 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.542 ' HG2' ' HG ' ' A' ' 129' ' ' SER . 26.2 Cg_endo -86.65 -167.1 0.34 Allowed 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-O 124.047 1.603 . . . . 25.0 111.664 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.86 69.58 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 118.901 -2.375 . . . . 25.0 106.178 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.542 ' HG ' ' HG2' ' A' ' 127' ' ' PRO . 89.5 p -79.79 18.88 0.72 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 124.616 2.151 . . . . 25.0 109.314 176.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -73.39 -27.1 61.29 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 118.117 -2.865 . . . . 25.0 103.528 168.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.76 134.2 40.51 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 112.954 -1.93 . . . . 25.0 106.235 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 tp -87.65 -28.4 21.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.52 -1.659 . . . . 75.0 106.52 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . 0.281 44.8 t -71.68 139.86 49.39 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.874 -1.766 . . . . 25.0 110.654 173.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.638 ' CE1' ' HH ' ' A' ' 97' ' ' TYR . 24.7 t-80 -149.39 156.24 41.73 Favored 'General case' 0 C--O 1.273 2.331 0 N-CA-C 106.608 -1.627 . . . . 25.0 106.608 -164.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -97.81 140.53 32.04 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 115.757 -2.068 . . . . 25.0 115.056 170.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.9 mm -127.55 130.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 125.367 1.667 . . . . 25.0 107.624 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -87.96 129.35 35.27 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-O 123.737 1.732 . . . . 50.0 108.259 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.5 mm -107.63 124.75 34.03 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 112.691 -2.05 . . . . 25.0 106.809 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.27 151.44 76.57 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-O 124.498 1.791 . . . . 25.0 107.806 176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -116.73 29.71 7.77 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 111.124 -2.762 . . . . 25.0 112.457 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -75.02 -27.99 60.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.285 -2.234 . . . . 50.0 115.656 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -152.5 164.21 38.04 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 126.026 2.079 . . . . 25.0 106.799 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -83.56 158.75 21.84 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 106.953 -1.499 . . . . 50.0 106.953 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.31 121.99 0.59 Allowed Glycine 0 N--CA 1.481 1.683 0 N-CA-C 117.054 1.582 . . . . 25.0 117.054 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.04 139.19 58.18 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 114.279 1.214 . . . . 50.0 114.279 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -135.57 168.38 19.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 119.821 -1.799 . . . . 25.0 108.147 -169.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -112.4 139.09 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 102.1 -3.296 . . . . 50.0 102.1 162.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.9 129.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 118.635 0.652 . . . . 25.0 110.801 165.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.46 143.15 48.66 Favored 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 117.087 -1.435 . . . . 50.0 113.59 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.01 160.5 37.55 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 126.143 2.152 . . . . 25.0 111.296 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . 0.288 39.5 t -144.3 125.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.29 1.036 . . . . 50.0 109.088 174.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -104.79 112.3 25.36 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 101.157 -3.645 . . . . 25.0 101.157 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -100.62 133.37 45.18 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.0 129.03 31.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 O-C-N 125.242 1.588 . . . . 50.0 109.834 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.75 -18.45 32.97 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -159.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -86.12 2.79 45.36 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 116.005 1.854 . . . . 25.0 116.005 -172.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 t -143.32 158.69 43.42 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.102 -1.444 . . . . 25.0 107.102 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -82.24 -7.44 59.62 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.327 0.967 . . . . 25.0 110.226 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -86.12 163.72 17.7 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.42 148.98 52.3 Favored 'General case' 0 C--O 1.274 2.357 0 N-CA-C 102.02 -3.326 . . . . 25.0 102.02 164.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -102.73 139.36 38.41 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 106.387 -1.708 . . . . 50.0 106.387 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -116.72 153.12 32.93 Favored 'General case' 0 C--O 1.277 2.502 0 C-N-CA 125.013 1.325 . . . . 50.0 108.499 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.72 138.34 23.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.661 0.743 . . . . 25.0 109.745 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.15 142.27 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 106.489 -1.671 . . . . 75.0 106.489 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.9 mt -136.28 127.09 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 104.166 -2.531 . . . . 25.0 104.166 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.91 145.78 25.33 Favored 'General case' 0 C--O 1.203 -1.353 0 N-CA-C 103.986 -2.598 . . . . 25.0 103.986 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.3 m -149.74 156.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 114.093 1.146 . . . . 50.0 114.093 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -121.77 99.87 6.69 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 105.202 -2.147 . . . . 25.0 105.202 172.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.09 121.27 31.26 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.48 -2.785 . . . . 50.0 103.48 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.21 165.79 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 117.099 2.259 . . . . 50.0 117.099 -171.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.64 158.81 15.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt . . . . . 0 C--O 1.261 1.684 0 C-N-CA 119.857 -0.737 . . . . 25.0 112.808 172.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.2 m80 . . . . . 1 N--CA 1.554 4.728 0 CA-C-O 121.705 0.764 . . . . 25.0 111.38 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.73 118.04 0.47 Allowed Glycine 0 CA--C 1.541 1.699 0 O-C-N 117.368 -3.333 . . . . 25.0 107.343 -14.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -130.63 144.82 51.68 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 122.058 2.929 . . . . 50.0 111.209 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.5 mt -99.19 115.43 39.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 101.296 -3.594 . . . . 25.0 101.296 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -88.42 -40.28 13.63 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 125.709 1.88 . . . . 25.0 110.621 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -146.82 145.26 22.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 117.163 2.283 . . . . 25.0 117.163 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.83 149.09 93.44 Favored 'Cis proline' 0 C--O 1.271 2.161 0 CA-C-N 121.161 1.45 . . . . 25.0 115.474 -7.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.21 -168.37 45.18 Favored Glycine 0 N--CA 1.483 1.776 0 O-C-N 126.625 2.453 . . . . 25.0 112.454 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 t -125.91 120.54 30.68 Favored 'General case' 0 C--O 1.266 1.945 0 O-C-N 125.865 1.568 . . . . 25.0 109.794 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -70.11 -35.95 74.5 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.171 -0.678 . . . . 25.0 109.171 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.09 81.97 Favored 'General case' 0 C--O 1.206 -1.231 0 C-N-CA 123.792 0.837 . . . . 25.0 109.84 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -36.51 82.03 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.452 0.908 . . . . 25.0 113.452 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 C--O 1.182 -2.48 0 O-C-N 125.371 1.669 . . . . 75.0 109.862 177.653 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.5 ptp . . . . . 0 CA--C 1.577 2.017 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.2 -50.12 50.3 Favored 'General case' 0 C--O 1.201 -1.449 0 C-N-CA 113.737 -3.185 . . . . 50.0 110.984 175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.98 76.72 27.48 Favored Pre-proline 0 C--O 1.252 1.193 0 O-C-N 120.996 -1.065 . . . . 25.0 110.524 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.68 -21.02 29.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 1 C-N-CA 111.497 -5.202 . . . . 25.0 115.309 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -81.7 2.23 30.64 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 118.94 -2.35 . . . . 25.0 114.362 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 t -118.22 98.95 6.55 Favored 'General case' 0 C--O 1.292 3.303 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.9 mt -126.14 133.52 51.57 Favored 'General case' 0 C--O 1.294 3.399 1 N-CA-C 99.821 -4.14 . . . . 50.0 99.821 157.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -121.83 134.78 54.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 113.975 1.102 . . . . 25.0 113.975 -170.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.24 125.93 32.27 Favored 'General case' 0 C--O 1.198 -1.624 0 C-N-CA 125.335 1.454 . . . . 25.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -113.94 132.27 56.01 Favored 'General case' 0 C--O 1.273 2.3 0 CA-C-N 121.278 1.853 . . . . 25.0 112.778 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttt . . . . . 0 C--O 1.213 -0.817 0 O-C-N 126.495 2.372 . . . . 25.0 112.434 -173.209 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.202 -1.43 0 N-CA-C 115.394 1.628 . . . . 50.0 115.394 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -77.18 -11.4 59.81 Favored 'General case' 0 CA--C 1.604 3.053 0 C-N-CA 117.482 -1.687 . . . . 50.0 107.213 161.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.97 69.09 Favored Glycine 0 C--O 1.248 0.971 0 CA-C-O 125.43 2.683 . . . . 25.0 111.828 173.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.26 -27.2 70.41 Favored Glycine 0 C--O 1.205 -1.696 0 O-C-N 120.435 -1.627 . . . . 25.0 113.26 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.94 -39.43 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 104.779 -2.304 . . . . 25.0 104.779 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.8 -34.69 78.96 Favored 'General case' 0 CA--C 1.58 2.116 0 O-C-N 124.496 1.123 . . . . 75.0 112.732 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.16 -19.47 33.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 124.228 1.966 . . . . 50.0 115.538 -167.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -77.53 8.57 4.15 Favored 'General case' 0 C--O 1.258 1.552 0 O-C-N 118.307 -2.746 . . . . 25.0 115.945 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -145.01 60.8 1.31 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.828 -1.533 . . . . 25.0 110.601 163.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -130.33 151.41 50.86 Favored 'General case' 0 CA--C 1.599 2.829 0 C-N-CA 119.439 -0.905 . . . . 25.0 111.982 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.6 -26.29 68.62 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 118.018 -2.926 . . . . 25.0 108.547 166.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -93.51 24.92 3.71 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.422 -1.311 . . . . 25.0 111.067 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.91 100.76 0.43 Allowed 'General case' 0 C--O 1.196 -1.749 0 CA-C-O 125.556 2.598 . . . . 25.0 110.557 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -32.73 137.53 0.07 Allowed 'General case' 0 C--N 1.317 -0.824 2 CA-C-N 103.45 -6.25 . . . . 25.0 115.821 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -77.2 128.45 34.4 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 121.676 -0.64 . . . . 50.0 110.808 -155.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -98.86 147.32 25.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 119.818 3.266 . . . . 25.0 119.818 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -137.81 155.18 49.29 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 102.28 -3.23 . . . . 25.0 102.28 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.0 mt -105.56 126.21 60.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 1 N-CA-C 97.913 -4.847 . . . . 25.0 97.913 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.6 mtp -130.46 140.16 50.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.323 1.049 . . . . 25.0 111.286 -168.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 p -75.44 173.23 11.22 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 116.059 1.874 . . . . 25.0 116.059 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.48 -178.77 48.47 Favored Glycine 0 C--O 1.283 3.182 0 N-CA-C 105.184 -3.166 . . . . 25.0 105.184 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.17 -170.56 31.7 Favored Glycine 2 N--CA 1.389 -4.453 0 CA-C-N 111.313 -2.443 . . . . 25.0 111.314 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.49 136.79 36.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.368 2.084 . . . . 25.0 112.444 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -137.18 161.46 36.1 Favored 'General case' 0 N--CA 1.522 3.16 0 O-C-N 124.939 1.399 . . . . 25.0 108.494 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 m -112.65 130.84 55.9 Favored 'General case' 0 C--O 1.274 2.353 0 CA-C-O 122.438 1.113 . . . . 25.0 109.491 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -118.35 116.99 27.87 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 113.402 -1.727 . . . . 50.0 109.556 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 m -137.36 135.63 37.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 114.958 1.466 . . . . 25.0 114.958 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -114.95 161.49 18.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.847 -2.279 . . . . 25.0 104.847 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 t -146.5 147.97 31.73 Favored 'General case' 0 C--O 1.265 1.874 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.44 148.98 32.84 Favored 'General case' 0 CA--C 1.603 3.007 0 O-C-N 118.264 -2.773 . . . . 50.0 106.372 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.5 p -77.76 2.35 17.28 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 118.133 2.642 . . . . 25.0 118.133 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.45 159.54 57.48 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.655 1.182 . . . . 25.0 108.535 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.04 163.82 36.23 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 114.716 -3.056 . . . . 25.0 111.144 171.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -139.03 151.16 46.58 Favored 'General case' 0 C--O 1.183 -2.409 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 163.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.59 121.5 19.82 Favored 'General case' 0 C--O 1.253 1.265 0 CA-C-N 113.424 -1.716 . . . . 25.0 106.624 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.1 m -142.99 138.91 30.38 Favored 'General case' 0 C--N 1.317 -0.832 1 N-CA-C 99.674 -4.195 . . . . 25.0 99.674 -172.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.0 p -78.94 -48.64 14.17 Favored 'General case' 0 C--O 1.272 2.241 0 CA-C-O 124.025 1.869 . . . . 25.0 110.924 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -163.48 175.9 10.28 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.442 -1.411 . . . . 25.0 109.353 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -144.46 154.07 42.55 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 126.085 1.754 . . . . 25.0 108.697 167.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -128.43 160.55 31.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 116.792 -1.575 . . . . 25.0 109.692 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -134.91 148.5 50.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 103.663 -2.717 . . . . 50.0 103.663 162.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -139.2 168.59 19.49 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 103.998 -2.593 . . . . 50.0 103.998 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.4 pt -136.32 160.96 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 104.581 -2.378 . . . . 25.0 104.581 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -123.78 148.33 46.76 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 113.206 -1.815 . . . . 25.0 106.622 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -125.95 93.86 3.94 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 117.893 -1.523 . . . . 25.0 108.07 -172.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.84 165.99 3.67 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 120.114 -1.617 . . . . 25.0 112.757 168.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.82 48.5 Favored Glycine 0 C--O 1.192 -2.52 0 O-C-N 119.811 -1.806 . . . . 25.0 109.822 -171.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.59 159.57 32.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.073 1.416 . . . . 25.0 110.933 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.32 128.8 86.9 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 101.877 -3.379 . . . . 25.0 101.877 170.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 108' ' ' LYS . 72.3 Cg_endo -74.77 -27.06 10.81 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 114.048 -3.501 . . . . 25.0 117.359 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -81.59 1.23 34.75 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.48 1.491 . . . . 75.0 108.575 -165.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 106' ' ' PRO . 25.0 mmtp -118.24 166.53 13.5 Favored Pre-proline 0 CA--C 1.578 2.052 0 O-C-N 127.976 3.297 . . . . 25.0 111.798 -161.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -47.33 30.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.374 2 C-N-CA 130.171 7.247 . . . . 25.0 124.528 174.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -52.28 -27.88 16.83 Favored 'General case' 0 C--O 1.188 -2.178 0 O-C-N 120.141 -1.599 . . . . 50.0 114.835 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -71.57 -14.48 62.1 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 123.706 0.629 . . . . 25.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -116.43 -60.52 1.85 Allowed 'General case' 0 C--O 1.168 -3.235 0 C-N-CA 126.854 2.062 . . . . 25.0 111.817 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.56 -25.37 35.88 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -102.74 28.65 5.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.761 0.791 . . . . 25.0 112.885 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -137.85 151.73 48.36 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.914 -2.625 . . . . 50.0 103.914 156.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -130.01 147.88 51.8 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 119.008 -0.52 . . . . 25.0 111.408 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.8 tp -65.94 136.21 55.78 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 106.28 -1.748 . . . . 50.0 106.28 156.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.53 -15.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 120.24 1.382 . . . . 25.0 107.698 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.8 157.23 15.71 Favored Glycine 0 C--O 1.284 3.279 0 CA-C-O 117.057 -1.968 . . . . 25.0 110.971 163.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.14 150.32 49.55 Favored 'General case' 0 C--O 1.263 1.773 0 CA-C-N 118.067 0.934 . . . . 25.0 112.774 162.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -126.34 111.24 23.56 Favored Pre-proline 0 C--O 1.255 1.382 0 C-N-CA 125.432 1.493 . . . . 50.0 114.997 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -79.31 157.59 26.0 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 114.07 -3.487 . . . . 25.0 119.278 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . 0.279 53.1 t-80 -121.96 65.2 0.91 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 124.292 1.996 . . . . 25.0 107.122 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.15 26.47 8.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 111.624 -2.535 . . . . 50.0 110.458 -166.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.83 57.96 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-O 124.016 1.898 . . . . 25.0 108.806 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.96 160.48 0.65 Allowed Pre-proline 0 C--O 1.266 1.957 0 N-CA-C 118.479 2.77 . . . . 25.0 118.479 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.72 -166.62 0.1 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 123.099 2.533 . . . . 25.0 115.652 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.09 -23.13 7.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.189 1.922 . . . . 25.0 116.189 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.8 p -69.3 -8.44 46.16 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 114.395 1.257 . . . . 25.0 114.395 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -53.67 -29.07 36.88 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 117.217 -1.373 . . . . 25.0 113.811 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . 0.261 85.1 m-20 -68.15 143.59 55.34 Favored 'General case' 0 C--O 1.19 -2.064 0 CA-C-O 123.641 1.686 . . . . 25.0 111.359 -174.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -20.65 66.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.374 1.869 . . . . 75.0 110.073 -170.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.0 t -83.24 127.47 33.66 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.29 1.959 . . . . 25.0 116.29 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -137.45 146.95 44.94 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 124.503 2.097 . . . . 25.0 112.533 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -98.03 129.89 44.87 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.762 -1.211 . . . . 25.0 110.445 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . 0.266 35.9 mm -131.12 120.62 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.81 1.244 . . . . 25.0 107.904 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -76.58 126.07 30.34 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.898 -1.519 . . . . 50.0 106.898 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.9 129.08 31.99 Favored Pre-proline 0 C--N 1.364 1.221 0 CA-C-O 115.91 -1.995 . . . . 25.0 109.798 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.14 156.04 47.43 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 116.156 -2.096 . . . . 25.0 110.836 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -109.45 -8.63 15.01 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 126.527 1.931 . . . . 25.0 115.773 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -93.94 -13.58 26.93 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 115.833 1.79 . . . . 50.0 115.833 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.61 163.4 22.83 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.127 1.528 . . . . 25.0 115.127 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.01 146.13 34.41 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 124.94 1.4 . . . . 50.0 113.769 158.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.72 158.99 11.21 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 118.826 2.291 . . . . 25.0 118.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -72.79 136.99 45.52 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.975 -1.613 . . . . 50.0 111.149 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -142.87 166.11 25.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.152 -0.476 . . . . 25.0 110.526 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.77 130.95 73.24 Favored 'Isoleucine or valine' 0 C--O 1.267 1.98 0 N-CA-C 101.887 -3.375 . . . . 50.0 101.887 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.3 mt -101.63 123.86 55.04 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.93 1 N-CA-C 98.639 -4.578 . . . . 25.0 98.639 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.38 143.22 43.86 Favored 'General case' 0 C--O 1.189 -2.106 0 N-CA-C 104.527 -2.397 . . . . 50.0 104.527 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.4 34.94 Favored 'General case' 0 CA--C 1.456 -2.65 0 O-C-N 119.87 -1.769 . . . . 25.0 113.097 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.84 125.46 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 CA-C-N 110.143 -3.208 . . . . 50.0 108.489 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -108.06 104.22 13.61 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.873 -1.158 . . . . 25.0 107.873 166.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -78.28 72.74 4.82 Favored 'General case' 0 C--O 1.26 1.653 0 O-C-N 126.267 2.229 . . . . 25.0 106.47 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.64 116.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.773 0 C-N-CA 126.174 1.79 . . . . 50.0 113.374 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.8 -22.31 23.32 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -7.87 0.37 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 119.642 3.201 . . . . 25.0 119.642 171.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.2 p -135.34 165.08 26.27 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 103.089 -2.93 . . . . 25.0 103.089 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -76.97 -41.87 41.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 119.576 -1.953 . . . . 25.0 110.103 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -81.44 168.66 18.08 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 105.098 -2.186 . . . . 25.0 105.098 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -116.34 153.47 31.93 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 102.95 -2.982 . . . . 25.0 102.95 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -97.6 150.05 21.56 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 107.714 -1.217 . . . . 50.0 107.714 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -140.79 162.53 35.2 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 104.957 -2.238 . . . . 50.0 104.957 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 144.64 12.02 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 103.377 -2.823 . . . . 25.0 103.377 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.38 155.03 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 123.082 1.42 . . . . 75.0 114.6 165.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.46 117.64 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 101.13 -3.656 . . . . 25.0 101.13 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -82.28 127.49 33.26 Favored 'General case' 1 C--O 1.318 4.668 0 CA-C-O 124.614 2.15 . . . . 25.0 106.169 170.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.14 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 116.573 -3.83 . . . . 50.0 115.217 175.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.31 98.18 5.94 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 106.189 -1.782 . . . . 25.0 106.189 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.23 122.74 32.8 Favored 'General case' 0 C--O 1.261 1.695 0 N-CA-C 101.555 -3.498 . . . . 50.0 101.555 -168.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.08 162.57 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 118.607 -2.558 . . . . 50.0 117.366 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -84.63 164.39 18.69 Favored 'General case' 0 C--O 1.282 2.77 0 O-C-N 120.738 -1.226 . . . . 25.0 108.301 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 40.9 pttt . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 116.971 -1.49 . . . . 25.0 108.548 179.072 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 . . . . . 0 C--O 1.262 1.757 0 N-CA-C 113.553 0.946 . . . . 25.0 113.553 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.07 179.44 30.29 Favored Glycine 0 C--O 1.282 3.146 0 CA-C-O 115.706 -2.719 . . . . 25.0 113.844 -172.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.61 153.17 44.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 119.067 1.433 . . . . 50.0 113.033 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 6' ' ' LYS . 19.1 mt -71.03 124.14 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 119.127 -2.233 . . . . 25.0 110.257 -171.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -100.89 11.03 40.4 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 123.516 1.627 . . . . 25.0 109.014 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.451 ' H ' HG23 ' A' ' 4' ' ' ILE . 51.1 mtmt 86.91 159.24 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.679 1 C-N-CA 133.354 4.661 . . . . 25.0 112.529 172.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 139.97 47.87 Favored 'Cis proline' 0 CA--C 1.466 -2.895 0 C-N-CA 132.672 2.363 . . . . 25.0 114.193 2.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.18 69.15 1.21 Allowed Glycine 0 C--N 1.281 -2.496 0 CA-C-N 112.036 -2.347 . . . . 25.0 113.393 165.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -69.86 137.7 51.92 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 125.795 2.712 . . . . 25.0 108.69 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -93.63 -18.8 21.78 Favored 'General case' 0 C--O 1.281 2.759 0 N-CA-C 103.746 -2.686 . . . . 25.0 103.746 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.02 75.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.898 0.856 . . . . 25.0 112.078 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.48 77.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.913 -1.494 . . . . 25.0 110.362 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt . . . . . 0 CA--C 1.57 1.722 0 CA-C-N 113.03 -1.895 . . . . 75.0 109.396 -172.681 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 C--O 1.173 -2.928 0 N-CA-C 119.84 3.274 . . . . 25.0 119.84 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -64.9 -38.09 89.83 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 115.12 -0.945 . . . . 50.0 110.565 169.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.52 60.81 5.76 Favored Pre-proline 0 C--O 1.275 2.423 0 CA-C-N 115.025 -0.989 . . . . 25.0 112.878 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.19 -22.22 9.96 Favored 'Trans proline' 0 N--CA 1.477 0.546 1 C-N-CA 110.086 -6.143 . . . . 25.0 115.525 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -77.6 -15.39 59.26 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.963 -1.086 . . . . 25.0 111.28 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.4 t -73.66 116.93 14.83 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 118.271 -1.371 . . . . 25.0 111.391 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.5 mt -118.23 145.55 44.92 Favored 'General case' 0 C--O 1.164 -3.408 0 N-CA-C 104.501 -2.407 . . . . 50.0 104.501 162.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.6 157.88 45.3 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 124.765 2.222 . . . . 25.0 107.984 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.71 155.51 49.02 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 105.161 -2.163 . . . . 25.0 105.161 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.0 156.58 47.93 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 120.986 1.721 . . . . 25.0 110.957 166.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.6 mttt . . . . . 0 N--CA 1.505 2.308 0 N-CA-C 114.657 1.354 . . . . 25.0 114.657 174.803 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.2 mt . . . . . 0 CA--C 1.566 1.564 0 CA-C-O 117.668 -1.158 . . . . 50.0 114.005 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -71.56 -36.5 70.94 Favored 'General case' 0 C--O 1.262 1.713 0 N-CA-C 106.902 -1.518 . . . . 50.0 106.902 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.19 -16.52 78.61 Favored Glycine 1 C--O 1.156 -4.726 0 CA-C-O 123.362 1.535 . . . . 25.0 115.082 171.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.38 -17.01 73.98 Favored Glycine 0 C--N 1.307 -1.07 0 O-C-N 118.916 -2.52 . . . . 25.0 112.02 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -77.63 -34.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.53 0 N-CA-C 106.23 -1.767 . . . . 25.0 106.23 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.18 -23.0 57.65 Favored 'General case' 0 C--O 1.27 2.149 0 O-C-N 119.268 -2.145 . . . . 75.0 107.746 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -73.22 -8.2 54.79 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 113.566 -1.652 . . . . 50.0 112.726 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -77.36 7.7 5.01 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 124.378 2.037 . . . . 25.0 113.485 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -131.26 34.35 4.01 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.294 -1.373 . . . . 25.0 107.294 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 t -142.58 157.73 44.4 Favored 'General case' 0 C--O 1.252 1.229 0 O-C-N 119.954 -1.716 . . . . 25.0 111.656 -164.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.41 -25.08 66.96 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-O 122.466 1.126 . . . . 25.0 109.694 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.09 13.66 16.26 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.062 2.545 . . . . 25.0 108.173 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -76.41 99.62 4.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.313 -2.847 . . . . 25.0 103.313 167.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -46.72 145.13 2.03 Favored 'General case' 0 C--N 1.309 -1.155 1 CA-C-N 107.105 -4.589 . . . . 25.0 113.597 166.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -80.03 147.8 31.35 Favored 'General case' 0 C--O 1.21 -0.998 0 CA-C-O 115.626 -2.13 . . . . 50.0 110.4 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.91 101.66 13.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 126.246 2.216 . . . . 25.0 107.354 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -73.28 119.39 17.45 Favored 'General case' 0 C--O 1.284 2.911 0 N-CA-C 107.048 -1.464 . . . . 25.0 107.048 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.7 mt -81.53 130.97 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.0 ttt -147.82 134.55 19.98 Favored 'General case' 0 C--O 1.178 -2.695 0 N-CA-C 107.893 -1.151 . . . . 25.0 107.893 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 p -79.72 150.27 30.9 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.524 -2.398 . . . . 25.0 104.524 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.93 163.23 37.77 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 119.793 2.677 . . . . 25.0 119.793 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.75 -177.92 18.49 Favored Glycine 0 C--O 1.27 2.402 0 N-CA-C 105.998 -2.841 . . . . 25.0 105.998 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 9.3 pt-20 -82.48 152.24 26.16 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 125.437 2.542 . . . . 25.0 106.307 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.94 154.28 51.16 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 118.334 -2.729 . . . . 25.0 105.603 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.3 m -117.88 131.79 56.5 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 103.15 -2.907 . . . . 25.0 103.15 163.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -115.64 141.54 47.93 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.352 -1.351 . . . . 50.0 107.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -139.41 129.18 24.71 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 113.043 -1.889 . . . . 25.0 111.907 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -131.59 162.58 30.0 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 101.655 -3.461 . . . . 25.0 101.655 -174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.4 p -132.46 140.01 48.22 Favored 'General case' 0 CA--C 1.488 -1.417 0 O-C-N 121.597 -0.689 . . . . 25.0 111.748 156.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -79.74 154.75 28.33 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.035 -1.469 . . . . 50.0 107.035 164.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.9 t -91.96 -19.72 22.13 Favored 'General case' 0 C--O 1.257 1.449 0 N-CA-C 106.762 -1.57 . . . . 25.0 106.762 -165.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.95 139.39 13.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 CA-C-O 117.305 -1.331 . . . . 25.0 109.12 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.85 131.86 34.8 Favored 'Trans proline' 0 CA--C 1.599 3.729 0 C-N-CA 115.461 -2.56 . . . . 25.0 111.225 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.16 160.43 42.85 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -81.61 161.48 23.47 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 116.048 1.87 . . . . 25.0 116.048 -158.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.1 m -154.97 134.96 12.97 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.332 -1.358 . . . . 25.0 107.332 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.1 p -91.52 -41.22 10.93 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.49 -1.67 . . . . 25.0 106.49 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -161.39 172.53 16.37 Favored 'General case' 0 C--O 1.281 2.732 0 N-CA-C 104.95 -2.241 . . . . 25.0 104.95 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -144.53 152.52 40.69 Favored 'General case' 0 C--O 1.258 1.533 0 N-CA-C 114.477 1.288 . . . . 25.0 114.477 167.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -128.98 142.25 50.99 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.385 -1.293 . . . . 25.0 110.59 -167.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.74 144.19 47.38 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-N 120.276 1.398 . . . . 50.0 107.556 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.3 167.57 20.47 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 105.61 -1.996 . . . . 50.0 105.61 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.3 pt -129.6 147.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 172.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.6 p -77.79 154.89 31.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 117.739 -1.124 . . . . 25.0 109.565 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -144.86 80.09 1.61 Allowed 'General case' 0 C--O 1.239 0.545 0 N-CA-C 117.411 2.374 . . . . 25.0 117.411 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -47.24 157.72 0.18 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 125.411 2.529 . . . . 25.0 115.124 167.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.95 32.71 23.05 Favored Glycine 0 C--O 1.204 -1.767 0 C-N-CA 116.985 -2.531 . . . . 25.0 112.108 167.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -60.66 159.41 10.83 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.989 1.848 . . . . 25.0 115.989 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -74.82 134.34 75.35 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.126 -1.435 . . . . 25.0 107.126 162.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.23 -26.5 49.26 Favored 'Trans proline' 0 C--N 1.362 1.26 0 N-CA-C 120.164 3.102 . . . . 25.0 120.164 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.18 -6.5 58.59 Favored 'General case' 0 C--O 1.191 -1.994 0 C-N-CA 116.96 -1.896 . . . . 75.0 110.198 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -66.27 157.6 80.9 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 111.684 -2.507 . . . . 25.0 110.913 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.14 51.16 1.29 Allowed 'Trans proline' 0 C--N 1.37 1.668 1 N-CA-C 122.829 4.126 . . . . 25.0 122.829 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -2.45 -66.31 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 1 C-N-CA 132.092 4.157 . . . . 50.0 118.968 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -72.34 -8.6 55.8 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 122.189 2.268 . . . . 25.0 114.652 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 -55.4 2.58 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 124.523 1.129 . . . . 25.0 109.32 165.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.85 -25.69 1.39 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 117.323 2.342 . . . . 25.0 117.323 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -82.96 8.45 12.64 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.27 160.57 39.85 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 119.938 -1.726 . . . . 50.0 108.49 159.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -144.44 134.37 23.89 Favored 'General case' 0 C--O 1.182 -2.5 0 N-CA-C 105.821 -1.918 . . . . 25.0 105.821 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.41 132.57 50.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.678 1.191 . . . . 50.0 111.358 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.8 tt -111.15 -18.15 7.85 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 N-CA-C 106.224 -1.769 . . . . 25.0 106.224 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.29 156.03 13.11 Favored Glycine 0 C--N 1.306 -1.095 0 O-C-N 120.542 -1.349 . . . . 25.0 113.085 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.14 139.41 24.61 Favored 'General case' 0 C--O 1.266 1.943 0 CA-C-O 123.769 1.747 . . . . 25.0 107.065 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -128.81 107.21 18.44 Favored Pre-proline 0 C--O 1.255 1.381 0 CA-C-N 114.63 -1.168 . . . . 50.0 110.056 -170.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.95 164.52 31.49 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 113.331 -3.979 . . . . 25.0 115.038 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -139.98 2.98 1.98 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 118.058 2.614 . . . . 25.0 118.058 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -90.29 -24.92 20.77 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 107.637 -1.246 . . . . 50.0 107.637 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.62 160.93 27.43 Favored Glycine 0 C--N 1.352 1.437 1 N-CA-C 95.207 -7.157 . . . . 25.0 95.207 155.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.5 t -154.8 149.11 19.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 120.543 2.171 . . . . 25.0 112.706 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.03 -178.03 3.59 Favored 'Trans proline' 0 N--CA 1.436 -1.86 0 C-N-CA 114.866 -2.956 . . . . 25.0 111.008 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -15.8 5.37 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 118.474 -2.641 . . . . 25.0 115.496 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.53 4.02 0.43 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.103 1.89 . . . . 25.0 116.103 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -57.47 -33.54 68.08 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 127.108 2.163 . . . . 25.0 115.05 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -48.57 131.37 17.5 Favored 'General case' 0 C--O 1.18 -2.592 0 CA-C-N 119.367 0.985 . . . . 25.0 113.201 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.3 tp -65.86 -29.9 70.42 Favored 'General case' 0 C--O 1.268 2.077 0 CA-C-O 122.017 0.913 . . . . 75.0 113.355 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 132.5 47.46 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 121.748 -0.595 . . . . 25.0 110.67 166.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -153.84 161.05 42.36 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.597 1.665 . . . . 25.0 110.559 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -112.12 137.52 50.07 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.518 1.303 . . . . 25.0 114.518 -172.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.3 mt -132.53 133.23 59.89 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 102.956 -2.979 . . . . 25.0 102.956 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 73.5 t80 -101.0 134.19 44.36 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 105.716 -1.957 . . . . 50.0 105.716 173.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.4 mm -125.17 110.38 26.85 Favored Pre-proline 0 C--O 1.2 -1.509 0 N-CA-C 102.127 -3.286 . . . . 25.0 102.127 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.25 149.83 70.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 115.101 -2.799 . . . . 25.0 109.854 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -92.51 47.07 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.77 -14.69 60.74 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 118.791 -2.443 . . . . 50.0 114.487 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -166.44 169.45 13.89 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 103.946 -2.613 . . . . 25.0 103.946 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -98.15 152.57 19.22 Favored 'General case' 0 C--O 1.281 2.741 0 N-CA-C 100.459 -3.904 . . . . 50.0 100.459 163.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.24 164.19 17.72 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-O 123.386 1.548 . . . . 25.0 111.163 -171.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.91 157.65 45.06 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 117.105 -3.585 . . . . 50.0 116.844 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -158.42 175.94 13.07 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 100.652 -3.833 . . . . 25.0 100.652 170.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.75 146.92 6.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 123.449 0.7 . . . . 50.0 111.726 167.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.94 128.39 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 O-C-N 119.329 -2.107 . . . . 25.0 106.252 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -115.7 153.77 30.75 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 115.683 -2.103 . . . . 50.0 106.531 -167.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.49 44.2 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 121.48 1.945 . . . . 25.0 114.536 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.41 135.44 57.84 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.714 0 C-N-CA 125.028 1.331 . . . . 50.0 111.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -115.77 137.8 51.74 Favored 'General case' 0 C--O 1.277 2.543 0 C-N-CA 127.583 2.353 . . . . 25.0 107.273 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -118.0 144.82 45.22 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 103.269 -2.863 . . . . 25.0 103.269 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.33 113.27 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 105.538 -2.023 . . . . 50.0 105.538 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.0 -14.29 62.29 Favored 'General case' 0 C--O 1.262 1.728 0 N-CA-C 115.255 1.576 . . . . 25.0 115.255 -167.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -71.3 -25.09 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 126.39 2.306 . . . . 25.0 111.16 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.9 p -120.13 165.45 14.75 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 112.272 -2.24 . . . . 25.0 111.819 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -100.7 -9.79 21.49 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 123.808 1.766 . . . . 25.0 107.374 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -78.66 159.42 28.03 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 113.121 -1.854 . . . . 25.0 112.841 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.44 148.58 42.95 Favored 'General case' 0 CA--C 1.557 1.242 1 N-CA-C 98.837 -4.505 . . . . 25.0 98.837 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -126.67 139.48 53.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.276 -1.379 . . . . 50.0 107.276 -165.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -140.19 159.46 42.13 Favored 'General case' 0 C--O 1.203 -1.365 0 O-C-N 126.427 2.329 . . . . 50.0 110.404 -166.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -148.38 161.83 40.79 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.206 1.402 . . . . 25.0 111.816 166.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.52 130.6 50.43 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.178 0 N-CA-C 106.207 -1.775 . . . . 75.0 106.207 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -126.92 120.8 56.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.772 -1.566 . . . . 25.0 106.772 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -91.12 145.49 24.64 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 107.445 -1.316 . . . . 25.0 107.445 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.42 163.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 C-N-CA 127.187 2.195 . . . . 50.0 112.903 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.58 108.57 6.02 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 127.235 2.214 . . . . 25.0 109.701 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.33 116.49 30.45 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 102.867 -3.012 . . . . 50.0 102.867 -161.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.8 m -125.18 167.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.127 -1.029 . . . . 50.0 113.015 -156.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.88 155.03 31.2 Favored 'General case' 0 C--O 1.263 1.766 0 O-C-N 124.715 1.259 . . . . 25.0 108.277 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 C--O 1.249 1.059 0 CA-C-N 113.672 -1.603 . . . . 25.0 106.825 -177.346 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.527 -1.702 . . . . 25.0 113.252 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.53 166.72 39.14 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 117.155 -2.45 . . . . 25.0 116.658 -170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.81 173.35 13.83 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 106.681 -1.6 . . . . 50.0 106.681 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.0 121.96 54.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 N-CA-C 102.897 -3.001 . . . . 25.0 102.897 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.6 -41.81 16.03 Favored 'General case' 0 C--O 1.18 -2.569 0 C-N-CA 127.631 2.372 . . . . 25.0 113.837 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -152.7 155.74 32.69 Favored Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 105.838 -1.912 . . . . 25.0 105.838 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -60.51 139.18 23.0 Favored 'Cis proline' 0 C--N 1.358 1.028 0 C-N-CA 132.291 2.204 . . . . 25.0 116.209 3.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.58 -177.17 54.41 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 122.639 1.133 . . . . 25.0 114.123 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -123.08 103.01 8.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 125.129 2.395 . . . . 25.0 107.548 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -58.77 -27.83 65.35 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 119.861 -1.774 . . . . 25.0 112.988 167.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.79 73.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 122.902 1.334 . . . . 25.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.86 73.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 122.058 0.932 . . . . 25.0 108.857 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.566 1.578 0 C-N-CA 127.192 2.197 . . . . 75.0 109.721 -178.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 ppp? . . . . . 0 C--O 1.255 1.372 0 N-CA-C 118.811 2.893 . . . . 25.0 118.811 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -66.82 -41.29 87.73 Favored 'General case' 0 C--O 1.267 1.974 0 C-N-CA 124.104 0.961 . . . . 50.0 111.321 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.94 56.68 8.23 Favored Pre-proline 0 C--O 1.249 1.051 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.05 -20.89 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.318 0 N-CA-C 120.555 3.252 . . . . 25.0 120.555 -167.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -94.33 -2.85 51.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 116.849 -1.94 . . . . 25.0 113.179 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 t -77.09 87.25 3.58 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 122.191 0.996 . . . . 25.0 111.164 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.13 80.05 1.33 Allowed 'General case' 0 C--O 1.252 1.194 0 N-CA-C 107.729 -1.212 . . . . 50.0 107.729 -167.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -141.2 135.7 31.03 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 121.147 1.794 . . . . 25.0 114.43 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.68 166.11 31.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.044 -2.576 . . . . 25.0 104.044 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -84.93 146.56 27.19 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 tttt . . . . . 0 CA--C 1.507 -0.688 0 C-N-CA 124.647 1.179 . . . . 25.0 111.319 170.047 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 C--O 1.278 2.595 0 CA-C-O 122.785 1.278 . . . . 50.0 110.371 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -66.68 -14.04 62.0 Favored 'General case' 0 C--O 1.175 -2.824 0 C-N-CA 118.635 -1.226 . . . . 50.0 113.512 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.51 73.13 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 106.973 -2.451 . . . . 25.0 106.973 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.14 -11.26 84.58 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 124.461 2.145 . . . . 25.0 117.283 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -79.77 -32.19 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.375 0 CA-C-O 125.891 2.758 . . . . 25.0 107.126 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.48 -17.55 51.29 Favored 'General case' 0 CA--C 1.468 -2.181 0 CA-C-N 113.267 -1.788 . . . . 75.0 109.41 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.15 2.53 2.11 Favored 'General case' 0 C--O 1.197 -1.662 0 CA-C-O 123.928 1.823 . . . . 50.0 115.832 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -85.52 40.98 0.87 Allowed 'General case' 0 C--O 1.263 1.788 0 O-C-N 120.285 -1.509 . . . . 25.0 107.998 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.47 49.25 0.48 Allowed 'General case' 0 C--O 1.262 1.757 0 N-CA-C 105.847 -1.909 . . . . 25.0 105.847 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.8 t -147.01 157.3 43.58 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 126.747 2.019 . . . . 25.0 108.194 -162.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -31.41 67.46 Favored 'General case' 0 C--O 1.261 1.687 0 N-CA-C 102.177 -3.268 . . . . 25.0 102.177 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -88.19 21.11 2.91 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 120.308 -0.557 . . . . 25.0 109.671 -171.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -68.62 98.53 0.89 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 125.602 2.62 . . . . 25.0 103.946 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -33.78 144.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 1 CA-C-N 105.865 -5.152 . . . . 25.0 113.416 165.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -66.94 134.49 52.11 Favored 'General case' 0 C--O 1.263 1.767 0 O-C-N 125.233 1.583 . . . . 50.0 107.098 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -80.57 153.65 27.94 Favored 'General case' 0 CA--C 1.483 -1.598 0 O-C-N 120.589 -1.32 . . . . 25.0 110.481 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -136.93 143.3 42.83 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 117.29 2.33 . . . . 25.0 117.29 157.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.84 134.27 39.82 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.705 0 N-CA-C 105.406 -2.072 . . . . 25.0 105.406 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 66.3 mtm -144.32 146.92 32.87 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 118.624 -2.547 . . . . 25.0 105.895 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 p -86.58 171.55 10.94 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 124.143 1.925 . . . . 25.0 108.079 168.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.26 -173.77 17.09 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 124.455 2.142 . . . . 25.0 115.502 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.84 -176.7 38.03 Favored Glycine 0 C--O 1.266 2.106 0 N-CA-C 108.006 -2.038 . . . . 25.0 108.006 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -66.55 149.37 50.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 116.344 -1.789 . . . . 25.0 110.843 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -147.24 137.43 23.26 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 126.679 2.487 . . . . 25.0 105.675 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -93.61 105.96 17.97 Favored 'General case' 0 CA--C 1.479 -1.774 0 O-C-N 126.532 2.395 . . . . 25.0 105.152 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -76.64 142.23 40.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 103.061 -2.94 . . . . 50.0 103.061 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -136.46 103.28 5.21 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 118.385 -2.697 . . . . 25.0 106.75 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -100.78 126.7 47.37 Favored 'General case' 0 C--O 1.177 -2.754 0 N-CA-C 102.688 -3.079 . . . . 25.0 102.688 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -123.33 120.63 33.63 Favored 'General case' 0 C--O 1.175 -2.818 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -113.5 153.76 28.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.905 -1.498 . . . . 50.0 109.022 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 t -116.31 8.24 14.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 126.573 2.421 . . . . 25.0 113.271 174.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.91 119.39 25.86 Favored Pre-proline 0 C--N 1.349 0.586 0 C-N-CA 128.084 2.554 . . . . 25.0 111.451 -167.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -68.6 -37.94 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 124.922 2.011 . . . . 25.0 116.11 160.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -68.28 139.56 55.96 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 123.224 1.488 . . . . 25.0 110.857 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -78.68 129.74 35.06 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 112.887 -1.96 . . . . 25.0 113.479 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -93.05 164.02 13.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.067 -1.646 . . . . 25.0 108.918 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -96.7 -49.94 4.89 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 120.698 -1.251 . . . . 25.0 110.185 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -166.46 170.88 12.45 Favored 'General case' 0 C--O 1.262 1.738 0 CA-C-O 118.354 -0.831 . . . . 25.0 110.758 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -144.13 153.06 41.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.096 -0.954 . . . . 25.0 109.315 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -131.16 142.59 50.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.832 -2.655 . . . . 25.0 103.832 -164.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -142.36 135.44 28.61 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 117.512 -3.242 . . . . 50.0 113.002 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -146.38 167.16 24.28 Favored 'General case' 0 C--O 1.163 -3.495 0 O-C-N 119.546 -1.971 . . . . 50.0 111.105 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -120.1 173.97 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 125.933 2.02 . . . . 25.0 113.369 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -135.56 154.12 51.47 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 124.063 0.852 . . . . 25.0 112.711 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -137.81 100.77 4.27 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.388 1.625 . . . . 25.0 115.388 -165.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -42.86 162.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 120.73 3.604 . . . . 25.0 120.73 157.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.1 28.5 Favored Glycine 0 N--CA 1.488 2.113 0 CA-C-O 126.056 3.031 . . . . 25.0 107.763 165.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -67.62 160.89 26.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.06 -2.07 . . . . 25.0 114.067 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.02 111.75 20.43 Favored Pre-proline 0 C--O 1.194 -1.816 0 N-CA-C 107.127 -1.434 . . . . 25.0 107.127 155.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -64.35 -24.48 64.59 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 C-N-CA 123.671 2.914 . . . . 25.0 114.855 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.23 -15.99 50.5 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.379 1.049 . . . . 75.0 113.195 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -71.88 161.79 76.8 Favored Pre-proline 0 N--CA 1.483 1.199 0 CA-C-O 116.884 -1.531 . . . . 25.0 108.584 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -54.08 31.16 0.02 OUTLIER 'Trans proline' 0 CA--C 1.574 2.485 2 C-N-CA 126.302 4.668 . . . . 25.0 122.66 160.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -8.9 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 1 N-CA-C 122.386 4.217 . . . . 50.0 122.386 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.52 -16.83 64.44 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 117.118 -3.489 . . . . 25.0 109.586 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.26 -57.33 2.29 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 126.033 2.083 . . . . 25.0 106.955 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.76 -24.63 66.95 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.536 1.773 . . . . 25.0 115.299 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -69.88 -4.69 21.48 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-O 116.513 -1.708 . . . . 25.0 114.903 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -118.32 150.29 39.75 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 122.807 2.549 . . . . 50.0 110.011 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.81 149.64 38.9 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 119.823 -1.798 . . . . 25.0 111.382 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.1 tp -76.44 123.84 26.64 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 116.054 -1.927 . . . . 50.0 108.93 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.0 tt -95.29 -11.68 8.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.83 173.5 33.53 Favored Glycine 0 C--O 1.19 -2.633 0 N-CA-C 116.645 1.418 . . . . 25.0 116.645 164.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -157.32 132.12 8.73 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.344 -1.428 . . . . 25.0 111.295 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.44 130.32 18.02 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 105.033 -2.21 . . . . 50.0 105.033 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -82.56 163.87 16.56 Favored 'Trans proline' 0 C--N 1.372 1.769 0 CA-C-O 124.83 1.929 . . . . 25.0 116.229 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -82.87 136.05 34.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 113.732 -1.576 . . . . 25.0 108.426 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.7 32.14 11.5 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.9 1.68 . . . . 50.0 111.008 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.28 165.11 43.64 Favored Glycine 0 N--CA 1.425 -2.088 0 O-C-N 119.502 -1.999 . . . . 25.0 108.625 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 t -66.17 -38.31 21.4 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-O 116.241 -1.838 . . . . 25.0 112.872 -173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.24 160.94 23.19 Favored 'Trans proline' 0 C--N 1.38 2.231 1 C-N-CA 108.351 -7.299 . . . . 25.0 107.874 -170.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.37 -26.1 11.5 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 126.876 3.227 . . . . 25.0 114.08 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -66.91 2.83 1.26 Allowed 'General case' 0 CA--C 1.512 -0.49 1 N-CA-C 122.615 4.302 . . . . 25.0 122.615 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.03 5.48 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 121.438 3.866 . . . . 25.0 121.438 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.25 141.5 41.7 Favored 'General case' 0 C--O 1.276 2.499 0 N-CA-C 121.55 3.907 . . . . 25.0 121.55 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.18 -25.72 63.57 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 106.589 -1.634 . . . . 75.0 106.589 -165.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 t -90.37 127.79 36.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 O-C-N 117.819 -3.051 . . . . 25.0 110.583 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -125.64 155.44 40.81 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 117.014 2.227 . . . . 25.0 117.014 164.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -79.72 125.63 29.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 113.139 -3.315 . . . . 25.0 108.304 169.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.7 mm -124.38 129.03 74.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 123.582 2.901 . . . . 25.0 105.968 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -81.59 127.2 32.62 Favored 'General case' 0 C--O 1.276 2.462 0 O-C-N 120.472 -1.393 . . . . 50.0 113.399 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.64 116.27 61.3 Favored Pre-proline 0 CA--C 1.515 -0.4 0 C-N-CA 130.768 3.627 . . . . 25.0 105.842 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.57 158.3 58.26 Favored 'Trans proline' 0 C--O 1.193 -1.728 1 C-N-CA 111.925 -4.916 . . . . 25.0 115.848 175.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -115.86 9.26 14.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.268 1.509 . . . . 25.0 109.427 -170.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.23 -8.66 57.55 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.113 2.264 . . . . 50.0 117.113 -171.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -146.5 170.21 17.35 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.274 -2.491 . . . . 25.0 104.274 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -111.99 131.68 55.25 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 101.269 -3.604 . . . . 50.0 101.269 160.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -176.08 164.4 34.37 Favored Glycine 0 C--N 1.302 -1.357 0 CA-C-O 124.756 2.309 . . . . 25.0 113.649 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.15 139.75 34.17 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.569 -1.548 . . . . 50.0 111.125 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -154.69 159.62 40.86 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 104.884 -2.265 . . . . 25.0 104.884 -171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.54 134.54 66.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 113.781 -3.009 . . . . 50.0 112.839 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.6 mt -110.01 130.18 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 O-C-N 127.453 2.97 . . . . 25.0 106.553 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.51 143.18 50.8 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 103.324 -2.843 . . . . 50.0 103.324 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.61 153.1 49.94 Favored 'General case' 0 C--O 1.257 1.455 0 N-CA-C 104.723 -2.325 . . . . 25.0 104.723 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.82 135.66 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-N 113.7 -1.591 . . . . 50.0 107.258 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.49 124.97 31.26 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-N 119.782 1.174 . . . . 25.0 110.067 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 143.58 34.31 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 125.274 1.609 . . . . 25.0 112.853 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -99.32 135.19 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 123.901 1.81 . . . . 50.0 111.159 174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 -34.14 20.81 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.3 -1.5 . . . . 25.0 111.691 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -72.96 -17.59 61.46 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 124.872 1.358 . . . . 25.0 110.32 -171.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 p -146.06 179.26 7.61 Favored 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 109.204 -0.665 . . . . 25.0 109.204 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -87.02 9.98 17.89 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-O 122.571 1.177 . . . . 25.0 111.873 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -73.6 150.78 41.16 Favored 'General case' 0 C--O 1.281 2.733 0 CA-C-O 123.118 1.437 . . . . 25.0 110.291 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.33 160.16 43.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 103.017 -2.957 . . . . 25.0 103.017 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -145.23 173.78 11.65 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.022 -1.844 . . . . 50.0 106.022 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.48 149.07 46.54 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 105.588 -2.005 . . . . 50.0 105.588 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.67 145.2 42.35 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 121.409 1.913 . . . . 25.0 108.192 -173.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.6 p -141.64 145.33 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 CA-C-N 119.399 1.0 . . . . 75.0 111.929 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.11 134.41 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 103.65 -2.722 . . . . 25.0 103.65 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.53 135.25 33.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.899 -1.046 . . . . 25.0 110.767 169.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.41 133.2 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 119.398 -2.064 . . . . 50.0 111.758 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -106.45 89.96 3.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 102.353 -3.203 . . . . 25.0 102.353 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.48 118.97 32.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.578 -1.646 . . . . 50.0 107.007 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.38 157.61 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 123.989 1.852 . . . . 50.0 114.21 -170.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -74.23 143.83 44.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 100.38 -3.933 . . . . 25.0 100.38 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 CA--C 1.55 0.97 0 C-N-CA 126.768 2.027 . . . . 25.0 108.521 -175.45 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 123.279 1.514 . . . . 25.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.43 -149.13 28.63 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 117.477 1.751 . . . . 25.0 117.477 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.19 133.68 40.2 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.121 1.368 . . . . 50.0 108.726 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.71 120.85 35.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 119.809 1.186 . . . . 25.0 108.268 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -98.2 -29.46 13.2 Favored 'General case' 0 C--O 1.281 2.733 0 C-N-CA 125.079 1.352 . . . . 25.0 112.816 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -153.31 146.79 18.12 Favored Pre-proline 0 CA--C 1.559 1.298 1 N-CA-C 98.742 -4.54 . . . . 25.0 98.742 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.38 131.11 8.81 Favored 'Cis proline' 0 C--N 1.311 -1.436 0 C-N-CA 131.058 1.691 . . . . 25.0 115.743 15.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.47 177.29 44.39 Favored Glycine 0 C--O 1.192 -2.494 0 N-CA-C 118.632 2.213 . . . . 25.0 118.632 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -103.58 125.65 50.24 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 105.201 -2.148 . . . . 25.0 105.201 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -61.93 -34.0 75.29 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 123.789 0.681 . . . . 25.0 109.74 170.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.09 -33.13 73.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 116.718 -1.993 . . . . 25.0 111.284 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.69 78.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.248 -0.908 . . . . 25.0 111.665 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mp . . . . . 0 C--N 1.279 -2.495 0 CA-C-O 122.277 1.037 . . . . 75.0 111.362 177.778 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.9 ptt? . . . . . 0 N--CA 1.415 -2.184 0 CA-C-O 123.868 1.794 . . . . 25.0 115.741 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -62.5 -40.15 95.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.407 1.632 . . . . 50.0 115.407 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -143.12 46.18 0.67 Allowed Pre-proline 0 CA--C 1.473 -2.009 0 N-CA-C 119.044 2.979 . . . . 25.0 119.044 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.35 -30.7 29.73 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 O-C-N 116.918 -2.201 . . . . 25.0 113.513 -167.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -77.89 -1.07 29.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.374 1.99 . . . . 25.0 116.374 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.5 16.69 3.0 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 121.122 3.749 . . . . 25.0 121.122 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.78 114.64 18.85 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 125.39 2.519 . . . . 50.0 110.819 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -99.2 162.43 13.06 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 117.633 -3.167 . . . . 25.0 110.822 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.87 14.97 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.72 1.263 . . . . 25.0 112.388 -172.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -92.35 -172.61 3.15 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.401 1.572 . . . . 25.0 109.792 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 105.388 -2.078 . . . . 25.0 105.388 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.7 mt . . . . . 0 C--O 1.217 -0.609 0 N-CA-C 117.426 2.38 . . . . 50.0 117.426 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.83 -36.45 70.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 104.465 -2.42 . . . . 50.0 104.465 161.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.25 -20.62 75.24 Favored Glycine 0 C--O 1.269 2.285 0 CA-C-O 126.009 3.005 . . . . 25.0 108.53 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.52 -20.17 65.48 Favored Glycine 0 C--O 1.197 -2.214 0 O-C-N 116.841 -3.741 . . . . 25.0 115.189 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.8 mt -71.8 -46.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 111.793 -2.203 . . . . 25.0 105.645 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.96 -17.52 57.09 Favored 'General case' 0 CA--C 1.574 1.877 0 O-C-N 118.892 -2.38 . . . . 75.0 116.582 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -66.4 -29.25 69.37 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 123.805 1.764 . . . . 50.0 110.467 167.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.64 24.52 1.21 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.975 2.321 . . . . 25.0 113.983 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.6 48.78 1.43 Allowed 'General case' 0 C--O 1.25 1.114 0 O-C-N 119.52 -1.988 . . . . 25.0 110.951 157.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.271 13.7 t -133.56 174.94 9.89 Favored 'General case' 0 C--O 1.216 -0.702 0 O-C-N 125.365 1.666 . . . . 25.0 111.642 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.68 -17.39 59.97 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 123.849 1.785 . . . . 25.0 107.877 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -89.69 32.38 0.89 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 112.43 -2.168 . . . . 25.0 112.041 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -81.84 84.63 6.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 125.258 2.456 . . . . 25.0 116.354 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -40.06 150.83 0.05 Allowed 'General case' 0 C--O 1.292 3.293 1 CA-C-N 107.438 -4.437 . . . . 25.0 113.077 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -66.32 152.35 45.16 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 105.507 -2.034 . . . . 50.0 105.507 -167.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.51 151.48 27.52 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.79 132.39 28.81 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 117.321 2.341 . . . . 25.0 117.321 168.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -90.0 133.98 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 117.409 -1.281 . . . . 25.0 108.936 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.4 ttt -150.02 142.65 24.54 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 120.359 1.436 . . . . 25.0 111.189 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.2 p -79.35 166.95 21.53 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.285 0.846 . . . . 25.0 113.285 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 147.73 45.45 Favored Glycine 0 C--O 1.257 1.578 0 O-C-N 118.535 -2.603 . . . . 25.0 114.002 172.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.99 -166.04 33.38 Favored Glycine 0 CA--C 1.572 3.599 0 O-C-N 119.693 -2.063 . . . . 25.0 108.658 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -65.44 136.94 57.09 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.13 -1.806 . . . . 25.0 109.848 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -121.15 148.96 43.51 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 103.45 -2.796 . . . . 25.0 103.45 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -122.39 126.2 47.5 Favored 'General case' 0 C--O 1.201 -1.463 0 C-N-CA 124.807 1.243 . . . . 25.0 107.652 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -116.9 79.38 1.32 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 103.535 -2.765 . . . . 50.0 103.535 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -82.95 101.31 10.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.635 -1.166 . . . . 25.0 108.504 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -106.96 137.4 45.1 Favored 'General case' 0 CA--C 1.556 1.187 1 N-CA-C 99.708 -4.182 . . . . 25.0 99.708 173.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 t -151.13 143.46 24.17 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 123.787 1.756 . . . . 25.0 113.671 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -143.11 170.32 15.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 117.791 -1.1 . . . . 50.0 108.593 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . 0.287 9.1 t -72.13 -30.66 65.25 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 124.681 2.182 . . . . 25.0 112.737 175.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.47 152.81 69.79 Favored Pre-proline 0 C--O 1.262 1.721 0 O-C-N 116.78 -3.7 . . . . 25.0 109.062 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.46 161.45 42.38 Favored 'Trans proline' 0 C--O 1.282 2.677 0 C-N-CA 115.61 -2.46 . . . . 25.0 108.52 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -126.06 162.33 25.56 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 117.557 -3.215 . . . . 25.0 112.905 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.41 124.98 23.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 105.026 -2.213 . . . . 25.0 105.026 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -147.12 150.84 35.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 169.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.0 p -94.53 -31.14 14.05 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 120.447 1.476 . . . . 25.0 109.442 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . 0.261 7.2 tt0 -158.54 160.88 37.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 118.604 0.638 . . . . 25.0 109.396 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -142.91 148.93 37.75 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 123.784 1.754 . . . . 25.0 106.815 166.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.96 151.8 51.17 Favored 'General case' 0 C--N 1.27 -2.876 0 O-C-N 119.089 -2.257 . . . . 25.0 108.871 -169.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.21 130.07 45.83 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 105.104 -2.184 . . . . 50.0 105.104 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.43 155.83 23.57 Favored 'General case' 0 C--O 1.182 -2.468 0 CA-C-N 111.857 -2.428 . . . . 50.0 104.512 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.1 pt -134.62 155.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-N 112.129 -2.305 . . . . 25.0 112.291 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.729 ' HG1' ' H ' ' A' ' 147' ' ' VAL . 15.1 p -70.63 156.88 38.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 124.523 2.106 . . . . 25.0 115.108 168.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -130.68 95.43 3.85 Favored 'General case' 0 C--O 1.188 -2.132 0 O-C-N 116.988 -3.57 . . . . 25.0 114.922 173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -68.9 157.07 37.37 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 107.869 -1.16 . . . . 25.0 107.869 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.55 37.75 89.9 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-O 126.077 3.043 . . . . 25.0 110.985 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -67.16 159.84 28.09 Favored 'General case' 0 C--O 1.267 1.987 0 CA-C-O 125.686 2.66 . . . . 25.0 110.777 -171.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -67.46 123.89 87.79 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-N 111.958 -2.383 . . . . 25.0 107.279 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.53 -17.67 20.63 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 117.923 2.24 . . . . 25.0 117.923 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.71 8.44 39.22 Favored 'General case' 0 C--O 1.253 1.252 0 O-C-N 119.696 -1.877 . . . . 75.0 108.407 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -122.18 162.42 37.62 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 112.203 -2.271 . . . . 25.0 114.596 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.88 95.0 1.06 Allowed 'Trans proline' 0 CA--C 1.463 -3.04 0 N-CA-C 117.052 1.905 . . . . 25.0 117.052 -168.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -21.34 -60.76 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 127.064 2.146 . . . . 50.0 116.355 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -77.47 3.33 13.68 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 119.1 -2.25 . . . . 25.0 113.735 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.258 84.2 mtt180 -119.99 -42.19 2.61 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 127.422 2.289 . . . . 25.0 110.868 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.93 -15.74 5.47 Favored 'General case' 0 C--O 1.283 2.84 0 O-C-N 119.812 -1.805 . . . . 25.0 111.833 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -98.58 17.02 20.09 Favored 'General case' 0 C--O 1.271 2.192 0 N-CA-C 118.639 2.829 . . . . 25.0 118.639 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -144.85 161.28 39.67 Favored 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 118.762 -1.175 . . . . 50.0 107.898 168.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.79 158.59 43.84 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.71 137.74 35.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.049 -1.834 . . . . 50.0 106.049 164.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.287 16.7 tt -94.98 -26.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 116.268 -1.825 . . . . 25.0 111.964 169.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.92 156.12 13.65 Favored Glycine 0 N--CA 1.432 -1.58 0 O-C-N 124.893 1.371 . . . . 25.0 112.345 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.26 143.01 50.24 Favored 'General case' 0 N--CA 1.394 -3.251 0 CA-C-O 124.442 2.067 . . . . 25.0 108.351 170.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.4 96.53 48.06 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.325 -1.307 . . . . 50.0 108.173 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.97 159.23 50.84 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 114.056 -3.496 . . . . 25.0 110.601 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -139.91 47.74 1.82 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 115.629 1.715 . . . . 25.0 115.629 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -112.19 -24.86 9.6 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.767 -2.015 . . . . 50.0 107.143 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -160.89 40.21 0.43 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-O 124.925 2.403 . . . . 25.0 113.427 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -81.28 146.96 59.26 Favored Pre-proline 0 C--O 1.273 2.317 0 O-C-N 119.392 -2.24 . . . . 25.0 108.304 -154.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.466 ' HG2' ' HG ' ' A' ' 129' ' ' SER . 92.9 Cg_endo -73.57 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.768 1 C-N-CA 126.021 4.481 . . . . 25.0 107.031 169.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.6 -18.52 0.26 Allowed 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 121.081 3.734 . . . . 25.0 121.081 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.466 ' HG ' ' HG2' ' A' ' 127' ' ' PRO . 56.8 p -52.5 -9.41 0.11 Allowed 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 121.728 2.058 . . . . 25.0 114.582 162.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -60.03 -16.16 28.74 Favored 'General case' 0 N--CA 1.522 3.161 0 O-C-N 117.661 -3.149 . . . . 25.0 113.192 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.66 136.08 50.68 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 104.389 -2.449 . . . . 25.0 104.389 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -69.23 -24.83 64.06 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.504 -1.372 . . . . 75.0 111.196 -165.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.4 t -85.41 136.48 33.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 113.834 -1.53 . . . . 25.0 110.395 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.08 156.58 42.58 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 104.729 -2.323 . . . . 25.0 104.729 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -108.4 119.51 39.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 115.164 -2.351 . . . . 25.0 105.624 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.8 mm -118.42 119.23 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.312 0 C-N-CA 125.384 1.474 . . . . 25.0 111.19 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -77.16 133.77 38.86 Favored 'General case' 0 C--O 1.269 2.101 0 N-CA-C 105.022 -2.214 . . . . 50.0 105.022 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.3 mt -134.86 119.67 13.85 Favored Pre-proline 0 C--N 1.361 1.102 0 CA-C-O 122.908 1.337 . . . . 25.0 108.267 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.83 159.08 13.98 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 116.718 -1.721 . . . . 25.0 112.512 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -153.95 115.92 4.27 Favored 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.923 1.823 . . . . 25.0 115.923 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -105.95 -4.04 21.05 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 113.77 -1.559 . . . . 50.0 115.062 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -118.02 166.51 12.44 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 117.277 -3.389 . . . . 25.0 110.492 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.9 mp -116.55 136.6 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.947 -2.612 . . . . 50.0 103.947 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.97 174.18 25.47 Favored Glycine 0 C--N 1.306 -1.085 0 N-CA-C 119.913 2.725 . . . . 25.0 119.913 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.31 142.19 27.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.588 1.555 . . . . 50.0 108.268 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -146.25 162.73 37.44 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 104.672 -2.344 . . . . 25.0 104.672 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.729 ' H ' ' HG1' ' A' ' 100' ' ' THR . 96.9 t -127.64 136.81 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 123.828 3.013 . . . . 50.0 112.598 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.02 118.58 51.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.642 0 N-CA-C 105.439 -2.06 . . . . 25.0 105.439 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.5 130.76 44.55 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.417 2.056 . . . . 50.0 108.882 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -110.51 127.53 55.21 Favored 'General case' 0 C--O 1.246 0.902 0 O-C-N 120.145 -1.597 . . . . 25.0 109.704 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.87 132.73 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 O-C-N 126.083 2.114 . . . . 50.0 114.673 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 119.52 31.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.69 1.596 . . . . 25.0 109.304 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.42 72.08 4.42 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 126.294 2.246 . . . . 25.0 107.875 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.46 98.97 2.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.533 0 C-N-CA 117.51 -1.676 . . . . 50.0 111.164 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.68 -16.45 64.15 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.756 1.265 . . . . 25.0 113.804 -165.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -60.89 -32.99 72.42 Favored 'General case' 0 CA--C 1.601 2.913 0 CA-C-N 113.763 -1.562 . . . . 25.0 112.145 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.0 t -123.92 158.69 31.38 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.475 1.734 . . . . 25.0 110.019 -166.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.41 -23.73 58.99 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.18 165.05 7.74 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.751 1.019 . . . . 25.0 113.751 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.96 178.44 6.67 Favored 'General case' 0 C--O 1.209 -1.053 1 N-CA-C 98.25 -4.722 . . . . 25.0 98.25 175.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -126.22 130.43 50.93 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.891 -3.744 . . . . 50.0 100.891 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -135.33 138.67 43.63 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 126.15 1.78 . . . . 50.0 111.529 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -160.58 175.52 12.6 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 104.848 -2.278 . . . . 25.0 104.848 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 m -135.86 164.63 31.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 125.158 1.536 . . . . 75.0 107.392 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.0 mm -133.65 120.48 37.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 112.721 -2.036 . . . . 25.0 105.6 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -88.64 124.95 34.57 Favored 'General case' 0 C--O 1.262 1.753 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.518 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.68 158.1 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 117.077 2.251 . . . . 50.0 117.077 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.7 124.92 30.8 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 101.901 -3.37 . . . . 25.0 101.901 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 84.2 mt -114.07 130.53 56.56 Favored 'General case' 0 C--O 1.204 -1.34 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 -174.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.95 158.1 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 116.223 1.934 . . . . 50.0 116.223 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.7 132.38 35.18 Favored 'General case' 0 CA--C 1.585 2.311 0 O-C-N 125.842 1.964 . . . . 25.0 108.831 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.4 pttt . . . . . 0 CA--C 1.552 1.055 0 CA-C-O 118.235 -0.888 . . . . 25.0 110.884 -167.669 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.672 0.749 . . . . 25.0 111.349 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.35 179.71 27.32 Favored Glycine 0 C--O 1.267 2.203 0 C-N-CA 117.794 -2.146 . . . . 25.0 116.956 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -152.37 153.96 34.66 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.096 -2.414 . . . . 50.0 111.351 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.71 133.49 31.42 Favored 'Isoleucine or valine' 0 C--O 1.258 1.518 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 -163.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -120.29 -30.32 4.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.421 -1.312 . . . . 25.0 111.768 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.0 pttt -146.72 162.46 33.63 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 123.568 1.651 . . . . 25.0 107.148 151.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.69 148.95 87.33 Favored 'Cis proline' 0 N--CA 1.494 1.531 0 CA-C-O 123.439 1.35 . . . . 25.0 112.219 6.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.39 -175.69 52.55 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-O 126.013 3.007 . . . . 25.0 115.995 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.3 t -117.4 102.03 8.89 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 111.851 -2.175 . . . . 25.0 108.913 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -57.74 -31.93 66.95 Favored 'General case' 0 C--O 1.181 -2.533 0 O-C-N 123.784 0.678 . . . . 25.0 111.472 -169.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.67 65.58 Favored 'General case' 0 CA--C 1.558 1.269 0 O-C-N 118.365 -2.709 . . . . 25.0 111.925 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.11 -22.12 55.89 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.613 -1.625 . . . . 25.0 106.613 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt . . . . . 0 C--O 1.257 1.491 0 N-CA-C 114.049 1.129 . . . . 75.0 114.049 178.517 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.91 -53.72 55.03 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 118.271 -2.768 . . . . 50.0 111.595 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.93 67.83 41.89 Favored Pre-proline 0 CA--C 1.566 1.58 0 O-C-N 118.88 -2.387 . . . . 25.0 115.813 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.07 -11.49 22.02 Favored 'Trans proline' 0 C--O 1.206 -1.086 0 C-N-CA 124.449 3.433 . . . . 25.0 117.252 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 -8.15 30.21 Favored 'General case' 0 C--O 1.159 -3.663 0 N-CA-C 114.244 1.201 . . . . 25.0 114.244 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -70.44 50.83 0.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 119.412 3.115 . . . . 25.0 119.412 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.15 132.82 46.43 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.198 -1.408 . . . . 50.0 107.198 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 161.92 19.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 120.719 1.6 . . . . 25.0 110.615 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.2 41.42 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-O 115.499 -2.191 . . . . 25.0 108.272 161.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -112.43 142.99 44.3 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 121.962 2.164 . . . . 25.0 113.389 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mttp . . . . . 0 C--N 1.303 -1.422 0 O-C-N 117.987 -2.946 . . . . 25.0 104.487 -179.37 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 117.509 2.411 . . . . 50.0 117.509 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.34 -25.75 46.55 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.325 -2.843 . . . . 50.0 103.325 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.82 -17.92 62.52 Favored Glycine 0 C--O 1.209 -1.445 0 CA-C-O 125.286 2.604 . . . . 25.0 112.578 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.9 -25.28 71.89 Favored Glycine 0 CA--C 1.561 2.948 0 O-C-N 118.684 -2.656 . . . . 25.0 111.821 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.23 -38.03 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.14 -32.53 63.2 Favored 'General case' 0 C--O 1.198 -1.615 0 N-CA-C 104.95 -2.241 . . . . 75.0 104.95 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -68.47 -34.82 76.61 Favored 'General case' 0 C--O 1.264 1.834 0 N-CA-C 116.807 2.151 . . . . 50.0 116.807 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -76.65 16.42 0.51 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 125.789 2.709 . . . . 25.0 114.687 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -126.38 82.64 2.09 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 101.946 -3.353 . . . . 25.0 101.946 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -163.39 166.18 23.16 Favored 'General case' 0 CA--C 1.479 -1.784 0 O-C-N 123.636 0.585 . . . . 25.0 111.839 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -66.46 -29.43 69.56 Favored 'General case' 0 C--O 1.196 -1.754 0 O-C-N 117.448 -3.282 . . . . 25.0 109.977 171.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -82.04 21.88 0.84 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 112.876 -1.966 . . . . 25.0 112.66 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -74.0 97.34 2.83 Favored 'General case' 0 C--O 1.171 -3.054 0 CA-C-O 127.312 3.434 . . . . 25.0 109.649 158.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.1 p90 -29.64 135.41 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.375 1 CA-C-N 107.502 -4.408 . . . . 25.0 112.393 160.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -63.5 152.34 38.77 Favored 'General case' 0 C--O 1.268 2.037 0 N-CA-C 116.302 1.964 . . . . 50.0 116.302 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -101.56 162.01 13.22 Favored 'General case' 0 CA--C 1.479 -1.773 0 CA-C-N 113.513 -1.676 . . . . 25.0 111.576 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -153.47 146.41 24.47 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 124.472 1.109 . . . . 25.0 109.813 164.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.37 135.16 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 106.412 -1.699 . . . . 25.0 106.412 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.1 mtp -137.52 158.28 44.72 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 109.095 -0.706 . . . . 25.0 109.095 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.3 p -120.2 167.02 12.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.41 -164.98 40.36 Favored Glycine 0 C--O 1.266 2.105 0 C-N-CA 119.821 -1.181 . . . . 25.0 111.819 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.85 -173.66 32.24 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 120.573 -0.823 . . . . 25.0 111.104 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -82.02 141.71 32.99 Favored 'General case' 0 C--O 1.28 2.695 0 CA-C-O 124.071 1.891 . . . . 25.0 110.752 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.51 143.33 39.49 Favored 'General case' 0 C--O 1.19 -2.074 0 N-CA-C 104.133 -2.543 . . . . 25.0 104.133 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -98.56 126.14 44.04 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.273 -1.751 . . . . 25.0 106.273 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -110.85 150.73 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 116.179 -1.867 . . . . 50.0 106.154 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.607 ' HG1' ' HB2' ' A' ' 133' ' ' SER . 3.3 t -153.3 159.61 42.56 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 117.632 -1.175 . . . . 25.0 114.129 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -138.07 171.58 14.2 Favored 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.872 -3.01 . . . . 25.0 102.872 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 p -135.3 154.75 51.43 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.121 1.513 . . . . 25.0 107.94 153.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -94.02 154.2 17.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.902 0.858 . . . . 50.0 109.043 169.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.1 p -85.29 -27.02 26.24 Favored 'General case' 0 C--O 1.172 -2.98 0 O-C-N 120.396 -1.44 . . . . 25.0 111.691 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.67 141.66 13.89 Favored Pre-proline 0 CA--C 1.48 -1.739 0 N-CA-C 102.408 -3.182 . . . . 25.0 102.408 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.49 162.84 35.27 Favored 'Trans proline' 0 C--N 1.373 1.843 0 CA-C-O 123.507 1.378 . . . . 25.0 113.76 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.88 148.12 41.58 Favored 'General case' 0 CA--C 1.471 -2.059 0 CA-C-N 112.963 -1.926 . . . . 25.0 106.471 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -81.76 96.95 7.74 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 112.161 -2.291 . . . . 25.0 108.731 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.491 ' HG1' ' HE1' ' A' ' 152' ' ' TRP . 89.6 m -83.98 127.7 34.05 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 116.446 2.017 . . . . 25.0 116.446 -170.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 p -87.83 -42.27 12.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 118.335 -1.346 . . . . 25.0 110.486 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -168.29 168.21 11.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.068 -1.424 . . . . 25.0 109.866 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -140.66 164.65 29.6 Favored 'General case' 0 C--O 1.261 1.661 0 CA-C-N 123.199 2.727 . . . . 25.0 110.96 164.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -139.89 159.77 41.43 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 115.092 -2.385 . . . . 25.0 112.217 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.89 145.0 24.58 Favored 'General case' 0 C--O 1.246 0.901 0 O-C-N 124.951 1.407 . . . . 50.0 111.986 169.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -139.57 169.77 17.14 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 105.56 -2.015 . . . . 50.0 105.56 -172.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 pt -125.38 152.63 32.25 Favored 'Isoleucine or valine' 0 C--O 1.261 1.68 0 CA-C-O 123.791 1.758 . . . . 25.0 106.895 162.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.94 143.32 29.91 Favored 'General case' 0 C--N 1.387 2.206 0 N-CA-C 100.49 -3.892 . . . . 25.0 100.49 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -101.17 133.16 46.14 Favored 'General case' 0 C--O 1.183 -2.416 1 N-CA-C 100.085 -4.042 . . . . 25.0 100.085 -172.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -146.05 151.65 38.08 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 -163.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.21 37.13 9.25 Favored Glycine 0 C--O 1.202 -1.893 0 CA-C-O 125.087 2.493 . . . . 25.0 110.428 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -65.56 157.58 29.37 Favored 'General case' 0 CA--C 1.462 -2.413 0 C-N-CA 126.874 2.07 . . . . 25.0 114.908 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.97 123.05 89.15 Favored Pre-proline 0 CA--C 1.501 -0.942 1 O-C-N 115.438 -4.539 . . . . 25.0 108.937 155.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.77 -24.66 72.6 Favored 'Trans proline' 0 CA--C 1.499 -1.267 0 C-N-CA 115.017 -2.856 . . . . 25.0 117.102 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.96 -6.06 49.16 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 124.221 1.962 . . . . 75.0 113.854 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -56.1 161.95 3.34 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-N 112.663 -2.062 . . . . 25.0 112.254 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -77.55 70.37 6.9 Favored 'Trans proline' 0 C--O 1.175 -2.671 0 CA-C-O 125.972 2.405 . . . . 25.0 113.696 161.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 mt -46.63 -40.66 13.41 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 110.16 -3.2 . . . . 50.0 113.808 -168.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.79 -13.04 61.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 123.233 2.742 . . . . 25.0 115.42 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -117.78 -41.89 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 127.112 2.758 . . . . 25.0 111.627 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.22 -18.07 65.01 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 114.138 1.162 . . . . 25.0 114.138 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.35 33.45 1.4 Allowed 'General case' 0 C--N 1.316 -0.873 0 O-C-N 119.945 -1.722 . . . . 25.0 115.184 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -141.52 145.74 35.52 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.642 1.177 . . . . 50.0 108.538 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.45 142.61 50.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 115.309 1.596 . . . . 25.0 115.309 163.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.5 tp -77.76 137.96 38.74 Favored 'General case' 0 C--N 1.319 -0.753 1 N-CA-C 99.426 -4.287 . . . . 50.0 99.426 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.1 tt -124.52 -5.32 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 O-C-N 126.726 2.516 . . . . 25.0 108.902 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.12 170.31 37.28 Favored Glycine 0 C--O 1.273 2.576 0 N-CA-C 118.277 2.071 . . . . 25.0 118.277 154.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.99 145.6 24.24 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 123.449 1.595 . . . . 25.0 108.243 170.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -118.96 100.63 50.67 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 120.899 -1.125 . . . . 50.0 111.049 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.19 172.81 15.41 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 122.615 2.21 . . . . 25.0 108.398 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -133.88 48.17 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.819 -1.991 . . . . 25.0 108.358 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.7 -11.77 59.83 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 117.239 -1.784 . . . . 50.0 109.131 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 143.1 -171.79 24.84 Favored Glycine 0 C--N 1.294 -1.803 0 CA-C-O 116.927 -2.041 . . . . 25.0 113.091 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.0 154.27 0.12 Allowed Pre-proline 0 N--CA 1.428 -1.525 0 C-N-CA 129.127 2.971 . . . . 25.0 115.75 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.27 10.33 3.75 Favored 'Trans proline' 0 C--O 1.182 -2.277 1 C-N-CA 112.524 -4.517 . . . . 25.0 117.681 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.78 -25.92 62.21 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 119.711 -1.868 . . . . 25.0 109.165 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 81.3 p -71.61 -19.0 62.18 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 123.917 1.817 . . . . 25.0 111.67 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -72.46 -23.92 61.12 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 111.416 -2.629 . . . . 25.0 109.609 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.62 109.87 5.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 119.282 -2.136 . . . . 25.0 110.444 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.7 -36.22 14.46 Favored 'General case' 0 C--O 1.278 2.58 0 O-C-N 119.358 -2.088 . . . . 75.0 109.312 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.607 ' HB2' ' HG1' ' A' ' 83' ' ' THR . 42.7 t -73.73 131.66 41.83 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.176 0.99 . . . . 25.0 110.085 174.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.08 161.14 38.34 Favored 'General case' 0 C--O 1.275 2.429 0 CA-C-O 121.85 0.833 . . . . 25.0 109.293 -173.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -109.11 131.75 54.77 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.153 -0.931 . . . . 25.0 108.587 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.14 117.79 38.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -75.66 134.5 40.57 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 125.583 1.802 . . . . 50.0 106.971 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 18.1 mt -125.72 119.3 24.31 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 103.041 -2.948 . . . . 25.0 103.041 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.2 153.26 67.08 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 124.007 1.53 . . . . 25.0 112.361 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.29 50.98 0.78 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.201 1.477 . . . . 25.0 109.692 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.55 -35.4 75.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 118.606 2.817 . . . . 50.0 118.606 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -155.47 166.64 32.93 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.602 1.961 . . . . 25.0 112.861 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.6 mp -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 115.993 -0.549 . . . . 50.0 111.148 165.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 141.08 165.06 10.18 Favored Glycine 0 C--O 1.187 -2.842 0 C-N-CA 118.122 -1.99 . . . . 25.0 114.779 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.59 145.51 47.32 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 119.181 3.03 . . . . 50.0 119.181 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -142.9 157.37 44.65 Favored 'General case' 0 C--O 1.201 -1.478 0 N-CA-C 102.883 -3.006 . . . . 25.0 102.883 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.15 135.87 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 104.512 -2.403 . . . . 50.0 104.512 164.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.79 123.58 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 93.128 -6.619 . . . . 25.0 93.128 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 mp -106.29 145.03 32.14 Favored 'General case' 0 C--O 1.185 -2.292 0 C-N-CA 124.021 0.929 . . . . 50.0 109.647 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.36 45.88 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 115.971 -1.966 . . . . 25.0 113.619 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.52 128.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.265 1.911 0 O-C-N 125.006 1.442 . . . . 50.0 111.059 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.491 ' HE1' ' HG1' ' A' ' 92' ' ' THR . 2.4 t-105 -118.82 119.55 34.71 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 116.766 -1.588 . . . . 25.0 109.02 -177.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -92.35 135.6 33.89 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 103.704 -2.702 . . . . 25.0 103.704 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.6 t -118.46 126.81 75.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 104.154 -2.536 . . . . 50.0 104.154 -172.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.42 -16.97 63.0 Favored 'General case' 0 CA--C 1.476 -1.901 1 O-C-N 116.051 -4.156 . . . . 25.0 115.936 -166.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.19 -28.13 53.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 128.172 2.589 . . . . 25.0 112.753 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.3 p -134.75 164.8 26.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 116.775 2.139 . . . . 25.0 116.775 -158.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -95.1 -15.96 22.99 Favored 'General case' 0 C--O 1.184 -2.357 0 CA-C-O 124.47 2.081 . . . . 25.0 113.092 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -66.83 155.04 39.35 Favored 'General case' 0 C--O 1.287 3.04 0 O-C-N 118.86 -2.4 . . . . 25.0 111.084 155.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.82 140.74 22.84 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 103.354 -2.832 . . . . 25.0 103.354 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -83.78 165.67 18.64 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 105.119 -2.178 . . . . 50.0 105.119 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.12 160.58 43.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.853 -1.521 . . . . 50.0 109.241 164.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -147.65 154.2 40.32 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 116.787 -1.578 . . . . 25.0 110.416 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.5 m -138.85 128.28 31.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.56 -2.015 . . . . 75.0 105.56 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.8 mt -132.53 126.97 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.135 0 N-CA-C 106.262 -1.755 . . . . 25.0 106.262 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.97 135.3 33.72 Favored 'General case' 0 C--N 1.311 -1.086 1 O-C-N 115.773 -4.329 . . . . 25.0 108.813 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.86 134.96 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 O-C-N 117.246 -3.409 . . . . 50.0 102.802 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.42 99.11 12.02 Favored 'General case' 0 CA--C 1.554 1.102 0 O-C-N 119.769 -1.832 . . . . 25.0 106.192 171.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.33 128.43 35.49 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 121.696 2.044 . . . . 50.0 110.499 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.11 168.25 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . 0.312 26.1 t30 -83.07 146.82 28.49 Favored 'General case' 0 N--CA 1.385 -3.703 0 N-CA-C 106.775 -1.565 . . . . 25.0 106.775 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 CA--C 1.482 -1.651 0 CA-C-N 121.727 2.058 . . . . 25.0 110.042 170.757 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 161' ' ' PHE . 76.5 m80 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 125.118 2.389 . . . . 25.0 109.669 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.37 -161.38 14.22 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 112.712 -2.04 . . . . 25.0 108.257 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -149.96 162.71 39.82 Favored 'General case' 0 C--O 1.27 2.166 0 CA-C-N 114.138 -1.031 . . . . 50.0 110.703 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mm -85.16 139.14 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 O-C-N 125.554 1.784 . . . . 25.0 111.543 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.73 39.21 3.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 103.912 -2.625 . . . . 25.0 103.912 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 75.92 146.43 0.11 Allowed Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 127.451 2.3 . . . . 25.0 114.161 171.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.68 147.55 15.61 Favored 'Cis proline' 0 CA--C 1.491 -1.635 0 O-C-N 118.252 -1.499 . . . . 25.0 114.865 -18.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.07 33.38 6.04 Favored Glycine 0 C--O 1.187 -2.836 0 C-N-CA 124.867 1.222 . . . . 25.0 111.668 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.6 t -75.73 138.75 41.47 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 118.951 1.375 . . . . 25.0 108.266 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -85.39 -18.18 34.46 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 123.618 1.675 . . . . 25.0 106.568 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.79 80.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.12 -14.66 60.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.53 -0.731 . . . . 25.0 110.288 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 104.15 -2.537 . . . . 75.0 104.15 177.635 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.5 ptm . . . . . 0 C--O 1.199 -1.572 0 N-CA-C 120.718 3.599 . . . . 25.0 120.718 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.27 -43.29 95.3 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 119.172 -2.205 . . . . 50.0 112.162 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -145.05 62.6 9.22 Favored Pre-proline 0 C--O 1.275 2.415 0 N-CA-C 113.394 0.887 . . . . 25.0 113.394 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -15.64 47.03 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 116.325 -1.983 . . . . 25.0 112.817 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -66.06 -18.69 65.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.765 -1.835 . . . . 25.0 115.741 170.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -77.95 -4.42 46.83 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.584 0.707 . . . . 25.0 112.016 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.1 94.47 1.92 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 120.806 -1.184 . . . . 50.0 112.687 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -120.73 162.26 20.03 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 119.208 3.04 . . . . 25.0 119.208 -174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.25 170.94 15.22 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 104.804 -2.295 . . . . 25.0 104.804 -172.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -122.96 141.37 52.01 Favored 'General case' 0 C--O 1.275 2.42 0 O-C-N 124.89 1.369 . . . . 25.0 108.657 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt . . . . . 0 C--O 1.197 -1.701 0 O-C-N 125.544 1.778 . . . . 25.0 109.142 -178.834 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 CA--C 1.502 -0.888 0 N-CA-C 116.999 2.222 . . . . 50.0 116.999 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -74.99 -24.95 58.51 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 112.681 -2.054 . . . . 50.0 110.769 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.32 59.89 Favored Glycine 0 C--O 1.2 -2.002 0 O-C-N 127.294 2.871 . . . . 25.0 109.025 173.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.02 -30.45 78.03 Favored Glycine 0 C--N 1.358 1.797 0 N-CA-C 116.728 1.451 . . . . 25.0 116.728 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -80.41 -39.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.246 -2.502 . . . . 25.0 104.246 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.63 -27.4 66.85 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 126.631 1.973 . . . . 75.0 111.63 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.14 -10.45 59.77 Favored 'General case' 0 C--O 1.182 -2.456 0 O-C-N 121.169 -0.957 . . . . 50.0 109.469 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.71 -12.52 60.74 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 127.259 3.409 . . . . 25.0 112.979 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -148.55 69.15 1.09 Allowed 'General case' 0 C--O 1.277 2.501 0 CA-C-N 111.42 -2.627 . . . . 25.0 109.047 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.0 t -143.29 155.53 44.49 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 116.834 -1.555 . . . . 25.0 108.928 -170.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -55.0 -32.57 61.89 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 121.276 1.853 . . . . 25.0 114.624 158.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.53 -34.91 67.89 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 115.303 1.594 . . . . 25.0 115.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.314 24.8 ttp180 0.42 73.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.448 2.699 . . . . 25.0 116.458 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.16 149.3 45.66 Favored 'General case' 0 C--O 1.208 -1.112 1 CA-C-N 107.871 -4.24 . . . . 25.0 107.546 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -74.92 142.43 44.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.114 1.766 . . . . 50.0 114.139 -146.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 153.72 36.54 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 125.222 1.409 . . . . 25.0 111.107 -172.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -135.01 176.76 8.36 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 102.905 -2.998 . . . . 25.0 102.905 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -124.01 139.65 49.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 168.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . 0.267 60.6 mtp -143.94 171.24 14.52 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.683 1.128 . . . . 25.0 109.396 175.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.7 p -103.12 165.7 10.87 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.127 -1.608 . . . . 25.0 113.201 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.15 179.32 48.07 Favored Glycine 0 C--O 1.256 1.475 0 O-C-N 119.347 -2.096 . . . . 25.0 114.068 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.31 168.02 29.02 Favored Glycine 0 CA--C 1.542 1.757 0 CA-C-O 123.511 1.617 . . . . 25.0 112.849 -168.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.4 127.64 33.74 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.158 -2.217 . . . . 25.0 115.935 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.97 156.84 37.42 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m -103.72 141.04 36.76 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 112.37 -2.195 . . . . 25.0 108.904 166.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -123.66 149.08 45.86 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 115.695 -2.098 . . . . 50.0 105.606 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.8 m -132.25 138.19 47.81 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.373 -1.343 . . . . 25.0 107.373 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.84 161.04 24.81 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 103.02 -2.956 . . . . 25.0 103.02 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.0 t -140.16 137.11 34.15 Favored 'General case' 0 C--O 1.263 1.774 0 N-CA-C 106.799 -1.556 . . . . 25.0 106.799 160.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.36 125.76 50.7 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.569 1.548 . . . . 50.0 109.95 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -125.65 6.78 7.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 119.52 3.156 . . . . 25.0 119.52 -156.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . 0.313 . . -57.75 -63.38 3.89 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 114.512 -2.661 . . . . 25.0 117.111 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.29 176.86 37.44 Favored 'Cis proline' 0 CA--C 1.538 0.691 1 C-N-CA 136.676 4.032 . . . . 25.0 111.678 -9.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -131.02 164.35 25.6 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 102.84 -3.022 . . . . 25.0 102.84 165.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -89.11 150.04 22.91 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 105.125 -2.176 . . . . 25.0 105.125 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.4 m -137.84 134.82 35.58 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 107.733 -1.21 . . . . 25.0 107.733 -159.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 p -98.98 -34.27 10.5 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 117.437 -1.705 . . . . 25.0 110.978 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -156.03 151.22 26.6 Favored 'General case' 0 C--O 1.194 -1.841 0 C-N-CA 128.425 2.69 . . . . 25.0 111.492 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -137.96 136.27 36.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 119.452 -2.03 . . . . 25.0 108.459 150.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -142.72 163.43 32.84 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 117.861 -1.536 . . . . 25.0 111.701 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -149.43 141.29 23.7 Favored 'General case' 0 C--O 1.261 1.699 0 O-C-N 125.276 1.61 . . . . 50.0 114.259 -164.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -121.36 165.28 15.76 Favored 'General case' 0 C--O 1.183 -2.417 0 C-N-CA 126.535 1.934 . . . . 50.0 106.605 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.5 pt -127.3 159.69 37.28 Favored 'Isoleucine or valine' 0 C--O 1.261 1.681 0 CA-C-N 111.936 -2.393 . . . . 25.0 106.95 168.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.9 p -102.78 165.89 10.8 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 124.425 2.059 . . . . 25.0 105.699 156.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -105.63 -177.14 3.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 112.322 -2.217 . . . . 25.0 107.121 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -163.31 167.03 22.39 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.08 64.27 3.22 Favored Glycine 0 C--O 1.274 2.633 0 O-C-N 119.822 -1.798 . . . . 25.0 113.092 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.12 171.18 14.42 Favored 'General case' 0 C--O 1.193 -1.904 0 N-CA-C 116.38 1.993 . . . . 25.0 116.38 -166.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -85.39 110.92 32.89 Favored Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-O 117.1 -1.428 . . . . 25.0 110.974 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -57.99 -21.56 50.63 Favored 'Trans proline' 0 N--CA 1.447 -1.25 1 N-CA-C 123.68 4.454 . . . . 25.0 123.68 174.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.251 23.7 t70 -71.45 -17.83 62.35 Favored 'General case' 0 C--O 1.264 1.852 0 C-N-CA 116.151 -2.22 . . . . 75.0 114.032 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -72.01 161.12 80.52 Favored Pre-proline 0 C--N 1.38 1.921 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -41.01 22.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.542 2 C-N-CA 129.403 6.735 . . . . 25.0 124.373 161.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 53.7 mt -51.93 -35.57 46.17 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 116.507 -3.871 . . . . 50.0 116.991 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -68.11 -7.96 34.21 Favored 'General case' 0 C--O 1.198 -1.617 0 N-CA-C 115.046 1.499 . . . . 25.0 115.046 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -127.8 -60.3 1.17 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.453 -0.794 . . . . 25.0 110.074 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.1 -22.49 62.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 116.443 -1.741 . . . . 25.0 112.634 -168.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.8 20.8 18.07 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 127.042 2.713 . . . . 25.0 113.194 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -110.34 127.73 55.2 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 103.084 -2.932 . . . . 50.0 103.084 158.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.46 122.86 20.71 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.036 -1.865 . . . . 25.0 110.891 -169.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -62.25 117.62 6.32 Favored 'General case' 0 C--O 1.2 -1.522 0 N-CA-C 102.547 -3.131 . . . . 50.0 102.547 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.95 -11.14 9.3 Favored 'Isoleucine or valine' 0 C--O 1.265 1.919 0 CA-C-O 122.729 1.252 . . . . 25.0 112.594 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 174.83 30.1 Favored Glycine 0 C--N 1.365 2.192 0 N-CA-C 117.644 1.817 . . . . 25.0 117.644 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.81 155.13 43.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 128.612 3.183 . . . . 25.0 111.788 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.82 89.84 48.14 Favored Pre-proline 0 C--O 1.265 1.885 0 C-N-CA 128.682 2.793 . . . . 50.0 104.22 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.05 161.24 29.77 Favored 'Trans proline' 0 C--O 1.195 -1.674 1 C-N-CA 111.904 -4.93 . . . . 25.0 111.982 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -79.8 115.41 19.38 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.346 -1.741 . . . . 25.0 109.005 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -128.09 -8.11 5.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.147 1.339 . . . . 50.0 113.661 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.34 -15.67 62.82 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 115.762 1.065 . . . . 25.0 115.762 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -66.93 153.1 95.0 Favored Pre-proline 0 N--CA 1.492 1.652 1 N-CA-C 99.736 -4.172 . . . . 25.0 99.736 163.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.99 18.42 0.31 Allowed 'Trans proline' 0 CA--C 1.509 -0.76 0 N-CA-C 116.231 1.589 . . . . 25.0 116.231 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -31.87 68.04 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 154.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.1 m -76.02 -25.23 55.5 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-O 116.534 -1.698 . . . . 25.0 106.523 -172.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -82.6 -0.46 47.06 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 121.341 1.882 . . . . 25.0 115.851 176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -81.95 84.66 6.87 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.862 -1.135 . . . . 25.0 113.937 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.1 3.94 54.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.755 -1.566 . . . . 75.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.0 t -104.48 122.61 45.89 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 119.85 -1.781 . . . . 25.0 115.402 162.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -148.76 137.48 21.35 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.765 -1.569 . . . . 25.0 106.765 -154.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -84.34 132.67 34.58 Favored 'General case' 0 C--O 1.267 2.012 0 C-N-CA 126.022 1.729 . . . . 25.0 114.946 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.4 mt -131.06 124.82 56.62 Favored 'Isoleucine or valine' 0 C--O 1.262 1.754 0 O-C-N 119.739 -1.851 . . . . 25.0 107.445 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -77.67 126.03 30.25 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 112.913 0.708 . . . . 50.0 112.913 167.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.96 128.66 25.72 Favored Pre-proline 0 C--O 1.248 0.989 0 N-CA-C 102.476 -3.157 . . . . 25.0 102.476 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.99 157.96 53.52 Favored 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 112.587 -4.475 . . . . 25.0 112.658 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -101.34 36.87 1.9 Allowed 'General case' 0 C--O 1.211 -0.924 0 O-C-N 120.461 -1.399 . . . . 25.0 110.628 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -65.81 -46.65 77.84 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 119.765 3.246 . . . . 50.0 119.765 -167.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -150.9 173.32 14.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.213 2.205 . . . . 25.0 105.775 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.1 mp -84.83 169.0 14.59 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 101.497 -3.52 . . . . 50.0 101.497 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.78 176.53 22.35 Favored Glycine 0 CA--C 1.476 -2.362 0 CA-C-O 126.441 3.245 . . . . 25.0 113.014 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -93.17 163.98 13.42 Favored 'General case' 0 C--O 1.271 2.187 0 O-C-N 117.399 -3.413 . . . . 50.0 112.241 -164.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -162.16 173.44 14.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 127.442 2.297 . . . . 25.0 107.7 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.52 143.1 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.792 1.178 . . . . 50.0 113.894 174.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.0 mt -103.88 135.96 39.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 101.635 -3.469 . . . . 25.0 101.635 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -125.8 148.97 48.96 Favored 'General case' 0 C--O 1.187 -2.223 0 O-C-N 117.909 -2.995 . . . . 50.0 107.963 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.16 161.52 37.68 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 116.224 -1.846 . . . . 25.0 113.321 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.61 119.96 3.81 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 O-C-N 125.787 1.93 . . . . 50.0 106.162 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.13 117.63 31.76 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 127.169 2.188 . . . . 25.0 112.457 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.88 111.29 23.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 104.144 -2.539 . . . . 25.0 104.144 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.0 t -84.33 124.87 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.145 0 CA-C-O 124.118 1.913 . . . . 50.0 109.63 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.69 -24.13 62.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.107 -1.621 . . . . 25.0 111.309 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.09 -17.11 58.92 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 117.094 -1.842 . . . . 25.0 114.493 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.0 p -125.53 156.68 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 119.279 -2.138 . . . . 25.0 113.911 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.73 -29.61 69.63 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-O 122.641 1.21 . . . . 25.0 110.274 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -79.55 161.4 26.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 119.194 -2.191 . . . . 25.0 115.062 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.7 167.13 21.08 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 114.691 -1.141 . . . . 25.0 108.736 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 1' ' ' HIS . 63.2 m-85 -115.94 144.66 43.76 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.976 -1.12 . . . . 50.0 107.976 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -122.33 155.88 35.07 Favored 'General case' 0 C--O 1.242 0.707 0 O-C-N 125.84 1.963 . . . . 50.0 107.402 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -126.8 151.9 47.67 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.763 -1.562 . . . . 25.0 108.939 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.71 135.55 50.99 Favored 'Isoleucine or valine' 0 C--O 1.268 2.065 0 N-CA-C 105.91 -1.885 . . . . 75.0 105.91 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.6 mt -139.56 106.96 2.83 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 N-CA-C 105.642 -1.984 . . . . 25.0 105.642 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -84.71 131.41 34.58 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 120.247 -1.533 . . . . 25.0 113.837 174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.74 142.4 43.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 120.307 -1.496 . . . . 50.0 113.061 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -83.9 132.36 34.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 116.497 -1.716 . . . . 25.0 107.581 167.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.1 mt -126.4 131.51 51.72 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 103.146 -2.909 . . . . 50.0 103.146 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.0 171.51 17.58 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 105.683 -1.969 . . . . 50.0 105.683 -171.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.35 146.27 32.98 Favored 'General case' 0 C--O 1.283 2.844 0 O-C-N 120.972 -1.08 . . . . 25.0 111.575 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt . . . . . 0 C--O 1.289 3.17 0 CA-C-O 116.173 -1.87 . . . . 25.0 112.114 178.724 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.6 m80 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 118.228 -0.892 . . . . 25.0 108.666 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.67 -154.06 10.65 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 118.046 -2.026 . . . . 25.0 116.134 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.19 170.12 20.22 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 125.237 2.446 . . . . 50.0 105.956 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.7 mt -84.34 126.51 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 O-C-N 118.915 -2.366 . . . . 25.0 113.509 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -92.88 -28.3 16.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 116.204 1.927 . . . . 25.0 116.204 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -145.92 122.33 5.87 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 105.729 -1.952 . . . . 25.0 105.729 168.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.29 133.06 10.53 Favored 'Cis proline' 0 C--O 1.197 -1.551 0 C-N-CA 130.543 1.476 . . . . 25.0 113.116 -2.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.62 -88.99 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.805 -1.543 . . . . 25.0 116.146 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -54.5 134.4 46.23 Favored 'General case' 0 C--O 1.262 1.724 0 N-CA-C 114.811 1.412 . . . . 25.0 114.811 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 ttt-85 -118.86 -32.19 4.57 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 112.481 -2.145 . . . . 25.0 114.405 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.47 -24.06 62.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 116.788 2.144 . . . . 25.0 116.788 -172.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.19 60.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 124.437 2.065 . . . . 25.0 111.191 174.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 mt . . . . . 0 N--CA 1.492 1.642 1 O-C-N 115.572 -4.455 . . . . 75.0 109.67 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 C--O 1.206 -1.215 0 N-CA-C 117.681 2.474 . . . . 25.0 117.681 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -63.65 -38.44 91.14 Favored 'General case' 0 N--CA 1.432 -1.329 0 O-C-N 119.484 -2.01 . . . . 50.0 106.639 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.37 48.83 0.56 Allowed Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.371 1.248 . . . . 25.0 114.371 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.24 -19.99 21.83 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 O-C-N 116.571 -2.384 . . . . 25.0 117.449 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -83.83 -2.45 56.4 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 117.007 -1.473 . . . . 25.0 109.616 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.694 2.497 . . . . 25.0 113.722 -171.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.96 151.21 31.77 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 118.021 -2.925 . . . . 50.0 105.913 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -140.01 160.9 38.87 Favored 'General case' 0 C--O 1.186 -2.239 0 O-C-N 120.271 -1.518 . . . . 25.0 113.625 -170.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.79 149.8 35.01 Favored 'General case' 0 C--O 1.261 1.662 1 N-CA-C 99.912 -4.107 . . . . 25.0 99.912 163.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -91.33 146.16 24.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 105.06 -2.2 . . . . 25.0 105.06 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt . . . . . 0 CA--C 1.579 2.075 0 O-C-N 126.382 2.301 . . . . 25.0 110.587 176.65 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.6 mt . . . . . 0 C--O 1.251 1.133 0 CA-C-O 116.624 -1.655 . . . . 50.0 111.86 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -63.66 -25.96 68.45 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 107.007 -1.479 . . . . 50.0 107.007 142.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.86 -10.02 85.05 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 119.769 -1.832 . . . . 25.0 115.477 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.34 -2.31 47.97 Favored Glycine 0 C--O 1.286 3.386 0 N-CA-C 118.418 2.127 . . . . 25.0 118.418 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -63.2 -41.19 91.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 123.378 1.561 . . . . 25.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.04 -28.58 62.42 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 114.087 -1.415 . . . . 75.0 110.933 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -109.89 21.98 16.2 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-O 124.086 1.898 . . . . 50.0 113.971 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -75.84 41.72 0.22 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 120.991 3.7 . . . . 25.0 120.991 -170.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -138.12 45.6 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.767 -1.938 . . . . 25.0 105.767 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -143.31 -172.87 3.79 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.634 1.683 . . . . 25.0 110.784 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -61.48 -22.01 64.7 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.393 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -77.01 2.82 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 119.699 -1.876 . . . . 25.0 112.507 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -87.69 84.11 7.11 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 128.183 3.849 . . . . 25.0 112.918 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 148.87 34.78 Favored 'General case' 0 C--N 1.287 -2.117 1 CA-C-N 106.008 -5.087 . . . . 25.0 111.395 156.1 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -75.87 147.36 39.11 Favored 'General case' 0 C--O 1.188 -2.162 0 N-CA-C 105.911 -1.885 . . . . 50.0 105.911 -174.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -84.12 121.34 27.32 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -73.59 119.73 18.21 Favored 'General case' 0 CA--C 1.461 -2.477 0 C-N-CA 116.412 -2.115 . . . . 25.0 106.535 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.25 129.54 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 98.7 mmm -140.57 150.76 44.07 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 104.476 -2.416 . . . . 25.0 104.476 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -88.31 176.97 6.98 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 104.451 -2.425 . . . . 25.0 104.451 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.24 174.1 34.84 Favored Glycine 1 C--O 1.158 -4.628 0 N-CA-C 107.079 -2.409 . . . . 25.0 107.079 171.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.72 178.76 47.84 Favored Glycine 0 C--O 1.201 -1.911 0 C-N-CA 126.543 2.02 . . . . 25.0 112.851 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -72.81 141.37 48.02 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 114.417 -2.706 . . . . 25.0 114.006 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -132.6 156.55 46.68 Favored 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 105.974 -1.861 . . . . 25.0 105.974 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.4 m -89.18 107.59 19.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.741 -3.059 . . . . 25.0 102.741 -172.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.83 115.31 27.99 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 106.436 -1.69 . . . . 50.0 106.436 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.4 m -133.01 132.4 41.83 Favored 'General case' 0 C--O 1.267 1.976 0 N-CA-C 108.501 -0.926 . . . . 25.0 108.501 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -117.48 170.06 9.03 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 106.106 -1.812 . . . . 25.0 106.106 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -140.31 146.73 38.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.976 -2.601 . . . . 25.0 103.976 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.72 147.3 46.09 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 113.773 -1.558 . . . . 50.0 113.06 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 t -61.24 -23.39 65.6 Favored 'General case' 0 C--O 1.26 1.633 0 O-C-N 125.748 1.905 . . . . 25.0 113.714 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.19 32.06 Favored Pre-proline 0 CA--C 1.497 -1.082 0 N-CA-C 103.6 -2.741 . . . . 25.0 103.6 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -64.45 166.2 18.07 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 113.656 -3.762 . . . . 25.0 111.77 164.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -129.06 147.17 50.9 Favored 'General case' 0 C--O 1.197 -1.696 0 O-C-N 126.21 2.194 . . . . 25.0 106.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.76 125.71 25.66 Favored 'General case' 0 C--O 1.186 -2.256 0 O-C-N 126.051 2.095 . . . . 25.0 106.498 165.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.3 m -129.43 145.21 51.45 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 124.917 1.287 . . . . 25.0 109.921 -172.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -105.79 -48.95 3.51 Favored 'General case' 0 CA--C 1.624 3.815 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -152.51 160.48 43.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.295 -2.483 . . . . 25.0 104.295 177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -143.21 141.02 30.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.07 -1.423 . . . . 25.0 110.637 161.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.56 163.64 32.62 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.177 -0.952 . . . . 25.0 113.123 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -136.99 149.34 47.45 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 117.713 2.486 . . . . 50.0 117.713 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -127.87 164.8 21.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.596 1.558 . . . . 50.0 112.851 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.8 pt -127.78 152.35 35.75 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-N 113.93 -1.486 . . . . 25.0 109.254 173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.3 p -94.16 164.14 13.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 102.919 -2.993 . . . . 25.0 102.919 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -73.58 136.43 43.98 Favored 'General case' 0 C--O 1.185 -2.318 0 O-C-N 119.808 -1.808 . . . . 25.0 111.995 -163.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -71.88 114.51 10.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 119.162 -2.211 . . . . 25.0 108.53 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.6 47.97 3.58 Favored Glycine 0 C--O 1.277 2.792 0 CA-C-N 120.857 1.662 . . . . 25.0 110.393 -172.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.4 160.89 12.57 Favored 'General case' 0 CA--C 1.593 2.616 0 N-CA-C 107.186 -1.412 . . . . 25.0 107.186 -170.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -132.67 105.29 12.96 Favored Pre-proline 0 C--O 1.275 2.421 0 O-C-N 126.119 2.137 . . . . 25.0 107.142 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.97 -11.31 25.44 Favored 'Trans proline' 0 C--N 1.371 1.745 0 N-CA-C 116.872 1.835 . . . . 25.0 116.872 -174.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.85 -10.46 53.19 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.12 1.155 . . . . 75.0 114.12 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -89.25 175.53 3.88 Favored Pre-proline 0 C--O 1.215 -0.747 0 C-N-CA 126.961 2.104 . . . . 25.0 113.211 -176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -19.66 37.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 1 C-N-CA 134.626 10.218 . . . . 25.0 120.124 121.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.69 -36.02 23.69 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 129.571 3.149 . . . . 50.0 111.33 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.46 -5.72 58.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 119.887 -1.758 . . . . 25.0 110.942 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -130.26 -72.01 0.58 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.306 1.965 . . . . 25.0 116.306 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.75 -0.89 25.43 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 122.975 2.625 . . . . 25.0 114.274 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -75.64 -23.63 56.34 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.593 1.088 . . . . 25.0 111.337 163.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.27 154.79 21.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.969 -1.493 . . . . 50.0 106.969 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.58 158.22 40.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.312 -2.477 . . . . 25.0 104.312 159.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.3 tp -87.81 128.79 35.33 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 102.616 -3.105 . . . . 50.0 102.616 158.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.97 -21.77 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 106.926 -1.509 . . . . 25.0 106.926 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.91 164.56 30.41 Favored Glycine 0 C--O 1.202 -1.89 0 CA-C-N 119.719 1.145 . . . . 25.0 113.082 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.4 42.21 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 106.0 -1.852 . . . . 25.0 106.0 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.68 95.4 17.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-N 112.251 -2.25 . . . . 50.0 108.736 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.61 166.34 29.58 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 121.391 1.394 . . . . 25.0 109.87 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -124.32 140.59 52.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.197 -1.408 . . . . 25.0 107.197 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.3 -11.73 5.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 115.449 1.648 . . . . 50.0 115.449 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.03 -9.07 33.75 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 126.44 1.972 . . . . 25.0 110.892 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.6 p -74.46 154.27 87.81 Favored Pre-proline 0 C--O 1.197 -1.659 0 N-CA-C 100.827 -3.768 . . . . 25.0 100.827 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.39 25.53 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 117.202 -1.399 . . . . 25.0 113.932 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.55 -16.29 60.28 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 118.808 -2.433 . . . . 25.0 108.171 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.1 p -69.57 -13.97 62.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.667 -1.606 . . . . 25.0 113.659 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.92 -28.79 69.18 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.067 -0.97 . . . . 25.0 111.54 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -68.12 88.89 0.3 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.62 0.724 . . . . 25.0 109.979 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.6 tp -92.39 -27.6 17.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 126.412 3.006 . . . . 75.0 107.485 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.4 t -81.41 123.72 28.81 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 110.724 -2.944 . . . . 25.0 107.647 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -129.63 135.68 48.83 Favored 'General case' 0 CA--C 1.572 1.801 0 O-C-N 124.959 1.412 . . . . 25.0 108.841 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -69.78 130.53 42.56 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 116.233 -1.841 . . . . 25.0 106.117 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.8 mm -128.7 118.33 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.953 0 CA-C-N 121.058 1.754 . . . . 25.0 112.274 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -67.49 129.85 41.19 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 115.654 1.724 . . . . 50.0 115.654 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.26 118.4 44.01 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 118.1 -2.875 . . . . 25.0 107.555 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.34 146.41 45.14 Favored 'Trans proline' 0 CA--C 1.483 -2.06 0 C-N-CA 115.216 -2.723 . . . . 25.0 116.417 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -87.73 53.88 2.93 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 123.297 1.522 . . . . 25.0 108.05 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -84.33 -30.87 25.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 120.002 3.334 . . . . 50.0 120.002 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -152.22 177.96 9.99 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 114.047 -2.882 . . . . 25.0 104.505 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 mp -113.67 126.46 55.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 104.567 -2.383 . . . . 50.0 104.567 160.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.78 170.12 32.16 Favored Glycine 0 CA--C 1.473 -2.539 0 C-N-CA 118.148 -1.977 . . . . 25.0 114.533 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.86 135.61 53.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.36 1.464 . . . . 50.0 112.462 -168.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -147.0 167.69 23.39 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 125.349 1.656 . . . . 25.0 113.449 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.4 t -85.2 158.87 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 126.896 2.623 . . . . 50.0 104.559 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.8 mt -129.24 136.16 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 N-CA-C 103.43 -2.804 . . . . 25.0 103.43 162.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.34 153.03 39.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 104.741 -2.318 . . . . 50.0 104.741 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.61 157.4 45.52 Favored 'General case' 0 C--O 1.184 -2.371 0 CA-C-N 121.632 2.015 . . . . 25.0 106.61 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.52 134.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 126.832 2.583 . . . . 50.0 110.405 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -124.17 119.68 30.1 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 120.792 1.633 . . . . 25.0 108.084 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -84.4 89.13 7.33 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 119.563 -1.96 . . . . 25.0 111.461 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.67 103.65 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 113.23 -1.805 . . . . 50.0 106.5 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.12 -18.89 64.76 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 113.793 -1.549 . . . . 25.0 114.26 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.68 -26.35 66.99 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 119.178 3.029 . . . . 25.0 119.178 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 45.7 p -115.24 158.45 22.3 Favored 'General case' 0 C--O 1.262 1.725 0 N-CA-C 114.796 1.406 . . . . 25.0 114.796 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -28.15 27.81 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 106.918 -1.512 . . . . 25.0 106.918 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -66.7 157.89 31.53 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 124.615 2.15 . . . . 25.0 111.416 160.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.49 155.45 42.27 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 101.954 -3.35 . . . . 25.0 101.954 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -111.53 153.35 26.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.072 2.107 . . . . 50.0 115.905 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -142.59 152.1 42.2 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 124.019 1.866 . . . . 50.0 106.74 -162.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -155.38 149.26 25.49 Favored 'General case' 0 C--O 1.19 -2.068 0 O-C-N 120.043 -1.661 . . . . 25.0 111.534 167.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.81 127.5 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 125.269 1.606 . . . . 75.0 112.556 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 152.77 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-N 121.835 2.107 . . . . 25.0 108.676 172.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -88.93 156.82 18.67 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 118.94 2.941 . . . . 25.0 118.94 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.1 169.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 102.695 -3.076 . . . . 50.0 102.695 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -132.66 122.61 24.92 Favored 'General case' 0 C--O 1.258 1.505 0 N-CA-C 103.03 -2.952 . . . . 25.0 103.03 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.68 119.4 34.35 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 122.07 2.214 . . . . 50.0 106.329 -164.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.59 -175.65 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.268 2.063 0 CA-C-O 122.408 1.099 . . . . 50.0 113.359 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.97 151.49 43.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.634 1.716 . . . . 25.0 115.634 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 79.7 mttt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 121.586 1.994 . . . . 25.0 115.319 176.171 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . 0.402 ' HA ' ' CE3' ' A' ' 152' ' ' TRP . 24.0 p-80 . . . . . 0 C--O 1.293 3.366 0 CA-C-O 117.995 -1.002 . . . . 25.0 112.233 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.25 -124.02 31.0 Favored Glycine 0 CA--C 1.489 -1.579 0 CA-C-O 118.482 -1.177 . . . . 25.0 112.297 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -113.58 164.18 13.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 126.549 1.97 . . . . 50.0 110.97 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.4 mt -96.1 120.53 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 N-CA-C 102.972 -2.973 . . . . 25.0 102.972 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -91.72 -34.02 14.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 117.575 -1.202 . . . . 25.0 108.256 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.52 133.17 13.55 Favored Pre-proline 0 C--N 1.309 -1.185 0 C-N-CA 124.382 1.073 . . . . 25.0 110.097 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.57 144.77 80.83 Favored 'Cis proline' 0 C--O 1.249 1.033 0 CA-C-O 123.625 1.427 . . . . 25.0 109.39 -3.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.04 133.29 10.33 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 113.761 -1.563 . . . . 25.0 110.75 169.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 35.13 0.8 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.159 1.48 . . . . 25.0 108.699 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -65.16 -26.33 68.12 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 116.071 -1.919 . . . . 25.0 112.778 -166.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.74 57.29 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 122.224 2.284 . . . . 25.0 109.189 -175.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.35 97.13 Favored 'General case' 0 C--O 1.274 2.385 0 CA-C-N 114.641 -1.163 . . . . 25.0 112.574 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.31 0.576 . . . . 75.0 109.994 178.682 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 115.532 1.679 . . . . 25.0 115.532 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -62.64 -44.69 95.63 Favored 'General case' 0 C--O 1.286 3.024 0 N-CA-C 119.482 3.142 . . . . 50.0 119.482 -166.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.256 11.9 pt-20 -142.17 62.38 13.7 Favored Pre-proline 0 C--O 1.258 1.508 0 N-CA-C 117.018 2.229 . . . . 25.0 117.018 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.8 -21.78 37.81 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 117.049 -1.501 . . . . 25.0 113.408 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -71.61 -14.28 62.02 Favored 'General case' 0 C--O 1.261 1.697 0 O-C-N 119.537 -1.977 . . . . 25.0 115.482 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 m -85.4 2.38 44.63 Favored 'General case' 0 C--O 1.285 2.933 0 O-C-N 119.934 -1.729 . . . . 25.0 115.373 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.2 150.58 48.9 Favored 'General case' 0 C--O 1.273 2.337 0 N-CA-C 104.267 -2.494 . . . . 50.0 104.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -132.14 162.16 31.55 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.53 1.932 . . . . 25.0 108.016 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.61 178.4 9.37 Favored 'General case' 0 C--O 1.184 -2.372 0 CA-C-O 124.33 2.014 . . . . 25.0 110.743 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.86 175.64 5.63 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 115.851 1.797 . . . . 25.0 115.851 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 95.3 mttt . . . . . 0 C--O 1.215 -0.716 0 O-C-N 120.159 -1.588 . . . . 25.0 114.812 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.4 mt . . . . . 0 CA--C 1.496 -1.124 0 N-CA-C 106.523 -1.658 . . . . 50.0 106.523 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.01 -14.6 60.83 Favored 'General case' 0 C--O 1.271 2.205 0 N-CA-C 114.824 1.416 . . . . 50.0 114.824 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.41 -22.27 63.27 Favored Glycine 0 C--O 1.274 2.633 0 N-CA-C 110.028 -1.229 . . . . 25.0 110.028 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -13.01 83.67 Favored Glycine 0 C--O 1.268 2.258 0 O-C-N 119.391 -2.241 . . . . 25.0 110.829 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -38.04 66.44 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 O-C-N 117.461 -3.376 . . . . 25.0 105.964 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.64 -32.32 73.76 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.516 -1.365 . . . . 75.0 111.317 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.22 -15.3 61.44 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 119.973 -1.704 . . . . 50.0 111.025 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.26 87.3 mt-30 -92.83 17.76 10.02 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 120.095 -1.628 . . . . 25.0 114.997 168.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -137.71 49.7 1.97 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.631 -1.988 . . . . 25.0 105.631 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -157.85 179.31 9.32 Favored 'General case' 0 C--O 1.261 1.669 1 N-CA-C 100.094 -4.039 . . . . 25.0 100.094 -170.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -47.74 -32.11 5.53 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 117.949 2.574 . . . . 25.0 117.949 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.41 29.53 1.68 Allowed 'General case' 0 C--O 1.253 1.282 0 CA-C-N 121.357 1.89 . . . . 25.0 107.477 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -83.32 78.81 9.57 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 123.967 1.841 . . . . 25.0 107.714 153.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -56.67 158.87 4.25 Favored 'General case' 0 C--O 1.29 3.196 0 CA-C-N 111.15 -2.75 . . . . 25.0 112.781 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -65.94 157.8 29.76 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-N 113.563 -1.653 . . . . 50.0 107.329 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -108.7 144.57 36.32 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 123.676 1.703 . . . . 25.0 108.137 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -139.79 152.82 46.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.625 -1.625 . . . . 25.0 109.735 162.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.7 mt -85.62 136.38 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.591 1.541 . . . . 25.0 107.998 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.6 ttt -137.31 144.8 42.79 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 171.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.298 12.1 p -79.43 173.43 12.59 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 120.373 -1.454 . . . . 25.0 113.209 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.5 -163.76 8.67 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.203 -1.475 . . . . 25.0 111.743 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.6 -172.72 36.19 Favored Glycine 0 N--CA 1.486 1.976 0 O-C-N 119.572 -2.134 . . . . 25.0 113.017 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -77.56 142.55 38.95 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 117.609 2.448 . . . . 25.0 117.609 169.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -137.86 165.88 25.39 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 105.763 -1.94 . . . . 25.0 105.763 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.7 m -118.46 120.25 36.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.956 -1.868 . . . . 25.0 105.956 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.52 141.71 47.7 Favored 'General case' 0 C--O 1.17 -3.111 0 N-CA-C 105.279 -2.119 . . . . 50.0 105.279 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 m -136.84 140.29 42.31 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 116.116 -1.897 . . . . 25.0 113.689 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 143.52 51.22 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 122.367 2.349 . . . . 25.0 109.688 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -149.08 144.57 26.76 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 127.157 3.36 . . . . 25.0 108.393 -170.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -142.54 151.98 42.16 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-N 111.845 -2.434 . . . . 50.0 112.718 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.0 t -73.64 -9.09 58.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 O-C-N 125.678 1.861 . . . . 25.0 113.634 -169.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.96 159.71 67.44 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 117.064 -3.523 . . . . 25.0 103.833 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -73.14 139.7 29.94 Favored 'Trans proline' 0 C--N 1.307 -1.654 1 C-N-CA 111.761 -5.026 . . . . 25.0 110.301 166.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 2.486 47.9 p-80 73.12 12.79 4.91 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 123.308 2.777 . . . . 25.0 116.611 -5.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -65.58 115.89 6.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 118.442 -1.303 . . . . 25.0 113.256 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.491 ' HG1' ' HD1' ' A' ' 95' ' ' TRP . 14.0 t -75.73 160.26 30.22 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.084 -1.446 . . . . 25.0 112.071 -171.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 90.3 p -111.51 -26.37 9.1 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 118.246 0.475 . . . . 25.0 110.87 163.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -168.6 150.56 4.97 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 103.013 -2.958 . . . . 25.0 103.013 168.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.491 ' HD1' ' HG1' ' A' ' 92' ' ' THR . 16.7 p-90 -136.73 160.54 38.52 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-O 116.921 -1.514 . . . . 25.0 107.589 166.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -142.53 162.43 35.49 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.241 -1.763 . . . . 25.0 106.241 -163.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.27 127.63 45.9 Favored 'General case' 0 C--O 1.274 2.345 0 N-CA-C 103.953 -2.61 . . . . 50.0 103.953 158.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -117.61 149.91 39.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 118.17 -2.831 . . . . 50.0 107.898 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.8 pt -120.64 153.37 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 119.463 1.029 . . . . 25.0 112.626 168.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 p -71.54 147.34 47.79 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -95.88 84.79 3.93 Favored 'General case' 0 C--O 1.191 -1.987 0 CA-C-O 123.103 1.43 . . . . 25.0 109.577 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -49.83 155.29 0.89 Allowed 'General case' 0 C--N 1.354 0.777 0 N-CA-C 117.0 2.222 . . . . 25.0 117.0 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 15.56 76.98 Favored Glycine 0 C--O 1.266 2.129 0 CA-C-O 126.551 3.306 . . . . 25.0 120.889 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 179.2 2.83 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.35 -1.925 . . . . 25.0 113.759 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.93 142.43 11.74 Favored Pre-proline 0 CA--C 1.492 -1.255 0 O-C-N 126.38 2.3 . . . . 25.0 106.333 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -60.41 -22.74 72.6 Favored 'Trans proline' 0 CA--C 1.592 3.42 0 N-CA-C 117.677 2.145 . . . . 25.0 117.677 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 116.399 -2.12 . . . . 75.0 110.709 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -108.09 170.95 4.98 Favored Pre-proline 0 CA--C 1.599 2.856 0 C-N-CA 129.751 3.221 . . . . 25.0 103.272 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.33 16.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.393 1 N-CA-C 122.767 4.103 . . . . 25.0 122.767 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.66 -40.4 69.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 117.172 2.286 . . . . 50.0 117.172 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -75.36 -6.84 52.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 126.287 2.242 . . . . 25.0 114.401 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -116.26 -59.69 1.95 Allowed 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 127.259 2.224 . . . . 25.0 114.49 -171.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -141.67 29.6 1.73 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 123.469 1.604 . . . . 25.0 111.794 -159.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.89 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 111.763 -2.471 . . . . 25.0 116.985 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -129.29 166.21 19.9 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 123.157 2.708 . . . . 50.0 112.457 172.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.07 143.25 49.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 101.289 -3.597 . . . . 25.0 101.289 163.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 tp -86.3 120.94 28.19 Favored 'General case' 0 C--O 1.182 -2.482 0 O-C-N 127.507 3.004 . . . . 50.0 108.701 166.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.8 tt -101.93 -8.29 9.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 121.536 1.971 . . . . 25.0 110.172 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.65 154.55 9.64 Favored Glycine 0 C--O 1.207 -1.592 0 C-N-CA 116.086 -2.959 . . . . 25.0 113.791 165.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.55 145.85 32.04 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 122.999 3.399 . . . . 25.0 104.839 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.44 105.79 30.54 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-O 117.067 -1.444 . . . . 50.0 114.104 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -77.48 164.59 28.4 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 C-N-CA 115.809 -2.327 . . . . 25.0 115.436 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -74.22 112.76 10.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.666 -1.976 . . . . 25.0 105.666 167.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.66 -18.4 1.91 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 119.379 -2.076 . . . . 50.0 116.335 -165.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.63 16.65 33.32 Favored Glycine 0 N--CA 1.466 0.673 0 O-C-N 119.917 -1.739 . . . . 25.0 114.371 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -55.54 162.33 2.49 Favored Pre-proline 0 CA--C 1.568 1.661 0 O-C-N 125.664 1.45 . . . . 25.0 113.72 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -66.31 176.25 4.19 Favored 'Trans proline' 0 C--O 1.276 2.412 0 CA-C-O 123.452 1.355 . . . . 25.0 112.065 166.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.85 -12.44 0.31 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 119.585 3.18 . . . . 25.0 119.585 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 p -69.44 -0.57 6.68 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 120.131 -1.605 . . . . 25.0 111.737 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.27 4.85 7.93 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 117.587 2.439 . . . . 25.0 117.587 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -61.03 164.68 4.78 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.347 1.546 . . . . 25.0 114.157 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.8 30.61 0.11 Allowed 'General case' 0 N--CA 1.516 2.829 0 O-C-N 119.256 -2.153 . . . . 75.0 113.287 -171.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.4 t -113.8 149.72 34.53 Favored 'General case' 0 C--O 1.262 1.737 0 N-CA-C 103.232 -2.877 . . . . 25.0 103.232 170.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -146.27 142.56 28.45 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 123.87 0.868 . . . . 25.0 109.318 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -75.39 135.69 40.79 Favored 'General case' 0 C--O 1.172 -3.023 0 N-CA-C 105.592 -2.003 . . . . 25.0 105.592 162.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.9 129.82 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 104.776 -2.305 . . . . 25.0 104.776 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -90.49 135.08 33.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 112.672 -2.058 . . . . 50.0 112.036 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.04 108.74 41.89 Favored Pre-proline 0 C--N 1.307 -1.245 0 O-C-N 119.678 -1.889 . . . . 25.0 108.427 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.82 136.86 21.37 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 O-C-N 117.033 -2.141 . . . . 25.0 114.456 164.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -150.86 101.82 2.93 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.162 -0.961 . . . . 25.0 109.273 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -105.56 10.55 33.05 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 126.943 2.097 . . . . 50.0 108.632 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -132.87 -176.83 4.24 Favored 'General case' 0 C--O 1.21 -0.98 0 O-C-N 119.174 -2.204 . . . . 25.0 110.304 -173.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.44 148.99 51.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 103.443 -2.799 . . . . 50.0 103.443 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 145.62 174.42 17.79 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 121.206 3.243 . . . . 25.0 121.206 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -75.12 135.72 41.13 Favored 'General case' 0 C--O 1.279 2.614 0 N-CA-C 116.122 1.897 . . . . 50.0 116.122 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -139.82 172.78 12.28 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 103.631 -2.729 . . . . 25.0 103.631 174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.0 t -123.18 148.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 103.455 -2.794 . . . . 50.0 103.455 166.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.5 mt -115.66 137.86 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 1 N-CA-C 98.647 -4.575 . . . . 25.0 98.647 172.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.54 129.48 55.37 Favored 'General case' 0 C--O 1.187 -2.193 0 CA-C-N 119.172 0.896 . . . . 50.0 113.024 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.18 135.0 45.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.521 -1.362 . . . . 25.0 111.502 -173.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 69.2 t -124.96 137.37 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.972 0 N-CA-C 103.033 -2.951 . . . . 50.0 103.033 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.402 ' CE3' ' HA ' ' A' ' 1' ' ' HIS . 2.7 t90 -140.03 112.57 7.89 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.092 -2.558 . . . . 25.0 104.092 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.5 140.56 32.57 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 100.533 -3.877 . . . . 25.0 100.533 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.51 157.16 34.97 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 CA-C-O 122.715 1.245 . . . . 50.0 107.807 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 -24.36 36.01 Favored 'General case' 0 C--O 1.199 -1.595 0 CA-C-N 115.042 -0.981 . . . . 25.0 108.86 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -67.16 -35.48 79.77 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 115.17 1.544 . . . . 25.0 115.17 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.767 ' HG1' ' H ' ' A' ' 159' ' ' ASN . 1.3 t -135.29 159.05 42.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 115.066 -2.397 . . . . 25.0 107.899 -166.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.02 -27.03 41.26 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 120.873 1.669 . . . . 25.0 113.914 162.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.767 ' H ' ' HG1' ' A' ' 157' ' ' THR . 96.7 m-20 -73.04 163.16 28.57 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.531 -1.356 . . . . 25.0 110.861 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.81 -176.19 3.77 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 104.597 -2.372 . . . . 25.0 104.597 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.79 146.53 47.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.772 -0.825 . . . . 50.0 108.772 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -134.56 135.62 42.41 Favored 'General case' 0 C--O 1.172 -2.98 0 CA-C-O 115.377 -2.249 . . . . 50.0 106.535 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -144.93 172.08 13.55 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 121.371 1.896 . . . . 25.0 107.735 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 147.53 32.06 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 O-C-N 120.047 -1.658 . . . . 75.0 107.344 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.4 mm -130.15 122.42 53.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 103.429 -2.804 . . . . 25.0 103.429 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -87.11 123.76 32.52 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.217 -2.142 . . . . 25.0 105.217 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.13 155.14 38.03 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.656 -1.278 . . . . 50.0 112.765 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -116.31 130.45 56.78 Favored 'General case' 0 N--CA 1.436 -1.144 1 N-CA-C 96.279 -5.452 . . . . 25.0 96.279 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.2 mt -123.8 128.78 50.04 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 115.781 -2.057 . . . . 50.0 106.693 -171.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.17 159.0 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 O-C-N 127.101 2.75 . . . . 50.0 112.09 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -70.22 131.52 44.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 117.987 -2.945 . . . . 25.0 108.138 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.4 pttt . . . . . 0 C--O 1.28 2.685 0 N-CA-C 120.464 3.505 . . . . 25.0 120.464 -171.286 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . 0.421 ' CD2' ' HG ' ' A' ' 34' ' ' SER . 72.8 m80 . . . . . 0 N--CA 1.517 2.89 0 N-CA-C 112.667 0.617 . . . . 25.0 112.667 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.7 -146.99 4.46 Favored Glycine 0 C--O 1.253 1.294 0 CA-C-O 114.393 -3.448 . . . . 25.0 118.742 -162.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.3 168.95 23.19 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 122.285 3.043 . . . . 50.0 105.941 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.11 121.73 41.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.998 -2.593 . . . . 25.0 103.998 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -83.05 -36.45 24.92 Favored 'General case' 0 C--O 1.262 1.734 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -172.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.514 ' HE2' ' HG1' ' A' ' 83' ' ' THR . 47.6 pttt -160.89 159.98 25.08 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-O 113.634 -3.079 . . . . 25.0 106.352 -175.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -78.09 137.52 46.9 Favored 'Cis proline' 0 C--O 1.206 -1.112 0 O-C-N 124.721 1.906 . . . . 25.0 107.195 1.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.26 -171.98 44.74 Favored Glycine 0 CA--C 1.454 -3.725 0 CA-C-N 114.811 -1.086 . . . . 25.0 110.51 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.686 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 82.1 p -145.75 158.34 43.86 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 119.644 1.722 . . . . 25.0 107.003 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -82.47 -24.41 34.23 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 118.764 -1.174 . . . . 25.0 111.429 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.17 79.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.134 0.974 . . . . 25.0 111.648 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.686 ' H ' ' HG ' ' A' ' 9' ' ' SER . . . -59.15 -31.94 69.43 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 119.3 0.954 . . . . 25.0 113.477 175.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 C--O 1.192 -1.938 0 C-N-CA 124.261 1.025 . . . . 75.0 113.514 176.996 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.496 1.864 1 N-CA-C 122.437 4.236 . . . . 25.0 122.437 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -63.87 -41.55 97.74 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 114.43 1.27 . . . . 50.0 114.43 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -153.94 53.74 0.99 Allowed Pre-proline 0 C--O 1.274 2.394 0 O-C-N 120.119 -1.613 . . . . 25.0 110.539 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.01 -33.17 42.52 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 O-C-N 118.311 -1.468 . . . . 25.0 113.757 -165.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -67.13 -1.33 4.17 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 117.319 2.34 . . . . 25.0 117.319 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.421 ' HG ' ' CD2' ' A' ' 1' ' ' HIS . 1.1 t -82.81 55.39 3.02 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.94 1.696 . . . . 25.0 113.601 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.72 135.26 33.72 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 123.24 1.495 . . . . 50.0 107.004 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.21 149.86 39.7 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 125.663 2.649 . . . . 25.0 105.424 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.11 12.48 Favored 'General case' 0 C--O 1.259 1.587 0 N-CA-C 102.329 -3.211 . . . . 25.0 102.329 164.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -100.15 168.59 9.72 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.616 2.08 . . . . 25.0 116.616 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mttt . . . . . 0 N--CA 1.402 -2.858 0 CA-C-O 123.372 1.558 . . . . 25.0 111.512 172.831 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 108.045 -1.094 . . . . 50.0 108.045 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -76.05 -21.47 56.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.215 -1.394 . . . . 50.0 107.645 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 -20.6 58.75 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 104.347 -3.501 . . . . 25.0 104.347 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.13 -20.87 71.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 111.471 -2.365 . . . . 25.0 112.122 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.71 -37.31 23.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 118.208 -1.397 . . . . 25.0 113.809 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.0 -34.67 75.66 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 119.751 -1.843 . . . . 75.0 111.687 172.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.54 -5.56 56.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.463 2.554 . . . . 50.0 110.065 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -81.97 75.43 8.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 113.716 -1.584 . . . . 25.0 111.01 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -128.2 44.28 2.98 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 127.295 2.238 . . . . 25.0 105.817 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.0 t -127.32 -166.56 1.62 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.3 -3.222 . . . . 25.0 102.3 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.79 -17.62 64.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 117.673 2.471 . . . . 25.0 117.673 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.47 24.3 7.52 Favored 'General case' 0 CA--C 1.595 2.686 0 CA-C-O 124.557 2.122 . . . . 25.0 109.978 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -87.31 102.25 14.33 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 126.742 3.163 . . . . 25.0 109.047 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -35.59 143.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.482 2 CA-C-N 102.415 -6.721 . . . . 25.0 112.146 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -70.92 152.84 43.23 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 115.323 1.601 . . . . 50.0 115.323 -173.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -95.35 152.73 18.13 Favored 'General case' 0 CA--C 1.587 2.38 0 O-C-N 121.353 -0.842 . . . . 25.0 109.85 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.12 148.61 49.83 Favored 'General case' 0 C--O 1.198 -1.658 0 CA-C-N 120.83 1.65 . . . . 25.0 109.156 169.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.7 mt -107.7 134.08 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 122.926 2.603 . . . . 25.0 111.952 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 85.1 mmm -144.22 169.97 16.87 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.203 -1.777 . . . . 25.0 106.203 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -90.98 172.09 8.82 Favored 'General case' 0 CA--C 1.446 -3.032 0 CA-C-O 116.056 -1.926 . . . . 25.0 111.606 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.98 173.46 9.66 Favored Glycine 0 CA--C 1.495 -1.176 0 O-C-N 124.94 1.4 . . . . 25.0 112.792 165.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.62 163.99 29.26 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 117.127 -2.463 . . . . 25.0 107.86 -171.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.38 155.18 28.51 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 120.291 -1.711 . . . . 25.0 109.168 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -145.5 160.67 41.27 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 103.049 -2.945 . . . . 25.0 103.049 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -125.9 130.71 51.84 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 -171.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.79 116.53 25.39 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 102.078 -3.305 . . . . 50.0 102.078 -165.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.514 ' HG1' ' HE2' ' A' ' 6' ' ' LYS . 60.9 m -115.63 131.97 56.77 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 102.867 -3.012 . . . . 25.0 102.867 -167.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -119.1 153.07 35.39 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.215 -2.513 . . . . 25.0 104.215 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 t -144.0 147.94 34.58 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -133.41 147.12 51.74 Favored 'General case' 0 C--O 1.266 1.954 0 O-C-N 127.743 3.152 . . . . 50.0 113.665 176.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.2 t -71.23 -20.82 62.2 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 116.341 1.978 . . . . 25.0 116.341 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.34 145.79 56.78 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 121.849 0.833 . . . . 25.0 112.722 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.87 160.51 49.44 Favored 'Trans proline' 0 CA--C 1.488 -1.789 1 C-N-CA 112.056 -4.83 . . . . 25.0 111.791 169.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -135.18 155.29 50.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 125.131 1.372 . . . . 25.0 109.922 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.96 155.29 40.8 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.239 -1.393 . . . . 25.0 107.239 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -140.53 150.97 44.37 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 117.498 -1.681 . . . . 25.0 110.445 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.6 p -112.58 -38.85 4.5 Favored 'General case' 0 CA--C 1.484 -1.569 0 O-C-N 120.68 -1.262 . . . . 25.0 109.385 164.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -150.8 154.13 36.72 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 104.559 -2.386 . . . . 25.0 104.559 169.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -139.74 153.17 47.13 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 117.031 -1.867 . . . . 25.0 108.327 158.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -134.26 154.65 51.16 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 112.616 -2.084 . . . . 25.0 109.901 -157.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 147.0 50.03 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.381 -3.562 . . . . 50.0 101.381 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.75 158.86 43.44 Favored 'General case' 0 C--O 1.184 -2.35 0 CA-C-N 114.001 -1.454 . . . . 50.0 109.056 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 pt -135.91 149.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 106.124 -1.806 . . . . 25.0 106.124 168.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -76.05 137.19 40.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 164.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -86.17 98.15 10.74 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 126.423 1.889 . . . . 25.0 110.452 -164.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -59.65 150.23 28.15 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 119.773 1.17 . . . . 25.0 113.41 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.77 67.1 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 108.906 -1.677 . . . . 25.0 108.906 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -55.77 166.83 0.64 Allowed 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 125.937 1.695 . . . . 25.0 113.71 172.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.01 123.45 6.12 Favored Pre-proline 0 C--O 1.186 -2.26 0 N-CA-C 102.969 -2.974 . . . . 25.0 102.969 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.14 -15.55 39.5 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.383 1.388 . . . . 25.0 114.846 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.56 -6.59 51.04 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 117.526 -3.234 . . . . 75.0 115.458 173.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.09 166.66 15.21 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 101.409 -3.552 . . . . 25.0 101.409 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -43.56 7.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.698 1 C-N-CA 134.179 9.919 . . . . 25.0 120.308 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.28 -26.36 7.22 Favored 'General case' 0 CA--C 1.598 2.794 0 O-C-N 119.599 -1.938 . . . . 50.0 115.667 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -75.96 -2.5 30.73 Favored 'General case' 0 CA--C 1.482 -1.639 1 O-C-N 115.82 -4.3 . . . . 25.0 113.481 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.417 ' C ' ' H ' ' A' ' 114' ' ' ASP . 85.5 mtt-85 -126.76 -44.61 1.65 Allowed 'General case' 0 CA--C 1.457 -2.61 0 N-CA-C 114.208 1.188 . . . . 25.0 114.208 171.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.38 32.03 0.34 Allowed 'General case' 0 C--O 1.193 -1.872 0 O-C-N 127.938 3.274 . . . . 25.0 112.051 172.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 112' ' ' ARG . 23.4 t70 -62.11 -32.92 73.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 123.708 1.718 . . . . 25.0 113.107 174.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -103.94 156.54 17.76 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.385 -2.82 . . . . 50.0 103.385 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.95 139.05 50.14 Favored 'General case' 0 C--O 1.27 2.157 0 N-CA-C 102.911 -2.996 . . . . 25.0 102.911 151.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.99 111.84 5.97 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 125.169 1.388 . . . . 50.0 107.517 154.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.42 -16.01 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 O-C-N 125.982 2.051 . . . . 25.0 110.266 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.01 174.41 44.3 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 122.074 2.216 . . . . 25.0 110.383 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -160.45 147.49 15.82 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 114.487 1.292 . . . . 25.0 114.487 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.63 110.28 18.99 Favored Pre-proline 0 CA--C 1.593 2.623 0 C-N-CA 126.209 1.804 . . . . 50.0 108.964 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -88.07 161.6 7.25 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 N-CA-C 116.563 1.717 . . . . 25.0 116.563 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -78.26 115.42 17.97 Favored 'General case' 0 CA--C 1.469 -2.137 1 N-CA-C 99.907 -4.108 . . . . 25.0 99.907 171.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -102.3 -14.61 16.89 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.355 -0.839 . . . . 50.0 111.512 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.45 -23.0 2.7 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 105.273 -3.131 . . . . 25.0 105.273 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -78.88 148.02 71.48 Favored Pre-proline 0 C--O 1.266 1.937 0 N-CA-C 104.646 -2.353 . . . . 25.0 104.646 155.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -58.67 147.26 88.49 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 106.476 -2.163 . . . . 25.0 106.476 174.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.34 -19.26 46.89 Favored 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 64.4 p -83.35 6.19 20.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 125.778 1.924 . . . . 25.0 110.491 -176.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -55.06 -43.98 74.33 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 120.047 1.294 . . . . 25.0 113.871 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -110.3 98.43 7.67 Favored 'General case' 0 C--O 1.256 1.445 0 CA-C-O 116.676 -1.63 . . . . 25.0 108.694 166.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.7 tp -85.66 -11.37 53.99 Favored 'General case' 0 C--O 1.288 3.082 0 O-C-N 125.779 1.925 . . . . 75.0 110.626 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -103.92 138.25 40.76 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -143.06 148.24 36.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.138 1.336 . . . . 25.0 111.715 -164.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -103.6 150.13 24.25 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 125.87 1.981 . . . . 25.0 109.82 -170.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -141.1 127.48 20.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.261 -1.755 . . . . 25.0 106.261 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -84.86 126.93 33.89 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 119.215 0.916 . . . . 50.0 109.009 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -101.38 121.46 51.56 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 106.639 -1.615 . . . . 25.0 106.639 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -67.09 150.57 82.34 Favored 'Trans proline' 0 N--CA 1.481 0.793 1 C-N-CA 113.201 -4.066 . . . . 25.0 116.444 170.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.27 31.37 1.14 Allowed 'General case' 0 CA--C 1.573 1.861 0 CA-C-N 115.512 -0.767 . . . . 25.0 111.816 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.43 -44.77 70.66 Favored 'General case' 1 N--CA 1.545 4.277 0 O-C-N 120.883 -1.136 . . . . 50.0 114.021 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -152.14 166.92 30.16 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.816 0.672 . . . . 25.0 112.816 -170.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mp -83.83 149.22 26.54 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.785 -1.191 . . . . 50.0 107.785 167.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.05 -178.43 19.83 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-O 121.999 0.777 . . . . 25.0 114.962 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -120.42 159.35 25.28 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 117.485 2.402 . . . . 50.0 117.485 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -160.62 163.41 32.62 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 165.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.55 137.97 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.562 0 C-N-CA 124.299 1.04 . . . . 50.0 112.918 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.64 129.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 C-N-CA 125.085 1.354 . . . . 25.0 109.734 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.79 151.91 35.5 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 126.06 2.1 . . . . 50.0 113.881 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.05 51.37 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 104.463 -2.421 . . . . 25.0 104.463 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t -135.4 131.34 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 126.345 2.278 . . . . 50.0 107.259 -174.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -124.06 128.05 48.76 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 122.619 1.199 . . . . 25.0 108.592 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.73 144.65 34.55 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 123.502 1.62 . . . . 25.0 110.363 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.88 125.36 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 127.449 2.3 . . . . 50.0 111.744 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.49 62.67 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 103.239 -2.874 . . . . 25.0 103.239 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.3 -12.59 60.58 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 117.621 2.452 . . . . 25.0 117.621 -173.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.0 p -133.26 148.38 51.97 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 120.395 -1.441 . . . . 25.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -81.94 -25.21 35.07 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.9 0.88 . . . . 25.0 109.749 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.77 153.25 26.59 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 121.224 -0.922 . . . . 25.0 109.991 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.6 147.66 51.42 Favored 'General case' 0 C--O 1.175 -2.855 0 N-CA-C 105.465 -2.05 . . . . 25.0 105.465 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -120.73 137.29 54.57 Favored 'General case' 0 CA--C 1.479 -1.779 0 C-N-CA 117.996 -1.482 . . . . 50.0 112.21 -158.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -128.96 148.11 50.91 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.691 1.997 . . . . 50.0 114.92 -168.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -139.11 135.93 34.63 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 105.85 -1.907 . . . . 25.0 105.85 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.6 130.97 17.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.463 0 N-CA-C 114.578 1.325 . . . . 75.0 114.578 -169.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.47 123.76 55.91 Favored 'Isoleucine or valine' 0 C--O 1.273 2.32 0 O-C-N 124.728 1.267 . . . . 25.0 111.669 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.5 124.04 26.48 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.95 139.63 49.16 Favored 'Isoleucine or valine' 0 C--O 1.271 2.22 0 CA-C-O 125.311 2.481 . . . . 50.0 109.344 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -117.3 121.34 40.87 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 44.7 mt -131.27 120.42 23.17 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.803 -1.184 . . . . 50.0 107.803 -158.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.4 m -125.68 171.23 14.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 117.618 2.451 . . . . 50.0 117.618 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -74.11 159.59 32.39 Favored 'General case' 0 C--O 1.258 1.522 0 O-C-N 120.772 -1.205 . . . . 25.0 109.574 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.4 mttt . . . . . 0 C--O 1.259 1.568 0 O-C-N 126.821 2.576 . . . . 25.0 109.433 -177.545 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 . . . . . 0 C--O 1.267 1.997 0 CA-C-O 122.49 1.138 . . . . 25.0 111.638 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.76 -174.08 20.18 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-O 114.301 -3.499 . . . . 25.0 118.158 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.39 143.78 47.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 121.674 2.737 . . . . 50.0 107.141 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.5 mt -73.32 140.23 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 102.756 -3.053 . . . . 25.0 102.756 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -135.16 48.21 2.28 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 126.248 2.928 . . . . 25.0 113.834 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 mttt 75.65 163.19 0.14 Allowed Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 109.913 -3.312 . . . . 25.0 113.062 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.58 131.65 22.09 Favored 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 134.665 3.194 . . . . 25.0 108.693 7.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.54 154.5 17.87 Favored Glycine 0 C--O 1.282 3.133 0 N-CA-C 110.716 -0.953 . . . . 25.0 110.716 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 t -152.71 132.7 13.37 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.879 0.987 . . . . 25.0 111.449 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -85.83 -19.79 30.11 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.84 81.6 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 117.774 -1.57 . . . . 25.0 113.228 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.67 59.68 Favored 'General case' 0 C--O 1.269 2.117 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 115.867 1.803 . . . . 75.0 115.867 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.51 2.535 1 N-CA-C 124.284 4.92 . . . . 25.0 124.284 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -71.13 -46.87 60.77 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 116.301 -3.999 . . . . 50.0 114.547 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -145.69 60.57 6.74 Favored Pre-proline 0 C--O 1.2 -1.505 0 CA-C-O 124.646 2.165 . . . . 25.0 112.834 169.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.13 -10.89 28.22 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 117.279 -1.348 . . . . 25.0 113.647 -166.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -78.8 -15.13 58.79 Favored 'General case' 0 C--O 1.189 -2.08 0 C-N-CA 126.925 2.09 . . . . 25.0 111.641 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -122.55 141.87 51.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 113.43 0.9 . . . . 25.0 113.43 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.2 109.13 20.82 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 124.667 2.175 . . . . 50.0 105.234 156.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.86 151.14 25.29 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.402 -2.074 . . . . 25.0 105.402 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.91 170.62 15.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 123.526 1.631 . . . . 25.0 107.956 169.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -136.76 147.29 46.59 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 119.24 -2.163 . . . . 25.0 108.222 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 CA--C 1.565 1.524 0 N-CA-C 104.654 -2.35 . . . . 25.0 104.654 179.679 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 CA--C 1.569 1.686 0 CA-C-O 126.284 2.945 . . . . 50.0 112.8 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -74.98 -33.53 61.89 Favored 'General case' 0 C--O 1.265 1.877 0 CA-C-O 126.471 3.034 . . . . 50.0 105.456 154.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.5 -17.28 78.96 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-O 124.762 2.312 . . . . 25.0 110.191 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.88 -22.45 75.66 Favored Glycine 0 C--O 1.208 -1.512 0 CA-C-O 124.041 1.912 . . . . 25.0 112.66 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.16 -41.35 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 118.677 -2.661 . . . . 25.0 109.398 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.7 mt -72.21 -26.48 62.06 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 119.971 3.323 . . . . 75.0 119.971 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -66.5 -28.05 68.26 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.61 -1.255 . . . . 50.0 107.61 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -78.77 6.97 7.76 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 123.819 0.699 . . . . 25.0 111.31 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -126.15 39.64 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 104.306 -2.479 . . . . 25.0 104.306 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -154.98 169.44 24.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.264 -1.523 . . . . 25.0 107.544 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.73 -14.63 63.15 Favored 'General case' 0 C--O 1.182 -2.471 0 CA-C-O 124.745 2.212 . . . . 25.0 109.245 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -86.06 20.18 2.38 Favored 'General case' 0 N--CA 1.422 -1.852 0 O-C-N 119.03 -2.294 . . . . 25.0 112.319 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.92 96.91 2.18 Favored 'General case' 0 C--O 1.263 1.802 0 CA-C-O 124.803 2.24 . . . . 25.0 105.589 163.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -44.71 146.0 0.83 Allowed 'General case' 0 C--O 1.275 2.395 1 CA-C-N 106.598 -4.819 . . . . 25.0 109.74 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -79.78 132.34 36.13 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 119.681 -1.887 . . . . 50.0 112.037 -157.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.05 155.83 16.9 Favored 'General case' 0 C--N 1.365 1.256 0 CA-C-N 112.333 -2.212 . . . . 25.0 112.17 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -152.44 141.25 21.03 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.032 -1.467 . . . . 25.0 113.841 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.28 129.9 39.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.78 0 C-N-CA 117.045 -1.862 . . . . 25.0 106.611 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.4 ttt -139.92 157.77 45.15 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 121.177 1.808 . . . . 25.0 107.452 164.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 p -68.02 162.74 23.83 Favored 'General case' 0 CA--C 1.584 2.275 0 O-C-N 117.911 -2.993 . . . . 25.0 109.214 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.95 -156.27 3.38 Favored Glycine 0 C--O 1.209 -1.463 1 O-C-N 115.928 -4.232 . . . . 25.0 113.485 164.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 -173.38 38.02 Favored Glycine 0 C--O 1.192 -2.495 0 O-C-N 121.322 -1.105 . . . . 25.0 111.5 -165.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.62 133.15 51.66 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 120.491 2.145 . . . . 25.0 114.089 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -120.16 133.2 55.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.767 -1.568 . . . . 25.0 106.767 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.1 m -115.54 89.62 3.14 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 120.695 1.589 . . . . 25.0 111.573 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -74.4 117.7 16.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.618 0.767 . . . . 50.0 109.981 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -123.99 145.02 49.47 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.372 -2.084 . . . . 25.0 105.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -127.8 159.24 35.44 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 102.225 -3.25 . . . . 25.0 102.225 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.3 p -134.91 163.1 30.6 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 127.704 3.128 . . . . 25.0 108.245 166.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.36 137.9 52.89 Favored 'General case' 0 N--CA 1.496 1.863 1 N-CA-C 96.768 -5.271 . . . . 50.0 96.768 164.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.4 t -74.51 -20.68 59.89 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 116.031 -2.268 . . . . 25.0 105.713 -165.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.16 157.58 77.68 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 103.038 -2.949 . . . . 25.0 103.038 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.29 143.16 27.86 Favored 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 109.95 -6.233 . . . . 25.0 112.018 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -118.03 152.65 35.11 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.833 -2.284 . . . . 25.0 104.833 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.57 160.54 32.51 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.67 147.05 24.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 127.867 2.467 . . . . 25.0 113.389 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -108.64 -27.94 9.55 Favored 'General case' 0 C--O 1.26 1.617 0 N-CA-C 114.535 1.309 . . . . 25.0 114.535 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -174.43 173.74 2.9 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.054 -2.573 . . . . 25.0 104.054 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -153.24 169.43 23.06 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.982 -0.747 . . . . 25.0 108.982 163.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -145.01 151.79 39.12 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 114.434 -2.698 . . . . 25.0 106.764 -169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.88 147.18 21.22 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 124.737 2.208 . . . . 50.0 112.982 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -132.08 165.09 24.81 Favored 'General case' 1 C--O 1.306 4.059 0 CA-C-N 114.324 -1.307 . . . . 50.0 107.661 -162.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.4 pt -125.94 157.0 36.11 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.676 0 N-CA-C 101.311 -3.589 . . . . 25.0 101.311 161.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.9 p -76.3 150.15 36.98 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.346 -1.724 . . . . 25.0 106.346 169.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -143.49 76.85 1.54 Allowed 'General case' 0 N--CA 1.423 -1.791 0 O-C-N 120.641 -1.287 . . . . 25.0 108.221 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -56.44 153.45 9.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.11 -1.859 . . . . 25.0 112.851 167.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.73 37.77 22.08 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 116.79 -2.116 . . . . 25.0 109.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -64.5 157.22 27.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 126.598 1.999 . . . . 25.0 110.949 163.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -59.22 133.81 87.92 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 108.221 -1.029 . . . . 25.0 108.221 158.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.33 -36.14 98.9 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 N-CA-C 117.456 2.06 . . . . 25.0 117.456 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.66 -19.8 62.72 Favored 'General case' 0 C--O 1.267 1.994 0 N-CA-C 116.889 2.181 . . . . 75.0 116.889 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -58.16 159.08 11.88 Favored Pre-proline 0 C--O 1.205 -1.27 0 CA-C-N 113.13 -1.85 . . . . 25.0 110.231 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.45 23.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.193 -1.774 2 C-N-CA 127.128 5.219 . . . . 25.0 125.08 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 tp 14.79 -56.87 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.244 1 N-CA-C 125.56 5.393 . . . . 50.0 125.56 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -69.24 -31.54 70.17 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -96.72 -46.5 6.26 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.624 -1.626 . . . . 25.0 110.517 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.79 -3.78 1.75 Allowed 'General case' 0 C--O 1.206 -1.19 0 C-N-CA 118.82 -1.152 . . . . 25.0 113.058 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.7 -26.35 68.34 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 115.471 1.656 . . . . 25.0 115.471 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -127.51 153.23 46.59 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.207 -2.146 . . . . 50.0 105.207 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -126.68 130.61 50.74 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 111.877 -2.419 . . . . 25.0 111.258 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.18 111.44 3.43 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 105.508 -2.034 . . . . 50.0 105.508 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.73 -20.24 7.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.444 -1.317 . . . . 25.0 107.444 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.7 166.55 33.39 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.748 -1.22 . . . . 25.0 113.555 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.92 155.36 41.5 Favored 'General case' 0 C--O 1.181 -2.516 0 N-CA-C 104.124 -2.547 . . . . 25.0 104.124 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.3 107.12 17.6 Favored Pre-proline 0 C--O 1.271 2.213 0 N-CA-C 106.828 -1.545 . . . . 50.0 106.828 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.33 162.05 28.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 N-CA-C 107.553 -1.749 . . . . 25.0 107.553 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -139.66 63.01 1.5 Allowed 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 119.544 -0.862 . . . . 25.0 110.542 -170.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.15 -16.9 0.83 Allowed 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.533 1.679 . . . . 50.0 115.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -164.75 21.58 0.14 Allowed Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 125.412 1.482 . . . . 25.0 116.681 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.63 162.06 73.35 Favored Pre-proline 0 CA--C 1.556 1.201 0 O-C-N 124.88 0.988 . . . . 25.0 113.437 -174.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.29 -170.01 0.53 Allowed 'Trans proline' 0 C--O 1.264 1.808 0 CA-C-O 117.822 -0.991 . . . . 25.0 113.987 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.42 4.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 1 N-CA-C 122.027 4.084 . . . . 25.0 122.027 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 p -57.66 -17.6 15.73 Favored 'General case' 0 C--O 1.187 -2.224 0 CA-C-N 115.921 -0.582 . . . . 25.0 110.284 161.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -63.9 -16.71 62.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.183 0.809 . . . . 25.0 113.183 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -60.72 129.83 43.46 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 117.821 -1.085 . . . . 25.0 109.471 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.49 -5.01 17.06 Favored 'General case' 0 C--O 1.283 2.86 0 N-CA-C 120.357 3.465 . . . . 75.0 120.357 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.4 t -86.51 127.18 34.85 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 126.039 1.736 . . . . 25.0 109.141 160.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -134.67 130.13 35.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 118.921 2.934 . . . . 25.0 118.921 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -92.07 129.22 38.07 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.174 -1.375 . . . . 25.0 113.573 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.5 mt -121.09 124.03 71.29 Favored 'Isoleucine or valine' 0 C--O 1.271 2.194 0 N-CA-C 105.605 -1.998 . . . . 25.0 105.605 169.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -75.84 137.09 40.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.003 -2.221 . . . . 50.0 105.003 165.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -115.28 129.78 24.81 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 101.763 -3.421 . . . . 25.0 101.763 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.74 140.63 68.58 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 116.372 -1.952 . . . . 25.0 109.415 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -108.66 2.92 22.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.31 -23.71 32.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.517 2.043 . . . . 50.0 116.517 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -143.49 155.1 44.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 114.768 -2.539 . . . . 25.0 107.512 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -75.22 164.56 26.34 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 125.808 1.943 . . . . 50.0 109.605 170.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 175.81 135.28 2.09 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 108.12 -1.992 . . . . 25.0 108.12 170.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -115.3 148.53 39.1 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 124.973 1.309 . . . . 50.0 111.396 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -161.04 161.88 31.52 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 116.569 -1.681 . . . . 25.0 107.471 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.9 t -91.01 158.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 101.664 -3.458 . . . . 50.0 101.664 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.77 135.78 49.97 Favored 'Isoleucine or valine' 0 C--O 1.28 2.671 1 N-CA-C 98.048 -4.797 . . . . 25.0 98.048 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.26 148.2 48.77 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 103.749 -2.685 . . . . 50.0 103.749 168.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.09 153.0 41.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.588 -0.695 . . . . 25.0 110.718 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.9 140.64 46.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.625 0 C-N-CA 123.067 0.547 . . . . 50.0 111.304 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.19 133.76 45.83 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.788 1.235 . . . . 25.0 112.574 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.96 133.29 55.6 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.338 1.055 . . . . 25.0 112.663 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.9 t -131.64 111.87 19.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 102.119 -3.289 . . . . 50.0 102.119 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.62 -24.86 53.37 Favored 'General case' 0 C--O 1.17 -3.091 0 CA-C-O 117.753 -1.118 . . . . 25.0 108.288 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.98 -19.27 65.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 124.477 2.084 . . . . 25.0 115.858 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.7 p -118.82 150.83 39.16 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.151 -1.84 . . . . 25.0 114.202 -173.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -78.55 -25.55 45.47 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.344 -1.753 . . . . 25.0 109.974 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -63.33 152.22 38.55 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 118.611 -1.236 . . . . 25.0 114.133 163.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.88 158.34 44.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 105.588 -2.005 . . . . 25.0 105.588 174.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -131.36 146.06 52.11 Favored 'General case' 0 C--O 1.29 3.206 0 O-C-N 118.618 -2.551 . . . . 50.0 114.78 -170.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.01 170.54 15.83 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 102.466 -3.161 . . . . 50.0 102.466 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -164.34 167.36 19.86 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.2 p -145.32 134.99 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.935 -1.135 . . . . 75.0 107.935 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -141.85 146.26 23.14 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 101.972 -3.344 . . . . 25.0 101.972 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -122.17 152.18 40.21 Favored 'General case' 0 C--O 1.264 1.827 0 CA-C-N 121.072 1.76 . . . . 25.0 108.002 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.66 153.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.76 0 N-CA-C 110.185 -0.302 . . . . 50.0 110.185 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -131.79 94.52 3.52 Favored 'General case' 0 C--O 1.264 1.857 0 N-CA-C 101.401 -3.555 . . . . 25.0 101.401 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 53.3 mt -102.49 111.77 24.22 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.34 -1.475 . . . . 50.0 114.446 -170.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.5 m -128.11 173.71 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.964 2.579 . . . . 50.0 117.964 -153.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.37 147.13 23.65 Favored 'General case' 0 CA--C 1.494 -1.203 1 N-CA-C 99.541 -4.244 . . . . 25.0 99.541 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 C--O 1.269 2.088 0 N-CA-C 116.036 1.865 . . . . 25.0 116.036 169.206 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 N--CA 1.534 3.748 0 CA-C-O 123.846 1.784 . . . . 25.0 113.33 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.21 -32.44 0.09 OUTLIER Glycine 0 C--O 1.27 2.384 0 C-N-CA 127.632 2.539 . . . . 25.0 111.052 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.08 140.13 53.34 Favored 'General case' 0 CA--C 1.482 -1.643 0 C-N-CA 125.637 1.575 . . . . 50.0 109.8 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.5 mt -103.76 122.04 55.96 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 N-CA-C 100.703 -3.814 . . . . 25.0 100.703 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -92.63 -40.56 10.68 Favored 'General case' 0 C--O 1.182 -2.486 0 CA-C-N 119.14 0.882 . . . . 25.0 112.66 -173.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -144.82 154.41 55.35 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 115.887 -2.006 . . . . 25.0 106.634 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.65 136.45 45.14 Favored 'Cis proline' 0 N--CA 1.476 0.478 0 CA-C-N 121.909 1.718 . . . . 25.0 109.059 0.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.74 -162.44 38.29 Favored Glycine 0 C--O 1.214 -1.113 0 N-CA-C 120.082 2.793 . . . . 25.0 120.082 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -114.51 116.0 28.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.487 1.644 . . . . 25.0 111.282 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -73.11 -23.24 60.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.123 0.874 . . . . 25.0 109.588 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.47 72.63 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.234 1.814 . . . . 25.0 106.297 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.38 -37.95 68.22 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 124.216 0.947 . . . . 25.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 CA--C 1.544 0.741 0 O-C-N 123.803 0.689 . . . . 75.0 110.638 -179.763 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 C--O 1.2 -1.547 0 N-CA-C 114.601 1.334 . . . . 25.0 114.601 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -88.15 -37.83 15.85 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.291 -1.364 . . . . 50.0 111.319 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.51 48.02 0.25 Allowed Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 115.978 1.844 . . . . 25.0 115.978 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.16 -19.49 34.14 Favored 'Trans proline' 0 CA--C 1.569 2.261 1 C-N-CA 110.915 -5.59 . . . . 25.0 116.621 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.266 12.2 pt20 -109.15 -20.88 12.83 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.846 1.203 . . . . 25.0 113.911 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.1 p -96.58 22.45 8.02 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.297 1.046 . . . . 25.0 113.755 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.97 44.47 0.03 OUTLIER 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.669 1.988 . . . . 50.0 115.485 -172.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.77 156.63 39.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 120.766 3.617 . . . . 25.0 120.766 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.72 58.3 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 117.651 -1.166 . . . . 25.0 113.976 170.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.511 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 31.7 tttm -151.71 -164.23 1.93 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.831 3.014 . . . . 25.0 109.435 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' H ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 mttt . . . . . 0 C--O 1.235 0.291 0 CA-C-N 113.508 -1.678 . . . . 25.0 109.862 -170.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 CA--C 1.565 1.523 0 CA-C-O 123.163 1.459 . . . . 50.0 113.303 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 -35.79 32.92 Favored 'General case' 0 CA--C 1.586 2.337 0 N-CA-C 101.343 -3.577 . . . . 50.0 101.343 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.56 63.74 Favored Glycine 0 C--O 1.268 2.245 0 CA-C-N 114.014 -1.448 . . . . 25.0 113.07 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.66 77.56 Favored Glycine 0 C--O 1.201 -1.914 0 CA-C-N 119.058 1.429 . . . . 25.0 110.938 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -65.55 -43.57 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 106.885 -1.524 . . . . 25.0 106.885 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.12 -24.21 59.41 Favored 'General case' 0 C--O 1.172 -3.014 0 N-CA-C 107.686 -1.227 . . . . 75.0 107.686 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.69 -21.39 60.26 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 123.777 1.751 . . . . 50.0 111.171 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -103.95 16.35 26.5 Favored 'General case' 0 C--O 1.183 -2.441 0 O-C-N 118.213 -2.804 . . . . 25.0 108.37 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -128.95 49.73 2.2 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 102.303 -3.221 . . . . 25.0 102.303 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -152.5 -179.67 7.79 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 100.525 -3.88 . . . . 25.0 100.525 -162.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -66.8 -17.61 64.96 Favored 'General case' 0 CA--C 1.592 2.587 0 C-N-CA 117.651 -1.62 . . . . 25.0 114.413 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -94.68 48.77 1.22 Allowed 'General case' 0 CA--C 1.556 1.21 0 O-C-N 120.203 -1.561 . . . . 25.0 108.317 165.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -85.32 98.98 10.84 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 100.191 -4.003 . . . . 25.0 100.191 156.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -65.6 163.06 16.98 Favored 'General case' 0 C--O 1.256 1.43 1 CA-C-N 106.583 -4.826 . . . . 25.0 110.703 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -59.52 146.29 41.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 120.016 1.28 . . . . 50.0 112.366 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -129.33 154.4 46.92 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -139.77 150.72 45.09 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 118.282 -0.866 . . . . 25.0 112.038 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.98 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.127 0 CA-C-O 123.789 1.757 . . . . 25.0 110.561 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 30.6 mtm -147.0 172.0 14.39 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 120.147 -1.596 . . . . 25.0 113.493 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.1 p -71.53 165.21 24.35 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 105.071 -2.196 . . . . 25.0 105.071 168.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.06 176.62 53.11 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 106.378 -2.689 . . . . 25.0 106.378 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.94 -170.15 20.17 Favored Glycine 0 C--O 1.266 2.113 0 CA-C-N 120.342 2.071 . . . . 25.0 113.815 -170.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -74.68 137.39 42.11 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 112.922 -1.639 . . . . 25.0 109.852 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -127.62 159.1 35.69 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.719 1.208 . . . . 25.0 111.158 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.3 m -117.89 142.04 47.77 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 106.31 -1.737 . . . . 25.0 106.31 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -125.96 114.72 18.86 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 102.687 -3.079 . . . . 50.0 102.687 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 m -129.87 117.68 20.54 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.706 -1.588 . . . . 25.0 112.524 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . 0.308 0.8 OUTLIER -111.51 136.61 50.45 Favored 'General case' 0 C--O 1.3 3.717 0 N-CA-C 101.353 -3.573 . . . . 25.0 101.353 171.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -148.88 160.29 43.39 Favored 'General case' 0 C--O 1.181 -2.54 0 O-C-N 125.59 1.806 . . . . 25.0 108.887 -167.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.04 170.32 16.2 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.852 -1.067 . . . . 50.0 109.288 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.9 t -64.76 -25.42 67.92 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.907 -1.044 . . . . 25.0 111.45 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.34 153.23 74.54 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 125.096 1.497 . . . . 25.0 111.129 -171.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.99 169.39 20.61 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 117.331 -1.313 . . . . 25.0 112.53 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.258 3.2 m80 -127.09 161.51 28.26 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 103.81 -2.663 . . . . 25.0 103.81 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -81.86 57.93 3.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.091 0.956 . . . . 25.0 109.642 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 m -66.98 144.5 56.17 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 127.022 2.702 . . . . 25.0 108.878 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -117.37 -32.05 5.07 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 126.478 2.361 . . . . 25.0 109.822 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -165.59 154.68 12.02 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 124.755 1.222 . . . . 25.0 109.471 -170.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -141.74 164.56 29.88 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 145.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.33 36.4 m-70 -131.9 145.06 51.3 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 126.588 1.955 . . . . 25.0 107.776 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -139.54 148.34 42.46 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-O 122.713 1.244 . . . . 50.0 111.286 170.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.46 162.05 30.05 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 109.679 -3.418 . . . . 50.0 111.042 -164.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.2 151.05 33.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 102.25 -3.241 . . . . 25.0 102.25 176.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.6 m -82.32 113.88 20.41 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 125.883 1.989 . . . . 25.0 109.893 157.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -83.38 94.33 7.94 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-N 120.209 1.368 . . . . 25.0 109.57 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -61.76 161.19 10.51 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 124.671 1.188 . . . . 25.0 111.923 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.42 28.15 Favored Glycine 0 CA--C 1.497 -1.048 0 C-N-CA 119.0 -1.571 . . . . 25.0 116.504 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.21 159.89 32.18 Favored 'General case' 0 CA--C 1.581 2.145 0 C-N-CA 119.592 -0.843 . . . . 25.0 111.426 -171.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -71.31 117.1 53.74 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 102.377 -3.194 . . . . 25.0 102.377 149.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.81 -22.22 37.05 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 125.282 3.988 . . . . 25.0 117.525 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -75.08 -13.84 60.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.387 -1.446 . . . . 75.0 109.934 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.253 95.9 mttt -117.11 165.3 15.84 Favored Pre-proline 0 C--O 1.2 -1.504 2 N-CA-C 99.202 -4.37 . . . . 25.0 99.202 -171.75 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 3.38 14.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 2 C-N-CA 135.44 10.76 . . . . 25.0 127.967 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.1 tt -46.66 -43.53 17.69 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-O 115.616 -2.135 . . . . 50.0 113.768 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -75.39 -2.58 29.19 Favored 'General case' 0 C--O 1.169 -3.163 0 O-C-N 125.195 1.56 . . . . 25.0 113.207 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -121.94 -51.85 2.0 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 122.799 1.285 . . . . 25.0 112.155 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.55 -26.53 3.57 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 112.653 -2.067 . . . . 25.0 115.095 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -80.35 -7.78 59.22 Favored 'General case' 0 C--O 1.28 2.676 0 CA-C-N 113.489 -1.687 . . . . 25.0 111.04 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -141.64 47.56 1.66 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 118.236 -2.79 . . . . 50.0 106.631 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.8 122.45 29.15 Favored 'General case' 0 CA--C 1.558 1.286 0 O-C-N 118.143 -2.848 . . . . 25.0 111.5 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.6 tp -60.72 125.96 25.64 Favored 'General case' 0 C--O 1.266 1.94 0 N-CA-C 114.174 1.176 . . . . 50.0 114.174 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.7 tt -108.21 -22.4 5.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 116.799 -1.572 . . . . 25.0 106.999 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.12 -179.43 44.74 Favored Glycine 0 C--N 1.371 2.488 0 C-N-CA 118.746 -1.692 . . . . 25.0 116.193 161.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -146.59 153.99 40.98 Favored 'General case' 0 C--O 1.286 3.023 0 CA-C-O 123.279 1.514 . . . . 25.0 107.333 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.2 t -132.46 86.49 45.14 Favored Pre-proline 0 CA--C 1.62 3.648 0 N-CA-C 103.608 -2.738 . . . . 50.0 103.608 -173.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.18 154.33 61.98 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 115.234 -2.711 . . . . 25.0 112.259 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -144.59 96.44 2.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.37 1.618 . . . . 25.0 115.37 -157.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.34 -7.25 16.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.57 -1.65 . . . . 50.0 114.722 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.41 -171.1 42.1 Favored Glycine 0 C--O 1.283 3.194 1 N-CA-C 101.969 -4.452 . . . . 25.0 101.969 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.4 m -126.42 75.11 73.89 Favored Pre-proline 0 N--CA 1.508 2.439 0 N-CA-C 115.193 1.553 . . . . 25.0 115.193 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.3 170.19 17.81 Favored 'Trans proline' 0 C--O 1.213 -0.759 1 C-N-CA 111.984 -4.877 . . . . 25.0 106.208 150.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.76 67.02 Favored 'General case' 0 CA--C 1.573 1.842 0 O-C-N 119.373 -2.079 . . . . 25.0 115.567 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 95.5 p -68.02 -22.89 64.96 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 120.93 1.696 . . . . 25.0 114.407 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -111.97 19.59 17.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 127.039 2.712 . . . . 25.0 111.974 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -55.59 148.82 15.06 Favored 'General case' 0 N--CA 1.513 2.681 0 CA-C-O 122.82 1.295 . . . . 25.0 108.404 168.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tp -64.65 -36.4 84.14 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 111.483 -2.599 . . . . 75.0 110.795 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.7 t -91.81 153.76 19.36 Favored 'General case' 0 C--O 1.285 2.946 0 N-CA-C 104.12 -2.548 . . . . 25.0 104.12 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -147.41 164.63 32.72 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 112.82 0.674 . . . . 25.0 112.82 170.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -113.59 148.9 35.34 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 104.471 -2.418 . . . . 25.0 104.471 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -133.03 124.5 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 105.645 -1.983 . . . . 25.0 105.645 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . 0.254 70.0 t80 -90.91 132.75 35.74 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.124 -2.86 . . . . 50.0 109.039 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.6 mm -131.63 124.4 19.93 Favored Pre-proline 0 C--O 1.268 2.059 0 N-CA-C 103.254 -2.869 . . . . 25.0 103.254 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.19 165.89 29.96 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 114.51 -3.193 . . . . 25.0 116.697 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.53 39.35 1.06 Allowed 'General case' 0 C--O 1.295 3.46 0 CA-C-O 125.853 2.74 . . . . 25.0 111.27 175.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.86 -20.17 59.85 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 115.64 1.719 . . . . 50.0 115.64 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -148.92 170.32 18.56 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.63 139.46 38.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 101.631 -3.47 . . . . 50.0 101.631 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.13 176.67 20.19 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 118.328 -1.891 . . . . 25.0 115.47 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -81.86 146.25 29.95 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 117.985 2.587 . . . . 50.0 117.985 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -138.93 113.75 9.21 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.916 2.01 . . . . 25.0 111.138 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.76 130.87 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 116.176 -1.869 . . . . 50.0 108.625 -172.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.48 132.15 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 124.031 1.872 . . . . 25.0 109.907 167.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.1 mp -118.04 138.59 52.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 102.868 -3.012 . . . . 50.0 102.868 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.39 144.61 29.85 Favored 'General case' 0 C--O 1.29 3.187 0 O-C-N 119.826 -1.796 . . . . 25.0 111.835 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 79.8 t -124.67 135.14 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 102.728 -3.064 . . . . 50.0 102.728 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -135.26 114.83 12.66 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 125.428 1.705 . . . . 25.0 112.079 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -112.18 128.84 56.35 Favored 'General case' 0 C--O 1.284 2.885 0 O-C-N 123.872 0.732 . . . . 25.0 111.687 -162.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.6 t -121.7 119.07 57.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 115.823 -2.037 . . . . 50.0 107.319 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.71 -13.36 31.55 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 119.719 3.229 . . . . 25.0 119.719 -166.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -76.36 -18.65 58.78 Favored 'General case' 0 C--O 1.253 1.263 0 O-C-N 120.268 -1.52 . . . . 25.0 112.348 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -112.25 153.4 27.19 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 119.951 -1.718 . . . . 25.0 111.751 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -78.11 -28.2 48.56 Favored 'General case' 0 C--O 1.28 2.673 0 N-CA-C 103.161 -2.904 . . . . 25.0 103.161 171.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.08 179.34 3.34 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 119.177 -2.202 . . . . 25.0 113.23 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.57 151.56 36.49 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 125.84 1.656 . . . . 25.0 108.584 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -95.25 150.22 20.47 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 126.023 2.077 . . . . 50.0 111.778 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -133.56 130.7 38.79 Favored 'General case' 0 C--O 1.284 2.872 0 CA-C-N 114.741 -1.118 . . . . 50.0 108.205 -169.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.0 156.87 45.45 Favored 'General case' 0 C--O 1.267 1.988 0 CA-C-N 119.65 1.114 . . . . 25.0 112.22 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.8 127.94 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 107.631 -1.248 . . . . 75.0 107.631 -171.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.58 137.04 57.82 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 N-CA-C 107.465 -1.309 . . . . 25.0 107.465 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.67 126.95 50.18 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 123.648 0.593 . . . . 25.0 110.941 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.36 132.99 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 122.914 1.34 . . . . 50.0 111.697 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -96.23 113.42 25.01 Favored 'General case' 0 C--O 1.204 -1.339 0 N-CA-C 104.625 -2.361 . . . . 25.0 104.625 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.36 110.71 21.6 Favored 'General case' 0 CA--C 1.476 -1.896 0 CA-C-N 112.807 -1.997 . . . . 50.0 110.202 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.7 m -132.93 154.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-O 124.564 2.126 . . . . 50.0 112.615 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -59.11 126.38 27.46 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.0 pttp . . . . . 0 C--O 1.263 1.801 0 CA-C-O 116.061 -1.924 . . . . 25.0 108.53 179.045 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 118.996 -0.526 . . . . 25.0 111.217 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.65 173.64 42.03 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 120.482 1.492 . . . . 25.0 115.341 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -129.21 135.73 49.2 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 125.165 1.386 . . . . 50.0 112.746 -156.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.5 mt -89.57 121.53 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 119.229 -2.169 . . . . 25.0 111.151 -171.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -101.22 16.48 25.37 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.862 1.265 . . . . 25.0 110.245 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 64.87 166.27 0.11 Allowed Pre-proline 0 CA--C 1.594 2.652 0 C-N-CA 128.195 2.598 . . . . 25.0 111.14 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.55 141.3 45.07 Favored 'Cis proline' 0 C--O 1.204 -1.225 0 C-N-CA 132.621 2.342 . . . . 25.0 111.709 13.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.94 91.53 1.61 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 117.272 1.669 . . . . 25.0 117.272 168.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 t -75.63 144.44 41.71 Favored 'General case' 0 C--O 1.275 2.423 0 CA-C-O 123.183 1.468 . . . . 25.0 110.921 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -107.23 -22.93 12.44 Favored 'General case' 0 CA--C 1.581 2.138 0 CA-C-N 113.721 -1.581 . . . . 25.0 109.724 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.39 89.71 Favored 'General case' 0 C--O 1.264 1.856 0 CA-C-O 117.398 -1.287 . . . . 25.0 108.792 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -29.14 70.57 Favored 'General case' 0 C--O 1.279 2.656 0 O-C-N 125.764 1.915 . . . . 25.0 115.389 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 CA--C 1.565 1.534 0 O-C-N 120.433 -1.417 . . . . 75.0 109.575 176.859 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 C--O 1.257 1.452 0 N-CA-C 115.62 1.711 . . . . 25.0 115.62 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -64.58 -38.16 90.03 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.653 2.094 . . . . 50.0 116.653 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -147.41 64.26 8.54 Favored Pre-proline 0 C--O 1.262 1.76 0 CA-C-O 118.353 -0.832 . . . . 25.0 109.558 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 -21.67 12.96 Favored 'Trans proline' 0 N--CA 1.486 1.063 1 C-N-CA 110.775 -5.683 . . . . 25.0 117.537 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -72.48 -20.75 61.32 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 114.485 -2.674 . . . . 25.0 112.698 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.7 t -79.54 112.7 17.04 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 124.802 2.239 . . . . 25.0 109.615 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 mt -106.89 91.41 3.65 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 109.139 -3.664 . . . . 50.0 104.14 163.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.04 161.72 28.4 Favored 'General case' 0 CA--C 1.457 -2.618 0 C-N-CA 118.074 -1.45 . . . . 25.0 112.732 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.15 166.32 25.01 Favored 'General case' 0 C--O 1.187 -2.201 0 N-CA-C 102.674 -3.084 . . . . 25.0 102.674 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -130.12 140.49 50.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt . . . . . 0 N--CA 1.479 0.981 0 O-C-N 124.098 0.874 . . . . 25.0 109.296 177.125 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . 0.273 59.0 mt . . . . . 0 CA--C 1.507 -0.689 0 CA-C-O 121.999 0.904 . . . . 50.0 112.677 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -82.96 -40.13 20.45 Favored 'General case' 0 C--N 1.301 -1.534 1 N-CA-C 99.359 -4.311 . . . . 50.0 99.359 171.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.77 -16.41 80.34 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 126.661 3.367 . . . . 25.0 110.522 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.97 -23.33 72.75 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 110.116 -3.042 . . . . 25.0 112.323 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.8 -39.19 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 122.136 2.968 . . . . 25.0 109.217 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -73.83 -29.64 62.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 116.667 2.099 . . . . 75.0 116.667 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -66.97 -28.03 67.94 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 126.881 2.073 . . . . 50.0 110.705 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -91.56 39.3 1.0 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.722 -1.127 . . . . 25.0 110.924 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -136.31 59.68 1.7 Allowed 'General case' 0 C--N 1.281 -2.37 0 O-C-N 125.667 1.854 . . . . 25.0 107.335 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.9 p -169.21 168.28 9.89 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 113.255 -1.793 . . . . 25.0 106.756 -156.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.61 -20.45 60.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 126.869 2.605 . . . . 25.0 109.011 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -84.46 8.74 15.4 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 126.852 2.595 . . . . 25.0 115.614 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -68.79 86.54 0.33 Allowed 'General case' 0 C--O 1.271 2.209 0 CA-C-O 124.721 2.2 . . . . 25.0 107.247 163.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -40.09 148.44 0.08 Allowed 'General case' 0 N--CA 1.426 -1.648 1 CA-C-N 108.242 -4.072 . . . . 25.0 117.242 169.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -74.47 138.95 43.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 123.978 1.847 . . . . 50.0 111.799 -166.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -77.23 154.29 33.17 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 112.207 -2.269 . . . . 25.0 107.798 157.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -132.83 126.5 32.43 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.545 -3.872 . . . . 25.0 100.545 157.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -97.69 116.57 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 105.43 -2.063 . . . . 25.0 105.43 -166.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.9 ttt -132.88 154.27 50.54 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 119.788 -1.82 . . . . 25.0 109.838 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 p -74.79 158.19 33.9 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.66 -177.63 18.95 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 116.221 1.248 . . . . 25.0 116.221 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.61 -167.11 23.68 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 119.24 -1.457 . . . . 25.0 114.788 -174.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -71.24 135.76 47.64 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.997 -1.296 . . . . 25.0 108.764 163.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -134.63 140.65 46.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-O 116.122 -1.894 . . . . 25.0 112.114 -166.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.9 m -124.38 131.74 53.51 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.874 1.358 . . . . 25.0 111.264 171.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -112.67 124.74 53.23 Favored 'General case' 0 CA--C 1.605 3.06 1 N-CA-C 100.133 -4.025 . . . . 50.0 100.133 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.2 m -124.89 129.54 50.59 Favored 'General case' 0 C--O 1.273 2.297 0 CA-C-O 126.24 2.924 . . . . 25.0 111.864 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -123.39 155.84 36.6 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 111.35 -2.659 . . . . 25.0 108.38 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 45.4 p -125.02 143.84 50.7 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 104.382 -2.451 . . . . 25.0 104.382 170.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.36 150.26 28.3 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 104.537 -2.394 . . . . 50.0 104.537 165.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.5 t -76.07 -38.28 57.25 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 124.456 2.074 . . . . 25.0 110.229 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.79 137.69 11.29 Favored Pre-proline 0 N--CA 1.482 1.129 1 N-CA-C 96.18 -5.489 . . . . 25.0 96.18 165.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.06 172.47 16.3 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 CA-C-N 120.9 1.357 . . . . 25.0 112.902 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.344 30.9 m-70 -93.87 159.18 15.3 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 118.029 -2.919 . . . . 25.0 104.726 167.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -60.64 125.8 25.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 117.311 2.337 . . . . 25.0 117.311 167.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.9 m -139.26 134.59 32.85 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 106.721 -1.585 . . . . 25.0 106.721 -160.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.3 p -91.65 -29.02 17.11 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.907 1.337 . . . . 25.0 109.542 -171.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -172.64 171.57 4.47 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 116.421 -1.752 . . . . 25.0 108.292 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.434 ' CZ3' ' CD2' ' A' ' 123' ' ' HIS . 26.9 p90 -153.06 158.54 42.1 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-O 117.018 -1.468 . . . . 25.0 111.528 166.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.253 8.3 m-70 -139.96 144.37 37.01 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.011 1.278 . . . . 25.0 114.12 -167.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -123.72 137.95 54.61 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 121.209 1.822 . . . . 50.0 112.768 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -140.54 166.79 23.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.301 -1.74 . . . . 50.0 106.301 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.4 pt -134.68 166.15 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -83.17 150.93 25.94 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.168 0.44 . . . . 25.0 111.5 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -99.52 162.65 12.9 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -166.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -163.88 168.46 19.46 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 100.477 -3.898 . . . . 25.0 100.477 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.38 60.32 3.07 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 103.763 -3.735 . . . . 25.0 103.763 -174.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -146.5 171.67 14.71 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 114.776 -2.535 . . . . 25.0 112.476 -169.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.64 135.93 11.08 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 122.99 2.632 . . . . 25.0 104.576 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 108' ' ' LYS . 95.5 Cg_endo -64.04 -16.4 54.69 Favored 'Trans proline' 0 C--O 1.191 -1.868 1 N-CA-C 125.04 4.977 . . . . 25.0 125.04 -176.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -78.49 -1.79 35.46 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 117.061 -3.524 . . . . 75.0 112.284 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 106' ' ' PRO . 92.0 mttt -130.93 165.18 36.83 Favored Pre-proline 0 N--CA 1.406 -2.64 1 N-CA-C 100.19 -4.004 . . . . 25.0 100.19 -166.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -47.94 24.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 2 C-N-CA 127.703 5.602 . . . . 25.0 122.908 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -41.97 -39.28 1.83 Allowed 'General case' 0 CA--C 1.599 2.848 0 N-CA-C 120.059 3.355 . . . . 50.0 120.059 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -93.79 -10.75 33.12 Favored 'General case' 0 C--O 1.262 1.725 0 CA-C-N 120.041 1.292 . . . . 25.0 112.237 -176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -107.2 -45.32 4.14 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.601 1.191 . . . . 25.0 110.763 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.17 37.7 0.78 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.838 -1.541 . . . . 25.0 106.838 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.15 -20.73 64.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 125.478 2.561 . . . . 25.0 112.297 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.16 157.24 47.1 Favored 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.366 1.866 . . . . 50.0 106.208 165.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -141.27 144.22 34.53 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 125.179 1.549 . . . . 25.0 108.756 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.88 135.89 57.92 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 123.303 1.525 . . . . 50.0 111.074 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.266 2.4 tt -107.29 -26.51 3.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 103.698 -2.704 . . . . 25.0 103.698 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.54 171.68 38.29 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 123.396 1.553 . . . . 25.0 113.571 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.45 147.29 26.08 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.15 119.43 27.65 Favored Pre-proline 0 N--CA 1.484 1.254 0 N-CA-C 105.633 -1.988 . . . . 50.0 105.633 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.09 167.08 16.26 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 N-CA-C 102.585 -3.659 . . . . 25.0 102.585 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.434 ' CD2' ' CZ3' ' A' ' 95' ' ' TRP . 12.4 t-80 -136.2 61.87 1.63 Allowed 'General case' 0 C--O 1.261 1.703 0 N-CA-C 117.515 2.413 . . . . 25.0 117.515 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.43 -25.88 1.14 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 118.973 2.953 . . . . 50.0 118.973 165.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -162.12 12.95 0.12 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 119.713 -1.867 . . . . 25.0 114.581 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.81 170.1 5.56 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 118.976 2.954 . . . . 25.0 118.976 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.54 -166.16 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 120.734 0.956 . . . . 25.0 113.628 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.18 -1.88 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 119.269 3.063 . . . . 25.0 119.269 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.1 p -60.78 -21.45 63.09 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.741 -1.118 . . . . 25.0 113.391 168.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -71.71 -5.03 30.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 117.443 2.386 . . . . 25.0 117.443 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -65.62 133.31 50.87 Favored 'General case' 0 C--O 1.267 2.002 0 O-C-N 120.433 -1.417 . . . . 25.0 108.259 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.73 -30.96 66.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 124.777 2.227 . . . . 75.0 110.774 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.7 t -62.8 127.71 32.51 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 105.337 -2.097 . . . . 25.0 105.337 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.13 134.5 29.72 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 117.593 2.442 . . . . 25.0 117.593 -172.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -94.86 145.0 25.2 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 113.978 -1.464 . . . . 25.0 107.565 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -136.46 125.13 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.356 -2.09 . . . . 25.0 105.356 159.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -71.92 133.97 45.72 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 123.001 2.637 . . . . 50.0 109.062 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.52 110.54 44.74 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -65.88 154.38 74.17 Favored 'Trans proline' 0 N--CA 1.53 3.669 1 C-N-CA 112.309 -4.661 . . . . 25.0 114.053 172.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -91.69 53.52 2.26 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 115.757 -2.377 . . . . 25.0 112.029 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.5 -25.61 38.66 Favored 'General case' 0 C--O 1.261 1.679 0 N-CA-C 114.541 1.312 . . . . 50.0 114.541 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -155.26 173.29 16.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 119.139 0.881 . . . . 25.0 109.643 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -110.97 139.84 45.99 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 104.472 -2.418 . . . . 50.0 104.472 166.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 160.03 167.86 21.19 Favored Glycine 0 C--O 1.294 3.897 0 O-C-N 119.819 -1.801 . . . . 25.0 113.714 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -102.38 139.87 37.42 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 127.166 2.187 . . . . 50.0 111.401 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -156.27 165.24 36.94 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 103.169 -2.9 . . . . 25.0 103.169 166.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.51 161.77 3.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 CA-C-N 120.754 1.615 . . . . 50.0 111.102 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.38 126.77 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 N-CA-C 100.701 -3.814 . . . . 25.0 100.701 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.5 mt -103.81 154.59 19.42 Favored 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 120.555 1.525 . . . . 50.0 108.414 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.1 157.98 43.45 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 119.675 1.125 . . . . 25.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.09 134.02 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 105.007 -2.22 . . . . 50.0 105.007 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.75 108.09 10.44 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 105.041 -2.207 . . . . 25.0 105.041 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -86.37 95.4 9.65 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 125.325 2.488 . . . . 25.0 106.178 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.83 120.01 23.47 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.12 0 CA-C-N 113.56 -1.654 . . . . 50.0 107.396 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.76 -13.48 42.24 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.698 1.37 . . . . 25.0 114.698 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.95 -23.66 67.43 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.595 2.072 . . . . 25.0 116.595 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.5 p -138.03 158.03 45.15 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 110.875 -2.875 . . . . 25.0 107.218 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -75.18 -17.35 60.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 123.091 1.424 . . . . 25.0 111.547 164.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -69.72 154.84 41.42 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 162.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.09 178.52 7.32 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 100.55 -3.87 . . . . 25.0 100.55 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -124.0 153.97 40.51 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 125.919 2.012 . . . . 50.0 112.28 171.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -123.13 159.75 27.9 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 105.993 -1.854 . . . . 50.0 105.993 158.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -154.62 152.04 29.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 120.642 1.565 . . . . 25.0 108.31 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.282 1.1 p -133.91 136.44 53.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.958 1.361 . . . . 75.0 112.567 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.14 125.62 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.329 -1.36 . . . . 25.0 107.329 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.58 136.45 32.99 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 104.98 -2.23 . . . . 25.0 104.98 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 m -132.79 160.27 42.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 125.241 2.448 . . . . 50.0 110.026 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -130.96 111.74 12.33 Favored 'General case' 0 C--O 1.275 2.397 0 N-CA-C 104.233 -2.506 . . . . 25.0 104.233 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.7 mt -119.26 117.47 28.68 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 100.791 -3.781 . . . . 50.0 100.791 -167.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.2 m -115.22 170.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 116.889 2.181 . . . . 50.0 116.889 -167.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -78.91 151.57 31.65 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.9 tptt . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 115.574 -2.155 . . . . 25.0 111.971 178.271 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 . . . . . 0 N--CA 1.51 2.558 0 CA-C-O 120.573 0.225 . . . . 25.0 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.39 -160.01 30.15 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-O 116.812 -2.104 . . . . 25.0 117.027 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -129.87 156.54 44.22 Favored 'General case' 0 C--O 1.253 1.267 0 C-N-CA 126.921 2.088 . . . . 50.0 113.377 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -95.3 125.54 47.97 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 101.418 -3.549 . . . . 25.0 101.418 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -89.74 -40.48 12.48 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 113.706 -1.588 . . . . 25.0 113.738 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -148.54 150.55 34.06 Favored Pre-proline 0 CA--C 1.549 0.918 1 N-CA-C 99.532 -4.248 . . . . 25.0 99.532 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.44 139.13 59.72 Favored 'Cis proline' 0 N--CA 1.442 -1.529 0 CA-C-N 120.676 1.277 . . . . 25.0 113.604 1.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.89 -154.93 49.03 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 117.458 1.743 . . . . 25.0 117.458 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -137.33 114.66 10.95 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 125.319 1.448 . . . . 25.0 109.48 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -67.62 -24.51 65.48 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 123.896 1.808 . . . . 25.0 114.452 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.15 -30.75 71.29 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 118.139 -2.85 . . . . 25.0 114.536 171.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.36 90.44 Favored 'General case' 0 C--O 1.192 -1.946 0 CA-C-O 125.82 2.724 . . . . 25.0 110.323 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.625 0 CA-C-N 112.394 -2.185 . . . . 75.0 108.487 -169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.6 ptt? . . . . . 0 CA--C 1.503 -0.852 1 N-CA-C 122.17 4.137 . . . . 25.0 122.17 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.58 -50.77 16.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 124.956 2.312 . . . . 50.0 108.006 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -131.43 82.65 61.37 Favored Pre-proline 0 N--CA 1.511 2.606 0 CA-C-N 113.073 -1.876 . . . . 25.0 106.177 167.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.49 -16.86 54.85 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 116.273 -2.018 . . . . 25.0 116.105 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.45 -51.78 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.7 t -84.55 46.02 1.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 118.462 -2.649 . . . . 25.0 113.844 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.45 129.69 39.91 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-O 125.053 2.359 . . . . 50.0 105.475 173.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.41 146.27 42.63 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.014 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.82 41.37 0.67 Allowed 'General case' 0 C--O 1.193 -1.885 0 CA-C-O 124.379 2.038 . . . . 25.0 113.299 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -142.87 -73.84 0.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 118.811 -2.431 . . . . 25.0 112.889 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.8 mttt . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.728 1.611 . . . . 25.0 111.669 -165.416 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 CA--C 1.5 -0.946 0 N-CA-C 118.436 2.754 . . . . 50.0 118.436 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -70.97 -26.1 63.01 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.346 -3.205 . . . . 50.0 102.346 148.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.04 -16.68 68.91 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 119.881 -1.762 . . . . 25.0 109.003 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.95 -23.53 77.69 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 119.997 -1.097 . . . . 25.0 114.092 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.48 -44.41 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 117.012 -1.875 . . . . 25.0 109.519 165.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.11 1.02 2.24 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 126.235 2.921 . . . . 75.0 118.624 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.78 -14.93 60.78 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 112.262 -2.245 . . . . 50.0 110.721 170.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -72.74 5.15 3.35 Favored 'General case' 0 CA--C 1.485 -1.557 0 O-C-N 116.631 -3.793 . . . . 25.0 116.733 173.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -122.62 67.31 0.95 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 125.919 1.687 . . . . 25.0 107.258 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -147.18 151.24 36.43 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 117.192 2.293 . . . . 25.0 117.192 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -72.28 -30.22 64.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 118.246 -2.784 . . . . 25.0 109.02 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -106.02 31.36 5.14 Favored 'General case' 0 C--O 1.176 -2.776 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -78.46 101.71 7.45 Favored 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 97.859 -4.867 . . . . 25.0 97.859 164.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -43.15 155.96 0.05 Allowed 'General case' 0 C--O 1.262 1.714 0 CA-C-N 110.023 -3.262 . . . . 25.0 115.468 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -58.86 144.73 43.45 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 127.043 3.306 . . . . 50.0 117.076 -167.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -82.96 153.78 24.85 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 117.714 2.487 . . . . 25.0 117.714 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -152.35 156.52 39.74 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 117.981 -2.949 . . . . 25.0 109.138 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.2 tt -132.58 139.75 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 106.367 -1.716 . . . . 25.0 106.367 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtt -152.87 151.8 30.81 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 120.087 1.312 . . . . 25.0 110.255 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.5 p -84.55 176.68 8.46 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.071 -0.714 . . . . 25.0 109.071 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.65 168.8 53.86 Favored Glycine 0 C--O 1.209 -1.439 0 C-N-CA 120.825 -0.702 . . . . 25.0 112.065 168.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.62 174.26 15.56 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.472 -1.823 . . . . 25.0 110.687 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -71.06 134.04 46.77 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.279 -0.968 . . . . 25.0 111.807 162.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -133.73 147.35 51.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.131 -0.94 . . . . 25.0 110.77 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m -85.62 136.09 33.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 124.274 1.03 . . . . 25.0 110.597 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.42 134.81 49.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.067 -1.827 . . . . 50.0 106.067 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.4 m -114.66 120.93 41.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -120.27 149.02 42.96 Favored 'General case' 0 C--O 1.263 1.803 0 CA-C-O 118.288 -0.863 . . . . 25.0 109.446 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 t -143.35 158.18 43.85 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.275 1.852 . . . . 25.0 109.871 -171.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -86.15 147.93 25.91 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 104.443 -2.429 . . . . 50.0 104.443 161.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.7 t -110.41 -18.28 13.27 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 103.711 -2.7 . . . . 25.0 103.711 162.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 147.04 54.14 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 101.117 -3.66 . . . . 25.0 101.117 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.35 151.54 84.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 117.887 -0.942 . . . . 25.0 113.579 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -129.1 178.49 6.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 100.762 -3.792 . . . . 25.0 100.762 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -118.56 84.84 2.25 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.938 1.695 . . . . 25.0 107.007 157.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -75.56 149.52 38.31 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 103.233 -2.877 . . . . 25.0 103.233 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 p -106.16 -30.32 9.3 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-N 120.713 1.597 . . . . 25.0 114.56 168.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -164.21 158.34 18.92 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 118.614 -2.554 . . . . 25.0 104.674 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -149.69 162.04 41.01 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 120.167 -1.583 . . . . 25.0 110.156 163.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -128.79 156.58 43.35 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 127.009 2.124 . . . . 25.0 110.738 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -147.7 149.76 33.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 124.693 2.187 . . . . 50.0 105.959 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -146.3 168.6 20.68 Favored 'General case' 0 CA--C 1.501 -0.914 1 N-CA-C 98.813 -4.514 . . . . 50.0 98.813 -154.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.1 pt -134.51 158.0 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 117.07 -1.443 . . . . 25.0 108.693 162.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.9 m -95.14 133.32 39.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 125.525 1.766 . . . . 25.0 110.592 172.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -76.87 135.77 38.85 Favored 'General case' 0 C--O 1.297 3.563 0 CA-C-N 122.328 2.331 . . . . 25.0 109.998 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.32 164.71 26.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 103.999 -2.593 . . . . 25.0 103.999 171.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.33 3.24 65.21 Favored Glycine 0 C--O 1.276 2.739 0 N-CA-C 117.333 1.693 . . . . 25.0 117.333 169.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.87 176.97 5.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.711 1.004 . . . . 25.0 113.711 -174.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.56 138.04 11.38 Favored Pre-proline 0 C--O 1.194 -1.847 0 CA-C-O 116.188 -1.863 . . . . 25.0 109.944 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.51 -21.23 46.66 Favored 'Trans proline' 0 C--O 1.286 2.912 0 N-CA-C 117.983 2.263 . . . . 25.0 117.983 -174.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.53 3.13 12.0 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 118.977 -2.327 . . . . 75.0 113.198 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -129.38 174.04 5.02 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 100.615 -3.846 . . . . 25.0 100.615 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.6 21.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 N-CA-C 122.138 3.861 . . . . 25.0 122.138 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 tt -38.84 -33.74 0.12 Allowed 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.755 2.132 . . . . 50.0 116.755 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.28 -5.44 59.18 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 116.593 2.072 . . . . 25.0 116.593 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -116.15 -43.11 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 123.654 1.693 . . . . 25.0 110.105 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.2 4.77 1.14 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 113.315 -1.766 . . . . 25.0 112.883 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.63 -14.92 62.66 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 119.571 -0.852 . . . . 25.0 108.837 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.73 106.74 8.91 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -109.09 120.16 41.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 104.99 -2.226 . . . . 25.0 104.99 165.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.97 136.27 55.06 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 116.568 -1.682 . . . . 50.0 108.873 -176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.5 tp -110.29 -19.21 7.04 Favored 'Isoleucine or valine' 0 C--N 1.374 1.639 0 CA-C-O 125.868 2.747 . . . . 25.0 109.81 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.76 150.97 13.13 Favored Glycine 0 N--CA 1.444 -0.773 0 O-C-N 118.268 -2.77 . . . . 25.0 114.562 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . 0.257 . . -143.84 140.96 30.1 Favored 'General case' 0 CA--C 1.569 1.685 1 N-CA-C 98.955 -4.461 . . . . 25.0 98.955 -179.957 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.2 105.11 11.29 Favored Pre-proline 0 CA--C 1.497 -1.078 0 O-C-N 127.208 2.818 . . . . 50.0 103.465 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -66.22 167.17 18.98 Favored 'Trans proline' 0 C--O 1.203 -1.225 1 C-N-CA 109.828 -6.315 . . . . 25.0 111.896 166.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -144.01 83.18 1.73 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 118.435 -2.666 . . . . 25.0 111.795 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.93 -17.6 43.06 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 124.675 2.178 . . . . 50.0 113.183 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.01 -168.2 36.57 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 103.581 -3.808 . . . . 25.0 103.581 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 71.09 82.2 Favored Pre-proline 0 C--O 1.181 -2.523 0 CA-C-N 121.534 2.667 . . . . 25.0 114.278 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -67.67 172.06 11.09 Favored 'Trans proline' 0 C--O 1.286 2.906 1 C-N-CA 111.025 -5.517 . . . . 25.0 110.982 155.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.03 -35.76 67.22 Favored 'General case' 0 C--N 1.356 0.89 0 CA-C-O 116.396 -1.764 . . . . 25.0 113.656 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 98.4 p -59.22 -20.21 52.08 Favored 'General case' 0 C--O 1.296 3.536 0 O-C-N 127.532 3.02 . . . . 25.0 115.793 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -105.57 8.22 33.18 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 118.704 2.853 . . . . 25.0 118.704 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -60.19 151.91 25.96 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 125.72 2.676 . . . . 25.0 110.998 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mt -66.46 -27.03 67.49 Favored 'General case' 0 C--O 1.26 1.613 0 CA-C-N 113.202 -1.817 . . . . 75.0 114.56 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.4 m -96.44 145.55 25.56 Favored 'General case' 0 C--O 1.302 3.85 0 O-C-N 119.518 -1.989 . . . . 25.0 105.855 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -131.45 168.32 17.82 Favored 'General case' 0 C--O 1.192 -1.957 0 N-CA-C 116.318 1.97 . . . . 25.0 116.318 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.305 89.9 m-70 -121.3 116.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 121.608 2.004 . . . . 25.0 113.28 168.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mm -122.18 131.79 72.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 C-N-CA 118.745 -1.182 . . . . 25.0 108.981 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -75.78 134.08 40.52 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 107.18 -1.415 . . . . 50.0 107.18 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.04 132.02 22.55 Favored Pre-proline 0 C--O 1.204 -1.309 0 N-CA-C 102.892 -3.003 . . . . 25.0 102.892 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -62.27 143.66 94.34 Favored 'Trans proline' 0 CA--C 1.458 -3.324 1 C-N-CA 113.006 -4.196 . . . . 25.0 118.785 -175.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.73 -22.86 12.86 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 125.447 2.546 . . . . 25.0 114.267 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -77.46 -5.46 49.97 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 118.965 -2.334 . . . . 50.0 112.289 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -145.06 158.09 43.92 Favored 'General case' 0 C--O 1.204 -1.303 0 CA-C-N 112.739 -2.028 . . . . 25.0 112.388 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.2 mp -107.2 152.67 23.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.052 -2.944 . . . . 50.0 103.052 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 158.44 166.63 17.96 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.151 -0.968 . . . . 25.0 114.949 167.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -88.57 136.13 33.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.606 1.335 . . . . 50.0 114.606 166.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -149.45 167.84 25.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 104.213 -2.514 . . . . 25.0 104.213 -159.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.51 131.83 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.985 0 N-CA-C 103.537 -2.764 . . . . 50.0 103.537 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 94.5 mt -98.8 121.17 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 105.925 -1.88 . . . . 25.0 105.925 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.93 138.18 51.12 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 119.904 -1.747 . . . . 50.0 107.799 -175.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.26 145.51 43.64 Favored 'General case' 0 C--O 1.263 1.81 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -133.84 137.3 52.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 114.424 -2.703 . . . . 50.0 110.267 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -115.77 150.5 36.8 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.814 -1.921 . . . . 25.0 105.814 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -112.89 131.74 55.6 Favored 'General case' 0 C--N 1.307 -1.248 1 N-CA-C 99.085 -4.413 . . . . 25.0 99.085 163.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.21 120.82 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 105.046 -2.205 . . . . 50.0 105.046 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.8 -21.3 41.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 118.944 -0.551 . . . . 25.0 111.069 -173.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . 0.304 2.1 p-10 -82.82 -15.13 52.82 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 116.023 1.86 . . . . 25.0 116.023 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.1 p -112.67 156.58 22.51 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.177 -1.046 . . . . 25.0 108.177 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -90.5 -23.79 20.85 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.638 -1.225 . . . . 25.0 114.064 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -102.0 160.14 14.76 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 115.25 -0.886 . . . . 25.0 111.486 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.82 166.85 22.94 Favored 'General case' 0 C--O 1.253 1.258 0 CA-C-N 113.03 -1.896 . . . . 25.0 112.649 163.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -129.35 130.83 46.58 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 112.343 -2.208 . . . . 50.0 110.34 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -139.74 136.76 34.49 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 127.207 2.817 . . . . 50.0 108.323 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.62 149.53 20.37 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 106.881 -1.525 . . . . 25.0 106.881 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.9 m -127.51 162.72 32.38 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.595 0 N-CA-C 107.978 -1.119 . . . . 75.0 107.978 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.94 131.44 46.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 105.868 -1.901 . . . . 25.0 105.868 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.55 124.31 38.5 Favored 'General case' 0 CA--C 1.583 2.215 0 O-C-N 126.093 2.121 . . . . 25.0 106.357 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 m -123.46 158.75 28.67 Favored 'Isoleucine or valine' 0 C--O 1.285 2.933 0 C-N-CA 116.186 -2.206 . . . . 50.0 109.221 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -119.44 121.34 39.26 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 101.105 -3.665 . . . . 25.0 101.105 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.6 mt -112.28 95.99 5.77 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 105.488 -2.042 . . . . 50.0 105.488 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.8 172.73 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.801 -1.187 . . . . 50.0 113.192 -170.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -66.97 132.81 48.69 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 105.982 -1.859 . . . . 25.0 105.982 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.0 pttp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 115.612 -2.137 . . . . 25.0 110.194 177.546 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 . . . . . 1 N--CA 1.555 4.8 0 CA-C-O 122.761 1.267 . . . . 25.0 107.995 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -121.31 6.33 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.341 -1.409 . . . . 25.0 111.571 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.26 144.33 27.8 Favored 'General case' 0 C--O 1.267 2.023 0 O-C-N 119.196 -2.355 . . . . 50.0 106.438 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -86.86 126.09 40.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 N-CA-C 105.002 -2.221 . . . . 25.0 105.002 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -108.02 -35.31 6.64 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 117.039 -1.864 . . . . 25.0 110.449 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 148.86 57.56 Favored Pre-proline 0 C--O 1.256 1.406 0 N-CA-C 104.967 -2.234 . . . . 25.0 104.967 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -71.43 133.16 27.07 Favored 'Cis proline' 0 C--N 1.359 1.117 0 C-N-CA 132.848 2.437 . . . . 25.0 114.158 2.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.22 -144.12 49.05 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 115.104 0.802 . . . . 25.0 115.104 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -133.72 104.62 6.41 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 105.169 -2.16 . . . . 25.0 105.169 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -69.18 -18.06 63.88 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 117.806 -3.059 . . . . 25.0 109.471 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.19 70.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 116.403 -1.76 . . . . 25.0 111.169 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.56 63.82 Favored 'General case' 0 C--O 1.198 -1.624 0 N-CA-C 106.89 -1.522 . . . . 25.0 106.89 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.485 1.279 0 O-C-N 120.546 -1.346 . . . . 75.0 111.861 -177.758 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 116.86 -1.543 . . . . 25.0 115.111 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.78 -47.27 85.3 Favored 'General case' 0 N--CA 1.421 -1.917 0 O-C-N 126.297 2.248 . . . . 50.0 112.362 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.62 64.03 11.32 Favored Pre-proline 0 CA--C 1.505 -0.755 0 N-CA-C 113.753 1.02 . . . . 25.0 113.753 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.26 -19.87 37.96 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 N-CA-C 117.681 2.146 . . . . 25.0 117.681 -167.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -99.83 6.42 45.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.435 2.013 . . . . 25.0 116.435 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -136.73 38.52 2.62 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.692 1.597 . . . . 25.0 112.216 171.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 tp -77.5 99.32 5.64 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.055 -0.521 . . . . 50.0 110.968 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.28 147.1 52.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.071 -1.455 . . . . 25.0 107.071 -159.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.29 50.6 1.02 Allowed 'General case' 0 CA--C 1.606 3.12 0 N-CA-C 115.437 1.643 . . . . 25.0 115.437 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 45.4 tttt -134.76 -163.1 1.33 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.05 -1.833 . . . . 25.0 106.05 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' A' ' 38' ' ' LYS . 94.0 mttt . . . . . 0 N--CA 1.437 -1.082 0 O-C-N 125.638 1.837 . . . . 25.0 110.679 -168.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.9 mt . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 124.284 1.992 . . . . 50.0 111.428 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -71.12 -40.42 71.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.763 -2.31 . . . . 50.0 104.763 155.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.55 -22.98 47.74 Favored Glycine 0 CA--C 1.499 -0.966 0 O-C-N 118.82 -2.425 . . . . 25.0 114.582 167.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.13 74.6 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 126.069 3.038 . . . . 25.0 113.285 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.96 -33.22 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 117.771 -3.194 . . . . 25.0 105.381 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.13 -14.51 60.98 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 112.65 -2.068 . . . . 75.0 112.956 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.01 -25.97 65.7 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 111.724 -2.489 . . . . 50.0 112.02 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.51 11.27 5.85 Favored 'General case' 0 C--O 1.251 1.155 0 O-C-N 118.807 -2.433 . . . . 25.0 112.756 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -133.06 16.77 4.15 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.05 -1.656 . . . . 25.0 112.457 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -112.4 166.17 11.54 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.286 -0.87 . . . . 25.0 109.345 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.81 -22.6 65.16 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 105.78 -1.933 . . . . 25.0 105.78 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.98 39.64 1.52 Allowed 'General case' 0 C--O 1.168 -3.196 0 C-N-CA 125.55 1.54 . . . . 25.0 110.165 175.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -89.36 91.34 8.7 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-O 124.901 2.286 . . . . 25.0 105.704 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -57.24 139.2 53.43 Favored 'General case' 0 C--N 1.305 -1.34 1 CA-C-N 107.5 -4.409 . . . . 25.0 105.358 172.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -65.56 152.09 44.91 Favored 'General case' 0 C--O 1.286 3.017 0 CA-C-O 126.314 2.959 . . . . 50.0 115.086 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -87.27 134.92 33.49 Favored 'General case' 0 C--O 1.185 -2.318 0 CA-C-N 109.897 -3.32 . . . . 25.0 104.415 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -126.47 134.71 50.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 126.062 2.101 . . . . 25.0 112.883 171.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -93.99 141.25 15.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 tpt -146.3 147.75 31.7 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-O 123.028 1.394 . . . . 25.0 108.739 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 p -82.31 173.61 11.91 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 114.262 -1.335 . . . . 25.0 114.416 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.9 -179.0 35.45 Favored Glycine 0 C--O 1.264 2.019 0 O-C-N 120.053 -1.654 . . . . 25.0 110.526 163.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.76 179.05 32.11 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 106.252 -2.739 . . . . 25.0 106.252 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.75 138.9 39.27 Favored 'General case' 0 C--O 1.257 1.471 0 O-C-N 118.326 -2.867 . . . . 25.0 114.612 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -132.1 160.48 35.84 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 114.044 -1.434 . . . . 25.0 110.803 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -111.52 135.79 51.59 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-O 123.798 1.761 . . . . 25.0 111.597 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -112.97 119.55 38.3 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.79 -1.095 . . . . 50.0 111.518 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.4 m -134.72 129.21 34.36 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 107.275 -1.38 . . . . 25.0 107.275 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -120.77 151.21 39.86 Favored 'General case' 0 C--N 1.313 -1.011 1 N-CA-C 98.617 -4.586 . . . . 25.0 98.617 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -143.66 126.57 16.29 Favored 'General case' 0 C--O 1.263 1.811 0 O-C-N 125.344 1.652 . . . . 25.0 112.397 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -130.3 143.65 50.9 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 118.809 -2.432 . . . . 50.0 109.633 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -61.6 -23.96 66.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 118.522 2.786 . . . . 25.0 118.522 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.05 157.2 78.21 Favored Pre-proline 0 CA--C 1.493 -1.227 0 N-CA-C 101.257 -3.609 . . . . 25.0 101.257 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.26 159.1 11.24 Favored 'Trans proline' 0 N--CA 1.504 2.099 0 N-CA-C 103.003 -3.499 . . . . 25.0 103.003 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -89.83 167.62 12.71 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 102.667 -3.086 . . . . 25.0 102.667 159.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -88.7 117.13 27.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -139.32 156.36 47.08 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 122.613 0.365 . . . . 25.0 110.341 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p -98.83 -48.87 4.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.168 0.987 . . . . 25.0 111.378 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -159.42 160.3 34.68 Favored 'General case' 0 CA--C 1.474 -1.969 0 O-C-N 120.214 -1.553 . . . . 25.0 114.541 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -122.08 144.95 48.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 119.735 1.152 . . . . 25.0 111.221 162.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -122.93 153.56 39.54 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 114.253 -2.784 . . . . 25.0 110.283 -170.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.25 137.56 27.38 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 105.858 -1.904 . . . . 50.0 105.858 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -134.67 156.46 48.72 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 124.56 1.162 . . . . 50.0 110.081 -167.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.63 162.81 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 124.621 2.153 . . . . 25.0 110.006 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 54.8 m -111.9 127.27 55.79 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 118.75 -2.469 . . . . 25.0 108.285 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -99.01 179.49 4.61 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -164.03 177.13 8.72 Favored 'General case' 0 C--O 1.275 2.433 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.81 26.69 66.46 Favored Glycine 0 C--O 1.252 1.235 1 CA-C-O 129.379 4.877 . . . . 25.0 113.861 -166.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.19 150.31 21.04 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 108.83 -3.685 . . . . 25.0 112.95 -173.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . 0.288 9.7 t70 -98.45 141.54 23.1 Favored Pre-proline 0 C--O 1.194 -1.868 0 C-N-CA 127.772 2.429 . . . . 25.0 111.095 -172.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -67.52 -40.54 10.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 124.776 3.65 . . . . 25.0 121.038 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.67 -29.05 65.27 Favored 'General case' 0 C--O 1.197 -1.704 0 CA-C-O 126.225 2.917 . . . . 75.0 109.312 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.84 161.5 74.47 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 118.484 -2.635 . . . . 25.0 110.31 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.92 17.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.646 2 C-N-CA 127.978 5.785 . . . . 25.0 122.878 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.19 -37.5 15.94 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 116.091 1.885 . . . . 50.0 116.091 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -85.48 -10.66 55.78 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.423 1.638 . . . . 25.0 115.423 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 114' ' ' ASP . 99.4 mtt180 -104.21 -52.81 2.85 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 117.695 2.48 . . . . 25.0 117.695 174.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.67 34.8 0.28 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 127.028 2.705 . . . . 25.0 106.791 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 112' ' ' ARG . 36.0 t70 -63.65 -26.79 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.838 2.055 . . . . 25.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -127.71 145.69 50.82 Favored 'General case' 0 C--N 1.298 -1.674 1 N-CA-C 99.023 -4.436 . . . . 50.0 99.023 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -117.63 130.66 56.51 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 121.414 1.915 . . . . 25.0 110.73 168.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.1 tp -63.87 110.15 1.99 Allowed 'General case' 0 C--O 1.27 2.153 0 CA-C-O 118.311 -0.852 . . . . 50.0 110.467 168.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.6 tt -99.34 -17.85 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.14 166.34 36.35 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 116.319 1.288 . . . . 25.0 116.319 164.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.7 152.18 33.54 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.21 -1.404 . . . . 25.0 107.21 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.96 120.43 15.24 Favored Pre-proline 0 C--O 1.262 1.723 0 O-C-N 125.934 2.021 . . . . 50.0 110.185 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.72 152.67 53.36 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.262 1.276 . . . . 25.0 113.093 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.79 52.29 1.48 Allowed 'General case' 0 C--O 1.245 0.863 0 N-CA-C 105.318 -2.104 . . . . 25.0 105.318 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -83.64 -22.55 32.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.602 -1.629 . . . . 50.0 106.602 -167.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.05 178.89 31.47 Favored Glycine 0 C--O 1.204 -1.738 1 N-CA-C 102.714 -4.154 . . . . 25.0 102.714 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -123.75 56.87 11.27 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 119.434 3.124 . . . . 25.0 119.434 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.6 175.85 10.53 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 O-C-N 118.303 -1.472 . . . . 25.0 108.5 168.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.47 -13.77 43.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 25.0 113.311 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 80.7 p -84.76 -3.83 58.78 Favored 'General case' 0 C--O 1.189 -2.12 0 CA-C-N 119.383 0.992 . . . . 25.0 110.83 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -116.47 26.21 10.06 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 123.973 1.844 . . . . 25.0 110.673 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -68.61 149.97 48.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.825 -1.546 . . . . 25.0 106.825 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.73 -15.11 59.86 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 126.466 2.354 . . . . 75.0 115.781 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.4 t -81.31 123.61 28.67 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 104.223 -2.51 . . . . 25.0 104.223 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -118.71 147.22 44.06 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.664 -1.273 . . . . 25.0 108.047 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -110.53 136.35 49.78 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.9 mm -132.37 128.23 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -78.66 133.53 37.22 Favored 'General case' 0 C--O 1.255 1.365 0 O-C-N 125.696 1.873 . . . . 50.0 111.71 169.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.48 126.18 28.27 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-O 115.22 -2.324 . . . . 25.0 107.218 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.75 151.72 74.36 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 113.563 -3.824 . . . . 25.0 114.619 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -105.11 -8.05 18.7 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.08 -1.873 . . . . 25.0 111.921 -172.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.23 -1.7 24.62 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 126.315 2.259 . . . . 50.0 115.758 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -142.06 165.72 26.67 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 119.409 -2.057 . . . . 25.0 112.596 -172.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.15 147.06 50.54 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 101.184 -3.636 . . . . 50.0 101.184 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.44 174.44 21.56 Favored Glycine 0 CA--C 1.477 -2.326 0 N-CA-C 121.037 3.175 . . . . 25.0 121.037 161.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -82.39 140.48 33.45 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 113.588 -1.306 . . . . 50.0 111.834 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -149.38 165.97 30.46 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.108 -2.182 . . . . 25.0 105.108 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.12 141.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.684 0 N-CA-C 103.933 -2.618 . . . . 50.0 103.933 168.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 91.0 mt -127.54 132.33 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 116.749 -1.596 . . . . 25.0 109.019 -175.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.53 139.17 44.85 Favored 'General case' 0 C--O 1.263 1.793 0 O-C-N 128.467 3.605 . . . . 50.0 110.55 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.5 116.23 17.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 25.0 112.039 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 t -129.36 127.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 125.089 1.493 . . . . 50.0 108.572 -162.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -119.23 108.98 15.31 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 119.286 0.948 . . . . 25.0 113.027 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.32 116.41 11.62 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 126.762 2.025 . . . . 25.0 109.545 -173.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.4 t -87.68 136.38 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.44 -1.689 . . . . 50.0 106.44 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -95.63 -25.25 16.21 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 115.843 1.794 . . . . 25.0 115.843 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.0 5.65 50.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.082 1.42 . . . . 25.0 113.277 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.9 p -139.6 -177.23 4.85 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 104.179 -2.526 . . . . 25.0 104.179 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.78 -7.23 41.03 Favored 'General case' 0 CA--C 1.481 -1.704 0 O-C-N 125.089 1.493 . . . . 25.0 107.155 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.28 176.96 8.01 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 116.565 2.061 . . . . 25.0 116.565 -170.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.91 146.87 28.09 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -78.7 133.91 37.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.22 -1.77 . . . . 50.0 106.22 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -136.58 123.05 20.8 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 126.299 1.839 . . . . 50.0 110.752 -172.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.63 142.67 33.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 103.645 -2.724 . . . . 25.0 103.645 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.96 144.24 24.27 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 102.317 -3.216 . . . . 75.0 102.317 -168.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.2 mt -138.81 122.03 19.02 Favored 'Isoleucine or valine' 0 C--O 1.261 1.706 0 CA-C-O 124.131 1.92 . . . . 25.0 106.162 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -75.59 126.68 31.48 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 112.459 -2.155 . . . . 25.0 106.694 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.84 159.17 39.58 Favored 'Isoleucine or valine' 0 C--O 1.264 1.833 0 O-C-N 117.362 -3.336 . . . . 50.0 116.811 -171.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -133.14 113.65 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 103.953 -2.61 . . . . 25.0 103.953 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.9 mt -116.43 122.5 44.97 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 105.238 -2.134 . . . . 50.0 105.238 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.19 159.83 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 N-CA-C 117.749 2.5 . . . . 50.0 117.749 -172.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -61.36 140.28 58.04 Favored 'General case' 0 C--O 1.189 -2.102 0 O-C-N 121.026 -1.046 . . . . 25.0 110.779 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.9 pttt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 116.266 -1.826 . . . . 25.0 110.52 170.627 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.1 m80 . . . . . 0 N--CA 1.506 2.352 0 CA-C-O 123.733 1.73 . . . . 25.0 109.608 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.7 173.62 42.44 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 127.244 2.355 . . . . 25.0 116.754 -173.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -151.55 164.39 36.94 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-N 119.814 1.807 . . . . 50.0 113.357 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.67 135.24 27.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.647 -1.242 . . . . 25.0 107.647 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -107.89 -36.08 6.47 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 113.378 0.881 . . . . 25.0 113.378 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -148.7 158.84 39.41 Favored Pre-proline 0 C--O 1.286 3.011 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.17 145.26 77.58 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 C-N-CA 133.005 2.502 . . . . 25.0 111.966 -3.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.39 -169.61 52.76 Favored Glycine 0 C--O 1.214 -1.15 0 CA-C-N 113.107 -1.86 . . . . 25.0 111.767 162.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 t -140.89 121.7 14.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.598 1.959 . . . . 25.0 107.025 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.12 -16.8 36.82 Favored 'General case' 0 C--O 1.259 1.59 0 C-N-CA 116.975 -1.89 . . . . 25.0 107.724 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.66 -35.38 70.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 123.453 1.597 . . . . 25.0 110.783 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.28 92.64 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 112.875 -1.966 . . . . 25.0 111.965 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.1 -37.27 86.94 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 113.228 -1.806 . . . . 75.0 114.956 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.8 t -71.07 -16.8 62.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.383 -1.281 . . . . 25.0 113.04 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.5 m -81.13 168.81 18.17 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 -169.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.02 -7.66 31.0 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.872 -1.142 . . . . 25.0 113.336 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.25 -7.66 53.49 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.761 -1.212 . . . . 25.0 110.89 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -52.0 -40.09 60.44 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 105.415 -2.069 . . . . 50.0 105.415 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.54 -74.61 0.02 OUTLIER Glycine 0 N--CA 1.477 1.4 0 N-CA-C 105.753 -2.939 . . . . 25.0 105.753 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -173.49 -33.28 0.01 OUTLIER 'General case' 0 C--O 1.274 2.358 0 C-N-CA 127.274 2.23 . . . . 50.0 109.452 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.22 -17.75 6.06 Favored 'General case' 0 C--N 1.312 -1.049 1 N-CA-C 124.621 5.045 . . . . 50.0 124.621 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -111.68 164.69 12.75 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 108.451 -0.944 . . . . 25.0 108.451 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -164.91 169.98 15.87 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.234 -0.587 . . . . 50.0 111.365 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -153.5 55.8 0.75 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 106.475 -1.676 . . . . 25.0 106.475 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.5 t -66.02 -31.5 72.43 Favored 'General case' 0 N--CA 1.407 -2.597 0 CA-C-O 117.274 -1.346 . . . . 25.0 114.595 -160.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.39 39.65 91.59 Favored Glycine 0 CA--C 1.557 2.703 0 C-N-CA 119.582 -1.294 . . . . 25.0 114.701 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.0 m -53.32 -3.89 0.03 OUTLIER 'General case' 0 CA--C 1.586 2.332 0 CA-C-N 111.21 -2.495 . . . . 25.0 115.446 -168.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.27 -16.94 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 C-N-CA 128.484 2.714 . . . . 50.0 107.52 169.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -75.18 25.24 0.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.643 2.46 . . . . 25.0 117.643 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -63.61 -50.17 70.43 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 120.674 1.579 . . . . 50.0 113.538 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -135.69 42.8 0.78 Allowed Pre-proline 0 N--CA 1.517 2.911 0 N-CA-C 117.347 2.351 . . . . 25.0 117.347 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.43 -15.72 12.36 Favored 'Trans proline' 0 C--N 1.375 1.941 1 C-N-CA 108.82 -6.987 . . . . 25.0 118.324 -170.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -71.7 -39.17 70.38 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -83.86 51.76 2.12 Favored 'General case' 0 C--O 1.266 1.921 0 CA-C-N 113.265 -1.788 . . . . 25.0 112.408 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.4 tp -87.18 111.45 20.99 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.29 1.043 . . . . 50.0 108.325 170.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -78.45 161.78 26.86 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-O 124.869 2.271 . . . . 25.0 110.558 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.69 144.67 50.47 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 104.89 -2.263 . . . . 25.0 104.89 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -135.69 146.25 47.56 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 106.314 -1.735 . . . . 25.0 106.314 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -90.43 145.55 24.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.63 -2.359 . . . . 25.0 104.63 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.6 -151.97 43.85 Favored Glycine 0 C--O 1.198 -2.111 0 N-CA-C 106.347 -2.701 . . . . 25.0 106.347 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . 0.308 42.9 m-85 -135.02 172.01 7.99 Favored Pre-proline 0 C--O 1.249 1.051 0 N-CA-C 102.412 -3.181 . . . . 25.0 102.412 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -76.85 -178.26 23.6 Favored 'Cis proline' 0 N--CA 1.492 1.422 0 O-C-N 119.194 -1.003 . . . . 25.0 111.42 -2.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -122.91 -16.92 6.94 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.631 1.172 . . . . 25.0 111.464 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t 70.4 -61.08 0.48 Allowed 'General case' 0 C--O 1.292 3.293 0 C-N-CA 127.061 2.144 . . . . 25.0 109.844 -171.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.91 -163.29 5.01 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-O 125.088 2.493 . . . . 25.0 111.582 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.57 165.03 32.56 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 CA-C-O 115.845 -1.814 . . . . 25.0 113.797 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.46 135.65 56.6 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.835 1.334 . . . . 25.0 113.848 -172.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -129.02 178.44 6.4 Favored 'General case' 0 C--N 1.306 -1.31 1 N-CA-C 97.134 -5.136 . . . . 25.0 97.134 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.28 21.0 57.86 Favored Glycine 0 CA--C 1.468 -2.86 0 N-CA-C 109.798 -1.321 . . . . 25.0 109.798 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -111.46 22.39 15.15 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.482 0.658 . . . . 25.0 112.316 -169.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mt -70.83 -38.54 73.04 Favored 'Isoleucine or valine' 0 C--O 1.272 2.266 0 O-C-N 120.421 -1.424 . . . . 25.0 113.594 -173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.63 72.14 Favored 'General case' 0 C--O 1.265 1.897 0 CA-C-N 119.997 1.271 . . . . 25.0 112.377 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.0 p -73.15 -9.24 58.51 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 119.755 -1.841 . . . . 25.0 111.312 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.95 27.44 2.41 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 125.833 1.653 . . . . 25.0 115.269 -169.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.7 -31.09 65.41 Favored Glycine 0 C--O 1.246 0.855 0 N-CA-C 105.2 -3.16 . . . . 25.0 105.2 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.86 14.14 59.33 Favored Glycine 0 C--O 1.254 1.388 0 CA-C-N 119.12 1.46 . . . . 25.0 112.988 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.6 mt -125.88 -73.69 0.62 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 116.222 -1.847 . . . . 50.0 111.714 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.75 -32.75 73.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 125.982 2.051 . . . . 50.0 108.726 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.85 -13.28 69.86 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 125.079 2.489 . . . . 25.0 112.094 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.03 0.11 87.88 Favored Glycine 0 CA--C 1.488 -1.644 0 CA-C-N 112.921 -1.639 . . . . 25.0 112.082 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.9 -28.03 39.88 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 O-C-N 121.578 -0.954 . . . . 25.0 110.827 168.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.45 -22.99 61.0 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 117.611 -1.185 . . . . 75.0 112.097 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.17 -23.95 51.52 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.54 1.063 . . . . 50.0 110.116 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -87.02 11.78 12.86 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 125.324 1.64 . . . . 25.0 110.168 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -132.56 23.45 4.36 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.212 1.958 . . . . 25.0 110.636 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.7 t -87.94 155.97 19.58 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 114.496 -1.229 . . . . 25.0 109.487 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.57 -35.73 66.08 Favored 'General case' 0 CA--C 1.484 -1.561 0 O-C-N 120.334 -1.479 . . . . 25.0 112.115 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -79.45 -4.39 50.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.851 2.537 . . . . 25.0 117.851 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -74.95 86.1 2.28 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 111.742 -2.481 . . . . 25.0 113.081 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -76.52 175.77 8.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 109.194 -3.639 . . . . 25.0 111.391 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -75.98 152.81 36.91 Favored 'General case' 0 C--O 1.192 -1.95 0 CA-C-N 112.129 -2.305 . . . . 50.0 115.431 -144.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -75.28 128.48 35.53 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.843 -1.143 . . . . 25.0 109.913 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -84.5 130.55 34.74 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.394 -2.066 . . . . 25.0 108.501 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.17 125.9 44.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mmt -131.01 129.03 41.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 115.651 -2.119 . . . . 25.0 107.559 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.7 p -80.57 173.88 12.16 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 127.713 3.133 . . . . 25.0 107.685 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.91 159.69 46.04 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 117.693 1.837 . . . . 25.0 117.693 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 174.05 25.21 Favored Glycine 0 C--O 1.216 -1.001 0 CA-C-N 112.161 -2.019 . . . . 25.0 112.067 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.51 148.42 31.83 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 118.045 -3.032 . . . . 25.0 108.845 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.08 154.05 49.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.287 -1.746 . . . . 25.0 106.287 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.9 m -83.64 138.54 33.29 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.597 -1.241 . . . . 25.0 111.761 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . 0.294 71.0 m-85 -124.88 123.85 40.81 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 102.363 -3.199 . . . . 50.0 102.363 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.9 m -139.37 137.78 36.02 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.984 -1.858 . . . . 25.0 105.984 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -120.52 147.07 45.64 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 116.288 -1.815 . . . . 25.0 106.612 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 t -122.26 137.19 54.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.932 1.395 . . . . 25.0 107.368 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.22 158.15 36.4 Favored 'General case' 0 C--O 1.188 -2.132 0 CA-C-O 124.28 1.991 . . . . 50.0 113.311 -172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 p -120.04 16.14 12.46 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 102.964 -2.976 . . . . 25.0 102.964 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.42 125.29 79.18 Favored Pre-proline 0 C--O 1.255 1.366 0 CA-C-O 113.456 -3.164 . . . . 25.0 111.847 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -88.47 -6.5 6.06 Favored 'Trans proline' 0 C--N 1.292 -2.395 0 N-CA-C 108.954 -1.21 . . . . 25.0 108.954 156.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -56.03 139.01 48.16 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.165 -1.38 . . . . 25.0 114.526 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.44 109.28 20.41 Favored 'General case' 0 C--O 1.202 -1.437 0 N-CA-C 114.63 1.344 . . . . 25.0 114.63 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.7 m -66.21 148.44 51.84 Favored 'General case' 0 C--O 1.192 -1.946 0 N-CA-C 106.231 -1.766 . . . . 25.0 106.231 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 p -100.49 -42.06 6.74 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 124.258 1.98 . . . . 25.0 110.09 166.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -164.99 144.2 6.77 Favored 'General case' 0 C--O 1.191 -1.995 0 O-C-N 118.788 -2.445 . . . . 25.0 113.062 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.42 139.64 38.99 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 115.085 -2.646 . . . . 25.0 109.716 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -148.4 152.08 36.38 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.014 -1.678 . . . . 25.0 110.195 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.19 143.56 40.27 Favored 'General case' 0 C--O 1.197 -1.702 0 O-C-N 127.68 3.113 . . . . 50.0 110.9 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.87 166.63 17.12 Favored 'General case' 0 C--O 1.258 1.527 0 N-CA-C 106.39 -1.707 . . . . 50.0 106.39 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 pt -120.99 154.88 24.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 102.694 -3.076 . . . . 25.0 102.694 161.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.5 p -74.97 151.82 38.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.798 -1.189 . . . . 25.0 111.124 163.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -122.29 133.42 54.68 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.216 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.0 157.87 32.36 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 126.429 1.892 . . . . 25.0 108.734 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.87 38.56 7.94 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 118.121 -2.862 . . . . 25.0 118.333 165.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 168.5 9.7 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -144.08 124.29 7.58 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 114.814 -1.085 . . . . 25.0 109.96 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 108' ' ' LYS . 27.3 Cg_exo -58.26 -30.08 89.77 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 114.289 -3.341 . . . . 25.0 118.297 172.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.23 1.02 5.27 Favored 'General case' 0 C--O 1.198 -1.634 0 C-N-CA 116.542 -2.063 . . . . 75.0 115.403 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' H ' ' C ' ' A' ' 106' ' ' PRO . 55.1 mttp -132.84 173.13 6.25 Favored Pre-proline 0 C--O 1.199 -1.589 0 N-CA-C 104.849 -2.278 . . . . 25.0 104.849 -167.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -50.65 20.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.398 2 C-N-CA 129.738 6.959 . . . . 25.0 124.732 173.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -16.71 -49.82 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.017 1 N-CA-C 121.959 4.059 . . . . 50.0 121.959 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -77.58 -8.56 58.03 Favored 'General case' 0 CA--C 1.479 -1.76 1 O-C-N 114.005 -5.434 . . . . 25.0 113.306 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -108.85 -40.73 4.95 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 126.728 2.011 . . . . 25.0 114.76 164.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.27 13.97 1.69 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 127.791 3.182 . . . . 25.0 114.358 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -26.88 67.87 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.481 -0.933 . . . . 25.0 108.481 168.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -137.31 174.14 10.93 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 119.391 3.108 . . . . 50.0 119.391 -171.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -127.8 128.93 46.14 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.566 -1.197 . . . . 25.0 108.265 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 tp -70.16 123.35 21.41 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 103.46 -2.793 . . . . 50.0 103.46 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.9 pt -105.68 -12.93 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.54 1.162 . . . . 25.0 107.937 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.96 154.19 11.68 Favored Glycine 0 CA--C 1.501 -0.81 0 O-C-N 119.117 -2.239 . . . . 25.0 116.791 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.39 139.95 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 126.362 1.86 . . . . 25.0 109.944 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 t -134.69 103.64 11.05 Favored Pre-proline 0 CA--C 1.572 1.8 0 CA-C-O 125.727 2.68 . . . . 50.0 116.863 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.15 157.44 37.97 Favored 'Trans proline' 0 C--O 1.252 1.211 0 O-C-N 115.971 -2.7 . . . . 25.0 108.656 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -82.55 106.48 14.44 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-O 123.917 1.818 . . . . 25.0 110.37 171.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.466 ' H ' ' HG ' ' A' ' 129' ' ' SER . 19.3 t70 -140.12 -46.53 0.43 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 120.276 3.435 . . . . 50.0 120.276 -174.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 156.17 175.57 27.3 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 105.581 -3.008 . . . . 25.0 105.581 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 p 59.46 162.4 0.1 OUTLIER Pre-proline 0 C--O 1.251 1.176 0 N-CA-C 119.491 3.145 . . . . 25.0 119.491 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.63 1.98 3.87 Favored 'Trans proline' 0 C--N 1.371 1.716 1 C-N-CA 113.147 -4.102 . . . . 25.0 118.591 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -43.12 57.18 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 123.642 1.687 . . . . 25.0 109.877 172.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.466 ' HG ' ' H ' ' A' ' 124' ' ' ASP . 30.1 t -77.46 -26.67 51.65 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.819 -4.301 . . . . 25.0 111.576 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -67.26 -20.86 65.72 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 125.197 2.427 . . . . 25.0 115.614 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -62.31 127.69 32.51 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 112.071 -2.331 . . . . 25.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.5 tp -122.21 4.12 9.78 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.403 -1.702 . . . . 75.0 106.403 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.5 t -128.85 136.36 50.35 Favored 'General case' 0 CA--C 1.47 -2.131 0 N-CA-C 102.442 -3.17 . . . . 25.0 102.442 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -147.88 153.24 38.85 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 106.053 -1.832 . . . . 25.0 106.053 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.823 -1.561 . . . . 25.0 107.925 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.23 129.65 75.43 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-O 113.113 -3.327 . . . . 25.0 108.852 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -73.9 135.51 43.31 Favored 'General case' 0 C--O 1.187 -2.189 0 O-C-N 128.725 3.766 . . . . 50.0 114.173 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.4 mm -113.07 121.67 37.62 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 115.833 -2.032 . . . . 25.0 108.095 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -58.12 147.38 83.65 Favored 'Trans proline' 0 CA--C 1.483 -2.054 1 C-N-CA 112.099 -4.801 . . . . 25.0 114.946 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.08 -11.24 47.68 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 111.557 -2.565 . . . . 25.0 112.555 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -112.19 -9.26 13.94 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 118.818 -1.153 . . . . 50.0 111.464 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -108.99 160.91 15.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 118.921 -2.362 . . . . 25.0 112.387 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . 0.304 2.6 mp -138.95 132.92 31.09 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 128.191 2.596 . . . . 50.0 106.572 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.3 148.89 5.25 Favored Glycine 0 C--O 1.272 2.498 0 CA-C-O 127.078 3.599 . . . . 25.0 118.575 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.88 143.78 57.58 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 108.671 -3.765 . . . . 50.0 109.364 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -151.02 165.5 33.59 Favored 'General case' 0 C--O 1.269 2.094 0 N-CA-C 101.561 -3.496 . . . . 25.0 101.561 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.42 136.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 104.243 -2.503 . . . . 50.0 104.243 166.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -78.48 125.96 38.3 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 CA-C-O 114.711 -2.566 . . . . 25.0 106.031 164.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.36 131.62 53.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 103.104 -2.925 . . . . 50.0 103.104 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.29 146.15 44.32 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-O 126.345 2.974 . . . . 25.0 107.003 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -128.27 138.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 119.961 -1.712 . . . . 50.0 107.985 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -138.47 94.56 2.87 Favored 'General case' 0 C--O 1.196 -1.729 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -96.58 146.33 24.92 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-O 126.113 2.863 . . . . 25.0 105.184 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . 0.25 41.3 t -116.82 128.29 74.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 111.16 -2.745 . . . . 50.0 109.196 -169.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.56 -29.63 62.55 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.616 1.966 . . . . 25.0 110.579 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.05 -20.8 60.91 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 114.787 1.402 . . . . 25.0 114.787 -169.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.1 t -151.55 159.15 44.24 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 116.791 -1.576 . . . . 25.0 107.951 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.07 -1.36 28.6 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 117.765 -1.112 . . . . 25.0 112.596 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -103.34 160.57 14.58 Favored 'General case' 0 CA--C 1.569 1.695 0 O-C-N 124.91 1.381 . . . . 25.0 108.463 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.4 -173.89 4.52 Favored 'General case' 0 C--O 1.189 -2.093 0 O-C-N 120.304 -1.497 . . . . 25.0 109.545 -167.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -113.42 148.22 36.28 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.516 -1.661 . . . . 50.0 106.516 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -146.48 118.48 8.22 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.356 -2.461 . . . . 50.0 104.356 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.99 153.29 49.42 Favored 'General case' 0 C--O 1.265 1.899 0 O-C-N 120.734 -1.229 . . . . 25.0 110.063 -164.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.17 152.05 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 125.558 1.786 . . . . 75.0 108.367 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.2 mt -140.57 121.82 14.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.675 0 N-CA-C 105.046 -2.205 . . . . 25.0 105.046 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.47 142.67 44.85 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.522 -1.361 . . . . 25.0 108.632 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.2 163.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 124.903 1.377 . . . . 50.0 109.715 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -133.88 103.56 5.89 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.8 mt -99.73 133.51 43.98 Favored 'General case' 0 C--O 1.16 -3.611 0 N-CA-C 103.289 -2.856 . . . . 50.0 103.289 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.17 179.03 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-O 123.743 1.735 . . . . 50.0 111.908 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -64.94 172.21 3.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.748 -2.478 . . . . 25.0 115.969 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 114.784 -2.531 . . . . 25.0 107.985 -177.409 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.511 2.612 0 CA-C-O 123.853 1.787 . . . . 25.0 111.216 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.87 -160.92 30.3 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 111.829 -2.441 . . . . 25.0 118.642 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -156.06 157.34 35.92 Favored 'General case' 0 C--O 1.261 1.683 0 N-CA-C 105.123 -2.177 . . . . 50.0 105.123 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.2 mm -84.09 110.26 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 O-C-N 119.47 -2.018 . . . . 25.0 107.286 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.96 -38.78 20.57 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 123.044 2.657 . . . . 25.0 109.946 170.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.82 149.25 63.82 Favored Pre-proline 0 N--CA 1.518 2.974 0 N-CA-C 104.004 -2.591 . . . . 25.0 104.004 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.07 160.69 93.42 Favored 'Cis proline' 0 C--O 1.252 1.213 0 C-N-CA 129.47 1.029 . . . . 25.0 113.159 -9.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.0 -173.09 52.09 Favored Glycine 0 C--N 1.286 -2.23 0 N-CA-C 117.84 1.896 . . . . 25.0 117.84 155.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 t -153.59 75.96 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 103.009 -2.96 . . . . 25.0 103.009 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -70.55 -7.91 47.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.436 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.28 -40.74 49.16 Favored 'General case' 0 C--O 1.255 1.369 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 161.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.4 67.6 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 114.359 1.244 . . . . 25.0 114.359 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 mt -85.14 -11.15 55.77 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-O 122.743 1.259 . . . . 75.0 113.73 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.8 t -92.34 -25.6 18.47 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 125.768 2.699 . . . . 25.0 113.86 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -70.09 150.23 46.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 119.273 -2.142 . . . . 25.0 110.389 168.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -77.55 6.47 7.08 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.064 1.302 . . . . 25.0 110.398 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.11 -15.96 62.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.066 -1.646 . . . . 25.0 109.517 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -51.58 -18.97 1.29 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 118.069 -2.894 . . . . 50.0 118.329 163.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.55 7.8 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 120.72 3.048 . . . . 25.0 120.72 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 43.52 8.67 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 119.88 3.289 . . . . 50.0 119.88 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 mt -80.53 -41.21 24.6 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 123.92 3.055 . . . . 50.0 106.83 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -147.05 174.85 11.16 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 126.345 2.278 . . . . 25.0 105.472 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.56 160.26 25.63 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-O 123.386 1.565 . . . . 50.0 111.29 162.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -140.87 5.5 1.96 Allowed 'General case' 0 CA--C 1.577 1.993 0 C-N-CA 126.434 1.893 . . . . 25.0 113.041 -171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -74.31 -43.26 57.47 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 115.404 1.631 . . . . 25.0 115.404 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.73 119.04 1.37 Allowed Glycine 0 CA--C 1.542 1.775 0 N-CA-C 108.728 -1.749 . . . . 25.0 108.728 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.92 -13.03 42.36 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.904 -0.762 . . . . 25.0 111.59 -169.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -62.93 -14.63 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.59 -1.263 . . . . 50.0 107.59 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.39 -15.63 0.15 Allowed 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 121.0 3.704 . . . . 25.0 121.0 167.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.3 -34.1 73.31 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-N 114.983 -1.008 . . . . 50.0 109.15 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.02 47.02 0.54 Allowed Pre-proline 0 C--O 1.294 3.447 0 N-CA-C 118.172 2.656 . . . . 25.0 118.172 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.75 -11.37 31.72 Favored 'Trans proline' 0 CA--C 1.487 -1.874 0 C-N-CA 121.372 1.381 . . . . 25.0 111.966 -159.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -116.98 6.75 13.02 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.74 0.7 . . . . 25.0 112.363 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -89.83 55.73 3.26 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 117.906 -2.996 . . . . 25.0 112.17 -171.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.3 mt -103.67 96.08 6.48 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 118.009 -0.996 . . . . 50.0 112.964 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -123.87 157.4 34.28 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 103.721 -2.696 . . . . 25.0 103.721 166.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.84 42.2 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.713 -2.039 . . . . 25.0 110.225 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.02 150.07 47.03 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 121.992 2.178 . . . . 25.0 108.693 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -60.21 155.33 17.72 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.808 0.843 . . . . 25.0 111.605 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.92 99.93 2.26 Favored Glycine 0 C--O 1.198 -2.118 0 N-CA-C 117.493 1.757 . . . . 25.0 117.493 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -125.41 98.55 34.89 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 104.305 -2.48 . . . . 25.0 104.305 171.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -85.72 175.39 31.27 Favored 'Cis proline' 0 N--CA 1.507 2.274 0 CA-C-N 121.635 1.62 . . . . 25.0 113.315 -2.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -64.19 -33.25 75.36 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 113.066 0.765 . . . . 25.0 113.066 -168.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 t 56.58 -113.75 0.78 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 119.471 3.137 . . . . 25.0 119.471 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.67 150.43 51.42 Favored Glycine 0 CA--C 1.485 -1.788 0 CA-C-N 122.331 2.332 . . . . 25.0 109.364 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.51 -31.19 9.15 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 CA-C-N 122.282 3.041 . . . . 25.0 118.586 -166.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . 0.27 . . -66.84 126.4 28.94 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 117.656 2.465 . . . . 25.0 117.656 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -66.77 140.26 57.84 Favored 'General case' 0 CA--C 1.572 1.801 0 O-C-N 120.738 -1.226 . . . . 25.0 113.05 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.21 -10.82 73.56 Favored Glycine 0 C--O 1.295 3.921 0 CA-C-O 121.948 0.749 . . . . 25.0 113.842 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . 0.342 8.4 mm-40 -109.64 -0.46 18.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 121.058 -1.26 . . . . 25.0 113.373 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.12 -45.21 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 N-CA-C 118.451 2.759 . . . . 25.0 118.451 -162.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.09 5.33 11.3 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 124.959 1.304 . . . . 25.0 109.33 173.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.755 ' HG ' ' H ' ' A' ' 55' ' ' GLY . 91.0 p -84.62 -13.78 50.61 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 119.137 -2.227 . . . . 25.0 112.335 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 66.89 10.37 7.56 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 128.813 2.845 . . . . 25.0 111.27 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.755 ' H ' ' HG ' ' A' ' 53' ' ' SER . . . -74.53 -14.78 80.83 Favored Glycine 0 C--N 1.308 -0.995 0 N-CA-C 116.742 1.457 . . . . 25.0 116.742 -174.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.16 -1.19 82.09 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 112.52 -1.84 . . . . 25.0 113.06 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.4 mt -87.18 99.67 12.11 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-O 126.574 3.083 . . . . 50.0 104.696 172.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -73.69 -24.48 59.96 Favored 'General case' 0 CA--C 1.481 -1.678 1 O-C-N 116.272 -4.018 . . . . 50.0 113.975 -174.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -36.84 80.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-O 124.374 2.097 . . . . 25.0 108.239 167.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.85 -31.28 72.7 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 119.992 -1.887 . . . . 25.0 113.809 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.17 -50.23 65.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 117.582 -3.305 . . . . 25.0 110.432 167.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.98 -26.9 67.04 Favored 'General case' 1 C--O 1.319 4.725 0 CA-C-N 121.593 1.997 . . . . 75.0 107.418 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.11 -29.53 67.61 Favored 'General case' 0 C--O 1.27 2.133 0 C-N-CA 119.997 -0.681 . . . . 50.0 110.121 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -79.11 56.81 2.09 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-O 123.444 1.592 . . . . 25.0 109.391 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -91.94 60.41 3.84 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 118.644 -2.535 . . . . 25.0 106.39 167.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.0 p -146.97 -164.2 1.94 Allowed 'General case' 0 C--O 1.273 2.342 0 CA-C-N 111.303 -2.681 . . . . 25.0 116.633 -164.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.44 -26.92 68.76 Favored 'General case' 0 C--O 1.267 1.981 0 O-C-N 119.604 -1.935 . . . . 25.0 111.17 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -87.35 16.01 5.81 Favored 'General case' 0 C--O 1.264 1.845 0 N-CA-C 116.01 1.856 . . . . 25.0 116.01 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -75.21 89.39 2.53 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 123.879 1.799 . . . . 25.0 108.676 173.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -18.49 142.79 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 108.596 -3.911 . . . . 25.0 121.148 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.13 125.79 26.07 Favored 'General case' 0 N--CA 1.42 -1.949 0 O-C-N 125.459 1.724 . . . . 50.0 111.546 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -117.78 149.74 40.29 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 119.213 3.042 . . . . 25.0 119.213 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -142.61 126.07 16.73 Favored 'General case' 0 CA--C 1.591 2.538 0 N-CA-C 117.276 2.324 . . . . 25.0 117.276 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.54 125.37 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 O-C-N 117.735 -3.103 . . . . 25.0 106.919 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttt -148.06 161.84 40.59 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 102.539 -3.134 . . . . 25.0 102.539 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 64.6 p -88.71 166.67 13.91 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 119.672 -1.893 . . . . 25.0 112.209 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.87 176.41 51.1 Favored Glycine 0 C--O 1.256 1.499 0 C-N-CA 116.792 -2.623 . . . . 25.0 115.704 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.89 -171.79 19.12 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 105.118 -3.193 . . . . 25.0 105.118 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.64 141.1 58.89 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 103.792 -2.67 . . . . 25.0 103.792 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -111.26 144.34 40.59 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 101.814 -3.402 . . . . 25.0 101.814 158.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -126.15 120.83 31.13 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 100.996 -3.705 . . . . 25.0 100.996 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -114.59 119.33 36.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 118.73 -2.481 . . . . 50.0 109.61 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 m -131.61 97.26 4.17 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 100.019 -4.067 . . . . 25.0 100.019 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -112.53 116.28 29.99 Favored 'General case' 1 N--CA 1.539 4.01 0 O-C-N 126.614 2.446 . . . . 25.0 106.657 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.251 2.1 p -127.07 157.33 39.91 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 125.56 1.788 . . . . 25.0 106.228 -162.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -113.52 140.43 48.14 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 127.503 2.321 . . . . 50.0 107.097 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -88.1 -9.59 52.79 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 123.807 1.765 . . . . 25.0 108.773 -169.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.94 149.1 38.05 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 101.639 -3.467 . . . . 25.0 101.639 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.68 147.36 75.72 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 118.167 -0.755 . . . . 25.0 113.558 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -141.85 141.83 33.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 117.647 -1.168 . . . . 25.0 110.935 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -80.75 159.58 25.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 117.99 -1.484 . . . . 25.0 113.776 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.9 m -150.48 148.23 28.47 Favored 'General case' 0 C--O 1.208 -1.122 0 C-N-CA 125.903 1.681 . . . . 25.0 109.695 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.7 p -111.21 -29.39 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.583 1.953 . . . . 25.0 112.486 170.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -166.96 158.87 12.84 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.405 1.482 . . . . 25.0 107.777 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -143.74 146.35 33.08 Favored 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -144.48 149.37 35.85 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 120.329 -1.482 . . . . 25.0 110.59 -167.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.433 ' HH ' ' HZ3' ' A' ' 152' ' ' TRP . 97.6 m-85 -130.59 134.7 47.21 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 113.097 -1.865 . . . . 50.0 110.776 172.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.33 171.09 11.81 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 103.493 -2.78 . . . . 50.0 103.493 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.39 155.95 41.17 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 N-CA-C 103.321 -2.844 . . . . 25.0 103.321 167.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.295 33.5 p -81.52 153.91 26.55 Favored 'General case' 0 CA--C 1.469 -2.173 0 CA-C-O 124.096 1.903 . . . . 25.0 106.925 165.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -87.85 107.99 18.95 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 112.392 -2.185 . . . . 25.0 110.884 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -49.57 117.7 2.37 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 105.696 -1.965 . . . . 25.0 105.696 155.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.66 33.28 34.77 Favored Glycine 0 C--O 1.192 -2.515 0 CA-C-O 117.693 -1.615 . . . . 25.0 115.726 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -51.02 159.83 0.55 Allowed 'General case' 0 C--O 1.259 1.576 0 CA-C-O 122.267 1.032 . . . . 25.0 108.446 169.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -102.9 107.49 55.06 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 102.075 -3.306 . . . . 25.0 102.075 167.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -72.54 -16.34 27.24 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.552 2.168 . . . . 25.0 116.28 -173.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -84.2 -2.61 57.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.392 -1.731 . . . . 75.0 106.873 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -132.48 154.54 81.58 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 103.513 -2.773 . . . . 25.0 103.513 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.381 72.4 Cg_exo -25.64 91.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.285 3 C-N-CA 125.506 4.138 . . . . 25.0 122.529 -167.468 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.42 -15.34 61.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 110.883 -2.871 . . . . 50.0 112.928 -171.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 6.36 11.21 Favored 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 120.027 -1.671 . . . . 25.0 111.866 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -136.62 -46.11 0.6 Allowed 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 118.166 2.654 . . . . 25.0 118.166 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.35 -4.48 53.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.44 1.644 . . . . 25.0 115.44 165.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.61 7.8 16.22 Favored 'General case' 0 C--O 1.274 2.346 0 C-N-CA 125.645 1.578 . . . . 25.0 114.917 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -141.69 166.95 23.34 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 126.041 2.088 . . . . 50.0 106.95 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -134.27 154.41 51.3 Favored 'General case' 0 C--O 1.176 -2.796 0 N-CA-C 105.954 -1.869 . . . . 25.0 105.954 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.32 120.72 38.21 Favored 'General case' 0 CA--C 1.58 2.097 0 O-C-N 120.507 -1.371 . . . . 50.0 112.647 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.292 4.8 tp -98.13 -19.51 5.94 Favored 'Isoleucine or valine' 0 C--O 1.274 2.352 0 C-N-CA 126.738 2.015 . . . . 25.0 106.416 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.77 164.93 26.31 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 113.331 -1.759 . . . . 25.0 117.149 162.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.84 157.65 45.66 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 101.531 -3.507 . . . . 25.0 101.531 166.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.9 130.44 13.01 Favored Pre-proline 0 C--O 1.245 0.866 0 N-CA-C 102.832 -3.025 . . . . 50.0 102.832 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.01 168.86 11.92 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 116.847 -1.636 . . . . 25.0 111.898 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -129.76 56.3 1.73 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.9 0.75 . . . . 25.0 109.57 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -123.93 -0.1 8.5 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 124.474 2.083 . . . . 50.0 113.316 -164.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -167.7 -165.72 25.58 Favored Glycine 0 C--O 1.258 1.608 0 N-CA-C 103.919 -3.673 . . . . 25.0 103.919 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.654 ' HG ' HH11 ' A' ' 130' ' ' ARG . 12.1 t -120.68 69.67 16.9 Favored Pre-proline 0 CA--C 1.556 1.19 0 O-C-N 126.411 1.889 . . . . 25.0 115.318 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.3 178.79 7.2 Favored 'Trans proline' 0 CA--C 1.578 2.682 0 C-N-CA 121.613 1.542 . . . . 25.0 112.618 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.67 71.31 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.36 2.14 2.5 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.992 1.317 . . . . 25.0 114.312 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.654 HH11 ' HG ' ' A' ' 126' ' ' SER . 50.4 ttt180 -70.94 -16.8 62.68 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 124.162 1.934 . . . . 25.0 111.04 170.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -68.24 125.77 27.45 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 103.906 -2.627 . . . . 25.0 103.906 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.8 tp -75.81 -7.14 53.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 118.25 -1.38 . . . . 75.0 113.997 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.9 t -85.23 144.53 28.07 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 104.705 -2.331 . . . . 25.0 104.705 173.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -137.79 135.78 36.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.178 0.806 . . . . 25.0 113.178 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -101.47 128.42 47.69 Favored 'General case' 0 C--O 1.301 3.807 0 CA-C-O 123.272 1.51 . . . . 25.0 108.912 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 46.3 mt -118.32 120.98 66.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 116.089 -2.244 . . . . 25.0 108.166 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -83.33 117.64 23.14 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 115.255 -2.578 . . . . 50.0 110.019 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.77 97.25 27.59 Favored Pre-proline 0 C--O 1.275 2.424 0 CA-C-O 123.321 1.534 . . . . 25.0 108.686 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 132.96 20.84 Favored 'Trans proline' 0 C--N 1.372 1.771 1 C-N-CA 113.121 -4.119 . . . . 25.0 110.298 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.43 97.06 3.14 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 117.321 -3.362 . . . . 25.0 109.979 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.69 -13.02 30.0 Favored 'General case' 0 C--O 1.267 1.977 0 N-CA-C 104.87 -2.27 . . . . 50.0 104.87 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -106.83 -173.68 2.35 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.643 -1.91 . . . . 25.0 112.82 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.53 129.87 45.05 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.169 -1.582 . . . . 50.0 111.609 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 152.9 -179.95 28.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 124.707 2.282 . . . . 25.0 116.113 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.14 158.84 38.58 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 117.113 -3.581 . . . . 50.0 117.192 -153.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -158.99 168.6 26.32 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 120.579 -1.325 . . . . 25.0 110.292 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.16 135.31 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.065 0 N-CA-C 103.775 -2.676 . . . . 50.0 103.775 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 mt -85.08 134.98 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 100.758 -3.793 . . . . 25.0 100.758 167.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.4 mt -116.5 135.18 54.05 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.387 -2.079 . . . . 50.0 105.387 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.7 136.59 54.94 Favored 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 97.282 -5.081 . . . . 25.0 97.282 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.5 120.44 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 O-C-N 125.491 1.744 . . . . 50.0 108.481 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.433 ' HZ3' ' HH ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -124.89 121.86 35.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.071 1.76 . . . . 25.0 107.881 -175.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -102.77 134.53 46.02 Favored 'General case' 0 N--CA 1.407 -2.625 0 O-C-N 120.413 -1.43 . . . . 25.0 110.346 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.59 99.11 3.65 Favored 'Isoleucine or valine' 0 C--O 1.262 1.747 0 N-CA-C 105.93 -1.878 . . . . 50.0 105.93 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.34 66.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 117.138 -1.825 . . . . 25.0 113.167 -167.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.3 -16.69 55.98 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.379 -1.282 . . . . 25.0 113.13 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.9 p -109.68 164.64 12.35 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 120.15 1.341 . . . . 25.0 109.621 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -81.75 -36.88 28.04 Favored 'General case' 0 C--O 1.285 2.933 0 CA-C-O 123.699 1.714 . . . . 25.0 110.38 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.61 154.38 20.02 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 112.369 -2.196 . . . . 25.0 108.378 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -111.0 158.15 19.12 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 124.941 1.297 . . . . 25.0 111.411 168.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -109.94 142.71 40.91 Favored 'General case' 0 C--O 1.269 2.104 0 O-C-N 119.391 -2.068 . . . . 50.0 109.032 -165.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.16 162.34 41.06 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-O 123.459 1.599 . . . . 50.0 111.872 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -138.86 157.6 45.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.921 -1.112 . . . . 25.0 108.047 166.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.1 133.04 63.2 Favored 'Isoleucine or valine' 0 C--O 1.258 1.53 0 O-C-N 120.117 -1.614 . . . . 75.0 109.363 165.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.2 mt -136.1 119.64 23.71 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 N-CA-C 102.421 -3.177 . . . . 25.0 102.421 -169.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -83.42 133.42 34.92 Favored 'General case' 0 CA--C 1.613 3.376 0 CA-C-O 123.094 1.426 . . . . 25.0 111.241 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.53 144.33 38.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 O-C-N 119.76 -1.838 . . . . 50.0 111.577 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.78 135.14 54.97 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 100.626 -3.842 . . . . 25.0 100.626 167.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 mt -126.36 129.34 48.61 Favored 'General case' 0 C--O 1.294 3.431 0 N-CA-C 104.75 -2.315 . . . . 50.0 104.75 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.01 163.9 30.78 Favored 'Isoleucine or valine' 0 C--O 1.277 2.523 0 N-CA-C 115.714 1.746 . . . . 50.0 115.714 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -71.01 134.36 47.07 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.161 -0.962 . . . . 25.0 111.638 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.657 -1.163 . . . . 25.0 112.826 -173.622 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . 0.259 47.0 p-80 . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 122.897 1.332 . . . . 25.0 109.553 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.52 -165.02 38.85 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-O 116.546 -2.252 . . . . 25.0 114.783 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.71 151.58 33.89 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-N 122.18 2.99 . . . . 50.0 116.056 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.445 HG23 ' H ' ' A' ' 6' ' ' LYS . 43.9 mm -66.78 132.09 32.26 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.722 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.11 39.98 3.42 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 126.4 3.0 . . . . 25.0 107.454 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' H ' HG23 ' A' ' 4' ' ' ILE . 96.2 mttt 72.09 163.53 0.14 Allowed Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 108.512 -3.949 . . . . 25.0 115.078 169.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.78 122.05 0.42 Allowed 'Cis proline' 0 C--N 1.357 0.98 0 C-N-CA 133.055 2.523 . . . . 25.0 114.14 3.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.47 147.93 13.28 Favored Glycine 0 C--O 1.252 1.238 0 CA-C-N 114.019 -1.446 . . . . 25.0 111.239 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -145.92 134.58 22.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.406 -1.643 . . . . 25.0 108.45 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -75.16 -17.1 60.46 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 117.086 -3.509 . . . . 25.0 111.88 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.78 56.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 116.374 -1.774 . . . . 25.0 107.65 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.72 63.32 Favored 'General case' 1 C--O 1.306 4.054 0 CA-C-N 122.002 2.183 . . . . 25.0 109.642 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.64 -8.42 59.19 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.142 -0.974 . . . . 75.0 110.021 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.1 t -78.32 -15.39 58.78 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 114.358 1.244 . . . . 25.0 114.358 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 t -80.88 137.52 36.16 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 114.77 -1.105 . . . . 25.0 110.048 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.91 -19.42 34.78 Favored 'General case' 0 C--O 1.184 -2.345 0 N-CA-C 105.486 -2.042 . . . . 25.0 105.486 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.89 79.65 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-O 122.8 1.286 . . . . 25.0 113.783 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.27 -25.81 67.35 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.126 -1.609 . . . . 50.0 109.659 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.68 18.48 29.51 Favored Glycine 0 C--O 1.184 -2.977 0 CA-C-N 122.357 2.344 . . . . 25.0 109.493 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.4 t80 57.11 -51.56 0.03 OUTLIER 'General case' 0 C--O 1.204 -1.307 0 C-N-CA 128.732 2.813 . . . . 50.0 114.826 -169.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.6 mt -133.91 10.68 3.94 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.23 1.412 . . . . 50.0 112.46 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -141.59 167.38 22.29 Favored 'General case' 0 C--O 1.19 -2.046 0 N-CA-C 104.165 -2.532 . . . . 25.0 104.165 -173.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.38 169.81 23.38 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 104.235 -2.506 . . . . 50.0 104.235 -172.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -159.19 68.43 0.43 Allowed 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 105.731 -1.951 . . . . 25.0 105.731 -173.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.9 t -69.27 -33.2 72.85 Favored 'General case' 0 C--O 1.183 -2.439 0 N-CA-C 118.22 2.674 . . . . 25.0 118.22 -161.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.55 37.47 35.21 Favored Glycine 0 C--O 1.192 -2.505 0 N-CA-C 119.718 2.647 . . . . 25.0 119.718 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 m -56.32 2.06 0.02 OUTLIER 'General case' 0 C--O 1.268 2.073 1 N-CA-C 122.64 4.311 . . . . 25.0 122.64 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.11 -8.09 5.16 Favored 'Isoleucine or valine' 0 C--O 1.278 2.574 0 N-CA-C 115.847 1.795 . . . . 50.0 115.847 158.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 ptm -52.37 10.83 0.0 OUTLIER 'General case' 0 C--O 1.278 2.578 1 N-CA-C 122.734 4.346 . . . . 25.0 122.734 171.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -57.48 -47.83 80.82 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 120.242 -1.536 . . . . 50.0 113.717 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -149.35 44.66 0.34 Allowed Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 119.733 3.234 . . . . 25.0 119.733 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -79.34 -17.32 11.63 Favored 'Trans proline' 0 C--O 1.272 2.206 0 C-N-CA 115.112 -2.792 . . . . 25.0 114.413 -167.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -92.66 5.77 49.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 116.85 -1.547 . . . . 25.0 112.253 170.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -119.29 16.66 13.11 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 124.983 1.427 . . . . 25.0 111.597 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 mt -73.19 124.85 26.42 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 126.115 1.766 . . . . 50.0 108.361 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.41 164.86 20.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 118.955 -2.341 . . . . 25.0 112.334 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.26 139.02 26.83 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.188 -1.824 . . . . 25.0 111.882 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -59.8 137.55 58.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 118.206 -2.809 . . . . 25.0 112.552 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -69.28 159.85 32.32 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.559 -3.213 . . . . 25.0 103.336 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.24 -155.2 24.66 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 113.612 -1.631 . . . . 25.0 114.893 -174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.09 129.22 24.15 Favored Pre-proline 0 N--CA 1.517 2.925 0 CA-C-O 117.642 -1.171 . . . . 25.0 112.296 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.99 178.88 32.75 Favored 'Cis proline' 0 C--O 1.25 1.103 0 CA-C-N 121.706 1.645 . . . . 25.0 110.3 -9.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -156.67 -19.94 0.1 Allowed 'General case' 0 C--O 1.211 -0.964 0 O-C-N 127.447 2.967 . . . . 25.0 116.932 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -49.81 -54.48 18.99 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.02 168.19 51.88 Favored Glycine 0 C--O 1.287 3.465 0 N-CA-C 108.69 -1.764 . . . . 25.0 108.69 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.16 -28.04 13.13 Favored 'Trans proline' 0 C--O 1.266 1.902 0 C-N-CA 122.279 1.986 . . . . 25.0 115.843 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.04 140.78 58.29 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 119.791 -1.818 . . . . 25.0 109.341 -172.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -154.28 144.19 21.8 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 103.681 -2.711 . . . . 25.0 103.681 171.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.45 -24.39 13.87 Favored Glycine 0 N--CA 1.486 2.019 0 CA-C-O 115.789 -2.673 . . . . 25.0 108.324 164.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -134.84 33.55 3.18 Favored 'General case' 0 C--O 1.275 2.427 0 CA-C-N 121.902 2.851 . . . . 25.0 113.429 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.6 mm -69.9 -46.42 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 120.181 -0.608 . . . . 25.0 112.09 -161.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.59 78.38 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.492 -0.883 . . . . 25.0 111.421 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.7 p -79.49 -8.76 59.36 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.163 1.542 . . . . 25.0 115.163 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.03 23.42 11.57 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 125.19 1.556 . . . . 25.0 107.836 -171.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.23 -23.93 73.32 Favored Glycine 1 CA--C 1.581 4.212 0 CA-C-O 115.931 -2.594 . . . . 25.0 113.927 -175.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.58 -13.37 80.25 Favored Glycine 0 N--CA 1.473 1.151 0 N-CA-C 108.43 -1.868 . . . . 25.0 108.43 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.2 mt -104.38 -64.62 1.09 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.916 1.358 . . . . 50.0 112.053 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -68.78 -22.96 64.25 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.547 -0.909 . . . . 50.0 108.547 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -26.43 62.84 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 117.049 -1.973 . . . . 25.0 116.058 166.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.63 -21.22 64.72 Favored Glycine 0 C--O 1.186 -2.855 0 CA-C-O 114.435 -3.425 . . . . 25.0 112.829 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.68 -34.39 23.46 Favored 'Isoleucine or valine' 0 C--O 1.293 3.361 0 CA-C-N 124.147 3.973 . . . . 25.0 112.402 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.72 -18.85 56.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 125.794 1.934 . . . . 75.0 107.51 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.266 4.8 t70 -43.19 -39.77 3.05 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 115.35 1.611 . . . . 50.0 115.35 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -78.05 10.63 2.76 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 116.442 2.015 . . . . 25.0 116.442 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -147.97 47.11 1.08 Allowed 'General case' 0 C--O 1.255 1.395 0 C-N-CA 128.179 2.591 . . . . 25.0 110.269 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 t -144.52 161.19 39.71 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 119.254 3.057 . . . . 25.0 119.254 -166.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -68.21 -17.4 64.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 122.151 2.251 . . . . 25.0 108.907 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -96.54 26.25 4.56 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.322 36.5 ttp180 -78.56 67.79 4.4 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-O 123.491 1.615 . . . . 25.0 110.418 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -61.84 145.39 52.83 Favored 'General case' 0 CA--C 1.454 -2.715 1 CA-C-N 107.191 -4.549 . . . . 25.0 111.745 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -77.17 144.48 38.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.38 -1.736 . . . . 50.0 113.354 -166.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -107.76 165.53 11.37 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-O 118.311 -0.852 . . . . 25.0 111.541 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.409 ' H ' ' HA ' ' A' ' 167' ' ' VAL . 3.6 m80 -127.72 122.16 32.17 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 126.204 1.802 . . . . 25.0 107.023 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.3 mt -83.7 126.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 103.511 -2.774 . . . . 25.0 103.511 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.8 mtp -138.15 156.4 47.77 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 126.051 2.834 . . . . 25.0 105.013 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.7 p -91.88 166.05 12.93 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.786 -2.302 . . . . 25.0 104.786 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.74 167.85 52.05 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-O 116.793 -2.115 . . . . 25.0 115.213 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.4 171.01 12.95 Favored Glycine 0 CA--C 1.555 2.559 1 N-CA-C 102.906 -4.077 . . . . 25.0 102.906 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -62.92 144.9 56.32 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.572 -1.546 . . . . 25.0 111.258 168.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -136.11 146.75 47.33 Favored 'General case' 0 CA--C 1.445 -3.082 0 O-C-N 119.802 -1.811 . . . . 25.0 107.907 162.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.1 m -101.91 137.27 40.43 Favored 'General case' 0 CA--C 1.468 -2.198 0 C-N-CA 124.907 1.283 . . . . 25.0 109.216 167.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -114.79 140.93 48.52 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.856 -1.778 . . . . 50.0 106.669 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -127.32 136.16 51.54 Favored 'General case' 0 C--O 1.19 -2.059 0 CA-C-O 125.014 2.34 . . . . 25.0 111.109 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -129.99 158.85 38.43 Favored 'General case' 0 C--O 1.28 2.676 1 N-CA-C 97.988 -4.819 . . . . 25.0 97.988 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 t -147.23 155.04 41.73 Favored 'General case' 0 CA--C 1.476 -1.886 0 CA-C-N 119.68 1.127 . . . . 25.0 111.108 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.22 162.26 28.27 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 105.162 -2.162 . . . . 50.0 105.162 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 t -116.51 -9.2 11.45 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-N 120.244 1.383 . . . . 25.0 113.107 167.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.6 31.29 Favored Pre-proline 0 CA--C 1.481 -1.687 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 168.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.01 155.88 61.03 Favored 'Trans proline' 0 CA--C 1.486 -1.887 1 C-N-CA 113.032 -4.179 . . . . 25.0 116.586 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -86.02 156.56 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 104.601 -2.37 . . . . 25.0 104.601 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -80.16 132.22 35.87 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.762 -2.31 . . . . 25.0 104.762 166.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 m -152.48 153.59 33.8 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 116.039 -1.934 . . . . 25.0 109.542 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 p -114.66 -43.27 3.17 Favored 'General case' 0 C--O 1.275 2.43 0 C-N-CA 125.201 1.401 . . . . 25.0 108.76 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -151.16 144.6 24.87 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 117.911 -2.993 . . . . 25.0 110.766 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . 0.262 51.5 p-90 -114.45 150.01 35.4 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 117.902 -1.519 . . . . 25.0 112.403 166.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -136.17 150.28 48.97 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 103.885 -2.635 . . . . 25.0 103.885 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . 0.252 7.1 p90 -147.23 149.4 32.83 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 106.12 -1.808 . . . . 50.0 106.12 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -152.98 163.54 39.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.42 -1.696 . . . . 50.0 106.42 -157.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.02 167.3 20.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 115.529 -2.177 . . . . 25.0 107.657 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.4 p -96.69 157.95 15.66 Favored 'General case' 0 C--O 1.203 -1.373 0 O-C-N 125.718 1.886 . . . . 25.0 109.298 170.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -74.03 92.02 2.11 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 111.292 -2.685 . . . . 25.0 114.274 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.99 113.93 2.11 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 126.457 2.348 . . . . 25.0 114.323 165.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.13 35.47 9.7 Favored Glycine 0 C--O 1.25 1.131 0 CA-C-N 115.05 -0.977 . . . . 25.0 114.097 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 162.4 28.81 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 113.603 -1.299 . . . . 25.0 112.75 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.15 143.83 40.02 Favored Pre-proline 0 C--O 1.194 -1.867 0 CA-C-N 115.518 -0.764 . . . . 25.0 109.394 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 108' ' ' LYS . 72.4 Cg_endo -75.62 -18.18 17.64 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 114.85 -2.967 . . . . 25.0 118.82 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -83.69 9.2 12.26 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 118.779 -2.451 . . . . 75.0 109.172 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 106' ' ' PRO . 84.9 mttt -128.0 169.74 11.9 Favored Pre-proline 0 C--O 1.285 2.954 0 N-CA-C 101.74 -3.43 . . . . 25.0 101.74 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -55.66 28.21 0.02 OUTLIER 'Trans proline' 0 C--O 1.243 0.753 1 C-N-CA 129.121 6.547 . . . . 25.0 122.359 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.95 -40.15 66.56 Favored 'General case' 0 C--O 1.197 -1.659 0 CA-C-N 119.773 1.17 . . . . 50.0 112.939 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -85.34 -5.7 59.29 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 115.938 1.829 . . . . 25.0 115.938 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -111.37 -66.54 1.07 Allowed 'General case' 0 CA--C 1.475 -1.937 0 O-C-N 119.978 -1.701 . . . . 25.0 107.927 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.24 54.02 1.2 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.516 2.326 . . . . 25.0 109.251 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . 0.251 9.9 t0 -60.68 -42.24 96.73 Favored 'General case' 0 CA--C 1.596 2.746 0 CA-C-N 110.099 -3.228 . . . . 25.0 110.267 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 126.172 2.17 . . . . 50.0 112.428 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -141.8 129.52 21.62 Favored 'General case' 0 C--O 1.195 -1.774 0 O-C-N 126.364 2.29 . . . . 25.0 112.057 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.06 129.94 41.52 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 115.192 -2.337 . . . . 50.0 110.685 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.4 tt -105.59 -20.5 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 122.114 2.233 . . . . 25.0 106.797 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.65 161.36 27.22 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 120.567 -0.825 . . . . 25.0 114.566 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.5 133.4 14.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 123.0 1.381 . . . . 25.0 111.064 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.76 97.61 38.46 Favored Pre-proline 0 N--CA 1.499 1.982 0 CA-C-N 112.552 -2.113 . . . . 50.0 111.228 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.99 152.73 76.53 Favored 'Trans proline' 0 C--N 1.347 0.479 0 N-CA-C 116.79 1.804 . . . . 25.0 116.79 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -79.09 69.31 5.25 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.702 1.251 . . . . 25.0 111.222 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.588 ' N ' ' HG ' ' A' ' 129' ' ' SER . 65.3 m-20 -74.95 -31.32 61.46 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 119.341 -2.099 . . . . 50.0 113.089 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.17 -5.26 71.53 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-O 117.94 -1.478 . . . . 25.0 113.89 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.0 p -71.7 166.19 42.24 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 126.429 1.899 . . . . 25.0 109.054 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.29 -10.94 26.36 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 116.23 -2.046 . . . . 25.0 117.039 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.4 -30.8 42.56 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 121.616 -0.677 . . . . 25.0 109.21 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.588 ' HG ' ' N ' ' A' ' 124' ' ' ASP . 48.0 t -74.87 -44.86 46.7 Favored 'General case' 0 C--O 1.285 2.936 0 CA-C-O 124.141 1.924 . . . . 25.0 108.086 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -64.01 -23.96 67.53 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 111.941 -2.39 . . . . 25.0 113.799 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.25 109.19 12.16 Favored 'General case' 0 CA--C 1.58 2.115 0 O-C-N 124.99 1.431 . . . . 25.0 110.38 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.1 tp -83.35 -33.78 25.76 Favored 'General case' 0 C--O 1.193 -1.901 0 C-N-CA 127.214 2.206 . . . . 75.0 108.17 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -80.36 128.27 33.37 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 115.987 -2.285 . . . . 25.0 108.45 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -124.44 153.86 41.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 125.314 1.634 . . . . 25.0 114.327 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -98.59 148.55 23.67 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.6 mt -142.27 129.2 19.38 Favored 'Isoleucine or valine' 0 C--O 1.264 1.818 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -75.95 120.11 20.84 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 120.401 -1.437 . . . . 50.0 113.135 169.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.53 122.81 44.96 Favored Pre-proline 0 C--O 1.206 -1.227 0 N-CA-C 101.918 -3.364 . . . . 25.0 101.918 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -61.43 153.2 67.73 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 123.775 1.408 . . . . 25.0 109.805 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -110.35 -0.09 17.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 119.566 -1.959 . . . . 25.0 112.493 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.91 -8.36 57.33 Favored 'General case' 0 C--O 1.265 1.896 0 N-CA-C 116.583 2.068 . . . . 50.0 116.583 -172.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -133.92 151.38 51.47 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 116.798 2.147 . . . . 25.0 116.798 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.0 155.73 17.54 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.56 1.544 . . . . 50.0 107.676 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.17 157.01 10.08 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 123.371 4.108 . . . . 25.0 123.371 172.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.68 146.0 31.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 123.09 1.424 . . . . 50.0 113.494 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.11 159.14 43.72 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.12 -1.4 . . . . 25.0 109.913 162.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.71 142.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 O-C-N 125.233 1.583 . . . . 50.0 108.156 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 mt -109.85 134.66 51.27 Favored 'Isoleucine or valine' 0 C--O 1.25 1.105 0 CA-C-O 118.201 -0.904 . . . . 25.0 109.76 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.24 155.39 35.96 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 124.913 2.292 . . . . 50.0 108.27 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.6 153.77 48.66 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 118.998 -2.313 . . . . 25.0 109.277 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.86 118.52 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 128.707 2.803 . . . . 50.0 106.29 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -107.63 88.25 2.69 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 126.36 2.287 . . . . 25.0 107.106 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.36 141.69 39.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.158 -1.589 . . . . 25.0 111.832 -163.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.02 123.77 59.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-O 116.991 -1.48 . . . . 50.0 112.464 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.94 20.07 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 120.231 1.378 . . . . 25.0 111.671 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.52 -20.84 65.49 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -124.51 159.88 29.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.932 1.456 . . . . 25.0 114.932 -173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.04 -39.7 87.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 116.61 2.078 . . . . 25.0 116.61 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -91.87 160.55 15.24 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 118.508 -0.758 . . . . 25.0 112.299 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.57 159.9 40.93 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 101.221 -3.622 . . . . 25.0 101.221 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -90.99 153.36 20.21 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 124.379 1.071 . . . . 50.0 108.538 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -136.95 164.71 27.7 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.849 -1.94 . . . . 50.0 111.021 164.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.54 133.38 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 111.991 -2.368 . . . . 75.0 115.557 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -135.33 136.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 124.091 1.901 . . . . 25.0 106.413 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . 0.284 22.3 t0 -102.92 150.43 23.53 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 101.246 -3.613 . . . . 25.0 101.246 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.409 ' HA ' ' H ' ' A' ' 73' ' ' HIS . 27.2 m -144.83 167.07 11.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 116.631 -1.652 . . . . 50.0 107.662 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -133.52 132.97 41.59 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.3 mt -126.12 117.12 22.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 107.813 -1.18 . . . . 50.0 107.813 -164.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.0 162.31 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 117.926 2.565 . . . . 50.0 117.926 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -69.84 160.93 30.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.235 1.814 . . . . 25.0 107.835 166.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.1 mttt . . . . . 0 C--O 1.266 1.953 0 N-CA-C 118.318 2.71 . . . . 25.0 118.318 -176.855 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 51.5 m80 . . . . . 1 N--CA 1.572 5.642 0 CA-C-O 120.832 0.349 . . . . 25.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.01 174.15 36.76 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-O 117.409 -1.773 . . . . 25.0 116.865 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -126.29 171.45 10.93 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 123.436 1.589 . . . . 50.0 107.703 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm -81.73 116.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 O-C-N 120.024 -1.672 . . . . 25.0 108.539 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.05 -40.92 30.06 Favored 'General case' 0 C--O 1.268 2.058 0 CA-C-N 115.424 -0.807 . . . . 25.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -154.55 136.34 9.36 Favored Pre-proline 0 C--O 1.199 -1.599 0 N-CA-C 105.183 -2.154 . . . . 25.0 105.183 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.03 145.61 65.66 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 C-N-CA 130.698 1.541 . . . . 25.0 115.226 -1.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.32 170.31 50.47 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 120.916 -0.659 . . . . 25.0 111.758 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 84.7 p -70.28 162.18 28.96 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.314 2.339 . . . . 25.0 117.314 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -68.71 -3.45 12.16 Favored 'General case' 0 CA--C 1.581 2.16 0 CA-C-N 118.916 0.78 . . . . 25.0 110.471 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.23 -27.71 68.18 Favored 'General case' 0 C--O 1.197 -1.666 0 C-N-CA 118.949 -1.1 . . . . 25.0 110.911 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.82 91.84 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-O 122.962 1.363 . . . . 25.0 108.436 171.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.77 -10.71 59.42 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 124.215 1.959 . . . . 75.0 115.634 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -86.1 -9.57 56.44 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 118.346 -2.721 . . . . 25.0 108.384 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.8 t -65.54 150.09 48.98 Favored 'General case' 0 C--O 1.208 -1.122 0 O-C-N 119.396 -2.065 . . . . 25.0 106.99 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -75.54 -3.35 33.67 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 117.954 2.576 . . . . 25.0 117.954 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.4 -23.65 67.01 Favored 'General case' 0 C--O 1.199 -1.563 0 C-N-CA 125.178 1.391 . . . . 25.0 110.67 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -75.32 3.65 8.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.244 1.942 . . . . 50.0 116.244 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.76 -20.42 1.82 Allowed Glycine 0 C--O 1.255 1.437 0 O-C-N 119.357 -2.089 . . . . 25.0 117.875 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . 0.272 75.3 t80 76.2 -47.58 0.56 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 119.716 3.228 . . . . 50.0 119.716 168.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.9 mt -62.47 -31.06 71.73 Favored 'General case' 0 C--O 1.26 1.609 0 O-C-N 121.316 -0.865 . . . . 50.0 109.205 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -142.5 165.21 28.03 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 118.476 -0.774 . . . . 25.0 112.965 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -163.58 168.97 19.33 Favored 'General case' 0 C--O 1.175 -2.843 0 N-CA-C 105.304 -2.11 . . . . 50.0 105.304 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -152.37 76.07 1.14 Allowed 'General case' 0 C--O 1.193 -1.886 0 N-CA-C 107.902 -1.147 . . . . 25.0 107.902 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -38.11 65.83 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.763 -1.211 . . . . 25.0 114.136 -176.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.01 101.82 0.42 Allowed Glycine 0 CA--C 1.541 1.713 0 N-CA-C 119.467 2.547 . . . . 25.0 119.467 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 m -47.66 -16.15 0.07 Allowed 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 118.574 2.805 . . . . 25.0 118.574 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 70' ' ' TRP . 0.6 OUTLIER -62.98 -18.66 21.82 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.738 0 O-C-N 119.992 -1.692 . . . . 50.0 111.699 178.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -74.55 -17.21 60.77 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.265 1.026 . . . . 25.0 111.905 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -74.55 -50.17 19.07 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.818 -1.537 . . . . 50.0 111.086 -162.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -143.41 63.39 12.49 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.742 -1.224 . . . . 25.0 112.38 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.74 -26.47 38.91 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 115.869 -2.287 . . . . 25.0 114.203 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -60.01 -9.81 3.53 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.024 2.602 . . . . 25.0 118.024 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -74.91 -5.47 43.91 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 116.633 -1.651 . . . . 25.0 113.236 -168.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.0 122.58 25.11 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 120.6 1.545 . . . . 50.0 112.807 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -136.2 165.17 26.36 Favored 'General case' 0 C--O 1.261 1.691 0 N-CA-C 114.87 1.433 . . . . 25.0 114.87 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.92 143.96 30.83 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 160.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -87.92 158.58 18.65 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 103.514 -2.772 . . . . 25.0 103.514 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -76.74 167.47 21.77 Favored 'General case' 0 C--O 1.29 3.186 0 CA-C-O 123.316 1.531 . . . . 25.0 106.982 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.41 17.25 10.69 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 114.335 -3.48 . . . . 25.0 116.253 -171.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -87.96 152.34 50.83 Favored Pre-proline 0 C--O 1.254 1.331 1 CA-C-N 124.974 4.387 . . . . 25.0 108.853 -172.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.72 -179.66 27.95 Favored 'Cis proline' 0 N--CA 1.471 0.16 0 C-N-CA 134.693 3.205 . . . . 25.0 111.221 -3.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -73.8 -22.24 59.88 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 116.559 -2.057 . . . . 25.0 114.4 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -58.47 -47.73 83.1 Favored 'General case' 0 C--O 1.199 -1.598 0 N-CA-C 118.423 2.749 . . . . 25.0 118.423 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.47 175.48 54.4 Favored Glycine 0 N--CA 1.496 2.699 0 O-C-N 118.872 -2.392 . . . . 25.0 111.887 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.52 165.11 33.5 Favored 'Trans proline' 0 CA--C 1.485 -1.973 0 O-C-N 123.133 1.07 . . . . 25.0 113.356 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.82 39.6 Favored 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 118.041 -1.464 . . . . 25.0 112.613 171.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.32 -176.32 4.78 Favored 'General case' 0 C--N 1.311 -1.078 1 N-CA-C 97.721 -4.918 . . . . 25.0 97.721 162.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.34 -1.49 87.44 Favored Glycine 0 C--O 1.2 -1.977 0 O-C-N 118.244 -2.785 . . . . 25.0 115.542 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -77.23 0.7 20.96 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.978 -1.111 . . . . 25.0 111.987 -169.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.7 mt -72.58 -35.17 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 105.388 -2.078 . . . . 25.0 105.388 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.6 96.43 Favored 'General case' 0 C--O 1.284 2.909 0 N-CA-C 115.606 1.706 . . . . 25.0 115.606 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.4 p -92.2 -9.28 42.86 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.377 -0.374 . . . . 25.0 109.996 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.52 17.8 9.89 Favored 'General case' 0 N--CA 1.514 2.763 0 C-N-CA 128.745 2.818 . . . . 25.0 111.591 -174.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.94 -13.78 80.61 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 114.187 -1.37 . . . . 25.0 110.782 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.11 9.16 31.38 Favored Glycine 0 CA--C 1.556 2.61 0 N-CA-C 107.837 -2.105 . . . . 25.0 107.837 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 60' ' ' GLY . 29.6 mt -123.64 31.13 5.99 Favored 'General case' 0 C--O 1.199 -1.604 0 CA-C-N 113.946 -1.127 . . . . 50.0 112.992 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -69.82 -25.59 63.84 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 101.253 -3.61 . . . . 50.0 101.253 157.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.43 -15.45 80.33 Favored Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.804 -1.553 . . . . 25.0 110.433 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 57' ' ' LEU . . . -66.48 -29.85 75.51 Favored Glycine 0 CA--C 1.493 -1.342 0 O-C-N 126.954 2.208 . . . . 25.0 113.081 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.51 -42.08 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 O-C-N 119.805 -1.997 . . . . 25.0 111.985 174.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.44 -23.94 50.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.83 -1.174 . . . . 75.0 107.83 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.7 -31.2 64.84 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.73 1.252 . . . . 50.0 113.216 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -89.93 35.48 0.85 Allowed 'General case' 0 C--O 1.161 -3.556 0 CA-C-N 114.167 -1.379 . . . . 25.0 111.059 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -159.7 50.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 100.432 -3.914 . . . . 25.0 100.432 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.8 t -140.69 179.58 6.61 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 102.081 -3.303 . . . . 25.0 102.081 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.55 -31.55 65.36 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 123.677 2.944 . . . . 25.0 111.478 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.89 21.59 0.84 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 116.945 -1.503 . . . . 25.0 114.549 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -60.8 90.25 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.809 2.444 . . . . 25.0 106.014 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.4 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -17.25 131.03 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.5 2 CA-C-N 106.614 -4.812 . . . . 25.0 118.806 171.881 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -68.93 142.86 54.61 Favored 'General case' 0 CA--C 1.476 -1.901 0 N-CA-C 117.733 2.494 . . . . 50.0 117.733 -160.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -112.76 147.2 37.37 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.046 1.748 . . . . 25.0 108.496 -166.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -122.84 137.61 54.88 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-O 116.493 -1.718 . . . . 25.0 108.451 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.0 mt -96.47 119.49 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 105.585 -2.006 . . . . 25.0 105.585 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.8 mtp -128.1 174.63 9.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.824 1.249 . . . . 25.0 111.718 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -112.54 171.16 7.69 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.434 1.493 . . . . 25.0 110.147 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.67 170.42 53.21 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 105.997 -2.841 . . . . 25.0 105.997 171.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.14 178.21 15.4 Favored Glycine 0 C--N 1.285 -2.302 2 O-C-N 115.882 -4.305 . . . . 25.0 109.614 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.81 137.32 51.72 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 127.645 2.615 . . . . 25.0 113.651 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -110.74 134.93 52.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 111.765 -2.47 . . . . 25.0 106.189 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -92.18 134.03 35.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 117.56 -3.212 . . . . 25.0 112.948 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.85 127.0 50.03 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 118.829 -2.419 . . . . 50.0 109.371 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.0 m -140.22 126.93 20.43 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.415 -1.328 . . . . 25.0 107.415 -167.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -104.05 162.95 12.72 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 128.938 3.899 . . . . 25.0 109.014 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 t -149.29 146.47 27.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 103.331 -2.84 . . . . 25.0 103.331 165.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.48 143.07 49.46 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 127.123 2.169 . . . . 50.0 111.42 173.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -96.77 -5.16 39.2 Favored 'General case' 0 C--O 1.27 2.169 0 C-N-CA 127.072 2.149 . . . . 25.0 115.173 -168.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.87 137.57 12.59 Favored Pre-proline 0 N--CA 1.481 1.112 0 N-CA-C 103.529 -2.767 . . . . 25.0 103.529 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.5 137.78 61.7 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 115.404 -2.597 . . . . 25.0 116.167 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -148.03 169.2 20.45 Favored 'General case' 0 CA--C 1.557 1.222 1 N-CA-C 99.761 -4.163 . . . . 25.0 99.761 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -111.57 113.11 25.3 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 123.744 1.735 . . . . 25.0 108.402 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.673 ' HG1' ' HE1' ' A' ' 152' ' ' TRP . 15.9 m -71.98 136.02 46.62 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 113.094 -1.866 . . . . 25.0 111.847 172.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 -47.13 5.44 Favored 'General case' 0 C--O 1.274 2.376 0 CA-C-O 122.722 1.248 . . . . 25.0 112.624 167.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.24 159.01 44.75 Favored 'General case' 0 C--O 1.219 -0.547 1 O-C-N 116.011 -4.18 . . . . 25.0 102.242 175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -142.06 152.03 42.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 116.821 -1.952 . . . . 25.0 112.604 160.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -129.1 151.58 49.62 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 126.425 1.89 . . . . 25.0 109.771 -156.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.68 147.17 50.05 Favored 'General case' 0 C--O 1.194 -1.834 0 O-C-N 123.498 0.499 . . . . 50.0 111.311 156.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.31 163.02 28.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 104.286 -2.487 . . . . 50.0 104.286 172.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.79 133.55 67.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 163.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -73.48 131.94 42.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 101.88 -3.378 . . . . 25.0 101.88 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -87.27 104.41 16.37 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 125.8 2.714 . . . . 25.0 105.753 -169.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.08 113.25 1.46 Allowed 'General case' 0 C--O 1.279 2.607 0 O-C-N 119.233 -2.167 . . . . 25.0 110.341 153.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.88 40.21 7.72 Favored Glycine 0 C--O 1.181 -3.162 0 C-N-CA 116.912 -2.566 . . . . 25.0 108.837 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -55.87 160.63 2.59 Favored 'General case' 0 CA--C 1.579 2.063 0 O-C-N 120.376 -1.661 . . . . 25.0 109.851 168.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -80.71 117.12 66.46 Favored Pre-proline 0 C--O 1.266 1.933 0 N-CA-C 102.596 -3.113 . . . . 25.0 102.596 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.11 -25.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 N-CA-C 116.36 1.638 . . . . 25.0 116.36 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.33 -6.19 57.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 112.217 -2.265 . . . . 75.0 106.111 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.55 150.9 46.36 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 114.847 -2.501 . . . . 25.0 110.027 -171.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.294 0.0 OUTLIER -2.52 87.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.264 1.794 2 C-N-CA 125.642 4.228 . . . . 25.0 122.698 176.045 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.57 -34.12 72.3 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 110.301 -3.136 . . . . 50.0 109.595 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -87.81 -10.05 52.04 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.695 2.109 . . . . 25.0 116.695 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.84 -38.41 0.64 Allowed 'General case' 0 C--O 1.185 -2.308 0 N-CA-C 121.468 3.877 . . . . 25.0 121.468 -170.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.6 -9.63 59.44 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 117.18 -3.45 . . . . 25.0 111.871 171.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.63 4.98 10.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.378 -0.929 . . . . 25.0 112.849 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.62 167.33 22.18 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.755 0.788 . . . . 50.0 112.782 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -117.73 141.83 47.95 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.193 160.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 tp -67.33 132.09 47.01 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.319 -2.104 . . . . 50.0 105.319 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 tt -110.97 -14.2 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 118.928 2.936 . . . . 25.0 118.928 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.82 165.69 30.9 Favored Glycine 0 C--O 1.212 -1.269 0 CA-C-O 115.217 -2.991 . . . . 25.0 112.43 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.36 21.88 Favored 'General case' 0 N--CA 1.418 -2.054 0 O-C-N 126.025 1.662 . . . . 25.0 108.329 168.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.38 101.02 28.42 Favored Pre-proline 0 C--N 1.312 -1.059 0 C-N-CA 125.473 1.509 . . . . 50.0 111.892 -170.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.64 170.47 8.94 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 115.752 -2.365 . . . . 25.0 113.607 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -97.31 78.27 2.71 Favored 'General case' 0 C--O 1.175 -2.851 0 CA-C-O 115.959 -1.972 . . . . 25.0 108.546 167.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.47 37.47 1.22 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.21 1.481 . . . . 50.0 110.596 -158.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.59 35.01 17.86 Favored Glycine 0 C--O 1.263 1.92 0 N-CA-C 108.834 -1.706 . . . . 25.0 108.834 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.4 m -75.3 147.01 82.27 Favored Pre-proline 0 C--O 1.263 1.796 0 N-CA-C 117.558 2.429 . . . . 25.0 117.558 -154.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HG2' ' HG ' ' A' ' 129' ' ' SER . 72.7 Cg_endo -72.28 177.28 7.48 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 115.564 -2.491 . . . . 25.0 109.267 170.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.06 6.2 0.99 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.836 2.162 . . . . 25.0 116.836 -167.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.429 ' HG ' ' HG2' ' A' ' 127' ' ' PRO . 89.4 p -68.05 -4.44 13.45 Favored 'General case' 0 C--O 1.182 -2.494 0 CA-C-N 114.299 -1.318 . . . . 25.0 109.29 163.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.2 ttp85 -69.88 -16.52 63.25 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 114.154 1.168 . . . . 25.0 114.154 167.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -52.44 133.25 35.35 Favored 'General case' 0 C--O 1.191 -1.995 0 CA-C-O 121.905 0.859 . . . . 25.0 108.732 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -70.66 -13.12 61.95 Favored 'General case' 0 C--O 1.187 -2.197 0 CA-C-O 123.466 1.603 . . . . 75.0 111.504 -161.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.8 t -98.0 141.62 30.74 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 118.487 -2.633 . . . . 25.0 110.405 163.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -132.59 157.16 45.44 Favored 'General case' 0 C--O 1.161 -3.559 0 N-CA-C 103.376 -2.824 . . . . 25.0 103.376 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -120.9 148.45 44.03 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 100.863 -3.754 . . . . 25.0 100.863 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 50.6 mm -129.78 125.69 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -79.76 136.77 36.83 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.94 -0.475 . . . . 50.0 109.853 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.2 mm -125.96 119.76 23.99 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 126.623 2.452 . . . . 25.0 109.403 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.25 159.83 33.02 Favored 'Trans proline' 0 C--N 1.359 1.131 1 C-N-CA 113.288 -4.008 . . . . 25.0 115.353 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.51 43.45 1.1 Allowed 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 122.906 1.336 . . . . 25.0 110.833 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.23 -42.51 99.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 111.089 -2.778 . . . . 50.0 114.351 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -149.47 154.2 38.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.897 1.679 . . . . 25.0 108.742 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.25 154.81 34.9 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.859 -1.534 . . . . 50.0 106.859 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.25 168.02 11.95 Favored Glycine 0 C--N 1.364 2.104 0 O-C-N 126.224 2.202 . . . . 25.0 118.177 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.26 153.52 41.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 117.697 2.48 . . . . 50.0 117.697 -165.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.96 147.09 39.99 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 120.879 -1.138 . . . . 25.0 109.392 160.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.48 133.81 46.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 N-CA-C 103.852 -2.647 . . . . 50.0 103.852 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.81 137.92 31.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 103.962 -2.607 . . . . 25.0 103.962 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.6 mt -122.82 145.77 48.13 Favored 'General case' 0 C--O 1.184 -2.351 0 N-CA-C 104.681 -2.34 . . . . 50.0 104.681 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.22 156.48 44.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 117.983 -1.008 . . . . 25.0 110.344 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.5 132.63 31.63 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 O-C-N 127.715 3.134 . . . . 50.0 105.793 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.673 ' HE1' ' HG1' ' A' ' 92' ' ' THR . 14.8 t90 -105.4 130.69 53.45 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 104.131 -2.544 . . . . 25.0 104.131 170.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -103.71 126.8 51.08 Favored 'General case' 0 C--O 1.264 1.835 0 O-C-N 118.751 -2.468 . . . . 25.0 104.962 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.06 133.06 64.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 O-C-N 116.656 -3.778 . . . . 50.0 107.823 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.25 -11.73 59.7 Favored 'General case' 0 C--O 1.178 -2.698 0 O-C-N 121.337 -0.852 . . . . 25.0 110.791 -171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -35.53 81.41 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.078 1.894 . . . . 25.0 114.077 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.2 p -143.79 159.82 41.84 Favored 'General case' 0 C--O 1.274 2.393 0 O-C-N 120.924 -1.11 . . . . 25.0 112.089 -164.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -76.98 -23.98 52.28 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.999 -1.111 . . . . 25.0 107.999 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.49 151.85 45.54 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.041 -0.981 . . . . 25.0 110.85 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -123.9 159.0 30.65 Favored 'General case' 0 C--O 1.27 2.182 0 N-CA-C 102.039 -3.319 . . . . 25.0 102.039 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -111.72 154.41 25.04 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 104.31 -2.478 . . . . 50.0 104.31 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.36 149.48 50.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 110.971 -2.831 . . . . 50.0 106.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -133.74 129.85 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.253 33.9 m -121.73 135.37 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 117.576 -3.203 . . . . 75.0 112.99 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 95.8 mt -135.64 132.59 51.47 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 105.07 -2.196 . . . . 25.0 105.07 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -104.7 141.4 36.53 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 106.118 -1.808 . . . . 25.0 106.118 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.92 149.25 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 107.725 -1.213 . . . . 50.0 107.725 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.42 94.43 4.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 118.26 20.96 Favored 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 125.161 1.384 . . . . 50.0 108.333 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.1 m -117.5 157.84 18.47 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-O 124.448 2.071 . . . . 50.0 108.501 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -91.64 162.55 14.45 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 111.252 -2.703 . . . . 25.0 106.401 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 CA--C 1.565 1.548 0 O-C-N 118.742 -2.474 . . . . 25.0 108.166 166.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 N--CA 1.517 2.9 0 CA-C-O 123.532 1.634 . . . . 25.0 113.724 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.46 -174.81 24.92 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 125.074 2.486 . . . . 25.0 111.921 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.59 161.95 39.43 Favored 'General case' 0 CA--C 1.47 -2.113 0 CA-C-N 110.77 -2.715 . . . . 50.0 108.891 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 mt -97.8 123.52 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 N-CA-C 103.805 -2.665 . . . . 25.0 103.805 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.35 -38.93 18.22 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 119.609 -1.932 . . . . 25.0 111.383 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -136.45 160.01 68.4 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 118.005 -0.998 . . . . 25.0 110.169 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.13 141.4 62.24 Favored 'Cis proline' 0 CA--C 1.477 -2.327 0 C-N-CA 133.479 2.7 . . . . 25.0 114.386 -1.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.36 -168.66 45.16 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 119.253 2.461 . . . . 25.0 119.253 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t -145.92 156.17 43.35 Favored 'General case' 0 C--O 1.266 1.944 0 CA-C-N 119.196 1.498 . . . . 25.0 107.7 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -79.25 -8.46 59.06 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.87 1.319 . . . . 25.0 109.917 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.47 -29.47 64.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.428 -0.795 . . . . 25.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.13 -27.84 67.65 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 118.686 2.847 . . . . 25.0 118.686 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.31 -21.04 17.46 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 125.903 2.002 . . . . 75.0 111.554 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.1 t -81.46 -19.71 41.81 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 105.745 -1.946 . . . . 25.0 105.745 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.61 ' HG ' ' H ' ' A' ' 17' ' ' ALA . 25.0 t -60.34 151.45 27.75 Favored 'General case' 0 C--O 1.285 2.952 0 O-C-N 118.82 -2.425 . . . . 25.0 111.792 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -65.57 -26.99 68.11 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 118.522 -2.611 . . . . 25.0 110.701 169.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.61 ' H ' ' HG ' ' A' ' 15' ' ' SER . . . -69.33 -19.68 63.87 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-O 123.225 1.488 . . . . 25.0 111.965 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -51.55 -17.16 0.75 Allowed 'General case' 0 C--O 1.187 -2.23 0 N-CA-C 114.181 1.178 . . . . 50.0 114.181 168.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.37 2.7 0.8 Allowed Glycine 0 CA--C 1.532 1.126 1 CA-C-O 112.695 -4.392 . . . . 25.0 114.418 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . 0.289 6.9 t80 52.72 27.7 5.55 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 123.9 3.85 . . . . 50.0 116.837 -165.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.9 mt -66.55 -29.76 69.91 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 114.123 1.157 . . . . 50.0 114.123 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 45.05 59.35 3.51 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 126.467 2.354 . . . . 25.0 117.035 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -164.96 161.85 20.22 Favored 'General case' 0 CA--C 1.576 1.949 0 O-C-N 125.478 1.736 . . . . 50.0 111.223 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 52.43 48.19 23.12 Favored 'General case' 0 CA--C 1.567 1.625 1 N-CA-C 122.467 4.247 . . . . 25.0 122.467 171.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.7 -10.43 59.76 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 124.406 1.066 . . . . 25.0 111.811 165.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.09 125.15 4.71 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 120.558 1.526 . . . . 25.0 113.95 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -5.16 2.67 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 115.601 1.704 . . . . 25.0 115.601 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 m -55.59 -18.4 4.54 Favored 'Isoleucine or valine' 0 C--O 1.254 1.331 0 N-CA-C 113.792 1.034 . . . . 50.0 113.792 164.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.0 ptp -54.94 -30.18 58.13 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -101.47 -46.08 5.1 Favored 'General case' 0 CA--C 1.485 -1.529 0 O-C-N 120.908 -1.12 . . . . 50.0 110.452 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -114.3 79.06 4.93 Favored Pre-proline 0 C--O 1.264 1.826 0 N-CA-C 115.654 1.724 . . . . 25.0 115.654 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.18 -20.77 8.35 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 114.958 1.099 . . . . 25.0 114.958 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -127.5 2.36 6.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 120.25 3.426 . . . . 25.0 120.25 -161.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 49.55 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.006 -1.059 . . . . 25.0 108.163 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.59 79.92 8.16 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.42 0.628 . . . . 50.0 111.679 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -135.76 150.98 49.68 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 116.819 -1.563 . . . . 25.0 110.71 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.02 166.52 25.83 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.414 -3.18 . . . . 25.0 102.414 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -93.23 142.56 27.18 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 117.345 -1.742 . . . . 25.0 111.714 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -58.06 146.2 33.81 Favored 'General case' 0 C--O 1.205 -1.272 0 C-N-CA 119.472 -0.891 . . . . 25.0 109.112 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.12 -160.98 53.63 Favored Glycine 0 C--O 1.266 2.151 0 O-C-N 120.133 -1.605 . . . . 25.0 116.182 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -152.27 168.48 11.23 Favored Pre-proline 0 CA--C 1.574 1.867 0 O-C-N 127.101 2.295 . . . . 25.0 108.342 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.96 134.46 2.01 Favored 'Cis proline' 0 C--N 1.39 2.75 1 C-N-CA 137.16 4.233 . . . . 25.0 117.2 -6.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -131.56 -1.3 3.89 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 116.019 1.859 . . . . 25.0 116.019 -163.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 t 62.19 -78.21 0.03 OUTLIER 'General case' 0 C--O 1.194 -1.857 0 N-CA-C 117.645 2.461 . . . . 25.0 117.645 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.63 177.57 26.09 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 117.639 -2.22 . . . . 25.0 110.609 163.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.69 148.71 78.28 Favored 'Trans proline' 0 C--N 1.367 1.501 0 CA-C-N 120.17 1.985 . . . . 25.0 113.85 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.1 151.74 26.88 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-O 124.798 2.237 . . . . 25.0 108.106 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -140.34 176.19 8.97 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 100.218 -3.994 . . . . 25.0 100.218 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.34 34.47 74.67 Favored Glycine 0 N--CA 1.426 -1.998 0 C-N-CA 118.824 -1.655 . . . . 25.0 110.17 -153.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -130.92 54.55 1.9 Allowed 'General case' 0 C--O 1.27 2.145 1 N-CA-C 98.524 -4.621 . . . . 25.0 98.524 -171.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 66.8 mt -74.21 -30.4 26.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 111.545 -2.57 . . . . 25.0 107.849 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.68 -30.73 46.32 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.993 1.849 . . . . 25.0 115.993 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 p -89.46 -5.78 57.04 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.331 -0.856 . . . . 25.0 112.642 168.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.32 13.42 3.99 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 127.047 2.139 . . . . 25.0 111.452 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.92 -33.9 85.41 Favored Glycine 0 CA--C 1.495 -1.219 0 O-C-N 119.21 -2.181 . . . . 25.0 111.377 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.22 -0.67 86.82 Favored Glycine 0 C--O 1.198 -2.121 0 CA-C-N 113.838 -1.181 . . . . 25.0 111.484 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt -112.02 -16.56 13.05 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 114.715 1.376 . . . . 50.0 114.715 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.09 -34.99 69.09 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.775 -1.935 . . . . 50.0 105.775 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -11.3 85.26 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-O 122.805 1.225 . . . . 25.0 110.245 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.6 -29.9 76.21 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 123.85 1.805 . . . . 25.0 114.599 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -74.92 -39.19 44.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 O-C-N 119.986 -1.89 . . . . 25.0 107.111 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -68.88 -27.8 66.12 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 119.269 -2.144 . . . . 75.0 109.783 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 -27.6 67.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.521 -1.362 . . . . 50.0 110.843 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -80.09 3.7 19.53 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 120.574 -1.329 . . . . 25.0 107.641 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -128.45 43.85 3.06 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.122 -2.918 . . . . 25.0 103.122 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 t -134.9 161.14 36.08 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.563 -1.336 . . . . 25.0 109.799 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.17 -29.02 68.41 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-N 114.45 -1.25 . . . . 25.0 111.553 161.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -72.65 0.39 10.77 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.911 1.449 . . . . 25.0 114.911 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -76.13 93.33 3.32 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 103.755 -2.683 . . . . 25.0 103.755 169.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -45.29 153.83 0.2 Allowed 'General case' 0 C--O 1.263 1.791 0 CA-C-N 111.411 -2.631 . . . . 25.0 107.972 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -56.19 136.17 52.93 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 115.247 1.573 . . . . 50.0 115.247 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -94.32 156.24 16.61 Favored 'General case' 0 N--CA 1.528 3.444 0 CA-C-O 117.399 -1.286 . . . . 25.0 112.886 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -153.8 151.95 30.14 Favored 'General case' 0 C--O 1.26 1.65 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 tt -87.43 135.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtp -144.56 -172.76 3.87 Favored 'General case' 0 C--O 1.186 -2.255 0 CA-C-O 123.06 1.409 . . . . 25.0 109.029 -171.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 p -127.37 172.65 10.45 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 104.61 -2.367 . . . . 25.0 104.61 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.61 -178.26 25.2 Favored Glycine 0 CA--C 1.542 1.754 0 O-C-N 124.692 1.245 . . . . 25.0 112.754 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.54 -156.3 30.29 Favored Glycine 0 CA--C 1.559 2.83 0 CA-C-O 115.697 -2.724 . . . . 25.0 111.032 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -72.64 143.33 48.2 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 120.472 3.508 . . . . 25.0 120.472 -171.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -125.5 143.51 50.97 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 101.51 -3.515 . . . . 25.0 101.51 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.7 m -99.11 127.21 45.03 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 105.331 -2.1 . . . . 25.0 105.331 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.61 128.44 55.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 104.191 -2.522 . . . . 50.0 104.191 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.2 m -134.2 109.13 8.67 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 105.4 -2.074 . . . . 25.0 105.4 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -83.31 149.75 26.56 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.641 -1.163 . . . . 25.0 107.896 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.3 t -142.54 122.68 13.76 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 120.922 1.692 . . . . 25.0 109.652 173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.73 143.27 39.76 Favored 'General case' 0 N--CA 1.423 -1.782 0 O-C-N 119.503 -1.998 . . . . 50.0 113.987 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -91.43 -12.67 34.05 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.487 -2.142 . . . . 25.0 110.433 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.18 143.76 25.9 Favored Pre-proline 0 C--O 1.273 2.315 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 168.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.08 140.88 25.75 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 124.078 3.185 . . . . 25.0 117.732 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -138.6 151.4 47.23 Favored 'General case' 0 CA--C 1.55 0.958 1 N-CA-C 97.77 -4.9 . . . . 25.0 97.77 172.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . 0.254 67.2 m-80 -78.68 109.69 13.14 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 121.998 2.181 . . . . 25.0 113.772 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.406 HG21 ' CE3' ' A' ' 95' ' ' TRP . 7.9 m -79.38 135.69 36.77 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 123.684 1.707 . . . . 25.0 109.729 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.3 p -80.59 -50.11 10.41 Favored 'General case' 0 CA--C 1.571 1.759 0 O-C-N 116.632 -3.792 . . . . 25.0 106.706 171.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -164.27 173.88 11.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 127.084 2.154 . . . . 25.0 113.513 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.406 ' CE3' HG21 ' A' ' 92' ' ' THR . 37.6 p90 -143.32 158.36 43.7 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.098 -1.002 . . . . 25.0 112.767 164.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -133.84 155.25 50.18 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -150.14 149.93 30.95 Favored 'General case' 0 C--O 1.283 2.867 0 CA-C-N 120.789 1.631 . . . . 50.0 114.137 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.64 158.35 44.26 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.632 1.573 . . . . 50.0 109.929 -157.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.22 159.88 13.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 164.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 p -71.82 155.71 40.12 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.648 1.217 . . . . 25.0 110.783 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -124.04 113.07 17.91 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.653 -1.279 . . . . 25.0 113.821 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.08 161.23 8.84 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 114.461 -2.685 . . . . 25.0 110.384 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.1 -0.16 47.74 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 122.827 2.558 . . . . 25.0 115.427 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -59.51 159.05 8.74 Favored 'General case' 0 C--O 1.271 2.199 0 N-CA-C 113.892 1.071 . . . . 25.0 113.892 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -160.77 144.02 9.86 Favored Pre-proline 0 C--O 1.193 -1.916 0 N-CA-C 104.486 -2.412 . . . . 25.0 104.486 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -69.87 -15.94 36.89 Favored 'Trans proline' 0 C--O 1.177 -2.528 0 C-N-CA 114.003 -3.532 . . . . 25.0 119.594 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.84 -21.19 65.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.918 1.818 . . . . 75.0 109.131 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -99.47 163.54 18.36 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 103.384 -2.821 . . . . 25.0 103.384 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -32.37 30.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.249 1 C-N-CA 129.759 6.973 . . . . 25.0 121.64 154.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -40.39 60.26 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 115.922 -1.989 . . . . 50.0 114.794 -175.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -75.59 -7.93 55.48 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 116.636 2.087 . . . . 25.0 116.636 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.413 ' C ' ' H ' ' A' ' 114' ' ' ASP . 51.8 mtp180 -120.08 -62.55 1.47 Allowed 'General case' 0 C--O 1.198 -1.621 0 O-C-N 121.25 -0.906 . . . . 25.0 112.441 -166.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.51 18.25 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 118.014 2.598 . . . . 25.0 118.014 163.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 112' ' ' ARG . 35.9 t0 -65.37 -26.51 68.04 Favored 'General case' 0 CA--C 1.483 -1.602 0 O-C-N 127.116 2.76 . . . . 25.0 109.65 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -141.07 160.52 39.9 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 103.586 -2.746 . . . . 50.0 103.586 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -129.95 135.15 47.99 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 106.65 -1.611 . . . . 25.0 106.65 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.64 145.48 54.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 104.173 -2.528 . . . . 50.0 104.173 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.7 tt -128.71 -12.52 2.94 Favored 'Isoleucine or valine' 0 C--O 1.263 1.783 0 CA-C-O 125.848 2.737 . . . . 25.0 112.252 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.75 167.12 37.85 Favored Glycine 0 C--O 1.268 2.234 0 CA-C-O 124.142 1.968 . . . . 25.0 112.266 168.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.84 161.29 40.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 112.991 -1.605 . . . . 25.0 107.968 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.49 111.68 15.16 Favored Pre-proline 0 C--O 1.207 -1.177 0 N-CA-C 104.124 -2.546 . . . . 50.0 104.124 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.4 162.05 36.67 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 117.144 -1.438 . . . . 25.0 110.885 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -120.11 49.6 1.39 Allowed 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.229 -1.767 . . . . 25.0 106.229 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -76.06 -32.34 59.24 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 112.38 -2.191 . . . . 50.0 110.133 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 172.04 -175.6 45.3 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 119.98 -1.7 . . . . 25.0 115.341 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 57.8 m 72.19 155.72 0.16 Allowed Pre-proline 0 CA--C 1.569 1.698 0 N-CA-C 117.658 2.466 . . . . 25.0 117.658 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.23 -3.33 13.64 Favored 'Trans proline' 0 CA--C 1.572 2.415 0 C-N-CA 115.642 -2.439 . . . . 25.0 113.38 -166.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.25 76.52 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 116.84 2.163 . . . . 25.0 116.84 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 83.8 p -80.81 -21.95 40.44 Favored 'General case' 0 C--O 1.273 2.314 0 CA-C-O 124.259 1.981 . . . . 25.0 110.894 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -72.81 -28.55 62.63 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.111 -1.859 . . . . 25.0 111.918 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.55 140.59 39.75 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.709 -3.071 . . . . 25.0 102.709 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mt -103.67 -38.63 7.02 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 124.346 2.022 . . . . 75.0 109.934 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 t -77.36 127.05 31.9 Favored 'General case' 0 N--CA 1.411 -2.421 0 O-C-N 120.361 -1.462 . . . . 25.0 108.392 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -140.04 156.43 46.61 Favored 'General case' 0 CA--C 1.488 -1.442 0 O-C-N 118.937 -2.352 . . . . 25.0 110.607 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -106.1 141.25 37.78 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 125.308 1.63 . . . . 25.0 107.893 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.91 121.13 46.38 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.187 0 C-N-CA 125.944 1.698 . . . . 25.0 109.995 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -82.47 126.14 31.9 Favored 'General case' 0 C--O 1.175 -2.82 0 CA-C-N 121.103 1.774 . . . . 50.0 106.667 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -110.79 123.56 35.22 Favored Pre-proline 0 C--O 1.265 1.879 0 N-CA-C 103.584 -2.747 . . . . 25.0 103.584 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.41 146.17 55.44 Favored 'Trans proline' 0 CA--C 1.585 3.037 0 C-N-CA 116.847 -1.635 . . . . 25.0 115.351 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.1 67.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 125.828 2.727 . . . . 25.0 104.879 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -62.92 -28.6 70.18 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 119.729 -1.857 . . . . 50.0 113.238 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -143.63 158.85 43.36 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.368 -1.716 . . . . 25.0 106.368 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.95 138.56 39.74 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 102.028 -3.323 . . . . 50.0 102.028 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 147.14 177.49 21.71 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 124.992 2.44 . . . . 25.0 116.18 -173.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 137.88 56.6 Favored 'General case' 0 C--O 1.192 -1.953 0 C-N-CA 126.287 1.835 . . . . 50.0 113.443 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -145.96 167.22 23.84 Favored 'General case' 0 C--O 1.255 1.355 0 C-N-CA 126.684 1.994 . . . . 25.0 109.017 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 t -124.16 144.47 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.425 -1.324 . . . . 50.0 107.425 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.16 113.05 43.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.303 -2.851 . . . . 25.0 103.303 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.56 153.06 21.66 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-N 119.029 0.831 . . . . 50.0 110.55 -170.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.52 136.95 23.86 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 120.515 -1.365 . . . . 25.0 109.416 -173.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.56 136.12 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.403 -0.919 . . . . 50.0 112.0 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -118.65 125.62 50.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.181 2.592 . . . . 25.0 104.893 -170.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -113.69 140.98 47.79 Favored 'General case' 0 C--O 1.269 2.109 0 O-C-N 125.679 1.862 . . . . 25.0 108.996 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.3 139.74 26.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 N-CA-C 104.914 -2.254 . . . . 50.0 104.914 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.6 -20.44 20.89 Favored 'General case' 0 C--O 1.196 -1.753 0 CA-C-N 112.324 -2.216 . . . . 25.0 112.149 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.27 -23.75 54.44 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.905 1.817 . . . . 25.0 115.905 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.2 p -145.3 -179.79 6.88 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 115.6 -2.143 . . . . 25.0 113.245 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -89.01 1.1 56.04 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-O 126.379 2.99 . . . . 25.0 113.014 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.43 158.54 31.26 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 119.781 -1.824 . . . . 25.0 112.739 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.75 159.35 29.99 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -145.42 158.24 43.87 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 124.648 2.166 . . . . 50.0 109.643 172.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -118.47 144.38 46.04 Favored 'General case' 0 C--O 1.193 -1.909 0 CA-C-N 110.824 -2.898 . . . . 50.0 104.101 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -141.51 138.04 32.49 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.312 -1.328 . . . . 25.0 107.886 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.61 156.49 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 120.596 1.543 . . . . 75.0 109.715 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.46 115.16 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.444 1.592 . . . . 25.0 108.322 172.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.18 118.65 22.06 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 117.155 -1.402 . . . . 25.0 108.618 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.88 156.48 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 120.466 1.484 . . . . 50.0 113.45 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -111.7 98.63 7.55 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 103.173 -2.899 . . . . 25.0 103.173 171.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.17 135.02 34.07 Favored 'General case' 0 N--CA 1.499 2.009 1 N-CA-C 99.734 -4.173 . . . . 50.0 99.734 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.01 169.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 119.564 -1.96 . . . . 50.0 113.67 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -59.8 139.42 57.32 Favored 'General case' 0 C--O 1.282 2.791 0 C-N-CA 119.23 -0.988 . . . . 25.0 109.814 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 CA--C 1.577 1.983 0 N-CA-C 115.756 1.762 . . . . 25.0 115.756 177.227 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.882 -1.056 . . . . 25.0 109.245 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.99 170.45 37.66 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 120.764 3.066 . . . . 25.0 120.764 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -136.49 151.79 49.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.818 1.784 . . . . 50.0 115.818 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.28 139.17 20.32 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 101.181 -3.636 . . . . 25.0 101.181 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -112.08 -28.14 8.11 Favored 'General case' 0 C--N 1.362 1.112 0 N-CA-C 113.519 0.933 . . . . 25.0 113.519 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -151.5 140.53 13.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 104.597 -2.371 . . . . 25.0 104.597 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.97 147.27 86.85 Favored 'Cis proline' 0 N--CA 1.499 1.834 0 CA-C-N 119.844 0.98 . . . . 25.0 114.53 -5.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.25 174.25 47.54 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.939 1.936 . . . . 25.0 117.939 161.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -131.62 141.45 49.64 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.472 1.909 . . . . 25.0 107.663 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -58.07 -31.5 67.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 115.105 1.52 . . . . 25.0 115.105 167.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.51 -35.05 70.62 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 125.961 2.038 . . . . 25.0 112.175 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.02 94.66 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.399 -0.813 . . . . 25.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.23 -16.59 49.03 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.302 -0.999 . . . . 75.0 108.302 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -84.62 -11.74 55.37 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.803 1.241 . . . . 25.0 111.806 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.2 t -65.55 138.84 58.32 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 114.899 1.444 . . . . 25.0 114.899 -173.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -73.96 0.52 13.24 Favored 'General case' 0 C--O 1.177 -2.754 0 O-C-N 117.753 -3.092 . . . . 25.0 114.249 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.85 -36.07 82.72 Favored 'General case' 0 CA--C 1.561 1.384 0 O-C-N 119.315 -2.116 . . . . 25.0 110.262 158.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -69.79 -53.27 19.04 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.502 1.144 . . . . 50.0 110.463 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.16 64.34 2.33 Favored Glycine 0 N--CA 1.501 2.979 0 CA-C-O 126.299 3.166 . . . . 25.0 113.382 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -65.62 -39.06 91.07 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 110.119 -3.041 . . . . 50.0 110.664 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.1 mt -91.12 -40.43 11.6 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 114.858 1.429 . . . . 50.0 114.858 -173.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -152.76 159.68 43.11 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 102.341 -3.207 . . . . 25.0 102.341 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.97 164.14 27.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 104.126 -2.546 . . . . 50.0 104.126 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -150.55 22.04 0.81 Allowed 'General case' 0 CA--C 1.576 1.973 0 O-C-N 125.088 1.493 . . . . 25.0 110.719 -162.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.7 t -61.98 -21.68 65.03 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 119.855 3.28 . . . . 25.0 119.855 -163.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.1 44.25 45.44 Favored Glycine 0 C--O 1.262 1.866 0 C-N-CA 116.211 -2.9 . . . . 25.0 110.683 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.52 -8.52 0.56 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 117.685 2.476 . . . . 25.0 117.685 -159.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.13 -17.55 6.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 O-C-N 121.079 -1.013 . . . . 50.0 109.549 165.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -2.13 0.51 Allowed 'General case' 0 C--O 1.281 2.72 1 O-C-N 115.792 -4.317 . . . . 25.0 117.563 164.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -65.95 -46.75 77.0 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 123.304 2.775 . . . . 50.0 104.784 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.37 73.04 31.25 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 117.529 2.418 . . . . 25.0 117.529 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -71.57 -21.18 26.05 Favored 'Trans proline' 0 C--N 1.393 2.882 0 CA-C-O 122.863 1.11 . . . . 25.0 112.066 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -82.87 -1.22 51.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.345 1.545 . . . . 25.0 112.11 -171.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 t -76.33 -18.0 59.14 Favored 'General case' 0 C--O 1.285 2.961 0 CA-C-N 111.317 -2.674 . . . . 25.0 109.148 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.52 119.22 15.36 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.731 1.605 . . . . 50.0 108.486 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -152.68 176.34 11.86 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 105.151 -2.166 . . . . 25.0 105.151 -172.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.25 144.58 30.87 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 166.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -129.3 145.88 51.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.459 1.481 . . . . 25.0 109.616 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -58.06 160.42 4.89 Favored 'General case' 0 C--O 1.199 -1.595 0 CA-C-N 113.435 -1.712 . . . . 25.0 109.738 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.74 -143.74 29.39 Favored Glycine 0 C--O 1.253 1.309 0 N-CA-C 109.351 -1.5 . . . . 25.0 109.351 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -152.96 161.14 29.86 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 110.816 -2.692 . . . . 25.0 109.957 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -60.8 126.53 3.38 Favored 'Cis proline' 0 CA--C 1.487 -1.851 0 C-N-CA 134.673 3.197 . . . . 25.0 112.386 -2.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -61.98 -34.21 75.73 Favored 'General case' 0 CA--C 1.586 2.355 0 O-C-N 126.244 2.215 . . . . 25.0 108.641 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t 62.38 -81.66 0.02 OUTLIER 'General case' 0 C--O 1.248 0.975 0 O-C-N 125.894 1.996 . . . . 25.0 112.527 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.05 -173.57 15.46 Favored Glycine 0 C--O 1.286 3.364 0 CA-C-O 126.884 3.491 . . . . 25.0 112.904 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -63.84 164.62 21.05 Favored 'Trans proline' 0 C--O 1.258 1.497 0 C-N-CA 123.428 2.752 . . . . 25.0 111.62 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.87 74.01 0.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.976 -1.465 . . . . 25.0 110.719 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -67.72 153.29 44.04 Favored 'General case' 0 C--O 1.289 3.184 0 O-C-N 119.9 -1.75 . . . . 25.0 113.268 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.05 -2.46 69.68 Favored Glycine 0 C--O 1.197 -2.214 0 N-CA-C 117.607 1.803 . . . . 25.0 117.607 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -102.53 40.03 1.42 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.805 1.764 . . . . 25.0 107.549 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 mm -63.18 -46.05 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 120.178 -1.576 . . . . 25.0 110.213 -170.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.1 -28.77 67.63 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 117.674 -1.61 . . . . 25.0 110.59 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.8 p -88.06 -6.15 58.09 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 118.126 -2.859 . . . . 25.0 113.166 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.41 31.82 21.38 Favored 'General case' 0 CA--C 1.459 -2.542 0 C-N-CA 127.683 2.393 . . . . 25.0 111.182 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.01 -12.74 71.87 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.11 -1.619 . . . . 25.0 116.353 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.42 -9.76 22.99 Favored Glycine 0 CA--C 1.5 -0.855 0 O-C-N 121.717 -0.872 . . . . 25.0 112.688 165.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.9 mt -115.29 4.62 14.49 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 115.631 1.715 . . . . 50.0 115.631 -169.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -78.26 -22.77 47.82 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 104.198 -2.519 . . . . 50.0 104.198 152.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.58 -18.6 77.38 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.356 -0.838 . . . . 25.0 111.385 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.3 -34.46 80.36 Favored Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 109.972 -1.251 . . . . 25.0 109.972 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 40.5 mt -61.93 -40.18 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 O-C-N 119.925 -1.926 . . . . 25.0 113.326 -175.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.04 -29.8 68.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 122.585 1.183 . . . . 75.0 109.576 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.66 -36.35 62.82 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 120.287 -1.508 . . . . 50.0 110.118 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -77.92 20.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 114.684 1.365 . . . . 25.0 114.684 166.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -147.12 40.99 1.07 Allowed 'General case' 0 C--O 1.264 1.822 0 CA-C-O 125.691 2.662 . . . . 25.0 110.097 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -137.63 -177.78 4.95 Favored 'General case' 0 CA--C 1.58 2.119 0 CA-C-N 112.325 -2.216 . . . . 25.0 115.064 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -60.09 -23.69 64.01 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 125.652 2.644 . . . . 25.0 114.789 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -93.03 18.26 9.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 118.894 -2.379 . . . . 25.0 109.599 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -70.12 90.05 0.65 Allowed 'General case' 0 C--O 1.287 3.044 0 CA-C-O 127.681 3.61 . . . . 25.0 108.581 170.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -52.48 160.91 0.76 Allowed 'General case' 0 C--O 1.272 2.241 0 CA-C-N 109.288 -3.596 . . . . 25.0 110.072 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -62.34 142.75 57.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.451 1.1 . . . . 50.0 113.755 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.8 143.58 26.58 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -117.56 125.36 50.69 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-N 123.005 2.639 . . . . 25.0 108.737 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mt -83.49 123.9 39.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 116.332 -0.395 . . . . 25.0 110.864 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.7 mtp -138.84 157.44 46.06 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.446 1.117 . . . . 25.0 110.217 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.4 p -89.28 179.25 6.15 Favored 'General case' 0 C--O 1.273 2.32 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.13 -170.1 29.58 Favored Glycine 0 C--O 1.194 -2.364 0 N-CA-C 110.195 -1.162 . . . . 25.0 110.195 163.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.76 179.12 46.22 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 118.736 -1.697 . . . . 25.0 115.978 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.45 149.17 36.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 119.228 -2.336 . . . . 25.0 108.549 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -129.12 157.09 42.74 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.208 -1.814 . . . . 25.0 107.93 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -120.89 157.84 28.96 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 127.078 2.736 . . . . 25.0 110.19 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -143.15 152.45 41.81 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.509 1.124 . . . . 50.0 108.534 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.0 m -137.93 141.93 40.58 Favored 'General case' 0 CA--C 1.426 -3.812 0 C-N-CA 125.304 1.442 . . . . 25.0 107.684 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -135.52 167.92 20.2 Favored 'General case' 0 C--O 1.262 1.741 1 N-CA-C 99.058 -4.423 . . . . 25.0 99.058 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -131.29 146.46 52.31 Favored 'General case' 0 C--O 1.278 2.587 0 N-CA-C 105.24 -2.133 . . . . 25.0 105.24 162.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -95.87 148.01 23.05 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-O 116.834 -1.555 . . . . 50.0 108.706 159.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -103.96 -24.5 13.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.521 1.964 . . . . 25.0 113.809 173.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 137.6 52.59 Favored Pre-proline 0 N--CA 1.425 -1.677 0 O-C-N 120.218 -1.551 . . . . 25.0 109.836 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -67.86 135.32 34.95 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 116.661 -1.759 . . . . 25.0 112.684 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -152.39 169.49 22.43 Favored 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.538 -2.023 . . . . 25.0 105.538 -163.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -127.58 96.21 4.47 Favored 'General case' 0 C--O 1.273 2.291 0 CA-C-O 118.186 -0.912 . . . . 25.0 108.961 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.2 m -65.4 143.22 57.87 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 120.943 1.701 . . . . 25.0 108.99 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 p -105.76 -48.79 3.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 116.46 2.022 . . . . 25.0 116.46 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -162.93 172.42 15.11 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 120.703 1.592 . . . . 25.0 110.748 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.28 149.05 32.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.442 1.019 . . . . 25.0 113.445 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -122.73 157.68 31.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 114.388 -2.72 . . . . 25.0 110.884 -170.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.638 ' HH ' ' CE1' ' A' ' 134' ' ' HIS . 0.7 OUTLIER -155.06 128.84 8.64 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 125.32 2.486 . . . . 50.0 109.339 178.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -142.02 147.17 36.44 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 112.66 -2.064 . . . . 50.0 110.067 -168.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.1 163.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 124.071 0.948 . . . . 25.0 110.387 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 p -62.61 156.51 23.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 116.964 -1.493 . . . . 25.0 111.819 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -91.5 97.95 11.38 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 124.373 2.035 . . . . 25.0 111.404 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -56.86 154.04 9.97 Favored 'General case' 0 C--O 1.187 -2.198 0 O-C-N 117.213 -3.43 . . . . 25.0 113.782 159.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 3.03 50.34 Favored Glycine 0 CA--C 1.545 1.963 0 N-CA-C 120.454 2.941 . . . . 25.0 120.454 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.8 169.17 0.1 Allowed 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.02 1.41 . . . . 25.0 112.611 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.08 130.62 9.4 Favored Pre-proline 0 C--N 1.31 -1.114 0 N-CA-C 102.996 -2.965 . . . . 25.0 102.996 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -59.3 -31.53 95.23 Favored 'Trans proline' 0 C--N 1.373 1.848 0 N-CA-C 116.037 1.514 . . . . 25.0 116.037 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -76.81 -1.74 29.76 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 125.051 1.469 . . . . 75.0 112.186 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -121.15 -176.83 0.43 Allowed Pre-proline 0 CA--C 1.584 2.288 1 N-CA-C 100.053 -4.054 . . . . 25.0 100.053 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -55.49 16.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.477 -2.362 2 C-N-CA 126.754 4.969 . . . . 25.0 123.235 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.97 -39.91 20.79 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 124.828 3.467 . . . . 50.0 119.171 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -77.22 -20.02 55.86 Favored 'General case' 0 C--O 1.194 -1.823 0 O-C-N 120.242 -1.536 . . . . 25.0 110.867 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -91.73 -53.53 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.424 -1.423 . . . . 25.0 112.033 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.4 42.98 0.85 Allowed 'General case' 0 C--N 1.319 -0.76 0 O-C-N 119.343 -2.098 . . . . 25.0 110.527 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.92 -31.37 70.89 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 125.613 1.565 . . . . 25.0 112.434 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 146.13 47.77 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 125.318 2.485 . . . . 50.0 109.46 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -129.89 132.47 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.138 -1.601 . . . . 25.0 107.249 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.1 tp -73.56 141.04 46.67 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 100.309 -3.96 . . . . 50.0 100.309 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.12 -14.43 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 25.0 112.035 166.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.42 -173.82 43.16 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 125.893 1.996 . . . . 25.0 114.793 159.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.35 153.7 30.88 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.164 -2.902 . . . . 25.0 103.164 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.17 122.01 5.67 Favored Pre-proline 0 C--O 1.259 1.598 0 CA-C-N 119.777 1.171 . . . . 50.0 108.292 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -75.57 164.06 32.99 Favored 'Trans proline' 0 CA--C 1.494 -1.509 0 C-N-CA 115.991 -2.206 . . . . 25.0 115.312 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -133.82 72.95 1.48 Allowed 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 128.353 2.661 . . . . 25.0 109.941 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -74.76 -24.26 58.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 118.643 2.831 . . . . 50.0 118.643 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -170.58 -92.44 0.08 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 127.723 3.14 . . . . 25.0 109.889 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 t -122.0 61.07 12.95 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 114.237 1.199 . . . . 25.0 114.237 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.542 ' HG2' ' HG ' ' A' ' 129' ' ' SER . 26.2 Cg_endo -86.65 -167.1 0.34 Allowed 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-O 124.047 1.603 . . . . 25.0 111.664 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.86 69.58 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 118.901 -2.375 . . . . 25.0 106.178 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.542 ' HG ' ' HG2' ' A' ' 127' ' ' PRO . 89.5 p -79.79 18.88 0.72 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 124.616 2.151 . . . . 25.0 109.314 176.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -73.39 -27.1 61.29 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 118.117 -2.865 . . . . 25.0 103.528 168.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.76 134.2 40.51 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 112.954 -1.93 . . . . 25.0 106.235 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 tp -87.65 -28.4 21.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.52 -1.659 . . . . 75.0 106.52 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . 0.281 44.8 t -71.68 139.86 49.39 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.874 -1.766 . . . . 25.0 110.654 173.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.638 ' CE1' ' HH ' ' A' ' 97' ' ' TYR . 24.7 t-80 -149.39 156.24 41.73 Favored 'General case' 0 C--O 1.273 2.331 0 N-CA-C 106.608 -1.627 . . . . 25.0 106.608 -164.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -97.81 140.53 32.04 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 115.757 -2.068 . . . . 25.0 115.056 170.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.9 mm -127.55 130.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 125.367 1.667 . . . . 25.0 107.624 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -87.96 129.35 35.27 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-O 123.737 1.732 . . . . 50.0 108.259 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.5 mm -107.63 124.75 34.03 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 112.691 -2.05 . . . . 25.0 106.809 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.27 151.44 76.57 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-O 124.498 1.791 . . . . 25.0 107.806 176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -116.73 29.71 7.77 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 111.124 -2.762 . . . . 25.0 112.457 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -75.02 -27.99 60.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.285 -2.234 . . . . 50.0 115.656 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -152.5 164.21 38.04 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 126.026 2.079 . . . . 25.0 106.799 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -83.56 158.75 21.84 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 106.953 -1.499 . . . . 50.0 106.953 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.31 121.99 0.59 Allowed Glycine 0 N--CA 1.481 1.683 0 N-CA-C 117.054 1.582 . . . . 25.0 117.054 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.04 139.19 58.18 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 114.279 1.214 . . . . 50.0 114.279 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -135.57 168.38 19.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 119.821 -1.799 . . . . 25.0 108.147 -169.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -112.4 139.09 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 102.1 -3.296 . . . . 50.0 102.1 162.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.9 129.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 118.635 0.652 . . . . 25.0 110.801 165.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.46 143.15 48.66 Favored 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 117.087 -1.435 . . . . 50.0 113.59 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.01 160.5 37.55 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 126.143 2.152 . . . . 25.0 111.296 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . 0.288 39.5 t -144.3 125.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.29 1.036 . . . . 50.0 109.088 174.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -104.79 112.3 25.36 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 101.157 -3.645 . . . . 25.0 101.157 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -100.62 133.37 45.18 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.0 129.03 31.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 O-C-N 125.242 1.588 . . . . 50.0 109.834 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.75 -18.45 32.97 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -159.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -86.12 2.79 45.36 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 116.005 1.854 . . . . 25.0 116.005 -172.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 t -143.32 158.69 43.42 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.102 -1.444 . . . . 25.0 107.102 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -82.24 -7.44 59.62 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.327 0.967 . . . . 25.0 110.226 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -86.12 163.72 17.7 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.42 148.98 52.3 Favored 'General case' 0 C--O 1.274 2.357 0 N-CA-C 102.02 -3.326 . . . . 25.0 102.02 164.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -102.73 139.36 38.41 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 106.387 -1.708 . . . . 50.0 106.387 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -116.72 153.12 32.93 Favored 'General case' 0 C--O 1.277 2.502 0 C-N-CA 125.013 1.325 . . . . 50.0 108.499 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.72 138.34 23.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.661 0.743 . . . . 25.0 109.745 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.15 142.27 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 106.489 -1.671 . . . . 75.0 106.489 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.9 mt -136.28 127.09 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 104.166 -2.531 . . . . 25.0 104.166 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.91 145.78 25.33 Favored 'General case' 0 C--O 1.203 -1.353 0 N-CA-C 103.986 -2.598 . . . . 25.0 103.986 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.3 m -149.74 156.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 114.093 1.146 . . . . 50.0 114.093 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -121.77 99.87 6.69 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 105.202 -2.147 . . . . 25.0 105.202 172.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.09 121.27 31.26 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.48 -2.785 . . . . 50.0 103.48 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.21 165.79 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 117.099 2.259 . . . . 50.0 117.099 -171.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.64 158.81 15.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt . . . . . 0 C--O 1.261 1.684 0 C-N-CA 119.857 -0.737 . . . . 25.0 112.808 172.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.2 m80 . . . . . 1 N--CA 1.554 4.728 0 CA-C-O 121.705 0.764 . . . . 25.0 111.38 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.73 118.04 0.47 Allowed Glycine 0 CA--C 1.541 1.699 0 O-C-N 117.368 -3.333 . . . . 25.0 107.343 -14.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -130.63 144.82 51.68 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 122.058 2.929 . . . . 50.0 111.209 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.5 mt -99.19 115.43 39.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 101.296 -3.594 . . . . 25.0 101.296 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -88.42 -40.28 13.63 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 125.709 1.88 . . . . 25.0 110.621 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -146.82 145.26 22.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 117.163 2.283 . . . . 25.0 117.163 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.83 149.09 93.44 Favored 'Cis proline' 0 C--O 1.271 2.161 0 CA-C-N 121.161 1.45 . . . . 25.0 115.474 -7.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.21 -168.37 45.18 Favored Glycine 0 N--CA 1.483 1.776 0 O-C-N 126.625 2.453 . . . . 25.0 112.454 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 t -125.91 120.54 30.68 Favored 'General case' 0 C--O 1.266 1.945 0 O-C-N 125.865 1.568 . . . . 25.0 109.794 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -70.11 -35.95 74.5 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.171 -0.678 . . . . 25.0 109.171 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.09 81.97 Favored 'General case' 0 C--O 1.206 -1.231 0 C-N-CA 123.792 0.837 . . . . 25.0 109.84 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -36.51 82.03 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.452 0.908 . . . . 25.0 113.452 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.36 -27.01 65.88 Favored 'General case' 0 C--O 1.182 -2.48 0 O-C-N 125.371 1.669 . . . . 75.0 109.862 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.61 -23.1 46.11 Favored 'General case' 0 CA--C 1.56 1.342 0 O-C-N 124.316 1.01 . . . . 25.0 108.436 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.0 p -82.61 170.98 14.56 Favored 'General case' 0 C--O 1.189 -2.088 0 CA-C-O 123.99 1.852 . . . . 25.0 112.24 -169.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -72.68 -12.62 61.1 Favored 'General case' 0 CA--C 1.554 1.119 0 O-C-N 117.179 -3.451 . . . . 25.0 112.284 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.49 -12.67 60.07 Favored 'General case' 0 CA--C 1.562 1.421 0 O-C-N 120.021 -1.674 . . . . 25.0 112.104 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -52.46 -40.87 62.79 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.305 -1.77 . . . . 50.0 114.184 161.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.24 89.25 0.12 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 103.198 -3.961 . . . . 25.0 103.198 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -47.56 -31.09 4.06 Favored 'General case' 0 C--O 1.269 2.098 0 C-N-CA 127.663 2.385 . . . . 50.0 116.56 -166.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 mt -72.15 -13.99 61.7 Favored 'General case' 0 C--O 1.263 1.784 0 C-N-CA 117.553 -1.659 . . . . 50.0 111.772 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -144.13 158.26 43.82 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.299 0.852 . . . . 25.0 113.299 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -166.95 -178.8 4.38 Favored 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 107.48 -1.304 . . . . 50.0 107.48 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -153.93 48.24 0.64 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 127.387 2.929 . . . . 25.0 106.192 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -142.06 -3.28 1.1 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 118.45 2.759 . . . . 25.0 118.45 -168.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.73 -39.51 91.37 Favored Glycine 0 C--O 1.284 3.245 0 CA-C-N 114.087 -1.415 . . . . 25.0 112.734 -163.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 m -91.4 -32.48 15.63 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-O 127.579 3.562 . . . . 25.0 113.092 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.2 t -65.94 -30.28 49.51 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 111.328 -2.669 . . . . 50.0 113.747 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.5 ptp -68.44 -9.02 45.83 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.2 -50.12 50.3 Favored 'General case' 0 C--O 1.201 -1.449 0 C-N-CA 113.737 -3.185 . . . . 50.0 110.984 175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.98 76.72 27.48 Favored Pre-proline 0 C--O 1.252 1.193 0 O-C-N 120.996 -1.065 . . . . 25.0 110.524 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.68 -21.02 29.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 1 C-N-CA 111.497 -5.202 . . . . 25.0 115.309 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -81.7 2.23 30.64 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 118.94 -2.35 . . . . 25.0 114.362 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 t -118.22 98.95 6.55 Favored 'General case' 0 C--O 1.292 3.303 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.9 mt -126.14 133.52 51.57 Favored 'General case' 0 C--O 1.294 3.399 1 N-CA-C 99.821 -4.14 . . . . 50.0 99.821 157.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -121.83 134.78 54.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 113.975 1.102 . . . . 25.0 113.975 -170.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.24 125.93 32.27 Favored 'General case' 0 C--O 1.198 -1.624 0 C-N-CA 125.335 1.454 . . . . 25.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -113.94 132.27 56.01 Favored 'General case' 0 C--O 1.273 2.3 0 CA-C-N 121.278 1.853 . . . . 25.0 112.778 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -61.56 151.55 32.86 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 126.495 2.372 . . . . 25.0 112.434 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.63 -149.51 38.48 Favored Glycine 0 C--O 1.185 -2.966 0 CA-C-O 119.189 -0.784 . . . . 25.0 114.471 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -102.76 166.3 12.18 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 123.963 0.905 . . . . 25.0 109.93 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.0 -168.73 6.76 Favored 'Cis proline' 0 CA--C 1.552 1.415 0 C-N-CA 132.716 2.382 . . . . 25.0 110.697 3.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -63.07 -42.45 99.66 Favored 'General case' 0 C--O 1.191 -2.005 0 N-CA-C 115.704 1.742 . . . . 25.0 115.704 171.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.72 -95.4 0.05 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-N 114.495 -1.23 . . . . 25.0 113.948 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.34 168.47 11.65 Favored Glycine 0 C--O 1.269 2.287 0 C-N-CA 118.121 -1.99 . . . . 25.0 113.32 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.03 161.81 44.31 Favored 'Trans proline' 0 CA--C 1.492 -1.59 1 C-N-CA 125.489 4.126 . . . . 25.0 114.017 175.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.54 68.71 1.64 Allowed 'General case' 0 C--O 1.261 1.678 0 CA-C-N 113.681 -1.6 . . . . 25.0 111.039 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -151.17 138.47 19.37 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 130.324 3.45 . . . . 25.0 107.245 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.14 79.59 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 119.42 -1.372 . . . . 25.0 111.099 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -122.68 43.74 2.83 Favored 'General case' 0 C--O 1.275 2.428 0 CA-C-O 125.383 2.516 . . . . 25.0 108.862 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.0 mt -82.75 -43.53 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 111.495 -2.593 . . . . 25.0 108.657 -159.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.01 -31.04 68.5 Favored 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 116.744 -1.598 . . . . 25.0 110.637 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.4 t -95.22 -3.71 47.16 Favored 'General case' 0 C--O 1.291 3.251 0 CA-C-O 125.149 2.404 . . . . 25.0 108.369 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.5 25.36 14.43 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 118.886 2.921 . . . . 25.0 118.886 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.38 -21.56 64.4 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 108.006 -2.037 . . . . 25.0 108.006 169.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.41 34.94 2.51 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 120.227 2.851 . . . . 25.0 120.227 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.72 0.19 52.21 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 115.394 1.628 . . . . 50.0 115.394 -170.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -77.18 -11.4 59.81 Favored 'General case' 0 CA--C 1.604 3.053 0 C-N-CA 117.482 -1.687 . . . . 50.0 107.213 161.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.97 69.09 Favored Glycine 0 C--O 1.248 0.971 0 CA-C-O 125.43 2.683 . . . . 25.0 111.828 173.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.26 -27.2 70.41 Favored Glycine 0 C--O 1.205 -1.696 0 O-C-N 120.435 -1.627 . . . . 25.0 113.26 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.94 -39.43 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 104.779 -2.304 . . . . 25.0 104.779 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.8 -34.69 78.96 Favored 'General case' 0 CA--C 1.58 2.116 0 O-C-N 124.496 1.123 . . . . 75.0 112.732 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.16 -19.47 33.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 124.228 1.966 . . . . 50.0 115.538 -167.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -77.53 8.57 4.15 Favored 'General case' 0 C--O 1.258 1.552 0 O-C-N 118.307 -2.746 . . . . 25.0 115.945 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -145.01 60.8 1.31 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.828 -1.533 . . . . 25.0 110.601 163.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -130.33 151.41 50.86 Favored 'General case' 0 CA--C 1.599 2.829 0 C-N-CA 119.439 -0.905 . . . . 25.0 111.982 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.6 -26.29 68.62 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 118.018 -2.926 . . . . 25.0 108.547 166.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -93.51 24.92 3.71 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.422 -1.311 . . . . 25.0 111.067 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.91 100.76 0.43 Allowed 'General case' 0 C--O 1.196 -1.749 0 CA-C-O 125.556 2.598 . . . . 25.0 110.557 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -32.73 137.53 0.07 Allowed 'General case' 0 C--N 1.317 -0.824 2 CA-C-N 103.45 -6.25 . . . . 25.0 115.821 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -77.2 128.45 34.4 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 121.676 -0.64 . . . . 50.0 110.808 -155.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -98.86 147.32 25.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 119.818 3.266 . . . . 25.0 119.818 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -137.81 155.18 49.29 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 102.28 -3.23 . . . . 25.0 102.28 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.0 mt -105.56 126.21 60.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 1 N-CA-C 97.913 -4.847 . . . . 25.0 97.913 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.6 mtp -130.46 140.16 50.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.323 1.049 . . . . 25.0 111.286 -168.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 p -75.44 173.23 11.22 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 116.059 1.874 . . . . 25.0 116.059 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.48 -178.77 48.47 Favored Glycine 0 C--O 1.283 3.182 0 N-CA-C 105.184 -3.166 . . . . 25.0 105.184 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.17 -170.56 31.7 Favored Glycine 2 N--CA 1.389 -4.453 0 CA-C-N 111.313 -2.443 . . . . 25.0 111.314 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.49 136.79 36.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.368 2.084 . . . . 25.0 112.444 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -137.18 161.46 36.1 Favored 'General case' 0 N--CA 1.522 3.16 0 O-C-N 124.939 1.399 . . . . 25.0 108.494 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 m -112.65 130.84 55.9 Favored 'General case' 0 C--O 1.274 2.353 0 CA-C-O 122.438 1.113 . . . . 25.0 109.491 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -118.35 116.99 27.87 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 113.402 -1.727 . . . . 50.0 109.556 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 m -137.36 135.63 37.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 114.958 1.466 . . . . 25.0 114.958 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -114.95 161.49 18.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.847 -2.279 . . . . 25.0 104.847 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 t -146.5 147.97 31.73 Favored 'General case' 0 C--O 1.265 1.874 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.44 148.98 32.84 Favored 'General case' 0 CA--C 1.603 3.007 0 O-C-N 118.264 -2.773 . . . . 50.0 106.372 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.5 p -77.76 2.35 17.28 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 118.133 2.642 . . . . 25.0 118.133 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.45 159.54 57.48 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.655 1.182 . . . . 25.0 108.535 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.04 163.82 36.23 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 114.716 -3.056 . . . . 25.0 111.144 171.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -139.03 151.16 46.58 Favored 'General case' 0 C--O 1.183 -2.409 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 163.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.59 121.5 19.82 Favored 'General case' 0 C--O 1.253 1.265 0 CA-C-N 113.424 -1.716 . . . . 25.0 106.624 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.1 m -142.99 138.91 30.38 Favored 'General case' 0 C--N 1.317 -0.832 1 N-CA-C 99.674 -4.195 . . . . 25.0 99.674 -172.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.0 p -78.94 -48.64 14.17 Favored 'General case' 0 C--O 1.272 2.241 0 CA-C-O 124.025 1.869 . . . . 25.0 110.924 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -163.48 175.9 10.28 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.442 -1.411 . . . . 25.0 109.353 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -144.46 154.07 42.55 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 126.085 1.754 . . . . 25.0 108.697 167.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -128.43 160.55 31.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 116.792 -1.575 . . . . 25.0 109.692 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -134.91 148.5 50.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 103.663 -2.717 . . . . 50.0 103.663 162.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -139.2 168.59 19.49 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 103.998 -2.593 . . . . 50.0 103.998 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.4 pt -136.32 160.96 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 104.581 -2.378 . . . . 25.0 104.581 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -123.78 148.33 46.76 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 113.206 -1.815 . . . . 25.0 106.622 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -125.95 93.86 3.94 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 117.893 -1.523 . . . . 25.0 108.07 -172.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.84 165.99 3.67 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 120.114 -1.617 . . . . 25.0 112.757 168.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.82 48.5 Favored Glycine 0 C--O 1.192 -2.52 0 O-C-N 119.811 -1.806 . . . . 25.0 109.822 -171.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.59 159.57 32.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.073 1.416 . . . . 25.0 110.933 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.32 128.8 86.9 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 101.877 -3.379 . . . . 25.0 101.877 170.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 108' ' ' LYS . 72.3 Cg_endo -74.77 -27.06 10.81 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 114.048 -3.501 . . . . 25.0 117.359 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -81.59 1.23 34.75 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.48 1.491 . . . . 75.0 108.575 -165.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 106' ' ' PRO . 25.0 mmtp -118.24 166.53 13.5 Favored Pre-proline 0 CA--C 1.578 2.052 0 O-C-N 127.976 3.297 . . . . 25.0 111.798 -161.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -47.33 30.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.374 2 C-N-CA 130.171 7.247 . . . . 25.0 124.528 174.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -52.28 -27.88 16.83 Favored 'General case' 0 C--O 1.188 -2.178 0 O-C-N 120.141 -1.599 . . . . 50.0 114.835 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -71.57 -14.48 62.1 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 123.706 0.629 . . . . 25.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -116.43 -60.52 1.85 Allowed 'General case' 0 C--O 1.168 -3.235 0 C-N-CA 126.854 2.062 . . . . 25.0 111.817 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.56 -25.37 35.88 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -102.74 28.65 5.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.761 0.791 . . . . 25.0 112.885 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -137.85 151.73 48.36 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.914 -2.625 . . . . 50.0 103.914 156.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -130.01 147.88 51.8 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 119.008 -0.52 . . . . 25.0 111.408 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.8 tp -65.94 136.21 55.78 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 106.28 -1.748 . . . . 50.0 106.28 156.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.53 -15.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 120.24 1.382 . . . . 25.0 107.698 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.8 157.23 15.71 Favored Glycine 0 C--O 1.284 3.279 0 CA-C-O 117.057 -1.968 . . . . 25.0 110.971 163.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.14 150.32 49.55 Favored 'General case' 0 C--O 1.263 1.773 0 CA-C-N 118.067 0.934 . . . . 25.0 112.774 162.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -126.34 111.24 23.56 Favored Pre-proline 0 C--O 1.255 1.382 0 C-N-CA 125.432 1.493 . . . . 50.0 114.997 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -79.31 157.59 26.0 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 114.07 -3.487 . . . . 25.0 119.278 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . 0.279 53.1 t-80 -121.96 65.2 0.91 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 124.292 1.996 . . . . 25.0 107.122 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.15 26.47 8.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 111.624 -2.535 . . . . 50.0 110.458 -166.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.83 57.96 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-O 124.016 1.898 . . . . 25.0 108.806 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.96 160.48 0.65 Allowed Pre-proline 0 C--O 1.266 1.957 0 N-CA-C 118.479 2.77 . . . . 25.0 118.479 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.72 -166.62 0.1 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 123.099 2.533 . . . . 25.0 115.652 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.09 -23.13 7.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.189 1.922 . . . . 25.0 116.189 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.8 p -69.3 -8.44 46.16 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 114.395 1.257 . . . . 25.0 114.395 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -53.67 -29.07 36.88 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 117.217 -1.373 . . . . 25.0 113.811 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . 0.261 85.1 m-20 -68.15 143.59 55.34 Favored 'General case' 0 C--O 1.19 -2.064 0 CA-C-O 123.641 1.686 . . . . 25.0 111.359 -174.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -20.65 66.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.374 1.869 . . . . 75.0 110.073 -170.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.0 t -83.24 127.47 33.66 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.29 1.959 . . . . 25.0 116.29 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -137.45 146.95 44.94 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 124.503 2.097 . . . . 25.0 112.533 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -98.03 129.89 44.87 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.762 -1.211 . . . . 25.0 110.445 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . 0.266 35.9 mm -131.12 120.62 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.81 1.244 . . . . 25.0 107.904 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -76.58 126.07 30.34 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.898 -1.519 . . . . 50.0 106.898 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.9 129.08 31.99 Favored Pre-proline 0 C--N 1.364 1.221 0 CA-C-O 115.91 -1.995 . . . . 25.0 109.798 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.14 156.04 47.43 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 116.156 -2.096 . . . . 25.0 110.836 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -109.45 -8.63 15.01 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 126.527 1.931 . . . . 25.0 115.773 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -93.94 -13.58 26.93 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 115.833 1.79 . . . . 50.0 115.833 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.61 163.4 22.83 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.127 1.528 . . . . 25.0 115.127 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.01 146.13 34.41 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 124.94 1.4 . . . . 50.0 113.769 158.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.72 158.99 11.21 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 118.826 2.291 . . . . 25.0 118.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -72.79 136.99 45.52 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.975 -1.613 . . . . 50.0 111.149 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -142.87 166.11 25.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.152 -0.476 . . . . 25.0 110.526 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.77 130.95 73.24 Favored 'Isoleucine or valine' 0 C--O 1.267 1.98 0 N-CA-C 101.887 -3.375 . . . . 50.0 101.887 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.3 mt -101.63 123.86 55.04 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.93 1 N-CA-C 98.639 -4.578 . . . . 25.0 98.639 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.38 143.22 43.86 Favored 'General case' 0 C--O 1.189 -2.106 0 N-CA-C 104.527 -2.397 . . . . 50.0 104.527 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.4 34.94 Favored 'General case' 0 CA--C 1.456 -2.65 0 O-C-N 119.87 -1.769 . . . . 25.0 113.097 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.84 125.46 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 CA-C-N 110.143 -3.208 . . . . 50.0 108.489 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -108.06 104.22 13.61 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.873 -1.158 . . . . 25.0 107.873 166.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -78.28 72.74 4.82 Favored 'General case' 0 C--O 1.26 1.653 0 O-C-N 126.267 2.229 . . . . 25.0 106.47 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.64 116.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.773 0 C-N-CA 126.174 1.79 . . . . 50.0 113.374 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.8 -22.31 23.32 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -7.87 0.37 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 119.642 3.201 . . . . 25.0 119.642 171.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.2 p -135.34 165.08 26.27 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 103.089 -2.93 . . . . 25.0 103.089 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -76.97 -41.87 41.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 119.576 -1.953 . . . . 25.0 110.103 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -81.44 168.66 18.08 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 105.098 -2.186 . . . . 25.0 105.098 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -116.34 153.47 31.93 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 102.95 -2.982 . . . . 25.0 102.95 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -97.6 150.05 21.56 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 107.714 -1.217 . . . . 50.0 107.714 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -140.79 162.53 35.2 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 104.957 -2.238 . . . . 50.0 104.957 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 144.64 12.02 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 103.377 -2.823 . . . . 25.0 103.377 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.38 155.03 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 123.082 1.42 . . . . 75.0 114.6 165.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.46 117.64 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 101.13 -3.656 . . . . 25.0 101.13 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -82.28 127.49 33.26 Favored 'General case' 1 C--O 1.318 4.668 0 CA-C-O 124.614 2.15 . . . . 25.0 106.169 170.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.14 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 116.573 -3.83 . . . . 50.0 115.217 175.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.31 98.18 5.94 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 106.189 -1.782 . . . . 25.0 106.189 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.23 122.74 32.8 Favored 'General case' 0 C--O 1.261 1.695 0 N-CA-C 101.555 -3.498 . . . . 50.0 101.555 -168.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.08 162.57 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 118.607 -2.558 . . . . 50.0 117.366 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -84.63 164.39 18.69 Favored 'General case' 0 C--O 1.282 2.77 0 O-C-N 120.738 -1.226 . . . . 25.0 108.301 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 40.9 pttt . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 116.971 -1.49 . . . . 25.0 108.548 179.072 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 . . . . . 0 C--O 1.262 1.757 0 N-CA-C 113.553 0.946 . . . . 25.0 113.553 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.07 179.44 30.29 Favored Glycine 0 C--O 1.282 3.146 0 CA-C-O 115.706 -2.719 . . . . 25.0 113.844 -172.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.61 153.17 44.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 119.067 1.433 . . . . 50.0 113.033 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 6' ' ' LYS . 19.1 mt -71.03 124.14 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 119.127 -2.233 . . . . 25.0 110.257 -171.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -100.89 11.03 40.4 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 123.516 1.627 . . . . 25.0 109.014 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' H ' HG23 ' A' ' 4' ' ' ILE . 51.1 mtmt 86.91 159.24 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.679 1 C-N-CA 133.354 4.661 . . . . 25.0 112.529 172.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 139.97 47.87 Favored 'Cis proline' 0 CA--C 1.466 -2.895 0 C-N-CA 132.672 2.363 . . . . 25.0 114.193 2.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.18 69.15 1.21 Allowed Glycine 0 C--N 1.281 -2.496 0 CA-C-N 112.036 -2.347 . . . . 25.0 113.393 165.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -69.86 137.7 51.92 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 125.795 2.712 . . . . 25.0 108.69 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -93.63 -18.8 21.78 Favored 'General case' 0 C--O 1.281 2.759 0 N-CA-C 103.746 -2.686 . . . . 25.0 103.746 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.02 75.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.898 0.856 . . . . 25.0 112.078 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.48 77.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.913 -1.494 . . . . 25.0 110.362 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -85.98 -15.89 40.05 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 113.03 -1.895 . . . . 75.0 109.396 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 t -79.63 -11.46 59.87 Favored 'General case' 0 N--CA 1.416 -2.132 0 C-N-CA 125.991 1.716 . . . . 25.0 114.263 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.5 t -48.91 135.04 16.12 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 125.905 1.682 . . . . 25.0 109.738 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.259 40.8 tt0 -66.54 -20.84 66.12 Favored 'General case' 0 CA--C 1.588 2.418 0 C-N-CA 127.388 2.275 . . . . 25.0 110.045 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.66 -13.48 22.81 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.158 1.54 . . . . 25.0 115.158 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -54.33 -21.87 10.56 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 113.478 0.918 . . . . 50.0 113.478 166.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.97 17.29 0.04 OUTLIER Glycine 0 C--O 1.214 -1.132 0 O-C-N 118.213 -2.804 . . . . 25.0 119.361 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.3 t80 54.26 21.08 2.92 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.733 1.753 . . . . 50.0 115.733 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.18 -34.42 22.08 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.608 -1.933 . . . . 50.0 108.75 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -114.23 176.53 5.0 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 119.505 1.048 . . . . 25.0 108.383 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.56 172.22 8.92 Favored 'General case' 0 N--CA 1.523 3.22 0 CA-C-O 117.114 -1.422 . . . . 50.0 113.527 168.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -35.67 -37.8 0.1 Allowed 'General case' 0 C--O 1.181 -2.549 0 N-CA-C 119.027 2.973 . . . . 25.0 119.027 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -146.36 -21.67 0.43 Allowed 'General case' 0 C--O 1.217 -0.636 0 O-C-N 127.135 2.772 . . . . 25.0 111.531 151.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.53 121.36 2.91 Favored Glycine 0 C--O 1.208 -1.495 0 N-CA-C 106.277 -2.729 . . . . 25.0 106.277 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -7.89 0.39 Allowed 'General case' 0 CA--C 1.574 1.876 1 N-CA-C 122.574 4.287 . . . . 25.0 122.574 -167.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.42 -13.3 8.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 CA-C-N 120.301 1.41 . . . . 50.0 112.382 168.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.9 ptm -53.23 -13.51 0.54 Allowed 'General case' 0 C--O 1.173 -2.928 0 N-CA-C 119.84 3.274 . . . . 25.0 119.84 172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -64.9 -38.09 89.83 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 115.12 -0.945 . . . . 50.0 110.565 169.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.52 60.81 5.76 Favored Pre-proline 0 C--O 1.275 2.423 0 CA-C-N 115.025 -0.989 . . . . 25.0 112.878 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.19 -22.22 9.96 Favored 'Trans proline' 0 N--CA 1.477 0.546 1 C-N-CA 110.086 -6.143 . . . . 25.0 115.525 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -77.6 -15.39 59.26 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.963 -1.086 . . . . 25.0 111.28 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.4 t -73.66 116.93 14.83 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 118.271 -1.371 . . . . 25.0 111.391 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.5 mt -118.23 145.55 44.92 Favored 'General case' 0 C--O 1.164 -3.408 0 N-CA-C 104.501 -2.407 . . . . 50.0 104.501 162.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.6 157.88 45.3 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 124.765 2.222 . . . . 25.0 107.984 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.71 155.51 49.02 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 105.161 -2.163 . . . . 25.0 105.161 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.0 156.58 47.93 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 120.986 1.721 . . . . 25.0 110.957 166.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -76.02 157.5 32.94 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 114.657 1.354 . . . . 25.0 114.657 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.39 163.39 13.17 Favored Glycine 0 C--O 1.19 -2.632 0 N-CA-C 105.042 -3.223 . . . . 25.0 105.042 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.1 156.51 72.25 Favored Pre-proline 0 N--CA 1.438 -1.037 0 C-N-CA 128.055 2.542 . . . . 25.0 113.554 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.08 -28.93 5.38 Favored 'Cis proline' 0 C--N 1.371 1.742 0 C-N-CA 130.375 1.406 . . . . 25.0 114.111 -0.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -130.83 10.81 5.11 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-N 120.994 1.725 . . . . 25.0 113.193 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t 61.31 -146.43 0.43 Allowed 'General case' 0 CA--C 1.478 -1.806 0 O-C-N 126.401 2.313 . . . . 25.0 110.271 -168.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.54 -163.44 0.73 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 118.996 -1.574 . . . . 25.0 114.505 169.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.32 169.52 15.28 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 122.502 2.135 . . . . 25.0 113.404 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.16 79.29 0.14 Allowed 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 123.277 1.513 . . . . 25.0 114.854 -170.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -147.03 158.3 43.88 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 96.026 -5.546 . . . . 25.0 96.026 171.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.71 37.19 67.05 Favored Glycine 0 C--O 1.273 2.59 0 N-CA-C 109.793 -1.323 . . . . 25.0 109.793 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -97.12 21.34 9.97 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.889 1.276 . . . . 25.0 108.808 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.1 mt -75.15 -44.75 43.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.25 -1.018 . . . . 25.0 108.25 -166.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.36 -31.1 72.17 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 119.565 -1.96 . . . . 25.0 110.847 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.6 p -82.08 7.94 12.07 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.973 1.842 . . . . 25.0 115.973 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.22 10.0 0.03 OUTLIER 'General case' 0 C--O 1.26 1.639 0 N-CA-C 116.547 2.055 . . . . 25.0 116.547 -167.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.92 -40.54 98.51 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 122.285 2.312 . . . . 25.0 108.955 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.65 -2.03 79.3 Favored Glycine 0 CA--C 1.568 3.354 0 C-N-CA 119.408 -1.377 . . . . 25.0 114.354 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.2 mt -112.15 -23.51 10.39 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 117.668 -1.158 . . . . 50.0 114.005 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -71.56 -36.5 70.94 Favored 'General case' 0 C--O 1.262 1.713 0 N-CA-C 106.902 -1.518 . . . . 50.0 106.902 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.19 -16.52 78.61 Favored Glycine 1 C--O 1.156 -4.726 0 CA-C-O 123.362 1.535 . . . . 25.0 115.082 171.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.38 -17.01 73.98 Favored Glycine 0 C--N 1.307 -1.07 0 O-C-N 118.916 -2.52 . . . . 25.0 112.02 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -77.63 -34.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.53 0 N-CA-C 106.23 -1.767 . . . . 25.0 106.23 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.18 -23.0 57.65 Favored 'General case' 0 C--O 1.27 2.149 0 O-C-N 119.268 -2.145 . . . . 75.0 107.746 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -73.22 -8.2 54.79 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 113.566 -1.652 . . . . 50.0 112.726 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -77.36 7.7 5.01 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 124.378 2.037 . . . . 25.0 113.485 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -131.26 34.35 4.01 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.294 -1.373 . . . . 25.0 107.294 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 t -142.58 157.73 44.4 Favored 'General case' 0 C--O 1.252 1.229 0 O-C-N 119.954 -1.716 . . . . 25.0 111.656 -164.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.41 -25.08 66.96 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-O 122.466 1.126 . . . . 25.0 109.694 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.09 13.66 16.26 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.062 2.545 . . . . 25.0 108.173 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -76.41 99.62 4.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.313 -2.847 . . . . 25.0 103.313 167.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -46.72 145.13 2.03 Favored 'General case' 0 C--N 1.309 -1.155 1 CA-C-N 107.105 -4.589 . . . . 25.0 113.597 166.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -80.03 147.8 31.35 Favored 'General case' 0 C--O 1.21 -0.998 0 CA-C-O 115.626 -2.13 . . . . 50.0 110.4 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.91 101.66 13.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 126.246 2.216 . . . . 25.0 107.354 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -73.28 119.39 17.45 Favored 'General case' 0 C--O 1.284 2.911 0 N-CA-C 107.048 -1.464 . . . . 25.0 107.048 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.7 mt -81.53 130.97 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.0 ttt -147.82 134.55 19.98 Favored 'General case' 0 C--O 1.178 -2.695 0 N-CA-C 107.893 -1.151 . . . . 25.0 107.893 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 p -79.72 150.27 30.9 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.524 -2.398 . . . . 25.0 104.524 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.93 163.23 37.77 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 119.793 2.677 . . . . 25.0 119.793 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.75 -177.92 18.49 Favored Glycine 0 C--O 1.27 2.402 0 N-CA-C 105.998 -2.841 . . . . 25.0 105.998 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 9.3 pt-20 -82.48 152.24 26.16 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 125.437 2.542 . . . . 25.0 106.307 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.94 154.28 51.16 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 118.334 -2.729 . . . . 25.0 105.603 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.3 m -117.88 131.79 56.5 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 103.15 -2.907 . . . . 25.0 103.15 163.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -115.64 141.54 47.93 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.352 -1.351 . . . . 50.0 107.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -139.41 129.18 24.71 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 113.043 -1.889 . . . . 25.0 111.907 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -131.59 162.58 30.0 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 101.655 -3.461 . . . . 25.0 101.655 -174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.4 p -132.46 140.01 48.22 Favored 'General case' 0 CA--C 1.488 -1.417 0 O-C-N 121.597 -0.689 . . . . 25.0 111.748 156.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -79.74 154.75 28.33 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.035 -1.469 . . . . 50.0 107.035 164.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.9 t -91.96 -19.72 22.13 Favored 'General case' 0 C--O 1.257 1.449 0 N-CA-C 106.762 -1.57 . . . . 25.0 106.762 -165.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.95 139.39 13.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 CA-C-O 117.305 -1.331 . . . . 25.0 109.12 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.85 131.86 34.8 Favored 'Trans proline' 0 CA--C 1.599 3.729 0 C-N-CA 115.461 -2.56 . . . . 25.0 111.225 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.16 160.43 42.85 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -81.61 161.48 23.47 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 116.048 1.87 . . . . 25.0 116.048 -158.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.1 m -154.97 134.96 12.97 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.332 -1.358 . . . . 25.0 107.332 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.1 p -91.52 -41.22 10.93 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.49 -1.67 . . . . 25.0 106.49 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -161.39 172.53 16.37 Favored 'General case' 0 C--O 1.281 2.732 0 N-CA-C 104.95 -2.241 . . . . 25.0 104.95 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -144.53 152.52 40.69 Favored 'General case' 0 C--O 1.258 1.533 0 N-CA-C 114.477 1.288 . . . . 25.0 114.477 167.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -128.98 142.25 50.99 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.385 -1.293 . . . . 25.0 110.59 -167.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.74 144.19 47.38 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-N 120.276 1.398 . . . . 50.0 107.556 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.3 167.57 20.47 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 105.61 -1.996 . . . . 50.0 105.61 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.3 pt -129.6 147.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 172.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.6 p -77.79 154.89 31.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 117.739 -1.124 . . . . 25.0 109.565 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -144.86 80.09 1.61 Allowed 'General case' 0 C--O 1.239 0.545 0 N-CA-C 117.411 2.374 . . . . 25.0 117.411 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -47.24 157.72 0.18 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 125.411 2.529 . . . . 25.0 115.124 167.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.95 32.71 23.05 Favored Glycine 0 C--O 1.204 -1.767 0 C-N-CA 116.985 -2.531 . . . . 25.0 112.108 167.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -60.66 159.41 10.83 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.989 1.848 . . . . 25.0 115.989 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -74.82 134.34 75.35 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.126 -1.435 . . . . 25.0 107.126 162.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.23 -26.5 49.26 Favored 'Trans proline' 0 C--N 1.362 1.26 0 N-CA-C 120.164 3.102 . . . . 25.0 120.164 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.18 -6.5 58.59 Favored 'General case' 0 C--O 1.191 -1.994 0 C-N-CA 116.96 -1.896 . . . . 75.0 110.198 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -66.27 157.6 80.9 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 111.684 -2.507 . . . . 25.0 110.913 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.14 51.16 1.29 Allowed 'Trans proline' 0 C--N 1.37 1.668 1 N-CA-C 122.829 4.126 . . . . 25.0 122.829 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -2.45 -66.31 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 1 C-N-CA 132.092 4.157 . . . . 50.0 118.968 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -72.34 -8.6 55.8 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 122.189 2.268 . . . . 25.0 114.652 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 -55.4 2.58 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 124.523 1.129 . . . . 25.0 109.32 165.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.85 -25.69 1.39 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 117.323 2.342 . . . . 25.0 117.323 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -82.96 8.45 12.64 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.27 160.57 39.85 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 119.938 -1.726 . . . . 50.0 108.49 159.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -144.44 134.37 23.89 Favored 'General case' 0 C--O 1.182 -2.5 0 N-CA-C 105.821 -1.918 . . . . 25.0 105.821 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.41 132.57 50.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.678 1.191 . . . . 50.0 111.358 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.8 tt -111.15 -18.15 7.85 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 N-CA-C 106.224 -1.769 . . . . 25.0 106.224 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.29 156.03 13.11 Favored Glycine 0 C--N 1.306 -1.095 0 O-C-N 120.542 -1.349 . . . . 25.0 113.085 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.14 139.41 24.61 Favored 'General case' 0 C--O 1.266 1.943 0 CA-C-O 123.769 1.747 . . . . 25.0 107.065 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -128.81 107.21 18.44 Favored Pre-proline 0 C--O 1.255 1.381 0 CA-C-N 114.63 -1.168 . . . . 50.0 110.056 -170.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.95 164.52 31.49 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 113.331 -3.979 . . . . 25.0 115.038 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -139.98 2.98 1.98 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 118.058 2.614 . . . . 25.0 118.058 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -90.29 -24.92 20.77 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 107.637 -1.246 . . . . 50.0 107.637 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.62 160.93 27.43 Favored Glycine 0 C--N 1.352 1.437 1 N-CA-C 95.207 -7.157 . . . . 25.0 95.207 155.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.5 t -154.8 149.11 19.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 120.543 2.171 . . . . 25.0 112.706 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.03 -178.03 3.59 Favored 'Trans proline' 0 N--CA 1.436 -1.86 0 C-N-CA 114.866 -2.956 . . . . 25.0 111.008 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -15.8 5.37 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 118.474 -2.641 . . . . 25.0 115.496 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.53 4.02 0.43 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.103 1.89 . . . . 25.0 116.103 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -57.47 -33.54 68.08 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 127.108 2.163 . . . . 25.0 115.05 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -48.57 131.37 17.5 Favored 'General case' 0 C--O 1.18 -2.592 0 CA-C-N 119.367 0.985 . . . . 25.0 113.201 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.3 tp -65.86 -29.9 70.42 Favored 'General case' 0 C--O 1.268 2.077 0 CA-C-O 122.017 0.913 . . . . 75.0 113.355 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 132.5 47.46 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 121.748 -0.595 . . . . 25.0 110.67 166.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -153.84 161.05 42.36 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.597 1.665 . . . . 25.0 110.559 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -112.12 137.52 50.07 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.518 1.303 . . . . 25.0 114.518 -172.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.3 mt -132.53 133.23 59.89 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 102.956 -2.979 . . . . 25.0 102.956 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 73.5 t80 -101.0 134.19 44.36 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 105.716 -1.957 . . . . 50.0 105.716 173.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.4 mm -125.17 110.38 26.85 Favored Pre-proline 0 C--O 1.2 -1.509 0 N-CA-C 102.127 -3.286 . . . . 25.0 102.127 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.25 149.83 70.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 115.101 -2.799 . . . . 25.0 109.854 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -92.51 47.07 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.77 -14.69 60.74 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 118.791 -2.443 . . . . 50.0 114.487 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -166.44 169.45 13.89 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 103.946 -2.613 . . . . 25.0 103.946 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -98.15 152.57 19.22 Favored 'General case' 0 C--O 1.281 2.741 0 N-CA-C 100.459 -3.904 . . . . 50.0 100.459 163.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.24 164.19 17.72 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-O 123.386 1.548 . . . . 25.0 111.163 -171.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.91 157.65 45.06 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 117.105 -3.585 . . . . 50.0 116.844 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -158.42 175.94 13.07 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 100.652 -3.833 . . . . 25.0 100.652 170.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.75 146.92 6.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 123.449 0.7 . . . . 50.0 111.726 167.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.94 128.39 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 O-C-N 119.329 -2.107 . . . . 25.0 106.252 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -115.7 153.77 30.75 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 115.683 -2.103 . . . . 50.0 106.531 -167.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.49 44.2 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 121.48 1.945 . . . . 25.0 114.536 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.41 135.44 57.84 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.714 0 C-N-CA 125.028 1.331 . . . . 50.0 111.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -115.77 137.8 51.74 Favored 'General case' 0 C--O 1.277 2.543 0 C-N-CA 127.583 2.353 . . . . 25.0 107.273 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -118.0 144.82 45.22 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 103.269 -2.863 . . . . 25.0 103.269 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.33 113.27 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 105.538 -2.023 . . . . 50.0 105.538 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.0 -14.29 62.29 Favored 'General case' 0 C--O 1.262 1.728 0 N-CA-C 115.255 1.576 . . . . 25.0 115.255 -167.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -71.3 -25.09 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 126.39 2.306 . . . . 25.0 111.16 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.9 p -120.13 165.45 14.75 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 112.272 -2.24 . . . . 25.0 111.819 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -100.7 -9.79 21.49 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 123.808 1.766 . . . . 25.0 107.374 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -78.66 159.42 28.03 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 113.121 -1.854 . . . . 25.0 112.841 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.44 148.58 42.95 Favored 'General case' 0 CA--C 1.557 1.242 1 N-CA-C 98.837 -4.505 . . . . 25.0 98.837 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -126.67 139.48 53.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.276 -1.379 . . . . 50.0 107.276 -165.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -140.19 159.46 42.13 Favored 'General case' 0 C--O 1.203 -1.365 0 O-C-N 126.427 2.329 . . . . 50.0 110.404 -166.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -148.38 161.83 40.79 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.206 1.402 . . . . 25.0 111.816 166.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.52 130.6 50.43 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.178 0 N-CA-C 106.207 -1.775 . . . . 75.0 106.207 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -126.92 120.8 56.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.772 -1.566 . . . . 25.0 106.772 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -91.12 145.49 24.64 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 107.445 -1.316 . . . . 25.0 107.445 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.42 163.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 C-N-CA 127.187 2.195 . . . . 50.0 112.903 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.58 108.57 6.02 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 127.235 2.214 . . . . 25.0 109.701 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.33 116.49 30.45 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 102.867 -3.012 . . . . 50.0 102.867 -161.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.8 m -125.18 167.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.127 -1.029 . . . . 50.0 113.015 -156.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.88 155.03 31.2 Favored 'General case' 0 C--O 1.263 1.766 0 O-C-N 124.715 1.259 . . . . 25.0 108.277 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 C--O 1.249 1.059 0 CA-C-N 113.672 -1.603 . . . . 25.0 106.825 -177.346 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.527 -1.702 . . . . 25.0 113.252 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.53 166.72 39.14 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 117.155 -2.45 . . . . 25.0 116.658 -170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.81 173.35 13.83 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 106.681 -1.6 . . . . 50.0 106.681 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.0 121.96 54.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 N-CA-C 102.897 -3.001 . . . . 25.0 102.897 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.6 -41.81 16.03 Favored 'General case' 0 C--O 1.18 -2.569 0 C-N-CA 127.631 2.372 . . . . 25.0 113.837 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -152.7 155.74 32.69 Favored Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 105.838 -1.912 . . . . 25.0 105.838 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -60.51 139.18 23.0 Favored 'Cis proline' 0 C--N 1.358 1.028 0 C-N-CA 132.291 2.204 . . . . 25.0 116.209 3.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.58 -177.17 54.41 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 122.639 1.133 . . . . 25.0 114.123 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -123.08 103.01 8.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 125.129 2.395 . . . . 25.0 107.548 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -58.77 -27.83 65.35 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 119.861 -1.774 . . . . 25.0 112.988 167.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.79 73.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 122.902 1.334 . . . . 25.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.86 73.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 122.058 0.932 . . . . 25.0 108.857 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.5 -17.5 64.19 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 127.192 2.197 . . . . 75.0 109.721 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.15 -20.94 26.29 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 108.49 -0.93 . . . . 25.0 108.49 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.0 t -80.47 121.75 26.13 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 116.518 -1.706 . . . . 25.0 110.026 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.4 -29.7 69.28 Favored 'General case' 0 C--O 1.195 -1.806 0 CA-C-N 121.994 2.179 . . . . 25.0 107.64 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.76 71.77 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 115.863 1.801 . . . . 25.0 115.863 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.49 -22.29 62.67 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 109.531 -0.544 . . . . 50.0 109.531 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.43 27.37 8.49 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 109.963 -1.255 . . . . 25.0 109.963 172.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.5 t80 60.51 -51.52 0.09 Allowed 'General case' 0 C--O 1.27 2.17 0 C-N-CA 128.952 2.901 . . . . 50.0 117.606 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 23.0 mt -123.64 -10.44 7.85 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.254 -1.529 . . . . 50.0 113.838 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -128.87 157.66 40.92 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 116.374 1.991 . . . . 25.0 116.374 -154.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -155.74 157.69 36.96 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 125.099 2.381 . . . . 50.0 109.232 -172.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -143.85 31.16 1.29 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.724 -2.035 . . . . 25.0 114.104 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -20.53 61.25 Favored 'General case' 0 C--O 1.267 1.996 0 CA-C-N 113.37 -1.741 . . . . 25.0 113.426 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 28' ' ' VAL . . . 92.07 138.82 8.43 Favored Glycine 0 CA--C 1.473 -2.575 0 N-CA-C 104.08 -3.608 . . . . 25.0 104.08 -171.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.1 p -57.6 -7.28 0.62 Allowed 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 114.632 1.345 . . . . 25.0 114.632 175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 26' ' ' GLY . 3.2 t -58.78 -30.93 43.55 Favored 'Isoleucine or valine' 0 C--O 1.262 1.732 0 C-N-CA 127.434 2.294 . . . . 50.0 109.498 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -61.63 1.65 0.23 Allowed 'General case' 0 C--O 1.255 1.372 0 N-CA-C 118.811 2.893 . . . . 25.0 118.811 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -66.82 -41.29 87.73 Favored 'General case' 0 C--O 1.267 1.974 0 C-N-CA 124.104 0.961 . . . . 50.0 111.321 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.94 56.68 8.23 Favored Pre-proline 0 C--O 1.249 1.051 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.05 -20.89 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.318 0 N-CA-C 120.555 3.252 . . . . 25.0 120.555 -167.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -94.33 -2.85 51.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 116.849 -1.94 . . . . 25.0 113.179 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 t -77.09 87.25 3.58 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 122.191 0.996 . . . . 25.0 111.164 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.13 80.05 1.33 Allowed 'General case' 0 C--O 1.252 1.194 0 N-CA-C 107.729 -1.212 . . . . 50.0 107.729 -167.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -141.2 135.7 31.03 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 121.147 1.794 . . . . 25.0 114.43 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.68 166.11 31.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.044 -2.576 . . . . 25.0 104.044 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -84.93 146.56 27.19 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -58.96 147.3 34.78 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.647 1.179 . . . . 25.0 111.319 170.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.73 -156.15 13.45 Favored Glycine 0 N--CA 1.414 -2.808 0 CA-C-O 124.752 2.307 . . . . 25.0 111.37 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -129.76 168.1 17.81 Favored Pre-proline 0 C--O 1.264 1.86 0 CA-C-N 109.921 -3.139 . . . . 25.0 103.904 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -13.02 15.74 Favored 'Cis proline' 0 CA--C 1.555 1.527 0 N-CA-C 121.255 3.521 . . . . 25.0 121.255 -8.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 87.24 -34.96 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 124.971 1.308 . . . . 25.0 110.102 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -78.24 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.24 1.416 . . . . 25.0 108.542 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.99 163.98 52.0 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 119.289 -2.132 . . . . 25.0 110.181 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.6 -23.2 27.23 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 113.399 -3.934 . . . . 25.0 117.305 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.13 113.17 7.06 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 104.566 -2.383 . . . . 25.0 104.566 168.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.83 128.6 12.46 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 126.523 1.929 . . . . 25.0 114.597 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.83 -28.83 0.23 Allowed Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 120.603 3.001 . . . . 25.0 120.603 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -96.4 39.02 1.17 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 104.545 -2.391 . . . . 25.0 104.545 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.1 -47.34 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.559 0.744 . . . . 25.0 109.974 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.95 73.82 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.603 1.705 . . . . 25.0 115.603 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.4 p -91.97 -11.45 36.07 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.53 1.532 . . . . 25.0 113.7 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.57 31.82 21.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 112.247 -2.252 . . . . 25.0 112.818 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -20.47 76.45 Favored Glycine 0 C--O 1.267 2.182 0 C-N-CA 118.329 -1.891 . . . . 25.0 116.647 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.8 8.0 76.71 Favored Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 119.817 1.809 . . . . 25.0 112.32 173.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 mt -117.51 -172.84 2.31 Favored 'General case' 0 C--O 1.278 2.595 0 C-N-CA 126.679 1.992 . . . . 50.0 110.371 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -66.68 -14.04 62.0 Favored 'General case' 0 C--O 1.175 -2.824 0 C-N-CA 118.635 -1.226 . . . . 50.0 113.512 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.51 73.13 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 106.973 -2.451 . . . . 25.0 106.973 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.14 -11.26 84.58 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 124.461 2.145 . . . . 25.0 117.283 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -79.77 -32.19 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.375 0 CA-C-O 125.891 2.758 . . . . 25.0 107.126 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.48 -17.55 51.29 Favored 'General case' 0 CA--C 1.468 -2.181 0 CA-C-N 113.267 -1.788 . . . . 75.0 109.41 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.15 2.53 2.11 Favored 'General case' 0 C--O 1.197 -1.662 0 CA-C-O 123.928 1.823 . . . . 50.0 115.832 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -85.52 40.98 0.87 Allowed 'General case' 0 C--O 1.263 1.788 0 O-C-N 120.285 -1.509 . . . . 25.0 107.998 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.47 49.25 0.48 Allowed 'General case' 0 C--O 1.262 1.757 0 N-CA-C 105.847 -1.909 . . . . 25.0 105.847 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.8 t -147.01 157.3 43.58 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 126.747 2.019 . . . . 25.0 108.194 -162.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -31.41 67.46 Favored 'General case' 0 C--O 1.261 1.687 0 N-CA-C 102.177 -3.268 . . . . 25.0 102.177 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -88.19 21.11 2.91 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 120.308 -0.557 . . . . 25.0 109.671 -171.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -68.62 98.53 0.89 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 125.602 2.62 . . . . 25.0 103.946 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -33.78 144.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 1 CA-C-N 105.865 -5.152 . . . . 25.0 113.416 165.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -66.94 134.49 52.11 Favored 'General case' 0 C--O 1.263 1.767 0 O-C-N 125.233 1.583 . . . . 50.0 107.098 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -80.57 153.65 27.94 Favored 'General case' 0 CA--C 1.483 -1.598 0 O-C-N 120.589 -1.32 . . . . 25.0 110.481 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -136.93 143.3 42.83 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 117.29 2.33 . . . . 25.0 117.29 157.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.84 134.27 39.82 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.705 0 N-CA-C 105.406 -2.072 . . . . 25.0 105.406 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 66.3 mtm -144.32 146.92 32.87 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 118.624 -2.547 . . . . 25.0 105.895 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 p -86.58 171.55 10.94 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 124.143 1.925 . . . . 25.0 108.079 168.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.26 -173.77 17.09 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 124.455 2.142 . . . . 25.0 115.502 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.84 -176.7 38.03 Favored Glycine 0 C--O 1.266 2.106 0 N-CA-C 108.006 -2.038 . . . . 25.0 108.006 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -66.55 149.37 50.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 116.344 -1.789 . . . . 25.0 110.843 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -147.24 137.43 23.26 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 126.679 2.487 . . . . 25.0 105.675 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -93.61 105.96 17.97 Favored 'General case' 0 CA--C 1.479 -1.774 0 O-C-N 126.532 2.395 . . . . 25.0 105.152 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -76.64 142.23 40.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 103.061 -2.94 . . . . 50.0 103.061 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -136.46 103.28 5.21 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 118.385 -2.697 . . . . 25.0 106.75 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -100.78 126.7 47.37 Favored 'General case' 0 C--O 1.177 -2.754 0 N-CA-C 102.688 -3.079 . . . . 25.0 102.688 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -123.33 120.63 33.63 Favored 'General case' 0 C--O 1.175 -2.818 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -113.5 153.76 28.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.905 -1.498 . . . . 50.0 109.022 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 t -116.31 8.24 14.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 126.573 2.421 . . . . 25.0 113.271 174.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.91 119.39 25.86 Favored Pre-proline 0 C--N 1.349 0.586 0 C-N-CA 128.084 2.554 . . . . 25.0 111.451 -167.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -68.6 -37.94 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 124.922 2.011 . . . . 25.0 116.11 160.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -68.28 139.56 55.96 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 123.224 1.488 . . . . 25.0 110.857 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -78.68 129.74 35.06 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 112.887 -1.96 . . . . 25.0 113.479 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -93.05 164.02 13.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.067 -1.646 . . . . 25.0 108.918 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -96.7 -49.94 4.89 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 120.698 -1.251 . . . . 25.0 110.185 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -166.46 170.88 12.45 Favored 'General case' 0 C--O 1.262 1.738 0 CA-C-O 118.354 -0.831 . . . . 25.0 110.758 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -144.13 153.06 41.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.096 -0.954 . . . . 25.0 109.315 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -131.16 142.59 50.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.832 -2.655 . . . . 25.0 103.832 -164.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -142.36 135.44 28.61 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 117.512 -3.242 . . . . 50.0 113.002 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -146.38 167.16 24.28 Favored 'General case' 0 C--O 1.163 -3.495 0 O-C-N 119.546 -1.971 . . . . 50.0 111.105 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -120.1 173.97 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 125.933 2.02 . . . . 25.0 113.369 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -135.56 154.12 51.47 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 124.063 0.852 . . . . 25.0 112.711 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -137.81 100.77 4.27 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.388 1.625 . . . . 25.0 115.388 -165.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -42.86 162.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 120.73 3.604 . . . . 25.0 120.73 157.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.1 28.5 Favored Glycine 0 N--CA 1.488 2.113 0 CA-C-O 126.056 3.031 . . . . 25.0 107.763 165.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -67.62 160.89 26.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.06 -2.07 . . . . 25.0 114.067 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.02 111.75 20.43 Favored Pre-proline 0 C--O 1.194 -1.816 0 N-CA-C 107.127 -1.434 . . . . 25.0 107.127 155.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -64.35 -24.48 64.59 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 C-N-CA 123.671 2.914 . . . . 25.0 114.855 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.23 -15.99 50.5 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.379 1.049 . . . . 75.0 113.195 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -71.88 161.79 76.8 Favored Pre-proline 0 N--CA 1.483 1.199 0 CA-C-O 116.884 -1.531 . . . . 25.0 108.584 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -54.08 31.16 0.02 OUTLIER 'Trans proline' 0 CA--C 1.574 2.485 2 C-N-CA 126.302 4.668 . . . . 25.0 122.66 160.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -8.9 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 1 N-CA-C 122.386 4.217 . . . . 50.0 122.386 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.52 -16.83 64.44 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 117.118 -3.489 . . . . 25.0 109.586 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.26 -57.33 2.29 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 126.033 2.083 . . . . 25.0 106.955 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.76 -24.63 66.95 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.536 1.773 . . . . 25.0 115.299 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -69.88 -4.69 21.48 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-O 116.513 -1.708 . . . . 25.0 114.903 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -118.32 150.29 39.75 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 122.807 2.549 . . . . 50.0 110.011 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.81 149.64 38.9 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 119.823 -1.798 . . . . 25.0 111.382 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.1 tp -76.44 123.84 26.64 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 116.054 -1.927 . . . . 50.0 108.93 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.0 tt -95.29 -11.68 8.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.83 173.5 33.53 Favored Glycine 0 C--O 1.19 -2.633 0 N-CA-C 116.645 1.418 . . . . 25.0 116.645 164.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -157.32 132.12 8.73 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.344 -1.428 . . . . 25.0 111.295 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.44 130.32 18.02 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 105.033 -2.21 . . . . 50.0 105.033 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -82.56 163.87 16.56 Favored 'Trans proline' 0 C--N 1.372 1.769 0 CA-C-O 124.83 1.929 . . . . 25.0 116.229 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -82.87 136.05 34.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 113.732 -1.576 . . . . 25.0 108.426 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.7 32.14 11.5 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.9 1.68 . . . . 50.0 111.008 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.28 165.11 43.64 Favored Glycine 0 N--CA 1.425 -2.088 0 O-C-N 119.502 -1.999 . . . . 25.0 108.625 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 t -66.17 -38.31 21.4 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-O 116.241 -1.838 . . . . 25.0 112.872 -173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.24 160.94 23.19 Favored 'Trans proline' 0 C--N 1.38 2.231 1 C-N-CA 108.351 -7.299 . . . . 25.0 107.874 -170.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.37 -26.1 11.5 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 126.876 3.227 . . . . 25.0 114.08 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -66.91 2.83 1.26 Allowed 'General case' 0 CA--C 1.512 -0.49 1 N-CA-C 122.615 4.302 . . . . 25.0 122.615 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.03 5.48 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 121.438 3.866 . . . . 25.0 121.438 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.25 141.5 41.7 Favored 'General case' 0 C--O 1.276 2.499 0 N-CA-C 121.55 3.907 . . . . 25.0 121.55 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.18 -25.72 63.57 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 106.589 -1.634 . . . . 75.0 106.589 -165.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 t -90.37 127.79 36.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 O-C-N 117.819 -3.051 . . . . 25.0 110.583 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -125.64 155.44 40.81 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 117.014 2.227 . . . . 25.0 117.014 164.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -79.72 125.63 29.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 113.139 -3.315 . . . . 25.0 108.304 169.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.7 mm -124.38 129.03 74.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 123.582 2.901 . . . . 25.0 105.968 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -81.59 127.2 32.62 Favored 'General case' 0 C--O 1.276 2.462 0 O-C-N 120.472 -1.393 . . . . 50.0 113.399 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.64 116.27 61.3 Favored Pre-proline 0 CA--C 1.515 -0.4 0 C-N-CA 130.768 3.627 . . . . 25.0 105.842 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.57 158.3 58.26 Favored 'Trans proline' 0 C--O 1.193 -1.728 1 C-N-CA 111.925 -4.916 . . . . 25.0 115.848 175.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -115.86 9.26 14.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.268 1.509 . . . . 25.0 109.427 -170.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.23 -8.66 57.55 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.113 2.264 . . . . 50.0 117.113 -171.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -146.5 170.21 17.35 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.274 -2.491 . . . . 25.0 104.274 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -111.99 131.68 55.25 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 101.269 -3.604 . . . . 50.0 101.269 160.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -176.08 164.4 34.37 Favored Glycine 0 C--N 1.302 -1.357 0 CA-C-O 124.756 2.309 . . . . 25.0 113.649 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.15 139.75 34.17 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.569 -1.548 . . . . 50.0 111.125 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -154.69 159.62 40.86 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 104.884 -2.265 . . . . 25.0 104.884 -171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.54 134.54 66.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 113.781 -3.009 . . . . 50.0 112.839 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.6 mt -110.01 130.18 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 O-C-N 127.453 2.97 . . . . 25.0 106.553 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.51 143.18 50.8 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 103.324 -2.843 . . . . 50.0 103.324 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.61 153.1 49.94 Favored 'General case' 0 C--O 1.257 1.455 0 N-CA-C 104.723 -2.325 . . . . 25.0 104.723 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.82 135.66 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-N 113.7 -1.591 . . . . 50.0 107.258 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.49 124.97 31.26 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-N 119.782 1.174 . . . . 25.0 110.067 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 143.58 34.31 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 125.274 1.609 . . . . 25.0 112.853 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -99.32 135.19 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 123.901 1.81 . . . . 50.0 111.159 174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 -34.14 20.81 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.3 -1.5 . . . . 25.0 111.691 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -72.96 -17.59 61.46 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 124.872 1.358 . . . . 25.0 110.32 -171.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 p -146.06 179.26 7.61 Favored 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 109.204 -0.665 . . . . 25.0 109.204 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -87.02 9.98 17.89 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-O 122.571 1.177 . . . . 25.0 111.873 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -73.6 150.78 41.16 Favored 'General case' 0 C--O 1.281 2.733 0 CA-C-O 123.118 1.437 . . . . 25.0 110.291 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.33 160.16 43.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 103.017 -2.957 . . . . 25.0 103.017 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -145.23 173.78 11.65 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.022 -1.844 . . . . 50.0 106.022 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.48 149.07 46.54 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 105.588 -2.005 . . . . 50.0 105.588 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.67 145.2 42.35 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 121.409 1.913 . . . . 25.0 108.192 -173.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.6 p -141.64 145.33 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 CA-C-N 119.399 1.0 . . . . 75.0 111.929 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.11 134.41 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 103.65 -2.722 . . . . 25.0 103.65 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.53 135.25 33.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.899 -1.046 . . . . 25.0 110.767 169.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.41 133.2 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 119.398 -2.064 . . . . 50.0 111.758 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -106.45 89.96 3.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 102.353 -3.203 . . . . 25.0 102.353 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.48 118.97 32.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.578 -1.646 . . . . 50.0 107.007 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.38 157.61 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 123.989 1.852 . . . . 50.0 114.21 -170.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -74.23 143.83 44.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 100.38 -3.933 . . . . 25.0 100.38 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 CA--C 1.55 0.97 0 C-N-CA 126.768 2.027 . . . . 25.0 108.521 -175.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 123.279 1.514 . . . . 25.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.43 -149.13 28.63 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 117.477 1.751 . . . . 25.0 117.477 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.19 133.68 40.2 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.121 1.368 . . . . 50.0 108.726 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.71 120.85 35.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 119.809 1.186 . . . . 25.0 108.268 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -98.2 -29.46 13.2 Favored 'General case' 0 C--O 1.281 2.733 0 C-N-CA 125.079 1.352 . . . . 25.0 112.816 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -153.31 146.79 18.12 Favored Pre-proline 0 CA--C 1.559 1.298 1 N-CA-C 98.742 -4.54 . . . . 25.0 98.742 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.38 131.11 8.81 Favored 'Cis proline' 0 C--N 1.311 -1.436 0 C-N-CA 131.058 1.691 . . . . 25.0 115.743 15.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.47 177.29 44.39 Favored Glycine 0 C--O 1.192 -2.494 0 N-CA-C 118.632 2.213 . . . . 25.0 118.632 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -103.58 125.65 50.24 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 105.201 -2.148 . . . . 25.0 105.201 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -61.93 -34.0 75.29 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 123.789 0.681 . . . . 25.0 109.74 170.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.09 -33.13 73.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 116.718 -1.993 . . . . 25.0 111.284 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.69 78.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.248 -0.908 . . . . 25.0 111.665 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mp -80.12 -30.65 39.08 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-O 122.277 1.037 . . . . 75.0 111.362 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -65.28 -25.49 67.67 Favored 'General case' 0 C--O 1.269 2.087 0 O-C-N 121.517 -0.739 . . . . 25.0 111.288 172.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.5 t -70.45 140.75 52.04 Favored 'General case' 0 CA--C 1.47 -2.116 0 O-C-N 119.159 -2.213 . . . . 25.0 105.495 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -66.45 -11.35 51.58 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 116.557 -1.687 . . . . 25.0 110.717 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.41 -37.6 85.58 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 120.863 1.665 . . . . 25.0 109.634 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -79.54 -38.47 34.12 Favored 'General case' 0 C--O 1.208 -1.086 0 O-C-N 120.652 -1.28 . . . . 50.0 111.074 169.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.06 17.91 9.8 Favored Glycine 0 C--N 1.362 1.988 0 N-CA-C 116.419 1.328 . . . . 25.0 116.419 -152.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -59.21 -41.69 89.2 Favored 'General case' 0 C--O 1.176 -2.788 0 O-C-N 120.054 -1.85 . . . . 50.0 114.77 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.06 -15.2 62.96 Favored 'General case' 0 CA--C 1.467 -2.22 0 O-C-N 118.631 -2.543 . . . . 50.0 115.959 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -109.99 175.54 5.4 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 124.604 1.162 . . . . 25.0 111.753 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mp -55.81 151.96 10.52 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 119.568 -1.957 . . . . 50.0 115.449 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -35.7 -43.12 0.27 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.41 3.115 . . . . 25.0 119.41 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 t -146.45 6.53 0.97 Allowed 'General case' 0 C--O 1.257 1.448 0 N-CA-C 117.143 2.275 . . . . 25.0 117.143 -169.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.52 82.62 0.22 Allowed Glycine 0 C--O 1.17 -3.845 0 CA-C-O 118.383 -1.232 . . . . 25.0 112.739 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.72 -10.89 0.12 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 118.174 2.657 . . . . 25.0 118.174 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 p -58.01 -22.2 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-N 120.634 1.561 . . . . 50.0 109.597 172.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -47.02 -22.45 0.34 Allowed 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 123.868 1.794 . . . . 25.0 115.741 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -62.5 -40.15 95.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.407 1.632 . . . . 50.0 115.407 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -143.12 46.18 0.67 Allowed Pre-proline 0 CA--C 1.473 -2.009 0 N-CA-C 119.044 2.979 . . . . 25.0 119.044 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.35 -30.7 29.73 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 O-C-N 116.918 -2.201 . . . . 25.0 113.513 -167.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -77.89 -1.07 29.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.374 1.99 . . . . 25.0 116.374 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.5 16.69 3.0 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 121.122 3.749 . . . . 25.0 121.122 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.78 114.64 18.85 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 125.39 2.519 . . . . 50.0 110.819 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -99.2 162.43 13.06 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 117.633 -3.167 . . . . 25.0 110.822 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.87 14.97 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.72 1.263 . . . . 25.0 112.388 -172.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -92.35 -172.61 3.15 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.401 1.572 . . . . 25.0 109.792 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.34 138.25 17.15 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 105.388 -2.078 . . . . 25.0 105.388 172.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.86 -5.8 0.53 Allowed Glycine 0 C--O 1.195 -2.312 0 O-C-N 128.042 3.339 . . . . 25.0 111.761 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -65.83 138.98 96.68 Favored Pre-proline 0 N--CA 1.477 0.914 0 CA-C-O 115.074 -2.393 . . . . 25.0 109.212 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.51 115.68 2.91 Favored 'Cis proline' 0 C--O 1.2 -1.405 0 O-C-N 125.966 2.561 . . . . 25.0 111.418 -2.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -60.14 -26.96 66.67 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 117.815 2.524 . . . . 25.0 117.815 -165.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.86 -39.3 53.46 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 116.985 2.216 . . . . 25.0 116.985 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.06 179.72 38.37 Favored Glycine 0 CA--C 1.563 3.063 0 O-C-N 120.539 -1.351 . . . . 25.0 113.803 -172.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -63.25 165.55 16.95 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 123.3 2.666 . . . . 25.0 106.028 166.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.99 133.55 32.63 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 119.416 3.117 . . . . 25.0 119.416 -166.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -64.08 150.92 44.46 Favored 'General case' 0 C--O 1.272 2.258 0 CA-C-N 114.447 -1.251 . . . . 25.0 109.464 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.97 -1.9 78.63 Favored Glycine 0 C--O 1.196 -2.23 1 CA-C-O 113.268 -4.073 . . . . 25.0 109.801 175.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -129.98 9.47 5.33 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 120.836 2.318 . . . . 25.0 108.574 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.49 -36.91 43.14 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.217 0 C-N-CA 124.648 1.179 . . . . 25.0 110.329 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.34 -48.36 23.42 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 120.945 -1.097 . . . . 25.0 112.142 -175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.5 p -136.12 -5.6 2.11 Favored 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 118.129 2.64 . . . . 25.0 118.129 -168.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 41.32 38.77 0.85 Allowed 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 126.98 2.112 . . . . 25.0 114.763 -163.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.37 -29.99 70.31 Favored Glycine 0 C--O 1.213 -1.184 0 O-C-N 120.621 -1.299 . . . . 25.0 109.951 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.02 -19.35 71.75 Favored Glycine 0 CA--C 1.553 2.458 0 O-C-N 120.95 -1.324 . . . . 25.0 116.171 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.73 -12.41 13.37 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 117.426 2.38 . . . . 50.0 117.426 173.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.83 -36.45 70.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 104.465 -2.42 . . . . 50.0 104.465 161.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.25 -20.62 75.24 Favored Glycine 0 C--O 1.269 2.285 0 CA-C-O 126.009 3.005 . . . . 25.0 108.53 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.52 -20.17 65.48 Favored Glycine 0 C--O 1.197 -2.214 0 O-C-N 116.841 -3.741 . . . . 25.0 115.189 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.8 mt -71.8 -46.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 111.793 -2.203 . . . . 25.0 105.645 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.96 -17.52 57.09 Favored 'General case' 0 CA--C 1.574 1.877 0 O-C-N 118.892 -2.38 . . . . 75.0 116.582 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -66.4 -29.25 69.37 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 123.805 1.764 . . . . 50.0 110.467 167.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.64 24.52 1.21 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.975 2.321 . . . . 25.0 113.983 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.6 48.78 1.43 Allowed 'General case' 0 C--O 1.25 1.114 0 O-C-N 119.52 -1.988 . . . . 25.0 110.951 157.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.271 13.7 t -133.56 174.94 9.89 Favored 'General case' 0 C--O 1.216 -0.702 0 O-C-N 125.365 1.666 . . . . 25.0 111.642 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.68 -17.39 59.97 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 123.849 1.785 . . . . 25.0 107.877 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -89.69 32.38 0.89 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 112.43 -2.168 . . . . 25.0 112.041 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -81.84 84.63 6.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 125.258 2.456 . . . . 25.0 116.354 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -40.06 150.83 0.05 Allowed 'General case' 0 C--O 1.292 3.293 1 CA-C-N 107.438 -4.437 . . . . 25.0 113.077 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -66.32 152.35 45.16 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 105.507 -2.034 . . . . 50.0 105.507 -167.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.51 151.48 27.52 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.79 132.39 28.81 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 117.321 2.341 . . . . 25.0 117.321 168.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -90.0 133.98 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 117.409 -1.281 . . . . 25.0 108.936 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.4 ttt -150.02 142.65 24.54 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 120.359 1.436 . . . . 25.0 111.189 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.2 p -79.35 166.95 21.53 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.285 0.846 . . . . 25.0 113.285 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 147.73 45.45 Favored Glycine 0 C--O 1.257 1.578 0 O-C-N 118.535 -2.603 . . . . 25.0 114.002 172.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.99 -166.04 33.38 Favored Glycine 0 CA--C 1.572 3.599 0 O-C-N 119.693 -2.063 . . . . 25.0 108.658 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -65.44 136.94 57.09 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.13 -1.806 . . . . 25.0 109.848 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -121.15 148.96 43.51 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 103.45 -2.796 . . . . 25.0 103.45 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -122.39 126.2 47.5 Favored 'General case' 0 C--O 1.201 -1.463 0 C-N-CA 124.807 1.243 . . . . 25.0 107.652 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -116.9 79.38 1.32 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 103.535 -2.765 . . . . 50.0 103.535 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -82.95 101.31 10.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.635 -1.166 . . . . 25.0 108.504 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -106.96 137.4 45.1 Favored 'General case' 0 CA--C 1.556 1.187 1 N-CA-C 99.708 -4.182 . . . . 25.0 99.708 173.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 t -151.13 143.46 24.17 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 123.787 1.756 . . . . 25.0 113.671 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -143.11 170.32 15.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 117.791 -1.1 . . . . 50.0 108.593 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . 0.287 9.1 t -72.13 -30.66 65.25 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 124.681 2.182 . . . . 25.0 112.737 175.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.47 152.81 69.79 Favored Pre-proline 0 C--O 1.262 1.721 0 O-C-N 116.78 -3.7 . . . . 25.0 109.062 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.46 161.45 42.38 Favored 'Trans proline' 0 C--O 1.282 2.677 0 C-N-CA 115.61 -2.46 . . . . 25.0 108.52 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -126.06 162.33 25.56 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 117.557 -3.215 . . . . 25.0 112.905 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.41 124.98 23.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 105.026 -2.213 . . . . 25.0 105.026 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -147.12 150.84 35.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 169.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.0 p -94.53 -31.14 14.05 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 120.447 1.476 . . . . 25.0 109.442 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . 0.261 7.2 tt0 -158.54 160.88 37.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 118.604 0.638 . . . . 25.0 109.396 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -142.91 148.93 37.75 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 123.784 1.754 . . . . 25.0 106.815 166.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.96 151.8 51.17 Favored 'General case' 0 C--N 1.27 -2.876 0 O-C-N 119.089 -2.257 . . . . 25.0 108.871 -169.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.21 130.07 45.83 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 105.104 -2.184 . . . . 50.0 105.104 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.43 155.83 23.57 Favored 'General case' 0 C--O 1.182 -2.468 0 CA-C-N 111.857 -2.428 . . . . 50.0 104.512 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.1 pt -134.62 155.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-N 112.129 -2.305 . . . . 25.0 112.291 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.729 ' HG1' ' H ' ' A' ' 147' ' ' VAL . 15.1 p -70.63 156.88 38.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 124.523 2.106 . . . . 25.0 115.108 168.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -130.68 95.43 3.85 Favored 'General case' 0 C--O 1.188 -2.132 0 O-C-N 116.988 -3.57 . . . . 25.0 114.922 173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -68.9 157.07 37.37 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 107.869 -1.16 . . . . 25.0 107.869 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.55 37.75 89.9 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-O 126.077 3.043 . . . . 25.0 110.985 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -67.16 159.84 28.09 Favored 'General case' 0 C--O 1.267 1.987 0 CA-C-O 125.686 2.66 . . . . 25.0 110.777 -171.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -67.46 123.89 87.79 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-N 111.958 -2.383 . . . . 25.0 107.279 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.53 -17.67 20.63 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 117.923 2.24 . . . . 25.0 117.923 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.71 8.44 39.22 Favored 'General case' 0 C--O 1.253 1.252 0 O-C-N 119.696 -1.877 . . . . 75.0 108.407 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -122.18 162.42 37.62 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 112.203 -2.271 . . . . 25.0 114.596 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.88 95.0 1.06 Allowed 'Trans proline' 0 CA--C 1.463 -3.04 0 N-CA-C 117.052 1.905 . . . . 25.0 117.052 -168.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -21.34 -60.76 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 127.064 2.146 . . . . 50.0 116.355 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -77.47 3.33 13.68 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 119.1 -2.25 . . . . 25.0 113.735 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.258 84.2 mtt180 -119.99 -42.19 2.61 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 127.422 2.289 . . . . 25.0 110.868 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.93 -15.74 5.47 Favored 'General case' 0 C--O 1.283 2.84 0 O-C-N 119.812 -1.805 . . . . 25.0 111.833 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -98.58 17.02 20.09 Favored 'General case' 0 C--O 1.271 2.192 0 N-CA-C 118.639 2.829 . . . . 25.0 118.639 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -144.85 161.28 39.67 Favored 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 118.762 -1.175 . . . . 50.0 107.898 168.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.79 158.59 43.84 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.71 137.74 35.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.049 -1.834 . . . . 50.0 106.049 164.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.287 16.7 tt -94.98 -26.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 116.268 -1.825 . . . . 25.0 111.964 169.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.92 156.12 13.65 Favored Glycine 0 N--CA 1.432 -1.58 0 O-C-N 124.893 1.371 . . . . 25.0 112.345 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.26 143.01 50.24 Favored 'General case' 0 N--CA 1.394 -3.251 0 CA-C-O 124.442 2.067 . . . . 25.0 108.351 170.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.4 96.53 48.06 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.325 -1.307 . . . . 50.0 108.173 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.97 159.23 50.84 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 114.056 -3.496 . . . . 25.0 110.601 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -139.91 47.74 1.82 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 115.629 1.715 . . . . 25.0 115.629 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -112.19 -24.86 9.6 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.767 -2.015 . . . . 50.0 107.143 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -160.89 40.21 0.43 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-O 124.925 2.403 . . . . 25.0 113.427 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -81.28 146.96 59.26 Favored Pre-proline 0 C--O 1.273 2.317 0 O-C-N 119.392 -2.24 . . . . 25.0 108.304 -154.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.466 ' HG2' ' HG ' ' A' ' 129' ' ' SER . 92.9 Cg_endo -73.57 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.768 1 C-N-CA 126.021 4.481 . . . . 25.0 107.031 169.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.6 -18.52 0.26 Allowed 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 121.081 3.734 . . . . 25.0 121.081 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.466 ' HG ' ' HG2' ' A' ' 127' ' ' PRO . 56.8 p -52.5 -9.41 0.11 Allowed 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 121.728 2.058 . . . . 25.0 114.582 162.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -60.03 -16.16 28.74 Favored 'General case' 0 N--CA 1.522 3.161 0 O-C-N 117.661 -3.149 . . . . 25.0 113.192 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.66 136.08 50.68 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 104.389 -2.449 . . . . 25.0 104.389 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -69.23 -24.83 64.06 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.504 -1.372 . . . . 75.0 111.196 -165.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.4 t -85.41 136.48 33.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 113.834 -1.53 . . . . 25.0 110.395 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.08 156.58 42.58 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 104.729 -2.323 . . . . 25.0 104.729 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -108.4 119.51 39.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 115.164 -2.351 . . . . 25.0 105.624 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.8 mm -118.42 119.23 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.312 0 C-N-CA 125.384 1.474 . . . . 25.0 111.19 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -77.16 133.77 38.86 Favored 'General case' 0 C--O 1.269 2.101 0 N-CA-C 105.022 -2.214 . . . . 50.0 105.022 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.3 mt -134.86 119.67 13.85 Favored Pre-proline 0 C--N 1.361 1.102 0 CA-C-O 122.908 1.337 . . . . 25.0 108.267 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.83 159.08 13.98 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 116.718 -1.721 . . . . 25.0 112.512 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -153.95 115.92 4.27 Favored 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.923 1.823 . . . . 25.0 115.923 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -105.95 -4.04 21.05 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 113.77 -1.559 . . . . 50.0 115.062 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -118.02 166.51 12.44 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 117.277 -3.389 . . . . 25.0 110.492 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.9 mp -116.55 136.6 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.947 -2.612 . . . . 50.0 103.947 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.97 174.18 25.47 Favored Glycine 0 C--N 1.306 -1.085 0 N-CA-C 119.913 2.725 . . . . 25.0 119.913 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.31 142.19 27.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.588 1.555 . . . . 50.0 108.268 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -146.25 162.73 37.44 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 104.672 -2.344 . . . . 25.0 104.672 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.729 ' H ' ' HG1' ' A' ' 100' ' ' THR . 96.9 t -127.64 136.81 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 123.828 3.013 . . . . 50.0 112.598 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.02 118.58 51.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.642 0 N-CA-C 105.439 -2.06 . . . . 25.0 105.439 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.5 130.76 44.55 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.417 2.056 . . . . 50.0 108.882 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -110.51 127.53 55.21 Favored 'General case' 0 C--O 1.246 0.902 0 O-C-N 120.145 -1.597 . . . . 25.0 109.704 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.87 132.73 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 O-C-N 126.083 2.114 . . . . 50.0 114.673 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 119.52 31.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.69 1.596 . . . . 25.0 109.304 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.42 72.08 4.42 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 126.294 2.246 . . . . 25.0 107.875 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.46 98.97 2.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.533 0 C-N-CA 117.51 -1.676 . . . . 50.0 111.164 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.68 -16.45 64.15 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.756 1.265 . . . . 25.0 113.804 -165.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -60.89 -32.99 72.42 Favored 'General case' 0 CA--C 1.601 2.913 0 CA-C-N 113.763 -1.562 . . . . 25.0 112.145 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.0 t -123.92 158.69 31.38 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.475 1.734 . . . . 25.0 110.019 -166.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.41 -23.73 58.99 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.18 165.05 7.74 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.751 1.019 . . . . 25.0 113.751 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.96 178.44 6.67 Favored 'General case' 0 C--O 1.209 -1.053 1 N-CA-C 98.25 -4.722 . . . . 25.0 98.25 175.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -126.22 130.43 50.93 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.891 -3.744 . . . . 50.0 100.891 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -135.33 138.67 43.63 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 126.15 1.78 . . . . 50.0 111.529 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -160.58 175.52 12.6 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 104.848 -2.278 . . . . 25.0 104.848 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 m -135.86 164.63 31.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 125.158 1.536 . . . . 75.0 107.392 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.0 mm -133.65 120.48 37.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 112.721 -2.036 . . . . 25.0 105.6 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -88.64 124.95 34.57 Favored 'General case' 0 C--O 1.262 1.753 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.518 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.68 158.1 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 117.077 2.251 . . . . 50.0 117.077 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.7 124.92 30.8 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 101.901 -3.37 . . . . 25.0 101.901 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 84.2 mt -114.07 130.53 56.56 Favored 'General case' 0 C--O 1.204 -1.34 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 -174.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.95 158.1 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 116.223 1.934 . . . . 50.0 116.223 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.7 132.38 35.18 Favored 'General case' 0 CA--C 1.585 2.311 0 O-C-N 125.842 1.964 . . . . 25.0 108.831 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.4 pttt . . . . . 0 CA--C 1.552 1.055 0 CA-C-O 118.235 -0.888 . . . . 25.0 110.884 -167.669 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.672 0.749 . . . . 25.0 111.349 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.35 179.71 27.32 Favored Glycine 0 C--O 1.267 2.203 0 C-N-CA 117.794 -2.146 . . . . 25.0 116.956 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -152.37 153.96 34.66 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.096 -2.414 . . . . 50.0 111.351 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.71 133.49 31.42 Favored 'Isoleucine or valine' 0 C--O 1.258 1.518 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 -163.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -120.29 -30.32 4.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.421 -1.312 . . . . 25.0 111.768 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.0 pttt -146.72 162.46 33.63 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 123.568 1.651 . . . . 25.0 107.148 151.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.69 148.95 87.33 Favored 'Cis proline' 0 N--CA 1.494 1.531 0 CA-C-O 123.439 1.35 . . . . 25.0 112.219 6.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.39 -175.69 52.55 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-O 126.013 3.007 . . . . 25.0 115.995 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.3 t -117.4 102.03 8.89 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 111.851 -2.175 . . . . 25.0 108.913 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -57.74 -31.93 66.95 Favored 'General case' 0 C--O 1.181 -2.533 0 O-C-N 123.784 0.678 . . . . 25.0 111.472 -169.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.67 65.58 Favored 'General case' 0 CA--C 1.558 1.269 0 O-C-N 118.365 -2.709 . . . . 25.0 111.925 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.11 -22.12 55.89 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.613 -1.625 . . . . 25.0 106.613 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt -74.83 -33.31 62.15 Favored 'General case' 0 C--O 1.257 1.491 0 N-CA-C 114.049 1.129 . . . . 75.0 114.049 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.51 -49.74 14.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.881 -1.054 . . . . 25.0 113.522 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.5 m -61.63 163.15 7.44 Favored 'General case' 0 N--CA 1.512 2.644 0 C-N-CA 126.927 2.091 . . . . 25.0 114.328 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -68.62 -47.67 66.06 Favored 'General case' 0 C--O 1.287 3.041 0 CA-C-N 114.432 -1.258 . . . . 25.0 112.838 -167.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.38 -38.38 0.01 OUTLIER 'General case' 0 C--O 1.201 -1.465 0 O-C-N 125.65 1.844 . . . . 25.0 111.859 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -89.54 17.73 6.07 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 125.962 1.705 . . . . 50.0 113.082 -152.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.4 29.75 15.89 Favored Glycine 0 CA--C 1.457 -3.559 0 CA-C-O 113.655 -3.858 . . . . 25.0 114.138 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . 0.26 36.4 t80 31.65 47.66 0.07 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 126.462 1.919 . . . . 50.0 115.145 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.48 -27.29 56.04 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 104.704 -2.332 . . . . 50.0 104.704 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -123.7 160.53 27.01 Favored 'General case' 0 C--O 1.297 3.601 0 N-CA-C 108.723 -0.843 . . . . 25.0 108.723 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.56 164.02 27.22 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 126.157 2.161 . . . . 50.0 107.103 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -179.3 -23.85 0.0 OUTLIER 'General case' 0 C--O 1.27 2.14 0 C-N-CA 124.547 1.139 . . . . 25.0 113.568 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 t -96.66 -6.11 37.35 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 119.508 3.151 . . . . 25.0 119.508 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.31 127.41 4.87 Favored Glycine 0 CA--C 1.486 -1.749 0 N-CA-C 108.088 -2.005 . . . . 25.0 108.088 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -60.46 -15.89 31.17 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 113.9 -1.15 . . . . 25.0 112.901 -172.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.37 -20.96 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 O-C-N 124.158 0.911 . . . . 50.0 110.005 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.1 ptm -53.82 -22.28 9.29 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.849 0.859 . . . . 25.0 112.86 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.91 -53.72 55.03 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 118.271 -2.768 . . . . 50.0 111.595 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.93 67.83 41.89 Favored Pre-proline 0 CA--C 1.566 1.58 0 O-C-N 118.88 -2.387 . . . . 25.0 115.813 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.07 -11.49 22.02 Favored 'Trans proline' 0 C--O 1.206 -1.086 0 C-N-CA 124.449 3.433 . . . . 25.0 117.252 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 -8.15 30.21 Favored 'General case' 0 C--O 1.159 -3.663 0 N-CA-C 114.244 1.201 . . . . 25.0 114.244 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -70.44 50.83 0.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 119.412 3.115 . . . . 25.0 119.412 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.15 132.82 46.43 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.198 -1.408 . . . . 50.0 107.198 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 161.92 19.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 120.719 1.6 . . . . 25.0 110.615 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.2 41.42 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-O 115.499 -2.191 . . . . 25.0 108.272 161.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -112.43 142.99 44.3 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 121.962 2.164 . . . . 25.0 113.389 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -76.82 150.22 36.14 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 117.987 -2.946 . . . . 25.0 104.487 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.21 148.86 6.23 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 106.242 -2.743 . . . . 25.0 106.242 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -134.82 146.1 57.44 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 117.959 -1.019 . . . . 25.0 111.526 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.85 -19.31 7.27 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 121.299 -2.375 . . . . 25.0 113.547 -8.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -144.5 -27.48 0.5 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 116.982 -1.887 . . . . 25.0 113.248 160.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 51.49 -87.94 0.01 OUTLIER 'General case' 0 C--O 1.246 0.894 0 O-C-N 119.603 -1.935 . . . . 25.0 113.278 -167.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.24 -172.26 18.5 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 109.569 -1.412 . . . . 25.0 109.569 175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -64.69 157.62 54.86 Favored 'Trans proline' 0 CA--C 1.554 1.509 0 CA-C-N 121.208 2.504 . . . . 25.0 116.794 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.64 91.9 0.83 Allowed 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 114.074 1.138 . . . . 25.0 114.074 -174.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -123.19 158.58 30.49 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 101.183 -3.636 . . . . 25.0 101.183 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.58 11.79 60.3 Favored Glycine 0 N--CA 1.48 1.604 0 O-C-N 128.637 3.71 . . . . 25.0 110.094 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.41 ' HA ' ' HG ' ' A' ' 53' ' ' SER . 17.8 mm100 -73.61 -22.79 59.91 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 118.669 2.84 . . . . 25.0 118.669 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 mm -86.79 -36.92 10.76 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.307 0 CA-C-N 114.026 -1.443 . . . . 25.0 108.597 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.67 86.98 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 118.204 -1.398 . . . . 25.0 113.589 170.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.41 ' HG ' ' HA ' ' A' ' 50' ' ' GLN . 60.0 p -70.29 -6.41 34.77 Favored 'General case' 0 C--O 1.184 -2.376 0 O-C-N 123.723 0.64 . . . . 25.0 112.332 173.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.282 . . 47.86 24.34 0.57 Allowed 'General case' 0 C--O 1.251 1.141 1 N-CA-C 125.992 5.553 . . . . 25.0 125.992 -173.228 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.49 -21.14 52.54 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 113.311 -1.768 . . . . 25.0 113.561 168.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.36 15.99 58.38 Favored Glycine 0 CA--C 1.474 -2.475 0 CA-C-O 116.078 -2.512 . . . . 25.0 116.904 -173.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.13 -19.77 39.36 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 122.295 3.048 . . . . 50.0 117.509 -161.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.34 -25.75 46.55 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.325 -2.843 . . . . 50.0 103.325 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.82 -17.92 62.52 Favored Glycine 0 C--O 1.209 -1.445 0 CA-C-O 125.286 2.604 . . . . 25.0 112.578 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.9 -25.28 71.89 Favored Glycine 0 CA--C 1.561 2.948 0 O-C-N 118.684 -2.656 . . . . 25.0 111.821 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.23 -38.03 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.14 -32.53 63.2 Favored 'General case' 0 C--O 1.198 -1.615 0 N-CA-C 104.95 -2.241 . . . . 75.0 104.95 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -68.47 -34.82 76.61 Favored 'General case' 0 C--O 1.264 1.834 0 N-CA-C 116.807 2.151 . . . . 50.0 116.807 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -76.65 16.42 0.51 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 125.789 2.709 . . . . 25.0 114.687 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -126.38 82.64 2.09 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 101.946 -3.353 . . . . 25.0 101.946 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -163.39 166.18 23.16 Favored 'General case' 0 CA--C 1.479 -1.784 0 O-C-N 123.636 0.585 . . . . 25.0 111.839 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -66.46 -29.43 69.56 Favored 'General case' 0 C--O 1.196 -1.754 0 O-C-N 117.448 -3.282 . . . . 25.0 109.977 171.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -82.04 21.88 0.84 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 112.876 -1.966 . . . . 25.0 112.66 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -74.0 97.34 2.83 Favored 'General case' 0 C--O 1.171 -3.054 0 CA-C-O 127.312 3.434 . . . . 25.0 109.649 158.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.1 p90 -29.64 135.41 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.375 1 CA-C-N 107.502 -4.408 . . . . 25.0 112.393 160.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -63.5 152.34 38.77 Favored 'General case' 0 C--O 1.268 2.037 0 N-CA-C 116.302 1.964 . . . . 50.0 116.302 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -101.56 162.01 13.22 Favored 'General case' 0 CA--C 1.479 -1.773 0 CA-C-N 113.513 -1.676 . . . . 25.0 111.576 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -153.47 146.41 24.47 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 124.472 1.109 . . . . 25.0 109.813 164.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.37 135.16 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 106.412 -1.699 . . . . 25.0 106.412 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.1 mtp -137.52 158.28 44.72 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 109.095 -0.706 . . . . 25.0 109.095 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.3 p -120.2 167.02 12.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.41 -164.98 40.36 Favored Glycine 0 C--O 1.266 2.105 0 C-N-CA 119.821 -1.181 . . . . 25.0 111.819 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.85 -173.66 32.24 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 120.573 -0.823 . . . . 25.0 111.104 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -82.02 141.71 32.99 Favored 'General case' 0 C--O 1.28 2.695 0 CA-C-O 124.071 1.891 . . . . 25.0 110.752 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.51 143.33 39.49 Favored 'General case' 0 C--O 1.19 -2.074 0 N-CA-C 104.133 -2.543 . . . . 25.0 104.133 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -98.56 126.14 44.04 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.273 -1.751 . . . . 25.0 106.273 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -110.85 150.73 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 116.179 -1.867 . . . . 50.0 106.154 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.607 ' HG1' ' HB2' ' A' ' 133' ' ' SER . 3.3 t -153.3 159.61 42.56 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 117.632 -1.175 . . . . 25.0 114.129 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -138.07 171.58 14.2 Favored 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.872 -3.01 . . . . 25.0 102.872 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 p -135.3 154.75 51.43 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.121 1.513 . . . . 25.0 107.94 153.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -94.02 154.2 17.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.902 0.858 . . . . 50.0 109.043 169.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.1 p -85.29 -27.02 26.24 Favored 'General case' 0 C--O 1.172 -2.98 0 O-C-N 120.396 -1.44 . . . . 25.0 111.691 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.67 141.66 13.89 Favored Pre-proline 0 CA--C 1.48 -1.739 0 N-CA-C 102.408 -3.182 . . . . 25.0 102.408 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.49 162.84 35.27 Favored 'Trans proline' 0 C--N 1.373 1.843 0 CA-C-O 123.507 1.378 . . . . 25.0 113.76 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.88 148.12 41.58 Favored 'General case' 0 CA--C 1.471 -2.059 0 CA-C-N 112.963 -1.926 . . . . 25.0 106.471 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -81.76 96.95 7.74 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 112.161 -2.291 . . . . 25.0 108.731 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.491 ' HG1' ' HE1' ' A' ' 152' ' ' TRP . 89.6 m -83.98 127.7 34.05 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 116.446 2.017 . . . . 25.0 116.446 -170.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 p -87.83 -42.27 12.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 118.335 -1.346 . . . . 25.0 110.486 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -168.29 168.21 11.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.068 -1.424 . . . . 25.0 109.866 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -140.66 164.65 29.6 Favored 'General case' 0 C--O 1.261 1.661 0 CA-C-N 123.199 2.727 . . . . 25.0 110.96 164.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -139.89 159.77 41.43 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 115.092 -2.385 . . . . 25.0 112.217 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.89 145.0 24.58 Favored 'General case' 0 C--O 1.246 0.901 0 O-C-N 124.951 1.407 . . . . 50.0 111.986 169.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -139.57 169.77 17.14 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 105.56 -2.015 . . . . 50.0 105.56 -172.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 pt -125.38 152.63 32.25 Favored 'Isoleucine or valine' 0 C--O 1.261 1.68 0 CA-C-O 123.791 1.758 . . . . 25.0 106.895 162.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.94 143.32 29.91 Favored 'General case' 0 C--N 1.387 2.206 0 N-CA-C 100.49 -3.892 . . . . 25.0 100.49 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -101.17 133.16 46.14 Favored 'General case' 0 C--O 1.183 -2.416 1 N-CA-C 100.085 -4.042 . . . . 25.0 100.085 -172.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -146.05 151.65 38.08 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 -163.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.21 37.13 9.25 Favored Glycine 0 C--O 1.202 -1.893 0 CA-C-O 125.087 2.493 . . . . 25.0 110.428 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -65.56 157.58 29.37 Favored 'General case' 0 CA--C 1.462 -2.413 0 C-N-CA 126.874 2.07 . . . . 25.0 114.908 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.97 123.05 89.15 Favored Pre-proline 0 CA--C 1.501 -0.942 1 O-C-N 115.438 -4.539 . . . . 25.0 108.937 155.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.77 -24.66 72.6 Favored 'Trans proline' 0 CA--C 1.499 -1.267 0 C-N-CA 115.017 -2.856 . . . . 25.0 117.102 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.96 -6.06 49.16 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 124.221 1.962 . . . . 75.0 113.854 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -56.1 161.95 3.34 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-N 112.663 -2.062 . . . . 25.0 112.254 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -77.55 70.37 6.9 Favored 'Trans proline' 0 C--O 1.175 -2.671 0 CA-C-O 125.972 2.405 . . . . 25.0 113.696 161.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 mt -46.63 -40.66 13.41 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 110.16 -3.2 . . . . 50.0 113.808 -168.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.79 -13.04 61.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 123.233 2.742 . . . . 25.0 115.42 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -117.78 -41.89 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 127.112 2.758 . . . . 25.0 111.627 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.22 -18.07 65.01 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 114.138 1.162 . . . . 25.0 114.138 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.35 33.45 1.4 Allowed 'General case' 0 C--N 1.316 -0.873 0 O-C-N 119.945 -1.722 . . . . 25.0 115.184 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -141.52 145.74 35.52 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.642 1.177 . . . . 50.0 108.538 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.45 142.61 50.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 115.309 1.596 . . . . 25.0 115.309 163.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.5 tp -77.76 137.96 38.74 Favored 'General case' 0 C--N 1.319 -0.753 1 N-CA-C 99.426 -4.287 . . . . 50.0 99.426 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.1 tt -124.52 -5.32 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 O-C-N 126.726 2.516 . . . . 25.0 108.902 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.12 170.31 37.28 Favored Glycine 0 C--O 1.273 2.576 0 N-CA-C 118.277 2.071 . . . . 25.0 118.277 154.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.99 145.6 24.24 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 123.449 1.595 . . . . 25.0 108.243 170.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -118.96 100.63 50.67 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 120.899 -1.125 . . . . 50.0 111.049 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.19 172.81 15.41 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 122.615 2.21 . . . . 25.0 108.398 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -133.88 48.17 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.819 -1.991 . . . . 25.0 108.358 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.7 -11.77 59.83 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 117.239 -1.784 . . . . 50.0 109.131 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 143.1 -171.79 24.84 Favored Glycine 0 C--N 1.294 -1.803 0 CA-C-O 116.927 -2.041 . . . . 25.0 113.091 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.0 154.27 0.12 Allowed Pre-proline 0 N--CA 1.428 -1.525 0 C-N-CA 129.127 2.971 . . . . 25.0 115.75 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.27 10.33 3.75 Favored 'Trans proline' 0 C--O 1.182 -2.277 1 C-N-CA 112.524 -4.517 . . . . 25.0 117.681 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.78 -25.92 62.21 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 119.711 -1.868 . . . . 25.0 109.165 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 81.3 p -71.61 -19.0 62.18 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 123.917 1.817 . . . . 25.0 111.67 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -72.46 -23.92 61.12 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 111.416 -2.629 . . . . 25.0 109.609 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.62 109.87 5.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 119.282 -2.136 . . . . 25.0 110.444 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.7 -36.22 14.46 Favored 'General case' 0 C--O 1.278 2.58 0 O-C-N 119.358 -2.088 . . . . 75.0 109.312 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.607 ' HB2' ' HG1' ' A' ' 83' ' ' THR . 42.7 t -73.73 131.66 41.83 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.176 0.99 . . . . 25.0 110.085 174.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.08 161.14 38.34 Favored 'General case' 0 C--O 1.275 2.429 0 CA-C-O 121.85 0.833 . . . . 25.0 109.293 -173.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -109.11 131.75 54.77 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.153 -0.931 . . . . 25.0 108.587 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.14 117.79 38.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -75.66 134.5 40.57 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 125.583 1.802 . . . . 50.0 106.971 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 18.1 mt -125.72 119.3 24.31 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 103.041 -2.948 . . . . 25.0 103.041 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.2 153.26 67.08 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 124.007 1.53 . . . . 25.0 112.361 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.29 50.98 0.78 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.201 1.477 . . . . 25.0 109.692 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.55 -35.4 75.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 118.606 2.817 . . . . 50.0 118.606 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -155.47 166.64 32.93 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.602 1.961 . . . . 25.0 112.861 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.6 mp -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 115.993 -0.549 . . . . 50.0 111.148 165.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 141.08 165.06 10.18 Favored Glycine 0 C--O 1.187 -2.842 0 C-N-CA 118.122 -1.99 . . . . 25.0 114.779 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.59 145.51 47.32 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 119.181 3.03 . . . . 50.0 119.181 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -142.9 157.37 44.65 Favored 'General case' 0 C--O 1.201 -1.478 0 N-CA-C 102.883 -3.006 . . . . 25.0 102.883 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.15 135.87 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 104.512 -2.403 . . . . 50.0 104.512 164.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.79 123.58 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 93.128 -6.619 . . . . 25.0 93.128 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 mp -106.29 145.03 32.14 Favored 'General case' 0 C--O 1.185 -2.292 0 C-N-CA 124.021 0.929 . . . . 50.0 109.647 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.36 45.88 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 115.971 -1.966 . . . . 25.0 113.619 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.52 128.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.265 1.911 0 O-C-N 125.006 1.442 . . . . 50.0 111.059 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.491 ' HE1' ' HG1' ' A' ' 92' ' ' THR . 2.4 t-105 -118.82 119.55 34.71 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 116.766 -1.588 . . . . 25.0 109.02 -177.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -92.35 135.6 33.89 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 103.704 -2.702 . . . . 25.0 103.704 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.6 t -118.46 126.81 75.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 104.154 -2.536 . . . . 50.0 104.154 -172.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.42 -16.97 63.0 Favored 'General case' 0 CA--C 1.476 -1.901 1 O-C-N 116.051 -4.156 . . . . 25.0 115.936 -166.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.19 -28.13 53.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 128.172 2.589 . . . . 25.0 112.753 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.3 p -134.75 164.8 26.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 116.775 2.139 . . . . 25.0 116.775 -158.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -95.1 -15.96 22.99 Favored 'General case' 0 C--O 1.184 -2.357 0 CA-C-O 124.47 2.081 . . . . 25.0 113.092 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -66.83 155.04 39.35 Favored 'General case' 0 C--O 1.287 3.04 0 O-C-N 118.86 -2.4 . . . . 25.0 111.084 155.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.82 140.74 22.84 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 103.354 -2.832 . . . . 25.0 103.354 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -83.78 165.67 18.64 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 105.119 -2.178 . . . . 50.0 105.119 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.12 160.58 43.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.853 -1.521 . . . . 50.0 109.241 164.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -147.65 154.2 40.32 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 116.787 -1.578 . . . . 25.0 110.416 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.5 m -138.85 128.28 31.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.56 -2.015 . . . . 75.0 105.56 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.8 mt -132.53 126.97 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.135 0 N-CA-C 106.262 -1.755 . . . . 25.0 106.262 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.97 135.3 33.72 Favored 'General case' 0 C--N 1.311 -1.086 1 O-C-N 115.773 -4.329 . . . . 25.0 108.813 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.86 134.96 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 O-C-N 117.246 -3.409 . . . . 50.0 102.802 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.42 99.11 12.02 Favored 'General case' 0 CA--C 1.554 1.102 0 O-C-N 119.769 -1.832 . . . . 25.0 106.192 171.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.33 128.43 35.49 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 121.696 2.044 . . . . 50.0 110.499 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.11 168.25 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . 0.312 26.1 t30 -83.07 146.82 28.49 Favored 'General case' 0 N--CA 1.385 -3.703 0 N-CA-C 106.775 -1.565 . . . . 25.0 106.775 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 CA--C 1.482 -1.651 0 CA-C-N 121.727 2.058 . . . . 25.0 110.042 170.757 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 161' ' ' PHE . 76.5 m80 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 125.118 2.389 . . . . 25.0 109.669 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.37 -161.38 14.22 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 112.712 -2.04 . . . . 25.0 108.257 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -149.96 162.71 39.82 Favored 'General case' 0 C--O 1.27 2.166 0 CA-C-N 114.138 -1.031 . . . . 50.0 110.703 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mm -85.16 139.14 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 O-C-N 125.554 1.784 . . . . 25.0 111.543 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.73 39.21 3.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 103.912 -2.625 . . . . 25.0 103.912 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 75.92 146.43 0.11 Allowed Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 127.451 2.3 . . . . 25.0 114.161 171.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.68 147.55 15.61 Favored 'Cis proline' 0 CA--C 1.491 -1.635 0 O-C-N 118.252 -1.499 . . . . 25.0 114.865 -18.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.07 33.38 6.04 Favored Glycine 0 C--O 1.187 -2.836 0 C-N-CA 124.867 1.222 . . . . 25.0 111.668 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.6 t -75.73 138.75 41.47 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 118.951 1.375 . . . . 25.0 108.266 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -85.39 -18.18 34.46 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 123.618 1.675 . . . . 25.0 106.568 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.79 80.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.12 -14.66 60.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.53 -0.731 . . . . 25.0 110.288 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.1 mt -92.18 -21.45 20.37 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 104.15 -2.537 . . . . 75.0 104.15 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.88 -25.29 21.07 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.109 -1.441 . . . . 25.0 107.109 -175.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.1 t -62.63 112.25 2.42 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 116.853 2.168 . . . . 25.0 116.853 173.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -73.36 -31.84 64.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.295 1.438 . . . . 25.0 107.213 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.79 92.03 Favored 'General case' 0 CA--C 1.581 2.166 0 O-C-N 120.836 -1.165 . . . . 25.0 110.209 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -47.89 -44.83 29.95 Favored 'General case' 0 C--O 1.275 2.445 0 N-CA-C 117.818 2.525 . . . . 50.0 117.818 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.68 19.86 32.79 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 104.111 -3.596 . . . . 25.0 104.111 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.8 t80 45.42 -50.55 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 121.727 3.973 . . . . 50.0 121.727 -165.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.71 -7.2 10.56 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.804 1.288 . . . . 50.0 112.701 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -122.97 153.86 39.19 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 117.65 -1.167 . . . . 25.0 108.448 -166.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -161.47 167.64 25.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.075 -2.195 . . . . 50.0 105.075 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.64 42.06 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 127.177 2.798 . . . . 25.0 117.435 -162.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -67.8 -22.92 65.16 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.375 0.88 . . . . 25.0 113.375 -166.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.82 95.01 1.05 Allowed Glycine 0 C--O 1.189 -2.687 0 C-N-CA 119.518 -1.325 . . . . 25.0 112.924 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 m -68.04 -9.28 44.66 Favored 'General case' 0 C--O 1.256 1.399 0 N-CA-C 114.544 1.313 . . . . 25.0 114.544 -171.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.65 -13.0 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 115.219 1.563 . . . . 50.0 115.219 169.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.5 ptm -70.11 18.39 0.05 Allowed 'General case' 0 C--O 1.199 -1.572 0 N-CA-C 120.718 3.599 . . . . 25.0 120.718 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.27 -43.29 95.3 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 119.172 -2.205 . . . . 50.0 112.162 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -145.05 62.6 9.22 Favored Pre-proline 0 C--O 1.275 2.415 0 N-CA-C 113.394 0.887 . . . . 25.0 113.394 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -15.64 47.03 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 116.325 -1.983 . . . . 25.0 112.817 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -66.06 -18.69 65.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.765 -1.835 . . . . 25.0 115.741 170.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -77.95 -4.42 46.83 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.584 0.707 . . . . 25.0 112.016 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.1 94.47 1.92 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 120.806 -1.184 . . . . 50.0 112.687 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -120.73 162.26 20.03 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 119.208 3.04 . . . . 25.0 119.208 -174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.25 170.94 15.22 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 104.804 -2.295 . . . . 25.0 104.804 -172.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -122.96 141.37 52.01 Favored 'General case' 0 C--O 1.275 2.42 0 O-C-N 124.89 1.369 . . . . 25.0 108.657 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -72.91 156.18 39.13 Favored 'General case' 0 C--O 1.197 -1.701 0 O-C-N 125.544 1.778 . . . . 25.0 109.142 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.58 -166.16 25.64 Favored Glycine 0 C--O 1.205 -1.663 0 N-CA-C 109.555 -1.418 . . . . 25.0 109.555 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -132.02 139.2 34.27 Favored Pre-proline 0 CA--C 1.573 1.859 0 O-C-N 128.072 2.866 . . . . 25.0 106.773 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.55 162.46 88.65 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 121.13 1.439 . . . . 25.0 114.867 -0.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -165.28 -2.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 117.371 2.36 . . . . 25.0 117.371 -168.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -32.12 -65.5 0.14 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 117.555 2.428 . . . . 25.0 117.555 -170.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.78 176.22 46.24 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 116.686 1.434 . . . . 25.0 116.686 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.64 -27.73 12.49 Favored 'Trans proline' 0 C--O 1.272 2.221 0 CA-C-O 118.666 -0.639 . . . . 25.0 113.006 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.26 156.5 20.24 Favored 'General case' 0 CA--C 1.479 -1.756 0 C-N-CA 124.634 1.173 . . . . 25.0 111.344 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -148.89 152.54 36.6 Favored 'General case' 0 C--O 1.26 1.606 0 N-CA-C 107.195 -1.409 . . . . 25.0 107.195 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.68 -21.27 33.81 Favored Glycine 0 C--O 1.215 -1.06 0 CA-C-O 117.118 -1.935 . . . . 25.0 115.352 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -135.48 47.22 2.31 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 127.237 2.215 . . . . 25.0 110.339 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.5 mm -72.73 -38.4 57.95 Favored 'Isoleucine or valine' 1 C--O 1.306 4.038 0 CA-C-N 114.146 -1.388 . . . . 25.0 110.602 -168.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.59 69.21 Favored 'General case' 0 C--O 1.167 -3.258 0 N-CA-C 116.276 1.954 . . . . 25.0 116.276 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.8 p -87.72 -4.57 58.9 Favored 'General case' 0 CA--C 1.565 1.537 0 O-C-N 119.552 -1.967 . . . . 25.0 112.796 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.45 37.03 11.11 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 119.861 1.21 . . . . 25.0 110.703 -169.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.49 -18.63 78.95 Favored Glycine 0 N--CA 1.412 -2.939 0 O-C-N 119.831 -1.793 . . . . 25.0 114.401 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.21 -2.21 89.33 Favored Glycine 0 C--O 1.26 1.758 0 CA-C-O 116.979 -2.011 . . . . 25.0 111.797 166.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 mt -111.42 -54.94 2.56 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 116.999 2.222 . . . . 50.0 116.999 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -74.99 -24.95 58.51 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 112.681 -2.054 . . . . 50.0 110.769 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.32 59.89 Favored Glycine 0 C--O 1.2 -2.002 0 O-C-N 127.294 2.871 . . . . 25.0 109.025 173.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.02 -30.45 78.03 Favored Glycine 0 C--N 1.358 1.797 0 N-CA-C 116.728 1.451 . . . . 25.0 116.728 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -80.41 -39.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.246 -2.502 . . . . 25.0 104.246 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.63 -27.4 66.85 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 126.631 1.973 . . . . 75.0 111.63 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.14 -10.45 59.77 Favored 'General case' 0 C--O 1.182 -2.456 0 O-C-N 121.169 -0.957 . . . . 50.0 109.469 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.71 -12.52 60.74 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 127.259 3.409 . . . . 25.0 112.979 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -148.55 69.15 1.09 Allowed 'General case' 0 C--O 1.277 2.501 0 CA-C-N 111.42 -2.627 . . . . 25.0 109.047 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.0 t -143.29 155.53 44.49 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 116.834 -1.555 . . . . 25.0 108.928 -170.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -55.0 -32.57 61.89 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 121.276 1.853 . . . . 25.0 114.624 158.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.53 -34.91 67.89 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 115.303 1.594 . . . . 25.0 115.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.314 24.8 ttp180 0.42 73.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.448 2.699 . . . . 25.0 116.458 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.16 149.3 45.66 Favored 'General case' 0 C--O 1.208 -1.112 1 CA-C-N 107.871 -4.24 . . . . 25.0 107.546 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -74.92 142.43 44.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.114 1.766 . . . . 50.0 114.139 -146.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 153.72 36.54 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 125.222 1.409 . . . . 25.0 111.107 -172.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -135.01 176.76 8.36 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 102.905 -2.998 . . . . 25.0 102.905 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -124.01 139.65 49.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 168.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . 0.267 60.6 mtp -143.94 171.24 14.52 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.683 1.128 . . . . 25.0 109.396 175.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.7 p -103.12 165.7 10.87 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.127 -1.608 . . . . 25.0 113.201 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.15 179.32 48.07 Favored Glycine 0 C--O 1.256 1.475 0 O-C-N 119.347 -2.096 . . . . 25.0 114.068 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.31 168.02 29.02 Favored Glycine 0 CA--C 1.542 1.757 0 CA-C-O 123.511 1.617 . . . . 25.0 112.849 -168.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.4 127.64 33.74 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.158 -2.217 . . . . 25.0 115.935 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.97 156.84 37.42 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m -103.72 141.04 36.76 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 112.37 -2.195 . . . . 25.0 108.904 166.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -123.66 149.08 45.86 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 115.695 -2.098 . . . . 50.0 105.606 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.8 m -132.25 138.19 47.81 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.373 -1.343 . . . . 25.0 107.373 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.84 161.04 24.81 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 103.02 -2.956 . . . . 25.0 103.02 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.0 t -140.16 137.11 34.15 Favored 'General case' 0 C--O 1.263 1.774 0 N-CA-C 106.799 -1.556 . . . . 25.0 106.799 160.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.36 125.76 50.7 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.569 1.548 . . . . 50.0 109.95 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -125.65 6.78 7.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 119.52 3.156 . . . . 25.0 119.52 -156.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . 0.313 . . -57.75 -63.38 3.89 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 114.512 -2.661 . . . . 25.0 117.111 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.29 176.86 37.44 Favored 'Cis proline' 0 CA--C 1.538 0.691 1 C-N-CA 136.676 4.032 . . . . 25.0 111.678 -9.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -131.02 164.35 25.6 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 102.84 -3.022 . . . . 25.0 102.84 165.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -89.11 150.04 22.91 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 105.125 -2.176 . . . . 25.0 105.125 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.4 m -137.84 134.82 35.58 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 107.733 -1.21 . . . . 25.0 107.733 -159.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 p -98.98 -34.27 10.5 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 117.437 -1.705 . . . . 25.0 110.978 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -156.03 151.22 26.6 Favored 'General case' 0 C--O 1.194 -1.841 0 C-N-CA 128.425 2.69 . . . . 25.0 111.492 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -137.96 136.27 36.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 119.452 -2.03 . . . . 25.0 108.459 150.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -142.72 163.43 32.84 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 117.861 -1.536 . . . . 25.0 111.701 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -149.43 141.29 23.7 Favored 'General case' 0 C--O 1.261 1.699 0 O-C-N 125.276 1.61 . . . . 50.0 114.259 -164.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -121.36 165.28 15.76 Favored 'General case' 0 C--O 1.183 -2.417 0 C-N-CA 126.535 1.934 . . . . 50.0 106.605 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.5 pt -127.3 159.69 37.28 Favored 'Isoleucine or valine' 0 C--O 1.261 1.681 0 CA-C-N 111.936 -2.393 . . . . 25.0 106.95 168.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.9 p -102.78 165.89 10.8 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 124.425 2.059 . . . . 25.0 105.699 156.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -105.63 -177.14 3.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 112.322 -2.217 . . . . 25.0 107.121 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -163.31 167.03 22.39 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.08 64.27 3.22 Favored Glycine 0 C--O 1.274 2.633 0 O-C-N 119.822 -1.798 . . . . 25.0 113.092 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.12 171.18 14.42 Favored 'General case' 0 C--O 1.193 -1.904 0 N-CA-C 116.38 1.993 . . . . 25.0 116.38 -166.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -85.39 110.92 32.89 Favored Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-O 117.1 -1.428 . . . . 25.0 110.974 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -57.99 -21.56 50.63 Favored 'Trans proline' 0 N--CA 1.447 -1.25 1 N-CA-C 123.68 4.454 . . . . 25.0 123.68 174.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.251 23.7 t70 -71.45 -17.83 62.35 Favored 'General case' 0 C--O 1.264 1.852 0 C-N-CA 116.151 -2.22 . . . . 75.0 114.032 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -72.01 161.12 80.52 Favored Pre-proline 0 C--N 1.38 1.921 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -41.01 22.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.542 2 C-N-CA 129.403 6.735 . . . . 25.0 124.373 161.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 53.7 mt -51.93 -35.57 46.17 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 116.507 -3.871 . . . . 50.0 116.991 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -68.11 -7.96 34.21 Favored 'General case' 0 C--O 1.198 -1.617 0 N-CA-C 115.046 1.499 . . . . 25.0 115.046 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -127.8 -60.3 1.17 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.453 -0.794 . . . . 25.0 110.074 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.1 -22.49 62.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 116.443 -1.741 . . . . 25.0 112.634 -168.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.8 20.8 18.07 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 127.042 2.713 . . . . 25.0 113.194 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -110.34 127.73 55.2 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 103.084 -2.932 . . . . 50.0 103.084 158.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.46 122.86 20.71 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.036 -1.865 . . . . 25.0 110.891 -169.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -62.25 117.62 6.32 Favored 'General case' 0 C--O 1.2 -1.522 0 N-CA-C 102.547 -3.131 . . . . 50.0 102.547 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.95 -11.14 9.3 Favored 'Isoleucine or valine' 0 C--O 1.265 1.919 0 CA-C-O 122.729 1.252 . . . . 25.0 112.594 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 174.83 30.1 Favored Glycine 0 C--N 1.365 2.192 0 N-CA-C 117.644 1.817 . . . . 25.0 117.644 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.81 155.13 43.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 128.612 3.183 . . . . 25.0 111.788 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.82 89.84 48.14 Favored Pre-proline 0 C--O 1.265 1.885 0 C-N-CA 128.682 2.793 . . . . 50.0 104.22 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.05 161.24 29.77 Favored 'Trans proline' 0 C--O 1.195 -1.674 1 C-N-CA 111.904 -4.93 . . . . 25.0 111.982 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -79.8 115.41 19.38 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.346 -1.741 . . . . 25.0 109.005 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -128.09 -8.11 5.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.147 1.339 . . . . 50.0 113.661 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.34 -15.67 62.82 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 115.762 1.065 . . . . 25.0 115.762 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -66.93 153.1 95.0 Favored Pre-proline 0 N--CA 1.492 1.652 1 N-CA-C 99.736 -4.172 . . . . 25.0 99.736 163.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.99 18.42 0.31 Allowed 'Trans proline' 0 CA--C 1.509 -0.76 0 N-CA-C 116.231 1.589 . . . . 25.0 116.231 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -31.87 68.04 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 154.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.1 m -76.02 -25.23 55.5 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-O 116.534 -1.698 . . . . 25.0 106.523 -172.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -82.6 -0.46 47.06 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 121.341 1.882 . . . . 25.0 115.851 176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -81.95 84.66 6.87 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.862 -1.135 . . . . 25.0 113.937 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.1 3.94 54.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.755 -1.566 . . . . 75.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.0 t -104.48 122.61 45.89 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 119.85 -1.781 . . . . 25.0 115.402 162.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -148.76 137.48 21.35 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.765 -1.569 . . . . 25.0 106.765 -154.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -84.34 132.67 34.58 Favored 'General case' 0 C--O 1.267 2.012 0 C-N-CA 126.022 1.729 . . . . 25.0 114.946 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.4 mt -131.06 124.82 56.62 Favored 'Isoleucine or valine' 0 C--O 1.262 1.754 0 O-C-N 119.739 -1.851 . . . . 25.0 107.445 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -77.67 126.03 30.25 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 112.913 0.708 . . . . 50.0 112.913 167.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.96 128.66 25.72 Favored Pre-proline 0 C--O 1.248 0.989 0 N-CA-C 102.476 -3.157 . . . . 25.0 102.476 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.99 157.96 53.52 Favored 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 112.587 -4.475 . . . . 25.0 112.658 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -101.34 36.87 1.9 Allowed 'General case' 0 C--O 1.211 -0.924 0 O-C-N 120.461 -1.399 . . . . 25.0 110.628 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -65.81 -46.65 77.84 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 119.765 3.246 . . . . 50.0 119.765 -167.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -150.9 173.32 14.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.213 2.205 . . . . 25.0 105.775 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.1 mp -84.83 169.0 14.59 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 101.497 -3.52 . . . . 50.0 101.497 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.78 176.53 22.35 Favored Glycine 0 CA--C 1.476 -2.362 0 CA-C-O 126.441 3.245 . . . . 25.0 113.014 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -93.17 163.98 13.42 Favored 'General case' 0 C--O 1.271 2.187 0 O-C-N 117.399 -3.413 . . . . 50.0 112.241 -164.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -162.16 173.44 14.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 127.442 2.297 . . . . 25.0 107.7 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.52 143.1 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.792 1.178 . . . . 50.0 113.894 174.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.0 mt -103.88 135.96 39.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 101.635 -3.469 . . . . 25.0 101.635 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -125.8 148.97 48.96 Favored 'General case' 0 C--O 1.187 -2.223 0 O-C-N 117.909 -2.995 . . . . 50.0 107.963 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.16 161.52 37.68 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 116.224 -1.846 . . . . 25.0 113.321 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.61 119.96 3.81 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 O-C-N 125.787 1.93 . . . . 50.0 106.162 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.13 117.63 31.76 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 127.169 2.188 . . . . 25.0 112.457 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.88 111.29 23.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 104.144 -2.539 . . . . 25.0 104.144 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.0 t -84.33 124.87 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.145 0 CA-C-O 124.118 1.913 . . . . 50.0 109.63 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.69 -24.13 62.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.107 -1.621 . . . . 25.0 111.309 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.09 -17.11 58.92 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 117.094 -1.842 . . . . 25.0 114.493 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.0 p -125.53 156.68 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 119.279 -2.138 . . . . 25.0 113.911 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.73 -29.61 69.63 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-O 122.641 1.21 . . . . 25.0 110.274 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -79.55 161.4 26.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 119.194 -2.191 . . . . 25.0 115.062 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.7 167.13 21.08 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 114.691 -1.141 . . . . 25.0 108.736 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 1' ' ' HIS . 63.2 m-85 -115.94 144.66 43.76 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.976 -1.12 . . . . 50.0 107.976 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -122.33 155.88 35.07 Favored 'General case' 0 C--O 1.242 0.707 0 O-C-N 125.84 1.963 . . . . 50.0 107.402 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -126.8 151.9 47.67 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.763 -1.562 . . . . 25.0 108.939 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.71 135.55 50.99 Favored 'Isoleucine or valine' 0 C--O 1.268 2.065 0 N-CA-C 105.91 -1.885 . . . . 75.0 105.91 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.6 mt -139.56 106.96 2.83 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 N-CA-C 105.642 -1.984 . . . . 25.0 105.642 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -84.71 131.41 34.58 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 120.247 -1.533 . . . . 25.0 113.837 174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.74 142.4 43.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 120.307 -1.496 . . . . 50.0 113.061 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -83.9 132.36 34.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 116.497 -1.716 . . . . 25.0 107.581 167.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.1 mt -126.4 131.51 51.72 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 103.146 -2.909 . . . . 50.0 103.146 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.0 171.51 17.58 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 105.683 -1.969 . . . . 50.0 105.683 -171.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.35 146.27 32.98 Favored 'General case' 0 C--O 1.283 2.844 0 O-C-N 120.972 -1.08 . . . . 25.0 111.575 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt . . . . . 0 C--O 1.289 3.17 0 CA-C-O 116.173 -1.87 . . . . 25.0 112.114 178.724 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.6 m80 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 118.228 -0.892 . . . . 25.0 108.666 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.67 -154.06 10.65 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 118.046 -2.026 . . . . 25.0 116.134 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.19 170.12 20.22 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 125.237 2.446 . . . . 50.0 105.956 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.7 mt -84.34 126.51 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 O-C-N 118.915 -2.366 . . . . 25.0 113.509 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -92.88 -28.3 16.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 116.204 1.927 . . . . 25.0 116.204 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -145.92 122.33 5.87 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 105.729 -1.952 . . . . 25.0 105.729 168.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.29 133.06 10.53 Favored 'Cis proline' 0 C--O 1.197 -1.551 0 C-N-CA 130.543 1.476 . . . . 25.0 113.116 -2.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.62 -88.99 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.805 -1.543 . . . . 25.0 116.146 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -54.5 134.4 46.23 Favored 'General case' 0 C--O 1.262 1.724 0 N-CA-C 114.811 1.412 . . . . 25.0 114.811 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 ttt-85 -118.86 -32.19 4.57 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 112.481 -2.145 . . . . 25.0 114.405 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.47 -24.06 62.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 116.788 2.144 . . . . 25.0 116.788 -172.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.19 60.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 124.437 2.065 . . . . 25.0 111.191 174.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 mt -80.05 -31.17 39.5 Favored 'General case' 0 N--CA 1.492 1.642 1 O-C-N 115.572 -4.455 . . . . 75.0 109.67 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -26.38 67.32 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 111.361 -2.654 . . . . 25.0 116.796 173.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 t -50.85 147.83 4.62 Favored 'General case' 0 C--O 1.283 2.842 0 CA-C-N 114.227 -1.351 . . . . 25.0 114.218 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -72.21 0.19 10.44 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 126.868 2.605 . . . . 25.0 113.302 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.45 4.74 1.63 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.557 1.17 . . . . 25.0 114.043 174.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -57.58 -27.65 62.9 Favored 'General case' 0 C--O 1.202 -1.431 0 O-C-N 118.906 -2.371 . . . . 50.0 113.478 152.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.02 20.4 0.1 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 116.324 1.29 . . . . 25.0 116.324 169.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 58.85 7.8 0.85 Allowed 'General case' 0 C--N 1.387 2.219 0 N-CA-C 117.016 2.228 . . . . 50.0 117.016 156.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.0 mt -74.09 -37.42 64.18 Favored 'General case' 0 C--O 1.286 2.987 0 O-C-N 121.309 -0.87 . . . . 50.0 109.719 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -152.87 177.95 10.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 128.039 2.536 . . . . 25.0 111.641 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.82 157.34 12.43 Favored 'General case' 0 C--O 1.255 1.381 0 N-CA-C 116.509 2.04 . . . . 50.0 116.509 161.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -138.8 14.24 2.69 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 110.965 -2.834 . . . . 25.0 113.271 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -85.72 -43.61 13.24 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 111.968 -2.378 . . . . 25.0 111.16 -164.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.19 72.73 1.22 Allowed Glycine 0 CA--C 1.493 -1.343 0 CA-C-O 116.113 -2.493 . . . . 25.0 116.345 -169.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 m -57.94 -10.69 1.89 Allowed 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 120.387 2.093 . . . . 25.0 114.728 -166.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.68 -10.56 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-N 119.301 0.955 . . . . 50.0 109.733 169.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -45.36 -18.91 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 117.681 2.474 . . . . 25.0 117.681 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -63.65 -38.44 91.14 Favored 'General case' 0 N--CA 1.432 -1.329 0 O-C-N 119.484 -2.01 . . . . 50.0 106.639 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.37 48.83 0.56 Allowed Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.371 1.248 . . . . 25.0 114.371 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.24 -19.99 21.83 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 O-C-N 116.571 -2.384 . . . . 25.0 117.449 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -83.83 -2.45 56.4 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 117.007 -1.473 . . . . 25.0 109.616 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.694 2.497 . . . . 25.0 113.722 -171.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.96 151.21 31.77 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 118.021 -2.925 . . . . 50.0 105.913 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -140.01 160.9 38.87 Favored 'General case' 0 C--O 1.186 -2.239 0 O-C-N 120.271 -1.518 . . . . 25.0 113.625 -170.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.79 149.8 35.01 Favored 'General case' 0 C--O 1.261 1.662 1 N-CA-C 99.912 -4.107 . . . . 25.0 99.912 163.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -91.33 146.16 24.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 105.06 -2.2 . . . . 25.0 105.06 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -76.98 162.97 27.14 Favored 'General case' 0 CA--C 1.579 2.075 0 O-C-N 126.382 2.301 . . . . 25.0 110.587 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.66 -176.73 16.76 Favored Glycine 0 CA--C 1.472 -2.623 1 N-CA-C 102.78 -4.128 . . . . 25.0 102.78 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -61.54 142.97 93.9 Favored Pre-proline 0 N--CA 1.395 -3.178 0 CA-C-N 120.618 2.209 . . . . 25.0 110.782 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -86.35 23.89 17.38 Favored 'Cis proline' 0 C--O 1.174 -2.684 1 C-N-CA 136.612 4.005 . . . . 25.0 120.475 -4.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -52.59 -34.4 50.53 Favored 'General case' 0 C--O 1.261 1.663 1 N-CA-C 122.686 4.328 . . . . 25.0 122.686 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -57.52 -38.15 74.18 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 118.69 -2.506 . . . . 25.0 114.675 167.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.34 -176.62 19.94 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.778 -1.101 . . . . 25.0 111.698 -174.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.4 168.09 23.39 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 CA-C-O 125.836 2.349 . . . . 25.0 110.795 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.95 94.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 119.772 3.249 . . . . 25.0 119.772 -168.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -119.25 166.12 13.38 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 123.765 1.745 . . . . 25.0 106.304 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.46 11.63 56.89 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-N 113.896 -1.502 . . . . 25.0 113.667 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -116.4 -11.78 11.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 116.248 1.944 . . . . 25.0 116.248 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.4 mt -67.78 -37.84 79.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.562 -0.903 . . . . 25.0 108.562 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.54 -10.3 24.98 Favored 'General case' 0 C--O 1.262 1.724 0 N-CA-C 116.102 1.89 . . . . 25.0 116.102 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.466 ' HG ' ' H ' ' A' ' 55' ' ' GLY . 62.7 p -113.37 -3.34 13.79 Favored 'General case' 0 C--O 1.184 -2.35 0 C-N-CA 125.797 1.639 . . . . 25.0 113.069 172.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.48 43.51 23.69 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.751 1.22 . . . . 25.0 113.252 -161.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.466 ' H ' ' HG ' ' A' ' 53' ' ' SER . . . -91.48 -7.87 64.68 Favored Glycine 0 C--O 1.203 -1.828 0 CA-C-N 113.902 -1.499 . . . . 25.0 111.342 158.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.16 23.56 11.12 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 125.267 1.413 . . . . 25.0 113.69 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.6 mt -88.51 34.66 0.76 Allowed 'General case' 0 C--O 1.251 1.133 0 CA-C-O 116.624 -1.655 . . . . 50.0 111.86 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -63.66 -25.96 68.45 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 107.007 -1.479 . . . . 50.0 107.007 142.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.86 -10.02 85.05 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 119.769 -1.832 . . . . 25.0 115.477 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.34 -2.31 47.97 Favored Glycine 0 C--O 1.286 3.386 0 N-CA-C 118.418 2.127 . . . . 25.0 118.418 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -63.2 -41.19 91.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 123.378 1.561 . . . . 25.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.04 -28.58 62.42 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 114.087 -1.415 . . . . 75.0 110.933 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -109.89 21.98 16.2 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-O 124.086 1.898 . . . . 50.0 113.971 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -75.84 41.72 0.22 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 120.991 3.7 . . . . 25.0 120.991 -170.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -138.12 45.6 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.767 -1.938 . . . . 25.0 105.767 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -143.31 -172.87 3.79 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.634 1.683 . . . . 25.0 110.784 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -61.48 -22.01 64.7 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.393 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -77.01 2.82 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 119.699 -1.876 . . . . 25.0 112.507 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -87.69 84.11 7.11 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 128.183 3.849 . . . . 25.0 112.918 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 148.87 34.78 Favored 'General case' 0 C--N 1.287 -2.117 1 CA-C-N 106.008 -5.087 . . . . 25.0 111.395 156.1 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -75.87 147.36 39.11 Favored 'General case' 0 C--O 1.188 -2.162 0 N-CA-C 105.911 -1.885 . . . . 50.0 105.911 -174.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -84.12 121.34 27.32 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -73.59 119.73 18.21 Favored 'General case' 0 CA--C 1.461 -2.477 0 C-N-CA 116.412 -2.115 . . . . 25.0 106.535 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.25 129.54 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 98.7 mmm -140.57 150.76 44.07 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 104.476 -2.416 . . . . 25.0 104.476 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -88.31 176.97 6.98 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 104.451 -2.425 . . . . 25.0 104.451 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.24 174.1 34.84 Favored Glycine 1 C--O 1.158 -4.628 0 N-CA-C 107.079 -2.409 . . . . 25.0 107.079 171.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.72 178.76 47.84 Favored Glycine 0 C--O 1.201 -1.911 0 C-N-CA 126.543 2.02 . . . . 25.0 112.851 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -72.81 141.37 48.02 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 114.417 -2.706 . . . . 25.0 114.006 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -132.6 156.55 46.68 Favored 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 105.974 -1.861 . . . . 25.0 105.974 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.4 m -89.18 107.59 19.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.741 -3.059 . . . . 25.0 102.741 -172.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.83 115.31 27.99 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 106.436 -1.69 . . . . 50.0 106.436 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.4 m -133.01 132.4 41.83 Favored 'General case' 0 C--O 1.267 1.976 0 N-CA-C 108.501 -0.926 . . . . 25.0 108.501 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -117.48 170.06 9.03 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 106.106 -1.812 . . . . 25.0 106.106 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -140.31 146.73 38.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.976 -2.601 . . . . 25.0 103.976 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.72 147.3 46.09 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 113.773 -1.558 . . . . 50.0 113.06 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 t -61.24 -23.39 65.6 Favored 'General case' 0 C--O 1.26 1.633 0 O-C-N 125.748 1.905 . . . . 25.0 113.714 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.19 32.06 Favored Pre-proline 0 CA--C 1.497 -1.082 0 N-CA-C 103.6 -2.741 . . . . 25.0 103.6 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -64.45 166.2 18.07 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 113.656 -3.762 . . . . 25.0 111.77 164.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -129.06 147.17 50.9 Favored 'General case' 0 C--O 1.197 -1.696 0 O-C-N 126.21 2.194 . . . . 25.0 106.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.76 125.71 25.66 Favored 'General case' 0 C--O 1.186 -2.256 0 O-C-N 126.051 2.095 . . . . 25.0 106.498 165.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.3 m -129.43 145.21 51.45 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 124.917 1.287 . . . . 25.0 109.921 -172.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -105.79 -48.95 3.51 Favored 'General case' 0 CA--C 1.624 3.815 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -152.51 160.48 43.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.295 -2.483 . . . . 25.0 104.295 177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -143.21 141.02 30.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.07 -1.423 . . . . 25.0 110.637 161.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.56 163.64 32.62 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.177 -0.952 . . . . 25.0 113.123 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -136.99 149.34 47.45 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 117.713 2.486 . . . . 50.0 117.713 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -127.87 164.8 21.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.596 1.558 . . . . 50.0 112.851 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.8 pt -127.78 152.35 35.75 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-N 113.93 -1.486 . . . . 25.0 109.254 173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.3 p -94.16 164.14 13.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 102.919 -2.993 . . . . 25.0 102.919 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -73.58 136.43 43.98 Favored 'General case' 0 C--O 1.185 -2.318 0 O-C-N 119.808 -1.808 . . . . 25.0 111.995 -163.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -71.88 114.51 10.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 119.162 -2.211 . . . . 25.0 108.53 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.6 47.97 3.58 Favored Glycine 0 C--O 1.277 2.792 0 CA-C-N 120.857 1.662 . . . . 25.0 110.393 -172.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.4 160.89 12.57 Favored 'General case' 0 CA--C 1.593 2.616 0 N-CA-C 107.186 -1.412 . . . . 25.0 107.186 -170.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -132.67 105.29 12.96 Favored Pre-proline 0 C--O 1.275 2.421 0 O-C-N 126.119 2.137 . . . . 25.0 107.142 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.97 -11.31 25.44 Favored 'Trans proline' 0 C--N 1.371 1.745 0 N-CA-C 116.872 1.835 . . . . 25.0 116.872 -174.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.85 -10.46 53.19 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.12 1.155 . . . . 75.0 114.12 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -89.25 175.53 3.88 Favored Pre-proline 0 C--O 1.215 -0.747 0 C-N-CA 126.961 2.104 . . . . 25.0 113.211 -176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -19.66 37.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 1 C-N-CA 134.626 10.218 . . . . 25.0 120.124 121.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.69 -36.02 23.69 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 129.571 3.149 . . . . 50.0 111.33 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.46 -5.72 58.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 119.887 -1.758 . . . . 25.0 110.942 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -130.26 -72.01 0.58 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.306 1.965 . . . . 25.0 116.306 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.75 -0.89 25.43 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 122.975 2.625 . . . . 25.0 114.274 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -75.64 -23.63 56.34 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.593 1.088 . . . . 25.0 111.337 163.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.27 154.79 21.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.969 -1.493 . . . . 50.0 106.969 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.58 158.22 40.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.312 -2.477 . . . . 25.0 104.312 159.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.3 tp -87.81 128.79 35.33 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 102.616 -3.105 . . . . 50.0 102.616 158.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.97 -21.77 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 106.926 -1.509 . . . . 25.0 106.926 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.91 164.56 30.41 Favored Glycine 0 C--O 1.202 -1.89 0 CA-C-N 119.719 1.145 . . . . 25.0 113.082 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.4 42.21 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 106.0 -1.852 . . . . 25.0 106.0 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.68 95.4 17.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-N 112.251 -2.25 . . . . 50.0 108.736 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.61 166.34 29.58 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 121.391 1.394 . . . . 25.0 109.87 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -124.32 140.59 52.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.197 -1.408 . . . . 25.0 107.197 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.3 -11.73 5.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 115.449 1.648 . . . . 50.0 115.449 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.03 -9.07 33.75 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 126.44 1.972 . . . . 25.0 110.892 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.6 p -74.46 154.27 87.81 Favored Pre-proline 0 C--O 1.197 -1.659 0 N-CA-C 100.827 -3.768 . . . . 25.0 100.827 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.39 25.53 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 117.202 -1.399 . . . . 25.0 113.932 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.55 -16.29 60.28 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 118.808 -2.433 . . . . 25.0 108.171 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.1 p -69.57 -13.97 62.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.667 -1.606 . . . . 25.0 113.659 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.92 -28.79 69.18 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.067 -0.97 . . . . 25.0 111.54 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -68.12 88.89 0.3 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.62 0.724 . . . . 25.0 109.979 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.6 tp -92.39 -27.6 17.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 126.412 3.006 . . . . 75.0 107.485 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.4 t -81.41 123.72 28.81 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 110.724 -2.944 . . . . 25.0 107.647 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -129.63 135.68 48.83 Favored 'General case' 0 CA--C 1.572 1.801 0 O-C-N 124.959 1.412 . . . . 25.0 108.841 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -69.78 130.53 42.56 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 116.233 -1.841 . . . . 25.0 106.117 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.8 mm -128.7 118.33 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.953 0 CA-C-N 121.058 1.754 . . . . 25.0 112.274 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -67.49 129.85 41.19 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 115.654 1.724 . . . . 50.0 115.654 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.26 118.4 44.01 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 118.1 -2.875 . . . . 25.0 107.555 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.34 146.41 45.14 Favored 'Trans proline' 0 CA--C 1.483 -2.06 0 C-N-CA 115.216 -2.723 . . . . 25.0 116.417 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -87.73 53.88 2.93 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 123.297 1.522 . . . . 25.0 108.05 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -84.33 -30.87 25.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 120.002 3.334 . . . . 50.0 120.002 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -152.22 177.96 9.99 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 114.047 -2.882 . . . . 25.0 104.505 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 mp -113.67 126.46 55.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 104.567 -2.383 . . . . 50.0 104.567 160.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.78 170.12 32.16 Favored Glycine 0 CA--C 1.473 -2.539 0 C-N-CA 118.148 -1.977 . . . . 25.0 114.533 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.86 135.61 53.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.36 1.464 . . . . 50.0 112.462 -168.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -147.0 167.69 23.39 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 125.349 1.656 . . . . 25.0 113.449 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.4 t -85.2 158.87 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 126.896 2.623 . . . . 50.0 104.559 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.8 mt -129.24 136.16 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 N-CA-C 103.43 -2.804 . . . . 25.0 103.43 162.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.34 153.03 39.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 104.741 -2.318 . . . . 50.0 104.741 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.61 157.4 45.52 Favored 'General case' 0 C--O 1.184 -2.371 0 CA-C-N 121.632 2.015 . . . . 25.0 106.61 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.52 134.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 126.832 2.583 . . . . 50.0 110.405 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -124.17 119.68 30.1 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 120.792 1.633 . . . . 25.0 108.084 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -84.4 89.13 7.33 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 119.563 -1.96 . . . . 25.0 111.461 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.67 103.65 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 113.23 -1.805 . . . . 50.0 106.5 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.12 -18.89 64.76 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 113.793 -1.549 . . . . 25.0 114.26 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.68 -26.35 66.99 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 119.178 3.029 . . . . 25.0 119.178 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 45.7 p -115.24 158.45 22.3 Favored 'General case' 0 C--O 1.262 1.725 0 N-CA-C 114.796 1.406 . . . . 25.0 114.796 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -28.15 27.81 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 106.918 -1.512 . . . . 25.0 106.918 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -66.7 157.89 31.53 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 124.615 2.15 . . . . 25.0 111.416 160.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.49 155.45 42.27 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 101.954 -3.35 . . . . 25.0 101.954 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -111.53 153.35 26.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.072 2.107 . . . . 50.0 115.905 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -142.59 152.1 42.2 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 124.019 1.866 . . . . 50.0 106.74 -162.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -155.38 149.26 25.49 Favored 'General case' 0 C--O 1.19 -2.068 0 O-C-N 120.043 -1.661 . . . . 25.0 111.534 167.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.81 127.5 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 125.269 1.606 . . . . 75.0 112.556 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 152.77 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-N 121.835 2.107 . . . . 25.0 108.676 172.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -88.93 156.82 18.67 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 118.94 2.941 . . . . 25.0 118.94 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.1 169.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 102.695 -3.076 . . . . 50.0 102.695 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -132.66 122.61 24.92 Favored 'General case' 0 C--O 1.258 1.505 0 N-CA-C 103.03 -2.952 . . . . 25.0 103.03 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.68 119.4 34.35 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 122.07 2.214 . . . . 50.0 106.329 -164.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.59 -175.65 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.268 2.063 0 CA-C-O 122.408 1.099 . . . . 50.0 113.359 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.97 151.49 43.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.634 1.716 . . . . 25.0 115.634 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 79.7 mttt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 121.586 1.994 . . . . 25.0 115.319 176.171 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.402 ' HA ' ' CE3' ' A' ' 152' ' ' TRP . 24.0 p-80 . . . . . 0 C--O 1.293 3.366 0 CA-C-O 117.995 -1.002 . . . . 25.0 112.233 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.25 -124.02 31.0 Favored Glycine 0 CA--C 1.489 -1.579 0 CA-C-O 118.482 -1.177 . . . . 25.0 112.297 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -113.58 164.18 13.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 126.549 1.97 . . . . 50.0 110.97 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.4 mt -96.1 120.53 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 N-CA-C 102.972 -2.973 . . . . 25.0 102.972 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -91.72 -34.02 14.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 117.575 -1.202 . . . . 25.0 108.256 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.52 133.17 13.55 Favored Pre-proline 0 C--N 1.309 -1.185 0 C-N-CA 124.382 1.073 . . . . 25.0 110.097 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.57 144.77 80.83 Favored 'Cis proline' 0 C--O 1.249 1.033 0 CA-C-O 123.625 1.427 . . . . 25.0 109.39 -3.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.04 133.29 10.33 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 113.761 -1.563 . . . . 25.0 110.75 169.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 35.13 0.8 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.159 1.48 . . . . 25.0 108.699 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -65.16 -26.33 68.12 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 116.071 -1.919 . . . . 25.0 112.778 -166.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.74 57.29 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 122.224 2.284 . . . . 25.0 109.189 -175.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.35 97.13 Favored 'General case' 0 C--O 1.274 2.385 0 CA-C-N 114.641 -1.163 . . . . 25.0 112.574 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.1 mt -66.84 -34.25 77.39 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.31 0.576 . . . . 75.0 109.994 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 t -65.22 -26.36 68.09 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 123.006 1.384 . . . . 25.0 113.36 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.488 ' HG ' ' H ' ' A' ' 17' ' ' ALA . 35.4 t -64.53 132.73 50.73 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 119.577 -1.952 . . . . 25.0 110.355 -177.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -67.65 -27.15 66.63 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' H ' ' HG ' ' A' ' 15' ' ' SER . . . -81.43 -25.16 36.38 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-O 122.368 1.08 . . . . 25.0 110.827 -167.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -54.81 -41.38 70.55 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 114.31 1.226 . . . . 50.0 114.31 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.1 19.57 22.61 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 108.602 -1.799 . . . . 25.0 108.602 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.4 t80 37.54 -49.01 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.786 1 N-CA-C 127.677 6.177 . . . . 50.0 127.677 -159.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.8 mt -108.6 15.91 23.37 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.172 0.589 . . . . 50.0 112.398 -174.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -75.45 159.58 31.2 Favored 'General case' 0 C--O 1.185 -2.302 0 N-CA-C 116.019 1.859 . . . . 25.0 116.019 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 mp -62.49 171.48 1.94 Allowed 'General case' 0 C--O 1.254 1.311 0 O-C-N 124.277 0.985 . . . . 50.0 111.453 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -71.18 -18.44 62.49 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 115.711 -2.396 . . . . 25.0 113.39 -159.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.9 t -141.26 -15.95 0.85 Allowed 'General case' 0 C--O 1.288 3.098 0 C-N-CA 119.383 -0.927 . . . . 25.0 113.47 161.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.13 59.06 1.7 Allowed Glycine 0 CA--C 1.543 1.823 0 CA-C-O 116.207 -2.44 . . . . 25.0 116.024 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.7 m -54.67 -2.19 0.03 OUTLIER 'General case' 0 C--O 1.27 2.159 0 N-CA-C 120.447 3.499 . . . . 25.0 120.447 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.2 p -56.4 -23.02 15.79 Favored 'Isoleucine or valine' 0 C--O 1.258 1.548 0 N-CA-C 105.349 -2.093 . . . . 50.0 105.349 162.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -62.26 -7.42 4.23 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 115.532 1.679 . . . . 25.0 115.532 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -62.64 -44.69 95.63 Favored 'General case' 0 C--O 1.286 3.024 0 N-CA-C 119.482 3.142 . . . . 50.0 119.482 -166.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.256 11.9 pt-20 -142.17 62.38 13.7 Favored Pre-proline 0 C--O 1.258 1.508 0 N-CA-C 117.018 2.229 . . . . 25.0 117.018 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.8 -21.78 37.81 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 117.049 -1.501 . . . . 25.0 113.408 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -71.61 -14.28 62.02 Favored 'General case' 0 C--O 1.261 1.697 0 O-C-N 119.537 -1.977 . . . . 25.0 115.482 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 m -85.4 2.38 44.63 Favored 'General case' 0 C--O 1.285 2.933 0 O-C-N 119.934 -1.729 . . . . 25.0 115.373 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.2 150.58 48.9 Favored 'General case' 0 C--O 1.273 2.337 0 N-CA-C 104.267 -2.494 . . . . 50.0 104.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -132.14 162.16 31.55 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.53 1.932 . . . . 25.0 108.016 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.61 178.4 9.37 Favored 'General case' 0 C--O 1.184 -2.372 0 CA-C-O 124.33 2.014 . . . . 25.0 110.743 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.86 175.64 5.63 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 115.851 1.797 . . . . 25.0 115.851 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 95.3 mttt -57.68 144.15 38.92 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 120.159 -1.588 . . . . 25.0 114.812 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.4 -17.99 27.45 Favored Glycine 0 N--CA 1.479 1.546 0 C-N-CA 118.071 -2.014 . . . . 25.0 112.123 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -69.72 135.04 88.05 Favored Pre-proline 0 C--O 1.261 1.666 0 CA-C-N 118.341 1.071 . . . . 25.0 113.738 -166.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.86 121.01 1.24 Allowed 'Cis proline' 0 C--O 1.269 2.029 0 C-N-CA 134.062 2.942 . . . . 25.0 117.816 -18.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -59.13 -21.64 59.62 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 117.991 2.589 . . . . 25.0 117.991 -166.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 t -46.65 -50.02 18.33 Favored 'General case' 1 C--O 1.151 -4.094 0 N-CA-C 118.176 2.658 . . . . 25.0 118.176 177.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.67 -173.25 30.53 Favored Glycine 0 C--N 1.359 1.835 0 N-CA-C 119.457 2.543 . . . . 25.0 119.457 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.68 -178.52 4.7 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 121.879 1.719 . . . . 25.0 116.398 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.64 134.11 54.3 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 116.537 2.051 . . . . 25.0 116.537 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -84.53 139.83 31.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.829 -1.532 . . . . 25.0 109.676 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.96 1.59 76.15 Favored Glycine 0 C--O 1.259 1.708 0 CA-C-O 124.397 2.11 . . . . 25.0 115.67 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -72.74 -17.77 61.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 117.803 -1.559 . . . . 25.0 111.926 -174.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.5 mm -74.78 -40.66 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 1 O-C-N 115.274 -4.641 . . . . 25.0 107.815 172.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.93 -29.48 66.65 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 119.166 -2.209 . . . . 25.0 115.496 -172.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.6 p -78.95 -11.68 60.01 Favored 'General case' 0 C--O 1.204 -1.338 0 O-C-N 125.585 1.803 . . . . 25.0 110.358 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.49 20.36 12.13 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 127.696 2.399 . . . . 25.0 115.552 -170.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.99 -23.38 77.98 Favored Glycine 0 C--O 1.261 1.795 0 C-N-CA 126.129 1.824 . . . . 25.0 112.699 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.49 8.34 68.96 Favored Glycine 0 C--O 1.254 1.368 0 C-N-CA 125.411 1.482 . . . . 25.0 109.43 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.4 mt -132.71 -176.94 4.27 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 128.214 2.605 . . . . 50.0 106.523 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.01 -14.6 60.83 Favored 'General case' 0 C--O 1.271 2.205 0 N-CA-C 114.824 1.416 . . . . 50.0 114.824 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.41 -22.27 63.27 Favored Glycine 0 C--O 1.274 2.633 0 N-CA-C 110.028 -1.229 . . . . 25.0 110.028 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -13.01 83.67 Favored Glycine 0 C--O 1.268 2.258 0 O-C-N 119.391 -2.241 . . . . 25.0 110.829 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -38.04 66.44 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 O-C-N 117.461 -3.376 . . . . 25.0 105.964 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.64 -32.32 73.76 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.516 -1.365 . . . . 75.0 111.317 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.22 -15.3 61.44 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 119.973 -1.704 . . . . 50.0 111.025 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.26 87.3 mt-30 -92.83 17.76 10.02 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 120.095 -1.628 . . . . 25.0 114.997 168.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -137.71 49.7 1.97 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.631 -1.988 . . . . 25.0 105.631 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -157.85 179.31 9.32 Favored 'General case' 0 C--O 1.261 1.669 1 N-CA-C 100.094 -4.039 . . . . 25.0 100.094 -170.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -47.74 -32.11 5.53 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 117.949 2.574 . . . . 25.0 117.949 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.41 29.53 1.68 Allowed 'General case' 0 C--O 1.253 1.282 0 CA-C-N 121.357 1.89 . . . . 25.0 107.477 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -83.32 78.81 9.57 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 123.967 1.841 . . . . 25.0 107.714 153.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -56.67 158.87 4.25 Favored 'General case' 0 C--O 1.29 3.196 0 CA-C-N 111.15 -2.75 . . . . 25.0 112.781 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -65.94 157.8 29.76 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-N 113.563 -1.653 . . . . 50.0 107.329 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -108.7 144.57 36.32 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 123.676 1.703 . . . . 25.0 108.137 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -139.79 152.82 46.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.625 -1.625 . . . . 25.0 109.735 162.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.7 mt -85.62 136.38 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.591 1.541 . . . . 25.0 107.998 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.6 ttt -137.31 144.8 42.79 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 171.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.298 12.1 p -79.43 173.43 12.59 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 120.373 -1.454 . . . . 25.0 113.209 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.5 -163.76 8.67 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.203 -1.475 . . . . 25.0 111.743 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.6 -172.72 36.19 Favored Glycine 0 N--CA 1.486 1.976 0 O-C-N 119.572 -2.134 . . . . 25.0 113.017 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -77.56 142.55 38.95 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 117.609 2.448 . . . . 25.0 117.609 169.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -137.86 165.88 25.39 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 105.763 -1.94 . . . . 25.0 105.763 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.7 m -118.46 120.25 36.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.956 -1.868 . . . . 25.0 105.956 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.52 141.71 47.7 Favored 'General case' 0 C--O 1.17 -3.111 0 N-CA-C 105.279 -2.119 . . . . 50.0 105.279 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 m -136.84 140.29 42.31 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 116.116 -1.897 . . . . 25.0 113.689 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 143.52 51.22 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 122.367 2.349 . . . . 25.0 109.688 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -149.08 144.57 26.76 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 127.157 3.36 . . . . 25.0 108.393 -170.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -142.54 151.98 42.16 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-N 111.845 -2.434 . . . . 50.0 112.718 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.0 t -73.64 -9.09 58.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 O-C-N 125.678 1.861 . . . . 25.0 113.634 -169.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.96 159.71 67.44 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 117.064 -3.523 . . . . 25.0 103.833 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -73.14 139.7 29.94 Favored 'Trans proline' 0 C--N 1.307 -1.654 1 C-N-CA 111.761 -5.026 . . . . 25.0 110.301 166.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 2.486 47.9 p-80 73.12 12.79 4.91 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 123.308 2.777 . . . . 25.0 116.611 -5.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -65.58 115.89 6.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 118.442 -1.303 . . . . 25.0 113.256 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.491 ' HG1' ' HD1' ' A' ' 95' ' ' TRP . 14.0 t -75.73 160.26 30.22 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.084 -1.446 . . . . 25.0 112.071 -171.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 90.3 p -111.51 -26.37 9.1 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 118.246 0.475 . . . . 25.0 110.87 163.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -168.6 150.56 4.97 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 103.013 -2.958 . . . . 25.0 103.013 168.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.491 ' HD1' ' HG1' ' A' ' 92' ' ' THR . 16.7 p-90 -136.73 160.54 38.52 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-O 116.921 -1.514 . . . . 25.0 107.589 166.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -142.53 162.43 35.49 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.241 -1.763 . . . . 25.0 106.241 -163.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.27 127.63 45.9 Favored 'General case' 0 C--O 1.274 2.345 0 N-CA-C 103.953 -2.61 . . . . 50.0 103.953 158.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -117.61 149.91 39.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 118.17 -2.831 . . . . 50.0 107.898 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.8 pt -120.64 153.37 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 119.463 1.029 . . . . 25.0 112.626 168.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 p -71.54 147.34 47.79 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -95.88 84.79 3.93 Favored 'General case' 0 C--O 1.191 -1.987 0 CA-C-O 123.103 1.43 . . . . 25.0 109.577 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -49.83 155.29 0.89 Allowed 'General case' 0 C--N 1.354 0.777 0 N-CA-C 117.0 2.222 . . . . 25.0 117.0 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 15.56 76.98 Favored Glycine 0 C--O 1.266 2.129 0 CA-C-O 126.551 3.306 . . . . 25.0 120.889 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 179.2 2.83 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.35 -1.925 . . . . 25.0 113.759 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.93 142.43 11.74 Favored Pre-proline 0 CA--C 1.492 -1.255 0 O-C-N 126.38 2.3 . . . . 25.0 106.333 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -60.41 -22.74 72.6 Favored 'Trans proline' 0 CA--C 1.592 3.42 0 N-CA-C 117.677 2.145 . . . . 25.0 117.677 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 116.399 -2.12 . . . . 75.0 110.709 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -108.09 170.95 4.98 Favored Pre-proline 0 CA--C 1.599 2.856 0 C-N-CA 129.751 3.221 . . . . 25.0 103.272 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.33 16.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.393 1 N-CA-C 122.767 4.103 . . . . 25.0 122.767 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.66 -40.4 69.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 117.172 2.286 . . . . 50.0 117.172 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -75.36 -6.84 52.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 126.287 2.242 . . . . 25.0 114.401 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -116.26 -59.69 1.95 Allowed 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 127.259 2.224 . . . . 25.0 114.49 -171.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -141.67 29.6 1.73 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 123.469 1.604 . . . . 25.0 111.794 -159.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.89 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 111.763 -2.471 . . . . 25.0 116.985 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -129.29 166.21 19.9 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 123.157 2.708 . . . . 50.0 112.457 172.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.07 143.25 49.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 101.289 -3.597 . . . . 25.0 101.289 163.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 tp -86.3 120.94 28.19 Favored 'General case' 0 C--O 1.182 -2.482 0 O-C-N 127.507 3.004 . . . . 50.0 108.701 166.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.8 tt -101.93 -8.29 9.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 121.536 1.971 . . . . 25.0 110.172 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.65 154.55 9.64 Favored Glycine 0 C--O 1.207 -1.592 0 C-N-CA 116.086 -2.959 . . . . 25.0 113.791 165.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.55 145.85 32.04 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 122.999 3.399 . . . . 25.0 104.839 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.44 105.79 30.54 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-O 117.067 -1.444 . . . . 50.0 114.104 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -77.48 164.59 28.4 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 C-N-CA 115.809 -2.327 . . . . 25.0 115.436 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -74.22 112.76 10.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.666 -1.976 . . . . 25.0 105.666 167.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.66 -18.4 1.91 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 119.379 -2.076 . . . . 50.0 116.335 -165.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.63 16.65 33.32 Favored Glycine 0 N--CA 1.466 0.673 0 O-C-N 119.917 -1.739 . . . . 25.0 114.371 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -55.54 162.33 2.49 Favored Pre-proline 0 CA--C 1.568 1.661 0 O-C-N 125.664 1.45 . . . . 25.0 113.72 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -66.31 176.25 4.19 Favored 'Trans proline' 0 C--O 1.276 2.412 0 CA-C-O 123.452 1.355 . . . . 25.0 112.065 166.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.85 -12.44 0.31 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 119.585 3.18 . . . . 25.0 119.585 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 p -69.44 -0.57 6.68 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 120.131 -1.605 . . . . 25.0 111.737 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.27 4.85 7.93 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 117.587 2.439 . . . . 25.0 117.587 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -61.03 164.68 4.78 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.347 1.546 . . . . 25.0 114.157 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.8 30.61 0.11 Allowed 'General case' 0 N--CA 1.516 2.829 0 O-C-N 119.256 -2.153 . . . . 75.0 113.287 -171.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.4 t -113.8 149.72 34.53 Favored 'General case' 0 C--O 1.262 1.737 0 N-CA-C 103.232 -2.877 . . . . 25.0 103.232 170.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -146.27 142.56 28.45 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 123.87 0.868 . . . . 25.0 109.318 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -75.39 135.69 40.79 Favored 'General case' 0 C--O 1.172 -3.023 0 N-CA-C 105.592 -2.003 . . . . 25.0 105.592 162.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.9 129.82 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 104.776 -2.305 . . . . 25.0 104.776 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -90.49 135.08 33.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 112.672 -2.058 . . . . 50.0 112.036 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.04 108.74 41.89 Favored Pre-proline 0 C--N 1.307 -1.245 0 O-C-N 119.678 -1.889 . . . . 25.0 108.427 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.82 136.86 21.37 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 O-C-N 117.033 -2.141 . . . . 25.0 114.456 164.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -150.86 101.82 2.93 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.162 -0.961 . . . . 25.0 109.273 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -105.56 10.55 33.05 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 126.943 2.097 . . . . 50.0 108.632 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -132.87 -176.83 4.24 Favored 'General case' 0 C--O 1.21 -0.98 0 O-C-N 119.174 -2.204 . . . . 25.0 110.304 -173.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.44 148.99 51.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 103.443 -2.799 . . . . 50.0 103.443 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 145.62 174.42 17.79 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 121.206 3.243 . . . . 25.0 121.206 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -75.12 135.72 41.13 Favored 'General case' 0 C--O 1.279 2.614 0 N-CA-C 116.122 1.897 . . . . 50.0 116.122 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -139.82 172.78 12.28 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 103.631 -2.729 . . . . 25.0 103.631 174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.0 t -123.18 148.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 103.455 -2.794 . . . . 50.0 103.455 166.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.5 mt -115.66 137.86 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 1 N-CA-C 98.647 -4.575 . . . . 25.0 98.647 172.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.54 129.48 55.37 Favored 'General case' 0 C--O 1.187 -2.193 0 CA-C-N 119.172 0.896 . . . . 50.0 113.024 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.18 135.0 45.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.521 -1.362 . . . . 25.0 111.502 -173.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 69.2 t -124.96 137.37 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.972 0 N-CA-C 103.033 -2.951 . . . . 50.0 103.033 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.402 ' CE3' ' HA ' ' A' ' 1' ' ' HIS . 2.7 t90 -140.03 112.57 7.89 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.092 -2.558 . . . . 25.0 104.092 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.5 140.56 32.57 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 100.533 -3.877 . . . . 25.0 100.533 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.51 157.16 34.97 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 CA-C-O 122.715 1.245 . . . . 50.0 107.807 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 -24.36 36.01 Favored 'General case' 0 C--O 1.199 -1.595 0 CA-C-N 115.042 -0.981 . . . . 25.0 108.86 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -67.16 -35.48 79.77 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 115.17 1.544 . . . . 25.0 115.17 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.767 ' HG1' ' H ' ' A' ' 159' ' ' ASN . 1.3 t -135.29 159.05 42.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 115.066 -2.397 . . . . 25.0 107.899 -166.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.02 -27.03 41.26 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 120.873 1.669 . . . . 25.0 113.914 162.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.767 ' H ' ' HG1' ' A' ' 157' ' ' THR . 96.7 m-20 -73.04 163.16 28.57 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.531 -1.356 . . . . 25.0 110.861 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.81 -176.19 3.77 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 104.597 -2.372 . . . . 25.0 104.597 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.79 146.53 47.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.772 -0.825 . . . . 50.0 108.772 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -134.56 135.62 42.41 Favored 'General case' 0 C--O 1.172 -2.98 0 CA-C-O 115.377 -2.249 . . . . 50.0 106.535 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -144.93 172.08 13.55 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 121.371 1.896 . . . . 25.0 107.735 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 147.53 32.06 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 O-C-N 120.047 -1.658 . . . . 75.0 107.344 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.4 mm -130.15 122.42 53.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 103.429 -2.804 . . . . 25.0 103.429 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -87.11 123.76 32.52 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.217 -2.142 . . . . 25.0 105.217 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.13 155.14 38.03 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.656 -1.278 . . . . 50.0 112.765 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -116.31 130.45 56.78 Favored 'General case' 0 N--CA 1.436 -1.144 1 N-CA-C 96.279 -5.452 . . . . 25.0 96.279 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.2 mt -123.8 128.78 50.04 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 115.781 -2.057 . . . . 50.0 106.693 -171.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.17 159.0 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 O-C-N 127.101 2.75 . . . . 50.0 112.09 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -70.22 131.52 44.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 117.987 -2.945 . . . . 25.0 108.138 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.4 pttt . . . . . 0 C--O 1.28 2.685 0 N-CA-C 120.464 3.505 . . . . 25.0 120.464 -171.286 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.421 ' CD2' ' HG ' ' A' ' 34' ' ' SER . 72.8 m80 . . . . . 0 N--CA 1.517 2.89 0 N-CA-C 112.667 0.617 . . . . 25.0 112.667 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.7 -146.99 4.46 Favored Glycine 0 C--O 1.253 1.294 0 CA-C-O 114.393 -3.448 . . . . 25.0 118.742 -162.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.3 168.95 23.19 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 122.285 3.043 . . . . 50.0 105.941 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.11 121.73 41.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.998 -2.593 . . . . 25.0 103.998 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -83.05 -36.45 24.92 Favored 'General case' 0 C--O 1.262 1.734 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -172.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.514 ' HE2' ' HG1' ' A' ' 83' ' ' THR . 47.6 pttt -160.89 159.98 25.08 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-O 113.634 -3.079 . . . . 25.0 106.352 -175.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -78.09 137.52 46.9 Favored 'Cis proline' 0 C--O 1.206 -1.112 0 O-C-N 124.721 1.906 . . . . 25.0 107.195 1.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.26 -171.98 44.74 Favored Glycine 0 CA--C 1.454 -3.725 0 CA-C-N 114.811 -1.086 . . . . 25.0 110.51 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.686 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 82.1 p -145.75 158.34 43.86 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 119.644 1.722 . . . . 25.0 107.003 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -82.47 -24.41 34.23 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 118.764 -1.174 . . . . 25.0 111.429 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.17 79.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.134 0.974 . . . . 25.0 111.648 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.686 ' H ' ' HG ' ' A' ' 9' ' ' SER . . . -59.15 -31.94 69.43 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 119.3 0.954 . . . . 25.0 113.477 175.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 mt -85.99 -24.23 26.55 Favored 'General case' 0 C--O 1.192 -1.938 0 C-N-CA 124.261 1.025 . . . . 75.0 113.514 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.0 t -65.96 -32.03 73.28 Favored 'General case' 0 C--O 1.205 -1.281 0 O-C-N 125.348 1.655 . . . . 25.0 111.37 173.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -58.83 147.53 33.27 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.16 -1.382 . . . . 25.0 114.306 172.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.79 -11.53 58.95 Favored 'General case' 0 C--O 1.187 -2.21 0 C-N-CA 118.856 -1.137 . . . . 25.0 111.529 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.62 -24.78 9.03 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 118.927 2.936 . . . . 25.0 118.927 -167.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.13 -28.34 51.97 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 115.74 1.756 . . . . 50.0 115.74 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.58 -26.93 0.07 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 117.927 1.931 . . . . 25.0 117.927 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 50.15 26.27 2.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 119.455 -2.203 . . . . 50.0 112.089 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.4 mt -86.02 -37.83 18.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 118.302 -2.749 . . . . 50.0 107.134 -173.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -171.13 170.21 6.21 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 115.125 -2.369 . . . . 25.0 109.529 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mp -69.45 151.16 46.42 Favored 'General case' 0 C--O 1.263 1.81 0 CA-C-N 121.314 1.87 . . . . 50.0 109.941 175.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -150.81 30.03 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 113.598 -1.637 . . . . 25.0 108.98 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.4 t -70.12 -36.9 75.13 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.377 1.084 . . . . 25.0 112.156 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.95 97.61 0.18 Allowed Glycine 0 C--N 1.285 -2.298 0 C-N-CA 117.332 -2.366 . . . . 25.0 116.767 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.2 m -54.64 -8.5 0.24 Allowed 'General case' 0 C--O 1.249 1.056 0 C-N-CA 126.68 1.992 . . . . 25.0 115.354 -171.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.26 -18.05 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 N-CA-C 115.15 1.537 . . . . 50.0 115.15 161.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -48.4 -16.74 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 1 N-CA-C 122.437 4.236 . . . . 25.0 122.437 177.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -63.87 -41.55 97.74 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 114.43 1.27 . . . . 50.0 114.43 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -153.94 53.74 0.99 Allowed Pre-proline 0 C--O 1.274 2.394 0 O-C-N 120.119 -1.613 . . . . 25.0 110.539 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.01 -33.17 42.52 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 O-C-N 118.311 -1.468 . . . . 25.0 113.757 -165.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -67.13 -1.33 4.17 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 117.319 2.34 . . . . 25.0 117.319 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.421 ' HG ' ' CD2' ' A' ' 1' ' ' HIS . 1.1 t -82.81 55.39 3.02 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.94 1.696 . . . . 25.0 113.601 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.72 135.26 33.72 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 123.24 1.495 . . . . 50.0 107.004 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.21 149.86 39.7 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 125.663 2.649 . . . . 25.0 105.424 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.11 12.48 Favored 'General case' 0 C--O 1.259 1.587 0 N-CA-C 102.329 -3.211 . . . . 25.0 102.329 164.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -100.15 168.59 9.72 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.616 2.08 . . . . 25.0 116.616 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -54.0 144.63 18.63 Favored 'General case' 0 N--CA 1.402 -2.858 0 CA-C-O 123.372 1.558 . . . . 25.0 111.512 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.53 166.91 38.13 Favored Glycine 0 C--O 1.255 1.443 1 N-CA-C 99.406 -5.478 . . . . 25.0 99.406 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -142.31 149.21 50.72 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 113.267 -1.467 . . . . 25.0 113.156 -173.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.74 108.7 0.34 Allowed 'Cis proline' 0 CA--C 1.552 1.394 0 C-N-CA 129.639 1.099 . . . . 25.0 112.512 -28.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -22.12 66.79 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 117.427 -3.295 . . . . 25.0 114.628 -167.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -43.23 99.26 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 119.512 1.051 . . . . 25.0 111.671 168.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.68 -156.23 6.9 Favored Glycine 0 N--CA 1.477 1.413 0 O-C-N 124.296 0.998 . . . . 25.0 111.866 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.86 162.35 35.35 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 CA-C-N 118.603 1.201 . . . . 25.0 114.26 -168.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.62 125.13 21.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 126.95 2.657 . . . . 25.0 112.887 -162.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -136.93 159.59 41.41 Favored 'General case' 0 CA--C 1.499 -1.009 1 N-CA-C 98.537 -4.616 . . . . 25.0 98.537 169.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.87 -14.01 59.66 Favored Glycine 0 C--O 1.22 -0.722 0 CA-C-O 125.17 2.539 . . . . 25.0 114.302 171.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -96.81 12.89 30.48 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 119.668 -2.078 . . . . 25.0 112.896 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.85 -57.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.97 -1.122 . . . . 25.0 107.97 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.27 79.0 Favored 'General case' 0 CA--C 1.591 2.557 0 CA-C-O 122.574 1.178 . . . . 25.0 110.85 -172.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.607 ' HG ' ' H ' ' A' ' 55' ' ' GLY . 95.6 p -76.19 -12.45 60.1 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 117.04 -3.538 . . . . 25.0 112.158 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.22 22.59 10.85 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 111.888 -2.415 . . . . 25.0 113.31 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.607 ' H ' ' HG ' ' A' ' 53' ' ' SER . . . -89.78 -2.48 75.39 Favored Glycine 0 C--O 1.184 -3.008 0 CA-C-O 127.241 3.689 . . . . 25.0 112.519 -173.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.3 -3.26 69.74 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 108.32 -1.912 . . . . 25.0 108.32 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -84.87 118.01 24.24 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 119.446 1.623 . . . . 50.0 108.045 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -76.05 -21.47 56.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.215 -1.394 . . . . 50.0 107.645 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 -20.6 58.75 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 104.347 -3.501 . . . . 25.0 104.347 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.13 -20.87 71.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 111.471 -2.365 . . . . 25.0 112.122 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.71 -37.31 23.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 118.208 -1.397 . . . . 25.0 113.809 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.0 -34.67 75.66 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 119.751 -1.843 . . . . 75.0 111.687 172.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.54 -5.56 56.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.463 2.554 . . . . 50.0 110.065 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -81.97 75.43 8.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 113.716 -1.584 . . . . 25.0 111.01 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -128.2 44.28 2.98 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 127.295 2.238 . . . . 25.0 105.817 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.0 t -127.32 -166.56 1.62 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.3 -3.222 . . . . 25.0 102.3 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.79 -17.62 64.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 117.673 2.471 . . . . 25.0 117.673 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.47 24.3 7.52 Favored 'General case' 0 CA--C 1.595 2.686 0 CA-C-O 124.557 2.122 . . . . 25.0 109.978 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -87.31 102.25 14.33 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 126.742 3.163 . . . . 25.0 109.047 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -35.59 143.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.482 2 CA-C-N 102.415 -6.721 . . . . 25.0 112.146 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -70.92 152.84 43.23 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 115.323 1.601 . . . . 50.0 115.323 -173.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -95.35 152.73 18.13 Favored 'General case' 0 CA--C 1.587 2.38 0 O-C-N 121.353 -0.842 . . . . 25.0 109.85 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.12 148.61 49.83 Favored 'General case' 0 C--O 1.198 -1.658 0 CA-C-N 120.83 1.65 . . . . 25.0 109.156 169.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.7 mt -107.7 134.08 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 122.926 2.603 . . . . 25.0 111.952 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 85.1 mmm -144.22 169.97 16.87 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.203 -1.777 . . . . 25.0 106.203 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -90.98 172.09 8.82 Favored 'General case' 0 CA--C 1.446 -3.032 0 CA-C-O 116.056 -1.926 . . . . 25.0 111.606 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.98 173.46 9.66 Favored Glycine 0 CA--C 1.495 -1.176 0 O-C-N 124.94 1.4 . . . . 25.0 112.792 165.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.62 163.99 29.26 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 117.127 -2.463 . . . . 25.0 107.86 -171.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.38 155.18 28.51 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 120.291 -1.711 . . . . 25.0 109.168 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -145.5 160.67 41.27 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 103.049 -2.945 . . . . 25.0 103.049 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -125.9 130.71 51.84 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 -171.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.79 116.53 25.39 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 102.078 -3.305 . . . . 50.0 102.078 -165.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.514 ' HG1' ' HE2' ' A' ' 6' ' ' LYS . 60.9 m -115.63 131.97 56.77 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 102.867 -3.012 . . . . 25.0 102.867 -167.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -119.1 153.07 35.39 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.215 -2.513 . . . . 25.0 104.215 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 t -144.0 147.94 34.58 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -133.41 147.12 51.74 Favored 'General case' 0 C--O 1.266 1.954 0 O-C-N 127.743 3.152 . . . . 50.0 113.665 176.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.2 t -71.23 -20.82 62.2 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 116.341 1.978 . . . . 25.0 116.341 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.34 145.79 56.78 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 121.849 0.833 . . . . 25.0 112.722 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.87 160.51 49.44 Favored 'Trans proline' 0 CA--C 1.488 -1.789 1 C-N-CA 112.056 -4.83 . . . . 25.0 111.791 169.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -135.18 155.29 50.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 125.131 1.372 . . . . 25.0 109.922 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.96 155.29 40.8 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.239 -1.393 . . . . 25.0 107.239 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -140.53 150.97 44.37 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 117.498 -1.681 . . . . 25.0 110.445 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.6 p -112.58 -38.85 4.5 Favored 'General case' 0 CA--C 1.484 -1.569 0 O-C-N 120.68 -1.262 . . . . 25.0 109.385 164.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -150.8 154.13 36.72 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 104.559 -2.386 . . . . 25.0 104.559 169.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -139.74 153.17 47.13 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 117.031 -1.867 . . . . 25.0 108.327 158.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -134.26 154.65 51.16 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 112.616 -2.084 . . . . 25.0 109.901 -157.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 147.0 50.03 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.381 -3.562 . . . . 50.0 101.381 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.75 158.86 43.44 Favored 'General case' 0 C--O 1.184 -2.35 0 CA-C-N 114.001 -1.454 . . . . 50.0 109.056 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 pt -135.91 149.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 106.124 -1.806 . . . . 25.0 106.124 168.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -76.05 137.19 40.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 164.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -86.17 98.15 10.74 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 126.423 1.889 . . . . 25.0 110.452 -164.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -59.65 150.23 28.15 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 119.773 1.17 . . . . 25.0 113.41 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.77 67.1 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 108.906 -1.677 . . . . 25.0 108.906 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -55.77 166.83 0.64 Allowed 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 125.937 1.695 . . . . 25.0 113.71 172.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.01 123.45 6.12 Favored Pre-proline 0 C--O 1.186 -2.26 0 N-CA-C 102.969 -2.974 . . . . 25.0 102.969 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.14 -15.55 39.5 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.383 1.388 . . . . 25.0 114.846 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.56 -6.59 51.04 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 117.526 -3.234 . . . . 75.0 115.458 173.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.09 166.66 15.21 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 101.409 -3.552 . . . . 25.0 101.409 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -43.56 7.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.698 1 C-N-CA 134.179 9.919 . . . . 25.0 120.308 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.28 -26.36 7.22 Favored 'General case' 0 CA--C 1.598 2.794 0 O-C-N 119.599 -1.938 . . . . 50.0 115.667 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -75.96 -2.5 30.73 Favored 'General case' 0 CA--C 1.482 -1.639 1 O-C-N 115.82 -4.3 . . . . 25.0 113.481 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.417 ' C ' ' H ' ' A' ' 114' ' ' ASP . 85.5 mtt-85 -126.76 -44.61 1.65 Allowed 'General case' 0 CA--C 1.457 -2.61 0 N-CA-C 114.208 1.188 . . . . 25.0 114.208 171.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.38 32.03 0.34 Allowed 'General case' 0 C--O 1.193 -1.872 0 O-C-N 127.938 3.274 . . . . 25.0 112.051 172.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 112' ' ' ARG . 23.4 t70 -62.11 -32.92 73.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 123.708 1.718 . . . . 25.0 113.107 174.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -103.94 156.54 17.76 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.385 -2.82 . . . . 50.0 103.385 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.95 139.05 50.14 Favored 'General case' 0 C--O 1.27 2.157 0 N-CA-C 102.911 -2.996 . . . . 25.0 102.911 151.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.99 111.84 5.97 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 125.169 1.388 . . . . 50.0 107.517 154.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.42 -16.01 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 O-C-N 125.982 2.051 . . . . 25.0 110.266 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.01 174.41 44.3 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 122.074 2.216 . . . . 25.0 110.383 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -160.45 147.49 15.82 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 114.487 1.292 . . . . 25.0 114.487 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.63 110.28 18.99 Favored Pre-proline 0 CA--C 1.593 2.623 0 C-N-CA 126.209 1.804 . . . . 50.0 108.964 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -88.07 161.6 7.25 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 N-CA-C 116.563 1.717 . . . . 25.0 116.563 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -78.26 115.42 17.97 Favored 'General case' 0 CA--C 1.469 -2.137 1 N-CA-C 99.907 -4.108 . . . . 25.0 99.907 171.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -102.3 -14.61 16.89 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.355 -0.839 . . . . 50.0 111.512 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.45 -23.0 2.7 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 105.273 -3.131 . . . . 25.0 105.273 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -78.88 148.02 71.48 Favored Pre-proline 0 C--O 1.266 1.937 0 N-CA-C 104.646 -2.353 . . . . 25.0 104.646 155.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -58.67 147.26 88.49 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 106.476 -2.163 . . . . 25.0 106.476 174.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.34 -19.26 46.89 Favored 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 64.4 p -83.35 6.19 20.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 125.778 1.924 . . . . 25.0 110.491 -176.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -55.06 -43.98 74.33 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 120.047 1.294 . . . . 25.0 113.871 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -110.3 98.43 7.67 Favored 'General case' 0 C--O 1.256 1.445 0 CA-C-O 116.676 -1.63 . . . . 25.0 108.694 166.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.7 tp -85.66 -11.37 53.99 Favored 'General case' 0 C--O 1.288 3.082 0 O-C-N 125.779 1.925 . . . . 75.0 110.626 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -103.92 138.25 40.76 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -143.06 148.24 36.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.138 1.336 . . . . 25.0 111.715 -164.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -103.6 150.13 24.25 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 125.87 1.981 . . . . 25.0 109.82 -170.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -141.1 127.48 20.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.261 -1.755 . . . . 25.0 106.261 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -84.86 126.93 33.89 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 119.215 0.916 . . . . 50.0 109.009 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -101.38 121.46 51.56 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 106.639 -1.615 . . . . 25.0 106.639 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -67.09 150.57 82.34 Favored 'Trans proline' 0 N--CA 1.481 0.793 1 C-N-CA 113.201 -4.066 . . . . 25.0 116.444 170.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.27 31.37 1.14 Allowed 'General case' 0 CA--C 1.573 1.861 0 CA-C-N 115.512 -0.767 . . . . 25.0 111.816 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.43 -44.77 70.66 Favored 'General case' 1 N--CA 1.545 4.277 0 O-C-N 120.883 -1.136 . . . . 50.0 114.021 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -152.14 166.92 30.16 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.816 0.672 . . . . 25.0 112.816 -170.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mp -83.83 149.22 26.54 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.785 -1.191 . . . . 50.0 107.785 167.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.05 -178.43 19.83 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-O 121.999 0.777 . . . . 25.0 114.962 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -120.42 159.35 25.28 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 117.485 2.402 . . . . 50.0 117.485 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -160.62 163.41 32.62 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 165.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.55 137.97 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.562 0 C-N-CA 124.299 1.04 . . . . 50.0 112.918 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.64 129.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 C-N-CA 125.085 1.354 . . . . 25.0 109.734 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.79 151.91 35.5 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 126.06 2.1 . . . . 50.0 113.881 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.05 51.37 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 104.463 -2.421 . . . . 25.0 104.463 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t -135.4 131.34 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 126.345 2.278 . . . . 50.0 107.259 -174.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -124.06 128.05 48.76 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 122.619 1.199 . . . . 25.0 108.592 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.73 144.65 34.55 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 123.502 1.62 . . . . 25.0 110.363 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.88 125.36 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 127.449 2.3 . . . . 50.0 111.744 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.49 62.67 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 103.239 -2.874 . . . . 25.0 103.239 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.3 -12.59 60.58 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 117.621 2.452 . . . . 25.0 117.621 -173.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.0 p -133.26 148.38 51.97 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 120.395 -1.441 . . . . 25.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -81.94 -25.21 35.07 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.9 0.88 . . . . 25.0 109.749 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.77 153.25 26.59 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 121.224 -0.922 . . . . 25.0 109.991 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.6 147.66 51.42 Favored 'General case' 0 C--O 1.175 -2.855 0 N-CA-C 105.465 -2.05 . . . . 25.0 105.465 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -120.73 137.29 54.57 Favored 'General case' 0 CA--C 1.479 -1.779 0 C-N-CA 117.996 -1.482 . . . . 50.0 112.21 -158.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -128.96 148.11 50.91 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.691 1.997 . . . . 50.0 114.92 -168.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -139.11 135.93 34.63 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 105.85 -1.907 . . . . 25.0 105.85 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.6 130.97 17.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.463 0 N-CA-C 114.578 1.325 . . . . 75.0 114.578 -169.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.47 123.76 55.91 Favored 'Isoleucine or valine' 0 C--O 1.273 2.32 0 O-C-N 124.728 1.267 . . . . 25.0 111.669 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.5 124.04 26.48 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.95 139.63 49.16 Favored 'Isoleucine or valine' 0 C--O 1.271 2.22 0 CA-C-O 125.311 2.481 . . . . 50.0 109.344 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -117.3 121.34 40.87 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 44.7 mt -131.27 120.42 23.17 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.803 -1.184 . . . . 50.0 107.803 -158.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.4 m -125.68 171.23 14.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 117.618 2.451 . . . . 50.0 117.618 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -74.11 159.59 32.39 Favored 'General case' 0 C--O 1.258 1.522 0 O-C-N 120.772 -1.205 . . . . 25.0 109.574 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.4 mttt . . . . . 0 C--O 1.259 1.568 0 O-C-N 126.821 2.576 . . . . 25.0 109.433 -177.545 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 . . . . . 0 C--O 1.267 1.997 0 CA-C-O 122.49 1.138 . . . . 25.0 111.638 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.76 -174.08 20.18 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-O 114.301 -3.499 . . . . 25.0 118.158 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.39 143.78 47.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 121.674 2.737 . . . . 50.0 107.141 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.5 mt -73.32 140.23 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 102.756 -3.053 . . . . 25.0 102.756 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -135.16 48.21 2.28 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 126.248 2.928 . . . . 25.0 113.834 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 mttt 75.65 163.19 0.14 Allowed Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 109.913 -3.312 . . . . 25.0 113.062 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.58 131.65 22.09 Favored 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 134.665 3.194 . . . . 25.0 108.693 7.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.54 154.5 17.87 Favored Glycine 0 C--O 1.282 3.133 0 N-CA-C 110.716 -0.953 . . . . 25.0 110.716 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 t -152.71 132.7 13.37 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.879 0.987 . . . . 25.0 111.449 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -85.83 -19.79 30.11 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.84 81.6 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 117.774 -1.57 . . . . 25.0 113.228 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.67 59.68 Favored 'General case' 0 C--O 1.269 2.117 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -90.25 -8.86 49.93 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.867 1.803 . . . . 75.0 115.867 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -45.98 -40.43 10.4 Favored 'General case' 0 C--O 1.189 -2.082 0 CA-C-N 112.566 -2.106 . . . . 25.0 113.485 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.0 p -68.41 175.14 3.53 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 118.748 2.87 . . . . 25.0 118.748 -160.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.34 -15.41 1.61 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.511 1.925 . . . . 25.0 113.916 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 -19.63 52.06 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -65.91 -3.14 4.65 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 117.258 -3.401 . . . . 50.0 116.228 169.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.29 -28.05 1.53 Allowed Glycine 0 CA--C 1.561 2.927 0 N-CA-C 117.909 1.923 . . . . 25.0 117.909 173.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.8 t80 60.88 25.9 15.82 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 123.613 1.673 . . . . 50.0 109.951 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.2 mt -93.13 -29.19 15.88 Favored 'General case' 0 C--O 1.191 -1.998 0 CA-C-N 114.775 -1.102 . . . . 50.0 112.082 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -137.09 170.86 15.39 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 102.401 -3.185 . . . . 25.0 102.401 -171.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -56.12 156.13 5.84 Favored 'General case' 0 C--O 1.193 -1.884 0 O-C-N 125.344 1.653 . . . . 50.0 109.029 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -100.43 25.24 7.88 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 117.137 -3.477 . . . . 25.0 115.134 -141.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.34 -41.49 0.3 Allowed 'General case' 0 C--O 1.266 1.972 0 CA-C-O 118.573 -0.727 . . . . 25.0 112.582 173.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.25 121.71 4.85 Favored Glycine 0 C--O 1.201 -1.964 0 C-N-CA 118.386 -1.864 . . . . 25.0 110.403 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -54.32 -23.44 15.28 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 119.042 2.978 . . . . 25.0 119.042 -165.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -64.01 -15.79 17.61 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 CA-C-O 118.354 -0.831 . . . . 50.0 112.789 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm -37.3 -15.09 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.535 1 N-CA-C 124.284 4.92 . . . . 25.0 124.284 172.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -71.13 -46.87 60.77 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 116.301 -3.999 . . . . 50.0 114.547 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -145.69 60.57 6.74 Favored Pre-proline 0 C--O 1.2 -1.505 0 CA-C-O 124.646 2.165 . . . . 25.0 112.834 169.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.13 -10.89 28.22 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 117.279 -1.348 . . . . 25.0 113.647 -166.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -78.8 -15.13 58.79 Favored 'General case' 0 C--O 1.189 -2.08 0 C-N-CA 126.925 2.09 . . . . 25.0 111.641 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -122.55 141.87 51.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 113.43 0.9 . . . . 25.0 113.43 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.2 109.13 20.82 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 124.667 2.175 . . . . 50.0 105.234 156.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.86 151.14 25.29 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.402 -2.074 . . . . 25.0 105.402 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.91 170.62 15.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 123.526 1.631 . . . . 25.0 107.956 169.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -136.76 147.29 46.59 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 119.24 -2.163 . . . . 25.0 108.222 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -76.64 135.94 39.15 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 104.654 -2.35 . . . . 25.0 104.654 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.09 164.61 24.07 Favored Glycine 0 C--O 1.202 -1.899 0 O-C-N 118.514 -2.616 . . . . 25.0 114.357 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -143.63 152.85 57.36 Favored Pre-proline 0 C--O 1.193 -1.878 0 O-C-N 119.144 -2.386 . . . . 25.0 116.142 -168.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -68.15 -15.73 10.03 Favored 'Cis proline' 0 C--O 1.272 2.188 0 CA-C-O 114.892 -2.212 . . . . 25.0 117.227 0.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -145.21 19.94 1.57 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 122.239 2.291 . . . . 25.0 116.77 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t 63.34 -171.16 0.17 Allowed 'General case' 0 N--CA 1.529 3.479 0 CA-C-N 113.503 -1.681 . . . . 25.0 111.642 -168.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.18 -68.48 1.64 Allowed Glycine 0 C--O 1.204 -1.774 0 CA-C-O 115.409 -2.884 . . . . 25.0 116.971 -166.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -63.0 170.44 7.5 Favored 'Trans proline' 0 CA--C 1.495 -1.426 1 C-N-CA 128.589 6.192 . . . . 25.0 111.568 148.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.41 68.23 0.13 Allowed 'General case' 0 C--O 1.269 2.095 0 O-C-N 118.195 -2.816 . . . . 25.0 112.56 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -78.07 161.85 27.13 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 125.68 1.592 . . . . 25.0 111.946 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.73 72.98 Favored Glycine 0 C--O 1.2 -1.994 0 CA-C-O 124.503 2.168 . . . . 25.0 116.678 -167.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -69.77 -23.73 63.41 Favored 'General case' 0 CA--C 1.556 1.181 0 O-C-N 119.645 -2.091 . . . . 25.0 109.485 -172.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.9 mt -83.86 -27.62 7.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 103.152 -2.907 . . . . 25.0 103.152 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.45 -26.29 59.95 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 118.39 -2.694 . . . . 25.0 110.35 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -92.2 -0.44 57.42 Favored 'General case' 0 N--CA 1.527 3.4 0 CA-C-O 124.157 1.932 . . . . 25.0 111.635 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 48.62 13.27 0.05 OUTLIER 'General case' 0 CA--C 1.587 2.373 0 CA-C-N 112.096 -2.32 . . . . 25.0 117.198 -156.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.88 -40.09 89.37 Favored Glycine 0 C--N 1.305 -1.181 0 CA-C-O 127.232 3.684 . . . . 25.0 110.31 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.82 9.84 54.52 Favored Glycine 0 C--O 1.185 -2.943 0 CA-C-N 111.114 -2.543 . . . . 25.0 112.347 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -116.05 -12.5 11.29 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 126.284 2.945 . . . . 50.0 112.8 173.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -74.98 -33.53 61.89 Favored 'General case' 0 C--O 1.265 1.877 0 CA-C-O 126.471 3.034 . . . . 50.0 105.456 154.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.5 -17.28 78.96 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-O 124.762 2.312 . . . . 25.0 110.191 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.88 -22.45 75.66 Favored Glycine 0 C--O 1.208 -1.512 0 CA-C-O 124.041 1.912 . . . . 25.0 112.66 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.16 -41.35 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 118.677 -2.661 . . . . 25.0 109.398 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.7 mt -72.21 -26.48 62.06 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 119.971 3.323 . . . . 75.0 119.971 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -66.5 -28.05 68.26 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.61 -1.255 . . . . 50.0 107.61 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -78.77 6.97 7.76 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 123.819 0.699 . . . . 25.0 111.31 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -126.15 39.64 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 104.306 -2.479 . . . . 25.0 104.306 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -154.98 169.44 24.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.264 -1.523 . . . . 25.0 107.544 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.73 -14.63 63.15 Favored 'General case' 0 C--O 1.182 -2.471 0 CA-C-O 124.745 2.212 . . . . 25.0 109.245 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -86.06 20.18 2.38 Favored 'General case' 0 N--CA 1.422 -1.852 0 O-C-N 119.03 -2.294 . . . . 25.0 112.319 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.92 96.91 2.18 Favored 'General case' 0 C--O 1.263 1.802 0 CA-C-O 124.803 2.24 . . . . 25.0 105.589 163.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -44.71 146.0 0.83 Allowed 'General case' 0 C--O 1.275 2.395 1 CA-C-N 106.598 -4.819 . . . . 25.0 109.74 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -79.78 132.34 36.13 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 119.681 -1.887 . . . . 50.0 112.037 -157.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.05 155.83 16.9 Favored 'General case' 0 C--N 1.365 1.256 0 CA-C-N 112.333 -2.212 . . . . 25.0 112.17 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -152.44 141.25 21.03 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.032 -1.467 . . . . 25.0 113.841 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.28 129.9 39.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.78 0 C-N-CA 117.045 -1.862 . . . . 25.0 106.611 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.4 ttt -139.92 157.77 45.15 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 121.177 1.808 . . . . 25.0 107.452 164.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 p -68.02 162.74 23.83 Favored 'General case' 0 CA--C 1.584 2.275 0 O-C-N 117.911 -2.993 . . . . 25.0 109.214 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.95 -156.27 3.38 Favored Glycine 0 C--O 1.209 -1.463 1 O-C-N 115.928 -4.232 . . . . 25.0 113.485 164.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 -173.38 38.02 Favored Glycine 0 C--O 1.192 -2.495 0 O-C-N 121.322 -1.105 . . . . 25.0 111.5 -165.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.62 133.15 51.66 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 120.491 2.145 . . . . 25.0 114.089 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -120.16 133.2 55.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.767 -1.568 . . . . 25.0 106.767 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.1 m -115.54 89.62 3.14 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 120.695 1.589 . . . . 25.0 111.573 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -74.4 117.7 16.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.618 0.767 . . . . 50.0 109.981 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -123.99 145.02 49.47 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.372 -2.084 . . . . 25.0 105.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -127.8 159.24 35.44 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 102.225 -3.25 . . . . 25.0 102.225 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.3 p -134.91 163.1 30.6 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 127.704 3.128 . . . . 25.0 108.245 166.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.36 137.9 52.89 Favored 'General case' 0 N--CA 1.496 1.863 1 N-CA-C 96.768 -5.271 . . . . 50.0 96.768 164.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.4 t -74.51 -20.68 59.89 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 116.031 -2.268 . . . . 25.0 105.713 -165.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.16 157.58 77.68 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 103.038 -2.949 . . . . 25.0 103.038 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.29 143.16 27.86 Favored 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 109.95 -6.233 . . . . 25.0 112.018 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -118.03 152.65 35.11 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.833 -2.284 . . . . 25.0 104.833 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.57 160.54 32.51 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.67 147.05 24.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 127.867 2.467 . . . . 25.0 113.389 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -108.64 -27.94 9.55 Favored 'General case' 0 C--O 1.26 1.617 0 N-CA-C 114.535 1.309 . . . . 25.0 114.535 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -174.43 173.74 2.9 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.054 -2.573 . . . . 25.0 104.054 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -153.24 169.43 23.06 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.982 -0.747 . . . . 25.0 108.982 163.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -145.01 151.79 39.12 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 114.434 -2.698 . . . . 25.0 106.764 -169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.88 147.18 21.22 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 124.737 2.208 . . . . 50.0 112.982 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -132.08 165.09 24.81 Favored 'General case' 1 C--O 1.306 4.059 0 CA-C-N 114.324 -1.307 . . . . 50.0 107.661 -162.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.4 pt -125.94 157.0 36.11 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.676 0 N-CA-C 101.311 -3.589 . . . . 25.0 101.311 161.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.9 p -76.3 150.15 36.98 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.346 -1.724 . . . . 25.0 106.346 169.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -143.49 76.85 1.54 Allowed 'General case' 0 N--CA 1.423 -1.791 0 O-C-N 120.641 -1.287 . . . . 25.0 108.221 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -56.44 153.45 9.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.11 -1.859 . . . . 25.0 112.851 167.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.73 37.77 22.08 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 116.79 -2.116 . . . . 25.0 109.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -64.5 157.22 27.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 126.598 1.999 . . . . 25.0 110.949 163.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -59.22 133.81 87.92 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 108.221 -1.029 . . . . 25.0 108.221 158.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.33 -36.14 98.9 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 N-CA-C 117.456 2.06 . . . . 25.0 117.456 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.66 -19.8 62.72 Favored 'General case' 0 C--O 1.267 1.994 0 N-CA-C 116.889 2.181 . . . . 75.0 116.889 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -58.16 159.08 11.88 Favored Pre-proline 0 C--O 1.205 -1.27 0 CA-C-N 113.13 -1.85 . . . . 25.0 110.231 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.45 23.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.193 -1.774 2 C-N-CA 127.128 5.219 . . . . 25.0 125.08 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 tp 14.79 -56.87 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.244 1 N-CA-C 125.56 5.393 . . . . 50.0 125.56 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -69.24 -31.54 70.17 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -96.72 -46.5 6.26 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.624 -1.626 . . . . 25.0 110.517 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.79 -3.78 1.75 Allowed 'General case' 0 C--O 1.206 -1.19 0 C-N-CA 118.82 -1.152 . . . . 25.0 113.058 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.7 -26.35 68.34 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 115.471 1.656 . . . . 25.0 115.471 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -127.51 153.23 46.59 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.207 -2.146 . . . . 50.0 105.207 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -126.68 130.61 50.74 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 111.877 -2.419 . . . . 25.0 111.258 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.18 111.44 3.43 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 105.508 -2.034 . . . . 50.0 105.508 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.73 -20.24 7.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.444 -1.317 . . . . 25.0 107.444 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.7 166.55 33.39 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.748 -1.22 . . . . 25.0 113.555 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.92 155.36 41.5 Favored 'General case' 0 C--O 1.181 -2.516 0 N-CA-C 104.124 -2.547 . . . . 25.0 104.124 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.3 107.12 17.6 Favored Pre-proline 0 C--O 1.271 2.213 0 N-CA-C 106.828 -1.545 . . . . 50.0 106.828 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.33 162.05 28.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 N-CA-C 107.553 -1.749 . . . . 25.0 107.553 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -139.66 63.01 1.5 Allowed 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 119.544 -0.862 . . . . 25.0 110.542 -170.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.15 -16.9 0.83 Allowed 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.533 1.679 . . . . 50.0 115.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -164.75 21.58 0.14 Allowed Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 125.412 1.482 . . . . 25.0 116.681 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.63 162.06 73.35 Favored Pre-proline 0 CA--C 1.556 1.201 0 O-C-N 124.88 0.988 . . . . 25.0 113.437 -174.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.29 -170.01 0.53 Allowed 'Trans proline' 0 C--O 1.264 1.808 0 CA-C-O 117.822 -0.991 . . . . 25.0 113.987 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.42 4.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 1 N-CA-C 122.027 4.084 . . . . 25.0 122.027 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 p -57.66 -17.6 15.73 Favored 'General case' 0 C--O 1.187 -2.224 0 CA-C-N 115.921 -0.582 . . . . 25.0 110.284 161.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -63.9 -16.71 62.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.183 0.809 . . . . 25.0 113.183 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -60.72 129.83 43.46 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 117.821 -1.085 . . . . 25.0 109.471 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.49 -5.01 17.06 Favored 'General case' 0 C--O 1.283 2.86 0 N-CA-C 120.357 3.465 . . . . 75.0 120.357 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.4 t -86.51 127.18 34.85 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 126.039 1.736 . . . . 25.0 109.141 160.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -134.67 130.13 35.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 118.921 2.934 . . . . 25.0 118.921 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -92.07 129.22 38.07 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.174 -1.375 . . . . 25.0 113.573 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.5 mt -121.09 124.03 71.29 Favored 'Isoleucine or valine' 0 C--O 1.271 2.194 0 N-CA-C 105.605 -1.998 . . . . 25.0 105.605 169.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -75.84 137.09 40.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.003 -2.221 . . . . 50.0 105.003 165.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -115.28 129.78 24.81 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 101.763 -3.421 . . . . 25.0 101.763 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.74 140.63 68.58 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 116.372 -1.952 . . . . 25.0 109.415 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -108.66 2.92 22.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.31 -23.71 32.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.517 2.043 . . . . 50.0 116.517 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -143.49 155.1 44.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 114.768 -2.539 . . . . 25.0 107.512 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -75.22 164.56 26.34 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 125.808 1.943 . . . . 50.0 109.605 170.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 175.81 135.28 2.09 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 108.12 -1.992 . . . . 25.0 108.12 170.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -115.3 148.53 39.1 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 124.973 1.309 . . . . 50.0 111.396 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -161.04 161.88 31.52 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 116.569 -1.681 . . . . 25.0 107.471 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.9 t -91.01 158.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 101.664 -3.458 . . . . 50.0 101.664 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.77 135.78 49.97 Favored 'Isoleucine or valine' 0 C--O 1.28 2.671 1 N-CA-C 98.048 -4.797 . . . . 25.0 98.048 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.26 148.2 48.77 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 103.749 -2.685 . . . . 50.0 103.749 168.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.09 153.0 41.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.588 -0.695 . . . . 25.0 110.718 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.9 140.64 46.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.625 0 C-N-CA 123.067 0.547 . . . . 50.0 111.304 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.19 133.76 45.83 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.788 1.235 . . . . 25.0 112.574 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.96 133.29 55.6 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.338 1.055 . . . . 25.0 112.663 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.9 t -131.64 111.87 19.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 102.119 -3.289 . . . . 50.0 102.119 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.62 -24.86 53.37 Favored 'General case' 0 C--O 1.17 -3.091 0 CA-C-O 117.753 -1.118 . . . . 25.0 108.288 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.98 -19.27 65.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 124.477 2.084 . . . . 25.0 115.858 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.7 p -118.82 150.83 39.16 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.151 -1.84 . . . . 25.0 114.202 -173.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -78.55 -25.55 45.47 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.344 -1.753 . . . . 25.0 109.974 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -63.33 152.22 38.55 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 118.611 -1.236 . . . . 25.0 114.133 163.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.88 158.34 44.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 105.588 -2.005 . . . . 25.0 105.588 174.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -131.36 146.06 52.11 Favored 'General case' 0 C--O 1.29 3.206 0 O-C-N 118.618 -2.551 . . . . 50.0 114.78 -170.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.01 170.54 15.83 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 102.466 -3.161 . . . . 50.0 102.466 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -164.34 167.36 19.86 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.2 p -145.32 134.99 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.935 -1.135 . . . . 75.0 107.935 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -141.85 146.26 23.14 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 101.972 -3.344 . . . . 25.0 101.972 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -122.17 152.18 40.21 Favored 'General case' 0 C--O 1.264 1.827 0 CA-C-N 121.072 1.76 . . . . 25.0 108.002 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.66 153.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.76 0 N-CA-C 110.185 -0.302 . . . . 50.0 110.185 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -131.79 94.52 3.52 Favored 'General case' 0 C--O 1.264 1.857 0 N-CA-C 101.401 -3.555 . . . . 25.0 101.401 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 53.3 mt -102.49 111.77 24.22 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.34 -1.475 . . . . 50.0 114.446 -170.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.5 m -128.11 173.71 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.964 2.579 . . . . 50.0 117.964 -153.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.37 147.13 23.65 Favored 'General case' 0 CA--C 1.494 -1.203 1 N-CA-C 99.541 -4.244 . . . . 25.0 99.541 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 C--O 1.269 2.088 0 N-CA-C 116.036 1.865 . . . . 25.0 116.036 169.206 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 N--CA 1.534 3.748 0 CA-C-O 123.846 1.784 . . . . 25.0 113.33 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.21 -32.44 0.09 OUTLIER Glycine 0 C--O 1.27 2.384 0 C-N-CA 127.632 2.539 . . . . 25.0 111.052 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.08 140.13 53.34 Favored 'General case' 0 CA--C 1.482 -1.643 0 C-N-CA 125.637 1.575 . . . . 50.0 109.8 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.5 mt -103.76 122.04 55.96 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 N-CA-C 100.703 -3.814 . . . . 25.0 100.703 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -92.63 -40.56 10.68 Favored 'General case' 0 C--O 1.182 -2.486 0 CA-C-N 119.14 0.882 . . . . 25.0 112.66 -173.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -144.82 154.41 55.35 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 115.887 -2.006 . . . . 25.0 106.634 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.65 136.45 45.14 Favored 'Cis proline' 0 N--CA 1.476 0.478 0 CA-C-N 121.909 1.718 . . . . 25.0 109.059 0.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.74 -162.44 38.29 Favored Glycine 0 C--O 1.214 -1.113 0 N-CA-C 120.082 2.793 . . . . 25.0 120.082 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -114.51 116.0 28.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.487 1.644 . . . . 25.0 111.282 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -73.11 -23.24 60.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.123 0.874 . . . . 25.0 109.588 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.47 72.63 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.234 1.814 . . . . 25.0 106.297 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.38 -37.95 68.22 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 124.216 0.947 . . . . 25.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -94.66 -32.2 13.49 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.803 0.689 . . . . 75.0 110.638 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 t -74.21 -23.31 59.17 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 119.665 -1.897 . . . . 25.0 115.96 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.3 p -94.47 155.94 16.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 123.876 1.798 . . . . 25.0 108.244 -164.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.25 61.8 mt-10 -89.76 -13.12 37.43 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.497 -2.038 . . . . 25.0 105.497 166.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.88 85.79 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -174.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -56.28 -49.08 75.27 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 115.602 1.704 . . . . 50.0 115.602 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.78 -0.96 0.64 Allowed Glycine 0 C--N 1.308 -0.993 0 N-CA-C 118.743 2.257 . . . . 25.0 118.743 -167.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.4 t80 59.26 -46.79 0.07 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 120.016 3.339 . . . . 50.0 120.016 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.06 -19.36 61.19 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 123.731 2.969 . . . . 50.0 115.551 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -149.27 175.56 11.3 Favored 'General case' 0 CA--C 1.499 -0.994 1 N-CA-C 100.064 -4.05 . . . . 25.0 100.064 -171.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.81 170.77 18.93 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 103.132 -2.914 . . . . 50.0 103.132 170.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -147.38 70.9 1.19 Allowed 'General case' 0 C--N 1.319 -0.726 0 O-C-N 118.698 -2.501 . . . . 25.0 108.598 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.91 -19.05 2.62 Favored 'General case' 0 C--O 1.193 -1.88 0 CA-C-N 112.208 -2.269 . . . . 25.0 113.997 -175.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.76 -107.52 1.32 Allowed Glycine 0 C--O 1.211 -1.342 0 CA-C-O 123.163 1.424 . . . . 25.0 115.091 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -96.27 -29.08 14.21 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 112.483 -1.859 . . . . 25.0 111.309 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.49 -28.57 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 CA-C-N 115.457 -0.792 . . . . 50.0 111.668 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.3 ptt? -62.61 -23.09 66.86 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 114.601 1.334 . . . . 25.0 114.601 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -88.15 -37.83 15.85 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.291 -1.364 . . . . 50.0 111.319 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.51 48.02 0.25 Allowed Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 115.978 1.844 . . . . 25.0 115.978 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.16 -19.49 34.14 Favored 'Trans proline' 0 CA--C 1.569 2.261 1 C-N-CA 110.915 -5.59 . . . . 25.0 116.621 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.266 12.2 pt20 -109.15 -20.88 12.83 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.846 1.203 . . . . 25.0 113.911 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.1 p -96.58 22.45 8.02 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.297 1.046 . . . . 25.0 113.755 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.97 44.47 0.03 OUTLIER 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.669 1.988 . . . . 50.0 115.485 -172.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.77 156.63 39.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 120.766 3.617 . . . . 25.0 120.766 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.72 58.3 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 117.651 -1.166 . . . . 25.0 113.976 170.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.511 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 31.7 tttm -151.71 -164.23 1.93 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.831 3.014 . . . . 25.0 109.435 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' H ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 mttt -65.21 159.38 23.78 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 113.508 -1.678 . . . . 25.0 109.862 -170.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.38 169.97 39.38 Favored Glycine 0 C--N 1.359 1.819 0 CA-C-O 118.41 -1.217 . . . . 25.0 116.082 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -115.02 97.14 47.17 Favored Pre-proline 0 CA--C 1.583 2.247 0 O-C-N 125.962 1.625 . . . . 25.0 114.643 -176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.4 177.33 33.47 Favored 'Cis proline' 0 CA--C 1.547 1.129 0 C-N-CA 132.783 2.41 . . . . 25.0 109.429 -8.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -75.55 -29.97 59.57 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 118.608 2.818 . . . . 25.0 118.608 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t 56.4 -60.65 0.02 OUTLIER 'General case' 0 C--O 1.175 -2.83 0 C-N-CA 131.488 3.915 . . . . 25.0 118.039 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.65 176.53 35.56 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-O 114.221 -3.544 . . . . 25.0 113.96 -176.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.08 168.8 18.06 Favored 'Trans proline' 0 C--O 1.258 1.492 1 C-N-CA 129.629 6.886 . . . . 25.0 109.679 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.69 136.34 57.66 Favored 'General case' 0 C--O 1.203 -1.392 0 N-CA-C 107.735 -1.209 . . . . 25.0 107.735 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -82.01 130.14 34.99 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 119.077 -2.264 . . . . 25.0 107.692 -166.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.75 3.82 6.31 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 113.557 -3.913 . . . . 25.0 115.571 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.457 HE22 ' HG ' ' A' ' 53' ' ' SER . 33.9 tp60 42.08 39.4 1.34 Allowed 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.143 1.972 . . . . 25.0 108.899 -168.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.4 mt -72.5 -41.42 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 119.262 -2.149 . . . . 25.0 110.605 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.7 81.79 Favored 'General case' 0 C--O 1.26 1.641 0 N-CA-C 114.425 1.268 . . . . 25.0 114.425 -168.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.457 ' HG ' HE22 ' A' ' 50' ' ' GLN . 78.0 p -87.67 -15.94 35.77 Favored 'General case' 0 C--O 1.263 1.816 0 O-C-N 123.887 0.742 . . . . 25.0 109.265 -177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.06 -16.62 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 121.571 3.915 . . . . 25.0 121.571 165.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.08 -25.23 76.08 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-O 122.186 0.881 . . . . 25.0 111.574 172.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.67 -11.75 66.15 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 113.746 -1.227 . . . . 25.0 115.916 166.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.7 mt -85.01 -20.92 29.76 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 119.084 -2.421 . . . . 50.0 113.303 172.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 -35.79 32.92 Favored 'General case' 0 CA--C 1.586 2.337 0 N-CA-C 101.343 -3.577 . . . . 50.0 101.343 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.56 63.74 Favored Glycine 0 C--O 1.268 2.245 0 CA-C-N 114.014 -1.448 . . . . 25.0 113.07 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.66 77.56 Favored Glycine 0 C--O 1.201 -1.914 0 CA-C-N 119.058 1.429 . . . . 25.0 110.938 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -65.55 -43.57 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 106.885 -1.524 . . . . 25.0 106.885 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.12 -24.21 59.41 Favored 'General case' 0 C--O 1.172 -3.014 0 N-CA-C 107.686 -1.227 . . . . 75.0 107.686 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.69 -21.39 60.26 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 123.777 1.751 . . . . 50.0 111.171 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -103.95 16.35 26.5 Favored 'General case' 0 C--O 1.183 -2.441 0 O-C-N 118.213 -2.804 . . . . 25.0 108.37 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -128.95 49.73 2.2 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 102.303 -3.221 . . . . 25.0 102.303 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -152.5 -179.67 7.79 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 100.525 -3.88 . . . . 25.0 100.525 -162.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -66.8 -17.61 64.96 Favored 'General case' 0 CA--C 1.592 2.587 0 C-N-CA 117.651 -1.62 . . . . 25.0 114.413 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -94.68 48.77 1.22 Allowed 'General case' 0 CA--C 1.556 1.21 0 O-C-N 120.203 -1.561 . . . . 25.0 108.317 165.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -85.32 98.98 10.84 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 100.191 -4.003 . . . . 25.0 100.191 156.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -65.6 163.06 16.98 Favored 'General case' 0 C--O 1.256 1.43 1 CA-C-N 106.583 -4.826 . . . . 25.0 110.703 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -59.52 146.29 41.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 120.016 1.28 . . . . 50.0 112.366 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -129.33 154.4 46.92 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -139.77 150.72 45.09 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 118.282 -0.866 . . . . 25.0 112.038 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.98 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.127 0 CA-C-O 123.789 1.757 . . . . 25.0 110.561 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 30.6 mtm -147.0 172.0 14.39 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 120.147 -1.596 . . . . 25.0 113.493 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.1 p -71.53 165.21 24.35 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 105.071 -2.196 . . . . 25.0 105.071 168.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.06 176.62 53.11 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 106.378 -2.689 . . . . 25.0 106.378 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.94 -170.15 20.17 Favored Glycine 0 C--O 1.266 2.113 0 CA-C-N 120.342 2.071 . . . . 25.0 113.815 -170.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -74.68 137.39 42.11 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 112.922 -1.639 . . . . 25.0 109.852 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -127.62 159.1 35.69 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.719 1.208 . . . . 25.0 111.158 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.3 m -117.89 142.04 47.77 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 106.31 -1.737 . . . . 25.0 106.31 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -125.96 114.72 18.86 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 102.687 -3.079 . . . . 50.0 102.687 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 m -129.87 117.68 20.54 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.706 -1.588 . . . . 25.0 112.524 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . 0.308 0.8 OUTLIER -111.51 136.61 50.45 Favored 'General case' 0 C--O 1.3 3.717 0 N-CA-C 101.353 -3.573 . . . . 25.0 101.353 171.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -148.88 160.29 43.39 Favored 'General case' 0 C--O 1.181 -2.54 0 O-C-N 125.59 1.806 . . . . 25.0 108.887 -167.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.04 170.32 16.2 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.852 -1.067 . . . . 50.0 109.288 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.9 t -64.76 -25.42 67.92 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.907 -1.044 . . . . 25.0 111.45 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.34 153.23 74.54 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 125.096 1.497 . . . . 25.0 111.129 -171.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.99 169.39 20.61 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 117.331 -1.313 . . . . 25.0 112.53 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.258 3.2 m80 -127.09 161.51 28.26 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 103.81 -2.663 . . . . 25.0 103.81 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -81.86 57.93 3.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.091 0.956 . . . . 25.0 109.642 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 m -66.98 144.5 56.17 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 127.022 2.702 . . . . 25.0 108.878 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -117.37 -32.05 5.07 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 126.478 2.361 . . . . 25.0 109.822 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -165.59 154.68 12.02 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 124.755 1.222 . . . . 25.0 109.471 -170.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -141.74 164.56 29.88 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 145.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.33 36.4 m-70 -131.9 145.06 51.3 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 126.588 1.955 . . . . 25.0 107.776 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -139.54 148.34 42.46 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-O 122.713 1.244 . . . . 50.0 111.286 170.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.46 162.05 30.05 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 109.679 -3.418 . . . . 50.0 111.042 -164.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.2 151.05 33.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 102.25 -3.241 . . . . 25.0 102.25 176.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.6 m -82.32 113.88 20.41 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 125.883 1.989 . . . . 25.0 109.893 157.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -83.38 94.33 7.94 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-N 120.209 1.368 . . . . 25.0 109.57 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -61.76 161.19 10.51 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 124.671 1.188 . . . . 25.0 111.923 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.42 28.15 Favored Glycine 0 CA--C 1.497 -1.048 0 C-N-CA 119.0 -1.571 . . . . 25.0 116.504 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.21 159.89 32.18 Favored 'General case' 0 CA--C 1.581 2.145 0 C-N-CA 119.592 -0.843 . . . . 25.0 111.426 -171.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -71.31 117.1 53.74 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 102.377 -3.194 . . . . 25.0 102.377 149.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.81 -22.22 37.05 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 125.282 3.988 . . . . 25.0 117.525 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -75.08 -13.84 60.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.387 -1.446 . . . . 75.0 109.934 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.253 95.9 mttt -117.11 165.3 15.84 Favored Pre-proline 0 C--O 1.2 -1.504 2 N-CA-C 99.202 -4.37 . . . . 25.0 99.202 -171.75 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 3.38 14.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 2 C-N-CA 135.44 10.76 . . . . 25.0 127.967 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.1 tt -46.66 -43.53 17.69 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-O 115.616 -2.135 . . . . 50.0 113.768 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -75.39 -2.58 29.19 Favored 'General case' 0 C--O 1.169 -3.163 0 O-C-N 125.195 1.56 . . . . 25.0 113.207 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -121.94 -51.85 2.0 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 122.799 1.285 . . . . 25.0 112.155 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.55 -26.53 3.57 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 112.653 -2.067 . . . . 25.0 115.095 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -80.35 -7.78 59.22 Favored 'General case' 0 C--O 1.28 2.676 0 CA-C-N 113.489 -1.687 . . . . 25.0 111.04 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -141.64 47.56 1.66 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 118.236 -2.79 . . . . 50.0 106.631 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.8 122.45 29.15 Favored 'General case' 0 CA--C 1.558 1.286 0 O-C-N 118.143 -2.848 . . . . 25.0 111.5 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.6 tp -60.72 125.96 25.64 Favored 'General case' 0 C--O 1.266 1.94 0 N-CA-C 114.174 1.176 . . . . 50.0 114.174 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.7 tt -108.21 -22.4 5.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 116.799 -1.572 . . . . 25.0 106.999 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.12 -179.43 44.74 Favored Glycine 0 C--N 1.371 2.488 0 C-N-CA 118.746 -1.692 . . . . 25.0 116.193 161.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -146.59 153.99 40.98 Favored 'General case' 0 C--O 1.286 3.023 0 CA-C-O 123.279 1.514 . . . . 25.0 107.333 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.2 t -132.46 86.49 45.14 Favored Pre-proline 0 CA--C 1.62 3.648 0 N-CA-C 103.608 -2.738 . . . . 50.0 103.608 -173.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.18 154.33 61.98 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 115.234 -2.711 . . . . 25.0 112.259 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -144.59 96.44 2.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.37 1.618 . . . . 25.0 115.37 -157.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.34 -7.25 16.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.57 -1.65 . . . . 50.0 114.722 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.41 -171.1 42.1 Favored Glycine 0 C--O 1.283 3.194 1 N-CA-C 101.969 -4.452 . . . . 25.0 101.969 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.4 m -126.42 75.11 73.89 Favored Pre-proline 0 N--CA 1.508 2.439 0 N-CA-C 115.193 1.553 . . . . 25.0 115.193 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.3 170.19 17.81 Favored 'Trans proline' 0 C--O 1.213 -0.759 1 C-N-CA 111.984 -4.877 . . . . 25.0 106.208 150.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.76 67.02 Favored 'General case' 0 CA--C 1.573 1.842 0 O-C-N 119.373 -2.079 . . . . 25.0 115.567 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 95.5 p -68.02 -22.89 64.96 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 120.93 1.696 . . . . 25.0 114.407 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -111.97 19.59 17.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 127.039 2.712 . . . . 25.0 111.974 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -55.59 148.82 15.06 Favored 'General case' 0 N--CA 1.513 2.681 0 CA-C-O 122.82 1.295 . . . . 25.0 108.404 168.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tp -64.65 -36.4 84.14 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 111.483 -2.599 . . . . 75.0 110.795 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.7 t -91.81 153.76 19.36 Favored 'General case' 0 C--O 1.285 2.946 0 N-CA-C 104.12 -2.548 . . . . 25.0 104.12 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -147.41 164.63 32.72 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 112.82 0.674 . . . . 25.0 112.82 170.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -113.59 148.9 35.34 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 104.471 -2.418 . . . . 25.0 104.471 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -133.03 124.5 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 105.645 -1.983 . . . . 25.0 105.645 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . 0.254 70.0 t80 -90.91 132.75 35.74 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.124 -2.86 . . . . 50.0 109.039 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.6 mm -131.63 124.4 19.93 Favored Pre-proline 0 C--O 1.268 2.059 0 N-CA-C 103.254 -2.869 . . . . 25.0 103.254 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.19 165.89 29.96 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 114.51 -3.193 . . . . 25.0 116.697 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.53 39.35 1.06 Allowed 'General case' 0 C--O 1.295 3.46 0 CA-C-O 125.853 2.74 . . . . 25.0 111.27 175.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.86 -20.17 59.85 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 115.64 1.719 . . . . 50.0 115.64 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -148.92 170.32 18.56 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.63 139.46 38.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 101.631 -3.47 . . . . 50.0 101.631 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.13 176.67 20.19 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 118.328 -1.891 . . . . 25.0 115.47 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -81.86 146.25 29.95 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 117.985 2.587 . . . . 50.0 117.985 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -138.93 113.75 9.21 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.916 2.01 . . . . 25.0 111.138 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.76 130.87 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 116.176 -1.869 . . . . 50.0 108.625 -172.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.48 132.15 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 124.031 1.872 . . . . 25.0 109.907 167.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.1 mp -118.04 138.59 52.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 102.868 -3.012 . . . . 50.0 102.868 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.39 144.61 29.85 Favored 'General case' 0 C--O 1.29 3.187 0 O-C-N 119.826 -1.796 . . . . 25.0 111.835 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 79.8 t -124.67 135.14 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 102.728 -3.064 . . . . 50.0 102.728 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -135.26 114.83 12.66 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 125.428 1.705 . . . . 25.0 112.079 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -112.18 128.84 56.35 Favored 'General case' 0 C--O 1.284 2.885 0 O-C-N 123.872 0.732 . . . . 25.0 111.687 -162.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.6 t -121.7 119.07 57.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 115.823 -2.037 . . . . 50.0 107.319 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.71 -13.36 31.55 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 119.719 3.229 . . . . 25.0 119.719 -166.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -76.36 -18.65 58.78 Favored 'General case' 0 C--O 1.253 1.263 0 O-C-N 120.268 -1.52 . . . . 25.0 112.348 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -112.25 153.4 27.19 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 119.951 -1.718 . . . . 25.0 111.751 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -78.11 -28.2 48.56 Favored 'General case' 0 C--O 1.28 2.673 0 N-CA-C 103.161 -2.904 . . . . 25.0 103.161 171.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.08 179.34 3.34 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 119.177 -2.202 . . . . 25.0 113.23 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.57 151.56 36.49 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 125.84 1.656 . . . . 25.0 108.584 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -95.25 150.22 20.47 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 126.023 2.077 . . . . 50.0 111.778 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -133.56 130.7 38.79 Favored 'General case' 0 C--O 1.284 2.872 0 CA-C-N 114.741 -1.118 . . . . 50.0 108.205 -169.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.0 156.87 45.45 Favored 'General case' 0 C--O 1.267 1.988 0 CA-C-N 119.65 1.114 . . . . 25.0 112.22 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.8 127.94 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 107.631 -1.248 . . . . 75.0 107.631 -171.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.58 137.04 57.82 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 N-CA-C 107.465 -1.309 . . . . 25.0 107.465 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.67 126.95 50.18 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 123.648 0.593 . . . . 25.0 110.941 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.36 132.99 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 122.914 1.34 . . . . 50.0 111.697 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -96.23 113.42 25.01 Favored 'General case' 0 C--O 1.204 -1.339 0 N-CA-C 104.625 -2.361 . . . . 25.0 104.625 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.36 110.71 21.6 Favored 'General case' 0 CA--C 1.476 -1.896 0 CA-C-N 112.807 -1.997 . . . . 50.0 110.202 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.7 m -132.93 154.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-O 124.564 2.126 . . . . 50.0 112.615 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -59.11 126.38 27.46 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.0 pttp . . . . . 0 C--O 1.263 1.801 0 CA-C-O 116.061 -1.924 . . . . 25.0 108.53 179.045 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 118.996 -0.526 . . . . 25.0 111.217 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.65 173.64 42.03 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 120.482 1.492 . . . . 25.0 115.341 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -129.21 135.73 49.2 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 125.165 1.386 . . . . 50.0 112.746 -156.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.5 mt -89.57 121.53 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 119.229 -2.169 . . . . 25.0 111.151 -171.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -101.22 16.48 25.37 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.862 1.265 . . . . 25.0 110.245 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 64.87 166.27 0.11 Allowed Pre-proline 0 CA--C 1.594 2.652 0 C-N-CA 128.195 2.598 . . . . 25.0 111.14 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.55 141.3 45.07 Favored 'Cis proline' 0 C--O 1.204 -1.225 0 C-N-CA 132.621 2.342 . . . . 25.0 111.709 13.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.94 91.53 1.61 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 117.272 1.669 . . . . 25.0 117.272 168.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 t -75.63 144.44 41.71 Favored 'General case' 0 C--O 1.275 2.423 0 CA-C-O 123.183 1.468 . . . . 25.0 110.921 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -107.23 -22.93 12.44 Favored 'General case' 0 CA--C 1.581 2.138 0 CA-C-N 113.721 -1.581 . . . . 25.0 109.724 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.39 89.71 Favored 'General case' 0 C--O 1.264 1.856 0 CA-C-O 117.398 -1.287 . . . . 25.0 108.792 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -29.14 70.57 Favored 'General case' 0 C--O 1.279 2.656 0 O-C-N 125.764 1.915 . . . . 25.0 115.389 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt -80.98 -21.55 40.22 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 120.433 -1.417 . . . . 75.0 109.575 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -11.09 59.68 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 116.334 1.976 . . . . 25.0 116.334 174.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.8 t -65.6 165.7 11.92 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 114.913 1.449 . . . . 25.0 114.913 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.18 -24.51 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 1 N-CA-C 124.498 4.999 . . . . 25.0 124.498 -169.343 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.63 -20.19 66.21 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.705 1.602 . . . . 25.0 110.404 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -52.78 -18.91 2.1 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 117.685 2.476 . . . . 50.0 117.685 165.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.43 7.65 0.21 Allowed Glycine 0 C--O 1.211 -1.3 0 N-CA-C 122.888 3.915 . . . . 25.0 122.888 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 49.86 0.47 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 131.047 3.739 . . . . 50.0 117.584 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.6 mt -94.6 -12.14 28.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 118.251 -2.78 . . . . 50.0 116.156 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -132.77 -171.98 2.8 Favored 'General case' 0 C--O 1.182 -2.479 0 O-C-N 121.782 -0.573 . . . . 25.0 109.671 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mp -65.57 159.68 24.11 Favored 'General case' 0 C--O 1.245 0.855 0 O-C-N 120.541 -1.349 . . . . 50.0 114.095 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -78.56 2.38 19.42 Favored 'General case' 0 C--O 1.191 -1.991 0 C-N-CA 125.909 1.683 . . . . 25.0 112.274 -169.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -147.93 -38.81 0.18 Allowed 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 119.355 -0.938 . . . . 25.0 111.083 138.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.64 131.0 5.68 Favored Glycine 0 C--O 1.267 2.207 0 N-CA-C 106.058 -2.817 . . . . 25.0 106.058 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 m -52.05 -12.33 0.22 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.864 3.283 . . . . 25.0 119.864 -174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.94 -4.85 6.24 Favored 'Isoleucine or valine' 0 C--O 1.256 1.396 0 O-C-N 118.553 -2.592 . . . . 50.0 112.116 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.9 ptm -55.48 -10.07 0.58 Allowed 'General case' 0 C--O 1.257 1.452 0 N-CA-C 115.62 1.711 . . . . 25.0 115.62 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -64.58 -38.16 90.03 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.653 2.094 . . . . 50.0 116.653 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -147.41 64.26 8.54 Favored Pre-proline 0 C--O 1.262 1.76 0 CA-C-O 118.353 -0.832 . . . . 25.0 109.558 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 -21.67 12.96 Favored 'Trans proline' 0 N--CA 1.486 1.063 1 C-N-CA 110.775 -5.683 . . . . 25.0 117.537 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -72.48 -20.75 61.32 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 114.485 -2.674 . . . . 25.0 112.698 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.7 t -79.54 112.7 17.04 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 124.802 2.239 . . . . 25.0 109.615 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 mt -106.89 91.41 3.65 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 109.139 -3.664 . . . . 50.0 104.14 163.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.04 161.72 28.4 Favored 'General case' 0 CA--C 1.457 -2.618 0 C-N-CA 118.074 -1.45 . . . . 25.0 112.732 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.15 166.32 25.01 Favored 'General case' 0 C--O 1.187 -2.201 0 N-CA-C 102.674 -3.084 . . . . 25.0 102.674 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -130.12 140.49 50.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -73.09 170.05 15.73 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.098 0.874 . . . . 25.0 109.296 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.51 168.2 40.11 Favored Glycine 0 CA--C 1.557 2.712 0 CA-C-O 122.895 1.275 . . . . 25.0 113.367 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.75 167.43 10.17 Favored Pre-proline 0 C--O 1.26 1.632 0 N-CA-C 103.399 -2.815 . . . . 25.0 103.399 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.34 -56.75 0.14 OUTLIER 'Cis proline' 0 C--O 1.199 -1.429 0 C-N-CA 130.449 1.437 . . . . 25.0 112.173 -1.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -147.81 -31.76 0.29 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 124.041 1.877 . . . . 25.0 111.336 132.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.11 -53.62 0.52 Allowed 'General case' 0 C--O 1.274 2.355 0 N-CA-C 118.239 2.681 . . . . 25.0 118.239 -174.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.76 -157.5 4.77 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 105.736 -2.946 . . . . 25.0 105.736 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.33 170.68 12.93 Favored 'Trans proline' 0 C--N 1.331 -0.357 0 O-C-N 123.935 1.492 . . . . 25.0 109.926 -172.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.85 109.5 0.58 Allowed 'General case' 0 C--O 1.179 -2.634 0 N-CA-C 114.541 1.311 . . . . 25.0 114.541 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -119.18 170.29 9.21 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 118.24 -2.788 . . . . 25.0 108.796 -174.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.7 -5.64 77.53 Favored Glycine 0 C--O 1.268 2.269 0 CA-C-N 112.126 -2.306 . . . . 25.0 115.296 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -87.72 -28.07 21.99 Favored 'General case' 0 N--CA 1.414 -2.227 0 O-C-N 125.249 1.205 . . . . 25.0 107.858 -169.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.2 mt -73.46 -32.2 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.646 0 CA-C-O 116.856 -1.545 . . . . 25.0 108.492 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.7 -24.78 67.07 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 116.838 2.162 . . . . 25.0 116.838 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.4 p -100.19 5.86 44.76 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 124.291 0.994 . . . . 25.0 109.68 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.98 14.99 0.22 Allowed 'General case' 0 C--O 1.182 -2.457 0 C-N-CA 128.647 2.779 . . . . 25.0 117.235 -167.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.94 -34.79 90.89 Favored Glycine 0 C--O 1.257 1.591 0 O-C-N 120.38 -1.45 . . . . 25.0 109.606 169.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.87 -12.88 68.54 Favored Glycine 0 C--O 1.253 1.34 0 CA-C-O 116.458 -2.301 . . . . 25.0 112.081 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . 0.273 59.0 mt -110.23 -12.46 14.46 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.533 1.666 . . . . 50.0 112.677 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -82.96 -40.13 20.45 Favored 'General case' 0 C--N 1.301 -1.534 1 N-CA-C 99.359 -4.311 . . . . 50.0 99.359 171.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.77 -16.41 80.34 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 126.661 3.367 . . . . 25.0 110.522 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.97 -23.33 72.75 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 110.116 -3.042 . . . . 25.0 112.323 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.8 -39.19 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 122.136 2.968 . . . . 25.0 109.217 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -73.83 -29.64 62.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 116.667 2.099 . . . . 75.0 116.667 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -66.97 -28.03 67.94 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 126.881 2.073 . . . . 50.0 110.705 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -91.56 39.3 1.0 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.722 -1.127 . . . . 25.0 110.924 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -136.31 59.68 1.7 Allowed 'General case' 0 C--N 1.281 -2.37 0 O-C-N 125.667 1.854 . . . . 25.0 107.335 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.9 p -169.21 168.28 9.89 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 113.255 -1.793 . . . . 25.0 106.756 -156.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.61 -20.45 60.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 126.869 2.605 . . . . 25.0 109.011 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -84.46 8.74 15.4 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 126.852 2.595 . . . . 25.0 115.614 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -68.79 86.54 0.33 Allowed 'General case' 0 C--O 1.271 2.209 0 CA-C-O 124.721 2.2 . . . . 25.0 107.247 163.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -40.09 148.44 0.08 Allowed 'General case' 0 N--CA 1.426 -1.648 1 CA-C-N 108.242 -4.072 . . . . 25.0 117.242 169.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -74.47 138.95 43.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 123.978 1.847 . . . . 50.0 111.799 -166.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -77.23 154.29 33.17 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 112.207 -2.269 . . . . 25.0 107.798 157.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -132.83 126.5 32.43 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.545 -3.872 . . . . 25.0 100.545 157.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -97.69 116.57 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 105.43 -2.063 . . . . 25.0 105.43 -166.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.9 ttt -132.88 154.27 50.54 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 119.788 -1.82 . . . . 25.0 109.838 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 p -74.79 158.19 33.9 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.66 -177.63 18.95 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 116.221 1.248 . . . . 25.0 116.221 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.61 -167.11 23.68 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 119.24 -1.457 . . . . 25.0 114.788 -174.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -71.24 135.76 47.64 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.997 -1.296 . . . . 25.0 108.764 163.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -134.63 140.65 46.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-O 116.122 -1.894 . . . . 25.0 112.114 -166.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.9 m -124.38 131.74 53.51 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.874 1.358 . . . . 25.0 111.264 171.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -112.67 124.74 53.23 Favored 'General case' 0 CA--C 1.605 3.06 1 N-CA-C 100.133 -4.025 . . . . 50.0 100.133 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.2 m -124.89 129.54 50.59 Favored 'General case' 0 C--O 1.273 2.297 0 CA-C-O 126.24 2.924 . . . . 25.0 111.864 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -123.39 155.84 36.6 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 111.35 -2.659 . . . . 25.0 108.38 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 45.4 p -125.02 143.84 50.7 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 104.382 -2.451 . . . . 25.0 104.382 170.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.36 150.26 28.3 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 104.537 -2.394 . . . . 50.0 104.537 165.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.5 t -76.07 -38.28 57.25 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 124.456 2.074 . . . . 25.0 110.229 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.79 137.69 11.29 Favored Pre-proline 0 N--CA 1.482 1.129 1 N-CA-C 96.18 -5.489 . . . . 25.0 96.18 165.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.06 172.47 16.3 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 CA-C-N 120.9 1.357 . . . . 25.0 112.902 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.344 30.9 m-70 -93.87 159.18 15.3 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 118.029 -2.919 . . . . 25.0 104.726 167.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -60.64 125.8 25.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 117.311 2.337 . . . . 25.0 117.311 167.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.9 m -139.26 134.59 32.85 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 106.721 -1.585 . . . . 25.0 106.721 -160.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.3 p -91.65 -29.02 17.11 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.907 1.337 . . . . 25.0 109.542 -171.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -172.64 171.57 4.47 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 116.421 -1.752 . . . . 25.0 108.292 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.434 ' CZ3' ' CD2' ' A' ' 123' ' ' HIS . 26.9 p90 -153.06 158.54 42.1 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-O 117.018 -1.468 . . . . 25.0 111.528 166.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.253 8.3 m-70 -139.96 144.37 37.01 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.011 1.278 . . . . 25.0 114.12 -167.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -123.72 137.95 54.61 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 121.209 1.822 . . . . 50.0 112.768 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -140.54 166.79 23.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.301 -1.74 . . . . 50.0 106.301 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.4 pt -134.68 166.15 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -83.17 150.93 25.94 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.168 0.44 . . . . 25.0 111.5 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -99.52 162.65 12.9 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -166.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -163.88 168.46 19.46 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 100.477 -3.898 . . . . 25.0 100.477 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.38 60.32 3.07 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 103.763 -3.735 . . . . 25.0 103.763 -174.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -146.5 171.67 14.71 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 114.776 -2.535 . . . . 25.0 112.476 -169.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.64 135.93 11.08 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 122.99 2.632 . . . . 25.0 104.576 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 108' ' ' LYS . 95.5 Cg_endo -64.04 -16.4 54.69 Favored 'Trans proline' 0 C--O 1.191 -1.868 1 N-CA-C 125.04 4.977 . . . . 25.0 125.04 -176.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -78.49 -1.79 35.46 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 117.061 -3.524 . . . . 75.0 112.284 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 106' ' ' PRO . 92.0 mttt -130.93 165.18 36.83 Favored Pre-proline 0 N--CA 1.406 -2.64 1 N-CA-C 100.19 -4.004 . . . . 25.0 100.19 -166.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -47.94 24.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 2 C-N-CA 127.703 5.602 . . . . 25.0 122.908 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -41.97 -39.28 1.83 Allowed 'General case' 0 CA--C 1.599 2.848 0 N-CA-C 120.059 3.355 . . . . 50.0 120.059 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -93.79 -10.75 33.12 Favored 'General case' 0 C--O 1.262 1.725 0 CA-C-N 120.041 1.292 . . . . 25.0 112.237 -176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -107.2 -45.32 4.14 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.601 1.191 . . . . 25.0 110.763 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.17 37.7 0.78 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.838 -1.541 . . . . 25.0 106.838 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.15 -20.73 64.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 125.478 2.561 . . . . 25.0 112.297 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.16 157.24 47.1 Favored 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.366 1.866 . . . . 50.0 106.208 165.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -141.27 144.22 34.53 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 125.179 1.549 . . . . 25.0 108.756 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.88 135.89 57.92 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 123.303 1.525 . . . . 50.0 111.074 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.266 2.4 tt -107.29 -26.51 3.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 103.698 -2.704 . . . . 25.0 103.698 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.54 171.68 38.29 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 123.396 1.553 . . . . 25.0 113.571 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.45 147.29 26.08 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.15 119.43 27.65 Favored Pre-proline 0 N--CA 1.484 1.254 0 N-CA-C 105.633 -1.988 . . . . 50.0 105.633 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.09 167.08 16.26 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 N-CA-C 102.585 -3.659 . . . . 25.0 102.585 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.434 ' CD2' ' CZ3' ' A' ' 95' ' ' TRP . 12.4 t-80 -136.2 61.87 1.63 Allowed 'General case' 0 C--O 1.261 1.703 0 N-CA-C 117.515 2.413 . . . . 25.0 117.515 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.43 -25.88 1.14 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 118.973 2.953 . . . . 50.0 118.973 165.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -162.12 12.95 0.12 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 119.713 -1.867 . . . . 25.0 114.581 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.81 170.1 5.56 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 118.976 2.954 . . . . 25.0 118.976 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.54 -166.16 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 120.734 0.956 . . . . 25.0 113.628 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.18 -1.88 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 119.269 3.063 . . . . 25.0 119.269 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.1 p -60.78 -21.45 63.09 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.741 -1.118 . . . . 25.0 113.391 168.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -71.71 -5.03 30.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 117.443 2.386 . . . . 25.0 117.443 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -65.62 133.31 50.87 Favored 'General case' 0 C--O 1.267 2.002 0 O-C-N 120.433 -1.417 . . . . 25.0 108.259 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.73 -30.96 66.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 124.777 2.227 . . . . 75.0 110.774 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.7 t -62.8 127.71 32.51 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 105.337 -2.097 . . . . 25.0 105.337 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.13 134.5 29.72 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 117.593 2.442 . . . . 25.0 117.593 -172.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -94.86 145.0 25.2 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 113.978 -1.464 . . . . 25.0 107.565 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -136.46 125.13 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.356 -2.09 . . . . 25.0 105.356 159.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -71.92 133.97 45.72 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 123.001 2.637 . . . . 50.0 109.062 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.52 110.54 44.74 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -65.88 154.38 74.17 Favored 'Trans proline' 0 N--CA 1.53 3.669 1 C-N-CA 112.309 -4.661 . . . . 25.0 114.053 172.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -91.69 53.52 2.26 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 115.757 -2.377 . . . . 25.0 112.029 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.5 -25.61 38.66 Favored 'General case' 0 C--O 1.261 1.679 0 N-CA-C 114.541 1.312 . . . . 50.0 114.541 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -155.26 173.29 16.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 119.139 0.881 . . . . 25.0 109.643 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -110.97 139.84 45.99 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 104.472 -2.418 . . . . 50.0 104.472 166.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 160.03 167.86 21.19 Favored Glycine 0 C--O 1.294 3.897 0 O-C-N 119.819 -1.801 . . . . 25.0 113.714 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -102.38 139.87 37.42 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 127.166 2.187 . . . . 50.0 111.401 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -156.27 165.24 36.94 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 103.169 -2.9 . . . . 25.0 103.169 166.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.51 161.77 3.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 CA-C-N 120.754 1.615 . . . . 50.0 111.102 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.38 126.77 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 N-CA-C 100.701 -3.814 . . . . 25.0 100.701 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.5 mt -103.81 154.59 19.42 Favored 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 120.555 1.525 . . . . 50.0 108.414 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.1 157.98 43.45 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 119.675 1.125 . . . . 25.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.09 134.02 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 105.007 -2.22 . . . . 50.0 105.007 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.75 108.09 10.44 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 105.041 -2.207 . . . . 25.0 105.041 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -86.37 95.4 9.65 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 125.325 2.488 . . . . 25.0 106.178 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.83 120.01 23.47 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.12 0 CA-C-N 113.56 -1.654 . . . . 50.0 107.396 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.76 -13.48 42.24 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.698 1.37 . . . . 25.0 114.698 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.95 -23.66 67.43 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.595 2.072 . . . . 25.0 116.595 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.5 p -138.03 158.03 45.15 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 110.875 -2.875 . . . . 25.0 107.218 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -75.18 -17.35 60.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 123.091 1.424 . . . . 25.0 111.547 164.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -69.72 154.84 41.42 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 162.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.09 178.52 7.32 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 100.55 -3.87 . . . . 25.0 100.55 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -124.0 153.97 40.51 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 125.919 2.012 . . . . 50.0 112.28 171.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -123.13 159.75 27.9 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 105.993 -1.854 . . . . 50.0 105.993 158.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -154.62 152.04 29.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 120.642 1.565 . . . . 25.0 108.31 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.282 1.1 p -133.91 136.44 53.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.958 1.361 . . . . 75.0 112.567 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.14 125.62 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.329 -1.36 . . . . 25.0 107.329 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.58 136.45 32.99 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 104.98 -2.23 . . . . 25.0 104.98 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 m -132.79 160.27 42.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 125.241 2.448 . . . . 50.0 110.026 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -130.96 111.74 12.33 Favored 'General case' 0 C--O 1.275 2.397 0 N-CA-C 104.233 -2.506 . . . . 25.0 104.233 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.7 mt -119.26 117.47 28.68 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 100.791 -3.781 . . . . 50.0 100.791 -167.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.2 m -115.22 170.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 116.889 2.181 . . . . 50.0 116.889 -167.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -78.91 151.57 31.65 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.9 tptt . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 115.574 -2.155 . . . . 25.0 111.971 178.271 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 . . . . . 0 N--CA 1.51 2.558 0 CA-C-O 120.573 0.225 . . . . 25.0 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.39 -160.01 30.15 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-O 116.812 -2.104 . . . . 25.0 117.027 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -129.87 156.54 44.22 Favored 'General case' 0 C--O 1.253 1.267 0 C-N-CA 126.921 2.088 . . . . 50.0 113.377 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -95.3 125.54 47.97 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 101.418 -3.549 . . . . 25.0 101.418 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -89.74 -40.48 12.48 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 113.706 -1.588 . . . . 25.0 113.738 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -148.54 150.55 34.06 Favored Pre-proline 0 CA--C 1.549 0.918 1 N-CA-C 99.532 -4.248 . . . . 25.0 99.532 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.44 139.13 59.72 Favored 'Cis proline' 0 N--CA 1.442 -1.529 0 CA-C-N 120.676 1.277 . . . . 25.0 113.604 1.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.89 -154.93 49.03 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 117.458 1.743 . . . . 25.0 117.458 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -137.33 114.66 10.95 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 125.319 1.448 . . . . 25.0 109.48 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -67.62 -24.51 65.48 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 123.896 1.808 . . . . 25.0 114.452 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.15 -30.75 71.29 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 118.139 -2.85 . . . . 25.0 114.536 171.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.36 90.44 Favored 'General case' 0 C--O 1.192 -1.946 0 CA-C-O 125.82 2.724 . . . . 25.0 110.323 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.43 -17.22 49.61 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 112.394 -2.185 . . . . 75.0 108.487 -169.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 t -67.98 -13.67 62.36 Favored 'General case' 0 C--O 1.186 -2.283 0 O-C-N 123.991 0.807 . . . . 25.0 111.131 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.534 ' HG ' ' N ' ' A' ' 16' ' ' GLU . 29.9 t -63.0 156.42 24.68 Favored 'General case' 0 CA--C 1.603 3.019 0 N-CA-C 114.102 1.149 . . . . 25.0 114.102 -173.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.534 ' N ' ' HG ' ' A' ' 15' ' ' SER . 94.6 mt-10 -74.89 -33.59 62.07 Favored 'General case' 0 C--O 1.196 -1.719 0 CA-C-N 114.853 -1.067 . . . . 25.0 110.31 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.23 -35.17 79.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.149 1.907 . . . . 25.0 116.149 172.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -61.26 -47.88 83.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.711 1.745 . . . . 50.0 115.711 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.64 72.6 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 109.834 -1.306 . . . . 25.0 109.834 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.0 t80 147.19 -56.81 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 111.697 -2.251 . . . . 50.0 109.558 159.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.11 -20.37 8.06 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 119.425 3.12 . . . . 50.0 119.425 161.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -143.03 150.64 39.85 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 -167.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.26 2.0 pt? -78.95 155.86 28.77 Favored 'General case' 0 C--O 1.206 -1.202 0 C-N-CA 119.589 -0.844 . . . . 50.0 110.993 -166.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -136.89 64.69 1.53 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 100.313 -3.958 . . . . 25.0 100.313 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.7 t -153.1 -59.0 0.14 Allowed 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 127.25 2.843 . . . . 25.0 110.955 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.18 -76.93 2.14 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 127.237 2.351 . . . . 25.0 117.332 169.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 m -115.78 -2.97 12.27 Favored 'General case' 0 C--O 1.185 -2.332 0 N-CA-C 117.961 2.578 . . . . 25.0 117.961 -173.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -58.49 -45.58 90.03 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.392 0 CA-C-O 124.001 1.858 . . . . 50.0 112.692 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -69.82 -2.92 13.52 Favored 'General case' 0 CA--C 1.503 -0.852 1 N-CA-C 122.17 4.137 . . . . 25.0 122.17 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.58 -50.77 16.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 124.956 2.312 . . . . 50.0 108.006 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -131.43 82.65 61.37 Favored Pre-proline 0 N--CA 1.511 2.606 0 CA-C-N 113.073 -1.876 . . . . 25.0 106.177 167.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.49 -16.86 54.85 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 116.273 -2.018 . . . . 25.0 116.105 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.45 -51.78 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.7 t -84.55 46.02 1.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 118.462 -2.649 . . . . 25.0 113.844 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.45 129.69 39.91 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-O 125.053 2.359 . . . . 50.0 105.475 173.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.41 146.27 42.63 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.014 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.82 41.37 0.67 Allowed 'General case' 0 C--O 1.193 -1.885 0 CA-C-O 124.379 2.038 . . . . 25.0 113.299 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -142.87 -73.84 0.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 118.811 -2.431 . . . . 25.0 112.889 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.93 177.38 8.81 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.728 1.611 . . . . 25.0 111.669 -165.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.4 28.02 6.96 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 124.733 1.271 . . . . 25.0 113.887 -169.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -71.55 151.69 93.78 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 108.297 -1.001 . . . . 25.0 108.297 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.38 124.63 6.97 Favored 'Cis proline' 0 C--N 1.368 1.578 0 C-N-CA 130.776 1.574 . . . . 25.0 111.641 -15.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -72.18 -18.85 61.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.277 -1.514 . . . . 25.0 111.413 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m 73.76 -45.36 0.6 Allowed 'General case' 0 C--N 1.363 1.157 0 C-N-CA 127.93 2.492 . . . . 25.0 116.24 174.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.92 -178.73 27.66 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 114.943 -3.143 . . . . 25.0 111.649 167.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.15 149.47 91.35 Favored 'Trans proline' 0 CA--C 1.59 3.309 0 CA-C-N 122.125 2.962 . . . . 25.0 110.058 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.86 132.74 32.1 Favored 'General case' 0 N--CA 1.507 2.398 0 C-N-CA 128.115 2.566 . . . . 25.0 116.411 -167.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.11 120.91 13.55 Favored 'General case' 0 C--O 1.256 1.399 0 CA-C-O 117.841 -1.076 . . . . 25.0 113.474 -169.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.14 -13.4 50.11 Favored Glycine 0 CA--C 1.486 -1.773 0 O-C-N 126.777 2.548 . . . . 25.0 117.497 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 42.34 40.44 1.82 Allowed 'General case' 0 C--O 1.247 0.956 0 C-N-CA 130.024 3.33 . . . . 25.0 113.782 -175.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.1 mt -65.21 -29.13 46.36 Favored 'Isoleucine or valine' 0 C--O 1.256 1.416 0 CA-C-N 113.512 -1.676 . . . . 25.0 112.605 -162.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.66 79.8 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 115.009 1.485 . . . . 25.0 115.009 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.6 p -141.15 -9.82 0.99 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 119.677 -1.889 . . . . 25.0 114.616 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.63 25.94 1.62 Allowed 'General case' 0 CA--C 1.577 2.014 0 C-N-CA 124.978 1.311 . . . . 25.0 113.012 -166.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.32 -29.64 71.79 Favored Glycine 0 C--O 1.237 0.305 0 CA-C-N 119.83 1.195 . . . . 25.0 112.67 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.08 -16.31 68.51 Favored Glycine 0 C--O 1.263 1.911 0 O-C-N 120.327 -1.69 . . . . 25.0 111.65 171.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mt -113.44 48.14 1.08 Allowed 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 118.436 2.754 . . . . 50.0 118.436 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -70.97 -26.1 63.01 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.346 -3.205 . . . . 50.0 102.346 148.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.04 -16.68 68.91 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 119.881 -1.762 . . . . 25.0 109.003 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.95 -23.53 77.69 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 119.997 -1.097 . . . . 25.0 114.092 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.48 -44.41 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 117.012 -1.875 . . . . 25.0 109.519 165.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.11 1.02 2.24 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 126.235 2.921 . . . . 75.0 118.624 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.78 -14.93 60.78 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 112.262 -2.245 . . . . 50.0 110.721 170.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -72.74 5.15 3.35 Favored 'General case' 0 CA--C 1.485 -1.557 0 O-C-N 116.631 -3.793 . . . . 25.0 116.733 173.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -122.62 67.31 0.95 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 125.919 1.687 . . . . 25.0 107.258 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -147.18 151.24 36.43 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 117.192 2.293 . . . . 25.0 117.192 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -72.28 -30.22 64.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 118.246 -2.784 . . . . 25.0 109.02 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -106.02 31.36 5.14 Favored 'General case' 0 C--O 1.176 -2.776 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -78.46 101.71 7.45 Favored 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 97.859 -4.867 . . . . 25.0 97.859 164.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -43.15 155.96 0.05 Allowed 'General case' 0 C--O 1.262 1.714 0 CA-C-N 110.023 -3.262 . . . . 25.0 115.468 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -58.86 144.73 43.45 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 127.043 3.306 . . . . 50.0 117.076 -167.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -82.96 153.78 24.85 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 117.714 2.487 . . . . 25.0 117.714 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -152.35 156.52 39.74 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 117.981 -2.949 . . . . 25.0 109.138 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.2 tt -132.58 139.75 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 106.367 -1.716 . . . . 25.0 106.367 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtt -152.87 151.8 30.81 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 120.087 1.312 . . . . 25.0 110.255 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.5 p -84.55 176.68 8.46 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.071 -0.714 . . . . 25.0 109.071 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.65 168.8 53.86 Favored Glycine 0 C--O 1.209 -1.439 0 C-N-CA 120.825 -0.702 . . . . 25.0 112.065 168.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.62 174.26 15.56 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.472 -1.823 . . . . 25.0 110.687 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -71.06 134.04 46.77 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.279 -0.968 . . . . 25.0 111.807 162.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -133.73 147.35 51.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.131 -0.94 . . . . 25.0 110.77 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m -85.62 136.09 33.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 124.274 1.03 . . . . 25.0 110.597 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.42 134.81 49.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.067 -1.827 . . . . 50.0 106.067 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.4 m -114.66 120.93 41.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -120.27 149.02 42.96 Favored 'General case' 0 C--O 1.263 1.803 0 CA-C-O 118.288 -0.863 . . . . 25.0 109.446 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 t -143.35 158.18 43.85 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.275 1.852 . . . . 25.0 109.871 -171.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -86.15 147.93 25.91 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 104.443 -2.429 . . . . 50.0 104.443 161.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.7 t -110.41 -18.28 13.27 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 103.711 -2.7 . . . . 25.0 103.711 162.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 147.04 54.14 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 101.117 -3.66 . . . . 25.0 101.117 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.35 151.54 84.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 117.887 -0.942 . . . . 25.0 113.579 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -129.1 178.49 6.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 100.762 -3.792 . . . . 25.0 100.762 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -118.56 84.84 2.25 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.938 1.695 . . . . 25.0 107.007 157.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -75.56 149.52 38.31 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 103.233 -2.877 . . . . 25.0 103.233 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 p -106.16 -30.32 9.3 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-N 120.713 1.597 . . . . 25.0 114.56 168.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -164.21 158.34 18.92 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 118.614 -2.554 . . . . 25.0 104.674 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -149.69 162.04 41.01 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 120.167 -1.583 . . . . 25.0 110.156 163.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -128.79 156.58 43.35 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 127.009 2.124 . . . . 25.0 110.738 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -147.7 149.76 33.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 124.693 2.187 . . . . 50.0 105.959 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -146.3 168.6 20.68 Favored 'General case' 0 CA--C 1.501 -0.914 1 N-CA-C 98.813 -4.514 . . . . 50.0 98.813 -154.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.1 pt -134.51 158.0 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 117.07 -1.443 . . . . 25.0 108.693 162.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.9 m -95.14 133.32 39.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 125.525 1.766 . . . . 25.0 110.592 172.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -76.87 135.77 38.85 Favored 'General case' 0 C--O 1.297 3.563 0 CA-C-N 122.328 2.331 . . . . 25.0 109.998 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.32 164.71 26.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 103.999 -2.593 . . . . 25.0 103.999 171.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.33 3.24 65.21 Favored Glycine 0 C--O 1.276 2.739 0 N-CA-C 117.333 1.693 . . . . 25.0 117.333 169.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.87 176.97 5.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.711 1.004 . . . . 25.0 113.711 -174.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.56 138.04 11.38 Favored Pre-proline 0 C--O 1.194 -1.847 0 CA-C-O 116.188 -1.863 . . . . 25.0 109.944 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.51 -21.23 46.66 Favored 'Trans proline' 0 C--O 1.286 2.912 0 N-CA-C 117.983 2.263 . . . . 25.0 117.983 -174.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.53 3.13 12.0 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 118.977 -2.327 . . . . 75.0 113.198 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -129.38 174.04 5.02 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 100.615 -3.846 . . . . 25.0 100.615 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.6 21.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 N-CA-C 122.138 3.861 . . . . 25.0 122.138 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 tt -38.84 -33.74 0.12 Allowed 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.755 2.132 . . . . 50.0 116.755 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.28 -5.44 59.18 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 116.593 2.072 . . . . 25.0 116.593 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -116.15 -43.11 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 123.654 1.693 . . . . 25.0 110.105 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.2 4.77 1.14 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 113.315 -1.766 . . . . 25.0 112.883 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.63 -14.92 62.66 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 119.571 -0.852 . . . . 25.0 108.837 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.73 106.74 8.91 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -109.09 120.16 41.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 104.99 -2.226 . . . . 25.0 104.99 165.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.97 136.27 55.06 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 116.568 -1.682 . . . . 50.0 108.873 -176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.5 tp -110.29 -19.21 7.04 Favored 'Isoleucine or valine' 0 C--N 1.374 1.639 0 CA-C-O 125.868 2.747 . . . . 25.0 109.81 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.76 150.97 13.13 Favored Glycine 0 N--CA 1.444 -0.773 0 O-C-N 118.268 -2.77 . . . . 25.0 114.562 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . 0.257 . . -143.84 140.96 30.1 Favored 'General case' 0 CA--C 1.569 1.685 1 N-CA-C 98.955 -4.461 . . . . 25.0 98.955 -179.957 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.2 105.11 11.29 Favored Pre-proline 0 CA--C 1.497 -1.078 0 O-C-N 127.208 2.818 . . . . 50.0 103.465 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -66.22 167.17 18.98 Favored 'Trans proline' 0 C--O 1.203 -1.225 1 C-N-CA 109.828 -6.315 . . . . 25.0 111.896 166.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -144.01 83.18 1.73 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 118.435 -2.666 . . . . 25.0 111.795 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.93 -17.6 43.06 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 124.675 2.178 . . . . 50.0 113.183 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.01 -168.2 36.57 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 103.581 -3.808 . . . . 25.0 103.581 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 71.09 82.2 Favored Pre-proline 0 C--O 1.181 -2.523 0 CA-C-N 121.534 2.667 . . . . 25.0 114.278 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -67.67 172.06 11.09 Favored 'Trans proline' 0 C--O 1.286 2.906 1 C-N-CA 111.025 -5.517 . . . . 25.0 110.982 155.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.03 -35.76 67.22 Favored 'General case' 0 C--N 1.356 0.89 0 CA-C-O 116.396 -1.764 . . . . 25.0 113.656 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 98.4 p -59.22 -20.21 52.08 Favored 'General case' 0 C--O 1.296 3.536 0 O-C-N 127.532 3.02 . . . . 25.0 115.793 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -105.57 8.22 33.18 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 118.704 2.853 . . . . 25.0 118.704 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -60.19 151.91 25.96 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 125.72 2.676 . . . . 25.0 110.998 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mt -66.46 -27.03 67.49 Favored 'General case' 0 C--O 1.26 1.613 0 CA-C-N 113.202 -1.817 . . . . 75.0 114.56 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.4 m -96.44 145.55 25.56 Favored 'General case' 0 C--O 1.302 3.85 0 O-C-N 119.518 -1.989 . . . . 25.0 105.855 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -131.45 168.32 17.82 Favored 'General case' 0 C--O 1.192 -1.957 0 N-CA-C 116.318 1.97 . . . . 25.0 116.318 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.305 89.9 m-70 -121.3 116.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 121.608 2.004 . . . . 25.0 113.28 168.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mm -122.18 131.79 72.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 C-N-CA 118.745 -1.182 . . . . 25.0 108.981 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -75.78 134.08 40.52 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 107.18 -1.415 . . . . 50.0 107.18 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.04 132.02 22.55 Favored Pre-proline 0 C--O 1.204 -1.309 0 N-CA-C 102.892 -3.003 . . . . 25.0 102.892 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -62.27 143.66 94.34 Favored 'Trans proline' 0 CA--C 1.458 -3.324 1 C-N-CA 113.006 -4.196 . . . . 25.0 118.785 -175.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.73 -22.86 12.86 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 125.447 2.546 . . . . 25.0 114.267 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -77.46 -5.46 49.97 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 118.965 -2.334 . . . . 50.0 112.289 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -145.06 158.09 43.92 Favored 'General case' 0 C--O 1.204 -1.303 0 CA-C-N 112.739 -2.028 . . . . 25.0 112.388 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.2 mp -107.2 152.67 23.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.052 -2.944 . . . . 50.0 103.052 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 158.44 166.63 17.96 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.151 -0.968 . . . . 25.0 114.949 167.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -88.57 136.13 33.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.606 1.335 . . . . 50.0 114.606 166.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -149.45 167.84 25.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 104.213 -2.514 . . . . 25.0 104.213 -159.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.51 131.83 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.985 0 N-CA-C 103.537 -2.764 . . . . 50.0 103.537 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 94.5 mt -98.8 121.17 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 105.925 -1.88 . . . . 25.0 105.925 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.93 138.18 51.12 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 119.904 -1.747 . . . . 50.0 107.799 -175.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.26 145.51 43.64 Favored 'General case' 0 C--O 1.263 1.81 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -133.84 137.3 52.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 114.424 -2.703 . . . . 50.0 110.267 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -115.77 150.5 36.8 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.814 -1.921 . . . . 25.0 105.814 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -112.89 131.74 55.6 Favored 'General case' 0 C--N 1.307 -1.248 1 N-CA-C 99.085 -4.413 . . . . 25.0 99.085 163.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.21 120.82 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 105.046 -2.205 . . . . 50.0 105.046 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.8 -21.3 41.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 118.944 -0.551 . . . . 25.0 111.069 -173.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . 0.304 2.1 p-10 -82.82 -15.13 52.82 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 116.023 1.86 . . . . 25.0 116.023 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.1 p -112.67 156.58 22.51 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.177 -1.046 . . . . 25.0 108.177 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -90.5 -23.79 20.85 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.638 -1.225 . . . . 25.0 114.064 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -102.0 160.14 14.76 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 115.25 -0.886 . . . . 25.0 111.486 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.82 166.85 22.94 Favored 'General case' 0 C--O 1.253 1.258 0 CA-C-N 113.03 -1.896 . . . . 25.0 112.649 163.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -129.35 130.83 46.58 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 112.343 -2.208 . . . . 50.0 110.34 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -139.74 136.76 34.49 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 127.207 2.817 . . . . 50.0 108.323 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.62 149.53 20.37 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 106.881 -1.525 . . . . 25.0 106.881 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.9 m -127.51 162.72 32.38 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.595 0 N-CA-C 107.978 -1.119 . . . . 75.0 107.978 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.94 131.44 46.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 105.868 -1.901 . . . . 25.0 105.868 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.55 124.31 38.5 Favored 'General case' 0 CA--C 1.583 2.215 0 O-C-N 126.093 2.121 . . . . 25.0 106.357 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 m -123.46 158.75 28.67 Favored 'Isoleucine or valine' 0 C--O 1.285 2.933 0 C-N-CA 116.186 -2.206 . . . . 50.0 109.221 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -119.44 121.34 39.26 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 101.105 -3.665 . . . . 25.0 101.105 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.6 mt -112.28 95.99 5.77 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 105.488 -2.042 . . . . 50.0 105.488 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.8 172.73 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.801 -1.187 . . . . 50.0 113.192 -170.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -66.97 132.81 48.69 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 105.982 -1.859 . . . . 25.0 105.982 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.0 pttp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 115.612 -2.137 . . . . 25.0 110.194 177.546 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 . . . . . 1 N--CA 1.555 4.8 0 CA-C-O 122.761 1.267 . . . . 25.0 107.995 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -121.31 6.33 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.341 -1.409 . . . . 25.0 111.571 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.26 144.33 27.8 Favored 'General case' 0 C--O 1.267 2.023 0 O-C-N 119.196 -2.355 . . . . 50.0 106.438 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -86.86 126.09 40.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 N-CA-C 105.002 -2.221 . . . . 25.0 105.002 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -108.02 -35.31 6.64 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 117.039 -1.864 . . . . 25.0 110.449 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 148.86 57.56 Favored Pre-proline 0 C--O 1.256 1.406 0 N-CA-C 104.967 -2.234 . . . . 25.0 104.967 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -71.43 133.16 27.07 Favored 'Cis proline' 0 C--N 1.359 1.117 0 C-N-CA 132.848 2.437 . . . . 25.0 114.158 2.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.22 -144.12 49.05 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 115.104 0.802 . . . . 25.0 115.104 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -133.72 104.62 6.41 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 105.169 -2.16 . . . . 25.0 105.169 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -69.18 -18.06 63.88 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 117.806 -3.059 . . . . 25.0 109.471 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.19 70.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 116.403 -1.76 . . . . 25.0 111.169 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.56 63.82 Favored 'General case' 0 C--O 1.198 -1.624 0 N-CA-C 106.89 -1.522 . . . . 25.0 106.89 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.61 -28.97 59.07 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.546 -1.346 . . . . 75.0 111.861 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.5 t -72.87 -36.78 67.46 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 112.76 -2.018 . . . . 25.0 113.502 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 p -56.02 148.55 17.33 Favored 'General case' 0 C--O 1.273 2.331 0 N-CA-C 119.375 3.102 . . . . 25.0 119.375 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.62 -37.09 72.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.464 -0.773 . . . . 25.0 110.627 169.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.5 -6.01 37.33 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.816 0.846 . . . . 25.0 111.875 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -58.58 -37.79 76.54 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 123.025 1.393 . . . . 50.0 109.911 170.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.88 -1.33 0.72 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 122.571 3.788 . . . . 25.0 122.571 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 43.71 16.3 0.01 OUTLIER 'General case' 0 C--O 1.29 3.234 0 N-CA-C 121.523 3.897 . . . . 50.0 121.523 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.1 mt -121.74 -36.89 2.95 Favored 'General case' 0 N--CA 1.517 2.906 0 O-C-N 120.782 -1.199 . . . . 50.0 110.45 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -149.1 -168.37 3.09 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 120.412 -1.43 . . . . 25.0 111.701 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -168.27 157.64 9.39 Favored 'General case' 0 C--O 1.209 -1.069 0 O-C-N 127.926 3.266 . . . . 50.0 108.894 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -160.47 45.6 0.21 Allowed 'General case' 0 N--CA 1.517 2.912 1 CA-C-O 129.395 4.426 . . . . 25.0 114.539 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.8 t -87.46 -5.63 58.74 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 117.843 -3.036 . . . . 25.0 113.166 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.79 -35.74 87.51 Favored Glycine 0 C--O 1.179 -3.339 0 N-CA-C 119.239 2.456 . . . . 25.0 119.239 -158.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 m -83.45 -12.69 56.07 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 121.859 2.83 . . . . 25.0 110.579 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -89.61 -45.77 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.522 0 N-CA-C 105.022 -2.214 . . . . 50.0 105.022 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.3 ptm -76.13 -7.28 54.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 117.783 -3.073 . . . . 25.0 115.111 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.78 -47.27 85.3 Favored 'General case' 0 N--CA 1.421 -1.917 0 O-C-N 126.297 2.248 . . . . 50.0 112.362 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.62 64.03 11.32 Favored Pre-proline 0 CA--C 1.505 -0.755 0 N-CA-C 113.753 1.02 . . . . 25.0 113.753 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.26 -19.87 37.96 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 N-CA-C 117.681 2.146 . . . . 25.0 117.681 -167.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -99.83 6.42 45.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.435 2.013 . . . . 25.0 116.435 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -136.73 38.52 2.62 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.692 1.597 . . . . 25.0 112.216 171.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 tp -77.5 99.32 5.64 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.055 -0.521 . . . . 50.0 110.968 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.28 147.1 52.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.071 -1.455 . . . . 25.0 107.071 -159.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.29 50.6 1.02 Allowed 'General case' 0 CA--C 1.606 3.12 0 N-CA-C 115.437 1.643 . . . . 25.0 115.437 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 45.4 tttt -134.76 -163.1 1.33 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.05 -1.833 . . . . 25.0 106.05 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' A' ' 38' ' ' LYS . 94.0 mttt -68.76 163.74 23.38 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 125.638 1.837 . . . . 25.0 110.679 -168.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.07 178.22 47.38 Favored Glycine 0 N--CA 1.439 -1.126 1 CA-C-O 112.158 -4.69 . . . . 25.0 103.986 176.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -127.02 104.59 22.74 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 121.275 2.538 . . . . 25.0 110.434 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.89 158.17 85.2 Favored 'Cis proline' 0 C--O 1.259 1.569 0 C-N-CA 134.078 2.949 . . . . 25.0 112.451 2.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -65.58 -32.9 74.73 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 121.619 2.009 . . . . 25.0 107.019 -172.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t 76.28 -71.7 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.767 1.627 . . . . 25.0 114.012 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.78 -175.17 27.48 Favored Glycine 0 N--CA 1.484 1.847 0 CA-C-O 124.208 2.005 . . . . 25.0 109.514 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.95 -172.0 1.13 Allowed 'Trans proline' 0 N--CA 1.514 2.712 0 O-C-N 119.48 -0.853 . . . . 25.0 113.421 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.71 133.74 55.92 Favored 'General case' 0 CA--C 1.555 1.163 0 O-C-N 118.266 -2.771 . . . . 25.0 109.353 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -66.9 121.11 14.78 Favored 'General case' 1 C--O 1.314 4.482 0 N-CA-C 118.628 2.825 . . . . 25.0 118.628 -173.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.12 1.71 88.15 Favored Glycine 0 C--O 1.25 1.119 0 CA-C-O 115.91 -2.605 . . . . 25.0 111.863 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 36.95 38.32 0.09 Allowed 'General case' 0 CA--C 1.568 1.642 0 O-C-N 126.757 2.092 . . . . 25.0 115.887 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.9 mt -69.45 -40.07 79.42 Favored 'Isoleucine or valine' 0 C--O 1.263 1.779 0 CA-C-N 114.91 -1.041 . . . . 25.0 108.77 -160.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.91 -48.73 79.01 Favored 'General case' 0 C--O 1.185 -2.295 0 O-C-N 119.309 -2.119 . . . . 25.0 113.713 -169.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 t -108.66 -22.49 12.23 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 125.017 1.448 . . . . 25.0 109.948 -167.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.269 . . 59.66 9.8 1.74 Allowed 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 117.348 2.351 . . . . 25.0 117.348 -171.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.82 -20.39 73.71 Favored Glycine 0 C--O 1.258 1.647 0 O-C-N 118.651 -2.53 . . . . 25.0 107.483 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.1 -17.2 69.65 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 122.407 3.723 . . . . 25.0 122.407 164.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.9 mt -110.96 -20.19 12.52 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 124.284 1.992 . . . . 50.0 111.428 -172.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -71.12 -40.42 71.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.763 -2.31 . . . . 50.0 104.763 155.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.55 -22.98 47.74 Favored Glycine 0 CA--C 1.499 -0.966 0 O-C-N 118.82 -2.425 . . . . 25.0 114.582 167.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.13 74.6 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 126.069 3.038 . . . . 25.0 113.285 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.96 -33.22 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 117.771 -3.194 . . . . 25.0 105.381 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.13 -14.51 60.98 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 112.65 -2.068 . . . . 75.0 112.956 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.01 -25.97 65.7 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 111.724 -2.489 . . . . 50.0 112.02 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.51 11.27 5.85 Favored 'General case' 0 C--O 1.251 1.155 0 O-C-N 118.807 -2.433 . . . . 25.0 112.756 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -133.06 16.77 4.15 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.05 -1.656 . . . . 25.0 112.457 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -112.4 166.17 11.54 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.286 -0.87 . . . . 25.0 109.345 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.81 -22.6 65.16 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 105.78 -1.933 . . . . 25.0 105.78 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.98 39.64 1.52 Allowed 'General case' 0 C--O 1.168 -3.196 0 C-N-CA 125.55 1.54 . . . . 25.0 110.165 175.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -89.36 91.34 8.7 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-O 124.901 2.286 . . . . 25.0 105.704 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -57.24 139.2 53.43 Favored 'General case' 0 C--N 1.305 -1.34 1 CA-C-N 107.5 -4.409 . . . . 25.0 105.358 172.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -65.56 152.09 44.91 Favored 'General case' 0 C--O 1.286 3.017 0 CA-C-O 126.314 2.959 . . . . 50.0 115.086 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -87.27 134.92 33.49 Favored 'General case' 0 C--O 1.185 -2.318 0 CA-C-N 109.897 -3.32 . . . . 25.0 104.415 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -126.47 134.71 50.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 126.062 2.101 . . . . 25.0 112.883 171.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -93.99 141.25 15.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 tpt -146.3 147.75 31.7 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-O 123.028 1.394 . . . . 25.0 108.739 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 p -82.31 173.61 11.91 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 114.262 -1.335 . . . . 25.0 114.416 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.9 -179.0 35.45 Favored Glycine 0 C--O 1.264 2.019 0 O-C-N 120.053 -1.654 . . . . 25.0 110.526 163.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.76 179.05 32.11 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 106.252 -2.739 . . . . 25.0 106.252 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.75 138.9 39.27 Favored 'General case' 0 C--O 1.257 1.471 0 O-C-N 118.326 -2.867 . . . . 25.0 114.612 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -132.1 160.48 35.84 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 114.044 -1.434 . . . . 25.0 110.803 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -111.52 135.79 51.59 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-O 123.798 1.761 . . . . 25.0 111.597 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -112.97 119.55 38.3 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.79 -1.095 . . . . 50.0 111.518 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.4 m -134.72 129.21 34.36 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 107.275 -1.38 . . . . 25.0 107.275 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -120.77 151.21 39.86 Favored 'General case' 0 C--N 1.313 -1.011 1 N-CA-C 98.617 -4.586 . . . . 25.0 98.617 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -143.66 126.57 16.29 Favored 'General case' 0 C--O 1.263 1.811 0 O-C-N 125.344 1.652 . . . . 25.0 112.397 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -130.3 143.65 50.9 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 118.809 -2.432 . . . . 50.0 109.633 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -61.6 -23.96 66.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 118.522 2.786 . . . . 25.0 118.522 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.05 157.2 78.21 Favored Pre-proline 0 CA--C 1.493 -1.227 0 N-CA-C 101.257 -3.609 . . . . 25.0 101.257 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.26 159.1 11.24 Favored 'Trans proline' 0 N--CA 1.504 2.099 0 N-CA-C 103.003 -3.499 . . . . 25.0 103.003 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -89.83 167.62 12.71 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 102.667 -3.086 . . . . 25.0 102.667 159.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -88.7 117.13 27.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -139.32 156.36 47.08 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 122.613 0.365 . . . . 25.0 110.341 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p -98.83 -48.87 4.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.168 0.987 . . . . 25.0 111.378 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -159.42 160.3 34.68 Favored 'General case' 0 CA--C 1.474 -1.969 0 O-C-N 120.214 -1.553 . . . . 25.0 114.541 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -122.08 144.95 48.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 119.735 1.152 . . . . 25.0 111.221 162.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -122.93 153.56 39.54 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 114.253 -2.784 . . . . 25.0 110.283 -170.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.25 137.56 27.38 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 105.858 -1.904 . . . . 50.0 105.858 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -134.67 156.46 48.72 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 124.56 1.162 . . . . 50.0 110.081 -167.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.63 162.81 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 124.621 2.153 . . . . 25.0 110.006 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 54.8 m -111.9 127.27 55.79 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 118.75 -2.469 . . . . 25.0 108.285 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -99.01 179.49 4.61 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -164.03 177.13 8.72 Favored 'General case' 0 C--O 1.275 2.433 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.81 26.69 66.46 Favored Glycine 0 C--O 1.252 1.235 1 CA-C-O 129.379 4.877 . . . . 25.0 113.861 -166.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.19 150.31 21.04 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 108.83 -3.685 . . . . 25.0 112.95 -173.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . 0.288 9.7 t70 -98.45 141.54 23.1 Favored Pre-proline 0 C--O 1.194 -1.868 0 C-N-CA 127.772 2.429 . . . . 25.0 111.095 -172.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -67.52 -40.54 10.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 124.776 3.65 . . . . 25.0 121.038 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.67 -29.05 65.27 Favored 'General case' 0 C--O 1.197 -1.704 0 CA-C-O 126.225 2.917 . . . . 75.0 109.312 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.84 161.5 74.47 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 118.484 -2.635 . . . . 25.0 110.31 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.92 17.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.646 2 C-N-CA 127.978 5.785 . . . . 25.0 122.878 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.19 -37.5 15.94 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 116.091 1.885 . . . . 50.0 116.091 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -85.48 -10.66 55.78 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.423 1.638 . . . . 25.0 115.423 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 114' ' ' ASP . 99.4 mtt180 -104.21 -52.81 2.85 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 117.695 2.48 . . . . 25.0 117.695 174.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.67 34.8 0.28 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 127.028 2.705 . . . . 25.0 106.791 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 112' ' ' ARG . 36.0 t70 -63.65 -26.79 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.838 2.055 . . . . 25.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -127.71 145.69 50.82 Favored 'General case' 0 C--N 1.298 -1.674 1 N-CA-C 99.023 -4.436 . . . . 50.0 99.023 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -117.63 130.66 56.51 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 121.414 1.915 . . . . 25.0 110.73 168.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.1 tp -63.87 110.15 1.99 Allowed 'General case' 0 C--O 1.27 2.153 0 CA-C-O 118.311 -0.852 . . . . 50.0 110.467 168.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.6 tt -99.34 -17.85 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.14 166.34 36.35 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 116.319 1.288 . . . . 25.0 116.319 164.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.7 152.18 33.54 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.21 -1.404 . . . . 25.0 107.21 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.96 120.43 15.24 Favored Pre-proline 0 C--O 1.262 1.723 0 O-C-N 125.934 2.021 . . . . 50.0 110.185 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.72 152.67 53.36 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.262 1.276 . . . . 25.0 113.093 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.79 52.29 1.48 Allowed 'General case' 0 C--O 1.245 0.863 0 N-CA-C 105.318 -2.104 . . . . 25.0 105.318 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -83.64 -22.55 32.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.602 -1.629 . . . . 50.0 106.602 -167.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.05 178.89 31.47 Favored Glycine 0 C--O 1.204 -1.738 1 N-CA-C 102.714 -4.154 . . . . 25.0 102.714 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -123.75 56.87 11.27 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 119.434 3.124 . . . . 25.0 119.434 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.6 175.85 10.53 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 O-C-N 118.303 -1.472 . . . . 25.0 108.5 168.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.47 -13.77 43.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 25.0 113.311 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 80.7 p -84.76 -3.83 58.78 Favored 'General case' 0 C--O 1.189 -2.12 0 CA-C-N 119.383 0.992 . . . . 25.0 110.83 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -116.47 26.21 10.06 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 123.973 1.844 . . . . 25.0 110.673 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -68.61 149.97 48.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.825 -1.546 . . . . 25.0 106.825 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.73 -15.11 59.86 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 126.466 2.354 . . . . 75.0 115.781 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.4 t -81.31 123.61 28.67 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 104.223 -2.51 . . . . 25.0 104.223 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -118.71 147.22 44.06 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.664 -1.273 . . . . 25.0 108.047 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -110.53 136.35 49.78 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.9 mm -132.37 128.23 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -78.66 133.53 37.22 Favored 'General case' 0 C--O 1.255 1.365 0 O-C-N 125.696 1.873 . . . . 50.0 111.71 169.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.48 126.18 28.27 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-O 115.22 -2.324 . . . . 25.0 107.218 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.75 151.72 74.36 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 113.563 -3.824 . . . . 25.0 114.619 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -105.11 -8.05 18.7 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.08 -1.873 . . . . 25.0 111.921 -172.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.23 -1.7 24.62 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 126.315 2.259 . . . . 50.0 115.758 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -142.06 165.72 26.67 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 119.409 -2.057 . . . . 25.0 112.596 -172.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.15 147.06 50.54 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 101.184 -3.636 . . . . 50.0 101.184 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.44 174.44 21.56 Favored Glycine 0 CA--C 1.477 -2.326 0 N-CA-C 121.037 3.175 . . . . 25.0 121.037 161.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -82.39 140.48 33.45 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 113.588 -1.306 . . . . 50.0 111.834 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -149.38 165.97 30.46 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.108 -2.182 . . . . 25.0 105.108 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.12 141.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.684 0 N-CA-C 103.933 -2.618 . . . . 50.0 103.933 168.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 91.0 mt -127.54 132.33 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 116.749 -1.596 . . . . 25.0 109.019 -175.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.53 139.17 44.85 Favored 'General case' 0 C--O 1.263 1.793 0 O-C-N 128.467 3.605 . . . . 50.0 110.55 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.5 116.23 17.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 25.0 112.039 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 t -129.36 127.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 125.089 1.493 . . . . 50.0 108.572 -162.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -119.23 108.98 15.31 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 119.286 0.948 . . . . 25.0 113.027 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.32 116.41 11.62 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 126.762 2.025 . . . . 25.0 109.545 -173.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.4 t -87.68 136.38 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.44 -1.689 . . . . 50.0 106.44 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -95.63 -25.25 16.21 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 115.843 1.794 . . . . 25.0 115.843 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.0 5.65 50.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.082 1.42 . . . . 25.0 113.277 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.9 p -139.6 -177.23 4.85 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 104.179 -2.526 . . . . 25.0 104.179 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.78 -7.23 41.03 Favored 'General case' 0 CA--C 1.481 -1.704 0 O-C-N 125.089 1.493 . . . . 25.0 107.155 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.28 176.96 8.01 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 116.565 2.061 . . . . 25.0 116.565 -170.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.91 146.87 28.09 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -78.7 133.91 37.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.22 -1.77 . . . . 50.0 106.22 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -136.58 123.05 20.8 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 126.299 1.839 . . . . 50.0 110.752 -172.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.63 142.67 33.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 103.645 -2.724 . . . . 25.0 103.645 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.96 144.24 24.27 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 102.317 -3.216 . . . . 75.0 102.317 -168.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.2 mt -138.81 122.03 19.02 Favored 'Isoleucine or valine' 0 C--O 1.261 1.706 0 CA-C-O 124.131 1.92 . . . . 25.0 106.162 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -75.59 126.68 31.48 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 112.459 -2.155 . . . . 25.0 106.694 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.84 159.17 39.58 Favored 'Isoleucine or valine' 0 C--O 1.264 1.833 0 O-C-N 117.362 -3.336 . . . . 50.0 116.811 -171.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -133.14 113.65 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 103.953 -2.61 . . . . 25.0 103.953 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.9 mt -116.43 122.5 44.97 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 105.238 -2.134 . . . . 50.0 105.238 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.19 159.83 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 N-CA-C 117.749 2.5 . . . . 50.0 117.749 -172.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -61.36 140.28 58.04 Favored 'General case' 0 C--O 1.189 -2.102 0 O-C-N 121.026 -1.046 . . . . 25.0 110.779 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.9 pttt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 116.266 -1.826 . . . . 25.0 110.52 170.627 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 . . . . . 0 N--CA 1.506 2.352 0 CA-C-O 123.733 1.73 . . . . 25.0 109.608 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.7 173.62 42.44 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 127.244 2.355 . . . . 25.0 116.754 -173.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -151.55 164.39 36.94 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-N 119.814 1.807 . . . . 50.0 113.357 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.67 135.24 27.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.647 -1.242 . . . . 25.0 107.647 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -107.89 -36.08 6.47 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 113.378 0.881 . . . . 25.0 113.378 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -148.7 158.84 39.41 Favored Pre-proline 0 C--O 1.286 3.011 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.17 145.26 77.58 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 C-N-CA 133.005 2.502 . . . . 25.0 111.966 -3.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.39 -169.61 52.76 Favored Glycine 0 C--O 1.214 -1.15 0 CA-C-N 113.107 -1.86 . . . . 25.0 111.767 162.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 t -140.89 121.7 14.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.598 1.959 . . . . 25.0 107.025 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.12 -16.8 36.82 Favored 'General case' 0 C--O 1.259 1.59 0 C-N-CA 116.975 -1.89 . . . . 25.0 107.724 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.66 -35.38 70.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 123.453 1.597 . . . . 25.0 110.783 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.28 92.64 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 112.875 -1.966 . . . . 25.0 111.965 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.257 1.456 0 CA-C-N 113.228 -1.806 . . . . 75.0 114.956 175.726 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 117.643 2.46 . . . . 25.0 117.643 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -63.61 -50.17 70.43 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 120.674 1.579 . . . . 50.0 113.538 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -135.69 42.8 0.78 Allowed Pre-proline 0 N--CA 1.517 2.911 0 N-CA-C 117.347 2.351 . . . . 25.0 117.347 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.43 -15.72 12.36 Favored 'Trans proline' 0 C--N 1.375 1.941 1 C-N-CA 108.82 -6.987 . . . . 25.0 118.324 -170.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -71.7 -39.17 70.38 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -83.86 51.76 2.12 Favored 'General case' 0 C--O 1.266 1.921 0 CA-C-N 113.265 -1.788 . . . . 25.0 112.408 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.4 tp -87.18 111.45 20.99 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.29 1.043 . . . . 50.0 108.325 170.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -78.45 161.78 26.86 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-O 124.869 2.271 . . . . 25.0 110.558 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.69 144.67 50.47 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 104.89 -2.263 . . . . 25.0 104.89 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -135.69 146.25 47.56 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 106.314 -1.735 . . . . 25.0 106.314 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.2 mttt . . . . . 0 N--CA 1.428 -1.528 0 N-CA-C 104.63 -2.359 . . . . 25.0 104.63 175.576 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.6 mt . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 116.222 -1.847 . . . . 50.0 111.714 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.75 -32.75 73.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 125.982 2.051 . . . . 50.0 108.726 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.85 -13.28 69.86 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 125.079 2.489 . . . . 25.0 112.094 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.03 0.11 87.88 Favored Glycine 0 CA--C 1.488 -1.644 0 CA-C-N 112.921 -1.639 . . . . 25.0 112.082 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.9 -28.03 39.88 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 O-C-N 121.578 -0.954 . . . . 25.0 110.827 168.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.45 -22.99 61.0 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 117.611 -1.185 . . . . 75.0 112.097 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.17 -23.95 51.52 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.54 1.063 . . . . 50.0 110.116 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -87.02 11.78 12.86 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 125.324 1.64 . . . . 25.0 110.168 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -132.56 23.45 4.36 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.212 1.958 . . . . 25.0 110.636 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.7 t -87.94 155.97 19.58 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 114.496 -1.229 . . . . 25.0 109.487 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.57 -35.73 66.08 Favored 'General case' 0 CA--C 1.484 -1.561 0 O-C-N 120.334 -1.479 . . . . 25.0 112.115 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -79.45 -4.39 50.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.851 2.537 . . . . 25.0 117.851 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -74.95 86.1 2.28 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 111.742 -2.481 . . . . 25.0 113.081 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -76.52 175.77 8.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 109.194 -3.639 . . . . 25.0 111.391 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -75.98 152.81 36.91 Favored 'General case' 0 C--O 1.192 -1.95 0 CA-C-N 112.129 -2.305 . . . . 50.0 115.431 -144.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -75.28 128.48 35.53 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.843 -1.143 . . . . 25.0 109.913 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -84.5 130.55 34.74 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.394 -2.066 . . . . 25.0 108.501 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.17 125.9 44.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mmt -131.01 129.03 41.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 115.651 -2.119 . . . . 25.0 107.559 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.7 p -80.57 173.88 12.16 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 127.713 3.133 . . . . 25.0 107.685 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.91 159.69 46.04 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 117.693 1.837 . . . . 25.0 117.693 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 174.05 25.21 Favored Glycine 0 C--O 1.216 -1.001 0 CA-C-N 112.161 -2.019 . . . . 25.0 112.067 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.51 148.42 31.83 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 118.045 -3.032 . . . . 25.0 108.845 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.08 154.05 49.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.287 -1.746 . . . . 25.0 106.287 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.9 m -83.64 138.54 33.29 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.597 -1.241 . . . . 25.0 111.761 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . 0.294 71.0 m-85 -124.88 123.85 40.81 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 102.363 -3.199 . . . . 50.0 102.363 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.9 m -139.37 137.78 36.02 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.984 -1.858 . . . . 25.0 105.984 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -120.52 147.07 45.64 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 116.288 -1.815 . . . . 25.0 106.612 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 t -122.26 137.19 54.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.932 1.395 . . . . 25.0 107.368 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.22 158.15 36.4 Favored 'General case' 0 C--O 1.188 -2.132 0 CA-C-O 124.28 1.991 . . . . 50.0 113.311 -172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 p -120.04 16.14 12.46 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 102.964 -2.976 . . . . 25.0 102.964 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.42 125.29 79.18 Favored Pre-proline 0 C--O 1.255 1.366 0 CA-C-O 113.456 -3.164 . . . . 25.0 111.847 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -88.47 -6.5 6.06 Favored 'Trans proline' 0 C--N 1.292 -2.395 0 N-CA-C 108.954 -1.21 . . . . 25.0 108.954 156.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -56.03 139.01 48.16 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.165 -1.38 . . . . 25.0 114.526 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.44 109.28 20.41 Favored 'General case' 0 C--O 1.202 -1.437 0 N-CA-C 114.63 1.344 . . . . 25.0 114.63 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.7 m -66.21 148.44 51.84 Favored 'General case' 0 C--O 1.192 -1.946 0 N-CA-C 106.231 -1.766 . . . . 25.0 106.231 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 p -100.49 -42.06 6.74 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 124.258 1.98 . . . . 25.0 110.09 166.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -164.99 144.2 6.77 Favored 'General case' 0 C--O 1.191 -1.995 0 O-C-N 118.788 -2.445 . . . . 25.0 113.062 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.42 139.64 38.99 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 115.085 -2.646 . . . . 25.0 109.716 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.4 152.08 36.38 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.014 -1.678 . . . . 25.0 110.195 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.19 143.56 40.27 Favored 'General case' 0 C--O 1.197 -1.702 0 O-C-N 127.68 3.113 . . . . 50.0 110.9 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.87 166.63 17.12 Favored 'General case' 0 C--O 1.258 1.527 0 N-CA-C 106.39 -1.707 . . . . 50.0 106.39 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 pt -120.99 154.88 24.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 102.694 -3.076 . . . . 25.0 102.694 161.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.5 p -74.97 151.82 38.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.798 -1.189 . . . . 25.0 111.124 163.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -122.29 133.42 54.68 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.216 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.0 157.87 32.36 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 126.429 1.892 . . . . 25.0 108.734 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.87 38.56 7.94 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 118.121 -2.862 . . . . 25.0 118.333 165.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 168.5 9.7 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -144.08 124.29 7.58 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 114.814 -1.085 . . . . 25.0 109.96 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -58.26 -30.08 89.77 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 114.289 -3.341 . . . . 25.0 118.297 172.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.23 1.02 5.27 Favored 'General case' 0 C--O 1.198 -1.634 0 C-N-CA 116.542 -2.063 . . . . 75.0 115.403 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -132.84 173.13 6.25 Favored Pre-proline 0 C--O 1.199 -1.589 0 N-CA-C 104.849 -2.278 . . . . 25.0 104.849 -167.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 27.1 Cg_exo -50.65 20.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.398 2 C-N-CA 129.738 6.959 . . . . 25.0 124.732 173.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -16.71 -49.82 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.017 1 N-CA-C 121.959 4.059 . . . . 50.0 121.959 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -77.58 -8.56 58.03 Favored 'General case' 0 CA--C 1.479 -1.76 1 O-C-N 114.005 -5.434 . . . . 25.0 113.306 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -108.85 -40.73 4.95 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 126.728 2.011 . . . . 25.0 114.76 164.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 109' ' ' PRO . . . -79.27 13.97 1.69 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 127.791 3.182 . . . . 25.0 114.358 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -26.88 67.87 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.481 -0.933 . . . . 25.0 108.481 168.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -137.31 174.14 10.93 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 119.391 3.108 . . . . 50.0 119.391 -171.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -127.8 128.93 46.14 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.566 -1.197 . . . . 25.0 108.265 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 tp -70.16 123.35 21.41 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 103.46 -2.793 . . . . 50.0 103.46 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.9 pt -105.68 -12.93 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.54 1.162 . . . . 25.0 107.937 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.96 154.19 11.68 Favored Glycine 0 CA--C 1.501 -0.81 0 O-C-N 119.117 -2.239 . . . . 25.0 116.791 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.39 139.95 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 126.362 1.86 . . . . 25.0 109.944 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 t -134.69 103.64 11.05 Favored Pre-proline 0 CA--C 1.572 1.8 0 CA-C-O 125.727 2.68 . . . . 50.0 116.863 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.15 157.44 37.97 Favored 'Trans proline' 0 C--O 1.252 1.211 0 O-C-N 115.971 -2.7 . . . . 25.0 108.656 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -82.55 106.48 14.44 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-O 123.917 1.818 . . . . 25.0 110.37 171.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -140.12 -46.53 0.43 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 120.276 3.435 . . . . 50.0 120.276 -174.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 156.17 175.57 27.3 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 105.581 -3.008 . . . . 25.0 105.581 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 p 59.46 162.4 0.1 OUTLIER Pre-proline 0 C--O 1.251 1.176 0 N-CA-C 119.491 3.145 . . . . 25.0 119.491 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.63 1.98 3.87 Favored 'Trans proline' 0 C--N 1.371 1.716 1 C-N-CA 113.147 -4.102 . . . . 25.0 118.591 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -43.12 57.18 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 123.642 1.687 . . . . 25.0 109.877 172.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.1 t -77.46 -26.67 51.65 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.819 -4.301 . . . . 25.0 111.576 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -67.26 -20.86 65.72 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 125.197 2.427 . . . . 25.0 115.614 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -62.31 127.69 32.51 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 112.071 -2.331 . . . . 25.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.5 tp -122.21 4.12 9.78 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.403 -1.702 . . . . 75.0 106.403 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.5 t -128.85 136.36 50.35 Favored 'General case' 0 CA--C 1.47 -2.131 0 N-CA-C 102.442 -3.17 . . . . 25.0 102.442 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -147.88 153.24 38.85 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 106.053 -1.832 . . . . 25.0 106.053 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.823 -1.561 . . . . 25.0 107.925 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.23 129.65 75.43 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-O 113.113 -3.327 . . . . 25.0 108.852 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -73.9 135.51 43.31 Favored 'General case' 0 C--O 1.187 -2.189 0 O-C-N 128.725 3.766 . . . . 50.0 114.173 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.4 mm -113.07 121.67 37.62 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 115.833 -2.032 . . . . 25.0 108.095 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -58.12 147.38 83.65 Favored 'Trans proline' 0 CA--C 1.483 -2.054 1 C-N-CA 112.099 -4.801 . . . . 25.0 114.946 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.08 -11.24 47.68 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 111.557 -2.565 . . . . 25.0 112.555 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -112.19 -9.26 13.94 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 118.818 -1.153 . . . . 50.0 111.464 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -108.99 160.91 15.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 118.921 -2.362 . . . . 25.0 112.387 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 170' ' ' VAL 0.304 2.6 mp -138.95 132.92 31.09 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 128.191 2.596 . . . . 50.0 106.572 178.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.3 148.89 5.25 Favored Glycine 0 C--O 1.272 2.498 0 CA-C-O 127.078 3.599 . . . . 25.0 118.575 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.88 143.78 57.58 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 108.671 -3.765 . . . . 50.0 109.364 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -151.02 165.5 33.59 Favored 'General case' 0 C--O 1.269 2.094 0 N-CA-C 101.561 -3.496 . . . . 25.0 101.561 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.42 136.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 104.243 -2.503 . . . . 50.0 104.243 166.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -78.48 125.96 38.3 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 CA-C-O 114.711 -2.566 . . . . 25.0 106.031 164.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.36 131.62 53.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 103.104 -2.925 . . . . 50.0 103.104 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.29 146.15 44.32 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-O 126.345 2.974 . . . . 25.0 107.003 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -128.27 138.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 119.961 -1.712 . . . . 50.0 107.985 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -138.47 94.56 2.87 Favored 'General case' 0 C--O 1.196 -1.729 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -96.58 146.33 24.92 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-O 126.113 2.863 . . . . 25.0 105.184 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . 0.25 41.3 t -116.82 128.29 74.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 111.16 -2.745 . . . . 50.0 109.196 -169.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.56 -29.63 62.55 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.616 1.966 . . . . 25.0 110.579 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.05 -20.8 60.91 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 114.787 1.402 . . . . 25.0 114.787 -169.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.1 t -151.55 159.15 44.24 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 116.791 -1.576 . . . . 25.0 107.951 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.07 -1.36 28.6 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 117.765 -1.112 . . . . 25.0 112.596 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -103.34 160.57 14.58 Favored 'General case' 0 CA--C 1.569 1.695 0 O-C-N 124.91 1.381 . . . . 25.0 108.463 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.4 -173.89 4.52 Favored 'General case' 0 C--O 1.189 -2.093 0 O-C-N 120.304 -1.497 . . . . 25.0 109.545 -167.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -113.42 148.22 36.28 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.516 -1.661 . . . . 50.0 106.516 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -146.48 118.48 8.22 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.356 -2.461 . . . . 50.0 104.356 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.99 153.29 49.42 Favored 'General case' 0 C--O 1.265 1.899 0 O-C-N 120.734 -1.229 . . . . 25.0 110.063 -164.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.17 152.05 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 125.558 1.786 . . . . 75.0 108.367 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.2 mt -140.57 121.82 14.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.675 0 N-CA-C 105.046 -2.205 . . . . 25.0 105.046 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.47 142.67 44.85 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.522 -1.361 . . . . 25.0 108.632 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.2 163.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 124.903 1.377 . . . . 50.0 109.715 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -133.88 103.56 5.89 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.8 mt -99.73 133.51 43.98 Favored 'General case' 0 C--O 1.16 -3.611 0 N-CA-C 103.289 -2.856 . . . . 50.0 103.289 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 16.0 m -139.17 179.03 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-O 123.743 1.735 . . . . 50.0 111.908 -174.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -64.94 172.21 3.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.748 -2.478 . . . . 25.0 115.969 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 114.784 -2.531 . . . . 25.0 107.985 -177.409 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.511 2.612 0 CA-C-O 123.853 1.787 . . . . 25.0 111.216 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.87 -160.92 30.3 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 111.829 -2.441 . . . . 25.0 118.642 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -156.06 157.34 35.92 Favored 'General case' 0 C--O 1.261 1.683 0 N-CA-C 105.123 -2.177 . . . . 50.0 105.123 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.2 mm -84.09 110.26 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 O-C-N 119.47 -2.018 . . . . 25.0 107.286 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.96 -38.78 20.57 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 123.044 2.657 . . . . 25.0 109.946 170.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.82 149.25 63.82 Favored Pre-proline 0 N--CA 1.518 2.974 0 N-CA-C 104.004 -2.591 . . . . 25.0 104.004 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.07 160.69 93.42 Favored 'Cis proline' 0 C--O 1.252 1.213 0 C-N-CA 129.47 1.029 . . . . 25.0 113.159 -9.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.0 -173.09 52.09 Favored Glycine 0 C--N 1.286 -2.23 0 N-CA-C 117.84 1.896 . . . . 25.0 117.84 155.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 t -153.59 75.96 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 103.009 -2.96 . . . . 25.0 103.009 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -70.55 -7.91 47.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.436 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.28 -40.74 49.16 Favored 'General case' 0 C--O 1.255 1.369 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 161.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.4 67.6 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 114.359 1.244 . . . . 25.0 114.359 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 mt . . . . . 0 C--O 1.21 -1.005 0 CA-C-O 122.743 1.259 . . . . 75.0 113.73 175.502 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.205 -1.284 0 N-CA-C 121.0 3.704 . . . . 25.0 121.0 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.3 -34.1 73.31 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-N 114.983 -1.008 . . . . 50.0 109.15 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.02 47.02 0.54 Allowed Pre-proline 0 C--O 1.294 3.447 0 N-CA-C 118.172 2.656 . . . . 25.0 118.172 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.75 -11.37 31.72 Favored 'Trans proline' 0 CA--C 1.487 -1.874 0 C-N-CA 121.372 1.381 . . . . 25.0 111.966 -159.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -116.98 6.75 13.02 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.74 0.7 . . . . 25.0 112.363 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -89.83 55.73 3.26 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 117.906 -2.996 . . . . 25.0 112.17 -171.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.3 mt -103.67 96.08 6.48 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 118.009 -0.996 . . . . 50.0 112.964 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -123.87 157.4 34.28 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 103.721 -2.696 . . . . 25.0 103.721 166.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.84 42.2 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.713 -2.039 . . . . 25.0 110.225 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.02 150.07 47.03 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 121.992 2.178 . . . . 25.0 108.693 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.9 mttt . . . . . 0 N--CA 1.441 -0.908 0 C-N-CA 123.808 0.843 . . . . 25.0 111.605 171.302 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.4 mt . . . . . 0 C--O 1.27 2.184 0 CA-C-O 126.574 3.083 . . . . 50.0 104.696 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -73.69 -24.48 59.96 Favored 'General case' 0 CA--C 1.481 -1.678 1 O-C-N 116.272 -4.018 . . . . 50.0 113.975 -174.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -36.84 80.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-O 124.374 2.097 . . . . 25.0 108.239 167.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.85 -31.28 72.7 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 119.992 -1.887 . . . . 25.0 113.809 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.17 -50.23 65.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 117.582 -3.305 . . . . 25.0 110.432 167.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.98 -26.9 67.04 Favored 'General case' 1 C--O 1.319 4.725 0 CA-C-N 121.593 1.997 . . . . 75.0 107.418 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.11 -29.53 67.61 Favored 'General case' 0 C--O 1.27 2.133 0 C-N-CA 119.997 -0.681 . . . . 50.0 110.121 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -79.11 56.81 2.09 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-O 123.444 1.592 . . . . 25.0 109.391 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -91.94 60.41 3.84 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 118.644 -2.535 . . . . 25.0 106.39 167.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.0 p -146.97 -164.2 1.94 Allowed 'General case' 0 C--O 1.273 2.342 0 CA-C-N 111.303 -2.681 . . . . 25.0 116.633 -164.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.44 -26.92 68.76 Favored 'General case' 0 C--O 1.267 1.981 0 O-C-N 119.604 -1.935 . . . . 25.0 111.17 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -87.35 16.01 5.81 Favored 'General case' 0 C--O 1.264 1.845 0 N-CA-C 116.01 1.856 . . . . 25.0 116.01 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -75.21 89.39 2.53 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 123.879 1.799 . . . . 25.0 108.676 173.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -18.49 142.79 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 108.596 -3.911 . . . . 25.0 121.148 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.13 125.79 26.07 Favored 'General case' 0 N--CA 1.42 -1.949 0 O-C-N 125.459 1.724 . . . . 50.0 111.546 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -117.78 149.74 40.29 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 119.213 3.042 . . . . 25.0 119.213 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -142.61 126.07 16.73 Favored 'General case' 0 CA--C 1.591 2.538 0 N-CA-C 117.276 2.324 . . . . 25.0 117.276 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.54 125.37 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 O-C-N 117.735 -3.103 . . . . 25.0 106.919 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttt -148.06 161.84 40.59 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 102.539 -3.134 . . . . 25.0 102.539 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 64.6 p -88.71 166.67 13.91 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 119.672 -1.893 . . . . 25.0 112.209 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.87 176.41 51.1 Favored Glycine 0 C--O 1.256 1.499 0 C-N-CA 116.792 -2.623 . . . . 25.0 115.704 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.89 -171.79 19.12 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 105.118 -3.193 . . . . 25.0 105.118 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.64 141.1 58.89 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 103.792 -2.67 . . . . 25.0 103.792 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -111.26 144.34 40.59 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 101.814 -3.402 . . . . 25.0 101.814 158.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -126.15 120.83 31.13 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 100.996 -3.705 . . . . 25.0 100.996 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.44 ' CE2' HD12 ' A' ' 136' ' ' ILE . 77.9 m-85 -114.59 119.33 36.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 118.73 -2.481 . . . . 50.0 109.61 -172.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 m -131.61 97.26 4.17 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 100.019 -4.067 . . . . 25.0 100.019 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -112.53 116.28 29.99 Favored 'General case' 1 N--CA 1.539 4.01 0 O-C-N 126.614 2.446 . . . . 25.0 106.657 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.251 2.1 p -127.07 157.33 39.91 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 125.56 1.788 . . . . 25.0 106.228 -162.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -113.52 140.43 48.14 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 127.503 2.321 . . . . 50.0 107.097 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -88.1 -9.59 52.79 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 123.807 1.765 . . . . 25.0 108.773 -169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.94 149.1 38.05 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 101.639 -3.467 . . . . 25.0 101.639 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.68 147.36 75.72 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 118.167 -0.755 . . . . 25.0 113.558 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -141.85 141.83 33.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 117.647 -1.168 . . . . 25.0 110.935 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -80.75 159.58 25.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 117.99 -1.484 . . . . 25.0 113.776 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.9 m -150.48 148.23 28.47 Favored 'General case' 0 C--O 1.208 -1.122 0 C-N-CA 125.903 1.681 . . . . 25.0 109.695 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.7 p -111.21 -29.39 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.583 1.953 . . . . 25.0 112.486 170.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -166.96 158.87 12.84 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.405 1.482 . . . . 25.0 107.777 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -143.74 146.35 33.08 Favored 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 2.2 m-70 -144.48 149.37 35.85 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 120.329 -1.482 . . . . 25.0 110.59 -167.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -130.59 134.7 47.21 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 113.097 -1.865 . . . . 50.0 110.776 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.33 171.09 11.81 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 103.493 -2.78 . . . . 50.0 103.493 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.39 155.95 41.17 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 N-CA-C 103.321 -2.844 . . . . 25.0 103.321 167.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.295 33.5 p -81.52 153.91 26.55 Favored 'General case' 0 CA--C 1.469 -2.173 0 CA-C-O 124.096 1.903 . . . . 25.0 106.925 165.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -87.85 107.99 18.95 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 112.392 -2.185 . . . . 25.0 110.884 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -49.57 117.7 2.37 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 105.696 -1.965 . . . . 25.0 105.696 155.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.66 33.28 34.77 Favored Glycine 0 C--O 1.192 -2.515 0 CA-C-O 117.693 -1.615 . . . . 25.0 115.726 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -51.02 159.83 0.55 Allowed 'General case' 0 C--O 1.259 1.576 0 CA-C-O 122.267 1.032 . . . . 25.0 108.446 169.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -102.9 107.49 55.06 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 102.075 -3.306 . . . . 25.0 102.075 167.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -72.54 -16.34 27.24 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.552 2.168 . . . . 25.0 116.28 -173.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -84.2 -2.61 57.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.392 -1.731 . . . . 75.0 106.873 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -132.48 154.54 81.58 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 103.513 -2.773 . . . . 25.0 103.513 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.381 72.4 Cg_exo -25.64 91.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.285 3 C-N-CA 125.506 4.138 . . . . 25.0 122.529 -167.468 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.42 -15.34 61.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 110.883 -2.871 . . . . 50.0 112.928 -171.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 6.36 11.21 Favored 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 120.027 -1.671 . . . . 25.0 111.866 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -136.62 -46.11 0.6 Allowed 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 118.166 2.654 . . . . 25.0 118.166 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.35 -4.48 53.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.44 1.644 . . . . 25.0 115.44 165.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.61 7.8 16.22 Favored 'General case' 0 C--O 1.274 2.346 0 C-N-CA 125.645 1.578 . . . . 25.0 114.917 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -141.69 166.95 23.34 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 126.041 2.088 . . . . 50.0 106.95 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -134.27 154.41 51.3 Favored 'General case' 0 C--O 1.176 -2.796 0 N-CA-C 105.954 -1.869 . . . . 25.0 105.954 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.32 120.72 38.21 Favored 'General case' 0 CA--C 1.58 2.097 0 O-C-N 120.507 -1.371 . . . . 50.0 112.647 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.292 4.8 tp -98.13 -19.51 5.94 Favored 'Isoleucine or valine' 0 C--O 1.274 2.352 0 C-N-CA 126.738 2.015 . . . . 25.0 106.416 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.77 164.93 26.31 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 113.331 -1.759 . . . . 25.0 117.149 162.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . . . -138.84 157.65 45.66 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 101.531 -3.507 . . . . 25.0 101.531 166.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.9 130.44 13.01 Favored Pre-proline 0 C--O 1.245 0.866 0 N-CA-C 102.832 -3.025 . . . . 50.0 102.832 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.01 168.86 11.92 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 116.847 -1.636 . . . . 25.0 111.898 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -129.76 56.3 1.73 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.9 0.75 . . . . 25.0 109.57 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -123.93 -0.1 8.5 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 124.474 2.083 . . . . 50.0 113.316 -164.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -167.7 -165.72 25.58 Favored Glycine 0 C--O 1.258 1.608 0 N-CA-C 103.919 -3.673 . . . . 25.0 103.919 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.1 t -120.68 69.67 16.9 Favored Pre-proline 0 CA--C 1.556 1.19 0 O-C-N 126.411 1.889 . . . . 25.0 115.318 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.3 178.79 7.2 Favored 'Trans proline' 0 CA--C 1.578 2.682 0 C-N-CA 121.613 1.542 . . . . 25.0 112.618 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.67 71.31 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.36 2.14 2.5 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.992 1.317 . . . . 25.0 114.312 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -70.94 -16.8 62.68 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 124.162 1.934 . . . . 25.0 111.04 170.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -68.24 125.77 27.45 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 103.906 -2.627 . . . . 25.0 103.906 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.8 tp -75.81 -7.14 53.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 118.25 -1.38 . . . . 75.0 113.997 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.9 t -85.23 144.53 28.07 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 104.705 -2.331 . . . . 25.0 104.705 173.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -137.79 135.78 36.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.178 0.806 . . . . 25.0 113.178 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -101.47 128.42 47.69 Favored 'General case' 0 C--O 1.301 3.807 0 CA-C-O 123.272 1.51 . . . . 25.0 108.912 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 82' ' ' PHE . 46.3 mt -118.32 120.98 66.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 116.089 -2.244 . . . . 25.0 108.166 175.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -83.33 117.64 23.14 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 115.255 -2.578 . . . . 50.0 110.019 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.77 97.25 27.59 Favored Pre-proline 0 C--O 1.275 2.424 0 CA-C-O 123.321 1.534 . . . . 25.0 108.686 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 132.96 20.84 Favored 'Trans proline' 0 C--N 1.372 1.771 1 C-N-CA 113.121 -4.119 . . . . 25.0 110.298 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.43 97.06 3.14 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 117.321 -3.362 . . . . 25.0 109.979 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.69 -13.02 30.0 Favored 'General case' 0 C--O 1.267 1.977 0 N-CA-C 104.87 -2.27 . . . . 50.0 104.87 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -106.83 -173.68 2.35 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.643 -1.91 . . . . 25.0 112.82 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.53 129.87 45.05 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.169 -1.582 . . . . 50.0 111.609 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 152.9 -179.95 28.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 124.707 2.282 . . . . 25.0 116.113 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.14 158.84 38.58 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 117.113 -3.581 . . . . 50.0 117.192 -153.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -158.99 168.6 26.32 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 120.579 -1.325 . . . . 25.0 110.292 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.16 135.31 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.065 0 N-CA-C 103.775 -2.676 . . . . 50.0 103.775 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 mt -85.08 134.98 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 100.758 -3.793 . . . . 25.0 100.758 167.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.4 mt -116.5 135.18 54.05 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.387 -2.079 . . . . 50.0 105.387 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.7 136.59 54.94 Favored 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 97.282 -5.081 . . . . 25.0 97.282 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.5 120.44 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 O-C-N 125.491 1.744 . . . . 50.0 108.481 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.89 121.86 35.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.071 1.76 . . . . 25.0 107.881 -175.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -102.77 134.53 46.02 Favored 'General case' 0 N--CA 1.407 -2.625 0 O-C-N 120.413 -1.43 . . . . 25.0 110.346 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.59 99.11 3.65 Favored 'Isoleucine or valine' 0 C--O 1.262 1.747 0 N-CA-C 105.93 -1.878 . . . . 50.0 105.93 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.34 66.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 117.138 -1.825 . . . . 25.0 113.167 -167.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.3 -16.69 55.98 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.379 -1.282 . . . . 25.0 113.13 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.9 p -109.68 164.64 12.35 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 120.15 1.341 . . . . 25.0 109.621 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -81.75 -36.88 28.04 Favored 'General case' 0 C--O 1.285 2.933 0 CA-C-O 123.699 1.714 . . . . 25.0 110.38 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.61 154.38 20.02 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 112.369 -2.196 . . . . 25.0 108.378 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -111.0 158.15 19.12 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 124.941 1.297 . . . . 25.0 111.411 168.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -109.94 142.71 40.91 Favored 'General case' 0 C--O 1.269 2.104 0 O-C-N 119.391 -2.068 . . . . 50.0 109.032 -165.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.16 162.34 41.06 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-O 123.459 1.599 . . . . 50.0 111.872 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -138.86 157.6 45.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.921 -1.112 . . . . 25.0 108.047 166.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.1 133.04 63.2 Favored 'Isoleucine or valine' 0 C--O 1.258 1.53 0 O-C-N 120.117 -1.614 . . . . 75.0 109.363 165.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.2 mt -136.1 119.64 23.71 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 N-CA-C 102.421 -3.177 . . . . 25.0 102.421 -169.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -83.42 133.42 34.92 Favored 'General case' 0 CA--C 1.613 3.376 0 CA-C-O 123.094 1.426 . . . . 25.0 111.241 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.53 144.33 38.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 O-C-N 119.76 -1.838 . . . . 50.0 111.577 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.78 135.14 54.97 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 100.626 -3.842 . . . . 25.0 100.626 167.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 mt -126.36 129.34 48.61 Favored 'General case' 0 C--O 1.294 3.431 0 N-CA-C 104.75 -2.315 . . . . 50.0 104.75 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.01 163.9 30.78 Favored 'Isoleucine or valine' 0 C--O 1.277 2.523 0 N-CA-C 115.714 1.746 . . . . 50.0 115.714 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -71.01 134.36 47.07 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.161 -0.962 . . . . 25.0 111.638 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.657 -1.163 . . . . 25.0 112.826 -173.622 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . 0.259 47.0 p-80 . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 122.897 1.332 . . . . 25.0 109.553 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.52 -165.02 38.85 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-O 116.546 -2.252 . . . . 25.0 114.783 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.71 151.58 33.89 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-N 122.18 2.99 . . . . 50.0 116.056 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 6' ' ' LYS . 43.9 mm -66.78 132.09 32.26 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.722 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.11 39.98 3.42 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 126.4 3.0 . . . . 25.0 107.454 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.577 ' H ' HG22 ' A' ' 4' ' ' ILE . 96.2 mttt 72.09 163.53 0.14 Allowed Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 108.512 -3.949 . . . . 25.0 115.078 169.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.78 122.05 0.42 Allowed 'Cis proline' 0 C--N 1.357 0.98 0 C-N-CA 133.055 2.523 . . . . 25.0 114.14 3.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.47 147.93 13.28 Favored Glycine 0 C--O 1.252 1.238 0 CA-C-N 114.019 -1.446 . . . . 25.0 111.239 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -145.92 134.58 22.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.406 -1.643 . . . . 25.0 108.45 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -75.16 -17.1 60.46 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 117.086 -3.509 . . . . 25.0 111.88 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.78 56.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 116.374 -1.774 . . . . 25.0 107.65 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.72 63.32 Favored 'General case' 1 C--O 1.306 4.054 0 CA-C-N 122.002 2.183 . . . . 25.0 109.642 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--N 1.301 -1.52 0 O-C-N 121.142 -0.974 . . . . 75.0 110.021 -178.253 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 ptm . . . . . 0 C--O 1.278 2.578 1 N-CA-C 122.734 4.346 . . . . 25.0 122.734 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -57.48 -47.83 80.82 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 120.242 -1.536 . . . . 50.0 113.717 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -149.35 44.66 0.34 Allowed Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 119.733 3.234 . . . . 25.0 119.733 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -79.34 -17.32 11.63 Favored 'Trans proline' 0 C--O 1.272 2.206 0 C-N-CA 115.112 -2.792 . . . . 25.0 114.413 -167.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -92.66 5.77 49.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 116.85 -1.547 . . . . 25.0 112.253 170.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -119.29 16.66 13.11 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 124.983 1.427 . . . . 25.0 111.597 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 mt -73.19 124.85 26.42 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 126.115 1.766 . . . . 50.0 108.361 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.41 164.86 20.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 118.955 -2.341 . . . . 25.0 112.334 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.26 139.02 26.83 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.188 -1.824 . . . . 25.0 111.882 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 82.1 tttt -59.8 137.55 58.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 118.206 -2.809 . . . . 25.0 112.552 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 117.559 -3.213 . . . . 25.0 103.336 178.191 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 117.797 -1.097 . . . . 50.0 112.053 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -68.78 -22.96 64.25 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.547 -0.909 . . . . 50.0 108.547 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -26.43 62.84 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 117.049 -1.973 . . . . 25.0 116.058 166.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.63 -21.22 64.72 Favored Glycine 0 C--O 1.186 -2.855 0 CA-C-O 114.435 -3.425 . . . . 25.0 112.829 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.68 -34.39 23.46 Favored 'Isoleucine or valine' 0 C--O 1.293 3.361 0 CA-C-N 124.147 3.973 . . . . 25.0 112.402 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.72 -18.85 56.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 125.794 1.934 . . . . 75.0 107.51 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.266 4.8 t70 -43.19 -39.77 3.05 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 115.35 1.611 . . . . 50.0 115.35 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -78.05 10.63 2.76 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 116.442 2.015 . . . . 25.0 116.442 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -147.97 47.11 1.08 Allowed 'General case' 0 C--O 1.255 1.395 0 C-N-CA 128.179 2.591 . . . . 25.0 110.269 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 t -144.52 161.19 39.71 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 119.254 3.057 . . . . 25.0 119.254 -166.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -68.21 -17.4 64.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 122.151 2.251 . . . . 25.0 108.907 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -96.54 26.25 4.56 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.322 36.5 ttp180 -78.56 67.79 4.4 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-O 123.491 1.615 . . . . 25.0 110.418 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -61.84 145.39 52.83 Favored 'General case' 0 CA--C 1.454 -2.715 1 CA-C-N 107.191 -4.549 . . . . 25.0 111.745 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.435 ' H ' ' HD1' ' A' ' 71' ' ' PHE . 5.8 p90 -77.17 144.48 38.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.38 -1.736 . . . . 50.0 113.354 -166.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 166' ' ' ASP . 59.8 mttm -107.76 165.53 11.37 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-O 118.311 -0.852 . . . . 25.0 111.541 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.512 ' H ' ' HA ' ' A' ' 167' ' ' VAL . 3.6 m80 -127.72 122.16 32.17 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 126.204 1.802 . . . . 25.0 107.023 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.3 mt -83.7 126.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 103.511 -2.774 . . . . 25.0 103.511 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.8 mtp -138.15 156.4 47.77 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 126.051 2.834 . . . . 25.0 105.013 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.7 p -91.88 166.05 12.93 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.786 -2.302 . . . . 25.0 104.786 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.74 167.85 52.05 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-O 116.793 -2.115 . . . . 25.0 115.213 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.4 171.01 12.95 Favored Glycine 0 CA--C 1.555 2.559 1 N-CA-C 102.906 -4.077 . . . . 25.0 102.906 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 11.7 tt0 -62.92 144.9 56.32 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.572 -1.546 . . . . 25.0 111.258 168.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -136.11 146.75 47.33 Favored 'General case' 0 CA--C 1.445 -3.082 0 O-C-N 119.802 -1.811 . . . . 25.0 107.907 162.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.1 m -101.91 137.27 40.43 Favored 'General case' 0 CA--C 1.468 -2.198 0 C-N-CA 124.907 1.283 . . . . 25.0 109.216 167.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -114.79 140.93 48.52 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.856 -1.778 . . . . 50.0 106.669 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -127.32 136.16 51.54 Favored 'General case' 0 C--O 1.19 -2.059 0 CA-C-O 125.014 2.34 . . . . 25.0 111.109 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -129.99 158.85 38.43 Favored 'General case' 0 C--O 1.28 2.676 1 N-CA-C 97.988 -4.819 . . . . 25.0 97.988 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 t -147.23 155.04 41.73 Favored 'General case' 0 CA--C 1.476 -1.886 0 CA-C-N 119.68 1.127 . . . . 25.0 111.108 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.22 162.26 28.27 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 105.162 -2.162 . . . . 50.0 105.162 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 t -116.51 -9.2 11.45 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-N 120.244 1.383 . . . . 25.0 113.107 167.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.6 31.29 Favored Pre-proline 0 CA--C 1.481 -1.687 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 168.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.01 155.88 61.03 Favored 'Trans proline' 0 CA--C 1.486 -1.887 1 C-N-CA 113.032 -4.179 . . . . 25.0 116.586 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -86.02 156.56 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 104.601 -2.37 . . . . 25.0 104.601 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -80.16 132.22 35.87 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.762 -2.31 . . . . 25.0 104.762 166.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 m -152.48 153.59 33.8 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 116.039 -1.934 . . . . 25.0 109.542 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 p -114.66 -43.27 3.17 Favored 'General case' 0 C--O 1.275 2.43 0 C-N-CA 125.201 1.401 . . . . 25.0 108.76 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -151.16 144.6 24.87 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 117.911 -2.993 . . . . 25.0 110.766 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . 0.262 51.5 p-90 -114.45 150.01 35.4 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 117.902 -1.519 . . . . 25.0 112.403 166.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -136.17 150.28 48.97 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 103.885 -2.635 . . . . 25.0 103.885 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . 0.252 7.1 p90 -147.23 149.4 32.83 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 106.12 -1.808 . . . . 50.0 106.12 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -152.98 163.54 39.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.42 -1.696 . . . . 50.0 106.42 -157.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.02 167.3 20.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 115.529 -2.177 . . . . 25.0 107.657 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.4 p -96.69 157.95 15.66 Favored 'General case' 0 C--O 1.203 -1.373 0 O-C-N 125.718 1.886 . . . . 25.0 109.298 170.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -74.03 92.02 2.11 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 111.292 -2.685 . . . . 25.0 114.274 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.99 113.93 2.11 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 126.457 2.348 . . . . 25.0 114.323 165.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.13 35.47 9.7 Favored Glycine 0 C--O 1.25 1.131 0 CA-C-N 115.05 -0.977 . . . . 25.0 114.097 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 162.4 28.81 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 113.603 -1.299 . . . . 25.0 112.75 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.15 143.83 40.02 Favored Pre-proline 0 C--O 1.194 -1.867 0 CA-C-N 115.518 -0.764 . . . . 25.0 109.394 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.62 -18.18 17.64 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 114.85 -2.967 . . . . 25.0 118.82 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -83.69 9.2 12.26 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 118.779 -2.451 . . . . 75.0 109.172 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -128.0 169.74 11.9 Favored Pre-proline 0 C--O 1.285 2.954 0 N-CA-C 101.74 -3.43 . . . . 25.0 101.74 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -55.66 28.21 0.02 OUTLIER 'Trans proline' 0 C--O 1.243 0.753 1 C-N-CA 129.121 6.547 . . . . 25.0 122.359 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.95 -40.15 66.56 Favored 'General case' 0 C--O 1.197 -1.659 0 CA-C-N 119.773 1.17 . . . . 50.0 112.939 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -85.34 -5.7 59.29 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 115.938 1.829 . . . . 25.0 115.938 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -111.37 -66.54 1.07 Allowed 'General case' 0 CA--C 1.475 -1.937 0 O-C-N 119.978 -1.701 . . . . 25.0 107.927 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.24 54.02 1.2 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.516 2.326 . . . . 25.0 109.251 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . 0.251 9.9 t0 -60.68 -42.24 96.73 Favored 'General case' 0 CA--C 1.596 2.746 0 CA-C-N 110.099 -3.228 . . . . 25.0 110.267 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 126.172 2.17 . . . . 50.0 112.428 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -141.8 129.52 21.62 Favored 'General case' 0 C--O 1.195 -1.774 0 O-C-N 126.364 2.29 . . . . 25.0 112.057 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.06 129.94 41.52 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 115.192 -2.337 . . . . 50.0 110.685 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.4 tt -105.59 -20.5 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 122.114 2.233 . . . . 25.0 106.797 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.65 161.36 27.22 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 120.567 -0.825 . . . . 25.0 114.566 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.5 133.4 14.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 123.0 1.381 . . . . 25.0 111.064 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.76 97.61 38.46 Favored Pre-proline 0 N--CA 1.499 1.982 0 CA-C-N 112.552 -2.113 . . . . 50.0 111.228 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.99 152.73 76.53 Favored 'Trans proline' 0 C--N 1.347 0.479 0 N-CA-C 116.79 1.804 . . . . 25.0 116.79 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -79.09 69.31 5.25 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.702 1.251 . . . . 25.0 111.222 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -74.95 -31.32 61.46 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 119.341 -2.099 . . . . 50.0 113.089 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.17 -5.26 71.53 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-O 117.94 -1.478 . . . . 25.0 113.89 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.0 p -71.7 166.19 42.24 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 126.429 1.899 . . . . 25.0 109.054 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.29 -10.94 26.36 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 116.23 -2.046 . . . . 25.0 117.039 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.4 -30.8 42.56 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 121.616 -0.677 . . . . 25.0 109.21 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 48.0 t -74.87 -44.86 46.7 Favored 'General case' 0 C--O 1.285 2.936 0 CA-C-O 124.141 1.924 . . . . 25.0 108.086 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -64.01 -23.96 67.53 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 111.941 -2.39 . . . . 25.0 113.799 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.25 109.19 12.16 Favored 'General case' 0 CA--C 1.58 2.115 0 O-C-N 124.99 1.431 . . . . 25.0 110.38 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.1 tp -83.35 -33.78 25.76 Favored 'General case' 0 C--O 1.193 -1.901 0 C-N-CA 127.214 2.206 . . . . 75.0 108.17 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -80.36 128.27 33.37 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 115.987 -2.285 . . . . 25.0 108.45 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -124.44 153.86 41.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 125.314 1.634 . . . . 25.0 114.327 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -98.59 148.55 23.67 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.6 mt -142.27 129.2 19.38 Favored 'Isoleucine or valine' 0 C--O 1.264 1.818 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 71.1 t80 -75.95 120.11 20.84 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 120.401 -1.437 . . . . 50.0 113.135 169.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.53 122.81 44.96 Favored Pre-proline 0 C--O 1.206 -1.227 0 N-CA-C 101.918 -3.364 . . . . 25.0 101.918 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -61.43 153.2 67.73 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 123.775 1.408 . . . . 25.0 109.805 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -110.35 -0.09 17.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 119.566 -1.959 . . . . 25.0 112.493 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.91 -8.36 57.33 Favored 'General case' 0 C--O 1.265 1.896 0 N-CA-C 116.583 2.068 . . . . 50.0 116.583 -172.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -133.92 151.38 51.47 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 116.798 2.147 . . . . 25.0 116.798 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 171' ' ' ASN . 90.5 mt -100.0 155.73 17.54 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.56 1.544 . . . . 50.0 107.676 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.17 157.01 10.08 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 123.371 4.108 . . . . 25.0 123.371 172.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 0.1 OUTLIER -80.68 146.0 31.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 123.09 1.424 . . . . 50.0 113.494 -174.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 159.14 43.72 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.12 -1.4 . . . . 25.0 109.913 162.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.71 142.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 O-C-N 125.233 1.583 . . . . 50.0 108.156 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 mt -109.85 134.66 51.27 Favored 'Isoleucine or valine' 0 C--O 1.25 1.105 0 CA-C-O 118.201 -0.904 . . . . 25.0 109.76 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.24 155.39 35.96 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 124.913 2.292 . . . . 50.0 108.27 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.6 153.77 48.66 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 118.998 -2.313 . . . . 25.0 109.277 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.86 118.52 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 128.707 2.803 . . . . 50.0 106.29 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -107.63 88.25 2.69 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 126.36 2.287 . . . . 25.0 107.106 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.494 ' HA ' ' HB1' ' A' ' 160' ' ' ALA . 24.6 t70 -77.36 141.69 39.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.158 -1.589 . . . . 25.0 111.832 -163.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.02 123.77 59.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-O 116.991 -1.48 . . . . 50.0 112.464 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.94 20.07 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 120.231 1.378 . . . . 25.0 111.671 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.52 -20.84 65.49 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -124.51 159.88 29.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.932 1.456 . . . . 25.0 114.932 -173.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.04 -39.7 87.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 116.61 2.078 . . . . 25.0 116.61 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 3.1 m-20 -91.87 160.55 15.24 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 118.508 -0.758 . . . . 25.0 112.299 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 153' ' ' ASP . . . -138.57 159.9 40.93 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 101.221 -3.622 . . . . 25.0 101.221 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -90.99 153.36 20.21 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 124.379 1.071 . . . . 50.0 108.538 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -136.95 164.71 27.7 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.849 -1.94 . . . . 50.0 111.021 164.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.54 133.38 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 111.991 -2.368 . . . . 75.0 115.557 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -135.33 136.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 124.091 1.901 . . . . 25.0 106.413 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 72' ' ' LYS 0.284 22.3 t0 -102.92 150.43 23.53 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 101.246 -3.613 . . . . 25.0 101.246 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 73' ' ' HIS . 27.2 m -144.83 167.07 11.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 116.631 -1.652 . . . . 50.0 107.662 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 10.4 t0 -133.52 132.97 41.59 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.3 mt -126.12 117.12 22.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 107.813 -1.18 . . . . 50.0 107.813 -164.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.0 162.31 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 117.926 2.565 . . . . 50.0 117.926 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.4 ' H ' HD23 ' A' ' 143' ' ' LEU . 7.1 m120 -69.84 160.93 30.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.235 1.814 . . . . 25.0 107.835 166.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.1 mttt . . . . . 0 C--O 1.266 1.953 0 N-CA-C 118.318 2.71 . . . . 25.0 118.318 -176.855 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 51.5 m80 . . . . . 1 N--CA 1.572 5.642 0 CA-C-O 120.832 0.349 . . . . 25.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.01 174.15 36.76 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-O 117.409 -1.773 . . . . 25.0 116.865 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -126.29 171.45 10.93 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 123.436 1.589 . . . . 50.0 107.703 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm -81.73 116.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 O-C-N 120.024 -1.672 . . . . 25.0 108.539 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.05 -40.92 30.06 Favored 'General case' 0 C--O 1.268 2.058 0 CA-C-N 115.424 -0.807 . . . . 25.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -154.55 136.34 9.36 Favored Pre-proline 0 C--O 1.199 -1.599 0 N-CA-C 105.183 -2.154 . . . . 25.0 105.183 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.03 145.61 65.66 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 C-N-CA 130.698 1.541 . . . . 25.0 115.226 -1.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.32 170.31 50.47 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 120.916 -0.659 . . . . 25.0 111.758 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 84.7 p -70.28 162.18 28.96 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.314 2.339 . . . . 25.0 117.314 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -68.71 -3.45 12.16 Favored 'General case' 0 CA--C 1.581 2.16 0 CA-C-N 118.916 0.78 . . . . 25.0 110.471 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.23 -27.71 68.18 Favored 'General case' 0 C--O 1.197 -1.666 0 C-N-CA 118.949 -1.1 . . . . 25.0 110.911 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.82 91.84 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-O 122.962 1.363 . . . . 25.0 108.436 171.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 124.215 1.959 . . . . 75.0 115.634 -178.255 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.51 -0.562 0 CA-C-O 120.863 0.364 . . . . 25.0 111.905 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -74.55 -50.17 19.07 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.818 -1.537 . . . . 50.0 111.086 -162.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -143.41 63.39 12.49 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.742 -1.224 . . . . 25.0 112.38 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.74 -26.47 38.91 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 115.869 -2.287 . . . . 25.0 114.203 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -60.01 -9.81 3.53 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.024 2.602 . . . . 25.0 118.024 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -74.91 -5.47 43.91 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 116.633 -1.651 . . . . 25.0 113.236 -168.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.0 122.58 25.11 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 120.6 1.545 . . . . 50.0 112.807 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -136.2 165.17 26.36 Favored 'General case' 0 C--O 1.261 1.691 0 N-CA-C 114.87 1.433 . . . . 25.0 114.87 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.92 143.96 30.83 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 160.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -87.92 158.58 18.65 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 103.514 -2.772 . . . . 25.0 103.514 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.2 mttp . . . . . 0 C--O 1.29 3.186 0 CA-C-O 123.316 1.531 . . . . 25.0 106.982 170.341 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 60' ' ' GLY . 29.6 mt . . . . . 0 C--O 1.199 -1.604 0 CA-C-O 118.163 -0.923 . . . . 50.0 112.992 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -69.82 -25.59 63.84 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 101.253 -3.61 . . . . 50.0 101.253 157.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.43 -15.45 80.33 Favored Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.804 -1.553 . . . . 25.0 110.433 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 57' ' ' LEU . . . -66.48 -29.85 75.51 Favored Glycine 0 CA--C 1.493 -1.342 0 O-C-N 126.954 2.208 . . . . 25.0 113.081 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.51 -42.08 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 O-C-N 119.805 -1.997 . . . . 25.0 111.985 174.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.44 -23.94 50.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.83 -1.174 . . . . 75.0 107.83 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.7 -31.2 64.84 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.73 1.252 . . . . 50.0 113.216 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -89.93 35.48 0.85 Allowed 'General case' 0 C--O 1.161 -3.556 0 CA-C-N 114.167 -1.379 . . . . 25.0 111.059 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -159.7 50.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 100.432 -3.914 . . . . 25.0 100.432 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.8 t -140.69 179.58 6.61 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 102.081 -3.303 . . . . 25.0 102.081 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.55 -31.55 65.36 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 123.677 2.944 . . . . 25.0 111.478 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.89 21.59 0.84 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 116.945 -1.503 . . . . 25.0 114.549 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -60.8 90.25 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.809 2.444 . . . . 25.0 106.014 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -17.25 131.03 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.5 2 CA-C-N 106.614 -4.812 . . . . 25.0 118.806 171.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -68.93 142.86 54.61 Favored 'General case' 0 CA--C 1.476 -1.901 0 N-CA-C 117.733 2.494 . . . . 50.0 117.733 -160.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -112.76 147.2 37.37 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.046 1.748 . . . . 25.0 108.496 -166.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -122.84 137.61 54.88 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-O 116.493 -1.718 . . . . 25.0 108.451 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.0 mt -96.47 119.49 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 105.585 -2.006 . . . . 25.0 105.585 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.8 mtp -128.1 174.63 9.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.824 1.249 . . . . 25.0 111.718 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -112.54 171.16 7.69 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.434 1.493 . . . . 25.0 110.147 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.67 170.42 53.21 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 105.997 -2.841 . . . . 25.0 105.997 171.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.14 178.21 15.4 Favored Glycine 0 C--N 1.285 -2.302 2 O-C-N 115.882 -4.305 . . . . 25.0 109.614 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.81 137.32 51.72 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 127.645 2.615 . . . . 25.0 113.651 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -110.74 134.93 52.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 111.765 -2.47 . . . . 25.0 106.189 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -92.18 134.03 35.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 117.56 -3.212 . . . . 25.0 112.948 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.85 127.0 50.03 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 118.829 -2.419 . . . . 50.0 109.371 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.0 m -140.22 126.93 20.43 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.415 -1.328 . . . . 25.0 107.415 -167.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -104.05 162.95 12.72 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 128.938 3.899 . . . . 25.0 109.014 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 t -149.29 146.47 27.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 103.331 -2.84 . . . . 25.0 103.331 165.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.48 143.07 49.46 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 127.123 2.169 . . . . 50.0 111.42 173.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -96.77 -5.16 39.2 Favored 'General case' 0 C--O 1.27 2.169 0 C-N-CA 127.072 2.149 . . . . 25.0 115.173 -168.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.87 137.57 12.59 Favored Pre-proline 0 N--CA 1.481 1.112 0 N-CA-C 103.529 -2.767 . . . . 25.0 103.529 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.5 137.78 61.7 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 115.404 -2.597 . . . . 25.0 116.167 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -148.03 169.2 20.45 Favored 'General case' 0 CA--C 1.557 1.222 1 N-CA-C 99.761 -4.163 . . . . 25.0 99.761 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -111.57 113.11 25.3 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 123.744 1.735 . . . . 25.0 108.402 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.9 m -71.98 136.02 46.62 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 113.094 -1.866 . . . . 25.0 111.847 172.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 -47.13 5.44 Favored 'General case' 0 C--O 1.274 2.376 0 CA-C-O 122.722 1.248 . . . . 25.0 112.624 167.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.24 159.01 44.75 Favored 'General case' 0 C--O 1.219 -0.547 1 O-C-N 116.011 -4.18 . . . . 25.0 102.242 175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -142.06 152.03 42.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 116.821 -1.952 . . . . 25.0 112.604 160.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -129.1 151.58 49.62 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 126.425 1.89 . . . . 25.0 109.771 -156.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.68 147.17 50.05 Favored 'General case' 0 C--O 1.194 -1.834 0 O-C-N 123.498 0.499 . . . . 50.0 111.311 156.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.31 163.02 28.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 104.286 -2.487 . . . . 50.0 104.286 172.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.79 133.55 67.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 163.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -73.48 131.94 42.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 101.88 -3.378 . . . . 25.0 101.88 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -87.27 104.41 16.37 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 125.8 2.714 . . . . 25.0 105.753 -169.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.08 113.25 1.46 Allowed 'General case' 0 C--O 1.279 2.607 0 O-C-N 119.233 -2.167 . . . . 25.0 110.341 153.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.88 40.21 7.72 Favored Glycine 0 C--O 1.181 -3.162 0 C-N-CA 116.912 -2.566 . . . . 25.0 108.837 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -55.87 160.63 2.59 Favored 'General case' 0 CA--C 1.579 2.063 0 O-C-N 120.376 -1.661 . . . . 25.0 109.851 168.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -80.71 117.12 66.46 Favored Pre-proline 0 C--O 1.266 1.933 0 N-CA-C 102.596 -3.113 . . . . 25.0 102.596 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.11 -25.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 N-CA-C 116.36 1.638 . . . . 25.0 116.36 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.33 -6.19 57.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 112.217 -2.265 . . . . 75.0 106.111 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.55 150.9 46.36 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 114.847 -2.501 . . . . 25.0 110.027 -171.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.294 0.0 OUTLIER -2.52 87.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.264 1.794 2 C-N-CA 125.642 4.228 . . . . 25.0 122.698 176.045 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.57 -34.12 72.3 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 110.301 -3.136 . . . . 50.0 109.595 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -87.81 -10.05 52.04 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.695 2.109 . . . . 25.0 116.695 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.84 -38.41 0.64 Allowed 'General case' 0 C--O 1.185 -2.308 0 N-CA-C 121.468 3.877 . . . . 25.0 121.468 -170.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.6 -9.63 59.44 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 117.18 -3.45 . . . . 25.0 111.871 171.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.63 4.98 10.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.378 -0.929 . . . . 25.0 112.849 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.62 167.33 22.18 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.755 0.788 . . . . 50.0 112.782 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -117.73 141.83 47.95 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.193 160.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 tp -67.33 132.09 47.01 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.319 -2.104 . . . . 50.0 105.319 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 tt -110.97 -14.2 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 118.928 2.936 . . . . 25.0 118.928 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.82 165.69 30.9 Favored Glycine 0 C--O 1.212 -1.269 0 CA-C-O 115.217 -2.991 . . . . 25.0 112.43 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.36 21.88 Favored 'General case' 0 N--CA 1.418 -2.054 0 O-C-N 126.025 1.662 . . . . 25.0 108.329 168.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.38 101.02 28.42 Favored Pre-proline 0 C--N 1.312 -1.059 0 C-N-CA 125.473 1.509 . . . . 50.0 111.892 -170.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.64 170.47 8.94 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 115.752 -2.365 . . . . 25.0 113.607 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -97.31 78.27 2.71 Favored 'General case' 0 C--O 1.175 -2.851 0 CA-C-O 115.959 -1.972 . . . . 25.0 108.546 167.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.47 37.47 1.22 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.21 1.481 . . . . 50.0 110.596 -158.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.59 35.01 17.86 Favored Glycine 0 C--O 1.263 1.92 0 N-CA-C 108.834 -1.706 . . . . 25.0 108.834 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.4 m -75.3 147.01 82.27 Favored Pre-proline 0 C--O 1.263 1.796 0 N-CA-C 117.558 2.429 . . . . 25.0 117.558 -154.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.28 177.28 7.48 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 115.564 -2.491 . . . . 25.0 109.267 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.06 6.2 0.99 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.836 2.162 . . . . 25.0 116.836 -167.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.4 p -68.05 -4.44 13.45 Favored 'General case' 0 C--O 1.182 -2.494 0 CA-C-N 114.299 -1.318 . . . . 25.0 109.29 163.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.2 ttp85 -69.88 -16.52 63.25 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 114.154 1.168 . . . . 25.0 114.154 167.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -52.44 133.25 35.35 Favored 'General case' 0 C--O 1.191 -1.995 0 CA-C-O 121.905 0.859 . . . . 25.0 108.732 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -70.66 -13.12 61.95 Favored 'General case' 0 C--O 1.187 -2.197 0 CA-C-O 123.466 1.603 . . . . 75.0 111.504 -161.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.8 t -98.0 141.62 30.74 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 118.487 -2.633 . . . . 25.0 110.405 163.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -132.59 157.16 45.44 Favored 'General case' 0 C--O 1.161 -3.559 0 N-CA-C 103.376 -2.824 . . . . 25.0 103.376 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -120.9 148.45 44.03 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 100.863 -3.754 . . . . 25.0 100.863 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 50.6 mm -129.78 125.69 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -79.76 136.77 36.83 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.94 -0.475 . . . . 50.0 109.853 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.2 mm -125.96 119.76 23.99 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 126.623 2.452 . . . . 25.0 109.403 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.25 159.83 33.02 Favored 'Trans proline' 0 C--N 1.359 1.131 1 C-N-CA 113.288 -4.008 . . . . 25.0 115.353 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.51 43.45 1.1 Allowed 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 122.906 1.336 . . . . 25.0 110.833 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.23 -42.51 99.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 111.089 -2.778 . . . . 50.0 114.351 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -149.47 154.2 38.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.897 1.679 . . . . 25.0 108.742 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.25 154.81 34.9 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.859 -1.534 . . . . 50.0 106.859 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.25 168.02 11.95 Favored Glycine 0 C--N 1.364 2.104 0 O-C-N 126.224 2.202 . . . . 25.0 118.177 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.26 153.52 41.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 117.697 2.48 . . . . 50.0 117.697 -165.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.96 147.09 39.99 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 120.879 -1.138 . . . . 25.0 109.392 160.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.48 133.81 46.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 N-CA-C 103.852 -2.647 . . . . 50.0 103.852 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.81 137.92 31.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 103.962 -2.607 . . . . 25.0 103.962 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.6 mt -122.82 145.77 48.13 Favored 'General case' 0 C--O 1.184 -2.351 0 N-CA-C 104.681 -2.34 . . . . 50.0 104.681 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.22 156.48 44.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 117.983 -1.008 . . . . 25.0 110.344 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.5 132.63 31.63 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 O-C-N 127.715 3.134 . . . . 50.0 105.793 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -105.4 130.69 53.45 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 104.131 -2.544 . . . . 25.0 104.131 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -103.71 126.8 51.08 Favored 'General case' 0 C--O 1.264 1.835 0 O-C-N 118.751 -2.468 . . . . 25.0 104.962 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.06 133.06 64.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 O-C-N 116.656 -3.778 . . . . 50.0 107.823 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.25 -11.73 59.7 Favored 'General case' 0 C--O 1.178 -2.698 0 O-C-N 121.337 -0.852 . . . . 25.0 110.791 -171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -35.53 81.41 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.078 1.894 . . . . 25.0 114.077 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.2 p -143.79 159.82 41.84 Favored 'General case' 0 C--O 1.274 2.393 0 O-C-N 120.924 -1.11 . . . . 25.0 112.089 -164.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -76.98 -23.98 52.28 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.999 -1.111 . . . . 25.0 107.999 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.49 151.85 45.54 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.041 -0.981 . . . . 25.0 110.85 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -123.9 159.0 30.65 Favored 'General case' 0 C--O 1.27 2.182 0 N-CA-C 102.039 -3.319 . . . . 25.0 102.039 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -111.72 154.41 25.04 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 104.31 -2.478 . . . . 50.0 104.31 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.36 149.48 50.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 110.971 -2.831 . . . . 50.0 106.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -133.74 129.85 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.253 33.9 m -121.73 135.37 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 117.576 -3.203 . . . . 75.0 112.99 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 95.8 mt -135.64 132.59 51.47 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 105.07 -2.196 . . . . 25.0 105.07 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -104.7 141.4 36.53 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 106.118 -1.808 . . . . 25.0 106.118 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.92 149.25 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 107.725 -1.213 . . . . 50.0 107.725 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.42 94.43 4.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 118.26 20.96 Favored 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 125.161 1.384 . . . . 50.0 108.333 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.1 m -117.5 157.84 18.47 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-O 124.448 2.071 . . . . 50.0 108.501 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -91.64 162.55 14.45 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 111.252 -2.703 . . . . 25.0 106.401 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 CA--C 1.565 1.548 0 O-C-N 118.742 -2.474 . . . . 25.0 108.166 166.94 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 N--CA 1.517 2.9 0 CA-C-O 123.532 1.634 . . . . 25.0 113.724 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.46 -174.81 24.92 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 125.074 2.486 . . . . 25.0 111.921 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.59 161.95 39.43 Favored 'General case' 0 CA--C 1.47 -2.113 0 CA-C-N 110.77 -2.715 . . . . 50.0 108.891 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 mt -97.8 123.52 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 N-CA-C 103.805 -2.665 . . . . 25.0 103.805 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.35 -38.93 18.22 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 119.609 -1.932 . . . . 25.0 111.383 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -136.45 160.01 68.4 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 118.005 -0.998 . . . . 25.0 110.169 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.13 141.4 62.24 Favored 'Cis proline' 0 CA--C 1.477 -2.327 0 C-N-CA 133.479 2.7 . . . . 25.0 114.386 -1.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.36 -168.66 45.16 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 119.253 2.461 . . . . 25.0 119.253 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t -145.92 156.17 43.35 Favored 'General case' 0 C--O 1.266 1.944 0 CA-C-N 119.196 1.498 . . . . 25.0 107.7 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -79.25 -8.46 59.06 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.87 1.319 . . . . 25.0 109.917 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.47 -29.47 64.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.428 -0.795 . . . . 25.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.13 -27.84 67.65 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 118.686 2.847 . . . . 25.0 118.686 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--N 1.306 -1.288 0 O-C-N 125.903 2.002 . . . . 75.0 111.554 -178.382 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.0 ptp . . . . . 0 N--CA 1.439 -1.01 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -101.47 -46.08 5.1 Favored 'General case' 0 CA--C 1.485 -1.529 0 O-C-N 120.908 -1.12 . . . . 50.0 110.452 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -114.3 79.06 4.93 Favored Pre-proline 0 C--O 1.264 1.826 0 N-CA-C 115.654 1.724 . . . . 25.0 115.654 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.18 -20.77 8.35 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 114.958 1.099 . . . . 25.0 114.958 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -127.5 2.36 6.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 120.25 3.426 . . . . 25.0 120.25 -161.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 49.55 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.006 -1.059 . . . . 25.0 108.163 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.59 79.92 8.16 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.42 0.628 . . . . 50.0 111.679 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -135.76 150.98 49.68 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 116.819 -1.563 . . . . 25.0 110.71 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.02 166.52 25.83 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.414 -3.18 . . . . 25.0 102.414 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -93.23 142.56 27.18 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 117.345 -1.742 . . . . 25.0 111.714 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mttt . . . . . 0 C--O 1.205 -1.272 0 C-N-CA 119.472 -0.891 . . . . 25.0 109.112 175.89 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 CA--C 1.475 -1.91 0 N-CA-C 114.715 1.376 . . . . 50.0 114.715 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.09 -34.99 69.09 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.775 -1.935 . . . . 50.0 105.775 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -11.3 85.26 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-O 122.805 1.225 . . . . 25.0 110.245 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.6 -29.9 76.21 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 123.85 1.805 . . . . 25.0 114.599 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -74.92 -39.19 44.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 O-C-N 119.986 -1.89 . . . . 25.0 107.111 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -68.88 -27.8 66.12 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 119.269 -2.144 . . . . 75.0 109.783 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 -27.6 67.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.521 -1.362 . . . . 50.0 110.843 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -80.09 3.7 19.53 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 120.574 -1.329 . . . . 25.0 107.641 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -128.45 43.85 3.06 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.122 -2.918 . . . . 25.0 103.122 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 t -134.9 161.14 36.08 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.563 -1.336 . . . . 25.0 109.799 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.17 -29.02 68.41 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-N 114.45 -1.25 . . . . 25.0 111.553 161.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -72.65 0.39 10.77 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.911 1.449 . . . . 25.0 114.911 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -76.13 93.33 3.32 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 103.755 -2.683 . . . . 25.0 103.755 169.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -45.29 153.83 0.2 Allowed 'General case' 0 C--O 1.263 1.791 0 CA-C-N 111.411 -2.631 . . . . 25.0 107.972 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -56.19 136.17 52.93 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 115.247 1.573 . . . . 50.0 115.247 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -94.32 156.24 16.61 Favored 'General case' 0 N--CA 1.528 3.444 0 CA-C-O 117.399 -1.286 . . . . 25.0 112.886 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -153.8 151.95 30.14 Favored 'General case' 0 C--O 1.26 1.65 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 tt -87.43 135.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtp -144.56 -172.76 3.87 Favored 'General case' 0 C--O 1.186 -2.255 0 CA-C-O 123.06 1.409 . . . . 25.0 109.029 -171.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 p -127.37 172.65 10.45 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 104.61 -2.367 . . . . 25.0 104.61 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.61 -178.26 25.2 Favored Glycine 0 CA--C 1.542 1.754 0 O-C-N 124.692 1.245 . . . . 25.0 112.754 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.54 -156.3 30.29 Favored Glycine 0 CA--C 1.559 2.83 0 CA-C-O 115.697 -2.724 . . . . 25.0 111.032 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -72.64 143.33 48.2 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 120.472 3.508 . . . . 25.0 120.472 -171.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -125.5 143.51 50.97 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 101.51 -3.515 . . . . 25.0 101.51 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.7 m -99.11 127.21 45.03 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 105.331 -2.1 . . . . 25.0 105.331 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.61 128.44 55.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 104.191 -2.522 . . . . 50.0 104.191 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.2 m -134.2 109.13 8.67 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 105.4 -2.074 . . . . 25.0 105.4 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -83.31 149.75 26.56 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.641 -1.163 . . . . 25.0 107.896 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.3 t -142.54 122.68 13.76 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 120.922 1.692 . . . . 25.0 109.652 173.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.73 143.27 39.76 Favored 'General case' 0 N--CA 1.423 -1.782 0 O-C-N 119.503 -1.998 . . . . 50.0 113.987 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -91.43 -12.67 34.05 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.487 -2.142 . . . . 25.0 110.433 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.18 143.76 25.9 Favored Pre-proline 0 C--O 1.273 2.315 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 168.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.08 140.88 25.75 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 124.078 3.185 . . . . 25.0 117.732 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -138.6 151.4 47.23 Favored 'General case' 0 CA--C 1.55 0.958 1 N-CA-C 97.77 -4.9 . . . . 25.0 97.77 172.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . 0.254 67.2 m-80 -78.68 109.69 13.14 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 121.998 2.181 . . . . 25.0 113.772 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.473 HG21 ' CE3' ' A' ' 95' ' ' TRP . 7.9 m -79.38 135.69 36.77 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 123.684 1.707 . . . . 25.0 109.729 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 155' ' ' ALA . 2.3 p -80.59 -50.11 10.41 Favored 'General case' 0 CA--C 1.571 1.759 0 O-C-N 116.632 -3.792 . . . . 25.0 106.706 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -164.27 173.88 11.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 127.084 2.154 . . . . 25.0 113.513 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.473 ' CE3' HG21 ' A' ' 92' ' ' THR . 37.6 p90 -143.32 158.36 43.7 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.098 -1.002 . . . . 25.0 112.767 164.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -133.84 155.25 50.18 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -150.14 149.93 30.95 Favored 'General case' 0 C--O 1.283 2.867 0 CA-C-N 120.789 1.631 . . . . 50.0 114.137 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.64 158.35 44.26 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.632 1.573 . . . . 50.0 109.929 -157.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.22 159.88 13.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 164.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 p -71.82 155.71 40.12 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.648 1.217 . . . . 25.0 110.783 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -124.04 113.07 17.91 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.653 -1.279 . . . . 25.0 113.821 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.08 161.23 8.84 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 114.461 -2.685 . . . . 25.0 110.384 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.1 -0.16 47.74 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 122.827 2.558 . . . . 25.0 115.427 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -59.51 159.05 8.74 Favored 'General case' 0 C--O 1.271 2.199 0 N-CA-C 113.892 1.071 . . . . 25.0 113.892 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -160.77 144.02 9.86 Favored Pre-proline 0 C--O 1.193 -1.916 0 N-CA-C 104.486 -2.412 . . . . 25.0 104.486 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -69.87 -15.94 36.89 Favored 'Trans proline' 0 C--O 1.177 -2.528 0 C-N-CA 114.003 -3.532 . . . . 25.0 119.594 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.84 -21.19 65.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.918 1.818 . . . . 75.0 109.131 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -99.47 163.54 18.36 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 103.384 -2.821 . . . . 25.0 103.384 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -32.37 30.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.249 1 C-N-CA 129.759 6.973 . . . . 25.0 121.64 154.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -40.39 60.26 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 115.922 -1.989 . . . . 50.0 114.794 -175.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -75.59 -7.93 55.48 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 116.636 2.087 . . . . 25.0 116.636 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -120.08 -62.55 1.47 Allowed 'General case' 0 C--O 1.198 -1.621 0 O-C-N 121.25 -0.906 . . . . 25.0 112.441 -166.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.51 18.25 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 118.014 2.598 . . . . 25.0 118.014 163.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -65.37 -26.51 68.04 Favored 'General case' 0 CA--C 1.483 -1.602 0 O-C-N 127.116 2.76 . . . . 25.0 109.65 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -141.07 160.52 39.9 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 103.586 -2.746 . . . . 50.0 103.586 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -129.95 135.15 47.99 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 106.65 -1.611 . . . . 25.0 106.65 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.64 145.48 54.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 104.173 -2.528 . . . . 50.0 104.173 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.7 tt -128.71 -12.52 2.94 Favored 'Isoleucine or valine' 0 C--O 1.263 1.783 0 CA-C-O 125.848 2.737 . . . . 25.0 112.252 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.75 167.12 37.85 Favored Glycine 0 C--O 1.268 2.234 0 CA-C-O 124.142 1.968 . . . . 25.0 112.266 168.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.84 161.29 40.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 112.991 -1.605 . . . . 25.0 107.968 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.49 111.68 15.16 Favored Pre-proline 0 C--O 1.207 -1.177 0 N-CA-C 104.124 -2.546 . . . . 50.0 104.124 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.4 162.05 36.67 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 117.144 -1.438 . . . . 25.0 110.885 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 129' ' ' SER . 65.6 t-80 -120.11 49.6 1.39 Allowed 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.229 -1.767 . . . . 25.0 106.229 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -76.06 -32.34 59.24 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 112.38 -2.191 . . . . 50.0 110.133 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 172.04 -175.6 45.3 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 119.98 -1.7 . . . . 25.0 115.341 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 57.8 m 72.19 155.72 0.16 Allowed Pre-proline 0 CA--C 1.569 1.698 0 N-CA-C 117.658 2.466 . . . . 25.0 117.658 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.23 -3.33 13.64 Favored 'Trans proline' 0 CA--C 1.572 2.415 0 C-N-CA 115.642 -2.439 . . . . 25.0 113.38 -166.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.25 76.52 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 116.84 2.163 . . . . 25.0 116.84 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 123' ' ' HIS . 83.8 p -80.81 -21.95 40.44 Favored 'General case' 0 C--O 1.273 2.314 0 CA-C-O 124.259 1.981 . . . . 25.0 110.894 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -72.81 -28.55 62.63 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.111 -1.859 . . . . 25.0 111.918 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.55 140.59 39.75 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.709 -3.071 . . . . 25.0 102.709 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mt -103.67 -38.63 7.02 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 124.346 2.022 . . . . 75.0 109.934 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 t -77.36 127.05 31.9 Favored 'General case' 0 N--CA 1.411 -2.421 0 O-C-N 120.361 -1.462 . . . . 25.0 108.392 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -140.04 156.43 46.61 Favored 'General case' 0 CA--C 1.488 -1.442 0 O-C-N 118.937 -2.352 . . . . 25.0 110.607 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -106.1 141.25 37.78 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 125.308 1.63 . . . . 25.0 107.893 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.91 121.13 46.38 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.187 0 C-N-CA 125.944 1.698 . . . . 25.0 109.995 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -82.47 126.14 31.9 Favored 'General case' 0 C--O 1.175 -2.82 0 CA-C-N 121.103 1.774 . . . . 50.0 106.667 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -110.79 123.56 35.22 Favored Pre-proline 0 C--O 1.265 1.879 0 N-CA-C 103.584 -2.747 . . . . 25.0 103.584 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.41 146.17 55.44 Favored 'Trans proline' 0 CA--C 1.585 3.037 0 C-N-CA 116.847 -1.635 . . . . 25.0 115.351 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.1 67.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 125.828 2.727 . . . . 25.0 104.879 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -62.92 -28.6 70.18 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 119.729 -1.857 . . . . 50.0 113.238 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -143.63 158.85 43.36 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.368 -1.716 . . . . 25.0 106.368 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.95 138.56 39.74 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 102.028 -3.323 . . . . 50.0 102.028 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 147.14 177.49 21.71 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 124.992 2.44 . . . . 25.0 116.18 -173.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 137.88 56.6 Favored 'General case' 0 C--O 1.192 -1.953 0 C-N-CA 126.287 1.835 . . . . 50.0 113.443 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -145.96 167.22 23.84 Favored 'General case' 0 C--O 1.255 1.355 0 C-N-CA 126.684 1.994 . . . . 25.0 109.017 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 t -124.16 144.47 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.425 -1.324 . . . . 50.0 107.425 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.16 113.05 43.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.303 -2.851 . . . . 25.0 103.303 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.56 153.06 21.66 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-N 119.029 0.831 . . . . 50.0 110.55 -170.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.52 136.95 23.86 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 120.515 -1.365 . . . . 25.0 109.416 -173.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.56 136.12 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.403 -0.919 . . . . 50.0 112.0 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -118.65 125.62 50.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.181 2.592 . . . . 25.0 104.893 -170.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -113.69 140.98 47.79 Favored 'General case' 0 C--O 1.269 2.109 0 O-C-N 125.679 1.862 . . . . 25.0 108.996 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.3 139.74 26.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 N-CA-C 104.914 -2.254 . . . . 50.0 104.914 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -92.6 -20.44 20.89 Favored 'General case' 0 C--O 1.196 -1.753 0 CA-C-N 112.324 -2.216 . . . . 25.0 112.149 177.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.27 -23.75 54.44 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.905 1.817 . . . . 25.0 115.905 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.2 p -145.3 -179.79 6.88 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 115.6 -2.143 . . . . 25.0 113.245 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -89.01 1.1 56.04 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-O 126.379 2.99 . . . . 25.0 113.014 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.43 158.54 31.26 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 119.781 -1.824 . . . . 25.0 112.739 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.75 159.35 29.99 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -145.42 158.24 43.87 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 124.648 2.166 . . . . 50.0 109.643 172.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -118.47 144.38 46.04 Favored 'General case' 0 C--O 1.193 -1.909 0 CA-C-N 110.824 -2.898 . . . . 50.0 104.101 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -141.51 138.04 32.49 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.312 -1.328 . . . . 25.0 107.886 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.61 156.49 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 120.596 1.543 . . . . 75.0 109.715 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.46 115.16 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.444 1.592 . . . . 25.0 108.322 172.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.18 118.65 22.06 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 117.155 -1.402 . . . . 25.0 108.618 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.88 156.48 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 120.466 1.484 . . . . 50.0 113.45 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -111.7 98.63 7.55 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 103.173 -2.899 . . . . 25.0 103.173 171.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.17 135.02 34.07 Favored 'General case' 0 N--CA 1.499 2.009 1 N-CA-C 99.734 -4.173 . . . . 50.0 99.734 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.01 169.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 119.564 -1.96 . . . . 50.0 113.67 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -59.8 139.42 57.32 Favored 'General case' 0 C--O 1.282 2.791 0 C-N-CA 119.23 -0.988 . . . . 25.0 109.814 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 CA--C 1.577 1.983 0 N-CA-C 115.756 1.762 . . . . 25.0 115.756 177.227 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.882 -1.056 . . . . 25.0 109.245 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.99 170.45 37.66 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 120.764 3.066 . . . . 25.0 120.764 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -136.49 151.79 49.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.818 1.784 . . . . 50.0 115.818 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.28 139.17 20.32 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 101.181 -3.636 . . . . 25.0 101.181 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -112.08 -28.14 8.11 Favored 'General case' 0 C--N 1.362 1.112 0 N-CA-C 113.519 0.933 . . . . 25.0 113.519 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -151.5 140.53 13.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 104.597 -2.371 . . . . 25.0 104.597 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.97 147.27 86.85 Favored 'Cis proline' 0 N--CA 1.499 1.834 0 CA-C-N 119.844 0.98 . . . . 25.0 114.53 -5.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.25 174.25 47.54 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.939 1.936 . . . . 25.0 117.939 161.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -131.62 141.45 49.64 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.472 1.909 . . . . 25.0 107.663 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -58.07 -31.5 67.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 115.105 1.52 . . . . 25.0 115.105 167.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.51 -35.05 70.62 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 125.961 2.038 . . . . 25.0 112.175 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.02 94.66 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.399 -0.813 . . . . 25.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.246 0.87 0 N-CA-C 108.302 -0.999 . . . . 75.0 108.302 -176.231 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.281 2.72 0 N-CA-C 117.563 2.431 . . . . 25.0 117.563 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -65.95 -46.75 77.0 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 123.304 2.775 . . . . 50.0 104.784 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.37 73.04 31.25 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 117.529 2.418 . . . . 25.0 117.529 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -71.57 -21.18 26.05 Favored 'Trans proline' 0 C--N 1.393 2.882 0 CA-C-O 122.863 1.11 . . . . 25.0 112.066 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -82.87 -1.22 51.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.345 1.545 . . . . 25.0 112.11 -171.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 t -76.33 -18.0 59.14 Favored 'General case' 0 C--O 1.285 2.961 0 CA-C-N 111.317 -2.674 . . . . 25.0 109.148 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.52 119.22 15.36 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.731 1.605 . . . . 50.0 108.486 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -152.68 176.34 11.86 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 105.151 -2.166 . . . . 25.0 105.151 -172.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.25 144.58 30.87 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 166.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -129.3 145.88 51.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.459 1.481 . . . . 25.0 109.616 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 C--O 1.199 -1.595 0 CA-C-N 113.435 -1.712 . . . . 25.0 109.738 169.519 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.505 2.279 0 N-CA-C 115.631 1.715 . . . . 50.0 115.631 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -78.26 -22.77 47.82 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 104.198 -2.519 . . . . 50.0 104.198 152.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.58 -18.6 77.38 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.356 -0.838 . . . . 25.0 111.385 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.3 -34.46 80.36 Favored Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 109.972 -1.251 . . . . 25.0 109.972 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 40.5 mt -61.93 -40.18 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 O-C-N 119.925 -1.926 . . . . 25.0 113.326 -175.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.04 -29.8 68.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 122.585 1.183 . . . . 75.0 109.576 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.66 -36.35 62.82 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 120.287 -1.508 . . . . 50.0 110.118 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -77.92 20.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 114.684 1.365 . . . . 25.0 114.684 166.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -147.12 40.99 1.07 Allowed 'General case' 0 C--O 1.264 1.822 0 CA-C-O 125.691 2.662 . . . . 25.0 110.097 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -137.63 -177.78 4.95 Favored 'General case' 0 CA--C 1.58 2.119 0 CA-C-N 112.325 -2.216 . . . . 25.0 115.064 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -60.09 -23.69 64.01 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 125.652 2.644 . . . . 25.0 114.789 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -93.03 18.26 9.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 118.894 -2.379 . . . . 25.0 109.599 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -70.12 90.05 0.65 Allowed 'General case' 0 C--O 1.287 3.044 0 CA-C-O 127.681 3.61 . . . . 25.0 108.581 170.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -52.48 160.91 0.76 Allowed 'General case' 0 C--O 1.272 2.241 0 CA-C-N 109.288 -3.596 . . . . 25.0 110.072 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -62.34 142.75 57.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.451 1.1 . . . . 50.0 113.755 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.8 143.58 26.58 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -117.56 125.36 50.69 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-N 123.005 2.639 . . . . 25.0 108.737 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mt -83.49 123.9 39.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 116.332 -0.395 . . . . 25.0 110.864 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.7 mtp -138.84 157.44 46.06 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.446 1.117 . . . . 25.0 110.217 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.4 p -89.28 179.25 6.15 Favored 'General case' 0 C--O 1.273 2.32 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.13 -170.1 29.58 Favored Glycine 0 C--O 1.194 -2.364 0 N-CA-C 110.195 -1.162 . . . . 25.0 110.195 163.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.76 179.12 46.22 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 118.736 -1.697 . . . . 25.0 115.978 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.45 149.17 36.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 119.228 -2.336 . . . . 25.0 108.549 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -129.12 157.09 42.74 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.208 -1.814 . . . . 25.0 107.93 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -120.89 157.84 28.96 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 127.078 2.736 . . . . 25.0 110.19 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -143.15 152.45 41.81 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.509 1.124 . . . . 50.0 108.534 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.0 m -137.93 141.93 40.58 Favored 'General case' 0 CA--C 1.426 -3.812 0 C-N-CA 125.304 1.442 . . . . 25.0 107.684 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -135.52 167.92 20.2 Favored 'General case' 0 C--O 1.262 1.741 1 N-CA-C 99.058 -4.423 . . . . 25.0 99.058 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -131.29 146.46 52.31 Favored 'General case' 0 C--O 1.278 2.587 0 N-CA-C 105.24 -2.133 . . . . 25.0 105.24 162.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -95.87 148.01 23.05 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-O 116.834 -1.555 . . . . 50.0 108.706 159.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -103.96 -24.5 13.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.521 1.964 . . . . 25.0 113.809 173.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 137.6 52.59 Favored Pre-proline 0 N--CA 1.425 -1.677 0 O-C-N 120.218 -1.551 . . . . 25.0 109.836 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -67.86 135.32 34.95 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 116.661 -1.759 . . . . 25.0 112.684 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -152.39 169.49 22.43 Favored 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.538 -2.023 . . . . 25.0 105.538 -163.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -127.58 96.21 4.47 Favored 'General case' 0 C--O 1.273 2.291 0 CA-C-O 118.186 -0.912 . . . . 25.0 108.961 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.2 m -65.4 143.22 57.87 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 120.943 1.701 . . . . 25.0 108.99 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 p -105.76 -48.79 3.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 116.46 2.022 . . . . 25.0 116.46 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -162.93 172.42 15.11 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 120.703 1.592 . . . . 25.0 110.748 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.28 149.05 32.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.442 1.019 . . . . 25.0 113.445 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -122.73 157.68 31.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 114.388 -2.72 . . . . 25.0 110.884 -170.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.06 128.84 8.64 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 125.32 2.486 . . . . 50.0 109.339 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' A' ' 117' ' ' LEU . 5.8 p90 -142.02 147.17 36.44 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 112.66 -2.064 . . . . 50.0 110.067 -168.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.1 163.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 124.071 0.948 . . . . 25.0 110.387 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 p -62.61 156.51 23.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 116.964 -1.493 . . . . 25.0 111.819 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -91.5 97.95 11.38 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 124.373 2.035 . . . . 25.0 111.404 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -56.86 154.04 9.97 Favored 'General case' 0 C--O 1.187 -2.198 0 O-C-N 117.213 -3.43 . . . . 25.0 113.782 159.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 3.03 50.34 Favored Glycine 0 CA--C 1.545 1.963 0 N-CA-C 120.454 2.941 . . . . 25.0 120.454 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.8 169.17 0.1 Allowed 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.02 1.41 . . . . 25.0 112.611 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.08 130.62 9.4 Favored Pre-proline 0 C--N 1.31 -1.114 0 N-CA-C 102.996 -2.965 . . . . 25.0 102.996 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -59.3 -31.53 95.23 Favored 'Trans proline' 0 C--N 1.373 1.848 0 N-CA-C 116.037 1.514 . . . . 25.0 116.037 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -76.81 -1.74 29.76 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 125.051 1.469 . . . . 75.0 112.186 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -121.15 -176.83 0.43 Allowed Pre-proline 0 CA--C 1.584 2.288 1 N-CA-C 100.053 -4.054 . . . . 25.0 100.053 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -55.49 16.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.477 -2.362 2 C-N-CA 126.754 4.969 . . . . 25.0 123.235 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.97 -39.91 20.79 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 124.828 3.467 . . . . 50.0 119.171 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -77.22 -20.02 55.86 Favored 'General case' 0 C--O 1.194 -1.823 0 O-C-N 120.242 -1.536 . . . . 25.0 110.867 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -91.73 -53.53 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.424 -1.423 . . . . 25.0 112.033 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.4 42.98 0.85 Allowed 'General case' 0 C--N 1.319 -0.76 0 O-C-N 119.343 -2.098 . . . . 25.0 110.527 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.92 -31.37 70.89 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 125.613 1.565 . . . . 25.0 112.434 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 146.13 47.77 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 125.318 2.485 . . . . 50.0 109.46 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -129.89 132.47 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.138 -1.601 . . . . 25.0 107.249 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 98' ' ' TYR . 15.1 tp -73.56 141.04 46.67 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 100.309 -3.96 . . . . 50.0 100.309 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.12 -14.43 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 25.0 112.035 166.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.42 -173.82 43.16 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 125.893 1.996 . . . . 25.0 114.793 159.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.35 153.7 30.88 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.164 -2.902 . . . . 25.0 103.164 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.17 122.01 5.67 Favored Pre-proline 0 C--O 1.259 1.598 0 CA-C-N 119.777 1.171 . . . . 50.0 108.292 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -75.57 164.06 32.99 Favored 'Trans proline' 0 CA--C 1.494 -1.509 0 C-N-CA 115.991 -2.206 . . . . 25.0 115.312 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -133.82 72.95 1.48 Allowed 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 128.353 2.661 . . . . 25.0 109.941 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -74.76 -24.26 58.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 118.643 2.831 . . . . 50.0 118.643 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -170.58 -92.44 0.08 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 127.723 3.14 . . . . 25.0 109.889 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 t -122.0 61.07 12.95 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 114.237 1.199 . . . . 25.0 114.237 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -86.65 -167.1 0.34 Allowed 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-O 124.047 1.603 . . . . 25.0 111.664 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.86 69.58 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 118.901 -2.375 . . . . 25.0 106.178 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.5 p -79.79 18.88 0.72 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 124.616 2.151 . . . . 25.0 109.314 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -73.39 -27.1 61.29 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 118.117 -2.865 . . . . 25.0 103.528 168.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.76 134.2 40.51 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 112.954 -1.93 . . . . 25.0 106.235 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 tp -87.65 -28.4 21.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.52 -1.659 . . . . 75.0 106.52 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . 0.281 44.8 t -71.68 139.86 49.39 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.874 -1.766 . . . . 25.0 110.654 173.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -149.39 156.24 41.73 Favored 'General case' 0 C--O 1.273 2.331 0 N-CA-C 106.608 -1.627 . . . . 25.0 106.608 -164.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -97.81 140.53 32.04 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 115.757 -2.068 . . . . 25.0 115.056 170.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.9 mm -127.55 130.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 125.367 1.667 . . . . 25.0 107.624 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -87.96 129.35 35.27 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-O 123.737 1.732 . . . . 50.0 108.259 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.5 mm -107.63 124.75 34.03 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 112.691 -2.05 . . . . 25.0 106.809 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.27 151.44 76.57 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-O 124.498 1.791 . . . . 25.0 107.806 176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -116.73 29.71 7.77 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 111.124 -2.762 . . . . 25.0 112.457 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -75.02 -27.99 60.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.285 -2.234 . . . . 50.0 115.656 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -152.5 164.21 38.04 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 126.026 2.079 . . . . 25.0 106.799 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -83.56 158.75 21.84 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 106.953 -1.499 . . . . 50.0 106.953 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.31 121.99 0.59 Allowed Glycine 0 N--CA 1.481 1.683 0 N-CA-C 117.054 1.582 . . . . 25.0 117.054 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 0.2 OUTLIER -66.04 139.19 58.18 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 114.279 1.214 . . . . 50.0 114.279 -178.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -135.57 168.38 19.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 119.821 -1.799 . . . . 25.0 108.147 -169.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -112.4 139.09 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 102.1 -3.296 . . . . 50.0 102.1 162.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.9 129.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 118.635 0.652 . . . . 25.0 110.801 165.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.46 143.15 48.66 Favored 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 117.087 -1.435 . . . . 50.0 113.59 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.01 160.5 37.55 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 126.143 2.152 . . . . 25.0 111.296 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . 0.288 39.5 t -144.3 125.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.29 1.036 . . . . 50.0 109.088 174.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -104.79 112.3 25.36 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 101.157 -3.645 . . . . 25.0 101.157 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -100.62 133.37 45.18 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.0 129.03 31.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 O-C-N 125.242 1.588 . . . . 50.0 109.834 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.75 -18.45 32.97 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -159.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -86.12 2.79 45.36 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 116.005 1.854 . . . . 25.0 116.005 -172.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 t -143.32 158.69 43.42 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.102 -1.444 . . . . 25.0 107.102 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -82.24 -7.44 59.62 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.327 0.967 . . . . 25.0 110.226 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -86.12 163.72 17.7 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.42 148.98 52.3 Favored 'General case' 0 C--O 1.274 2.357 0 N-CA-C 102.02 -3.326 . . . . 25.0 102.02 164.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -102.73 139.36 38.41 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 106.387 -1.708 . . . . 50.0 106.387 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -116.72 153.12 32.93 Favored 'General case' 0 C--O 1.277 2.502 0 C-N-CA 125.013 1.325 . . . . 50.0 108.499 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.72 138.34 23.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.661 0.743 . . . . 25.0 109.745 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.15 142.27 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 106.489 -1.671 . . . . 75.0 106.489 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.9 mt -136.28 127.09 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 104.166 -2.531 . . . . 25.0 104.166 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.91 145.78 25.33 Favored 'General case' 0 C--O 1.203 -1.353 0 N-CA-C 103.986 -2.598 . . . . 25.0 103.986 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.3 m -149.74 156.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 114.093 1.146 . . . . 50.0 114.093 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 54.1 t0 -121.77 99.87 6.69 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 105.202 -2.147 . . . . 25.0 105.202 172.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.09 121.27 31.26 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.48 -2.785 . . . . 50.0 103.48 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.21 165.79 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 117.099 2.259 . . . . 50.0 117.099 -171.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.64 158.81 15.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt . . . . . 0 C--O 1.261 1.684 0 C-N-CA 119.857 -0.737 . . . . 25.0 112.808 172.981 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.2 m80 . . . . . 1 N--CA 1.554 4.728 0 CA-C-O 121.705 0.764 . . . . 25.0 111.38 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.73 118.04 0.47 Allowed Glycine 0 CA--C 1.541 1.699 0 O-C-N 117.368 -3.333 . . . . 25.0 107.343 -14.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -130.63 144.82 51.68 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 122.058 2.929 . . . . 50.0 111.209 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.5 mt -99.19 115.43 39.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 101.296 -3.594 . . . . 25.0 101.296 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -88.42 -40.28 13.63 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 125.709 1.88 . . . . 25.0 110.621 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -146.82 145.26 22.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 117.163 2.283 . . . . 25.0 117.163 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.83 149.09 93.44 Favored 'Cis proline' 0 C--O 1.271 2.161 0 CA-C-N 121.161 1.45 . . . . 25.0 115.474 -7.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.21 -168.37 45.18 Favored Glycine 0 N--CA 1.483 1.776 0 O-C-N 126.625 2.453 . . . . 25.0 112.454 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 t -125.91 120.54 30.68 Favored 'General case' 0 C--O 1.266 1.945 0 O-C-N 125.865 1.568 . . . . 25.0 109.794 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -70.11 -35.95 74.5 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.171 -0.678 . . . . 25.0 109.171 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.09 81.97 Favored 'General case' 0 C--O 1.206 -1.231 0 C-N-CA 123.792 0.837 . . . . 25.0 109.84 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -36.51 82.03 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.452 0.908 . . . . 25.0 113.452 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 C--O 1.182 -2.48 0 O-C-N 125.371 1.669 . . . . 75.0 109.862 177.653 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.5 ptp . . . . . 0 CA--C 1.577 2.017 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.2 -50.12 50.3 Favored 'General case' 0 C--O 1.201 -1.449 0 C-N-CA 113.737 -3.185 . . . . 50.0 110.984 175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.98 76.72 27.48 Favored Pre-proline 0 C--O 1.252 1.193 0 O-C-N 120.996 -1.065 . . . . 25.0 110.524 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.68 -21.02 29.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 1 C-N-CA 111.497 -5.202 . . . . 25.0 115.309 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -81.7 2.23 30.64 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 118.94 -2.35 . . . . 25.0 114.362 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 t -118.22 98.95 6.55 Favored 'General case' 0 C--O 1.292 3.303 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.9 mt -126.14 133.52 51.57 Favored 'General case' 0 C--O 1.294 3.399 1 N-CA-C 99.821 -4.14 . . . . 50.0 99.821 157.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -121.83 134.78 54.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 113.975 1.102 . . . . 25.0 113.975 -170.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.24 125.93 32.27 Favored 'General case' 0 C--O 1.198 -1.624 0 C-N-CA 125.335 1.454 . . . . 25.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -113.94 132.27 56.01 Favored 'General case' 0 C--O 1.273 2.3 0 CA-C-N 121.278 1.853 . . . . 25.0 112.778 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttt . . . . . 0 C--O 1.213 -0.817 0 O-C-N 126.495 2.372 . . . . 25.0 112.434 -173.209 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.202 -1.43 0 N-CA-C 115.394 1.628 . . . . 50.0 115.394 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -77.18 -11.4 59.81 Favored 'General case' 0 CA--C 1.604 3.053 0 C-N-CA 117.482 -1.687 . . . . 50.0 107.213 161.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.97 69.09 Favored Glycine 0 C--O 1.248 0.971 0 CA-C-O 125.43 2.683 . . . . 25.0 111.828 173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.26 -27.2 70.41 Favored Glycine 0 C--O 1.205 -1.696 0 O-C-N 120.435 -1.627 . . . . 25.0 113.26 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.94 -39.43 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 104.779 -2.304 . . . . 25.0 104.779 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.8 -34.69 78.96 Favored 'General case' 0 CA--C 1.58 2.116 0 O-C-N 124.496 1.123 . . . . 75.0 112.732 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.16 -19.47 33.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 124.228 1.966 . . . . 50.0 115.538 -167.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -77.53 8.57 4.15 Favored 'General case' 0 C--O 1.258 1.552 0 O-C-N 118.307 -2.746 . . . . 25.0 115.945 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -145.01 60.8 1.31 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.828 -1.533 . . . . 25.0 110.601 163.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -130.33 151.41 50.86 Favored 'General case' 0 CA--C 1.599 2.829 0 C-N-CA 119.439 -0.905 . . . . 25.0 111.982 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.6 -26.29 68.62 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 118.018 -2.926 . . . . 25.0 108.547 166.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -93.51 24.92 3.71 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.422 -1.311 . . . . 25.0 111.067 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.91 100.76 0.43 Allowed 'General case' 0 C--O 1.196 -1.749 0 CA-C-O 125.556 2.598 . . . . 25.0 110.557 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -32.73 137.53 0.07 Allowed 'General case' 0 C--N 1.317 -0.824 2 CA-C-N 103.45 -6.25 . . . . 25.0 115.821 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -77.2 128.45 34.4 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 121.676 -0.64 . . . . 50.0 110.808 -155.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -98.86 147.32 25.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 119.818 3.266 . . . . 25.0 119.818 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -137.81 155.18 49.29 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 102.28 -3.23 . . . . 25.0 102.28 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.0 mt -105.56 126.21 60.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 1 N-CA-C 97.913 -4.847 . . . . 25.0 97.913 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.6 mtp -130.46 140.16 50.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.323 1.049 . . . . 25.0 111.286 -168.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 p -75.44 173.23 11.22 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 116.059 1.874 . . . . 25.0 116.059 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.48 -178.77 48.47 Favored Glycine 0 C--O 1.283 3.182 0 N-CA-C 105.184 -3.166 . . . . 25.0 105.184 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.17 -170.56 31.7 Favored Glycine 2 N--CA 1.389 -4.453 0 CA-C-N 111.313 -2.443 . . . . 25.0 111.314 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 45.5 mt-10 -80.49 136.79 36.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.368 2.084 . . . . 25.0 112.444 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -137.18 161.46 36.1 Favored 'General case' 0 N--CA 1.522 3.16 0 O-C-N 124.939 1.399 . . . . 25.0 108.494 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 m -112.65 130.84 55.9 Favored 'General case' 0 C--O 1.274 2.353 0 CA-C-O 122.438 1.113 . . . . 25.0 109.491 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -118.35 116.99 27.87 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 113.402 -1.727 . . . . 50.0 109.556 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 m -137.36 135.63 37.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 114.958 1.466 . . . . 25.0 114.958 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -114.95 161.49 18.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.847 -2.279 . . . . 25.0 104.847 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 t -146.5 147.97 31.73 Favored 'General case' 0 C--O 1.265 1.874 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.44 148.98 32.84 Favored 'General case' 0 CA--C 1.603 3.007 0 O-C-N 118.264 -2.773 . . . . 50.0 106.372 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.5 p -77.76 2.35 17.28 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 118.133 2.642 . . . . 25.0 118.133 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.45 159.54 57.48 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.655 1.182 . . . . 25.0 108.535 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.04 163.82 36.23 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 114.716 -3.056 . . . . 25.0 111.144 171.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -139.03 151.16 46.58 Favored 'General case' 0 C--O 1.183 -2.409 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 163.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.59 121.5 19.82 Favored 'General case' 0 C--O 1.253 1.265 0 CA-C-N 113.424 -1.716 . . . . 25.0 106.624 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.1 m -142.99 138.91 30.38 Favored 'General case' 0 C--N 1.317 -0.832 1 N-CA-C 99.674 -4.195 . . . . 25.0 99.674 -172.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.0 p -78.94 -48.64 14.17 Favored 'General case' 0 C--O 1.272 2.241 0 CA-C-O 124.025 1.869 . . . . 25.0 110.924 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -163.48 175.9 10.28 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.442 -1.411 . . . . 25.0 109.353 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -144.46 154.07 42.55 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 126.085 1.754 . . . . 25.0 108.697 167.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -128.43 160.55 31.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 116.792 -1.575 . . . . 25.0 109.692 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -134.91 148.5 50.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 103.663 -2.717 . . . . 50.0 103.663 162.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -139.2 168.59 19.49 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 103.998 -2.593 . . . . 50.0 103.998 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.4 pt -136.32 160.96 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 104.581 -2.378 . . . . 25.0 104.581 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -123.78 148.33 46.76 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 113.206 -1.815 . . . . 25.0 106.622 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -125.95 93.86 3.94 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 117.893 -1.523 . . . . 25.0 108.07 -172.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.84 165.99 3.67 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 120.114 -1.617 . . . . 25.0 112.757 168.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.82 48.5 Favored Glycine 0 C--O 1.192 -2.52 0 O-C-N 119.811 -1.806 . . . . 25.0 109.822 -171.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.59 159.57 32.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.073 1.416 . . . . 25.0 110.933 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.32 128.8 86.9 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 101.877 -3.379 . . . . 25.0 101.877 170.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 108' ' ' LYS . 72.3 Cg_endo -74.77 -27.06 10.81 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 114.048 -3.501 . . . . 25.0 117.359 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -81.59 1.23 34.75 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.48 1.491 . . . . 75.0 108.575 -165.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 106' ' ' PRO . 25.0 mmtp -118.24 166.53 13.5 Favored Pre-proline 0 CA--C 1.578 2.052 0 O-C-N 127.976 3.297 . . . . 25.0 111.798 -161.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -47.33 30.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.374 2 C-N-CA 130.171 7.247 . . . . 25.0 124.528 174.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -52.28 -27.88 16.83 Favored 'General case' 0 C--O 1.188 -2.178 0 O-C-N 120.141 -1.599 . . . . 50.0 114.835 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -71.57 -14.48 62.1 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 123.706 0.629 . . . . 25.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -116.43 -60.52 1.85 Allowed 'General case' 0 C--O 1.168 -3.235 0 C-N-CA 126.854 2.062 . . . . 25.0 111.817 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.56 -25.37 35.88 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -102.74 28.65 5.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.761 0.791 . . . . 25.0 112.885 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -137.85 151.73 48.36 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.914 -2.625 . . . . 50.0 103.914 156.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -130.01 147.88 51.8 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 119.008 -0.52 . . . . 25.0 111.408 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.8 tp -65.94 136.21 55.78 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 106.28 -1.748 . . . . 50.0 106.28 156.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.53 -15.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 120.24 1.382 . . . . 25.0 107.698 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.8 157.23 15.71 Favored Glycine 0 C--O 1.284 3.279 0 CA-C-O 117.057 -1.968 . . . . 25.0 110.971 163.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.14 150.32 49.55 Favored 'General case' 0 C--O 1.263 1.773 0 CA-C-N 118.067 0.934 . . . . 25.0 112.774 162.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -126.34 111.24 23.56 Favored Pre-proline 0 C--O 1.255 1.382 0 C-N-CA 125.432 1.493 . . . . 50.0 114.997 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -79.31 157.59 26.0 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 114.07 -3.487 . . . . 25.0 119.278 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . 0.279 53.1 t-80 -121.96 65.2 0.91 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 124.292 1.996 . . . . 25.0 107.122 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.15 26.47 8.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 111.624 -2.535 . . . . 50.0 110.458 -166.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.83 57.96 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-O 124.016 1.898 . . . . 25.0 108.806 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.96 160.48 0.65 Allowed Pre-proline 0 C--O 1.266 1.957 0 N-CA-C 118.479 2.77 . . . . 25.0 118.479 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.72 -166.62 0.1 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 123.099 2.533 . . . . 25.0 115.652 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.09 -23.13 7.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.189 1.922 . . . . 25.0 116.189 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.8 p -69.3 -8.44 46.16 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 114.395 1.257 . . . . 25.0 114.395 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -53.67 -29.07 36.88 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 117.217 -1.373 . . . . 25.0 113.811 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . 0.261 85.1 m-20 -68.15 143.59 55.34 Favored 'General case' 0 C--O 1.19 -2.064 0 CA-C-O 123.641 1.686 . . . . 25.0 111.359 -174.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -20.65 66.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.374 1.869 . . . . 75.0 110.073 -170.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.0 t -83.24 127.47 33.66 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.29 1.959 . . . . 25.0 116.29 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -137.45 146.95 44.94 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 124.503 2.097 . . . . 25.0 112.533 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -98.03 129.89 44.87 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.762 -1.211 . . . . 25.0 110.445 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . 0.266 35.9 mm -131.12 120.62 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.81 1.244 . . . . 25.0 107.904 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 89.9 t80 -76.58 126.07 30.34 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.898 -1.519 . . . . 50.0 106.898 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.9 129.08 31.99 Favored Pre-proline 0 C--N 1.364 1.221 0 CA-C-O 115.91 -1.995 . . . . 25.0 109.798 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.14 156.04 47.43 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 116.156 -2.096 . . . . 25.0 110.836 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -109.45 -8.63 15.01 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 126.527 1.931 . . . . 25.0 115.773 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -93.94 -13.58 26.93 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 115.833 1.79 . . . . 50.0 115.833 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.61 163.4 22.83 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.127 1.528 . . . . 25.0 115.127 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.01 146.13 34.41 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 124.94 1.4 . . . . 50.0 113.769 158.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.72 158.99 11.21 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 118.826 2.291 . . . . 25.0 118.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -72.79 136.99 45.52 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.975 -1.613 . . . . 50.0 111.149 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -142.87 166.11 25.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.152 -0.476 . . . . 25.0 110.526 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.77 130.95 73.24 Favored 'Isoleucine or valine' 0 C--O 1.267 1.98 0 N-CA-C 101.887 -3.375 . . . . 50.0 101.887 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.3 mt -101.63 123.86 55.04 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.93 1 N-CA-C 98.639 -4.578 . . . . 25.0 98.639 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.497 ' HA ' HG12 ' A' ' 164' ' ' VAL . 4.1 mp -112.38 143.22 43.86 Favored 'General case' 0 C--O 1.189 -2.106 0 N-CA-C 104.527 -2.397 . . . . 50.0 104.527 -173.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.4 34.94 Favored 'General case' 0 CA--C 1.456 -2.65 0 O-C-N 119.87 -1.769 . . . . 25.0 113.097 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.84 125.46 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 CA-C-N 110.143 -3.208 . . . . 50.0 108.489 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -108.06 104.22 13.61 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.873 -1.158 . . . . 25.0 107.873 166.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -78.28 72.74 4.82 Favored 'General case' 0 C--O 1.26 1.653 0 O-C-N 126.267 2.229 . . . . 25.0 106.47 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.64 116.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.773 0 C-N-CA 126.174 1.79 . . . . 50.0 113.374 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.8 -22.31 23.32 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -7.87 0.37 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 119.642 3.201 . . . . 25.0 119.642 171.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.2 p -135.34 165.08 26.27 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 103.089 -2.93 . . . . 25.0 103.089 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -76.97 -41.87 41.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 119.576 -1.953 . . . . 25.0 110.103 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -81.44 168.66 18.08 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 105.098 -2.186 . . . . 25.0 105.098 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -116.34 153.47 31.93 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 102.95 -2.982 . . . . 25.0 102.95 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -97.6 150.05 21.56 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 107.714 -1.217 . . . . 50.0 107.714 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -140.79 162.53 35.2 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 104.957 -2.238 . . . . 50.0 104.957 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 144.64 12.02 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 103.377 -2.823 . . . . 25.0 103.377 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 149' ' ' LEU . 24.0 m -123.38 155.03 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 123.082 1.42 . . . . 75.0 114.6 165.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.46 117.64 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 101.13 -3.656 . . . . 25.0 101.13 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -82.28 127.49 33.26 Favored 'General case' 1 C--O 1.318 4.668 0 CA-C-O 124.614 2.15 . . . . 25.0 106.169 170.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.14 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 116.573 -3.83 . . . . 50.0 115.217 175.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.31 98.18 5.94 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 106.189 -1.782 . . . . 25.0 106.189 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.23 122.74 32.8 Favored 'General case' 0 C--O 1.261 1.695 0 N-CA-C 101.555 -3.498 . . . . 50.0 101.555 -168.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.08 162.57 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 118.607 -2.558 . . . . 50.0 117.366 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -84.63 164.39 18.69 Favored 'General case' 0 C--O 1.282 2.77 0 O-C-N 120.738 -1.226 . . . . 25.0 108.301 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 40.9 pttt . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 116.971 -1.49 . . . . 25.0 108.548 179.072 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 . . . . . 0 C--O 1.262 1.757 0 N-CA-C 113.553 0.946 . . . . 25.0 113.553 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.07 179.44 30.29 Favored Glycine 0 C--O 1.282 3.146 0 CA-C-O 115.706 -2.719 . . . . 25.0 113.844 -172.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.61 153.17 44.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 119.067 1.433 . . . . 50.0 113.033 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 6' ' ' LYS . 19.1 mt -71.03 124.14 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 119.127 -2.233 . . . . 25.0 110.257 -171.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -100.89 11.03 40.4 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 123.516 1.627 . . . . 25.0 109.014 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 4' ' ' ILE . 51.1 mtmt 86.91 159.24 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.679 1 C-N-CA 133.354 4.661 . . . . 25.0 112.529 172.269 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 139.97 47.87 Favored 'Cis proline' 0 CA--C 1.466 -2.895 0 C-N-CA 132.672 2.363 . . . . 25.0 114.193 2.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.18 69.15 1.21 Allowed Glycine 0 C--N 1.281 -2.496 0 CA-C-N 112.036 -2.347 . . . . 25.0 113.393 165.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -69.86 137.7 51.92 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 125.795 2.712 . . . . 25.0 108.69 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -93.63 -18.8 21.78 Favored 'General case' 0 C--O 1.281 2.759 0 N-CA-C 103.746 -2.686 . . . . 25.0 103.746 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.02 75.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.898 0.856 . . . . 25.0 112.078 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.48 77.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.913 -1.494 . . . . 25.0 110.362 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt . . . . . 0 CA--C 1.57 1.722 0 CA-C-N 113.03 -1.895 . . . . 75.0 109.396 -172.681 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 C--O 1.173 -2.928 0 N-CA-C 119.84 3.274 . . . . 25.0 119.84 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -64.9 -38.09 89.83 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 115.12 -0.945 . . . . 50.0 110.565 169.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.52 60.81 5.76 Favored Pre-proline 0 C--O 1.275 2.423 0 CA-C-N 115.025 -0.989 . . . . 25.0 112.878 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.19 -22.22 9.96 Favored 'Trans proline' 0 N--CA 1.477 0.546 1 C-N-CA 110.086 -6.143 . . . . 25.0 115.525 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -77.6 -15.39 59.26 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.963 -1.086 . . . . 25.0 111.28 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.4 t -73.66 116.93 14.83 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 118.271 -1.371 . . . . 25.0 111.391 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 162' ' ' TYR . 66.5 mt -118.23 145.55 44.92 Favored 'General case' 0 C--O 1.164 -3.408 0 N-CA-C 104.501 -2.407 . . . . 50.0 104.501 162.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.6 157.88 45.3 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 124.765 2.222 . . . . 25.0 107.984 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.71 155.51 49.02 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 105.161 -2.163 . . . . 25.0 105.161 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.0 156.58 47.93 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 120.986 1.721 . . . . 25.0 110.957 166.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.6 mttt . . . . . 0 N--CA 1.505 2.308 0 N-CA-C 114.657 1.354 . . . . 25.0 114.657 174.803 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.2 mt . . . . . 0 CA--C 1.566 1.564 0 CA-C-O 117.668 -1.158 . . . . 50.0 114.005 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -71.56 -36.5 70.94 Favored 'General case' 0 C--O 1.262 1.713 0 N-CA-C 106.902 -1.518 . . . . 50.0 106.902 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.19 -16.52 78.61 Favored Glycine 1 C--O 1.156 -4.726 0 CA-C-O 123.362 1.535 . . . . 25.0 115.082 171.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.38 -17.01 73.98 Favored Glycine 0 C--N 1.307 -1.07 0 O-C-N 118.916 -2.52 . . . . 25.0 112.02 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -77.63 -34.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.53 0 N-CA-C 106.23 -1.767 . . . . 25.0 106.23 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.18 -23.0 57.65 Favored 'General case' 0 C--O 1.27 2.149 0 O-C-N 119.268 -2.145 . . . . 75.0 107.746 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -73.22 -8.2 54.79 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 113.566 -1.652 . . . . 50.0 112.726 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -77.36 7.7 5.01 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 124.378 2.037 . . . . 25.0 113.485 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -131.26 34.35 4.01 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.294 -1.373 . . . . 25.0 107.294 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 t -142.58 157.73 44.4 Favored 'General case' 0 C--O 1.252 1.229 0 O-C-N 119.954 -1.716 . . . . 25.0 111.656 -164.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.41 -25.08 66.96 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-O 122.466 1.126 . . . . 25.0 109.694 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.09 13.66 16.26 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.062 2.545 . . . . 25.0 108.173 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -76.41 99.62 4.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.313 -2.847 . . . . 25.0 103.313 167.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -46.72 145.13 2.03 Favored 'General case' 0 C--N 1.309 -1.155 1 CA-C-N 107.105 -4.589 . . . . 25.0 113.597 166.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -80.03 147.8 31.35 Favored 'General case' 0 C--O 1.21 -0.998 0 CA-C-O 115.626 -2.13 . . . . 50.0 110.4 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.91 101.66 13.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 126.246 2.216 . . . . 25.0 107.354 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -73.28 119.39 17.45 Favored 'General case' 0 C--O 1.284 2.911 0 N-CA-C 107.048 -1.464 . . . . 25.0 107.048 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.7 mt -81.53 130.97 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.0 ttt -147.82 134.55 19.98 Favored 'General case' 0 C--O 1.178 -2.695 0 N-CA-C 107.893 -1.151 . . . . 25.0 107.893 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 p -79.72 150.27 30.9 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.524 -2.398 . . . . 25.0 104.524 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.93 163.23 37.77 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 119.793 2.677 . . . . 25.0 119.793 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.75 -177.92 18.49 Favored Glycine 0 C--O 1.27 2.402 0 N-CA-C 105.998 -2.841 . . . . 25.0 105.998 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 9.3 pt-20 -82.48 152.24 26.16 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 125.437 2.542 . . . . 25.0 106.307 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.94 154.28 51.16 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 118.334 -2.729 . . . . 25.0 105.603 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.3 m -117.88 131.79 56.5 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 103.15 -2.907 . . . . 25.0 103.15 163.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -115.64 141.54 47.93 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.352 -1.351 . . . . 50.0 107.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -139.41 129.18 24.71 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 113.043 -1.889 . . . . 25.0 111.907 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -131.59 162.58 30.0 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 101.655 -3.461 . . . . 25.0 101.655 -174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.4 p -132.46 140.01 48.22 Favored 'General case' 0 CA--C 1.488 -1.417 0 O-C-N 121.597 -0.689 . . . . 25.0 111.748 156.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.447 ' CD2' ' HE1' ' A' ' 90' ' ' HIS . 76.4 m-85 -79.74 154.75 28.33 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.035 -1.469 . . . . 50.0 107.035 164.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.9 t -91.96 -19.72 22.13 Favored 'General case' 0 C--O 1.257 1.449 0 N-CA-C 106.762 -1.57 . . . . 25.0 106.762 -165.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.95 139.39 13.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 CA-C-O 117.305 -1.331 . . . . 25.0 109.12 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.85 131.86 34.8 Favored 'Trans proline' 0 CA--C 1.599 3.729 0 C-N-CA 115.461 -2.56 . . . . 25.0 111.225 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.447 ' HE1' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -153.16 160.43 42.85 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -81.61 161.48 23.47 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 116.048 1.87 . . . . 25.0 116.048 -158.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.416 HG21 ' HE3' ' A' ' 95' ' ' TRP . 53.1 m -154.97 134.96 12.97 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.332 -1.358 . . . . 25.0 107.332 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.1 p -91.52 -41.22 10.93 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.49 -1.67 . . . . 25.0 106.49 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -161.39 172.53 16.37 Favored 'General case' 0 C--O 1.281 2.732 0 N-CA-C 104.95 -2.241 . . . . 25.0 104.95 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.416 ' HE3' HG21 ' A' ' 92' ' ' THR . 3.5 p90 -144.53 152.52 40.69 Favored 'General case' 0 C--O 1.258 1.533 0 N-CA-C 114.477 1.288 . . . . 25.0 114.477 167.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -128.98 142.25 50.99 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.385 -1.293 . . . . 25.0 110.59 -167.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.74 144.19 47.38 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-N 120.276 1.398 . . . . 50.0 107.556 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.3 167.57 20.47 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 105.61 -1.996 . . . . 50.0 105.61 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.3 pt -129.6 147.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 172.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.6 p -77.79 154.89 31.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 117.739 -1.124 . . . . 25.0 109.565 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -144.86 80.09 1.61 Allowed 'General case' 0 C--O 1.239 0.545 0 N-CA-C 117.411 2.374 . . . . 25.0 117.411 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -47.24 157.72 0.18 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 125.411 2.529 . . . . 25.0 115.124 167.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.95 32.71 23.05 Favored Glycine 0 C--O 1.204 -1.767 0 C-N-CA 116.985 -2.531 . . . . 25.0 112.108 167.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -60.66 159.41 10.83 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.989 1.848 . . . . 25.0 115.989 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -74.82 134.34 75.35 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.126 -1.435 . . . . 25.0 107.126 162.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.23 -26.5 49.26 Favored 'Trans proline' 0 C--N 1.362 1.26 0 N-CA-C 120.164 3.102 . . . . 25.0 120.164 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.18 -6.5 58.59 Favored 'General case' 0 C--O 1.191 -1.994 0 C-N-CA 116.96 -1.896 . . . . 75.0 110.198 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -66.27 157.6 80.9 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 111.684 -2.507 . . . . 25.0 110.913 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.14 51.16 1.29 Allowed 'Trans proline' 0 C--N 1.37 1.668 1 N-CA-C 122.829 4.126 . . . . 25.0 122.829 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -2.45 -66.31 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 1 C-N-CA 132.092 4.157 . . . . 50.0 118.968 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -72.34 -8.6 55.8 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 122.189 2.268 . . . . 25.0 114.652 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 -55.4 2.58 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 124.523 1.129 . . . . 25.0 109.32 165.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.85 -25.69 1.39 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 117.323 2.342 . . . . 25.0 117.323 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -82.96 8.45 12.64 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.27 160.57 39.85 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 119.938 -1.726 . . . . 50.0 108.49 159.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -144.44 134.37 23.89 Favored 'General case' 0 C--O 1.182 -2.5 0 N-CA-C 105.821 -1.918 . . . . 25.0 105.821 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.41 132.57 50.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.678 1.191 . . . . 50.0 111.358 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.8 tt -111.15 -18.15 7.85 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 N-CA-C 106.224 -1.769 . . . . 25.0 106.224 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.29 156.03 13.11 Favored Glycine 0 C--N 1.306 -1.095 0 O-C-N 120.542 -1.349 . . . . 25.0 113.085 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.14 139.41 24.61 Favored 'General case' 0 C--O 1.266 1.943 0 CA-C-O 123.769 1.747 . . . . 25.0 107.065 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -128.81 107.21 18.44 Favored Pre-proline 0 C--O 1.255 1.381 0 CA-C-N 114.63 -1.168 . . . . 50.0 110.056 -170.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.95 164.52 31.49 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 113.331 -3.979 . . . . 25.0 115.038 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -139.98 2.98 1.98 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 118.058 2.614 . . . . 25.0 118.058 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -90.29 -24.92 20.77 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 107.637 -1.246 . . . . 50.0 107.637 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.62 160.93 27.43 Favored Glycine 0 C--N 1.352 1.437 1 N-CA-C 95.207 -7.157 . . . . 25.0 95.207 155.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.5 t -154.8 149.11 19.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 120.543 2.171 . . . . 25.0 112.706 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.03 -178.03 3.59 Favored 'Trans proline' 0 N--CA 1.436 -1.86 0 C-N-CA 114.866 -2.956 . . . . 25.0 111.008 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -15.8 5.37 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 118.474 -2.641 . . . . 25.0 115.496 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.53 4.02 0.43 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.103 1.89 . . . . 25.0 116.103 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -57.47 -33.54 68.08 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 127.108 2.163 . . . . 25.0 115.05 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -48.57 131.37 17.5 Favored 'General case' 0 C--O 1.18 -2.592 0 CA-C-N 119.367 0.985 . . . . 25.0 113.201 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.3 tp -65.86 -29.9 70.42 Favored 'General case' 0 C--O 1.268 2.077 0 CA-C-O 122.017 0.913 . . . . 75.0 113.355 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 132.5 47.46 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 121.748 -0.595 . . . . 25.0 110.67 166.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -153.84 161.05 42.36 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.597 1.665 . . . . 25.0 110.559 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -112.12 137.52 50.07 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.518 1.303 . . . . 25.0 114.518 -172.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.3 mt -132.53 133.23 59.89 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 102.956 -2.979 . . . . 25.0 102.956 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 73.5 t80 -101.0 134.19 44.36 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 105.716 -1.957 . . . . 50.0 105.716 173.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.4 mm -125.17 110.38 26.85 Favored Pre-proline 0 C--O 1.2 -1.509 0 N-CA-C 102.127 -3.286 . . . . 25.0 102.127 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.25 149.83 70.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 115.101 -2.799 . . . . 25.0 109.854 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -92.51 47.07 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.77 -14.69 60.74 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 118.791 -2.443 . . . . 50.0 114.487 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -166.44 169.45 13.89 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 103.946 -2.613 . . . . 25.0 103.946 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.6 pt? -98.15 152.57 19.22 Favored 'General case' 0 C--O 1.281 2.741 0 N-CA-C 100.459 -3.904 . . . . 50.0 100.459 163.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.24 164.19 17.72 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-O 123.386 1.548 . . . . 25.0 111.163 -171.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.91 157.65 45.06 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 117.105 -3.585 . . . . 50.0 116.844 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -158.42 175.94 13.07 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 100.652 -3.833 . . . . 25.0 100.652 170.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.75 146.92 6.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 123.449 0.7 . . . . 50.0 111.726 167.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.94 128.39 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 O-C-N 119.329 -2.107 . . . . 25.0 106.252 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -115.7 153.77 30.75 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 115.683 -2.103 . . . . 50.0 106.531 -167.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.49 44.2 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 121.48 1.945 . . . . 25.0 114.536 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.41 135.44 57.84 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.714 0 C-N-CA 125.028 1.331 . . . . 50.0 111.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -115.77 137.8 51.74 Favored 'General case' 0 C--O 1.277 2.543 0 C-N-CA 127.583 2.353 . . . . 25.0 107.273 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -118.0 144.82 45.22 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 103.269 -2.863 . . . . 25.0 103.269 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.33 113.27 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 105.538 -2.023 . . . . 50.0 105.538 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.0 -14.29 62.29 Favored 'General case' 0 C--O 1.262 1.728 0 N-CA-C 115.255 1.576 . . . . 25.0 115.255 -167.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -71.3 -25.09 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 126.39 2.306 . . . . 25.0 111.16 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.9 p -120.13 165.45 14.75 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 112.272 -2.24 . . . . 25.0 111.819 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -100.7 -9.79 21.49 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 123.808 1.766 . . . . 25.0 107.374 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -78.66 159.42 28.03 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 113.121 -1.854 . . . . 25.0 112.841 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.44 148.58 42.95 Favored 'General case' 0 CA--C 1.557 1.242 1 N-CA-C 98.837 -4.505 . . . . 25.0 98.837 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -126.67 139.48 53.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.276 -1.379 . . . . 50.0 107.276 -165.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 35' ' ' LEU . 75.7 m-85 -140.19 159.46 42.13 Favored 'General case' 0 C--O 1.203 -1.365 0 O-C-N 126.427 2.329 . . . . 50.0 110.404 -166.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -148.38 161.83 40.79 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.206 1.402 . . . . 25.0 111.816 166.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.52 130.6 50.43 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.178 0 N-CA-C 106.207 -1.775 . . . . 75.0 106.207 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -126.92 120.8 56.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.772 -1.566 . . . . 25.0 106.772 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -91.12 145.49 24.64 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 107.445 -1.316 . . . . 25.0 107.445 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.42 163.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 C-N-CA 127.187 2.195 . . . . 50.0 112.903 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.58 108.57 6.02 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 127.235 2.214 . . . . 25.0 109.701 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.33 116.49 30.45 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 102.867 -3.012 . . . . 50.0 102.867 -161.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 31.8 m -125.18 167.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.127 -1.029 . . . . 50.0 113.015 -156.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.88 155.03 31.2 Favored 'General case' 0 C--O 1.263 1.766 0 O-C-N 124.715 1.259 . . . . 25.0 108.277 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 C--O 1.249 1.059 0 CA-C-N 113.672 -1.603 . . . . 25.0 106.825 -177.346 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.527 -1.702 . . . . 25.0 113.252 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.53 166.72 39.14 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 117.155 -2.45 . . . . 25.0 116.658 -170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.81 173.35 13.83 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 106.681 -1.6 . . . . 50.0 106.681 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.0 121.96 54.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 N-CA-C 102.897 -3.001 . . . . 25.0 102.897 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.6 -41.81 16.03 Favored 'General case' 0 C--O 1.18 -2.569 0 C-N-CA 127.631 2.372 . . . . 25.0 113.837 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -152.7 155.74 32.69 Favored Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 105.838 -1.912 . . . . 25.0 105.838 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -60.51 139.18 23.0 Favored 'Cis proline' 0 C--N 1.358 1.028 0 C-N-CA 132.291 2.204 . . . . 25.0 116.209 3.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.58 -177.17 54.41 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 122.639 1.133 . . . . 25.0 114.123 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -123.08 103.01 8.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 125.129 2.395 . . . . 25.0 107.548 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -58.77 -27.83 65.35 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 119.861 -1.774 . . . . 25.0 112.988 167.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.79 73.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 122.902 1.334 . . . . 25.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.86 73.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 122.058 0.932 . . . . 25.0 108.857 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.566 1.578 0 C-N-CA 127.192 2.197 . . . . 75.0 109.721 -178.916 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 ppp? . . . . . 0 C--O 1.255 1.372 0 N-CA-C 118.811 2.893 . . . . 25.0 118.811 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -66.82 -41.29 87.73 Favored 'General case' 0 C--O 1.267 1.974 0 C-N-CA 124.104 0.961 . . . . 50.0 111.321 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.94 56.68 8.23 Favored Pre-proline 0 C--O 1.249 1.051 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.05 -20.89 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.318 0 N-CA-C 120.555 3.252 . . . . 25.0 120.555 -167.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -94.33 -2.85 51.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 116.849 -1.94 . . . . 25.0 113.179 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 t -77.09 87.25 3.58 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 122.191 0.996 . . . . 25.0 111.164 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.13 80.05 1.33 Allowed 'General case' 0 C--O 1.252 1.194 0 N-CA-C 107.729 -1.212 . . . . 50.0 107.729 -167.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -141.2 135.7 31.03 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 121.147 1.794 . . . . 25.0 114.43 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.68 166.11 31.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.044 -2.576 . . . . 25.0 104.044 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -84.93 146.56 27.19 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 tttt . . . . . 0 CA--C 1.507 -0.688 0 C-N-CA 124.647 1.179 . . . . 25.0 111.319 170.047 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 C--O 1.278 2.595 0 CA-C-O 122.785 1.278 . . . . 50.0 110.371 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -66.68 -14.04 62.0 Favored 'General case' 0 C--O 1.175 -2.824 0 C-N-CA 118.635 -1.226 . . . . 50.0 113.512 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.51 73.13 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 106.973 -2.451 . . . . 25.0 106.973 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.14 -11.26 84.58 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 124.461 2.145 . . . . 25.0 117.283 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -79.77 -32.19 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.375 0 CA-C-O 125.891 2.758 . . . . 25.0 107.126 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.48 -17.55 51.29 Favored 'General case' 0 CA--C 1.468 -2.181 0 CA-C-N 113.267 -1.788 . . . . 75.0 109.41 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.15 2.53 2.11 Favored 'General case' 0 C--O 1.197 -1.662 0 CA-C-O 123.928 1.823 . . . . 50.0 115.832 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -85.52 40.98 0.87 Allowed 'General case' 0 C--O 1.263 1.788 0 O-C-N 120.285 -1.509 . . . . 25.0 107.998 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.47 49.25 0.48 Allowed 'General case' 0 C--O 1.262 1.757 0 N-CA-C 105.847 -1.909 . . . . 25.0 105.847 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.8 t -147.01 157.3 43.58 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 126.747 2.019 . . . . 25.0 108.194 -162.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -31.41 67.46 Favored 'General case' 0 C--O 1.261 1.687 0 N-CA-C 102.177 -3.268 . . . . 25.0 102.177 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -88.19 21.11 2.91 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 120.308 -0.557 . . . . 25.0 109.671 -171.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -68.62 98.53 0.89 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 125.602 2.62 . . . . 25.0 103.946 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -33.78 144.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 1 CA-C-N 105.865 -5.152 . . . . 25.0 113.416 165.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -66.94 134.49 52.11 Favored 'General case' 0 C--O 1.263 1.767 0 O-C-N 125.233 1.583 . . . . 50.0 107.098 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -80.57 153.65 27.94 Favored 'General case' 0 CA--C 1.483 -1.598 0 O-C-N 120.589 -1.32 . . . . 25.0 110.481 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -136.93 143.3 42.83 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 117.29 2.33 . . . . 25.0 117.29 157.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.84 134.27 39.82 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.705 0 N-CA-C 105.406 -2.072 . . . . 25.0 105.406 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 66.3 mtm -144.32 146.92 32.87 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 118.624 -2.547 . . . . 25.0 105.895 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 p -86.58 171.55 10.94 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 124.143 1.925 . . . . 25.0 108.079 168.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.26 -173.77 17.09 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 124.455 2.142 . . . . 25.0 115.502 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.84 -176.7 38.03 Favored Glycine 0 C--O 1.266 2.106 0 N-CA-C 108.006 -2.038 . . . . 25.0 108.006 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 68.1 mm-40 -66.55 149.37 50.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 116.344 -1.789 . . . . 25.0 110.843 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -147.24 137.43 23.26 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 126.679 2.487 . . . . 25.0 105.675 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -93.61 105.96 17.97 Favored 'General case' 0 CA--C 1.479 -1.774 0 O-C-N 126.532 2.395 . . . . 25.0 105.152 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -76.64 142.23 40.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 103.061 -2.94 . . . . 50.0 103.061 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -136.46 103.28 5.21 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 118.385 -2.697 . . . . 25.0 106.75 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -100.78 126.7 47.37 Favored 'General case' 0 C--O 1.177 -2.754 0 N-CA-C 102.688 -3.079 . . . . 25.0 102.688 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -123.33 120.63 33.63 Favored 'General case' 0 C--O 1.175 -2.818 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -113.5 153.76 28.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.905 -1.498 . . . . 50.0 109.022 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 t -116.31 8.24 14.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 126.573 2.421 . . . . 25.0 113.271 174.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.91 119.39 25.86 Favored Pre-proline 0 C--N 1.349 0.586 0 C-N-CA 128.084 2.554 . . . . 25.0 111.451 -167.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -68.6 -37.94 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 124.922 2.011 . . . . 25.0 116.11 160.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.433 ' HD1' HG13 ' A' ' 154' ' ' VAL . 12.9 p80 -68.28 139.56 55.96 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 123.224 1.488 . . . . 25.0 110.857 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -78.68 129.74 35.06 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 112.887 -1.96 . . . . 25.0 113.479 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 154' ' ' VAL . 31.9 p -93.05 164.02 13.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.067 -1.646 . . . . 25.0 108.918 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -96.7 -49.94 4.89 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 120.698 -1.251 . . . . 25.0 110.185 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -166.46 170.88 12.45 Favored 'General case' 0 C--O 1.262 1.738 0 CA-C-O 118.354 -0.831 . . . . 25.0 110.758 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -144.13 153.06 41.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.096 -0.954 . . . . 25.0 109.315 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -131.16 142.59 50.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.832 -2.655 . . . . 25.0 103.832 -164.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -142.36 135.44 28.61 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 117.512 -3.242 . . . . 50.0 113.002 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 117' ' ' LEU . 14.5 p90 -146.38 167.16 24.28 Favored 'General case' 0 C--O 1.163 -3.495 0 O-C-N 119.546 -1.971 . . . . 50.0 111.105 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -120.1 173.97 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 125.933 2.02 . . . . 25.0 113.369 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -135.56 154.12 51.47 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 124.063 0.852 . . . . 25.0 112.711 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -137.81 100.77 4.27 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.388 1.625 . . . . 25.0 115.388 -165.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -42.86 162.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 120.73 3.604 . . . . 25.0 120.73 157.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.1 28.5 Favored Glycine 0 N--CA 1.488 2.113 0 CA-C-O 126.056 3.031 . . . . 25.0 107.763 165.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -67.62 160.89 26.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.06 -2.07 . . . . 25.0 114.067 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.02 111.75 20.43 Favored Pre-proline 0 C--O 1.194 -1.816 0 N-CA-C 107.127 -1.434 . . . . 25.0 107.127 155.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -64.35 -24.48 64.59 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 C-N-CA 123.671 2.914 . . . . 25.0 114.855 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.23 -15.99 50.5 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.379 1.049 . . . . 75.0 113.195 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -71.88 161.79 76.8 Favored Pre-proline 0 N--CA 1.483 1.199 0 CA-C-O 116.884 -1.531 . . . . 25.0 108.584 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -54.08 31.16 0.02 OUTLIER 'Trans proline' 0 CA--C 1.574 2.485 2 C-N-CA 126.302 4.668 . . . . 25.0 122.66 160.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -8.9 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 1 N-CA-C 122.386 4.217 . . . . 50.0 122.386 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.52 -16.83 64.44 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 117.118 -3.489 . . . . 25.0 109.586 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.26 -57.33 2.29 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 126.033 2.083 . . . . 25.0 106.955 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.76 -24.63 66.95 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.536 1.773 . . . . 25.0 115.299 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -69.88 -4.69 21.48 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-O 116.513 -1.708 . . . . 25.0 114.903 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -118.32 150.29 39.75 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 122.807 2.549 . . . . 50.0 110.011 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.81 149.64 38.9 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 119.823 -1.798 . . . . 25.0 111.382 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 98' ' ' TYR . 21.1 tp -76.44 123.84 26.64 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 116.054 -1.927 . . . . 50.0 108.93 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.0 tt -95.29 -11.68 8.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.83 173.5 33.53 Favored Glycine 0 C--O 1.19 -2.633 0 N-CA-C 116.645 1.418 . . . . 25.0 116.645 164.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -157.32 132.12 8.73 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.344 -1.428 . . . . 25.0 111.295 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.44 130.32 18.02 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 105.033 -2.21 . . . . 50.0 105.033 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -82.56 163.87 16.56 Favored 'Trans proline' 0 C--N 1.372 1.769 0 CA-C-O 124.83 1.929 . . . . 25.0 116.229 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -82.87 136.05 34.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 113.732 -1.576 . . . . 25.0 108.426 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.7 32.14 11.5 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.9 1.68 . . . . 50.0 111.008 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.28 165.11 43.64 Favored Glycine 0 N--CA 1.425 -2.088 0 O-C-N 119.502 -1.999 . . . . 25.0 108.625 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 t -66.17 -38.31 21.4 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-O 116.241 -1.838 . . . . 25.0 112.872 -173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.24 160.94 23.19 Favored 'Trans proline' 0 C--N 1.38 2.231 1 C-N-CA 108.351 -7.299 . . . . 25.0 107.874 -170.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.37 -26.1 11.5 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 126.876 3.227 . . . . 25.0 114.08 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -66.91 2.83 1.26 Allowed 'General case' 0 CA--C 1.512 -0.49 1 N-CA-C 122.615 4.302 . . . . 25.0 122.615 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.03 5.48 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 121.438 3.866 . . . . 25.0 121.438 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.25 141.5 41.7 Favored 'General case' 0 C--O 1.276 2.499 0 N-CA-C 121.55 3.907 . . . . 25.0 121.55 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.18 -25.72 63.57 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 106.589 -1.634 . . . . 75.0 106.589 -165.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 t -90.37 127.79 36.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 O-C-N 117.819 -3.051 . . . . 25.0 110.583 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -125.64 155.44 40.81 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 117.014 2.227 . . . . 25.0 117.014 164.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -79.72 125.63 29.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 113.139 -3.315 . . . . 25.0 108.304 169.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.7 mm -124.38 129.03 74.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 123.582 2.901 . . . . 25.0 105.968 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 79.0 t80 -81.59 127.2 32.62 Favored 'General case' 0 C--O 1.276 2.462 0 O-C-N 120.472 -1.393 . . . . 50.0 113.399 177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.64 116.27 61.3 Favored Pre-proline 0 CA--C 1.515 -0.4 0 C-N-CA 130.768 3.627 . . . . 25.0 105.842 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.57 158.3 58.26 Favored 'Trans proline' 0 C--O 1.193 -1.728 1 C-N-CA 111.925 -4.916 . . . . 25.0 115.848 175.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -115.86 9.26 14.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.268 1.509 . . . . 25.0 109.427 -170.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.23 -8.66 57.55 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.113 2.264 . . . . 50.0 117.113 -171.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -146.5 170.21 17.35 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.274 -2.491 . . . . 25.0 104.274 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.1 pt? -111.99 131.68 55.25 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 101.269 -3.604 . . . . 50.0 101.269 160.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -176.08 164.4 34.37 Favored Glycine 0 C--N 1.302 -1.357 0 CA-C-O 124.756 2.309 . . . . 25.0 113.649 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.15 139.75 34.17 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.569 -1.548 . . . . 50.0 111.125 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -154.69 159.62 40.86 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 104.884 -2.265 . . . . 25.0 104.884 -171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.54 134.54 66.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 113.781 -3.009 . . . . 50.0 112.839 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.6 mt -110.01 130.18 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 O-C-N 127.453 2.97 . . . . 25.0 106.553 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.51 143.18 50.8 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 103.324 -2.843 . . . . 50.0 103.324 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.61 153.1 49.94 Favored 'General case' 0 C--O 1.257 1.455 0 N-CA-C 104.723 -2.325 . . . . 25.0 104.723 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.82 135.66 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-N 113.7 -1.591 . . . . 50.0 107.258 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.49 124.97 31.26 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-N 119.782 1.174 . . . . 25.0 110.067 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 143.58 34.31 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 125.274 1.609 . . . . 25.0 112.853 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.433 HG13 ' HD1' ' A' ' 90' ' ' HIS . 39.0 t -99.32 135.19 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 123.901 1.81 . . . . 50.0 111.159 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 -34.14 20.81 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.3 -1.5 . . . . 25.0 111.691 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -72.96 -17.59 61.46 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 124.872 1.358 . . . . 25.0 110.32 -171.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 p -146.06 179.26 7.61 Favored 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 109.204 -0.665 . . . . 25.0 109.204 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -87.02 9.98 17.89 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-O 122.571 1.177 . . . . 25.0 111.873 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -73.6 150.78 41.16 Favored 'General case' 0 C--O 1.281 2.733 0 CA-C-O 123.118 1.437 . . . . 25.0 110.291 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.33 160.16 43.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 103.017 -2.957 . . . . 25.0 103.017 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -145.23 173.78 11.65 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.022 -1.844 . . . . 50.0 106.022 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.48 149.07 46.54 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 105.588 -2.005 . . . . 50.0 105.588 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.67 145.2 42.35 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 121.409 1.913 . . . . 25.0 108.192 -173.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.6 p -141.64 145.33 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 CA-C-N 119.399 1.0 . . . . 75.0 111.929 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.11 134.41 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 103.65 -2.722 . . . . 25.0 103.65 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.53 135.25 33.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.899 -1.046 . . . . 25.0 110.767 169.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.41 133.2 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 119.398 -2.064 . . . . 50.0 111.758 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -106.45 89.96 3.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 102.353 -3.203 . . . . 25.0 102.353 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.48 118.97 32.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.578 -1.646 . . . . 50.0 107.007 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 5.1 m -120.38 157.61 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 123.989 1.852 . . . . 50.0 114.21 -170.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -74.23 143.83 44.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 100.38 -3.933 . . . . 25.0 100.38 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 CA--C 1.55 0.97 0 C-N-CA 126.768 2.027 . . . . 25.0 108.521 -175.45 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 123.279 1.514 . . . . 25.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.43 -149.13 28.63 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 117.477 1.751 . . . . 25.0 117.477 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.19 133.68 40.2 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.121 1.368 . . . . 50.0 108.726 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.71 120.85 35.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 119.809 1.186 . . . . 25.0 108.268 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -98.2 -29.46 13.2 Favored 'General case' 0 C--O 1.281 2.733 0 C-N-CA 125.079 1.352 . . . . 25.0 112.816 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -153.31 146.79 18.12 Favored Pre-proline 0 CA--C 1.559 1.298 1 N-CA-C 98.742 -4.54 . . . . 25.0 98.742 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.38 131.11 8.81 Favored 'Cis proline' 0 C--N 1.311 -1.436 0 C-N-CA 131.058 1.691 . . . . 25.0 115.743 15.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.47 177.29 44.39 Favored Glycine 0 C--O 1.192 -2.494 0 N-CA-C 118.632 2.213 . . . . 25.0 118.632 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -103.58 125.65 50.24 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 105.201 -2.148 . . . . 25.0 105.201 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -61.93 -34.0 75.29 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 123.789 0.681 . . . . 25.0 109.74 170.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.09 -33.13 73.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 116.718 -1.993 . . . . 25.0 111.284 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.69 78.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.248 -0.908 . . . . 25.0 111.665 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mp . . . . . 0 C--N 1.279 -2.495 0 CA-C-O 122.277 1.037 . . . . 75.0 111.362 177.778 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.9 ptt? . . . . . 0 N--CA 1.415 -2.184 0 CA-C-O 123.868 1.794 . . . . 25.0 115.741 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -62.5 -40.15 95.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.407 1.632 . . . . 50.0 115.407 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -143.12 46.18 0.67 Allowed Pre-proline 0 CA--C 1.473 -2.009 0 N-CA-C 119.044 2.979 . . . . 25.0 119.044 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.35 -30.7 29.73 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 O-C-N 116.918 -2.201 . . . . 25.0 113.513 -167.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -77.89 -1.07 29.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.374 1.99 . . . . 25.0 116.374 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.5 16.69 3.0 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 121.122 3.749 . . . . 25.0 121.122 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.78 114.64 18.85 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 125.39 2.519 . . . . 50.0 110.819 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -99.2 162.43 13.06 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 117.633 -3.167 . . . . 25.0 110.822 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.87 14.97 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.72 1.263 . . . . 25.0 112.388 -172.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -92.35 -172.61 3.15 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.401 1.572 . . . . 25.0 109.792 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 105.388 -2.078 . . . . 25.0 105.388 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 60' ' ' GLY . 46.7 mt . . . . . 0 C--O 1.217 -0.609 0 N-CA-C 117.426 2.38 . . . . 50.0 117.426 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.83 -36.45 70.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 104.465 -2.42 . . . . 50.0 104.465 161.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.25 -20.62 75.24 Favored Glycine 0 C--O 1.269 2.285 0 CA-C-O 126.009 3.005 . . . . 25.0 108.53 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 57' ' ' LEU . . . -64.52 -20.17 65.48 Favored Glycine 0 C--O 1.197 -2.214 0 O-C-N 116.841 -3.741 . . . . 25.0 115.189 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.8 mt -71.8 -46.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 111.793 -2.203 . . . . 25.0 105.645 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.96 -17.52 57.09 Favored 'General case' 0 CA--C 1.574 1.877 0 O-C-N 118.892 -2.38 . . . . 75.0 116.582 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -66.4 -29.25 69.37 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 123.805 1.764 . . . . 50.0 110.467 167.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.64 24.52 1.21 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.975 2.321 . . . . 25.0 113.983 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.6 48.78 1.43 Allowed 'General case' 0 C--O 1.25 1.114 0 O-C-N 119.52 -1.988 . . . . 25.0 110.951 157.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.271 13.7 t -133.56 174.94 9.89 Favored 'General case' 0 C--O 1.216 -0.702 0 O-C-N 125.365 1.666 . . . . 25.0 111.642 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.68 -17.39 59.97 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 123.849 1.785 . . . . 25.0 107.877 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -89.69 32.38 0.89 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 112.43 -2.168 . . . . 25.0 112.041 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -81.84 84.63 6.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 125.258 2.456 . . . . 25.0 116.354 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -40.06 150.83 0.05 Allowed 'General case' 0 C--O 1.292 3.293 1 CA-C-N 107.438 -4.437 . . . . 25.0 113.077 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -66.32 152.35 45.16 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 105.507 -2.034 . . . . 50.0 105.507 -167.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.51 151.48 27.52 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -139.79 132.39 28.81 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 117.321 2.341 . . . . 25.0 117.321 168.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -90.0 133.98 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 117.409 -1.281 . . . . 25.0 108.936 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.4 ttt -150.02 142.65 24.54 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 120.359 1.436 . . . . 25.0 111.189 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.459 HG22 HG23 ' A' ' 170' ' ' VAL . 32.2 p -79.35 166.95 21.53 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.285 0.846 . . . . 25.0 113.285 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 147.73 45.45 Favored Glycine 0 C--O 1.257 1.578 0 O-C-N 118.535 -2.603 . . . . 25.0 114.002 172.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.99 -166.04 33.38 Favored Glycine 0 CA--C 1.572 3.599 0 O-C-N 119.693 -2.063 . . . . 25.0 108.658 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -65.44 136.94 57.09 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.13 -1.806 . . . . 25.0 109.848 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -121.15 148.96 43.51 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 103.45 -2.796 . . . . 25.0 103.45 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -122.39 126.2 47.5 Favored 'General case' 0 C--O 1.201 -1.463 0 C-N-CA 124.807 1.243 . . . . 25.0 107.652 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -116.9 79.38 1.32 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 103.535 -2.765 . . . . 50.0 103.535 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -82.95 101.31 10.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.635 -1.166 . . . . 25.0 108.504 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -106.96 137.4 45.1 Favored 'General case' 0 CA--C 1.556 1.187 1 N-CA-C 99.708 -4.182 . . . . 25.0 99.708 173.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 t -151.13 143.46 24.17 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 123.787 1.756 . . . . 25.0 113.671 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -143.11 170.32 15.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 117.791 -1.1 . . . . 50.0 108.593 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . 0.287 9.1 t -72.13 -30.66 65.25 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 124.681 2.182 . . . . 25.0 112.737 175.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.47 152.81 69.79 Favored Pre-proline 0 C--O 1.262 1.721 0 O-C-N 116.78 -3.7 . . . . 25.0 109.062 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.46 161.45 42.38 Favored 'Trans proline' 0 C--O 1.282 2.677 0 C-N-CA 115.61 -2.46 . . . . 25.0 108.52 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -126.06 162.33 25.56 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 117.557 -3.215 . . . . 25.0 112.905 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.41 124.98 23.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 105.026 -2.213 . . . . 25.0 105.026 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -147.12 150.84 35.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 169.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.0 p -94.53 -31.14 14.05 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 120.447 1.476 . . . . 25.0 109.442 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . 0.261 51.6 tt0 -158.54 160.88 37.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 118.604 0.638 . . . . 25.0 109.396 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -142.91 148.93 37.75 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 123.784 1.754 . . . . 25.0 106.815 166.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.96 151.8 51.17 Favored 'General case' 0 C--N 1.27 -2.876 0 O-C-N 119.089 -2.257 . . . . 25.0 108.871 -169.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.21 130.07 45.83 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 105.104 -2.184 . . . . 50.0 105.104 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.43 155.83 23.57 Favored 'General case' 0 C--O 1.182 -2.468 0 CA-C-N 111.857 -2.428 . . . . 50.0 104.512 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.1 pt -134.62 155.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-N 112.129 -2.305 . . . . 25.0 112.291 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 p -70.63 156.88 38.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 124.523 2.106 . . . . 25.0 115.108 168.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -130.68 95.43 3.85 Favored 'General case' 0 C--O 1.188 -2.132 0 O-C-N 116.988 -3.57 . . . . 25.0 114.922 173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -68.9 157.07 37.37 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 107.869 -1.16 . . . . 25.0 107.869 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.55 37.75 89.9 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-O 126.077 3.043 . . . . 25.0 110.985 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -67.16 159.84 28.09 Favored 'General case' 0 C--O 1.267 1.987 0 CA-C-O 125.686 2.66 . . . . 25.0 110.777 -171.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -67.46 123.89 87.79 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-N 111.958 -2.383 . . . . 25.0 107.279 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.53 -17.67 20.63 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 117.923 2.24 . . . . 25.0 117.923 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.71 8.44 39.22 Favored 'General case' 0 C--O 1.253 1.252 0 O-C-N 119.696 -1.877 . . . . 75.0 108.407 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -122.18 162.42 37.62 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 112.203 -2.271 . . . . 25.0 114.596 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.88 95.0 1.06 Allowed 'Trans proline' 0 CA--C 1.463 -3.04 0 N-CA-C 117.052 1.905 . . . . 25.0 117.052 -168.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -21.34 -60.76 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 127.064 2.146 . . . . 50.0 116.355 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -77.47 3.33 13.68 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 119.1 -2.25 . . . . 25.0 113.735 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.258 84.2 mtt180 -119.99 -42.19 2.61 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 127.422 2.289 . . . . 25.0 110.868 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.93 -15.74 5.47 Favored 'General case' 0 C--O 1.283 2.84 0 O-C-N 119.812 -1.805 . . . . 25.0 111.833 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -98.58 17.02 20.09 Favored 'General case' 0 C--O 1.271 2.192 0 N-CA-C 118.639 2.829 . . . . 25.0 118.639 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -144.85 161.28 39.67 Favored 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 118.762 -1.175 . . . . 50.0 107.898 168.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.79 158.59 43.84 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.71 137.74 35.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.049 -1.834 . . . . 50.0 106.049 164.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.287 16.7 tt -94.98 -26.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 116.268 -1.825 . . . . 25.0 111.964 169.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.92 156.12 13.65 Favored Glycine 0 N--CA 1.432 -1.58 0 O-C-N 124.893 1.371 . . . . 25.0 112.345 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.26 143.01 50.24 Favored 'General case' 0 N--CA 1.394 -3.251 0 CA-C-O 124.442 2.067 . . . . 25.0 108.351 170.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.4 96.53 48.06 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.325 -1.307 . . . . 50.0 108.173 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.97 159.23 50.84 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 114.056 -3.496 . . . . 25.0 110.601 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -139.91 47.74 1.82 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 115.629 1.715 . . . . 25.0 115.629 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -112.19 -24.86 9.6 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.767 -2.015 . . . . 50.0 107.143 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -160.89 40.21 0.43 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-O 124.925 2.403 . . . . 25.0 113.427 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -81.28 146.96 59.26 Favored Pre-proline 0 C--O 1.273 2.317 0 O-C-N 119.392 -2.24 . . . . 25.0 108.304 -154.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.57 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.768 1 C-N-CA 126.021 4.481 . . . . 25.0 107.031 169.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.6 -18.52 0.26 Allowed 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 121.081 3.734 . . . . 25.0 121.081 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 56.8 p -52.5 -9.41 0.11 Allowed 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 121.728 2.058 . . . . 25.0 114.582 162.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -60.03 -16.16 28.74 Favored 'General case' 0 N--CA 1.522 3.161 0 O-C-N 117.661 -3.149 . . . . 25.0 113.192 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.66 136.08 50.68 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 104.389 -2.449 . . . . 25.0 104.389 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -69.23 -24.83 64.06 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.504 -1.372 . . . . 75.0 111.196 -165.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.4 t -85.41 136.48 33.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 113.834 -1.53 . . . . 25.0 110.395 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.08 156.58 42.58 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 104.729 -2.323 . . . . 25.0 104.729 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -108.4 119.51 39.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 115.164 -2.351 . . . . 25.0 105.624 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.8 mm -118.42 119.23 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.312 0 C-N-CA 125.384 1.474 . . . . 25.0 111.19 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -77.16 133.77 38.86 Favored 'General case' 0 C--O 1.269 2.101 0 N-CA-C 105.022 -2.214 . . . . 50.0 105.022 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.3 mt -134.86 119.67 13.85 Favored Pre-proline 0 C--N 1.361 1.102 0 CA-C-O 122.908 1.337 . . . . 25.0 108.267 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.83 159.08 13.98 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 116.718 -1.721 . . . . 25.0 112.512 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 169' ' ' LEU . 11.5 tp10 -153.95 115.92 4.27 Favored 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.923 1.823 . . . . 25.0 115.923 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -105.95 -4.04 21.05 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 113.77 -1.559 . . . . 50.0 115.062 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -118.02 166.51 12.44 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 117.277 -3.389 . . . . 25.0 110.492 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.9 mp -116.55 136.6 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.947 -2.612 . . . . 50.0 103.947 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.97 174.18 25.47 Favored Glycine 0 C--N 1.306 -1.085 0 N-CA-C 119.913 2.725 . . . . 25.0 119.913 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.31 142.19 27.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.588 1.555 . . . . 50.0 108.268 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -146.25 162.73 37.44 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 104.672 -2.344 . . . . 25.0 104.672 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.9 t -127.64 136.81 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 123.828 3.013 . . . . 50.0 112.598 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 76.9 mt -104.02 118.58 51.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.642 0 N-CA-C 105.439 -2.06 . . . . 25.0 105.439 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.5 130.76 44.55 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.417 2.056 . . . . 50.0 108.882 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -110.51 127.53 55.21 Favored 'General case' 0 C--O 1.246 0.902 0 O-C-N 120.145 -1.597 . . . . 25.0 109.704 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.87 132.73 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 O-C-N 126.083 2.114 . . . . 50.0 114.673 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 119.52 31.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.69 1.596 . . . . 25.0 109.304 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.42 72.08 4.42 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 126.294 2.246 . . . . 25.0 107.875 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.46 98.97 2.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.533 0 C-N-CA 117.51 -1.676 . . . . 50.0 111.164 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.68 -16.45 64.15 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.756 1.265 . . . . 25.0 113.804 -165.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -60.89 -32.99 72.42 Favored 'General case' 0 CA--C 1.601 2.913 0 CA-C-N 113.763 -1.562 . . . . 25.0 112.145 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.0 t -123.92 158.69 31.38 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.475 1.734 . . . . 25.0 110.019 -166.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.41 -23.73 58.99 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.18 165.05 7.74 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.751 1.019 . . . . 25.0 113.751 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.96 178.44 6.67 Favored 'General case' 0 C--O 1.209 -1.053 1 N-CA-C 98.25 -4.722 . . . . 25.0 98.25 175.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -126.22 130.43 50.93 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.891 -3.744 . . . . 50.0 100.891 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -135.33 138.67 43.63 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 126.15 1.78 . . . . 50.0 111.529 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -160.58 175.52 12.6 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 104.848 -2.278 . . . . 25.0 104.848 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 148' ' ' ILE . 26.5 m -135.86 164.63 31.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 125.158 1.536 . . . . 75.0 107.392 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.0 mm -133.65 120.48 37.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 112.721 -2.036 . . . . 25.0 105.6 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -88.64 124.95 34.57 Favored 'General case' 0 C--O 1.262 1.753 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.518 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.68 158.1 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 117.077 2.251 . . . . 50.0 117.077 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.7 124.92 30.8 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 101.901 -3.37 . . . . 25.0 101.901 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 140' ' ' GLU . 84.2 mt -114.07 130.53 56.56 Favored 'General case' 0 C--O 1.204 -1.34 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 -174.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.459 HG23 HG22 ' A' ' 76' ' ' THR . 27.6 m -124.95 158.1 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 116.223 1.934 . . . . 50.0 116.223 -173.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.7 132.38 35.18 Favored 'General case' 0 CA--C 1.585 2.311 0 O-C-N 125.842 1.964 . . . . 25.0 108.831 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.4 pttt . . . . . 0 CA--C 1.552 1.055 0 CA-C-O 118.235 -0.888 . . . . 25.0 110.884 -167.669 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.672 0.749 . . . . 25.0 111.349 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.35 179.71 27.32 Favored Glycine 0 C--O 1.267 2.203 0 C-N-CA 117.794 -2.146 . . . . 25.0 116.956 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -152.37 153.96 34.66 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.096 -2.414 . . . . 50.0 111.351 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.71 133.49 31.42 Favored 'Isoleucine or valine' 0 C--O 1.258 1.518 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 -163.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -120.29 -30.32 4.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.421 -1.312 . . . . 25.0 111.768 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG2' HG22 ' A' ' 83' ' ' THR . 19.0 pttt -146.72 162.46 33.63 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 123.568 1.651 . . . . 25.0 107.148 151.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.69 148.95 87.33 Favored 'Cis proline' 0 N--CA 1.494 1.531 0 CA-C-O 123.439 1.35 . . . . 25.0 112.219 6.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.39 -175.69 52.55 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-O 126.013 3.007 . . . . 25.0 115.995 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.3 t -117.4 102.03 8.89 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 111.851 -2.175 . . . . 25.0 108.913 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -57.74 -31.93 66.95 Favored 'General case' 0 C--O 1.181 -2.533 0 O-C-N 123.784 0.678 . . . . 25.0 111.472 -169.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.67 65.58 Favored 'General case' 0 CA--C 1.558 1.269 0 O-C-N 118.365 -2.709 . . . . 25.0 111.925 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.11 -22.12 55.89 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.613 -1.625 . . . . 25.0 106.613 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt . . . . . 0 C--O 1.257 1.491 0 N-CA-C 114.049 1.129 . . . . 75.0 114.049 178.517 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.91 -53.72 55.03 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 118.271 -2.768 . . . . 50.0 111.595 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.93 67.83 41.89 Favored Pre-proline 0 CA--C 1.566 1.58 0 O-C-N 118.88 -2.387 . . . . 25.0 115.813 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.07 -11.49 22.02 Favored 'Trans proline' 0 C--O 1.206 -1.086 0 C-N-CA 124.449 3.433 . . . . 25.0 117.252 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 -8.15 30.21 Favored 'General case' 0 C--O 1.159 -3.663 0 N-CA-C 114.244 1.201 . . . . 25.0 114.244 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -70.44 50.83 0.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 119.412 3.115 . . . . 25.0 119.412 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.15 132.82 46.43 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.198 -1.408 . . . . 50.0 107.198 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 161.92 19.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 120.719 1.6 . . . . 25.0 110.615 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.2 41.42 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-O 115.499 -2.191 . . . . 25.0 108.272 161.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -112.43 142.99 44.3 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 121.962 2.164 . . . . 25.0 113.389 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mttp . . . . . 0 C--N 1.303 -1.422 0 O-C-N 117.987 -2.946 . . . . 25.0 104.487 -179.37 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 117.509 2.411 . . . . 50.0 117.509 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.34 -25.75 46.55 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.325 -2.843 . . . . 50.0 103.325 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.82 -17.92 62.52 Favored Glycine 0 C--O 1.209 -1.445 0 CA-C-O 125.286 2.604 . . . . 25.0 112.578 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.9 -25.28 71.89 Favored Glycine 0 CA--C 1.561 2.948 0 O-C-N 118.684 -2.656 . . . . 25.0 111.821 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.23 -38.03 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.14 -32.53 63.2 Favored 'General case' 0 C--O 1.198 -1.615 0 N-CA-C 104.95 -2.241 . . . . 75.0 104.95 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -68.47 -34.82 76.61 Favored 'General case' 0 C--O 1.264 1.834 0 N-CA-C 116.807 2.151 . . . . 50.0 116.807 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -76.65 16.42 0.51 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 125.789 2.709 . . . . 25.0 114.687 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -126.38 82.64 2.09 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 101.946 -3.353 . . . . 25.0 101.946 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -163.39 166.18 23.16 Favored 'General case' 0 CA--C 1.479 -1.784 0 O-C-N 123.636 0.585 . . . . 25.0 111.839 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -66.46 -29.43 69.56 Favored 'General case' 0 C--O 1.196 -1.754 0 O-C-N 117.448 -3.282 . . . . 25.0 109.977 171.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -82.04 21.88 0.84 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 112.876 -1.966 . . . . 25.0 112.66 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -74.0 97.34 2.83 Favored 'General case' 0 C--O 1.171 -3.054 0 CA-C-O 127.312 3.434 . . . . 25.0 109.649 158.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.1 p90 -29.64 135.41 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.375 1 CA-C-N 107.502 -4.408 . . . . 25.0 112.393 160.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -63.5 152.34 38.77 Favored 'General case' 0 C--O 1.268 2.037 0 N-CA-C 116.302 1.964 . . . . 50.0 116.302 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -101.56 162.01 13.22 Favored 'General case' 0 CA--C 1.479 -1.773 0 CA-C-N 113.513 -1.676 . . . . 25.0 111.576 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -153.47 146.41 24.47 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 124.472 1.109 . . . . 25.0 109.813 164.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.37 135.16 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 106.412 -1.699 . . . . 25.0 106.412 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.1 mtp -137.52 158.28 44.72 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 109.095 -0.706 . . . . 25.0 109.095 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.3 p -120.2 167.02 12.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.41 -164.98 40.36 Favored Glycine 0 C--O 1.266 2.105 0 C-N-CA 119.821 -1.181 . . . . 25.0 111.819 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.85 -173.66 32.24 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 120.573 -0.823 . . . . 25.0 111.104 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -82.02 141.71 32.99 Favored 'General case' 0 C--O 1.28 2.695 0 CA-C-O 124.071 1.891 . . . . 25.0 110.752 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.51 143.33 39.49 Favored 'General case' 0 C--O 1.19 -2.074 0 N-CA-C 104.133 -2.543 . . . . 25.0 104.133 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -98.56 126.14 44.04 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.273 -1.751 . . . . 25.0 106.273 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -110.85 150.73 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 116.179 -1.867 . . . . 50.0 106.154 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.449 HG22 ' HG2' ' A' ' 6' ' ' LYS . 3.3 t -153.3 159.61 42.56 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 117.632 -1.175 . . . . 25.0 114.129 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -138.07 171.58 14.2 Favored 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.872 -3.01 . . . . 25.0 102.872 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 p -135.3 154.75 51.43 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.121 1.513 . . . . 25.0 107.94 153.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -94.02 154.2 17.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.902 0.858 . . . . 50.0 109.043 169.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.1 p -85.29 -27.02 26.24 Favored 'General case' 0 C--O 1.172 -2.98 0 O-C-N 120.396 -1.44 . . . . 25.0 111.691 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.67 141.66 13.89 Favored Pre-proline 0 CA--C 1.48 -1.739 0 N-CA-C 102.408 -3.182 . . . . 25.0 102.408 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.49 162.84 35.27 Favored 'Trans proline' 0 C--N 1.373 1.843 0 CA-C-O 123.507 1.378 . . . . 25.0 113.76 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.88 148.12 41.58 Favored 'General case' 0 CA--C 1.471 -2.059 0 CA-C-N 112.963 -1.926 . . . . 25.0 106.471 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -81.76 96.95 7.74 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 112.161 -2.291 . . . . 25.0 108.731 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.6 m -83.98 127.7 34.05 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 116.446 2.017 . . . . 25.0 116.446 -170.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 p -87.83 -42.27 12.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 118.335 -1.346 . . . . 25.0 110.486 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -168.29 168.21 11.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.068 -1.424 . . . . 25.0 109.866 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -140.66 164.65 29.6 Favored 'General case' 0 C--O 1.261 1.661 0 CA-C-N 123.199 2.727 . . . . 25.0 110.96 164.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -139.89 159.77 41.43 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 115.092 -2.385 . . . . 25.0 112.217 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.89 145.0 24.58 Favored 'General case' 0 C--O 1.246 0.901 0 O-C-N 124.951 1.407 . . . . 50.0 111.986 169.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 117' ' ' LEU . 58.9 m-85 -139.57 169.77 17.14 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 105.56 -2.015 . . . . 50.0 105.56 -172.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 pt -125.38 152.63 32.25 Favored 'Isoleucine or valine' 0 C--O 1.261 1.68 0 CA-C-O 123.791 1.758 . . . . 25.0 106.895 162.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.94 143.32 29.91 Favored 'General case' 0 C--N 1.387 2.206 0 N-CA-C 100.49 -3.892 . . . . 25.0 100.49 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -101.17 133.16 46.14 Favored 'General case' 0 C--O 1.183 -2.416 1 N-CA-C 100.085 -4.042 . . . . 25.0 100.085 -172.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -146.05 151.65 38.08 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 -163.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.21 37.13 9.25 Favored Glycine 0 C--O 1.202 -1.893 0 CA-C-O 125.087 2.493 . . . . 25.0 110.428 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -65.56 157.58 29.37 Favored 'General case' 0 CA--C 1.462 -2.413 0 C-N-CA 126.874 2.07 . . . . 25.0 114.908 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.97 123.05 89.15 Favored Pre-proline 0 CA--C 1.501 -0.942 1 O-C-N 115.438 -4.539 . . . . 25.0 108.937 155.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.77 -24.66 72.6 Favored 'Trans proline' 0 CA--C 1.499 -1.267 0 C-N-CA 115.017 -2.856 . . . . 25.0 117.102 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.96 -6.06 49.16 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 124.221 1.962 . . . . 75.0 113.854 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -56.1 161.95 3.34 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-N 112.663 -2.062 . . . . 25.0 112.254 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -77.55 70.37 6.9 Favored 'Trans proline' 0 C--O 1.175 -2.671 0 CA-C-O 125.972 2.405 . . . . 25.0 113.696 161.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 mt -46.63 -40.66 13.41 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 110.16 -3.2 . . . . 50.0 113.808 -168.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.79 -13.04 61.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 123.233 2.742 . . . . 25.0 115.42 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -117.78 -41.89 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 127.112 2.758 . . . . 25.0 111.627 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.22 -18.07 65.01 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 114.138 1.162 . . . . 25.0 114.138 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.35 33.45 1.4 Allowed 'General case' 0 C--N 1.316 -0.873 0 O-C-N 119.945 -1.722 . . . . 25.0 115.184 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -141.52 145.74 35.52 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.642 1.177 . . . . 50.0 108.538 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.45 142.61 50.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 115.309 1.596 . . . . 25.0 115.309 163.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 98' ' ' TYR . 41.5 tp -77.76 137.96 38.74 Favored 'General case' 0 C--N 1.319 -0.753 1 N-CA-C 99.426 -4.287 . . . . 50.0 99.426 179.462 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.1 tt -124.52 -5.32 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 O-C-N 126.726 2.516 . . . . 25.0 108.902 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.12 170.31 37.28 Favored Glycine 0 C--O 1.273 2.576 0 N-CA-C 118.277 2.071 . . . . 25.0 118.277 154.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.99 145.6 24.24 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 123.449 1.595 . . . . 25.0 108.243 170.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -118.96 100.63 50.67 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 120.899 -1.125 . . . . 50.0 111.049 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.19 172.81 15.41 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 122.615 2.21 . . . . 25.0 108.398 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -133.88 48.17 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.819 -1.991 . . . . 25.0 108.358 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.7 -11.77 59.83 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 117.239 -1.784 . . . . 50.0 109.131 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 143.1 -171.79 24.84 Favored Glycine 0 C--N 1.294 -1.803 0 CA-C-O 116.927 -2.041 . . . . 25.0 113.091 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.0 154.27 0.12 Allowed Pre-proline 0 N--CA 1.428 -1.525 0 C-N-CA 129.127 2.971 . . . . 25.0 115.75 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.27 10.33 3.75 Favored 'Trans proline' 0 C--O 1.182 -2.277 1 C-N-CA 112.524 -4.517 . . . . 25.0 117.681 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.78 -25.92 62.21 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 119.711 -1.868 . . . . 25.0 109.165 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 81.3 p -71.61 -19.0 62.18 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 123.917 1.817 . . . . 25.0 111.67 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -72.46 -23.92 61.12 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 111.416 -2.629 . . . . 25.0 109.609 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.62 109.87 5.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 119.282 -2.136 . . . . 25.0 110.444 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.7 -36.22 14.46 Favored 'General case' 0 C--O 1.278 2.58 0 O-C-N 119.358 -2.088 . . . . 75.0 109.312 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.7 t -73.73 131.66 41.83 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.176 0.99 . . . . 25.0 110.085 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.08 161.14 38.34 Favored 'General case' 0 C--O 1.275 2.429 0 CA-C-O 121.85 0.833 . . . . 25.0 109.293 -173.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -109.11 131.75 54.77 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.153 -0.931 . . . . 25.0 108.587 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.14 117.79 38.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -75.66 134.5 40.57 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 125.583 1.802 . . . . 50.0 106.971 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 18.1 mt -125.72 119.3 24.31 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 103.041 -2.948 . . . . 25.0 103.041 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.2 153.26 67.08 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 124.007 1.53 . . . . 25.0 112.361 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.29 50.98 0.78 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.201 1.477 . . . . 25.0 109.692 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.55 -35.4 75.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 118.606 2.817 . . . . 50.0 118.606 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -155.47 166.64 32.93 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.602 1.961 . . . . 25.0 112.861 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.6 mp -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 115.993 -0.549 . . . . 50.0 111.148 165.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 141.08 165.06 10.18 Favored Glycine 0 C--O 1.187 -2.842 0 C-N-CA 118.122 -1.99 . . . . 25.0 114.779 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.59 145.51 47.32 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 119.181 3.03 . . . . 50.0 119.181 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -142.9 157.37 44.65 Favored 'General case' 0 C--O 1.201 -1.478 0 N-CA-C 102.883 -3.006 . . . . 25.0 102.883 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.15 135.87 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 104.512 -2.403 . . . . 50.0 104.512 164.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.79 123.58 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 93.128 -6.619 . . . . 25.0 93.128 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 mp -106.29 145.03 32.14 Favored 'General case' 0 C--O 1.185 -2.292 0 C-N-CA 124.021 0.929 . . . . 50.0 109.647 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.36 45.88 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 115.971 -1.966 . . . . 25.0 113.619 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.52 128.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.265 1.911 0 O-C-N 125.006 1.442 . . . . 50.0 111.059 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -118.82 119.55 34.71 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 116.766 -1.588 . . . . 25.0 109.02 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -92.35 135.6 33.89 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 103.704 -2.702 . . . . 25.0 103.704 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.6 t -118.46 126.81 75.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 104.154 -2.536 . . . . 50.0 104.154 -172.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.42 -16.97 63.0 Favored 'General case' 0 CA--C 1.476 -1.901 1 O-C-N 116.051 -4.156 . . . . 25.0 115.936 -166.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.19 -28.13 53.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 128.172 2.589 . . . . 25.0 112.753 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.3 p -134.75 164.8 26.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 116.775 2.139 . . . . 25.0 116.775 -158.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -95.1 -15.96 22.99 Favored 'General case' 0 C--O 1.184 -2.357 0 CA-C-O 124.47 2.081 . . . . 25.0 113.092 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -66.83 155.04 39.35 Favored 'General case' 0 C--O 1.287 3.04 0 O-C-N 118.86 -2.4 . . . . 25.0 111.084 155.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.82 140.74 22.84 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 103.354 -2.832 . . . . 25.0 103.354 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -83.78 165.67 18.64 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 105.119 -2.178 . . . . 50.0 105.119 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.12 160.58 43.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.853 -1.521 . . . . 50.0 109.241 164.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -147.65 154.2 40.32 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 116.787 -1.578 . . . . 25.0 110.416 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.5 m -138.85 128.28 31.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.56 -2.015 . . . . 75.0 105.56 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.8 mt -132.53 126.97 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.135 0 N-CA-C 106.262 -1.755 . . . . 25.0 106.262 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.97 135.3 33.72 Favored 'General case' 0 C--N 1.311 -1.086 1 O-C-N 115.773 -4.329 . . . . 25.0 108.813 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.86 134.96 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 O-C-N 117.246 -3.409 . . . . 50.0 102.802 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.42 99.11 12.02 Favored 'General case' 0 CA--C 1.554 1.102 0 O-C-N 119.769 -1.832 . . . . 25.0 106.192 171.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.33 128.43 35.49 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 121.696 2.044 . . . . 50.0 110.499 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.11 168.25 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . 0.312 26.1 t30 -83.07 146.82 28.49 Favored 'General case' 0 N--CA 1.385 -3.703 0 N-CA-C 106.775 -1.565 . . . . 25.0 106.775 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 CA--C 1.482 -1.651 0 CA-C-N 121.727 2.058 . . . . 25.0 110.042 170.757 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' HIS . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 161' ' ' PHE . 76.5 m80 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 125.118 2.389 . . . . 25.0 109.669 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.37 -161.38 14.22 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 112.712 -2.04 . . . . 25.0 108.257 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -149.96 162.71 39.82 Favored 'General case' 0 C--O 1.27 2.166 0 CA-C-N 114.138 -1.031 . . . . 50.0 110.703 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mm -85.16 139.14 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 O-C-N 125.554 1.784 . . . . 25.0 111.543 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.73 39.21 3.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 103.912 -2.625 . . . . 25.0 103.912 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 75.92 146.43 0.11 Allowed Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 127.451 2.3 . . . . 25.0 114.161 171.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.68 147.55 15.61 Favored 'Cis proline' 0 CA--C 1.491 -1.635 0 O-C-N 118.252 -1.499 . . . . 25.0 114.865 -18.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.07 33.38 6.04 Favored Glycine 0 C--O 1.187 -2.836 0 C-N-CA 124.867 1.222 . . . . 25.0 111.668 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.6 t -75.73 138.75 41.47 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 118.951 1.375 . . . . 25.0 108.266 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -85.39 -18.18 34.46 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 123.618 1.675 . . . . 25.0 106.568 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.79 80.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.12 -14.66 60.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.53 -0.731 . . . . 25.0 110.288 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 104.15 -2.537 . . . . 75.0 104.15 177.635 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.5 ptm . . . . . 0 C--O 1.199 -1.572 0 N-CA-C 120.718 3.599 . . . . 25.0 120.718 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.27 -43.29 95.3 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 119.172 -2.205 . . . . 50.0 112.162 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -145.05 62.6 9.22 Favored Pre-proline 0 C--O 1.275 2.415 0 N-CA-C 113.394 0.887 . . . . 25.0 113.394 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -15.64 47.03 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 116.325 -1.983 . . . . 25.0 112.817 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -66.06 -18.69 65.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.765 -1.835 . . . . 25.0 115.741 170.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -77.95 -4.42 46.83 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.584 0.707 . . . . 25.0 112.016 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.1 94.47 1.92 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 120.806 -1.184 . . . . 50.0 112.687 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -120.73 162.26 20.03 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 119.208 3.04 . . . . 25.0 119.208 -174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . . . -136.25 170.94 15.22 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 104.804 -2.295 . . . . 25.0 104.804 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -122.96 141.37 52.01 Favored 'General case' 0 C--O 1.275 2.42 0 O-C-N 124.89 1.369 . . . . 25.0 108.657 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt . . . . . 0 C--O 1.197 -1.701 0 O-C-N 125.544 1.778 . . . . 25.0 109.142 -178.834 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 CA--C 1.502 -0.888 0 N-CA-C 116.999 2.222 . . . . 50.0 116.999 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -74.99 -24.95 58.51 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 112.681 -2.054 . . . . 50.0 110.769 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.32 59.89 Favored Glycine 0 C--O 1.2 -2.002 0 O-C-N 127.294 2.871 . . . . 25.0 109.025 173.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.02 -30.45 78.03 Favored Glycine 0 C--N 1.358 1.797 0 N-CA-C 116.728 1.451 . . . . 25.0 116.728 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -80.41 -39.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.246 -2.502 . . . . 25.0 104.246 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.63 -27.4 66.85 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 126.631 1.973 . . . . 75.0 111.63 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.14 -10.45 59.77 Favored 'General case' 0 C--O 1.182 -2.456 0 O-C-N 121.169 -0.957 . . . . 50.0 109.469 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.71 -12.52 60.74 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 127.259 3.409 . . . . 25.0 112.979 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -148.55 69.15 1.09 Allowed 'General case' 0 C--O 1.277 2.501 0 CA-C-N 111.42 -2.627 . . . . 25.0 109.047 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.0 t -143.29 155.53 44.49 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 116.834 -1.555 . . . . 25.0 108.928 -170.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -55.0 -32.57 61.89 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 121.276 1.853 . . . . 25.0 114.624 158.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.53 -34.91 67.89 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 115.303 1.594 . . . . 25.0 115.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.314 24.8 ttp180 0.42 73.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.448 2.699 . . . . 25.0 116.458 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.16 149.3 45.66 Favored 'General case' 0 C--O 1.208 -1.112 1 CA-C-N 107.871 -4.24 . . . . 25.0 107.546 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -74.92 142.43 44.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.114 1.766 . . . . 50.0 114.139 -146.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 153.72 36.54 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 125.222 1.409 . . . . 25.0 111.107 -172.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -135.01 176.76 8.36 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 102.905 -2.998 . . . . 25.0 102.905 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -124.01 139.65 49.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 168.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . 0.267 60.6 mtp -143.94 171.24 14.52 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.683 1.128 . . . . 25.0 109.396 175.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.7 p -103.12 165.7 10.87 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.127 -1.608 . . . . 25.0 113.201 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.15 179.32 48.07 Favored Glycine 0 C--O 1.256 1.475 0 O-C-N 119.347 -2.096 . . . . 25.0 114.068 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.31 168.02 29.02 Favored Glycine 0 CA--C 1.542 1.757 0 CA-C-O 123.511 1.617 . . . . 25.0 112.849 -168.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.4 127.64 33.74 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.158 -2.217 . . . . 25.0 115.935 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.97 156.84 37.42 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m -103.72 141.04 36.76 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 112.37 -2.195 . . . . 25.0 108.904 166.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -123.66 149.08 45.86 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 115.695 -2.098 . . . . 50.0 105.606 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.8 m -132.25 138.19 47.81 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.373 -1.343 . . . . 25.0 107.373 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.84 161.04 24.81 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 103.02 -2.956 . . . . 25.0 103.02 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.0 t -140.16 137.11 34.15 Favored 'General case' 0 C--O 1.263 1.774 0 N-CA-C 106.799 -1.556 . . . . 25.0 106.799 160.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.36 125.76 50.7 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.569 1.548 . . . . 50.0 109.95 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -125.65 6.78 7.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 119.52 3.156 . . . . 25.0 119.52 -156.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . 0.313 . . -57.75 -63.38 3.89 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 114.512 -2.661 . . . . 25.0 117.111 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.29 176.86 37.44 Favored 'Cis proline' 0 CA--C 1.538 0.691 1 C-N-CA 136.676 4.032 . . . . 25.0 111.678 -9.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -131.02 164.35 25.6 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 102.84 -3.022 . . . . 25.0 102.84 165.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -89.11 150.04 22.91 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 105.125 -2.176 . . . . 25.0 105.125 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.4 m -137.84 134.82 35.58 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 107.733 -1.21 . . . . 25.0 107.733 -159.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 p -98.98 -34.27 10.5 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 117.437 -1.705 . . . . 25.0 110.978 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -156.03 151.22 26.6 Favored 'General case' 0 C--O 1.194 -1.841 0 C-N-CA 128.425 2.69 . . . . 25.0 111.492 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -137.96 136.27 36.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 119.452 -2.03 . . . . 25.0 108.459 150.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -142.72 163.43 32.84 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 117.861 -1.536 . . . . 25.0 111.701 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -149.43 141.29 23.7 Favored 'General case' 0 C--O 1.261 1.699 0 O-C-N 125.276 1.61 . . . . 50.0 114.259 -164.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -121.36 165.28 15.76 Favored 'General case' 0 C--O 1.183 -2.417 0 C-N-CA 126.535 1.934 . . . . 50.0 106.605 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.5 pt -127.3 159.69 37.28 Favored 'Isoleucine or valine' 0 C--O 1.261 1.681 0 CA-C-N 111.936 -2.393 . . . . 25.0 106.95 168.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.9 p -102.78 165.89 10.8 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 124.425 2.059 . . . . 25.0 105.699 156.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -105.63 -177.14 3.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 112.322 -2.217 . . . . 25.0 107.121 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -163.31 167.03 22.39 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.08 64.27 3.22 Favored Glycine 0 C--O 1.274 2.633 0 O-C-N 119.822 -1.798 . . . . 25.0 113.092 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.12 171.18 14.42 Favored 'General case' 0 C--O 1.193 -1.904 0 N-CA-C 116.38 1.993 . . . . 25.0 116.38 -166.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -85.39 110.92 32.89 Favored Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-O 117.1 -1.428 . . . . 25.0 110.974 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -57.99 -21.56 50.63 Favored 'Trans proline' 0 N--CA 1.447 -1.25 1 N-CA-C 123.68 4.454 . . . . 25.0 123.68 174.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.251 23.7 t70 -71.45 -17.83 62.35 Favored 'General case' 0 C--O 1.264 1.852 0 C-N-CA 116.151 -2.22 . . . . 75.0 114.032 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -72.01 161.12 80.52 Favored Pre-proline 0 C--N 1.38 1.921 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -41.01 22.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.542 2 C-N-CA 129.403 6.735 . . . . 25.0 124.373 161.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 53.7 mt -51.93 -35.57 46.17 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 116.507 -3.871 . . . . 50.0 116.991 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -68.11 -7.96 34.21 Favored 'General case' 0 C--O 1.198 -1.617 0 N-CA-C 115.046 1.499 . . . . 25.0 115.046 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -127.8 -60.3 1.17 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.453 -0.794 . . . . 25.0 110.074 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.1 -22.49 62.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 116.443 -1.741 . . . . 25.0 112.634 -168.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.8 20.8 18.07 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 127.042 2.713 . . . . 25.0 113.194 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -110.34 127.73 55.2 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 103.084 -2.932 . . . . 50.0 103.084 158.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.46 122.86 20.71 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.036 -1.865 . . . . 25.0 110.891 -169.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -62.25 117.62 6.32 Favored 'General case' 0 C--O 1.2 -1.522 0 N-CA-C 102.547 -3.131 . . . . 50.0 102.547 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.95 -11.14 9.3 Favored 'Isoleucine or valine' 0 C--O 1.265 1.919 0 CA-C-O 122.729 1.252 . . . . 25.0 112.594 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 174.83 30.1 Favored Glycine 0 C--N 1.365 2.192 0 N-CA-C 117.644 1.817 . . . . 25.0 117.644 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.81 155.13 43.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 128.612 3.183 . . . . 25.0 111.788 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.82 89.84 48.14 Favored Pre-proline 0 C--O 1.265 1.885 0 C-N-CA 128.682 2.793 . . . . 50.0 104.22 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.05 161.24 29.77 Favored 'Trans proline' 0 C--O 1.195 -1.674 1 C-N-CA 111.904 -4.93 . . . . 25.0 111.982 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -79.8 115.41 19.38 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.346 -1.741 . . . . 25.0 109.005 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -128.09 -8.11 5.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.147 1.339 . . . . 50.0 113.661 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.34 -15.67 62.82 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 115.762 1.065 . . . . 25.0 115.762 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -66.93 153.1 95.0 Favored Pre-proline 0 N--CA 1.492 1.652 1 N-CA-C 99.736 -4.172 . . . . 25.0 99.736 163.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.99 18.42 0.31 Allowed 'Trans proline' 0 CA--C 1.509 -0.76 0 N-CA-C 116.231 1.589 . . . . 25.0 116.231 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -31.87 68.04 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 154.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.1 m -76.02 -25.23 55.5 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-O 116.534 -1.698 . . . . 25.0 106.523 -172.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -82.6 -0.46 47.06 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 121.341 1.882 . . . . 25.0 115.851 176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -81.95 84.66 6.87 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.862 -1.135 . . . . 25.0 113.937 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.1 3.94 54.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.755 -1.566 . . . . 75.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.0 t -104.48 122.61 45.89 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 119.85 -1.781 . . . . 25.0 115.402 162.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -148.76 137.48 21.35 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.765 -1.569 . . . . 25.0 106.765 -154.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -84.34 132.67 34.58 Favored 'General case' 0 C--O 1.267 2.012 0 C-N-CA 126.022 1.729 . . . . 25.0 114.946 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.4 mt -131.06 124.82 56.62 Favored 'Isoleucine or valine' 0 C--O 1.262 1.754 0 O-C-N 119.739 -1.851 . . . . 25.0 107.445 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -77.67 126.03 30.25 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 112.913 0.708 . . . . 50.0 112.913 167.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.96 128.66 25.72 Favored Pre-proline 0 C--O 1.248 0.989 0 N-CA-C 102.476 -3.157 . . . . 25.0 102.476 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.99 157.96 53.52 Favored 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 112.587 -4.475 . . . . 25.0 112.658 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -101.34 36.87 1.9 Allowed 'General case' 0 C--O 1.211 -0.924 0 O-C-N 120.461 -1.399 . . . . 25.0 110.628 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -65.81 -46.65 77.84 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 119.765 3.246 . . . . 50.0 119.765 -167.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -150.9 173.32 14.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.213 2.205 . . . . 25.0 105.775 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 6.1 mp -84.83 169.0 14.59 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 101.497 -3.52 . . . . 50.0 101.497 170.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.78 176.53 22.35 Favored Glycine 0 CA--C 1.476 -2.362 0 CA-C-O 126.441 3.245 . . . . 25.0 113.014 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 24.4 p90 -93.17 163.98 13.42 Favored 'General case' 0 C--O 1.271 2.187 0 O-C-N 117.399 -3.413 . . . . 50.0 112.241 -164.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -162.16 173.44 14.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 127.442 2.297 . . . . 25.0 107.7 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.52 143.1 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.792 1.178 . . . . 50.0 113.894 174.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.0 mt -103.88 135.96 39.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 101.635 -3.469 . . . . 25.0 101.635 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -125.8 148.97 48.96 Favored 'General case' 0 C--O 1.187 -2.223 0 O-C-N 117.909 -2.995 . . . . 50.0 107.963 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.16 161.52 37.68 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 116.224 -1.846 . . . . 25.0 113.321 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.61 119.96 3.81 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 O-C-N 125.787 1.93 . . . . 50.0 106.162 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.13 117.63 31.76 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 127.169 2.188 . . . . 25.0 112.457 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.88 111.29 23.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 104.144 -2.539 . . . . 25.0 104.144 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.0 t -84.33 124.87 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.145 0 CA-C-O 124.118 1.913 . . . . 50.0 109.63 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.69 -24.13 62.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.107 -1.621 . . . . 25.0 111.309 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.09 -17.11 58.92 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 117.094 -1.842 . . . . 25.0 114.493 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.0 p -125.53 156.68 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 119.279 -2.138 . . . . 25.0 113.911 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.73 -29.61 69.63 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-O 122.641 1.21 . . . . 25.0 110.274 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -79.55 161.4 26.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 119.194 -2.191 . . . . 25.0 115.062 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . . . -133.7 167.13 21.08 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 114.691 -1.141 . . . . 25.0 108.736 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 1' ' ' HIS . 63.2 m-85 -115.94 144.66 43.76 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.976 -1.12 . . . . 50.0 107.976 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -122.33 155.88 35.07 Favored 'General case' 0 C--O 1.242 0.707 0 O-C-N 125.84 1.963 . . . . 50.0 107.402 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -126.8 151.9 47.67 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.763 -1.562 . . . . 25.0 108.939 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.71 135.55 50.99 Favored 'Isoleucine or valine' 0 C--O 1.268 2.065 0 N-CA-C 105.91 -1.885 . . . . 75.0 105.91 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.6 mt -139.56 106.96 2.83 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 N-CA-C 105.642 -1.984 . . . . 25.0 105.642 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -84.71 131.41 34.58 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 120.247 -1.533 . . . . 25.0 113.837 174.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.74 142.4 43.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 120.307 -1.496 . . . . 50.0 113.061 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 45.3 t0 -83.9 132.36 34.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 116.497 -1.716 . . . . 25.0 107.581 167.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.1 mt -126.4 131.51 51.72 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 103.146 -2.909 . . . . 50.0 103.146 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.3 m -135.0 171.51 17.58 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 105.683 -1.969 . . . . 50.0 105.683 -171.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.35 146.27 32.98 Favored 'General case' 0 C--O 1.283 2.844 0 O-C-N 120.972 -1.08 . . . . 25.0 111.575 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt . . . . . 0 C--O 1.289 3.17 0 CA-C-O 116.173 -1.87 . . . . 25.0 112.114 178.724 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.6 m80 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 118.228 -0.892 . . . . 25.0 108.666 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.67 -154.06 10.65 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 118.046 -2.026 . . . . 25.0 116.134 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.19 170.12 20.22 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 125.237 2.446 . . . . 50.0 105.956 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.7 mt -84.34 126.51 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 O-C-N 118.915 -2.366 . . . . 25.0 113.509 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -92.88 -28.3 16.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 116.204 1.927 . . . . 25.0 116.204 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -145.92 122.33 5.87 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 105.729 -1.952 . . . . 25.0 105.729 168.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.29 133.06 10.53 Favored 'Cis proline' 0 C--O 1.197 -1.551 0 C-N-CA 130.543 1.476 . . . . 25.0 113.116 -2.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.62 -88.99 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.805 -1.543 . . . . 25.0 116.146 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -54.5 134.4 46.23 Favored 'General case' 0 C--O 1.262 1.724 0 N-CA-C 114.811 1.412 . . . . 25.0 114.811 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 ttt-85 -118.86 -32.19 4.57 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 112.481 -2.145 . . . . 25.0 114.405 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.47 -24.06 62.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 116.788 2.144 . . . . 25.0 116.788 -172.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.19 60.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 124.437 2.065 . . . . 25.0 111.191 174.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 13' ' ' LEU . 23.2 mt . . . . . 0 N--CA 1.492 1.642 1 O-C-N 115.572 -4.455 . . . . 75.0 109.67 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 C--O 1.206 -1.215 0 N-CA-C 117.681 2.474 . . . . 25.0 117.681 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -63.65 -38.44 91.14 Favored 'General case' 0 N--CA 1.432 -1.329 0 O-C-N 119.484 -2.01 . . . . 50.0 106.639 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.37 48.83 0.56 Allowed Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.371 1.248 . . . . 25.0 114.371 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.24 -19.99 21.83 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 O-C-N 116.571 -2.384 . . . . 25.0 117.449 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -83.83 -2.45 56.4 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 117.007 -1.473 . . . . 25.0 109.616 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.694 2.497 . . . . 25.0 113.722 -171.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.96 151.21 31.77 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 118.021 -2.925 . . . . 50.0 105.913 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -140.01 160.9 38.87 Favored 'General case' 0 C--O 1.186 -2.239 0 O-C-N 120.271 -1.518 . . . . 25.0 113.625 -170.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.79 149.8 35.01 Favored 'General case' 0 C--O 1.261 1.662 1 N-CA-C 99.912 -4.107 . . . . 25.0 99.912 163.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 82.0 tttt -91.33 146.16 24.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 105.06 -2.2 . . . . 25.0 105.06 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt . . . . . 0 CA--C 1.579 2.075 0 O-C-N 126.382 2.301 . . . . 25.0 110.587 176.65 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.6 mt . . . . . 0 C--O 1.251 1.133 0 CA-C-O 116.624 -1.655 . . . . 50.0 111.86 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -63.66 -25.96 68.45 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 107.007 -1.479 . . . . 50.0 107.007 142.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.86 -10.02 85.05 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 119.769 -1.832 . . . . 25.0 115.477 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.34 -2.31 47.97 Favored Glycine 0 C--O 1.286 3.386 0 N-CA-C 118.418 2.127 . . . . 25.0 118.418 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -63.2 -41.19 91.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 123.378 1.561 . . . . 25.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.04 -28.58 62.42 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 114.087 -1.415 . . . . 75.0 110.933 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -109.89 21.98 16.2 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-O 124.086 1.898 . . . . 50.0 113.971 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -75.84 41.72 0.22 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 120.991 3.7 . . . . 25.0 120.991 -170.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -138.12 45.6 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.767 -1.938 . . . . 25.0 105.767 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -143.31 -172.87 3.79 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.634 1.683 . . . . 25.0 110.784 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -61.48 -22.01 64.7 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.393 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -77.01 2.82 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 119.699 -1.876 . . . . 25.0 112.507 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -87.69 84.11 7.11 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 128.183 3.849 . . . . 25.0 112.918 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 148.87 34.78 Favored 'General case' 0 C--N 1.287 -2.117 1 CA-C-N 106.008 -5.087 . . . . 25.0 111.395 156.1 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -75.87 147.36 39.11 Favored 'General case' 0 C--O 1.188 -2.162 0 N-CA-C 105.911 -1.885 . . . . 50.0 105.911 -174.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HE3' ' CG ' ' A' ' 145' ' ' TYR . 24.3 mtpt -84.12 121.34 27.32 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 174.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -73.59 119.73 18.21 Favored 'General case' 0 CA--C 1.461 -2.477 0 C-N-CA 116.412 -2.115 . . . . 25.0 106.535 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.25 129.54 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 98.7 mmm -140.57 150.76 44.07 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 104.476 -2.416 . . . . 25.0 104.476 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -88.31 176.97 6.98 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 104.451 -2.425 . . . . 25.0 104.451 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.24 174.1 34.84 Favored Glycine 1 C--O 1.158 -4.628 0 N-CA-C 107.079 -2.409 . . . . 25.0 107.079 171.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.72 178.76 47.84 Favored Glycine 0 C--O 1.201 -1.911 0 C-N-CA 126.543 2.02 . . . . 25.0 112.851 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -72.81 141.37 48.02 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 114.417 -2.706 . . . . 25.0 114.006 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -132.6 156.55 46.68 Favored 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 105.974 -1.861 . . . . 25.0 105.974 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.4 m -89.18 107.59 19.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.741 -3.059 . . . . 25.0 102.741 -172.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.83 115.31 27.99 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 106.436 -1.69 . . . . 50.0 106.436 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.4 m -133.01 132.4 41.83 Favored 'General case' 0 C--O 1.267 1.976 0 N-CA-C 108.501 -0.926 . . . . 25.0 108.501 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -117.48 170.06 9.03 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 106.106 -1.812 . . . . 25.0 106.106 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -140.31 146.73 38.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.976 -2.601 . . . . 25.0 103.976 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.72 147.3 46.09 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 113.773 -1.558 . . . . 50.0 113.06 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 t -61.24 -23.39 65.6 Favored 'General case' 0 C--O 1.26 1.633 0 O-C-N 125.748 1.905 . . . . 25.0 113.714 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.19 32.06 Favored Pre-proline 0 CA--C 1.497 -1.082 0 N-CA-C 103.6 -2.741 . . . . 25.0 103.6 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -64.45 166.2 18.07 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 113.656 -3.762 . . . . 25.0 111.77 164.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -129.06 147.17 50.9 Favored 'General case' 0 C--O 1.197 -1.696 0 O-C-N 126.21 2.194 . . . . 25.0 106.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.76 125.71 25.66 Favored 'General case' 0 C--O 1.186 -2.256 0 O-C-N 126.051 2.095 . . . . 25.0 106.498 165.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.3 m -129.43 145.21 51.45 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 124.917 1.287 . . . . 25.0 109.921 -172.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -105.79 -48.95 3.51 Favored 'General case' 0 CA--C 1.624 3.815 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 41.9 tt0 -152.51 160.48 43.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.295 -2.483 . . . . 25.0 104.295 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -143.21 141.02 30.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.07 -1.423 . . . . 25.0 110.637 161.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 163.64 32.62 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.177 -0.952 . . . . 25.0 113.123 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -136.99 149.34 47.45 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 117.713 2.486 . . . . 50.0 117.713 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -127.87 164.8 21.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.596 1.558 . . . . 50.0 112.851 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.8 pt -127.78 152.35 35.75 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-N 113.93 -1.486 . . . . 25.0 109.254 173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.3 p -94.16 164.14 13.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 102.919 -2.993 . . . . 25.0 102.919 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -73.58 136.43 43.98 Favored 'General case' 0 C--O 1.185 -2.318 0 O-C-N 119.808 -1.808 . . . . 25.0 111.995 -163.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -71.88 114.51 10.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 119.162 -2.211 . . . . 25.0 108.53 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.6 47.97 3.58 Favored Glycine 0 C--O 1.277 2.792 0 CA-C-N 120.857 1.662 . . . . 25.0 110.393 -172.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.4 160.89 12.57 Favored 'General case' 0 CA--C 1.593 2.616 0 N-CA-C 107.186 -1.412 . . . . 25.0 107.186 -170.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -132.67 105.29 12.96 Favored Pre-proline 0 C--O 1.275 2.421 0 O-C-N 126.119 2.137 . . . . 25.0 107.142 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.97 -11.31 25.44 Favored 'Trans proline' 0 C--N 1.371 1.745 0 N-CA-C 116.872 1.835 . . . . 25.0 116.872 -174.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.85 -10.46 53.19 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.12 1.155 . . . . 75.0 114.12 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -89.25 175.53 3.88 Favored Pre-proline 0 C--O 1.215 -0.747 0 C-N-CA 126.961 2.104 . . . . 25.0 113.211 -176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -19.66 37.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 1 C-N-CA 134.626 10.218 . . . . 25.0 120.124 121.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.69 -36.02 23.69 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 129.571 3.149 . . . . 50.0 111.33 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.46 -5.72 58.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 119.887 -1.758 . . . . 25.0 110.942 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -130.26 -72.01 0.58 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.306 1.965 . . . . 25.0 116.306 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.75 -0.89 25.43 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 122.975 2.625 . . . . 25.0 114.274 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -75.64 -23.63 56.34 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.593 1.088 . . . . 25.0 111.337 163.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.27 154.79 21.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.969 -1.493 . . . . 50.0 106.969 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.58 158.22 40.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.312 -2.477 . . . . 25.0 104.312 159.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.3 tp -87.81 128.79 35.33 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 102.616 -3.105 . . . . 50.0 102.616 158.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.97 -21.77 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 106.926 -1.509 . . . . 25.0 106.926 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.91 164.56 30.41 Favored Glycine 0 C--O 1.202 -1.89 0 CA-C-N 119.719 1.145 . . . . 25.0 113.082 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.4 42.21 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 106.0 -1.852 . . . . 25.0 106.0 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.68 95.4 17.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-N 112.251 -2.25 . . . . 50.0 108.736 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 97.1 Cg_endo -74.61 166.34 29.58 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 121.391 1.394 . . . . 25.0 109.87 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -124.32 140.59 52.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.197 -1.408 . . . . 25.0 107.197 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.3 -11.73 5.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 115.449 1.648 . . . . 50.0 115.449 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.03 -9.07 33.75 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 126.44 1.972 . . . . 25.0 110.892 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.6 p -74.46 154.27 87.81 Favored Pre-proline 0 C--O 1.197 -1.659 0 N-CA-C 100.827 -3.768 . . . . 25.0 100.827 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.39 25.53 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 117.202 -1.399 . . . . 25.0 113.932 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.55 -16.29 60.28 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 118.808 -2.433 . . . . 25.0 108.171 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.1 p -69.57 -13.97 62.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.667 -1.606 . . . . 25.0 113.659 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.92 -28.79 69.18 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.067 -0.97 . . . . 25.0 111.54 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -68.12 88.89 0.3 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.62 0.724 . . . . 25.0 109.979 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.6 tp -92.39 -27.6 17.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 126.412 3.006 . . . . 75.0 107.485 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.4 t -81.41 123.72 28.81 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 110.724 -2.944 . . . . 25.0 107.647 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -129.63 135.68 48.83 Favored 'General case' 0 CA--C 1.572 1.801 0 O-C-N 124.959 1.412 . . . . 25.0 108.841 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -69.78 130.53 42.56 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 116.233 -1.841 . . . . 25.0 106.117 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.8 mm -128.7 118.33 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.953 0 CA-C-N 121.058 1.754 . . . . 25.0 112.274 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -67.49 129.85 41.19 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 115.654 1.724 . . . . 50.0 115.654 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.26 118.4 44.01 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 118.1 -2.875 . . . . 25.0 107.555 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.34 146.41 45.14 Favored 'Trans proline' 0 CA--C 1.483 -2.06 0 C-N-CA 115.216 -2.723 . . . . 25.0 116.417 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -87.73 53.88 2.93 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 123.297 1.522 . . . . 25.0 108.05 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -84.33 -30.87 25.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 120.002 3.334 . . . . 50.0 120.002 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -152.22 177.96 9.99 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 114.047 -2.882 . . . . 25.0 104.505 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 mp -113.67 126.46 55.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 104.567 -2.383 . . . . 50.0 104.567 160.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.78 170.12 32.16 Favored Glycine 0 CA--C 1.473 -2.539 0 C-N-CA 118.148 -1.977 . . . . 25.0 114.533 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.444 ' CG ' ' HE3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -112.86 135.61 53.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.36 1.464 . . . . 50.0 112.462 -168.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -147.0 167.69 23.39 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 125.349 1.656 . . . . 25.0 113.449 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.4 t -85.2 158.87 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 126.896 2.623 . . . . 50.0 104.559 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.8 mt -129.24 136.16 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 N-CA-C 103.43 -2.804 . . . . 25.0 103.43 162.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.34 153.03 39.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 104.741 -2.318 . . . . 50.0 104.741 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.61 157.4 45.52 Favored 'General case' 0 C--O 1.184 -2.371 0 CA-C-N 121.632 2.015 . . . . 25.0 106.61 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.52 134.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 126.832 2.583 . . . . 50.0 110.405 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -124.17 119.68 30.1 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 120.792 1.633 . . . . 25.0 108.084 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -84.4 89.13 7.33 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 119.563 -1.96 . . . . 25.0 111.461 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.67 103.65 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 113.23 -1.805 . . . . 50.0 106.5 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.12 -18.89 64.76 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 113.793 -1.549 . . . . 25.0 114.26 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.68 -26.35 66.99 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 119.178 3.029 . . . . 25.0 119.178 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 45.7 p -115.24 158.45 22.3 Favored 'General case' 0 C--O 1.262 1.725 0 N-CA-C 114.796 1.406 . . . . 25.0 114.796 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -28.15 27.81 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 106.918 -1.512 . . . . 25.0 106.918 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 86.1 m-20 -66.7 157.89 31.53 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 124.615 2.15 . . . . 25.0 111.416 160.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.49 155.45 42.27 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 101.954 -3.35 . . . . 25.0 101.954 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -111.53 153.35 26.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.072 2.107 . . . . 50.0 115.905 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -142.59 152.1 42.2 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 124.019 1.866 . . . . 50.0 106.74 -162.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -155.38 149.26 25.49 Favored 'General case' 0 C--O 1.19 -2.068 0 O-C-N 120.043 -1.661 . . . . 25.0 111.534 167.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.81 127.5 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 125.269 1.606 . . . . 75.0 112.556 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 152.77 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-N 121.835 2.107 . . . . 25.0 108.676 172.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -88.93 156.82 18.67 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 118.94 2.941 . . . . 25.0 118.94 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.1 169.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 102.695 -3.076 . . . . 50.0 102.695 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -132.66 122.61 24.92 Favored 'General case' 0 C--O 1.258 1.505 0 N-CA-C 103.03 -2.952 . . . . 25.0 103.03 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.68 119.4 34.35 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 122.07 2.214 . . . . 50.0 106.329 -164.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.59 -175.65 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.268 2.063 0 CA-C-O 122.408 1.099 . . . . 50.0 113.359 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.97 151.49 43.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.634 1.716 . . . . 25.0 115.634 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 79.7 mttt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 121.586 1.994 . . . . 25.0 115.319 176.171 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' HIS . . . . . 0.44 ' HA ' ' CE3' ' A' ' 152' ' ' TRP . 24.0 p-80 . . . . . 0 C--O 1.293 3.366 0 CA-C-O 117.995 -1.002 . . . . 25.0 112.233 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.25 -124.02 31.0 Favored Glycine 0 CA--C 1.489 -1.579 0 CA-C-O 118.482 -1.177 . . . . 25.0 112.297 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -113.58 164.18 13.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 126.549 1.97 . . . . 50.0 110.97 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.4 mt -96.1 120.53 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 N-CA-C 102.972 -2.973 . . . . 25.0 102.972 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -91.72 -34.02 14.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 117.575 -1.202 . . . . 25.0 108.256 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.52 133.17 13.55 Favored Pre-proline 0 C--N 1.309 -1.185 0 C-N-CA 124.382 1.073 . . . . 25.0 110.097 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.57 144.77 80.83 Favored 'Cis proline' 0 C--O 1.249 1.033 0 CA-C-O 123.625 1.427 . . . . 25.0 109.39 -3.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.04 133.29 10.33 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 113.761 -1.563 . . . . 25.0 110.75 169.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 35.13 0.8 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.159 1.48 . . . . 25.0 108.699 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -65.16 -26.33 68.12 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 116.071 -1.919 . . . . 25.0 112.778 -166.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.74 57.29 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 122.224 2.284 . . . . 25.0 109.189 -175.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.35 97.13 Favored 'General case' 0 C--O 1.274 2.385 0 CA-C-N 114.641 -1.163 . . . . 25.0 112.574 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.31 0.576 . . . . 75.0 109.994 178.682 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 115.532 1.679 . . . . 25.0 115.532 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -62.64 -44.69 95.63 Favored 'General case' 0 C--O 1.286 3.024 0 N-CA-C 119.482 3.142 . . . . 50.0 119.482 -166.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.256 11.9 pt-20 -142.17 62.38 13.7 Favored Pre-proline 0 C--O 1.258 1.508 0 N-CA-C 117.018 2.229 . . . . 25.0 117.018 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.8 -21.78 37.81 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 117.049 -1.501 . . . . 25.0 113.408 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -71.61 -14.28 62.02 Favored 'General case' 0 C--O 1.261 1.697 0 O-C-N 119.537 -1.977 . . . . 25.0 115.482 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 m -85.4 2.38 44.63 Favored 'General case' 0 C--O 1.285 2.933 0 O-C-N 119.934 -1.729 . . . . 25.0 115.373 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.2 150.58 48.9 Favored 'General case' 0 C--O 1.273 2.337 0 N-CA-C 104.267 -2.494 . . . . 50.0 104.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -132.14 162.16 31.55 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.53 1.932 . . . . 25.0 108.016 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.61 178.4 9.37 Favored 'General case' 0 C--O 1.184 -2.372 0 CA-C-O 124.33 2.014 . . . . 25.0 110.743 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.86 175.64 5.63 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 115.851 1.797 . . . . 25.0 115.851 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 95.3 mttt . . . . . 0 C--O 1.215 -0.716 0 O-C-N 120.159 -1.588 . . . . 25.0 114.812 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.4 mt . . . . . 0 CA--C 1.496 -1.124 0 N-CA-C 106.523 -1.658 . . . . 50.0 106.523 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.01 -14.6 60.83 Favored 'General case' 0 C--O 1.271 2.205 0 N-CA-C 114.824 1.416 . . . . 50.0 114.824 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.41 -22.27 63.27 Favored Glycine 0 C--O 1.274 2.633 0 N-CA-C 110.028 -1.229 . . . . 25.0 110.028 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -13.01 83.67 Favored Glycine 0 C--O 1.268 2.258 0 O-C-N 119.391 -2.241 . . . . 25.0 110.829 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -38.04 66.44 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 O-C-N 117.461 -3.376 . . . . 25.0 105.964 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.64 -32.32 73.76 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.516 -1.365 . . . . 75.0 111.317 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.22 -15.3 61.44 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 119.973 -1.704 . . . . 50.0 111.025 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.26 87.3 mt-30 -92.83 17.76 10.02 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 120.095 -1.628 . . . . 25.0 114.997 168.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -137.71 49.7 1.97 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.631 -1.988 . . . . 25.0 105.631 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -157.85 179.31 9.32 Favored 'General case' 0 C--O 1.261 1.669 1 N-CA-C 100.094 -4.039 . . . . 25.0 100.094 -170.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -47.74 -32.11 5.53 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 117.949 2.574 . . . . 25.0 117.949 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.41 29.53 1.68 Allowed 'General case' 0 C--O 1.253 1.282 0 CA-C-N 121.357 1.89 . . . . 25.0 107.477 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -83.32 78.81 9.57 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 123.967 1.841 . . . . 25.0 107.714 153.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -56.67 158.87 4.25 Favored 'General case' 0 C--O 1.29 3.196 0 CA-C-N 111.15 -2.75 . . . . 25.0 112.781 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -65.94 157.8 29.76 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-N 113.563 -1.653 . . . . 50.0 107.329 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -108.7 144.57 36.32 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 123.676 1.703 . . . . 25.0 108.137 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -139.79 152.82 46.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.625 -1.625 . . . . 25.0 109.735 162.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.7 mt -85.62 136.38 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.591 1.541 . . . . 25.0 107.998 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.6 ttt -137.31 144.8 42.79 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 171.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.298 12.1 p -79.43 173.43 12.59 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 120.373 -1.454 . . . . 25.0 113.209 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.5 -163.76 8.67 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.203 -1.475 . . . . 25.0 111.743 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.6 -172.72 36.19 Favored Glycine 0 N--CA 1.486 1.976 0 O-C-N 119.572 -2.134 . . . . 25.0 113.017 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -77.56 142.55 38.95 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 117.609 2.448 . . . . 25.0 117.609 169.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -137.86 165.88 25.39 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 105.763 -1.94 . . . . 25.0 105.763 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.7 m -118.46 120.25 36.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.956 -1.868 . . . . 25.0 105.956 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.52 141.71 47.7 Favored 'General case' 0 C--O 1.17 -3.111 0 N-CA-C 105.279 -2.119 . . . . 50.0 105.279 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 m -136.84 140.29 42.31 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 116.116 -1.897 . . . . 25.0 113.689 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 143.52 51.22 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 122.367 2.349 . . . . 25.0 109.688 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -149.08 144.57 26.76 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 127.157 3.36 . . . . 25.0 108.393 -170.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -142.54 151.98 42.16 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-N 111.845 -2.434 . . . . 50.0 112.718 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.0 t -73.64 -9.09 58.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 O-C-N 125.678 1.861 . . . . 25.0 113.634 -169.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.96 159.71 67.44 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 117.064 -3.523 . . . . 25.0 103.833 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -73.14 139.7 29.94 Favored 'Trans proline' 0 C--N 1.307 -1.654 1 C-N-CA 111.761 -5.026 . . . . 25.0 110.301 166.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 2.486 47.9 p-80 73.12 12.79 4.91 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 123.308 2.777 . . . . 25.0 116.611 -5.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -65.58 115.89 6.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 118.442 -1.303 . . . . 25.0 113.256 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.0 t -75.73 160.26 30.22 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.084 -1.446 . . . . 25.0 112.071 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 90.3 p -111.51 -26.37 9.1 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 118.246 0.475 . . . . 25.0 110.87 163.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 61.8 tt0 -168.6 150.56 4.97 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 103.013 -2.958 . . . . 25.0 103.013 168.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -136.73 160.54 38.52 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-O 116.921 -1.514 . . . . 25.0 107.589 166.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 6.2 m-70 -142.53 162.43 35.49 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.241 -1.763 . . . . 25.0 106.241 -163.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.27 127.63 45.9 Favored 'General case' 0 C--O 1.274 2.345 0 N-CA-C 103.953 -2.61 . . . . 50.0 103.953 158.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -117.61 149.91 39.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 118.17 -2.831 . . . . 50.0 107.898 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.8 pt -120.64 153.37 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 119.463 1.029 . . . . 25.0 112.626 168.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 p -71.54 147.34 47.79 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -95.88 84.79 3.93 Favored 'General case' 0 C--O 1.191 -1.987 0 CA-C-O 123.103 1.43 . . . . 25.0 109.577 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -49.83 155.29 0.89 Allowed 'General case' 0 C--N 1.354 0.777 0 N-CA-C 117.0 2.222 . . . . 25.0 117.0 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 15.56 76.98 Favored Glycine 0 C--O 1.266 2.129 0 CA-C-O 126.551 3.306 . . . . 25.0 120.889 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 179.2 2.83 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.35 -1.925 . . . . 25.0 113.759 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.93 142.43 11.74 Favored Pre-proline 0 CA--C 1.492 -1.255 0 O-C-N 126.38 2.3 . . . . 25.0 106.333 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -60.41 -22.74 72.6 Favored 'Trans proline' 0 CA--C 1.592 3.42 0 N-CA-C 117.677 2.145 . . . . 25.0 117.677 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 116.399 -2.12 . . . . 75.0 110.709 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -108.09 170.95 4.98 Favored Pre-proline 0 CA--C 1.599 2.856 0 C-N-CA 129.751 3.221 . . . . 25.0 103.272 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.33 16.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.393 1 N-CA-C 122.767 4.103 . . . . 25.0 122.767 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.66 -40.4 69.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 117.172 2.286 . . . . 50.0 117.172 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -75.36 -6.84 52.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 126.287 2.242 . . . . 25.0 114.401 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -116.26 -59.69 1.95 Allowed 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 127.259 2.224 . . . . 25.0 114.49 -171.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -141.67 29.6 1.73 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 123.469 1.604 . . . . 25.0 111.794 -159.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.89 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 111.763 -2.471 . . . . 25.0 116.985 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -129.29 166.21 19.9 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 123.157 2.708 . . . . 50.0 112.457 172.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.07 143.25 49.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 101.289 -3.597 . . . . 25.0 101.289 163.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 tp -86.3 120.94 28.19 Favored 'General case' 0 C--O 1.182 -2.482 0 O-C-N 127.507 3.004 . . . . 50.0 108.701 166.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.8 tt -101.93 -8.29 9.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 121.536 1.971 . . . . 25.0 110.172 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.65 154.55 9.64 Favored Glycine 0 C--O 1.207 -1.592 0 C-N-CA 116.086 -2.959 . . . . 25.0 113.791 165.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . . . -144.55 145.85 32.04 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 122.999 3.399 . . . . 25.0 104.839 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.44 105.79 30.54 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-O 117.067 -1.444 . . . . 50.0 114.104 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 42.5 Cg_endo -77.48 164.59 28.4 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 C-N-CA 115.809 -2.327 . . . . 25.0 115.436 172.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -74.22 112.76 10.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.666 -1.976 . . . . 25.0 105.666 167.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.66 -18.4 1.91 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 119.379 -2.076 . . . . 50.0 116.335 -165.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.63 16.65 33.32 Favored Glycine 0 N--CA 1.466 0.673 0 O-C-N 119.917 -1.739 . . . . 25.0 114.371 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -55.54 162.33 2.49 Favored Pre-proline 0 CA--C 1.568 1.661 0 O-C-N 125.664 1.45 . . . . 25.0 113.72 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -66.31 176.25 4.19 Favored 'Trans proline' 0 C--O 1.276 2.412 0 CA-C-O 123.452 1.355 . . . . 25.0 112.065 166.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.85 -12.44 0.31 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 119.585 3.18 . . . . 25.0 119.585 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 p -69.44 -0.57 6.68 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 120.131 -1.605 . . . . 25.0 111.737 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.27 4.85 7.93 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 117.587 2.439 . . . . 25.0 117.587 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -61.03 164.68 4.78 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.347 1.546 . . . . 25.0 114.157 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.8 30.61 0.11 Allowed 'General case' 0 N--CA 1.516 2.829 0 O-C-N 119.256 -2.153 . . . . 75.0 113.287 -171.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.4 t -113.8 149.72 34.53 Favored 'General case' 0 C--O 1.262 1.737 0 N-CA-C 103.232 -2.877 . . . . 25.0 103.232 170.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -146.27 142.56 28.45 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 123.87 0.868 . . . . 25.0 109.318 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -75.39 135.69 40.79 Favored 'General case' 0 C--O 1.172 -3.023 0 N-CA-C 105.592 -2.003 . . . . 25.0 105.592 162.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.9 129.82 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 104.776 -2.305 . . . . 25.0 104.776 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -90.49 135.08 33.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 112.672 -2.058 . . . . 50.0 112.036 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.04 108.74 41.89 Favored Pre-proline 0 C--N 1.307 -1.245 0 O-C-N 119.678 -1.889 . . . . 25.0 108.427 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.82 136.86 21.37 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 O-C-N 117.033 -2.141 . . . . 25.0 114.456 164.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -150.86 101.82 2.93 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.162 -0.961 . . . . 25.0 109.273 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -105.56 10.55 33.05 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 126.943 2.097 . . . . 50.0 108.632 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -132.87 -176.83 4.24 Favored 'General case' 0 C--O 1.21 -0.98 0 O-C-N 119.174 -2.204 . . . . 25.0 110.304 -173.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.44 148.99 51.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 103.443 -2.799 . . . . 50.0 103.443 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 145.62 174.42 17.79 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 121.206 3.243 . . . . 25.0 121.206 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -75.12 135.72 41.13 Favored 'General case' 0 C--O 1.279 2.614 0 N-CA-C 116.122 1.897 . . . . 50.0 116.122 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -139.82 172.78 12.28 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 103.631 -2.729 . . . . 25.0 103.631 174.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.0 t -123.18 148.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 103.455 -2.794 . . . . 50.0 103.455 166.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.5 mt -115.66 137.86 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 1 N-CA-C 98.647 -4.575 . . . . 25.0 98.647 172.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.54 129.48 55.37 Favored 'General case' 0 C--O 1.187 -2.193 0 CA-C-N 119.172 0.896 . . . . 50.0 113.024 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.18 135.0 45.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.521 -1.362 . . . . 25.0 111.502 -173.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 69.2 t -124.96 137.37 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.972 0 N-CA-C 103.033 -2.951 . . . . 50.0 103.033 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.44 ' CE3' ' HA ' ' A' ' 1' ' ' HIS . 2.7 t90 -140.03 112.57 7.89 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.092 -2.558 . . . . 25.0 104.092 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.5 140.56 32.57 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 100.533 -3.877 . . . . 25.0 100.533 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.51 157.16 34.97 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 CA-C-O 122.715 1.245 . . . . 50.0 107.807 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 -24.36 36.01 Favored 'General case' 0 C--O 1.199 -1.595 0 CA-C-N 115.042 -0.981 . . . . 25.0 108.86 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -67.16 -35.48 79.77 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 115.17 1.544 . . . . 25.0 115.17 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 t -135.29 159.05 42.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 115.066 -2.397 . . . . 25.0 107.899 -166.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.02 -27.03 41.26 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 120.873 1.669 . . . . 25.0 113.914 162.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 96.7 m-20 -73.04 163.16 28.57 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.531 -1.356 . . . . 25.0 110.861 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.81 -176.19 3.77 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 104.597 -2.372 . . . . 25.0 104.597 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.79 146.53 47.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.772 -0.825 . . . . 50.0 108.772 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -134.56 135.62 42.41 Favored 'General case' 0 C--O 1.172 -2.98 0 CA-C-O 115.377 -2.249 . . . . 50.0 106.535 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -144.93 172.08 13.55 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 121.371 1.896 . . . . 25.0 107.735 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 147.53 32.06 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 O-C-N 120.047 -1.658 . . . . 75.0 107.344 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.4 mm -130.15 122.42 53.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 103.429 -2.804 . . . . 25.0 103.429 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -87.11 123.76 32.52 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.217 -2.142 . . . . 25.0 105.217 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.13 155.14 38.03 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.656 -1.278 . . . . 50.0 112.765 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -116.31 130.45 56.78 Favored 'General case' 0 N--CA 1.436 -1.144 1 N-CA-C 96.279 -5.452 . . . . 25.0 96.279 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.2 mt -123.8 128.78 50.04 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 115.781 -2.057 . . . . 50.0 106.693 -171.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.17 159.0 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 O-C-N 127.101 2.75 . . . . 50.0 112.09 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -70.22 131.52 44.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 117.987 -2.945 . . . . 25.0 108.138 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.4 pttt . . . . . 0 C--O 1.28 2.685 0 N-CA-C 120.464 3.505 . . . . 25.0 120.464 -171.286 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.8 m80 . . . . . 0 N--CA 1.517 2.89 0 N-CA-C 112.667 0.617 . . . . 25.0 112.667 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.7 -146.99 4.46 Favored Glycine 0 C--O 1.253 1.294 0 CA-C-O 114.393 -3.448 . . . . 25.0 118.742 -162.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.3 168.95 23.19 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 122.285 3.043 . . . . 50.0 105.941 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.11 121.73 41.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.998 -2.593 . . . . 25.0 103.998 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -83.05 -36.45 24.92 Favored 'General case' 0 C--O 1.262 1.734 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -172.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -160.89 159.98 25.08 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-O 113.634 -3.079 . . . . 25.0 106.352 -175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -78.09 137.52 46.9 Favored 'Cis proline' 0 C--O 1.206 -1.112 0 O-C-N 124.721 1.906 . . . . 25.0 107.195 1.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.26 -171.98 44.74 Favored Glycine 0 CA--C 1.454 -3.725 0 CA-C-N 114.811 -1.086 . . . . 25.0 110.51 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.1 p -145.75 158.34 43.86 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 119.644 1.722 . . . . 25.0 107.003 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -82.47 -24.41 34.23 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 118.764 -1.174 . . . . 25.0 111.429 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.17 79.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.134 0.974 . . . . 25.0 111.648 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.15 -31.94 69.43 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 119.3 0.954 . . . . 25.0 113.477 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 C--O 1.192 -1.938 0 C-N-CA 124.261 1.025 . . . . 75.0 113.514 176.996 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.496 1.864 1 N-CA-C 122.437 4.236 . . . . 25.0 122.437 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -63.87 -41.55 97.74 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 114.43 1.27 . . . . 50.0 114.43 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -153.94 53.74 0.99 Allowed Pre-proline 0 C--O 1.274 2.394 0 O-C-N 120.119 -1.613 . . . . 25.0 110.539 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.01 -33.17 42.52 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 O-C-N 118.311 -1.468 . . . . 25.0 113.757 -165.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -1.33 4.17 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 117.319 2.34 . . . . 25.0 117.319 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -82.81 55.39 3.02 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.94 1.696 . . . . 25.0 113.601 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.72 135.26 33.72 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 123.24 1.495 . . . . 50.0 107.004 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.21 149.86 39.7 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 125.663 2.649 . . . . 25.0 105.424 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.11 12.48 Favored 'General case' 0 C--O 1.259 1.587 0 N-CA-C 102.329 -3.211 . . . . 25.0 102.329 164.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -100.15 168.59 9.72 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.616 2.08 . . . . 25.0 116.616 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mttt . . . . . 0 N--CA 1.402 -2.858 0 CA-C-O 123.372 1.558 . . . . 25.0 111.512 172.831 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 108.045 -1.094 . . . . 50.0 108.045 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -76.05 -21.47 56.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.215 -1.394 . . . . 50.0 107.645 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 -20.6 58.75 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 104.347 -3.501 . . . . 25.0 104.347 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.13 -20.87 71.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 111.471 -2.365 . . . . 25.0 112.122 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.71 -37.31 23.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 118.208 -1.397 . . . . 25.0 113.809 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.0 -34.67 75.66 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 119.751 -1.843 . . . . 75.0 111.687 172.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.54 -5.56 56.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.463 2.554 . . . . 50.0 110.065 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -81.97 75.43 8.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 113.716 -1.584 . . . . 25.0 111.01 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -128.2 44.28 2.98 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 127.295 2.238 . . . . 25.0 105.817 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.0 t -127.32 -166.56 1.62 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.3 -3.222 . . . . 25.0 102.3 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.79 -17.62 64.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 117.673 2.471 . . . . 25.0 117.673 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.47 24.3 7.52 Favored 'General case' 0 CA--C 1.595 2.686 0 CA-C-O 124.557 2.122 . . . . 25.0 109.978 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -87.31 102.25 14.33 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 126.742 3.163 . . . . 25.0 109.047 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -35.59 143.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.482 2 CA-C-N 102.415 -6.721 . . . . 25.0 112.146 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -70.92 152.84 43.23 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 115.323 1.601 . . . . 50.0 115.323 -173.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -95.35 152.73 18.13 Favored 'General case' 0 CA--C 1.587 2.38 0 O-C-N 121.353 -0.842 . . . . 25.0 109.85 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.12 148.61 49.83 Favored 'General case' 0 C--O 1.198 -1.658 0 CA-C-N 120.83 1.65 . . . . 25.0 109.156 169.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.7 mt -107.7 134.08 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 122.926 2.603 . . . . 25.0 111.952 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 85.1 mmm -144.22 169.97 16.87 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.203 -1.777 . . . . 25.0 106.203 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -90.98 172.09 8.82 Favored 'General case' 0 CA--C 1.446 -3.032 0 CA-C-O 116.056 -1.926 . . . . 25.0 111.606 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.98 173.46 9.66 Favored Glycine 0 CA--C 1.495 -1.176 0 O-C-N 124.94 1.4 . . . . 25.0 112.792 165.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.62 163.99 29.26 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 117.127 -2.463 . . . . 25.0 107.86 -171.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.38 155.18 28.51 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 120.291 -1.711 . . . . 25.0 109.168 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -145.5 160.67 41.27 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 103.049 -2.945 . . . . 25.0 103.049 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -125.9 130.71 51.84 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 -171.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.79 116.53 25.39 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 102.078 -3.305 . . . . 50.0 102.078 -165.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 133' ' ' SER . 60.9 m -115.63 131.97 56.77 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 102.867 -3.012 . . . . 25.0 102.867 -167.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -119.1 153.07 35.39 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.215 -2.513 . . . . 25.0 104.215 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 t -144.0 147.94 34.58 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -133.41 147.12 51.74 Favored 'General case' 0 C--O 1.266 1.954 0 O-C-N 127.743 3.152 . . . . 50.0 113.665 176.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.2 t -71.23 -20.82 62.2 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 116.341 1.978 . . . . 25.0 116.341 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.34 145.79 56.78 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 121.849 0.833 . . . . 25.0 112.722 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.87 160.51 49.44 Favored 'Trans proline' 0 CA--C 1.488 -1.789 1 C-N-CA 112.056 -4.83 . . . . 25.0 111.791 169.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -135.18 155.29 50.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 125.131 1.372 . . . . 25.0 109.922 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.96 155.29 40.8 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.239 -1.393 . . . . 25.0 107.239 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -140.53 150.97 44.37 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 117.498 -1.681 . . . . 25.0 110.445 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.6 p -112.58 -38.85 4.5 Favored 'General case' 0 CA--C 1.484 -1.569 0 O-C-N 120.68 -1.262 . . . . 25.0 109.385 164.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 35.3 tt0 -150.8 154.13 36.72 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 104.559 -2.386 . . . . 25.0 104.559 169.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -139.74 153.17 47.13 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 117.031 -1.867 . . . . 25.0 108.327 158.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -134.26 154.65 51.16 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 112.616 -2.084 . . . . 25.0 109.901 -157.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 147.0 50.03 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.381 -3.562 . . . . 50.0 101.381 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.75 158.86 43.44 Favored 'General case' 0 C--O 1.184 -2.35 0 CA-C-N 114.001 -1.454 . . . . 50.0 109.056 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 pt -135.91 149.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 106.124 -1.806 . . . . 25.0 106.124 168.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -76.05 137.19 40.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 164.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -86.17 98.15 10.74 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 126.423 1.889 . . . . 25.0 110.452 -164.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -59.65 150.23 28.15 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 119.773 1.17 . . . . 25.0 113.41 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.77 67.1 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 108.906 -1.677 . . . . 25.0 108.906 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -55.77 166.83 0.64 Allowed 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 125.937 1.695 . . . . 25.0 113.71 172.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.01 123.45 6.12 Favored Pre-proline 0 C--O 1.186 -2.26 0 N-CA-C 102.969 -2.974 . . . . 25.0 102.969 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.14 -15.55 39.5 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.383 1.388 . . . . 25.0 114.846 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.56 -6.59 51.04 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 117.526 -3.234 . . . . 75.0 115.458 173.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.09 166.66 15.21 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 101.409 -3.552 . . . . 25.0 101.409 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -43.56 7.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.698 1 C-N-CA 134.179 9.919 . . . . 25.0 120.308 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.28 -26.36 7.22 Favored 'General case' 0 CA--C 1.598 2.794 0 O-C-N 119.599 -1.938 . . . . 50.0 115.667 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -75.96 -2.5 30.73 Favored 'General case' 0 CA--C 1.482 -1.639 1 O-C-N 115.82 -4.3 . . . . 25.0 113.481 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -126.76 -44.61 1.65 Allowed 'General case' 0 CA--C 1.457 -2.61 0 N-CA-C 114.208 1.188 . . . . 25.0 114.208 171.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.38 32.03 0.34 Allowed 'General case' 0 C--O 1.193 -1.872 0 O-C-N 127.938 3.274 . . . . 25.0 112.051 172.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.11 -32.92 73.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 123.708 1.718 . . . . 25.0 113.107 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -103.94 156.54 17.76 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.385 -2.82 . . . . 50.0 103.385 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.95 139.05 50.14 Favored 'General case' 0 C--O 1.27 2.157 0 N-CA-C 102.911 -2.996 . . . . 25.0 102.911 151.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.99 111.84 5.97 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 125.169 1.388 . . . . 50.0 107.517 154.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.42 -16.01 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 O-C-N 125.982 2.051 . . . . 25.0 110.266 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.01 174.41 44.3 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 122.074 2.216 . . . . 25.0 110.383 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -160.45 147.49 15.82 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 114.487 1.292 . . . . 25.0 114.487 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.63 110.28 18.99 Favored Pre-proline 0 CA--C 1.593 2.623 0 C-N-CA 126.209 1.804 . . . . 50.0 108.964 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 89.0 Cg_endo -88.07 161.6 7.25 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 N-CA-C 116.563 1.717 . . . . 25.0 116.563 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -78.26 115.42 17.97 Favored 'General case' 0 CA--C 1.469 -2.137 1 N-CA-C 99.907 -4.108 . . . . 25.0 99.907 171.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -102.3 -14.61 16.89 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.355 -0.839 . . . . 50.0 111.512 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.45 -23.0 2.7 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 105.273 -3.131 . . . . 25.0 105.273 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -78.88 148.02 71.48 Favored Pre-proline 0 C--O 1.266 1.937 0 N-CA-C 104.646 -2.353 . . . . 25.0 104.646 155.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -58.67 147.26 88.49 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 106.476 -2.163 . . . . 25.0 106.476 174.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.34 -19.26 46.89 Favored 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 64.4 p -83.35 6.19 20.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 125.778 1.924 . . . . 25.0 110.491 -176.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -55.06 -43.98 74.33 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 120.047 1.294 . . . . 25.0 113.871 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -110.3 98.43 7.67 Favored 'General case' 0 C--O 1.256 1.445 0 CA-C-O 116.676 -1.63 . . . . 25.0 108.694 166.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.7 tp -85.66 -11.37 53.99 Favored 'General case' 0 C--O 1.288 3.082 0 O-C-N 125.779 1.925 . . . . 75.0 110.626 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 83' ' ' THR . 29.3 t -103.92 138.25 40.76 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -143.06 148.24 36.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.138 1.336 . . . . 25.0 111.715 -164.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -103.6 150.13 24.25 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 125.87 1.981 . . . . 25.0 109.82 -170.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -141.1 127.48 20.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.261 -1.755 . . . . 25.0 106.261 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -84.86 126.93 33.89 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 119.215 0.916 . . . . 50.0 109.009 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -101.38 121.46 51.56 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 106.639 -1.615 . . . . 25.0 106.639 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -67.09 150.57 82.34 Favored 'Trans proline' 0 N--CA 1.481 0.793 1 C-N-CA 113.201 -4.066 . . . . 25.0 116.444 170.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.27 31.37 1.14 Allowed 'General case' 0 CA--C 1.573 1.861 0 CA-C-N 115.512 -0.767 . . . . 25.0 111.816 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.43 -44.77 70.66 Favored 'General case' 1 N--CA 1.545 4.277 0 O-C-N 120.883 -1.136 . . . . 50.0 114.021 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -152.14 166.92 30.16 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.816 0.672 . . . . 25.0 112.816 -170.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mp -83.83 149.22 26.54 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.785 -1.191 . . . . 50.0 107.785 167.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.05 -178.43 19.83 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-O 121.999 0.777 . . . . 25.0 114.962 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -120.42 159.35 25.28 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 117.485 2.402 . . . . 50.0 117.485 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -160.62 163.41 32.62 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 165.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.55 137.97 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.562 0 C-N-CA 124.299 1.04 . . . . 50.0 112.918 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.64 129.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 C-N-CA 125.085 1.354 . . . . 25.0 109.734 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.79 151.91 35.5 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 126.06 2.1 . . . . 50.0 113.881 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.05 51.37 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 104.463 -2.421 . . . . 25.0 104.463 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 162' ' ' TYR . 58.4 t -135.4 131.34 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 126.345 2.278 . . . . 50.0 107.259 -174.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -124.06 128.05 48.76 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 122.619 1.199 . . . . 25.0 108.592 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.73 144.65 34.55 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 123.502 1.62 . . . . 25.0 110.363 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.88 125.36 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 127.449 2.3 . . . . 50.0 111.744 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.49 62.67 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 103.239 -2.874 . . . . 25.0 103.239 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.3 -12.59 60.58 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 117.621 2.452 . . . . 25.0 117.621 -173.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.0 p -133.26 148.38 51.97 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 120.395 -1.441 . . . . 25.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -81.94 -25.21 35.07 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.9 0.88 . . . . 25.0 109.749 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.77 153.25 26.59 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 121.224 -0.922 . . . . 25.0 109.991 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.6 147.66 51.42 Favored 'General case' 0 C--O 1.175 -2.855 0 N-CA-C 105.465 -2.05 . . . . 25.0 105.465 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -120.73 137.29 54.57 Favored 'General case' 0 CA--C 1.479 -1.779 0 C-N-CA 117.996 -1.482 . . . . 50.0 112.21 -158.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.417 ' CD2' HG22 ' A' ' 151' ' ' VAL . 7.8 m-85 -128.96 148.11 50.91 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.691 1.997 . . . . 50.0 114.92 -168.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -139.11 135.93 34.63 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 105.85 -1.907 . . . . 25.0 105.85 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.6 130.97 17.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.463 0 N-CA-C 114.578 1.325 . . . . 75.0 114.578 -169.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.47 123.76 55.91 Favored 'Isoleucine or valine' 0 C--O 1.273 2.32 0 O-C-N 124.728 1.267 . . . . 25.0 111.669 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.5 124.04 26.48 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.95 139.63 49.16 Favored 'Isoleucine or valine' 0 C--O 1.271 2.22 0 CA-C-O 125.311 2.481 . . . . 50.0 109.344 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -117.3 121.34 40.87 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 44.7 mt -131.27 120.42 23.17 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.803 -1.184 . . . . 50.0 107.803 -158.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.4 m -125.68 171.23 14.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 117.618 2.451 . . . . 50.0 117.618 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -74.11 159.59 32.39 Favored 'General case' 0 C--O 1.258 1.522 0 O-C-N 120.772 -1.205 . . . . 25.0 109.574 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.4 mttt . . . . . 0 C--O 1.259 1.568 0 O-C-N 126.821 2.576 . . . . 25.0 109.433 -177.545 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 . . . . . 0 C--O 1.267 1.997 0 CA-C-O 122.49 1.138 . . . . 25.0 111.638 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.76 -174.08 20.18 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-O 114.301 -3.499 . . . . 25.0 118.158 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.39 143.78 47.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 121.674 2.737 . . . . 50.0 107.141 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.5 mt -73.32 140.23 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 102.756 -3.053 . . . . 25.0 102.756 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -135.16 48.21 2.28 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 126.248 2.928 . . . . 25.0 113.834 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 mttt 75.65 163.19 0.14 Allowed Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 109.913 -3.312 . . . . 25.0 113.062 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.58 131.65 22.09 Favored 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 134.665 3.194 . . . . 25.0 108.693 7.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.54 154.5 17.87 Favored Glycine 0 C--O 1.282 3.133 0 N-CA-C 110.716 -0.953 . . . . 25.0 110.716 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 t -152.71 132.7 13.37 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.879 0.987 . . . . 25.0 111.449 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -85.83 -19.79 30.11 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.84 81.6 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 117.774 -1.57 . . . . 25.0 113.228 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.67 59.68 Favored 'General case' 0 C--O 1.269 2.117 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 115.867 1.803 . . . . 75.0 115.867 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.51 2.535 1 N-CA-C 124.284 4.92 . . . . 25.0 124.284 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -71.13 -46.87 60.77 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 116.301 -3.999 . . . . 50.0 114.547 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB2' HE22 ' A' ' 33' ' ' GLN . 7.1 pt-20 -145.69 60.57 6.74 Favored Pre-proline 0 C--O 1.2 -1.505 0 CA-C-O 124.646 2.165 . . . . 25.0 112.834 169.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.13 -10.89 28.22 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 117.279 -1.348 . . . . 25.0 113.647 -166.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.496 HE22 ' HB2' ' A' ' 31' ' ' GLU . 2.8 pm0 -78.8 -15.13 58.79 Favored 'General case' 0 C--O 1.189 -2.08 0 C-N-CA 126.925 2.09 . . . . 25.0 111.641 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -122.55 141.87 51.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 113.43 0.9 . . . . 25.0 113.43 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.2 109.13 20.82 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 124.667 2.175 . . . . 50.0 105.234 156.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.86 151.14 25.29 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.402 -2.074 . . . . 25.0 105.402 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.91 170.62 15.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 123.526 1.631 . . . . 25.0 107.956 169.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -136.76 147.29 46.59 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 119.24 -2.163 . . . . 25.0 108.222 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 CA--C 1.565 1.524 0 N-CA-C 104.654 -2.35 . . . . 25.0 104.654 179.679 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 CA--C 1.569 1.686 0 CA-C-O 126.284 2.945 . . . . 50.0 112.8 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -74.98 -33.53 61.89 Favored 'General case' 0 C--O 1.265 1.877 0 CA-C-O 126.471 3.034 . . . . 50.0 105.456 154.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.5 -17.28 78.96 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-O 124.762 2.312 . . . . 25.0 110.191 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.88 -22.45 75.66 Favored Glycine 0 C--O 1.208 -1.512 0 CA-C-O 124.041 1.912 . . . . 25.0 112.66 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.16 -41.35 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 118.677 -2.661 . . . . 25.0 109.398 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.7 mt -72.21 -26.48 62.06 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 119.971 3.323 . . . . 75.0 119.971 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -66.5 -28.05 68.26 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.61 -1.255 . . . . 50.0 107.61 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -78.77 6.97 7.76 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 123.819 0.699 . . . . 25.0 111.31 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -126.15 39.64 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 104.306 -2.479 . . . . 25.0 104.306 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -154.98 169.44 24.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.264 -1.523 . . . . 25.0 107.544 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.73 -14.63 63.15 Favored 'General case' 0 C--O 1.182 -2.471 0 CA-C-O 124.745 2.212 . . . . 25.0 109.245 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -86.06 20.18 2.38 Favored 'General case' 0 N--CA 1.422 -1.852 0 O-C-N 119.03 -2.294 . . . . 25.0 112.319 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.92 96.91 2.18 Favored 'General case' 0 C--O 1.263 1.802 0 CA-C-O 124.803 2.24 . . . . 25.0 105.589 163.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -44.71 146.0 0.83 Allowed 'General case' 0 C--O 1.275 2.395 1 CA-C-N 106.598 -4.819 . . . . 25.0 109.74 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -79.78 132.34 36.13 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 119.681 -1.887 . . . . 50.0 112.037 -157.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.05 155.83 16.9 Favored 'General case' 0 C--N 1.365 1.256 0 CA-C-N 112.333 -2.212 . . . . 25.0 112.17 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -152.44 141.25 21.03 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.032 -1.467 . . . . 25.0 113.841 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.28 129.9 39.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.78 0 C-N-CA 117.045 -1.862 . . . . 25.0 106.611 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' A' ' 169' ' ' LEU . 26.4 ttt -139.92 157.77 45.15 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 121.177 1.808 . . . . 25.0 107.452 164.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 p -68.02 162.74 23.83 Favored 'General case' 0 CA--C 1.584 2.275 0 O-C-N 117.911 -2.993 . . . . 25.0 109.214 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.95 -156.27 3.38 Favored Glycine 0 C--O 1.209 -1.463 1 O-C-N 115.928 -4.232 . . . . 25.0 113.485 164.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 -173.38 38.02 Favored Glycine 0 C--O 1.192 -2.495 0 O-C-N 121.322 -1.105 . . . . 25.0 111.5 -165.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.62 133.15 51.66 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 120.491 2.145 . . . . 25.0 114.089 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -120.16 133.2 55.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.767 -1.568 . . . . 25.0 106.767 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.1 m -115.54 89.62 3.14 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 120.695 1.589 . . . . 25.0 111.573 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -74.4 117.7 16.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.618 0.767 . . . . 50.0 109.981 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -123.99 145.02 49.47 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.372 -2.084 . . . . 25.0 105.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -127.8 159.24 35.44 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 102.225 -3.25 . . . . 25.0 102.225 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.3 p -134.91 163.1 30.6 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 127.704 3.128 . . . . 25.0 108.245 166.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.36 137.9 52.89 Favored 'General case' 0 N--CA 1.496 1.863 1 N-CA-C 96.768 -5.271 . . . . 50.0 96.768 164.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.4 t -74.51 -20.68 59.89 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 116.031 -2.268 . . . . 25.0 105.713 -165.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.16 157.58 77.68 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 103.038 -2.949 . . . . 25.0 103.038 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.29 143.16 27.86 Favored 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 109.95 -6.233 . . . . 25.0 112.018 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -118.03 152.65 35.11 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.833 -2.284 . . . . 25.0 104.833 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.57 160.54 32.51 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.67 147.05 24.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 127.867 2.467 . . . . 25.0 113.389 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -108.64 -27.94 9.55 Favored 'General case' 0 C--O 1.26 1.617 0 N-CA-C 114.535 1.309 . . . . 25.0 114.535 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -174.43 173.74 2.9 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.054 -2.573 . . . . 25.0 104.054 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -153.24 169.43 23.06 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.982 -0.747 . . . . 25.0 108.982 163.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -145.01 151.79 39.12 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 114.434 -2.698 . . . . 25.0 106.764 -169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.88 147.18 21.22 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 124.737 2.208 . . . . 50.0 112.982 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -132.08 165.09 24.81 Favored 'General case' 1 C--O 1.306 4.059 0 CA-C-N 114.324 -1.307 . . . . 50.0 107.661 -162.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.4 pt -125.94 157.0 36.11 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.676 0 N-CA-C 101.311 -3.589 . . . . 25.0 101.311 161.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 115' ' ' PHE . 34.9 p -76.3 150.15 36.98 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.346 -1.724 . . . . 25.0 106.346 169.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -143.49 76.85 1.54 Allowed 'General case' 0 N--CA 1.423 -1.791 0 O-C-N 120.641 -1.287 . . . . 25.0 108.221 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -56.44 153.45 9.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.11 -1.859 . . . . 25.0 112.851 167.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.73 37.77 22.08 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 116.79 -2.116 . . . . 25.0 109.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -64.5 157.22 27.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 126.598 1.999 . . . . 25.0 110.949 163.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -59.22 133.81 87.92 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 108.221 -1.029 . . . . 25.0 108.221 158.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.33 -36.14 98.9 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 N-CA-C 117.456 2.06 . . . . 25.0 117.456 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.66 -19.8 62.72 Favored 'General case' 0 C--O 1.267 1.994 0 N-CA-C 116.889 2.181 . . . . 75.0 116.889 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -58.16 159.08 11.88 Favored Pre-proline 0 C--O 1.205 -1.27 0 CA-C-N 113.13 -1.85 . . . . 25.0 110.231 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.45 23.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.193 -1.774 2 C-N-CA 127.128 5.219 . . . . 25.0 125.08 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 tp 14.79 -56.87 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.244 1 N-CA-C 125.56 5.393 . . . . 50.0 125.56 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -69.24 -31.54 70.17 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -96.72 -46.5 6.26 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.624 -1.626 . . . . 25.0 110.517 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.79 -3.78 1.75 Allowed 'General case' 0 C--O 1.206 -1.19 0 C-N-CA 118.82 -1.152 . . . . 25.0 113.058 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.7 -26.35 68.34 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 115.471 1.656 . . . . 25.0 115.471 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 29.8 p90 -127.51 153.23 46.59 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.207 -2.146 . . . . 50.0 105.207 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -126.68 130.61 50.74 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 111.877 -2.419 . . . . 25.0 111.258 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.18 111.44 3.43 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 105.508 -2.034 . . . . 50.0 105.508 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.73 -20.24 7.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.444 -1.317 . . . . 25.0 107.444 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.7 166.55 33.39 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.748 -1.22 . . . . 25.0 113.555 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.92 155.36 41.5 Favored 'General case' 0 C--O 1.181 -2.516 0 N-CA-C 104.124 -2.547 . . . . 25.0 104.124 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.3 107.12 17.6 Favored Pre-proline 0 C--O 1.271 2.213 0 N-CA-C 106.828 -1.545 . . . . 50.0 106.828 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.33 162.05 28.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 N-CA-C 107.553 -1.749 . . . . 25.0 107.553 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -139.66 63.01 1.5 Allowed 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 119.544 -0.862 . . . . 25.0 110.542 -170.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.15 -16.9 0.83 Allowed 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.533 1.679 . . . . 50.0 115.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -164.75 21.58 0.14 Allowed Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 125.412 1.482 . . . . 25.0 116.681 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.63 162.06 73.35 Favored Pre-proline 0 CA--C 1.556 1.201 0 O-C-N 124.88 0.988 . . . . 25.0 113.437 -174.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.29 -170.01 0.53 Allowed 'Trans proline' 0 C--O 1.264 1.808 0 CA-C-O 117.822 -0.991 . . . . 25.0 113.987 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.42 4.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 1 N-CA-C 122.027 4.084 . . . . 25.0 122.027 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 p -57.66 -17.6 15.73 Favored 'General case' 0 C--O 1.187 -2.224 0 CA-C-N 115.921 -0.582 . . . . 25.0 110.284 161.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -63.9 -16.71 62.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.183 0.809 . . . . 25.0 113.183 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -60.72 129.83 43.46 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 117.821 -1.085 . . . . 25.0 109.471 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.49 -5.01 17.06 Favored 'General case' 0 C--O 1.283 2.86 0 N-CA-C 120.357 3.465 . . . . 75.0 120.357 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.4 t -86.51 127.18 34.85 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 126.039 1.736 . . . . 25.0 109.141 160.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -134.67 130.13 35.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 118.921 2.934 . . . . 25.0 118.921 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -92.07 129.22 38.07 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.174 -1.375 . . . . 25.0 113.573 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.5 mt -121.09 124.03 71.29 Favored 'Isoleucine or valine' 0 C--O 1.271 2.194 0 N-CA-C 105.605 -1.998 . . . . 25.0 105.605 169.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -75.84 137.09 40.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.003 -2.221 . . . . 50.0 105.003 165.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -115.28 129.78 24.81 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 101.763 -3.421 . . . . 25.0 101.763 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.74 140.63 68.58 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 116.372 -1.952 . . . . 25.0 109.415 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -108.66 2.92 22.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.31 -23.71 32.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.517 2.043 . . . . 50.0 116.517 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -143.49 155.1 44.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 114.768 -2.539 . . . . 25.0 107.512 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.5 pt? -75.22 164.56 26.34 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 125.808 1.943 . . . . 50.0 109.605 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 175.81 135.28 2.09 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 108.12 -1.992 . . . . 25.0 108.12 170.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -115.3 148.53 39.1 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 124.973 1.309 . . . . 50.0 111.396 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -161.04 161.88 31.52 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 116.569 -1.681 . . . . 25.0 107.471 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.9 t -91.01 158.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 101.664 -3.458 . . . . 50.0 101.664 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.77 135.78 49.97 Favored 'Isoleucine or valine' 0 C--O 1.28 2.671 1 N-CA-C 98.048 -4.797 . . . . 25.0 98.048 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.26 148.2 48.77 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 103.749 -2.685 . . . . 50.0 103.749 168.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.09 153.0 41.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.588 -0.695 . . . . 25.0 110.718 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.9 140.64 46.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.625 0 C-N-CA 123.067 0.547 . . . . 50.0 111.304 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.19 133.76 45.83 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.788 1.235 . . . . 25.0 112.574 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.96 133.29 55.6 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.338 1.055 . . . . 25.0 112.663 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.9 t -131.64 111.87 19.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 102.119 -3.289 . . . . 50.0 102.119 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.62 -24.86 53.37 Favored 'General case' 0 C--O 1.17 -3.091 0 CA-C-O 117.753 -1.118 . . . . 25.0 108.288 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.98 -19.27 65.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 124.477 2.084 . . . . 25.0 115.858 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.7 p -118.82 150.83 39.16 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.151 -1.84 . . . . 25.0 114.202 -173.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -78.55 -25.55 45.47 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.344 -1.753 . . . . 25.0 109.974 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -63.33 152.22 38.55 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 118.611 -1.236 . . . . 25.0 114.133 163.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.88 158.34 44.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 105.588 -2.005 . . . . 25.0 105.588 174.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -131.36 146.06 52.11 Favored 'General case' 0 C--O 1.29 3.206 0 O-C-N 118.618 -2.551 . . . . 50.0 114.78 -170.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.01 170.54 15.83 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 102.466 -3.161 . . . . 50.0 102.466 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -164.34 167.36 19.86 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.2 p -145.32 134.99 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.935 -1.135 . . . . 75.0 107.935 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -141.85 146.26 23.14 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 101.972 -3.344 . . . . 25.0 101.972 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -122.17 152.18 40.21 Favored 'General case' 0 C--O 1.264 1.827 0 CA-C-N 121.072 1.76 . . . . 25.0 108.002 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.66 153.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.76 0 N-CA-C 110.185 -0.302 . . . . 50.0 110.185 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -131.79 94.52 3.52 Favored 'General case' 0 C--O 1.264 1.857 0 N-CA-C 101.401 -3.555 . . . . 25.0 101.401 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 75' ' ' MET . 53.3 mt -102.49 111.77 24.22 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.34 -1.475 . . . . 50.0 114.446 -170.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 33.5 m -128.11 173.71 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.964 2.579 . . . . 50.0 117.964 -153.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.37 147.13 23.65 Favored 'General case' 0 CA--C 1.494 -1.203 1 N-CA-C 99.541 -4.244 . . . . 25.0 99.541 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 C--O 1.269 2.088 0 N-CA-C 116.036 1.865 . . . . 25.0 116.036 169.206 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 3.0 p80 . . . . . 0 N--CA 1.534 3.748 0 CA-C-O 123.846 1.784 . . . . 25.0 113.33 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 33' ' ' GLN . . . -144.21 -32.44 0.09 OUTLIER Glycine 0 C--O 1.27 2.384 0 C-N-CA 127.632 2.539 . . . . 25.0 111.052 169.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.08 140.13 53.34 Favored 'General case' 0 CA--C 1.482 -1.643 0 C-N-CA 125.637 1.575 . . . . 50.0 109.8 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.5 mt -103.76 122.04 55.96 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 N-CA-C 100.703 -3.814 . . . . 25.0 100.703 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -92.63 -40.56 10.68 Favored 'General case' 0 C--O 1.182 -2.486 0 CA-C-N 119.14 0.882 . . . . 25.0 112.66 -173.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -144.82 154.41 55.35 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 115.887 -2.006 . . . . 25.0 106.634 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.65 136.45 45.14 Favored 'Cis proline' 0 N--CA 1.476 0.478 0 CA-C-N 121.909 1.718 . . . . 25.0 109.059 0.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.74 -162.44 38.29 Favored Glycine 0 C--O 1.214 -1.113 0 N-CA-C 120.082 2.793 . . . . 25.0 120.082 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -114.51 116.0 28.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.487 1.644 . . . . 25.0 111.282 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -73.11 -23.24 60.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.123 0.874 . . . . 25.0 109.588 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.47 72.63 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.234 1.814 . . . . 25.0 106.297 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.38 -37.95 68.22 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 124.216 0.947 . . . . 25.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 CA--C 1.544 0.741 0 O-C-N 123.803 0.689 . . . . 75.0 110.638 -179.763 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 C--O 1.2 -1.547 0 N-CA-C 114.601 1.334 . . . . 25.0 114.601 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -88.15 -37.83 15.85 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.291 -1.364 . . . . 50.0 111.319 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.51 48.02 0.25 Allowed Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 115.978 1.844 . . . . 25.0 115.978 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.16 -19.49 34.14 Favored 'Trans proline' 0 CA--C 1.569 2.261 1 C-N-CA 110.915 -5.59 . . . . 25.0 116.621 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.459 ' HB3' ' HA2' ' A' ' 2' ' ' GLY 0.266 12.2 pt20 -109.15 -20.88 12.83 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.846 1.203 . . . . 25.0 113.911 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.1 p -96.58 22.45 8.02 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.297 1.046 . . . . 25.0 113.755 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.97 44.47 0.03 OUTLIER 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.669 1.988 . . . . 50.0 115.485 -172.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 161' ' ' PHE . 47.0 mt-10 -71.77 156.63 39.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 120.766 3.617 . . . . 25.0 120.766 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.72 58.3 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 117.651 -1.166 . . . . 25.0 113.976 170.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 31.7 tttm -151.71 -164.23 1.93 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.831 3.014 . . . . 25.0 109.435 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.544 ' H ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 mttt . . . . . 0 C--O 1.235 0.291 0 CA-C-N 113.508 -1.678 . . . . 25.0 109.862 -170.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 CA--C 1.565 1.523 0 CA-C-O 123.163 1.459 . . . . 50.0 113.303 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 -35.79 32.92 Favored 'General case' 0 CA--C 1.586 2.337 0 N-CA-C 101.343 -3.577 . . . . 50.0 101.343 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.56 63.74 Favored Glycine 0 C--O 1.268 2.245 0 CA-C-N 114.014 -1.448 . . . . 25.0 113.07 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.66 77.56 Favored Glycine 0 C--O 1.201 -1.914 0 CA-C-N 119.058 1.429 . . . . 25.0 110.938 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -65.55 -43.57 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 106.885 -1.524 . . . . 25.0 106.885 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.12 -24.21 59.41 Favored 'General case' 0 C--O 1.172 -3.014 0 N-CA-C 107.686 -1.227 . . . . 75.0 107.686 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.69 -21.39 60.26 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 123.777 1.751 . . . . 50.0 111.171 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -103.95 16.35 26.5 Favored 'General case' 0 C--O 1.183 -2.441 0 O-C-N 118.213 -2.804 . . . . 25.0 108.37 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -128.95 49.73 2.2 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 102.303 -3.221 . . . . 25.0 102.303 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -152.5 -179.67 7.79 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 100.525 -3.88 . . . . 25.0 100.525 -162.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -66.8 -17.61 64.96 Favored 'General case' 0 CA--C 1.592 2.587 0 C-N-CA 117.651 -1.62 . . . . 25.0 114.413 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -94.68 48.77 1.22 Allowed 'General case' 0 CA--C 1.556 1.21 0 O-C-N 120.203 -1.561 . . . . 25.0 108.317 165.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -85.32 98.98 10.84 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 100.191 -4.003 . . . . 25.0 100.191 156.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -65.6 163.06 16.98 Favored 'General case' 0 C--O 1.256 1.43 1 CA-C-N 106.583 -4.826 . . . . 25.0 110.703 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -59.52 146.29 41.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 120.016 1.28 . . . . 50.0 112.366 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -129.33 154.4 46.92 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -139.77 150.72 45.09 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 118.282 -0.866 . . . . 25.0 112.038 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.98 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.127 0 CA-C-O 123.789 1.757 . . . . 25.0 110.561 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 30.6 mtm -147.0 172.0 14.39 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 120.147 -1.596 . . . . 25.0 113.493 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.1 p -71.53 165.21 24.35 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 105.071 -2.196 . . . . 25.0 105.071 168.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.06 176.62 53.11 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 106.378 -2.689 . . . . 25.0 106.378 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.94 -170.15 20.17 Favored Glycine 0 C--O 1.266 2.113 0 CA-C-N 120.342 2.071 . . . . 25.0 113.815 -170.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -74.68 137.39 42.11 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 112.922 -1.639 . . . . 25.0 109.852 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -127.62 159.1 35.69 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.719 1.208 . . . . 25.0 111.158 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.3 m -117.89 142.04 47.77 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 106.31 -1.737 . . . . 25.0 106.31 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -125.96 114.72 18.86 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 102.687 -3.079 . . . . 50.0 102.687 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 m -129.87 117.68 20.54 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.706 -1.588 . . . . 25.0 112.524 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . 0.308 0.8 OUTLIER -111.51 136.61 50.45 Favored 'General case' 0 C--O 1.3 3.717 0 N-CA-C 101.353 -3.573 . . . . 25.0 101.353 171.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -148.88 160.29 43.39 Favored 'General case' 0 C--O 1.181 -2.54 0 O-C-N 125.59 1.806 . . . . 25.0 108.887 -167.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.04 170.32 16.2 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.852 -1.067 . . . . 50.0 109.288 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.9 t -64.76 -25.42 67.92 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.907 -1.044 . . . . 25.0 111.45 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.34 153.23 74.54 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 125.096 1.497 . . . . 25.0 111.129 -171.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.99 169.39 20.61 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 117.331 -1.313 . . . . 25.0 112.53 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.258 3.2 m80 -127.09 161.51 28.26 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 103.81 -2.663 . . . . 25.0 103.81 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -81.86 57.93 3.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.091 0.956 . . . . 25.0 109.642 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 154' ' ' VAL . 4.5 m -66.98 144.5 56.17 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 127.022 2.702 . . . . 25.0 108.878 -178.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -117.37 -32.05 5.07 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 126.478 2.361 . . . . 25.0 109.822 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 50.3 tt0 -165.59 154.68 12.02 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 124.755 1.222 . . . . 25.0 109.471 -170.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -141.74 164.56 29.88 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 145.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.33 36.4 m-70 -131.9 145.06 51.3 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 126.588 1.955 . . . . 25.0 107.776 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -139.54 148.34 42.46 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-O 122.713 1.244 . . . . 50.0 111.286 170.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.46 162.05 30.05 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 109.679 -3.418 . . . . 50.0 111.042 -164.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.2 151.05 33.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 102.25 -3.241 . . . . 25.0 102.25 176.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 114' ' ' ASP . 71.6 m -82.32 113.88 20.41 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 125.883 1.989 . . . . 25.0 109.893 157.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -83.38 94.33 7.94 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-N 120.209 1.368 . . . . 25.0 109.57 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -61.76 161.19 10.51 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 124.671 1.188 . . . . 25.0 111.923 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.42 28.15 Favored Glycine 0 CA--C 1.497 -1.048 0 C-N-CA 119.0 -1.571 . . . . 25.0 116.504 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.21 159.89 32.18 Favored 'General case' 0 CA--C 1.581 2.145 0 C-N-CA 119.592 -0.843 . . . . 25.0 111.426 -171.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -71.31 117.1 53.74 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 102.377 -3.194 . . . . 25.0 102.377 149.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.81 -22.22 37.05 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 125.282 3.988 . . . . 25.0 117.525 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -75.08 -13.84 60.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.387 -1.446 . . . . 75.0 109.934 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.253 95.9 mttt -117.11 165.3 15.84 Favored Pre-proline 0 C--O 1.2 -1.504 2 N-CA-C 99.202 -4.37 . . . . 25.0 99.202 -171.75 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 3.38 14.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 2 C-N-CA 135.44 10.76 . . . . 25.0 127.967 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.1 tt -46.66 -43.53 17.69 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-O 115.616 -2.135 . . . . 50.0 113.768 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -75.39 -2.58 29.19 Favored 'General case' 0 C--O 1.169 -3.163 0 O-C-N 125.195 1.56 . . . . 25.0 113.207 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -121.94 -51.85 2.0 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 122.799 1.285 . . . . 25.0 112.155 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.55 -26.53 3.57 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 112.653 -2.067 . . . . 25.0 115.095 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.47 ' HA ' HG23 ' A' ' 100' ' ' THR . 20.2 t0 -80.35 -7.78 59.22 Favored 'General case' 0 C--O 1.28 2.676 0 CA-C-N 113.489 -1.687 . . . . 25.0 111.04 -176.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -141.64 47.56 1.66 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 118.236 -2.79 . . . . 50.0 106.631 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.8 122.45 29.15 Favored 'General case' 0 CA--C 1.558 1.286 0 O-C-N 118.143 -2.848 . . . . 25.0 111.5 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.6 tp -60.72 125.96 25.64 Favored 'General case' 0 C--O 1.266 1.94 0 N-CA-C 114.174 1.176 . . . . 50.0 114.174 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.7 tt -108.21 -22.4 5.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 116.799 -1.572 . . . . 25.0 106.999 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.12 -179.43 44.74 Favored Glycine 0 C--N 1.371 2.488 0 C-N-CA 118.746 -1.692 . . . . 25.0 116.193 161.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -146.59 153.99 40.98 Favored 'General case' 0 C--O 1.286 3.023 0 CA-C-O 123.279 1.514 . . . . 25.0 107.333 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.2 t -132.46 86.49 45.14 Favored Pre-proline 0 CA--C 1.62 3.648 0 N-CA-C 103.608 -2.738 . . . . 50.0 103.608 -173.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 71.9 Cg_endo -71.18 154.33 61.98 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 115.234 -2.711 . . . . 25.0 112.259 171.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -144.59 96.44 2.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.37 1.618 . . . . 25.0 115.37 -157.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.34 -7.25 16.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.57 -1.65 . . . . 50.0 114.722 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.41 -171.1 42.1 Favored Glycine 0 C--O 1.283 3.194 1 N-CA-C 101.969 -4.452 . . . . 25.0 101.969 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.4 m -126.42 75.11 73.89 Favored Pre-proline 0 N--CA 1.508 2.439 0 N-CA-C 115.193 1.553 . . . . 25.0 115.193 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.3 170.19 17.81 Favored 'Trans proline' 0 C--O 1.213 -0.759 1 C-N-CA 111.984 -4.877 . . . . 25.0 106.208 150.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.76 67.02 Favored 'General case' 0 CA--C 1.573 1.842 0 O-C-N 119.373 -2.079 . . . . 25.0 115.567 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 95.5 p -68.02 -22.89 64.96 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 120.93 1.696 . . . . 25.0 114.407 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -111.97 19.59 17.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 127.039 2.712 . . . . 25.0 111.974 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -55.59 148.82 15.06 Favored 'General case' 0 N--CA 1.513 2.681 0 CA-C-O 122.82 1.295 . . . . 25.0 108.404 168.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tp -64.65 -36.4 84.14 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 111.483 -2.599 . . . . 75.0 110.795 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.7 t -91.81 153.76 19.36 Favored 'General case' 0 C--O 1.285 2.946 0 N-CA-C 104.12 -2.548 . . . . 25.0 104.12 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -147.41 164.63 32.72 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 112.82 0.674 . . . . 25.0 112.82 170.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -113.59 148.9 35.34 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 104.471 -2.418 . . . . 25.0 104.471 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -133.03 124.5 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 105.645 -1.983 . . . . 25.0 105.645 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . 0.254 70.0 t80 -90.91 132.75 35.74 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.124 -2.86 . . . . 50.0 109.039 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.6 mm -131.63 124.4 19.93 Favored Pre-proline 0 C--O 1.268 2.059 0 N-CA-C 103.254 -2.869 . . . . 25.0 103.254 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.19 165.89 29.96 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 114.51 -3.193 . . . . 25.0 116.697 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.53 39.35 1.06 Allowed 'General case' 0 C--O 1.295 3.46 0 CA-C-O 125.853 2.74 . . . . 25.0 111.27 175.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.86 -20.17 59.85 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 115.64 1.719 . . . . 50.0 115.64 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -148.92 170.32 18.56 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.63 139.46 38.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 101.631 -3.47 . . . . 50.0 101.631 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.13 176.67 20.19 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 118.328 -1.891 . . . . 25.0 115.47 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -81.86 146.25 29.95 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 117.985 2.587 . . . . 50.0 117.985 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -138.93 113.75 9.21 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.916 2.01 . . . . 25.0 111.138 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.76 130.87 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 116.176 -1.869 . . . . 50.0 108.625 -172.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.48 132.15 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 124.031 1.872 . . . . 25.0 109.907 167.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HG ' HG23 ' A' ' 164' ' ' VAL . 3.1 mp -118.04 138.59 52.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 102.868 -3.012 . . . . 50.0 102.868 -175.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.39 144.61 29.85 Favored 'General case' 0 C--O 1.29 3.187 0 O-C-N 119.826 -1.796 . . . . 25.0 111.835 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 79.8 t -124.67 135.14 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 102.728 -3.064 . . . . 50.0 102.728 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -135.26 114.83 12.66 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 125.428 1.705 . . . . 25.0 112.079 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -112.18 128.84 56.35 Favored 'General case' 0 C--O 1.284 2.885 0 O-C-N 123.872 0.732 . . . . 25.0 111.687 -162.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 79.6 t -121.7 119.07 57.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 115.823 -2.037 . . . . 50.0 107.319 -169.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.71 -13.36 31.55 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 119.719 3.229 . . . . 25.0 119.719 -166.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -76.36 -18.65 58.78 Favored 'General case' 0 C--O 1.253 1.263 0 O-C-N 120.268 -1.52 . . . . 25.0 112.348 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -112.25 153.4 27.19 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 119.951 -1.718 . . . . 25.0 111.751 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -78.11 -28.2 48.56 Favored 'General case' 0 C--O 1.28 2.673 0 N-CA-C 103.161 -2.904 . . . . 25.0 103.161 171.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.08 179.34 3.34 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 119.177 -2.202 . . . . 25.0 113.23 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.57 151.56 36.49 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 125.84 1.656 . . . . 25.0 108.584 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 84.2 m-85 -95.25 150.22 20.47 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 126.023 2.077 . . . . 50.0 111.778 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -133.56 130.7 38.79 Favored 'General case' 0 C--O 1.284 2.872 0 CA-C-N 114.741 -1.118 . . . . 50.0 108.205 -169.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.0 156.87 45.45 Favored 'General case' 0 C--O 1.267 1.988 0 CA-C-N 119.65 1.114 . . . . 25.0 112.22 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.412 HG23 ' HG ' ' A' ' 149' ' ' LEU . 6.6 p -146.8 127.94 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 107.631 -1.248 . . . . 75.0 107.631 -171.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.58 137.04 57.82 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 N-CA-C 107.465 -1.309 . . . . 25.0 107.465 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.67 126.95 50.18 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 123.648 0.593 . . . . 25.0 110.941 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.36 132.99 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 122.914 1.34 . . . . 50.0 111.697 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -96.23 113.42 25.01 Favored 'General case' 0 C--O 1.204 -1.339 0 N-CA-C 104.625 -2.361 . . . . 25.0 104.625 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.36 110.71 21.6 Favored 'General case' 0 CA--C 1.476 -1.896 0 CA-C-N 112.807 -1.997 . . . . 50.0 110.202 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.7 m -132.93 154.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-O 124.564 2.126 . . . . 50.0 112.615 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -59.11 126.38 27.46 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.0 pttp . . . . . 0 C--O 1.263 1.801 0 CA-C-O 116.061 -1.924 . . . . 25.0 108.53 179.045 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 118.996 -0.526 . . . . 25.0 111.217 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.65 173.64 42.03 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 120.482 1.492 . . . . 25.0 115.341 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -129.21 135.73 49.2 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 125.165 1.386 . . . . 50.0 112.746 -156.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.5 mt -89.57 121.53 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 119.229 -2.169 . . . . 25.0 111.151 -171.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -101.22 16.48 25.37 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.862 1.265 . . . . 25.0 110.245 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 64.87 166.27 0.11 Allowed Pre-proline 0 CA--C 1.594 2.652 0 C-N-CA 128.195 2.598 . . . . 25.0 111.14 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.55 141.3 45.07 Favored 'Cis proline' 0 C--O 1.204 -1.225 0 C-N-CA 132.621 2.342 . . . . 25.0 111.709 13.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.94 91.53 1.61 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 117.272 1.669 . . . . 25.0 117.272 168.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 t -75.63 144.44 41.71 Favored 'General case' 0 C--O 1.275 2.423 0 CA-C-O 123.183 1.468 . . . . 25.0 110.921 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -107.23 -22.93 12.44 Favored 'General case' 0 CA--C 1.581 2.138 0 CA-C-N 113.721 -1.581 . . . . 25.0 109.724 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.39 89.71 Favored 'General case' 0 C--O 1.264 1.856 0 CA-C-O 117.398 -1.287 . . . . 25.0 108.792 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -29.14 70.57 Favored 'General case' 0 C--O 1.279 2.656 0 O-C-N 125.764 1.915 . . . . 25.0 115.389 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 CA--C 1.565 1.534 0 O-C-N 120.433 -1.417 . . . . 75.0 109.575 176.859 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 C--O 1.257 1.452 0 N-CA-C 115.62 1.711 . . . . 25.0 115.62 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -64.58 -38.16 90.03 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.653 2.094 . . . . 50.0 116.653 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -147.41 64.26 8.54 Favored Pre-proline 0 C--O 1.262 1.76 0 CA-C-O 118.353 -0.832 . . . . 25.0 109.558 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 -21.67 12.96 Favored 'Trans proline' 0 N--CA 1.486 1.063 1 C-N-CA 110.775 -5.683 . . . . 25.0 117.537 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -72.48 -20.75 61.32 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 114.485 -2.674 . . . . 25.0 112.698 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.7 t -79.54 112.7 17.04 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 124.802 2.239 . . . . 25.0 109.615 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 mt -106.89 91.41 3.65 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 109.139 -3.664 . . . . 50.0 104.14 163.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.04 161.72 28.4 Favored 'General case' 0 CA--C 1.457 -2.618 0 C-N-CA 118.074 -1.45 . . . . 25.0 112.732 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.15 166.32 25.01 Favored 'General case' 0 C--O 1.187 -2.201 0 N-CA-C 102.674 -3.084 . . . . 25.0 102.674 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -130.12 140.49 50.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt . . . . . 0 N--CA 1.479 0.981 0 O-C-N 124.098 0.874 . . . . 25.0 109.296 177.125 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . 0.273 59.0 mt . . . . . 0 CA--C 1.507 -0.689 0 CA-C-O 121.999 0.904 . . . . 50.0 112.677 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -82.96 -40.13 20.45 Favored 'General case' 0 C--N 1.301 -1.534 1 N-CA-C 99.359 -4.311 . . . . 50.0 99.359 171.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.77 -16.41 80.34 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 126.661 3.367 . . . . 25.0 110.522 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.97 -23.33 72.75 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 110.116 -3.042 . . . . 25.0 112.323 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.8 -39.19 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 122.136 2.968 . . . . 25.0 109.217 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -73.83 -29.64 62.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 116.667 2.099 . . . . 75.0 116.667 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -66.97 -28.03 67.94 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 126.881 2.073 . . . . 50.0 110.705 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -91.56 39.3 1.0 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.722 -1.127 . . . . 25.0 110.924 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -136.31 59.68 1.7 Allowed 'General case' 0 C--N 1.281 -2.37 0 O-C-N 125.667 1.854 . . . . 25.0 107.335 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.9 p -169.21 168.28 9.89 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 113.255 -1.793 . . . . 25.0 106.756 -156.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.61 -20.45 60.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 126.869 2.605 . . . . 25.0 109.011 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -84.46 8.74 15.4 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 126.852 2.595 . . . . 25.0 115.614 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -68.79 86.54 0.33 Allowed 'General case' 0 C--O 1.271 2.209 0 CA-C-O 124.721 2.2 . . . . 25.0 107.247 163.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -40.09 148.44 0.08 Allowed 'General case' 0 N--CA 1.426 -1.648 1 CA-C-N 108.242 -4.072 . . . . 25.0 117.242 169.371 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -74.47 138.95 43.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 123.978 1.847 . . . . 50.0 111.799 -166.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -77.23 154.29 33.17 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 112.207 -2.269 . . . . 25.0 107.798 157.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -132.83 126.5 32.43 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.545 -3.872 . . . . 25.0 100.545 157.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -97.69 116.57 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 105.43 -2.063 . . . . 25.0 105.43 -166.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.9 ttt -132.88 154.27 50.54 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 119.788 -1.82 . . . . 25.0 109.838 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 p -74.79 158.19 33.9 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.66 -177.63 18.95 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 116.221 1.248 . . . . 25.0 116.221 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.61 -167.11 23.68 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 119.24 -1.457 . . . . 25.0 114.788 -174.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -71.24 135.76 47.64 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.997 -1.296 . . . . 25.0 108.764 163.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -134.63 140.65 46.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-O 116.122 -1.894 . . . . 25.0 112.114 -166.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.9 m -124.38 131.74 53.51 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.874 1.358 . . . . 25.0 111.264 171.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -112.67 124.74 53.23 Favored 'General case' 0 CA--C 1.605 3.06 1 N-CA-C 100.133 -4.025 . . . . 50.0 100.133 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.2 m -124.89 129.54 50.59 Favored 'General case' 0 C--O 1.273 2.297 0 CA-C-O 126.24 2.924 . . . . 25.0 111.864 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -123.39 155.84 36.6 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 111.35 -2.659 . . . . 25.0 108.38 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 45.4 p -125.02 143.84 50.7 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 104.382 -2.451 . . . . 25.0 104.382 170.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.36 150.26 28.3 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 104.537 -2.394 . . . . 50.0 104.537 165.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.5 t -76.07 -38.28 57.25 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 124.456 2.074 . . . . 25.0 110.229 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.79 137.69 11.29 Favored Pre-proline 0 N--CA 1.482 1.129 1 N-CA-C 96.18 -5.489 . . . . 25.0 96.18 165.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.06 172.47 16.3 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 CA-C-N 120.9 1.357 . . . . 25.0 112.902 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.344 30.9 m-70 -93.87 159.18 15.3 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 118.029 -2.919 . . . . 25.0 104.726 167.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -60.64 125.8 25.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 117.311 2.337 . . . . 25.0 117.311 167.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.9 m -139.26 134.59 32.85 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 106.721 -1.585 . . . . 25.0 106.721 -160.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.3 p -91.65 -29.02 17.11 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.907 1.337 . . . . 25.0 109.542 -171.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -172.64 171.57 4.47 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 116.421 -1.752 . . . . 25.0 108.292 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.9 p90 -153.06 158.54 42.1 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-O 117.018 -1.468 . . . . 25.0 111.528 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.415 ' HD2' ' HB ' ' A' ' 151' ' ' VAL 0.253 8.3 m-70 -139.96 144.37 37.01 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.011 1.278 . . . . 25.0 114.12 -167.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -123.72 137.95 54.61 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 121.209 1.822 . . . . 50.0 112.768 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -140.54 166.79 23.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.301 -1.74 . . . . 50.0 106.301 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.4 pt -134.68 166.15 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -83.17 150.93 25.94 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.168 0.44 . . . . 25.0 111.5 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -99.52 162.65 12.9 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -166.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -163.88 168.46 19.46 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 100.477 -3.898 . . . . 25.0 100.477 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.38 60.32 3.07 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 103.763 -3.735 . . . . 25.0 103.763 -174.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -146.5 171.67 14.71 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 114.776 -2.535 . . . . 25.0 112.476 -169.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.64 135.93 11.08 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 122.99 2.632 . . . . 25.0 104.576 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -64.04 -16.4 54.69 Favored 'Trans proline' 0 C--O 1.191 -1.868 1 N-CA-C 125.04 4.977 . . . . 25.0 125.04 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -78.49 -1.79 35.46 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 117.061 -3.524 . . . . 75.0 112.284 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -130.93 165.18 36.83 Favored Pre-proline 0 N--CA 1.406 -2.64 1 N-CA-C 100.19 -4.004 . . . . 25.0 100.19 -166.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -47.94 24.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 2 C-N-CA 127.703 5.602 . . . . 25.0 122.908 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -41.97 -39.28 1.83 Allowed 'General case' 0 CA--C 1.599 2.848 0 N-CA-C 120.059 3.355 . . . . 50.0 120.059 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -93.79 -10.75 33.12 Favored 'General case' 0 C--O 1.262 1.725 0 CA-C-N 120.041 1.292 . . . . 25.0 112.237 -176.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -107.2 -45.32 4.14 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.601 1.191 . . . . 25.0 110.763 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.17 37.7 0.78 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.838 -1.541 . . . . 25.0 106.838 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.15 -20.73 64.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 125.478 2.561 . . . . 25.0 112.297 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.16 157.24 47.1 Favored 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.366 1.866 . . . . 50.0 106.208 165.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -141.27 144.22 34.53 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 125.179 1.549 . . . . 25.0 108.756 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.88 135.89 57.92 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 123.303 1.525 . . . . 50.0 111.074 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.266 2.4 tt -107.29 -26.51 3.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 103.698 -2.704 . . . . 25.0 103.698 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.54 171.68 38.29 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 123.396 1.553 . . . . 25.0 113.571 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.45 147.29 26.08 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.15 119.43 27.65 Favored Pre-proline 0 N--CA 1.484 1.254 0 N-CA-C 105.633 -1.988 . . . . 50.0 105.633 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.09 167.08 16.26 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 N-CA-C 102.585 -3.659 . . . . 25.0 102.585 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -136.2 61.87 1.63 Allowed 'General case' 0 C--O 1.261 1.703 0 N-CA-C 117.515 2.413 . . . . 25.0 117.515 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.43 -25.88 1.14 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 118.973 2.953 . . . . 50.0 118.973 165.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -162.12 12.95 0.12 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 119.713 -1.867 . . . . 25.0 114.581 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.81 170.1 5.56 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 118.976 2.954 . . . . 25.0 118.976 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.54 -166.16 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 120.734 0.956 . . . . 25.0 113.628 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.18 -1.88 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 119.269 3.063 . . . . 25.0 119.269 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.1 p -60.78 -21.45 63.09 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.741 -1.118 . . . . 25.0 113.391 168.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -71.71 -5.03 30.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 117.443 2.386 . . . . 25.0 117.443 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -65.62 133.31 50.87 Favored 'General case' 0 C--O 1.267 2.002 0 O-C-N 120.433 -1.417 . . . . 25.0 108.259 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.73 -30.96 66.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 124.777 2.227 . . . . 75.0 110.774 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.7 t -62.8 127.71 32.51 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 105.337 -2.097 . . . . 25.0 105.337 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.13 134.5 29.72 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 117.593 2.442 . . . . 25.0 117.593 -172.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -94.86 145.0 25.2 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 113.978 -1.464 . . . . 25.0 107.565 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -136.46 125.13 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.356 -2.09 . . . . 25.0 105.356 159.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -71.92 133.97 45.72 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 123.001 2.637 . . . . 50.0 109.062 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.52 110.54 44.74 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -65.88 154.38 74.17 Favored 'Trans proline' 0 N--CA 1.53 3.669 1 C-N-CA 112.309 -4.661 . . . . 25.0 114.053 172.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -91.69 53.52 2.26 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 115.757 -2.377 . . . . 25.0 112.029 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.5 -25.61 38.66 Favored 'General case' 0 C--O 1.261 1.679 0 N-CA-C 114.541 1.312 . . . . 50.0 114.541 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -155.26 173.29 16.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 119.139 0.881 . . . . 25.0 109.643 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.1 pt? -110.97 139.84 45.99 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 104.472 -2.418 . . . . 50.0 104.472 166.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 160.03 167.86 21.19 Favored Glycine 0 C--O 1.294 3.897 0 O-C-N 119.819 -1.801 . . . . 25.0 113.714 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -102.38 139.87 37.42 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 127.166 2.187 . . . . 50.0 111.401 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -156.27 165.24 36.94 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 103.169 -2.9 . . . . 25.0 103.169 166.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.51 161.77 3.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 CA-C-N 120.754 1.615 . . . . 50.0 111.102 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.38 126.77 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 N-CA-C 100.701 -3.814 . . . . 25.0 100.701 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.5 mt -103.81 154.59 19.42 Favored 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 120.555 1.525 . . . . 50.0 108.414 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.1 157.98 43.45 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 119.675 1.125 . . . . 25.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 162' ' ' TYR . 58.8 t -131.09 134.02 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 105.007 -2.22 . . . . 50.0 105.007 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.75 108.09 10.44 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 105.041 -2.207 . . . . 25.0 105.041 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -86.37 95.4 9.65 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 125.325 2.488 . . . . 25.0 106.178 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.83 120.01 23.47 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.12 0 CA-C-N 113.56 -1.654 . . . . 50.0 107.396 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.76 -13.48 42.24 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.698 1.37 . . . . 25.0 114.698 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.95 -23.66 67.43 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.595 2.072 . . . . 25.0 116.595 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.5 p -138.03 158.03 45.15 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 110.875 -2.875 . . . . 25.0 107.218 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -75.18 -17.35 60.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 123.091 1.424 . . . . 25.0 111.547 164.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -69.72 154.84 41.42 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 162.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.09 178.52 7.32 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 100.55 -3.87 . . . . 25.0 100.55 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -124.0 153.97 40.51 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 125.919 2.012 . . . . 50.0 112.28 171.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.426 ' CD2' HG22 ' A' ' 151' ' ' VAL . 11.1 m-85 -123.13 159.75 27.9 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 105.993 -1.854 . . . . 50.0 105.993 158.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -154.62 152.04 29.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 120.642 1.565 . . . . 25.0 108.31 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.282 1.1 p -133.91 136.44 53.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.958 1.361 . . . . 75.0 112.567 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.14 125.62 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.329 -1.36 . . . . 25.0 107.329 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.58 136.45 32.99 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 104.98 -2.23 . . . . 25.0 104.98 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 m -132.79 160.27 42.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 125.241 2.448 . . . . 50.0 110.026 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -130.96 111.74 12.33 Favored 'General case' 0 C--O 1.275 2.397 0 N-CA-C 104.233 -2.506 . . . . 25.0 104.233 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.7 mt -119.26 117.47 28.68 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 100.791 -3.781 . . . . 50.0 100.791 -167.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 19.2 m -115.22 170.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 116.889 2.181 . . . . 50.0 116.889 -167.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -78.91 151.57 31.65 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.9 tptt . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 115.574 -2.155 . . . . 25.0 111.971 178.271 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 . . . . . 0 N--CA 1.51 2.558 0 CA-C-O 120.573 0.225 . . . . 25.0 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.39 -160.01 30.15 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-O 116.812 -2.104 . . . . 25.0 117.027 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -129.87 156.54 44.22 Favored 'General case' 0 C--O 1.253 1.267 0 C-N-CA 126.921 2.088 . . . . 50.0 113.377 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -95.3 125.54 47.97 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 101.418 -3.549 . . . . 25.0 101.418 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -89.74 -40.48 12.48 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 113.706 -1.588 . . . . 25.0 113.738 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -148.54 150.55 34.06 Favored Pre-proline 0 CA--C 1.549 0.918 1 N-CA-C 99.532 -4.248 . . . . 25.0 99.532 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.44 139.13 59.72 Favored 'Cis proline' 0 N--CA 1.442 -1.529 0 CA-C-N 120.676 1.277 . . . . 25.0 113.604 1.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.89 -154.93 49.03 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 117.458 1.743 . . . . 25.0 117.458 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -137.33 114.66 10.95 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 125.319 1.448 . . . . 25.0 109.48 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -67.62 -24.51 65.48 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 123.896 1.808 . . . . 25.0 114.452 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.15 -30.75 71.29 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 118.139 -2.85 . . . . 25.0 114.536 171.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.36 90.44 Favored 'General case' 0 C--O 1.192 -1.946 0 CA-C-O 125.82 2.724 . . . . 25.0 110.323 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.625 0 CA-C-N 112.394 -2.185 . . . . 75.0 108.487 -169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.6 ptt? . . . . . 0 CA--C 1.503 -0.852 1 N-CA-C 122.17 4.137 . . . . 25.0 122.17 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.58 -50.77 16.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 124.956 2.312 . . . . 50.0 108.006 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -131.43 82.65 61.37 Favored Pre-proline 0 N--CA 1.511 2.606 0 CA-C-N 113.073 -1.876 . . . . 25.0 106.177 167.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.49 -16.86 54.85 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 116.273 -2.018 . . . . 25.0 116.105 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.45 -51.78 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.7 t -84.55 46.02 1.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 118.462 -2.649 . . . . 25.0 113.844 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.45 129.69 39.91 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-O 125.053 2.359 . . . . 50.0 105.475 173.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.41 146.27 42.63 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.014 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.82 41.37 0.67 Allowed 'General case' 0 C--O 1.193 -1.885 0 CA-C-O 124.379 2.038 . . . . 25.0 113.299 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -142.87 -73.84 0.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 118.811 -2.431 . . . . 25.0 112.889 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.8 mttt . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.728 1.611 . . . . 25.0 111.669 -165.416 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 CA--C 1.5 -0.946 0 N-CA-C 118.436 2.754 . . . . 50.0 118.436 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -70.97 -26.1 63.01 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.346 -3.205 . . . . 50.0 102.346 148.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.04 -16.68 68.91 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 119.881 -1.762 . . . . 25.0 109.003 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.95 -23.53 77.69 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 119.997 -1.097 . . . . 25.0 114.092 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.48 -44.41 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 117.012 -1.875 . . . . 25.0 109.519 165.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.11 1.02 2.24 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 126.235 2.921 . . . . 75.0 118.624 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.78 -14.93 60.78 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 112.262 -2.245 . . . . 50.0 110.721 170.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -72.74 5.15 3.35 Favored 'General case' 0 CA--C 1.485 -1.557 0 O-C-N 116.631 -3.793 . . . . 25.0 116.733 173.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -122.62 67.31 0.95 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 125.919 1.687 . . . . 25.0 107.258 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -147.18 151.24 36.43 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 117.192 2.293 . . . . 25.0 117.192 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -72.28 -30.22 64.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 118.246 -2.784 . . . . 25.0 109.02 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -106.02 31.36 5.14 Favored 'General case' 0 C--O 1.176 -2.776 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -78.46 101.71 7.45 Favored 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 97.859 -4.867 . . . . 25.0 97.859 164.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -43.15 155.96 0.05 Allowed 'General case' 0 C--O 1.262 1.714 0 CA-C-N 110.023 -3.262 . . . . 25.0 115.468 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -58.86 144.73 43.45 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 127.043 3.306 . . . . 50.0 117.076 -167.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -82.96 153.78 24.85 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 117.714 2.487 . . . . 25.0 117.714 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -152.35 156.52 39.74 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 117.981 -2.949 . . . . 25.0 109.138 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.2 tt -132.58 139.75 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 106.367 -1.716 . . . . 25.0 106.367 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtt -152.87 151.8 30.81 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 120.087 1.312 . . . . 25.0 110.255 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.5 p -84.55 176.68 8.46 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.071 -0.714 . . . . 25.0 109.071 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.65 168.8 53.86 Favored Glycine 0 C--O 1.209 -1.439 0 C-N-CA 120.825 -0.702 . . . . 25.0 112.065 168.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.62 174.26 15.56 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.472 -1.823 . . . . 25.0 110.687 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -71.06 134.04 46.77 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.279 -0.968 . . . . 25.0 111.807 162.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -133.73 147.35 51.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.131 -0.94 . . . . 25.0 110.77 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m -85.62 136.09 33.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 124.274 1.03 . . . . 25.0 110.597 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.42 134.81 49.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.067 -1.827 . . . . 50.0 106.067 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.4 m -114.66 120.93 41.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -120.27 149.02 42.96 Favored 'General case' 0 C--O 1.263 1.803 0 CA-C-O 118.288 -0.863 . . . . 25.0 109.446 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 t -143.35 158.18 43.85 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.275 1.852 . . . . 25.0 109.871 -171.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -86.15 147.93 25.91 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 104.443 -2.429 . . . . 50.0 104.443 161.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.7 t -110.41 -18.28 13.27 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 103.711 -2.7 . . . . 25.0 103.711 162.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 147.04 54.14 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 101.117 -3.66 . . . . 25.0 101.117 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.35 151.54 84.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 117.887 -0.942 . . . . 25.0 113.579 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -129.1 178.49 6.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 100.762 -3.792 . . . . 25.0 100.762 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -118.56 84.84 2.25 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.938 1.695 . . . . 25.0 107.007 157.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -75.56 149.52 38.31 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 103.233 -2.877 . . . . 25.0 103.233 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 p -106.16 -30.32 9.3 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-N 120.713 1.597 . . . . 25.0 114.56 168.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 51.2 tt0 -164.21 158.34 18.92 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 118.614 -2.554 . . . . 25.0 104.674 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -149.69 162.04 41.01 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 120.167 -1.583 . . . . 25.0 110.156 163.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -128.79 156.58 43.35 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 127.009 2.124 . . . . 25.0 110.738 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -147.7 149.76 33.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 124.693 2.187 . . . . 50.0 105.959 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -146.3 168.6 20.68 Favored 'General case' 0 CA--C 1.501 -0.914 1 N-CA-C 98.813 -4.514 . . . . 50.0 98.813 -154.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.1 pt -134.51 158.0 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 117.07 -1.443 . . . . 25.0 108.693 162.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.451 HG23 ' HA ' ' A' ' 114' ' ' ASP . 49.9 m -95.14 133.32 39.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 125.525 1.766 . . . . 25.0 110.592 172.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -76.87 135.77 38.85 Favored 'General case' 0 C--O 1.297 3.563 0 CA-C-N 122.328 2.331 . . . . 25.0 109.998 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.32 164.71 26.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 103.999 -2.593 . . . . 25.0 103.999 171.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.33 3.24 65.21 Favored Glycine 0 C--O 1.276 2.739 0 N-CA-C 117.333 1.693 . . . . 25.0 117.333 169.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.87 176.97 5.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.711 1.004 . . . . 25.0 113.711 -174.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.56 138.04 11.38 Favored Pre-proline 0 C--O 1.194 -1.847 0 CA-C-O 116.188 -1.863 . . . . 25.0 109.944 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.51 -21.23 46.66 Favored 'Trans proline' 0 C--O 1.286 2.912 0 N-CA-C 117.983 2.263 . . . . 25.0 117.983 -174.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.53 3.13 12.0 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 118.977 -2.327 . . . . 75.0 113.198 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -129.38 174.04 5.02 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 100.615 -3.846 . . . . 25.0 100.615 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.6 21.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 N-CA-C 122.138 3.861 . . . . 25.0 122.138 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 tt -38.84 -33.74 0.12 Allowed 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.755 2.132 . . . . 50.0 116.755 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.28 -5.44 59.18 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 116.593 2.072 . . . . 25.0 116.593 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -116.15 -43.11 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 123.654 1.693 . . . . 25.0 110.105 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.2 4.77 1.14 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 113.315 -1.766 . . . . 25.0 112.883 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.451 ' HA ' HG23 ' A' ' 100' ' ' THR . 26.2 t0 -70.63 -14.92 62.66 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 119.571 -0.852 . . . . 25.0 108.837 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.73 106.74 8.91 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -109.09 120.16 41.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 104.99 -2.226 . . . . 25.0 104.99 165.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.97 136.27 55.06 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 116.568 -1.682 . . . . 50.0 108.873 -176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.5 tp -110.29 -19.21 7.04 Favored 'Isoleucine or valine' 0 C--N 1.374 1.639 0 CA-C-O 125.868 2.747 . . . . 25.0 109.81 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.76 150.97 13.13 Favored Glycine 0 N--CA 1.444 -0.773 0 O-C-N 118.268 -2.77 . . . . 25.0 114.562 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . 0.257 . . -143.84 140.96 30.1 Favored 'General case' 0 CA--C 1.569 1.685 1 N-CA-C 98.955 -4.461 . . . . 25.0 98.955 -179.957 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.2 105.11 11.29 Favored Pre-proline 0 CA--C 1.497 -1.078 0 O-C-N 127.208 2.818 . . . . 50.0 103.465 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 61.6 Cg_endo -66.22 167.17 18.98 Favored 'Trans proline' 0 C--O 1.203 -1.225 1 C-N-CA 109.828 -6.315 . . . . 25.0 111.896 166.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -144.01 83.18 1.73 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 118.435 -2.666 . . . . 25.0 111.795 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.93 -17.6 43.06 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 124.675 2.178 . . . . 50.0 113.183 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.01 -168.2 36.57 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 103.581 -3.808 . . . . 25.0 103.581 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 71.09 82.2 Favored Pre-proline 0 C--O 1.181 -2.523 0 CA-C-N 121.534 2.667 . . . . 25.0 114.278 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -67.67 172.06 11.09 Favored 'Trans proline' 0 C--O 1.286 2.906 1 C-N-CA 111.025 -5.517 . . . . 25.0 110.982 155.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.03 -35.76 67.22 Favored 'General case' 0 C--N 1.356 0.89 0 CA-C-O 116.396 -1.764 . . . . 25.0 113.656 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 98.4 p -59.22 -20.21 52.08 Favored 'General case' 0 C--O 1.296 3.536 0 O-C-N 127.532 3.02 . . . . 25.0 115.793 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -105.57 8.22 33.18 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 118.704 2.853 . . . . 25.0 118.704 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -60.19 151.91 25.96 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 125.72 2.676 . . . . 25.0 110.998 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mt -66.46 -27.03 67.49 Favored 'General case' 0 C--O 1.26 1.613 0 CA-C-N 113.202 -1.817 . . . . 75.0 114.56 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.4 m -96.44 145.55 25.56 Favored 'General case' 0 C--O 1.302 3.85 0 O-C-N 119.518 -1.989 . . . . 25.0 105.855 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -131.45 168.32 17.82 Favored 'General case' 0 C--O 1.192 -1.957 0 N-CA-C 116.318 1.97 . . . . 25.0 116.318 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.305 89.9 m-70 -121.3 116.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 121.608 2.004 . . . . 25.0 113.28 168.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mm -122.18 131.79 72.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 C-N-CA 118.745 -1.182 . . . . 25.0 108.981 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -75.78 134.08 40.52 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 107.18 -1.415 . . . . 50.0 107.18 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.04 132.02 22.55 Favored Pre-proline 0 C--O 1.204 -1.309 0 N-CA-C 102.892 -3.003 . . . . 25.0 102.892 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -62.27 143.66 94.34 Favored 'Trans proline' 0 CA--C 1.458 -3.324 1 C-N-CA 113.006 -4.196 . . . . 25.0 118.785 -175.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.73 -22.86 12.86 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 125.447 2.546 . . . . 25.0 114.267 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -77.46 -5.46 49.97 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 118.965 -2.334 . . . . 50.0 112.289 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -145.06 158.09 43.92 Favored 'General case' 0 C--O 1.204 -1.303 0 CA-C-N 112.739 -2.028 . . . . 25.0 112.388 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.2 mp -107.2 152.67 23.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.052 -2.944 . . . . 50.0 103.052 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 158.44 166.63 17.96 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.151 -0.968 . . . . 25.0 114.949 167.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -88.57 136.13 33.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.606 1.335 . . . . 50.0 114.606 166.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -149.45 167.84 25.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 104.213 -2.514 . . . . 25.0 104.213 -159.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.51 131.83 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.985 0 N-CA-C 103.537 -2.764 . . . . 50.0 103.537 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 94.5 mt -98.8 121.17 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 105.925 -1.88 . . . . 25.0 105.925 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.93 138.18 51.12 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 119.904 -1.747 . . . . 50.0 107.799 -175.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.26 145.51 43.64 Favored 'General case' 0 C--O 1.263 1.81 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -133.84 137.3 52.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 114.424 -2.703 . . . . 50.0 110.267 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -115.77 150.5 36.8 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.814 -1.921 . . . . 25.0 105.814 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -112.89 131.74 55.6 Favored 'General case' 0 C--N 1.307 -1.248 1 N-CA-C 99.085 -4.413 . . . . 25.0 99.085 163.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.21 120.82 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 105.046 -2.205 . . . . 50.0 105.046 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.8 -21.3 41.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 118.944 -0.551 . . . . 25.0 111.069 -173.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . 0.304 2.1 p-10 -82.82 -15.13 52.82 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 116.023 1.86 . . . . 25.0 116.023 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.505 ' HG1' ' HE1' ' A' ' 161' ' ' PHE . 39.1 p -112.67 156.58 22.51 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.177 -1.046 . . . . 25.0 108.177 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -90.5 -23.79 20.85 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.638 -1.225 . . . . 25.0 114.064 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -102.0 160.14 14.76 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 115.25 -0.886 . . . . 25.0 111.486 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.82 166.85 22.94 Favored 'General case' 0 C--O 1.253 1.258 0 CA-C-N 113.03 -1.896 . . . . 25.0 112.649 163.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.505 ' HE1' ' HG1' ' A' ' 157' ' ' THR . 52.7 m-85 -129.35 130.83 46.58 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 112.343 -2.208 . . . . 50.0 110.34 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -139.74 136.76 34.49 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 127.207 2.817 . . . . 50.0 108.323 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.62 149.53 20.37 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 106.881 -1.525 . . . . 25.0 106.881 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.9 m -127.51 162.72 32.38 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.595 0 N-CA-C 107.978 -1.119 . . . . 75.0 107.978 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.94 131.44 46.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 105.868 -1.901 . . . . 25.0 105.868 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.55 124.31 38.5 Favored 'General case' 0 CA--C 1.583 2.215 0 O-C-N 126.093 2.121 . . . . 25.0 106.357 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 m -123.46 158.75 28.67 Favored 'Isoleucine or valine' 0 C--O 1.285 2.933 0 C-N-CA 116.186 -2.206 . . . . 50.0 109.221 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -119.44 121.34 39.26 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 101.105 -3.665 . . . . 25.0 101.105 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.6 mt -112.28 95.99 5.77 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 105.488 -2.042 . . . . 50.0 105.488 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.8 172.73 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.801 -1.187 . . . . 50.0 113.192 -170.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -66.97 132.81 48.69 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 105.982 -1.859 . . . . 25.0 105.982 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.0 pttp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 115.612 -2.137 . . . . 25.0 110.194 177.546 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 . . . . . 1 N--CA 1.555 4.8 0 CA-C-O 122.761 1.267 . . . . 25.0 107.995 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -121.31 6.33 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.341 -1.409 . . . . 25.0 111.571 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.26 144.33 27.8 Favored 'General case' 0 C--O 1.267 2.023 0 O-C-N 119.196 -2.355 . . . . 50.0 106.438 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -86.86 126.09 40.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 N-CA-C 105.002 -2.221 . . . . 25.0 105.002 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -108.02 -35.31 6.64 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 117.039 -1.864 . . . . 25.0 110.449 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 148.86 57.56 Favored Pre-proline 0 C--O 1.256 1.406 0 N-CA-C 104.967 -2.234 . . . . 25.0 104.967 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -71.43 133.16 27.07 Favored 'Cis proline' 0 C--N 1.359 1.117 0 C-N-CA 132.848 2.437 . . . . 25.0 114.158 2.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.22 -144.12 49.05 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 115.104 0.802 . . . . 25.0 115.104 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -133.72 104.62 6.41 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 105.169 -2.16 . . . . 25.0 105.169 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -69.18 -18.06 63.88 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 117.806 -3.059 . . . . 25.0 109.471 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.19 70.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 116.403 -1.76 . . . . 25.0 111.169 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.56 63.82 Favored 'General case' 0 C--O 1.198 -1.624 0 N-CA-C 106.89 -1.522 . . . . 25.0 106.89 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.485 1.279 0 O-C-N 120.546 -1.346 . . . . 75.0 111.861 -177.758 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 116.86 -1.543 . . . . 25.0 115.111 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.78 -47.27 85.3 Favored 'General case' 0 N--CA 1.421 -1.917 0 O-C-N 126.297 2.248 . . . . 50.0 112.362 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.62 64.03 11.32 Favored Pre-proline 0 CA--C 1.505 -0.755 0 N-CA-C 113.753 1.02 . . . . 25.0 113.753 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.26 -19.87 37.96 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 N-CA-C 117.681 2.146 . . . . 25.0 117.681 -167.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -99.83 6.42 45.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.435 2.013 . . . . 25.0 116.435 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -136.73 38.52 2.62 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.692 1.597 . . . . 25.0 112.216 171.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 tp -77.5 99.32 5.64 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.055 -0.521 . . . . 50.0 110.968 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.28 147.1 52.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.071 -1.455 . . . . 25.0 107.071 -159.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.29 50.6 1.02 Allowed 'General case' 0 CA--C 1.606 3.12 0 N-CA-C 115.437 1.643 . . . . 25.0 115.437 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 45.4 tttt -134.76 -163.1 1.33 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.05 -1.833 . . . . 25.0 106.05 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.451 ' H ' ' HG2' ' A' ' 38' ' ' LYS . 94.0 mttt . . . . . 0 N--CA 1.437 -1.082 0 O-C-N 125.638 1.837 . . . . 25.0 110.679 -168.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.9 mt . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 124.284 1.992 . . . . 50.0 111.428 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -71.12 -40.42 71.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.763 -2.31 . . . . 50.0 104.763 155.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.55 -22.98 47.74 Favored Glycine 0 CA--C 1.499 -0.966 0 O-C-N 118.82 -2.425 . . . . 25.0 114.582 167.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.13 74.6 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 126.069 3.038 . . . . 25.0 113.285 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.96 -33.22 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 117.771 -3.194 . . . . 25.0 105.381 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.13 -14.51 60.98 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 112.65 -2.068 . . . . 75.0 112.956 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.01 -25.97 65.7 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 111.724 -2.489 . . . . 50.0 112.02 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.51 11.27 5.85 Favored 'General case' 0 C--O 1.251 1.155 0 O-C-N 118.807 -2.433 . . . . 25.0 112.756 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -133.06 16.77 4.15 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.05 -1.656 . . . . 25.0 112.457 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -112.4 166.17 11.54 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.286 -0.87 . . . . 25.0 109.345 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.81 -22.6 65.16 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 105.78 -1.933 . . . . 25.0 105.78 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.98 39.64 1.52 Allowed 'General case' 0 C--O 1.168 -3.196 0 C-N-CA 125.55 1.54 . . . . 25.0 110.165 175.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -89.36 91.34 8.7 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-O 124.901 2.286 . . . . 25.0 105.704 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -57.24 139.2 53.43 Favored 'General case' 0 C--N 1.305 -1.34 1 CA-C-N 107.5 -4.409 . . . . 25.0 105.358 172.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -65.56 152.09 44.91 Favored 'General case' 0 C--O 1.286 3.017 0 CA-C-O 126.314 2.959 . . . . 50.0 115.086 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -87.27 134.92 33.49 Favored 'General case' 0 C--O 1.185 -2.318 0 CA-C-N 109.897 -3.32 . . . . 25.0 104.415 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -126.47 134.71 50.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 126.062 2.101 . . . . 25.0 112.883 171.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -93.99 141.25 15.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 tpt -146.3 147.75 31.7 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-O 123.028 1.394 . . . . 25.0 108.739 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 p -82.31 173.61 11.91 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 114.262 -1.335 . . . . 25.0 114.416 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.9 -179.0 35.45 Favored Glycine 0 C--O 1.264 2.019 0 O-C-N 120.053 -1.654 . . . . 25.0 110.526 163.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.76 179.05 32.11 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 106.252 -2.739 . . . . 25.0 106.252 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.75 138.9 39.27 Favored 'General case' 0 C--O 1.257 1.471 0 O-C-N 118.326 -2.867 . . . . 25.0 114.612 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -132.1 160.48 35.84 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 114.044 -1.434 . . . . 25.0 110.803 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -111.52 135.79 51.59 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-O 123.798 1.761 . . . . 25.0 111.597 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -112.97 119.55 38.3 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.79 -1.095 . . . . 50.0 111.518 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.4 m -134.72 129.21 34.36 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 107.275 -1.38 . . . . 25.0 107.275 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -120.77 151.21 39.86 Favored 'General case' 0 C--N 1.313 -1.011 1 N-CA-C 98.617 -4.586 . . . . 25.0 98.617 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -143.66 126.57 16.29 Favored 'General case' 0 C--O 1.263 1.811 0 O-C-N 125.344 1.652 . . . . 25.0 112.397 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -130.3 143.65 50.9 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 118.809 -2.432 . . . . 50.0 109.633 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -61.6 -23.96 66.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 118.522 2.786 . . . . 25.0 118.522 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.05 157.2 78.21 Favored Pre-proline 0 CA--C 1.493 -1.227 0 N-CA-C 101.257 -3.609 . . . . 25.0 101.257 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.26 159.1 11.24 Favored 'Trans proline' 0 N--CA 1.504 2.099 0 N-CA-C 103.003 -3.499 . . . . 25.0 103.003 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -89.83 167.62 12.71 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 102.667 -3.086 . . . . 25.0 102.667 159.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -88.7 117.13 27.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -139.32 156.36 47.08 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 122.613 0.365 . . . . 25.0 110.341 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p -98.83 -48.87 4.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.168 0.987 . . . . 25.0 111.378 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -159.42 160.3 34.68 Favored 'General case' 0 CA--C 1.474 -1.969 0 O-C-N 120.214 -1.553 . . . . 25.0 114.541 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -122.08 144.95 48.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 119.735 1.152 . . . . 25.0 111.221 162.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -122.93 153.56 39.54 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 114.253 -2.784 . . . . 25.0 110.283 -170.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.25 137.56 27.38 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 105.858 -1.904 . . . . 50.0 105.858 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -134.67 156.46 48.72 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 124.56 1.162 . . . . 50.0 110.081 -167.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.451 HG22 HG12 ' A' ' 148' ' ' ILE . 24.2 pt -126.63 162.81 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 124.621 2.153 . . . . 25.0 110.006 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 147' ' ' VAL . 54.8 m -111.9 127.27 55.79 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 118.75 -2.469 . . . . 25.0 108.285 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.449 ' HG3' ' CE3' ' A' ' 104' ' ' TRP . 52.8 pttt -99.01 179.49 4.61 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -164.03 177.13 8.72 Favored 'General case' 0 C--O 1.275 2.433 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.81 26.69 66.46 Favored Glycine 0 C--O 1.252 1.235 1 CA-C-O 129.379 4.877 . . . . 25.0 113.861 -166.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.449 ' CE3' ' HG3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -97.19 150.31 21.04 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 108.83 -3.685 . . . . 25.0 112.95 -173.466 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 106' ' ' PRO 0.288 9.7 t70 -98.45 141.54 23.1 Favored Pre-proline 0 C--O 1.194 -1.868 0 C-N-CA 127.772 2.429 . . . . 25.0 111.095 -172.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 105' ' ' ASP . 31.3 Cg_exo -67.52 -40.54 10.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 124.776 3.65 . . . . 25.0 121.038 -173.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.67 -29.05 65.27 Favored 'General case' 0 C--O 1.197 -1.704 0 CA-C-O 126.225 2.917 . . . . 75.0 109.312 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.84 161.5 74.47 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 118.484 -2.635 . . . . 25.0 110.31 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.92 17.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.646 2 C-N-CA 127.978 5.785 . . . . 25.0 122.878 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.19 -37.5 15.94 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 116.091 1.885 . . . . 50.0 116.091 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -85.48 -10.66 55.78 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.423 1.638 . . . . 25.0 115.423 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 114' ' ' ASP . 99.4 mtt180 -104.21 -52.81 2.85 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 117.695 2.48 . . . . 25.0 117.695 174.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.67 34.8 0.28 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 127.028 2.705 . . . . 25.0 106.791 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 112' ' ' ARG . 36.0 t70 -63.65 -26.79 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.838 2.055 . . . . 25.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -127.71 145.69 50.82 Favored 'General case' 0 C--N 1.298 -1.674 1 N-CA-C 99.023 -4.436 . . . . 50.0 99.023 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -117.63 130.66 56.51 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 121.414 1.915 . . . . 25.0 110.73 168.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.1 tp -63.87 110.15 1.99 Allowed 'General case' 0 C--O 1.27 2.153 0 CA-C-O 118.311 -0.852 . . . . 50.0 110.467 168.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.6 tt -99.34 -17.85 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.14 166.34 36.35 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 116.319 1.288 . . . . 25.0 116.319 164.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.7 152.18 33.54 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.21 -1.404 . . . . 25.0 107.21 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.96 120.43 15.24 Favored Pre-proline 0 C--O 1.262 1.723 0 O-C-N 125.934 2.021 . . . . 50.0 110.185 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.72 152.67 53.36 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.262 1.276 . . . . 25.0 113.093 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.79 52.29 1.48 Allowed 'General case' 0 C--O 1.245 0.863 0 N-CA-C 105.318 -2.104 . . . . 25.0 105.318 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -83.64 -22.55 32.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.602 -1.629 . . . . 50.0 106.602 -167.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.05 178.89 31.47 Favored Glycine 0 C--O 1.204 -1.738 1 N-CA-C 102.714 -4.154 . . . . 25.0 102.714 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -123.75 56.87 11.27 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 119.434 3.124 . . . . 25.0 119.434 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.6 175.85 10.53 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 O-C-N 118.303 -1.472 . . . . 25.0 108.5 168.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.47 -13.77 43.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 25.0 113.311 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 80.7 p -84.76 -3.83 58.78 Favored 'General case' 0 C--O 1.189 -2.12 0 CA-C-N 119.383 0.992 . . . . 25.0 110.83 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -116.47 26.21 10.06 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 123.973 1.844 . . . . 25.0 110.673 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -68.61 149.97 48.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.825 -1.546 . . . . 25.0 106.825 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.73 -15.11 59.86 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 126.466 2.354 . . . . 75.0 115.781 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.4 t -81.31 123.61 28.67 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 104.223 -2.51 . . . . 25.0 104.223 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -118.71 147.22 44.06 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.664 -1.273 . . . . 25.0 108.047 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -110.53 136.35 49.78 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.9 mm -132.37 128.23 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -78.66 133.53 37.22 Favored 'General case' 0 C--O 1.255 1.365 0 O-C-N 125.696 1.873 . . . . 50.0 111.71 169.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.48 126.18 28.27 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-O 115.22 -2.324 . . . . 25.0 107.218 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.75 151.72 74.36 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 113.563 -3.824 . . . . 25.0 114.619 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -105.11 -8.05 18.7 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.08 -1.873 . . . . 25.0 111.921 -172.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.23 -1.7 24.62 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 126.315 2.259 . . . . 50.0 115.758 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -142.06 165.72 26.67 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 119.409 -2.057 . . . . 25.0 112.596 -172.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 3.8 mp -128.15 147.06 50.54 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 101.184 -3.636 . . . . 50.0 101.184 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.44 174.44 21.56 Favored Glycine 0 CA--C 1.477 -2.326 0 N-CA-C 121.037 3.175 . . . . 25.0 121.037 161.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -82.39 140.48 33.45 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 113.588 -1.306 . . . . 50.0 111.834 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -149.38 165.97 30.46 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.108 -2.182 . . . . 25.0 105.108 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.405 ' H ' ' HB ' ' A' ' 100' ' ' THR . 5.0 t -125.12 141.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.684 0 N-CA-C 103.933 -2.618 . . . . 50.0 103.933 168.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 99' ' ' ILE . 91.0 mt -127.54 132.33 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 116.749 -1.596 . . . . 25.0 109.019 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.53 139.17 44.85 Favored 'General case' 0 C--O 1.263 1.793 0 O-C-N 128.467 3.605 . . . . 50.0 110.55 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.5 116.23 17.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 25.0 112.039 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 t -129.36 127.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 125.089 1.493 . . . . 50.0 108.572 -162.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -119.23 108.98 15.31 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 119.286 0.948 . . . . 25.0 113.027 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.32 116.41 11.62 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 126.762 2.025 . . . . 25.0 109.545 -173.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.4 t -87.68 136.38 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.44 -1.689 . . . . 50.0 106.44 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -95.63 -25.25 16.21 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 115.843 1.794 . . . . 25.0 115.843 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.0 5.65 50.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.082 1.42 . . . . 25.0 113.277 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.9 p -139.6 -177.23 4.85 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 104.179 -2.526 . . . . 25.0 104.179 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.78 -7.23 41.03 Favored 'General case' 0 CA--C 1.481 -1.704 0 O-C-N 125.089 1.493 . . . . 25.0 107.155 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -85.28 176.96 8.01 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 116.565 2.061 . . . . 25.0 116.565 -170.567 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.91 146.87 28.09 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -78.7 133.91 37.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.22 -1.77 . . . . 50.0 106.22 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -136.58 123.05 20.8 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 126.299 1.839 . . . . 50.0 110.752 -172.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.63 142.67 33.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 103.645 -2.724 . . . . 25.0 103.645 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.96 144.24 24.27 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 102.317 -3.216 . . . . 75.0 102.317 -168.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.2 mt -138.81 122.03 19.02 Favored 'Isoleucine or valine' 0 C--O 1.261 1.706 0 CA-C-O 124.131 1.92 . . . . 25.0 106.162 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -75.59 126.68 31.48 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 112.459 -2.155 . . . . 25.0 106.694 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.84 159.17 39.58 Favored 'Isoleucine or valine' 0 C--O 1.264 1.833 0 O-C-N 117.362 -3.336 . . . . 50.0 116.811 -171.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -133.14 113.65 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 103.953 -2.61 . . . . 25.0 103.953 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.9 mt -116.43 122.5 44.97 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 105.238 -2.134 . . . . 50.0 105.238 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.3 m -135.19 159.83 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 N-CA-C 117.749 2.5 . . . . 50.0 117.749 -172.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -61.36 140.28 58.04 Favored 'General case' 0 C--O 1.189 -2.102 0 O-C-N 121.026 -1.046 . . . . 25.0 110.779 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.9 pttt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 116.266 -1.826 . . . . 25.0 110.52 170.627 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 . . . . . 0 N--CA 1.506 2.352 0 CA-C-O 123.733 1.73 . . . . 25.0 109.608 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.7 173.62 42.44 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 127.244 2.355 . . . . 25.0 116.754 -173.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -151.55 164.39 36.94 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-N 119.814 1.807 . . . . 50.0 113.357 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.67 135.24 27.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.647 -1.242 . . . . 25.0 107.647 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -107.89 -36.08 6.47 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 113.378 0.881 . . . . 25.0 113.378 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -148.7 158.84 39.41 Favored Pre-proline 0 C--O 1.286 3.011 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.17 145.26 77.58 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 C-N-CA 133.005 2.502 . . . . 25.0 111.966 -3.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.39 -169.61 52.76 Favored Glycine 0 C--O 1.214 -1.15 0 CA-C-N 113.107 -1.86 . . . . 25.0 111.767 162.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 t -140.89 121.7 14.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.598 1.959 . . . . 25.0 107.025 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.12 -16.8 36.82 Favored 'General case' 0 C--O 1.259 1.59 0 C-N-CA 116.975 -1.89 . . . . 25.0 107.724 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.66 -35.38 70.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 123.453 1.597 . . . . 25.0 110.783 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.28 92.64 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 112.875 -1.966 . . . . 25.0 111.965 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.1 -37.27 86.94 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 113.228 -1.806 . . . . 75.0 114.956 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.8 t -71.07 -16.8 62.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.383 -1.281 . . . . 25.0 113.04 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.5 m -81.13 168.81 18.17 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 -169.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.02 -7.66 31.0 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.872 -1.142 . . . . 25.0 113.336 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.25 -7.66 53.49 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.761 -1.212 . . . . 25.0 110.89 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -52.0 -40.09 60.44 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 105.415 -2.069 . . . . 50.0 105.415 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.54 -74.61 0.02 OUTLIER Glycine 0 N--CA 1.477 1.4 0 N-CA-C 105.753 -2.939 . . . . 25.0 105.753 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -173.49 -33.28 0.01 OUTLIER 'General case' 0 C--O 1.274 2.358 0 C-N-CA 127.274 2.23 . . . . 50.0 109.452 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.22 -17.75 6.06 Favored 'General case' 0 C--N 1.312 -1.049 1 N-CA-C 124.621 5.045 . . . . 50.0 124.621 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -111.68 164.69 12.75 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 108.451 -0.944 . . . . 25.0 108.451 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -164.91 169.98 15.87 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.234 -0.587 . . . . 50.0 111.365 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -153.5 55.8 0.75 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 106.475 -1.676 . . . . 25.0 106.475 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.5 t -66.02 -31.5 72.43 Favored 'General case' 0 N--CA 1.407 -2.597 0 CA-C-O 117.274 -1.346 . . . . 25.0 114.595 -160.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.39 39.65 91.59 Favored Glycine 0 CA--C 1.557 2.703 0 C-N-CA 119.582 -1.294 . . . . 25.0 114.701 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.0 m -53.32 -3.89 0.03 OUTLIER 'General case' 0 CA--C 1.586 2.332 0 CA-C-N 111.21 -2.495 . . . . 25.0 115.446 -168.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.27 -16.94 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 C-N-CA 128.484 2.714 . . . . 50.0 107.52 169.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -75.18 25.24 0.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.643 2.46 . . . . 25.0 117.643 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -63.61 -50.17 70.43 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 120.674 1.579 . . . . 50.0 113.538 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -135.69 42.8 0.78 Allowed Pre-proline 0 N--CA 1.517 2.911 0 N-CA-C 117.347 2.351 . . . . 25.0 117.347 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.43 -15.72 12.36 Favored 'Trans proline' 0 C--N 1.375 1.941 1 C-N-CA 108.82 -6.987 . . . . 25.0 118.324 -170.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -71.7 -39.17 70.38 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -83.86 51.76 2.12 Favored 'General case' 0 C--O 1.266 1.921 0 CA-C-N 113.265 -1.788 . . . . 25.0 112.408 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.4 tp -87.18 111.45 20.99 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.29 1.043 . . . . 50.0 108.325 170.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -78.45 161.78 26.86 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-O 124.869 2.271 . . . . 25.0 110.558 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.69 144.67 50.47 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 104.89 -2.263 . . . . 25.0 104.89 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -135.69 146.25 47.56 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 106.314 -1.735 . . . . 25.0 106.314 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -90.43 145.55 24.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.63 -2.359 . . . . 25.0 104.63 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.6 -151.97 43.85 Favored Glycine 0 C--O 1.198 -2.111 0 N-CA-C 106.347 -2.701 . . . . 25.0 106.347 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . 0.308 42.9 m-85 -135.02 172.01 7.99 Favored Pre-proline 0 C--O 1.249 1.051 0 N-CA-C 102.412 -3.181 . . . . 25.0 102.412 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -76.85 -178.26 23.6 Favored 'Cis proline' 0 N--CA 1.492 1.422 0 O-C-N 119.194 -1.003 . . . . 25.0 111.42 -2.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -122.91 -16.92 6.94 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.631 1.172 . . . . 25.0 111.464 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t 70.4 -61.08 0.48 Allowed 'General case' 0 C--O 1.292 3.293 0 C-N-CA 127.061 2.144 . . . . 25.0 109.844 -171.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.91 -163.29 5.01 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-O 125.088 2.493 . . . . 25.0 111.582 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.57 165.03 32.56 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 CA-C-O 115.845 -1.814 . . . . 25.0 113.797 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.46 135.65 56.6 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.835 1.334 . . . . 25.0 113.848 -172.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -129.02 178.44 6.4 Favored 'General case' 0 C--N 1.306 -1.31 1 N-CA-C 97.134 -5.136 . . . . 25.0 97.134 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.28 21.0 57.86 Favored Glycine 0 CA--C 1.468 -2.86 0 N-CA-C 109.798 -1.321 . . . . 25.0 109.798 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -111.46 22.39 15.15 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.482 0.658 . . . . 25.0 112.316 -169.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mt -70.83 -38.54 73.04 Favored 'Isoleucine or valine' 0 C--O 1.272 2.266 0 O-C-N 120.421 -1.424 . . . . 25.0 113.594 -173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.63 72.14 Favored 'General case' 0 C--O 1.265 1.897 0 CA-C-N 119.997 1.271 . . . . 25.0 112.377 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.0 p -73.15 -9.24 58.51 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 119.755 -1.841 . . . . 25.0 111.312 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.95 27.44 2.41 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 125.833 1.653 . . . . 25.0 115.269 -169.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.7 -31.09 65.41 Favored Glycine 0 C--O 1.246 0.855 0 N-CA-C 105.2 -3.16 . . . . 25.0 105.2 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.86 14.14 59.33 Favored Glycine 0 C--O 1.254 1.388 0 CA-C-N 119.12 1.46 . . . . 25.0 112.988 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.6 mt -125.88 -73.69 0.62 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 116.222 -1.847 . . . . 50.0 111.714 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.75 -32.75 73.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 125.982 2.051 . . . . 50.0 108.726 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.85 -13.28 69.86 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 125.079 2.489 . . . . 25.0 112.094 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.03 0.11 87.88 Favored Glycine 0 CA--C 1.488 -1.644 0 CA-C-N 112.921 -1.639 . . . . 25.0 112.082 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.9 -28.03 39.88 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 O-C-N 121.578 -0.954 . . . . 25.0 110.827 168.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.45 -22.99 61.0 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 117.611 -1.185 . . . . 75.0 112.097 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.17 -23.95 51.52 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.54 1.063 . . . . 50.0 110.116 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -87.02 11.78 12.86 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 125.324 1.64 . . . . 25.0 110.168 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -132.56 23.45 4.36 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.212 1.958 . . . . 25.0 110.636 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.7 t -87.94 155.97 19.58 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 114.496 -1.229 . . . . 25.0 109.487 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.57 -35.73 66.08 Favored 'General case' 0 CA--C 1.484 -1.561 0 O-C-N 120.334 -1.479 . . . . 25.0 112.115 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -79.45 -4.39 50.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.851 2.537 . . . . 25.0 117.851 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -74.95 86.1 2.28 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 111.742 -2.481 . . . . 25.0 113.081 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -76.52 175.77 8.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 109.194 -3.639 . . . . 25.0 111.391 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -75.98 152.81 36.91 Favored 'General case' 0 C--O 1.192 -1.95 0 CA-C-N 112.129 -2.305 . . . . 50.0 115.431 -144.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -75.28 128.48 35.53 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.843 -1.143 . . . . 25.0 109.913 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -84.5 130.55 34.74 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.394 -2.066 . . . . 25.0 108.501 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.17 125.9 44.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mmt -131.01 129.03 41.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 115.651 -2.119 . . . . 25.0 107.559 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.7 p -80.57 173.88 12.16 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 127.713 3.133 . . . . 25.0 107.685 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.91 159.69 46.04 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 117.693 1.837 . . . . 25.0 117.693 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 174.05 25.21 Favored Glycine 0 C--O 1.216 -1.001 0 CA-C-N 112.161 -2.019 . . . . 25.0 112.067 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.51 148.42 31.83 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 118.045 -3.032 . . . . 25.0 108.845 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.08 154.05 49.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.287 -1.746 . . . . 25.0 106.287 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.9 m -83.64 138.54 33.29 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.597 -1.241 . . . . 25.0 111.761 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . 0.294 71.0 m-85 -124.88 123.85 40.81 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 102.363 -3.199 . . . . 50.0 102.363 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.9 m -139.37 137.78 36.02 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.984 -1.858 . . . . 25.0 105.984 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -120.52 147.07 45.64 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 116.288 -1.815 . . . . 25.0 106.612 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 t -122.26 137.19 54.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.932 1.395 . . . . 25.0 107.368 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.22 158.15 36.4 Favored 'General case' 0 C--O 1.188 -2.132 0 CA-C-O 124.28 1.991 . . . . 50.0 113.311 -172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 p -120.04 16.14 12.46 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 102.964 -2.976 . . . . 25.0 102.964 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.42 125.29 79.18 Favored Pre-proline 0 C--O 1.255 1.366 0 CA-C-O 113.456 -3.164 . . . . 25.0 111.847 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -88.47 -6.5 6.06 Favored 'Trans proline' 0 C--N 1.292 -2.395 0 N-CA-C 108.954 -1.21 . . . . 25.0 108.954 156.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -56.03 139.01 48.16 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.165 -1.38 . . . . 25.0 114.526 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.44 109.28 20.41 Favored 'General case' 0 C--O 1.202 -1.437 0 N-CA-C 114.63 1.344 . . . . 25.0 114.63 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.7 m -66.21 148.44 51.84 Favored 'General case' 0 C--O 1.192 -1.946 0 N-CA-C 106.231 -1.766 . . . . 25.0 106.231 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 p -100.49 -42.06 6.74 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 124.258 1.98 . . . . 25.0 110.09 166.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -164.99 144.2 6.77 Favored 'General case' 0 C--O 1.191 -1.995 0 O-C-N 118.788 -2.445 . . . . 25.0 113.062 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.42 139.64 38.99 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 115.085 -2.646 . . . . 25.0 109.716 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.4 152.08 36.38 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.014 -1.678 . . . . 25.0 110.195 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.19 143.56 40.27 Favored 'General case' 0 C--O 1.197 -1.702 0 O-C-N 127.68 3.113 . . . . 50.0 110.9 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.87 166.63 17.12 Favored 'General case' 0 C--O 1.258 1.527 0 N-CA-C 106.39 -1.707 . . . . 50.0 106.39 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 pt -120.99 154.88 24.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 102.694 -3.076 . . . . 25.0 102.694 161.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.5 p -74.97 151.82 38.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.798 -1.189 . . . . 25.0 111.124 163.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -122.29 133.42 54.68 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.216 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.0 157.87 32.36 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 126.429 1.892 . . . . 25.0 108.734 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.87 38.56 7.94 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 118.121 -2.862 . . . . 25.0 118.333 165.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 168.5 9.7 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -144.08 124.29 7.58 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 114.814 -1.085 . . . . 25.0 109.96 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -58.26 -30.08 89.77 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 114.289 -3.341 . . . . 25.0 118.297 172.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.23 1.02 5.27 Favored 'General case' 0 C--O 1.198 -1.634 0 C-N-CA 116.542 -2.063 . . . . 75.0 115.403 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -132.84 173.13 6.25 Favored Pre-proline 0 C--O 1.199 -1.589 0 N-CA-C 104.849 -2.278 . . . . 25.0 104.849 -167.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 27.1 Cg_exo -50.65 20.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.398 2 C-N-CA 129.738 6.959 . . . . 25.0 124.732 173.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -16.71 -49.82 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.017 1 N-CA-C 121.959 4.059 . . . . 50.0 121.959 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -77.58 -8.56 58.03 Favored 'General case' 0 CA--C 1.479 -1.76 1 O-C-N 114.005 -5.434 . . . . 25.0 113.306 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -108.85 -40.73 4.95 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 126.728 2.011 . . . . 25.0 114.76 164.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 109' ' ' PRO . . . -79.27 13.97 1.69 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 127.791 3.182 . . . . 25.0 114.358 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -26.88 67.87 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.481 -0.933 . . . . 25.0 108.481 168.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -137.31 174.14 10.93 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 119.391 3.108 . . . . 50.0 119.391 -171.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -127.8 128.93 46.14 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.566 -1.197 . . . . 25.0 108.265 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 tp -70.16 123.35 21.41 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 103.46 -2.793 . . . . 50.0 103.46 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.9 pt -105.68 -12.93 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.54 1.162 . . . . 25.0 107.937 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.96 154.19 11.68 Favored Glycine 0 CA--C 1.501 -0.81 0 O-C-N 119.117 -2.239 . . . . 25.0 116.791 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.39 139.95 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 126.362 1.86 . . . . 25.0 109.944 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 t -134.69 103.64 11.05 Favored Pre-proline 0 CA--C 1.572 1.8 0 CA-C-O 125.727 2.68 . . . . 50.0 116.863 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.15 157.44 37.97 Favored 'Trans proline' 0 C--O 1.252 1.211 0 O-C-N 115.971 -2.7 . . . . 25.0 108.656 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -82.55 106.48 14.44 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-O 123.917 1.818 . . . . 25.0 110.37 171.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -140.12 -46.53 0.43 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 120.276 3.435 . . . . 50.0 120.276 -174.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 156.17 175.57 27.3 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 105.581 -3.008 . . . . 25.0 105.581 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 p 59.46 162.4 0.1 OUTLIER Pre-proline 0 C--O 1.251 1.176 0 N-CA-C 119.491 3.145 . . . . 25.0 119.491 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.63 1.98 3.87 Favored 'Trans proline' 0 C--N 1.371 1.716 1 C-N-CA 113.147 -4.102 . . . . 25.0 118.591 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -43.12 57.18 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 123.642 1.687 . . . . 25.0 109.877 172.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.1 t -77.46 -26.67 51.65 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.819 -4.301 . . . . 25.0 111.576 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -67.26 -20.86 65.72 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 125.197 2.427 . . . . 25.0 115.614 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -62.31 127.69 32.51 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 112.071 -2.331 . . . . 25.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.5 tp -122.21 4.12 9.78 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.403 -1.702 . . . . 75.0 106.403 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.5 t -128.85 136.36 50.35 Favored 'General case' 0 CA--C 1.47 -2.131 0 N-CA-C 102.442 -3.17 . . . . 25.0 102.442 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -147.88 153.24 38.85 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 106.053 -1.832 . . . . 25.0 106.053 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.823 -1.561 . . . . 25.0 107.925 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.23 129.65 75.43 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-O 113.113 -3.327 . . . . 25.0 108.852 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -73.9 135.51 43.31 Favored 'General case' 0 C--O 1.187 -2.189 0 O-C-N 128.725 3.766 . . . . 50.0 114.173 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.4 mm -113.07 121.67 37.62 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 115.833 -2.032 . . . . 25.0 108.095 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -58.12 147.38 83.65 Favored 'Trans proline' 0 CA--C 1.483 -2.054 1 C-N-CA 112.099 -4.801 . . . . 25.0 114.946 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.08 -11.24 47.68 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 111.557 -2.565 . . . . 25.0 112.555 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -112.19 -9.26 13.94 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 118.818 -1.153 . . . . 50.0 111.464 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -108.99 160.91 15.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 118.921 -2.362 . . . . 25.0 112.387 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 170' ' ' VAL 0.304 2.6 mp -138.95 132.92 31.09 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 128.191 2.596 . . . . 50.0 106.572 178.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.3 148.89 5.25 Favored Glycine 0 C--O 1.272 2.498 0 CA-C-O 127.078 3.599 . . . . 25.0 118.575 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.88 143.78 57.58 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 108.671 -3.765 . . . . 50.0 109.364 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -151.02 165.5 33.59 Favored 'General case' 0 C--O 1.269 2.094 0 N-CA-C 101.561 -3.496 . . . . 25.0 101.561 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.42 136.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 104.243 -2.503 . . . . 50.0 104.243 166.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -78.48 125.96 38.3 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 CA-C-O 114.711 -2.566 . . . . 25.0 106.031 164.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.36 131.62 53.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 103.104 -2.925 . . . . 50.0 103.104 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.29 146.15 44.32 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-O 126.345 2.974 . . . . 25.0 107.003 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -128.27 138.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 119.961 -1.712 . . . . 50.0 107.985 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -138.47 94.56 2.87 Favored 'General case' 0 C--O 1.196 -1.729 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -96.58 146.33 24.92 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-O 126.113 2.863 . . . . 25.0 105.184 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . 0.25 41.3 t -116.82 128.29 74.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 111.16 -2.745 . . . . 50.0 109.196 -169.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.56 -29.63 62.55 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.616 1.966 . . . . 25.0 110.579 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.05 -20.8 60.91 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 114.787 1.402 . . . . 25.0 114.787 -169.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.1 t -151.55 159.15 44.24 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 116.791 -1.576 . . . . 25.0 107.951 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.07 -1.36 28.6 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 117.765 -1.112 . . . . 25.0 112.596 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -103.34 160.57 14.58 Favored 'General case' 0 CA--C 1.569 1.695 0 O-C-N 124.91 1.381 . . . . 25.0 108.463 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.4 -173.89 4.52 Favored 'General case' 0 C--O 1.189 -2.093 0 O-C-N 120.304 -1.497 . . . . 25.0 109.545 -167.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -113.42 148.22 36.28 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.516 -1.661 . . . . 50.0 106.516 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -146.48 118.48 8.22 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.356 -2.461 . . . . 50.0 104.356 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.99 153.29 49.42 Favored 'General case' 0 C--O 1.265 1.899 0 O-C-N 120.734 -1.229 . . . . 25.0 110.063 -164.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.17 152.05 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 125.558 1.786 . . . . 75.0 108.367 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.2 mt -140.57 121.82 14.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.675 0 N-CA-C 105.046 -2.205 . . . . 25.0 105.046 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.47 142.67 44.85 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.522 -1.361 . . . . 25.0 108.632 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.2 163.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 124.903 1.377 . . . . 50.0 109.715 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -133.88 103.56 5.89 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.8 mt -99.73 133.51 43.98 Favored 'General case' 0 C--O 1.16 -3.611 0 N-CA-C 103.289 -2.856 . . . . 50.0 103.289 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 16.0 m -139.17 179.03 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-O 123.743 1.735 . . . . 50.0 111.908 -174.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -64.94 172.21 3.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.748 -2.478 . . . . 25.0 115.969 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 114.784 -2.531 . . . . 25.0 107.985 -177.409 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.511 2.612 0 CA-C-O 123.853 1.787 . . . . 25.0 111.216 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.87 -160.92 30.3 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 111.829 -2.441 . . . . 25.0 118.642 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -156.06 157.34 35.92 Favored 'General case' 0 C--O 1.261 1.683 0 N-CA-C 105.123 -2.177 . . . . 50.0 105.123 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.2 mm -84.09 110.26 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 O-C-N 119.47 -2.018 . . . . 25.0 107.286 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.96 -38.78 20.57 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 123.044 2.657 . . . . 25.0 109.946 170.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.82 149.25 63.82 Favored Pre-proline 0 N--CA 1.518 2.974 0 N-CA-C 104.004 -2.591 . . . . 25.0 104.004 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.07 160.69 93.42 Favored 'Cis proline' 0 C--O 1.252 1.213 0 C-N-CA 129.47 1.029 . . . . 25.0 113.159 -9.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.0 -173.09 52.09 Favored Glycine 0 C--N 1.286 -2.23 0 N-CA-C 117.84 1.896 . . . . 25.0 117.84 155.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 t -153.59 75.96 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 103.009 -2.96 . . . . 25.0 103.009 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -70.55 -7.91 47.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.436 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.28 -40.74 49.16 Favored 'General case' 0 C--O 1.255 1.369 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 161.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.4 67.6 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 114.359 1.244 . . . . 25.0 114.359 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 mt -85.14 -11.15 55.77 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-O 122.743 1.259 . . . . 75.0 113.73 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.8 t -92.34 -25.6 18.47 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 125.768 2.699 . . . . 25.0 113.86 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -70.09 150.23 46.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 119.273 -2.142 . . . . 25.0 110.389 168.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -77.55 6.47 7.08 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.064 1.302 . . . . 25.0 110.398 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.11 -15.96 62.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.066 -1.646 . . . . 25.0 109.517 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -51.58 -18.97 1.29 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 118.069 -2.894 . . . . 50.0 118.329 163.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.55 7.8 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 120.72 3.048 . . . . 25.0 120.72 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 43.52 8.67 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 119.88 3.289 . . . . 50.0 119.88 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 mt -80.53 -41.21 24.6 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 123.92 3.055 . . . . 50.0 106.83 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -147.05 174.85 11.16 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 126.345 2.278 . . . . 25.0 105.472 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.56 160.26 25.63 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-O 123.386 1.565 . . . . 50.0 111.29 162.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -140.87 5.5 1.96 Allowed 'General case' 0 CA--C 1.577 1.993 0 C-N-CA 126.434 1.893 . . . . 25.0 113.041 -171.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -74.31 -43.26 57.47 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 115.404 1.631 . . . . 25.0 115.404 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.73 119.04 1.37 Allowed Glycine 0 CA--C 1.542 1.775 0 N-CA-C 108.728 -1.749 . . . . 25.0 108.728 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.92 -13.03 42.36 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.904 -0.762 . . . . 25.0 111.59 -169.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -62.93 -14.63 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.59 -1.263 . . . . 50.0 107.59 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.39 -15.63 0.15 Allowed 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 121.0 3.704 . . . . 25.0 121.0 167.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.3 -34.1 73.31 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-N 114.983 -1.008 . . . . 50.0 109.15 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.02 47.02 0.54 Allowed Pre-proline 0 C--O 1.294 3.447 0 N-CA-C 118.172 2.656 . . . . 25.0 118.172 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.75 -11.37 31.72 Favored 'Trans proline' 0 CA--C 1.487 -1.874 0 C-N-CA 121.372 1.381 . . . . 25.0 111.966 -159.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -116.98 6.75 13.02 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.74 0.7 . . . . 25.0 112.363 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -89.83 55.73 3.26 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 117.906 -2.996 . . . . 25.0 112.17 -171.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.3 mt -103.67 96.08 6.48 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 118.009 -0.996 . . . . 50.0 112.964 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -123.87 157.4 34.28 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 103.721 -2.696 . . . . 25.0 103.721 166.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.84 42.2 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.713 -2.039 . . . . 25.0 110.225 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.02 150.07 47.03 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 121.992 2.178 . . . . 25.0 108.693 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -60.21 155.33 17.72 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.808 0.843 . . . . 25.0 111.605 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.92 99.93 2.26 Favored Glycine 0 C--O 1.198 -2.118 0 N-CA-C 117.493 1.757 . . . . 25.0 117.493 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -125.41 98.55 34.89 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 104.305 -2.48 . . . . 25.0 104.305 171.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -85.72 175.39 31.27 Favored 'Cis proline' 0 N--CA 1.507 2.274 0 CA-C-N 121.635 1.62 . . . . 25.0 113.315 -2.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -64.19 -33.25 75.36 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 113.066 0.765 . . . . 25.0 113.066 -168.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 t 56.58 -113.75 0.78 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 119.471 3.137 . . . . 25.0 119.471 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.67 150.43 51.42 Favored Glycine 0 CA--C 1.485 -1.788 0 CA-C-N 122.331 2.332 . . . . 25.0 109.364 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.51 -31.19 9.15 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 CA-C-N 122.282 3.041 . . . . 25.0 118.586 -166.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . 0.27 . . -66.84 126.4 28.94 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 117.656 2.465 . . . . 25.0 117.656 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -66.77 140.26 57.84 Favored 'General case' 0 CA--C 1.572 1.801 0 O-C-N 120.738 -1.226 . . . . 25.0 113.05 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.21 -10.82 73.56 Favored Glycine 0 C--O 1.295 3.921 0 CA-C-O 121.948 0.749 . . . . 25.0 113.842 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . 0.342 8.4 mm-40 -109.64 -0.46 18.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 121.058 -1.26 . . . . 25.0 113.373 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.12 -45.21 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 N-CA-C 118.451 2.759 . . . . 25.0 118.451 -162.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.09 5.33 11.3 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 124.959 1.304 . . . . 25.0 109.33 173.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -84.62 -13.78 50.61 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 119.137 -2.227 . . . . 25.0 112.335 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 66.89 10.37 7.56 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 128.813 2.845 . . . . 25.0 111.27 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.53 -14.78 80.83 Favored Glycine 0 C--N 1.308 -0.995 0 N-CA-C 116.742 1.457 . . . . 25.0 116.742 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.16 -1.19 82.09 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 112.52 -1.84 . . . . 25.0 113.06 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.4 mt -87.18 99.67 12.11 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-O 126.574 3.083 . . . . 50.0 104.696 172.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -73.69 -24.48 59.96 Favored 'General case' 0 CA--C 1.481 -1.678 1 O-C-N 116.272 -4.018 . . . . 50.0 113.975 -174.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -36.84 80.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-O 124.374 2.097 . . . . 25.0 108.239 167.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.85 -31.28 72.7 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 119.992 -1.887 . . . . 25.0 113.809 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.17 -50.23 65.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 117.582 -3.305 . . . . 25.0 110.432 167.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.98 -26.9 67.04 Favored 'General case' 1 C--O 1.319 4.725 0 CA-C-N 121.593 1.997 . . . . 75.0 107.418 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.11 -29.53 67.61 Favored 'General case' 0 C--O 1.27 2.133 0 C-N-CA 119.997 -0.681 . . . . 50.0 110.121 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -79.11 56.81 2.09 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-O 123.444 1.592 . . . . 25.0 109.391 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -91.94 60.41 3.84 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 118.644 -2.535 . . . . 25.0 106.39 167.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.0 p -146.97 -164.2 1.94 Allowed 'General case' 0 C--O 1.273 2.342 0 CA-C-N 111.303 -2.681 . . . . 25.0 116.633 -164.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.44 -26.92 68.76 Favored 'General case' 0 C--O 1.267 1.981 0 O-C-N 119.604 -1.935 . . . . 25.0 111.17 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -87.35 16.01 5.81 Favored 'General case' 0 C--O 1.264 1.845 0 N-CA-C 116.01 1.856 . . . . 25.0 116.01 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -75.21 89.39 2.53 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 123.879 1.799 . . . . 25.0 108.676 173.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -18.49 142.79 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 108.596 -3.911 . . . . 25.0 121.148 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.13 125.79 26.07 Favored 'General case' 0 N--CA 1.42 -1.949 0 O-C-N 125.459 1.724 . . . . 50.0 111.546 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -117.78 149.74 40.29 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 119.213 3.042 . . . . 25.0 119.213 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -142.61 126.07 16.73 Favored 'General case' 0 CA--C 1.591 2.538 0 N-CA-C 117.276 2.324 . . . . 25.0 117.276 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.54 125.37 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 O-C-N 117.735 -3.103 . . . . 25.0 106.919 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttt -148.06 161.84 40.59 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 102.539 -3.134 . . . . 25.0 102.539 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 64.6 p -88.71 166.67 13.91 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 119.672 -1.893 . . . . 25.0 112.209 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.87 176.41 51.1 Favored Glycine 0 C--O 1.256 1.499 0 C-N-CA 116.792 -2.623 . . . . 25.0 115.704 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.89 -171.79 19.12 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 105.118 -3.193 . . . . 25.0 105.118 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.64 141.1 58.89 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 103.792 -2.67 . . . . 25.0 103.792 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -111.26 144.34 40.59 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 101.814 -3.402 . . . . 25.0 101.814 158.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -126.15 120.83 31.13 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 100.996 -3.705 . . . . 25.0 100.996 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.44 ' CE2' HD12 ' A' ' 136' ' ' ILE . 77.9 m-85 -114.59 119.33 36.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 118.73 -2.481 . . . . 50.0 109.61 -172.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 m -131.61 97.26 4.17 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 100.019 -4.067 . . . . 25.0 100.019 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -112.53 116.28 29.99 Favored 'General case' 1 N--CA 1.539 4.01 0 O-C-N 126.614 2.446 . . . . 25.0 106.657 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.251 2.1 p -127.07 157.33 39.91 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 125.56 1.788 . . . . 25.0 106.228 -162.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -113.52 140.43 48.14 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 127.503 2.321 . . . . 50.0 107.097 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -88.1 -9.59 52.79 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 123.807 1.765 . . . . 25.0 108.773 -169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.94 149.1 38.05 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 101.639 -3.467 . . . . 25.0 101.639 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.68 147.36 75.72 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 118.167 -0.755 . . . . 25.0 113.558 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -141.85 141.83 33.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 117.647 -1.168 . . . . 25.0 110.935 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -80.75 159.58 25.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 117.99 -1.484 . . . . 25.0 113.776 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.9 m -150.48 148.23 28.47 Favored 'General case' 0 C--O 1.208 -1.122 0 C-N-CA 125.903 1.681 . . . . 25.0 109.695 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.7 p -111.21 -29.39 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.583 1.953 . . . . 25.0 112.486 170.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -166.96 158.87 12.84 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.405 1.482 . . . . 25.0 107.777 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -143.74 146.35 33.08 Favored 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 2.2 m-70 -144.48 149.37 35.85 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 120.329 -1.482 . . . . 25.0 110.59 -167.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -130.59 134.7 47.21 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 113.097 -1.865 . . . . 50.0 110.776 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.33 171.09 11.81 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 103.493 -2.78 . . . . 50.0 103.493 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.39 155.95 41.17 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 N-CA-C 103.321 -2.844 . . . . 25.0 103.321 167.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.295 33.5 p -81.52 153.91 26.55 Favored 'General case' 0 CA--C 1.469 -2.173 0 CA-C-O 124.096 1.903 . . . . 25.0 106.925 165.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -87.85 107.99 18.95 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 112.392 -2.185 . . . . 25.0 110.884 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -49.57 117.7 2.37 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 105.696 -1.965 . . . . 25.0 105.696 155.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.66 33.28 34.77 Favored Glycine 0 C--O 1.192 -2.515 0 CA-C-O 117.693 -1.615 . . . . 25.0 115.726 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -51.02 159.83 0.55 Allowed 'General case' 0 C--O 1.259 1.576 0 CA-C-O 122.267 1.032 . . . . 25.0 108.446 169.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -102.9 107.49 55.06 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 102.075 -3.306 . . . . 25.0 102.075 167.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -72.54 -16.34 27.24 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.552 2.168 . . . . 25.0 116.28 -173.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -84.2 -2.61 57.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.392 -1.731 . . . . 75.0 106.873 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -132.48 154.54 81.58 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 103.513 -2.773 . . . . 25.0 103.513 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.381 72.4 Cg_exo -25.64 91.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.285 3 C-N-CA 125.506 4.138 . . . . 25.0 122.529 -167.468 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.42 -15.34 61.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 110.883 -2.871 . . . . 50.0 112.928 -171.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 6.36 11.21 Favored 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 120.027 -1.671 . . . . 25.0 111.866 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -136.62 -46.11 0.6 Allowed 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 118.166 2.654 . . . . 25.0 118.166 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.35 -4.48 53.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.44 1.644 . . . . 25.0 115.44 165.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.61 7.8 16.22 Favored 'General case' 0 C--O 1.274 2.346 0 C-N-CA 125.645 1.578 . . . . 25.0 114.917 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -141.69 166.95 23.34 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 126.041 2.088 . . . . 50.0 106.95 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -134.27 154.41 51.3 Favored 'General case' 0 C--O 1.176 -2.796 0 N-CA-C 105.954 -1.869 . . . . 25.0 105.954 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.32 120.72 38.21 Favored 'General case' 0 CA--C 1.58 2.097 0 O-C-N 120.507 -1.371 . . . . 50.0 112.647 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.292 4.8 tp -98.13 -19.51 5.94 Favored 'Isoleucine or valine' 0 C--O 1.274 2.352 0 C-N-CA 126.738 2.015 . . . . 25.0 106.416 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.77 164.93 26.31 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 113.331 -1.759 . . . . 25.0 117.149 162.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . . . -138.84 157.65 45.66 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 101.531 -3.507 . . . . 25.0 101.531 166.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.9 130.44 13.01 Favored Pre-proline 0 C--O 1.245 0.866 0 N-CA-C 102.832 -3.025 . . . . 50.0 102.832 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.01 168.86 11.92 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 116.847 -1.636 . . . . 25.0 111.898 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -129.76 56.3 1.73 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.9 0.75 . . . . 25.0 109.57 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -123.93 -0.1 8.5 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 124.474 2.083 . . . . 50.0 113.316 -164.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -167.7 -165.72 25.58 Favored Glycine 0 C--O 1.258 1.608 0 N-CA-C 103.919 -3.673 . . . . 25.0 103.919 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.1 t -120.68 69.67 16.9 Favored Pre-proline 0 CA--C 1.556 1.19 0 O-C-N 126.411 1.889 . . . . 25.0 115.318 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.3 178.79 7.2 Favored 'Trans proline' 0 CA--C 1.578 2.682 0 C-N-CA 121.613 1.542 . . . . 25.0 112.618 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.67 71.31 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.36 2.14 2.5 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.992 1.317 . . . . 25.0 114.312 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -70.94 -16.8 62.68 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 124.162 1.934 . . . . 25.0 111.04 170.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -68.24 125.77 27.45 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 103.906 -2.627 . . . . 25.0 103.906 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.8 tp -75.81 -7.14 53.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 118.25 -1.38 . . . . 75.0 113.997 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.9 t -85.23 144.53 28.07 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 104.705 -2.331 . . . . 25.0 104.705 173.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -137.79 135.78 36.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.178 0.806 . . . . 25.0 113.178 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -101.47 128.42 47.69 Favored 'General case' 0 C--O 1.301 3.807 0 CA-C-O 123.272 1.51 . . . . 25.0 108.912 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 82' ' ' PHE . 46.3 mt -118.32 120.98 66.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 116.089 -2.244 . . . . 25.0 108.166 175.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -83.33 117.64 23.14 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 115.255 -2.578 . . . . 50.0 110.019 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.77 97.25 27.59 Favored Pre-proline 0 C--O 1.275 2.424 0 CA-C-O 123.321 1.534 . . . . 25.0 108.686 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 132.96 20.84 Favored 'Trans proline' 0 C--N 1.372 1.771 1 C-N-CA 113.121 -4.119 . . . . 25.0 110.298 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.43 97.06 3.14 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 117.321 -3.362 . . . . 25.0 109.979 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.69 -13.02 30.0 Favored 'General case' 0 C--O 1.267 1.977 0 N-CA-C 104.87 -2.27 . . . . 50.0 104.87 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -106.83 -173.68 2.35 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.643 -1.91 . . . . 25.0 112.82 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.53 129.87 45.05 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.169 -1.582 . . . . 50.0 111.609 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 152.9 -179.95 28.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 124.707 2.282 . . . . 25.0 116.113 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.14 158.84 38.58 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 117.113 -3.581 . . . . 50.0 117.192 -153.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -158.99 168.6 26.32 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 120.579 -1.325 . . . . 25.0 110.292 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.16 135.31 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.065 0 N-CA-C 103.775 -2.676 . . . . 50.0 103.775 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 mt -85.08 134.98 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 100.758 -3.793 . . . . 25.0 100.758 167.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.4 mt -116.5 135.18 54.05 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.387 -2.079 . . . . 50.0 105.387 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.7 136.59 54.94 Favored 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 97.282 -5.081 . . . . 25.0 97.282 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.5 120.44 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 O-C-N 125.491 1.744 . . . . 50.0 108.481 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.89 121.86 35.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.071 1.76 . . . . 25.0 107.881 -175.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -102.77 134.53 46.02 Favored 'General case' 0 N--CA 1.407 -2.625 0 O-C-N 120.413 -1.43 . . . . 25.0 110.346 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.59 99.11 3.65 Favored 'Isoleucine or valine' 0 C--O 1.262 1.747 0 N-CA-C 105.93 -1.878 . . . . 50.0 105.93 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.34 66.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 117.138 -1.825 . . . . 25.0 113.167 -167.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.3 -16.69 55.98 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.379 -1.282 . . . . 25.0 113.13 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.9 p -109.68 164.64 12.35 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 120.15 1.341 . . . . 25.0 109.621 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -81.75 -36.88 28.04 Favored 'General case' 0 C--O 1.285 2.933 0 CA-C-O 123.699 1.714 . . . . 25.0 110.38 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.61 154.38 20.02 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 112.369 -2.196 . . . . 25.0 108.378 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -111.0 158.15 19.12 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 124.941 1.297 . . . . 25.0 111.411 168.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -109.94 142.71 40.91 Favored 'General case' 0 C--O 1.269 2.104 0 O-C-N 119.391 -2.068 . . . . 50.0 109.032 -165.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.16 162.34 41.06 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-O 123.459 1.599 . . . . 50.0 111.872 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -138.86 157.6 45.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.921 -1.112 . . . . 25.0 108.047 166.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.1 133.04 63.2 Favored 'Isoleucine or valine' 0 C--O 1.258 1.53 0 O-C-N 120.117 -1.614 . . . . 75.0 109.363 165.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.2 mt -136.1 119.64 23.71 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 N-CA-C 102.421 -3.177 . . . . 25.0 102.421 -169.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -83.42 133.42 34.92 Favored 'General case' 0 CA--C 1.613 3.376 0 CA-C-O 123.094 1.426 . . . . 25.0 111.241 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.53 144.33 38.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 O-C-N 119.76 -1.838 . . . . 50.0 111.577 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.78 135.14 54.97 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 100.626 -3.842 . . . . 25.0 100.626 167.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 mt -126.36 129.34 48.61 Favored 'General case' 0 C--O 1.294 3.431 0 N-CA-C 104.75 -2.315 . . . . 50.0 104.75 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.01 163.9 30.78 Favored 'Isoleucine or valine' 0 C--O 1.277 2.523 0 N-CA-C 115.714 1.746 . . . . 50.0 115.714 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -71.01 134.36 47.07 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.161 -0.962 . . . . 25.0 111.638 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.657 -1.163 . . . . 25.0 112.826 -173.622 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . 0.259 47.0 p-80 . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 122.897 1.332 . . . . 25.0 109.553 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.52 -165.02 38.85 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-O 116.546 -2.252 . . . . 25.0 114.783 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.71 151.58 33.89 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-N 122.18 2.99 . . . . 50.0 116.056 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 6' ' ' LYS . 43.9 mm -66.78 132.09 32.26 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.722 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.11 39.98 3.42 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 126.4 3.0 . . . . 25.0 107.454 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.577 ' H ' HG22 ' A' ' 4' ' ' ILE . 96.2 mttt 72.09 163.53 0.14 Allowed Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 108.512 -3.949 . . . . 25.0 115.078 169.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.78 122.05 0.42 Allowed 'Cis proline' 0 C--N 1.357 0.98 0 C-N-CA 133.055 2.523 . . . . 25.0 114.14 3.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.47 147.93 13.28 Favored Glycine 0 C--O 1.252 1.238 0 CA-C-N 114.019 -1.446 . . . . 25.0 111.239 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -145.92 134.58 22.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.406 -1.643 . . . . 25.0 108.45 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -75.16 -17.1 60.46 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 117.086 -3.509 . . . . 25.0 111.88 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.78 56.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 116.374 -1.774 . . . . 25.0 107.65 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.72 63.32 Favored 'General case' 1 C--O 1.306 4.054 0 CA-C-N 122.002 2.183 . . . . 25.0 109.642 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.64 -8.42 59.19 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.142 -0.974 . . . . 75.0 110.021 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.1 t -78.32 -15.39 58.78 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 114.358 1.244 . . . . 25.0 114.358 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 t -80.88 137.52 36.16 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 114.77 -1.105 . . . . 25.0 110.048 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.91 -19.42 34.78 Favored 'General case' 0 C--O 1.184 -2.345 0 N-CA-C 105.486 -2.042 . . . . 25.0 105.486 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.89 79.65 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-O 122.8 1.286 . . . . 25.0 113.783 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.27 -25.81 67.35 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.126 -1.609 . . . . 50.0 109.659 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.68 18.48 29.51 Favored Glycine 0 C--O 1.184 -2.977 0 CA-C-N 122.357 2.344 . . . . 25.0 109.493 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.4 t80 57.11 -51.56 0.03 OUTLIER 'General case' 0 C--O 1.204 -1.307 0 C-N-CA 128.732 2.813 . . . . 50.0 114.826 -169.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.6 mt -133.91 10.68 3.94 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.23 1.412 . . . . 50.0 112.46 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -141.59 167.38 22.29 Favored 'General case' 0 C--O 1.19 -2.046 0 N-CA-C 104.165 -2.532 . . . . 25.0 104.165 -173.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.38 169.81 23.38 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 104.235 -2.506 . . . . 50.0 104.235 -172.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -159.19 68.43 0.43 Allowed 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 105.731 -1.951 . . . . 25.0 105.731 -173.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.9 t -69.27 -33.2 72.85 Favored 'General case' 0 C--O 1.183 -2.439 0 N-CA-C 118.22 2.674 . . . . 25.0 118.22 -161.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.55 37.47 35.21 Favored Glycine 0 C--O 1.192 -2.505 0 N-CA-C 119.718 2.647 . . . . 25.0 119.718 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 m -56.32 2.06 0.02 OUTLIER 'General case' 0 C--O 1.268 2.073 1 N-CA-C 122.64 4.311 . . . . 25.0 122.64 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.11 -8.09 5.16 Favored 'Isoleucine or valine' 0 C--O 1.278 2.574 0 N-CA-C 115.847 1.795 . . . . 50.0 115.847 158.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 ptm -52.37 10.83 0.0 OUTLIER 'General case' 0 C--O 1.278 2.578 1 N-CA-C 122.734 4.346 . . . . 25.0 122.734 171.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -57.48 -47.83 80.82 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 120.242 -1.536 . . . . 50.0 113.717 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -149.35 44.66 0.34 Allowed Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 119.733 3.234 . . . . 25.0 119.733 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -79.34 -17.32 11.63 Favored 'Trans proline' 0 C--O 1.272 2.206 0 C-N-CA 115.112 -2.792 . . . . 25.0 114.413 -167.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -92.66 5.77 49.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 116.85 -1.547 . . . . 25.0 112.253 170.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -119.29 16.66 13.11 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 124.983 1.427 . . . . 25.0 111.597 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 mt -73.19 124.85 26.42 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 126.115 1.766 . . . . 50.0 108.361 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.41 164.86 20.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 118.955 -2.341 . . . . 25.0 112.334 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.26 139.02 26.83 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.188 -1.824 . . . . 25.0 111.882 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 82.1 tttt -59.8 137.55 58.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 118.206 -2.809 . . . . 25.0 112.552 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -69.28 159.85 32.32 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.559 -3.213 . . . . 25.0 103.336 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.24 -155.2 24.66 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 113.612 -1.631 . . . . 25.0 114.893 -174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.09 129.22 24.15 Favored Pre-proline 0 N--CA 1.517 2.925 0 CA-C-O 117.642 -1.171 . . . . 25.0 112.296 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.99 178.88 32.75 Favored 'Cis proline' 0 C--O 1.25 1.103 0 CA-C-N 121.706 1.645 . . . . 25.0 110.3 -9.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -156.67 -19.94 0.1 Allowed 'General case' 0 C--O 1.211 -0.964 0 O-C-N 127.447 2.967 . . . . 25.0 116.932 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -49.81 -54.48 18.99 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.02 168.19 51.88 Favored Glycine 0 C--O 1.287 3.465 0 N-CA-C 108.69 -1.764 . . . . 25.0 108.69 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.16 -28.04 13.13 Favored 'Trans proline' 0 C--O 1.266 1.902 0 C-N-CA 122.279 1.986 . . . . 25.0 115.843 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.04 140.78 58.29 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 119.791 -1.818 . . . . 25.0 109.341 -172.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -154.28 144.19 21.8 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 103.681 -2.711 . . . . 25.0 103.681 171.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.45 -24.39 13.87 Favored Glycine 0 N--CA 1.486 2.019 0 CA-C-O 115.789 -2.673 . . . . 25.0 108.324 164.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -134.84 33.55 3.18 Favored 'General case' 0 C--O 1.275 2.427 0 CA-C-N 121.902 2.851 . . . . 25.0 113.429 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.6 mm -69.9 -46.42 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 120.181 -0.608 . . . . 25.0 112.09 -161.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.59 78.38 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.492 -0.883 . . . . 25.0 111.421 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.7 p -79.49 -8.76 59.36 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.163 1.542 . . . . 25.0 115.163 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.03 23.42 11.57 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 125.19 1.556 . . . . 25.0 107.836 -171.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.23 -23.93 73.32 Favored Glycine 1 CA--C 1.581 4.212 0 CA-C-O 115.931 -2.594 . . . . 25.0 113.927 -175.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.58 -13.37 80.25 Favored Glycine 0 N--CA 1.473 1.151 0 N-CA-C 108.43 -1.868 . . . . 25.0 108.43 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.2 mt -104.38 -64.62 1.09 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.916 1.358 . . . . 50.0 112.053 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -68.78 -22.96 64.25 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.547 -0.909 . . . . 50.0 108.547 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -26.43 62.84 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 117.049 -1.973 . . . . 25.0 116.058 166.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.63 -21.22 64.72 Favored Glycine 0 C--O 1.186 -2.855 0 CA-C-O 114.435 -3.425 . . . . 25.0 112.829 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.68 -34.39 23.46 Favored 'Isoleucine or valine' 0 C--O 1.293 3.361 0 CA-C-N 124.147 3.973 . . . . 25.0 112.402 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.72 -18.85 56.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 125.794 1.934 . . . . 75.0 107.51 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.266 4.8 t70 -43.19 -39.77 3.05 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 115.35 1.611 . . . . 50.0 115.35 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -78.05 10.63 2.76 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 116.442 2.015 . . . . 25.0 116.442 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -147.97 47.11 1.08 Allowed 'General case' 0 C--O 1.255 1.395 0 C-N-CA 128.179 2.591 . . . . 25.0 110.269 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 t -144.52 161.19 39.71 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 119.254 3.057 . . . . 25.0 119.254 -166.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -68.21 -17.4 64.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 122.151 2.251 . . . . 25.0 108.907 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -96.54 26.25 4.56 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.322 36.5 ttp180 -78.56 67.79 4.4 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-O 123.491 1.615 . . . . 25.0 110.418 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -61.84 145.39 52.83 Favored 'General case' 0 CA--C 1.454 -2.715 1 CA-C-N 107.191 -4.549 . . . . 25.0 111.745 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.435 ' H ' ' HD1' ' A' ' 71' ' ' PHE . 5.8 p90 -77.17 144.48 38.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.38 -1.736 . . . . 50.0 113.354 -166.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 166' ' ' ASP . 59.8 mttm -107.76 165.53 11.37 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-O 118.311 -0.852 . . . . 25.0 111.541 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.512 ' H ' ' HA ' ' A' ' 167' ' ' VAL . 3.6 m80 -127.72 122.16 32.17 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 126.204 1.802 . . . . 25.0 107.023 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.3 mt -83.7 126.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 103.511 -2.774 . . . . 25.0 103.511 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.8 mtp -138.15 156.4 47.77 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 126.051 2.834 . . . . 25.0 105.013 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.7 p -91.88 166.05 12.93 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.786 -2.302 . . . . 25.0 104.786 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.74 167.85 52.05 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-O 116.793 -2.115 . . . . 25.0 115.213 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.4 171.01 12.95 Favored Glycine 0 CA--C 1.555 2.559 1 N-CA-C 102.906 -4.077 . . . . 25.0 102.906 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 11.7 tt0 -62.92 144.9 56.32 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.572 -1.546 . . . . 25.0 111.258 168.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -136.11 146.75 47.33 Favored 'General case' 0 CA--C 1.445 -3.082 0 O-C-N 119.802 -1.811 . . . . 25.0 107.907 162.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.1 m -101.91 137.27 40.43 Favored 'General case' 0 CA--C 1.468 -2.198 0 C-N-CA 124.907 1.283 . . . . 25.0 109.216 167.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -114.79 140.93 48.52 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.856 -1.778 . . . . 50.0 106.669 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -127.32 136.16 51.54 Favored 'General case' 0 C--O 1.19 -2.059 0 CA-C-O 125.014 2.34 . . . . 25.0 111.109 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -129.99 158.85 38.43 Favored 'General case' 0 C--O 1.28 2.676 1 N-CA-C 97.988 -4.819 . . . . 25.0 97.988 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 t -147.23 155.04 41.73 Favored 'General case' 0 CA--C 1.476 -1.886 0 CA-C-N 119.68 1.127 . . . . 25.0 111.108 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.22 162.26 28.27 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 105.162 -2.162 . . . . 50.0 105.162 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 t -116.51 -9.2 11.45 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-N 120.244 1.383 . . . . 25.0 113.107 167.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.6 31.29 Favored Pre-proline 0 CA--C 1.481 -1.687 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 168.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.01 155.88 61.03 Favored 'Trans proline' 0 CA--C 1.486 -1.887 1 C-N-CA 113.032 -4.179 . . . . 25.0 116.586 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -86.02 156.56 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 104.601 -2.37 . . . . 25.0 104.601 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -80.16 132.22 35.87 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.762 -2.31 . . . . 25.0 104.762 166.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 m -152.48 153.59 33.8 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 116.039 -1.934 . . . . 25.0 109.542 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 p -114.66 -43.27 3.17 Favored 'General case' 0 C--O 1.275 2.43 0 C-N-CA 125.201 1.401 . . . . 25.0 108.76 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -151.16 144.6 24.87 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 117.911 -2.993 . . . . 25.0 110.766 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . 0.262 51.5 p-90 -114.45 150.01 35.4 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 117.902 -1.519 . . . . 25.0 112.403 166.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -136.17 150.28 48.97 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 103.885 -2.635 . . . . 25.0 103.885 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . 0.252 7.1 p90 -147.23 149.4 32.83 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 106.12 -1.808 . . . . 50.0 106.12 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -152.98 163.54 39.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.42 -1.696 . . . . 50.0 106.42 -157.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.02 167.3 20.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 115.529 -2.177 . . . . 25.0 107.657 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.4 p -96.69 157.95 15.66 Favored 'General case' 0 C--O 1.203 -1.373 0 O-C-N 125.718 1.886 . . . . 25.0 109.298 170.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -74.03 92.02 2.11 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 111.292 -2.685 . . . . 25.0 114.274 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.99 113.93 2.11 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 126.457 2.348 . . . . 25.0 114.323 165.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.13 35.47 9.7 Favored Glycine 0 C--O 1.25 1.131 0 CA-C-N 115.05 -0.977 . . . . 25.0 114.097 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 162.4 28.81 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 113.603 -1.299 . . . . 25.0 112.75 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.15 143.83 40.02 Favored Pre-proline 0 C--O 1.194 -1.867 0 CA-C-N 115.518 -0.764 . . . . 25.0 109.394 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.62 -18.18 17.64 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 114.85 -2.967 . . . . 25.0 118.82 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -83.69 9.2 12.26 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 118.779 -2.451 . . . . 75.0 109.172 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -128.0 169.74 11.9 Favored Pre-proline 0 C--O 1.285 2.954 0 N-CA-C 101.74 -3.43 . . . . 25.0 101.74 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -55.66 28.21 0.02 OUTLIER 'Trans proline' 0 C--O 1.243 0.753 1 C-N-CA 129.121 6.547 . . . . 25.0 122.359 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.95 -40.15 66.56 Favored 'General case' 0 C--O 1.197 -1.659 0 CA-C-N 119.773 1.17 . . . . 50.0 112.939 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -85.34 -5.7 59.29 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 115.938 1.829 . . . . 25.0 115.938 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -111.37 -66.54 1.07 Allowed 'General case' 0 CA--C 1.475 -1.937 0 O-C-N 119.978 -1.701 . . . . 25.0 107.927 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.24 54.02 1.2 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.516 2.326 . . . . 25.0 109.251 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . 0.251 9.9 t0 -60.68 -42.24 96.73 Favored 'General case' 0 CA--C 1.596 2.746 0 CA-C-N 110.099 -3.228 . . . . 25.0 110.267 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 126.172 2.17 . . . . 50.0 112.428 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -141.8 129.52 21.62 Favored 'General case' 0 C--O 1.195 -1.774 0 O-C-N 126.364 2.29 . . . . 25.0 112.057 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.06 129.94 41.52 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 115.192 -2.337 . . . . 50.0 110.685 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.4 tt -105.59 -20.5 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 122.114 2.233 . . . . 25.0 106.797 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.65 161.36 27.22 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 120.567 -0.825 . . . . 25.0 114.566 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.5 133.4 14.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 123.0 1.381 . . . . 25.0 111.064 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.76 97.61 38.46 Favored Pre-proline 0 N--CA 1.499 1.982 0 CA-C-N 112.552 -2.113 . . . . 50.0 111.228 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.99 152.73 76.53 Favored 'Trans proline' 0 C--N 1.347 0.479 0 N-CA-C 116.79 1.804 . . . . 25.0 116.79 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -79.09 69.31 5.25 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.702 1.251 . . . . 25.0 111.222 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -74.95 -31.32 61.46 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 119.341 -2.099 . . . . 50.0 113.089 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.17 -5.26 71.53 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-O 117.94 -1.478 . . . . 25.0 113.89 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.0 p -71.7 166.19 42.24 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 126.429 1.899 . . . . 25.0 109.054 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.29 -10.94 26.36 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 116.23 -2.046 . . . . 25.0 117.039 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.4 -30.8 42.56 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 121.616 -0.677 . . . . 25.0 109.21 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 48.0 t -74.87 -44.86 46.7 Favored 'General case' 0 C--O 1.285 2.936 0 CA-C-O 124.141 1.924 . . . . 25.0 108.086 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -64.01 -23.96 67.53 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 111.941 -2.39 . . . . 25.0 113.799 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.25 109.19 12.16 Favored 'General case' 0 CA--C 1.58 2.115 0 O-C-N 124.99 1.431 . . . . 25.0 110.38 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.1 tp -83.35 -33.78 25.76 Favored 'General case' 0 C--O 1.193 -1.901 0 C-N-CA 127.214 2.206 . . . . 75.0 108.17 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -80.36 128.27 33.37 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 115.987 -2.285 . . . . 25.0 108.45 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -124.44 153.86 41.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 125.314 1.634 . . . . 25.0 114.327 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -98.59 148.55 23.67 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.6 mt -142.27 129.2 19.38 Favored 'Isoleucine or valine' 0 C--O 1.264 1.818 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 71.1 t80 -75.95 120.11 20.84 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 120.401 -1.437 . . . . 50.0 113.135 169.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.53 122.81 44.96 Favored Pre-proline 0 C--O 1.206 -1.227 0 N-CA-C 101.918 -3.364 . . . . 25.0 101.918 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -61.43 153.2 67.73 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 123.775 1.408 . . . . 25.0 109.805 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -110.35 -0.09 17.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 119.566 -1.959 . . . . 25.0 112.493 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.91 -8.36 57.33 Favored 'General case' 0 C--O 1.265 1.896 0 N-CA-C 116.583 2.068 . . . . 50.0 116.583 -172.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -133.92 151.38 51.47 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 116.798 2.147 . . . . 25.0 116.798 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 171' ' ' ASN . 90.5 mt -100.0 155.73 17.54 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.56 1.544 . . . . 50.0 107.676 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.17 157.01 10.08 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 123.371 4.108 . . . . 25.0 123.371 172.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 0.1 OUTLIER -80.68 146.0 31.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 123.09 1.424 . . . . 50.0 113.494 -174.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 159.14 43.72 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.12 -1.4 . . . . 25.0 109.913 162.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.71 142.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 O-C-N 125.233 1.583 . . . . 50.0 108.156 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 mt -109.85 134.66 51.27 Favored 'Isoleucine or valine' 0 C--O 1.25 1.105 0 CA-C-O 118.201 -0.904 . . . . 25.0 109.76 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.24 155.39 35.96 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 124.913 2.292 . . . . 50.0 108.27 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.6 153.77 48.66 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 118.998 -2.313 . . . . 25.0 109.277 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.86 118.52 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 128.707 2.803 . . . . 50.0 106.29 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -107.63 88.25 2.69 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 126.36 2.287 . . . . 25.0 107.106 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.494 ' HA ' ' HB1' ' A' ' 160' ' ' ALA . 24.6 t70 -77.36 141.69 39.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.158 -1.589 . . . . 25.0 111.832 -163.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.02 123.77 59.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-O 116.991 -1.48 . . . . 50.0 112.464 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.94 20.07 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 120.231 1.378 . . . . 25.0 111.671 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.52 -20.84 65.49 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -124.51 159.88 29.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.932 1.456 . . . . 25.0 114.932 -173.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.04 -39.7 87.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 116.61 2.078 . . . . 25.0 116.61 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 3.1 m-20 -91.87 160.55 15.24 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 118.508 -0.758 . . . . 25.0 112.299 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 153' ' ' ASP . . . -138.57 159.9 40.93 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 101.221 -3.622 . . . . 25.0 101.221 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -90.99 153.36 20.21 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 124.379 1.071 . . . . 50.0 108.538 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -136.95 164.71 27.7 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.849 -1.94 . . . . 50.0 111.021 164.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.54 133.38 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 111.991 -2.368 . . . . 75.0 115.557 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -135.33 136.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 124.091 1.901 . . . . 25.0 106.413 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 72' ' ' LYS 0.284 22.3 t0 -102.92 150.43 23.53 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 101.246 -3.613 . . . . 25.0 101.246 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 73' ' ' HIS . 27.2 m -144.83 167.07 11.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 116.631 -1.652 . . . . 50.0 107.662 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 10.4 t0 -133.52 132.97 41.59 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.3 mt -126.12 117.12 22.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 107.813 -1.18 . . . . 50.0 107.813 -164.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.0 162.31 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 117.926 2.565 . . . . 50.0 117.926 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.4 ' H ' HD23 ' A' ' 143' ' ' LEU . 7.1 m120 -69.84 160.93 30.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.235 1.814 . . . . 25.0 107.835 166.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.1 mttt . . . . . 0 C--O 1.266 1.953 0 N-CA-C 118.318 2.71 . . . . 25.0 118.318 -176.855 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 51.5 m80 . . . . . 1 N--CA 1.572 5.642 0 CA-C-O 120.832 0.349 . . . . 25.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.01 174.15 36.76 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-O 117.409 -1.773 . . . . 25.0 116.865 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -126.29 171.45 10.93 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 123.436 1.589 . . . . 50.0 107.703 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm -81.73 116.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 O-C-N 120.024 -1.672 . . . . 25.0 108.539 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.05 -40.92 30.06 Favored 'General case' 0 C--O 1.268 2.058 0 CA-C-N 115.424 -0.807 . . . . 25.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -154.55 136.34 9.36 Favored Pre-proline 0 C--O 1.199 -1.599 0 N-CA-C 105.183 -2.154 . . . . 25.0 105.183 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.03 145.61 65.66 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 C-N-CA 130.698 1.541 . . . . 25.0 115.226 -1.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.32 170.31 50.47 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 120.916 -0.659 . . . . 25.0 111.758 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 84.7 p -70.28 162.18 28.96 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.314 2.339 . . . . 25.0 117.314 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -68.71 -3.45 12.16 Favored 'General case' 0 CA--C 1.581 2.16 0 CA-C-N 118.916 0.78 . . . . 25.0 110.471 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.23 -27.71 68.18 Favored 'General case' 0 C--O 1.197 -1.666 0 C-N-CA 118.949 -1.1 . . . . 25.0 110.911 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.82 91.84 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-O 122.962 1.363 . . . . 25.0 108.436 171.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.77 -10.71 59.42 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 124.215 1.959 . . . . 75.0 115.634 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -86.1 -9.57 56.44 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 118.346 -2.721 . . . . 25.0 108.384 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.8 t -65.54 150.09 48.98 Favored 'General case' 0 C--O 1.208 -1.122 0 O-C-N 119.396 -2.065 . . . . 25.0 106.99 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -75.54 -3.35 33.67 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 117.954 2.576 . . . . 25.0 117.954 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.4 -23.65 67.01 Favored 'General case' 0 C--O 1.199 -1.563 0 C-N-CA 125.178 1.391 . . . . 25.0 110.67 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -75.32 3.65 8.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.244 1.942 . . . . 50.0 116.244 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.76 -20.42 1.82 Allowed Glycine 0 C--O 1.255 1.437 0 O-C-N 119.357 -2.089 . . . . 25.0 117.875 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . 0.272 75.3 t80 76.2 -47.58 0.56 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 119.716 3.228 . . . . 50.0 119.716 168.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.9 mt -62.47 -31.06 71.73 Favored 'General case' 0 C--O 1.26 1.609 0 O-C-N 121.316 -0.865 . . . . 50.0 109.205 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -142.5 165.21 28.03 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 118.476 -0.774 . . . . 25.0 112.965 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -163.58 168.97 19.33 Favored 'General case' 0 C--O 1.175 -2.843 0 N-CA-C 105.304 -2.11 . . . . 50.0 105.304 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -152.37 76.07 1.14 Allowed 'General case' 0 C--O 1.193 -1.886 0 N-CA-C 107.902 -1.147 . . . . 25.0 107.902 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -38.11 65.83 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.763 -1.211 . . . . 25.0 114.136 -176.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.01 101.82 0.42 Allowed Glycine 0 CA--C 1.541 1.713 0 N-CA-C 119.467 2.547 . . . . 25.0 119.467 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 m -47.66 -16.15 0.07 Allowed 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 118.574 2.805 . . . . 25.0 118.574 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 70' ' ' TRP . 0.6 OUTLIER -62.98 -18.66 21.82 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.738 0 O-C-N 119.992 -1.692 . . . . 50.0 111.699 178.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -74.55 -17.21 60.77 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.265 1.026 . . . . 25.0 111.905 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -74.55 -50.17 19.07 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.818 -1.537 . . . . 50.0 111.086 -162.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -143.41 63.39 12.49 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.742 -1.224 . . . . 25.0 112.38 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.74 -26.47 38.91 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 115.869 -2.287 . . . . 25.0 114.203 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -60.01 -9.81 3.53 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.024 2.602 . . . . 25.0 118.024 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -74.91 -5.47 43.91 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 116.633 -1.651 . . . . 25.0 113.236 -168.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.0 122.58 25.11 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 120.6 1.545 . . . . 50.0 112.807 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -136.2 165.17 26.36 Favored 'General case' 0 C--O 1.261 1.691 0 N-CA-C 114.87 1.433 . . . . 25.0 114.87 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.92 143.96 30.83 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 160.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -87.92 158.58 18.65 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 103.514 -2.772 . . . . 25.0 103.514 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -76.74 167.47 21.77 Favored 'General case' 0 C--O 1.29 3.186 0 CA-C-O 123.316 1.531 . . . . 25.0 106.982 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.41 17.25 10.69 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 114.335 -3.48 . . . . 25.0 116.253 -171.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -87.96 152.34 50.83 Favored Pre-proline 0 C--O 1.254 1.331 1 CA-C-N 124.974 4.387 . . . . 25.0 108.853 -172.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.72 -179.66 27.95 Favored 'Cis proline' 0 N--CA 1.471 0.16 0 C-N-CA 134.693 3.205 . . . . 25.0 111.221 -3.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -73.8 -22.24 59.88 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 116.559 -2.057 . . . . 25.0 114.4 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -58.47 -47.73 83.1 Favored 'General case' 0 C--O 1.199 -1.598 0 N-CA-C 118.423 2.749 . . . . 25.0 118.423 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.47 175.48 54.4 Favored Glycine 0 N--CA 1.496 2.699 0 O-C-N 118.872 -2.392 . . . . 25.0 111.887 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.52 165.11 33.5 Favored 'Trans proline' 0 CA--C 1.485 -1.973 0 O-C-N 123.133 1.07 . . . . 25.0 113.356 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.82 39.6 Favored 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 118.041 -1.464 . . . . 25.0 112.613 171.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.32 -176.32 4.78 Favored 'General case' 0 C--N 1.311 -1.078 1 N-CA-C 97.721 -4.918 . . . . 25.0 97.721 162.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.34 -1.49 87.44 Favored Glycine 0 C--O 1.2 -1.977 0 O-C-N 118.244 -2.785 . . . . 25.0 115.542 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -77.23 0.7 20.96 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.978 -1.111 . . . . 25.0 111.987 -169.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.7 mt -72.58 -35.17 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 105.388 -2.078 . . . . 25.0 105.388 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.6 96.43 Favored 'General case' 0 C--O 1.284 2.909 0 N-CA-C 115.606 1.706 . . . . 25.0 115.606 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.4 p -92.2 -9.28 42.86 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.377 -0.374 . . . . 25.0 109.996 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.52 17.8 9.89 Favored 'General case' 0 N--CA 1.514 2.763 0 C-N-CA 128.745 2.818 . . . . 25.0 111.591 -174.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.94 -13.78 80.61 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 114.187 -1.37 . . . . 25.0 110.782 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.11 9.16 31.38 Favored Glycine 0 CA--C 1.556 2.61 0 N-CA-C 107.837 -2.105 . . . . 25.0 107.837 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 60' ' ' GLY . 29.6 mt -123.64 31.13 5.99 Favored 'General case' 0 C--O 1.199 -1.604 0 CA-C-N 113.946 -1.127 . . . . 50.0 112.992 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -69.82 -25.59 63.84 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 101.253 -3.61 . . . . 50.0 101.253 157.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.43 -15.45 80.33 Favored Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.804 -1.553 . . . . 25.0 110.433 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 57' ' ' LEU . . . -66.48 -29.85 75.51 Favored Glycine 0 CA--C 1.493 -1.342 0 O-C-N 126.954 2.208 . . . . 25.0 113.081 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.51 -42.08 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 O-C-N 119.805 -1.997 . . . . 25.0 111.985 174.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.44 -23.94 50.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.83 -1.174 . . . . 75.0 107.83 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.7 -31.2 64.84 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.73 1.252 . . . . 50.0 113.216 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -89.93 35.48 0.85 Allowed 'General case' 0 C--O 1.161 -3.556 0 CA-C-N 114.167 -1.379 . . . . 25.0 111.059 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -159.7 50.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 100.432 -3.914 . . . . 25.0 100.432 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.8 t -140.69 179.58 6.61 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 102.081 -3.303 . . . . 25.0 102.081 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.55 -31.55 65.36 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 123.677 2.944 . . . . 25.0 111.478 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.89 21.59 0.84 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 116.945 -1.503 . . . . 25.0 114.549 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -60.8 90.25 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.809 2.444 . . . . 25.0 106.014 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.491 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -17.25 131.03 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.5 2 CA-C-N 106.614 -4.812 . . . . 25.0 118.806 171.881 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -68.93 142.86 54.61 Favored 'General case' 0 CA--C 1.476 -1.901 0 N-CA-C 117.733 2.494 . . . . 50.0 117.733 -160.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -112.76 147.2 37.37 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.046 1.748 . . . . 25.0 108.496 -166.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -122.84 137.61 54.88 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-O 116.493 -1.718 . . . . 25.0 108.451 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.0 mt -96.47 119.49 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 105.585 -2.006 . . . . 25.0 105.585 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.8 mtp -128.1 174.63 9.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.824 1.249 . . . . 25.0 111.718 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -112.54 171.16 7.69 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.434 1.493 . . . . 25.0 110.147 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.67 170.42 53.21 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 105.997 -2.841 . . . . 25.0 105.997 171.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.14 178.21 15.4 Favored Glycine 0 C--N 1.285 -2.302 2 O-C-N 115.882 -4.305 . . . . 25.0 109.614 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.81 137.32 51.72 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 127.645 2.615 . . . . 25.0 113.651 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -110.74 134.93 52.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 111.765 -2.47 . . . . 25.0 106.189 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -92.18 134.03 35.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 117.56 -3.212 . . . . 25.0 112.948 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.85 127.0 50.03 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 118.829 -2.419 . . . . 50.0 109.371 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.0 m -140.22 126.93 20.43 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.415 -1.328 . . . . 25.0 107.415 -167.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -104.05 162.95 12.72 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 128.938 3.899 . . . . 25.0 109.014 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 t -149.29 146.47 27.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 103.331 -2.84 . . . . 25.0 103.331 165.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.48 143.07 49.46 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 127.123 2.169 . . . . 50.0 111.42 173.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -96.77 -5.16 39.2 Favored 'General case' 0 C--O 1.27 2.169 0 C-N-CA 127.072 2.149 . . . . 25.0 115.173 -168.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.87 137.57 12.59 Favored Pre-proline 0 N--CA 1.481 1.112 0 N-CA-C 103.529 -2.767 . . . . 25.0 103.529 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.5 137.78 61.7 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 115.404 -2.597 . . . . 25.0 116.167 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -148.03 169.2 20.45 Favored 'General case' 0 CA--C 1.557 1.222 1 N-CA-C 99.761 -4.163 . . . . 25.0 99.761 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -111.57 113.11 25.3 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 123.744 1.735 . . . . 25.0 108.402 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.9 m -71.98 136.02 46.62 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 113.094 -1.866 . . . . 25.0 111.847 172.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 -47.13 5.44 Favored 'General case' 0 C--O 1.274 2.376 0 CA-C-O 122.722 1.248 . . . . 25.0 112.624 167.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.24 159.01 44.75 Favored 'General case' 0 C--O 1.219 -0.547 1 O-C-N 116.011 -4.18 . . . . 25.0 102.242 175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -142.06 152.03 42.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 116.821 -1.952 . . . . 25.0 112.604 160.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -129.1 151.58 49.62 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 126.425 1.89 . . . . 25.0 109.771 -156.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.68 147.17 50.05 Favored 'General case' 0 C--O 1.194 -1.834 0 O-C-N 123.498 0.499 . . . . 50.0 111.311 156.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.31 163.02 28.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 104.286 -2.487 . . . . 50.0 104.286 172.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.79 133.55 67.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 163.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -73.48 131.94 42.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 101.88 -3.378 . . . . 25.0 101.88 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -87.27 104.41 16.37 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 125.8 2.714 . . . . 25.0 105.753 -169.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.08 113.25 1.46 Allowed 'General case' 0 C--O 1.279 2.607 0 O-C-N 119.233 -2.167 . . . . 25.0 110.341 153.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.88 40.21 7.72 Favored Glycine 0 C--O 1.181 -3.162 0 C-N-CA 116.912 -2.566 . . . . 25.0 108.837 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -55.87 160.63 2.59 Favored 'General case' 0 CA--C 1.579 2.063 0 O-C-N 120.376 -1.661 . . . . 25.0 109.851 168.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -80.71 117.12 66.46 Favored Pre-proline 0 C--O 1.266 1.933 0 N-CA-C 102.596 -3.113 . . . . 25.0 102.596 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.11 -25.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 N-CA-C 116.36 1.638 . . . . 25.0 116.36 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.33 -6.19 57.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 112.217 -2.265 . . . . 75.0 106.111 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.55 150.9 46.36 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 114.847 -2.501 . . . . 25.0 110.027 -171.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.294 0.0 OUTLIER -2.52 87.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.264 1.794 2 C-N-CA 125.642 4.228 . . . . 25.0 122.698 176.045 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.57 -34.12 72.3 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 110.301 -3.136 . . . . 50.0 109.595 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -87.81 -10.05 52.04 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.695 2.109 . . . . 25.0 116.695 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.84 -38.41 0.64 Allowed 'General case' 0 C--O 1.185 -2.308 0 N-CA-C 121.468 3.877 . . . . 25.0 121.468 -170.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.6 -9.63 59.44 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 117.18 -3.45 . . . . 25.0 111.871 171.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.63 4.98 10.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.378 -0.929 . . . . 25.0 112.849 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.62 167.33 22.18 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.755 0.788 . . . . 50.0 112.782 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -117.73 141.83 47.95 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.193 160.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 tp -67.33 132.09 47.01 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.319 -2.104 . . . . 50.0 105.319 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 tt -110.97 -14.2 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 118.928 2.936 . . . . 25.0 118.928 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.82 165.69 30.9 Favored Glycine 0 C--O 1.212 -1.269 0 CA-C-O 115.217 -2.991 . . . . 25.0 112.43 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.36 21.88 Favored 'General case' 0 N--CA 1.418 -2.054 0 O-C-N 126.025 1.662 . . . . 25.0 108.329 168.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.38 101.02 28.42 Favored Pre-proline 0 C--N 1.312 -1.059 0 C-N-CA 125.473 1.509 . . . . 50.0 111.892 -170.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.64 170.47 8.94 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 115.752 -2.365 . . . . 25.0 113.607 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -97.31 78.27 2.71 Favored 'General case' 0 C--O 1.175 -2.851 0 CA-C-O 115.959 -1.972 . . . . 25.0 108.546 167.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.47 37.47 1.22 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.21 1.481 . . . . 50.0 110.596 -158.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.59 35.01 17.86 Favored Glycine 0 C--O 1.263 1.92 0 N-CA-C 108.834 -1.706 . . . . 25.0 108.834 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.4 m -75.3 147.01 82.27 Favored Pre-proline 0 C--O 1.263 1.796 0 N-CA-C 117.558 2.429 . . . . 25.0 117.558 -154.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.28 177.28 7.48 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 115.564 -2.491 . . . . 25.0 109.267 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.06 6.2 0.99 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.836 2.162 . . . . 25.0 116.836 -167.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.4 p -68.05 -4.44 13.45 Favored 'General case' 0 C--O 1.182 -2.494 0 CA-C-N 114.299 -1.318 . . . . 25.0 109.29 163.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.2 ttp85 -69.88 -16.52 63.25 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 114.154 1.168 . . . . 25.0 114.154 167.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -52.44 133.25 35.35 Favored 'General case' 0 C--O 1.191 -1.995 0 CA-C-O 121.905 0.859 . . . . 25.0 108.732 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -70.66 -13.12 61.95 Favored 'General case' 0 C--O 1.187 -2.197 0 CA-C-O 123.466 1.603 . . . . 75.0 111.504 -161.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.8 t -98.0 141.62 30.74 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 118.487 -2.633 . . . . 25.0 110.405 163.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -132.59 157.16 45.44 Favored 'General case' 0 C--O 1.161 -3.559 0 N-CA-C 103.376 -2.824 . . . . 25.0 103.376 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -120.9 148.45 44.03 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 100.863 -3.754 . . . . 25.0 100.863 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 50.6 mm -129.78 125.69 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -79.76 136.77 36.83 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.94 -0.475 . . . . 50.0 109.853 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.2 mm -125.96 119.76 23.99 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 126.623 2.452 . . . . 25.0 109.403 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.25 159.83 33.02 Favored 'Trans proline' 0 C--N 1.359 1.131 1 C-N-CA 113.288 -4.008 . . . . 25.0 115.353 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.51 43.45 1.1 Allowed 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 122.906 1.336 . . . . 25.0 110.833 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.23 -42.51 99.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 111.089 -2.778 . . . . 50.0 114.351 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -149.47 154.2 38.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.897 1.679 . . . . 25.0 108.742 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.25 154.81 34.9 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.859 -1.534 . . . . 50.0 106.859 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.25 168.02 11.95 Favored Glycine 0 C--N 1.364 2.104 0 O-C-N 126.224 2.202 . . . . 25.0 118.177 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.26 153.52 41.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 117.697 2.48 . . . . 50.0 117.697 -165.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.96 147.09 39.99 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 120.879 -1.138 . . . . 25.0 109.392 160.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.48 133.81 46.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 N-CA-C 103.852 -2.647 . . . . 50.0 103.852 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.81 137.92 31.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 103.962 -2.607 . . . . 25.0 103.962 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.6 mt -122.82 145.77 48.13 Favored 'General case' 0 C--O 1.184 -2.351 0 N-CA-C 104.681 -2.34 . . . . 50.0 104.681 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.22 156.48 44.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 117.983 -1.008 . . . . 25.0 110.344 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.5 132.63 31.63 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 O-C-N 127.715 3.134 . . . . 50.0 105.793 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -105.4 130.69 53.45 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 104.131 -2.544 . . . . 25.0 104.131 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -103.71 126.8 51.08 Favored 'General case' 0 C--O 1.264 1.835 0 O-C-N 118.751 -2.468 . . . . 25.0 104.962 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.06 133.06 64.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 O-C-N 116.656 -3.778 . . . . 50.0 107.823 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.25 -11.73 59.7 Favored 'General case' 0 C--O 1.178 -2.698 0 O-C-N 121.337 -0.852 . . . . 25.0 110.791 -171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -35.53 81.41 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.078 1.894 . . . . 25.0 114.077 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.2 p -143.79 159.82 41.84 Favored 'General case' 0 C--O 1.274 2.393 0 O-C-N 120.924 -1.11 . . . . 25.0 112.089 -164.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -76.98 -23.98 52.28 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.999 -1.111 . . . . 25.0 107.999 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.49 151.85 45.54 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.041 -0.981 . . . . 25.0 110.85 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -123.9 159.0 30.65 Favored 'General case' 0 C--O 1.27 2.182 0 N-CA-C 102.039 -3.319 . . . . 25.0 102.039 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -111.72 154.41 25.04 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 104.31 -2.478 . . . . 50.0 104.31 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.36 149.48 50.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 110.971 -2.831 . . . . 50.0 106.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -133.74 129.85 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.253 33.9 m -121.73 135.37 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 117.576 -3.203 . . . . 75.0 112.99 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 95.8 mt -135.64 132.59 51.47 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 105.07 -2.196 . . . . 25.0 105.07 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -104.7 141.4 36.53 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 106.118 -1.808 . . . . 25.0 106.118 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.92 149.25 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 107.725 -1.213 . . . . 50.0 107.725 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.42 94.43 4.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 118.26 20.96 Favored 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 125.161 1.384 . . . . 50.0 108.333 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.1 m -117.5 157.84 18.47 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-O 124.448 2.071 . . . . 50.0 108.501 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -91.64 162.55 14.45 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 111.252 -2.703 . . . . 25.0 106.401 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 CA--C 1.565 1.548 0 O-C-N 118.742 -2.474 . . . . 25.0 108.166 166.94 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 N--CA 1.517 2.9 0 CA-C-O 123.532 1.634 . . . . 25.0 113.724 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.46 -174.81 24.92 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 125.074 2.486 . . . . 25.0 111.921 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.59 161.95 39.43 Favored 'General case' 0 CA--C 1.47 -2.113 0 CA-C-N 110.77 -2.715 . . . . 50.0 108.891 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 mt -97.8 123.52 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 N-CA-C 103.805 -2.665 . . . . 25.0 103.805 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.35 -38.93 18.22 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 119.609 -1.932 . . . . 25.0 111.383 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -136.45 160.01 68.4 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 118.005 -0.998 . . . . 25.0 110.169 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.13 141.4 62.24 Favored 'Cis proline' 0 CA--C 1.477 -2.327 0 C-N-CA 133.479 2.7 . . . . 25.0 114.386 -1.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.36 -168.66 45.16 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 119.253 2.461 . . . . 25.0 119.253 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t -145.92 156.17 43.35 Favored 'General case' 0 C--O 1.266 1.944 0 CA-C-N 119.196 1.498 . . . . 25.0 107.7 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -79.25 -8.46 59.06 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.87 1.319 . . . . 25.0 109.917 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.47 -29.47 64.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.428 -0.795 . . . . 25.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.13 -27.84 67.65 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 118.686 2.847 . . . . 25.0 118.686 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.31 -21.04 17.46 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 125.903 2.002 . . . . 75.0 111.554 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.1 t -81.46 -19.71 41.81 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 105.745 -1.946 . . . . 25.0 105.745 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.0 t -60.34 151.45 27.75 Favored 'General case' 0 C--O 1.285 2.952 0 O-C-N 118.82 -2.425 . . . . 25.0 111.792 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -65.57 -26.99 68.11 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 118.522 -2.611 . . . . 25.0 110.701 169.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.33 -19.68 63.87 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-O 123.225 1.488 . . . . 25.0 111.965 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -51.55 -17.16 0.75 Allowed 'General case' 0 C--O 1.187 -2.23 0 N-CA-C 114.181 1.178 . . . . 50.0 114.181 168.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.37 2.7 0.8 Allowed Glycine 0 CA--C 1.532 1.126 1 CA-C-O 112.695 -4.392 . . . . 25.0 114.418 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . 0.289 6.9 t80 52.72 27.7 5.55 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 123.9 3.85 . . . . 50.0 116.837 -165.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.9 mt -66.55 -29.76 69.91 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 114.123 1.157 . . . . 50.0 114.123 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 45.05 59.35 3.51 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 126.467 2.354 . . . . 25.0 117.035 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -164.96 161.85 20.22 Favored 'General case' 0 CA--C 1.576 1.949 0 O-C-N 125.478 1.736 . . . . 50.0 111.223 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 52.43 48.19 23.12 Favored 'General case' 0 CA--C 1.567 1.625 1 N-CA-C 122.467 4.247 . . . . 25.0 122.467 171.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.7 -10.43 59.76 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 124.406 1.066 . . . . 25.0 111.811 165.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.09 125.15 4.71 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 120.558 1.526 . . . . 25.0 113.95 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -5.16 2.67 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 115.601 1.704 . . . . 25.0 115.601 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 m -55.59 -18.4 4.54 Favored 'Isoleucine or valine' 0 C--O 1.254 1.331 0 N-CA-C 113.792 1.034 . . . . 50.0 113.792 164.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.0 ptp -54.94 -30.18 58.13 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -101.47 -46.08 5.1 Favored 'General case' 0 CA--C 1.485 -1.529 0 O-C-N 120.908 -1.12 . . . . 50.0 110.452 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -114.3 79.06 4.93 Favored Pre-proline 0 C--O 1.264 1.826 0 N-CA-C 115.654 1.724 . . . . 25.0 115.654 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.18 -20.77 8.35 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 114.958 1.099 . . . . 25.0 114.958 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -127.5 2.36 6.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 120.25 3.426 . . . . 25.0 120.25 -161.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 49.55 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.006 -1.059 . . . . 25.0 108.163 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.59 79.92 8.16 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.42 0.628 . . . . 50.0 111.679 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -135.76 150.98 49.68 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 116.819 -1.563 . . . . 25.0 110.71 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.02 166.52 25.83 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.414 -3.18 . . . . 25.0 102.414 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -93.23 142.56 27.18 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 117.345 -1.742 . . . . 25.0 111.714 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -58.06 146.2 33.81 Favored 'General case' 0 C--O 1.205 -1.272 0 C-N-CA 119.472 -0.891 . . . . 25.0 109.112 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.12 -160.98 53.63 Favored Glycine 0 C--O 1.266 2.151 0 O-C-N 120.133 -1.605 . . . . 25.0 116.182 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -152.27 168.48 11.23 Favored Pre-proline 0 CA--C 1.574 1.867 0 O-C-N 127.101 2.295 . . . . 25.0 108.342 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.96 134.46 2.01 Favored 'Cis proline' 0 C--N 1.39 2.75 1 C-N-CA 137.16 4.233 . . . . 25.0 117.2 -6.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -131.56 -1.3 3.89 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 116.019 1.859 . . . . 25.0 116.019 -163.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 t 62.19 -78.21 0.03 OUTLIER 'General case' 0 C--O 1.194 -1.857 0 N-CA-C 117.645 2.461 . . . . 25.0 117.645 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.63 177.57 26.09 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 117.639 -2.22 . . . . 25.0 110.609 163.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.69 148.71 78.28 Favored 'Trans proline' 0 C--N 1.367 1.501 0 CA-C-N 120.17 1.985 . . . . 25.0 113.85 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.1 151.74 26.88 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-O 124.798 2.237 . . . . 25.0 108.106 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -140.34 176.19 8.97 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 100.218 -3.994 . . . . 25.0 100.218 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.34 34.47 74.67 Favored Glycine 0 N--CA 1.426 -1.998 0 C-N-CA 118.824 -1.655 . . . . 25.0 110.17 -153.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -130.92 54.55 1.9 Allowed 'General case' 0 C--O 1.27 2.145 1 N-CA-C 98.524 -4.621 . . . . 25.0 98.524 -171.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 66.8 mt -74.21 -30.4 26.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 111.545 -2.57 . . . . 25.0 107.849 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.68 -30.73 46.32 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.993 1.849 . . . . 25.0 115.993 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 p -89.46 -5.78 57.04 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.331 -0.856 . . . . 25.0 112.642 168.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.32 13.42 3.99 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 127.047 2.139 . . . . 25.0 111.452 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.92 -33.9 85.41 Favored Glycine 0 CA--C 1.495 -1.219 0 O-C-N 119.21 -2.181 . . . . 25.0 111.377 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.22 -0.67 86.82 Favored Glycine 0 C--O 1.198 -2.121 0 CA-C-N 113.838 -1.181 . . . . 25.0 111.484 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt -112.02 -16.56 13.05 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 114.715 1.376 . . . . 50.0 114.715 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.09 -34.99 69.09 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.775 -1.935 . . . . 50.0 105.775 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -11.3 85.26 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-O 122.805 1.225 . . . . 25.0 110.245 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.6 -29.9 76.21 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 123.85 1.805 . . . . 25.0 114.599 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -74.92 -39.19 44.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 O-C-N 119.986 -1.89 . . . . 25.0 107.111 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -68.88 -27.8 66.12 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 119.269 -2.144 . . . . 75.0 109.783 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 -27.6 67.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.521 -1.362 . . . . 50.0 110.843 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -80.09 3.7 19.53 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 120.574 -1.329 . . . . 25.0 107.641 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -128.45 43.85 3.06 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.122 -2.918 . . . . 25.0 103.122 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 t -134.9 161.14 36.08 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.563 -1.336 . . . . 25.0 109.799 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.17 -29.02 68.41 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-N 114.45 -1.25 . . . . 25.0 111.553 161.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -72.65 0.39 10.77 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.911 1.449 . . . . 25.0 114.911 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -76.13 93.33 3.32 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 103.755 -2.683 . . . . 25.0 103.755 169.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -45.29 153.83 0.2 Allowed 'General case' 0 C--O 1.263 1.791 0 CA-C-N 111.411 -2.631 . . . . 25.0 107.972 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -56.19 136.17 52.93 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 115.247 1.573 . . . . 50.0 115.247 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -94.32 156.24 16.61 Favored 'General case' 0 N--CA 1.528 3.444 0 CA-C-O 117.399 -1.286 . . . . 25.0 112.886 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -153.8 151.95 30.14 Favored 'General case' 0 C--O 1.26 1.65 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 tt -87.43 135.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtp -144.56 -172.76 3.87 Favored 'General case' 0 C--O 1.186 -2.255 0 CA-C-O 123.06 1.409 . . . . 25.0 109.029 -171.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 p -127.37 172.65 10.45 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 104.61 -2.367 . . . . 25.0 104.61 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.61 -178.26 25.2 Favored Glycine 0 CA--C 1.542 1.754 0 O-C-N 124.692 1.245 . . . . 25.0 112.754 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.54 -156.3 30.29 Favored Glycine 0 CA--C 1.559 2.83 0 CA-C-O 115.697 -2.724 . . . . 25.0 111.032 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -72.64 143.33 48.2 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 120.472 3.508 . . . . 25.0 120.472 -171.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -125.5 143.51 50.97 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 101.51 -3.515 . . . . 25.0 101.51 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.7 m -99.11 127.21 45.03 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 105.331 -2.1 . . . . 25.0 105.331 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.61 128.44 55.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 104.191 -2.522 . . . . 50.0 104.191 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.2 m -134.2 109.13 8.67 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 105.4 -2.074 . . . . 25.0 105.4 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -83.31 149.75 26.56 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.641 -1.163 . . . . 25.0 107.896 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.3 t -142.54 122.68 13.76 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 120.922 1.692 . . . . 25.0 109.652 173.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.73 143.27 39.76 Favored 'General case' 0 N--CA 1.423 -1.782 0 O-C-N 119.503 -1.998 . . . . 50.0 113.987 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -91.43 -12.67 34.05 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.487 -2.142 . . . . 25.0 110.433 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.18 143.76 25.9 Favored Pre-proline 0 C--O 1.273 2.315 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 168.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.08 140.88 25.75 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 124.078 3.185 . . . . 25.0 117.732 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -138.6 151.4 47.23 Favored 'General case' 0 CA--C 1.55 0.958 1 N-CA-C 97.77 -4.9 . . . . 25.0 97.77 172.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . 0.254 67.2 m-80 -78.68 109.69 13.14 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 121.998 2.181 . . . . 25.0 113.772 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.473 HG21 ' CE3' ' A' ' 95' ' ' TRP . 7.9 m -79.38 135.69 36.77 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 123.684 1.707 . . . . 25.0 109.729 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 155' ' ' ALA . 2.3 p -80.59 -50.11 10.41 Favored 'General case' 0 CA--C 1.571 1.759 0 O-C-N 116.632 -3.792 . . . . 25.0 106.706 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -164.27 173.88 11.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 127.084 2.154 . . . . 25.0 113.513 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.473 ' CE3' HG21 ' A' ' 92' ' ' THR . 37.6 p90 -143.32 158.36 43.7 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.098 -1.002 . . . . 25.0 112.767 164.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -133.84 155.25 50.18 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -150.14 149.93 30.95 Favored 'General case' 0 C--O 1.283 2.867 0 CA-C-N 120.789 1.631 . . . . 50.0 114.137 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.64 158.35 44.26 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.632 1.573 . . . . 50.0 109.929 -157.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.22 159.88 13.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 164.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 p -71.82 155.71 40.12 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.648 1.217 . . . . 25.0 110.783 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -124.04 113.07 17.91 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.653 -1.279 . . . . 25.0 113.821 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.08 161.23 8.84 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 114.461 -2.685 . . . . 25.0 110.384 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.1 -0.16 47.74 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 122.827 2.558 . . . . 25.0 115.427 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -59.51 159.05 8.74 Favored 'General case' 0 C--O 1.271 2.199 0 N-CA-C 113.892 1.071 . . . . 25.0 113.892 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -160.77 144.02 9.86 Favored Pre-proline 0 C--O 1.193 -1.916 0 N-CA-C 104.486 -2.412 . . . . 25.0 104.486 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -69.87 -15.94 36.89 Favored 'Trans proline' 0 C--O 1.177 -2.528 0 C-N-CA 114.003 -3.532 . . . . 25.0 119.594 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.84 -21.19 65.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.918 1.818 . . . . 75.0 109.131 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -99.47 163.54 18.36 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 103.384 -2.821 . . . . 25.0 103.384 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -32.37 30.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.249 1 C-N-CA 129.759 6.973 . . . . 25.0 121.64 154.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -40.39 60.26 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 115.922 -1.989 . . . . 50.0 114.794 -175.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -75.59 -7.93 55.48 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 116.636 2.087 . . . . 25.0 116.636 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -120.08 -62.55 1.47 Allowed 'General case' 0 C--O 1.198 -1.621 0 O-C-N 121.25 -0.906 . . . . 25.0 112.441 -166.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.51 18.25 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 118.014 2.598 . . . . 25.0 118.014 163.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -65.37 -26.51 68.04 Favored 'General case' 0 CA--C 1.483 -1.602 0 O-C-N 127.116 2.76 . . . . 25.0 109.65 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -141.07 160.52 39.9 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 103.586 -2.746 . . . . 50.0 103.586 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -129.95 135.15 47.99 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 106.65 -1.611 . . . . 25.0 106.65 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.64 145.48 54.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 104.173 -2.528 . . . . 50.0 104.173 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.7 tt -128.71 -12.52 2.94 Favored 'Isoleucine or valine' 0 C--O 1.263 1.783 0 CA-C-O 125.848 2.737 . . . . 25.0 112.252 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.75 167.12 37.85 Favored Glycine 0 C--O 1.268 2.234 0 CA-C-O 124.142 1.968 . . . . 25.0 112.266 168.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.84 161.29 40.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 112.991 -1.605 . . . . 25.0 107.968 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.49 111.68 15.16 Favored Pre-proline 0 C--O 1.207 -1.177 0 N-CA-C 104.124 -2.546 . . . . 50.0 104.124 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.4 162.05 36.67 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 117.144 -1.438 . . . . 25.0 110.885 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 129' ' ' SER . 65.6 t-80 -120.11 49.6 1.39 Allowed 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.229 -1.767 . . . . 25.0 106.229 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -76.06 -32.34 59.24 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 112.38 -2.191 . . . . 50.0 110.133 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 172.04 -175.6 45.3 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 119.98 -1.7 . . . . 25.0 115.341 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 57.8 m 72.19 155.72 0.16 Allowed Pre-proline 0 CA--C 1.569 1.698 0 N-CA-C 117.658 2.466 . . . . 25.0 117.658 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.23 -3.33 13.64 Favored 'Trans proline' 0 CA--C 1.572 2.415 0 C-N-CA 115.642 -2.439 . . . . 25.0 113.38 -166.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.25 76.52 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 116.84 2.163 . . . . 25.0 116.84 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 123' ' ' HIS . 83.8 p -80.81 -21.95 40.44 Favored 'General case' 0 C--O 1.273 2.314 0 CA-C-O 124.259 1.981 . . . . 25.0 110.894 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -72.81 -28.55 62.63 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.111 -1.859 . . . . 25.0 111.918 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.55 140.59 39.75 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.709 -3.071 . . . . 25.0 102.709 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mt -103.67 -38.63 7.02 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 124.346 2.022 . . . . 75.0 109.934 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 t -77.36 127.05 31.9 Favored 'General case' 0 N--CA 1.411 -2.421 0 O-C-N 120.361 -1.462 . . . . 25.0 108.392 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -140.04 156.43 46.61 Favored 'General case' 0 CA--C 1.488 -1.442 0 O-C-N 118.937 -2.352 . . . . 25.0 110.607 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -106.1 141.25 37.78 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 125.308 1.63 . . . . 25.0 107.893 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.91 121.13 46.38 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.187 0 C-N-CA 125.944 1.698 . . . . 25.0 109.995 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -82.47 126.14 31.9 Favored 'General case' 0 C--O 1.175 -2.82 0 CA-C-N 121.103 1.774 . . . . 50.0 106.667 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -110.79 123.56 35.22 Favored Pre-proline 0 C--O 1.265 1.879 0 N-CA-C 103.584 -2.747 . . . . 25.0 103.584 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.41 146.17 55.44 Favored 'Trans proline' 0 CA--C 1.585 3.037 0 C-N-CA 116.847 -1.635 . . . . 25.0 115.351 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.1 67.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 125.828 2.727 . . . . 25.0 104.879 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -62.92 -28.6 70.18 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 119.729 -1.857 . . . . 50.0 113.238 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -143.63 158.85 43.36 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.368 -1.716 . . . . 25.0 106.368 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.95 138.56 39.74 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 102.028 -3.323 . . . . 50.0 102.028 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 147.14 177.49 21.71 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 124.992 2.44 . . . . 25.0 116.18 -173.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 137.88 56.6 Favored 'General case' 0 C--O 1.192 -1.953 0 C-N-CA 126.287 1.835 . . . . 50.0 113.443 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -145.96 167.22 23.84 Favored 'General case' 0 C--O 1.255 1.355 0 C-N-CA 126.684 1.994 . . . . 25.0 109.017 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 t -124.16 144.47 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.425 -1.324 . . . . 50.0 107.425 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.16 113.05 43.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.303 -2.851 . . . . 25.0 103.303 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.56 153.06 21.66 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-N 119.029 0.831 . . . . 50.0 110.55 -170.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.52 136.95 23.86 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 120.515 -1.365 . . . . 25.0 109.416 -173.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.56 136.12 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.403 -0.919 . . . . 50.0 112.0 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -118.65 125.62 50.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.181 2.592 . . . . 25.0 104.893 -170.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -113.69 140.98 47.79 Favored 'General case' 0 C--O 1.269 2.109 0 O-C-N 125.679 1.862 . . . . 25.0 108.996 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.3 139.74 26.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 N-CA-C 104.914 -2.254 . . . . 50.0 104.914 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -92.6 -20.44 20.89 Favored 'General case' 0 C--O 1.196 -1.753 0 CA-C-N 112.324 -2.216 . . . . 25.0 112.149 177.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.27 -23.75 54.44 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.905 1.817 . . . . 25.0 115.905 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.2 p -145.3 -179.79 6.88 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 115.6 -2.143 . . . . 25.0 113.245 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -89.01 1.1 56.04 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-O 126.379 2.99 . . . . 25.0 113.014 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.43 158.54 31.26 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 119.781 -1.824 . . . . 25.0 112.739 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.75 159.35 29.99 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -145.42 158.24 43.87 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 124.648 2.166 . . . . 50.0 109.643 172.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -118.47 144.38 46.04 Favored 'General case' 0 C--O 1.193 -1.909 0 CA-C-N 110.824 -2.898 . . . . 50.0 104.101 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -141.51 138.04 32.49 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.312 -1.328 . . . . 25.0 107.886 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.61 156.49 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 120.596 1.543 . . . . 75.0 109.715 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.46 115.16 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.444 1.592 . . . . 25.0 108.322 172.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.18 118.65 22.06 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 117.155 -1.402 . . . . 25.0 108.618 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.88 156.48 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 120.466 1.484 . . . . 50.0 113.45 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -111.7 98.63 7.55 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 103.173 -2.899 . . . . 25.0 103.173 171.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.17 135.02 34.07 Favored 'General case' 0 N--CA 1.499 2.009 1 N-CA-C 99.734 -4.173 . . . . 50.0 99.734 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.01 169.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 119.564 -1.96 . . . . 50.0 113.67 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -59.8 139.42 57.32 Favored 'General case' 0 C--O 1.282 2.791 0 C-N-CA 119.23 -0.988 . . . . 25.0 109.814 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 CA--C 1.577 1.983 0 N-CA-C 115.756 1.762 . . . . 25.0 115.756 177.227 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.882 -1.056 . . . . 25.0 109.245 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.99 170.45 37.66 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 120.764 3.066 . . . . 25.0 120.764 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -136.49 151.79 49.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.818 1.784 . . . . 50.0 115.818 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.28 139.17 20.32 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 101.181 -3.636 . . . . 25.0 101.181 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -112.08 -28.14 8.11 Favored 'General case' 0 C--N 1.362 1.112 0 N-CA-C 113.519 0.933 . . . . 25.0 113.519 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -151.5 140.53 13.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 104.597 -2.371 . . . . 25.0 104.597 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.97 147.27 86.85 Favored 'Cis proline' 0 N--CA 1.499 1.834 0 CA-C-N 119.844 0.98 . . . . 25.0 114.53 -5.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.25 174.25 47.54 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.939 1.936 . . . . 25.0 117.939 161.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -131.62 141.45 49.64 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.472 1.909 . . . . 25.0 107.663 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -58.07 -31.5 67.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 115.105 1.52 . . . . 25.0 115.105 167.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.51 -35.05 70.62 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 125.961 2.038 . . . . 25.0 112.175 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.02 94.66 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.399 -0.813 . . . . 25.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.23 -16.59 49.03 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.302 -0.999 . . . . 75.0 108.302 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -84.62 -11.74 55.37 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.803 1.241 . . . . 25.0 111.806 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.2 t -65.55 138.84 58.32 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 114.899 1.444 . . . . 25.0 114.899 -173.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -73.96 0.52 13.24 Favored 'General case' 0 C--O 1.177 -2.754 0 O-C-N 117.753 -3.092 . . . . 25.0 114.249 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.85 -36.07 82.72 Favored 'General case' 0 CA--C 1.561 1.384 0 O-C-N 119.315 -2.116 . . . . 25.0 110.262 158.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -69.79 -53.27 19.04 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.502 1.144 . . . . 50.0 110.463 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.16 64.34 2.33 Favored Glycine 0 N--CA 1.501 2.979 0 CA-C-O 126.299 3.166 . . . . 25.0 113.382 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -65.62 -39.06 91.07 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 110.119 -3.041 . . . . 50.0 110.664 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.1 mt -91.12 -40.43 11.6 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 114.858 1.429 . . . . 50.0 114.858 -173.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -152.76 159.68 43.11 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 102.341 -3.207 . . . . 25.0 102.341 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.97 164.14 27.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 104.126 -2.546 . . . . 50.0 104.126 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -150.55 22.04 0.81 Allowed 'General case' 0 CA--C 1.576 1.973 0 O-C-N 125.088 1.493 . . . . 25.0 110.719 -162.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.7 t -61.98 -21.68 65.03 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 119.855 3.28 . . . . 25.0 119.855 -163.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.1 44.25 45.44 Favored Glycine 0 C--O 1.262 1.866 0 C-N-CA 116.211 -2.9 . . . . 25.0 110.683 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.52 -8.52 0.56 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 117.685 2.476 . . . . 25.0 117.685 -159.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.13 -17.55 6.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 O-C-N 121.079 -1.013 . . . . 50.0 109.549 165.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -2.13 0.51 Allowed 'General case' 0 C--O 1.281 2.72 1 O-C-N 115.792 -4.317 . . . . 25.0 117.563 164.211 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -65.95 -46.75 77.0 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 123.304 2.775 . . . . 50.0 104.784 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.37 73.04 31.25 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 117.529 2.418 . . . . 25.0 117.529 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -71.57 -21.18 26.05 Favored 'Trans proline' 0 C--N 1.393 2.882 0 CA-C-O 122.863 1.11 . . . . 25.0 112.066 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -82.87 -1.22 51.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.345 1.545 . . . . 25.0 112.11 -171.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 t -76.33 -18.0 59.14 Favored 'General case' 0 C--O 1.285 2.961 0 CA-C-N 111.317 -2.674 . . . . 25.0 109.148 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.52 119.22 15.36 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.731 1.605 . . . . 50.0 108.486 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -152.68 176.34 11.86 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 105.151 -2.166 . . . . 25.0 105.151 -172.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.25 144.58 30.87 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 166.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -129.3 145.88 51.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.459 1.481 . . . . 25.0 109.616 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -58.06 160.42 4.89 Favored 'General case' 0 C--O 1.199 -1.595 0 CA-C-N 113.435 -1.712 . . . . 25.0 109.738 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.74 -143.74 29.39 Favored Glycine 0 C--O 1.253 1.309 0 N-CA-C 109.351 -1.5 . . . . 25.0 109.351 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -152.96 161.14 29.86 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 110.816 -2.692 . . . . 25.0 109.957 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -60.8 126.53 3.38 Favored 'Cis proline' 0 CA--C 1.487 -1.851 0 C-N-CA 134.673 3.197 . . . . 25.0 112.386 -2.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -61.98 -34.21 75.73 Favored 'General case' 0 CA--C 1.586 2.355 0 O-C-N 126.244 2.215 . . . . 25.0 108.641 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t 62.38 -81.66 0.02 OUTLIER 'General case' 0 C--O 1.248 0.975 0 O-C-N 125.894 1.996 . . . . 25.0 112.527 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.05 -173.57 15.46 Favored Glycine 0 C--O 1.286 3.364 0 CA-C-O 126.884 3.491 . . . . 25.0 112.904 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -63.84 164.62 21.05 Favored 'Trans proline' 0 C--O 1.258 1.497 0 C-N-CA 123.428 2.752 . . . . 25.0 111.62 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.87 74.01 0.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.976 -1.465 . . . . 25.0 110.719 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -67.72 153.29 44.04 Favored 'General case' 0 C--O 1.289 3.184 0 O-C-N 119.9 -1.75 . . . . 25.0 113.268 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.05 -2.46 69.68 Favored Glycine 0 C--O 1.197 -2.214 0 N-CA-C 117.607 1.803 . . . . 25.0 117.607 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -102.53 40.03 1.42 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.805 1.764 . . . . 25.0 107.549 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 mm -63.18 -46.05 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 120.178 -1.576 . . . . 25.0 110.213 -170.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.1 -28.77 67.63 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 117.674 -1.61 . . . . 25.0 110.59 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.8 p -88.06 -6.15 58.09 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 118.126 -2.859 . . . . 25.0 113.166 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.41 31.82 21.38 Favored 'General case' 0 CA--C 1.459 -2.542 0 C-N-CA 127.683 2.393 . . . . 25.0 111.182 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.01 -12.74 71.87 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.11 -1.619 . . . . 25.0 116.353 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.42 -9.76 22.99 Favored Glycine 0 CA--C 1.5 -0.855 0 O-C-N 121.717 -0.872 . . . . 25.0 112.688 165.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.9 mt -115.29 4.62 14.49 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 115.631 1.715 . . . . 50.0 115.631 -169.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -78.26 -22.77 47.82 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 104.198 -2.519 . . . . 50.0 104.198 152.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.58 -18.6 77.38 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.356 -0.838 . . . . 25.0 111.385 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.3 -34.46 80.36 Favored Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 109.972 -1.251 . . . . 25.0 109.972 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 40.5 mt -61.93 -40.18 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 O-C-N 119.925 -1.926 . . . . 25.0 113.326 -175.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.04 -29.8 68.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 122.585 1.183 . . . . 75.0 109.576 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.66 -36.35 62.82 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 120.287 -1.508 . . . . 50.0 110.118 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -77.92 20.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 114.684 1.365 . . . . 25.0 114.684 166.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -147.12 40.99 1.07 Allowed 'General case' 0 C--O 1.264 1.822 0 CA-C-O 125.691 2.662 . . . . 25.0 110.097 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -137.63 -177.78 4.95 Favored 'General case' 0 CA--C 1.58 2.119 0 CA-C-N 112.325 -2.216 . . . . 25.0 115.064 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -60.09 -23.69 64.01 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 125.652 2.644 . . . . 25.0 114.789 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -93.03 18.26 9.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 118.894 -2.379 . . . . 25.0 109.599 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -70.12 90.05 0.65 Allowed 'General case' 0 C--O 1.287 3.044 0 CA-C-O 127.681 3.61 . . . . 25.0 108.581 170.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -52.48 160.91 0.76 Allowed 'General case' 0 C--O 1.272 2.241 0 CA-C-N 109.288 -3.596 . . . . 25.0 110.072 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -62.34 142.75 57.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.451 1.1 . . . . 50.0 113.755 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.8 143.58 26.58 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -117.56 125.36 50.69 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-N 123.005 2.639 . . . . 25.0 108.737 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mt -83.49 123.9 39.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 116.332 -0.395 . . . . 25.0 110.864 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.7 mtp -138.84 157.44 46.06 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.446 1.117 . . . . 25.0 110.217 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.4 p -89.28 179.25 6.15 Favored 'General case' 0 C--O 1.273 2.32 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.13 -170.1 29.58 Favored Glycine 0 C--O 1.194 -2.364 0 N-CA-C 110.195 -1.162 . . . . 25.0 110.195 163.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.76 179.12 46.22 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 118.736 -1.697 . . . . 25.0 115.978 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.45 149.17 36.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 119.228 -2.336 . . . . 25.0 108.549 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -129.12 157.09 42.74 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.208 -1.814 . . . . 25.0 107.93 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -120.89 157.84 28.96 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 127.078 2.736 . . . . 25.0 110.19 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -143.15 152.45 41.81 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.509 1.124 . . . . 50.0 108.534 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.0 m -137.93 141.93 40.58 Favored 'General case' 0 CA--C 1.426 -3.812 0 C-N-CA 125.304 1.442 . . . . 25.0 107.684 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -135.52 167.92 20.2 Favored 'General case' 0 C--O 1.262 1.741 1 N-CA-C 99.058 -4.423 . . . . 25.0 99.058 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -131.29 146.46 52.31 Favored 'General case' 0 C--O 1.278 2.587 0 N-CA-C 105.24 -2.133 . . . . 25.0 105.24 162.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -95.87 148.01 23.05 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-O 116.834 -1.555 . . . . 50.0 108.706 159.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -103.96 -24.5 13.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.521 1.964 . . . . 25.0 113.809 173.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 137.6 52.59 Favored Pre-proline 0 N--CA 1.425 -1.677 0 O-C-N 120.218 -1.551 . . . . 25.0 109.836 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -67.86 135.32 34.95 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 116.661 -1.759 . . . . 25.0 112.684 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -152.39 169.49 22.43 Favored 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.538 -2.023 . . . . 25.0 105.538 -163.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -127.58 96.21 4.47 Favored 'General case' 0 C--O 1.273 2.291 0 CA-C-O 118.186 -0.912 . . . . 25.0 108.961 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.2 m -65.4 143.22 57.87 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 120.943 1.701 . . . . 25.0 108.99 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 p -105.76 -48.79 3.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 116.46 2.022 . . . . 25.0 116.46 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -162.93 172.42 15.11 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 120.703 1.592 . . . . 25.0 110.748 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.28 149.05 32.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.442 1.019 . . . . 25.0 113.445 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -122.73 157.68 31.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 114.388 -2.72 . . . . 25.0 110.884 -170.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.06 128.84 8.64 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 125.32 2.486 . . . . 50.0 109.339 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' A' ' 117' ' ' LEU . 5.8 p90 -142.02 147.17 36.44 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 112.66 -2.064 . . . . 50.0 110.067 -168.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.1 163.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 124.071 0.948 . . . . 25.0 110.387 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 p -62.61 156.51 23.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 116.964 -1.493 . . . . 25.0 111.819 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -91.5 97.95 11.38 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 124.373 2.035 . . . . 25.0 111.404 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -56.86 154.04 9.97 Favored 'General case' 0 C--O 1.187 -2.198 0 O-C-N 117.213 -3.43 . . . . 25.0 113.782 159.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 3.03 50.34 Favored Glycine 0 CA--C 1.545 1.963 0 N-CA-C 120.454 2.941 . . . . 25.0 120.454 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.8 169.17 0.1 Allowed 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.02 1.41 . . . . 25.0 112.611 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.08 130.62 9.4 Favored Pre-proline 0 C--N 1.31 -1.114 0 N-CA-C 102.996 -2.965 . . . . 25.0 102.996 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -59.3 -31.53 95.23 Favored 'Trans proline' 0 C--N 1.373 1.848 0 N-CA-C 116.037 1.514 . . . . 25.0 116.037 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -76.81 -1.74 29.76 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 125.051 1.469 . . . . 75.0 112.186 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -121.15 -176.83 0.43 Allowed Pre-proline 0 CA--C 1.584 2.288 1 N-CA-C 100.053 -4.054 . . . . 25.0 100.053 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -55.49 16.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.477 -2.362 2 C-N-CA 126.754 4.969 . . . . 25.0 123.235 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.97 -39.91 20.79 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 124.828 3.467 . . . . 50.0 119.171 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -77.22 -20.02 55.86 Favored 'General case' 0 C--O 1.194 -1.823 0 O-C-N 120.242 -1.536 . . . . 25.0 110.867 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -91.73 -53.53 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.424 -1.423 . . . . 25.0 112.033 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.4 42.98 0.85 Allowed 'General case' 0 C--N 1.319 -0.76 0 O-C-N 119.343 -2.098 . . . . 25.0 110.527 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.92 -31.37 70.89 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 125.613 1.565 . . . . 25.0 112.434 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 146.13 47.77 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 125.318 2.485 . . . . 50.0 109.46 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -129.89 132.47 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.138 -1.601 . . . . 25.0 107.249 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 98' ' ' TYR . 15.1 tp -73.56 141.04 46.67 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 100.309 -3.96 . . . . 50.0 100.309 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.12 -14.43 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 25.0 112.035 166.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.42 -173.82 43.16 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 125.893 1.996 . . . . 25.0 114.793 159.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.35 153.7 30.88 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.164 -2.902 . . . . 25.0 103.164 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.17 122.01 5.67 Favored Pre-proline 0 C--O 1.259 1.598 0 CA-C-N 119.777 1.171 . . . . 50.0 108.292 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -75.57 164.06 32.99 Favored 'Trans proline' 0 CA--C 1.494 -1.509 0 C-N-CA 115.991 -2.206 . . . . 25.0 115.312 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -133.82 72.95 1.48 Allowed 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 128.353 2.661 . . . . 25.0 109.941 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -74.76 -24.26 58.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 118.643 2.831 . . . . 50.0 118.643 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -170.58 -92.44 0.08 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 127.723 3.14 . . . . 25.0 109.889 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 t -122.0 61.07 12.95 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 114.237 1.199 . . . . 25.0 114.237 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -86.65 -167.1 0.34 Allowed 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-O 124.047 1.603 . . . . 25.0 111.664 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.86 69.58 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 118.901 -2.375 . . . . 25.0 106.178 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.5 p -79.79 18.88 0.72 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 124.616 2.151 . . . . 25.0 109.314 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -73.39 -27.1 61.29 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 118.117 -2.865 . . . . 25.0 103.528 168.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.76 134.2 40.51 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 112.954 -1.93 . . . . 25.0 106.235 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 tp -87.65 -28.4 21.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.52 -1.659 . . . . 75.0 106.52 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . 0.281 44.8 t -71.68 139.86 49.39 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.874 -1.766 . . . . 25.0 110.654 173.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -149.39 156.24 41.73 Favored 'General case' 0 C--O 1.273 2.331 0 N-CA-C 106.608 -1.627 . . . . 25.0 106.608 -164.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -97.81 140.53 32.04 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 115.757 -2.068 . . . . 25.0 115.056 170.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.9 mm -127.55 130.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 125.367 1.667 . . . . 25.0 107.624 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -87.96 129.35 35.27 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-O 123.737 1.732 . . . . 50.0 108.259 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.5 mm -107.63 124.75 34.03 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 112.691 -2.05 . . . . 25.0 106.809 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.27 151.44 76.57 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-O 124.498 1.791 . . . . 25.0 107.806 176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -116.73 29.71 7.77 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 111.124 -2.762 . . . . 25.0 112.457 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -75.02 -27.99 60.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.285 -2.234 . . . . 50.0 115.656 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -152.5 164.21 38.04 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 126.026 2.079 . . . . 25.0 106.799 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -83.56 158.75 21.84 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 106.953 -1.499 . . . . 50.0 106.953 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.31 121.99 0.59 Allowed Glycine 0 N--CA 1.481 1.683 0 N-CA-C 117.054 1.582 . . . . 25.0 117.054 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 0.2 OUTLIER -66.04 139.19 58.18 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 114.279 1.214 . . . . 50.0 114.279 -178.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -135.57 168.38 19.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 119.821 -1.799 . . . . 25.0 108.147 -169.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -112.4 139.09 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 102.1 -3.296 . . . . 50.0 102.1 162.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.9 129.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 118.635 0.652 . . . . 25.0 110.801 165.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.46 143.15 48.66 Favored 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 117.087 -1.435 . . . . 50.0 113.59 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.01 160.5 37.55 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 126.143 2.152 . . . . 25.0 111.296 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . 0.288 39.5 t -144.3 125.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.29 1.036 . . . . 50.0 109.088 174.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -104.79 112.3 25.36 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 101.157 -3.645 . . . . 25.0 101.157 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -100.62 133.37 45.18 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.0 129.03 31.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 O-C-N 125.242 1.588 . . . . 50.0 109.834 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.75 -18.45 32.97 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -159.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -86.12 2.79 45.36 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 116.005 1.854 . . . . 25.0 116.005 -172.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 t -143.32 158.69 43.42 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.102 -1.444 . . . . 25.0 107.102 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -82.24 -7.44 59.62 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.327 0.967 . . . . 25.0 110.226 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -86.12 163.72 17.7 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.42 148.98 52.3 Favored 'General case' 0 C--O 1.274 2.357 0 N-CA-C 102.02 -3.326 . . . . 25.0 102.02 164.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -102.73 139.36 38.41 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 106.387 -1.708 . . . . 50.0 106.387 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -116.72 153.12 32.93 Favored 'General case' 0 C--O 1.277 2.502 0 C-N-CA 125.013 1.325 . . . . 50.0 108.499 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.72 138.34 23.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.661 0.743 . . . . 25.0 109.745 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.15 142.27 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 106.489 -1.671 . . . . 75.0 106.489 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.9 mt -136.28 127.09 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 104.166 -2.531 . . . . 25.0 104.166 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.91 145.78 25.33 Favored 'General case' 0 C--O 1.203 -1.353 0 N-CA-C 103.986 -2.598 . . . . 25.0 103.986 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.3 m -149.74 156.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 114.093 1.146 . . . . 50.0 114.093 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 54.1 t0 -121.77 99.87 6.69 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 105.202 -2.147 . . . . 25.0 105.202 172.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.09 121.27 31.26 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.48 -2.785 . . . . 50.0 103.48 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.21 165.79 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 117.099 2.259 . . . . 50.0 117.099 -171.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.64 158.81 15.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt . . . . . 0 C--O 1.261 1.684 0 C-N-CA 119.857 -0.737 . . . . 25.0 112.808 172.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.2 m80 . . . . . 1 N--CA 1.554 4.728 0 CA-C-O 121.705 0.764 . . . . 25.0 111.38 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.73 118.04 0.47 Allowed Glycine 0 CA--C 1.541 1.699 0 O-C-N 117.368 -3.333 . . . . 25.0 107.343 -14.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -130.63 144.82 51.68 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 122.058 2.929 . . . . 50.0 111.209 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.5 mt -99.19 115.43 39.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 101.296 -3.594 . . . . 25.0 101.296 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -88.42 -40.28 13.63 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 125.709 1.88 . . . . 25.0 110.621 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -146.82 145.26 22.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 117.163 2.283 . . . . 25.0 117.163 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.83 149.09 93.44 Favored 'Cis proline' 0 C--O 1.271 2.161 0 CA-C-N 121.161 1.45 . . . . 25.0 115.474 -7.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.21 -168.37 45.18 Favored Glycine 0 N--CA 1.483 1.776 0 O-C-N 126.625 2.453 . . . . 25.0 112.454 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 t -125.91 120.54 30.68 Favored 'General case' 0 C--O 1.266 1.945 0 O-C-N 125.865 1.568 . . . . 25.0 109.794 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -70.11 -35.95 74.5 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.171 -0.678 . . . . 25.0 109.171 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.09 81.97 Favored 'General case' 0 C--O 1.206 -1.231 0 C-N-CA 123.792 0.837 . . . . 25.0 109.84 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -36.51 82.03 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.452 0.908 . . . . 25.0 113.452 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.36 -27.01 65.88 Favored 'General case' 0 C--O 1.182 -2.48 0 O-C-N 125.371 1.669 . . . . 75.0 109.862 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.61 -23.1 46.11 Favored 'General case' 0 CA--C 1.56 1.342 0 O-C-N 124.316 1.01 . . . . 25.0 108.436 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.0 p -82.61 170.98 14.56 Favored 'General case' 0 C--O 1.189 -2.088 0 CA-C-O 123.99 1.852 . . . . 25.0 112.24 -169.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -72.68 -12.62 61.1 Favored 'General case' 0 CA--C 1.554 1.119 0 O-C-N 117.179 -3.451 . . . . 25.0 112.284 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.49 -12.67 60.07 Favored 'General case' 0 CA--C 1.562 1.421 0 O-C-N 120.021 -1.674 . . . . 25.0 112.104 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -52.46 -40.87 62.79 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.305 -1.77 . . . . 50.0 114.184 161.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.24 89.25 0.12 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 103.198 -3.961 . . . . 25.0 103.198 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -47.56 -31.09 4.06 Favored 'General case' 0 C--O 1.269 2.098 0 C-N-CA 127.663 2.385 . . . . 50.0 116.56 -166.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 mt -72.15 -13.99 61.7 Favored 'General case' 0 C--O 1.263 1.784 0 C-N-CA 117.553 -1.659 . . . . 50.0 111.772 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -144.13 158.26 43.82 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.299 0.852 . . . . 25.0 113.299 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -166.95 -178.8 4.38 Favored 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 107.48 -1.304 . . . . 50.0 107.48 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -153.93 48.24 0.64 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 127.387 2.929 . . . . 25.0 106.192 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -142.06 -3.28 1.1 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 118.45 2.759 . . . . 25.0 118.45 -168.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.73 -39.51 91.37 Favored Glycine 0 C--O 1.284 3.245 0 CA-C-N 114.087 -1.415 . . . . 25.0 112.734 -163.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 m -91.4 -32.48 15.63 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-O 127.579 3.562 . . . . 25.0 113.092 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.2 t -65.94 -30.28 49.51 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 111.328 -2.669 . . . . 50.0 113.747 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.5 ptp -68.44 -9.02 45.83 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.2 -50.12 50.3 Favored 'General case' 0 C--O 1.201 -1.449 0 C-N-CA 113.737 -3.185 . . . . 50.0 110.984 175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.98 76.72 27.48 Favored Pre-proline 0 C--O 1.252 1.193 0 O-C-N 120.996 -1.065 . . . . 25.0 110.524 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.68 -21.02 29.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 1 C-N-CA 111.497 -5.202 . . . . 25.0 115.309 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -81.7 2.23 30.64 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 118.94 -2.35 . . . . 25.0 114.362 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 t -118.22 98.95 6.55 Favored 'General case' 0 C--O 1.292 3.303 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.9 mt -126.14 133.52 51.57 Favored 'General case' 0 C--O 1.294 3.399 1 N-CA-C 99.821 -4.14 . . . . 50.0 99.821 157.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -121.83 134.78 54.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 113.975 1.102 . . . . 25.0 113.975 -170.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.24 125.93 32.27 Favored 'General case' 0 C--O 1.198 -1.624 0 C-N-CA 125.335 1.454 . . . . 25.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -113.94 132.27 56.01 Favored 'General case' 0 C--O 1.273 2.3 0 CA-C-N 121.278 1.853 . . . . 25.0 112.778 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -61.56 151.55 32.86 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 126.495 2.372 . . . . 25.0 112.434 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.63 -149.51 38.48 Favored Glycine 0 C--O 1.185 -2.966 0 CA-C-O 119.189 -0.784 . . . . 25.0 114.471 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -102.76 166.3 12.18 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 123.963 0.905 . . . . 25.0 109.93 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.0 -168.73 6.76 Favored 'Cis proline' 0 CA--C 1.552 1.415 0 C-N-CA 132.716 2.382 . . . . 25.0 110.697 3.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -63.07 -42.45 99.66 Favored 'General case' 0 C--O 1.191 -2.005 0 N-CA-C 115.704 1.742 . . . . 25.0 115.704 171.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.72 -95.4 0.05 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-N 114.495 -1.23 . . . . 25.0 113.948 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.34 168.47 11.65 Favored Glycine 0 C--O 1.269 2.287 0 C-N-CA 118.121 -1.99 . . . . 25.0 113.32 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.03 161.81 44.31 Favored 'Trans proline' 0 CA--C 1.492 -1.59 1 C-N-CA 125.489 4.126 . . . . 25.0 114.017 175.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.54 68.71 1.64 Allowed 'General case' 0 C--O 1.261 1.678 0 CA-C-N 113.681 -1.6 . . . . 25.0 111.039 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -151.17 138.47 19.37 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 130.324 3.45 . . . . 25.0 107.245 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.14 79.59 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 119.42 -1.372 . . . . 25.0 111.099 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -122.68 43.74 2.83 Favored 'General case' 0 C--O 1.275 2.428 0 CA-C-O 125.383 2.516 . . . . 25.0 108.862 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.0 mt -82.75 -43.53 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 111.495 -2.593 . . . . 25.0 108.657 -159.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.01 -31.04 68.5 Favored 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 116.744 -1.598 . . . . 25.0 110.637 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.4 t -95.22 -3.71 47.16 Favored 'General case' 0 C--O 1.291 3.251 0 CA-C-O 125.149 2.404 . . . . 25.0 108.369 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.5 25.36 14.43 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 118.886 2.921 . . . . 25.0 118.886 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.38 -21.56 64.4 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 108.006 -2.037 . . . . 25.0 108.006 169.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.41 34.94 2.51 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 120.227 2.851 . . . . 25.0 120.227 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.72 0.19 52.21 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 115.394 1.628 . . . . 50.0 115.394 -170.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -77.18 -11.4 59.81 Favored 'General case' 0 CA--C 1.604 3.053 0 C-N-CA 117.482 -1.687 . . . . 50.0 107.213 161.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.97 69.09 Favored Glycine 0 C--O 1.248 0.971 0 CA-C-O 125.43 2.683 . . . . 25.0 111.828 173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.26 -27.2 70.41 Favored Glycine 0 C--O 1.205 -1.696 0 O-C-N 120.435 -1.627 . . . . 25.0 113.26 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.94 -39.43 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 104.779 -2.304 . . . . 25.0 104.779 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.8 -34.69 78.96 Favored 'General case' 0 CA--C 1.58 2.116 0 O-C-N 124.496 1.123 . . . . 75.0 112.732 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.16 -19.47 33.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 124.228 1.966 . . . . 50.0 115.538 -167.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -77.53 8.57 4.15 Favored 'General case' 0 C--O 1.258 1.552 0 O-C-N 118.307 -2.746 . . . . 25.0 115.945 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -145.01 60.8 1.31 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.828 -1.533 . . . . 25.0 110.601 163.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -130.33 151.41 50.86 Favored 'General case' 0 CA--C 1.599 2.829 0 C-N-CA 119.439 -0.905 . . . . 25.0 111.982 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.6 -26.29 68.62 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 118.018 -2.926 . . . . 25.0 108.547 166.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -93.51 24.92 3.71 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.422 -1.311 . . . . 25.0 111.067 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.91 100.76 0.43 Allowed 'General case' 0 C--O 1.196 -1.749 0 CA-C-O 125.556 2.598 . . . . 25.0 110.557 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -32.73 137.53 0.07 Allowed 'General case' 0 C--N 1.317 -0.824 2 CA-C-N 103.45 -6.25 . . . . 25.0 115.821 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -77.2 128.45 34.4 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 121.676 -0.64 . . . . 50.0 110.808 -155.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -98.86 147.32 25.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 119.818 3.266 . . . . 25.0 119.818 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -137.81 155.18 49.29 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 102.28 -3.23 . . . . 25.0 102.28 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.0 mt -105.56 126.21 60.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 1 N-CA-C 97.913 -4.847 . . . . 25.0 97.913 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.6 mtp -130.46 140.16 50.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.323 1.049 . . . . 25.0 111.286 -168.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 p -75.44 173.23 11.22 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 116.059 1.874 . . . . 25.0 116.059 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.48 -178.77 48.47 Favored Glycine 0 C--O 1.283 3.182 0 N-CA-C 105.184 -3.166 . . . . 25.0 105.184 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.17 -170.56 31.7 Favored Glycine 2 N--CA 1.389 -4.453 0 CA-C-N 111.313 -2.443 . . . . 25.0 111.314 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 45.5 mt-10 -80.49 136.79 36.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.368 2.084 . . . . 25.0 112.444 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -137.18 161.46 36.1 Favored 'General case' 0 N--CA 1.522 3.16 0 O-C-N 124.939 1.399 . . . . 25.0 108.494 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 m -112.65 130.84 55.9 Favored 'General case' 0 C--O 1.274 2.353 0 CA-C-O 122.438 1.113 . . . . 25.0 109.491 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -118.35 116.99 27.87 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 113.402 -1.727 . . . . 50.0 109.556 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 m -137.36 135.63 37.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 114.958 1.466 . . . . 25.0 114.958 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -114.95 161.49 18.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.847 -2.279 . . . . 25.0 104.847 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 t -146.5 147.97 31.73 Favored 'General case' 0 C--O 1.265 1.874 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.44 148.98 32.84 Favored 'General case' 0 CA--C 1.603 3.007 0 O-C-N 118.264 -2.773 . . . . 50.0 106.372 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.5 p -77.76 2.35 17.28 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 118.133 2.642 . . . . 25.0 118.133 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.45 159.54 57.48 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.655 1.182 . . . . 25.0 108.535 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.04 163.82 36.23 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 114.716 -3.056 . . . . 25.0 111.144 171.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -139.03 151.16 46.58 Favored 'General case' 0 C--O 1.183 -2.409 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 163.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.59 121.5 19.82 Favored 'General case' 0 C--O 1.253 1.265 0 CA-C-N 113.424 -1.716 . . . . 25.0 106.624 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.1 m -142.99 138.91 30.38 Favored 'General case' 0 C--N 1.317 -0.832 1 N-CA-C 99.674 -4.195 . . . . 25.0 99.674 -172.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.0 p -78.94 -48.64 14.17 Favored 'General case' 0 C--O 1.272 2.241 0 CA-C-O 124.025 1.869 . . . . 25.0 110.924 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -163.48 175.9 10.28 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.442 -1.411 . . . . 25.0 109.353 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -144.46 154.07 42.55 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 126.085 1.754 . . . . 25.0 108.697 167.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -128.43 160.55 31.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 116.792 -1.575 . . . . 25.0 109.692 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -134.91 148.5 50.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 103.663 -2.717 . . . . 50.0 103.663 162.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -139.2 168.59 19.49 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 103.998 -2.593 . . . . 50.0 103.998 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.4 pt -136.32 160.96 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 104.581 -2.378 . . . . 25.0 104.581 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -123.78 148.33 46.76 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 113.206 -1.815 . . . . 25.0 106.622 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -125.95 93.86 3.94 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 117.893 -1.523 . . . . 25.0 108.07 -172.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.84 165.99 3.67 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 120.114 -1.617 . . . . 25.0 112.757 168.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.82 48.5 Favored Glycine 0 C--O 1.192 -2.52 0 O-C-N 119.811 -1.806 . . . . 25.0 109.822 -171.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.59 159.57 32.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.073 1.416 . . . . 25.0 110.933 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.32 128.8 86.9 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 101.877 -3.379 . . . . 25.0 101.877 170.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 108' ' ' LYS . 72.3 Cg_endo -74.77 -27.06 10.81 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 114.048 -3.501 . . . . 25.0 117.359 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -81.59 1.23 34.75 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.48 1.491 . . . . 75.0 108.575 -165.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 106' ' ' PRO . 25.0 mmtp -118.24 166.53 13.5 Favored Pre-proline 0 CA--C 1.578 2.052 0 O-C-N 127.976 3.297 . . . . 25.0 111.798 -161.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -47.33 30.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.374 2 C-N-CA 130.171 7.247 . . . . 25.0 124.528 174.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -52.28 -27.88 16.83 Favored 'General case' 0 C--O 1.188 -2.178 0 O-C-N 120.141 -1.599 . . . . 50.0 114.835 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -71.57 -14.48 62.1 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 123.706 0.629 . . . . 25.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -116.43 -60.52 1.85 Allowed 'General case' 0 C--O 1.168 -3.235 0 C-N-CA 126.854 2.062 . . . . 25.0 111.817 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.56 -25.37 35.88 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -102.74 28.65 5.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.761 0.791 . . . . 25.0 112.885 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -137.85 151.73 48.36 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.914 -2.625 . . . . 50.0 103.914 156.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -130.01 147.88 51.8 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 119.008 -0.52 . . . . 25.0 111.408 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.8 tp -65.94 136.21 55.78 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 106.28 -1.748 . . . . 50.0 106.28 156.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.53 -15.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 120.24 1.382 . . . . 25.0 107.698 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.8 157.23 15.71 Favored Glycine 0 C--O 1.284 3.279 0 CA-C-O 117.057 -1.968 . . . . 25.0 110.971 163.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.14 150.32 49.55 Favored 'General case' 0 C--O 1.263 1.773 0 CA-C-N 118.067 0.934 . . . . 25.0 112.774 162.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -126.34 111.24 23.56 Favored Pre-proline 0 C--O 1.255 1.382 0 C-N-CA 125.432 1.493 . . . . 50.0 114.997 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -79.31 157.59 26.0 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 114.07 -3.487 . . . . 25.0 119.278 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . 0.279 53.1 t-80 -121.96 65.2 0.91 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 124.292 1.996 . . . . 25.0 107.122 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.15 26.47 8.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 111.624 -2.535 . . . . 50.0 110.458 -166.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.83 57.96 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-O 124.016 1.898 . . . . 25.0 108.806 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.96 160.48 0.65 Allowed Pre-proline 0 C--O 1.266 1.957 0 N-CA-C 118.479 2.77 . . . . 25.0 118.479 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.72 -166.62 0.1 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 123.099 2.533 . . . . 25.0 115.652 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.09 -23.13 7.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.189 1.922 . . . . 25.0 116.189 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.8 p -69.3 -8.44 46.16 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 114.395 1.257 . . . . 25.0 114.395 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -53.67 -29.07 36.88 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 117.217 -1.373 . . . . 25.0 113.811 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . 0.261 85.1 m-20 -68.15 143.59 55.34 Favored 'General case' 0 C--O 1.19 -2.064 0 CA-C-O 123.641 1.686 . . . . 25.0 111.359 -174.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -20.65 66.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.374 1.869 . . . . 75.0 110.073 -170.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.0 t -83.24 127.47 33.66 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.29 1.959 . . . . 25.0 116.29 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -137.45 146.95 44.94 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 124.503 2.097 . . . . 25.0 112.533 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -98.03 129.89 44.87 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.762 -1.211 . . . . 25.0 110.445 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . 0.266 35.9 mm -131.12 120.62 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.81 1.244 . . . . 25.0 107.904 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 89.9 t80 -76.58 126.07 30.34 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.898 -1.519 . . . . 50.0 106.898 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.9 129.08 31.99 Favored Pre-proline 0 C--N 1.364 1.221 0 CA-C-O 115.91 -1.995 . . . . 25.0 109.798 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.14 156.04 47.43 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 116.156 -2.096 . . . . 25.0 110.836 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -109.45 -8.63 15.01 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 126.527 1.931 . . . . 25.0 115.773 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -93.94 -13.58 26.93 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 115.833 1.79 . . . . 50.0 115.833 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.61 163.4 22.83 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.127 1.528 . . . . 25.0 115.127 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.01 146.13 34.41 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 124.94 1.4 . . . . 50.0 113.769 158.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.72 158.99 11.21 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 118.826 2.291 . . . . 25.0 118.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -72.79 136.99 45.52 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.975 -1.613 . . . . 50.0 111.149 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -142.87 166.11 25.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.152 -0.476 . . . . 25.0 110.526 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.77 130.95 73.24 Favored 'Isoleucine or valine' 0 C--O 1.267 1.98 0 N-CA-C 101.887 -3.375 . . . . 50.0 101.887 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.3 mt -101.63 123.86 55.04 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.93 1 N-CA-C 98.639 -4.578 . . . . 25.0 98.639 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.497 ' HA ' HG12 ' A' ' 164' ' ' VAL . 4.1 mp -112.38 143.22 43.86 Favored 'General case' 0 C--O 1.189 -2.106 0 N-CA-C 104.527 -2.397 . . . . 50.0 104.527 -173.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.4 34.94 Favored 'General case' 0 CA--C 1.456 -2.65 0 O-C-N 119.87 -1.769 . . . . 25.0 113.097 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.84 125.46 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 CA-C-N 110.143 -3.208 . . . . 50.0 108.489 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -108.06 104.22 13.61 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.873 -1.158 . . . . 25.0 107.873 166.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -78.28 72.74 4.82 Favored 'General case' 0 C--O 1.26 1.653 0 O-C-N 126.267 2.229 . . . . 25.0 106.47 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.64 116.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.773 0 C-N-CA 126.174 1.79 . . . . 50.0 113.374 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.8 -22.31 23.32 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -7.87 0.37 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 119.642 3.201 . . . . 25.0 119.642 171.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.2 p -135.34 165.08 26.27 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 103.089 -2.93 . . . . 25.0 103.089 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -76.97 -41.87 41.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 119.576 -1.953 . . . . 25.0 110.103 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -81.44 168.66 18.08 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 105.098 -2.186 . . . . 25.0 105.098 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -116.34 153.47 31.93 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 102.95 -2.982 . . . . 25.0 102.95 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -97.6 150.05 21.56 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 107.714 -1.217 . . . . 50.0 107.714 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -140.79 162.53 35.2 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 104.957 -2.238 . . . . 50.0 104.957 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 144.64 12.02 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 103.377 -2.823 . . . . 25.0 103.377 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 149' ' ' LEU . 24.0 m -123.38 155.03 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 123.082 1.42 . . . . 75.0 114.6 165.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.46 117.64 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 101.13 -3.656 . . . . 25.0 101.13 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -82.28 127.49 33.26 Favored 'General case' 1 C--O 1.318 4.668 0 CA-C-O 124.614 2.15 . . . . 25.0 106.169 170.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.14 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 116.573 -3.83 . . . . 50.0 115.217 175.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.31 98.18 5.94 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 106.189 -1.782 . . . . 25.0 106.189 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.23 122.74 32.8 Favored 'General case' 0 C--O 1.261 1.695 0 N-CA-C 101.555 -3.498 . . . . 50.0 101.555 -168.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.08 162.57 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 118.607 -2.558 . . . . 50.0 117.366 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -84.63 164.39 18.69 Favored 'General case' 0 C--O 1.282 2.77 0 O-C-N 120.738 -1.226 . . . . 25.0 108.301 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 40.9 pttt . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 116.971 -1.49 . . . . 25.0 108.548 179.072 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 . . . . . 0 C--O 1.262 1.757 0 N-CA-C 113.553 0.946 . . . . 25.0 113.553 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.07 179.44 30.29 Favored Glycine 0 C--O 1.282 3.146 0 CA-C-O 115.706 -2.719 . . . . 25.0 113.844 -172.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.61 153.17 44.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 119.067 1.433 . . . . 50.0 113.033 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 6' ' ' LYS . 19.1 mt -71.03 124.14 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 119.127 -2.233 . . . . 25.0 110.257 -171.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -100.89 11.03 40.4 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 123.516 1.627 . . . . 25.0 109.014 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 4' ' ' ILE . 51.1 mtmt 86.91 159.24 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.679 1 C-N-CA 133.354 4.661 . . . . 25.0 112.529 172.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 139.97 47.87 Favored 'Cis proline' 0 CA--C 1.466 -2.895 0 C-N-CA 132.672 2.363 . . . . 25.0 114.193 2.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.18 69.15 1.21 Allowed Glycine 0 C--N 1.281 -2.496 0 CA-C-N 112.036 -2.347 . . . . 25.0 113.393 165.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -69.86 137.7 51.92 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 125.795 2.712 . . . . 25.0 108.69 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -93.63 -18.8 21.78 Favored 'General case' 0 C--O 1.281 2.759 0 N-CA-C 103.746 -2.686 . . . . 25.0 103.746 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.02 75.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.898 0.856 . . . . 25.0 112.078 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.48 77.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.913 -1.494 . . . . 25.0 110.362 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -85.98 -15.89 40.05 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 113.03 -1.895 . . . . 75.0 109.396 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 t -79.63 -11.46 59.87 Favored 'General case' 0 N--CA 1.416 -2.132 0 C-N-CA 125.991 1.716 . . . . 25.0 114.263 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.5 t -48.91 135.04 16.12 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 125.905 1.682 . . . . 25.0 109.738 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.259 40.8 tt0 -66.54 -20.84 66.12 Favored 'General case' 0 CA--C 1.588 2.418 0 C-N-CA 127.388 2.275 . . . . 25.0 110.045 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.66 -13.48 22.81 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.158 1.54 . . . . 25.0 115.158 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -54.33 -21.87 10.56 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 113.478 0.918 . . . . 50.0 113.478 166.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.97 17.29 0.04 OUTLIER Glycine 0 C--O 1.214 -1.132 0 O-C-N 118.213 -2.804 . . . . 25.0 119.361 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.3 t80 54.26 21.08 2.92 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.733 1.753 . . . . 50.0 115.733 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.18 -34.42 22.08 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.608 -1.933 . . . . 50.0 108.75 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -114.23 176.53 5.0 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 119.505 1.048 . . . . 25.0 108.383 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.56 172.22 8.92 Favored 'General case' 0 N--CA 1.523 3.22 0 CA-C-O 117.114 -1.422 . . . . 50.0 113.527 168.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -35.67 -37.8 0.1 Allowed 'General case' 0 C--O 1.181 -2.549 0 N-CA-C 119.027 2.973 . . . . 25.0 119.027 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -146.36 -21.67 0.43 Allowed 'General case' 0 C--O 1.217 -0.636 0 O-C-N 127.135 2.772 . . . . 25.0 111.531 151.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.53 121.36 2.91 Favored Glycine 0 C--O 1.208 -1.495 0 N-CA-C 106.277 -2.729 . . . . 25.0 106.277 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -7.89 0.39 Allowed 'General case' 0 CA--C 1.574 1.876 1 N-CA-C 122.574 4.287 . . . . 25.0 122.574 -167.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.42 -13.3 8.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 CA-C-N 120.301 1.41 . . . . 50.0 112.382 168.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.9 ptm -53.23 -13.51 0.54 Allowed 'General case' 0 C--O 1.173 -2.928 0 N-CA-C 119.84 3.274 . . . . 25.0 119.84 172.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -64.9 -38.09 89.83 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 115.12 -0.945 . . . . 50.0 110.565 169.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.52 60.81 5.76 Favored Pre-proline 0 C--O 1.275 2.423 0 CA-C-N 115.025 -0.989 . . . . 25.0 112.878 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.19 -22.22 9.96 Favored 'Trans proline' 0 N--CA 1.477 0.546 1 C-N-CA 110.086 -6.143 . . . . 25.0 115.525 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -77.6 -15.39 59.26 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.963 -1.086 . . . . 25.0 111.28 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.4 t -73.66 116.93 14.83 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 118.271 -1.371 . . . . 25.0 111.391 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 162' ' ' TYR . 66.5 mt -118.23 145.55 44.92 Favored 'General case' 0 C--O 1.164 -3.408 0 N-CA-C 104.501 -2.407 . . . . 50.0 104.501 162.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.6 157.88 45.3 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 124.765 2.222 . . . . 25.0 107.984 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.71 155.51 49.02 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 105.161 -2.163 . . . . 25.0 105.161 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.0 156.58 47.93 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 120.986 1.721 . . . . 25.0 110.957 166.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -76.02 157.5 32.94 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 114.657 1.354 . . . . 25.0 114.657 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.39 163.39 13.17 Favored Glycine 0 C--O 1.19 -2.632 0 N-CA-C 105.042 -3.223 . . . . 25.0 105.042 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.1 156.51 72.25 Favored Pre-proline 0 N--CA 1.438 -1.037 0 C-N-CA 128.055 2.542 . . . . 25.0 113.554 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.08 -28.93 5.38 Favored 'Cis proline' 0 C--N 1.371 1.742 0 C-N-CA 130.375 1.406 . . . . 25.0 114.111 -0.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -130.83 10.81 5.11 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-N 120.994 1.725 . . . . 25.0 113.193 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t 61.31 -146.43 0.43 Allowed 'General case' 0 CA--C 1.478 -1.806 0 O-C-N 126.401 2.313 . . . . 25.0 110.271 -168.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.54 -163.44 0.73 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 118.996 -1.574 . . . . 25.0 114.505 169.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.32 169.52 15.28 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 122.502 2.135 . . . . 25.0 113.404 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.16 79.29 0.14 Allowed 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 123.277 1.513 . . . . 25.0 114.854 -170.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -147.03 158.3 43.88 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 96.026 -5.546 . . . . 25.0 96.026 171.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.71 37.19 67.05 Favored Glycine 0 C--O 1.273 2.59 0 N-CA-C 109.793 -1.323 . . . . 25.0 109.793 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -97.12 21.34 9.97 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.889 1.276 . . . . 25.0 108.808 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.1 mt -75.15 -44.75 43.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.25 -1.018 . . . . 25.0 108.25 -166.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.36 -31.1 72.17 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 119.565 -1.96 . . . . 25.0 110.847 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.6 p -82.08 7.94 12.07 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.973 1.842 . . . . 25.0 115.973 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.22 10.0 0.03 OUTLIER 'General case' 0 C--O 1.26 1.639 0 N-CA-C 116.547 2.055 . . . . 25.0 116.547 -167.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.92 -40.54 98.51 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 122.285 2.312 . . . . 25.0 108.955 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.65 -2.03 79.3 Favored Glycine 0 CA--C 1.568 3.354 0 C-N-CA 119.408 -1.377 . . . . 25.0 114.354 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.2 mt -112.15 -23.51 10.39 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 117.668 -1.158 . . . . 50.0 114.005 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -71.56 -36.5 70.94 Favored 'General case' 0 C--O 1.262 1.713 0 N-CA-C 106.902 -1.518 . . . . 50.0 106.902 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.19 -16.52 78.61 Favored Glycine 1 C--O 1.156 -4.726 0 CA-C-O 123.362 1.535 . . . . 25.0 115.082 171.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.38 -17.01 73.98 Favored Glycine 0 C--N 1.307 -1.07 0 O-C-N 118.916 -2.52 . . . . 25.0 112.02 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -77.63 -34.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.53 0 N-CA-C 106.23 -1.767 . . . . 25.0 106.23 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.18 -23.0 57.65 Favored 'General case' 0 C--O 1.27 2.149 0 O-C-N 119.268 -2.145 . . . . 75.0 107.746 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -73.22 -8.2 54.79 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 113.566 -1.652 . . . . 50.0 112.726 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -77.36 7.7 5.01 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 124.378 2.037 . . . . 25.0 113.485 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -131.26 34.35 4.01 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.294 -1.373 . . . . 25.0 107.294 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 t -142.58 157.73 44.4 Favored 'General case' 0 C--O 1.252 1.229 0 O-C-N 119.954 -1.716 . . . . 25.0 111.656 -164.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.41 -25.08 66.96 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-O 122.466 1.126 . . . . 25.0 109.694 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.09 13.66 16.26 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.062 2.545 . . . . 25.0 108.173 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -76.41 99.62 4.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.313 -2.847 . . . . 25.0 103.313 167.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -46.72 145.13 2.03 Favored 'General case' 0 C--N 1.309 -1.155 1 CA-C-N 107.105 -4.589 . . . . 25.0 113.597 166.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -80.03 147.8 31.35 Favored 'General case' 0 C--O 1.21 -0.998 0 CA-C-O 115.626 -2.13 . . . . 50.0 110.4 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.91 101.66 13.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 126.246 2.216 . . . . 25.0 107.354 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -73.28 119.39 17.45 Favored 'General case' 0 C--O 1.284 2.911 0 N-CA-C 107.048 -1.464 . . . . 25.0 107.048 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.7 mt -81.53 130.97 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.0 ttt -147.82 134.55 19.98 Favored 'General case' 0 C--O 1.178 -2.695 0 N-CA-C 107.893 -1.151 . . . . 25.0 107.893 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 p -79.72 150.27 30.9 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.524 -2.398 . . . . 25.0 104.524 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.93 163.23 37.77 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 119.793 2.677 . . . . 25.0 119.793 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.75 -177.92 18.49 Favored Glycine 0 C--O 1.27 2.402 0 N-CA-C 105.998 -2.841 . . . . 25.0 105.998 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 9.3 pt-20 -82.48 152.24 26.16 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 125.437 2.542 . . . . 25.0 106.307 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.94 154.28 51.16 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 118.334 -2.729 . . . . 25.0 105.603 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.3 m -117.88 131.79 56.5 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 103.15 -2.907 . . . . 25.0 103.15 163.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -115.64 141.54 47.93 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.352 -1.351 . . . . 50.0 107.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -139.41 129.18 24.71 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 113.043 -1.889 . . . . 25.0 111.907 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -131.59 162.58 30.0 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 101.655 -3.461 . . . . 25.0 101.655 -174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.4 p -132.46 140.01 48.22 Favored 'General case' 0 CA--C 1.488 -1.417 0 O-C-N 121.597 -0.689 . . . . 25.0 111.748 156.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.447 ' CD2' ' HE1' ' A' ' 90' ' ' HIS . 76.4 m-85 -79.74 154.75 28.33 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.035 -1.469 . . . . 50.0 107.035 164.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.9 t -91.96 -19.72 22.13 Favored 'General case' 0 C--O 1.257 1.449 0 N-CA-C 106.762 -1.57 . . . . 25.0 106.762 -165.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.95 139.39 13.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 CA-C-O 117.305 -1.331 . . . . 25.0 109.12 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.85 131.86 34.8 Favored 'Trans proline' 0 CA--C 1.599 3.729 0 C-N-CA 115.461 -2.56 . . . . 25.0 111.225 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.447 ' HE1' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -153.16 160.43 42.85 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -81.61 161.48 23.47 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 116.048 1.87 . . . . 25.0 116.048 -158.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.416 HG21 ' HE3' ' A' ' 95' ' ' TRP . 53.1 m -154.97 134.96 12.97 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.332 -1.358 . . . . 25.0 107.332 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.1 p -91.52 -41.22 10.93 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.49 -1.67 . . . . 25.0 106.49 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -161.39 172.53 16.37 Favored 'General case' 0 C--O 1.281 2.732 0 N-CA-C 104.95 -2.241 . . . . 25.0 104.95 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.416 ' HE3' HG21 ' A' ' 92' ' ' THR . 3.5 p90 -144.53 152.52 40.69 Favored 'General case' 0 C--O 1.258 1.533 0 N-CA-C 114.477 1.288 . . . . 25.0 114.477 167.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -128.98 142.25 50.99 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.385 -1.293 . . . . 25.0 110.59 -167.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.74 144.19 47.38 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-N 120.276 1.398 . . . . 50.0 107.556 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.3 167.57 20.47 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 105.61 -1.996 . . . . 50.0 105.61 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.3 pt -129.6 147.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 172.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.6 p -77.79 154.89 31.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 117.739 -1.124 . . . . 25.0 109.565 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -144.86 80.09 1.61 Allowed 'General case' 0 C--O 1.239 0.545 0 N-CA-C 117.411 2.374 . . . . 25.0 117.411 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -47.24 157.72 0.18 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 125.411 2.529 . . . . 25.0 115.124 167.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.95 32.71 23.05 Favored Glycine 0 C--O 1.204 -1.767 0 C-N-CA 116.985 -2.531 . . . . 25.0 112.108 167.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -60.66 159.41 10.83 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.989 1.848 . . . . 25.0 115.989 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -74.82 134.34 75.35 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.126 -1.435 . . . . 25.0 107.126 162.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.23 -26.5 49.26 Favored 'Trans proline' 0 C--N 1.362 1.26 0 N-CA-C 120.164 3.102 . . . . 25.0 120.164 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.18 -6.5 58.59 Favored 'General case' 0 C--O 1.191 -1.994 0 C-N-CA 116.96 -1.896 . . . . 75.0 110.198 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -66.27 157.6 80.9 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 111.684 -2.507 . . . . 25.0 110.913 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.14 51.16 1.29 Allowed 'Trans proline' 0 C--N 1.37 1.668 1 N-CA-C 122.829 4.126 . . . . 25.0 122.829 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -2.45 -66.31 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 1 C-N-CA 132.092 4.157 . . . . 50.0 118.968 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -72.34 -8.6 55.8 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 122.189 2.268 . . . . 25.0 114.652 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 -55.4 2.58 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 124.523 1.129 . . . . 25.0 109.32 165.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.85 -25.69 1.39 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 117.323 2.342 . . . . 25.0 117.323 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -82.96 8.45 12.64 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.27 160.57 39.85 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 119.938 -1.726 . . . . 50.0 108.49 159.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -144.44 134.37 23.89 Favored 'General case' 0 C--O 1.182 -2.5 0 N-CA-C 105.821 -1.918 . . . . 25.0 105.821 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.41 132.57 50.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.678 1.191 . . . . 50.0 111.358 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.8 tt -111.15 -18.15 7.85 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 N-CA-C 106.224 -1.769 . . . . 25.0 106.224 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.29 156.03 13.11 Favored Glycine 0 C--N 1.306 -1.095 0 O-C-N 120.542 -1.349 . . . . 25.0 113.085 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.14 139.41 24.61 Favored 'General case' 0 C--O 1.266 1.943 0 CA-C-O 123.769 1.747 . . . . 25.0 107.065 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -128.81 107.21 18.44 Favored Pre-proline 0 C--O 1.255 1.381 0 CA-C-N 114.63 -1.168 . . . . 50.0 110.056 -170.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.95 164.52 31.49 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 113.331 -3.979 . . . . 25.0 115.038 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -139.98 2.98 1.98 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 118.058 2.614 . . . . 25.0 118.058 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -90.29 -24.92 20.77 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 107.637 -1.246 . . . . 50.0 107.637 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.62 160.93 27.43 Favored Glycine 0 C--N 1.352 1.437 1 N-CA-C 95.207 -7.157 . . . . 25.0 95.207 155.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.5 t -154.8 149.11 19.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 120.543 2.171 . . . . 25.0 112.706 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.03 -178.03 3.59 Favored 'Trans proline' 0 N--CA 1.436 -1.86 0 C-N-CA 114.866 -2.956 . . . . 25.0 111.008 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -15.8 5.37 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 118.474 -2.641 . . . . 25.0 115.496 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.53 4.02 0.43 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.103 1.89 . . . . 25.0 116.103 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -57.47 -33.54 68.08 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 127.108 2.163 . . . . 25.0 115.05 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -48.57 131.37 17.5 Favored 'General case' 0 C--O 1.18 -2.592 0 CA-C-N 119.367 0.985 . . . . 25.0 113.201 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.3 tp -65.86 -29.9 70.42 Favored 'General case' 0 C--O 1.268 2.077 0 CA-C-O 122.017 0.913 . . . . 75.0 113.355 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 132.5 47.46 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 121.748 -0.595 . . . . 25.0 110.67 166.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -153.84 161.05 42.36 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.597 1.665 . . . . 25.0 110.559 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -112.12 137.52 50.07 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.518 1.303 . . . . 25.0 114.518 -172.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.3 mt -132.53 133.23 59.89 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 102.956 -2.979 . . . . 25.0 102.956 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 73.5 t80 -101.0 134.19 44.36 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 105.716 -1.957 . . . . 50.0 105.716 173.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.4 mm -125.17 110.38 26.85 Favored Pre-proline 0 C--O 1.2 -1.509 0 N-CA-C 102.127 -3.286 . . . . 25.0 102.127 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.25 149.83 70.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 115.101 -2.799 . . . . 25.0 109.854 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -92.51 47.07 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.77 -14.69 60.74 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 118.791 -2.443 . . . . 50.0 114.487 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -166.44 169.45 13.89 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 103.946 -2.613 . . . . 25.0 103.946 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.6 pt? -98.15 152.57 19.22 Favored 'General case' 0 C--O 1.281 2.741 0 N-CA-C 100.459 -3.904 . . . . 50.0 100.459 163.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.24 164.19 17.72 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-O 123.386 1.548 . . . . 25.0 111.163 -171.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.91 157.65 45.06 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 117.105 -3.585 . . . . 50.0 116.844 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -158.42 175.94 13.07 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 100.652 -3.833 . . . . 25.0 100.652 170.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.75 146.92 6.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 123.449 0.7 . . . . 50.0 111.726 167.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.94 128.39 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 O-C-N 119.329 -2.107 . . . . 25.0 106.252 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -115.7 153.77 30.75 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 115.683 -2.103 . . . . 50.0 106.531 -167.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.49 44.2 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 121.48 1.945 . . . . 25.0 114.536 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.41 135.44 57.84 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.714 0 C-N-CA 125.028 1.331 . . . . 50.0 111.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -115.77 137.8 51.74 Favored 'General case' 0 C--O 1.277 2.543 0 C-N-CA 127.583 2.353 . . . . 25.0 107.273 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -118.0 144.82 45.22 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 103.269 -2.863 . . . . 25.0 103.269 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.33 113.27 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 105.538 -2.023 . . . . 50.0 105.538 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.0 -14.29 62.29 Favored 'General case' 0 C--O 1.262 1.728 0 N-CA-C 115.255 1.576 . . . . 25.0 115.255 -167.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -71.3 -25.09 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 126.39 2.306 . . . . 25.0 111.16 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.9 p -120.13 165.45 14.75 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 112.272 -2.24 . . . . 25.0 111.819 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -100.7 -9.79 21.49 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 123.808 1.766 . . . . 25.0 107.374 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -78.66 159.42 28.03 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 113.121 -1.854 . . . . 25.0 112.841 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.44 148.58 42.95 Favored 'General case' 0 CA--C 1.557 1.242 1 N-CA-C 98.837 -4.505 . . . . 25.0 98.837 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -126.67 139.48 53.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.276 -1.379 . . . . 50.0 107.276 -165.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 35' ' ' LEU . 75.7 m-85 -140.19 159.46 42.13 Favored 'General case' 0 C--O 1.203 -1.365 0 O-C-N 126.427 2.329 . . . . 50.0 110.404 -166.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -148.38 161.83 40.79 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.206 1.402 . . . . 25.0 111.816 166.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.52 130.6 50.43 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.178 0 N-CA-C 106.207 -1.775 . . . . 75.0 106.207 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -126.92 120.8 56.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.772 -1.566 . . . . 25.0 106.772 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -91.12 145.49 24.64 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 107.445 -1.316 . . . . 25.0 107.445 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.42 163.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 C-N-CA 127.187 2.195 . . . . 50.0 112.903 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.58 108.57 6.02 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 127.235 2.214 . . . . 25.0 109.701 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.33 116.49 30.45 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 102.867 -3.012 . . . . 50.0 102.867 -161.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 31.8 m -125.18 167.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.127 -1.029 . . . . 50.0 113.015 -156.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.88 155.03 31.2 Favored 'General case' 0 C--O 1.263 1.766 0 O-C-N 124.715 1.259 . . . . 25.0 108.277 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 C--O 1.249 1.059 0 CA-C-N 113.672 -1.603 . . . . 25.0 106.825 -177.346 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.527 -1.702 . . . . 25.0 113.252 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.53 166.72 39.14 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 117.155 -2.45 . . . . 25.0 116.658 -170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.81 173.35 13.83 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 106.681 -1.6 . . . . 50.0 106.681 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.0 121.96 54.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 N-CA-C 102.897 -3.001 . . . . 25.0 102.897 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.6 -41.81 16.03 Favored 'General case' 0 C--O 1.18 -2.569 0 C-N-CA 127.631 2.372 . . . . 25.0 113.837 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -152.7 155.74 32.69 Favored Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 105.838 -1.912 . . . . 25.0 105.838 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -60.51 139.18 23.0 Favored 'Cis proline' 0 C--N 1.358 1.028 0 C-N-CA 132.291 2.204 . . . . 25.0 116.209 3.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.58 -177.17 54.41 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 122.639 1.133 . . . . 25.0 114.123 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -123.08 103.01 8.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 125.129 2.395 . . . . 25.0 107.548 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -58.77 -27.83 65.35 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 119.861 -1.774 . . . . 25.0 112.988 167.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.79 73.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 122.902 1.334 . . . . 25.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.86 73.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 122.058 0.932 . . . . 25.0 108.857 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.5 -17.5 64.19 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 127.192 2.197 . . . . 75.0 109.721 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.15 -20.94 26.29 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 108.49 -0.93 . . . . 25.0 108.49 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.0 t -80.47 121.75 26.13 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 116.518 -1.706 . . . . 25.0 110.026 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.4 -29.7 69.28 Favored 'General case' 0 C--O 1.195 -1.806 0 CA-C-N 121.994 2.179 . . . . 25.0 107.64 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.76 71.77 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 115.863 1.801 . . . . 25.0 115.863 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.49 -22.29 62.67 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 109.531 -0.544 . . . . 50.0 109.531 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.43 27.37 8.49 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 109.963 -1.255 . . . . 25.0 109.963 172.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.5 t80 60.51 -51.52 0.09 Allowed 'General case' 0 C--O 1.27 2.17 0 C-N-CA 128.952 2.901 . . . . 50.0 117.606 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 23.0 mt -123.64 -10.44 7.85 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.254 -1.529 . . . . 50.0 113.838 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -128.87 157.66 40.92 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 116.374 1.991 . . . . 25.0 116.374 -154.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -155.74 157.69 36.96 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 125.099 2.381 . . . . 50.0 109.232 -172.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -143.85 31.16 1.29 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.724 -2.035 . . . . 25.0 114.104 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -20.53 61.25 Favored 'General case' 0 C--O 1.267 1.996 0 CA-C-N 113.37 -1.741 . . . . 25.0 113.426 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.07 138.82 8.43 Favored Glycine 0 CA--C 1.473 -2.575 0 N-CA-C 104.08 -3.608 . . . . 25.0 104.08 -171.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.1 p -57.6 -7.28 0.62 Allowed 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 114.632 1.345 . . . . 25.0 114.632 175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 28' ' ' VAL . 3.2 t -58.78 -30.93 43.55 Favored 'Isoleucine or valine' 0 C--O 1.262 1.732 0 C-N-CA 127.434 2.294 . . . . 50.0 109.498 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -61.63 1.65 0.23 Allowed 'General case' 0 C--O 1.255 1.372 0 N-CA-C 118.811 2.893 . . . . 25.0 118.811 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -66.82 -41.29 87.73 Favored 'General case' 0 C--O 1.267 1.974 0 C-N-CA 124.104 0.961 . . . . 50.0 111.321 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.94 56.68 8.23 Favored Pre-proline 0 C--O 1.249 1.051 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.05 -20.89 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.318 0 N-CA-C 120.555 3.252 . . . . 25.0 120.555 -167.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -94.33 -2.85 51.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 116.849 -1.94 . . . . 25.0 113.179 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 t -77.09 87.25 3.58 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 122.191 0.996 . . . . 25.0 111.164 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.13 80.05 1.33 Allowed 'General case' 0 C--O 1.252 1.194 0 N-CA-C 107.729 -1.212 . . . . 50.0 107.729 -167.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -141.2 135.7 31.03 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 121.147 1.794 . . . . 25.0 114.43 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.68 166.11 31.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.044 -2.576 . . . . 25.0 104.044 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -84.93 146.56 27.19 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -58.96 147.3 34.78 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.647 1.179 . . . . 25.0 111.319 170.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.73 -156.15 13.45 Favored Glycine 0 N--CA 1.414 -2.808 0 CA-C-O 124.752 2.307 . . . . 25.0 111.37 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -129.76 168.1 17.81 Favored Pre-proline 0 C--O 1.264 1.86 0 CA-C-N 109.921 -3.139 . . . . 25.0 103.904 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -13.02 15.74 Favored 'Cis proline' 0 CA--C 1.555 1.527 0 N-CA-C 121.255 3.521 . . . . 25.0 121.255 -8.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 87.24 -34.96 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 124.971 1.308 . . . . 25.0 110.102 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -78.24 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.24 1.416 . . . . 25.0 108.542 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.99 163.98 52.0 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 119.289 -2.132 . . . . 25.0 110.181 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.6 -23.2 27.23 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 113.399 -3.934 . . . . 25.0 117.305 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.13 113.17 7.06 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 104.566 -2.383 . . . . 25.0 104.566 168.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.83 128.6 12.46 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 126.523 1.929 . . . . 25.0 114.597 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.83 -28.83 0.23 Allowed Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 120.603 3.001 . . . . 25.0 120.603 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -96.4 39.02 1.17 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 104.545 -2.391 . . . . 25.0 104.545 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.1 -47.34 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.559 0.744 . . . . 25.0 109.974 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.95 73.82 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.603 1.705 . . . . 25.0 115.603 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.4 p -91.97 -11.45 36.07 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.53 1.532 . . . . 25.0 113.7 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.57 31.82 21.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 112.247 -2.252 . . . . 25.0 112.818 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -20.47 76.45 Favored Glycine 0 C--O 1.267 2.182 0 C-N-CA 118.329 -1.891 . . . . 25.0 116.647 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.8 8.0 76.71 Favored Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 119.817 1.809 . . . . 25.0 112.32 173.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 mt -117.51 -172.84 2.31 Favored 'General case' 0 C--O 1.278 2.595 0 C-N-CA 126.679 1.992 . . . . 50.0 110.371 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -66.68 -14.04 62.0 Favored 'General case' 0 C--O 1.175 -2.824 0 C-N-CA 118.635 -1.226 . . . . 50.0 113.512 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.51 73.13 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 106.973 -2.451 . . . . 25.0 106.973 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.14 -11.26 84.58 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 124.461 2.145 . . . . 25.0 117.283 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -79.77 -32.19 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.375 0 CA-C-O 125.891 2.758 . . . . 25.0 107.126 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.48 -17.55 51.29 Favored 'General case' 0 CA--C 1.468 -2.181 0 CA-C-N 113.267 -1.788 . . . . 75.0 109.41 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.15 2.53 2.11 Favored 'General case' 0 C--O 1.197 -1.662 0 CA-C-O 123.928 1.823 . . . . 50.0 115.832 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -85.52 40.98 0.87 Allowed 'General case' 0 C--O 1.263 1.788 0 O-C-N 120.285 -1.509 . . . . 25.0 107.998 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.47 49.25 0.48 Allowed 'General case' 0 C--O 1.262 1.757 0 N-CA-C 105.847 -1.909 . . . . 25.0 105.847 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.8 t -147.01 157.3 43.58 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 126.747 2.019 . . . . 25.0 108.194 -162.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -31.41 67.46 Favored 'General case' 0 C--O 1.261 1.687 0 N-CA-C 102.177 -3.268 . . . . 25.0 102.177 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -88.19 21.11 2.91 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 120.308 -0.557 . . . . 25.0 109.671 -171.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -68.62 98.53 0.89 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 125.602 2.62 . . . . 25.0 103.946 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -33.78 144.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 1 CA-C-N 105.865 -5.152 . . . . 25.0 113.416 165.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -66.94 134.49 52.11 Favored 'General case' 0 C--O 1.263 1.767 0 O-C-N 125.233 1.583 . . . . 50.0 107.098 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -80.57 153.65 27.94 Favored 'General case' 0 CA--C 1.483 -1.598 0 O-C-N 120.589 -1.32 . . . . 25.0 110.481 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -136.93 143.3 42.83 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 117.29 2.33 . . . . 25.0 117.29 157.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.84 134.27 39.82 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.705 0 N-CA-C 105.406 -2.072 . . . . 25.0 105.406 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 66.3 mtm -144.32 146.92 32.87 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 118.624 -2.547 . . . . 25.0 105.895 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 p -86.58 171.55 10.94 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 124.143 1.925 . . . . 25.0 108.079 168.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.26 -173.77 17.09 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 124.455 2.142 . . . . 25.0 115.502 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.84 -176.7 38.03 Favored Glycine 0 C--O 1.266 2.106 0 N-CA-C 108.006 -2.038 . . . . 25.0 108.006 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 68.1 mm-40 -66.55 149.37 50.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 116.344 -1.789 . . . . 25.0 110.843 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -147.24 137.43 23.26 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 126.679 2.487 . . . . 25.0 105.675 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -93.61 105.96 17.97 Favored 'General case' 0 CA--C 1.479 -1.774 0 O-C-N 126.532 2.395 . . . . 25.0 105.152 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -76.64 142.23 40.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 103.061 -2.94 . . . . 50.0 103.061 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -136.46 103.28 5.21 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 118.385 -2.697 . . . . 25.0 106.75 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -100.78 126.7 47.37 Favored 'General case' 0 C--O 1.177 -2.754 0 N-CA-C 102.688 -3.079 . . . . 25.0 102.688 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -123.33 120.63 33.63 Favored 'General case' 0 C--O 1.175 -2.818 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -113.5 153.76 28.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.905 -1.498 . . . . 50.0 109.022 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 t -116.31 8.24 14.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 126.573 2.421 . . . . 25.0 113.271 174.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.91 119.39 25.86 Favored Pre-proline 0 C--N 1.349 0.586 0 C-N-CA 128.084 2.554 . . . . 25.0 111.451 -167.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -68.6 -37.94 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 124.922 2.011 . . . . 25.0 116.11 160.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.433 ' HD1' HG13 ' A' ' 154' ' ' VAL . 12.9 p80 -68.28 139.56 55.96 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 123.224 1.488 . . . . 25.0 110.857 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -78.68 129.74 35.06 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 112.887 -1.96 . . . . 25.0 113.479 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 154' ' ' VAL . 31.9 p -93.05 164.02 13.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.067 -1.646 . . . . 25.0 108.918 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -96.7 -49.94 4.89 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 120.698 -1.251 . . . . 25.0 110.185 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -166.46 170.88 12.45 Favored 'General case' 0 C--O 1.262 1.738 0 CA-C-O 118.354 -0.831 . . . . 25.0 110.758 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -144.13 153.06 41.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.096 -0.954 . . . . 25.0 109.315 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -131.16 142.59 50.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.832 -2.655 . . . . 25.0 103.832 -164.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -142.36 135.44 28.61 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 117.512 -3.242 . . . . 50.0 113.002 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 117' ' ' LEU . 14.5 p90 -146.38 167.16 24.28 Favored 'General case' 0 C--O 1.163 -3.495 0 O-C-N 119.546 -1.971 . . . . 50.0 111.105 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -120.1 173.97 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 125.933 2.02 . . . . 25.0 113.369 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -135.56 154.12 51.47 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 124.063 0.852 . . . . 25.0 112.711 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -137.81 100.77 4.27 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.388 1.625 . . . . 25.0 115.388 -165.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -42.86 162.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 120.73 3.604 . . . . 25.0 120.73 157.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.1 28.5 Favored Glycine 0 N--CA 1.488 2.113 0 CA-C-O 126.056 3.031 . . . . 25.0 107.763 165.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -67.62 160.89 26.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.06 -2.07 . . . . 25.0 114.067 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.02 111.75 20.43 Favored Pre-proline 0 C--O 1.194 -1.816 0 N-CA-C 107.127 -1.434 . . . . 25.0 107.127 155.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -64.35 -24.48 64.59 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 C-N-CA 123.671 2.914 . . . . 25.0 114.855 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.23 -15.99 50.5 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.379 1.049 . . . . 75.0 113.195 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -71.88 161.79 76.8 Favored Pre-proline 0 N--CA 1.483 1.199 0 CA-C-O 116.884 -1.531 . . . . 25.0 108.584 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -54.08 31.16 0.02 OUTLIER 'Trans proline' 0 CA--C 1.574 2.485 2 C-N-CA 126.302 4.668 . . . . 25.0 122.66 160.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -8.9 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 1 N-CA-C 122.386 4.217 . . . . 50.0 122.386 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.52 -16.83 64.44 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 117.118 -3.489 . . . . 25.0 109.586 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.26 -57.33 2.29 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 126.033 2.083 . . . . 25.0 106.955 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.76 -24.63 66.95 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.536 1.773 . . . . 25.0 115.299 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -69.88 -4.69 21.48 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-O 116.513 -1.708 . . . . 25.0 114.903 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -118.32 150.29 39.75 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 122.807 2.549 . . . . 50.0 110.011 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.81 149.64 38.9 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 119.823 -1.798 . . . . 25.0 111.382 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 98' ' ' TYR . 21.1 tp -76.44 123.84 26.64 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 116.054 -1.927 . . . . 50.0 108.93 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.0 tt -95.29 -11.68 8.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.83 173.5 33.53 Favored Glycine 0 C--O 1.19 -2.633 0 N-CA-C 116.645 1.418 . . . . 25.0 116.645 164.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -157.32 132.12 8.73 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.344 -1.428 . . . . 25.0 111.295 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.44 130.32 18.02 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 105.033 -2.21 . . . . 50.0 105.033 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -82.56 163.87 16.56 Favored 'Trans proline' 0 C--N 1.372 1.769 0 CA-C-O 124.83 1.929 . . . . 25.0 116.229 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -82.87 136.05 34.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 113.732 -1.576 . . . . 25.0 108.426 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.7 32.14 11.5 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.9 1.68 . . . . 50.0 111.008 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.28 165.11 43.64 Favored Glycine 0 N--CA 1.425 -2.088 0 O-C-N 119.502 -1.999 . . . . 25.0 108.625 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 t -66.17 -38.31 21.4 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-O 116.241 -1.838 . . . . 25.0 112.872 -173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.24 160.94 23.19 Favored 'Trans proline' 0 C--N 1.38 2.231 1 C-N-CA 108.351 -7.299 . . . . 25.0 107.874 -170.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.37 -26.1 11.5 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 126.876 3.227 . . . . 25.0 114.08 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -66.91 2.83 1.26 Allowed 'General case' 0 CA--C 1.512 -0.49 1 N-CA-C 122.615 4.302 . . . . 25.0 122.615 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.03 5.48 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 121.438 3.866 . . . . 25.0 121.438 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.25 141.5 41.7 Favored 'General case' 0 C--O 1.276 2.499 0 N-CA-C 121.55 3.907 . . . . 25.0 121.55 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.18 -25.72 63.57 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 106.589 -1.634 . . . . 75.0 106.589 -165.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 t -90.37 127.79 36.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 O-C-N 117.819 -3.051 . . . . 25.0 110.583 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -125.64 155.44 40.81 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 117.014 2.227 . . . . 25.0 117.014 164.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -79.72 125.63 29.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 113.139 -3.315 . . . . 25.0 108.304 169.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.7 mm -124.38 129.03 74.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 123.582 2.901 . . . . 25.0 105.968 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 79.0 t80 -81.59 127.2 32.62 Favored 'General case' 0 C--O 1.276 2.462 0 O-C-N 120.472 -1.393 . . . . 50.0 113.399 177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.64 116.27 61.3 Favored Pre-proline 0 CA--C 1.515 -0.4 0 C-N-CA 130.768 3.627 . . . . 25.0 105.842 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.57 158.3 58.26 Favored 'Trans proline' 0 C--O 1.193 -1.728 1 C-N-CA 111.925 -4.916 . . . . 25.0 115.848 175.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -115.86 9.26 14.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.268 1.509 . . . . 25.0 109.427 -170.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.23 -8.66 57.55 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.113 2.264 . . . . 50.0 117.113 -171.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -146.5 170.21 17.35 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.274 -2.491 . . . . 25.0 104.274 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.1 pt? -111.99 131.68 55.25 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 101.269 -3.604 . . . . 50.0 101.269 160.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -176.08 164.4 34.37 Favored Glycine 0 C--N 1.302 -1.357 0 CA-C-O 124.756 2.309 . . . . 25.0 113.649 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.15 139.75 34.17 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.569 -1.548 . . . . 50.0 111.125 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -154.69 159.62 40.86 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 104.884 -2.265 . . . . 25.0 104.884 -171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.54 134.54 66.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 113.781 -3.009 . . . . 50.0 112.839 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.6 mt -110.01 130.18 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 O-C-N 127.453 2.97 . . . . 25.0 106.553 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.51 143.18 50.8 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 103.324 -2.843 . . . . 50.0 103.324 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.61 153.1 49.94 Favored 'General case' 0 C--O 1.257 1.455 0 N-CA-C 104.723 -2.325 . . . . 25.0 104.723 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.82 135.66 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-N 113.7 -1.591 . . . . 50.0 107.258 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.49 124.97 31.26 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-N 119.782 1.174 . . . . 25.0 110.067 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 143.58 34.31 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 125.274 1.609 . . . . 25.0 112.853 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.433 HG13 ' HD1' ' A' ' 90' ' ' HIS . 39.0 t -99.32 135.19 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 123.901 1.81 . . . . 50.0 111.159 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 -34.14 20.81 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.3 -1.5 . . . . 25.0 111.691 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -72.96 -17.59 61.46 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 124.872 1.358 . . . . 25.0 110.32 -171.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 p -146.06 179.26 7.61 Favored 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 109.204 -0.665 . . . . 25.0 109.204 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -87.02 9.98 17.89 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-O 122.571 1.177 . . . . 25.0 111.873 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -73.6 150.78 41.16 Favored 'General case' 0 C--O 1.281 2.733 0 CA-C-O 123.118 1.437 . . . . 25.0 110.291 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.33 160.16 43.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 103.017 -2.957 . . . . 25.0 103.017 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -145.23 173.78 11.65 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.022 -1.844 . . . . 50.0 106.022 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.48 149.07 46.54 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 105.588 -2.005 . . . . 50.0 105.588 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.67 145.2 42.35 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 121.409 1.913 . . . . 25.0 108.192 -173.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.6 p -141.64 145.33 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 CA-C-N 119.399 1.0 . . . . 75.0 111.929 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.11 134.41 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 103.65 -2.722 . . . . 25.0 103.65 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.53 135.25 33.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.899 -1.046 . . . . 25.0 110.767 169.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.41 133.2 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 119.398 -2.064 . . . . 50.0 111.758 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -106.45 89.96 3.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 102.353 -3.203 . . . . 25.0 102.353 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.48 118.97 32.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.578 -1.646 . . . . 50.0 107.007 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 5.1 m -120.38 157.61 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 123.989 1.852 . . . . 50.0 114.21 -170.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -74.23 143.83 44.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 100.38 -3.933 . . . . 25.0 100.38 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 CA--C 1.55 0.97 0 C-N-CA 126.768 2.027 . . . . 25.0 108.521 -175.45 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 123.279 1.514 . . . . 25.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.43 -149.13 28.63 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 117.477 1.751 . . . . 25.0 117.477 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.19 133.68 40.2 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.121 1.368 . . . . 50.0 108.726 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.71 120.85 35.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 119.809 1.186 . . . . 25.0 108.268 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -98.2 -29.46 13.2 Favored 'General case' 0 C--O 1.281 2.733 0 C-N-CA 125.079 1.352 . . . . 25.0 112.816 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -153.31 146.79 18.12 Favored Pre-proline 0 CA--C 1.559 1.298 1 N-CA-C 98.742 -4.54 . . . . 25.0 98.742 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.38 131.11 8.81 Favored 'Cis proline' 0 C--N 1.311 -1.436 0 C-N-CA 131.058 1.691 . . . . 25.0 115.743 15.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.47 177.29 44.39 Favored Glycine 0 C--O 1.192 -2.494 0 N-CA-C 118.632 2.213 . . . . 25.0 118.632 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -103.58 125.65 50.24 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 105.201 -2.148 . . . . 25.0 105.201 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -61.93 -34.0 75.29 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 123.789 0.681 . . . . 25.0 109.74 170.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.09 -33.13 73.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 116.718 -1.993 . . . . 25.0 111.284 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.69 78.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.248 -0.908 . . . . 25.0 111.665 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mp -80.12 -30.65 39.08 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-O 122.277 1.037 . . . . 75.0 111.362 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -65.28 -25.49 67.67 Favored 'General case' 0 C--O 1.269 2.087 0 O-C-N 121.517 -0.739 . . . . 25.0 111.288 172.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.5 t -70.45 140.75 52.04 Favored 'General case' 0 CA--C 1.47 -2.116 0 O-C-N 119.159 -2.213 . . . . 25.0 105.495 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -66.45 -11.35 51.58 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 116.557 -1.687 . . . . 25.0 110.717 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.41 -37.6 85.58 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 120.863 1.665 . . . . 25.0 109.634 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -79.54 -38.47 34.12 Favored 'General case' 0 C--O 1.208 -1.086 0 O-C-N 120.652 -1.28 . . . . 50.0 111.074 169.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.06 17.91 9.8 Favored Glycine 0 C--N 1.362 1.988 0 N-CA-C 116.419 1.328 . . . . 25.0 116.419 -152.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -59.21 -41.69 89.2 Favored 'General case' 0 C--O 1.176 -2.788 0 O-C-N 120.054 -1.85 . . . . 50.0 114.77 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.06 -15.2 62.96 Favored 'General case' 0 CA--C 1.467 -2.22 0 O-C-N 118.631 -2.543 . . . . 50.0 115.959 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -109.99 175.54 5.4 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 124.604 1.162 . . . . 25.0 111.753 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mp -55.81 151.96 10.52 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 119.568 -1.957 . . . . 50.0 115.449 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -35.7 -43.12 0.27 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.41 3.115 . . . . 25.0 119.41 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 t -146.45 6.53 0.97 Allowed 'General case' 0 C--O 1.257 1.448 0 N-CA-C 117.143 2.275 . . . . 25.0 117.143 -169.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.52 82.62 0.22 Allowed Glycine 0 C--O 1.17 -3.845 0 CA-C-O 118.383 -1.232 . . . . 25.0 112.739 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.72 -10.89 0.12 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 118.174 2.657 . . . . 25.0 118.174 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 p -58.01 -22.2 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-N 120.634 1.561 . . . . 50.0 109.597 172.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -47.02 -22.45 0.34 Allowed 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 123.868 1.794 . . . . 25.0 115.741 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -62.5 -40.15 95.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.407 1.632 . . . . 50.0 115.407 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -143.12 46.18 0.67 Allowed Pre-proline 0 CA--C 1.473 -2.009 0 N-CA-C 119.044 2.979 . . . . 25.0 119.044 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.35 -30.7 29.73 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 O-C-N 116.918 -2.201 . . . . 25.0 113.513 -167.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -77.89 -1.07 29.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.374 1.99 . . . . 25.0 116.374 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.5 16.69 3.0 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 121.122 3.749 . . . . 25.0 121.122 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.78 114.64 18.85 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 125.39 2.519 . . . . 50.0 110.819 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -99.2 162.43 13.06 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 117.633 -3.167 . . . . 25.0 110.822 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.87 14.97 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.72 1.263 . . . . 25.0 112.388 -172.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -92.35 -172.61 3.15 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.401 1.572 . . . . 25.0 109.792 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.34 138.25 17.15 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 105.388 -2.078 . . . . 25.0 105.388 172.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.86 -5.8 0.53 Allowed Glycine 0 C--O 1.195 -2.312 0 O-C-N 128.042 3.339 . . . . 25.0 111.761 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -65.83 138.98 96.68 Favored Pre-proline 0 N--CA 1.477 0.914 0 CA-C-O 115.074 -2.393 . . . . 25.0 109.212 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.51 115.68 2.91 Favored 'Cis proline' 0 C--O 1.2 -1.405 0 O-C-N 125.966 2.561 . . . . 25.0 111.418 -2.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -60.14 -26.96 66.67 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 117.815 2.524 . . . . 25.0 117.815 -165.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.86 -39.3 53.46 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 116.985 2.216 . . . . 25.0 116.985 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.06 179.72 38.37 Favored Glycine 0 CA--C 1.563 3.063 0 O-C-N 120.539 -1.351 . . . . 25.0 113.803 -172.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -63.25 165.55 16.95 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 123.3 2.666 . . . . 25.0 106.028 166.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.99 133.55 32.63 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 119.416 3.117 . . . . 25.0 119.416 -166.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -64.08 150.92 44.46 Favored 'General case' 0 C--O 1.272 2.258 0 CA-C-N 114.447 -1.251 . . . . 25.0 109.464 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.97 -1.9 78.63 Favored Glycine 0 C--O 1.196 -2.23 1 CA-C-O 113.268 -4.073 . . . . 25.0 109.801 175.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -129.98 9.47 5.33 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 120.836 2.318 . . . . 25.0 108.574 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.49 -36.91 43.14 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.217 0 C-N-CA 124.648 1.179 . . . . 25.0 110.329 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.34 -48.36 23.42 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 120.945 -1.097 . . . . 25.0 112.142 -175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.5 p -136.12 -5.6 2.11 Favored 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 118.129 2.64 . . . . 25.0 118.129 -168.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 41.32 38.77 0.85 Allowed 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 126.98 2.112 . . . . 25.0 114.763 -163.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.37 -29.99 70.31 Favored Glycine 0 C--O 1.213 -1.184 0 O-C-N 120.621 -1.299 . . . . 25.0 109.951 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.02 -19.35 71.75 Favored Glycine 0 CA--C 1.553 2.458 0 O-C-N 120.95 -1.324 . . . . 25.0 116.171 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 60' ' ' GLY . 46.7 mt -112.73 -12.41 13.37 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 117.426 2.38 . . . . 50.0 117.426 173.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.83 -36.45 70.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 104.465 -2.42 . . . . 50.0 104.465 161.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.25 -20.62 75.24 Favored Glycine 0 C--O 1.269 2.285 0 CA-C-O 126.009 3.005 . . . . 25.0 108.53 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 57' ' ' LEU . . . -64.52 -20.17 65.48 Favored Glycine 0 C--O 1.197 -2.214 0 O-C-N 116.841 -3.741 . . . . 25.0 115.189 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.8 mt -71.8 -46.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 111.793 -2.203 . . . . 25.0 105.645 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.96 -17.52 57.09 Favored 'General case' 0 CA--C 1.574 1.877 0 O-C-N 118.892 -2.38 . . . . 75.0 116.582 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -66.4 -29.25 69.37 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 123.805 1.764 . . . . 50.0 110.467 167.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.64 24.52 1.21 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.975 2.321 . . . . 25.0 113.983 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.6 48.78 1.43 Allowed 'General case' 0 C--O 1.25 1.114 0 O-C-N 119.52 -1.988 . . . . 25.0 110.951 157.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.271 13.7 t -133.56 174.94 9.89 Favored 'General case' 0 C--O 1.216 -0.702 0 O-C-N 125.365 1.666 . . . . 25.0 111.642 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.68 -17.39 59.97 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 123.849 1.785 . . . . 25.0 107.877 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -89.69 32.38 0.89 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 112.43 -2.168 . . . . 25.0 112.041 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -81.84 84.63 6.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 125.258 2.456 . . . . 25.0 116.354 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -40.06 150.83 0.05 Allowed 'General case' 0 C--O 1.292 3.293 1 CA-C-N 107.438 -4.437 . . . . 25.0 113.077 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -66.32 152.35 45.16 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 105.507 -2.034 . . . . 50.0 105.507 -167.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.51 151.48 27.52 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -139.79 132.39 28.81 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 117.321 2.341 . . . . 25.0 117.321 168.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -90.0 133.98 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 117.409 -1.281 . . . . 25.0 108.936 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.4 ttt -150.02 142.65 24.54 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 120.359 1.436 . . . . 25.0 111.189 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.459 HG22 HG23 ' A' ' 170' ' ' VAL . 32.2 p -79.35 166.95 21.53 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.285 0.846 . . . . 25.0 113.285 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 147.73 45.45 Favored Glycine 0 C--O 1.257 1.578 0 O-C-N 118.535 -2.603 . . . . 25.0 114.002 172.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.99 -166.04 33.38 Favored Glycine 0 CA--C 1.572 3.599 0 O-C-N 119.693 -2.063 . . . . 25.0 108.658 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -65.44 136.94 57.09 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.13 -1.806 . . . . 25.0 109.848 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -121.15 148.96 43.51 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 103.45 -2.796 . . . . 25.0 103.45 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -122.39 126.2 47.5 Favored 'General case' 0 C--O 1.201 -1.463 0 C-N-CA 124.807 1.243 . . . . 25.0 107.652 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -116.9 79.38 1.32 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 103.535 -2.765 . . . . 50.0 103.535 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -82.95 101.31 10.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.635 -1.166 . . . . 25.0 108.504 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -106.96 137.4 45.1 Favored 'General case' 0 CA--C 1.556 1.187 1 N-CA-C 99.708 -4.182 . . . . 25.0 99.708 173.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 t -151.13 143.46 24.17 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 123.787 1.756 . . . . 25.0 113.671 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -143.11 170.32 15.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 117.791 -1.1 . . . . 50.0 108.593 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . 0.287 9.1 t -72.13 -30.66 65.25 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 124.681 2.182 . . . . 25.0 112.737 175.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.47 152.81 69.79 Favored Pre-proline 0 C--O 1.262 1.721 0 O-C-N 116.78 -3.7 . . . . 25.0 109.062 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.46 161.45 42.38 Favored 'Trans proline' 0 C--O 1.282 2.677 0 C-N-CA 115.61 -2.46 . . . . 25.0 108.52 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -126.06 162.33 25.56 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 117.557 -3.215 . . . . 25.0 112.905 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.41 124.98 23.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 105.026 -2.213 . . . . 25.0 105.026 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -147.12 150.84 35.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 169.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.0 p -94.53 -31.14 14.05 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 120.447 1.476 . . . . 25.0 109.442 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . 0.261 51.6 tt0 -158.54 160.88 37.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 118.604 0.638 . . . . 25.0 109.396 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -142.91 148.93 37.75 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 123.784 1.754 . . . . 25.0 106.815 166.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.96 151.8 51.17 Favored 'General case' 0 C--N 1.27 -2.876 0 O-C-N 119.089 -2.257 . . . . 25.0 108.871 -169.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.21 130.07 45.83 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 105.104 -2.184 . . . . 50.0 105.104 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.43 155.83 23.57 Favored 'General case' 0 C--O 1.182 -2.468 0 CA-C-N 111.857 -2.428 . . . . 50.0 104.512 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.1 pt -134.62 155.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-N 112.129 -2.305 . . . . 25.0 112.291 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 p -70.63 156.88 38.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 124.523 2.106 . . . . 25.0 115.108 168.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -130.68 95.43 3.85 Favored 'General case' 0 C--O 1.188 -2.132 0 O-C-N 116.988 -3.57 . . . . 25.0 114.922 173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -68.9 157.07 37.37 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 107.869 -1.16 . . . . 25.0 107.869 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.55 37.75 89.9 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-O 126.077 3.043 . . . . 25.0 110.985 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -67.16 159.84 28.09 Favored 'General case' 0 C--O 1.267 1.987 0 CA-C-O 125.686 2.66 . . . . 25.0 110.777 -171.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -67.46 123.89 87.79 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-N 111.958 -2.383 . . . . 25.0 107.279 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.53 -17.67 20.63 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 117.923 2.24 . . . . 25.0 117.923 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.71 8.44 39.22 Favored 'General case' 0 C--O 1.253 1.252 0 O-C-N 119.696 -1.877 . . . . 75.0 108.407 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -122.18 162.42 37.62 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 112.203 -2.271 . . . . 25.0 114.596 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.88 95.0 1.06 Allowed 'Trans proline' 0 CA--C 1.463 -3.04 0 N-CA-C 117.052 1.905 . . . . 25.0 117.052 -168.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -21.34 -60.76 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 127.064 2.146 . . . . 50.0 116.355 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -77.47 3.33 13.68 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 119.1 -2.25 . . . . 25.0 113.735 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.258 84.2 mtt180 -119.99 -42.19 2.61 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 127.422 2.289 . . . . 25.0 110.868 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.93 -15.74 5.47 Favored 'General case' 0 C--O 1.283 2.84 0 O-C-N 119.812 -1.805 . . . . 25.0 111.833 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -98.58 17.02 20.09 Favored 'General case' 0 C--O 1.271 2.192 0 N-CA-C 118.639 2.829 . . . . 25.0 118.639 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -144.85 161.28 39.67 Favored 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 118.762 -1.175 . . . . 50.0 107.898 168.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.79 158.59 43.84 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.71 137.74 35.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.049 -1.834 . . . . 50.0 106.049 164.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.287 16.7 tt -94.98 -26.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 116.268 -1.825 . . . . 25.0 111.964 169.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.92 156.12 13.65 Favored Glycine 0 N--CA 1.432 -1.58 0 O-C-N 124.893 1.371 . . . . 25.0 112.345 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.26 143.01 50.24 Favored 'General case' 0 N--CA 1.394 -3.251 0 CA-C-O 124.442 2.067 . . . . 25.0 108.351 170.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.4 96.53 48.06 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.325 -1.307 . . . . 50.0 108.173 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.97 159.23 50.84 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 114.056 -3.496 . . . . 25.0 110.601 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -139.91 47.74 1.82 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 115.629 1.715 . . . . 25.0 115.629 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -112.19 -24.86 9.6 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.767 -2.015 . . . . 50.0 107.143 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -160.89 40.21 0.43 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-O 124.925 2.403 . . . . 25.0 113.427 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -81.28 146.96 59.26 Favored Pre-proline 0 C--O 1.273 2.317 0 O-C-N 119.392 -2.24 . . . . 25.0 108.304 -154.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.57 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.768 1 C-N-CA 126.021 4.481 . . . . 25.0 107.031 169.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.6 -18.52 0.26 Allowed 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 121.081 3.734 . . . . 25.0 121.081 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 56.8 p -52.5 -9.41 0.11 Allowed 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 121.728 2.058 . . . . 25.0 114.582 162.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -60.03 -16.16 28.74 Favored 'General case' 0 N--CA 1.522 3.161 0 O-C-N 117.661 -3.149 . . . . 25.0 113.192 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.66 136.08 50.68 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 104.389 -2.449 . . . . 25.0 104.389 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -69.23 -24.83 64.06 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.504 -1.372 . . . . 75.0 111.196 -165.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.4 t -85.41 136.48 33.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 113.834 -1.53 . . . . 25.0 110.395 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.08 156.58 42.58 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 104.729 -2.323 . . . . 25.0 104.729 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -108.4 119.51 39.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 115.164 -2.351 . . . . 25.0 105.624 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.8 mm -118.42 119.23 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.312 0 C-N-CA 125.384 1.474 . . . . 25.0 111.19 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -77.16 133.77 38.86 Favored 'General case' 0 C--O 1.269 2.101 0 N-CA-C 105.022 -2.214 . . . . 50.0 105.022 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.3 mt -134.86 119.67 13.85 Favored Pre-proline 0 C--N 1.361 1.102 0 CA-C-O 122.908 1.337 . . . . 25.0 108.267 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.83 159.08 13.98 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 116.718 -1.721 . . . . 25.0 112.512 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 169' ' ' LEU . 11.5 tp10 -153.95 115.92 4.27 Favored 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.923 1.823 . . . . 25.0 115.923 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -105.95 -4.04 21.05 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 113.77 -1.559 . . . . 50.0 115.062 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -118.02 166.51 12.44 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 117.277 -3.389 . . . . 25.0 110.492 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.9 mp -116.55 136.6 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.947 -2.612 . . . . 50.0 103.947 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.97 174.18 25.47 Favored Glycine 0 C--N 1.306 -1.085 0 N-CA-C 119.913 2.725 . . . . 25.0 119.913 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.31 142.19 27.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.588 1.555 . . . . 50.0 108.268 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -146.25 162.73 37.44 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 104.672 -2.344 . . . . 25.0 104.672 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.9 t -127.64 136.81 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 123.828 3.013 . . . . 50.0 112.598 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 76.9 mt -104.02 118.58 51.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.642 0 N-CA-C 105.439 -2.06 . . . . 25.0 105.439 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.5 130.76 44.55 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.417 2.056 . . . . 50.0 108.882 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -110.51 127.53 55.21 Favored 'General case' 0 C--O 1.246 0.902 0 O-C-N 120.145 -1.597 . . . . 25.0 109.704 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.87 132.73 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 O-C-N 126.083 2.114 . . . . 50.0 114.673 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 119.52 31.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.69 1.596 . . . . 25.0 109.304 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.42 72.08 4.42 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 126.294 2.246 . . . . 25.0 107.875 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.46 98.97 2.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.533 0 C-N-CA 117.51 -1.676 . . . . 50.0 111.164 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.68 -16.45 64.15 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.756 1.265 . . . . 25.0 113.804 -165.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -60.89 -32.99 72.42 Favored 'General case' 0 CA--C 1.601 2.913 0 CA-C-N 113.763 -1.562 . . . . 25.0 112.145 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.0 t -123.92 158.69 31.38 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.475 1.734 . . . . 25.0 110.019 -166.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.41 -23.73 58.99 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.18 165.05 7.74 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.751 1.019 . . . . 25.0 113.751 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.96 178.44 6.67 Favored 'General case' 0 C--O 1.209 -1.053 1 N-CA-C 98.25 -4.722 . . . . 25.0 98.25 175.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -126.22 130.43 50.93 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.891 -3.744 . . . . 50.0 100.891 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -135.33 138.67 43.63 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 126.15 1.78 . . . . 50.0 111.529 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -160.58 175.52 12.6 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 104.848 -2.278 . . . . 25.0 104.848 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 148' ' ' ILE . 26.5 m -135.86 164.63 31.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 125.158 1.536 . . . . 75.0 107.392 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.0 mm -133.65 120.48 37.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 112.721 -2.036 . . . . 25.0 105.6 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -88.64 124.95 34.57 Favored 'General case' 0 C--O 1.262 1.753 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.518 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.68 158.1 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 117.077 2.251 . . . . 50.0 117.077 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.7 124.92 30.8 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 101.901 -3.37 . . . . 25.0 101.901 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 140' ' ' GLU . 84.2 mt -114.07 130.53 56.56 Favored 'General case' 0 C--O 1.204 -1.34 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 -174.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.459 HG23 HG22 ' A' ' 76' ' ' THR . 27.6 m -124.95 158.1 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 116.223 1.934 . . . . 50.0 116.223 -173.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.7 132.38 35.18 Favored 'General case' 0 CA--C 1.585 2.311 0 O-C-N 125.842 1.964 . . . . 25.0 108.831 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.4 pttt . . . . . 0 CA--C 1.552 1.055 0 CA-C-O 118.235 -0.888 . . . . 25.0 110.884 -167.669 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.672 0.749 . . . . 25.0 111.349 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.35 179.71 27.32 Favored Glycine 0 C--O 1.267 2.203 0 C-N-CA 117.794 -2.146 . . . . 25.0 116.956 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -152.37 153.96 34.66 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.096 -2.414 . . . . 50.0 111.351 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.71 133.49 31.42 Favored 'Isoleucine or valine' 0 C--O 1.258 1.518 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 -163.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -120.29 -30.32 4.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.421 -1.312 . . . . 25.0 111.768 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG2' HG22 ' A' ' 83' ' ' THR . 19.0 pttt -146.72 162.46 33.63 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 123.568 1.651 . . . . 25.0 107.148 151.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.69 148.95 87.33 Favored 'Cis proline' 0 N--CA 1.494 1.531 0 CA-C-O 123.439 1.35 . . . . 25.0 112.219 6.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.39 -175.69 52.55 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-O 126.013 3.007 . . . . 25.0 115.995 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.3 t -117.4 102.03 8.89 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 111.851 -2.175 . . . . 25.0 108.913 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -57.74 -31.93 66.95 Favored 'General case' 0 C--O 1.181 -2.533 0 O-C-N 123.784 0.678 . . . . 25.0 111.472 -169.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.67 65.58 Favored 'General case' 0 CA--C 1.558 1.269 0 O-C-N 118.365 -2.709 . . . . 25.0 111.925 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.11 -22.12 55.89 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.613 -1.625 . . . . 25.0 106.613 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt -74.83 -33.31 62.15 Favored 'General case' 0 C--O 1.257 1.491 0 N-CA-C 114.049 1.129 . . . . 75.0 114.049 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.51 -49.74 14.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.881 -1.054 . . . . 25.0 113.522 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.5 m -61.63 163.15 7.44 Favored 'General case' 0 N--CA 1.512 2.644 0 C-N-CA 126.927 2.091 . . . . 25.0 114.328 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -68.62 -47.67 66.06 Favored 'General case' 0 C--O 1.287 3.041 0 CA-C-N 114.432 -1.258 . . . . 25.0 112.838 -167.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.38 -38.38 0.01 OUTLIER 'General case' 0 C--O 1.201 -1.465 0 O-C-N 125.65 1.844 . . . . 25.0 111.859 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -89.54 17.73 6.07 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 125.962 1.705 . . . . 50.0 113.082 -152.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.4 29.75 15.89 Favored Glycine 0 CA--C 1.457 -3.559 0 CA-C-O 113.655 -3.858 . . . . 25.0 114.138 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . 0.26 36.4 t80 31.65 47.66 0.07 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 126.462 1.919 . . . . 50.0 115.145 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.48 -27.29 56.04 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 104.704 -2.332 . . . . 50.0 104.704 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -123.7 160.53 27.01 Favored 'General case' 0 C--O 1.297 3.601 0 N-CA-C 108.723 -0.843 . . . . 25.0 108.723 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.56 164.02 27.22 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 126.157 2.161 . . . . 50.0 107.103 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -179.3 -23.85 0.0 OUTLIER 'General case' 0 C--O 1.27 2.14 0 C-N-CA 124.547 1.139 . . . . 25.0 113.568 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 t -96.66 -6.11 37.35 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 119.508 3.151 . . . . 25.0 119.508 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 29' ' ' MET . . . 94.31 127.41 4.87 Favored Glycine 0 CA--C 1.486 -1.749 0 N-CA-C 108.088 -2.005 . . . . 25.0 108.088 -175.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -60.46 -15.89 31.17 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 113.9 -1.15 . . . . 25.0 112.901 -172.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.37 -20.96 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 O-C-N 124.158 0.911 . . . . 50.0 110.005 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 23.1 ptm -53.82 -22.28 9.29 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.849 0.859 . . . . 25.0 112.86 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.91 -53.72 55.03 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 118.271 -2.768 . . . . 50.0 111.595 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.93 67.83 41.89 Favored Pre-proline 0 CA--C 1.566 1.58 0 O-C-N 118.88 -2.387 . . . . 25.0 115.813 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.07 -11.49 22.02 Favored 'Trans proline' 0 C--O 1.206 -1.086 0 C-N-CA 124.449 3.433 . . . . 25.0 117.252 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 -8.15 30.21 Favored 'General case' 0 C--O 1.159 -3.663 0 N-CA-C 114.244 1.201 . . . . 25.0 114.244 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -70.44 50.83 0.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 119.412 3.115 . . . . 25.0 119.412 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.15 132.82 46.43 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.198 -1.408 . . . . 50.0 107.198 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 161.92 19.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 120.719 1.6 . . . . 25.0 110.615 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.2 41.42 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-O 115.499 -2.191 . . . . 25.0 108.272 161.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -112.43 142.99 44.3 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 121.962 2.164 . . . . 25.0 113.389 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -76.82 150.22 36.14 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 117.987 -2.946 . . . . 25.0 104.487 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.21 148.86 6.23 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 106.242 -2.743 . . . . 25.0 106.242 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -134.82 146.1 57.44 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 117.959 -1.019 . . . . 25.0 111.526 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.85 -19.31 7.27 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 121.299 -2.375 . . . . 25.0 113.547 -8.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -144.5 -27.48 0.5 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 116.982 -1.887 . . . . 25.0 113.248 160.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 51.49 -87.94 0.01 OUTLIER 'General case' 0 C--O 1.246 0.894 0 O-C-N 119.603 -1.935 . . . . 25.0 113.278 -167.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.24 -172.26 18.5 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 109.569 -1.412 . . . . 25.0 109.569 175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -64.69 157.62 54.86 Favored 'Trans proline' 0 CA--C 1.554 1.509 0 CA-C-N 121.208 2.504 . . . . 25.0 116.794 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.64 91.9 0.83 Allowed 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 114.074 1.138 . . . . 25.0 114.074 -174.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -123.19 158.58 30.49 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 101.183 -3.636 . . . . 25.0 101.183 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.58 11.79 60.3 Favored Glycine 0 N--CA 1.48 1.604 0 O-C-N 128.637 3.71 . . . . 25.0 110.094 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -73.61 -22.79 59.91 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 118.669 2.84 . . . . 25.0 118.669 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 mm -86.79 -36.92 10.76 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.307 0 CA-C-N 114.026 -1.443 . . . . 25.0 108.597 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.67 86.98 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 118.204 -1.398 . . . . 25.0 113.589 170.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.0 p -70.29 -6.41 34.77 Favored 'General case' 0 C--O 1.184 -2.376 0 O-C-N 123.723 0.64 . . . . 25.0 112.332 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.282 . . 47.86 24.34 0.57 Allowed 'General case' 0 C--O 1.251 1.141 1 N-CA-C 125.992 5.553 . . . . 25.0 125.992 -173.228 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.49 -21.14 52.54 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 113.311 -1.768 . . . . 25.0 113.561 168.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.36 15.99 58.38 Favored Glycine 0 CA--C 1.474 -2.475 0 CA-C-O 116.078 -2.512 . . . . 25.0 116.904 -173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.13 -19.77 39.36 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 122.295 3.048 . . . . 50.0 117.509 -161.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.34 -25.75 46.55 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.325 -2.843 . . . . 50.0 103.325 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.82 -17.92 62.52 Favored Glycine 0 C--O 1.209 -1.445 0 CA-C-O 125.286 2.604 . . . . 25.0 112.578 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.9 -25.28 71.89 Favored Glycine 0 CA--C 1.561 2.948 0 O-C-N 118.684 -2.656 . . . . 25.0 111.821 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.23 -38.03 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.14 -32.53 63.2 Favored 'General case' 0 C--O 1.198 -1.615 0 N-CA-C 104.95 -2.241 . . . . 75.0 104.95 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -68.47 -34.82 76.61 Favored 'General case' 0 C--O 1.264 1.834 0 N-CA-C 116.807 2.151 . . . . 50.0 116.807 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -76.65 16.42 0.51 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 125.789 2.709 . . . . 25.0 114.687 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -126.38 82.64 2.09 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 101.946 -3.353 . . . . 25.0 101.946 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -163.39 166.18 23.16 Favored 'General case' 0 CA--C 1.479 -1.784 0 O-C-N 123.636 0.585 . . . . 25.0 111.839 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -66.46 -29.43 69.56 Favored 'General case' 0 C--O 1.196 -1.754 0 O-C-N 117.448 -3.282 . . . . 25.0 109.977 171.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -82.04 21.88 0.84 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 112.876 -1.966 . . . . 25.0 112.66 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -74.0 97.34 2.83 Favored 'General case' 0 C--O 1.171 -3.054 0 CA-C-O 127.312 3.434 . . . . 25.0 109.649 158.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.1 p90 -29.64 135.41 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.375 1 CA-C-N 107.502 -4.408 . . . . 25.0 112.393 160.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -63.5 152.34 38.77 Favored 'General case' 0 C--O 1.268 2.037 0 N-CA-C 116.302 1.964 . . . . 50.0 116.302 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -101.56 162.01 13.22 Favored 'General case' 0 CA--C 1.479 -1.773 0 CA-C-N 113.513 -1.676 . . . . 25.0 111.576 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -153.47 146.41 24.47 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 124.472 1.109 . . . . 25.0 109.813 164.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.37 135.16 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 106.412 -1.699 . . . . 25.0 106.412 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.1 mtp -137.52 158.28 44.72 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 109.095 -0.706 . . . . 25.0 109.095 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.3 p -120.2 167.02 12.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.41 -164.98 40.36 Favored Glycine 0 C--O 1.266 2.105 0 C-N-CA 119.821 -1.181 . . . . 25.0 111.819 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.85 -173.66 32.24 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 120.573 -0.823 . . . . 25.0 111.104 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -82.02 141.71 32.99 Favored 'General case' 0 C--O 1.28 2.695 0 CA-C-O 124.071 1.891 . . . . 25.0 110.752 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.51 143.33 39.49 Favored 'General case' 0 C--O 1.19 -2.074 0 N-CA-C 104.133 -2.543 . . . . 25.0 104.133 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -98.56 126.14 44.04 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.273 -1.751 . . . . 25.0 106.273 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -110.85 150.73 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 116.179 -1.867 . . . . 50.0 106.154 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.449 HG22 ' HG2' ' A' ' 6' ' ' LYS . 3.3 t -153.3 159.61 42.56 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 117.632 -1.175 . . . . 25.0 114.129 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -138.07 171.58 14.2 Favored 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.872 -3.01 . . . . 25.0 102.872 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 p -135.3 154.75 51.43 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.121 1.513 . . . . 25.0 107.94 153.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -94.02 154.2 17.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.902 0.858 . . . . 50.0 109.043 169.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.1 p -85.29 -27.02 26.24 Favored 'General case' 0 C--O 1.172 -2.98 0 O-C-N 120.396 -1.44 . . . . 25.0 111.691 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.67 141.66 13.89 Favored Pre-proline 0 CA--C 1.48 -1.739 0 N-CA-C 102.408 -3.182 . . . . 25.0 102.408 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.49 162.84 35.27 Favored 'Trans proline' 0 C--N 1.373 1.843 0 CA-C-O 123.507 1.378 . . . . 25.0 113.76 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.88 148.12 41.58 Favored 'General case' 0 CA--C 1.471 -2.059 0 CA-C-N 112.963 -1.926 . . . . 25.0 106.471 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -81.76 96.95 7.74 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 112.161 -2.291 . . . . 25.0 108.731 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.6 m -83.98 127.7 34.05 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 116.446 2.017 . . . . 25.0 116.446 -170.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 p -87.83 -42.27 12.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 118.335 -1.346 . . . . 25.0 110.486 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -168.29 168.21 11.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.068 -1.424 . . . . 25.0 109.866 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -140.66 164.65 29.6 Favored 'General case' 0 C--O 1.261 1.661 0 CA-C-N 123.199 2.727 . . . . 25.0 110.96 164.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -139.89 159.77 41.43 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 115.092 -2.385 . . . . 25.0 112.217 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.89 145.0 24.58 Favored 'General case' 0 C--O 1.246 0.901 0 O-C-N 124.951 1.407 . . . . 50.0 111.986 169.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 117' ' ' LEU . 58.9 m-85 -139.57 169.77 17.14 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 105.56 -2.015 . . . . 50.0 105.56 -172.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 pt -125.38 152.63 32.25 Favored 'Isoleucine or valine' 0 C--O 1.261 1.68 0 CA-C-O 123.791 1.758 . . . . 25.0 106.895 162.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.94 143.32 29.91 Favored 'General case' 0 C--N 1.387 2.206 0 N-CA-C 100.49 -3.892 . . . . 25.0 100.49 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -101.17 133.16 46.14 Favored 'General case' 0 C--O 1.183 -2.416 1 N-CA-C 100.085 -4.042 . . . . 25.0 100.085 -172.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -146.05 151.65 38.08 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 -163.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.21 37.13 9.25 Favored Glycine 0 C--O 1.202 -1.893 0 CA-C-O 125.087 2.493 . . . . 25.0 110.428 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -65.56 157.58 29.37 Favored 'General case' 0 CA--C 1.462 -2.413 0 C-N-CA 126.874 2.07 . . . . 25.0 114.908 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.97 123.05 89.15 Favored Pre-proline 0 CA--C 1.501 -0.942 1 O-C-N 115.438 -4.539 . . . . 25.0 108.937 155.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.77 -24.66 72.6 Favored 'Trans proline' 0 CA--C 1.499 -1.267 0 C-N-CA 115.017 -2.856 . . . . 25.0 117.102 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.96 -6.06 49.16 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 124.221 1.962 . . . . 75.0 113.854 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -56.1 161.95 3.34 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-N 112.663 -2.062 . . . . 25.0 112.254 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -77.55 70.37 6.9 Favored 'Trans proline' 0 C--O 1.175 -2.671 0 CA-C-O 125.972 2.405 . . . . 25.0 113.696 161.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 mt -46.63 -40.66 13.41 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 110.16 -3.2 . . . . 50.0 113.808 -168.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.79 -13.04 61.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 123.233 2.742 . . . . 25.0 115.42 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -117.78 -41.89 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 127.112 2.758 . . . . 25.0 111.627 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.22 -18.07 65.01 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 114.138 1.162 . . . . 25.0 114.138 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.35 33.45 1.4 Allowed 'General case' 0 C--N 1.316 -0.873 0 O-C-N 119.945 -1.722 . . . . 25.0 115.184 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -141.52 145.74 35.52 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.642 1.177 . . . . 50.0 108.538 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.45 142.61 50.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 115.309 1.596 . . . . 25.0 115.309 163.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 98' ' ' TYR . 41.5 tp -77.76 137.96 38.74 Favored 'General case' 0 C--N 1.319 -0.753 1 N-CA-C 99.426 -4.287 . . . . 50.0 99.426 179.462 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.1 tt -124.52 -5.32 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 O-C-N 126.726 2.516 . . . . 25.0 108.902 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.12 170.31 37.28 Favored Glycine 0 C--O 1.273 2.576 0 N-CA-C 118.277 2.071 . . . . 25.0 118.277 154.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.99 145.6 24.24 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 123.449 1.595 . . . . 25.0 108.243 170.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -118.96 100.63 50.67 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 120.899 -1.125 . . . . 50.0 111.049 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.19 172.81 15.41 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 122.615 2.21 . . . . 25.0 108.398 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -133.88 48.17 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.819 -1.991 . . . . 25.0 108.358 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.7 -11.77 59.83 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 117.239 -1.784 . . . . 50.0 109.131 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 143.1 -171.79 24.84 Favored Glycine 0 C--N 1.294 -1.803 0 CA-C-O 116.927 -2.041 . . . . 25.0 113.091 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.0 154.27 0.12 Allowed Pre-proline 0 N--CA 1.428 -1.525 0 C-N-CA 129.127 2.971 . . . . 25.0 115.75 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.27 10.33 3.75 Favored 'Trans proline' 0 C--O 1.182 -2.277 1 C-N-CA 112.524 -4.517 . . . . 25.0 117.681 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.78 -25.92 62.21 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 119.711 -1.868 . . . . 25.0 109.165 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 81.3 p -71.61 -19.0 62.18 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 123.917 1.817 . . . . 25.0 111.67 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -72.46 -23.92 61.12 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 111.416 -2.629 . . . . 25.0 109.609 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.62 109.87 5.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 119.282 -2.136 . . . . 25.0 110.444 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.7 -36.22 14.46 Favored 'General case' 0 C--O 1.278 2.58 0 O-C-N 119.358 -2.088 . . . . 75.0 109.312 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.7 t -73.73 131.66 41.83 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.176 0.99 . . . . 25.0 110.085 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.08 161.14 38.34 Favored 'General case' 0 C--O 1.275 2.429 0 CA-C-O 121.85 0.833 . . . . 25.0 109.293 -173.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -109.11 131.75 54.77 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.153 -0.931 . . . . 25.0 108.587 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.14 117.79 38.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -75.66 134.5 40.57 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 125.583 1.802 . . . . 50.0 106.971 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 18.1 mt -125.72 119.3 24.31 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 103.041 -2.948 . . . . 25.0 103.041 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.2 153.26 67.08 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 124.007 1.53 . . . . 25.0 112.361 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.29 50.98 0.78 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.201 1.477 . . . . 25.0 109.692 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.55 -35.4 75.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 118.606 2.817 . . . . 50.0 118.606 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -155.47 166.64 32.93 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.602 1.961 . . . . 25.0 112.861 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.6 mp -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 115.993 -0.549 . . . . 50.0 111.148 165.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 141.08 165.06 10.18 Favored Glycine 0 C--O 1.187 -2.842 0 C-N-CA 118.122 -1.99 . . . . 25.0 114.779 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.59 145.51 47.32 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 119.181 3.03 . . . . 50.0 119.181 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -142.9 157.37 44.65 Favored 'General case' 0 C--O 1.201 -1.478 0 N-CA-C 102.883 -3.006 . . . . 25.0 102.883 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.15 135.87 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 104.512 -2.403 . . . . 50.0 104.512 164.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.79 123.58 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 93.128 -6.619 . . . . 25.0 93.128 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 mp -106.29 145.03 32.14 Favored 'General case' 0 C--O 1.185 -2.292 0 C-N-CA 124.021 0.929 . . . . 50.0 109.647 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.36 45.88 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 115.971 -1.966 . . . . 25.0 113.619 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.52 128.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.265 1.911 0 O-C-N 125.006 1.442 . . . . 50.0 111.059 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -118.82 119.55 34.71 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 116.766 -1.588 . . . . 25.0 109.02 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -92.35 135.6 33.89 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 103.704 -2.702 . . . . 25.0 103.704 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.6 t -118.46 126.81 75.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 104.154 -2.536 . . . . 50.0 104.154 -172.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.42 -16.97 63.0 Favored 'General case' 0 CA--C 1.476 -1.901 1 O-C-N 116.051 -4.156 . . . . 25.0 115.936 -166.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.19 -28.13 53.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 128.172 2.589 . . . . 25.0 112.753 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.3 p -134.75 164.8 26.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 116.775 2.139 . . . . 25.0 116.775 -158.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -95.1 -15.96 22.99 Favored 'General case' 0 C--O 1.184 -2.357 0 CA-C-O 124.47 2.081 . . . . 25.0 113.092 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -66.83 155.04 39.35 Favored 'General case' 0 C--O 1.287 3.04 0 O-C-N 118.86 -2.4 . . . . 25.0 111.084 155.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.82 140.74 22.84 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 103.354 -2.832 . . . . 25.0 103.354 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -83.78 165.67 18.64 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 105.119 -2.178 . . . . 50.0 105.119 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.12 160.58 43.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.853 -1.521 . . . . 50.0 109.241 164.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -147.65 154.2 40.32 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 116.787 -1.578 . . . . 25.0 110.416 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.5 m -138.85 128.28 31.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.56 -2.015 . . . . 75.0 105.56 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.8 mt -132.53 126.97 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.135 0 N-CA-C 106.262 -1.755 . . . . 25.0 106.262 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.97 135.3 33.72 Favored 'General case' 0 C--N 1.311 -1.086 1 O-C-N 115.773 -4.329 . . . . 25.0 108.813 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.86 134.96 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 O-C-N 117.246 -3.409 . . . . 50.0 102.802 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.42 99.11 12.02 Favored 'General case' 0 CA--C 1.554 1.102 0 O-C-N 119.769 -1.832 . . . . 25.0 106.192 171.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.33 128.43 35.49 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 121.696 2.044 . . . . 50.0 110.499 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.11 168.25 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . 0.312 26.1 t30 -83.07 146.82 28.49 Favored 'General case' 0 N--CA 1.385 -3.703 0 N-CA-C 106.775 -1.565 . . . . 25.0 106.775 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 CA--C 1.482 -1.651 0 CA-C-N 121.727 2.058 . . . . 25.0 110.042 170.757 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 161' ' ' PHE . 76.5 m80 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 125.118 2.389 . . . . 25.0 109.669 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.37 -161.38 14.22 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 112.712 -2.04 . . . . 25.0 108.257 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -149.96 162.71 39.82 Favored 'General case' 0 C--O 1.27 2.166 0 CA-C-N 114.138 -1.031 . . . . 50.0 110.703 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mm -85.16 139.14 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 O-C-N 125.554 1.784 . . . . 25.0 111.543 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.73 39.21 3.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 103.912 -2.625 . . . . 25.0 103.912 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 75.92 146.43 0.11 Allowed Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 127.451 2.3 . . . . 25.0 114.161 171.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.68 147.55 15.61 Favored 'Cis proline' 0 CA--C 1.491 -1.635 0 O-C-N 118.252 -1.499 . . . . 25.0 114.865 -18.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.07 33.38 6.04 Favored Glycine 0 C--O 1.187 -2.836 0 C-N-CA 124.867 1.222 . . . . 25.0 111.668 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.6 t -75.73 138.75 41.47 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 118.951 1.375 . . . . 25.0 108.266 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -85.39 -18.18 34.46 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 123.618 1.675 . . . . 25.0 106.568 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.79 80.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.12 -14.66 60.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.53 -0.731 . . . . 25.0 110.288 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.1 mt -92.18 -21.45 20.37 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 104.15 -2.537 . . . . 75.0 104.15 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.88 -25.29 21.07 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.109 -1.441 . . . . 25.0 107.109 -175.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.1 t -62.63 112.25 2.42 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 116.853 2.168 . . . . 25.0 116.853 173.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -73.36 -31.84 64.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.295 1.438 . . . . 25.0 107.213 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.79 92.03 Favored 'General case' 0 CA--C 1.581 2.166 0 O-C-N 120.836 -1.165 . . . . 25.0 110.209 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -47.89 -44.83 29.95 Favored 'General case' 0 C--O 1.275 2.445 0 N-CA-C 117.818 2.525 . . . . 50.0 117.818 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.68 19.86 32.79 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 104.111 -3.596 . . . . 25.0 104.111 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.8 t80 45.42 -50.55 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 121.727 3.973 . . . . 50.0 121.727 -165.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.71 -7.2 10.56 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.804 1.288 . . . . 50.0 112.701 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -122.97 153.86 39.19 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 117.65 -1.167 . . . . 25.0 108.448 -166.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -161.47 167.64 25.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.075 -2.195 . . . . 50.0 105.075 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.64 42.06 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 127.177 2.798 . . . . 25.0 117.435 -162.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -67.8 -22.92 65.16 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.375 0.88 . . . . 25.0 113.375 -166.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.82 95.01 1.05 Allowed Glycine 0 C--O 1.189 -2.687 0 C-N-CA 119.518 -1.325 . . . . 25.0 112.924 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 m -68.04 -9.28 44.66 Favored 'General case' 0 C--O 1.256 1.399 0 N-CA-C 114.544 1.313 . . . . 25.0 114.544 -171.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.65 -13.0 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 115.219 1.563 . . . . 50.0 115.219 169.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.5 ptm -70.11 18.39 0.05 Allowed 'General case' 0 C--O 1.199 -1.572 0 N-CA-C 120.718 3.599 . . . . 25.0 120.718 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.27 -43.29 95.3 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 119.172 -2.205 . . . . 50.0 112.162 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -145.05 62.6 9.22 Favored Pre-proline 0 C--O 1.275 2.415 0 N-CA-C 113.394 0.887 . . . . 25.0 113.394 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -15.64 47.03 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 116.325 -1.983 . . . . 25.0 112.817 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -66.06 -18.69 65.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.765 -1.835 . . . . 25.0 115.741 170.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -77.95 -4.42 46.83 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.584 0.707 . . . . 25.0 112.016 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.1 94.47 1.92 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 120.806 -1.184 . . . . 50.0 112.687 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -120.73 162.26 20.03 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 119.208 3.04 . . . . 25.0 119.208 -174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . . . -136.25 170.94 15.22 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 104.804 -2.295 . . . . 25.0 104.804 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -122.96 141.37 52.01 Favored 'General case' 0 C--O 1.275 2.42 0 O-C-N 124.89 1.369 . . . . 25.0 108.657 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -72.91 156.18 39.13 Favored 'General case' 0 C--O 1.197 -1.701 0 O-C-N 125.544 1.778 . . . . 25.0 109.142 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.58 -166.16 25.64 Favored Glycine 0 C--O 1.205 -1.663 0 N-CA-C 109.555 -1.418 . . . . 25.0 109.555 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -132.02 139.2 34.27 Favored Pre-proline 0 CA--C 1.573 1.859 0 O-C-N 128.072 2.866 . . . . 25.0 106.773 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.55 162.46 88.65 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 121.13 1.439 . . . . 25.0 114.867 -0.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -165.28 -2.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 117.371 2.36 . . . . 25.0 117.371 -168.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -32.12 -65.5 0.14 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 117.555 2.428 . . . . 25.0 117.555 -170.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.78 176.22 46.24 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 116.686 1.434 . . . . 25.0 116.686 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.64 -27.73 12.49 Favored 'Trans proline' 0 C--O 1.272 2.221 0 CA-C-O 118.666 -0.639 . . . . 25.0 113.006 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.26 156.5 20.24 Favored 'General case' 0 CA--C 1.479 -1.756 0 C-N-CA 124.634 1.173 . . . . 25.0 111.344 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -148.89 152.54 36.6 Favored 'General case' 0 C--O 1.26 1.606 0 N-CA-C 107.195 -1.409 . . . . 25.0 107.195 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.68 -21.27 33.81 Favored Glycine 0 C--O 1.215 -1.06 0 CA-C-O 117.118 -1.935 . . . . 25.0 115.352 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -135.48 47.22 2.31 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 127.237 2.215 . . . . 25.0 110.339 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.5 mm -72.73 -38.4 57.95 Favored 'Isoleucine or valine' 1 C--O 1.306 4.038 0 CA-C-N 114.146 -1.388 . . . . 25.0 110.602 -168.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.59 69.21 Favored 'General case' 0 C--O 1.167 -3.258 0 N-CA-C 116.276 1.954 . . . . 25.0 116.276 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.8 p -87.72 -4.57 58.9 Favored 'General case' 0 CA--C 1.565 1.537 0 O-C-N 119.552 -1.967 . . . . 25.0 112.796 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.45 37.03 11.11 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 119.861 1.21 . . . . 25.0 110.703 -169.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.49 -18.63 78.95 Favored Glycine 0 N--CA 1.412 -2.939 0 O-C-N 119.831 -1.793 . . . . 25.0 114.401 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.21 -2.21 89.33 Favored Glycine 0 C--O 1.26 1.758 0 CA-C-O 116.979 -2.011 . . . . 25.0 111.797 166.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 mt -111.42 -54.94 2.56 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 116.999 2.222 . . . . 50.0 116.999 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -74.99 -24.95 58.51 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 112.681 -2.054 . . . . 50.0 110.769 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.32 59.89 Favored Glycine 0 C--O 1.2 -2.002 0 O-C-N 127.294 2.871 . . . . 25.0 109.025 173.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.02 -30.45 78.03 Favored Glycine 0 C--N 1.358 1.797 0 N-CA-C 116.728 1.451 . . . . 25.0 116.728 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -80.41 -39.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.246 -2.502 . . . . 25.0 104.246 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.63 -27.4 66.85 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 126.631 1.973 . . . . 75.0 111.63 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.14 -10.45 59.77 Favored 'General case' 0 C--O 1.182 -2.456 0 O-C-N 121.169 -0.957 . . . . 50.0 109.469 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.71 -12.52 60.74 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 127.259 3.409 . . . . 25.0 112.979 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -148.55 69.15 1.09 Allowed 'General case' 0 C--O 1.277 2.501 0 CA-C-N 111.42 -2.627 . . . . 25.0 109.047 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.0 t -143.29 155.53 44.49 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 116.834 -1.555 . . . . 25.0 108.928 -170.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -55.0 -32.57 61.89 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 121.276 1.853 . . . . 25.0 114.624 158.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.53 -34.91 67.89 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 115.303 1.594 . . . . 25.0 115.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.314 24.8 ttp180 0.42 73.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.448 2.699 . . . . 25.0 116.458 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.16 149.3 45.66 Favored 'General case' 0 C--O 1.208 -1.112 1 CA-C-N 107.871 -4.24 . . . . 25.0 107.546 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -74.92 142.43 44.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.114 1.766 . . . . 50.0 114.139 -146.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 153.72 36.54 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 125.222 1.409 . . . . 25.0 111.107 -172.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -135.01 176.76 8.36 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 102.905 -2.998 . . . . 25.0 102.905 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -124.01 139.65 49.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 168.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . 0.267 60.6 mtp -143.94 171.24 14.52 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.683 1.128 . . . . 25.0 109.396 175.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.7 p -103.12 165.7 10.87 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.127 -1.608 . . . . 25.0 113.201 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.15 179.32 48.07 Favored Glycine 0 C--O 1.256 1.475 0 O-C-N 119.347 -2.096 . . . . 25.0 114.068 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.31 168.02 29.02 Favored Glycine 0 CA--C 1.542 1.757 0 CA-C-O 123.511 1.617 . . . . 25.0 112.849 -168.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.4 127.64 33.74 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.158 -2.217 . . . . 25.0 115.935 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.97 156.84 37.42 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m -103.72 141.04 36.76 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 112.37 -2.195 . . . . 25.0 108.904 166.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -123.66 149.08 45.86 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 115.695 -2.098 . . . . 50.0 105.606 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.8 m -132.25 138.19 47.81 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.373 -1.343 . . . . 25.0 107.373 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.84 161.04 24.81 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 103.02 -2.956 . . . . 25.0 103.02 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.0 t -140.16 137.11 34.15 Favored 'General case' 0 C--O 1.263 1.774 0 N-CA-C 106.799 -1.556 . . . . 25.0 106.799 160.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.36 125.76 50.7 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.569 1.548 . . . . 50.0 109.95 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -125.65 6.78 7.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 119.52 3.156 . . . . 25.0 119.52 -156.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . 0.313 . . -57.75 -63.38 3.89 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 114.512 -2.661 . . . . 25.0 117.111 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.29 176.86 37.44 Favored 'Cis proline' 0 CA--C 1.538 0.691 1 C-N-CA 136.676 4.032 . . . . 25.0 111.678 -9.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -131.02 164.35 25.6 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 102.84 -3.022 . . . . 25.0 102.84 165.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -89.11 150.04 22.91 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 105.125 -2.176 . . . . 25.0 105.125 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.4 m -137.84 134.82 35.58 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 107.733 -1.21 . . . . 25.0 107.733 -159.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 p -98.98 -34.27 10.5 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 117.437 -1.705 . . . . 25.0 110.978 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -156.03 151.22 26.6 Favored 'General case' 0 C--O 1.194 -1.841 0 C-N-CA 128.425 2.69 . . . . 25.0 111.492 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -137.96 136.27 36.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 119.452 -2.03 . . . . 25.0 108.459 150.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -142.72 163.43 32.84 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 117.861 -1.536 . . . . 25.0 111.701 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -149.43 141.29 23.7 Favored 'General case' 0 C--O 1.261 1.699 0 O-C-N 125.276 1.61 . . . . 50.0 114.259 -164.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -121.36 165.28 15.76 Favored 'General case' 0 C--O 1.183 -2.417 0 C-N-CA 126.535 1.934 . . . . 50.0 106.605 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.5 pt -127.3 159.69 37.28 Favored 'Isoleucine or valine' 0 C--O 1.261 1.681 0 CA-C-N 111.936 -2.393 . . . . 25.0 106.95 168.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.9 p -102.78 165.89 10.8 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 124.425 2.059 . . . . 25.0 105.699 156.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -105.63 -177.14 3.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 112.322 -2.217 . . . . 25.0 107.121 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -163.31 167.03 22.39 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.08 64.27 3.22 Favored Glycine 0 C--O 1.274 2.633 0 O-C-N 119.822 -1.798 . . . . 25.0 113.092 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.12 171.18 14.42 Favored 'General case' 0 C--O 1.193 -1.904 0 N-CA-C 116.38 1.993 . . . . 25.0 116.38 -166.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -85.39 110.92 32.89 Favored Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-O 117.1 -1.428 . . . . 25.0 110.974 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -57.99 -21.56 50.63 Favored 'Trans proline' 0 N--CA 1.447 -1.25 1 N-CA-C 123.68 4.454 . . . . 25.0 123.68 174.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.251 23.7 t70 -71.45 -17.83 62.35 Favored 'General case' 0 C--O 1.264 1.852 0 C-N-CA 116.151 -2.22 . . . . 75.0 114.032 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -72.01 161.12 80.52 Favored Pre-proline 0 C--N 1.38 1.921 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -41.01 22.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.542 2 C-N-CA 129.403 6.735 . . . . 25.0 124.373 161.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 53.7 mt -51.93 -35.57 46.17 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 116.507 -3.871 . . . . 50.0 116.991 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -68.11 -7.96 34.21 Favored 'General case' 0 C--O 1.198 -1.617 0 N-CA-C 115.046 1.499 . . . . 25.0 115.046 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -127.8 -60.3 1.17 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.453 -0.794 . . . . 25.0 110.074 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.1 -22.49 62.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 116.443 -1.741 . . . . 25.0 112.634 -168.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.8 20.8 18.07 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 127.042 2.713 . . . . 25.0 113.194 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -110.34 127.73 55.2 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 103.084 -2.932 . . . . 50.0 103.084 158.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.46 122.86 20.71 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.036 -1.865 . . . . 25.0 110.891 -169.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -62.25 117.62 6.32 Favored 'General case' 0 C--O 1.2 -1.522 0 N-CA-C 102.547 -3.131 . . . . 50.0 102.547 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.95 -11.14 9.3 Favored 'Isoleucine or valine' 0 C--O 1.265 1.919 0 CA-C-O 122.729 1.252 . . . . 25.0 112.594 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 174.83 30.1 Favored Glycine 0 C--N 1.365 2.192 0 N-CA-C 117.644 1.817 . . . . 25.0 117.644 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.81 155.13 43.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 128.612 3.183 . . . . 25.0 111.788 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.82 89.84 48.14 Favored Pre-proline 0 C--O 1.265 1.885 0 C-N-CA 128.682 2.793 . . . . 50.0 104.22 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.05 161.24 29.77 Favored 'Trans proline' 0 C--O 1.195 -1.674 1 C-N-CA 111.904 -4.93 . . . . 25.0 111.982 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -79.8 115.41 19.38 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.346 -1.741 . . . . 25.0 109.005 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -128.09 -8.11 5.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.147 1.339 . . . . 50.0 113.661 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.34 -15.67 62.82 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 115.762 1.065 . . . . 25.0 115.762 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -66.93 153.1 95.0 Favored Pre-proline 0 N--CA 1.492 1.652 1 N-CA-C 99.736 -4.172 . . . . 25.0 99.736 163.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.99 18.42 0.31 Allowed 'Trans proline' 0 CA--C 1.509 -0.76 0 N-CA-C 116.231 1.589 . . . . 25.0 116.231 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -31.87 68.04 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 154.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.1 m -76.02 -25.23 55.5 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-O 116.534 -1.698 . . . . 25.0 106.523 -172.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -82.6 -0.46 47.06 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 121.341 1.882 . . . . 25.0 115.851 176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -81.95 84.66 6.87 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.862 -1.135 . . . . 25.0 113.937 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.1 3.94 54.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.755 -1.566 . . . . 75.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.0 t -104.48 122.61 45.89 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 119.85 -1.781 . . . . 25.0 115.402 162.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -148.76 137.48 21.35 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.765 -1.569 . . . . 25.0 106.765 -154.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -84.34 132.67 34.58 Favored 'General case' 0 C--O 1.267 2.012 0 C-N-CA 126.022 1.729 . . . . 25.0 114.946 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.4 mt -131.06 124.82 56.62 Favored 'Isoleucine or valine' 0 C--O 1.262 1.754 0 O-C-N 119.739 -1.851 . . . . 25.0 107.445 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -77.67 126.03 30.25 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 112.913 0.708 . . . . 50.0 112.913 167.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.96 128.66 25.72 Favored Pre-proline 0 C--O 1.248 0.989 0 N-CA-C 102.476 -3.157 . . . . 25.0 102.476 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.99 157.96 53.52 Favored 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 112.587 -4.475 . . . . 25.0 112.658 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -101.34 36.87 1.9 Allowed 'General case' 0 C--O 1.211 -0.924 0 O-C-N 120.461 -1.399 . . . . 25.0 110.628 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -65.81 -46.65 77.84 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 119.765 3.246 . . . . 50.0 119.765 -167.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -150.9 173.32 14.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.213 2.205 . . . . 25.0 105.775 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 6.1 mp -84.83 169.0 14.59 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 101.497 -3.52 . . . . 50.0 101.497 170.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.78 176.53 22.35 Favored Glycine 0 CA--C 1.476 -2.362 0 CA-C-O 126.441 3.245 . . . . 25.0 113.014 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 24.4 p90 -93.17 163.98 13.42 Favored 'General case' 0 C--O 1.271 2.187 0 O-C-N 117.399 -3.413 . . . . 50.0 112.241 -164.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -162.16 173.44 14.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 127.442 2.297 . . . . 25.0 107.7 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.52 143.1 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.792 1.178 . . . . 50.0 113.894 174.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.0 mt -103.88 135.96 39.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 101.635 -3.469 . . . . 25.0 101.635 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -125.8 148.97 48.96 Favored 'General case' 0 C--O 1.187 -2.223 0 O-C-N 117.909 -2.995 . . . . 50.0 107.963 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.16 161.52 37.68 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 116.224 -1.846 . . . . 25.0 113.321 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.61 119.96 3.81 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 O-C-N 125.787 1.93 . . . . 50.0 106.162 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.13 117.63 31.76 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 127.169 2.188 . . . . 25.0 112.457 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.88 111.29 23.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 104.144 -2.539 . . . . 25.0 104.144 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.0 t -84.33 124.87 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.145 0 CA-C-O 124.118 1.913 . . . . 50.0 109.63 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.69 -24.13 62.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.107 -1.621 . . . . 25.0 111.309 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.09 -17.11 58.92 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 117.094 -1.842 . . . . 25.0 114.493 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.0 p -125.53 156.68 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 119.279 -2.138 . . . . 25.0 113.911 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.73 -29.61 69.63 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-O 122.641 1.21 . . . . 25.0 110.274 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -79.55 161.4 26.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 119.194 -2.191 . . . . 25.0 115.062 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . . . -133.7 167.13 21.08 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 114.691 -1.141 . . . . 25.0 108.736 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 1' ' ' HIS . 63.2 m-85 -115.94 144.66 43.76 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.976 -1.12 . . . . 50.0 107.976 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -122.33 155.88 35.07 Favored 'General case' 0 C--O 1.242 0.707 0 O-C-N 125.84 1.963 . . . . 50.0 107.402 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -126.8 151.9 47.67 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.763 -1.562 . . . . 25.0 108.939 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.71 135.55 50.99 Favored 'Isoleucine or valine' 0 C--O 1.268 2.065 0 N-CA-C 105.91 -1.885 . . . . 75.0 105.91 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.6 mt -139.56 106.96 2.83 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 N-CA-C 105.642 -1.984 . . . . 25.0 105.642 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -84.71 131.41 34.58 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 120.247 -1.533 . . . . 25.0 113.837 174.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.74 142.4 43.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 120.307 -1.496 . . . . 50.0 113.061 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 45.3 t0 -83.9 132.36 34.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 116.497 -1.716 . . . . 25.0 107.581 167.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.1 mt -126.4 131.51 51.72 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 103.146 -2.909 . . . . 50.0 103.146 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.3 m -135.0 171.51 17.58 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 105.683 -1.969 . . . . 50.0 105.683 -171.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.35 146.27 32.98 Favored 'General case' 0 C--O 1.283 2.844 0 O-C-N 120.972 -1.08 . . . . 25.0 111.575 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt . . . . . 0 C--O 1.289 3.17 0 CA-C-O 116.173 -1.87 . . . . 25.0 112.114 178.724 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.6 m80 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 118.228 -0.892 . . . . 25.0 108.666 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.67 -154.06 10.65 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 118.046 -2.026 . . . . 25.0 116.134 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.19 170.12 20.22 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 125.237 2.446 . . . . 50.0 105.956 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.7 mt -84.34 126.51 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 O-C-N 118.915 -2.366 . . . . 25.0 113.509 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -92.88 -28.3 16.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 116.204 1.927 . . . . 25.0 116.204 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -145.92 122.33 5.87 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 105.729 -1.952 . . . . 25.0 105.729 168.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.29 133.06 10.53 Favored 'Cis proline' 0 C--O 1.197 -1.551 0 C-N-CA 130.543 1.476 . . . . 25.0 113.116 -2.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.62 -88.99 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.805 -1.543 . . . . 25.0 116.146 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -54.5 134.4 46.23 Favored 'General case' 0 C--O 1.262 1.724 0 N-CA-C 114.811 1.412 . . . . 25.0 114.811 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 ttt-85 -118.86 -32.19 4.57 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 112.481 -2.145 . . . . 25.0 114.405 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 14' ' ' CYS . . . -70.47 -24.06 62.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 116.788 2.144 . . . . 25.0 116.788 -172.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.19 60.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 124.437 2.065 . . . . 25.0 111.191 174.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 13' ' ' LEU . 23.2 mt -80.05 -31.17 39.5 Favored 'General case' 0 N--CA 1.492 1.642 1 O-C-N 115.572 -4.455 . . . . 75.0 109.67 179.158 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -60.85 -26.38 67.32 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 111.361 -2.654 . . . . 25.0 116.796 173.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 t -50.85 147.83 4.62 Favored 'General case' 0 C--O 1.283 2.842 0 CA-C-N 114.227 -1.351 . . . . 25.0 114.218 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -72.21 0.19 10.44 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 126.868 2.605 . . . . 25.0 113.302 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.45 4.74 1.63 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.557 1.17 . . . . 25.0 114.043 174.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -57.58 -27.65 62.9 Favored 'General case' 0 C--O 1.202 -1.431 0 O-C-N 118.906 -2.371 . . . . 50.0 113.478 152.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.02 20.4 0.1 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 116.324 1.29 . . . . 25.0 116.324 169.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 58.85 7.8 0.85 Allowed 'General case' 0 C--N 1.387 2.219 0 N-CA-C 117.016 2.228 . . . . 50.0 117.016 156.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.0 mt -74.09 -37.42 64.18 Favored 'General case' 0 C--O 1.286 2.987 0 O-C-N 121.309 -0.87 . . . . 50.0 109.719 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -152.87 177.95 10.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 128.039 2.536 . . . . 25.0 111.641 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.82 157.34 12.43 Favored 'General case' 0 C--O 1.255 1.381 0 N-CA-C 116.509 2.04 . . . . 50.0 116.509 161.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -138.8 14.24 2.69 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 110.965 -2.834 . . . . 25.0 113.271 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -85.72 -43.61 13.24 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 111.968 -2.378 . . . . 25.0 111.16 -164.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.19 72.73 1.22 Allowed Glycine 0 CA--C 1.493 -1.343 0 CA-C-O 116.113 -2.493 . . . . 25.0 116.345 -169.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 m -57.94 -10.69 1.89 Allowed 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 120.387 2.093 . . . . 25.0 114.728 -166.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.68 -10.56 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-N 119.301 0.955 . . . . 50.0 109.733 169.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -45.36 -18.91 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 117.681 2.474 . . . . 25.0 117.681 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -63.65 -38.44 91.14 Favored 'General case' 0 N--CA 1.432 -1.329 0 O-C-N 119.484 -2.01 . . . . 50.0 106.639 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.37 48.83 0.56 Allowed Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.371 1.248 . . . . 25.0 114.371 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.24 -19.99 21.83 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 O-C-N 116.571 -2.384 . . . . 25.0 117.449 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -83.83 -2.45 56.4 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 117.007 -1.473 . . . . 25.0 109.616 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.694 2.497 . . . . 25.0 113.722 -171.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.96 151.21 31.77 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 118.021 -2.925 . . . . 50.0 105.913 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -140.01 160.9 38.87 Favored 'General case' 0 C--O 1.186 -2.239 0 O-C-N 120.271 -1.518 . . . . 25.0 113.625 -170.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.79 149.8 35.01 Favored 'General case' 0 C--O 1.261 1.662 1 N-CA-C 99.912 -4.107 . . . . 25.0 99.912 163.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 82.0 tttt -91.33 146.16 24.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 105.06 -2.2 . . . . 25.0 105.06 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -76.98 162.97 27.14 Favored 'General case' 0 CA--C 1.579 2.075 0 O-C-N 126.382 2.301 . . . . 25.0 110.587 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.66 -176.73 16.76 Favored Glycine 0 CA--C 1.472 -2.623 1 N-CA-C 102.78 -4.128 . . . . 25.0 102.78 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -61.54 142.97 93.9 Favored Pre-proline 0 N--CA 1.395 -3.178 0 CA-C-N 120.618 2.209 . . . . 25.0 110.782 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -86.35 23.89 17.38 Favored 'Cis proline' 0 C--O 1.174 -2.684 1 C-N-CA 136.612 4.005 . . . . 25.0 120.475 -4.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -52.59 -34.4 50.53 Favored 'General case' 0 C--O 1.261 1.663 1 N-CA-C 122.686 4.328 . . . . 25.0 122.686 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -57.52 -38.15 74.18 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 118.69 -2.506 . . . . 25.0 114.675 167.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.34 -176.62 19.94 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.778 -1.101 . . . . 25.0 111.698 -174.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.4 168.09 23.39 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 CA-C-O 125.836 2.349 . . . . 25.0 110.795 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.95 94.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 119.772 3.249 . . . . 25.0 119.772 -168.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -119.25 166.12 13.38 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 123.765 1.745 . . . . 25.0 106.304 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.46 11.63 56.89 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-N 113.896 -1.502 . . . . 25.0 113.667 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -116.4 -11.78 11.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 116.248 1.944 . . . . 25.0 116.248 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.4 mt -67.78 -37.84 79.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.562 -0.903 . . . . 25.0 108.562 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.54 -10.3 24.98 Favored 'General case' 0 C--O 1.262 1.724 0 N-CA-C 116.102 1.89 . . . . 25.0 116.102 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.7 p -113.37 -3.34 13.79 Favored 'General case' 0 C--O 1.184 -2.35 0 C-N-CA 125.797 1.639 . . . . 25.0 113.069 172.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.48 43.51 23.69 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.751 1.22 . . . . 25.0 113.252 -161.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.48 -7.87 64.68 Favored Glycine 0 C--O 1.203 -1.828 0 CA-C-N 113.902 -1.499 . . . . 25.0 111.342 158.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.16 23.56 11.12 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 125.267 1.413 . . . . 25.0 113.69 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.6 mt -88.51 34.66 0.76 Allowed 'General case' 0 C--O 1.251 1.133 0 CA-C-O 116.624 -1.655 . . . . 50.0 111.86 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -63.66 -25.96 68.45 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 107.007 -1.479 . . . . 50.0 107.007 142.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.86 -10.02 85.05 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 119.769 -1.832 . . . . 25.0 115.477 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.34 -2.31 47.97 Favored Glycine 0 C--O 1.286 3.386 0 N-CA-C 118.418 2.127 . . . . 25.0 118.418 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -63.2 -41.19 91.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 123.378 1.561 . . . . 25.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.04 -28.58 62.42 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 114.087 -1.415 . . . . 75.0 110.933 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -109.89 21.98 16.2 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-O 124.086 1.898 . . . . 50.0 113.971 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -75.84 41.72 0.22 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 120.991 3.7 . . . . 25.0 120.991 -170.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -138.12 45.6 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.767 -1.938 . . . . 25.0 105.767 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -143.31 -172.87 3.79 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.634 1.683 . . . . 25.0 110.784 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -61.48 -22.01 64.7 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.393 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -77.01 2.82 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 119.699 -1.876 . . . . 25.0 112.507 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -87.69 84.11 7.11 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 128.183 3.849 . . . . 25.0 112.918 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 148.87 34.78 Favored 'General case' 0 C--N 1.287 -2.117 1 CA-C-N 106.008 -5.087 . . . . 25.0 111.395 156.1 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -75.87 147.36 39.11 Favored 'General case' 0 C--O 1.188 -2.162 0 N-CA-C 105.911 -1.885 . . . . 50.0 105.911 -174.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HE3' ' CG ' ' A' ' 145' ' ' TYR . 24.3 mtpt -84.12 121.34 27.32 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 174.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -73.59 119.73 18.21 Favored 'General case' 0 CA--C 1.461 -2.477 0 C-N-CA 116.412 -2.115 . . . . 25.0 106.535 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.25 129.54 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 98.7 mmm -140.57 150.76 44.07 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 104.476 -2.416 . . . . 25.0 104.476 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -88.31 176.97 6.98 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 104.451 -2.425 . . . . 25.0 104.451 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.24 174.1 34.84 Favored Glycine 1 C--O 1.158 -4.628 0 N-CA-C 107.079 -2.409 . . . . 25.0 107.079 171.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.72 178.76 47.84 Favored Glycine 0 C--O 1.201 -1.911 0 C-N-CA 126.543 2.02 . . . . 25.0 112.851 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -72.81 141.37 48.02 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 114.417 -2.706 . . . . 25.0 114.006 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -132.6 156.55 46.68 Favored 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 105.974 -1.861 . . . . 25.0 105.974 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.4 m -89.18 107.59 19.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.741 -3.059 . . . . 25.0 102.741 -172.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.83 115.31 27.99 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 106.436 -1.69 . . . . 50.0 106.436 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.4 m -133.01 132.4 41.83 Favored 'General case' 0 C--O 1.267 1.976 0 N-CA-C 108.501 -0.926 . . . . 25.0 108.501 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -117.48 170.06 9.03 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 106.106 -1.812 . . . . 25.0 106.106 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -140.31 146.73 38.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.976 -2.601 . . . . 25.0 103.976 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.72 147.3 46.09 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 113.773 -1.558 . . . . 50.0 113.06 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 t -61.24 -23.39 65.6 Favored 'General case' 0 C--O 1.26 1.633 0 O-C-N 125.748 1.905 . . . . 25.0 113.714 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.19 32.06 Favored Pre-proline 0 CA--C 1.497 -1.082 0 N-CA-C 103.6 -2.741 . . . . 25.0 103.6 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -64.45 166.2 18.07 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 113.656 -3.762 . . . . 25.0 111.77 164.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -129.06 147.17 50.9 Favored 'General case' 0 C--O 1.197 -1.696 0 O-C-N 126.21 2.194 . . . . 25.0 106.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.76 125.71 25.66 Favored 'General case' 0 C--O 1.186 -2.256 0 O-C-N 126.051 2.095 . . . . 25.0 106.498 165.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.3 m -129.43 145.21 51.45 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 124.917 1.287 . . . . 25.0 109.921 -172.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -105.79 -48.95 3.51 Favored 'General case' 0 CA--C 1.624 3.815 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 41.9 tt0 -152.51 160.48 43.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.295 -2.483 . . . . 25.0 104.295 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -143.21 141.02 30.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.07 -1.423 . . . . 25.0 110.637 161.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 163.64 32.62 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.177 -0.952 . . . . 25.0 113.123 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -136.99 149.34 47.45 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 117.713 2.486 . . . . 50.0 117.713 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -127.87 164.8 21.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.596 1.558 . . . . 50.0 112.851 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.8 pt -127.78 152.35 35.75 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-N 113.93 -1.486 . . . . 25.0 109.254 173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.3 p -94.16 164.14 13.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 102.919 -2.993 . . . . 25.0 102.919 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -73.58 136.43 43.98 Favored 'General case' 0 C--O 1.185 -2.318 0 O-C-N 119.808 -1.808 . . . . 25.0 111.995 -163.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -71.88 114.51 10.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 119.162 -2.211 . . . . 25.0 108.53 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.6 47.97 3.58 Favored Glycine 0 C--O 1.277 2.792 0 CA-C-N 120.857 1.662 . . . . 25.0 110.393 -172.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.4 160.89 12.57 Favored 'General case' 0 CA--C 1.593 2.616 0 N-CA-C 107.186 -1.412 . . . . 25.0 107.186 -170.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -132.67 105.29 12.96 Favored Pre-proline 0 C--O 1.275 2.421 0 O-C-N 126.119 2.137 . . . . 25.0 107.142 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.97 -11.31 25.44 Favored 'Trans proline' 0 C--N 1.371 1.745 0 N-CA-C 116.872 1.835 . . . . 25.0 116.872 -174.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.85 -10.46 53.19 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.12 1.155 . . . . 75.0 114.12 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -89.25 175.53 3.88 Favored Pre-proline 0 C--O 1.215 -0.747 0 C-N-CA 126.961 2.104 . . . . 25.0 113.211 -176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -19.66 37.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 1 C-N-CA 134.626 10.218 . . . . 25.0 120.124 121.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.69 -36.02 23.69 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 129.571 3.149 . . . . 50.0 111.33 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.46 -5.72 58.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 119.887 -1.758 . . . . 25.0 110.942 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -130.26 -72.01 0.58 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.306 1.965 . . . . 25.0 116.306 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.75 -0.89 25.43 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 122.975 2.625 . . . . 25.0 114.274 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -75.64 -23.63 56.34 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.593 1.088 . . . . 25.0 111.337 163.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.27 154.79 21.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.969 -1.493 . . . . 50.0 106.969 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.58 158.22 40.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.312 -2.477 . . . . 25.0 104.312 159.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.3 tp -87.81 128.79 35.33 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 102.616 -3.105 . . . . 50.0 102.616 158.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.97 -21.77 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 106.926 -1.509 . . . . 25.0 106.926 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.91 164.56 30.41 Favored Glycine 0 C--O 1.202 -1.89 0 CA-C-N 119.719 1.145 . . . . 25.0 113.082 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.4 42.21 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 106.0 -1.852 . . . . 25.0 106.0 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.68 95.4 17.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-N 112.251 -2.25 . . . . 50.0 108.736 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 97.1 Cg_endo -74.61 166.34 29.58 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 121.391 1.394 . . . . 25.0 109.87 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -124.32 140.59 52.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.197 -1.408 . . . . 25.0 107.197 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.3 -11.73 5.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 115.449 1.648 . . . . 50.0 115.449 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.03 -9.07 33.75 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 126.44 1.972 . . . . 25.0 110.892 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.6 p -74.46 154.27 87.81 Favored Pre-proline 0 C--O 1.197 -1.659 0 N-CA-C 100.827 -3.768 . . . . 25.0 100.827 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.39 25.53 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 117.202 -1.399 . . . . 25.0 113.932 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.55 -16.29 60.28 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 118.808 -2.433 . . . . 25.0 108.171 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.1 p -69.57 -13.97 62.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.667 -1.606 . . . . 25.0 113.659 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.92 -28.79 69.18 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.067 -0.97 . . . . 25.0 111.54 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -68.12 88.89 0.3 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.62 0.724 . . . . 25.0 109.979 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.6 tp -92.39 -27.6 17.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 126.412 3.006 . . . . 75.0 107.485 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.4 t -81.41 123.72 28.81 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 110.724 -2.944 . . . . 25.0 107.647 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -129.63 135.68 48.83 Favored 'General case' 0 CA--C 1.572 1.801 0 O-C-N 124.959 1.412 . . . . 25.0 108.841 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -69.78 130.53 42.56 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 116.233 -1.841 . . . . 25.0 106.117 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.8 mm -128.7 118.33 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.953 0 CA-C-N 121.058 1.754 . . . . 25.0 112.274 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -67.49 129.85 41.19 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 115.654 1.724 . . . . 50.0 115.654 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.26 118.4 44.01 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 118.1 -2.875 . . . . 25.0 107.555 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.34 146.41 45.14 Favored 'Trans proline' 0 CA--C 1.483 -2.06 0 C-N-CA 115.216 -2.723 . . . . 25.0 116.417 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -87.73 53.88 2.93 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 123.297 1.522 . . . . 25.0 108.05 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -84.33 -30.87 25.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 120.002 3.334 . . . . 50.0 120.002 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -152.22 177.96 9.99 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 114.047 -2.882 . . . . 25.0 104.505 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 mp -113.67 126.46 55.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 104.567 -2.383 . . . . 50.0 104.567 160.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.78 170.12 32.16 Favored Glycine 0 CA--C 1.473 -2.539 0 C-N-CA 118.148 -1.977 . . . . 25.0 114.533 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.444 ' CG ' ' HE3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -112.86 135.61 53.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.36 1.464 . . . . 50.0 112.462 -168.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -147.0 167.69 23.39 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 125.349 1.656 . . . . 25.0 113.449 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.4 t -85.2 158.87 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 126.896 2.623 . . . . 50.0 104.559 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.8 mt -129.24 136.16 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 N-CA-C 103.43 -2.804 . . . . 25.0 103.43 162.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.34 153.03 39.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 104.741 -2.318 . . . . 50.0 104.741 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.61 157.4 45.52 Favored 'General case' 0 C--O 1.184 -2.371 0 CA-C-N 121.632 2.015 . . . . 25.0 106.61 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.52 134.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 126.832 2.583 . . . . 50.0 110.405 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -124.17 119.68 30.1 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 120.792 1.633 . . . . 25.0 108.084 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -84.4 89.13 7.33 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 119.563 -1.96 . . . . 25.0 111.461 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.67 103.65 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 113.23 -1.805 . . . . 50.0 106.5 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.12 -18.89 64.76 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 113.793 -1.549 . . . . 25.0 114.26 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.68 -26.35 66.99 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 119.178 3.029 . . . . 25.0 119.178 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 45.7 p -115.24 158.45 22.3 Favored 'General case' 0 C--O 1.262 1.725 0 N-CA-C 114.796 1.406 . . . . 25.0 114.796 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -28.15 27.81 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 106.918 -1.512 . . . . 25.0 106.918 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 86.1 m-20 -66.7 157.89 31.53 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 124.615 2.15 . . . . 25.0 111.416 160.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.49 155.45 42.27 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 101.954 -3.35 . . . . 25.0 101.954 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -111.53 153.35 26.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.072 2.107 . . . . 50.0 115.905 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -142.59 152.1 42.2 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 124.019 1.866 . . . . 50.0 106.74 -162.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -155.38 149.26 25.49 Favored 'General case' 0 C--O 1.19 -2.068 0 O-C-N 120.043 -1.661 . . . . 25.0 111.534 167.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.81 127.5 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 125.269 1.606 . . . . 75.0 112.556 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 152.77 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-N 121.835 2.107 . . . . 25.0 108.676 172.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -88.93 156.82 18.67 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 118.94 2.941 . . . . 25.0 118.94 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.1 169.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 102.695 -3.076 . . . . 50.0 102.695 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -132.66 122.61 24.92 Favored 'General case' 0 C--O 1.258 1.505 0 N-CA-C 103.03 -2.952 . . . . 25.0 103.03 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.68 119.4 34.35 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 122.07 2.214 . . . . 50.0 106.329 -164.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.59 -175.65 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.268 2.063 0 CA-C-O 122.408 1.099 . . . . 50.0 113.359 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.97 151.49 43.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.634 1.716 . . . . 25.0 115.634 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 79.7 mttt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 121.586 1.994 . . . . 25.0 115.319 176.171 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.44 ' HA ' ' CE3' ' A' ' 152' ' ' TRP . 24.0 p-80 . . . . . 0 C--O 1.293 3.366 0 CA-C-O 117.995 -1.002 . . . . 25.0 112.233 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.25 -124.02 31.0 Favored Glycine 0 CA--C 1.489 -1.579 0 CA-C-O 118.482 -1.177 . . . . 25.0 112.297 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -113.58 164.18 13.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 126.549 1.97 . . . . 50.0 110.97 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.4 mt -96.1 120.53 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 N-CA-C 102.972 -2.973 . . . . 25.0 102.972 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -91.72 -34.02 14.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 117.575 -1.202 . . . . 25.0 108.256 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.52 133.17 13.55 Favored Pre-proline 0 C--N 1.309 -1.185 0 C-N-CA 124.382 1.073 . . . . 25.0 110.097 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.57 144.77 80.83 Favored 'Cis proline' 0 C--O 1.249 1.033 0 CA-C-O 123.625 1.427 . . . . 25.0 109.39 -3.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.04 133.29 10.33 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 113.761 -1.563 . . . . 25.0 110.75 169.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 35.13 0.8 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.159 1.48 . . . . 25.0 108.699 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -65.16 -26.33 68.12 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 116.071 -1.919 . . . . 25.0 112.778 -166.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.74 57.29 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 122.224 2.284 . . . . 25.0 109.189 -175.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.35 97.13 Favored 'General case' 0 C--O 1.274 2.385 0 CA-C-N 114.641 -1.163 . . . . 25.0 112.574 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.1 mt -66.84 -34.25 77.39 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.31 0.576 . . . . 75.0 109.994 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 t -65.22 -26.36 68.09 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 123.006 1.384 . . . . 25.0 113.36 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -64.53 132.73 50.73 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 119.577 -1.952 . . . . 25.0 110.355 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -67.65 -27.15 66.63 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.43 -25.16 36.38 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-O 122.368 1.08 . . . . 25.0 110.827 -167.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -54.81 -41.38 70.55 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 114.31 1.226 . . . . 50.0 114.31 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.1 19.57 22.61 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 108.602 -1.799 . . . . 25.0 108.602 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.4 t80 37.54 -49.01 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.786 1 N-CA-C 127.677 6.177 . . . . 50.0 127.677 -159.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.8 mt -108.6 15.91 23.37 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.172 0.589 . . . . 50.0 112.398 -174.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -75.45 159.58 31.2 Favored 'General case' 0 C--O 1.185 -2.302 0 N-CA-C 116.019 1.859 . . . . 25.0 116.019 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 mp -62.49 171.48 1.94 Allowed 'General case' 0 C--O 1.254 1.311 0 O-C-N 124.277 0.985 . . . . 50.0 111.453 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -71.18 -18.44 62.49 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 115.711 -2.396 . . . . 25.0 113.39 -159.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.9 t -141.26 -15.95 0.85 Allowed 'General case' 0 C--O 1.288 3.098 0 C-N-CA 119.383 -0.927 . . . . 25.0 113.47 161.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.13 59.06 1.7 Allowed Glycine 0 CA--C 1.543 1.823 0 CA-C-O 116.207 -2.44 . . . . 25.0 116.024 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.415 ' HA ' ' HG2' ' A' ' 29' ' ' MET . 2.7 m -54.67 -2.19 0.03 OUTLIER 'General case' 0 C--O 1.27 2.159 0 N-CA-C 120.447 3.499 . . . . 25.0 120.447 -176.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.2 p -56.4 -23.02 15.79 Favored 'Isoleucine or valine' 0 C--O 1.258 1.548 0 N-CA-C 105.349 -2.093 . . . . 50.0 105.349 162.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.415 ' HG2' ' HA ' ' A' ' 27' ' ' SER . 27.2 ptt? -62.26 -7.42 4.23 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 115.532 1.679 . . . . 25.0 115.532 175.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -62.64 -44.69 95.63 Favored 'General case' 0 C--O 1.286 3.024 0 N-CA-C 119.482 3.142 . . . . 50.0 119.482 -166.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.256 11.9 pt-20 -142.17 62.38 13.7 Favored Pre-proline 0 C--O 1.258 1.508 0 N-CA-C 117.018 2.229 . . . . 25.0 117.018 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.8 -21.78 37.81 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 117.049 -1.501 . . . . 25.0 113.408 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -71.61 -14.28 62.02 Favored 'General case' 0 C--O 1.261 1.697 0 O-C-N 119.537 -1.977 . . . . 25.0 115.482 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 m -85.4 2.38 44.63 Favored 'General case' 0 C--O 1.285 2.933 0 O-C-N 119.934 -1.729 . . . . 25.0 115.373 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.2 150.58 48.9 Favored 'General case' 0 C--O 1.273 2.337 0 N-CA-C 104.267 -2.494 . . . . 50.0 104.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -132.14 162.16 31.55 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.53 1.932 . . . . 25.0 108.016 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.61 178.4 9.37 Favored 'General case' 0 C--O 1.184 -2.372 0 CA-C-O 124.33 2.014 . . . . 25.0 110.743 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.86 175.64 5.63 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 115.851 1.797 . . . . 25.0 115.851 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 95.3 mttt -57.68 144.15 38.92 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 120.159 -1.588 . . . . 25.0 114.812 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.4 -17.99 27.45 Favored Glycine 0 N--CA 1.479 1.546 0 C-N-CA 118.071 -2.014 . . . . 25.0 112.123 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -69.72 135.04 88.05 Favored Pre-proline 0 C--O 1.261 1.666 0 CA-C-N 118.341 1.071 . . . . 25.0 113.738 -166.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.86 121.01 1.24 Allowed 'Cis proline' 0 C--O 1.269 2.029 0 C-N-CA 134.062 2.942 . . . . 25.0 117.816 -18.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -59.13 -21.64 59.62 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 117.991 2.589 . . . . 25.0 117.991 -166.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 t -46.65 -50.02 18.33 Favored 'General case' 1 C--O 1.151 -4.094 0 N-CA-C 118.176 2.658 . . . . 25.0 118.176 177.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.67 -173.25 30.53 Favored Glycine 0 C--N 1.359 1.835 0 N-CA-C 119.457 2.543 . . . . 25.0 119.457 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.68 -178.52 4.7 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 121.879 1.719 . . . . 25.0 116.398 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.64 134.11 54.3 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 116.537 2.051 . . . . 25.0 116.537 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -84.53 139.83 31.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.829 -1.532 . . . . 25.0 109.676 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.96 1.59 76.15 Favored Glycine 0 C--O 1.259 1.708 0 CA-C-O 124.397 2.11 . . . . 25.0 115.67 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -72.74 -17.77 61.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 117.803 -1.559 . . . . 25.0 111.926 -174.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.5 mm -74.78 -40.66 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 1 O-C-N 115.274 -4.641 . . . . 25.0 107.815 172.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.93 -29.48 66.65 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 119.166 -2.209 . . . . 25.0 115.496 -172.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.6 p -78.95 -11.68 60.01 Favored 'General case' 0 C--O 1.204 -1.338 0 O-C-N 125.585 1.803 . . . . 25.0 110.358 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.49 20.36 12.13 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 127.696 2.399 . . . . 25.0 115.552 -170.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.99 -23.38 77.98 Favored Glycine 0 C--O 1.261 1.795 0 C-N-CA 126.129 1.824 . . . . 25.0 112.699 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.49 8.34 68.96 Favored Glycine 0 C--O 1.254 1.368 0 C-N-CA 125.411 1.482 . . . . 25.0 109.43 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.4 mt -132.71 -176.94 4.27 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 128.214 2.605 . . . . 50.0 106.523 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.01 -14.6 60.83 Favored 'General case' 0 C--O 1.271 2.205 0 N-CA-C 114.824 1.416 . . . . 50.0 114.824 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.41 -22.27 63.27 Favored Glycine 0 C--O 1.274 2.633 0 N-CA-C 110.028 -1.229 . . . . 25.0 110.028 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -13.01 83.67 Favored Glycine 0 C--O 1.268 2.258 0 O-C-N 119.391 -2.241 . . . . 25.0 110.829 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -38.04 66.44 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 O-C-N 117.461 -3.376 . . . . 25.0 105.964 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.64 -32.32 73.76 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.516 -1.365 . . . . 75.0 111.317 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.22 -15.3 61.44 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 119.973 -1.704 . . . . 50.0 111.025 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.26 87.3 mt-30 -92.83 17.76 10.02 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 120.095 -1.628 . . . . 25.0 114.997 168.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -137.71 49.7 1.97 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.631 -1.988 . . . . 25.0 105.631 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -157.85 179.31 9.32 Favored 'General case' 0 C--O 1.261 1.669 1 N-CA-C 100.094 -4.039 . . . . 25.0 100.094 -170.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -47.74 -32.11 5.53 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 117.949 2.574 . . . . 25.0 117.949 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.41 29.53 1.68 Allowed 'General case' 0 C--O 1.253 1.282 0 CA-C-N 121.357 1.89 . . . . 25.0 107.477 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -83.32 78.81 9.57 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 123.967 1.841 . . . . 25.0 107.714 153.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -56.67 158.87 4.25 Favored 'General case' 0 C--O 1.29 3.196 0 CA-C-N 111.15 -2.75 . . . . 25.0 112.781 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -65.94 157.8 29.76 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-N 113.563 -1.653 . . . . 50.0 107.329 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -108.7 144.57 36.32 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 123.676 1.703 . . . . 25.0 108.137 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -139.79 152.82 46.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.625 -1.625 . . . . 25.0 109.735 162.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.7 mt -85.62 136.38 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.591 1.541 . . . . 25.0 107.998 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.6 ttt -137.31 144.8 42.79 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 171.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.298 12.1 p -79.43 173.43 12.59 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 120.373 -1.454 . . . . 25.0 113.209 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.5 -163.76 8.67 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.203 -1.475 . . . . 25.0 111.743 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.6 -172.72 36.19 Favored Glycine 0 N--CA 1.486 1.976 0 O-C-N 119.572 -2.134 . . . . 25.0 113.017 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -77.56 142.55 38.95 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 117.609 2.448 . . . . 25.0 117.609 169.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -137.86 165.88 25.39 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 105.763 -1.94 . . . . 25.0 105.763 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.7 m -118.46 120.25 36.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.956 -1.868 . . . . 25.0 105.956 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.52 141.71 47.7 Favored 'General case' 0 C--O 1.17 -3.111 0 N-CA-C 105.279 -2.119 . . . . 50.0 105.279 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 m -136.84 140.29 42.31 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 116.116 -1.897 . . . . 25.0 113.689 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 143.52 51.22 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 122.367 2.349 . . . . 25.0 109.688 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -149.08 144.57 26.76 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 127.157 3.36 . . . . 25.0 108.393 -170.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -142.54 151.98 42.16 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-N 111.845 -2.434 . . . . 50.0 112.718 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.0 t -73.64 -9.09 58.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 O-C-N 125.678 1.861 . . . . 25.0 113.634 -169.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.96 159.71 67.44 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 117.064 -3.523 . . . . 25.0 103.833 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -73.14 139.7 29.94 Favored 'Trans proline' 0 C--N 1.307 -1.654 1 C-N-CA 111.761 -5.026 . . . . 25.0 110.301 166.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 2.486 47.9 p-80 73.12 12.79 4.91 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 123.308 2.777 . . . . 25.0 116.611 -5.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -65.58 115.89 6.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 118.442 -1.303 . . . . 25.0 113.256 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.0 t -75.73 160.26 30.22 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.084 -1.446 . . . . 25.0 112.071 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 90.3 p -111.51 -26.37 9.1 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 118.246 0.475 . . . . 25.0 110.87 163.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 61.8 tt0 -168.6 150.56 4.97 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 103.013 -2.958 . . . . 25.0 103.013 168.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -136.73 160.54 38.52 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-O 116.921 -1.514 . . . . 25.0 107.589 166.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 6.2 m-70 -142.53 162.43 35.49 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.241 -1.763 . . . . 25.0 106.241 -163.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.27 127.63 45.9 Favored 'General case' 0 C--O 1.274 2.345 0 N-CA-C 103.953 -2.61 . . . . 50.0 103.953 158.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -117.61 149.91 39.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 118.17 -2.831 . . . . 50.0 107.898 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.8 pt -120.64 153.37 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 119.463 1.029 . . . . 25.0 112.626 168.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 p -71.54 147.34 47.79 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -95.88 84.79 3.93 Favored 'General case' 0 C--O 1.191 -1.987 0 CA-C-O 123.103 1.43 . . . . 25.0 109.577 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -49.83 155.29 0.89 Allowed 'General case' 0 C--N 1.354 0.777 0 N-CA-C 117.0 2.222 . . . . 25.0 117.0 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 15.56 76.98 Favored Glycine 0 C--O 1.266 2.129 0 CA-C-O 126.551 3.306 . . . . 25.0 120.889 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 179.2 2.83 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.35 -1.925 . . . . 25.0 113.759 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.93 142.43 11.74 Favored Pre-proline 0 CA--C 1.492 -1.255 0 O-C-N 126.38 2.3 . . . . 25.0 106.333 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -60.41 -22.74 72.6 Favored 'Trans proline' 0 CA--C 1.592 3.42 0 N-CA-C 117.677 2.145 . . . . 25.0 117.677 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 116.399 -2.12 . . . . 75.0 110.709 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -108.09 170.95 4.98 Favored Pre-proline 0 CA--C 1.599 2.856 0 C-N-CA 129.751 3.221 . . . . 25.0 103.272 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.33 16.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.393 1 N-CA-C 122.767 4.103 . . . . 25.0 122.767 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.66 -40.4 69.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 117.172 2.286 . . . . 50.0 117.172 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -75.36 -6.84 52.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 126.287 2.242 . . . . 25.0 114.401 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -116.26 -59.69 1.95 Allowed 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 127.259 2.224 . . . . 25.0 114.49 -171.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -141.67 29.6 1.73 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 123.469 1.604 . . . . 25.0 111.794 -159.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.89 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 111.763 -2.471 . . . . 25.0 116.985 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -129.29 166.21 19.9 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 123.157 2.708 . . . . 50.0 112.457 172.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.07 143.25 49.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 101.289 -3.597 . . . . 25.0 101.289 163.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 tp -86.3 120.94 28.19 Favored 'General case' 0 C--O 1.182 -2.482 0 O-C-N 127.507 3.004 . . . . 50.0 108.701 166.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.8 tt -101.93 -8.29 9.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 121.536 1.971 . . . . 25.0 110.172 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.65 154.55 9.64 Favored Glycine 0 C--O 1.207 -1.592 0 C-N-CA 116.086 -2.959 . . . . 25.0 113.791 165.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . . . -144.55 145.85 32.04 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 122.999 3.399 . . . . 25.0 104.839 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.44 105.79 30.54 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-O 117.067 -1.444 . . . . 50.0 114.104 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 42.5 Cg_endo -77.48 164.59 28.4 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 C-N-CA 115.809 -2.327 . . . . 25.0 115.436 172.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -74.22 112.76 10.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.666 -1.976 . . . . 25.0 105.666 167.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.66 -18.4 1.91 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 119.379 -2.076 . . . . 50.0 116.335 -165.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.63 16.65 33.32 Favored Glycine 0 N--CA 1.466 0.673 0 O-C-N 119.917 -1.739 . . . . 25.0 114.371 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -55.54 162.33 2.49 Favored Pre-proline 0 CA--C 1.568 1.661 0 O-C-N 125.664 1.45 . . . . 25.0 113.72 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -66.31 176.25 4.19 Favored 'Trans proline' 0 C--O 1.276 2.412 0 CA-C-O 123.452 1.355 . . . . 25.0 112.065 166.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.85 -12.44 0.31 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 119.585 3.18 . . . . 25.0 119.585 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 p -69.44 -0.57 6.68 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 120.131 -1.605 . . . . 25.0 111.737 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.27 4.85 7.93 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 117.587 2.439 . . . . 25.0 117.587 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -61.03 164.68 4.78 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.347 1.546 . . . . 25.0 114.157 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.8 30.61 0.11 Allowed 'General case' 0 N--CA 1.516 2.829 0 O-C-N 119.256 -2.153 . . . . 75.0 113.287 -171.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.4 t -113.8 149.72 34.53 Favored 'General case' 0 C--O 1.262 1.737 0 N-CA-C 103.232 -2.877 . . . . 25.0 103.232 170.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -146.27 142.56 28.45 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 123.87 0.868 . . . . 25.0 109.318 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -75.39 135.69 40.79 Favored 'General case' 0 C--O 1.172 -3.023 0 N-CA-C 105.592 -2.003 . . . . 25.0 105.592 162.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.9 129.82 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 104.776 -2.305 . . . . 25.0 104.776 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -90.49 135.08 33.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 112.672 -2.058 . . . . 50.0 112.036 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.04 108.74 41.89 Favored Pre-proline 0 C--N 1.307 -1.245 0 O-C-N 119.678 -1.889 . . . . 25.0 108.427 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.82 136.86 21.37 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 O-C-N 117.033 -2.141 . . . . 25.0 114.456 164.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -150.86 101.82 2.93 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.162 -0.961 . . . . 25.0 109.273 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -105.56 10.55 33.05 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 126.943 2.097 . . . . 50.0 108.632 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -132.87 -176.83 4.24 Favored 'General case' 0 C--O 1.21 -0.98 0 O-C-N 119.174 -2.204 . . . . 25.0 110.304 -173.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.44 148.99 51.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 103.443 -2.799 . . . . 50.0 103.443 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 145.62 174.42 17.79 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 121.206 3.243 . . . . 25.0 121.206 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -75.12 135.72 41.13 Favored 'General case' 0 C--O 1.279 2.614 0 N-CA-C 116.122 1.897 . . . . 50.0 116.122 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -139.82 172.78 12.28 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 103.631 -2.729 . . . . 25.0 103.631 174.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.0 t -123.18 148.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 103.455 -2.794 . . . . 50.0 103.455 166.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.5 mt -115.66 137.86 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 1 N-CA-C 98.647 -4.575 . . . . 25.0 98.647 172.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.54 129.48 55.37 Favored 'General case' 0 C--O 1.187 -2.193 0 CA-C-N 119.172 0.896 . . . . 50.0 113.024 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.18 135.0 45.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.521 -1.362 . . . . 25.0 111.502 -173.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 69.2 t -124.96 137.37 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.972 0 N-CA-C 103.033 -2.951 . . . . 50.0 103.033 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.44 ' CE3' ' HA ' ' A' ' 1' ' ' HIS . 2.7 t90 -140.03 112.57 7.89 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.092 -2.558 . . . . 25.0 104.092 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.5 140.56 32.57 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 100.533 -3.877 . . . . 25.0 100.533 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.51 157.16 34.97 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 CA-C-O 122.715 1.245 . . . . 50.0 107.807 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 -24.36 36.01 Favored 'General case' 0 C--O 1.199 -1.595 0 CA-C-N 115.042 -0.981 . . . . 25.0 108.86 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -67.16 -35.48 79.77 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 115.17 1.544 . . . . 25.0 115.17 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 t -135.29 159.05 42.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 115.066 -2.397 . . . . 25.0 107.899 -166.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.02 -27.03 41.26 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 120.873 1.669 . . . . 25.0 113.914 162.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 96.7 m-20 -73.04 163.16 28.57 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.531 -1.356 . . . . 25.0 110.861 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.81 -176.19 3.77 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 104.597 -2.372 . . . . 25.0 104.597 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.79 146.53 47.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.772 -0.825 . . . . 50.0 108.772 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -134.56 135.62 42.41 Favored 'General case' 0 C--O 1.172 -2.98 0 CA-C-O 115.377 -2.249 . . . . 50.0 106.535 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -144.93 172.08 13.55 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 121.371 1.896 . . . . 25.0 107.735 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 147.53 32.06 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 O-C-N 120.047 -1.658 . . . . 75.0 107.344 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.4 mm -130.15 122.42 53.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 103.429 -2.804 . . . . 25.0 103.429 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -87.11 123.76 32.52 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.217 -2.142 . . . . 25.0 105.217 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.13 155.14 38.03 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.656 -1.278 . . . . 50.0 112.765 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -116.31 130.45 56.78 Favored 'General case' 0 N--CA 1.436 -1.144 1 N-CA-C 96.279 -5.452 . . . . 25.0 96.279 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.2 mt -123.8 128.78 50.04 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 115.781 -2.057 . . . . 50.0 106.693 -171.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.17 159.0 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 O-C-N 127.101 2.75 . . . . 50.0 112.09 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -70.22 131.52 44.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 117.987 -2.945 . . . . 25.0 108.138 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.4 pttt . . . . . 0 C--O 1.28 2.685 0 N-CA-C 120.464 3.505 . . . . 25.0 120.464 -171.286 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.8 m80 . . . . . 0 N--CA 1.517 2.89 0 N-CA-C 112.667 0.617 . . . . 25.0 112.667 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.7 -146.99 4.46 Favored Glycine 0 C--O 1.253 1.294 0 CA-C-O 114.393 -3.448 . . . . 25.0 118.742 -162.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.3 168.95 23.19 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 122.285 3.043 . . . . 50.0 105.941 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.11 121.73 41.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.998 -2.593 . . . . 25.0 103.998 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -83.05 -36.45 24.92 Favored 'General case' 0 C--O 1.262 1.734 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -172.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -160.89 159.98 25.08 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-O 113.634 -3.079 . . . . 25.0 106.352 -175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -78.09 137.52 46.9 Favored 'Cis proline' 0 C--O 1.206 -1.112 0 O-C-N 124.721 1.906 . . . . 25.0 107.195 1.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.26 -171.98 44.74 Favored Glycine 0 CA--C 1.454 -3.725 0 CA-C-N 114.811 -1.086 . . . . 25.0 110.51 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.1 p -145.75 158.34 43.86 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 119.644 1.722 . . . . 25.0 107.003 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -82.47 -24.41 34.23 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 118.764 -1.174 . . . . 25.0 111.429 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.17 79.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.134 0.974 . . . . 25.0 111.648 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.15 -31.94 69.43 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 119.3 0.954 . . . . 25.0 113.477 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 mt -85.99 -24.23 26.55 Favored 'General case' 0 C--O 1.192 -1.938 0 C-N-CA 124.261 1.025 . . . . 75.0 113.514 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.0 t -65.96 -32.03 73.28 Favored 'General case' 0 C--O 1.205 -1.281 0 O-C-N 125.348 1.655 . . . . 25.0 111.37 173.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -58.83 147.53 33.27 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.16 -1.382 . . . . 25.0 114.306 172.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.79 -11.53 58.95 Favored 'General case' 0 C--O 1.187 -2.21 0 C-N-CA 118.856 -1.137 . . . . 25.0 111.529 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . . . -52.62 -24.78 9.03 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 118.927 2.936 . . . . 25.0 118.927 -167.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.13 -28.34 51.97 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 115.74 1.756 . . . . 50.0 115.74 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.58 -26.93 0.07 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 117.927 1.931 . . . . 25.0 117.927 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.475 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 94.5 m-85 50.15 26.27 2.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 119.455 -2.203 . . . . 50.0 112.089 -170.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.4 mt -86.02 -37.83 18.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 118.302 -2.749 . . . . 50.0 107.134 -173.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -171.13 170.21 6.21 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 115.125 -2.369 . . . . 25.0 109.529 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mp -69.45 151.16 46.42 Favored 'General case' 0 C--O 1.263 1.81 0 CA-C-N 121.314 1.87 . . . . 50.0 109.941 175.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -150.81 30.03 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 113.598 -1.637 . . . . 25.0 108.98 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.4 t -70.12 -36.9 75.13 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.377 1.084 . . . . 25.0 112.156 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.95 97.61 0.18 Allowed Glycine 0 C--N 1.285 -2.298 0 C-N-CA 117.332 -2.366 . . . . 25.0 116.767 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.2 m -54.64 -8.5 0.24 Allowed 'General case' 0 C--O 1.249 1.056 0 C-N-CA 126.68 1.992 . . . . 25.0 115.354 -171.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.26 -18.05 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 N-CA-C 115.15 1.537 . . . . 50.0 115.15 161.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -48.4 -16.74 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 1 N-CA-C 122.437 4.236 . . . . 25.0 122.437 177.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -63.87 -41.55 97.74 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 114.43 1.27 . . . . 50.0 114.43 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -153.94 53.74 0.99 Allowed Pre-proline 0 C--O 1.274 2.394 0 O-C-N 120.119 -1.613 . . . . 25.0 110.539 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.01 -33.17 42.52 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 O-C-N 118.311 -1.468 . . . . 25.0 113.757 -165.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -1.33 4.17 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 117.319 2.34 . . . . 25.0 117.319 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -82.81 55.39 3.02 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.94 1.696 . . . . 25.0 113.601 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.72 135.26 33.72 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 123.24 1.495 . . . . 50.0 107.004 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.21 149.86 39.7 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 125.663 2.649 . . . . 25.0 105.424 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.11 12.48 Favored 'General case' 0 C--O 1.259 1.587 0 N-CA-C 102.329 -3.211 . . . . 25.0 102.329 164.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -100.15 168.59 9.72 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.616 2.08 . . . . 25.0 116.616 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -54.0 144.63 18.63 Favored 'General case' 0 N--CA 1.402 -2.858 0 CA-C-O 123.372 1.558 . . . . 25.0 111.512 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.53 166.91 38.13 Favored Glycine 0 C--O 1.255 1.443 1 N-CA-C 99.406 -5.478 . . . . 25.0 99.406 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -142.31 149.21 50.72 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 113.267 -1.467 . . . . 25.0 113.156 -173.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.74 108.7 0.34 Allowed 'Cis proline' 0 CA--C 1.552 1.394 0 C-N-CA 129.639 1.099 . . . . 25.0 112.512 -28.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -22.12 66.79 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 117.427 -3.295 . . . . 25.0 114.628 -167.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -43.23 99.26 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 119.512 1.051 . . . . 25.0 111.671 168.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.68 -156.23 6.9 Favored Glycine 0 N--CA 1.477 1.413 0 O-C-N 124.296 0.998 . . . . 25.0 111.866 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.86 162.35 35.35 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 CA-C-N 118.603 1.201 . . . . 25.0 114.26 -168.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.62 125.13 21.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 126.95 2.657 . . . . 25.0 112.887 -162.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -136.93 159.59 41.41 Favored 'General case' 0 CA--C 1.499 -1.009 1 N-CA-C 98.537 -4.616 . . . . 25.0 98.537 169.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.87 -14.01 59.66 Favored Glycine 0 C--O 1.22 -0.722 0 CA-C-O 125.17 2.539 . . . . 25.0 114.302 171.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -96.81 12.89 30.48 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 119.668 -2.078 . . . . 25.0 112.896 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.85 -57.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.97 -1.122 . . . . 25.0 107.97 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.27 79.0 Favored 'General case' 0 CA--C 1.591 2.557 0 CA-C-O 122.574 1.178 . . . . 25.0 110.85 -172.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.6 p -76.19 -12.45 60.1 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 117.04 -3.538 . . . . 25.0 112.158 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.22 22.59 10.85 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 111.888 -2.415 . . . . 25.0 113.31 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.78 -2.48 75.39 Favored Glycine 0 C--O 1.184 -3.008 0 CA-C-O 127.241 3.689 . . . . 25.0 112.519 -173.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.3 -3.26 69.74 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 108.32 -1.912 . . . . 25.0 108.32 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -84.87 118.01 24.24 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 119.446 1.623 . . . . 50.0 108.045 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -76.05 -21.47 56.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.215 -1.394 . . . . 50.0 107.645 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 -20.6 58.75 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 104.347 -3.501 . . . . 25.0 104.347 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.13 -20.87 71.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 111.471 -2.365 . . . . 25.0 112.122 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.71 -37.31 23.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 118.208 -1.397 . . . . 25.0 113.809 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.0 -34.67 75.66 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 119.751 -1.843 . . . . 75.0 111.687 172.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.54 -5.56 56.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.463 2.554 . . . . 50.0 110.065 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -81.97 75.43 8.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 113.716 -1.584 . . . . 25.0 111.01 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -128.2 44.28 2.98 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 127.295 2.238 . . . . 25.0 105.817 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.0 t -127.32 -166.56 1.62 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.3 -3.222 . . . . 25.0 102.3 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.79 -17.62 64.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 117.673 2.471 . . . . 25.0 117.673 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.47 24.3 7.52 Favored 'General case' 0 CA--C 1.595 2.686 0 CA-C-O 124.557 2.122 . . . . 25.0 109.978 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -87.31 102.25 14.33 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 126.742 3.163 . . . . 25.0 109.047 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -35.59 143.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.482 2 CA-C-N 102.415 -6.721 . . . . 25.0 112.146 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -70.92 152.84 43.23 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 115.323 1.601 . . . . 50.0 115.323 -173.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -95.35 152.73 18.13 Favored 'General case' 0 CA--C 1.587 2.38 0 O-C-N 121.353 -0.842 . . . . 25.0 109.85 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.12 148.61 49.83 Favored 'General case' 0 C--O 1.198 -1.658 0 CA-C-N 120.83 1.65 . . . . 25.0 109.156 169.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.7 mt -107.7 134.08 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 122.926 2.603 . . . . 25.0 111.952 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 85.1 mmm -144.22 169.97 16.87 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.203 -1.777 . . . . 25.0 106.203 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -90.98 172.09 8.82 Favored 'General case' 0 CA--C 1.446 -3.032 0 CA-C-O 116.056 -1.926 . . . . 25.0 111.606 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.98 173.46 9.66 Favored Glycine 0 CA--C 1.495 -1.176 0 O-C-N 124.94 1.4 . . . . 25.0 112.792 165.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.62 163.99 29.26 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 117.127 -2.463 . . . . 25.0 107.86 -171.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.38 155.18 28.51 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 120.291 -1.711 . . . . 25.0 109.168 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -145.5 160.67 41.27 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 103.049 -2.945 . . . . 25.0 103.049 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -125.9 130.71 51.84 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 -171.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.79 116.53 25.39 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 102.078 -3.305 . . . . 50.0 102.078 -165.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 133' ' ' SER . 60.9 m -115.63 131.97 56.77 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 102.867 -3.012 . . . . 25.0 102.867 -167.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -119.1 153.07 35.39 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.215 -2.513 . . . . 25.0 104.215 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 t -144.0 147.94 34.58 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -133.41 147.12 51.74 Favored 'General case' 0 C--O 1.266 1.954 0 O-C-N 127.743 3.152 . . . . 50.0 113.665 176.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.2 t -71.23 -20.82 62.2 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 116.341 1.978 . . . . 25.0 116.341 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.34 145.79 56.78 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 121.849 0.833 . . . . 25.0 112.722 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.87 160.51 49.44 Favored 'Trans proline' 0 CA--C 1.488 -1.789 1 C-N-CA 112.056 -4.83 . . . . 25.0 111.791 169.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -135.18 155.29 50.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 125.131 1.372 . . . . 25.0 109.922 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.96 155.29 40.8 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.239 -1.393 . . . . 25.0 107.239 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -140.53 150.97 44.37 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 117.498 -1.681 . . . . 25.0 110.445 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.6 p -112.58 -38.85 4.5 Favored 'General case' 0 CA--C 1.484 -1.569 0 O-C-N 120.68 -1.262 . . . . 25.0 109.385 164.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 35.3 tt0 -150.8 154.13 36.72 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 104.559 -2.386 . . . . 25.0 104.559 169.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -139.74 153.17 47.13 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 117.031 -1.867 . . . . 25.0 108.327 158.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -134.26 154.65 51.16 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 112.616 -2.084 . . . . 25.0 109.901 -157.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 147.0 50.03 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.381 -3.562 . . . . 50.0 101.381 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.75 158.86 43.44 Favored 'General case' 0 C--O 1.184 -2.35 0 CA-C-N 114.001 -1.454 . . . . 50.0 109.056 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 pt -135.91 149.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 106.124 -1.806 . . . . 25.0 106.124 168.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -76.05 137.19 40.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 164.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -86.17 98.15 10.74 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 126.423 1.889 . . . . 25.0 110.452 -164.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -59.65 150.23 28.15 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 119.773 1.17 . . . . 25.0 113.41 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.77 67.1 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 108.906 -1.677 . . . . 25.0 108.906 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -55.77 166.83 0.64 Allowed 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 125.937 1.695 . . . . 25.0 113.71 172.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.01 123.45 6.12 Favored Pre-proline 0 C--O 1.186 -2.26 0 N-CA-C 102.969 -2.974 . . . . 25.0 102.969 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.14 -15.55 39.5 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.383 1.388 . . . . 25.0 114.846 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.56 -6.59 51.04 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 117.526 -3.234 . . . . 75.0 115.458 173.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.09 166.66 15.21 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 101.409 -3.552 . . . . 25.0 101.409 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -43.56 7.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.698 1 C-N-CA 134.179 9.919 . . . . 25.0 120.308 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.28 -26.36 7.22 Favored 'General case' 0 CA--C 1.598 2.794 0 O-C-N 119.599 -1.938 . . . . 50.0 115.667 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -75.96 -2.5 30.73 Favored 'General case' 0 CA--C 1.482 -1.639 1 O-C-N 115.82 -4.3 . . . . 25.0 113.481 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -126.76 -44.61 1.65 Allowed 'General case' 0 CA--C 1.457 -2.61 0 N-CA-C 114.208 1.188 . . . . 25.0 114.208 171.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.38 32.03 0.34 Allowed 'General case' 0 C--O 1.193 -1.872 0 O-C-N 127.938 3.274 . . . . 25.0 112.051 172.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.11 -32.92 73.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 123.708 1.718 . . . . 25.0 113.107 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -103.94 156.54 17.76 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.385 -2.82 . . . . 50.0 103.385 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.95 139.05 50.14 Favored 'General case' 0 C--O 1.27 2.157 0 N-CA-C 102.911 -2.996 . . . . 25.0 102.911 151.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.99 111.84 5.97 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 125.169 1.388 . . . . 50.0 107.517 154.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.42 -16.01 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 O-C-N 125.982 2.051 . . . . 25.0 110.266 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.01 174.41 44.3 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 122.074 2.216 . . . . 25.0 110.383 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -160.45 147.49 15.82 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 114.487 1.292 . . . . 25.0 114.487 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.63 110.28 18.99 Favored Pre-proline 0 CA--C 1.593 2.623 0 C-N-CA 126.209 1.804 . . . . 50.0 108.964 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 89.0 Cg_endo -88.07 161.6 7.25 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 N-CA-C 116.563 1.717 . . . . 25.0 116.563 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -78.26 115.42 17.97 Favored 'General case' 0 CA--C 1.469 -2.137 1 N-CA-C 99.907 -4.108 . . . . 25.0 99.907 171.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -102.3 -14.61 16.89 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.355 -0.839 . . . . 50.0 111.512 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.45 -23.0 2.7 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 105.273 -3.131 . . . . 25.0 105.273 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -78.88 148.02 71.48 Favored Pre-proline 0 C--O 1.266 1.937 0 N-CA-C 104.646 -2.353 . . . . 25.0 104.646 155.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -58.67 147.26 88.49 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 106.476 -2.163 . . . . 25.0 106.476 174.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.34 -19.26 46.89 Favored 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 64.4 p -83.35 6.19 20.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 125.778 1.924 . . . . 25.0 110.491 -176.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -55.06 -43.98 74.33 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 120.047 1.294 . . . . 25.0 113.871 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -110.3 98.43 7.67 Favored 'General case' 0 C--O 1.256 1.445 0 CA-C-O 116.676 -1.63 . . . . 25.0 108.694 166.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.7 tp -85.66 -11.37 53.99 Favored 'General case' 0 C--O 1.288 3.082 0 O-C-N 125.779 1.925 . . . . 75.0 110.626 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 83' ' ' THR . 29.3 t -103.92 138.25 40.76 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -143.06 148.24 36.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.138 1.336 . . . . 25.0 111.715 -164.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -103.6 150.13 24.25 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 125.87 1.981 . . . . 25.0 109.82 -170.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -141.1 127.48 20.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.261 -1.755 . . . . 25.0 106.261 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -84.86 126.93 33.89 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 119.215 0.916 . . . . 50.0 109.009 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -101.38 121.46 51.56 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 106.639 -1.615 . . . . 25.0 106.639 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -67.09 150.57 82.34 Favored 'Trans proline' 0 N--CA 1.481 0.793 1 C-N-CA 113.201 -4.066 . . . . 25.0 116.444 170.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.27 31.37 1.14 Allowed 'General case' 0 CA--C 1.573 1.861 0 CA-C-N 115.512 -0.767 . . . . 25.0 111.816 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.43 -44.77 70.66 Favored 'General case' 1 N--CA 1.545 4.277 0 O-C-N 120.883 -1.136 . . . . 50.0 114.021 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -152.14 166.92 30.16 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.816 0.672 . . . . 25.0 112.816 -170.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mp -83.83 149.22 26.54 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.785 -1.191 . . . . 50.0 107.785 167.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.05 -178.43 19.83 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-O 121.999 0.777 . . . . 25.0 114.962 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -120.42 159.35 25.28 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 117.485 2.402 . . . . 50.0 117.485 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -160.62 163.41 32.62 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 165.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.55 137.97 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.562 0 C-N-CA 124.299 1.04 . . . . 50.0 112.918 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.64 129.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 C-N-CA 125.085 1.354 . . . . 25.0 109.734 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.79 151.91 35.5 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 126.06 2.1 . . . . 50.0 113.881 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.05 51.37 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 104.463 -2.421 . . . . 25.0 104.463 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 162' ' ' TYR . 58.4 t -135.4 131.34 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 126.345 2.278 . . . . 50.0 107.259 -174.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -124.06 128.05 48.76 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 122.619 1.199 . . . . 25.0 108.592 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.73 144.65 34.55 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 123.502 1.62 . . . . 25.0 110.363 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.88 125.36 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 127.449 2.3 . . . . 50.0 111.744 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.49 62.67 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 103.239 -2.874 . . . . 25.0 103.239 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.3 -12.59 60.58 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 117.621 2.452 . . . . 25.0 117.621 -173.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.0 p -133.26 148.38 51.97 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 120.395 -1.441 . . . . 25.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -81.94 -25.21 35.07 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.9 0.88 . . . . 25.0 109.749 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.77 153.25 26.59 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 121.224 -0.922 . . . . 25.0 109.991 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.6 147.66 51.42 Favored 'General case' 0 C--O 1.175 -2.855 0 N-CA-C 105.465 -2.05 . . . . 25.0 105.465 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -120.73 137.29 54.57 Favored 'General case' 0 CA--C 1.479 -1.779 0 C-N-CA 117.996 -1.482 . . . . 50.0 112.21 -158.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.417 ' CD2' HG22 ' A' ' 151' ' ' VAL . 7.8 m-85 -128.96 148.11 50.91 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.691 1.997 . . . . 50.0 114.92 -168.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -139.11 135.93 34.63 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 105.85 -1.907 . . . . 25.0 105.85 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.6 130.97 17.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.463 0 N-CA-C 114.578 1.325 . . . . 75.0 114.578 -169.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.47 123.76 55.91 Favored 'Isoleucine or valine' 0 C--O 1.273 2.32 0 O-C-N 124.728 1.267 . . . . 25.0 111.669 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.5 124.04 26.48 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.95 139.63 49.16 Favored 'Isoleucine or valine' 0 C--O 1.271 2.22 0 CA-C-O 125.311 2.481 . . . . 50.0 109.344 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -117.3 121.34 40.87 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 44.7 mt -131.27 120.42 23.17 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.803 -1.184 . . . . 50.0 107.803 -158.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.4 m -125.68 171.23 14.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 117.618 2.451 . . . . 50.0 117.618 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -74.11 159.59 32.39 Favored 'General case' 0 C--O 1.258 1.522 0 O-C-N 120.772 -1.205 . . . . 25.0 109.574 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.4 mttt . . . . . 0 C--O 1.259 1.568 0 O-C-N 126.821 2.576 . . . . 25.0 109.433 -177.545 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 . . . . . 0 C--O 1.267 1.997 0 CA-C-O 122.49 1.138 . . . . 25.0 111.638 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.76 -174.08 20.18 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-O 114.301 -3.499 . . . . 25.0 118.158 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.39 143.78 47.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 121.674 2.737 . . . . 50.0 107.141 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.5 mt -73.32 140.23 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 102.756 -3.053 . . . . 25.0 102.756 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -135.16 48.21 2.28 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 126.248 2.928 . . . . 25.0 113.834 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 mttt 75.65 163.19 0.14 Allowed Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 109.913 -3.312 . . . . 25.0 113.062 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.58 131.65 22.09 Favored 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 134.665 3.194 . . . . 25.0 108.693 7.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.54 154.5 17.87 Favored Glycine 0 C--O 1.282 3.133 0 N-CA-C 110.716 -0.953 . . . . 25.0 110.716 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 t -152.71 132.7 13.37 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.879 0.987 . . . . 25.0 111.449 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -85.83 -19.79 30.11 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.84 81.6 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 117.774 -1.57 . . . . 25.0 113.228 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.67 59.68 Favored 'General case' 0 C--O 1.269 2.117 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -90.25 -8.86 49.93 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.867 1.803 . . . . 75.0 115.867 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -45.98 -40.43 10.4 Favored 'General case' 0 C--O 1.189 -2.082 0 CA-C-N 112.566 -2.106 . . . . 25.0 113.485 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.0 p -68.41 175.14 3.53 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 118.748 2.87 . . . . 25.0 118.748 -160.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.34 -15.41 1.61 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.511 1.925 . . . . 25.0 113.916 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 -19.63 52.06 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -65.91 -3.14 4.65 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 117.258 -3.401 . . . . 50.0 116.228 169.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.29 -28.05 1.53 Allowed Glycine 0 CA--C 1.561 2.927 0 N-CA-C 117.909 1.923 . . . . 25.0 117.909 173.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.8 t80 60.88 25.9 15.82 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 123.613 1.673 . . . . 50.0 109.951 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.2 mt -93.13 -29.19 15.88 Favored 'General case' 0 C--O 1.191 -1.998 0 CA-C-N 114.775 -1.102 . . . . 50.0 112.082 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -137.09 170.86 15.39 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 102.401 -3.185 . . . . 25.0 102.401 -171.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -56.12 156.13 5.84 Favored 'General case' 0 C--O 1.193 -1.884 0 O-C-N 125.344 1.653 . . . . 50.0 109.029 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -100.43 25.24 7.88 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 117.137 -3.477 . . . . 25.0 115.134 -141.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.34 -41.49 0.3 Allowed 'General case' 0 C--O 1.266 1.972 0 CA-C-O 118.573 -0.727 . . . . 25.0 112.582 173.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.25 121.71 4.85 Favored Glycine 0 C--O 1.201 -1.964 0 C-N-CA 118.386 -1.864 . . . . 25.0 110.403 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -54.32 -23.44 15.28 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 119.042 2.978 . . . . 25.0 119.042 -165.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -64.01 -15.79 17.61 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 CA-C-O 118.354 -0.831 . . . . 50.0 112.789 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm -37.3 -15.09 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.535 1 N-CA-C 124.284 4.92 . . . . 25.0 124.284 172.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -71.13 -46.87 60.77 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 116.301 -3.999 . . . . 50.0 114.547 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB2' HE22 ' A' ' 33' ' ' GLN . 7.1 pt-20 -145.69 60.57 6.74 Favored Pre-proline 0 C--O 1.2 -1.505 0 CA-C-O 124.646 2.165 . . . . 25.0 112.834 169.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.13 -10.89 28.22 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 117.279 -1.348 . . . . 25.0 113.647 -166.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.496 HE22 ' HB2' ' A' ' 31' ' ' GLU . 2.8 pm0 -78.8 -15.13 58.79 Favored 'General case' 0 C--O 1.189 -2.08 0 C-N-CA 126.925 2.09 . . . . 25.0 111.641 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -122.55 141.87 51.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 113.43 0.9 . . . . 25.0 113.43 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.2 109.13 20.82 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 124.667 2.175 . . . . 50.0 105.234 156.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.86 151.14 25.29 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.402 -2.074 . . . . 25.0 105.402 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.91 170.62 15.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 123.526 1.631 . . . . 25.0 107.956 169.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -136.76 147.29 46.59 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 119.24 -2.163 . . . . 25.0 108.222 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -76.64 135.94 39.15 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 104.654 -2.35 . . . . 25.0 104.654 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.09 164.61 24.07 Favored Glycine 0 C--O 1.202 -1.899 0 O-C-N 118.514 -2.616 . . . . 25.0 114.357 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -143.63 152.85 57.36 Favored Pre-proline 0 C--O 1.193 -1.878 0 O-C-N 119.144 -2.386 . . . . 25.0 116.142 -168.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -68.15 -15.73 10.03 Favored 'Cis proline' 0 C--O 1.272 2.188 0 CA-C-O 114.892 -2.212 . . . . 25.0 117.227 0.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -145.21 19.94 1.57 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 122.239 2.291 . . . . 25.0 116.77 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t 63.34 -171.16 0.17 Allowed 'General case' 0 N--CA 1.529 3.479 0 CA-C-N 113.503 -1.681 . . . . 25.0 111.642 -168.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.18 -68.48 1.64 Allowed Glycine 0 C--O 1.204 -1.774 0 CA-C-O 115.409 -2.884 . . . . 25.0 116.971 -166.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -63.0 170.44 7.5 Favored 'Trans proline' 0 CA--C 1.495 -1.426 1 C-N-CA 128.589 6.192 . . . . 25.0 111.568 148.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.41 68.23 0.13 Allowed 'General case' 0 C--O 1.269 2.095 0 O-C-N 118.195 -2.816 . . . . 25.0 112.56 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -78.07 161.85 27.13 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 125.68 1.592 . . . . 25.0 111.946 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.73 72.98 Favored Glycine 0 C--O 1.2 -1.994 0 CA-C-O 124.503 2.168 . . . . 25.0 116.678 -167.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -69.77 -23.73 63.41 Favored 'General case' 0 CA--C 1.556 1.181 0 O-C-N 119.645 -2.091 . . . . 25.0 109.485 -172.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.486 HG23 HD21 ' A' ' 57' ' ' LEU . 92.9 mt -83.86 -27.62 7.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 103.152 -2.907 . . . . 25.0 103.152 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.45 -26.29 59.95 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 118.39 -2.694 . . . . 25.0 110.35 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -92.2 -0.44 57.42 Favored 'General case' 0 N--CA 1.527 3.4 0 CA-C-O 124.157 1.932 . . . . 25.0 111.635 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 48.62 13.27 0.05 OUTLIER 'General case' 0 CA--C 1.587 2.373 0 CA-C-N 112.096 -2.32 . . . . 25.0 117.198 -156.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.88 -40.09 89.37 Favored Glycine 0 C--N 1.305 -1.181 0 CA-C-O 127.232 3.684 . . . . 25.0 110.31 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.82 9.84 54.52 Favored Glycine 0 C--O 1.185 -2.943 0 CA-C-N 111.114 -2.543 . . . . 25.0 112.347 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.486 HD21 HG23 ' A' ' 51' ' ' ILE . 16.2 mt -116.05 -12.5 11.29 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 126.284 2.945 . . . . 50.0 112.8 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -74.98 -33.53 61.89 Favored 'General case' 0 C--O 1.265 1.877 0 CA-C-O 126.471 3.034 . . . . 50.0 105.456 154.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.5 -17.28 78.96 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-O 124.762 2.312 . . . . 25.0 110.191 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.88 -22.45 75.66 Favored Glycine 0 C--O 1.208 -1.512 0 CA-C-O 124.041 1.912 . . . . 25.0 112.66 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.16 -41.35 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 118.677 -2.661 . . . . 25.0 109.398 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.7 mt -72.21 -26.48 62.06 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 119.971 3.323 . . . . 75.0 119.971 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -66.5 -28.05 68.26 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.61 -1.255 . . . . 50.0 107.61 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -78.77 6.97 7.76 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 123.819 0.699 . . . . 25.0 111.31 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -126.15 39.64 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 104.306 -2.479 . . . . 25.0 104.306 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -154.98 169.44 24.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.264 -1.523 . . . . 25.0 107.544 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.73 -14.63 63.15 Favored 'General case' 0 C--O 1.182 -2.471 0 CA-C-O 124.745 2.212 . . . . 25.0 109.245 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -86.06 20.18 2.38 Favored 'General case' 0 N--CA 1.422 -1.852 0 O-C-N 119.03 -2.294 . . . . 25.0 112.319 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.92 96.91 2.18 Favored 'General case' 0 C--O 1.263 1.802 0 CA-C-O 124.803 2.24 . . . . 25.0 105.589 163.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -44.71 146.0 0.83 Allowed 'General case' 0 C--O 1.275 2.395 1 CA-C-N 106.598 -4.819 . . . . 25.0 109.74 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -79.78 132.34 36.13 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 119.681 -1.887 . . . . 50.0 112.037 -157.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.05 155.83 16.9 Favored 'General case' 0 C--N 1.365 1.256 0 CA-C-N 112.333 -2.212 . . . . 25.0 112.17 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -152.44 141.25 21.03 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.032 -1.467 . . . . 25.0 113.841 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.28 129.9 39.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.78 0 C-N-CA 117.045 -1.862 . . . . 25.0 106.611 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' A' ' 169' ' ' LEU . 26.4 ttt -139.92 157.77 45.15 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 121.177 1.808 . . . . 25.0 107.452 164.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 p -68.02 162.74 23.83 Favored 'General case' 0 CA--C 1.584 2.275 0 O-C-N 117.911 -2.993 . . . . 25.0 109.214 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.95 -156.27 3.38 Favored Glycine 0 C--O 1.209 -1.463 1 O-C-N 115.928 -4.232 . . . . 25.0 113.485 164.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 -173.38 38.02 Favored Glycine 0 C--O 1.192 -2.495 0 O-C-N 121.322 -1.105 . . . . 25.0 111.5 -165.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.62 133.15 51.66 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 120.491 2.145 . . . . 25.0 114.089 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -120.16 133.2 55.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.767 -1.568 . . . . 25.0 106.767 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.1 m -115.54 89.62 3.14 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 120.695 1.589 . . . . 25.0 111.573 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -74.4 117.7 16.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.618 0.767 . . . . 50.0 109.981 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -123.99 145.02 49.47 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.372 -2.084 . . . . 25.0 105.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -127.8 159.24 35.44 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 102.225 -3.25 . . . . 25.0 102.225 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.3 p -134.91 163.1 30.6 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 127.704 3.128 . . . . 25.0 108.245 166.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.36 137.9 52.89 Favored 'General case' 0 N--CA 1.496 1.863 1 N-CA-C 96.768 -5.271 . . . . 50.0 96.768 164.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.4 t -74.51 -20.68 59.89 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 116.031 -2.268 . . . . 25.0 105.713 -165.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.16 157.58 77.68 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 103.038 -2.949 . . . . 25.0 103.038 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.29 143.16 27.86 Favored 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 109.95 -6.233 . . . . 25.0 112.018 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -118.03 152.65 35.11 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.833 -2.284 . . . . 25.0 104.833 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.57 160.54 32.51 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.67 147.05 24.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 127.867 2.467 . . . . 25.0 113.389 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -108.64 -27.94 9.55 Favored 'General case' 0 C--O 1.26 1.617 0 N-CA-C 114.535 1.309 . . . . 25.0 114.535 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -174.43 173.74 2.9 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.054 -2.573 . . . . 25.0 104.054 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -153.24 169.43 23.06 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.982 -0.747 . . . . 25.0 108.982 163.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -145.01 151.79 39.12 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 114.434 -2.698 . . . . 25.0 106.764 -169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.88 147.18 21.22 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 124.737 2.208 . . . . 50.0 112.982 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -132.08 165.09 24.81 Favored 'General case' 1 C--O 1.306 4.059 0 CA-C-N 114.324 -1.307 . . . . 50.0 107.661 -162.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.4 pt -125.94 157.0 36.11 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.676 0 N-CA-C 101.311 -3.589 . . . . 25.0 101.311 161.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 115' ' ' PHE . 34.9 p -76.3 150.15 36.98 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.346 -1.724 . . . . 25.0 106.346 169.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -143.49 76.85 1.54 Allowed 'General case' 0 N--CA 1.423 -1.791 0 O-C-N 120.641 -1.287 . . . . 25.0 108.221 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -56.44 153.45 9.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.11 -1.859 . . . . 25.0 112.851 167.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.73 37.77 22.08 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 116.79 -2.116 . . . . 25.0 109.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -64.5 157.22 27.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 126.598 1.999 . . . . 25.0 110.949 163.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -59.22 133.81 87.92 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 108.221 -1.029 . . . . 25.0 108.221 158.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.33 -36.14 98.9 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 N-CA-C 117.456 2.06 . . . . 25.0 117.456 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.66 -19.8 62.72 Favored 'General case' 0 C--O 1.267 1.994 0 N-CA-C 116.889 2.181 . . . . 75.0 116.889 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -58.16 159.08 11.88 Favored Pre-proline 0 C--O 1.205 -1.27 0 CA-C-N 113.13 -1.85 . . . . 25.0 110.231 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.45 23.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.193 -1.774 2 C-N-CA 127.128 5.219 . . . . 25.0 125.08 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 tp 14.79 -56.87 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.244 1 N-CA-C 125.56 5.393 . . . . 50.0 125.56 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -69.24 -31.54 70.17 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -96.72 -46.5 6.26 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.624 -1.626 . . . . 25.0 110.517 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.79 -3.78 1.75 Allowed 'General case' 0 C--O 1.206 -1.19 0 C-N-CA 118.82 -1.152 . . . . 25.0 113.058 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.7 -26.35 68.34 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 115.471 1.656 . . . . 25.0 115.471 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 29.8 p90 -127.51 153.23 46.59 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.207 -2.146 . . . . 50.0 105.207 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -126.68 130.61 50.74 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 111.877 -2.419 . . . . 25.0 111.258 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.18 111.44 3.43 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 105.508 -2.034 . . . . 50.0 105.508 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.73 -20.24 7.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.444 -1.317 . . . . 25.0 107.444 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.7 166.55 33.39 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.748 -1.22 . . . . 25.0 113.555 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.92 155.36 41.5 Favored 'General case' 0 C--O 1.181 -2.516 0 N-CA-C 104.124 -2.547 . . . . 25.0 104.124 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.3 107.12 17.6 Favored Pre-proline 0 C--O 1.271 2.213 0 N-CA-C 106.828 -1.545 . . . . 50.0 106.828 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.33 162.05 28.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 N-CA-C 107.553 -1.749 . . . . 25.0 107.553 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -139.66 63.01 1.5 Allowed 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 119.544 -0.862 . . . . 25.0 110.542 -170.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.15 -16.9 0.83 Allowed 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.533 1.679 . . . . 50.0 115.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -164.75 21.58 0.14 Allowed Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 125.412 1.482 . . . . 25.0 116.681 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.63 162.06 73.35 Favored Pre-proline 0 CA--C 1.556 1.201 0 O-C-N 124.88 0.988 . . . . 25.0 113.437 -174.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.29 -170.01 0.53 Allowed 'Trans proline' 0 C--O 1.264 1.808 0 CA-C-O 117.822 -0.991 . . . . 25.0 113.987 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.42 4.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 1 N-CA-C 122.027 4.084 . . . . 25.0 122.027 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 p -57.66 -17.6 15.73 Favored 'General case' 0 C--O 1.187 -2.224 0 CA-C-N 115.921 -0.582 . . . . 25.0 110.284 161.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -63.9 -16.71 62.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.183 0.809 . . . . 25.0 113.183 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -60.72 129.83 43.46 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 117.821 -1.085 . . . . 25.0 109.471 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.49 -5.01 17.06 Favored 'General case' 0 C--O 1.283 2.86 0 N-CA-C 120.357 3.465 . . . . 75.0 120.357 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.4 t -86.51 127.18 34.85 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 126.039 1.736 . . . . 25.0 109.141 160.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -134.67 130.13 35.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 118.921 2.934 . . . . 25.0 118.921 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -92.07 129.22 38.07 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.174 -1.375 . . . . 25.0 113.573 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.5 mt -121.09 124.03 71.29 Favored 'Isoleucine or valine' 0 C--O 1.271 2.194 0 N-CA-C 105.605 -1.998 . . . . 25.0 105.605 169.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -75.84 137.09 40.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.003 -2.221 . . . . 50.0 105.003 165.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -115.28 129.78 24.81 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 101.763 -3.421 . . . . 25.0 101.763 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.74 140.63 68.58 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 116.372 -1.952 . . . . 25.0 109.415 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -108.66 2.92 22.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.31 -23.71 32.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.517 2.043 . . . . 50.0 116.517 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -143.49 155.1 44.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 114.768 -2.539 . . . . 25.0 107.512 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.5 pt? -75.22 164.56 26.34 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 125.808 1.943 . . . . 50.0 109.605 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 175.81 135.28 2.09 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 108.12 -1.992 . . . . 25.0 108.12 170.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -115.3 148.53 39.1 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 124.973 1.309 . . . . 50.0 111.396 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -161.04 161.88 31.52 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 116.569 -1.681 . . . . 25.0 107.471 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.9 t -91.01 158.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 101.664 -3.458 . . . . 50.0 101.664 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.77 135.78 49.97 Favored 'Isoleucine or valine' 0 C--O 1.28 2.671 1 N-CA-C 98.048 -4.797 . . . . 25.0 98.048 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.26 148.2 48.77 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 103.749 -2.685 . . . . 50.0 103.749 168.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.09 153.0 41.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.588 -0.695 . . . . 25.0 110.718 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.9 140.64 46.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.625 0 C-N-CA 123.067 0.547 . . . . 50.0 111.304 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.19 133.76 45.83 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.788 1.235 . . . . 25.0 112.574 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.96 133.29 55.6 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.338 1.055 . . . . 25.0 112.663 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.9 t -131.64 111.87 19.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 102.119 -3.289 . . . . 50.0 102.119 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.62 -24.86 53.37 Favored 'General case' 0 C--O 1.17 -3.091 0 CA-C-O 117.753 -1.118 . . . . 25.0 108.288 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.98 -19.27 65.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 124.477 2.084 . . . . 25.0 115.858 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.7 p -118.82 150.83 39.16 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.151 -1.84 . . . . 25.0 114.202 -173.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -78.55 -25.55 45.47 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.344 -1.753 . . . . 25.0 109.974 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -63.33 152.22 38.55 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 118.611 -1.236 . . . . 25.0 114.133 163.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.88 158.34 44.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 105.588 -2.005 . . . . 25.0 105.588 174.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -131.36 146.06 52.11 Favored 'General case' 0 C--O 1.29 3.206 0 O-C-N 118.618 -2.551 . . . . 50.0 114.78 -170.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.01 170.54 15.83 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 102.466 -3.161 . . . . 50.0 102.466 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -164.34 167.36 19.86 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.2 p -145.32 134.99 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.935 -1.135 . . . . 75.0 107.935 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -141.85 146.26 23.14 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 101.972 -3.344 . . . . 25.0 101.972 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -122.17 152.18 40.21 Favored 'General case' 0 C--O 1.264 1.827 0 CA-C-N 121.072 1.76 . . . . 25.0 108.002 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.66 153.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.76 0 N-CA-C 110.185 -0.302 . . . . 50.0 110.185 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -131.79 94.52 3.52 Favored 'General case' 0 C--O 1.264 1.857 0 N-CA-C 101.401 -3.555 . . . . 25.0 101.401 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 75' ' ' MET . 53.3 mt -102.49 111.77 24.22 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.34 -1.475 . . . . 50.0 114.446 -170.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 33.5 m -128.11 173.71 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.964 2.579 . . . . 50.0 117.964 -153.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.37 147.13 23.65 Favored 'General case' 0 CA--C 1.494 -1.203 1 N-CA-C 99.541 -4.244 . . . . 25.0 99.541 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 C--O 1.269 2.088 0 N-CA-C 116.036 1.865 . . . . 25.0 116.036 169.206 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 3.0 p80 . . . . . 0 N--CA 1.534 3.748 0 CA-C-O 123.846 1.784 . . . . 25.0 113.33 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 33' ' ' GLN . . . -144.21 -32.44 0.09 OUTLIER Glycine 0 C--O 1.27 2.384 0 C-N-CA 127.632 2.539 . . . . 25.0 111.052 169.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.08 140.13 53.34 Favored 'General case' 0 CA--C 1.482 -1.643 0 C-N-CA 125.637 1.575 . . . . 50.0 109.8 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.5 mt -103.76 122.04 55.96 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 N-CA-C 100.703 -3.814 . . . . 25.0 100.703 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -92.63 -40.56 10.68 Favored 'General case' 0 C--O 1.182 -2.486 0 CA-C-N 119.14 0.882 . . . . 25.0 112.66 -173.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -144.82 154.41 55.35 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 115.887 -2.006 . . . . 25.0 106.634 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.65 136.45 45.14 Favored 'Cis proline' 0 N--CA 1.476 0.478 0 CA-C-N 121.909 1.718 . . . . 25.0 109.059 0.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.74 -162.44 38.29 Favored Glycine 0 C--O 1.214 -1.113 0 N-CA-C 120.082 2.793 . . . . 25.0 120.082 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -114.51 116.0 28.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.487 1.644 . . . . 25.0 111.282 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -73.11 -23.24 60.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.123 0.874 . . . . 25.0 109.588 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.47 72.63 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.234 1.814 . . . . 25.0 106.297 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.38 -37.95 68.22 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 124.216 0.947 . . . . 25.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -94.66 -32.2 13.49 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.803 0.689 . . . . 75.0 110.638 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 11.0 t -74.21 -23.31 59.17 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 119.665 -1.897 . . . . 25.0 115.96 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.442 ' HB2' ' H ' ' A' ' 17' ' ' ALA . 72.3 p -94.47 155.94 16.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 123.876 1.798 . . . . 25.0 108.244 -164.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.25 61.8 mt-10 -89.76 -13.12 37.43 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.497 -2.038 . . . . 25.0 105.497 166.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' H ' ' HB2' ' A' ' 15' ' ' SER . . . -64.92 -36.88 85.79 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -174.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -56.28 -49.08 75.27 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 115.602 1.704 . . . . 50.0 115.602 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.78 -0.96 0.64 Allowed Glycine 0 C--N 1.308 -0.993 0 N-CA-C 118.743 2.257 . . . . 25.0 118.743 -167.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.4 t80 59.26 -46.79 0.07 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 120.016 3.339 . . . . 50.0 120.016 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.06 -19.36 61.19 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 123.731 2.969 . . . . 50.0 115.551 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -149.27 175.56 11.3 Favored 'General case' 0 CA--C 1.499 -0.994 1 N-CA-C 100.064 -4.05 . . . . 25.0 100.064 -171.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.81 170.77 18.93 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 103.132 -2.914 . . . . 50.0 103.132 170.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -147.38 70.9 1.19 Allowed 'General case' 0 C--N 1.319 -0.726 0 O-C-N 118.698 -2.501 . . . . 25.0 108.598 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -131.91 -19.05 2.62 Favored 'General case' 0 C--O 1.193 -1.88 0 CA-C-N 112.208 -2.269 . . . . 25.0 113.997 -175.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.76 -107.52 1.32 Allowed Glycine 0 C--O 1.211 -1.342 0 CA-C-O 123.163 1.424 . . . . 25.0 115.091 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -96.27 -29.08 14.21 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 112.483 -1.859 . . . . 25.0 111.309 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.49 -28.57 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 CA-C-N 115.457 -0.792 . . . . 50.0 111.668 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.3 ptt? -62.61 -23.09 66.86 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 114.601 1.334 . . . . 25.0 114.601 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -88.15 -37.83 15.85 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.291 -1.364 . . . . 50.0 111.319 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.51 48.02 0.25 Allowed Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 115.978 1.844 . . . . 25.0 115.978 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.16 -19.49 34.14 Favored 'Trans proline' 0 CA--C 1.569 2.261 1 C-N-CA 110.915 -5.59 . . . . 25.0 116.621 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.459 ' HB3' ' HA2' ' A' ' 2' ' ' GLY 0.266 12.2 pt20 -109.15 -20.88 12.83 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.846 1.203 . . . . 25.0 113.911 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.1 p -96.58 22.45 8.02 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.297 1.046 . . . . 25.0 113.755 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.97 44.47 0.03 OUTLIER 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.669 1.988 . . . . 50.0 115.485 -172.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 161' ' ' PHE . 47.0 mt-10 -71.77 156.63 39.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 120.766 3.617 . . . . 25.0 120.766 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.72 58.3 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 117.651 -1.166 . . . . 25.0 113.976 170.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 31.7 tttm -151.71 -164.23 1.93 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.831 3.014 . . . . 25.0 109.435 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.544 ' H ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 mttt -65.21 159.38 23.78 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 113.508 -1.678 . . . . 25.0 109.862 -170.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.38 169.97 39.38 Favored Glycine 0 C--N 1.359 1.819 0 CA-C-O 118.41 -1.217 . . . . 25.0 116.082 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -115.02 97.14 47.17 Favored Pre-proline 0 CA--C 1.583 2.247 0 O-C-N 125.962 1.625 . . . . 25.0 114.643 -176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.4 177.33 33.47 Favored 'Cis proline' 0 CA--C 1.547 1.129 0 C-N-CA 132.783 2.41 . . . . 25.0 109.429 -8.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -75.55 -29.97 59.57 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 118.608 2.818 . . . . 25.0 118.608 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t 56.4 -60.65 0.02 OUTLIER 'General case' 0 C--O 1.175 -2.83 0 C-N-CA 131.488 3.915 . . . . 25.0 118.039 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.65 176.53 35.56 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-O 114.221 -3.544 . . . . 25.0 113.96 -176.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.08 168.8 18.06 Favored 'Trans proline' 0 C--O 1.258 1.492 1 C-N-CA 129.629 6.886 . . . . 25.0 109.679 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.69 136.34 57.66 Favored 'General case' 0 C--O 1.203 -1.392 0 N-CA-C 107.735 -1.209 . . . . 25.0 107.735 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -82.01 130.14 34.99 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 119.077 -2.264 . . . . 25.0 107.692 -166.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.75 3.82 6.31 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 113.557 -3.913 . . . . 25.0 115.571 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 42.08 39.4 1.34 Allowed 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.143 1.972 . . . . 25.0 108.899 -168.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.4 mt -72.5 -41.42 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 119.262 -2.149 . . . . 25.0 110.605 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.7 81.79 Favored 'General case' 0 C--O 1.26 1.641 0 N-CA-C 114.425 1.268 . . . . 25.0 114.425 -168.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.0 p -87.67 -15.94 35.77 Favored 'General case' 0 C--O 1.263 1.816 0 O-C-N 123.887 0.742 . . . . 25.0 109.265 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.06 -16.62 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 121.571 3.915 . . . . 25.0 121.571 165.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.08 -25.23 76.08 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-O 122.186 0.881 . . . . 25.0 111.574 172.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.67 -11.75 66.15 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 113.746 -1.227 . . . . 25.0 115.916 166.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.7 mt -85.01 -20.92 29.76 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 119.084 -2.421 . . . . 50.0 113.303 172.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 -35.79 32.92 Favored 'General case' 0 CA--C 1.586 2.337 0 N-CA-C 101.343 -3.577 . . . . 50.0 101.343 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.56 63.74 Favored Glycine 0 C--O 1.268 2.245 0 CA-C-N 114.014 -1.448 . . . . 25.0 113.07 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.66 77.56 Favored Glycine 0 C--O 1.201 -1.914 0 CA-C-N 119.058 1.429 . . . . 25.0 110.938 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -65.55 -43.57 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 106.885 -1.524 . . . . 25.0 106.885 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.12 -24.21 59.41 Favored 'General case' 0 C--O 1.172 -3.014 0 N-CA-C 107.686 -1.227 . . . . 75.0 107.686 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.69 -21.39 60.26 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 123.777 1.751 . . . . 50.0 111.171 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -103.95 16.35 26.5 Favored 'General case' 0 C--O 1.183 -2.441 0 O-C-N 118.213 -2.804 . . . . 25.0 108.37 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -128.95 49.73 2.2 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 102.303 -3.221 . . . . 25.0 102.303 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -152.5 -179.67 7.79 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 100.525 -3.88 . . . . 25.0 100.525 -162.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -66.8 -17.61 64.96 Favored 'General case' 0 CA--C 1.592 2.587 0 C-N-CA 117.651 -1.62 . . . . 25.0 114.413 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -94.68 48.77 1.22 Allowed 'General case' 0 CA--C 1.556 1.21 0 O-C-N 120.203 -1.561 . . . . 25.0 108.317 165.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -85.32 98.98 10.84 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 100.191 -4.003 . . . . 25.0 100.191 156.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -65.6 163.06 16.98 Favored 'General case' 0 C--O 1.256 1.43 1 CA-C-N 106.583 -4.826 . . . . 25.0 110.703 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -59.52 146.29 41.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 120.016 1.28 . . . . 50.0 112.366 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -129.33 154.4 46.92 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -139.77 150.72 45.09 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 118.282 -0.866 . . . . 25.0 112.038 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.98 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.127 0 CA-C-O 123.789 1.757 . . . . 25.0 110.561 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 30.6 mtm -147.0 172.0 14.39 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 120.147 -1.596 . . . . 25.0 113.493 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.1 p -71.53 165.21 24.35 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 105.071 -2.196 . . . . 25.0 105.071 168.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.06 176.62 53.11 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 106.378 -2.689 . . . . 25.0 106.378 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.94 -170.15 20.17 Favored Glycine 0 C--O 1.266 2.113 0 CA-C-N 120.342 2.071 . . . . 25.0 113.815 -170.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -74.68 137.39 42.11 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 112.922 -1.639 . . . . 25.0 109.852 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -127.62 159.1 35.69 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.719 1.208 . . . . 25.0 111.158 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.3 m -117.89 142.04 47.77 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 106.31 -1.737 . . . . 25.0 106.31 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -125.96 114.72 18.86 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 102.687 -3.079 . . . . 50.0 102.687 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 m -129.87 117.68 20.54 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.706 -1.588 . . . . 25.0 112.524 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . 0.308 0.8 OUTLIER -111.51 136.61 50.45 Favored 'General case' 0 C--O 1.3 3.717 0 N-CA-C 101.353 -3.573 . . . . 25.0 101.353 171.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -148.88 160.29 43.39 Favored 'General case' 0 C--O 1.181 -2.54 0 O-C-N 125.59 1.806 . . . . 25.0 108.887 -167.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.04 170.32 16.2 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.852 -1.067 . . . . 50.0 109.288 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.9 t -64.76 -25.42 67.92 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.907 -1.044 . . . . 25.0 111.45 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.34 153.23 74.54 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 125.096 1.497 . . . . 25.0 111.129 -171.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.99 169.39 20.61 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 117.331 -1.313 . . . . 25.0 112.53 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.258 3.2 m80 -127.09 161.51 28.26 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 103.81 -2.663 . . . . 25.0 103.81 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -81.86 57.93 3.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.091 0.956 . . . . 25.0 109.642 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 154' ' ' VAL . 4.5 m -66.98 144.5 56.17 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 127.022 2.702 . . . . 25.0 108.878 -178.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -117.37 -32.05 5.07 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 126.478 2.361 . . . . 25.0 109.822 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 50.3 tt0 -165.59 154.68 12.02 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 124.755 1.222 . . . . 25.0 109.471 -170.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -141.74 164.56 29.88 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 145.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.33 36.4 m-70 -131.9 145.06 51.3 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 126.588 1.955 . . . . 25.0 107.776 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -139.54 148.34 42.46 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-O 122.713 1.244 . . . . 50.0 111.286 170.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.46 162.05 30.05 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 109.679 -3.418 . . . . 50.0 111.042 -164.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.2 151.05 33.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 102.25 -3.241 . . . . 25.0 102.25 176.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 114' ' ' ASP . 71.6 m -82.32 113.88 20.41 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 125.883 1.989 . . . . 25.0 109.893 157.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -83.38 94.33 7.94 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-N 120.209 1.368 . . . . 25.0 109.57 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -61.76 161.19 10.51 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 124.671 1.188 . . . . 25.0 111.923 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.42 28.15 Favored Glycine 0 CA--C 1.497 -1.048 0 C-N-CA 119.0 -1.571 . . . . 25.0 116.504 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.21 159.89 32.18 Favored 'General case' 0 CA--C 1.581 2.145 0 C-N-CA 119.592 -0.843 . . . . 25.0 111.426 -171.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -71.31 117.1 53.74 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 102.377 -3.194 . . . . 25.0 102.377 149.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.81 -22.22 37.05 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 125.282 3.988 . . . . 25.0 117.525 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -75.08 -13.84 60.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.387 -1.446 . . . . 75.0 109.934 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.253 95.9 mttt -117.11 165.3 15.84 Favored Pre-proline 0 C--O 1.2 -1.504 2 N-CA-C 99.202 -4.37 . . . . 25.0 99.202 -171.75 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 3.38 14.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 2 C-N-CA 135.44 10.76 . . . . 25.0 127.967 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.1 tt -46.66 -43.53 17.69 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-O 115.616 -2.135 . . . . 50.0 113.768 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -75.39 -2.58 29.19 Favored 'General case' 0 C--O 1.169 -3.163 0 O-C-N 125.195 1.56 . . . . 25.0 113.207 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -121.94 -51.85 2.0 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 122.799 1.285 . . . . 25.0 112.155 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.55 -26.53 3.57 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 112.653 -2.067 . . . . 25.0 115.095 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.47 ' HA ' HG23 ' A' ' 100' ' ' THR . 20.2 t0 -80.35 -7.78 59.22 Favored 'General case' 0 C--O 1.28 2.676 0 CA-C-N 113.489 -1.687 . . . . 25.0 111.04 -176.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -141.64 47.56 1.66 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 118.236 -2.79 . . . . 50.0 106.631 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.8 122.45 29.15 Favored 'General case' 0 CA--C 1.558 1.286 0 O-C-N 118.143 -2.848 . . . . 25.0 111.5 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.6 tp -60.72 125.96 25.64 Favored 'General case' 0 C--O 1.266 1.94 0 N-CA-C 114.174 1.176 . . . . 50.0 114.174 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.7 tt -108.21 -22.4 5.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 116.799 -1.572 . . . . 25.0 106.999 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.12 -179.43 44.74 Favored Glycine 0 C--N 1.371 2.488 0 C-N-CA 118.746 -1.692 . . . . 25.0 116.193 161.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -146.59 153.99 40.98 Favored 'General case' 0 C--O 1.286 3.023 0 CA-C-O 123.279 1.514 . . . . 25.0 107.333 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.2 t -132.46 86.49 45.14 Favored Pre-proline 0 CA--C 1.62 3.648 0 N-CA-C 103.608 -2.738 . . . . 50.0 103.608 -173.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 71.9 Cg_endo -71.18 154.33 61.98 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 115.234 -2.711 . . . . 25.0 112.259 171.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -144.59 96.44 2.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.37 1.618 . . . . 25.0 115.37 -157.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.34 -7.25 16.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.57 -1.65 . . . . 50.0 114.722 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.41 -171.1 42.1 Favored Glycine 0 C--O 1.283 3.194 1 N-CA-C 101.969 -4.452 . . . . 25.0 101.969 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.4 m -126.42 75.11 73.89 Favored Pre-proline 0 N--CA 1.508 2.439 0 N-CA-C 115.193 1.553 . . . . 25.0 115.193 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.3 170.19 17.81 Favored 'Trans proline' 0 C--O 1.213 -0.759 1 C-N-CA 111.984 -4.877 . . . . 25.0 106.208 150.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.76 67.02 Favored 'General case' 0 CA--C 1.573 1.842 0 O-C-N 119.373 -2.079 . . . . 25.0 115.567 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 95.5 p -68.02 -22.89 64.96 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 120.93 1.696 . . . . 25.0 114.407 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -111.97 19.59 17.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 127.039 2.712 . . . . 25.0 111.974 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -55.59 148.82 15.06 Favored 'General case' 0 N--CA 1.513 2.681 0 CA-C-O 122.82 1.295 . . . . 25.0 108.404 168.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tp -64.65 -36.4 84.14 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 111.483 -2.599 . . . . 75.0 110.795 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.7 t -91.81 153.76 19.36 Favored 'General case' 0 C--O 1.285 2.946 0 N-CA-C 104.12 -2.548 . . . . 25.0 104.12 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -147.41 164.63 32.72 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 112.82 0.674 . . . . 25.0 112.82 170.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -113.59 148.9 35.34 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 104.471 -2.418 . . . . 25.0 104.471 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -133.03 124.5 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 105.645 -1.983 . . . . 25.0 105.645 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . 0.254 70.0 t80 -90.91 132.75 35.74 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.124 -2.86 . . . . 50.0 109.039 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.6 mm -131.63 124.4 19.93 Favored Pre-proline 0 C--O 1.268 2.059 0 N-CA-C 103.254 -2.869 . . . . 25.0 103.254 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.19 165.89 29.96 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 114.51 -3.193 . . . . 25.0 116.697 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.53 39.35 1.06 Allowed 'General case' 0 C--O 1.295 3.46 0 CA-C-O 125.853 2.74 . . . . 25.0 111.27 175.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.86 -20.17 59.85 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 115.64 1.719 . . . . 50.0 115.64 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -148.92 170.32 18.56 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.63 139.46 38.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 101.631 -3.47 . . . . 50.0 101.631 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.13 176.67 20.19 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 118.328 -1.891 . . . . 25.0 115.47 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -81.86 146.25 29.95 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 117.985 2.587 . . . . 50.0 117.985 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -138.93 113.75 9.21 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.916 2.01 . . . . 25.0 111.138 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.76 130.87 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 116.176 -1.869 . . . . 50.0 108.625 -172.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.48 132.15 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 124.031 1.872 . . . . 25.0 109.907 167.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HG ' HG23 ' A' ' 164' ' ' VAL . 3.1 mp -118.04 138.59 52.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 102.868 -3.012 . . . . 50.0 102.868 -175.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.39 144.61 29.85 Favored 'General case' 0 C--O 1.29 3.187 0 O-C-N 119.826 -1.796 . . . . 25.0 111.835 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 79.8 t -124.67 135.14 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 102.728 -3.064 . . . . 50.0 102.728 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -135.26 114.83 12.66 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 125.428 1.705 . . . . 25.0 112.079 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -112.18 128.84 56.35 Favored 'General case' 0 C--O 1.284 2.885 0 O-C-N 123.872 0.732 . . . . 25.0 111.687 -162.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 79.6 t -121.7 119.07 57.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 115.823 -2.037 . . . . 50.0 107.319 -169.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.71 -13.36 31.55 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 119.719 3.229 . . . . 25.0 119.719 -166.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -76.36 -18.65 58.78 Favored 'General case' 0 C--O 1.253 1.263 0 O-C-N 120.268 -1.52 . . . . 25.0 112.348 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -112.25 153.4 27.19 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 119.951 -1.718 . . . . 25.0 111.751 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -78.11 -28.2 48.56 Favored 'General case' 0 C--O 1.28 2.673 0 N-CA-C 103.161 -2.904 . . . . 25.0 103.161 171.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.08 179.34 3.34 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 119.177 -2.202 . . . . 25.0 113.23 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.57 151.56 36.49 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 125.84 1.656 . . . . 25.0 108.584 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 84.2 m-85 -95.25 150.22 20.47 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 126.023 2.077 . . . . 50.0 111.778 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -133.56 130.7 38.79 Favored 'General case' 0 C--O 1.284 2.872 0 CA-C-N 114.741 -1.118 . . . . 50.0 108.205 -169.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.0 156.87 45.45 Favored 'General case' 0 C--O 1.267 1.988 0 CA-C-N 119.65 1.114 . . . . 25.0 112.22 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.412 HG23 ' HG ' ' A' ' 149' ' ' LEU . 6.6 p -146.8 127.94 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 107.631 -1.248 . . . . 75.0 107.631 -171.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.58 137.04 57.82 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 N-CA-C 107.465 -1.309 . . . . 25.0 107.465 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.67 126.95 50.18 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 123.648 0.593 . . . . 25.0 110.941 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.36 132.99 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 122.914 1.34 . . . . 50.0 111.697 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -96.23 113.42 25.01 Favored 'General case' 0 C--O 1.204 -1.339 0 N-CA-C 104.625 -2.361 . . . . 25.0 104.625 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.36 110.71 21.6 Favored 'General case' 0 CA--C 1.476 -1.896 0 CA-C-N 112.807 -1.997 . . . . 50.0 110.202 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.7 m -132.93 154.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-O 124.564 2.126 . . . . 50.0 112.615 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -59.11 126.38 27.46 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.0 pttp . . . . . 0 C--O 1.263 1.801 0 CA-C-O 116.061 -1.924 . . . . 25.0 108.53 179.045 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 118.996 -0.526 . . . . 25.0 111.217 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.65 173.64 42.03 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 120.482 1.492 . . . . 25.0 115.341 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -129.21 135.73 49.2 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 125.165 1.386 . . . . 50.0 112.746 -156.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.5 mt -89.57 121.53 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 119.229 -2.169 . . . . 25.0 111.151 -171.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -101.22 16.48 25.37 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.862 1.265 . . . . 25.0 110.245 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 64.87 166.27 0.11 Allowed Pre-proline 0 CA--C 1.594 2.652 0 C-N-CA 128.195 2.598 . . . . 25.0 111.14 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.55 141.3 45.07 Favored 'Cis proline' 0 C--O 1.204 -1.225 0 C-N-CA 132.621 2.342 . . . . 25.0 111.709 13.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.94 91.53 1.61 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 117.272 1.669 . . . . 25.0 117.272 168.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 t -75.63 144.44 41.71 Favored 'General case' 0 C--O 1.275 2.423 0 CA-C-O 123.183 1.468 . . . . 25.0 110.921 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -107.23 -22.93 12.44 Favored 'General case' 0 CA--C 1.581 2.138 0 CA-C-N 113.721 -1.581 . . . . 25.0 109.724 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.39 89.71 Favored 'General case' 0 C--O 1.264 1.856 0 CA-C-O 117.398 -1.287 . . . . 25.0 108.792 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -29.14 70.57 Favored 'General case' 0 C--O 1.279 2.656 0 O-C-N 125.764 1.915 . . . . 25.0 115.389 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt -80.98 -21.55 40.22 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 120.433 -1.417 . . . . 75.0 109.575 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -11.09 59.68 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 116.334 1.976 . . . . 25.0 116.334 174.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.8 t -65.6 165.7 11.92 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 114.913 1.449 . . . . 25.0 114.913 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.18 -24.51 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 1 N-CA-C 124.498 4.999 . . . . 25.0 124.498 -169.343 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.63 -20.19 66.21 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.705 1.602 . . . . 25.0 110.404 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -52.78 -18.91 2.1 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 117.685 2.476 . . . . 50.0 117.685 165.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.43 7.65 0.21 Allowed Glycine 0 C--O 1.211 -1.3 0 N-CA-C 122.888 3.915 . . . . 25.0 122.888 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 49.86 0.47 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 131.047 3.739 . . . . 50.0 117.584 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.6 mt -94.6 -12.14 28.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 118.251 -2.78 . . . . 50.0 116.156 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -132.77 -171.98 2.8 Favored 'General case' 0 C--O 1.182 -2.479 0 O-C-N 121.782 -0.573 . . . . 25.0 109.671 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mp -65.57 159.68 24.11 Favored 'General case' 0 C--O 1.245 0.855 0 O-C-N 120.541 -1.349 . . . . 50.0 114.095 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -78.56 2.38 19.42 Favored 'General case' 0 C--O 1.191 -1.991 0 C-N-CA 125.909 1.683 . . . . 25.0 112.274 -169.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -147.93 -38.81 0.18 Allowed 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 119.355 -0.938 . . . . 25.0 111.083 138.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.64 131.0 5.68 Favored Glycine 0 C--O 1.267 2.207 0 N-CA-C 106.058 -2.817 . . . . 25.0 106.058 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 m -52.05 -12.33 0.22 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.864 3.283 . . . . 25.0 119.864 -174.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.94 -4.85 6.24 Favored 'Isoleucine or valine' 0 C--O 1.256 1.396 0 O-C-N 118.553 -2.592 . . . . 50.0 112.116 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.9 ptm -55.48 -10.07 0.58 Allowed 'General case' 0 C--O 1.257 1.452 0 N-CA-C 115.62 1.711 . . . . 25.0 115.62 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -64.58 -38.16 90.03 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.653 2.094 . . . . 50.0 116.653 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -147.41 64.26 8.54 Favored Pre-proline 0 C--O 1.262 1.76 0 CA-C-O 118.353 -0.832 . . . . 25.0 109.558 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 -21.67 12.96 Favored 'Trans proline' 0 N--CA 1.486 1.063 1 C-N-CA 110.775 -5.683 . . . . 25.0 117.537 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -72.48 -20.75 61.32 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 114.485 -2.674 . . . . 25.0 112.698 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.7 t -79.54 112.7 17.04 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 124.802 2.239 . . . . 25.0 109.615 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 mt -106.89 91.41 3.65 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 109.139 -3.664 . . . . 50.0 104.14 163.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.04 161.72 28.4 Favored 'General case' 0 CA--C 1.457 -2.618 0 C-N-CA 118.074 -1.45 . . . . 25.0 112.732 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.15 166.32 25.01 Favored 'General case' 0 C--O 1.187 -2.201 0 N-CA-C 102.674 -3.084 . . . . 25.0 102.674 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -130.12 140.49 50.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -73.09 170.05 15.73 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.098 0.874 . . . . 25.0 109.296 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.51 168.2 40.11 Favored Glycine 0 CA--C 1.557 2.712 0 CA-C-O 122.895 1.275 . . . . 25.0 113.367 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.75 167.43 10.17 Favored Pre-proline 0 C--O 1.26 1.632 0 N-CA-C 103.399 -2.815 . . . . 25.0 103.399 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.34 -56.75 0.14 OUTLIER 'Cis proline' 0 C--O 1.199 -1.429 0 C-N-CA 130.449 1.437 . . . . 25.0 112.173 -1.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.41 ' H ' ' H ' ' A' ' 44' ' ' SER . 14.1 p80 -147.81 -31.76 0.29 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 124.041 1.877 . . . . 25.0 111.336 132.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.41 ' H ' ' H ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER 68.11 -53.62 0.52 Allowed 'General case' 0 C--O 1.274 2.355 0 N-CA-C 118.239 2.681 . . . . 25.0 118.239 -174.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.76 -157.5 4.77 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 105.736 -2.946 . . . . 25.0 105.736 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.33 170.68 12.93 Favored 'Trans proline' 0 C--N 1.331 -0.357 0 O-C-N 123.935 1.492 . . . . 25.0 109.926 -172.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.85 109.5 0.58 Allowed 'General case' 0 C--O 1.179 -2.634 0 N-CA-C 114.541 1.311 . . . . 25.0 114.541 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -119.18 170.29 9.21 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 118.24 -2.788 . . . . 25.0 108.796 -174.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.7 -5.64 77.53 Favored Glycine 0 C--O 1.268 2.269 0 CA-C-N 112.126 -2.306 . . . . 25.0 115.296 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -87.72 -28.07 21.99 Favored 'General case' 0 N--CA 1.414 -2.227 0 O-C-N 125.249 1.205 . . . . 25.0 107.858 -169.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.2 mt -73.46 -32.2 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.646 0 CA-C-O 116.856 -1.545 . . . . 25.0 108.492 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.7 -24.78 67.07 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 116.838 2.162 . . . . 25.0 116.838 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.4 p -100.19 5.86 44.76 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 124.291 0.994 . . . . 25.0 109.68 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.98 14.99 0.22 Allowed 'General case' 0 C--O 1.182 -2.457 0 C-N-CA 128.647 2.779 . . . . 25.0 117.235 -167.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.94 -34.79 90.89 Favored Glycine 0 C--O 1.257 1.591 0 O-C-N 120.38 -1.45 . . . . 25.0 109.606 169.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.87 -12.88 68.54 Favored Glycine 0 C--O 1.253 1.34 0 CA-C-O 116.458 -2.301 . . . . 25.0 112.081 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . 0.273 59.0 mt -110.23 -12.46 14.46 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.533 1.666 . . . . 50.0 112.677 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -82.96 -40.13 20.45 Favored 'General case' 0 C--N 1.301 -1.534 1 N-CA-C 99.359 -4.311 . . . . 50.0 99.359 171.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.77 -16.41 80.34 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 126.661 3.367 . . . . 25.0 110.522 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.97 -23.33 72.75 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 110.116 -3.042 . . . . 25.0 112.323 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.8 -39.19 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 122.136 2.968 . . . . 25.0 109.217 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -73.83 -29.64 62.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 116.667 2.099 . . . . 75.0 116.667 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -66.97 -28.03 67.94 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 126.881 2.073 . . . . 50.0 110.705 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -91.56 39.3 1.0 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.722 -1.127 . . . . 25.0 110.924 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -136.31 59.68 1.7 Allowed 'General case' 0 C--N 1.281 -2.37 0 O-C-N 125.667 1.854 . . . . 25.0 107.335 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.9 p -169.21 168.28 9.89 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 113.255 -1.793 . . . . 25.0 106.756 -156.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.61 -20.45 60.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 126.869 2.605 . . . . 25.0 109.011 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -84.46 8.74 15.4 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 126.852 2.595 . . . . 25.0 115.614 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -68.79 86.54 0.33 Allowed 'General case' 0 C--O 1.271 2.209 0 CA-C-O 124.721 2.2 . . . . 25.0 107.247 163.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -40.09 148.44 0.08 Allowed 'General case' 0 N--CA 1.426 -1.648 1 CA-C-N 108.242 -4.072 . . . . 25.0 117.242 169.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -74.47 138.95 43.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 123.978 1.847 . . . . 50.0 111.799 -166.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -77.23 154.29 33.17 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 112.207 -2.269 . . . . 25.0 107.798 157.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -132.83 126.5 32.43 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.545 -3.872 . . . . 25.0 100.545 157.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -97.69 116.57 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 105.43 -2.063 . . . . 25.0 105.43 -166.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.9 ttt -132.88 154.27 50.54 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 119.788 -1.82 . . . . 25.0 109.838 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 p -74.79 158.19 33.9 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.66 -177.63 18.95 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 116.221 1.248 . . . . 25.0 116.221 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.61 -167.11 23.68 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 119.24 -1.457 . . . . 25.0 114.788 -174.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -71.24 135.76 47.64 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.997 -1.296 . . . . 25.0 108.764 163.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -134.63 140.65 46.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-O 116.122 -1.894 . . . . 25.0 112.114 -166.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.9 m -124.38 131.74 53.51 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.874 1.358 . . . . 25.0 111.264 171.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -112.67 124.74 53.23 Favored 'General case' 0 CA--C 1.605 3.06 1 N-CA-C 100.133 -4.025 . . . . 50.0 100.133 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.2 m -124.89 129.54 50.59 Favored 'General case' 0 C--O 1.273 2.297 0 CA-C-O 126.24 2.924 . . . . 25.0 111.864 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -123.39 155.84 36.6 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 111.35 -2.659 . . . . 25.0 108.38 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 45.4 p -125.02 143.84 50.7 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 104.382 -2.451 . . . . 25.0 104.382 170.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.36 150.26 28.3 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 104.537 -2.394 . . . . 50.0 104.537 165.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.5 t -76.07 -38.28 57.25 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 124.456 2.074 . . . . 25.0 110.229 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.79 137.69 11.29 Favored Pre-proline 0 N--CA 1.482 1.129 1 N-CA-C 96.18 -5.489 . . . . 25.0 96.18 165.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.06 172.47 16.3 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 CA-C-N 120.9 1.357 . . . . 25.0 112.902 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.344 30.9 m-70 -93.87 159.18 15.3 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 118.029 -2.919 . . . . 25.0 104.726 167.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -60.64 125.8 25.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 117.311 2.337 . . . . 25.0 117.311 167.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.9 m -139.26 134.59 32.85 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 106.721 -1.585 . . . . 25.0 106.721 -160.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.3 p -91.65 -29.02 17.11 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.907 1.337 . . . . 25.0 109.542 -171.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -172.64 171.57 4.47 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 116.421 -1.752 . . . . 25.0 108.292 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.9 p90 -153.06 158.54 42.1 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-O 117.018 -1.468 . . . . 25.0 111.528 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.415 ' HD2' ' HB ' ' A' ' 151' ' ' VAL 0.253 8.3 m-70 -139.96 144.37 37.01 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.011 1.278 . . . . 25.0 114.12 -167.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -123.72 137.95 54.61 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 121.209 1.822 . . . . 50.0 112.768 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -140.54 166.79 23.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.301 -1.74 . . . . 50.0 106.301 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.4 pt -134.68 166.15 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -83.17 150.93 25.94 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.168 0.44 . . . . 25.0 111.5 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -99.52 162.65 12.9 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -166.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -163.88 168.46 19.46 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 100.477 -3.898 . . . . 25.0 100.477 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.38 60.32 3.07 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 103.763 -3.735 . . . . 25.0 103.763 -174.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -146.5 171.67 14.71 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 114.776 -2.535 . . . . 25.0 112.476 -169.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.64 135.93 11.08 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 122.99 2.632 . . . . 25.0 104.576 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -64.04 -16.4 54.69 Favored 'Trans proline' 0 C--O 1.191 -1.868 1 N-CA-C 125.04 4.977 . . . . 25.0 125.04 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -78.49 -1.79 35.46 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 117.061 -3.524 . . . . 75.0 112.284 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -130.93 165.18 36.83 Favored Pre-proline 0 N--CA 1.406 -2.64 1 N-CA-C 100.19 -4.004 . . . . 25.0 100.19 -166.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -47.94 24.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 2 C-N-CA 127.703 5.602 . . . . 25.0 122.908 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -41.97 -39.28 1.83 Allowed 'General case' 0 CA--C 1.599 2.848 0 N-CA-C 120.059 3.355 . . . . 50.0 120.059 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -93.79 -10.75 33.12 Favored 'General case' 0 C--O 1.262 1.725 0 CA-C-N 120.041 1.292 . . . . 25.0 112.237 -176.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -107.2 -45.32 4.14 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.601 1.191 . . . . 25.0 110.763 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.17 37.7 0.78 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.838 -1.541 . . . . 25.0 106.838 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.15 -20.73 64.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 125.478 2.561 . . . . 25.0 112.297 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.16 157.24 47.1 Favored 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.366 1.866 . . . . 50.0 106.208 165.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -141.27 144.22 34.53 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 125.179 1.549 . . . . 25.0 108.756 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.88 135.89 57.92 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 123.303 1.525 . . . . 50.0 111.074 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.266 2.4 tt -107.29 -26.51 3.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 103.698 -2.704 . . . . 25.0 103.698 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.54 171.68 38.29 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 123.396 1.553 . . . . 25.0 113.571 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.45 147.29 26.08 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.15 119.43 27.65 Favored Pre-proline 0 N--CA 1.484 1.254 0 N-CA-C 105.633 -1.988 . . . . 50.0 105.633 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.09 167.08 16.26 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 N-CA-C 102.585 -3.659 . . . . 25.0 102.585 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -136.2 61.87 1.63 Allowed 'General case' 0 C--O 1.261 1.703 0 N-CA-C 117.515 2.413 . . . . 25.0 117.515 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.43 -25.88 1.14 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 118.973 2.953 . . . . 50.0 118.973 165.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -162.12 12.95 0.12 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 119.713 -1.867 . . . . 25.0 114.581 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.81 170.1 5.56 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 118.976 2.954 . . . . 25.0 118.976 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.54 -166.16 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 120.734 0.956 . . . . 25.0 113.628 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.18 -1.88 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 119.269 3.063 . . . . 25.0 119.269 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.1 p -60.78 -21.45 63.09 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.741 -1.118 . . . . 25.0 113.391 168.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -71.71 -5.03 30.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 117.443 2.386 . . . . 25.0 117.443 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -65.62 133.31 50.87 Favored 'General case' 0 C--O 1.267 2.002 0 O-C-N 120.433 -1.417 . . . . 25.0 108.259 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.73 -30.96 66.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 124.777 2.227 . . . . 75.0 110.774 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.7 t -62.8 127.71 32.51 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 105.337 -2.097 . . . . 25.0 105.337 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.13 134.5 29.72 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 117.593 2.442 . . . . 25.0 117.593 -172.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -94.86 145.0 25.2 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 113.978 -1.464 . . . . 25.0 107.565 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -136.46 125.13 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.356 -2.09 . . . . 25.0 105.356 159.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -71.92 133.97 45.72 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 123.001 2.637 . . . . 50.0 109.062 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.52 110.54 44.74 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -65.88 154.38 74.17 Favored 'Trans proline' 0 N--CA 1.53 3.669 1 C-N-CA 112.309 -4.661 . . . . 25.0 114.053 172.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -91.69 53.52 2.26 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 115.757 -2.377 . . . . 25.0 112.029 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.5 -25.61 38.66 Favored 'General case' 0 C--O 1.261 1.679 0 N-CA-C 114.541 1.312 . . . . 50.0 114.541 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -155.26 173.29 16.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 119.139 0.881 . . . . 25.0 109.643 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.1 pt? -110.97 139.84 45.99 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 104.472 -2.418 . . . . 50.0 104.472 166.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 160.03 167.86 21.19 Favored Glycine 0 C--O 1.294 3.897 0 O-C-N 119.819 -1.801 . . . . 25.0 113.714 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -102.38 139.87 37.42 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 127.166 2.187 . . . . 50.0 111.401 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -156.27 165.24 36.94 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 103.169 -2.9 . . . . 25.0 103.169 166.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.51 161.77 3.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 CA-C-N 120.754 1.615 . . . . 50.0 111.102 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.38 126.77 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 N-CA-C 100.701 -3.814 . . . . 25.0 100.701 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.5 mt -103.81 154.59 19.42 Favored 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 120.555 1.525 . . . . 50.0 108.414 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.1 157.98 43.45 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 119.675 1.125 . . . . 25.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 162' ' ' TYR . 58.8 t -131.09 134.02 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 105.007 -2.22 . . . . 50.0 105.007 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.75 108.09 10.44 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 105.041 -2.207 . . . . 25.0 105.041 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -86.37 95.4 9.65 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 125.325 2.488 . . . . 25.0 106.178 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.83 120.01 23.47 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.12 0 CA-C-N 113.56 -1.654 . . . . 50.0 107.396 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.76 -13.48 42.24 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.698 1.37 . . . . 25.0 114.698 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.95 -23.66 67.43 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.595 2.072 . . . . 25.0 116.595 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.5 p -138.03 158.03 45.15 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 110.875 -2.875 . . . . 25.0 107.218 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -75.18 -17.35 60.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 123.091 1.424 . . . . 25.0 111.547 164.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -69.72 154.84 41.42 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 162.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.09 178.52 7.32 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 100.55 -3.87 . . . . 25.0 100.55 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -124.0 153.97 40.51 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 125.919 2.012 . . . . 50.0 112.28 171.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.426 ' CD2' HG22 ' A' ' 151' ' ' VAL . 11.1 m-85 -123.13 159.75 27.9 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 105.993 -1.854 . . . . 50.0 105.993 158.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -154.62 152.04 29.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 120.642 1.565 . . . . 25.0 108.31 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.282 1.1 p -133.91 136.44 53.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.958 1.361 . . . . 75.0 112.567 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.14 125.62 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.329 -1.36 . . . . 25.0 107.329 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.58 136.45 32.99 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 104.98 -2.23 . . . . 25.0 104.98 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 m -132.79 160.27 42.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 125.241 2.448 . . . . 50.0 110.026 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -130.96 111.74 12.33 Favored 'General case' 0 C--O 1.275 2.397 0 N-CA-C 104.233 -2.506 . . . . 25.0 104.233 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.7 mt -119.26 117.47 28.68 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 100.791 -3.781 . . . . 50.0 100.791 -167.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 19.2 m -115.22 170.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 116.889 2.181 . . . . 50.0 116.889 -167.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -78.91 151.57 31.65 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.9 tptt . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 115.574 -2.155 . . . . 25.0 111.971 178.271 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 . . . . . 0 N--CA 1.51 2.558 0 CA-C-O 120.573 0.225 . . . . 25.0 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.39 -160.01 30.15 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-O 116.812 -2.104 . . . . 25.0 117.027 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -129.87 156.54 44.22 Favored 'General case' 0 C--O 1.253 1.267 0 C-N-CA 126.921 2.088 . . . . 50.0 113.377 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -95.3 125.54 47.97 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 101.418 -3.549 . . . . 25.0 101.418 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -89.74 -40.48 12.48 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 113.706 -1.588 . . . . 25.0 113.738 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -148.54 150.55 34.06 Favored Pre-proline 0 CA--C 1.549 0.918 1 N-CA-C 99.532 -4.248 . . . . 25.0 99.532 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.44 139.13 59.72 Favored 'Cis proline' 0 N--CA 1.442 -1.529 0 CA-C-N 120.676 1.277 . . . . 25.0 113.604 1.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.89 -154.93 49.03 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 117.458 1.743 . . . . 25.0 117.458 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -137.33 114.66 10.95 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 125.319 1.448 . . . . 25.0 109.48 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -67.62 -24.51 65.48 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 123.896 1.808 . . . . 25.0 114.452 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.15 -30.75 71.29 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 118.139 -2.85 . . . . 25.0 114.536 171.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.36 90.44 Favored 'General case' 0 C--O 1.192 -1.946 0 CA-C-O 125.82 2.724 . . . . 25.0 110.323 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.43 -17.22 49.61 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 112.394 -2.185 . . . . 75.0 108.487 -169.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 t -67.98 -13.67 62.36 Favored 'General case' 0 C--O 1.186 -2.283 0 O-C-N 123.991 0.807 . . . . 25.0 111.131 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.9 t -63.0 156.42 24.68 Favored 'General case' 0 CA--C 1.603 3.019 0 N-CA-C 114.102 1.149 . . . . 25.0 114.102 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -74.89 -33.59 62.07 Favored 'General case' 0 C--O 1.196 -1.719 0 CA-C-N 114.853 -1.067 . . . . 25.0 110.31 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.23 -35.17 79.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.149 1.907 . . . . 25.0 116.149 172.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -61.26 -47.88 83.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.711 1.745 . . . . 50.0 115.711 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.64 72.6 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 109.834 -1.306 . . . . 25.0 109.834 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.0 t80 147.19 -56.81 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 111.697 -2.251 . . . . 50.0 109.558 159.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.11 -20.37 8.06 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 119.425 3.12 . . . . 50.0 119.425 161.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -143.03 150.64 39.85 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 -167.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.26 2.0 pt? -78.95 155.86 28.77 Favored 'General case' 0 C--O 1.206 -1.202 0 C-N-CA 119.589 -0.844 . . . . 50.0 110.993 -166.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -136.89 64.69 1.53 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 100.313 -3.958 . . . . 25.0 100.313 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.7 t -153.1 -59.0 0.14 Allowed 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 127.25 2.843 . . . . 25.0 110.955 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.18 -76.93 2.14 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 127.237 2.351 . . . . 25.0 117.332 169.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 m -115.78 -2.97 12.27 Favored 'General case' 0 C--O 1.185 -2.332 0 N-CA-C 117.961 2.578 . . . . 25.0 117.961 -173.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -58.49 -45.58 90.03 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.392 0 CA-C-O 124.001 1.858 . . . . 50.0 112.692 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -69.82 -2.92 13.52 Favored 'General case' 0 CA--C 1.503 -0.852 1 N-CA-C 122.17 4.137 . . . . 25.0 122.17 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.58 -50.77 16.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 124.956 2.312 . . . . 50.0 108.006 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -131.43 82.65 61.37 Favored Pre-proline 0 N--CA 1.511 2.606 0 CA-C-N 113.073 -1.876 . . . . 25.0 106.177 167.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.49 -16.86 54.85 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 116.273 -2.018 . . . . 25.0 116.105 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.45 -51.78 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.7 t -84.55 46.02 1.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 118.462 -2.649 . . . . 25.0 113.844 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.45 129.69 39.91 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-O 125.053 2.359 . . . . 50.0 105.475 173.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.41 146.27 42.63 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.014 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.82 41.37 0.67 Allowed 'General case' 0 C--O 1.193 -1.885 0 CA-C-O 124.379 2.038 . . . . 25.0 113.299 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -142.87 -73.84 0.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 118.811 -2.431 . . . . 25.0 112.889 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.93 177.38 8.81 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.728 1.611 . . . . 25.0 111.669 -165.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.4 28.02 6.96 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 124.733 1.271 . . . . 25.0 113.887 -169.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -71.55 151.69 93.78 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 108.297 -1.001 . . . . 25.0 108.297 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.38 124.63 6.97 Favored 'Cis proline' 0 C--N 1.368 1.578 0 C-N-CA 130.776 1.574 . . . . 25.0 111.641 -15.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -72.18 -18.85 61.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.277 -1.514 . . . . 25.0 111.413 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m 73.76 -45.36 0.6 Allowed 'General case' 0 C--N 1.363 1.157 0 C-N-CA 127.93 2.492 . . . . 25.0 116.24 174.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.92 -178.73 27.66 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 114.943 -3.143 . . . . 25.0 111.649 167.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.15 149.47 91.35 Favored 'Trans proline' 0 CA--C 1.59 3.309 0 CA-C-N 122.125 2.962 . . . . 25.0 110.058 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.86 132.74 32.1 Favored 'General case' 0 N--CA 1.507 2.398 0 C-N-CA 128.115 2.566 . . . . 25.0 116.411 -167.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.11 120.91 13.55 Favored 'General case' 0 C--O 1.256 1.399 0 CA-C-O 117.841 -1.076 . . . . 25.0 113.474 -169.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.14 -13.4 50.11 Favored Glycine 0 CA--C 1.486 -1.773 0 O-C-N 126.777 2.548 . . . . 25.0 117.497 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 42.34 40.44 1.82 Allowed 'General case' 0 C--O 1.247 0.956 0 C-N-CA 130.024 3.33 . . . . 25.0 113.782 -175.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.1 mt -65.21 -29.13 46.36 Favored 'Isoleucine or valine' 0 C--O 1.256 1.416 0 CA-C-N 113.512 -1.676 . . . . 25.0 112.605 -162.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.66 79.8 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 115.009 1.485 . . . . 25.0 115.009 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.6 p -141.15 -9.82 0.99 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 119.677 -1.889 . . . . 25.0 114.616 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.63 25.94 1.62 Allowed 'General case' 0 CA--C 1.577 2.014 0 C-N-CA 124.978 1.311 . . . . 25.0 113.012 -166.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.32 -29.64 71.79 Favored Glycine 0 C--O 1.237 0.305 0 CA-C-N 119.83 1.195 . . . . 25.0 112.67 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.08 -16.31 68.51 Favored Glycine 0 C--O 1.263 1.911 0 O-C-N 120.327 -1.69 . . . . 25.0 111.65 171.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mt -113.44 48.14 1.08 Allowed 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 118.436 2.754 . . . . 50.0 118.436 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -70.97 -26.1 63.01 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.346 -3.205 . . . . 50.0 102.346 148.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.04 -16.68 68.91 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 119.881 -1.762 . . . . 25.0 109.003 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.95 -23.53 77.69 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 119.997 -1.097 . . . . 25.0 114.092 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.48 -44.41 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 117.012 -1.875 . . . . 25.0 109.519 165.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.11 1.02 2.24 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 126.235 2.921 . . . . 75.0 118.624 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.78 -14.93 60.78 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 112.262 -2.245 . . . . 50.0 110.721 170.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -72.74 5.15 3.35 Favored 'General case' 0 CA--C 1.485 -1.557 0 O-C-N 116.631 -3.793 . . . . 25.0 116.733 173.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -122.62 67.31 0.95 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 125.919 1.687 . . . . 25.0 107.258 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -147.18 151.24 36.43 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 117.192 2.293 . . . . 25.0 117.192 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -72.28 -30.22 64.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 118.246 -2.784 . . . . 25.0 109.02 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -106.02 31.36 5.14 Favored 'General case' 0 C--O 1.176 -2.776 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -78.46 101.71 7.45 Favored 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 97.859 -4.867 . . . . 25.0 97.859 164.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -43.15 155.96 0.05 Allowed 'General case' 0 C--O 1.262 1.714 0 CA-C-N 110.023 -3.262 . . . . 25.0 115.468 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -58.86 144.73 43.45 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 127.043 3.306 . . . . 50.0 117.076 -167.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -82.96 153.78 24.85 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 117.714 2.487 . . . . 25.0 117.714 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -152.35 156.52 39.74 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 117.981 -2.949 . . . . 25.0 109.138 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.2 tt -132.58 139.75 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 106.367 -1.716 . . . . 25.0 106.367 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtt -152.87 151.8 30.81 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 120.087 1.312 . . . . 25.0 110.255 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.5 p -84.55 176.68 8.46 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.071 -0.714 . . . . 25.0 109.071 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.65 168.8 53.86 Favored Glycine 0 C--O 1.209 -1.439 0 C-N-CA 120.825 -0.702 . . . . 25.0 112.065 168.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.62 174.26 15.56 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.472 -1.823 . . . . 25.0 110.687 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -71.06 134.04 46.77 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.279 -0.968 . . . . 25.0 111.807 162.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -133.73 147.35 51.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.131 -0.94 . . . . 25.0 110.77 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m -85.62 136.09 33.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 124.274 1.03 . . . . 25.0 110.597 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.42 134.81 49.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.067 -1.827 . . . . 50.0 106.067 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.4 m -114.66 120.93 41.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -120.27 149.02 42.96 Favored 'General case' 0 C--O 1.263 1.803 0 CA-C-O 118.288 -0.863 . . . . 25.0 109.446 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 t -143.35 158.18 43.85 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.275 1.852 . . . . 25.0 109.871 -171.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -86.15 147.93 25.91 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 104.443 -2.429 . . . . 50.0 104.443 161.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.7 t -110.41 -18.28 13.27 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 103.711 -2.7 . . . . 25.0 103.711 162.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 147.04 54.14 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 101.117 -3.66 . . . . 25.0 101.117 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.35 151.54 84.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 117.887 -0.942 . . . . 25.0 113.579 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -129.1 178.49 6.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 100.762 -3.792 . . . . 25.0 100.762 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -118.56 84.84 2.25 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.938 1.695 . . . . 25.0 107.007 157.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -75.56 149.52 38.31 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 103.233 -2.877 . . . . 25.0 103.233 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 p -106.16 -30.32 9.3 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-N 120.713 1.597 . . . . 25.0 114.56 168.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 51.2 tt0 -164.21 158.34 18.92 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 118.614 -2.554 . . . . 25.0 104.674 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -149.69 162.04 41.01 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 120.167 -1.583 . . . . 25.0 110.156 163.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -128.79 156.58 43.35 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 127.009 2.124 . . . . 25.0 110.738 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -147.7 149.76 33.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 124.693 2.187 . . . . 50.0 105.959 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -146.3 168.6 20.68 Favored 'General case' 0 CA--C 1.501 -0.914 1 N-CA-C 98.813 -4.514 . . . . 50.0 98.813 -154.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.1 pt -134.51 158.0 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 117.07 -1.443 . . . . 25.0 108.693 162.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.451 HG23 ' HA ' ' A' ' 114' ' ' ASP . 49.9 m -95.14 133.32 39.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 125.525 1.766 . . . . 25.0 110.592 172.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -76.87 135.77 38.85 Favored 'General case' 0 C--O 1.297 3.563 0 CA-C-N 122.328 2.331 . . . . 25.0 109.998 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.32 164.71 26.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 103.999 -2.593 . . . . 25.0 103.999 171.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.33 3.24 65.21 Favored Glycine 0 C--O 1.276 2.739 0 N-CA-C 117.333 1.693 . . . . 25.0 117.333 169.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.87 176.97 5.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.711 1.004 . . . . 25.0 113.711 -174.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.56 138.04 11.38 Favored Pre-proline 0 C--O 1.194 -1.847 0 CA-C-O 116.188 -1.863 . . . . 25.0 109.944 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.51 -21.23 46.66 Favored 'Trans proline' 0 C--O 1.286 2.912 0 N-CA-C 117.983 2.263 . . . . 25.0 117.983 -174.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.53 3.13 12.0 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 118.977 -2.327 . . . . 75.0 113.198 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -129.38 174.04 5.02 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 100.615 -3.846 . . . . 25.0 100.615 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.6 21.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 N-CA-C 122.138 3.861 . . . . 25.0 122.138 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 tt -38.84 -33.74 0.12 Allowed 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.755 2.132 . . . . 50.0 116.755 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.28 -5.44 59.18 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 116.593 2.072 . . . . 25.0 116.593 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -116.15 -43.11 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 123.654 1.693 . . . . 25.0 110.105 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.2 4.77 1.14 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 113.315 -1.766 . . . . 25.0 112.883 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.451 ' HA ' HG23 ' A' ' 100' ' ' THR . 26.2 t0 -70.63 -14.92 62.66 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 119.571 -0.852 . . . . 25.0 108.837 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.73 106.74 8.91 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -109.09 120.16 41.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 104.99 -2.226 . . . . 25.0 104.99 165.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.97 136.27 55.06 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 116.568 -1.682 . . . . 50.0 108.873 -176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.5 tp -110.29 -19.21 7.04 Favored 'Isoleucine or valine' 0 C--N 1.374 1.639 0 CA-C-O 125.868 2.747 . . . . 25.0 109.81 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.76 150.97 13.13 Favored Glycine 0 N--CA 1.444 -0.773 0 O-C-N 118.268 -2.77 . . . . 25.0 114.562 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . 0.257 . . -143.84 140.96 30.1 Favored 'General case' 0 CA--C 1.569 1.685 1 N-CA-C 98.955 -4.461 . . . . 25.0 98.955 -179.957 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.2 105.11 11.29 Favored Pre-proline 0 CA--C 1.497 -1.078 0 O-C-N 127.208 2.818 . . . . 50.0 103.465 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 61.6 Cg_endo -66.22 167.17 18.98 Favored 'Trans proline' 0 C--O 1.203 -1.225 1 C-N-CA 109.828 -6.315 . . . . 25.0 111.896 166.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -144.01 83.18 1.73 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 118.435 -2.666 . . . . 25.0 111.795 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.93 -17.6 43.06 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 124.675 2.178 . . . . 50.0 113.183 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.01 -168.2 36.57 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 103.581 -3.808 . . . . 25.0 103.581 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 71.09 82.2 Favored Pre-proline 0 C--O 1.181 -2.523 0 CA-C-N 121.534 2.667 . . . . 25.0 114.278 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -67.67 172.06 11.09 Favored 'Trans proline' 0 C--O 1.286 2.906 1 C-N-CA 111.025 -5.517 . . . . 25.0 110.982 155.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.03 -35.76 67.22 Favored 'General case' 0 C--N 1.356 0.89 0 CA-C-O 116.396 -1.764 . . . . 25.0 113.656 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 98.4 p -59.22 -20.21 52.08 Favored 'General case' 0 C--O 1.296 3.536 0 O-C-N 127.532 3.02 . . . . 25.0 115.793 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -105.57 8.22 33.18 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 118.704 2.853 . . . . 25.0 118.704 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -60.19 151.91 25.96 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 125.72 2.676 . . . . 25.0 110.998 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mt -66.46 -27.03 67.49 Favored 'General case' 0 C--O 1.26 1.613 0 CA-C-N 113.202 -1.817 . . . . 75.0 114.56 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.4 m -96.44 145.55 25.56 Favored 'General case' 0 C--O 1.302 3.85 0 O-C-N 119.518 -1.989 . . . . 25.0 105.855 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -131.45 168.32 17.82 Favored 'General case' 0 C--O 1.192 -1.957 0 N-CA-C 116.318 1.97 . . . . 25.0 116.318 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.305 89.9 m-70 -121.3 116.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 121.608 2.004 . . . . 25.0 113.28 168.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mm -122.18 131.79 72.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 C-N-CA 118.745 -1.182 . . . . 25.0 108.981 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -75.78 134.08 40.52 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 107.18 -1.415 . . . . 50.0 107.18 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.04 132.02 22.55 Favored Pre-proline 0 C--O 1.204 -1.309 0 N-CA-C 102.892 -3.003 . . . . 25.0 102.892 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -62.27 143.66 94.34 Favored 'Trans proline' 0 CA--C 1.458 -3.324 1 C-N-CA 113.006 -4.196 . . . . 25.0 118.785 -175.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.73 -22.86 12.86 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 125.447 2.546 . . . . 25.0 114.267 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -77.46 -5.46 49.97 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 118.965 -2.334 . . . . 50.0 112.289 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -145.06 158.09 43.92 Favored 'General case' 0 C--O 1.204 -1.303 0 CA-C-N 112.739 -2.028 . . . . 25.0 112.388 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.2 mp -107.2 152.67 23.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.052 -2.944 . . . . 50.0 103.052 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 158.44 166.63 17.96 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.151 -0.968 . . . . 25.0 114.949 167.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -88.57 136.13 33.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.606 1.335 . . . . 50.0 114.606 166.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -149.45 167.84 25.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 104.213 -2.514 . . . . 25.0 104.213 -159.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.51 131.83 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.985 0 N-CA-C 103.537 -2.764 . . . . 50.0 103.537 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 94.5 mt -98.8 121.17 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 105.925 -1.88 . . . . 25.0 105.925 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.93 138.18 51.12 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 119.904 -1.747 . . . . 50.0 107.799 -175.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.26 145.51 43.64 Favored 'General case' 0 C--O 1.263 1.81 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -133.84 137.3 52.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 114.424 -2.703 . . . . 50.0 110.267 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -115.77 150.5 36.8 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.814 -1.921 . . . . 25.0 105.814 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -112.89 131.74 55.6 Favored 'General case' 0 C--N 1.307 -1.248 1 N-CA-C 99.085 -4.413 . . . . 25.0 99.085 163.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.21 120.82 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 105.046 -2.205 . . . . 50.0 105.046 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.8 -21.3 41.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 118.944 -0.551 . . . . 25.0 111.069 -173.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . 0.304 2.1 p-10 -82.82 -15.13 52.82 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 116.023 1.86 . . . . 25.0 116.023 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.505 ' HG1' ' HE1' ' A' ' 161' ' ' PHE . 39.1 p -112.67 156.58 22.51 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.177 -1.046 . . . . 25.0 108.177 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -90.5 -23.79 20.85 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.638 -1.225 . . . . 25.0 114.064 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -102.0 160.14 14.76 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 115.25 -0.886 . . . . 25.0 111.486 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.82 166.85 22.94 Favored 'General case' 0 C--O 1.253 1.258 0 CA-C-N 113.03 -1.896 . . . . 25.0 112.649 163.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.505 ' HE1' ' HG1' ' A' ' 157' ' ' THR . 52.7 m-85 -129.35 130.83 46.58 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 112.343 -2.208 . . . . 50.0 110.34 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -139.74 136.76 34.49 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 127.207 2.817 . . . . 50.0 108.323 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.62 149.53 20.37 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 106.881 -1.525 . . . . 25.0 106.881 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.9 m -127.51 162.72 32.38 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.595 0 N-CA-C 107.978 -1.119 . . . . 75.0 107.978 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.94 131.44 46.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 105.868 -1.901 . . . . 25.0 105.868 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.55 124.31 38.5 Favored 'General case' 0 CA--C 1.583 2.215 0 O-C-N 126.093 2.121 . . . . 25.0 106.357 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 m -123.46 158.75 28.67 Favored 'Isoleucine or valine' 0 C--O 1.285 2.933 0 C-N-CA 116.186 -2.206 . . . . 50.0 109.221 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -119.44 121.34 39.26 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 101.105 -3.665 . . . . 25.0 101.105 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.6 mt -112.28 95.99 5.77 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 105.488 -2.042 . . . . 50.0 105.488 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.8 172.73 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.801 -1.187 . . . . 50.0 113.192 -170.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -66.97 132.81 48.69 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 105.982 -1.859 . . . . 25.0 105.982 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.0 pttp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 115.612 -2.137 . . . . 25.0 110.194 177.546 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 . . . . . 1 N--CA 1.555 4.8 0 CA-C-O 122.761 1.267 . . . . 25.0 107.995 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -121.31 6.33 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.341 -1.409 . . . . 25.0 111.571 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.26 144.33 27.8 Favored 'General case' 0 C--O 1.267 2.023 0 O-C-N 119.196 -2.355 . . . . 50.0 106.438 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -86.86 126.09 40.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 N-CA-C 105.002 -2.221 . . . . 25.0 105.002 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -108.02 -35.31 6.64 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 117.039 -1.864 . . . . 25.0 110.449 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 148.86 57.56 Favored Pre-proline 0 C--O 1.256 1.406 0 N-CA-C 104.967 -2.234 . . . . 25.0 104.967 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -71.43 133.16 27.07 Favored 'Cis proline' 0 C--N 1.359 1.117 0 C-N-CA 132.848 2.437 . . . . 25.0 114.158 2.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.22 -144.12 49.05 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 115.104 0.802 . . . . 25.0 115.104 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -133.72 104.62 6.41 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 105.169 -2.16 . . . . 25.0 105.169 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -69.18 -18.06 63.88 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 117.806 -3.059 . . . . 25.0 109.471 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.19 70.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 116.403 -1.76 . . . . 25.0 111.169 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.56 63.82 Favored 'General case' 0 C--O 1.198 -1.624 0 N-CA-C 106.89 -1.522 . . . . 25.0 106.89 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.61 -28.97 59.07 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.546 -1.346 . . . . 75.0 111.861 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.5 t -72.87 -36.78 67.46 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 112.76 -2.018 . . . . 25.0 113.502 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 p -56.02 148.55 17.33 Favored 'General case' 0 C--O 1.273 2.331 0 N-CA-C 119.375 3.102 . . . . 25.0 119.375 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.62 -37.09 72.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.464 -0.773 . . . . 25.0 110.627 169.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.5 -6.01 37.33 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.816 0.846 . . . . 25.0 111.875 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -58.58 -37.79 76.54 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 123.025 1.393 . . . . 50.0 109.911 170.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.88 -1.33 0.72 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 122.571 3.788 . . . . 25.0 122.571 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 43.71 16.3 0.01 OUTLIER 'General case' 0 C--O 1.29 3.234 0 N-CA-C 121.523 3.897 . . . . 50.0 121.523 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.1 mt -121.74 -36.89 2.95 Favored 'General case' 0 N--CA 1.517 2.906 0 O-C-N 120.782 -1.199 . . . . 50.0 110.45 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -149.1 -168.37 3.09 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 120.412 -1.43 . . . . 25.0 111.701 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -168.27 157.64 9.39 Favored 'General case' 0 C--O 1.209 -1.069 0 O-C-N 127.926 3.266 . . . . 50.0 108.894 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -160.47 45.6 0.21 Allowed 'General case' 0 N--CA 1.517 2.912 1 CA-C-O 129.395 4.426 . . . . 25.0 114.539 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.8 t -87.46 -5.63 58.74 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 117.843 -3.036 . . . . 25.0 113.166 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.79 -35.74 87.51 Favored Glycine 0 C--O 1.179 -3.339 0 N-CA-C 119.239 2.456 . . . . 25.0 119.239 -158.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 m -83.45 -12.69 56.07 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 121.859 2.83 . . . . 25.0 110.579 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -89.61 -45.77 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.522 0 N-CA-C 105.022 -2.214 . . . . 50.0 105.022 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.3 ptm -76.13 -7.28 54.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 117.783 -3.073 . . . . 25.0 115.111 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.78 -47.27 85.3 Favored 'General case' 0 N--CA 1.421 -1.917 0 O-C-N 126.297 2.248 . . . . 50.0 112.362 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.62 64.03 11.32 Favored Pre-proline 0 CA--C 1.505 -0.755 0 N-CA-C 113.753 1.02 . . . . 25.0 113.753 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.26 -19.87 37.96 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 N-CA-C 117.681 2.146 . . . . 25.0 117.681 -167.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -99.83 6.42 45.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.435 2.013 . . . . 25.0 116.435 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -136.73 38.52 2.62 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.692 1.597 . . . . 25.0 112.216 171.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 tp -77.5 99.32 5.64 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.055 -0.521 . . . . 50.0 110.968 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.28 147.1 52.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.071 -1.455 . . . . 25.0 107.071 -159.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.29 50.6 1.02 Allowed 'General case' 0 CA--C 1.606 3.12 0 N-CA-C 115.437 1.643 . . . . 25.0 115.437 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 45.4 tttt -134.76 -163.1 1.33 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.05 -1.833 . . . . 25.0 106.05 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HA ' ' CE1' ' A' ' 43' ' ' HIS . 94.0 mttt -68.76 163.74 23.38 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 125.638 1.837 . . . . 25.0 110.679 -168.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.07 178.22 47.38 Favored Glycine 0 N--CA 1.439 -1.126 1 CA-C-O 112.158 -4.69 . . . . 25.0 103.986 176.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -127.02 104.59 22.74 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 121.275 2.538 . . . . 25.0 110.434 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.89 158.17 85.2 Favored 'Cis proline' 0 C--O 1.259 1.569 0 C-N-CA 134.078 2.949 . . . . 25.0 112.451 2.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.452 ' CE1' ' HA ' ' A' ' 39' ' ' LYS . 41.5 t60 -65.58 -32.9 74.73 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 121.619 2.009 . . . . 25.0 107.019 -172.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t 76.28 -71.7 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.767 1.627 . . . . 25.0 114.012 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.78 -175.17 27.48 Favored Glycine 0 N--CA 1.484 1.847 0 CA-C-O 124.208 2.005 . . . . 25.0 109.514 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.95 -172.0 1.13 Allowed 'Trans proline' 0 N--CA 1.514 2.712 0 O-C-N 119.48 -0.853 . . . . 25.0 113.421 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.71 133.74 55.92 Favored 'General case' 0 CA--C 1.555 1.163 0 O-C-N 118.266 -2.771 . . . . 25.0 109.353 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -66.9 121.11 14.78 Favored 'General case' 1 C--O 1.314 4.482 0 N-CA-C 118.628 2.825 . . . . 25.0 118.628 -173.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.12 1.71 88.15 Favored Glycine 0 C--O 1.25 1.119 0 CA-C-O 115.91 -2.605 . . . . 25.0 111.863 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 36.95 38.32 0.09 Allowed 'General case' 0 CA--C 1.568 1.642 0 O-C-N 126.757 2.092 . . . . 25.0 115.887 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.9 mt -69.45 -40.07 79.42 Favored 'Isoleucine or valine' 0 C--O 1.263 1.779 0 CA-C-N 114.91 -1.041 . . . . 25.0 108.77 -160.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.91 -48.73 79.01 Favored 'General case' 0 C--O 1.185 -2.295 0 O-C-N 119.309 -2.119 . . . . 25.0 113.713 -169.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 t -108.66 -22.49 12.23 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 125.017 1.448 . . . . 25.0 109.948 -167.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.269 . . 59.66 9.8 1.74 Allowed 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 117.348 2.351 . . . . 25.0 117.348 -171.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.82 -20.39 73.71 Favored Glycine 0 C--O 1.258 1.647 0 O-C-N 118.651 -2.53 . . . . 25.0 107.483 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.1 -17.2 69.65 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 122.407 3.723 . . . . 25.0 122.407 164.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.9 mt -110.96 -20.19 12.52 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 124.284 1.992 . . . . 50.0 111.428 -172.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -71.12 -40.42 71.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.763 -2.31 . . . . 50.0 104.763 155.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.55 -22.98 47.74 Favored Glycine 0 CA--C 1.499 -0.966 0 O-C-N 118.82 -2.425 . . . . 25.0 114.582 167.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.13 74.6 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 126.069 3.038 . . . . 25.0 113.285 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.96 -33.22 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 117.771 -3.194 . . . . 25.0 105.381 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.13 -14.51 60.98 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 112.65 -2.068 . . . . 75.0 112.956 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.01 -25.97 65.7 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 111.724 -2.489 . . . . 50.0 112.02 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.51 11.27 5.85 Favored 'General case' 0 C--O 1.251 1.155 0 O-C-N 118.807 -2.433 . . . . 25.0 112.756 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -133.06 16.77 4.15 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.05 -1.656 . . . . 25.0 112.457 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -112.4 166.17 11.54 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.286 -0.87 . . . . 25.0 109.345 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.81 -22.6 65.16 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 105.78 -1.933 . . . . 25.0 105.78 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.98 39.64 1.52 Allowed 'General case' 0 C--O 1.168 -3.196 0 C-N-CA 125.55 1.54 . . . . 25.0 110.165 175.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -89.36 91.34 8.7 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-O 124.901 2.286 . . . . 25.0 105.704 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -57.24 139.2 53.43 Favored 'General case' 0 C--N 1.305 -1.34 1 CA-C-N 107.5 -4.409 . . . . 25.0 105.358 172.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -65.56 152.09 44.91 Favored 'General case' 0 C--O 1.286 3.017 0 CA-C-O 126.314 2.959 . . . . 50.0 115.086 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -87.27 134.92 33.49 Favored 'General case' 0 C--O 1.185 -2.318 0 CA-C-N 109.897 -3.32 . . . . 25.0 104.415 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -126.47 134.71 50.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 126.062 2.101 . . . . 25.0 112.883 171.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -93.99 141.25 15.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 tpt -146.3 147.75 31.7 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-O 123.028 1.394 . . . . 25.0 108.739 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 p -82.31 173.61 11.91 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 114.262 -1.335 . . . . 25.0 114.416 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.9 -179.0 35.45 Favored Glycine 0 C--O 1.264 2.019 0 O-C-N 120.053 -1.654 . . . . 25.0 110.526 163.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.76 179.05 32.11 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 106.252 -2.739 . . . . 25.0 106.252 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.75 138.9 39.27 Favored 'General case' 0 C--O 1.257 1.471 0 O-C-N 118.326 -2.867 . . . . 25.0 114.612 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -132.1 160.48 35.84 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 114.044 -1.434 . . . . 25.0 110.803 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -111.52 135.79 51.59 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-O 123.798 1.761 . . . . 25.0 111.597 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -112.97 119.55 38.3 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.79 -1.095 . . . . 50.0 111.518 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.4 m -134.72 129.21 34.36 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 107.275 -1.38 . . . . 25.0 107.275 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -120.77 151.21 39.86 Favored 'General case' 0 C--N 1.313 -1.011 1 N-CA-C 98.617 -4.586 . . . . 25.0 98.617 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -143.66 126.57 16.29 Favored 'General case' 0 C--O 1.263 1.811 0 O-C-N 125.344 1.652 . . . . 25.0 112.397 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -130.3 143.65 50.9 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 118.809 -2.432 . . . . 50.0 109.633 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -61.6 -23.96 66.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 118.522 2.786 . . . . 25.0 118.522 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.05 157.2 78.21 Favored Pre-proline 0 CA--C 1.493 -1.227 0 N-CA-C 101.257 -3.609 . . . . 25.0 101.257 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.26 159.1 11.24 Favored 'Trans proline' 0 N--CA 1.504 2.099 0 N-CA-C 103.003 -3.499 . . . . 25.0 103.003 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -89.83 167.62 12.71 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 102.667 -3.086 . . . . 25.0 102.667 159.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -88.7 117.13 27.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -139.32 156.36 47.08 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 122.613 0.365 . . . . 25.0 110.341 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p -98.83 -48.87 4.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.168 0.987 . . . . 25.0 111.378 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -159.42 160.3 34.68 Favored 'General case' 0 CA--C 1.474 -1.969 0 O-C-N 120.214 -1.553 . . . . 25.0 114.541 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -122.08 144.95 48.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 119.735 1.152 . . . . 25.0 111.221 162.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -122.93 153.56 39.54 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 114.253 -2.784 . . . . 25.0 110.283 -170.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.25 137.56 27.38 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 105.858 -1.904 . . . . 50.0 105.858 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -134.67 156.46 48.72 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 124.56 1.162 . . . . 50.0 110.081 -167.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.451 HG22 HG12 ' A' ' 148' ' ' ILE . 24.2 pt -126.63 162.81 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 124.621 2.153 . . . . 25.0 110.006 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 147' ' ' VAL . 54.8 m -111.9 127.27 55.79 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 118.75 -2.469 . . . . 25.0 108.285 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.449 ' HG3' ' CE3' ' A' ' 104' ' ' TRP . 52.8 pttt -99.01 179.49 4.61 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -164.03 177.13 8.72 Favored 'General case' 0 C--O 1.275 2.433 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.81 26.69 66.46 Favored Glycine 0 C--O 1.252 1.235 1 CA-C-O 129.379 4.877 . . . . 25.0 113.861 -166.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.449 ' CE3' ' HG3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -97.19 150.31 21.04 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 108.83 -3.685 . . . . 25.0 112.95 -173.466 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 106' ' ' PRO 0.288 9.7 t70 -98.45 141.54 23.1 Favored Pre-proline 0 C--O 1.194 -1.868 0 C-N-CA 127.772 2.429 . . . . 25.0 111.095 -172.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 105' ' ' ASP . 31.3 Cg_exo -67.52 -40.54 10.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 124.776 3.65 . . . . 25.0 121.038 -173.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.67 -29.05 65.27 Favored 'General case' 0 C--O 1.197 -1.704 0 CA-C-O 126.225 2.917 . . . . 75.0 109.312 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.84 161.5 74.47 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 118.484 -2.635 . . . . 25.0 110.31 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.92 17.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.646 2 C-N-CA 127.978 5.785 . . . . 25.0 122.878 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.19 -37.5 15.94 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 116.091 1.885 . . . . 50.0 116.091 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -85.48 -10.66 55.78 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.423 1.638 . . . . 25.0 115.423 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 114' ' ' ASP . 99.4 mtt180 -104.21 -52.81 2.85 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 117.695 2.48 . . . . 25.0 117.695 174.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.67 34.8 0.28 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 127.028 2.705 . . . . 25.0 106.791 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 112' ' ' ARG . 36.0 t70 -63.65 -26.79 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.838 2.055 . . . . 25.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -127.71 145.69 50.82 Favored 'General case' 0 C--N 1.298 -1.674 1 N-CA-C 99.023 -4.436 . . . . 50.0 99.023 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -117.63 130.66 56.51 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 121.414 1.915 . . . . 25.0 110.73 168.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.1 tp -63.87 110.15 1.99 Allowed 'General case' 0 C--O 1.27 2.153 0 CA-C-O 118.311 -0.852 . . . . 50.0 110.467 168.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.6 tt -99.34 -17.85 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.14 166.34 36.35 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 116.319 1.288 . . . . 25.0 116.319 164.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.7 152.18 33.54 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.21 -1.404 . . . . 25.0 107.21 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.96 120.43 15.24 Favored Pre-proline 0 C--O 1.262 1.723 0 O-C-N 125.934 2.021 . . . . 50.0 110.185 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.72 152.67 53.36 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.262 1.276 . . . . 25.0 113.093 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.79 52.29 1.48 Allowed 'General case' 0 C--O 1.245 0.863 0 N-CA-C 105.318 -2.104 . . . . 25.0 105.318 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -83.64 -22.55 32.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.602 -1.629 . . . . 50.0 106.602 -167.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.05 178.89 31.47 Favored Glycine 0 C--O 1.204 -1.738 1 N-CA-C 102.714 -4.154 . . . . 25.0 102.714 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -123.75 56.87 11.27 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 119.434 3.124 . . . . 25.0 119.434 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.6 175.85 10.53 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 O-C-N 118.303 -1.472 . . . . 25.0 108.5 168.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.47 -13.77 43.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 25.0 113.311 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 80.7 p -84.76 -3.83 58.78 Favored 'General case' 0 C--O 1.189 -2.12 0 CA-C-N 119.383 0.992 . . . . 25.0 110.83 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -116.47 26.21 10.06 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 123.973 1.844 . . . . 25.0 110.673 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -68.61 149.97 48.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.825 -1.546 . . . . 25.0 106.825 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.73 -15.11 59.86 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 126.466 2.354 . . . . 75.0 115.781 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.4 t -81.31 123.61 28.67 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 104.223 -2.51 . . . . 25.0 104.223 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -118.71 147.22 44.06 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.664 -1.273 . . . . 25.0 108.047 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -110.53 136.35 49.78 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.9 mm -132.37 128.23 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -78.66 133.53 37.22 Favored 'General case' 0 C--O 1.255 1.365 0 O-C-N 125.696 1.873 . . . . 50.0 111.71 169.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.48 126.18 28.27 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-O 115.22 -2.324 . . . . 25.0 107.218 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.75 151.72 74.36 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 113.563 -3.824 . . . . 25.0 114.619 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -105.11 -8.05 18.7 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.08 -1.873 . . . . 25.0 111.921 -172.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.23 -1.7 24.62 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 126.315 2.259 . . . . 50.0 115.758 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -142.06 165.72 26.67 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 119.409 -2.057 . . . . 25.0 112.596 -172.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 3.8 mp -128.15 147.06 50.54 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 101.184 -3.636 . . . . 50.0 101.184 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.44 174.44 21.56 Favored Glycine 0 CA--C 1.477 -2.326 0 N-CA-C 121.037 3.175 . . . . 25.0 121.037 161.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -82.39 140.48 33.45 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 113.588 -1.306 . . . . 50.0 111.834 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -149.38 165.97 30.46 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.108 -2.182 . . . . 25.0 105.108 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.405 ' H ' ' HB ' ' A' ' 100' ' ' THR . 5.0 t -125.12 141.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.684 0 N-CA-C 103.933 -2.618 . . . . 50.0 103.933 168.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 99' ' ' ILE . 91.0 mt -127.54 132.33 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 116.749 -1.596 . . . . 25.0 109.019 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.53 139.17 44.85 Favored 'General case' 0 C--O 1.263 1.793 0 O-C-N 128.467 3.605 . . . . 50.0 110.55 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.5 116.23 17.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 25.0 112.039 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 t -129.36 127.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 125.089 1.493 . . . . 50.0 108.572 -162.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -119.23 108.98 15.31 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 119.286 0.948 . . . . 25.0 113.027 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.32 116.41 11.62 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 126.762 2.025 . . . . 25.0 109.545 -173.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.4 t -87.68 136.38 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.44 -1.689 . . . . 50.0 106.44 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -95.63 -25.25 16.21 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 115.843 1.794 . . . . 25.0 115.843 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.0 5.65 50.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.082 1.42 . . . . 25.0 113.277 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.9 p -139.6 -177.23 4.85 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 104.179 -2.526 . . . . 25.0 104.179 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.78 -7.23 41.03 Favored 'General case' 0 CA--C 1.481 -1.704 0 O-C-N 125.089 1.493 . . . . 25.0 107.155 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -85.28 176.96 8.01 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 116.565 2.061 . . . . 25.0 116.565 -170.567 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.91 146.87 28.09 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -78.7 133.91 37.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.22 -1.77 . . . . 50.0 106.22 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -136.58 123.05 20.8 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 126.299 1.839 . . . . 50.0 110.752 -172.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.63 142.67 33.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 103.645 -2.724 . . . . 25.0 103.645 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.96 144.24 24.27 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 102.317 -3.216 . . . . 75.0 102.317 -168.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.2 mt -138.81 122.03 19.02 Favored 'Isoleucine or valine' 0 C--O 1.261 1.706 0 CA-C-O 124.131 1.92 . . . . 25.0 106.162 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -75.59 126.68 31.48 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 112.459 -2.155 . . . . 25.0 106.694 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.84 159.17 39.58 Favored 'Isoleucine or valine' 0 C--O 1.264 1.833 0 O-C-N 117.362 -3.336 . . . . 50.0 116.811 -171.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -133.14 113.65 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 103.953 -2.61 . . . . 25.0 103.953 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.9 mt -116.43 122.5 44.97 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 105.238 -2.134 . . . . 50.0 105.238 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.3 m -135.19 159.83 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 N-CA-C 117.749 2.5 . . . . 50.0 117.749 -172.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -61.36 140.28 58.04 Favored 'General case' 0 C--O 1.189 -2.102 0 O-C-N 121.026 -1.046 . . . . 25.0 110.779 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.9 pttt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 116.266 -1.826 . . . . 25.0 110.52 170.627 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.1 m80 . . . . . 0 N--CA 1.506 2.352 0 CA-C-O 123.733 1.73 . . . . 25.0 109.608 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.7 173.62 42.44 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 127.244 2.355 . . . . 25.0 116.754 -173.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -151.55 164.39 36.94 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-N 119.814 1.807 . . . . 50.0 113.357 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.67 135.24 27.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.647 -1.242 . . . . 25.0 107.647 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -107.89 -36.08 6.47 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 113.378 0.881 . . . . 25.0 113.378 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -148.7 158.84 39.41 Favored Pre-proline 0 C--O 1.286 3.011 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.17 145.26 77.58 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 C-N-CA 133.005 2.502 . . . . 25.0 111.966 -3.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.39 -169.61 52.76 Favored Glycine 0 C--O 1.214 -1.15 0 CA-C-N 113.107 -1.86 . . . . 25.0 111.767 162.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 t -140.89 121.7 14.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.598 1.959 . . . . 25.0 107.025 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.12 -16.8 36.82 Favored 'General case' 0 C--O 1.259 1.59 0 C-N-CA 116.975 -1.89 . . . . 25.0 107.724 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.66 -35.38 70.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 123.453 1.597 . . . . 25.0 110.783 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.28 92.64 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 112.875 -1.966 . . . . 25.0 111.965 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.257 1.456 0 CA-C-N 113.228 -1.806 . . . . 75.0 114.956 175.726 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 117.643 2.46 . . . . 25.0 117.643 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -63.61 -50.17 70.43 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 120.674 1.579 . . . . 50.0 113.538 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -135.69 42.8 0.78 Allowed Pre-proline 0 N--CA 1.517 2.911 0 N-CA-C 117.347 2.351 . . . . 25.0 117.347 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.43 -15.72 12.36 Favored 'Trans proline' 0 C--N 1.375 1.941 1 C-N-CA 108.82 -6.987 . . . . 25.0 118.324 -170.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -71.7 -39.17 70.38 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -83.86 51.76 2.12 Favored 'General case' 0 C--O 1.266 1.921 0 CA-C-N 113.265 -1.788 . . . . 25.0 112.408 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.4 tp -87.18 111.45 20.99 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.29 1.043 . . . . 50.0 108.325 170.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -78.45 161.78 26.86 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-O 124.869 2.271 . . . . 25.0 110.558 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.69 144.67 50.47 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 104.89 -2.263 . . . . 25.0 104.89 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -135.69 146.25 47.56 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 106.314 -1.735 . . . . 25.0 106.314 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.2 mttt . . . . . 0 N--CA 1.428 -1.528 0 N-CA-C 104.63 -2.359 . . . . 25.0 104.63 175.576 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.6 mt . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 116.222 -1.847 . . . . 50.0 111.714 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.75 -32.75 73.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 125.982 2.051 . . . . 50.0 108.726 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.85 -13.28 69.86 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 125.079 2.489 . . . . 25.0 112.094 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.03 0.11 87.88 Favored Glycine 0 CA--C 1.488 -1.644 0 CA-C-N 112.921 -1.639 . . . . 25.0 112.082 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.9 -28.03 39.88 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 O-C-N 121.578 -0.954 . . . . 25.0 110.827 168.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.45 -22.99 61.0 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 117.611 -1.185 . . . . 75.0 112.097 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.17 -23.95 51.52 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.54 1.063 . . . . 50.0 110.116 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -87.02 11.78 12.86 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 125.324 1.64 . . . . 25.0 110.168 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -132.56 23.45 4.36 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.212 1.958 . . . . 25.0 110.636 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.7 t -87.94 155.97 19.58 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 114.496 -1.229 . . . . 25.0 109.487 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.57 -35.73 66.08 Favored 'General case' 0 CA--C 1.484 -1.561 0 O-C-N 120.334 -1.479 . . . . 25.0 112.115 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -79.45 -4.39 50.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.851 2.537 . . . . 25.0 117.851 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -74.95 86.1 2.28 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 111.742 -2.481 . . . . 25.0 113.081 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -76.52 175.77 8.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 109.194 -3.639 . . . . 25.0 111.391 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -75.98 152.81 36.91 Favored 'General case' 0 C--O 1.192 -1.95 0 CA-C-N 112.129 -2.305 . . . . 50.0 115.431 -144.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -75.28 128.48 35.53 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.843 -1.143 . . . . 25.0 109.913 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -84.5 130.55 34.74 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.394 -2.066 . . . . 25.0 108.501 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.17 125.9 44.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mmt -131.01 129.03 41.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 115.651 -2.119 . . . . 25.0 107.559 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.7 p -80.57 173.88 12.16 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 127.713 3.133 . . . . 25.0 107.685 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.91 159.69 46.04 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 117.693 1.837 . . . . 25.0 117.693 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 174.05 25.21 Favored Glycine 0 C--O 1.216 -1.001 0 CA-C-N 112.161 -2.019 . . . . 25.0 112.067 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.51 148.42 31.83 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 118.045 -3.032 . . . . 25.0 108.845 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.08 154.05 49.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.287 -1.746 . . . . 25.0 106.287 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.9 m -83.64 138.54 33.29 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.597 -1.241 . . . . 25.0 111.761 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . 0.294 71.0 m-85 -124.88 123.85 40.81 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 102.363 -3.199 . . . . 50.0 102.363 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.9 m -139.37 137.78 36.02 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.984 -1.858 . . . . 25.0 105.984 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -120.52 147.07 45.64 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 116.288 -1.815 . . . . 25.0 106.612 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 t -122.26 137.19 54.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.932 1.395 . . . . 25.0 107.368 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.22 158.15 36.4 Favored 'General case' 0 C--O 1.188 -2.132 0 CA-C-O 124.28 1.991 . . . . 50.0 113.311 -172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 p -120.04 16.14 12.46 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 102.964 -2.976 . . . . 25.0 102.964 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.42 125.29 79.18 Favored Pre-proline 0 C--O 1.255 1.366 0 CA-C-O 113.456 -3.164 . . . . 25.0 111.847 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -88.47 -6.5 6.06 Favored 'Trans proline' 0 C--N 1.292 -2.395 0 N-CA-C 108.954 -1.21 . . . . 25.0 108.954 156.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -56.03 139.01 48.16 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.165 -1.38 . . . . 25.0 114.526 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.44 109.28 20.41 Favored 'General case' 0 C--O 1.202 -1.437 0 N-CA-C 114.63 1.344 . . . . 25.0 114.63 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.7 m -66.21 148.44 51.84 Favored 'General case' 0 C--O 1.192 -1.946 0 N-CA-C 106.231 -1.766 . . . . 25.0 106.231 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 p -100.49 -42.06 6.74 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 124.258 1.98 . . . . 25.0 110.09 166.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -164.99 144.2 6.77 Favored 'General case' 0 C--O 1.191 -1.995 0 O-C-N 118.788 -2.445 . . . . 25.0 113.062 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.42 139.64 38.99 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 115.085 -2.646 . . . . 25.0 109.716 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -148.4 152.08 36.38 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.014 -1.678 . . . . 25.0 110.195 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.19 143.56 40.27 Favored 'General case' 0 C--O 1.197 -1.702 0 O-C-N 127.68 3.113 . . . . 50.0 110.9 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.87 166.63 17.12 Favored 'General case' 0 C--O 1.258 1.527 0 N-CA-C 106.39 -1.707 . . . . 50.0 106.39 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 pt -120.99 154.88 24.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 102.694 -3.076 . . . . 25.0 102.694 161.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.5 p -74.97 151.82 38.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.798 -1.189 . . . . 25.0 111.124 163.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -122.29 133.42 54.68 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.216 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.0 157.87 32.36 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 126.429 1.892 . . . . 25.0 108.734 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.87 38.56 7.94 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 118.121 -2.862 . . . . 25.0 118.333 165.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 168.5 9.7 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -144.08 124.29 7.58 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 114.814 -1.085 . . . . 25.0 109.96 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -58.26 -30.08 89.77 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 114.289 -3.341 . . . . 25.0 118.297 172.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.23 1.02 5.27 Favored 'General case' 0 C--O 1.198 -1.634 0 C-N-CA 116.542 -2.063 . . . . 75.0 115.403 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -132.84 173.13 6.25 Favored Pre-proline 0 C--O 1.199 -1.589 0 N-CA-C 104.849 -2.278 . . . . 25.0 104.849 -167.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 27.1 Cg_exo -50.65 20.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.398 2 C-N-CA 129.738 6.959 . . . . 25.0 124.732 173.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -16.71 -49.82 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.017 1 N-CA-C 121.959 4.059 . . . . 50.0 121.959 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -77.58 -8.56 58.03 Favored 'General case' 0 CA--C 1.479 -1.76 1 O-C-N 114.005 -5.434 . . . . 25.0 113.306 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -108.85 -40.73 4.95 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 126.728 2.011 . . . . 25.0 114.76 164.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 109' ' ' PRO . . . -79.27 13.97 1.69 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 127.791 3.182 . . . . 25.0 114.358 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -26.88 67.87 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.481 -0.933 . . . . 25.0 108.481 168.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -137.31 174.14 10.93 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 119.391 3.108 . . . . 50.0 119.391 -171.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -127.8 128.93 46.14 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.566 -1.197 . . . . 25.0 108.265 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 tp -70.16 123.35 21.41 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 103.46 -2.793 . . . . 50.0 103.46 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.9 pt -105.68 -12.93 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.54 1.162 . . . . 25.0 107.937 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.96 154.19 11.68 Favored Glycine 0 CA--C 1.501 -0.81 0 O-C-N 119.117 -2.239 . . . . 25.0 116.791 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.39 139.95 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 126.362 1.86 . . . . 25.0 109.944 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 t -134.69 103.64 11.05 Favored Pre-proline 0 CA--C 1.572 1.8 0 CA-C-O 125.727 2.68 . . . . 50.0 116.863 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.15 157.44 37.97 Favored 'Trans proline' 0 C--O 1.252 1.211 0 O-C-N 115.971 -2.7 . . . . 25.0 108.656 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -82.55 106.48 14.44 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-O 123.917 1.818 . . . . 25.0 110.37 171.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -140.12 -46.53 0.43 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 120.276 3.435 . . . . 50.0 120.276 -174.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 156.17 175.57 27.3 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 105.581 -3.008 . . . . 25.0 105.581 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 p 59.46 162.4 0.1 OUTLIER Pre-proline 0 C--O 1.251 1.176 0 N-CA-C 119.491 3.145 . . . . 25.0 119.491 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.63 1.98 3.87 Favored 'Trans proline' 0 C--N 1.371 1.716 1 C-N-CA 113.147 -4.102 . . . . 25.0 118.591 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -43.12 57.18 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 123.642 1.687 . . . . 25.0 109.877 172.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.1 t -77.46 -26.67 51.65 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.819 -4.301 . . . . 25.0 111.576 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -67.26 -20.86 65.72 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 125.197 2.427 . . . . 25.0 115.614 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -62.31 127.69 32.51 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 112.071 -2.331 . . . . 25.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.5 tp -122.21 4.12 9.78 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.403 -1.702 . . . . 75.0 106.403 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.5 t -128.85 136.36 50.35 Favored 'General case' 0 CA--C 1.47 -2.131 0 N-CA-C 102.442 -3.17 . . . . 25.0 102.442 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -147.88 153.24 38.85 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 106.053 -1.832 . . . . 25.0 106.053 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.823 -1.561 . . . . 25.0 107.925 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.23 129.65 75.43 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-O 113.113 -3.327 . . . . 25.0 108.852 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -73.9 135.51 43.31 Favored 'General case' 0 C--O 1.187 -2.189 0 O-C-N 128.725 3.766 . . . . 50.0 114.173 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.4 mm -113.07 121.67 37.62 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 115.833 -2.032 . . . . 25.0 108.095 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -58.12 147.38 83.65 Favored 'Trans proline' 0 CA--C 1.483 -2.054 1 C-N-CA 112.099 -4.801 . . . . 25.0 114.946 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.08 -11.24 47.68 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 111.557 -2.565 . . . . 25.0 112.555 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -112.19 -9.26 13.94 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 118.818 -1.153 . . . . 50.0 111.464 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -108.99 160.91 15.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 118.921 -2.362 . . . . 25.0 112.387 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 170' ' ' VAL 0.304 2.6 mp -138.95 132.92 31.09 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 128.191 2.596 . . . . 50.0 106.572 178.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.3 148.89 5.25 Favored Glycine 0 C--O 1.272 2.498 0 CA-C-O 127.078 3.599 . . . . 25.0 118.575 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.88 143.78 57.58 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 108.671 -3.765 . . . . 50.0 109.364 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -151.02 165.5 33.59 Favored 'General case' 0 C--O 1.269 2.094 0 N-CA-C 101.561 -3.496 . . . . 25.0 101.561 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.42 136.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 104.243 -2.503 . . . . 50.0 104.243 166.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -78.48 125.96 38.3 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 CA-C-O 114.711 -2.566 . . . . 25.0 106.031 164.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.36 131.62 53.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 103.104 -2.925 . . . . 50.0 103.104 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.29 146.15 44.32 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-O 126.345 2.974 . . . . 25.0 107.003 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -128.27 138.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 119.961 -1.712 . . . . 50.0 107.985 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -138.47 94.56 2.87 Favored 'General case' 0 C--O 1.196 -1.729 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -96.58 146.33 24.92 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-O 126.113 2.863 . . . . 25.0 105.184 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . 0.25 41.3 t -116.82 128.29 74.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 111.16 -2.745 . . . . 50.0 109.196 -169.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.56 -29.63 62.55 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.616 1.966 . . . . 25.0 110.579 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.05 -20.8 60.91 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 114.787 1.402 . . . . 25.0 114.787 -169.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.1 t -151.55 159.15 44.24 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 116.791 -1.576 . . . . 25.0 107.951 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.07 -1.36 28.6 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 117.765 -1.112 . . . . 25.0 112.596 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -103.34 160.57 14.58 Favored 'General case' 0 CA--C 1.569 1.695 0 O-C-N 124.91 1.381 . . . . 25.0 108.463 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.4 -173.89 4.52 Favored 'General case' 0 C--O 1.189 -2.093 0 O-C-N 120.304 -1.497 . . . . 25.0 109.545 -167.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -113.42 148.22 36.28 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.516 -1.661 . . . . 50.0 106.516 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -146.48 118.48 8.22 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.356 -2.461 . . . . 50.0 104.356 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.99 153.29 49.42 Favored 'General case' 0 C--O 1.265 1.899 0 O-C-N 120.734 -1.229 . . . . 25.0 110.063 -164.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.17 152.05 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 125.558 1.786 . . . . 75.0 108.367 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.2 mt -140.57 121.82 14.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.675 0 N-CA-C 105.046 -2.205 . . . . 25.0 105.046 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.47 142.67 44.85 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.522 -1.361 . . . . 25.0 108.632 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.2 163.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 124.903 1.377 . . . . 50.0 109.715 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -133.88 103.56 5.89 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.8 mt -99.73 133.51 43.98 Favored 'General case' 0 C--O 1.16 -3.611 0 N-CA-C 103.289 -2.856 . . . . 50.0 103.289 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 16.0 m -139.17 179.03 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-O 123.743 1.735 . . . . 50.0 111.908 -174.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -64.94 172.21 3.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.748 -2.478 . . . . 25.0 115.969 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 114.784 -2.531 . . . . 25.0 107.985 -177.409 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.511 2.612 0 CA-C-O 123.853 1.787 . . . . 25.0 111.216 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.87 -160.92 30.3 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 111.829 -2.441 . . . . 25.0 118.642 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -156.06 157.34 35.92 Favored 'General case' 0 C--O 1.261 1.683 0 N-CA-C 105.123 -2.177 . . . . 50.0 105.123 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.2 mm -84.09 110.26 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 O-C-N 119.47 -2.018 . . . . 25.0 107.286 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.96 -38.78 20.57 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 123.044 2.657 . . . . 25.0 109.946 170.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.82 149.25 63.82 Favored Pre-proline 0 N--CA 1.518 2.974 0 N-CA-C 104.004 -2.591 . . . . 25.0 104.004 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.07 160.69 93.42 Favored 'Cis proline' 0 C--O 1.252 1.213 0 C-N-CA 129.47 1.029 . . . . 25.0 113.159 -9.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.0 -173.09 52.09 Favored Glycine 0 C--N 1.286 -2.23 0 N-CA-C 117.84 1.896 . . . . 25.0 117.84 155.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 t -153.59 75.96 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 103.009 -2.96 . . . . 25.0 103.009 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -70.55 -7.91 47.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.436 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.28 -40.74 49.16 Favored 'General case' 0 C--O 1.255 1.369 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 161.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.4 67.6 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 114.359 1.244 . . . . 25.0 114.359 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 mt . . . . . 0 C--O 1.21 -1.005 0 CA-C-O 122.743 1.259 . . . . 75.0 113.73 175.502 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.205 -1.284 0 N-CA-C 121.0 3.704 . . . . 25.0 121.0 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.3 -34.1 73.31 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-N 114.983 -1.008 . . . . 50.0 109.15 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.02 47.02 0.54 Allowed Pre-proline 0 C--O 1.294 3.447 0 N-CA-C 118.172 2.656 . . . . 25.0 118.172 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.75 -11.37 31.72 Favored 'Trans proline' 0 CA--C 1.487 -1.874 0 C-N-CA 121.372 1.381 . . . . 25.0 111.966 -159.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -116.98 6.75 13.02 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.74 0.7 . . . . 25.0 112.363 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -89.83 55.73 3.26 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 117.906 -2.996 . . . . 25.0 112.17 -171.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.3 mt -103.67 96.08 6.48 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 118.009 -0.996 . . . . 50.0 112.964 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -123.87 157.4 34.28 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 103.721 -2.696 . . . . 25.0 103.721 166.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.84 42.2 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.713 -2.039 . . . . 25.0 110.225 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.02 150.07 47.03 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 121.992 2.178 . . . . 25.0 108.693 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.9 mttt . . . . . 0 N--CA 1.441 -0.908 0 C-N-CA 123.808 0.843 . . . . 25.0 111.605 171.302 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.4 mt . . . . . 0 C--O 1.27 2.184 0 CA-C-O 126.574 3.083 . . . . 50.0 104.696 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -73.69 -24.48 59.96 Favored 'General case' 0 CA--C 1.481 -1.678 1 O-C-N 116.272 -4.018 . . . . 50.0 113.975 -174.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -36.84 80.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-O 124.374 2.097 . . . . 25.0 108.239 167.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.85 -31.28 72.7 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 119.992 -1.887 . . . . 25.0 113.809 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.17 -50.23 65.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 117.582 -3.305 . . . . 25.0 110.432 167.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.98 -26.9 67.04 Favored 'General case' 1 C--O 1.319 4.725 0 CA-C-N 121.593 1.997 . . . . 75.0 107.418 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.11 -29.53 67.61 Favored 'General case' 0 C--O 1.27 2.133 0 C-N-CA 119.997 -0.681 . . . . 50.0 110.121 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -79.11 56.81 2.09 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-O 123.444 1.592 . . . . 25.0 109.391 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -91.94 60.41 3.84 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 118.644 -2.535 . . . . 25.0 106.39 167.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.0 p -146.97 -164.2 1.94 Allowed 'General case' 0 C--O 1.273 2.342 0 CA-C-N 111.303 -2.681 . . . . 25.0 116.633 -164.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.44 -26.92 68.76 Favored 'General case' 0 C--O 1.267 1.981 0 O-C-N 119.604 -1.935 . . . . 25.0 111.17 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -87.35 16.01 5.81 Favored 'General case' 0 C--O 1.264 1.845 0 N-CA-C 116.01 1.856 . . . . 25.0 116.01 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -75.21 89.39 2.53 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 123.879 1.799 . . . . 25.0 108.676 173.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -18.49 142.79 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 108.596 -3.911 . . . . 25.0 121.148 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.13 125.79 26.07 Favored 'General case' 0 N--CA 1.42 -1.949 0 O-C-N 125.459 1.724 . . . . 50.0 111.546 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -117.78 149.74 40.29 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 119.213 3.042 . . . . 25.0 119.213 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -142.61 126.07 16.73 Favored 'General case' 0 CA--C 1.591 2.538 0 N-CA-C 117.276 2.324 . . . . 25.0 117.276 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.54 125.37 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 O-C-N 117.735 -3.103 . . . . 25.0 106.919 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttt -148.06 161.84 40.59 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 102.539 -3.134 . . . . 25.0 102.539 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 64.6 p -88.71 166.67 13.91 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 119.672 -1.893 . . . . 25.0 112.209 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.87 176.41 51.1 Favored Glycine 0 C--O 1.256 1.499 0 C-N-CA 116.792 -2.623 . . . . 25.0 115.704 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.89 -171.79 19.12 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 105.118 -3.193 . . . . 25.0 105.118 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.64 141.1 58.89 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 103.792 -2.67 . . . . 25.0 103.792 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -111.26 144.34 40.59 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 101.814 -3.402 . . . . 25.0 101.814 158.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -126.15 120.83 31.13 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 100.996 -3.705 . . . . 25.0 100.996 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.44 ' CE2' HD12 ' A' ' 136' ' ' ILE . 77.9 m-85 -114.59 119.33 36.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 118.73 -2.481 . . . . 50.0 109.61 -172.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 m -131.61 97.26 4.17 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 100.019 -4.067 . . . . 25.0 100.019 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -112.53 116.28 29.99 Favored 'General case' 1 N--CA 1.539 4.01 0 O-C-N 126.614 2.446 . . . . 25.0 106.657 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.251 2.1 p -127.07 157.33 39.91 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 125.56 1.788 . . . . 25.0 106.228 -162.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -113.52 140.43 48.14 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 127.503 2.321 . . . . 50.0 107.097 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -88.1 -9.59 52.79 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 123.807 1.765 . . . . 25.0 108.773 -169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.94 149.1 38.05 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 101.639 -3.467 . . . . 25.0 101.639 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.68 147.36 75.72 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 118.167 -0.755 . . . . 25.0 113.558 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -141.85 141.83 33.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 117.647 -1.168 . . . . 25.0 110.935 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -80.75 159.58 25.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 117.99 -1.484 . . . . 25.0 113.776 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.9 m -150.48 148.23 28.47 Favored 'General case' 0 C--O 1.208 -1.122 0 C-N-CA 125.903 1.681 . . . . 25.0 109.695 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.7 p -111.21 -29.39 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.583 1.953 . . . . 25.0 112.486 170.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -166.96 158.87 12.84 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.405 1.482 . . . . 25.0 107.777 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -143.74 146.35 33.08 Favored 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 2.2 m-70 -144.48 149.37 35.85 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 120.329 -1.482 . . . . 25.0 110.59 -167.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -130.59 134.7 47.21 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 113.097 -1.865 . . . . 50.0 110.776 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.33 171.09 11.81 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 103.493 -2.78 . . . . 50.0 103.493 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.39 155.95 41.17 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 N-CA-C 103.321 -2.844 . . . . 25.0 103.321 167.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.295 33.5 p -81.52 153.91 26.55 Favored 'General case' 0 CA--C 1.469 -2.173 0 CA-C-O 124.096 1.903 . . . . 25.0 106.925 165.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -87.85 107.99 18.95 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 112.392 -2.185 . . . . 25.0 110.884 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -49.57 117.7 2.37 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 105.696 -1.965 . . . . 25.0 105.696 155.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.66 33.28 34.77 Favored Glycine 0 C--O 1.192 -2.515 0 CA-C-O 117.693 -1.615 . . . . 25.0 115.726 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -51.02 159.83 0.55 Allowed 'General case' 0 C--O 1.259 1.576 0 CA-C-O 122.267 1.032 . . . . 25.0 108.446 169.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -102.9 107.49 55.06 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 102.075 -3.306 . . . . 25.0 102.075 167.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -72.54 -16.34 27.24 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.552 2.168 . . . . 25.0 116.28 -173.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -84.2 -2.61 57.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.392 -1.731 . . . . 75.0 106.873 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -132.48 154.54 81.58 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 103.513 -2.773 . . . . 25.0 103.513 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.381 72.4 Cg_exo -25.64 91.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.285 3 C-N-CA 125.506 4.138 . . . . 25.0 122.529 -167.468 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.42 -15.34 61.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 110.883 -2.871 . . . . 50.0 112.928 -171.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 6.36 11.21 Favored 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 120.027 -1.671 . . . . 25.0 111.866 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -136.62 -46.11 0.6 Allowed 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 118.166 2.654 . . . . 25.0 118.166 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.35 -4.48 53.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.44 1.644 . . . . 25.0 115.44 165.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.61 7.8 16.22 Favored 'General case' 0 C--O 1.274 2.346 0 C-N-CA 125.645 1.578 . . . . 25.0 114.917 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -141.69 166.95 23.34 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 126.041 2.088 . . . . 50.0 106.95 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -134.27 154.41 51.3 Favored 'General case' 0 C--O 1.176 -2.796 0 N-CA-C 105.954 -1.869 . . . . 25.0 105.954 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.32 120.72 38.21 Favored 'General case' 0 CA--C 1.58 2.097 0 O-C-N 120.507 -1.371 . . . . 50.0 112.647 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.292 4.8 tp -98.13 -19.51 5.94 Favored 'Isoleucine or valine' 0 C--O 1.274 2.352 0 C-N-CA 126.738 2.015 . . . . 25.0 106.416 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.77 164.93 26.31 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 113.331 -1.759 . . . . 25.0 117.149 162.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . . . -138.84 157.65 45.66 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 101.531 -3.507 . . . . 25.0 101.531 166.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.9 130.44 13.01 Favored Pre-proline 0 C--O 1.245 0.866 0 N-CA-C 102.832 -3.025 . . . . 50.0 102.832 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.01 168.86 11.92 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 116.847 -1.636 . . . . 25.0 111.898 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -129.76 56.3 1.73 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.9 0.75 . . . . 25.0 109.57 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -123.93 -0.1 8.5 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 124.474 2.083 . . . . 50.0 113.316 -164.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -167.7 -165.72 25.58 Favored Glycine 0 C--O 1.258 1.608 0 N-CA-C 103.919 -3.673 . . . . 25.0 103.919 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.1 t -120.68 69.67 16.9 Favored Pre-proline 0 CA--C 1.556 1.19 0 O-C-N 126.411 1.889 . . . . 25.0 115.318 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.3 178.79 7.2 Favored 'Trans proline' 0 CA--C 1.578 2.682 0 C-N-CA 121.613 1.542 . . . . 25.0 112.618 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.67 71.31 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.36 2.14 2.5 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.992 1.317 . . . . 25.0 114.312 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -70.94 -16.8 62.68 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 124.162 1.934 . . . . 25.0 111.04 170.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -68.24 125.77 27.45 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 103.906 -2.627 . . . . 25.0 103.906 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.8 tp -75.81 -7.14 53.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 118.25 -1.38 . . . . 75.0 113.997 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.9 t -85.23 144.53 28.07 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 104.705 -2.331 . . . . 25.0 104.705 173.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -137.79 135.78 36.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.178 0.806 . . . . 25.0 113.178 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -101.47 128.42 47.69 Favored 'General case' 0 C--O 1.301 3.807 0 CA-C-O 123.272 1.51 . . . . 25.0 108.912 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 82' ' ' PHE . 46.3 mt -118.32 120.98 66.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 116.089 -2.244 . . . . 25.0 108.166 175.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -83.33 117.64 23.14 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 115.255 -2.578 . . . . 50.0 110.019 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.77 97.25 27.59 Favored Pre-proline 0 C--O 1.275 2.424 0 CA-C-O 123.321 1.534 . . . . 25.0 108.686 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 132.96 20.84 Favored 'Trans proline' 0 C--N 1.372 1.771 1 C-N-CA 113.121 -4.119 . . . . 25.0 110.298 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.43 97.06 3.14 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 117.321 -3.362 . . . . 25.0 109.979 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.69 -13.02 30.0 Favored 'General case' 0 C--O 1.267 1.977 0 N-CA-C 104.87 -2.27 . . . . 50.0 104.87 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -106.83 -173.68 2.35 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.643 -1.91 . . . . 25.0 112.82 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.53 129.87 45.05 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.169 -1.582 . . . . 50.0 111.609 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 152.9 -179.95 28.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 124.707 2.282 . . . . 25.0 116.113 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.14 158.84 38.58 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 117.113 -3.581 . . . . 50.0 117.192 -153.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -158.99 168.6 26.32 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 120.579 -1.325 . . . . 25.0 110.292 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.16 135.31 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.065 0 N-CA-C 103.775 -2.676 . . . . 50.0 103.775 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 mt -85.08 134.98 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 100.758 -3.793 . . . . 25.0 100.758 167.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.4 mt -116.5 135.18 54.05 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.387 -2.079 . . . . 50.0 105.387 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.7 136.59 54.94 Favored 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 97.282 -5.081 . . . . 25.0 97.282 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.5 120.44 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 O-C-N 125.491 1.744 . . . . 50.0 108.481 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.89 121.86 35.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.071 1.76 . . . . 25.0 107.881 -175.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -102.77 134.53 46.02 Favored 'General case' 0 N--CA 1.407 -2.625 0 O-C-N 120.413 -1.43 . . . . 25.0 110.346 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.59 99.11 3.65 Favored 'Isoleucine or valine' 0 C--O 1.262 1.747 0 N-CA-C 105.93 -1.878 . . . . 50.0 105.93 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.34 66.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 117.138 -1.825 . . . . 25.0 113.167 -167.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.3 -16.69 55.98 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.379 -1.282 . . . . 25.0 113.13 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.9 p -109.68 164.64 12.35 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 120.15 1.341 . . . . 25.0 109.621 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -81.75 -36.88 28.04 Favored 'General case' 0 C--O 1.285 2.933 0 CA-C-O 123.699 1.714 . . . . 25.0 110.38 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.61 154.38 20.02 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 112.369 -2.196 . . . . 25.0 108.378 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -111.0 158.15 19.12 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 124.941 1.297 . . . . 25.0 111.411 168.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -109.94 142.71 40.91 Favored 'General case' 0 C--O 1.269 2.104 0 O-C-N 119.391 -2.068 . . . . 50.0 109.032 -165.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.16 162.34 41.06 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-O 123.459 1.599 . . . . 50.0 111.872 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -138.86 157.6 45.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.921 -1.112 . . . . 25.0 108.047 166.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.1 133.04 63.2 Favored 'Isoleucine or valine' 0 C--O 1.258 1.53 0 O-C-N 120.117 -1.614 . . . . 75.0 109.363 165.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.2 mt -136.1 119.64 23.71 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 N-CA-C 102.421 -3.177 . . . . 25.0 102.421 -169.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -83.42 133.42 34.92 Favored 'General case' 0 CA--C 1.613 3.376 0 CA-C-O 123.094 1.426 . . . . 25.0 111.241 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.53 144.33 38.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 O-C-N 119.76 -1.838 . . . . 50.0 111.577 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.78 135.14 54.97 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 100.626 -3.842 . . . . 25.0 100.626 167.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 mt -126.36 129.34 48.61 Favored 'General case' 0 C--O 1.294 3.431 0 N-CA-C 104.75 -2.315 . . . . 50.0 104.75 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.01 163.9 30.78 Favored 'Isoleucine or valine' 0 C--O 1.277 2.523 0 N-CA-C 115.714 1.746 . . . . 50.0 115.714 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -71.01 134.36 47.07 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.161 -0.962 . . . . 25.0 111.638 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.657 -1.163 . . . . 25.0 112.826 -173.622 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . 0.259 47.0 p-80 . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 122.897 1.332 . . . . 25.0 109.553 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.52 -165.02 38.85 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-O 116.546 -2.252 . . . . 25.0 114.783 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.71 151.58 33.89 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-N 122.18 2.99 . . . . 50.0 116.056 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 6' ' ' LYS . 43.9 mm -66.78 132.09 32.26 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.722 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.11 39.98 3.42 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 126.4 3.0 . . . . 25.0 107.454 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.577 ' H ' HG22 ' A' ' 4' ' ' ILE . 96.2 mttt 72.09 163.53 0.14 Allowed Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 108.512 -3.949 . . . . 25.0 115.078 169.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.78 122.05 0.42 Allowed 'Cis proline' 0 C--N 1.357 0.98 0 C-N-CA 133.055 2.523 . . . . 25.0 114.14 3.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.47 147.93 13.28 Favored Glycine 0 C--O 1.252 1.238 0 CA-C-N 114.019 -1.446 . . . . 25.0 111.239 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -145.92 134.58 22.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.406 -1.643 . . . . 25.0 108.45 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -75.16 -17.1 60.46 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 117.086 -3.509 . . . . 25.0 111.88 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.78 56.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 116.374 -1.774 . . . . 25.0 107.65 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.72 63.32 Favored 'General case' 1 C--O 1.306 4.054 0 CA-C-N 122.002 2.183 . . . . 25.0 109.642 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--N 1.301 -1.52 0 O-C-N 121.142 -0.974 . . . . 75.0 110.021 -178.253 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 ptm . . . . . 0 C--O 1.278 2.578 1 N-CA-C 122.734 4.346 . . . . 25.0 122.734 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -57.48 -47.83 80.82 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 120.242 -1.536 . . . . 50.0 113.717 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -149.35 44.66 0.34 Allowed Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 119.733 3.234 . . . . 25.0 119.733 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -79.34 -17.32 11.63 Favored 'Trans proline' 0 C--O 1.272 2.206 0 C-N-CA 115.112 -2.792 . . . . 25.0 114.413 -167.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -92.66 5.77 49.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 116.85 -1.547 . . . . 25.0 112.253 170.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -119.29 16.66 13.11 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 124.983 1.427 . . . . 25.0 111.597 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 mt -73.19 124.85 26.42 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 126.115 1.766 . . . . 50.0 108.361 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.41 164.86 20.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 118.955 -2.341 . . . . 25.0 112.334 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.26 139.02 26.83 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.188 -1.824 . . . . 25.0 111.882 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 82.1 tttt -59.8 137.55 58.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 118.206 -2.809 . . . . 25.0 112.552 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 117.559 -3.213 . . . . 25.0 103.336 178.191 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 117.797 -1.097 . . . . 50.0 112.053 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -68.78 -22.96 64.25 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.547 -0.909 . . . . 50.0 108.547 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -26.43 62.84 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 117.049 -1.973 . . . . 25.0 116.058 166.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.63 -21.22 64.72 Favored Glycine 0 C--O 1.186 -2.855 0 CA-C-O 114.435 -3.425 . . . . 25.0 112.829 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.68 -34.39 23.46 Favored 'Isoleucine or valine' 0 C--O 1.293 3.361 0 CA-C-N 124.147 3.973 . . . . 25.0 112.402 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.72 -18.85 56.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 125.794 1.934 . . . . 75.0 107.51 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.266 4.8 t70 -43.19 -39.77 3.05 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 115.35 1.611 . . . . 50.0 115.35 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -78.05 10.63 2.76 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 116.442 2.015 . . . . 25.0 116.442 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -147.97 47.11 1.08 Allowed 'General case' 0 C--O 1.255 1.395 0 C-N-CA 128.179 2.591 . . . . 25.0 110.269 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 t -144.52 161.19 39.71 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 119.254 3.057 . . . . 25.0 119.254 -166.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -68.21 -17.4 64.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 122.151 2.251 . . . . 25.0 108.907 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -96.54 26.25 4.56 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.322 36.5 ttp180 -78.56 67.79 4.4 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-O 123.491 1.615 . . . . 25.0 110.418 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -61.84 145.39 52.83 Favored 'General case' 0 CA--C 1.454 -2.715 1 CA-C-N 107.191 -4.549 . . . . 25.0 111.745 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.435 ' H ' ' HD1' ' A' ' 71' ' ' PHE . 5.8 p90 -77.17 144.48 38.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.38 -1.736 . . . . 50.0 113.354 -166.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 166' ' ' ASP . 59.8 mttm -107.76 165.53 11.37 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-O 118.311 -0.852 . . . . 25.0 111.541 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.512 ' H ' ' HA ' ' A' ' 167' ' ' VAL . 3.6 m80 -127.72 122.16 32.17 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 126.204 1.802 . . . . 25.0 107.023 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.3 mt -83.7 126.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 103.511 -2.774 . . . . 25.0 103.511 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.8 mtp -138.15 156.4 47.77 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 126.051 2.834 . . . . 25.0 105.013 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.7 p -91.88 166.05 12.93 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.786 -2.302 . . . . 25.0 104.786 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.74 167.85 52.05 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-O 116.793 -2.115 . . . . 25.0 115.213 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.4 171.01 12.95 Favored Glycine 0 CA--C 1.555 2.559 1 N-CA-C 102.906 -4.077 . . . . 25.0 102.906 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 11.7 tt0 -62.92 144.9 56.32 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.572 -1.546 . . . . 25.0 111.258 168.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -136.11 146.75 47.33 Favored 'General case' 0 CA--C 1.445 -3.082 0 O-C-N 119.802 -1.811 . . . . 25.0 107.907 162.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.1 m -101.91 137.27 40.43 Favored 'General case' 0 CA--C 1.468 -2.198 0 C-N-CA 124.907 1.283 . . . . 25.0 109.216 167.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -114.79 140.93 48.52 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.856 -1.778 . . . . 50.0 106.669 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -127.32 136.16 51.54 Favored 'General case' 0 C--O 1.19 -2.059 0 CA-C-O 125.014 2.34 . . . . 25.0 111.109 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -129.99 158.85 38.43 Favored 'General case' 0 C--O 1.28 2.676 1 N-CA-C 97.988 -4.819 . . . . 25.0 97.988 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 t -147.23 155.04 41.73 Favored 'General case' 0 CA--C 1.476 -1.886 0 CA-C-N 119.68 1.127 . . . . 25.0 111.108 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.22 162.26 28.27 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 105.162 -2.162 . . . . 50.0 105.162 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 t -116.51 -9.2 11.45 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-N 120.244 1.383 . . . . 25.0 113.107 167.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.6 31.29 Favored Pre-proline 0 CA--C 1.481 -1.687 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 168.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.01 155.88 61.03 Favored 'Trans proline' 0 CA--C 1.486 -1.887 1 C-N-CA 113.032 -4.179 . . . . 25.0 116.586 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -86.02 156.56 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 104.601 -2.37 . . . . 25.0 104.601 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -80.16 132.22 35.87 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.762 -2.31 . . . . 25.0 104.762 166.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 m -152.48 153.59 33.8 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 116.039 -1.934 . . . . 25.0 109.542 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 p -114.66 -43.27 3.17 Favored 'General case' 0 C--O 1.275 2.43 0 C-N-CA 125.201 1.401 . . . . 25.0 108.76 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -151.16 144.6 24.87 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 117.911 -2.993 . . . . 25.0 110.766 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . 0.262 51.5 p-90 -114.45 150.01 35.4 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 117.902 -1.519 . . . . 25.0 112.403 166.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -136.17 150.28 48.97 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 103.885 -2.635 . . . . 25.0 103.885 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . 0.252 7.1 p90 -147.23 149.4 32.83 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 106.12 -1.808 . . . . 50.0 106.12 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -152.98 163.54 39.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.42 -1.696 . . . . 50.0 106.42 -157.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.02 167.3 20.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 115.529 -2.177 . . . . 25.0 107.657 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.4 p -96.69 157.95 15.66 Favored 'General case' 0 C--O 1.203 -1.373 0 O-C-N 125.718 1.886 . . . . 25.0 109.298 170.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -74.03 92.02 2.11 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 111.292 -2.685 . . . . 25.0 114.274 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.99 113.93 2.11 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 126.457 2.348 . . . . 25.0 114.323 165.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.13 35.47 9.7 Favored Glycine 0 C--O 1.25 1.131 0 CA-C-N 115.05 -0.977 . . . . 25.0 114.097 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 162.4 28.81 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 113.603 -1.299 . . . . 25.0 112.75 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.15 143.83 40.02 Favored Pre-proline 0 C--O 1.194 -1.867 0 CA-C-N 115.518 -0.764 . . . . 25.0 109.394 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.62 -18.18 17.64 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 114.85 -2.967 . . . . 25.0 118.82 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -83.69 9.2 12.26 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 118.779 -2.451 . . . . 75.0 109.172 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -128.0 169.74 11.9 Favored Pre-proline 0 C--O 1.285 2.954 0 N-CA-C 101.74 -3.43 . . . . 25.0 101.74 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -55.66 28.21 0.02 OUTLIER 'Trans proline' 0 C--O 1.243 0.753 1 C-N-CA 129.121 6.547 . . . . 25.0 122.359 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.95 -40.15 66.56 Favored 'General case' 0 C--O 1.197 -1.659 0 CA-C-N 119.773 1.17 . . . . 50.0 112.939 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -85.34 -5.7 59.29 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 115.938 1.829 . . . . 25.0 115.938 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -111.37 -66.54 1.07 Allowed 'General case' 0 CA--C 1.475 -1.937 0 O-C-N 119.978 -1.701 . . . . 25.0 107.927 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.24 54.02 1.2 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.516 2.326 . . . . 25.0 109.251 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . 0.251 9.9 t0 -60.68 -42.24 96.73 Favored 'General case' 0 CA--C 1.596 2.746 0 CA-C-N 110.099 -3.228 . . . . 25.0 110.267 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 126.172 2.17 . . . . 50.0 112.428 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -141.8 129.52 21.62 Favored 'General case' 0 C--O 1.195 -1.774 0 O-C-N 126.364 2.29 . . . . 25.0 112.057 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.06 129.94 41.52 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 115.192 -2.337 . . . . 50.0 110.685 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.4 tt -105.59 -20.5 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 122.114 2.233 . . . . 25.0 106.797 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.65 161.36 27.22 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 120.567 -0.825 . . . . 25.0 114.566 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.5 133.4 14.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 123.0 1.381 . . . . 25.0 111.064 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.76 97.61 38.46 Favored Pre-proline 0 N--CA 1.499 1.982 0 CA-C-N 112.552 -2.113 . . . . 50.0 111.228 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.99 152.73 76.53 Favored 'Trans proline' 0 C--N 1.347 0.479 0 N-CA-C 116.79 1.804 . . . . 25.0 116.79 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -79.09 69.31 5.25 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.702 1.251 . . . . 25.0 111.222 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -74.95 -31.32 61.46 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 119.341 -2.099 . . . . 50.0 113.089 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.17 -5.26 71.53 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-O 117.94 -1.478 . . . . 25.0 113.89 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.0 p -71.7 166.19 42.24 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 126.429 1.899 . . . . 25.0 109.054 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.29 -10.94 26.36 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 116.23 -2.046 . . . . 25.0 117.039 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.4 -30.8 42.56 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 121.616 -0.677 . . . . 25.0 109.21 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 48.0 t -74.87 -44.86 46.7 Favored 'General case' 0 C--O 1.285 2.936 0 CA-C-O 124.141 1.924 . . . . 25.0 108.086 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -64.01 -23.96 67.53 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 111.941 -2.39 . . . . 25.0 113.799 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.25 109.19 12.16 Favored 'General case' 0 CA--C 1.58 2.115 0 O-C-N 124.99 1.431 . . . . 25.0 110.38 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.1 tp -83.35 -33.78 25.76 Favored 'General case' 0 C--O 1.193 -1.901 0 C-N-CA 127.214 2.206 . . . . 75.0 108.17 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -80.36 128.27 33.37 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 115.987 -2.285 . . . . 25.0 108.45 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -124.44 153.86 41.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 125.314 1.634 . . . . 25.0 114.327 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -98.59 148.55 23.67 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.6 mt -142.27 129.2 19.38 Favored 'Isoleucine or valine' 0 C--O 1.264 1.818 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 71.1 t80 -75.95 120.11 20.84 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 120.401 -1.437 . . . . 50.0 113.135 169.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.53 122.81 44.96 Favored Pre-proline 0 C--O 1.206 -1.227 0 N-CA-C 101.918 -3.364 . . . . 25.0 101.918 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -61.43 153.2 67.73 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 123.775 1.408 . . . . 25.0 109.805 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -110.35 -0.09 17.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 119.566 -1.959 . . . . 25.0 112.493 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.91 -8.36 57.33 Favored 'General case' 0 C--O 1.265 1.896 0 N-CA-C 116.583 2.068 . . . . 50.0 116.583 -172.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -133.92 151.38 51.47 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 116.798 2.147 . . . . 25.0 116.798 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 171' ' ' ASN . 90.5 mt -100.0 155.73 17.54 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.56 1.544 . . . . 50.0 107.676 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.17 157.01 10.08 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 123.371 4.108 . . . . 25.0 123.371 172.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 0.1 OUTLIER -80.68 146.0 31.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 123.09 1.424 . . . . 50.0 113.494 -174.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.11 159.14 43.72 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.12 -1.4 . . . . 25.0 109.913 162.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.71 142.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 O-C-N 125.233 1.583 . . . . 50.0 108.156 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 mt -109.85 134.66 51.27 Favored 'Isoleucine or valine' 0 C--O 1.25 1.105 0 CA-C-O 118.201 -0.904 . . . . 25.0 109.76 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.24 155.39 35.96 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 124.913 2.292 . . . . 50.0 108.27 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.6 153.77 48.66 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 118.998 -2.313 . . . . 25.0 109.277 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.86 118.52 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 128.707 2.803 . . . . 50.0 106.29 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -107.63 88.25 2.69 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 126.36 2.287 . . . . 25.0 107.106 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.494 ' HA ' ' HB1' ' A' ' 160' ' ' ALA . 24.6 t70 -77.36 141.69 39.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.158 -1.589 . . . . 25.0 111.832 -163.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.02 123.77 59.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-O 116.991 -1.48 . . . . 50.0 112.464 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.94 20.07 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 120.231 1.378 . . . . 25.0 111.671 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.52 -20.84 65.49 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -124.51 159.88 29.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.932 1.456 . . . . 25.0 114.932 -173.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.04 -39.7 87.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 116.61 2.078 . . . . 25.0 116.61 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 3.1 m-20 -91.87 160.55 15.24 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 118.508 -0.758 . . . . 25.0 112.299 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 153' ' ' ASP . . . -138.57 159.9 40.93 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 101.221 -3.622 . . . . 25.0 101.221 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -90.99 153.36 20.21 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 124.379 1.071 . . . . 50.0 108.538 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -136.95 164.71 27.7 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.849 -1.94 . . . . 50.0 111.021 164.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.54 133.38 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 111.991 -2.368 . . . . 75.0 115.557 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -135.33 136.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 124.091 1.901 . . . . 25.0 106.413 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 72' ' ' LYS 0.284 22.3 t0 -102.92 150.43 23.53 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 101.246 -3.613 . . . . 25.0 101.246 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 73' ' ' HIS . 27.2 m -144.83 167.07 11.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 116.631 -1.652 . . . . 50.0 107.662 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 10.4 t0 -133.52 132.97 41.59 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.3 mt -126.12 117.12 22.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 107.813 -1.18 . . . . 50.0 107.813 -164.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.0 162.31 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 117.926 2.565 . . . . 50.0 117.926 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.4 ' H ' HD23 ' A' ' 143' ' ' LEU . 7.1 m120 -69.84 160.93 30.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.235 1.814 . . . . 25.0 107.835 166.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.1 mttt . . . . . 0 C--O 1.266 1.953 0 N-CA-C 118.318 2.71 . . . . 25.0 118.318 -176.855 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 51.5 m80 . . . . . 1 N--CA 1.572 5.642 0 CA-C-O 120.832 0.349 . . . . 25.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.01 174.15 36.76 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-O 117.409 -1.773 . . . . 25.0 116.865 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -126.29 171.45 10.93 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 123.436 1.589 . . . . 50.0 107.703 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm -81.73 116.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 O-C-N 120.024 -1.672 . . . . 25.0 108.539 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.05 -40.92 30.06 Favored 'General case' 0 C--O 1.268 2.058 0 CA-C-N 115.424 -0.807 . . . . 25.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -154.55 136.34 9.36 Favored Pre-proline 0 C--O 1.199 -1.599 0 N-CA-C 105.183 -2.154 . . . . 25.0 105.183 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.03 145.61 65.66 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 C-N-CA 130.698 1.541 . . . . 25.0 115.226 -1.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.32 170.31 50.47 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 120.916 -0.659 . . . . 25.0 111.758 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 84.7 p -70.28 162.18 28.96 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.314 2.339 . . . . 25.0 117.314 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -68.71 -3.45 12.16 Favored 'General case' 0 CA--C 1.581 2.16 0 CA-C-N 118.916 0.78 . . . . 25.0 110.471 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.23 -27.71 68.18 Favored 'General case' 0 C--O 1.197 -1.666 0 C-N-CA 118.949 -1.1 . . . . 25.0 110.911 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.82 91.84 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-O 122.962 1.363 . . . . 25.0 108.436 171.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 124.215 1.959 . . . . 75.0 115.634 -178.255 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.51 -0.562 0 CA-C-O 120.863 0.364 . . . . 25.0 111.905 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -74.55 -50.17 19.07 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.818 -1.537 . . . . 50.0 111.086 -162.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -143.41 63.39 12.49 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.742 -1.224 . . . . 25.0 112.38 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.74 -26.47 38.91 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 115.869 -2.287 . . . . 25.0 114.203 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -60.01 -9.81 3.53 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.024 2.602 . . . . 25.0 118.024 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -74.91 -5.47 43.91 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 116.633 -1.651 . . . . 25.0 113.236 -168.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.0 122.58 25.11 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 120.6 1.545 . . . . 50.0 112.807 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -136.2 165.17 26.36 Favored 'General case' 0 C--O 1.261 1.691 0 N-CA-C 114.87 1.433 . . . . 25.0 114.87 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.92 143.96 30.83 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 160.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -87.92 158.58 18.65 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 103.514 -2.772 . . . . 25.0 103.514 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.2 mttp . . . . . 0 C--O 1.29 3.186 0 CA-C-O 123.316 1.531 . . . . 25.0 106.982 170.341 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 60' ' ' GLY . 29.6 mt . . . . . 0 C--O 1.199 -1.604 0 CA-C-O 118.163 -0.923 . . . . 50.0 112.992 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -69.82 -25.59 63.84 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 101.253 -3.61 . . . . 50.0 101.253 157.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.43 -15.45 80.33 Favored Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.804 -1.553 . . . . 25.0 110.433 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 57' ' ' LEU . . . -66.48 -29.85 75.51 Favored Glycine 0 CA--C 1.493 -1.342 0 O-C-N 126.954 2.208 . . . . 25.0 113.081 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.51 -42.08 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 O-C-N 119.805 -1.997 . . . . 25.0 111.985 174.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.44 -23.94 50.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.83 -1.174 . . . . 75.0 107.83 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.7 -31.2 64.84 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.73 1.252 . . . . 50.0 113.216 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -89.93 35.48 0.85 Allowed 'General case' 0 C--O 1.161 -3.556 0 CA-C-N 114.167 -1.379 . . . . 25.0 111.059 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -159.7 50.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 100.432 -3.914 . . . . 25.0 100.432 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.8 t -140.69 179.58 6.61 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 102.081 -3.303 . . . . 25.0 102.081 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.55 -31.55 65.36 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 123.677 2.944 . . . . 25.0 111.478 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.89 21.59 0.84 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 116.945 -1.503 . . . . 25.0 114.549 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -60.8 90.25 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.809 2.444 . . . . 25.0 106.014 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -17.25 131.03 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.5 2 CA-C-N 106.614 -4.812 . . . . 25.0 118.806 171.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -68.93 142.86 54.61 Favored 'General case' 0 CA--C 1.476 -1.901 0 N-CA-C 117.733 2.494 . . . . 50.0 117.733 -160.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -112.76 147.2 37.37 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.046 1.748 . . . . 25.0 108.496 -166.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -122.84 137.61 54.88 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-O 116.493 -1.718 . . . . 25.0 108.451 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.0 mt -96.47 119.49 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 105.585 -2.006 . . . . 25.0 105.585 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.8 mtp -128.1 174.63 9.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.824 1.249 . . . . 25.0 111.718 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -112.54 171.16 7.69 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.434 1.493 . . . . 25.0 110.147 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.67 170.42 53.21 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 105.997 -2.841 . . . . 25.0 105.997 171.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.14 178.21 15.4 Favored Glycine 0 C--N 1.285 -2.302 2 O-C-N 115.882 -4.305 . . . . 25.0 109.614 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.81 137.32 51.72 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 127.645 2.615 . . . . 25.0 113.651 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -110.74 134.93 52.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 111.765 -2.47 . . . . 25.0 106.189 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -92.18 134.03 35.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 117.56 -3.212 . . . . 25.0 112.948 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.85 127.0 50.03 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 118.829 -2.419 . . . . 50.0 109.371 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.0 m -140.22 126.93 20.43 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.415 -1.328 . . . . 25.0 107.415 -167.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -104.05 162.95 12.72 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 128.938 3.899 . . . . 25.0 109.014 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 t -149.29 146.47 27.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 103.331 -2.84 . . . . 25.0 103.331 165.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.48 143.07 49.46 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 127.123 2.169 . . . . 50.0 111.42 173.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -96.77 -5.16 39.2 Favored 'General case' 0 C--O 1.27 2.169 0 C-N-CA 127.072 2.149 . . . . 25.0 115.173 -168.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.87 137.57 12.59 Favored Pre-proline 0 N--CA 1.481 1.112 0 N-CA-C 103.529 -2.767 . . . . 25.0 103.529 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.5 137.78 61.7 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 115.404 -2.597 . . . . 25.0 116.167 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -148.03 169.2 20.45 Favored 'General case' 0 CA--C 1.557 1.222 1 N-CA-C 99.761 -4.163 . . . . 25.0 99.761 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -111.57 113.11 25.3 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 123.744 1.735 . . . . 25.0 108.402 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.9 m -71.98 136.02 46.62 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 113.094 -1.866 . . . . 25.0 111.847 172.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 -47.13 5.44 Favored 'General case' 0 C--O 1.274 2.376 0 CA-C-O 122.722 1.248 . . . . 25.0 112.624 167.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.24 159.01 44.75 Favored 'General case' 0 C--O 1.219 -0.547 1 O-C-N 116.011 -4.18 . . . . 25.0 102.242 175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -142.06 152.03 42.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 116.821 -1.952 . . . . 25.0 112.604 160.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -129.1 151.58 49.62 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 126.425 1.89 . . . . 25.0 109.771 -156.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.68 147.17 50.05 Favored 'General case' 0 C--O 1.194 -1.834 0 O-C-N 123.498 0.499 . . . . 50.0 111.311 156.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.31 163.02 28.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 104.286 -2.487 . . . . 50.0 104.286 172.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.79 133.55 67.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 163.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -73.48 131.94 42.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 101.88 -3.378 . . . . 25.0 101.88 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -87.27 104.41 16.37 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 125.8 2.714 . . . . 25.0 105.753 -169.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.08 113.25 1.46 Allowed 'General case' 0 C--O 1.279 2.607 0 O-C-N 119.233 -2.167 . . . . 25.0 110.341 153.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.88 40.21 7.72 Favored Glycine 0 C--O 1.181 -3.162 0 C-N-CA 116.912 -2.566 . . . . 25.0 108.837 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -55.87 160.63 2.59 Favored 'General case' 0 CA--C 1.579 2.063 0 O-C-N 120.376 -1.661 . . . . 25.0 109.851 168.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -80.71 117.12 66.46 Favored Pre-proline 0 C--O 1.266 1.933 0 N-CA-C 102.596 -3.113 . . . . 25.0 102.596 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.11 -25.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 N-CA-C 116.36 1.638 . . . . 25.0 116.36 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.33 -6.19 57.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 112.217 -2.265 . . . . 75.0 106.111 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.55 150.9 46.36 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 114.847 -2.501 . . . . 25.0 110.027 -171.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.294 0.0 OUTLIER -2.52 87.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.264 1.794 2 C-N-CA 125.642 4.228 . . . . 25.0 122.698 176.045 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.57 -34.12 72.3 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 110.301 -3.136 . . . . 50.0 109.595 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -87.81 -10.05 52.04 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.695 2.109 . . . . 25.0 116.695 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.84 -38.41 0.64 Allowed 'General case' 0 C--O 1.185 -2.308 0 N-CA-C 121.468 3.877 . . . . 25.0 121.468 -170.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.6 -9.63 59.44 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 117.18 -3.45 . . . . 25.0 111.871 171.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.63 4.98 10.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.378 -0.929 . . . . 25.0 112.849 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.62 167.33 22.18 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.755 0.788 . . . . 50.0 112.782 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -117.73 141.83 47.95 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.193 160.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 tp -67.33 132.09 47.01 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.319 -2.104 . . . . 50.0 105.319 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 tt -110.97 -14.2 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 118.928 2.936 . . . . 25.0 118.928 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.82 165.69 30.9 Favored Glycine 0 C--O 1.212 -1.269 0 CA-C-O 115.217 -2.991 . . . . 25.0 112.43 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.36 21.88 Favored 'General case' 0 N--CA 1.418 -2.054 0 O-C-N 126.025 1.662 . . . . 25.0 108.329 168.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.38 101.02 28.42 Favored Pre-proline 0 C--N 1.312 -1.059 0 C-N-CA 125.473 1.509 . . . . 50.0 111.892 -170.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.64 170.47 8.94 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 115.752 -2.365 . . . . 25.0 113.607 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -97.31 78.27 2.71 Favored 'General case' 0 C--O 1.175 -2.851 0 CA-C-O 115.959 -1.972 . . . . 25.0 108.546 167.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.47 37.47 1.22 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.21 1.481 . . . . 50.0 110.596 -158.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.59 35.01 17.86 Favored Glycine 0 C--O 1.263 1.92 0 N-CA-C 108.834 -1.706 . . . . 25.0 108.834 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.4 m -75.3 147.01 82.27 Favored Pre-proline 0 C--O 1.263 1.796 0 N-CA-C 117.558 2.429 . . . . 25.0 117.558 -154.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.28 177.28 7.48 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 115.564 -2.491 . . . . 25.0 109.267 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.06 6.2 0.99 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.836 2.162 . . . . 25.0 116.836 -167.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.4 p -68.05 -4.44 13.45 Favored 'General case' 0 C--O 1.182 -2.494 0 CA-C-N 114.299 -1.318 . . . . 25.0 109.29 163.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.2 ttp85 -69.88 -16.52 63.25 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 114.154 1.168 . . . . 25.0 114.154 167.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -52.44 133.25 35.35 Favored 'General case' 0 C--O 1.191 -1.995 0 CA-C-O 121.905 0.859 . . . . 25.0 108.732 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -70.66 -13.12 61.95 Favored 'General case' 0 C--O 1.187 -2.197 0 CA-C-O 123.466 1.603 . . . . 75.0 111.504 -161.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.8 t -98.0 141.62 30.74 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 118.487 -2.633 . . . . 25.0 110.405 163.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -132.59 157.16 45.44 Favored 'General case' 0 C--O 1.161 -3.559 0 N-CA-C 103.376 -2.824 . . . . 25.0 103.376 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -120.9 148.45 44.03 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 100.863 -3.754 . . . . 25.0 100.863 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 50.6 mm -129.78 125.69 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -79.76 136.77 36.83 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.94 -0.475 . . . . 50.0 109.853 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.2 mm -125.96 119.76 23.99 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 126.623 2.452 . . . . 25.0 109.403 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.25 159.83 33.02 Favored 'Trans proline' 0 C--N 1.359 1.131 1 C-N-CA 113.288 -4.008 . . . . 25.0 115.353 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.51 43.45 1.1 Allowed 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 122.906 1.336 . . . . 25.0 110.833 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.23 -42.51 99.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 111.089 -2.778 . . . . 50.0 114.351 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -149.47 154.2 38.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.897 1.679 . . . . 25.0 108.742 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.25 154.81 34.9 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.859 -1.534 . . . . 50.0 106.859 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.25 168.02 11.95 Favored Glycine 0 C--N 1.364 2.104 0 O-C-N 126.224 2.202 . . . . 25.0 118.177 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.26 153.52 41.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 117.697 2.48 . . . . 50.0 117.697 -165.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.96 147.09 39.99 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 120.879 -1.138 . . . . 25.0 109.392 160.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.48 133.81 46.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 N-CA-C 103.852 -2.647 . . . . 50.0 103.852 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.81 137.92 31.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 103.962 -2.607 . . . . 25.0 103.962 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.6 mt -122.82 145.77 48.13 Favored 'General case' 0 C--O 1.184 -2.351 0 N-CA-C 104.681 -2.34 . . . . 50.0 104.681 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.22 156.48 44.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 117.983 -1.008 . . . . 25.0 110.344 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.5 132.63 31.63 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 O-C-N 127.715 3.134 . . . . 50.0 105.793 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -105.4 130.69 53.45 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 104.131 -2.544 . . . . 25.0 104.131 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -103.71 126.8 51.08 Favored 'General case' 0 C--O 1.264 1.835 0 O-C-N 118.751 -2.468 . . . . 25.0 104.962 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.06 133.06 64.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 O-C-N 116.656 -3.778 . . . . 50.0 107.823 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.25 -11.73 59.7 Favored 'General case' 0 C--O 1.178 -2.698 0 O-C-N 121.337 -0.852 . . . . 25.0 110.791 -171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -35.53 81.41 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.078 1.894 . . . . 25.0 114.077 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.2 p -143.79 159.82 41.84 Favored 'General case' 0 C--O 1.274 2.393 0 O-C-N 120.924 -1.11 . . . . 25.0 112.089 -164.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -76.98 -23.98 52.28 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.999 -1.111 . . . . 25.0 107.999 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.49 151.85 45.54 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.041 -0.981 . . . . 25.0 110.85 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -123.9 159.0 30.65 Favored 'General case' 0 C--O 1.27 2.182 0 N-CA-C 102.039 -3.319 . . . . 25.0 102.039 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -111.72 154.41 25.04 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 104.31 -2.478 . . . . 50.0 104.31 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.36 149.48 50.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 110.971 -2.831 . . . . 50.0 106.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -133.74 129.85 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.253 33.9 m -121.73 135.37 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 117.576 -3.203 . . . . 75.0 112.99 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 95.8 mt -135.64 132.59 51.47 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 105.07 -2.196 . . . . 25.0 105.07 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -104.7 141.4 36.53 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 106.118 -1.808 . . . . 25.0 106.118 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.92 149.25 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 107.725 -1.213 . . . . 50.0 107.725 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.42 94.43 4.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 118.26 20.96 Favored 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 125.161 1.384 . . . . 50.0 108.333 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.1 m -117.5 157.84 18.47 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-O 124.448 2.071 . . . . 50.0 108.501 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -91.64 162.55 14.45 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 111.252 -2.703 . . . . 25.0 106.401 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 CA--C 1.565 1.548 0 O-C-N 118.742 -2.474 . . . . 25.0 108.166 166.94 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 N--CA 1.517 2.9 0 CA-C-O 123.532 1.634 . . . . 25.0 113.724 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.46 -174.81 24.92 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 125.074 2.486 . . . . 25.0 111.921 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.59 161.95 39.43 Favored 'General case' 0 CA--C 1.47 -2.113 0 CA-C-N 110.77 -2.715 . . . . 50.0 108.891 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 mt -97.8 123.52 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 N-CA-C 103.805 -2.665 . . . . 25.0 103.805 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.35 -38.93 18.22 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 119.609 -1.932 . . . . 25.0 111.383 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -136.45 160.01 68.4 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 118.005 -0.998 . . . . 25.0 110.169 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.13 141.4 62.24 Favored 'Cis proline' 0 CA--C 1.477 -2.327 0 C-N-CA 133.479 2.7 . . . . 25.0 114.386 -1.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.36 -168.66 45.16 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 119.253 2.461 . . . . 25.0 119.253 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t -145.92 156.17 43.35 Favored 'General case' 0 C--O 1.266 1.944 0 CA-C-N 119.196 1.498 . . . . 25.0 107.7 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -79.25 -8.46 59.06 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.87 1.319 . . . . 25.0 109.917 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.47 -29.47 64.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.428 -0.795 . . . . 25.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.13 -27.84 67.65 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 118.686 2.847 . . . . 25.0 118.686 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--N 1.306 -1.288 0 O-C-N 125.903 2.002 . . . . 75.0 111.554 -178.382 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.0 ptp . . . . . 0 N--CA 1.439 -1.01 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -101.47 -46.08 5.1 Favored 'General case' 0 CA--C 1.485 -1.529 0 O-C-N 120.908 -1.12 . . . . 50.0 110.452 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -114.3 79.06 4.93 Favored Pre-proline 0 C--O 1.264 1.826 0 N-CA-C 115.654 1.724 . . . . 25.0 115.654 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.18 -20.77 8.35 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 114.958 1.099 . . . . 25.0 114.958 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -127.5 2.36 6.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 120.25 3.426 . . . . 25.0 120.25 -161.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 49.55 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.006 -1.059 . . . . 25.0 108.163 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.59 79.92 8.16 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.42 0.628 . . . . 50.0 111.679 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -135.76 150.98 49.68 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 116.819 -1.563 . . . . 25.0 110.71 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.02 166.52 25.83 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.414 -3.18 . . . . 25.0 102.414 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -93.23 142.56 27.18 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 117.345 -1.742 . . . . 25.0 111.714 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mttt . . . . . 0 C--O 1.205 -1.272 0 C-N-CA 119.472 -0.891 . . . . 25.0 109.112 175.89 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 CA--C 1.475 -1.91 0 N-CA-C 114.715 1.376 . . . . 50.0 114.715 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.09 -34.99 69.09 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.775 -1.935 . . . . 50.0 105.775 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -11.3 85.26 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-O 122.805 1.225 . . . . 25.0 110.245 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.6 -29.9 76.21 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 123.85 1.805 . . . . 25.0 114.599 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -74.92 -39.19 44.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 O-C-N 119.986 -1.89 . . . . 25.0 107.111 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -68.88 -27.8 66.12 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 119.269 -2.144 . . . . 75.0 109.783 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 -27.6 67.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.521 -1.362 . . . . 50.0 110.843 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -80.09 3.7 19.53 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 120.574 -1.329 . . . . 25.0 107.641 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -128.45 43.85 3.06 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.122 -2.918 . . . . 25.0 103.122 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 t -134.9 161.14 36.08 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.563 -1.336 . . . . 25.0 109.799 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.17 -29.02 68.41 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-N 114.45 -1.25 . . . . 25.0 111.553 161.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -72.65 0.39 10.77 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.911 1.449 . . . . 25.0 114.911 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -76.13 93.33 3.32 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 103.755 -2.683 . . . . 25.0 103.755 169.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -45.29 153.83 0.2 Allowed 'General case' 0 C--O 1.263 1.791 0 CA-C-N 111.411 -2.631 . . . . 25.0 107.972 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -56.19 136.17 52.93 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 115.247 1.573 . . . . 50.0 115.247 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -94.32 156.24 16.61 Favored 'General case' 0 N--CA 1.528 3.444 0 CA-C-O 117.399 -1.286 . . . . 25.0 112.886 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -153.8 151.95 30.14 Favored 'General case' 0 C--O 1.26 1.65 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 tt -87.43 135.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtp -144.56 -172.76 3.87 Favored 'General case' 0 C--O 1.186 -2.255 0 CA-C-O 123.06 1.409 . . . . 25.0 109.029 -171.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 p -127.37 172.65 10.45 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 104.61 -2.367 . . . . 25.0 104.61 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.61 -178.26 25.2 Favored Glycine 0 CA--C 1.542 1.754 0 O-C-N 124.692 1.245 . . . . 25.0 112.754 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.54 -156.3 30.29 Favored Glycine 0 CA--C 1.559 2.83 0 CA-C-O 115.697 -2.724 . . . . 25.0 111.032 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -72.64 143.33 48.2 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 120.472 3.508 . . . . 25.0 120.472 -171.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -125.5 143.51 50.97 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 101.51 -3.515 . . . . 25.0 101.51 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.7 m -99.11 127.21 45.03 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 105.331 -2.1 . . . . 25.0 105.331 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.61 128.44 55.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 104.191 -2.522 . . . . 50.0 104.191 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.2 m -134.2 109.13 8.67 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 105.4 -2.074 . . . . 25.0 105.4 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -83.31 149.75 26.56 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.641 -1.163 . . . . 25.0 107.896 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.3 t -142.54 122.68 13.76 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 120.922 1.692 . . . . 25.0 109.652 173.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.73 143.27 39.76 Favored 'General case' 0 N--CA 1.423 -1.782 0 O-C-N 119.503 -1.998 . . . . 50.0 113.987 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -91.43 -12.67 34.05 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.487 -2.142 . . . . 25.0 110.433 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.18 143.76 25.9 Favored Pre-proline 0 C--O 1.273 2.315 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 168.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.08 140.88 25.75 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 124.078 3.185 . . . . 25.0 117.732 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -138.6 151.4 47.23 Favored 'General case' 0 CA--C 1.55 0.958 1 N-CA-C 97.77 -4.9 . . . . 25.0 97.77 172.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . 0.254 67.2 m-80 -78.68 109.69 13.14 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 121.998 2.181 . . . . 25.0 113.772 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.473 HG21 ' CE3' ' A' ' 95' ' ' TRP . 7.9 m -79.38 135.69 36.77 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 123.684 1.707 . . . . 25.0 109.729 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 155' ' ' ALA . 2.3 p -80.59 -50.11 10.41 Favored 'General case' 0 CA--C 1.571 1.759 0 O-C-N 116.632 -3.792 . . . . 25.0 106.706 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -164.27 173.88 11.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 127.084 2.154 . . . . 25.0 113.513 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.473 ' CE3' HG21 ' A' ' 92' ' ' THR . 37.6 p90 -143.32 158.36 43.7 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.098 -1.002 . . . . 25.0 112.767 164.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -133.84 155.25 50.18 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -150.14 149.93 30.95 Favored 'General case' 0 C--O 1.283 2.867 0 CA-C-N 120.789 1.631 . . . . 50.0 114.137 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.64 158.35 44.26 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.632 1.573 . . . . 50.0 109.929 -157.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.22 159.88 13.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 164.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 p -71.82 155.71 40.12 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.648 1.217 . . . . 25.0 110.783 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -124.04 113.07 17.91 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.653 -1.279 . . . . 25.0 113.821 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.08 161.23 8.84 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 114.461 -2.685 . . . . 25.0 110.384 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.1 -0.16 47.74 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 122.827 2.558 . . . . 25.0 115.427 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -59.51 159.05 8.74 Favored 'General case' 0 C--O 1.271 2.199 0 N-CA-C 113.892 1.071 . . . . 25.0 113.892 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -160.77 144.02 9.86 Favored Pre-proline 0 C--O 1.193 -1.916 0 N-CA-C 104.486 -2.412 . . . . 25.0 104.486 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -69.87 -15.94 36.89 Favored 'Trans proline' 0 C--O 1.177 -2.528 0 C-N-CA 114.003 -3.532 . . . . 25.0 119.594 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.84 -21.19 65.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.918 1.818 . . . . 75.0 109.131 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -99.47 163.54 18.36 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 103.384 -2.821 . . . . 25.0 103.384 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -32.37 30.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.249 1 C-N-CA 129.759 6.973 . . . . 25.0 121.64 154.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -40.39 60.26 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 115.922 -1.989 . . . . 50.0 114.794 -175.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -75.59 -7.93 55.48 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 116.636 2.087 . . . . 25.0 116.636 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -120.08 -62.55 1.47 Allowed 'General case' 0 C--O 1.198 -1.621 0 O-C-N 121.25 -0.906 . . . . 25.0 112.441 -166.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.51 18.25 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 118.014 2.598 . . . . 25.0 118.014 163.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -65.37 -26.51 68.04 Favored 'General case' 0 CA--C 1.483 -1.602 0 O-C-N 127.116 2.76 . . . . 25.0 109.65 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -141.07 160.52 39.9 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 103.586 -2.746 . . . . 50.0 103.586 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -129.95 135.15 47.99 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 106.65 -1.611 . . . . 25.0 106.65 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.64 145.48 54.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 104.173 -2.528 . . . . 50.0 104.173 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.7 tt -128.71 -12.52 2.94 Favored 'Isoleucine or valine' 0 C--O 1.263 1.783 0 CA-C-O 125.848 2.737 . . . . 25.0 112.252 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.75 167.12 37.85 Favored Glycine 0 C--O 1.268 2.234 0 CA-C-O 124.142 1.968 . . . . 25.0 112.266 168.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.84 161.29 40.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 112.991 -1.605 . . . . 25.0 107.968 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.49 111.68 15.16 Favored Pre-proline 0 C--O 1.207 -1.177 0 N-CA-C 104.124 -2.546 . . . . 50.0 104.124 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.4 162.05 36.67 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 117.144 -1.438 . . . . 25.0 110.885 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 129' ' ' SER . 65.6 t-80 -120.11 49.6 1.39 Allowed 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.229 -1.767 . . . . 25.0 106.229 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -76.06 -32.34 59.24 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 112.38 -2.191 . . . . 50.0 110.133 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 172.04 -175.6 45.3 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 119.98 -1.7 . . . . 25.0 115.341 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 57.8 m 72.19 155.72 0.16 Allowed Pre-proline 0 CA--C 1.569 1.698 0 N-CA-C 117.658 2.466 . . . . 25.0 117.658 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.23 -3.33 13.64 Favored 'Trans proline' 0 CA--C 1.572 2.415 0 C-N-CA 115.642 -2.439 . . . . 25.0 113.38 -166.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.25 76.52 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 116.84 2.163 . . . . 25.0 116.84 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 123' ' ' HIS . 83.8 p -80.81 -21.95 40.44 Favored 'General case' 0 C--O 1.273 2.314 0 CA-C-O 124.259 1.981 . . . . 25.0 110.894 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -72.81 -28.55 62.63 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.111 -1.859 . . . . 25.0 111.918 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.55 140.59 39.75 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.709 -3.071 . . . . 25.0 102.709 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mt -103.67 -38.63 7.02 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 124.346 2.022 . . . . 75.0 109.934 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 t -77.36 127.05 31.9 Favored 'General case' 0 N--CA 1.411 -2.421 0 O-C-N 120.361 -1.462 . . . . 25.0 108.392 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -140.04 156.43 46.61 Favored 'General case' 0 CA--C 1.488 -1.442 0 O-C-N 118.937 -2.352 . . . . 25.0 110.607 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -106.1 141.25 37.78 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 125.308 1.63 . . . . 25.0 107.893 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.91 121.13 46.38 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.187 0 C-N-CA 125.944 1.698 . . . . 25.0 109.995 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -82.47 126.14 31.9 Favored 'General case' 0 C--O 1.175 -2.82 0 CA-C-N 121.103 1.774 . . . . 50.0 106.667 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -110.79 123.56 35.22 Favored Pre-proline 0 C--O 1.265 1.879 0 N-CA-C 103.584 -2.747 . . . . 25.0 103.584 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.41 146.17 55.44 Favored 'Trans proline' 0 CA--C 1.585 3.037 0 C-N-CA 116.847 -1.635 . . . . 25.0 115.351 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.1 67.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 125.828 2.727 . . . . 25.0 104.879 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -62.92 -28.6 70.18 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 119.729 -1.857 . . . . 50.0 113.238 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -143.63 158.85 43.36 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.368 -1.716 . . . . 25.0 106.368 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.95 138.56 39.74 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 102.028 -3.323 . . . . 50.0 102.028 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 147.14 177.49 21.71 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 124.992 2.44 . . . . 25.0 116.18 -173.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 137.88 56.6 Favored 'General case' 0 C--O 1.192 -1.953 0 C-N-CA 126.287 1.835 . . . . 50.0 113.443 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -145.96 167.22 23.84 Favored 'General case' 0 C--O 1.255 1.355 0 C-N-CA 126.684 1.994 . . . . 25.0 109.017 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 t -124.16 144.47 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.425 -1.324 . . . . 50.0 107.425 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.16 113.05 43.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.303 -2.851 . . . . 25.0 103.303 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.56 153.06 21.66 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-N 119.029 0.831 . . . . 50.0 110.55 -170.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.52 136.95 23.86 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 120.515 -1.365 . . . . 25.0 109.416 -173.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.56 136.12 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.403 -0.919 . . . . 50.0 112.0 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -118.65 125.62 50.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.181 2.592 . . . . 25.0 104.893 -170.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -113.69 140.98 47.79 Favored 'General case' 0 C--O 1.269 2.109 0 O-C-N 125.679 1.862 . . . . 25.0 108.996 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.3 139.74 26.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 N-CA-C 104.914 -2.254 . . . . 50.0 104.914 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -92.6 -20.44 20.89 Favored 'General case' 0 C--O 1.196 -1.753 0 CA-C-N 112.324 -2.216 . . . . 25.0 112.149 177.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.27 -23.75 54.44 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.905 1.817 . . . . 25.0 115.905 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.2 p -145.3 -179.79 6.88 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 115.6 -2.143 . . . . 25.0 113.245 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -89.01 1.1 56.04 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-O 126.379 2.99 . . . . 25.0 113.014 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.43 158.54 31.26 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 119.781 -1.824 . . . . 25.0 112.739 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.75 159.35 29.99 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -145.42 158.24 43.87 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 124.648 2.166 . . . . 50.0 109.643 172.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -118.47 144.38 46.04 Favored 'General case' 0 C--O 1.193 -1.909 0 CA-C-N 110.824 -2.898 . . . . 50.0 104.101 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -141.51 138.04 32.49 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.312 -1.328 . . . . 25.0 107.886 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.61 156.49 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 120.596 1.543 . . . . 75.0 109.715 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.46 115.16 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.444 1.592 . . . . 25.0 108.322 172.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.18 118.65 22.06 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 117.155 -1.402 . . . . 25.0 108.618 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.88 156.48 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 120.466 1.484 . . . . 50.0 113.45 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -111.7 98.63 7.55 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 103.173 -2.899 . . . . 25.0 103.173 171.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.17 135.02 34.07 Favored 'General case' 0 N--CA 1.499 2.009 1 N-CA-C 99.734 -4.173 . . . . 50.0 99.734 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.01 169.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 119.564 -1.96 . . . . 50.0 113.67 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -59.8 139.42 57.32 Favored 'General case' 0 C--O 1.282 2.791 0 C-N-CA 119.23 -0.988 . . . . 25.0 109.814 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 CA--C 1.577 1.983 0 N-CA-C 115.756 1.762 . . . . 25.0 115.756 177.227 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.882 -1.056 . . . . 25.0 109.245 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.99 170.45 37.66 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 120.764 3.066 . . . . 25.0 120.764 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -136.49 151.79 49.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.818 1.784 . . . . 50.0 115.818 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.28 139.17 20.32 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 101.181 -3.636 . . . . 25.0 101.181 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -112.08 -28.14 8.11 Favored 'General case' 0 C--N 1.362 1.112 0 N-CA-C 113.519 0.933 . . . . 25.0 113.519 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -151.5 140.53 13.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 104.597 -2.371 . . . . 25.0 104.597 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.97 147.27 86.85 Favored 'Cis proline' 0 N--CA 1.499 1.834 0 CA-C-N 119.844 0.98 . . . . 25.0 114.53 -5.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.25 174.25 47.54 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.939 1.936 . . . . 25.0 117.939 161.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -131.62 141.45 49.64 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.472 1.909 . . . . 25.0 107.663 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -58.07 -31.5 67.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 115.105 1.52 . . . . 25.0 115.105 167.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.51 -35.05 70.62 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 125.961 2.038 . . . . 25.0 112.175 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.02 94.66 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.399 -0.813 . . . . 25.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.246 0.87 0 N-CA-C 108.302 -0.999 . . . . 75.0 108.302 -176.231 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.281 2.72 0 N-CA-C 117.563 2.431 . . . . 25.0 117.563 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -65.95 -46.75 77.0 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 123.304 2.775 . . . . 50.0 104.784 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.37 73.04 31.25 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 117.529 2.418 . . . . 25.0 117.529 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -71.57 -21.18 26.05 Favored 'Trans proline' 0 C--N 1.393 2.882 0 CA-C-O 122.863 1.11 . . . . 25.0 112.066 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -82.87 -1.22 51.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.345 1.545 . . . . 25.0 112.11 -171.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 t -76.33 -18.0 59.14 Favored 'General case' 0 C--O 1.285 2.961 0 CA-C-N 111.317 -2.674 . . . . 25.0 109.148 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.52 119.22 15.36 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.731 1.605 . . . . 50.0 108.486 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -152.68 176.34 11.86 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 105.151 -2.166 . . . . 25.0 105.151 -172.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.25 144.58 30.87 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 166.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -129.3 145.88 51.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.459 1.481 . . . . 25.0 109.616 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 C--O 1.199 -1.595 0 CA-C-N 113.435 -1.712 . . . . 25.0 109.738 169.519 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.505 2.279 0 N-CA-C 115.631 1.715 . . . . 50.0 115.631 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -78.26 -22.77 47.82 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 104.198 -2.519 . . . . 50.0 104.198 152.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.58 -18.6 77.38 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.356 -0.838 . . . . 25.0 111.385 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.3 -34.46 80.36 Favored Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 109.972 -1.251 . . . . 25.0 109.972 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 40.5 mt -61.93 -40.18 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 O-C-N 119.925 -1.926 . . . . 25.0 113.326 -175.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.04 -29.8 68.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 122.585 1.183 . . . . 75.0 109.576 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.66 -36.35 62.82 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 120.287 -1.508 . . . . 50.0 110.118 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -77.92 20.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 114.684 1.365 . . . . 25.0 114.684 166.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -147.12 40.99 1.07 Allowed 'General case' 0 C--O 1.264 1.822 0 CA-C-O 125.691 2.662 . . . . 25.0 110.097 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -137.63 -177.78 4.95 Favored 'General case' 0 CA--C 1.58 2.119 0 CA-C-N 112.325 -2.216 . . . . 25.0 115.064 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -60.09 -23.69 64.01 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 125.652 2.644 . . . . 25.0 114.789 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -93.03 18.26 9.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 118.894 -2.379 . . . . 25.0 109.599 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -70.12 90.05 0.65 Allowed 'General case' 0 C--O 1.287 3.044 0 CA-C-O 127.681 3.61 . . . . 25.0 108.581 170.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -52.48 160.91 0.76 Allowed 'General case' 0 C--O 1.272 2.241 0 CA-C-N 109.288 -3.596 . . . . 25.0 110.072 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -62.34 142.75 57.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.451 1.1 . . . . 50.0 113.755 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.8 143.58 26.58 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -117.56 125.36 50.69 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-N 123.005 2.639 . . . . 25.0 108.737 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mt -83.49 123.9 39.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 116.332 -0.395 . . . . 25.0 110.864 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.7 mtp -138.84 157.44 46.06 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.446 1.117 . . . . 25.0 110.217 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.4 p -89.28 179.25 6.15 Favored 'General case' 0 C--O 1.273 2.32 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.13 -170.1 29.58 Favored Glycine 0 C--O 1.194 -2.364 0 N-CA-C 110.195 -1.162 . . . . 25.0 110.195 163.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.76 179.12 46.22 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 118.736 -1.697 . . . . 25.0 115.978 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.45 149.17 36.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 119.228 -2.336 . . . . 25.0 108.549 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -129.12 157.09 42.74 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.208 -1.814 . . . . 25.0 107.93 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -120.89 157.84 28.96 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 127.078 2.736 . . . . 25.0 110.19 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -143.15 152.45 41.81 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.509 1.124 . . . . 50.0 108.534 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.0 m -137.93 141.93 40.58 Favored 'General case' 0 CA--C 1.426 -3.812 0 C-N-CA 125.304 1.442 . . . . 25.0 107.684 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -135.52 167.92 20.2 Favored 'General case' 0 C--O 1.262 1.741 1 N-CA-C 99.058 -4.423 . . . . 25.0 99.058 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -131.29 146.46 52.31 Favored 'General case' 0 C--O 1.278 2.587 0 N-CA-C 105.24 -2.133 . . . . 25.0 105.24 162.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -95.87 148.01 23.05 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-O 116.834 -1.555 . . . . 50.0 108.706 159.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -103.96 -24.5 13.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.521 1.964 . . . . 25.0 113.809 173.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 137.6 52.59 Favored Pre-proline 0 N--CA 1.425 -1.677 0 O-C-N 120.218 -1.551 . . . . 25.0 109.836 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -67.86 135.32 34.95 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 116.661 -1.759 . . . . 25.0 112.684 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -152.39 169.49 22.43 Favored 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.538 -2.023 . . . . 25.0 105.538 -163.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -127.58 96.21 4.47 Favored 'General case' 0 C--O 1.273 2.291 0 CA-C-O 118.186 -0.912 . . . . 25.0 108.961 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.2 m -65.4 143.22 57.87 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 120.943 1.701 . . . . 25.0 108.99 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 p -105.76 -48.79 3.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 116.46 2.022 . . . . 25.0 116.46 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -162.93 172.42 15.11 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 120.703 1.592 . . . . 25.0 110.748 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.28 149.05 32.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.442 1.019 . . . . 25.0 113.445 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -122.73 157.68 31.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 114.388 -2.72 . . . . 25.0 110.884 -170.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.06 128.84 8.64 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 125.32 2.486 . . . . 50.0 109.339 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' A' ' 117' ' ' LEU . 5.8 p90 -142.02 147.17 36.44 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 112.66 -2.064 . . . . 50.0 110.067 -168.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.1 163.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 124.071 0.948 . . . . 25.0 110.387 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 p -62.61 156.51 23.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 116.964 -1.493 . . . . 25.0 111.819 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -91.5 97.95 11.38 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 124.373 2.035 . . . . 25.0 111.404 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -56.86 154.04 9.97 Favored 'General case' 0 C--O 1.187 -2.198 0 O-C-N 117.213 -3.43 . . . . 25.0 113.782 159.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 3.03 50.34 Favored Glycine 0 CA--C 1.545 1.963 0 N-CA-C 120.454 2.941 . . . . 25.0 120.454 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.8 169.17 0.1 Allowed 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.02 1.41 . . . . 25.0 112.611 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.08 130.62 9.4 Favored Pre-proline 0 C--N 1.31 -1.114 0 N-CA-C 102.996 -2.965 . . . . 25.0 102.996 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -59.3 -31.53 95.23 Favored 'Trans proline' 0 C--N 1.373 1.848 0 N-CA-C 116.037 1.514 . . . . 25.0 116.037 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -76.81 -1.74 29.76 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 125.051 1.469 . . . . 75.0 112.186 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -121.15 -176.83 0.43 Allowed Pre-proline 0 CA--C 1.584 2.288 1 N-CA-C 100.053 -4.054 . . . . 25.0 100.053 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -55.49 16.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.477 -2.362 2 C-N-CA 126.754 4.969 . . . . 25.0 123.235 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.97 -39.91 20.79 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 124.828 3.467 . . . . 50.0 119.171 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -77.22 -20.02 55.86 Favored 'General case' 0 C--O 1.194 -1.823 0 O-C-N 120.242 -1.536 . . . . 25.0 110.867 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -91.73 -53.53 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.424 -1.423 . . . . 25.0 112.033 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.4 42.98 0.85 Allowed 'General case' 0 C--N 1.319 -0.76 0 O-C-N 119.343 -2.098 . . . . 25.0 110.527 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.92 -31.37 70.89 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 125.613 1.565 . . . . 25.0 112.434 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 146.13 47.77 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 125.318 2.485 . . . . 50.0 109.46 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -129.89 132.47 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.138 -1.601 . . . . 25.0 107.249 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 98' ' ' TYR . 15.1 tp -73.56 141.04 46.67 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 100.309 -3.96 . . . . 50.0 100.309 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.12 -14.43 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 25.0 112.035 166.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.42 -173.82 43.16 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 125.893 1.996 . . . . 25.0 114.793 159.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.35 153.7 30.88 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.164 -2.902 . . . . 25.0 103.164 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.17 122.01 5.67 Favored Pre-proline 0 C--O 1.259 1.598 0 CA-C-N 119.777 1.171 . . . . 50.0 108.292 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -75.57 164.06 32.99 Favored 'Trans proline' 0 CA--C 1.494 -1.509 0 C-N-CA 115.991 -2.206 . . . . 25.0 115.312 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -133.82 72.95 1.48 Allowed 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 128.353 2.661 . . . . 25.0 109.941 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -74.76 -24.26 58.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 118.643 2.831 . . . . 50.0 118.643 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -170.58 -92.44 0.08 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 127.723 3.14 . . . . 25.0 109.889 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 t -122.0 61.07 12.95 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 114.237 1.199 . . . . 25.0 114.237 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -86.65 -167.1 0.34 Allowed 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-O 124.047 1.603 . . . . 25.0 111.664 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.86 69.58 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 118.901 -2.375 . . . . 25.0 106.178 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.5 p -79.79 18.88 0.72 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 124.616 2.151 . . . . 25.0 109.314 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -73.39 -27.1 61.29 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 118.117 -2.865 . . . . 25.0 103.528 168.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.76 134.2 40.51 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 112.954 -1.93 . . . . 25.0 106.235 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 tp -87.65 -28.4 21.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.52 -1.659 . . . . 75.0 106.52 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . 0.281 44.8 t -71.68 139.86 49.39 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.874 -1.766 . . . . 25.0 110.654 173.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -149.39 156.24 41.73 Favored 'General case' 0 C--O 1.273 2.331 0 N-CA-C 106.608 -1.627 . . . . 25.0 106.608 -164.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -97.81 140.53 32.04 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 115.757 -2.068 . . . . 25.0 115.056 170.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.9 mm -127.55 130.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 125.367 1.667 . . . . 25.0 107.624 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -87.96 129.35 35.27 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-O 123.737 1.732 . . . . 50.0 108.259 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.5 mm -107.63 124.75 34.03 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 112.691 -2.05 . . . . 25.0 106.809 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.27 151.44 76.57 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-O 124.498 1.791 . . . . 25.0 107.806 176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -116.73 29.71 7.77 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 111.124 -2.762 . . . . 25.0 112.457 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -75.02 -27.99 60.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.285 -2.234 . . . . 50.0 115.656 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -152.5 164.21 38.04 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 126.026 2.079 . . . . 25.0 106.799 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -83.56 158.75 21.84 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 106.953 -1.499 . . . . 50.0 106.953 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.31 121.99 0.59 Allowed Glycine 0 N--CA 1.481 1.683 0 N-CA-C 117.054 1.582 . . . . 25.0 117.054 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 0.2 OUTLIER -66.04 139.19 58.18 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 114.279 1.214 . . . . 50.0 114.279 -178.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -135.57 168.38 19.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 119.821 -1.799 . . . . 25.0 108.147 -169.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -112.4 139.09 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 102.1 -3.296 . . . . 50.0 102.1 162.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.9 129.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 118.635 0.652 . . . . 25.0 110.801 165.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.46 143.15 48.66 Favored 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 117.087 -1.435 . . . . 50.0 113.59 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.01 160.5 37.55 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 126.143 2.152 . . . . 25.0 111.296 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . 0.288 39.5 t -144.3 125.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.29 1.036 . . . . 50.0 109.088 174.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -104.79 112.3 25.36 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 101.157 -3.645 . . . . 25.0 101.157 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -100.62 133.37 45.18 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.0 129.03 31.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 O-C-N 125.242 1.588 . . . . 50.0 109.834 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.75 -18.45 32.97 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -159.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -86.12 2.79 45.36 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 116.005 1.854 . . . . 25.0 116.005 -172.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 t -143.32 158.69 43.42 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.102 -1.444 . . . . 25.0 107.102 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -82.24 -7.44 59.62 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.327 0.967 . . . . 25.0 110.226 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -86.12 163.72 17.7 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.42 148.98 52.3 Favored 'General case' 0 C--O 1.274 2.357 0 N-CA-C 102.02 -3.326 . . . . 25.0 102.02 164.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -102.73 139.36 38.41 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 106.387 -1.708 . . . . 50.0 106.387 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -116.72 153.12 32.93 Favored 'General case' 0 C--O 1.277 2.502 0 C-N-CA 125.013 1.325 . . . . 50.0 108.499 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.72 138.34 23.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.661 0.743 . . . . 25.0 109.745 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.15 142.27 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 106.489 -1.671 . . . . 75.0 106.489 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.9 mt -136.28 127.09 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 104.166 -2.531 . . . . 25.0 104.166 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.91 145.78 25.33 Favored 'General case' 0 C--O 1.203 -1.353 0 N-CA-C 103.986 -2.598 . . . . 25.0 103.986 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.3 m -149.74 156.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 114.093 1.146 . . . . 50.0 114.093 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 54.1 t0 -121.77 99.87 6.69 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 105.202 -2.147 . . . . 25.0 105.202 172.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.09 121.27 31.26 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.48 -2.785 . . . . 50.0 103.48 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.21 165.79 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 117.099 2.259 . . . . 50.0 117.099 -171.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.64 158.81 15.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt . . . . . 0 C--O 1.261 1.684 0 C-N-CA 119.857 -0.737 . . . . 25.0 112.808 172.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.2 m80 . . . . . 1 N--CA 1.554 4.728 0 CA-C-O 121.705 0.764 . . . . 25.0 111.38 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.73 118.04 0.47 Allowed Glycine 0 CA--C 1.541 1.699 0 O-C-N 117.368 -3.333 . . . . 25.0 107.343 -14.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -130.63 144.82 51.68 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 122.058 2.929 . . . . 50.0 111.209 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.5 mt -99.19 115.43 39.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 101.296 -3.594 . . . . 25.0 101.296 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -88.42 -40.28 13.63 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 125.709 1.88 . . . . 25.0 110.621 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -146.82 145.26 22.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 117.163 2.283 . . . . 25.0 117.163 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.83 149.09 93.44 Favored 'Cis proline' 0 C--O 1.271 2.161 0 CA-C-N 121.161 1.45 . . . . 25.0 115.474 -7.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.21 -168.37 45.18 Favored Glycine 0 N--CA 1.483 1.776 0 O-C-N 126.625 2.453 . . . . 25.0 112.454 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 t -125.91 120.54 30.68 Favored 'General case' 0 C--O 1.266 1.945 0 O-C-N 125.865 1.568 . . . . 25.0 109.794 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -70.11 -35.95 74.5 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.171 -0.678 . . . . 25.0 109.171 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.09 81.97 Favored 'General case' 0 C--O 1.206 -1.231 0 C-N-CA 123.792 0.837 . . . . 25.0 109.84 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -36.51 82.03 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.452 0.908 . . . . 25.0 113.452 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 C--O 1.182 -2.48 0 O-C-N 125.371 1.669 . . . . 75.0 109.862 177.653 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.5 ptp . . . . . 0 CA--C 1.577 2.017 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.2 -50.12 50.3 Favored 'General case' 0 C--O 1.201 -1.449 0 C-N-CA 113.737 -3.185 . . . . 50.0 110.984 175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.98 76.72 27.48 Favored Pre-proline 0 C--O 1.252 1.193 0 O-C-N 120.996 -1.065 . . . . 25.0 110.524 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.68 -21.02 29.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 1 C-N-CA 111.497 -5.202 . . . . 25.0 115.309 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -81.7 2.23 30.64 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 118.94 -2.35 . . . . 25.0 114.362 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 t -118.22 98.95 6.55 Favored 'General case' 0 C--O 1.292 3.303 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.9 mt -126.14 133.52 51.57 Favored 'General case' 0 C--O 1.294 3.399 1 N-CA-C 99.821 -4.14 . . . . 50.0 99.821 157.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -121.83 134.78 54.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 113.975 1.102 . . . . 25.0 113.975 -170.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.24 125.93 32.27 Favored 'General case' 0 C--O 1.198 -1.624 0 C-N-CA 125.335 1.454 . . . . 25.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -113.94 132.27 56.01 Favored 'General case' 0 C--O 1.273 2.3 0 CA-C-N 121.278 1.853 . . . . 25.0 112.778 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttt . . . . . 0 C--O 1.213 -0.817 0 O-C-N 126.495 2.372 . . . . 25.0 112.434 -173.209 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.202 -1.43 0 N-CA-C 115.394 1.628 . . . . 50.0 115.394 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -77.18 -11.4 59.81 Favored 'General case' 0 CA--C 1.604 3.053 0 C-N-CA 117.482 -1.687 . . . . 50.0 107.213 161.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.97 69.09 Favored Glycine 0 C--O 1.248 0.971 0 CA-C-O 125.43 2.683 . . . . 25.0 111.828 173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.26 -27.2 70.41 Favored Glycine 0 C--O 1.205 -1.696 0 O-C-N 120.435 -1.627 . . . . 25.0 113.26 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.94 -39.43 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 104.779 -2.304 . . . . 25.0 104.779 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.8 -34.69 78.96 Favored 'General case' 0 CA--C 1.58 2.116 0 O-C-N 124.496 1.123 . . . . 75.0 112.732 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.16 -19.47 33.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 124.228 1.966 . . . . 50.0 115.538 -167.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -77.53 8.57 4.15 Favored 'General case' 0 C--O 1.258 1.552 0 O-C-N 118.307 -2.746 . . . . 25.0 115.945 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -145.01 60.8 1.31 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.828 -1.533 . . . . 25.0 110.601 163.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -130.33 151.41 50.86 Favored 'General case' 0 CA--C 1.599 2.829 0 C-N-CA 119.439 -0.905 . . . . 25.0 111.982 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.6 -26.29 68.62 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 118.018 -2.926 . . . . 25.0 108.547 166.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -93.51 24.92 3.71 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.422 -1.311 . . . . 25.0 111.067 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.91 100.76 0.43 Allowed 'General case' 0 C--O 1.196 -1.749 0 CA-C-O 125.556 2.598 . . . . 25.0 110.557 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -32.73 137.53 0.07 Allowed 'General case' 0 C--N 1.317 -0.824 2 CA-C-N 103.45 -6.25 . . . . 25.0 115.821 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -77.2 128.45 34.4 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 121.676 -0.64 . . . . 50.0 110.808 -155.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -98.86 147.32 25.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 119.818 3.266 . . . . 25.0 119.818 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -137.81 155.18 49.29 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 102.28 -3.23 . . . . 25.0 102.28 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.0 mt -105.56 126.21 60.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 1 N-CA-C 97.913 -4.847 . . . . 25.0 97.913 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.6 mtp -130.46 140.16 50.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.323 1.049 . . . . 25.0 111.286 -168.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 p -75.44 173.23 11.22 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 116.059 1.874 . . . . 25.0 116.059 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.48 -178.77 48.47 Favored Glycine 0 C--O 1.283 3.182 0 N-CA-C 105.184 -3.166 . . . . 25.0 105.184 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.17 -170.56 31.7 Favored Glycine 2 N--CA 1.389 -4.453 0 CA-C-N 111.313 -2.443 . . . . 25.0 111.314 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 45.5 mt-10 -80.49 136.79 36.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.368 2.084 . . . . 25.0 112.444 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -137.18 161.46 36.1 Favored 'General case' 0 N--CA 1.522 3.16 0 O-C-N 124.939 1.399 . . . . 25.0 108.494 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 m -112.65 130.84 55.9 Favored 'General case' 0 C--O 1.274 2.353 0 CA-C-O 122.438 1.113 . . . . 25.0 109.491 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -118.35 116.99 27.87 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 113.402 -1.727 . . . . 50.0 109.556 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 m -137.36 135.63 37.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 114.958 1.466 . . . . 25.0 114.958 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -114.95 161.49 18.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.847 -2.279 . . . . 25.0 104.847 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 t -146.5 147.97 31.73 Favored 'General case' 0 C--O 1.265 1.874 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.44 148.98 32.84 Favored 'General case' 0 CA--C 1.603 3.007 0 O-C-N 118.264 -2.773 . . . . 50.0 106.372 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.5 p -77.76 2.35 17.28 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 118.133 2.642 . . . . 25.0 118.133 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.45 159.54 57.48 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.655 1.182 . . . . 25.0 108.535 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.04 163.82 36.23 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 114.716 -3.056 . . . . 25.0 111.144 171.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -139.03 151.16 46.58 Favored 'General case' 0 C--O 1.183 -2.409 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 163.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.59 121.5 19.82 Favored 'General case' 0 C--O 1.253 1.265 0 CA-C-N 113.424 -1.716 . . . . 25.0 106.624 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.1 m -142.99 138.91 30.38 Favored 'General case' 0 C--N 1.317 -0.832 1 N-CA-C 99.674 -4.195 . . . . 25.0 99.674 -172.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.0 p -78.94 -48.64 14.17 Favored 'General case' 0 C--O 1.272 2.241 0 CA-C-O 124.025 1.869 . . . . 25.0 110.924 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -163.48 175.9 10.28 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.442 -1.411 . . . . 25.0 109.353 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -144.46 154.07 42.55 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 126.085 1.754 . . . . 25.0 108.697 167.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -128.43 160.55 31.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 116.792 -1.575 . . . . 25.0 109.692 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -134.91 148.5 50.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 103.663 -2.717 . . . . 50.0 103.663 162.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -139.2 168.59 19.49 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 103.998 -2.593 . . . . 50.0 103.998 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.4 pt -136.32 160.96 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 104.581 -2.378 . . . . 25.0 104.581 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -123.78 148.33 46.76 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 113.206 -1.815 . . . . 25.0 106.622 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -125.95 93.86 3.94 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 117.893 -1.523 . . . . 25.0 108.07 -172.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.84 165.99 3.67 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 120.114 -1.617 . . . . 25.0 112.757 168.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.82 48.5 Favored Glycine 0 C--O 1.192 -2.52 0 O-C-N 119.811 -1.806 . . . . 25.0 109.822 -171.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.59 159.57 32.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.073 1.416 . . . . 25.0 110.933 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.32 128.8 86.9 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 101.877 -3.379 . . . . 25.0 101.877 170.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 108' ' ' LYS . 72.3 Cg_endo -74.77 -27.06 10.81 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 114.048 -3.501 . . . . 25.0 117.359 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -81.59 1.23 34.75 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.48 1.491 . . . . 75.0 108.575 -165.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 106' ' ' PRO . 25.0 mmtp -118.24 166.53 13.5 Favored Pre-proline 0 CA--C 1.578 2.052 0 O-C-N 127.976 3.297 . . . . 25.0 111.798 -161.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -47.33 30.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.374 2 C-N-CA 130.171 7.247 . . . . 25.0 124.528 174.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -52.28 -27.88 16.83 Favored 'General case' 0 C--O 1.188 -2.178 0 O-C-N 120.141 -1.599 . . . . 50.0 114.835 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -71.57 -14.48 62.1 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 123.706 0.629 . . . . 25.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -116.43 -60.52 1.85 Allowed 'General case' 0 C--O 1.168 -3.235 0 C-N-CA 126.854 2.062 . . . . 25.0 111.817 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.56 -25.37 35.88 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -102.74 28.65 5.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.761 0.791 . . . . 25.0 112.885 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -137.85 151.73 48.36 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.914 -2.625 . . . . 50.0 103.914 156.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -130.01 147.88 51.8 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 119.008 -0.52 . . . . 25.0 111.408 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.8 tp -65.94 136.21 55.78 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 106.28 -1.748 . . . . 50.0 106.28 156.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.53 -15.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 120.24 1.382 . . . . 25.0 107.698 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.8 157.23 15.71 Favored Glycine 0 C--O 1.284 3.279 0 CA-C-O 117.057 -1.968 . . . . 25.0 110.971 163.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.14 150.32 49.55 Favored 'General case' 0 C--O 1.263 1.773 0 CA-C-N 118.067 0.934 . . . . 25.0 112.774 162.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -126.34 111.24 23.56 Favored Pre-proline 0 C--O 1.255 1.382 0 C-N-CA 125.432 1.493 . . . . 50.0 114.997 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -79.31 157.59 26.0 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 114.07 -3.487 . . . . 25.0 119.278 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . 0.279 53.1 t-80 -121.96 65.2 0.91 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 124.292 1.996 . . . . 25.0 107.122 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.15 26.47 8.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 111.624 -2.535 . . . . 50.0 110.458 -166.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.83 57.96 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-O 124.016 1.898 . . . . 25.0 108.806 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.96 160.48 0.65 Allowed Pre-proline 0 C--O 1.266 1.957 0 N-CA-C 118.479 2.77 . . . . 25.0 118.479 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.72 -166.62 0.1 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 123.099 2.533 . . . . 25.0 115.652 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.09 -23.13 7.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.189 1.922 . . . . 25.0 116.189 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.8 p -69.3 -8.44 46.16 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 114.395 1.257 . . . . 25.0 114.395 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -53.67 -29.07 36.88 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 117.217 -1.373 . . . . 25.0 113.811 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . 0.261 85.1 m-20 -68.15 143.59 55.34 Favored 'General case' 0 C--O 1.19 -2.064 0 CA-C-O 123.641 1.686 . . . . 25.0 111.359 -174.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -20.65 66.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.374 1.869 . . . . 75.0 110.073 -170.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.0 t -83.24 127.47 33.66 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.29 1.959 . . . . 25.0 116.29 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -137.45 146.95 44.94 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 124.503 2.097 . . . . 25.0 112.533 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -98.03 129.89 44.87 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.762 -1.211 . . . . 25.0 110.445 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . 0.266 35.9 mm -131.12 120.62 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.81 1.244 . . . . 25.0 107.904 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 89.9 t80 -76.58 126.07 30.34 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.898 -1.519 . . . . 50.0 106.898 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.9 129.08 31.99 Favored Pre-proline 0 C--N 1.364 1.221 0 CA-C-O 115.91 -1.995 . . . . 25.0 109.798 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.14 156.04 47.43 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 116.156 -2.096 . . . . 25.0 110.836 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -109.45 -8.63 15.01 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 126.527 1.931 . . . . 25.0 115.773 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -93.94 -13.58 26.93 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 115.833 1.79 . . . . 50.0 115.833 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.61 163.4 22.83 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.127 1.528 . . . . 25.0 115.127 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.01 146.13 34.41 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 124.94 1.4 . . . . 50.0 113.769 158.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.72 158.99 11.21 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 118.826 2.291 . . . . 25.0 118.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -72.79 136.99 45.52 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.975 -1.613 . . . . 50.0 111.149 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -142.87 166.11 25.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.152 -0.476 . . . . 25.0 110.526 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.77 130.95 73.24 Favored 'Isoleucine or valine' 0 C--O 1.267 1.98 0 N-CA-C 101.887 -3.375 . . . . 50.0 101.887 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.3 mt -101.63 123.86 55.04 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.93 1 N-CA-C 98.639 -4.578 . . . . 25.0 98.639 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.497 ' HA ' HG12 ' A' ' 164' ' ' VAL . 4.1 mp -112.38 143.22 43.86 Favored 'General case' 0 C--O 1.189 -2.106 0 N-CA-C 104.527 -2.397 . . . . 50.0 104.527 -173.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.4 34.94 Favored 'General case' 0 CA--C 1.456 -2.65 0 O-C-N 119.87 -1.769 . . . . 25.0 113.097 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.84 125.46 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 CA-C-N 110.143 -3.208 . . . . 50.0 108.489 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -108.06 104.22 13.61 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.873 -1.158 . . . . 25.0 107.873 166.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -78.28 72.74 4.82 Favored 'General case' 0 C--O 1.26 1.653 0 O-C-N 126.267 2.229 . . . . 25.0 106.47 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.64 116.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.773 0 C-N-CA 126.174 1.79 . . . . 50.0 113.374 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.8 -22.31 23.32 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -7.87 0.37 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 119.642 3.201 . . . . 25.0 119.642 171.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.2 p -135.34 165.08 26.27 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 103.089 -2.93 . . . . 25.0 103.089 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -76.97 -41.87 41.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 119.576 -1.953 . . . . 25.0 110.103 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -81.44 168.66 18.08 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 105.098 -2.186 . . . . 25.0 105.098 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -116.34 153.47 31.93 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 102.95 -2.982 . . . . 25.0 102.95 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -97.6 150.05 21.56 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 107.714 -1.217 . . . . 50.0 107.714 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -140.79 162.53 35.2 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 104.957 -2.238 . . . . 50.0 104.957 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 144.64 12.02 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 103.377 -2.823 . . . . 25.0 103.377 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 149' ' ' LEU . 24.0 m -123.38 155.03 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 123.082 1.42 . . . . 75.0 114.6 165.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.46 117.64 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 101.13 -3.656 . . . . 25.0 101.13 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -82.28 127.49 33.26 Favored 'General case' 1 C--O 1.318 4.668 0 CA-C-O 124.614 2.15 . . . . 25.0 106.169 170.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.14 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 116.573 -3.83 . . . . 50.0 115.217 175.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.31 98.18 5.94 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 106.189 -1.782 . . . . 25.0 106.189 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.23 122.74 32.8 Favored 'General case' 0 C--O 1.261 1.695 0 N-CA-C 101.555 -3.498 . . . . 50.0 101.555 -168.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.08 162.57 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 118.607 -2.558 . . . . 50.0 117.366 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -84.63 164.39 18.69 Favored 'General case' 0 C--O 1.282 2.77 0 O-C-N 120.738 -1.226 . . . . 25.0 108.301 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 40.9 pttt . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 116.971 -1.49 . . . . 25.0 108.548 179.072 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 . . . . . 0 C--O 1.262 1.757 0 N-CA-C 113.553 0.946 . . . . 25.0 113.553 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.07 179.44 30.29 Favored Glycine 0 C--O 1.282 3.146 0 CA-C-O 115.706 -2.719 . . . . 25.0 113.844 -172.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.61 153.17 44.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 119.067 1.433 . . . . 50.0 113.033 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 6' ' ' LYS . 19.1 mt -71.03 124.14 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 119.127 -2.233 . . . . 25.0 110.257 -171.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -100.89 11.03 40.4 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 123.516 1.627 . . . . 25.0 109.014 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 4' ' ' ILE . 51.1 mtmt 86.91 159.24 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.679 1 C-N-CA 133.354 4.661 . . . . 25.0 112.529 172.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 139.97 47.87 Favored 'Cis proline' 0 CA--C 1.466 -2.895 0 C-N-CA 132.672 2.363 . . . . 25.0 114.193 2.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.18 69.15 1.21 Allowed Glycine 0 C--N 1.281 -2.496 0 CA-C-N 112.036 -2.347 . . . . 25.0 113.393 165.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -69.86 137.7 51.92 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 125.795 2.712 . . . . 25.0 108.69 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -93.63 -18.8 21.78 Favored 'General case' 0 C--O 1.281 2.759 0 N-CA-C 103.746 -2.686 . . . . 25.0 103.746 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.02 75.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.898 0.856 . . . . 25.0 112.078 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.48 77.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.913 -1.494 . . . . 25.0 110.362 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt . . . . . 0 CA--C 1.57 1.722 0 CA-C-N 113.03 -1.895 . . . . 75.0 109.396 -172.681 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 C--O 1.173 -2.928 0 N-CA-C 119.84 3.274 . . . . 25.0 119.84 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -64.9 -38.09 89.83 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 115.12 -0.945 . . . . 50.0 110.565 169.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.52 60.81 5.76 Favored Pre-proline 0 C--O 1.275 2.423 0 CA-C-N 115.025 -0.989 . . . . 25.0 112.878 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.19 -22.22 9.96 Favored 'Trans proline' 0 N--CA 1.477 0.546 1 C-N-CA 110.086 -6.143 . . . . 25.0 115.525 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -77.6 -15.39 59.26 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.963 -1.086 . . . . 25.0 111.28 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.4 t -73.66 116.93 14.83 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 118.271 -1.371 . . . . 25.0 111.391 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 162' ' ' TYR . 66.5 mt -118.23 145.55 44.92 Favored 'General case' 0 C--O 1.164 -3.408 0 N-CA-C 104.501 -2.407 . . . . 50.0 104.501 162.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.6 157.88 45.3 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 124.765 2.222 . . . . 25.0 107.984 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.71 155.51 49.02 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 105.161 -2.163 . . . . 25.0 105.161 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.0 156.58 47.93 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 120.986 1.721 . . . . 25.0 110.957 166.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.6 mttt . . . . . 0 N--CA 1.505 2.308 0 N-CA-C 114.657 1.354 . . . . 25.0 114.657 174.803 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.2 mt . . . . . 0 CA--C 1.566 1.564 0 CA-C-O 117.668 -1.158 . . . . 50.0 114.005 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -71.56 -36.5 70.94 Favored 'General case' 0 C--O 1.262 1.713 0 N-CA-C 106.902 -1.518 . . . . 50.0 106.902 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.19 -16.52 78.61 Favored Glycine 1 C--O 1.156 -4.726 0 CA-C-O 123.362 1.535 . . . . 25.0 115.082 171.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.38 -17.01 73.98 Favored Glycine 0 C--N 1.307 -1.07 0 O-C-N 118.916 -2.52 . . . . 25.0 112.02 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -77.63 -34.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.53 0 N-CA-C 106.23 -1.767 . . . . 25.0 106.23 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.18 -23.0 57.65 Favored 'General case' 0 C--O 1.27 2.149 0 O-C-N 119.268 -2.145 . . . . 75.0 107.746 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -73.22 -8.2 54.79 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 113.566 -1.652 . . . . 50.0 112.726 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -77.36 7.7 5.01 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 124.378 2.037 . . . . 25.0 113.485 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -131.26 34.35 4.01 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.294 -1.373 . . . . 25.0 107.294 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 t -142.58 157.73 44.4 Favored 'General case' 0 C--O 1.252 1.229 0 O-C-N 119.954 -1.716 . . . . 25.0 111.656 -164.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.41 -25.08 66.96 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-O 122.466 1.126 . . . . 25.0 109.694 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.09 13.66 16.26 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.062 2.545 . . . . 25.0 108.173 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -76.41 99.62 4.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.313 -2.847 . . . . 25.0 103.313 167.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -46.72 145.13 2.03 Favored 'General case' 0 C--N 1.309 -1.155 1 CA-C-N 107.105 -4.589 . . . . 25.0 113.597 166.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -80.03 147.8 31.35 Favored 'General case' 0 C--O 1.21 -0.998 0 CA-C-O 115.626 -2.13 . . . . 50.0 110.4 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.91 101.66 13.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 126.246 2.216 . . . . 25.0 107.354 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -73.28 119.39 17.45 Favored 'General case' 0 C--O 1.284 2.911 0 N-CA-C 107.048 -1.464 . . . . 25.0 107.048 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.7 mt -81.53 130.97 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.0 ttt -147.82 134.55 19.98 Favored 'General case' 0 C--O 1.178 -2.695 0 N-CA-C 107.893 -1.151 . . . . 25.0 107.893 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 p -79.72 150.27 30.9 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.524 -2.398 . . . . 25.0 104.524 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.93 163.23 37.77 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 119.793 2.677 . . . . 25.0 119.793 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.75 -177.92 18.49 Favored Glycine 0 C--O 1.27 2.402 0 N-CA-C 105.998 -2.841 . . . . 25.0 105.998 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 9.3 pt-20 -82.48 152.24 26.16 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 125.437 2.542 . . . . 25.0 106.307 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.94 154.28 51.16 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 118.334 -2.729 . . . . 25.0 105.603 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.3 m -117.88 131.79 56.5 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 103.15 -2.907 . . . . 25.0 103.15 163.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -115.64 141.54 47.93 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.352 -1.351 . . . . 50.0 107.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -139.41 129.18 24.71 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 113.043 -1.889 . . . . 25.0 111.907 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -131.59 162.58 30.0 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 101.655 -3.461 . . . . 25.0 101.655 -174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.4 p -132.46 140.01 48.22 Favored 'General case' 0 CA--C 1.488 -1.417 0 O-C-N 121.597 -0.689 . . . . 25.0 111.748 156.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.447 ' CD2' ' HE1' ' A' ' 90' ' ' HIS . 76.4 m-85 -79.74 154.75 28.33 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.035 -1.469 . . . . 50.0 107.035 164.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.9 t -91.96 -19.72 22.13 Favored 'General case' 0 C--O 1.257 1.449 0 N-CA-C 106.762 -1.57 . . . . 25.0 106.762 -165.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.95 139.39 13.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 CA-C-O 117.305 -1.331 . . . . 25.0 109.12 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.85 131.86 34.8 Favored 'Trans proline' 0 CA--C 1.599 3.729 0 C-N-CA 115.461 -2.56 . . . . 25.0 111.225 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.447 ' HE1' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -153.16 160.43 42.85 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -81.61 161.48 23.47 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 116.048 1.87 . . . . 25.0 116.048 -158.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.416 HG21 ' HE3' ' A' ' 95' ' ' TRP . 53.1 m -154.97 134.96 12.97 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.332 -1.358 . . . . 25.0 107.332 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.1 p -91.52 -41.22 10.93 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.49 -1.67 . . . . 25.0 106.49 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -161.39 172.53 16.37 Favored 'General case' 0 C--O 1.281 2.732 0 N-CA-C 104.95 -2.241 . . . . 25.0 104.95 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.416 ' HE3' HG21 ' A' ' 92' ' ' THR . 3.5 p90 -144.53 152.52 40.69 Favored 'General case' 0 C--O 1.258 1.533 0 N-CA-C 114.477 1.288 . . . . 25.0 114.477 167.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -128.98 142.25 50.99 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.385 -1.293 . . . . 25.0 110.59 -167.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.74 144.19 47.38 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-N 120.276 1.398 . . . . 50.0 107.556 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.3 167.57 20.47 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 105.61 -1.996 . . . . 50.0 105.61 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.3 pt -129.6 147.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 172.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.6 p -77.79 154.89 31.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 117.739 -1.124 . . . . 25.0 109.565 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -144.86 80.09 1.61 Allowed 'General case' 0 C--O 1.239 0.545 0 N-CA-C 117.411 2.374 . . . . 25.0 117.411 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -47.24 157.72 0.18 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 125.411 2.529 . . . . 25.0 115.124 167.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.95 32.71 23.05 Favored Glycine 0 C--O 1.204 -1.767 0 C-N-CA 116.985 -2.531 . . . . 25.0 112.108 167.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -60.66 159.41 10.83 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.989 1.848 . . . . 25.0 115.989 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -74.82 134.34 75.35 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.126 -1.435 . . . . 25.0 107.126 162.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.23 -26.5 49.26 Favored 'Trans proline' 0 C--N 1.362 1.26 0 N-CA-C 120.164 3.102 . . . . 25.0 120.164 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.18 -6.5 58.59 Favored 'General case' 0 C--O 1.191 -1.994 0 C-N-CA 116.96 -1.896 . . . . 75.0 110.198 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -66.27 157.6 80.9 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 111.684 -2.507 . . . . 25.0 110.913 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.14 51.16 1.29 Allowed 'Trans proline' 0 C--N 1.37 1.668 1 N-CA-C 122.829 4.126 . . . . 25.0 122.829 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -2.45 -66.31 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 1 C-N-CA 132.092 4.157 . . . . 50.0 118.968 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -72.34 -8.6 55.8 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 122.189 2.268 . . . . 25.0 114.652 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 -55.4 2.58 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 124.523 1.129 . . . . 25.0 109.32 165.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.85 -25.69 1.39 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 117.323 2.342 . . . . 25.0 117.323 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -82.96 8.45 12.64 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.27 160.57 39.85 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 119.938 -1.726 . . . . 50.0 108.49 159.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -144.44 134.37 23.89 Favored 'General case' 0 C--O 1.182 -2.5 0 N-CA-C 105.821 -1.918 . . . . 25.0 105.821 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.41 132.57 50.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.678 1.191 . . . . 50.0 111.358 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.8 tt -111.15 -18.15 7.85 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 N-CA-C 106.224 -1.769 . . . . 25.0 106.224 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.29 156.03 13.11 Favored Glycine 0 C--N 1.306 -1.095 0 O-C-N 120.542 -1.349 . . . . 25.0 113.085 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.14 139.41 24.61 Favored 'General case' 0 C--O 1.266 1.943 0 CA-C-O 123.769 1.747 . . . . 25.0 107.065 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -128.81 107.21 18.44 Favored Pre-proline 0 C--O 1.255 1.381 0 CA-C-N 114.63 -1.168 . . . . 50.0 110.056 -170.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.95 164.52 31.49 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 113.331 -3.979 . . . . 25.0 115.038 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -139.98 2.98 1.98 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 118.058 2.614 . . . . 25.0 118.058 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -90.29 -24.92 20.77 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 107.637 -1.246 . . . . 50.0 107.637 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.62 160.93 27.43 Favored Glycine 0 C--N 1.352 1.437 1 N-CA-C 95.207 -7.157 . . . . 25.0 95.207 155.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.5 t -154.8 149.11 19.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 120.543 2.171 . . . . 25.0 112.706 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.03 -178.03 3.59 Favored 'Trans proline' 0 N--CA 1.436 -1.86 0 C-N-CA 114.866 -2.956 . . . . 25.0 111.008 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -15.8 5.37 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 118.474 -2.641 . . . . 25.0 115.496 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.53 4.02 0.43 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.103 1.89 . . . . 25.0 116.103 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -57.47 -33.54 68.08 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 127.108 2.163 . . . . 25.0 115.05 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -48.57 131.37 17.5 Favored 'General case' 0 C--O 1.18 -2.592 0 CA-C-N 119.367 0.985 . . . . 25.0 113.201 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.3 tp -65.86 -29.9 70.42 Favored 'General case' 0 C--O 1.268 2.077 0 CA-C-O 122.017 0.913 . . . . 75.0 113.355 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 132.5 47.46 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 121.748 -0.595 . . . . 25.0 110.67 166.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -153.84 161.05 42.36 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.597 1.665 . . . . 25.0 110.559 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -112.12 137.52 50.07 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.518 1.303 . . . . 25.0 114.518 -172.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.3 mt -132.53 133.23 59.89 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 102.956 -2.979 . . . . 25.0 102.956 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 73.5 t80 -101.0 134.19 44.36 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 105.716 -1.957 . . . . 50.0 105.716 173.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.4 mm -125.17 110.38 26.85 Favored Pre-proline 0 C--O 1.2 -1.509 0 N-CA-C 102.127 -3.286 . . . . 25.0 102.127 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.25 149.83 70.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 115.101 -2.799 . . . . 25.0 109.854 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -92.51 47.07 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.77 -14.69 60.74 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 118.791 -2.443 . . . . 50.0 114.487 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -166.44 169.45 13.89 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 103.946 -2.613 . . . . 25.0 103.946 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.6 pt? -98.15 152.57 19.22 Favored 'General case' 0 C--O 1.281 2.741 0 N-CA-C 100.459 -3.904 . . . . 50.0 100.459 163.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.24 164.19 17.72 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-O 123.386 1.548 . . . . 25.0 111.163 -171.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.91 157.65 45.06 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 117.105 -3.585 . . . . 50.0 116.844 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -158.42 175.94 13.07 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 100.652 -3.833 . . . . 25.0 100.652 170.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.75 146.92 6.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 123.449 0.7 . . . . 50.0 111.726 167.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.94 128.39 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 O-C-N 119.329 -2.107 . . . . 25.0 106.252 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -115.7 153.77 30.75 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 115.683 -2.103 . . . . 50.0 106.531 -167.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.49 44.2 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 121.48 1.945 . . . . 25.0 114.536 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.41 135.44 57.84 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.714 0 C-N-CA 125.028 1.331 . . . . 50.0 111.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -115.77 137.8 51.74 Favored 'General case' 0 C--O 1.277 2.543 0 C-N-CA 127.583 2.353 . . . . 25.0 107.273 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -118.0 144.82 45.22 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 103.269 -2.863 . . . . 25.0 103.269 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.33 113.27 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 105.538 -2.023 . . . . 50.0 105.538 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.0 -14.29 62.29 Favored 'General case' 0 C--O 1.262 1.728 0 N-CA-C 115.255 1.576 . . . . 25.0 115.255 -167.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -71.3 -25.09 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 126.39 2.306 . . . . 25.0 111.16 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.9 p -120.13 165.45 14.75 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 112.272 -2.24 . . . . 25.0 111.819 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -100.7 -9.79 21.49 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 123.808 1.766 . . . . 25.0 107.374 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -78.66 159.42 28.03 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 113.121 -1.854 . . . . 25.0 112.841 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.44 148.58 42.95 Favored 'General case' 0 CA--C 1.557 1.242 1 N-CA-C 98.837 -4.505 . . . . 25.0 98.837 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -126.67 139.48 53.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.276 -1.379 . . . . 50.0 107.276 -165.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 35' ' ' LEU . 75.7 m-85 -140.19 159.46 42.13 Favored 'General case' 0 C--O 1.203 -1.365 0 O-C-N 126.427 2.329 . . . . 50.0 110.404 -166.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -148.38 161.83 40.79 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.206 1.402 . . . . 25.0 111.816 166.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.52 130.6 50.43 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.178 0 N-CA-C 106.207 -1.775 . . . . 75.0 106.207 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -126.92 120.8 56.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.772 -1.566 . . . . 25.0 106.772 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -91.12 145.49 24.64 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 107.445 -1.316 . . . . 25.0 107.445 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.42 163.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 C-N-CA 127.187 2.195 . . . . 50.0 112.903 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.58 108.57 6.02 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 127.235 2.214 . . . . 25.0 109.701 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.33 116.49 30.45 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 102.867 -3.012 . . . . 50.0 102.867 -161.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 31.8 m -125.18 167.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.127 -1.029 . . . . 50.0 113.015 -156.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.88 155.03 31.2 Favored 'General case' 0 C--O 1.263 1.766 0 O-C-N 124.715 1.259 . . . . 25.0 108.277 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 C--O 1.249 1.059 0 CA-C-N 113.672 -1.603 . . . . 25.0 106.825 -177.346 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.527 -1.702 . . . . 25.0 113.252 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.53 166.72 39.14 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 117.155 -2.45 . . . . 25.0 116.658 -170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.81 173.35 13.83 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 106.681 -1.6 . . . . 50.0 106.681 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.0 121.96 54.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 N-CA-C 102.897 -3.001 . . . . 25.0 102.897 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.6 -41.81 16.03 Favored 'General case' 0 C--O 1.18 -2.569 0 C-N-CA 127.631 2.372 . . . . 25.0 113.837 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -152.7 155.74 32.69 Favored Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 105.838 -1.912 . . . . 25.0 105.838 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -60.51 139.18 23.0 Favored 'Cis proline' 0 C--N 1.358 1.028 0 C-N-CA 132.291 2.204 . . . . 25.0 116.209 3.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.58 -177.17 54.41 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 122.639 1.133 . . . . 25.0 114.123 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -123.08 103.01 8.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 125.129 2.395 . . . . 25.0 107.548 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -58.77 -27.83 65.35 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 119.861 -1.774 . . . . 25.0 112.988 167.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.79 73.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 122.902 1.334 . . . . 25.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.86 73.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 122.058 0.932 . . . . 25.0 108.857 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.566 1.578 0 C-N-CA 127.192 2.197 . . . . 75.0 109.721 -178.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 ppp? . . . . . 0 C--O 1.255 1.372 0 N-CA-C 118.811 2.893 . . . . 25.0 118.811 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -66.82 -41.29 87.73 Favored 'General case' 0 C--O 1.267 1.974 0 C-N-CA 124.104 0.961 . . . . 50.0 111.321 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.94 56.68 8.23 Favored Pre-proline 0 C--O 1.249 1.051 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.05 -20.89 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.318 0 N-CA-C 120.555 3.252 . . . . 25.0 120.555 -167.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -94.33 -2.85 51.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 116.849 -1.94 . . . . 25.0 113.179 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 t -77.09 87.25 3.58 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 122.191 0.996 . . . . 25.0 111.164 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.13 80.05 1.33 Allowed 'General case' 0 C--O 1.252 1.194 0 N-CA-C 107.729 -1.212 . . . . 50.0 107.729 -167.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -141.2 135.7 31.03 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 121.147 1.794 . . . . 25.0 114.43 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.68 166.11 31.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.044 -2.576 . . . . 25.0 104.044 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -84.93 146.56 27.19 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 tttt . . . . . 0 CA--C 1.507 -0.688 0 C-N-CA 124.647 1.179 . . . . 25.0 111.319 170.047 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 C--O 1.278 2.595 0 CA-C-O 122.785 1.278 . . . . 50.0 110.371 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -66.68 -14.04 62.0 Favored 'General case' 0 C--O 1.175 -2.824 0 C-N-CA 118.635 -1.226 . . . . 50.0 113.512 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.51 73.13 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 106.973 -2.451 . . . . 25.0 106.973 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.14 -11.26 84.58 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 124.461 2.145 . . . . 25.0 117.283 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -79.77 -32.19 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.375 0 CA-C-O 125.891 2.758 . . . . 25.0 107.126 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.48 -17.55 51.29 Favored 'General case' 0 CA--C 1.468 -2.181 0 CA-C-N 113.267 -1.788 . . . . 75.0 109.41 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.15 2.53 2.11 Favored 'General case' 0 C--O 1.197 -1.662 0 CA-C-O 123.928 1.823 . . . . 50.0 115.832 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -85.52 40.98 0.87 Allowed 'General case' 0 C--O 1.263 1.788 0 O-C-N 120.285 -1.509 . . . . 25.0 107.998 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.47 49.25 0.48 Allowed 'General case' 0 C--O 1.262 1.757 0 N-CA-C 105.847 -1.909 . . . . 25.0 105.847 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.8 t -147.01 157.3 43.58 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 126.747 2.019 . . . . 25.0 108.194 -162.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -31.41 67.46 Favored 'General case' 0 C--O 1.261 1.687 0 N-CA-C 102.177 -3.268 . . . . 25.0 102.177 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -88.19 21.11 2.91 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 120.308 -0.557 . . . . 25.0 109.671 -171.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -68.62 98.53 0.89 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 125.602 2.62 . . . . 25.0 103.946 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -33.78 144.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 1 CA-C-N 105.865 -5.152 . . . . 25.0 113.416 165.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -66.94 134.49 52.11 Favored 'General case' 0 C--O 1.263 1.767 0 O-C-N 125.233 1.583 . . . . 50.0 107.098 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -80.57 153.65 27.94 Favored 'General case' 0 CA--C 1.483 -1.598 0 O-C-N 120.589 -1.32 . . . . 25.0 110.481 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -136.93 143.3 42.83 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 117.29 2.33 . . . . 25.0 117.29 157.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.84 134.27 39.82 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.705 0 N-CA-C 105.406 -2.072 . . . . 25.0 105.406 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 66.3 mtm -144.32 146.92 32.87 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 118.624 -2.547 . . . . 25.0 105.895 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 p -86.58 171.55 10.94 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 124.143 1.925 . . . . 25.0 108.079 168.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.26 -173.77 17.09 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 124.455 2.142 . . . . 25.0 115.502 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.84 -176.7 38.03 Favored Glycine 0 C--O 1.266 2.106 0 N-CA-C 108.006 -2.038 . . . . 25.0 108.006 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 68.1 mm-40 -66.55 149.37 50.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 116.344 -1.789 . . . . 25.0 110.843 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -147.24 137.43 23.26 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 126.679 2.487 . . . . 25.0 105.675 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -93.61 105.96 17.97 Favored 'General case' 0 CA--C 1.479 -1.774 0 O-C-N 126.532 2.395 . . . . 25.0 105.152 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -76.64 142.23 40.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 103.061 -2.94 . . . . 50.0 103.061 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -136.46 103.28 5.21 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 118.385 -2.697 . . . . 25.0 106.75 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -100.78 126.7 47.37 Favored 'General case' 0 C--O 1.177 -2.754 0 N-CA-C 102.688 -3.079 . . . . 25.0 102.688 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -123.33 120.63 33.63 Favored 'General case' 0 C--O 1.175 -2.818 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -113.5 153.76 28.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.905 -1.498 . . . . 50.0 109.022 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 t -116.31 8.24 14.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 126.573 2.421 . . . . 25.0 113.271 174.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.91 119.39 25.86 Favored Pre-proline 0 C--N 1.349 0.586 0 C-N-CA 128.084 2.554 . . . . 25.0 111.451 -167.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -68.6 -37.94 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 124.922 2.011 . . . . 25.0 116.11 160.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.433 ' HD1' HG13 ' A' ' 154' ' ' VAL . 12.9 p80 -68.28 139.56 55.96 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 123.224 1.488 . . . . 25.0 110.857 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -78.68 129.74 35.06 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 112.887 -1.96 . . . . 25.0 113.479 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 154' ' ' VAL . 31.9 p -93.05 164.02 13.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.067 -1.646 . . . . 25.0 108.918 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -96.7 -49.94 4.89 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 120.698 -1.251 . . . . 25.0 110.185 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -166.46 170.88 12.45 Favored 'General case' 0 C--O 1.262 1.738 0 CA-C-O 118.354 -0.831 . . . . 25.0 110.758 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -144.13 153.06 41.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.096 -0.954 . . . . 25.0 109.315 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -131.16 142.59 50.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.832 -2.655 . . . . 25.0 103.832 -164.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -142.36 135.44 28.61 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 117.512 -3.242 . . . . 50.0 113.002 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 117' ' ' LEU . 14.5 p90 -146.38 167.16 24.28 Favored 'General case' 0 C--O 1.163 -3.495 0 O-C-N 119.546 -1.971 . . . . 50.0 111.105 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -120.1 173.97 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 125.933 2.02 . . . . 25.0 113.369 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -135.56 154.12 51.47 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 124.063 0.852 . . . . 25.0 112.711 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -137.81 100.77 4.27 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.388 1.625 . . . . 25.0 115.388 -165.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -42.86 162.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 120.73 3.604 . . . . 25.0 120.73 157.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.1 28.5 Favored Glycine 0 N--CA 1.488 2.113 0 CA-C-O 126.056 3.031 . . . . 25.0 107.763 165.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -67.62 160.89 26.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.06 -2.07 . . . . 25.0 114.067 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.02 111.75 20.43 Favored Pre-proline 0 C--O 1.194 -1.816 0 N-CA-C 107.127 -1.434 . . . . 25.0 107.127 155.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -64.35 -24.48 64.59 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 C-N-CA 123.671 2.914 . . . . 25.0 114.855 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.23 -15.99 50.5 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.379 1.049 . . . . 75.0 113.195 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -71.88 161.79 76.8 Favored Pre-proline 0 N--CA 1.483 1.199 0 CA-C-O 116.884 -1.531 . . . . 25.0 108.584 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -54.08 31.16 0.02 OUTLIER 'Trans proline' 0 CA--C 1.574 2.485 2 C-N-CA 126.302 4.668 . . . . 25.0 122.66 160.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -8.9 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 1 N-CA-C 122.386 4.217 . . . . 50.0 122.386 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.52 -16.83 64.44 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 117.118 -3.489 . . . . 25.0 109.586 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.26 -57.33 2.29 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 126.033 2.083 . . . . 25.0 106.955 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.76 -24.63 66.95 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.536 1.773 . . . . 25.0 115.299 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -69.88 -4.69 21.48 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-O 116.513 -1.708 . . . . 25.0 114.903 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -118.32 150.29 39.75 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 122.807 2.549 . . . . 50.0 110.011 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.81 149.64 38.9 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 119.823 -1.798 . . . . 25.0 111.382 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 98' ' ' TYR . 21.1 tp -76.44 123.84 26.64 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 116.054 -1.927 . . . . 50.0 108.93 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.0 tt -95.29 -11.68 8.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.83 173.5 33.53 Favored Glycine 0 C--O 1.19 -2.633 0 N-CA-C 116.645 1.418 . . . . 25.0 116.645 164.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -157.32 132.12 8.73 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.344 -1.428 . . . . 25.0 111.295 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.44 130.32 18.02 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 105.033 -2.21 . . . . 50.0 105.033 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -82.56 163.87 16.56 Favored 'Trans proline' 0 C--N 1.372 1.769 0 CA-C-O 124.83 1.929 . . . . 25.0 116.229 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -82.87 136.05 34.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 113.732 -1.576 . . . . 25.0 108.426 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.7 32.14 11.5 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.9 1.68 . . . . 50.0 111.008 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.28 165.11 43.64 Favored Glycine 0 N--CA 1.425 -2.088 0 O-C-N 119.502 -1.999 . . . . 25.0 108.625 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 t -66.17 -38.31 21.4 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-O 116.241 -1.838 . . . . 25.0 112.872 -173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.24 160.94 23.19 Favored 'Trans proline' 0 C--N 1.38 2.231 1 C-N-CA 108.351 -7.299 . . . . 25.0 107.874 -170.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.37 -26.1 11.5 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 126.876 3.227 . . . . 25.0 114.08 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -66.91 2.83 1.26 Allowed 'General case' 0 CA--C 1.512 -0.49 1 N-CA-C 122.615 4.302 . . . . 25.0 122.615 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.03 5.48 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 121.438 3.866 . . . . 25.0 121.438 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.25 141.5 41.7 Favored 'General case' 0 C--O 1.276 2.499 0 N-CA-C 121.55 3.907 . . . . 25.0 121.55 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.18 -25.72 63.57 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 106.589 -1.634 . . . . 75.0 106.589 -165.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 t -90.37 127.79 36.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 O-C-N 117.819 -3.051 . . . . 25.0 110.583 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -125.64 155.44 40.81 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 117.014 2.227 . . . . 25.0 117.014 164.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -79.72 125.63 29.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 113.139 -3.315 . . . . 25.0 108.304 169.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.7 mm -124.38 129.03 74.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 123.582 2.901 . . . . 25.0 105.968 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 79.0 t80 -81.59 127.2 32.62 Favored 'General case' 0 C--O 1.276 2.462 0 O-C-N 120.472 -1.393 . . . . 50.0 113.399 177.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.64 116.27 61.3 Favored Pre-proline 0 CA--C 1.515 -0.4 0 C-N-CA 130.768 3.627 . . . . 25.0 105.842 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.57 158.3 58.26 Favored 'Trans proline' 0 C--O 1.193 -1.728 1 C-N-CA 111.925 -4.916 . . . . 25.0 115.848 175.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -115.86 9.26 14.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.268 1.509 . . . . 25.0 109.427 -170.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.23 -8.66 57.55 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.113 2.264 . . . . 50.0 117.113 -171.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -146.5 170.21 17.35 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.274 -2.491 . . . . 25.0 104.274 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.1 pt? -111.99 131.68 55.25 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 101.269 -3.604 . . . . 50.0 101.269 160.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -176.08 164.4 34.37 Favored Glycine 0 C--N 1.302 -1.357 0 CA-C-O 124.756 2.309 . . . . 25.0 113.649 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.15 139.75 34.17 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.569 -1.548 . . . . 50.0 111.125 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -154.69 159.62 40.86 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 104.884 -2.265 . . . . 25.0 104.884 -171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.54 134.54 66.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 113.781 -3.009 . . . . 50.0 112.839 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.6 mt -110.01 130.18 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 O-C-N 127.453 2.97 . . . . 25.0 106.553 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.51 143.18 50.8 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 103.324 -2.843 . . . . 50.0 103.324 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.61 153.1 49.94 Favored 'General case' 0 C--O 1.257 1.455 0 N-CA-C 104.723 -2.325 . . . . 25.0 104.723 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.82 135.66 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-N 113.7 -1.591 . . . . 50.0 107.258 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.49 124.97 31.26 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-N 119.782 1.174 . . . . 25.0 110.067 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 143.58 34.31 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 125.274 1.609 . . . . 25.0 112.853 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.433 HG13 ' HD1' ' A' ' 90' ' ' HIS . 39.0 t -99.32 135.19 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 123.901 1.81 . . . . 50.0 111.159 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 -34.14 20.81 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.3 -1.5 . . . . 25.0 111.691 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -72.96 -17.59 61.46 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 124.872 1.358 . . . . 25.0 110.32 -171.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 p -146.06 179.26 7.61 Favored 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 109.204 -0.665 . . . . 25.0 109.204 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -87.02 9.98 17.89 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-O 122.571 1.177 . . . . 25.0 111.873 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -73.6 150.78 41.16 Favored 'General case' 0 C--O 1.281 2.733 0 CA-C-O 123.118 1.437 . . . . 25.0 110.291 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.33 160.16 43.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 103.017 -2.957 . . . . 25.0 103.017 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -145.23 173.78 11.65 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.022 -1.844 . . . . 50.0 106.022 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.48 149.07 46.54 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 105.588 -2.005 . . . . 50.0 105.588 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.67 145.2 42.35 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 121.409 1.913 . . . . 25.0 108.192 -173.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.6 p -141.64 145.33 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 CA-C-N 119.399 1.0 . . . . 75.0 111.929 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.11 134.41 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 103.65 -2.722 . . . . 25.0 103.65 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.53 135.25 33.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.899 -1.046 . . . . 25.0 110.767 169.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.41 133.2 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 119.398 -2.064 . . . . 50.0 111.758 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -106.45 89.96 3.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 102.353 -3.203 . . . . 25.0 102.353 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.48 118.97 32.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.578 -1.646 . . . . 50.0 107.007 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 5.1 m -120.38 157.61 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 123.989 1.852 . . . . 50.0 114.21 -170.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -74.23 143.83 44.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 100.38 -3.933 . . . . 25.0 100.38 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 CA--C 1.55 0.97 0 C-N-CA 126.768 2.027 . . . . 25.0 108.521 -175.45 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 123.279 1.514 . . . . 25.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.43 -149.13 28.63 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 117.477 1.751 . . . . 25.0 117.477 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.19 133.68 40.2 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.121 1.368 . . . . 50.0 108.726 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.71 120.85 35.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 119.809 1.186 . . . . 25.0 108.268 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -98.2 -29.46 13.2 Favored 'General case' 0 C--O 1.281 2.733 0 C-N-CA 125.079 1.352 . . . . 25.0 112.816 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -153.31 146.79 18.12 Favored Pre-proline 0 CA--C 1.559 1.298 1 N-CA-C 98.742 -4.54 . . . . 25.0 98.742 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.38 131.11 8.81 Favored 'Cis proline' 0 C--N 1.311 -1.436 0 C-N-CA 131.058 1.691 . . . . 25.0 115.743 15.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.47 177.29 44.39 Favored Glycine 0 C--O 1.192 -2.494 0 N-CA-C 118.632 2.213 . . . . 25.0 118.632 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -103.58 125.65 50.24 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 105.201 -2.148 . . . . 25.0 105.201 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -61.93 -34.0 75.29 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 123.789 0.681 . . . . 25.0 109.74 170.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.09 -33.13 73.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 116.718 -1.993 . . . . 25.0 111.284 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.69 78.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.248 -0.908 . . . . 25.0 111.665 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mp . . . . . 0 C--N 1.279 -2.495 0 CA-C-O 122.277 1.037 . . . . 75.0 111.362 177.778 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.9 ptt? . . . . . 0 N--CA 1.415 -2.184 0 CA-C-O 123.868 1.794 . . . . 25.0 115.741 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -62.5 -40.15 95.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.407 1.632 . . . . 50.0 115.407 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -143.12 46.18 0.67 Allowed Pre-proline 0 CA--C 1.473 -2.009 0 N-CA-C 119.044 2.979 . . . . 25.0 119.044 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.35 -30.7 29.73 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 O-C-N 116.918 -2.201 . . . . 25.0 113.513 -167.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -77.89 -1.07 29.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.374 1.99 . . . . 25.0 116.374 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.5 16.69 3.0 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 121.122 3.749 . . . . 25.0 121.122 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.78 114.64 18.85 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 125.39 2.519 . . . . 50.0 110.819 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -99.2 162.43 13.06 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 117.633 -3.167 . . . . 25.0 110.822 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.87 14.97 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.72 1.263 . . . . 25.0 112.388 -172.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -92.35 -172.61 3.15 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.401 1.572 . . . . 25.0 109.792 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 105.388 -2.078 . . . . 25.0 105.388 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 60' ' ' GLY . 46.7 mt . . . . . 0 C--O 1.217 -0.609 0 N-CA-C 117.426 2.38 . . . . 50.0 117.426 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.83 -36.45 70.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 104.465 -2.42 . . . . 50.0 104.465 161.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.25 -20.62 75.24 Favored Glycine 0 C--O 1.269 2.285 0 CA-C-O 126.009 3.005 . . . . 25.0 108.53 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 57' ' ' LEU . . . -64.52 -20.17 65.48 Favored Glycine 0 C--O 1.197 -2.214 0 O-C-N 116.841 -3.741 . . . . 25.0 115.189 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.8 mt -71.8 -46.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 111.793 -2.203 . . . . 25.0 105.645 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.96 -17.52 57.09 Favored 'General case' 0 CA--C 1.574 1.877 0 O-C-N 118.892 -2.38 . . . . 75.0 116.582 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -66.4 -29.25 69.37 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 123.805 1.764 . . . . 50.0 110.467 167.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.64 24.52 1.21 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.975 2.321 . . . . 25.0 113.983 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.6 48.78 1.43 Allowed 'General case' 0 C--O 1.25 1.114 0 O-C-N 119.52 -1.988 . . . . 25.0 110.951 157.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.271 13.7 t -133.56 174.94 9.89 Favored 'General case' 0 C--O 1.216 -0.702 0 O-C-N 125.365 1.666 . . . . 25.0 111.642 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.68 -17.39 59.97 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 123.849 1.785 . . . . 25.0 107.877 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -89.69 32.38 0.89 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 112.43 -2.168 . . . . 25.0 112.041 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -81.84 84.63 6.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 125.258 2.456 . . . . 25.0 116.354 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -40.06 150.83 0.05 Allowed 'General case' 0 C--O 1.292 3.293 1 CA-C-N 107.438 -4.437 . . . . 25.0 113.077 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -66.32 152.35 45.16 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 105.507 -2.034 . . . . 50.0 105.507 -167.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.51 151.48 27.52 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.79 132.39 28.81 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 117.321 2.341 . . . . 25.0 117.321 168.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -90.0 133.98 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 117.409 -1.281 . . . . 25.0 108.936 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.4 ttt -150.02 142.65 24.54 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 120.359 1.436 . . . . 25.0 111.189 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.459 HG22 HG23 ' A' ' 170' ' ' VAL . 32.2 p -79.35 166.95 21.53 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.285 0.846 . . . . 25.0 113.285 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 147.73 45.45 Favored Glycine 0 C--O 1.257 1.578 0 O-C-N 118.535 -2.603 . . . . 25.0 114.002 172.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.99 -166.04 33.38 Favored Glycine 0 CA--C 1.572 3.599 0 O-C-N 119.693 -2.063 . . . . 25.0 108.658 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -65.44 136.94 57.09 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.13 -1.806 . . . . 25.0 109.848 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -121.15 148.96 43.51 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 103.45 -2.796 . . . . 25.0 103.45 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -122.39 126.2 47.5 Favored 'General case' 0 C--O 1.201 -1.463 0 C-N-CA 124.807 1.243 . . . . 25.0 107.652 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -116.9 79.38 1.32 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 103.535 -2.765 . . . . 50.0 103.535 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -82.95 101.31 10.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.635 -1.166 . . . . 25.0 108.504 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -106.96 137.4 45.1 Favored 'General case' 0 CA--C 1.556 1.187 1 N-CA-C 99.708 -4.182 . . . . 25.0 99.708 173.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 t -151.13 143.46 24.17 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 123.787 1.756 . . . . 25.0 113.671 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -143.11 170.32 15.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 117.791 -1.1 . . . . 50.0 108.593 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . 0.287 9.1 t -72.13 -30.66 65.25 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 124.681 2.182 . . . . 25.0 112.737 175.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.47 152.81 69.79 Favored Pre-proline 0 C--O 1.262 1.721 0 O-C-N 116.78 -3.7 . . . . 25.0 109.062 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.46 161.45 42.38 Favored 'Trans proline' 0 C--O 1.282 2.677 0 C-N-CA 115.61 -2.46 . . . . 25.0 108.52 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -126.06 162.33 25.56 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 117.557 -3.215 . . . . 25.0 112.905 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.41 124.98 23.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 105.026 -2.213 . . . . 25.0 105.026 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -147.12 150.84 35.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 169.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.0 p -94.53 -31.14 14.05 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 120.447 1.476 . . . . 25.0 109.442 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . 0.261 7.2 tt0 -158.54 160.88 37.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 118.604 0.638 . . . . 25.0 109.396 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -142.91 148.93 37.75 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 123.784 1.754 . . . . 25.0 106.815 166.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.96 151.8 51.17 Favored 'General case' 0 C--N 1.27 -2.876 0 O-C-N 119.089 -2.257 . . . . 25.0 108.871 -169.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.21 130.07 45.83 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 105.104 -2.184 . . . . 50.0 105.104 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.43 155.83 23.57 Favored 'General case' 0 C--O 1.182 -2.468 0 CA-C-N 111.857 -2.428 . . . . 50.0 104.512 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.1 pt -134.62 155.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-N 112.129 -2.305 . . . . 25.0 112.291 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 p -70.63 156.88 38.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 124.523 2.106 . . . . 25.0 115.108 168.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -130.68 95.43 3.85 Favored 'General case' 0 C--O 1.188 -2.132 0 O-C-N 116.988 -3.57 . . . . 25.0 114.922 173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -68.9 157.07 37.37 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 107.869 -1.16 . . . . 25.0 107.869 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.55 37.75 89.9 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-O 126.077 3.043 . . . . 25.0 110.985 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -67.16 159.84 28.09 Favored 'General case' 0 C--O 1.267 1.987 0 CA-C-O 125.686 2.66 . . . . 25.0 110.777 -171.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -67.46 123.89 87.79 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-N 111.958 -2.383 . . . . 25.0 107.279 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.53 -17.67 20.63 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 117.923 2.24 . . . . 25.0 117.923 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.71 8.44 39.22 Favored 'General case' 0 C--O 1.253 1.252 0 O-C-N 119.696 -1.877 . . . . 75.0 108.407 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -122.18 162.42 37.62 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 112.203 -2.271 . . . . 25.0 114.596 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.88 95.0 1.06 Allowed 'Trans proline' 0 CA--C 1.463 -3.04 0 N-CA-C 117.052 1.905 . . . . 25.0 117.052 -168.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -21.34 -60.76 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 127.064 2.146 . . . . 50.0 116.355 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -77.47 3.33 13.68 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 119.1 -2.25 . . . . 25.0 113.735 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.258 84.2 mtt180 -119.99 -42.19 2.61 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 127.422 2.289 . . . . 25.0 110.868 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.93 -15.74 5.47 Favored 'General case' 0 C--O 1.283 2.84 0 O-C-N 119.812 -1.805 . . . . 25.0 111.833 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -98.58 17.02 20.09 Favored 'General case' 0 C--O 1.271 2.192 0 N-CA-C 118.639 2.829 . . . . 25.0 118.639 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -144.85 161.28 39.67 Favored 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 118.762 -1.175 . . . . 50.0 107.898 168.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.79 158.59 43.84 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.71 137.74 35.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.049 -1.834 . . . . 50.0 106.049 164.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.287 16.7 tt -94.98 -26.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 116.268 -1.825 . . . . 25.0 111.964 169.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.92 156.12 13.65 Favored Glycine 0 N--CA 1.432 -1.58 0 O-C-N 124.893 1.371 . . . . 25.0 112.345 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.26 143.01 50.24 Favored 'General case' 0 N--CA 1.394 -3.251 0 CA-C-O 124.442 2.067 . . . . 25.0 108.351 170.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.4 96.53 48.06 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.325 -1.307 . . . . 50.0 108.173 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.97 159.23 50.84 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 114.056 -3.496 . . . . 25.0 110.601 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -139.91 47.74 1.82 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 115.629 1.715 . . . . 25.0 115.629 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -112.19 -24.86 9.6 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.767 -2.015 . . . . 50.0 107.143 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -160.89 40.21 0.43 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-O 124.925 2.403 . . . . 25.0 113.427 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -81.28 146.96 59.26 Favored Pre-proline 0 C--O 1.273 2.317 0 O-C-N 119.392 -2.24 . . . . 25.0 108.304 -154.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.57 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.768 1 C-N-CA 126.021 4.481 . . . . 25.0 107.031 169.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.6 -18.52 0.26 Allowed 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 121.081 3.734 . . . . 25.0 121.081 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 56.8 p -52.5 -9.41 0.11 Allowed 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 121.728 2.058 . . . . 25.0 114.582 162.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -60.03 -16.16 28.74 Favored 'General case' 0 N--CA 1.522 3.161 0 O-C-N 117.661 -3.149 . . . . 25.0 113.192 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.66 136.08 50.68 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 104.389 -2.449 . . . . 25.0 104.389 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -69.23 -24.83 64.06 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.504 -1.372 . . . . 75.0 111.196 -165.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.4 t -85.41 136.48 33.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 113.834 -1.53 . . . . 25.0 110.395 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.08 156.58 42.58 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 104.729 -2.323 . . . . 25.0 104.729 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -108.4 119.51 39.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 115.164 -2.351 . . . . 25.0 105.624 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.8 mm -118.42 119.23 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.312 0 C-N-CA 125.384 1.474 . . . . 25.0 111.19 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -77.16 133.77 38.86 Favored 'General case' 0 C--O 1.269 2.101 0 N-CA-C 105.022 -2.214 . . . . 50.0 105.022 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.3 mt -134.86 119.67 13.85 Favored Pre-proline 0 C--N 1.361 1.102 0 CA-C-O 122.908 1.337 . . . . 25.0 108.267 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.83 159.08 13.98 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 116.718 -1.721 . . . . 25.0 112.512 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 169' ' ' LEU . 11.5 tp10 -153.95 115.92 4.27 Favored 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.923 1.823 . . . . 25.0 115.923 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -105.95 -4.04 21.05 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 113.77 -1.559 . . . . 50.0 115.062 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -118.02 166.51 12.44 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 117.277 -3.389 . . . . 25.0 110.492 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.9 mp -116.55 136.6 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.947 -2.612 . . . . 50.0 103.947 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.97 174.18 25.47 Favored Glycine 0 C--N 1.306 -1.085 0 N-CA-C 119.913 2.725 . . . . 25.0 119.913 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.31 142.19 27.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.588 1.555 . . . . 50.0 108.268 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -146.25 162.73 37.44 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 104.672 -2.344 . . . . 25.0 104.672 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.9 t -127.64 136.81 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 123.828 3.013 . . . . 50.0 112.598 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 76.9 mt -104.02 118.58 51.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.642 0 N-CA-C 105.439 -2.06 . . . . 25.0 105.439 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.5 130.76 44.55 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.417 2.056 . . . . 50.0 108.882 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -110.51 127.53 55.21 Favored 'General case' 0 C--O 1.246 0.902 0 O-C-N 120.145 -1.597 . . . . 25.0 109.704 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.87 132.73 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 O-C-N 126.083 2.114 . . . . 50.0 114.673 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 119.52 31.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.69 1.596 . . . . 25.0 109.304 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.42 72.08 4.42 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 126.294 2.246 . . . . 25.0 107.875 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.46 98.97 2.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.533 0 C-N-CA 117.51 -1.676 . . . . 50.0 111.164 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.68 -16.45 64.15 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.756 1.265 . . . . 25.0 113.804 -165.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -60.89 -32.99 72.42 Favored 'General case' 0 CA--C 1.601 2.913 0 CA-C-N 113.763 -1.562 . . . . 25.0 112.145 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.0 t -123.92 158.69 31.38 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.475 1.734 . . . . 25.0 110.019 -166.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.41 -23.73 58.99 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.18 165.05 7.74 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.751 1.019 . . . . 25.0 113.751 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.96 178.44 6.67 Favored 'General case' 0 C--O 1.209 -1.053 1 N-CA-C 98.25 -4.722 . . . . 25.0 98.25 175.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -126.22 130.43 50.93 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.891 -3.744 . . . . 50.0 100.891 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -135.33 138.67 43.63 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 126.15 1.78 . . . . 50.0 111.529 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -160.58 175.52 12.6 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 104.848 -2.278 . . . . 25.0 104.848 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 148' ' ' ILE . 26.5 m -135.86 164.63 31.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 125.158 1.536 . . . . 75.0 107.392 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.0 mm -133.65 120.48 37.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 112.721 -2.036 . . . . 25.0 105.6 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -88.64 124.95 34.57 Favored 'General case' 0 C--O 1.262 1.753 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.518 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.68 158.1 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 117.077 2.251 . . . . 50.0 117.077 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.7 124.92 30.8 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 101.901 -3.37 . . . . 25.0 101.901 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 140' ' ' GLU . 84.2 mt -114.07 130.53 56.56 Favored 'General case' 0 C--O 1.204 -1.34 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 -174.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.459 HG23 HG22 ' A' ' 76' ' ' THR . 27.6 m -124.95 158.1 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 116.223 1.934 . . . . 50.0 116.223 -173.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.7 132.38 35.18 Favored 'General case' 0 CA--C 1.585 2.311 0 O-C-N 125.842 1.964 . . . . 25.0 108.831 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.4 pttt . . . . . 0 CA--C 1.552 1.055 0 CA-C-O 118.235 -0.888 . . . . 25.0 110.884 -167.669 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.672 0.749 . . . . 25.0 111.349 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.35 179.71 27.32 Favored Glycine 0 C--O 1.267 2.203 0 C-N-CA 117.794 -2.146 . . . . 25.0 116.956 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -152.37 153.96 34.66 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.096 -2.414 . . . . 50.0 111.351 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.71 133.49 31.42 Favored 'Isoleucine or valine' 0 C--O 1.258 1.518 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 -163.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -120.29 -30.32 4.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.421 -1.312 . . . . 25.0 111.768 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG2' HG22 ' A' ' 83' ' ' THR . 19.0 pttt -146.72 162.46 33.63 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 123.568 1.651 . . . . 25.0 107.148 151.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.69 148.95 87.33 Favored 'Cis proline' 0 N--CA 1.494 1.531 0 CA-C-O 123.439 1.35 . . . . 25.0 112.219 6.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.39 -175.69 52.55 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-O 126.013 3.007 . . . . 25.0 115.995 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.3 t -117.4 102.03 8.89 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 111.851 -2.175 . . . . 25.0 108.913 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -57.74 -31.93 66.95 Favored 'General case' 0 C--O 1.181 -2.533 0 O-C-N 123.784 0.678 . . . . 25.0 111.472 -169.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.67 65.58 Favored 'General case' 0 CA--C 1.558 1.269 0 O-C-N 118.365 -2.709 . . . . 25.0 111.925 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.11 -22.12 55.89 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.613 -1.625 . . . . 25.0 106.613 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt . . . . . 0 C--O 1.257 1.491 0 N-CA-C 114.049 1.129 . . . . 75.0 114.049 178.517 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.91 -53.72 55.03 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 118.271 -2.768 . . . . 50.0 111.595 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.93 67.83 41.89 Favored Pre-proline 0 CA--C 1.566 1.58 0 O-C-N 118.88 -2.387 . . . . 25.0 115.813 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.07 -11.49 22.02 Favored 'Trans proline' 0 C--O 1.206 -1.086 0 C-N-CA 124.449 3.433 . . . . 25.0 117.252 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 -8.15 30.21 Favored 'General case' 0 C--O 1.159 -3.663 0 N-CA-C 114.244 1.201 . . . . 25.0 114.244 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -70.44 50.83 0.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 119.412 3.115 . . . . 25.0 119.412 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.15 132.82 46.43 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.198 -1.408 . . . . 50.0 107.198 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 161.92 19.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 120.719 1.6 . . . . 25.0 110.615 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.2 41.42 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-O 115.499 -2.191 . . . . 25.0 108.272 161.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -112.43 142.99 44.3 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 121.962 2.164 . . . . 25.0 113.389 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mttp . . . . . 0 C--N 1.303 -1.422 0 O-C-N 117.987 -2.946 . . . . 25.0 104.487 -179.37 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 117.509 2.411 . . . . 50.0 117.509 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.34 -25.75 46.55 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.325 -2.843 . . . . 50.0 103.325 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.82 -17.92 62.52 Favored Glycine 0 C--O 1.209 -1.445 0 CA-C-O 125.286 2.604 . . . . 25.0 112.578 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.9 -25.28 71.89 Favored Glycine 0 CA--C 1.561 2.948 0 O-C-N 118.684 -2.656 . . . . 25.0 111.821 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.23 -38.03 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.14 -32.53 63.2 Favored 'General case' 0 C--O 1.198 -1.615 0 N-CA-C 104.95 -2.241 . . . . 75.0 104.95 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -68.47 -34.82 76.61 Favored 'General case' 0 C--O 1.264 1.834 0 N-CA-C 116.807 2.151 . . . . 50.0 116.807 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -76.65 16.42 0.51 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 125.789 2.709 . . . . 25.0 114.687 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -126.38 82.64 2.09 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 101.946 -3.353 . . . . 25.0 101.946 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -163.39 166.18 23.16 Favored 'General case' 0 CA--C 1.479 -1.784 0 O-C-N 123.636 0.585 . . . . 25.0 111.839 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -66.46 -29.43 69.56 Favored 'General case' 0 C--O 1.196 -1.754 0 O-C-N 117.448 -3.282 . . . . 25.0 109.977 171.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -82.04 21.88 0.84 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 112.876 -1.966 . . . . 25.0 112.66 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -74.0 97.34 2.83 Favored 'General case' 0 C--O 1.171 -3.054 0 CA-C-O 127.312 3.434 . . . . 25.0 109.649 158.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.1 p90 -29.64 135.41 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.375 1 CA-C-N 107.502 -4.408 . . . . 25.0 112.393 160.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -63.5 152.34 38.77 Favored 'General case' 0 C--O 1.268 2.037 0 N-CA-C 116.302 1.964 . . . . 50.0 116.302 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -101.56 162.01 13.22 Favored 'General case' 0 CA--C 1.479 -1.773 0 CA-C-N 113.513 -1.676 . . . . 25.0 111.576 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -153.47 146.41 24.47 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 124.472 1.109 . . . . 25.0 109.813 164.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.37 135.16 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 106.412 -1.699 . . . . 25.0 106.412 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.1 mtp -137.52 158.28 44.72 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 109.095 -0.706 . . . . 25.0 109.095 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.3 p -120.2 167.02 12.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.41 -164.98 40.36 Favored Glycine 0 C--O 1.266 2.105 0 C-N-CA 119.821 -1.181 . . . . 25.0 111.819 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.85 -173.66 32.24 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 120.573 -0.823 . . . . 25.0 111.104 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -82.02 141.71 32.99 Favored 'General case' 0 C--O 1.28 2.695 0 CA-C-O 124.071 1.891 . . . . 25.0 110.752 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.51 143.33 39.49 Favored 'General case' 0 C--O 1.19 -2.074 0 N-CA-C 104.133 -2.543 . . . . 25.0 104.133 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -98.56 126.14 44.04 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.273 -1.751 . . . . 25.0 106.273 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -110.85 150.73 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 116.179 -1.867 . . . . 50.0 106.154 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.449 HG22 ' HG2' ' A' ' 6' ' ' LYS . 3.3 t -153.3 159.61 42.56 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 117.632 -1.175 . . . . 25.0 114.129 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -138.07 171.58 14.2 Favored 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.872 -3.01 . . . . 25.0 102.872 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 p -135.3 154.75 51.43 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.121 1.513 . . . . 25.0 107.94 153.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -94.02 154.2 17.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.902 0.858 . . . . 50.0 109.043 169.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.1 p -85.29 -27.02 26.24 Favored 'General case' 0 C--O 1.172 -2.98 0 O-C-N 120.396 -1.44 . . . . 25.0 111.691 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.67 141.66 13.89 Favored Pre-proline 0 CA--C 1.48 -1.739 0 N-CA-C 102.408 -3.182 . . . . 25.0 102.408 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.49 162.84 35.27 Favored 'Trans proline' 0 C--N 1.373 1.843 0 CA-C-O 123.507 1.378 . . . . 25.0 113.76 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.88 148.12 41.58 Favored 'General case' 0 CA--C 1.471 -2.059 0 CA-C-N 112.963 -1.926 . . . . 25.0 106.471 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -81.76 96.95 7.74 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 112.161 -2.291 . . . . 25.0 108.731 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.6 m -83.98 127.7 34.05 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 116.446 2.017 . . . . 25.0 116.446 -170.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 p -87.83 -42.27 12.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 118.335 -1.346 . . . . 25.0 110.486 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -168.29 168.21 11.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.068 -1.424 . . . . 25.0 109.866 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -140.66 164.65 29.6 Favored 'General case' 0 C--O 1.261 1.661 0 CA-C-N 123.199 2.727 . . . . 25.0 110.96 164.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -139.89 159.77 41.43 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 115.092 -2.385 . . . . 25.0 112.217 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.89 145.0 24.58 Favored 'General case' 0 C--O 1.246 0.901 0 O-C-N 124.951 1.407 . . . . 50.0 111.986 169.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 117' ' ' LEU . 58.9 m-85 -139.57 169.77 17.14 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 105.56 -2.015 . . . . 50.0 105.56 -172.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 pt -125.38 152.63 32.25 Favored 'Isoleucine or valine' 0 C--O 1.261 1.68 0 CA-C-O 123.791 1.758 . . . . 25.0 106.895 162.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.94 143.32 29.91 Favored 'General case' 0 C--N 1.387 2.206 0 N-CA-C 100.49 -3.892 . . . . 25.0 100.49 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -101.17 133.16 46.14 Favored 'General case' 0 C--O 1.183 -2.416 1 N-CA-C 100.085 -4.042 . . . . 25.0 100.085 -172.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -146.05 151.65 38.08 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 -163.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.21 37.13 9.25 Favored Glycine 0 C--O 1.202 -1.893 0 CA-C-O 125.087 2.493 . . . . 25.0 110.428 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -65.56 157.58 29.37 Favored 'General case' 0 CA--C 1.462 -2.413 0 C-N-CA 126.874 2.07 . . . . 25.0 114.908 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.97 123.05 89.15 Favored Pre-proline 0 CA--C 1.501 -0.942 1 O-C-N 115.438 -4.539 . . . . 25.0 108.937 155.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.77 -24.66 72.6 Favored 'Trans proline' 0 CA--C 1.499 -1.267 0 C-N-CA 115.017 -2.856 . . . . 25.0 117.102 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.96 -6.06 49.16 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 124.221 1.962 . . . . 75.0 113.854 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -56.1 161.95 3.34 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-N 112.663 -2.062 . . . . 25.0 112.254 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -77.55 70.37 6.9 Favored 'Trans proline' 0 C--O 1.175 -2.671 0 CA-C-O 125.972 2.405 . . . . 25.0 113.696 161.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 mt -46.63 -40.66 13.41 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 110.16 -3.2 . . . . 50.0 113.808 -168.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.79 -13.04 61.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 123.233 2.742 . . . . 25.0 115.42 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -117.78 -41.89 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 127.112 2.758 . . . . 25.0 111.627 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.22 -18.07 65.01 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 114.138 1.162 . . . . 25.0 114.138 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.35 33.45 1.4 Allowed 'General case' 0 C--N 1.316 -0.873 0 O-C-N 119.945 -1.722 . . . . 25.0 115.184 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -141.52 145.74 35.52 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.642 1.177 . . . . 50.0 108.538 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.45 142.61 50.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 115.309 1.596 . . . . 25.0 115.309 163.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 98' ' ' TYR . 41.5 tp -77.76 137.96 38.74 Favored 'General case' 0 C--N 1.319 -0.753 1 N-CA-C 99.426 -4.287 . . . . 50.0 99.426 179.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.1 tt -124.52 -5.32 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 O-C-N 126.726 2.516 . . . . 25.0 108.902 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.12 170.31 37.28 Favored Glycine 0 C--O 1.273 2.576 0 N-CA-C 118.277 2.071 . . . . 25.0 118.277 154.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.99 145.6 24.24 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 123.449 1.595 . . . . 25.0 108.243 170.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -118.96 100.63 50.67 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 120.899 -1.125 . . . . 50.0 111.049 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.19 172.81 15.41 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 122.615 2.21 . . . . 25.0 108.398 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -133.88 48.17 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.819 -1.991 . . . . 25.0 108.358 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.7 -11.77 59.83 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 117.239 -1.784 . . . . 50.0 109.131 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 143.1 -171.79 24.84 Favored Glycine 0 C--N 1.294 -1.803 0 CA-C-O 116.927 -2.041 . . . . 25.0 113.091 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.0 154.27 0.12 Allowed Pre-proline 0 N--CA 1.428 -1.525 0 C-N-CA 129.127 2.971 . . . . 25.0 115.75 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.27 10.33 3.75 Favored 'Trans proline' 0 C--O 1.182 -2.277 1 C-N-CA 112.524 -4.517 . . . . 25.0 117.681 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.78 -25.92 62.21 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 119.711 -1.868 . . . . 25.0 109.165 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 81.3 p -71.61 -19.0 62.18 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 123.917 1.817 . . . . 25.0 111.67 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -72.46 -23.92 61.12 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 111.416 -2.629 . . . . 25.0 109.609 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.62 109.87 5.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 119.282 -2.136 . . . . 25.0 110.444 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.7 -36.22 14.46 Favored 'General case' 0 C--O 1.278 2.58 0 O-C-N 119.358 -2.088 . . . . 75.0 109.312 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.7 t -73.73 131.66 41.83 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.176 0.99 . . . . 25.0 110.085 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.08 161.14 38.34 Favored 'General case' 0 C--O 1.275 2.429 0 CA-C-O 121.85 0.833 . . . . 25.0 109.293 -173.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -109.11 131.75 54.77 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.153 -0.931 . . . . 25.0 108.587 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.14 117.79 38.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -75.66 134.5 40.57 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 125.583 1.802 . . . . 50.0 106.971 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 18.1 mt -125.72 119.3 24.31 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 103.041 -2.948 . . . . 25.0 103.041 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.2 153.26 67.08 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 124.007 1.53 . . . . 25.0 112.361 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.29 50.98 0.78 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.201 1.477 . . . . 25.0 109.692 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.55 -35.4 75.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 118.606 2.817 . . . . 50.0 118.606 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -155.47 166.64 32.93 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.602 1.961 . . . . 25.0 112.861 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.6 mp -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 115.993 -0.549 . . . . 50.0 111.148 165.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 141.08 165.06 10.18 Favored Glycine 0 C--O 1.187 -2.842 0 C-N-CA 118.122 -1.99 . . . . 25.0 114.779 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.59 145.51 47.32 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 119.181 3.03 . . . . 50.0 119.181 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -142.9 157.37 44.65 Favored 'General case' 0 C--O 1.201 -1.478 0 N-CA-C 102.883 -3.006 . . . . 25.0 102.883 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.15 135.87 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 104.512 -2.403 . . . . 50.0 104.512 164.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.79 123.58 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 93.128 -6.619 . . . . 25.0 93.128 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 mp -106.29 145.03 32.14 Favored 'General case' 0 C--O 1.185 -2.292 0 C-N-CA 124.021 0.929 . . . . 50.0 109.647 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.36 45.88 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 115.971 -1.966 . . . . 25.0 113.619 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.52 128.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.265 1.911 0 O-C-N 125.006 1.442 . . . . 50.0 111.059 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -118.82 119.55 34.71 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 116.766 -1.588 . . . . 25.0 109.02 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -92.35 135.6 33.89 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 103.704 -2.702 . . . . 25.0 103.704 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.6 t -118.46 126.81 75.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 104.154 -2.536 . . . . 50.0 104.154 -172.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.42 -16.97 63.0 Favored 'General case' 0 CA--C 1.476 -1.901 1 O-C-N 116.051 -4.156 . . . . 25.0 115.936 -166.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.19 -28.13 53.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 128.172 2.589 . . . . 25.0 112.753 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.3 p -134.75 164.8 26.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 116.775 2.139 . . . . 25.0 116.775 -158.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -95.1 -15.96 22.99 Favored 'General case' 0 C--O 1.184 -2.357 0 CA-C-O 124.47 2.081 . . . . 25.0 113.092 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -66.83 155.04 39.35 Favored 'General case' 0 C--O 1.287 3.04 0 O-C-N 118.86 -2.4 . . . . 25.0 111.084 155.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.82 140.74 22.84 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 103.354 -2.832 . . . . 25.0 103.354 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -83.78 165.67 18.64 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 105.119 -2.178 . . . . 50.0 105.119 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.12 160.58 43.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.853 -1.521 . . . . 50.0 109.241 164.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -147.65 154.2 40.32 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 116.787 -1.578 . . . . 25.0 110.416 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.5 m -138.85 128.28 31.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.56 -2.015 . . . . 75.0 105.56 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.8 mt -132.53 126.97 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.135 0 N-CA-C 106.262 -1.755 . . . . 25.0 106.262 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.97 135.3 33.72 Favored 'General case' 0 C--N 1.311 -1.086 1 O-C-N 115.773 -4.329 . . . . 25.0 108.813 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.86 134.96 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 O-C-N 117.246 -3.409 . . . . 50.0 102.802 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.42 99.11 12.02 Favored 'General case' 0 CA--C 1.554 1.102 0 O-C-N 119.769 -1.832 . . . . 25.0 106.192 171.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.33 128.43 35.49 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 121.696 2.044 . . . . 50.0 110.499 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.11 168.25 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . 0.312 26.1 t30 -83.07 146.82 28.49 Favored 'General case' 0 N--CA 1.385 -3.703 0 N-CA-C 106.775 -1.565 . . . . 25.0 106.775 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 CA--C 1.482 -1.651 0 CA-C-N 121.727 2.058 . . . . 25.0 110.042 170.757 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 161' ' ' PHE . 76.5 m80 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 125.118 2.389 . . . . 25.0 109.669 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.37 -161.38 14.22 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 112.712 -2.04 . . . . 25.0 108.257 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -149.96 162.71 39.82 Favored 'General case' 0 C--O 1.27 2.166 0 CA-C-N 114.138 -1.031 . . . . 50.0 110.703 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mm -85.16 139.14 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 O-C-N 125.554 1.784 . . . . 25.0 111.543 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.73 39.21 3.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 103.912 -2.625 . . . . 25.0 103.912 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 75.92 146.43 0.11 Allowed Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 127.451 2.3 . . . . 25.0 114.161 171.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.68 147.55 15.61 Favored 'Cis proline' 0 CA--C 1.491 -1.635 0 O-C-N 118.252 -1.499 . . . . 25.0 114.865 -18.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.07 33.38 6.04 Favored Glycine 0 C--O 1.187 -2.836 0 C-N-CA 124.867 1.222 . . . . 25.0 111.668 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.6 t -75.73 138.75 41.47 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 118.951 1.375 . . . . 25.0 108.266 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -85.39 -18.18 34.46 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 123.618 1.675 . . . . 25.0 106.568 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.79 80.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.12 -14.66 60.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.53 -0.731 . . . . 25.0 110.288 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 104.15 -2.537 . . . . 75.0 104.15 177.635 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.5 ptm . . . . . 0 C--O 1.199 -1.572 0 N-CA-C 120.718 3.599 . . . . 25.0 120.718 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.27 -43.29 95.3 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 119.172 -2.205 . . . . 50.0 112.162 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -145.05 62.6 9.22 Favored Pre-proline 0 C--O 1.275 2.415 0 N-CA-C 113.394 0.887 . . . . 25.0 113.394 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -15.64 47.03 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 116.325 -1.983 . . . . 25.0 112.817 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -66.06 -18.69 65.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.765 -1.835 . . . . 25.0 115.741 170.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -77.95 -4.42 46.83 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.584 0.707 . . . . 25.0 112.016 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.1 94.47 1.92 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 120.806 -1.184 . . . . 50.0 112.687 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -120.73 162.26 20.03 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 119.208 3.04 . . . . 25.0 119.208 -174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . . . -136.25 170.94 15.22 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 104.804 -2.295 . . . . 25.0 104.804 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -122.96 141.37 52.01 Favored 'General case' 0 C--O 1.275 2.42 0 O-C-N 124.89 1.369 . . . . 25.0 108.657 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt . . . . . 0 C--O 1.197 -1.701 0 O-C-N 125.544 1.778 . . . . 25.0 109.142 -178.834 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 CA--C 1.502 -0.888 0 N-CA-C 116.999 2.222 . . . . 50.0 116.999 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -74.99 -24.95 58.51 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 112.681 -2.054 . . . . 50.0 110.769 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.32 59.89 Favored Glycine 0 C--O 1.2 -2.002 0 O-C-N 127.294 2.871 . . . . 25.0 109.025 173.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.02 -30.45 78.03 Favored Glycine 0 C--N 1.358 1.797 0 N-CA-C 116.728 1.451 . . . . 25.0 116.728 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -80.41 -39.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.246 -2.502 . . . . 25.0 104.246 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.63 -27.4 66.85 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 126.631 1.973 . . . . 75.0 111.63 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.14 -10.45 59.77 Favored 'General case' 0 C--O 1.182 -2.456 0 O-C-N 121.169 -0.957 . . . . 50.0 109.469 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.71 -12.52 60.74 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 127.259 3.409 . . . . 25.0 112.979 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -148.55 69.15 1.09 Allowed 'General case' 0 C--O 1.277 2.501 0 CA-C-N 111.42 -2.627 . . . . 25.0 109.047 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.0 t -143.29 155.53 44.49 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 116.834 -1.555 . . . . 25.0 108.928 -170.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -55.0 -32.57 61.89 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 121.276 1.853 . . . . 25.0 114.624 158.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.53 -34.91 67.89 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 115.303 1.594 . . . . 25.0 115.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.314 24.8 ttp180 0.42 73.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.448 2.699 . . . . 25.0 116.458 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.16 149.3 45.66 Favored 'General case' 0 C--O 1.208 -1.112 1 CA-C-N 107.871 -4.24 . . . . 25.0 107.546 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -74.92 142.43 44.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.114 1.766 . . . . 50.0 114.139 -146.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 153.72 36.54 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 125.222 1.409 . . . . 25.0 111.107 -172.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -135.01 176.76 8.36 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 102.905 -2.998 . . . . 25.0 102.905 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -124.01 139.65 49.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 168.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . 0.267 60.6 mtp -143.94 171.24 14.52 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.683 1.128 . . . . 25.0 109.396 175.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.7 p -103.12 165.7 10.87 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.127 -1.608 . . . . 25.0 113.201 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.15 179.32 48.07 Favored Glycine 0 C--O 1.256 1.475 0 O-C-N 119.347 -2.096 . . . . 25.0 114.068 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.31 168.02 29.02 Favored Glycine 0 CA--C 1.542 1.757 0 CA-C-O 123.511 1.617 . . . . 25.0 112.849 -168.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.4 127.64 33.74 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.158 -2.217 . . . . 25.0 115.935 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.97 156.84 37.42 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m -103.72 141.04 36.76 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 112.37 -2.195 . . . . 25.0 108.904 166.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -123.66 149.08 45.86 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 115.695 -2.098 . . . . 50.0 105.606 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.8 m -132.25 138.19 47.81 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.373 -1.343 . . . . 25.0 107.373 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.84 161.04 24.81 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 103.02 -2.956 . . . . 25.0 103.02 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.0 t -140.16 137.11 34.15 Favored 'General case' 0 C--O 1.263 1.774 0 N-CA-C 106.799 -1.556 . . . . 25.0 106.799 160.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.36 125.76 50.7 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.569 1.548 . . . . 50.0 109.95 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -125.65 6.78 7.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 119.52 3.156 . . . . 25.0 119.52 -156.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . 0.313 . . -57.75 -63.38 3.89 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 114.512 -2.661 . . . . 25.0 117.111 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.29 176.86 37.44 Favored 'Cis proline' 0 CA--C 1.538 0.691 1 C-N-CA 136.676 4.032 . . . . 25.0 111.678 -9.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -131.02 164.35 25.6 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 102.84 -3.022 . . . . 25.0 102.84 165.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -89.11 150.04 22.91 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 105.125 -2.176 . . . . 25.0 105.125 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.4 m -137.84 134.82 35.58 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 107.733 -1.21 . . . . 25.0 107.733 -159.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 p -98.98 -34.27 10.5 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 117.437 -1.705 . . . . 25.0 110.978 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -156.03 151.22 26.6 Favored 'General case' 0 C--O 1.194 -1.841 0 C-N-CA 128.425 2.69 . . . . 25.0 111.492 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -137.96 136.27 36.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 119.452 -2.03 . . . . 25.0 108.459 150.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -142.72 163.43 32.84 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 117.861 -1.536 . . . . 25.0 111.701 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -149.43 141.29 23.7 Favored 'General case' 0 C--O 1.261 1.699 0 O-C-N 125.276 1.61 . . . . 50.0 114.259 -164.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -121.36 165.28 15.76 Favored 'General case' 0 C--O 1.183 -2.417 0 C-N-CA 126.535 1.934 . . . . 50.0 106.605 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.5 pt -127.3 159.69 37.28 Favored 'Isoleucine or valine' 0 C--O 1.261 1.681 0 CA-C-N 111.936 -2.393 . . . . 25.0 106.95 168.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.9 p -102.78 165.89 10.8 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 124.425 2.059 . . . . 25.0 105.699 156.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -105.63 -177.14 3.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 112.322 -2.217 . . . . 25.0 107.121 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -163.31 167.03 22.39 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.08 64.27 3.22 Favored Glycine 0 C--O 1.274 2.633 0 O-C-N 119.822 -1.798 . . . . 25.0 113.092 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.12 171.18 14.42 Favored 'General case' 0 C--O 1.193 -1.904 0 N-CA-C 116.38 1.993 . . . . 25.0 116.38 -166.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -85.39 110.92 32.89 Favored Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-O 117.1 -1.428 . . . . 25.0 110.974 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -57.99 -21.56 50.63 Favored 'Trans proline' 0 N--CA 1.447 -1.25 1 N-CA-C 123.68 4.454 . . . . 25.0 123.68 174.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.251 23.7 t70 -71.45 -17.83 62.35 Favored 'General case' 0 C--O 1.264 1.852 0 C-N-CA 116.151 -2.22 . . . . 75.0 114.032 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -72.01 161.12 80.52 Favored Pre-proline 0 C--N 1.38 1.921 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -41.01 22.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.542 2 C-N-CA 129.403 6.735 . . . . 25.0 124.373 161.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 53.7 mt -51.93 -35.57 46.17 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 116.507 -3.871 . . . . 50.0 116.991 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -68.11 -7.96 34.21 Favored 'General case' 0 C--O 1.198 -1.617 0 N-CA-C 115.046 1.499 . . . . 25.0 115.046 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -127.8 -60.3 1.17 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.453 -0.794 . . . . 25.0 110.074 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.1 -22.49 62.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 116.443 -1.741 . . . . 25.0 112.634 -168.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.8 20.8 18.07 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 127.042 2.713 . . . . 25.0 113.194 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -110.34 127.73 55.2 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 103.084 -2.932 . . . . 50.0 103.084 158.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.46 122.86 20.71 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.036 -1.865 . . . . 25.0 110.891 -169.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -62.25 117.62 6.32 Favored 'General case' 0 C--O 1.2 -1.522 0 N-CA-C 102.547 -3.131 . . . . 50.0 102.547 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.95 -11.14 9.3 Favored 'Isoleucine or valine' 0 C--O 1.265 1.919 0 CA-C-O 122.729 1.252 . . . . 25.0 112.594 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 174.83 30.1 Favored Glycine 0 C--N 1.365 2.192 0 N-CA-C 117.644 1.817 . . . . 25.0 117.644 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.81 155.13 43.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 128.612 3.183 . . . . 25.0 111.788 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.82 89.84 48.14 Favored Pre-proline 0 C--O 1.265 1.885 0 C-N-CA 128.682 2.793 . . . . 50.0 104.22 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.05 161.24 29.77 Favored 'Trans proline' 0 C--O 1.195 -1.674 1 C-N-CA 111.904 -4.93 . . . . 25.0 111.982 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -79.8 115.41 19.38 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.346 -1.741 . . . . 25.0 109.005 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -128.09 -8.11 5.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.147 1.339 . . . . 50.0 113.661 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.34 -15.67 62.82 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 115.762 1.065 . . . . 25.0 115.762 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -66.93 153.1 95.0 Favored Pre-proline 0 N--CA 1.492 1.652 1 N-CA-C 99.736 -4.172 . . . . 25.0 99.736 163.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.99 18.42 0.31 Allowed 'Trans proline' 0 CA--C 1.509 -0.76 0 N-CA-C 116.231 1.589 . . . . 25.0 116.231 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -31.87 68.04 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 154.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.1 m -76.02 -25.23 55.5 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-O 116.534 -1.698 . . . . 25.0 106.523 -172.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -82.6 -0.46 47.06 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 121.341 1.882 . . . . 25.0 115.851 176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -81.95 84.66 6.87 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.862 -1.135 . . . . 25.0 113.937 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.1 3.94 54.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.755 -1.566 . . . . 75.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.0 t -104.48 122.61 45.89 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 119.85 -1.781 . . . . 25.0 115.402 162.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -148.76 137.48 21.35 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.765 -1.569 . . . . 25.0 106.765 -154.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -84.34 132.67 34.58 Favored 'General case' 0 C--O 1.267 2.012 0 C-N-CA 126.022 1.729 . . . . 25.0 114.946 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.4 mt -131.06 124.82 56.62 Favored 'Isoleucine or valine' 0 C--O 1.262 1.754 0 O-C-N 119.739 -1.851 . . . . 25.0 107.445 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -77.67 126.03 30.25 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 112.913 0.708 . . . . 50.0 112.913 167.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.96 128.66 25.72 Favored Pre-proline 0 C--O 1.248 0.989 0 N-CA-C 102.476 -3.157 . . . . 25.0 102.476 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.99 157.96 53.52 Favored 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 112.587 -4.475 . . . . 25.0 112.658 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -101.34 36.87 1.9 Allowed 'General case' 0 C--O 1.211 -0.924 0 O-C-N 120.461 -1.399 . . . . 25.0 110.628 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -65.81 -46.65 77.84 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 119.765 3.246 . . . . 50.0 119.765 -167.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -150.9 173.32 14.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.213 2.205 . . . . 25.0 105.775 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 6.1 mp -84.83 169.0 14.59 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 101.497 -3.52 . . . . 50.0 101.497 170.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.78 176.53 22.35 Favored Glycine 0 CA--C 1.476 -2.362 0 CA-C-O 126.441 3.245 . . . . 25.0 113.014 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 24.4 p90 -93.17 163.98 13.42 Favored 'General case' 0 C--O 1.271 2.187 0 O-C-N 117.399 -3.413 . . . . 50.0 112.241 -164.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -162.16 173.44 14.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 127.442 2.297 . . . . 25.0 107.7 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.52 143.1 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.792 1.178 . . . . 50.0 113.894 174.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.0 mt -103.88 135.96 39.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 101.635 -3.469 . . . . 25.0 101.635 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -125.8 148.97 48.96 Favored 'General case' 0 C--O 1.187 -2.223 0 O-C-N 117.909 -2.995 . . . . 50.0 107.963 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.16 161.52 37.68 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 116.224 -1.846 . . . . 25.0 113.321 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.61 119.96 3.81 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 O-C-N 125.787 1.93 . . . . 50.0 106.162 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.13 117.63 31.76 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 127.169 2.188 . . . . 25.0 112.457 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.88 111.29 23.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 104.144 -2.539 . . . . 25.0 104.144 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.0 t -84.33 124.87 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.145 0 CA-C-O 124.118 1.913 . . . . 50.0 109.63 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.69 -24.13 62.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.107 -1.621 . . . . 25.0 111.309 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.09 -17.11 58.92 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 117.094 -1.842 . . . . 25.0 114.493 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.0 p -125.53 156.68 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 119.279 -2.138 . . . . 25.0 113.911 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.73 -29.61 69.63 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-O 122.641 1.21 . . . . 25.0 110.274 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -79.55 161.4 26.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 119.194 -2.191 . . . . 25.0 115.062 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . . . -133.7 167.13 21.08 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 114.691 -1.141 . . . . 25.0 108.736 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 1' ' ' HIS . 63.2 m-85 -115.94 144.66 43.76 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.976 -1.12 . . . . 50.0 107.976 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -122.33 155.88 35.07 Favored 'General case' 0 C--O 1.242 0.707 0 O-C-N 125.84 1.963 . . . . 50.0 107.402 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -126.8 151.9 47.67 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.763 -1.562 . . . . 25.0 108.939 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.71 135.55 50.99 Favored 'Isoleucine or valine' 0 C--O 1.268 2.065 0 N-CA-C 105.91 -1.885 . . . . 75.0 105.91 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.6 mt -139.56 106.96 2.83 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 N-CA-C 105.642 -1.984 . . . . 25.0 105.642 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -84.71 131.41 34.58 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 120.247 -1.533 . . . . 25.0 113.837 174.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.74 142.4 43.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 120.307 -1.496 . . . . 50.0 113.061 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 45.3 t0 -83.9 132.36 34.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 116.497 -1.716 . . . . 25.0 107.581 167.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.1 mt -126.4 131.51 51.72 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 103.146 -2.909 . . . . 50.0 103.146 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.3 m -135.0 171.51 17.58 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 105.683 -1.969 . . . . 50.0 105.683 -171.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.35 146.27 32.98 Favored 'General case' 0 C--O 1.283 2.844 0 O-C-N 120.972 -1.08 . . . . 25.0 111.575 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt . . . . . 0 C--O 1.289 3.17 0 CA-C-O 116.173 -1.87 . . . . 25.0 112.114 178.724 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.6 m80 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 118.228 -0.892 . . . . 25.0 108.666 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.67 -154.06 10.65 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 118.046 -2.026 . . . . 25.0 116.134 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.19 170.12 20.22 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 125.237 2.446 . . . . 50.0 105.956 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.7 mt -84.34 126.51 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 O-C-N 118.915 -2.366 . . . . 25.0 113.509 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -92.88 -28.3 16.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 116.204 1.927 . . . . 25.0 116.204 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -145.92 122.33 5.87 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 105.729 -1.952 . . . . 25.0 105.729 168.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.29 133.06 10.53 Favored 'Cis proline' 0 C--O 1.197 -1.551 0 C-N-CA 130.543 1.476 . . . . 25.0 113.116 -2.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.62 -88.99 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.805 -1.543 . . . . 25.0 116.146 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -54.5 134.4 46.23 Favored 'General case' 0 C--O 1.262 1.724 0 N-CA-C 114.811 1.412 . . . . 25.0 114.811 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 ttt-85 -118.86 -32.19 4.57 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 112.481 -2.145 . . . . 25.0 114.405 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.47 -24.06 62.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 116.788 2.144 . . . . 25.0 116.788 -172.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.19 60.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 124.437 2.065 . . . . 25.0 111.191 174.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 13' ' ' LEU . 23.2 mt . . . . . 0 N--CA 1.492 1.642 1 O-C-N 115.572 -4.455 . . . . 75.0 109.67 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 C--O 1.206 -1.215 0 N-CA-C 117.681 2.474 . . . . 25.0 117.681 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -63.65 -38.44 91.14 Favored 'General case' 0 N--CA 1.432 -1.329 0 O-C-N 119.484 -2.01 . . . . 50.0 106.639 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.37 48.83 0.56 Allowed Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.371 1.248 . . . . 25.0 114.371 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.24 -19.99 21.83 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 O-C-N 116.571 -2.384 . . . . 25.0 117.449 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -83.83 -2.45 56.4 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 117.007 -1.473 . . . . 25.0 109.616 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.694 2.497 . . . . 25.0 113.722 -171.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.96 151.21 31.77 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 118.021 -2.925 . . . . 50.0 105.913 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -140.01 160.9 38.87 Favored 'General case' 0 C--O 1.186 -2.239 0 O-C-N 120.271 -1.518 . . . . 25.0 113.625 -170.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.79 149.8 35.01 Favored 'General case' 0 C--O 1.261 1.662 1 N-CA-C 99.912 -4.107 . . . . 25.0 99.912 163.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 82.0 tttt -91.33 146.16 24.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 105.06 -2.2 . . . . 25.0 105.06 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt . . . . . 0 CA--C 1.579 2.075 0 O-C-N 126.382 2.301 . . . . 25.0 110.587 176.65 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.6 mt . . . . . 0 C--O 1.251 1.133 0 CA-C-O 116.624 -1.655 . . . . 50.0 111.86 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -63.66 -25.96 68.45 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 107.007 -1.479 . . . . 50.0 107.007 142.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.86 -10.02 85.05 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 119.769 -1.832 . . . . 25.0 115.477 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.34 -2.31 47.97 Favored Glycine 0 C--O 1.286 3.386 0 N-CA-C 118.418 2.127 . . . . 25.0 118.418 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -63.2 -41.19 91.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 123.378 1.561 . . . . 25.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.04 -28.58 62.42 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 114.087 -1.415 . . . . 75.0 110.933 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -109.89 21.98 16.2 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-O 124.086 1.898 . . . . 50.0 113.971 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -75.84 41.72 0.22 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 120.991 3.7 . . . . 25.0 120.991 -170.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -138.12 45.6 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.767 -1.938 . . . . 25.0 105.767 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -143.31 -172.87 3.79 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.634 1.683 . . . . 25.0 110.784 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -61.48 -22.01 64.7 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.393 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -77.01 2.82 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 119.699 -1.876 . . . . 25.0 112.507 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -87.69 84.11 7.11 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 128.183 3.849 . . . . 25.0 112.918 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 148.87 34.78 Favored 'General case' 0 C--N 1.287 -2.117 1 CA-C-N 106.008 -5.087 . . . . 25.0 111.395 156.1 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -75.87 147.36 39.11 Favored 'General case' 0 C--O 1.188 -2.162 0 N-CA-C 105.911 -1.885 . . . . 50.0 105.911 -174.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HE3' ' CG ' ' A' ' 145' ' ' TYR . 24.3 mtpt -84.12 121.34 27.32 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 174.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -73.59 119.73 18.21 Favored 'General case' 0 CA--C 1.461 -2.477 0 C-N-CA 116.412 -2.115 . . . . 25.0 106.535 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.25 129.54 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 98.7 mmm -140.57 150.76 44.07 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 104.476 -2.416 . . . . 25.0 104.476 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -88.31 176.97 6.98 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 104.451 -2.425 . . . . 25.0 104.451 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.24 174.1 34.84 Favored Glycine 1 C--O 1.158 -4.628 0 N-CA-C 107.079 -2.409 . . . . 25.0 107.079 171.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.72 178.76 47.84 Favored Glycine 0 C--O 1.201 -1.911 0 C-N-CA 126.543 2.02 . . . . 25.0 112.851 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -72.81 141.37 48.02 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 114.417 -2.706 . . . . 25.0 114.006 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -132.6 156.55 46.68 Favored 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 105.974 -1.861 . . . . 25.0 105.974 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.4 m -89.18 107.59 19.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.741 -3.059 . . . . 25.0 102.741 -172.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.83 115.31 27.99 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 106.436 -1.69 . . . . 50.0 106.436 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.4 m -133.01 132.4 41.83 Favored 'General case' 0 C--O 1.267 1.976 0 N-CA-C 108.501 -0.926 . . . . 25.0 108.501 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -117.48 170.06 9.03 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 106.106 -1.812 . . . . 25.0 106.106 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -140.31 146.73 38.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.976 -2.601 . . . . 25.0 103.976 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.72 147.3 46.09 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 113.773 -1.558 . . . . 50.0 113.06 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 t -61.24 -23.39 65.6 Favored 'General case' 0 C--O 1.26 1.633 0 O-C-N 125.748 1.905 . . . . 25.0 113.714 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.19 32.06 Favored Pre-proline 0 CA--C 1.497 -1.082 0 N-CA-C 103.6 -2.741 . . . . 25.0 103.6 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -64.45 166.2 18.07 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 113.656 -3.762 . . . . 25.0 111.77 164.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -129.06 147.17 50.9 Favored 'General case' 0 C--O 1.197 -1.696 0 O-C-N 126.21 2.194 . . . . 25.0 106.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.76 125.71 25.66 Favored 'General case' 0 C--O 1.186 -2.256 0 O-C-N 126.051 2.095 . . . . 25.0 106.498 165.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.3 m -129.43 145.21 51.45 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 124.917 1.287 . . . . 25.0 109.921 -172.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -105.79 -48.95 3.51 Favored 'General case' 0 CA--C 1.624 3.815 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 41.9 tt0 -152.51 160.48 43.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.295 -2.483 . . . . 25.0 104.295 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -143.21 141.02 30.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.07 -1.423 . . . . 25.0 110.637 161.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.56 163.64 32.62 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.177 -0.952 . . . . 25.0 113.123 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -136.99 149.34 47.45 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 117.713 2.486 . . . . 50.0 117.713 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -127.87 164.8 21.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.596 1.558 . . . . 50.0 112.851 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.8 pt -127.78 152.35 35.75 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-N 113.93 -1.486 . . . . 25.0 109.254 173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.3 p -94.16 164.14 13.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 102.919 -2.993 . . . . 25.0 102.919 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -73.58 136.43 43.98 Favored 'General case' 0 C--O 1.185 -2.318 0 O-C-N 119.808 -1.808 . . . . 25.0 111.995 -163.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -71.88 114.51 10.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 119.162 -2.211 . . . . 25.0 108.53 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.6 47.97 3.58 Favored Glycine 0 C--O 1.277 2.792 0 CA-C-N 120.857 1.662 . . . . 25.0 110.393 -172.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.4 160.89 12.57 Favored 'General case' 0 CA--C 1.593 2.616 0 N-CA-C 107.186 -1.412 . . . . 25.0 107.186 -170.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -132.67 105.29 12.96 Favored Pre-proline 0 C--O 1.275 2.421 0 O-C-N 126.119 2.137 . . . . 25.0 107.142 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.97 -11.31 25.44 Favored 'Trans proline' 0 C--N 1.371 1.745 0 N-CA-C 116.872 1.835 . . . . 25.0 116.872 -174.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.85 -10.46 53.19 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.12 1.155 . . . . 75.0 114.12 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -89.25 175.53 3.88 Favored Pre-proline 0 C--O 1.215 -0.747 0 C-N-CA 126.961 2.104 . . . . 25.0 113.211 -176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -19.66 37.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 1 C-N-CA 134.626 10.218 . . . . 25.0 120.124 121.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.69 -36.02 23.69 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 129.571 3.149 . . . . 50.0 111.33 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.46 -5.72 58.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 119.887 -1.758 . . . . 25.0 110.942 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -130.26 -72.01 0.58 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.306 1.965 . . . . 25.0 116.306 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.75 -0.89 25.43 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 122.975 2.625 . . . . 25.0 114.274 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -75.64 -23.63 56.34 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.593 1.088 . . . . 25.0 111.337 163.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.27 154.79 21.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.969 -1.493 . . . . 50.0 106.969 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.58 158.22 40.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.312 -2.477 . . . . 25.0 104.312 159.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.3 tp -87.81 128.79 35.33 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 102.616 -3.105 . . . . 50.0 102.616 158.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.97 -21.77 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 106.926 -1.509 . . . . 25.0 106.926 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.91 164.56 30.41 Favored Glycine 0 C--O 1.202 -1.89 0 CA-C-N 119.719 1.145 . . . . 25.0 113.082 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.4 42.21 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 106.0 -1.852 . . . . 25.0 106.0 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.68 95.4 17.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-N 112.251 -2.25 . . . . 50.0 108.736 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 97.1 Cg_endo -74.61 166.34 29.58 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 121.391 1.394 . . . . 25.0 109.87 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -124.32 140.59 52.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.197 -1.408 . . . . 25.0 107.197 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.3 -11.73 5.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 115.449 1.648 . . . . 50.0 115.449 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.03 -9.07 33.75 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 126.44 1.972 . . . . 25.0 110.892 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.6 p -74.46 154.27 87.81 Favored Pre-proline 0 C--O 1.197 -1.659 0 N-CA-C 100.827 -3.768 . . . . 25.0 100.827 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.39 25.53 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 117.202 -1.399 . . . . 25.0 113.932 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.55 -16.29 60.28 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 118.808 -2.433 . . . . 25.0 108.171 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.1 p -69.57 -13.97 62.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.667 -1.606 . . . . 25.0 113.659 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.92 -28.79 69.18 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.067 -0.97 . . . . 25.0 111.54 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -68.12 88.89 0.3 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.62 0.724 . . . . 25.0 109.979 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.6 tp -92.39 -27.6 17.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 126.412 3.006 . . . . 75.0 107.485 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.4 t -81.41 123.72 28.81 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 110.724 -2.944 . . . . 25.0 107.647 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -129.63 135.68 48.83 Favored 'General case' 0 CA--C 1.572 1.801 0 O-C-N 124.959 1.412 . . . . 25.0 108.841 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -69.78 130.53 42.56 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 116.233 -1.841 . . . . 25.0 106.117 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.8 mm -128.7 118.33 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.953 0 CA-C-N 121.058 1.754 . . . . 25.0 112.274 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -67.49 129.85 41.19 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 115.654 1.724 . . . . 50.0 115.654 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.26 118.4 44.01 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 118.1 -2.875 . . . . 25.0 107.555 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.34 146.41 45.14 Favored 'Trans proline' 0 CA--C 1.483 -2.06 0 C-N-CA 115.216 -2.723 . . . . 25.0 116.417 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -87.73 53.88 2.93 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 123.297 1.522 . . . . 25.0 108.05 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -84.33 -30.87 25.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 120.002 3.334 . . . . 50.0 120.002 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -152.22 177.96 9.99 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 114.047 -2.882 . . . . 25.0 104.505 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 mp -113.67 126.46 55.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 104.567 -2.383 . . . . 50.0 104.567 160.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.78 170.12 32.16 Favored Glycine 0 CA--C 1.473 -2.539 0 C-N-CA 118.148 -1.977 . . . . 25.0 114.533 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.444 ' CG ' ' HE3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -112.86 135.61 53.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.36 1.464 . . . . 50.0 112.462 -168.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -147.0 167.69 23.39 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 125.349 1.656 . . . . 25.0 113.449 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.4 t -85.2 158.87 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 126.896 2.623 . . . . 50.0 104.559 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.8 mt -129.24 136.16 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 N-CA-C 103.43 -2.804 . . . . 25.0 103.43 162.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.34 153.03 39.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 104.741 -2.318 . . . . 50.0 104.741 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.61 157.4 45.52 Favored 'General case' 0 C--O 1.184 -2.371 0 CA-C-N 121.632 2.015 . . . . 25.0 106.61 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.52 134.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 126.832 2.583 . . . . 50.0 110.405 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -124.17 119.68 30.1 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 120.792 1.633 . . . . 25.0 108.084 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -84.4 89.13 7.33 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 119.563 -1.96 . . . . 25.0 111.461 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.67 103.65 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 113.23 -1.805 . . . . 50.0 106.5 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.12 -18.89 64.76 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 113.793 -1.549 . . . . 25.0 114.26 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.68 -26.35 66.99 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 119.178 3.029 . . . . 25.0 119.178 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 45.7 p -115.24 158.45 22.3 Favored 'General case' 0 C--O 1.262 1.725 0 N-CA-C 114.796 1.406 . . . . 25.0 114.796 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -28.15 27.81 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 106.918 -1.512 . . . . 25.0 106.918 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 86.1 m-20 -66.7 157.89 31.53 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 124.615 2.15 . . . . 25.0 111.416 160.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.49 155.45 42.27 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 101.954 -3.35 . . . . 25.0 101.954 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -111.53 153.35 26.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.072 2.107 . . . . 50.0 115.905 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -142.59 152.1 42.2 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 124.019 1.866 . . . . 50.0 106.74 -162.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -155.38 149.26 25.49 Favored 'General case' 0 C--O 1.19 -2.068 0 O-C-N 120.043 -1.661 . . . . 25.0 111.534 167.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.81 127.5 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 125.269 1.606 . . . . 75.0 112.556 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 152.77 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-N 121.835 2.107 . . . . 25.0 108.676 172.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -88.93 156.82 18.67 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 118.94 2.941 . . . . 25.0 118.94 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.1 169.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 102.695 -3.076 . . . . 50.0 102.695 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -132.66 122.61 24.92 Favored 'General case' 0 C--O 1.258 1.505 0 N-CA-C 103.03 -2.952 . . . . 25.0 103.03 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.68 119.4 34.35 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 122.07 2.214 . . . . 50.0 106.329 -164.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.59 -175.65 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.268 2.063 0 CA-C-O 122.408 1.099 . . . . 50.0 113.359 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.97 151.49 43.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.634 1.716 . . . . 25.0 115.634 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 79.7 mttt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 121.586 1.994 . . . . 25.0 115.319 176.171 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . 0.44 ' HA ' ' CE3' ' A' ' 152' ' ' TRP . 24.0 p-80 . . . . . 0 C--O 1.293 3.366 0 CA-C-O 117.995 -1.002 . . . . 25.0 112.233 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.25 -124.02 31.0 Favored Glycine 0 CA--C 1.489 -1.579 0 CA-C-O 118.482 -1.177 . . . . 25.0 112.297 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -113.58 164.18 13.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 126.549 1.97 . . . . 50.0 110.97 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.4 mt -96.1 120.53 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 N-CA-C 102.972 -2.973 . . . . 25.0 102.972 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -91.72 -34.02 14.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 117.575 -1.202 . . . . 25.0 108.256 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.52 133.17 13.55 Favored Pre-proline 0 C--N 1.309 -1.185 0 C-N-CA 124.382 1.073 . . . . 25.0 110.097 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.57 144.77 80.83 Favored 'Cis proline' 0 C--O 1.249 1.033 0 CA-C-O 123.625 1.427 . . . . 25.0 109.39 -3.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.04 133.29 10.33 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 113.761 -1.563 . . . . 25.0 110.75 169.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 35.13 0.8 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.159 1.48 . . . . 25.0 108.699 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -65.16 -26.33 68.12 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 116.071 -1.919 . . . . 25.0 112.778 -166.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.74 57.29 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 122.224 2.284 . . . . 25.0 109.189 -175.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.35 97.13 Favored 'General case' 0 C--O 1.274 2.385 0 CA-C-N 114.641 -1.163 . . . . 25.0 112.574 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.31 0.576 . . . . 75.0 109.994 178.682 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 115.532 1.679 . . . . 25.0 115.532 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -62.64 -44.69 95.63 Favored 'General case' 0 C--O 1.286 3.024 0 N-CA-C 119.482 3.142 . . . . 50.0 119.482 -166.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.256 11.9 pt-20 -142.17 62.38 13.7 Favored Pre-proline 0 C--O 1.258 1.508 0 N-CA-C 117.018 2.229 . . . . 25.0 117.018 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.8 -21.78 37.81 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 117.049 -1.501 . . . . 25.0 113.408 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -71.61 -14.28 62.02 Favored 'General case' 0 C--O 1.261 1.697 0 O-C-N 119.537 -1.977 . . . . 25.0 115.482 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 m -85.4 2.38 44.63 Favored 'General case' 0 C--O 1.285 2.933 0 O-C-N 119.934 -1.729 . . . . 25.0 115.373 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.2 150.58 48.9 Favored 'General case' 0 C--O 1.273 2.337 0 N-CA-C 104.267 -2.494 . . . . 50.0 104.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -132.14 162.16 31.55 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.53 1.932 . . . . 25.0 108.016 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.61 178.4 9.37 Favored 'General case' 0 C--O 1.184 -2.372 0 CA-C-O 124.33 2.014 . . . . 25.0 110.743 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.86 175.64 5.63 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 115.851 1.797 . . . . 25.0 115.851 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 95.3 mttt . . . . . 0 C--O 1.215 -0.716 0 O-C-N 120.159 -1.588 . . . . 25.0 114.812 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.4 mt . . . . . 0 CA--C 1.496 -1.124 0 N-CA-C 106.523 -1.658 . . . . 50.0 106.523 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.01 -14.6 60.83 Favored 'General case' 0 C--O 1.271 2.205 0 N-CA-C 114.824 1.416 . . . . 50.0 114.824 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.41 -22.27 63.27 Favored Glycine 0 C--O 1.274 2.633 0 N-CA-C 110.028 -1.229 . . . . 25.0 110.028 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -13.01 83.67 Favored Glycine 0 C--O 1.268 2.258 0 O-C-N 119.391 -2.241 . . . . 25.0 110.829 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -38.04 66.44 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 O-C-N 117.461 -3.376 . . . . 25.0 105.964 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.64 -32.32 73.76 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.516 -1.365 . . . . 75.0 111.317 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.22 -15.3 61.44 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 119.973 -1.704 . . . . 50.0 111.025 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.26 87.3 mt-30 -92.83 17.76 10.02 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 120.095 -1.628 . . . . 25.0 114.997 168.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -137.71 49.7 1.97 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.631 -1.988 . . . . 25.0 105.631 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -157.85 179.31 9.32 Favored 'General case' 0 C--O 1.261 1.669 1 N-CA-C 100.094 -4.039 . . . . 25.0 100.094 -170.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -47.74 -32.11 5.53 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 117.949 2.574 . . . . 25.0 117.949 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.41 29.53 1.68 Allowed 'General case' 0 C--O 1.253 1.282 0 CA-C-N 121.357 1.89 . . . . 25.0 107.477 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -83.32 78.81 9.57 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 123.967 1.841 . . . . 25.0 107.714 153.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -56.67 158.87 4.25 Favored 'General case' 0 C--O 1.29 3.196 0 CA-C-N 111.15 -2.75 . . . . 25.0 112.781 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -65.94 157.8 29.76 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-N 113.563 -1.653 . . . . 50.0 107.329 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -108.7 144.57 36.32 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 123.676 1.703 . . . . 25.0 108.137 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -139.79 152.82 46.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.625 -1.625 . . . . 25.0 109.735 162.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.7 mt -85.62 136.38 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.591 1.541 . . . . 25.0 107.998 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.6 ttt -137.31 144.8 42.79 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 171.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.298 12.1 p -79.43 173.43 12.59 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 120.373 -1.454 . . . . 25.0 113.209 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.5 -163.76 8.67 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.203 -1.475 . . . . 25.0 111.743 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.6 -172.72 36.19 Favored Glycine 0 N--CA 1.486 1.976 0 O-C-N 119.572 -2.134 . . . . 25.0 113.017 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -77.56 142.55 38.95 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 117.609 2.448 . . . . 25.0 117.609 169.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -137.86 165.88 25.39 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 105.763 -1.94 . . . . 25.0 105.763 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.7 m -118.46 120.25 36.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.956 -1.868 . . . . 25.0 105.956 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.52 141.71 47.7 Favored 'General case' 0 C--O 1.17 -3.111 0 N-CA-C 105.279 -2.119 . . . . 50.0 105.279 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 m -136.84 140.29 42.31 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 116.116 -1.897 . . . . 25.0 113.689 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 143.52 51.22 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 122.367 2.349 . . . . 25.0 109.688 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -149.08 144.57 26.76 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 127.157 3.36 . . . . 25.0 108.393 -170.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -142.54 151.98 42.16 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-N 111.845 -2.434 . . . . 50.0 112.718 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.0 t -73.64 -9.09 58.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 O-C-N 125.678 1.861 . . . . 25.0 113.634 -169.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.96 159.71 67.44 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 117.064 -3.523 . . . . 25.0 103.833 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -73.14 139.7 29.94 Favored 'Trans proline' 0 C--N 1.307 -1.654 1 C-N-CA 111.761 -5.026 . . . . 25.0 110.301 166.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 2.486 47.9 p-80 73.12 12.79 4.91 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 123.308 2.777 . . . . 25.0 116.611 -5.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -65.58 115.89 6.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 118.442 -1.303 . . . . 25.0 113.256 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.0 t -75.73 160.26 30.22 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.084 -1.446 . . . . 25.0 112.071 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 90.3 p -111.51 -26.37 9.1 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 118.246 0.475 . . . . 25.0 110.87 163.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 61.8 tt0 -168.6 150.56 4.97 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 103.013 -2.958 . . . . 25.0 103.013 168.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -136.73 160.54 38.52 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-O 116.921 -1.514 . . . . 25.0 107.589 166.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 6.2 m-70 -142.53 162.43 35.49 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.241 -1.763 . . . . 25.0 106.241 -163.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.27 127.63 45.9 Favored 'General case' 0 C--O 1.274 2.345 0 N-CA-C 103.953 -2.61 . . . . 50.0 103.953 158.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -117.61 149.91 39.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 118.17 -2.831 . . . . 50.0 107.898 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.8 pt -120.64 153.37 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 119.463 1.029 . . . . 25.0 112.626 168.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 p -71.54 147.34 47.79 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -95.88 84.79 3.93 Favored 'General case' 0 C--O 1.191 -1.987 0 CA-C-O 123.103 1.43 . . . . 25.0 109.577 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -49.83 155.29 0.89 Allowed 'General case' 0 C--N 1.354 0.777 0 N-CA-C 117.0 2.222 . . . . 25.0 117.0 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 15.56 76.98 Favored Glycine 0 C--O 1.266 2.129 0 CA-C-O 126.551 3.306 . . . . 25.0 120.889 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 179.2 2.83 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.35 -1.925 . . . . 25.0 113.759 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.93 142.43 11.74 Favored Pre-proline 0 CA--C 1.492 -1.255 0 O-C-N 126.38 2.3 . . . . 25.0 106.333 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -60.41 -22.74 72.6 Favored 'Trans proline' 0 CA--C 1.592 3.42 0 N-CA-C 117.677 2.145 . . . . 25.0 117.677 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 116.399 -2.12 . . . . 75.0 110.709 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -108.09 170.95 4.98 Favored Pre-proline 0 CA--C 1.599 2.856 0 C-N-CA 129.751 3.221 . . . . 25.0 103.272 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.33 16.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.393 1 N-CA-C 122.767 4.103 . . . . 25.0 122.767 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.66 -40.4 69.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 117.172 2.286 . . . . 50.0 117.172 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -75.36 -6.84 52.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 126.287 2.242 . . . . 25.0 114.401 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -116.26 -59.69 1.95 Allowed 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 127.259 2.224 . . . . 25.0 114.49 -171.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -141.67 29.6 1.73 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 123.469 1.604 . . . . 25.0 111.794 -159.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.89 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 111.763 -2.471 . . . . 25.0 116.985 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -129.29 166.21 19.9 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 123.157 2.708 . . . . 50.0 112.457 172.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.07 143.25 49.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 101.289 -3.597 . . . . 25.0 101.289 163.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 tp -86.3 120.94 28.19 Favored 'General case' 0 C--O 1.182 -2.482 0 O-C-N 127.507 3.004 . . . . 50.0 108.701 166.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.8 tt -101.93 -8.29 9.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 121.536 1.971 . . . . 25.0 110.172 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.65 154.55 9.64 Favored Glycine 0 C--O 1.207 -1.592 0 C-N-CA 116.086 -2.959 . . . . 25.0 113.791 165.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . . . -144.55 145.85 32.04 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 122.999 3.399 . . . . 25.0 104.839 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.44 105.79 30.54 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-O 117.067 -1.444 . . . . 50.0 114.104 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 42.5 Cg_endo -77.48 164.59 28.4 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 C-N-CA 115.809 -2.327 . . . . 25.0 115.436 172.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -74.22 112.76 10.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.666 -1.976 . . . . 25.0 105.666 167.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.66 -18.4 1.91 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 119.379 -2.076 . . . . 50.0 116.335 -165.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.63 16.65 33.32 Favored Glycine 0 N--CA 1.466 0.673 0 O-C-N 119.917 -1.739 . . . . 25.0 114.371 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -55.54 162.33 2.49 Favored Pre-proline 0 CA--C 1.568 1.661 0 O-C-N 125.664 1.45 . . . . 25.0 113.72 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -66.31 176.25 4.19 Favored 'Trans proline' 0 C--O 1.276 2.412 0 CA-C-O 123.452 1.355 . . . . 25.0 112.065 166.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.85 -12.44 0.31 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 119.585 3.18 . . . . 25.0 119.585 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 p -69.44 -0.57 6.68 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 120.131 -1.605 . . . . 25.0 111.737 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.27 4.85 7.93 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 117.587 2.439 . . . . 25.0 117.587 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -61.03 164.68 4.78 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.347 1.546 . . . . 25.0 114.157 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.8 30.61 0.11 Allowed 'General case' 0 N--CA 1.516 2.829 0 O-C-N 119.256 -2.153 . . . . 75.0 113.287 -171.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.4 t -113.8 149.72 34.53 Favored 'General case' 0 C--O 1.262 1.737 0 N-CA-C 103.232 -2.877 . . . . 25.0 103.232 170.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -146.27 142.56 28.45 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 123.87 0.868 . . . . 25.0 109.318 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -75.39 135.69 40.79 Favored 'General case' 0 C--O 1.172 -3.023 0 N-CA-C 105.592 -2.003 . . . . 25.0 105.592 162.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.9 129.82 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 104.776 -2.305 . . . . 25.0 104.776 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -90.49 135.08 33.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 112.672 -2.058 . . . . 50.0 112.036 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.04 108.74 41.89 Favored Pre-proline 0 C--N 1.307 -1.245 0 O-C-N 119.678 -1.889 . . . . 25.0 108.427 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.82 136.86 21.37 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 O-C-N 117.033 -2.141 . . . . 25.0 114.456 164.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -150.86 101.82 2.93 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.162 -0.961 . . . . 25.0 109.273 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -105.56 10.55 33.05 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 126.943 2.097 . . . . 50.0 108.632 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -132.87 -176.83 4.24 Favored 'General case' 0 C--O 1.21 -0.98 0 O-C-N 119.174 -2.204 . . . . 25.0 110.304 -173.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.44 148.99 51.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 103.443 -2.799 . . . . 50.0 103.443 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 145.62 174.42 17.79 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 121.206 3.243 . . . . 25.0 121.206 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -75.12 135.72 41.13 Favored 'General case' 0 C--O 1.279 2.614 0 N-CA-C 116.122 1.897 . . . . 50.0 116.122 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -139.82 172.78 12.28 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 103.631 -2.729 . . . . 25.0 103.631 174.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.0 t -123.18 148.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 103.455 -2.794 . . . . 50.0 103.455 166.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.5 mt -115.66 137.86 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 1 N-CA-C 98.647 -4.575 . . . . 25.0 98.647 172.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.54 129.48 55.37 Favored 'General case' 0 C--O 1.187 -2.193 0 CA-C-N 119.172 0.896 . . . . 50.0 113.024 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.18 135.0 45.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.521 -1.362 . . . . 25.0 111.502 -173.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 69.2 t -124.96 137.37 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.972 0 N-CA-C 103.033 -2.951 . . . . 50.0 103.033 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.44 ' CE3' ' HA ' ' A' ' 1' ' ' HIS . 2.7 t90 -140.03 112.57 7.89 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.092 -2.558 . . . . 25.0 104.092 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.5 140.56 32.57 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 100.533 -3.877 . . . . 25.0 100.533 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.51 157.16 34.97 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 CA-C-O 122.715 1.245 . . . . 50.0 107.807 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 -24.36 36.01 Favored 'General case' 0 C--O 1.199 -1.595 0 CA-C-N 115.042 -0.981 . . . . 25.0 108.86 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -67.16 -35.48 79.77 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 115.17 1.544 . . . . 25.0 115.17 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 t -135.29 159.05 42.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 115.066 -2.397 . . . . 25.0 107.899 -166.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.02 -27.03 41.26 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 120.873 1.669 . . . . 25.0 113.914 162.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 96.7 m-20 -73.04 163.16 28.57 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.531 -1.356 . . . . 25.0 110.861 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.81 -176.19 3.77 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 104.597 -2.372 . . . . 25.0 104.597 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.79 146.53 47.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.772 -0.825 . . . . 50.0 108.772 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -134.56 135.62 42.41 Favored 'General case' 0 C--O 1.172 -2.98 0 CA-C-O 115.377 -2.249 . . . . 50.0 106.535 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -144.93 172.08 13.55 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 121.371 1.896 . . . . 25.0 107.735 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 147.53 32.06 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 O-C-N 120.047 -1.658 . . . . 75.0 107.344 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.4 mm -130.15 122.42 53.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 103.429 -2.804 . . . . 25.0 103.429 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -87.11 123.76 32.52 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.217 -2.142 . . . . 25.0 105.217 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.13 155.14 38.03 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.656 -1.278 . . . . 50.0 112.765 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -116.31 130.45 56.78 Favored 'General case' 0 N--CA 1.436 -1.144 1 N-CA-C 96.279 -5.452 . . . . 25.0 96.279 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.2 mt -123.8 128.78 50.04 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 115.781 -2.057 . . . . 50.0 106.693 -171.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.17 159.0 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 O-C-N 127.101 2.75 . . . . 50.0 112.09 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -70.22 131.52 44.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 117.987 -2.945 . . . . 25.0 108.138 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.4 pttt . . . . . 0 C--O 1.28 2.685 0 N-CA-C 120.464 3.505 . . . . 25.0 120.464 -171.286 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . 0.406 ' HB3' HE22 ' A' ' 33' ' ' GLN . 72.8 m80 . . . . . 0 N--CA 1.517 2.89 0 N-CA-C 112.667 0.617 . . . . 25.0 112.667 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.7 -146.99 4.46 Favored Glycine 0 C--O 1.253 1.294 0 CA-C-O 114.393 -3.448 . . . . 25.0 118.742 -162.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.3 168.95 23.19 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 122.285 3.043 . . . . 50.0 105.941 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.11 121.73 41.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.998 -2.593 . . . . 25.0 103.998 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -83.05 -36.45 24.92 Favored 'General case' 0 C--O 1.262 1.734 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -172.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -160.89 159.98 25.08 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-O 113.634 -3.079 . . . . 25.0 106.352 -175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -78.09 137.52 46.9 Favored 'Cis proline' 0 C--O 1.206 -1.112 0 O-C-N 124.721 1.906 . . . . 25.0 107.195 1.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.26 -171.98 44.74 Favored Glycine 0 CA--C 1.454 -3.725 0 CA-C-N 114.811 -1.086 . . . . 25.0 110.51 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.1 p -145.75 158.34 43.86 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 119.644 1.722 . . . . 25.0 107.003 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -82.47 -24.41 34.23 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 118.764 -1.174 . . . . 25.0 111.429 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.17 79.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.134 0.974 . . . . 25.0 111.648 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.15 -31.94 69.43 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 119.3 0.954 . . . . 25.0 113.477 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 C--O 1.192 -1.938 0 C-N-CA 124.261 1.025 . . . . 75.0 113.514 176.996 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.496 1.864 1 N-CA-C 122.437 4.236 . . . . 25.0 122.437 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -63.87 -41.55 97.74 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 114.43 1.27 . . . . 50.0 114.43 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -153.94 53.74 0.99 Allowed Pre-proline 0 C--O 1.274 2.394 0 O-C-N 120.119 -1.613 . . . . 25.0 110.539 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.01 -33.17 42.52 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 O-C-N 118.311 -1.468 . . . . 25.0 113.757 -165.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.406 HE22 ' HB3' ' A' ' 1' ' ' HIS . 3.7 pp0? -67.13 -1.33 4.17 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 117.319 2.34 . . . . 25.0 117.319 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -82.81 55.39 3.02 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.94 1.696 . . . . 25.0 113.601 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.72 135.26 33.72 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 123.24 1.495 . . . . 50.0 107.004 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.21 149.86 39.7 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 125.663 2.649 . . . . 25.0 105.424 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.11 12.48 Favored 'General case' 0 C--O 1.259 1.587 0 N-CA-C 102.329 -3.211 . . . . 25.0 102.329 164.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -100.15 168.59 9.72 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.616 2.08 . . . . 25.0 116.616 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mttt . . . . . 0 N--CA 1.402 -2.858 0 CA-C-O 123.372 1.558 . . . . 25.0 111.512 172.831 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 108.045 -1.094 . . . . 50.0 108.045 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -76.05 -21.47 56.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.215 -1.394 . . . . 50.0 107.645 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 -20.6 58.75 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 104.347 -3.501 . . . . 25.0 104.347 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.13 -20.87 71.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 111.471 -2.365 . . . . 25.0 112.122 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.71 -37.31 23.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 118.208 -1.397 . . . . 25.0 113.809 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.0 -34.67 75.66 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 119.751 -1.843 . . . . 75.0 111.687 172.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.54 -5.56 56.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.463 2.554 . . . . 50.0 110.065 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -81.97 75.43 8.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 113.716 -1.584 . . . . 25.0 111.01 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -128.2 44.28 2.98 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 127.295 2.238 . . . . 25.0 105.817 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.0 t -127.32 -166.56 1.62 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.3 -3.222 . . . . 25.0 102.3 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.79 -17.62 64.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 117.673 2.471 . . . . 25.0 117.673 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.47 24.3 7.52 Favored 'General case' 0 CA--C 1.595 2.686 0 CA-C-O 124.557 2.122 . . . . 25.0 109.978 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -87.31 102.25 14.33 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 126.742 3.163 . . . . 25.0 109.047 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -35.59 143.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.482 2 CA-C-N 102.415 -6.721 . . . . 25.0 112.146 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -70.92 152.84 43.23 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 115.323 1.601 . . . . 50.0 115.323 -173.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -95.35 152.73 18.13 Favored 'General case' 0 CA--C 1.587 2.38 0 O-C-N 121.353 -0.842 . . . . 25.0 109.85 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.12 148.61 49.83 Favored 'General case' 0 C--O 1.198 -1.658 0 CA-C-N 120.83 1.65 . . . . 25.0 109.156 169.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.7 mt -107.7 134.08 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 122.926 2.603 . . . . 25.0 111.952 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 85.1 mmm -144.22 169.97 16.87 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.203 -1.777 . . . . 25.0 106.203 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -90.98 172.09 8.82 Favored 'General case' 0 CA--C 1.446 -3.032 0 CA-C-O 116.056 -1.926 . . . . 25.0 111.606 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.98 173.46 9.66 Favored Glycine 0 CA--C 1.495 -1.176 0 O-C-N 124.94 1.4 . . . . 25.0 112.792 165.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.62 163.99 29.26 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 117.127 -2.463 . . . . 25.0 107.86 -171.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.38 155.18 28.51 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 120.291 -1.711 . . . . 25.0 109.168 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -145.5 160.67 41.27 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 103.049 -2.945 . . . . 25.0 103.049 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -125.9 130.71 51.84 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 -171.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.79 116.53 25.39 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 102.078 -3.305 . . . . 50.0 102.078 -165.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 133' ' ' SER . 60.9 m -115.63 131.97 56.77 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 102.867 -3.012 . . . . 25.0 102.867 -167.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -119.1 153.07 35.39 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.215 -2.513 . . . . 25.0 104.215 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 t -144.0 147.94 34.58 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -133.41 147.12 51.74 Favored 'General case' 0 C--O 1.266 1.954 0 O-C-N 127.743 3.152 . . . . 50.0 113.665 176.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.2 t -71.23 -20.82 62.2 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 116.341 1.978 . . . . 25.0 116.341 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.34 145.79 56.78 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 121.849 0.833 . . . . 25.0 112.722 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.87 160.51 49.44 Favored 'Trans proline' 0 CA--C 1.488 -1.789 1 C-N-CA 112.056 -4.83 . . . . 25.0 111.791 169.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -135.18 155.29 50.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 125.131 1.372 . . . . 25.0 109.922 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.96 155.29 40.8 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.239 -1.393 . . . . 25.0 107.239 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -140.53 150.97 44.37 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 117.498 -1.681 . . . . 25.0 110.445 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.6 p -112.58 -38.85 4.5 Favored 'General case' 0 CA--C 1.484 -1.569 0 O-C-N 120.68 -1.262 . . . . 25.0 109.385 164.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 17.0 tt0 -150.8 154.13 36.72 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 104.559 -2.386 . . . . 25.0 104.559 169.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -139.74 153.17 47.13 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 117.031 -1.867 . . . . 25.0 108.327 158.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -134.26 154.65 51.16 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 112.616 -2.084 . . . . 25.0 109.901 -157.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 147.0 50.03 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.381 -3.562 . . . . 50.0 101.381 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.75 158.86 43.44 Favored 'General case' 0 C--O 1.184 -2.35 0 CA-C-N 114.001 -1.454 . . . . 50.0 109.056 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 pt -135.91 149.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 106.124 -1.806 . . . . 25.0 106.124 168.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -76.05 137.19 40.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 164.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -86.17 98.15 10.74 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 126.423 1.889 . . . . 25.0 110.452 -164.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -59.65 150.23 28.15 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 119.773 1.17 . . . . 25.0 113.41 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.77 67.1 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 108.906 -1.677 . . . . 25.0 108.906 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -55.77 166.83 0.64 Allowed 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 125.937 1.695 . . . . 25.0 113.71 172.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.01 123.45 6.12 Favored Pre-proline 0 C--O 1.186 -2.26 0 N-CA-C 102.969 -2.974 . . . . 25.0 102.969 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.14 -15.55 39.5 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.383 1.388 . . . . 25.0 114.846 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.56 -6.59 51.04 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 117.526 -3.234 . . . . 75.0 115.458 173.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.09 166.66 15.21 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 101.409 -3.552 . . . . 25.0 101.409 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -43.56 7.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.698 1 C-N-CA 134.179 9.919 . . . . 25.0 120.308 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.28 -26.36 7.22 Favored 'General case' 0 CA--C 1.598 2.794 0 O-C-N 119.599 -1.938 . . . . 50.0 115.667 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -75.96 -2.5 30.73 Favored 'General case' 0 CA--C 1.482 -1.639 1 O-C-N 115.82 -4.3 . . . . 25.0 113.481 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -126.76 -44.61 1.65 Allowed 'General case' 0 CA--C 1.457 -2.61 0 N-CA-C 114.208 1.188 . . . . 25.0 114.208 171.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.38 32.03 0.34 Allowed 'General case' 0 C--O 1.193 -1.872 0 O-C-N 127.938 3.274 . . . . 25.0 112.051 172.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.11 -32.92 73.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 123.708 1.718 . . . . 25.0 113.107 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -103.94 156.54 17.76 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.385 -2.82 . . . . 50.0 103.385 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.95 139.05 50.14 Favored 'General case' 0 C--O 1.27 2.157 0 N-CA-C 102.911 -2.996 . . . . 25.0 102.911 151.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.99 111.84 5.97 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 125.169 1.388 . . . . 50.0 107.517 154.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.42 -16.01 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 O-C-N 125.982 2.051 . . . . 25.0 110.266 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.01 174.41 44.3 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 122.074 2.216 . . . . 25.0 110.383 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -160.45 147.49 15.82 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 114.487 1.292 . . . . 25.0 114.487 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.63 110.28 18.99 Favored Pre-proline 0 CA--C 1.593 2.623 0 C-N-CA 126.209 1.804 . . . . 50.0 108.964 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 89.0 Cg_endo -88.07 161.6 7.25 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 N-CA-C 116.563 1.717 . . . . 25.0 116.563 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -78.26 115.42 17.97 Favored 'General case' 0 CA--C 1.469 -2.137 1 N-CA-C 99.907 -4.108 . . . . 25.0 99.907 171.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -102.3 -14.61 16.89 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.355 -0.839 . . . . 50.0 111.512 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.45 -23.0 2.7 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 105.273 -3.131 . . . . 25.0 105.273 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -78.88 148.02 71.48 Favored Pre-proline 0 C--O 1.266 1.937 0 N-CA-C 104.646 -2.353 . . . . 25.0 104.646 155.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -58.67 147.26 88.49 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 106.476 -2.163 . . . . 25.0 106.476 174.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.34 -19.26 46.89 Favored 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 64.4 p -83.35 6.19 20.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 125.778 1.924 . . . . 25.0 110.491 -176.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -55.06 -43.98 74.33 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 120.047 1.294 . . . . 25.0 113.871 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -110.3 98.43 7.67 Favored 'General case' 0 C--O 1.256 1.445 0 CA-C-O 116.676 -1.63 . . . . 25.0 108.694 166.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.7 tp -85.66 -11.37 53.99 Favored 'General case' 0 C--O 1.288 3.082 0 O-C-N 125.779 1.925 . . . . 75.0 110.626 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 83' ' ' THR . 29.3 t -103.92 138.25 40.76 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -143.06 148.24 36.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.138 1.336 . . . . 25.0 111.715 -164.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -103.6 150.13 24.25 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 125.87 1.981 . . . . 25.0 109.82 -170.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -141.1 127.48 20.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.261 -1.755 . . . . 25.0 106.261 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -84.86 126.93 33.89 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 119.215 0.916 . . . . 50.0 109.009 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -101.38 121.46 51.56 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 106.639 -1.615 . . . . 25.0 106.639 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -67.09 150.57 82.34 Favored 'Trans proline' 0 N--CA 1.481 0.793 1 C-N-CA 113.201 -4.066 . . . . 25.0 116.444 170.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.27 31.37 1.14 Allowed 'General case' 0 CA--C 1.573 1.861 0 CA-C-N 115.512 -0.767 . . . . 25.0 111.816 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.43 -44.77 70.66 Favored 'General case' 1 N--CA 1.545 4.277 0 O-C-N 120.883 -1.136 . . . . 50.0 114.021 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -152.14 166.92 30.16 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.816 0.672 . . . . 25.0 112.816 -170.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mp -83.83 149.22 26.54 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.785 -1.191 . . . . 50.0 107.785 167.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.05 -178.43 19.83 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-O 121.999 0.777 . . . . 25.0 114.962 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -120.42 159.35 25.28 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 117.485 2.402 . . . . 50.0 117.485 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -160.62 163.41 32.62 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 165.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.55 137.97 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.562 0 C-N-CA 124.299 1.04 . . . . 50.0 112.918 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.64 129.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 C-N-CA 125.085 1.354 . . . . 25.0 109.734 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.79 151.91 35.5 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 126.06 2.1 . . . . 50.0 113.881 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.05 51.37 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 104.463 -2.421 . . . . 25.0 104.463 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 162' ' ' TYR . 58.4 t -135.4 131.34 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 126.345 2.278 . . . . 50.0 107.259 -174.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -124.06 128.05 48.76 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 122.619 1.199 . . . . 25.0 108.592 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.73 144.65 34.55 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 123.502 1.62 . . . . 25.0 110.363 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.88 125.36 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 127.449 2.3 . . . . 50.0 111.744 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.49 62.67 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 103.239 -2.874 . . . . 25.0 103.239 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.3 -12.59 60.58 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 117.621 2.452 . . . . 25.0 117.621 -173.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.0 p -133.26 148.38 51.97 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 120.395 -1.441 . . . . 25.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -81.94 -25.21 35.07 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.9 0.88 . . . . 25.0 109.749 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.77 153.25 26.59 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 121.224 -0.922 . . . . 25.0 109.991 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.6 147.66 51.42 Favored 'General case' 0 C--O 1.175 -2.855 0 N-CA-C 105.465 -2.05 . . . . 25.0 105.465 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -120.73 137.29 54.57 Favored 'General case' 0 CA--C 1.479 -1.779 0 C-N-CA 117.996 -1.482 . . . . 50.0 112.21 -158.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.417 ' CD2' HG22 ' A' ' 151' ' ' VAL . 7.8 m-85 -128.96 148.11 50.91 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.691 1.997 . . . . 50.0 114.92 -168.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -139.11 135.93 34.63 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 105.85 -1.907 . . . . 25.0 105.85 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.6 130.97 17.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.463 0 N-CA-C 114.578 1.325 . . . . 75.0 114.578 -169.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.47 123.76 55.91 Favored 'Isoleucine or valine' 0 C--O 1.273 2.32 0 O-C-N 124.728 1.267 . . . . 25.0 111.669 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.5 124.04 26.48 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.95 139.63 49.16 Favored 'Isoleucine or valine' 0 C--O 1.271 2.22 0 CA-C-O 125.311 2.481 . . . . 50.0 109.344 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -117.3 121.34 40.87 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 44.7 mt -131.27 120.42 23.17 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.803 -1.184 . . . . 50.0 107.803 -158.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.4 m -125.68 171.23 14.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 117.618 2.451 . . . . 50.0 117.618 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -74.11 159.59 32.39 Favored 'General case' 0 C--O 1.258 1.522 0 O-C-N 120.772 -1.205 . . . . 25.0 109.574 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.4 mttt . . . . . 0 C--O 1.259 1.568 0 O-C-N 126.821 2.576 . . . . 25.0 109.433 -177.545 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 . . . . . 0 C--O 1.267 1.997 0 CA-C-O 122.49 1.138 . . . . 25.0 111.638 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.76 -174.08 20.18 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-O 114.301 -3.499 . . . . 25.0 118.158 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.39 143.78 47.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 121.674 2.737 . . . . 50.0 107.141 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.5 mt -73.32 140.23 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 102.756 -3.053 . . . . 25.0 102.756 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -135.16 48.21 2.28 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 126.248 2.928 . . . . 25.0 113.834 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 mttt 75.65 163.19 0.14 Allowed Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 109.913 -3.312 . . . . 25.0 113.062 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.58 131.65 22.09 Favored 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 134.665 3.194 . . . . 25.0 108.693 7.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.54 154.5 17.87 Favored Glycine 0 C--O 1.282 3.133 0 N-CA-C 110.716 -0.953 . . . . 25.0 110.716 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 t -152.71 132.7 13.37 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.879 0.987 . . . . 25.0 111.449 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -85.83 -19.79 30.11 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.84 81.6 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 117.774 -1.57 . . . . 25.0 113.228 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.67 59.68 Favored 'General case' 0 C--O 1.269 2.117 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 115.867 1.803 . . . . 75.0 115.867 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.51 2.535 1 N-CA-C 124.284 4.92 . . . . 25.0 124.284 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -71.13 -46.87 60.77 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 116.301 -3.999 . . . . 50.0 114.547 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB2' HE22 ' A' ' 33' ' ' GLN . 7.1 pt-20 -145.69 60.57 6.74 Favored Pre-proline 0 C--O 1.2 -1.505 0 CA-C-O 124.646 2.165 . . . . 25.0 112.834 169.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.13 -10.89 28.22 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 117.279 -1.348 . . . . 25.0 113.647 -166.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.496 HE22 ' HB2' ' A' ' 31' ' ' GLU . 2.8 pm0 -78.8 -15.13 58.79 Favored 'General case' 0 C--O 1.189 -2.08 0 C-N-CA 126.925 2.09 . . . . 25.0 111.641 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -122.55 141.87 51.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 113.43 0.9 . . . . 25.0 113.43 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.2 109.13 20.82 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 124.667 2.175 . . . . 50.0 105.234 156.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.86 151.14 25.29 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.402 -2.074 . . . . 25.0 105.402 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.91 170.62 15.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 123.526 1.631 . . . . 25.0 107.956 169.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -136.76 147.29 46.59 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 119.24 -2.163 . . . . 25.0 108.222 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 CA--C 1.565 1.524 0 N-CA-C 104.654 -2.35 . . . . 25.0 104.654 179.679 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 CA--C 1.569 1.686 0 CA-C-O 126.284 2.945 . . . . 50.0 112.8 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -74.98 -33.53 61.89 Favored 'General case' 0 C--O 1.265 1.877 0 CA-C-O 126.471 3.034 . . . . 50.0 105.456 154.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.5 -17.28 78.96 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-O 124.762 2.312 . . . . 25.0 110.191 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.88 -22.45 75.66 Favored Glycine 0 C--O 1.208 -1.512 0 CA-C-O 124.041 1.912 . . . . 25.0 112.66 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.16 -41.35 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 118.677 -2.661 . . . . 25.0 109.398 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.7 mt -72.21 -26.48 62.06 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 119.971 3.323 . . . . 75.0 119.971 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -66.5 -28.05 68.26 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.61 -1.255 . . . . 50.0 107.61 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -78.77 6.97 7.76 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 123.819 0.699 . . . . 25.0 111.31 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -126.15 39.64 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 104.306 -2.479 . . . . 25.0 104.306 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -154.98 169.44 24.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.264 -1.523 . . . . 25.0 107.544 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.73 -14.63 63.15 Favored 'General case' 0 C--O 1.182 -2.471 0 CA-C-O 124.745 2.212 . . . . 25.0 109.245 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -86.06 20.18 2.38 Favored 'General case' 0 N--CA 1.422 -1.852 0 O-C-N 119.03 -2.294 . . . . 25.0 112.319 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.92 96.91 2.18 Favored 'General case' 0 C--O 1.263 1.802 0 CA-C-O 124.803 2.24 . . . . 25.0 105.589 163.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -44.71 146.0 0.83 Allowed 'General case' 0 C--O 1.275 2.395 1 CA-C-N 106.598 -4.819 . . . . 25.0 109.74 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -79.78 132.34 36.13 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 119.681 -1.887 . . . . 50.0 112.037 -157.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.05 155.83 16.9 Favored 'General case' 0 C--N 1.365 1.256 0 CA-C-N 112.333 -2.212 . . . . 25.0 112.17 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -152.44 141.25 21.03 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.032 -1.467 . . . . 25.0 113.841 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.28 129.9 39.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.78 0 C-N-CA 117.045 -1.862 . . . . 25.0 106.611 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' A' ' 169' ' ' LEU . 26.4 ttt -139.92 157.77 45.15 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 121.177 1.808 . . . . 25.0 107.452 164.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 p -68.02 162.74 23.83 Favored 'General case' 0 CA--C 1.584 2.275 0 O-C-N 117.911 -2.993 . . . . 25.0 109.214 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.95 -156.27 3.38 Favored Glycine 0 C--O 1.209 -1.463 1 O-C-N 115.928 -4.232 . . . . 25.0 113.485 164.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 -173.38 38.02 Favored Glycine 0 C--O 1.192 -2.495 0 O-C-N 121.322 -1.105 . . . . 25.0 111.5 -165.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.62 133.15 51.66 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 120.491 2.145 . . . . 25.0 114.089 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -120.16 133.2 55.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.767 -1.568 . . . . 25.0 106.767 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.1 m -115.54 89.62 3.14 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 120.695 1.589 . . . . 25.0 111.573 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -74.4 117.7 16.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.618 0.767 . . . . 50.0 109.981 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -123.99 145.02 49.47 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.372 -2.084 . . . . 25.0 105.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -127.8 159.24 35.44 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 102.225 -3.25 . . . . 25.0 102.225 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.3 p -134.91 163.1 30.6 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 127.704 3.128 . . . . 25.0 108.245 166.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.36 137.9 52.89 Favored 'General case' 0 N--CA 1.496 1.863 1 N-CA-C 96.768 -5.271 . . . . 50.0 96.768 164.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.4 t -74.51 -20.68 59.89 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 116.031 -2.268 . . . . 25.0 105.713 -165.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.16 157.58 77.68 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 103.038 -2.949 . . . . 25.0 103.038 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.29 143.16 27.86 Favored 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 109.95 -6.233 . . . . 25.0 112.018 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -118.03 152.65 35.11 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.833 -2.284 . . . . 25.0 104.833 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.57 160.54 32.51 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.67 147.05 24.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 127.867 2.467 . . . . 25.0 113.389 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -108.64 -27.94 9.55 Favored 'General case' 0 C--O 1.26 1.617 0 N-CA-C 114.535 1.309 . . . . 25.0 114.535 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -174.43 173.74 2.9 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.054 -2.573 . . . . 25.0 104.054 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -153.24 169.43 23.06 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.982 -0.747 . . . . 25.0 108.982 163.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -145.01 151.79 39.12 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 114.434 -2.698 . . . . 25.0 106.764 -169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.88 147.18 21.22 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 124.737 2.208 . . . . 50.0 112.982 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -132.08 165.09 24.81 Favored 'General case' 1 C--O 1.306 4.059 0 CA-C-N 114.324 -1.307 . . . . 50.0 107.661 -162.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.4 pt -125.94 157.0 36.11 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.676 0 N-CA-C 101.311 -3.589 . . . . 25.0 101.311 161.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 115' ' ' PHE . 34.9 p -76.3 150.15 36.98 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.346 -1.724 . . . . 25.0 106.346 169.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -143.49 76.85 1.54 Allowed 'General case' 0 N--CA 1.423 -1.791 0 O-C-N 120.641 -1.287 . . . . 25.0 108.221 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -56.44 153.45 9.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.11 -1.859 . . . . 25.0 112.851 167.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.73 37.77 22.08 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 116.79 -2.116 . . . . 25.0 109.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -64.5 157.22 27.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 126.598 1.999 . . . . 25.0 110.949 163.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -59.22 133.81 87.92 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 108.221 -1.029 . . . . 25.0 108.221 158.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.33 -36.14 98.9 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 N-CA-C 117.456 2.06 . . . . 25.0 117.456 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.66 -19.8 62.72 Favored 'General case' 0 C--O 1.267 1.994 0 N-CA-C 116.889 2.181 . . . . 75.0 116.889 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -58.16 159.08 11.88 Favored Pre-proline 0 C--O 1.205 -1.27 0 CA-C-N 113.13 -1.85 . . . . 25.0 110.231 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.45 23.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.193 -1.774 2 C-N-CA 127.128 5.219 . . . . 25.0 125.08 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 tp 14.79 -56.87 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.244 1 N-CA-C 125.56 5.393 . . . . 50.0 125.56 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -69.24 -31.54 70.17 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -96.72 -46.5 6.26 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.624 -1.626 . . . . 25.0 110.517 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.79 -3.78 1.75 Allowed 'General case' 0 C--O 1.206 -1.19 0 C-N-CA 118.82 -1.152 . . . . 25.0 113.058 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.7 -26.35 68.34 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 115.471 1.656 . . . . 25.0 115.471 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 29.8 p90 -127.51 153.23 46.59 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.207 -2.146 . . . . 50.0 105.207 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -126.68 130.61 50.74 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 111.877 -2.419 . . . . 25.0 111.258 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.18 111.44 3.43 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 105.508 -2.034 . . . . 50.0 105.508 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.73 -20.24 7.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.444 -1.317 . . . . 25.0 107.444 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.7 166.55 33.39 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.748 -1.22 . . . . 25.0 113.555 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.92 155.36 41.5 Favored 'General case' 0 C--O 1.181 -2.516 0 N-CA-C 104.124 -2.547 . . . . 25.0 104.124 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.3 107.12 17.6 Favored Pre-proline 0 C--O 1.271 2.213 0 N-CA-C 106.828 -1.545 . . . . 50.0 106.828 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.33 162.05 28.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 N-CA-C 107.553 -1.749 . . . . 25.0 107.553 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -139.66 63.01 1.5 Allowed 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 119.544 -0.862 . . . . 25.0 110.542 -170.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.15 -16.9 0.83 Allowed 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.533 1.679 . . . . 50.0 115.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -164.75 21.58 0.14 Allowed Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 125.412 1.482 . . . . 25.0 116.681 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.63 162.06 73.35 Favored Pre-proline 0 CA--C 1.556 1.201 0 O-C-N 124.88 0.988 . . . . 25.0 113.437 -174.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.29 -170.01 0.53 Allowed 'Trans proline' 0 C--O 1.264 1.808 0 CA-C-O 117.822 -0.991 . . . . 25.0 113.987 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.42 4.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 1 N-CA-C 122.027 4.084 . . . . 25.0 122.027 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 p -57.66 -17.6 15.73 Favored 'General case' 0 C--O 1.187 -2.224 0 CA-C-N 115.921 -0.582 . . . . 25.0 110.284 161.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -63.9 -16.71 62.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.183 0.809 . . . . 25.0 113.183 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -60.72 129.83 43.46 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 117.821 -1.085 . . . . 25.0 109.471 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.49 -5.01 17.06 Favored 'General case' 0 C--O 1.283 2.86 0 N-CA-C 120.357 3.465 . . . . 75.0 120.357 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.4 t -86.51 127.18 34.85 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 126.039 1.736 . . . . 25.0 109.141 160.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -134.67 130.13 35.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 118.921 2.934 . . . . 25.0 118.921 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -92.07 129.22 38.07 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.174 -1.375 . . . . 25.0 113.573 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.5 mt -121.09 124.03 71.29 Favored 'Isoleucine or valine' 0 C--O 1.271 2.194 0 N-CA-C 105.605 -1.998 . . . . 25.0 105.605 169.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -75.84 137.09 40.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.003 -2.221 . . . . 50.0 105.003 165.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -115.28 129.78 24.81 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 101.763 -3.421 . . . . 25.0 101.763 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.74 140.63 68.58 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 116.372 -1.952 . . . . 25.0 109.415 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -108.66 2.92 22.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.31 -23.71 32.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.517 2.043 . . . . 50.0 116.517 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -143.49 155.1 44.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 114.768 -2.539 . . . . 25.0 107.512 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.5 pt? -75.22 164.56 26.34 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 125.808 1.943 . . . . 50.0 109.605 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 175.81 135.28 2.09 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 108.12 -1.992 . . . . 25.0 108.12 170.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -115.3 148.53 39.1 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 124.973 1.309 . . . . 50.0 111.396 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -161.04 161.88 31.52 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 116.569 -1.681 . . . . 25.0 107.471 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.9 t -91.01 158.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 101.664 -3.458 . . . . 50.0 101.664 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.77 135.78 49.97 Favored 'Isoleucine or valine' 0 C--O 1.28 2.671 1 N-CA-C 98.048 -4.797 . . . . 25.0 98.048 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.26 148.2 48.77 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 103.749 -2.685 . . . . 50.0 103.749 168.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.09 153.0 41.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.588 -0.695 . . . . 25.0 110.718 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.9 140.64 46.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.625 0 C-N-CA 123.067 0.547 . . . . 50.0 111.304 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.19 133.76 45.83 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.788 1.235 . . . . 25.0 112.574 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.96 133.29 55.6 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.338 1.055 . . . . 25.0 112.663 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.9 t -131.64 111.87 19.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 102.119 -3.289 . . . . 50.0 102.119 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.62 -24.86 53.37 Favored 'General case' 0 C--O 1.17 -3.091 0 CA-C-O 117.753 -1.118 . . . . 25.0 108.288 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.98 -19.27 65.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 124.477 2.084 . . . . 25.0 115.858 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.7 p -118.82 150.83 39.16 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.151 -1.84 . . . . 25.0 114.202 -173.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -78.55 -25.55 45.47 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.344 -1.753 . . . . 25.0 109.974 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -63.33 152.22 38.55 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 118.611 -1.236 . . . . 25.0 114.133 163.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.88 158.34 44.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 105.588 -2.005 . . . . 25.0 105.588 174.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -131.36 146.06 52.11 Favored 'General case' 0 C--O 1.29 3.206 0 O-C-N 118.618 -2.551 . . . . 50.0 114.78 -170.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.01 170.54 15.83 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 102.466 -3.161 . . . . 50.0 102.466 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -164.34 167.36 19.86 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.2 p -145.32 134.99 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.935 -1.135 . . . . 75.0 107.935 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -141.85 146.26 23.14 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 101.972 -3.344 . . . . 25.0 101.972 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -122.17 152.18 40.21 Favored 'General case' 0 C--O 1.264 1.827 0 CA-C-N 121.072 1.76 . . . . 25.0 108.002 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.66 153.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.76 0 N-CA-C 110.185 -0.302 . . . . 50.0 110.185 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -131.79 94.52 3.52 Favored 'General case' 0 C--O 1.264 1.857 0 N-CA-C 101.401 -3.555 . . . . 25.0 101.401 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 75' ' ' MET . 53.3 mt -102.49 111.77 24.22 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.34 -1.475 . . . . 50.0 114.446 -170.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 33.5 m -128.11 173.71 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.964 2.579 . . . . 50.0 117.964 -153.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.37 147.13 23.65 Favored 'General case' 0 CA--C 1.494 -1.203 1 N-CA-C 99.541 -4.244 . . . . 25.0 99.541 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 C--O 1.269 2.088 0 N-CA-C 116.036 1.865 . . . . 25.0 116.036 169.206 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 N--CA 1.534 3.748 0 CA-C-O 123.846 1.784 . . . . 25.0 113.33 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 33' ' ' GLN . . . -144.21 -32.44 0.09 OUTLIER Glycine 0 C--O 1.27 2.384 0 C-N-CA 127.632 2.539 . . . . 25.0 111.052 169.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.08 140.13 53.34 Favored 'General case' 0 CA--C 1.482 -1.643 0 C-N-CA 125.637 1.575 . . . . 50.0 109.8 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.5 mt -103.76 122.04 55.96 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 N-CA-C 100.703 -3.814 . . . . 25.0 100.703 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -92.63 -40.56 10.68 Favored 'General case' 0 C--O 1.182 -2.486 0 CA-C-N 119.14 0.882 . . . . 25.0 112.66 -173.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -144.82 154.41 55.35 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 115.887 -2.006 . . . . 25.0 106.634 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.65 136.45 45.14 Favored 'Cis proline' 0 N--CA 1.476 0.478 0 CA-C-N 121.909 1.718 . . . . 25.0 109.059 0.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.74 -162.44 38.29 Favored Glycine 0 C--O 1.214 -1.113 0 N-CA-C 120.082 2.793 . . . . 25.0 120.082 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -114.51 116.0 28.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.487 1.644 . . . . 25.0 111.282 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -73.11 -23.24 60.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.123 0.874 . . . . 25.0 109.588 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.47 72.63 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.234 1.814 . . . . 25.0 106.297 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.38 -37.95 68.22 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 124.216 0.947 . . . . 25.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 CA--C 1.544 0.741 0 O-C-N 123.803 0.689 . . . . 75.0 110.638 -179.763 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 C--O 1.2 -1.547 0 N-CA-C 114.601 1.334 . . . . 25.0 114.601 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -88.15 -37.83 15.85 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.291 -1.364 . . . . 50.0 111.319 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.51 48.02 0.25 Allowed Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 115.978 1.844 . . . . 25.0 115.978 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.16 -19.49 34.14 Favored 'Trans proline' 0 CA--C 1.569 2.261 1 C-N-CA 110.915 -5.59 . . . . 25.0 116.621 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.459 ' HB3' ' HA2' ' A' ' 2' ' ' GLY 0.266 12.2 pt20 -109.15 -20.88 12.83 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.846 1.203 . . . . 25.0 113.911 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.1 p -96.58 22.45 8.02 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.297 1.046 . . . . 25.0 113.755 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.97 44.47 0.03 OUTLIER 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.669 1.988 . . . . 50.0 115.485 -172.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 161' ' ' PHE . 47.0 mt-10 -71.77 156.63 39.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 120.766 3.617 . . . . 25.0 120.766 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.72 58.3 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 117.651 -1.166 . . . . 25.0 113.976 170.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 31.7 tttm -151.71 -164.23 1.93 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.831 3.014 . . . . 25.0 109.435 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.544 ' H ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 mttt . . . . . 0 C--O 1.235 0.291 0 CA-C-N 113.508 -1.678 . . . . 25.0 109.862 -170.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 CA--C 1.565 1.523 0 CA-C-O 123.163 1.459 . . . . 50.0 113.303 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 -35.79 32.92 Favored 'General case' 0 CA--C 1.586 2.337 0 N-CA-C 101.343 -3.577 . . . . 50.0 101.343 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.56 63.74 Favored Glycine 0 C--O 1.268 2.245 0 CA-C-N 114.014 -1.448 . . . . 25.0 113.07 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.66 77.56 Favored Glycine 0 C--O 1.201 -1.914 0 CA-C-N 119.058 1.429 . . . . 25.0 110.938 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -65.55 -43.57 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 106.885 -1.524 . . . . 25.0 106.885 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.12 -24.21 59.41 Favored 'General case' 0 C--O 1.172 -3.014 0 N-CA-C 107.686 -1.227 . . . . 75.0 107.686 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.69 -21.39 60.26 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 123.777 1.751 . . . . 50.0 111.171 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -103.95 16.35 26.5 Favored 'General case' 0 C--O 1.183 -2.441 0 O-C-N 118.213 -2.804 . . . . 25.0 108.37 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -128.95 49.73 2.2 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 102.303 -3.221 . . . . 25.0 102.303 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -152.5 -179.67 7.79 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 100.525 -3.88 . . . . 25.0 100.525 -162.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -66.8 -17.61 64.96 Favored 'General case' 0 CA--C 1.592 2.587 0 C-N-CA 117.651 -1.62 . . . . 25.0 114.413 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -94.68 48.77 1.22 Allowed 'General case' 0 CA--C 1.556 1.21 0 O-C-N 120.203 -1.561 . . . . 25.0 108.317 165.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -85.32 98.98 10.84 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 100.191 -4.003 . . . . 25.0 100.191 156.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -65.6 163.06 16.98 Favored 'General case' 0 C--O 1.256 1.43 1 CA-C-N 106.583 -4.826 . . . . 25.0 110.703 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -59.52 146.29 41.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 120.016 1.28 . . . . 50.0 112.366 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -129.33 154.4 46.92 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -139.77 150.72 45.09 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 118.282 -0.866 . . . . 25.0 112.038 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.98 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.127 0 CA-C-O 123.789 1.757 . . . . 25.0 110.561 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 30.6 mtm -147.0 172.0 14.39 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 120.147 -1.596 . . . . 25.0 113.493 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.1 p -71.53 165.21 24.35 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 105.071 -2.196 . . . . 25.0 105.071 168.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.06 176.62 53.11 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 106.378 -2.689 . . . . 25.0 106.378 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.94 -170.15 20.17 Favored Glycine 0 C--O 1.266 2.113 0 CA-C-N 120.342 2.071 . . . . 25.0 113.815 -170.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -74.68 137.39 42.11 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 112.922 -1.639 . . . . 25.0 109.852 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -127.62 159.1 35.69 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.719 1.208 . . . . 25.0 111.158 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.3 m -117.89 142.04 47.77 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 106.31 -1.737 . . . . 25.0 106.31 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -125.96 114.72 18.86 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 102.687 -3.079 . . . . 50.0 102.687 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 m -129.87 117.68 20.54 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.706 -1.588 . . . . 25.0 112.524 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . 0.308 0.8 OUTLIER -111.51 136.61 50.45 Favored 'General case' 0 C--O 1.3 3.717 0 N-CA-C 101.353 -3.573 . . . . 25.0 101.353 171.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -148.88 160.29 43.39 Favored 'General case' 0 C--O 1.181 -2.54 0 O-C-N 125.59 1.806 . . . . 25.0 108.887 -167.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.04 170.32 16.2 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.852 -1.067 . . . . 50.0 109.288 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.9 t -64.76 -25.42 67.92 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.907 -1.044 . . . . 25.0 111.45 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.34 153.23 74.54 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 125.096 1.497 . . . . 25.0 111.129 -171.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.99 169.39 20.61 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 117.331 -1.313 . . . . 25.0 112.53 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.258 3.2 m80 -127.09 161.51 28.26 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 103.81 -2.663 . . . . 25.0 103.81 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -81.86 57.93 3.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.091 0.956 . . . . 25.0 109.642 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 154' ' ' VAL . 4.5 m -66.98 144.5 56.17 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 127.022 2.702 . . . . 25.0 108.878 -178.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -117.37 -32.05 5.07 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 126.478 2.361 . . . . 25.0 109.822 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 50.3 tt0 -165.59 154.68 12.02 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 124.755 1.222 . . . . 25.0 109.471 -170.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -141.74 164.56 29.88 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 145.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.33 36.4 m-70 -131.9 145.06 51.3 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 126.588 1.955 . . . . 25.0 107.776 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -139.54 148.34 42.46 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-O 122.713 1.244 . . . . 50.0 111.286 170.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.46 162.05 30.05 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 109.679 -3.418 . . . . 50.0 111.042 -164.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.2 151.05 33.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 102.25 -3.241 . . . . 25.0 102.25 176.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 114' ' ' ASP . 71.6 m -82.32 113.88 20.41 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 125.883 1.989 . . . . 25.0 109.893 157.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -83.38 94.33 7.94 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-N 120.209 1.368 . . . . 25.0 109.57 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -61.76 161.19 10.51 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 124.671 1.188 . . . . 25.0 111.923 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.42 28.15 Favored Glycine 0 CA--C 1.497 -1.048 0 C-N-CA 119.0 -1.571 . . . . 25.0 116.504 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.21 159.89 32.18 Favored 'General case' 0 CA--C 1.581 2.145 0 C-N-CA 119.592 -0.843 . . . . 25.0 111.426 -171.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -71.31 117.1 53.74 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 102.377 -3.194 . . . . 25.0 102.377 149.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.81 -22.22 37.05 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 125.282 3.988 . . . . 25.0 117.525 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -75.08 -13.84 60.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.387 -1.446 . . . . 75.0 109.934 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.253 95.9 mttt -117.11 165.3 15.84 Favored Pre-proline 0 C--O 1.2 -1.504 2 N-CA-C 99.202 -4.37 . . . . 25.0 99.202 -171.75 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 3.38 14.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 2 C-N-CA 135.44 10.76 . . . . 25.0 127.967 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.1 tt -46.66 -43.53 17.69 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-O 115.616 -2.135 . . . . 50.0 113.768 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -75.39 -2.58 29.19 Favored 'General case' 0 C--O 1.169 -3.163 0 O-C-N 125.195 1.56 . . . . 25.0 113.207 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -121.94 -51.85 2.0 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 122.799 1.285 . . . . 25.0 112.155 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.55 -26.53 3.57 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 112.653 -2.067 . . . . 25.0 115.095 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.47 ' HA ' HG23 ' A' ' 100' ' ' THR . 20.2 t0 -80.35 -7.78 59.22 Favored 'General case' 0 C--O 1.28 2.676 0 CA-C-N 113.489 -1.687 . . . . 25.0 111.04 -176.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -141.64 47.56 1.66 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 118.236 -2.79 . . . . 50.0 106.631 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.8 122.45 29.15 Favored 'General case' 0 CA--C 1.558 1.286 0 O-C-N 118.143 -2.848 . . . . 25.0 111.5 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.6 tp -60.72 125.96 25.64 Favored 'General case' 0 C--O 1.266 1.94 0 N-CA-C 114.174 1.176 . . . . 50.0 114.174 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.7 tt -108.21 -22.4 5.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 116.799 -1.572 . . . . 25.0 106.999 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.12 -179.43 44.74 Favored Glycine 0 C--N 1.371 2.488 0 C-N-CA 118.746 -1.692 . . . . 25.0 116.193 161.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -146.59 153.99 40.98 Favored 'General case' 0 C--O 1.286 3.023 0 CA-C-O 123.279 1.514 . . . . 25.0 107.333 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.2 t -132.46 86.49 45.14 Favored Pre-proline 0 CA--C 1.62 3.648 0 N-CA-C 103.608 -2.738 . . . . 50.0 103.608 -173.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 71.9 Cg_endo -71.18 154.33 61.98 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 115.234 -2.711 . . . . 25.0 112.259 171.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -144.59 96.44 2.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.37 1.618 . . . . 25.0 115.37 -157.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.34 -7.25 16.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.57 -1.65 . . . . 50.0 114.722 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.41 -171.1 42.1 Favored Glycine 0 C--O 1.283 3.194 1 N-CA-C 101.969 -4.452 . . . . 25.0 101.969 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.4 m -126.42 75.11 73.89 Favored Pre-proline 0 N--CA 1.508 2.439 0 N-CA-C 115.193 1.553 . . . . 25.0 115.193 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.3 170.19 17.81 Favored 'Trans proline' 0 C--O 1.213 -0.759 1 C-N-CA 111.984 -4.877 . . . . 25.0 106.208 150.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.76 67.02 Favored 'General case' 0 CA--C 1.573 1.842 0 O-C-N 119.373 -2.079 . . . . 25.0 115.567 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 95.5 p -68.02 -22.89 64.96 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 120.93 1.696 . . . . 25.0 114.407 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -111.97 19.59 17.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 127.039 2.712 . . . . 25.0 111.974 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -55.59 148.82 15.06 Favored 'General case' 0 N--CA 1.513 2.681 0 CA-C-O 122.82 1.295 . . . . 25.0 108.404 168.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tp -64.65 -36.4 84.14 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 111.483 -2.599 . . . . 75.0 110.795 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.7 t -91.81 153.76 19.36 Favored 'General case' 0 C--O 1.285 2.946 0 N-CA-C 104.12 -2.548 . . . . 25.0 104.12 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -147.41 164.63 32.72 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 112.82 0.674 . . . . 25.0 112.82 170.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -113.59 148.9 35.34 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 104.471 -2.418 . . . . 25.0 104.471 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -133.03 124.5 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 105.645 -1.983 . . . . 25.0 105.645 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . 0.254 70.0 t80 -90.91 132.75 35.74 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.124 -2.86 . . . . 50.0 109.039 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.6 mm -131.63 124.4 19.93 Favored Pre-proline 0 C--O 1.268 2.059 0 N-CA-C 103.254 -2.869 . . . . 25.0 103.254 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.19 165.89 29.96 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 114.51 -3.193 . . . . 25.0 116.697 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.53 39.35 1.06 Allowed 'General case' 0 C--O 1.295 3.46 0 CA-C-O 125.853 2.74 . . . . 25.0 111.27 175.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.86 -20.17 59.85 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 115.64 1.719 . . . . 50.0 115.64 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -148.92 170.32 18.56 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.63 139.46 38.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 101.631 -3.47 . . . . 50.0 101.631 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.13 176.67 20.19 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 118.328 -1.891 . . . . 25.0 115.47 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -81.86 146.25 29.95 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 117.985 2.587 . . . . 50.0 117.985 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -138.93 113.75 9.21 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.916 2.01 . . . . 25.0 111.138 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.76 130.87 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 116.176 -1.869 . . . . 50.0 108.625 -172.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.48 132.15 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 124.031 1.872 . . . . 25.0 109.907 167.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HG ' HG23 ' A' ' 164' ' ' VAL . 3.1 mp -118.04 138.59 52.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 102.868 -3.012 . . . . 50.0 102.868 -175.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.39 144.61 29.85 Favored 'General case' 0 C--O 1.29 3.187 0 O-C-N 119.826 -1.796 . . . . 25.0 111.835 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 79.8 t -124.67 135.14 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 102.728 -3.064 . . . . 50.0 102.728 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -135.26 114.83 12.66 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 125.428 1.705 . . . . 25.0 112.079 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -112.18 128.84 56.35 Favored 'General case' 0 C--O 1.284 2.885 0 O-C-N 123.872 0.732 . . . . 25.0 111.687 -162.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 79.6 t -121.7 119.07 57.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 115.823 -2.037 . . . . 50.0 107.319 -169.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.71 -13.36 31.55 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 119.719 3.229 . . . . 25.0 119.719 -166.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -76.36 -18.65 58.78 Favored 'General case' 0 C--O 1.253 1.263 0 O-C-N 120.268 -1.52 . . . . 25.0 112.348 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -112.25 153.4 27.19 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 119.951 -1.718 . . . . 25.0 111.751 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -78.11 -28.2 48.56 Favored 'General case' 0 C--O 1.28 2.673 0 N-CA-C 103.161 -2.904 . . . . 25.0 103.161 171.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.08 179.34 3.34 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 119.177 -2.202 . . . . 25.0 113.23 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.57 151.56 36.49 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 125.84 1.656 . . . . 25.0 108.584 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 84.2 m-85 -95.25 150.22 20.47 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 126.023 2.077 . . . . 50.0 111.778 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -133.56 130.7 38.79 Favored 'General case' 0 C--O 1.284 2.872 0 CA-C-N 114.741 -1.118 . . . . 50.0 108.205 -169.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.0 156.87 45.45 Favored 'General case' 0 C--O 1.267 1.988 0 CA-C-N 119.65 1.114 . . . . 25.0 112.22 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.412 HG23 ' HG ' ' A' ' 149' ' ' LEU . 6.6 p -146.8 127.94 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 107.631 -1.248 . . . . 75.0 107.631 -171.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.58 137.04 57.82 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 N-CA-C 107.465 -1.309 . . . . 25.0 107.465 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.67 126.95 50.18 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 123.648 0.593 . . . . 25.0 110.941 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.36 132.99 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 122.914 1.34 . . . . 50.0 111.697 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -96.23 113.42 25.01 Favored 'General case' 0 C--O 1.204 -1.339 0 N-CA-C 104.625 -2.361 . . . . 25.0 104.625 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.36 110.71 21.6 Favored 'General case' 0 CA--C 1.476 -1.896 0 CA-C-N 112.807 -1.997 . . . . 50.0 110.202 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.7 m -132.93 154.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-O 124.564 2.126 . . . . 50.0 112.615 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -59.11 126.38 27.46 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.0 pttp . . . . . 0 C--O 1.263 1.801 0 CA-C-O 116.061 -1.924 . . . . 25.0 108.53 179.045 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 118.996 -0.526 . . . . 25.0 111.217 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.65 173.64 42.03 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 120.482 1.492 . . . . 25.0 115.341 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -129.21 135.73 49.2 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 125.165 1.386 . . . . 50.0 112.746 -156.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.5 mt -89.57 121.53 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 119.229 -2.169 . . . . 25.0 111.151 -171.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -101.22 16.48 25.37 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.862 1.265 . . . . 25.0 110.245 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 64.87 166.27 0.11 Allowed Pre-proline 0 CA--C 1.594 2.652 0 C-N-CA 128.195 2.598 . . . . 25.0 111.14 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.55 141.3 45.07 Favored 'Cis proline' 0 C--O 1.204 -1.225 0 C-N-CA 132.621 2.342 . . . . 25.0 111.709 13.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.94 91.53 1.61 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 117.272 1.669 . . . . 25.0 117.272 168.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 t -75.63 144.44 41.71 Favored 'General case' 0 C--O 1.275 2.423 0 CA-C-O 123.183 1.468 . . . . 25.0 110.921 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -107.23 -22.93 12.44 Favored 'General case' 0 CA--C 1.581 2.138 0 CA-C-N 113.721 -1.581 . . . . 25.0 109.724 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.39 89.71 Favored 'General case' 0 C--O 1.264 1.856 0 CA-C-O 117.398 -1.287 . . . . 25.0 108.792 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -29.14 70.57 Favored 'General case' 0 C--O 1.279 2.656 0 O-C-N 125.764 1.915 . . . . 25.0 115.389 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 CA--C 1.565 1.534 0 O-C-N 120.433 -1.417 . . . . 75.0 109.575 176.859 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 C--O 1.257 1.452 0 N-CA-C 115.62 1.711 . . . . 25.0 115.62 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -64.58 -38.16 90.03 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.653 2.094 . . . . 50.0 116.653 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -147.41 64.26 8.54 Favored Pre-proline 0 C--O 1.262 1.76 0 CA-C-O 118.353 -0.832 . . . . 25.0 109.558 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 -21.67 12.96 Favored 'Trans proline' 0 N--CA 1.486 1.063 1 C-N-CA 110.775 -5.683 . . . . 25.0 117.537 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -72.48 -20.75 61.32 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 114.485 -2.674 . . . . 25.0 112.698 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.7 t -79.54 112.7 17.04 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 124.802 2.239 . . . . 25.0 109.615 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 mt -106.89 91.41 3.65 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 109.139 -3.664 . . . . 50.0 104.14 163.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.04 161.72 28.4 Favored 'General case' 0 CA--C 1.457 -2.618 0 C-N-CA 118.074 -1.45 . . . . 25.0 112.732 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.15 166.32 25.01 Favored 'General case' 0 C--O 1.187 -2.201 0 N-CA-C 102.674 -3.084 . . . . 25.0 102.674 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -130.12 140.49 50.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt . . . . . 0 N--CA 1.479 0.981 0 O-C-N 124.098 0.874 . . . . 25.0 109.296 177.125 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . 0.273 59.0 mt . . . . . 0 CA--C 1.507 -0.689 0 CA-C-O 121.999 0.904 . . . . 50.0 112.677 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -82.96 -40.13 20.45 Favored 'General case' 0 C--N 1.301 -1.534 1 N-CA-C 99.359 -4.311 . . . . 50.0 99.359 171.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.77 -16.41 80.34 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 126.661 3.367 . . . . 25.0 110.522 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.97 -23.33 72.75 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 110.116 -3.042 . . . . 25.0 112.323 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.8 -39.19 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 122.136 2.968 . . . . 25.0 109.217 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -73.83 -29.64 62.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 116.667 2.099 . . . . 75.0 116.667 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -66.97 -28.03 67.94 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 126.881 2.073 . . . . 50.0 110.705 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -91.56 39.3 1.0 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.722 -1.127 . . . . 25.0 110.924 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -136.31 59.68 1.7 Allowed 'General case' 0 C--N 1.281 -2.37 0 O-C-N 125.667 1.854 . . . . 25.0 107.335 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.9 p -169.21 168.28 9.89 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 113.255 -1.793 . . . . 25.0 106.756 -156.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.61 -20.45 60.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 126.869 2.605 . . . . 25.0 109.011 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -84.46 8.74 15.4 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 126.852 2.595 . . . . 25.0 115.614 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -68.79 86.54 0.33 Allowed 'General case' 0 C--O 1.271 2.209 0 CA-C-O 124.721 2.2 . . . . 25.0 107.247 163.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -40.09 148.44 0.08 Allowed 'General case' 0 N--CA 1.426 -1.648 1 CA-C-N 108.242 -4.072 . . . . 25.0 117.242 169.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -74.47 138.95 43.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 123.978 1.847 . . . . 50.0 111.799 -166.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -77.23 154.29 33.17 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 112.207 -2.269 . . . . 25.0 107.798 157.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -132.83 126.5 32.43 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.545 -3.872 . . . . 25.0 100.545 157.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -97.69 116.57 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 105.43 -2.063 . . . . 25.0 105.43 -166.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.9 ttt -132.88 154.27 50.54 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 119.788 -1.82 . . . . 25.0 109.838 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 p -74.79 158.19 33.9 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.66 -177.63 18.95 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 116.221 1.248 . . . . 25.0 116.221 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.61 -167.11 23.68 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 119.24 -1.457 . . . . 25.0 114.788 -174.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -71.24 135.76 47.64 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.997 -1.296 . . . . 25.0 108.764 163.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -134.63 140.65 46.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-O 116.122 -1.894 . . . . 25.0 112.114 -166.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.9 m -124.38 131.74 53.51 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.874 1.358 . . . . 25.0 111.264 171.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -112.67 124.74 53.23 Favored 'General case' 0 CA--C 1.605 3.06 1 N-CA-C 100.133 -4.025 . . . . 50.0 100.133 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.2 m -124.89 129.54 50.59 Favored 'General case' 0 C--O 1.273 2.297 0 CA-C-O 126.24 2.924 . . . . 25.0 111.864 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -123.39 155.84 36.6 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 111.35 -2.659 . . . . 25.0 108.38 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 45.4 p -125.02 143.84 50.7 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 104.382 -2.451 . . . . 25.0 104.382 170.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.36 150.26 28.3 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 104.537 -2.394 . . . . 50.0 104.537 165.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.5 t -76.07 -38.28 57.25 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 124.456 2.074 . . . . 25.0 110.229 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.79 137.69 11.29 Favored Pre-proline 0 N--CA 1.482 1.129 1 N-CA-C 96.18 -5.489 . . . . 25.0 96.18 165.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.06 172.47 16.3 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 CA-C-N 120.9 1.357 . . . . 25.0 112.902 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.344 30.9 m-70 -93.87 159.18 15.3 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 118.029 -2.919 . . . . 25.0 104.726 167.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -60.64 125.8 25.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 117.311 2.337 . . . . 25.0 117.311 167.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.9 m -139.26 134.59 32.85 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 106.721 -1.585 . . . . 25.0 106.721 -160.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.3 p -91.65 -29.02 17.11 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.907 1.337 . . . . 25.0 109.542 -171.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -172.64 171.57 4.47 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 116.421 -1.752 . . . . 25.0 108.292 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.434 ' CZ3' ' CD2' ' A' ' 123' ' ' HIS . 26.9 p90 -153.06 158.54 42.1 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-O 117.018 -1.468 . . . . 25.0 111.528 166.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.415 ' HD2' ' HB ' ' A' ' 151' ' ' VAL 0.253 8.3 m-70 -139.96 144.37 37.01 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.011 1.278 . . . . 25.0 114.12 -167.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -123.72 137.95 54.61 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 121.209 1.822 . . . . 50.0 112.768 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -140.54 166.79 23.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.301 -1.74 . . . . 50.0 106.301 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.4 pt -134.68 166.15 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -83.17 150.93 25.94 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.168 0.44 . . . . 25.0 111.5 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -99.52 162.65 12.9 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -166.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -163.88 168.46 19.46 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 100.477 -3.898 . . . . 25.0 100.477 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.38 60.32 3.07 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 103.763 -3.735 . . . . 25.0 103.763 -174.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -146.5 171.67 14.71 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 114.776 -2.535 . . . . 25.0 112.476 -169.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.64 135.93 11.08 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 122.99 2.632 . . . . 25.0 104.576 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -64.04 -16.4 54.69 Favored 'Trans proline' 0 C--O 1.191 -1.868 1 N-CA-C 125.04 4.977 . . . . 25.0 125.04 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -78.49 -1.79 35.46 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 117.061 -3.524 . . . . 75.0 112.284 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -130.93 165.18 36.83 Favored Pre-proline 0 N--CA 1.406 -2.64 1 N-CA-C 100.19 -4.004 . . . . 25.0 100.19 -166.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -47.94 24.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 2 C-N-CA 127.703 5.602 . . . . 25.0 122.908 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -41.97 -39.28 1.83 Allowed 'General case' 0 CA--C 1.599 2.848 0 N-CA-C 120.059 3.355 . . . . 50.0 120.059 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -93.79 -10.75 33.12 Favored 'General case' 0 C--O 1.262 1.725 0 CA-C-N 120.041 1.292 . . . . 25.0 112.237 -176.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -107.2 -45.32 4.14 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.601 1.191 . . . . 25.0 110.763 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.17 37.7 0.78 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.838 -1.541 . . . . 25.0 106.838 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.15 -20.73 64.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 125.478 2.561 . . . . 25.0 112.297 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.16 157.24 47.1 Favored 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.366 1.866 . . . . 50.0 106.208 165.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -141.27 144.22 34.53 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 125.179 1.549 . . . . 25.0 108.756 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.88 135.89 57.92 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 123.303 1.525 . . . . 50.0 111.074 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.266 2.4 tt -107.29 -26.51 3.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 103.698 -2.704 . . . . 25.0 103.698 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.54 171.68 38.29 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 123.396 1.553 . . . . 25.0 113.571 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.45 147.29 26.08 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.15 119.43 27.65 Favored Pre-proline 0 N--CA 1.484 1.254 0 N-CA-C 105.633 -1.988 . . . . 50.0 105.633 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.09 167.08 16.26 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 N-CA-C 102.585 -3.659 . . . . 25.0 102.585 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.434 ' CD2' ' CZ3' ' A' ' 95' ' ' TRP . 12.4 t-80 -136.2 61.87 1.63 Allowed 'General case' 0 C--O 1.261 1.703 0 N-CA-C 117.515 2.413 . . . . 25.0 117.515 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.43 -25.88 1.14 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 118.973 2.953 . . . . 50.0 118.973 165.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -162.12 12.95 0.12 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 119.713 -1.867 . . . . 25.0 114.581 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.81 170.1 5.56 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 118.976 2.954 . . . . 25.0 118.976 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.54 -166.16 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 120.734 0.956 . . . . 25.0 113.628 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.18 -1.88 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 119.269 3.063 . . . . 25.0 119.269 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.1 p -60.78 -21.45 63.09 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.741 -1.118 . . . . 25.0 113.391 168.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -71.71 -5.03 30.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 117.443 2.386 . . . . 25.0 117.443 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -65.62 133.31 50.87 Favored 'General case' 0 C--O 1.267 2.002 0 O-C-N 120.433 -1.417 . . . . 25.0 108.259 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.73 -30.96 66.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 124.777 2.227 . . . . 75.0 110.774 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.7 t -62.8 127.71 32.51 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 105.337 -2.097 . . . . 25.0 105.337 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.13 134.5 29.72 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 117.593 2.442 . . . . 25.0 117.593 -172.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -94.86 145.0 25.2 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 113.978 -1.464 . . . . 25.0 107.565 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -136.46 125.13 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.356 -2.09 . . . . 25.0 105.356 159.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -71.92 133.97 45.72 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 123.001 2.637 . . . . 50.0 109.062 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.52 110.54 44.74 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -65.88 154.38 74.17 Favored 'Trans proline' 0 N--CA 1.53 3.669 1 C-N-CA 112.309 -4.661 . . . . 25.0 114.053 172.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -91.69 53.52 2.26 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 115.757 -2.377 . . . . 25.0 112.029 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.5 -25.61 38.66 Favored 'General case' 0 C--O 1.261 1.679 0 N-CA-C 114.541 1.312 . . . . 50.0 114.541 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -155.26 173.29 16.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 119.139 0.881 . . . . 25.0 109.643 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.1 pt? -110.97 139.84 45.99 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 104.472 -2.418 . . . . 50.0 104.472 166.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 160.03 167.86 21.19 Favored Glycine 0 C--O 1.294 3.897 0 O-C-N 119.819 -1.801 . . . . 25.0 113.714 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -102.38 139.87 37.42 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 127.166 2.187 . . . . 50.0 111.401 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -156.27 165.24 36.94 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 103.169 -2.9 . . . . 25.0 103.169 166.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.51 161.77 3.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 CA-C-N 120.754 1.615 . . . . 50.0 111.102 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.38 126.77 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 N-CA-C 100.701 -3.814 . . . . 25.0 100.701 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.5 mt -103.81 154.59 19.42 Favored 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 120.555 1.525 . . . . 50.0 108.414 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.1 157.98 43.45 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 119.675 1.125 . . . . 25.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 162' ' ' TYR . 58.8 t -131.09 134.02 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 105.007 -2.22 . . . . 50.0 105.007 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.75 108.09 10.44 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 105.041 -2.207 . . . . 25.0 105.041 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -86.37 95.4 9.65 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 125.325 2.488 . . . . 25.0 106.178 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.83 120.01 23.47 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.12 0 CA-C-N 113.56 -1.654 . . . . 50.0 107.396 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.76 -13.48 42.24 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.698 1.37 . . . . 25.0 114.698 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.95 -23.66 67.43 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.595 2.072 . . . . 25.0 116.595 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.5 p -138.03 158.03 45.15 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 110.875 -2.875 . . . . 25.0 107.218 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -75.18 -17.35 60.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 123.091 1.424 . . . . 25.0 111.547 164.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -69.72 154.84 41.42 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 162.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.09 178.52 7.32 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 100.55 -3.87 . . . . 25.0 100.55 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -124.0 153.97 40.51 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 125.919 2.012 . . . . 50.0 112.28 171.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.426 ' CD2' HG22 ' A' ' 151' ' ' VAL . 11.1 m-85 -123.13 159.75 27.9 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 105.993 -1.854 . . . . 50.0 105.993 158.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -154.62 152.04 29.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 120.642 1.565 . . . . 25.0 108.31 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.282 1.1 p -133.91 136.44 53.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.958 1.361 . . . . 75.0 112.567 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.14 125.62 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.329 -1.36 . . . . 25.0 107.329 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.58 136.45 32.99 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 104.98 -2.23 . . . . 25.0 104.98 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 m -132.79 160.27 42.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 125.241 2.448 . . . . 50.0 110.026 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -130.96 111.74 12.33 Favored 'General case' 0 C--O 1.275 2.397 0 N-CA-C 104.233 -2.506 . . . . 25.0 104.233 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.7 mt -119.26 117.47 28.68 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 100.791 -3.781 . . . . 50.0 100.791 -167.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 19.2 m -115.22 170.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 116.889 2.181 . . . . 50.0 116.889 -167.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -78.91 151.57 31.65 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.9 tptt . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 115.574 -2.155 . . . . 25.0 111.971 178.271 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 . . . . . 0 N--CA 1.51 2.558 0 CA-C-O 120.573 0.225 . . . . 25.0 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.39 -160.01 30.15 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-O 116.812 -2.104 . . . . 25.0 117.027 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -129.87 156.54 44.22 Favored 'General case' 0 C--O 1.253 1.267 0 C-N-CA 126.921 2.088 . . . . 50.0 113.377 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -95.3 125.54 47.97 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 101.418 -3.549 . . . . 25.0 101.418 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -89.74 -40.48 12.48 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 113.706 -1.588 . . . . 25.0 113.738 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -148.54 150.55 34.06 Favored Pre-proline 0 CA--C 1.549 0.918 1 N-CA-C 99.532 -4.248 . . . . 25.0 99.532 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.44 139.13 59.72 Favored 'Cis proline' 0 N--CA 1.442 -1.529 0 CA-C-N 120.676 1.277 . . . . 25.0 113.604 1.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.89 -154.93 49.03 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 117.458 1.743 . . . . 25.0 117.458 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -137.33 114.66 10.95 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 125.319 1.448 . . . . 25.0 109.48 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -67.62 -24.51 65.48 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 123.896 1.808 . . . . 25.0 114.452 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.15 -30.75 71.29 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 118.139 -2.85 . . . . 25.0 114.536 171.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.36 90.44 Favored 'General case' 0 C--O 1.192 -1.946 0 CA-C-O 125.82 2.724 . . . . 25.0 110.323 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.625 0 CA-C-N 112.394 -2.185 . . . . 75.0 108.487 -169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.6 ptt? . . . . . 0 CA--C 1.503 -0.852 1 N-CA-C 122.17 4.137 . . . . 25.0 122.17 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.58 -50.77 16.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 124.956 2.312 . . . . 50.0 108.006 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -131.43 82.65 61.37 Favored Pre-proline 0 N--CA 1.511 2.606 0 CA-C-N 113.073 -1.876 . . . . 25.0 106.177 167.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.49 -16.86 54.85 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 116.273 -2.018 . . . . 25.0 116.105 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.45 -51.78 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.7 t -84.55 46.02 1.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 118.462 -2.649 . . . . 25.0 113.844 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.45 129.69 39.91 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-O 125.053 2.359 . . . . 50.0 105.475 173.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.41 146.27 42.63 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.014 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.82 41.37 0.67 Allowed 'General case' 0 C--O 1.193 -1.885 0 CA-C-O 124.379 2.038 . . . . 25.0 113.299 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -142.87 -73.84 0.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 118.811 -2.431 . . . . 25.0 112.889 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.8 mttt . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.728 1.611 . . . . 25.0 111.669 -165.416 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 CA--C 1.5 -0.946 0 N-CA-C 118.436 2.754 . . . . 50.0 118.436 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -70.97 -26.1 63.01 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.346 -3.205 . . . . 50.0 102.346 148.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.04 -16.68 68.91 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 119.881 -1.762 . . . . 25.0 109.003 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.95 -23.53 77.69 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 119.997 -1.097 . . . . 25.0 114.092 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.48 -44.41 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 117.012 -1.875 . . . . 25.0 109.519 165.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.11 1.02 2.24 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 126.235 2.921 . . . . 75.0 118.624 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.78 -14.93 60.78 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 112.262 -2.245 . . . . 50.0 110.721 170.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -72.74 5.15 3.35 Favored 'General case' 0 CA--C 1.485 -1.557 0 O-C-N 116.631 -3.793 . . . . 25.0 116.733 173.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -122.62 67.31 0.95 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 125.919 1.687 . . . . 25.0 107.258 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -147.18 151.24 36.43 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 117.192 2.293 . . . . 25.0 117.192 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -72.28 -30.22 64.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 118.246 -2.784 . . . . 25.0 109.02 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -106.02 31.36 5.14 Favored 'General case' 0 C--O 1.176 -2.776 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -78.46 101.71 7.45 Favored 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 97.859 -4.867 . . . . 25.0 97.859 164.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -43.15 155.96 0.05 Allowed 'General case' 0 C--O 1.262 1.714 0 CA-C-N 110.023 -3.262 . . . . 25.0 115.468 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -58.86 144.73 43.45 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 127.043 3.306 . . . . 50.0 117.076 -167.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -82.96 153.78 24.85 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 117.714 2.487 . . . . 25.0 117.714 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -152.35 156.52 39.74 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 117.981 -2.949 . . . . 25.0 109.138 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.2 tt -132.58 139.75 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 106.367 -1.716 . . . . 25.0 106.367 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtt -152.87 151.8 30.81 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 120.087 1.312 . . . . 25.0 110.255 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.5 p -84.55 176.68 8.46 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.071 -0.714 . . . . 25.0 109.071 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.65 168.8 53.86 Favored Glycine 0 C--O 1.209 -1.439 0 C-N-CA 120.825 -0.702 . . . . 25.0 112.065 168.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.62 174.26 15.56 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.472 -1.823 . . . . 25.0 110.687 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -71.06 134.04 46.77 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.279 -0.968 . . . . 25.0 111.807 162.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -133.73 147.35 51.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.131 -0.94 . . . . 25.0 110.77 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m -85.62 136.09 33.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 124.274 1.03 . . . . 25.0 110.597 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.42 134.81 49.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.067 -1.827 . . . . 50.0 106.067 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.4 m -114.66 120.93 41.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -120.27 149.02 42.96 Favored 'General case' 0 C--O 1.263 1.803 0 CA-C-O 118.288 -0.863 . . . . 25.0 109.446 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 t -143.35 158.18 43.85 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.275 1.852 . . . . 25.0 109.871 -171.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -86.15 147.93 25.91 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 104.443 -2.429 . . . . 50.0 104.443 161.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.7 t -110.41 -18.28 13.27 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 103.711 -2.7 . . . . 25.0 103.711 162.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 147.04 54.14 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 101.117 -3.66 . . . . 25.0 101.117 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.35 151.54 84.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 117.887 -0.942 . . . . 25.0 113.579 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -129.1 178.49 6.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 100.762 -3.792 . . . . 25.0 100.762 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -118.56 84.84 2.25 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.938 1.695 . . . . 25.0 107.007 157.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -75.56 149.52 38.31 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 103.233 -2.877 . . . . 25.0 103.233 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 p -106.16 -30.32 9.3 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-N 120.713 1.597 . . . . 25.0 114.56 168.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 51.2 tt0 -164.21 158.34 18.92 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 118.614 -2.554 . . . . 25.0 104.674 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -149.69 162.04 41.01 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 120.167 -1.583 . . . . 25.0 110.156 163.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -128.79 156.58 43.35 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 127.009 2.124 . . . . 25.0 110.738 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -147.7 149.76 33.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 124.693 2.187 . . . . 50.0 105.959 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -146.3 168.6 20.68 Favored 'General case' 0 CA--C 1.501 -0.914 1 N-CA-C 98.813 -4.514 . . . . 50.0 98.813 -154.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.1 pt -134.51 158.0 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 117.07 -1.443 . . . . 25.0 108.693 162.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.451 HG23 ' HA ' ' A' ' 114' ' ' ASP . 49.9 m -95.14 133.32 39.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 125.525 1.766 . . . . 25.0 110.592 172.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -76.87 135.77 38.85 Favored 'General case' 0 C--O 1.297 3.563 0 CA-C-N 122.328 2.331 . . . . 25.0 109.998 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.32 164.71 26.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 103.999 -2.593 . . . . 25.0 103.999 171.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.33 3.24 65.21 Favored Glycine 0 C--O 1.276 2.739 0 N-CA-C 117.333 1.693 . . . . 25.0 117.333 169.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.87 176.97 5.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.711 1.004 . . . . 25.0 113.711 -174.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.56 138.04 11.38 Favored Pre-proline 0 C--O 1.194 -1.847 0 CA-C-O 116.188 -1.863 . . . . 25.0 109.944 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.51 -21.23 46.66 Favored 'Trans proline' 0 C--O 1.286 2.912 0 N-CA-C 117.983 2.263 . . . . 25.0 117.983 -174.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.53 3.13 12.0 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 118.977 -2.327 . . . . 75.0 113.198 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -129.38 174.04 5.02 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 100.615 -3.846 . . . . 25.0 100.615 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.6 21.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 N-CA-C 122.138 3.861 . . . . 25.0 122.138 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 tt -38.84 -33.74 0.12 Allowed 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.755 2.132 . . . . 50.0 116.755 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.28 -5.44 59.18 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 116.593 2.072 . . . . 25.0 116.593 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -116.15 -43.11 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 123.654 1.693 . . . . 25.0 110.105 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.2 4.77 1.14 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 113.315 -1.766 . . . . 25.0 112.883 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.451 ' HA ' HG23 ' A' ' 100' ' ' THR . 26.2 t0 -70.63 -14.92 62.66 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 119.571 -0.852 . . . . 25.0 108.837 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.73 106.74 8.91 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -109.09 120.16 41.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 104.99 -2.226 . . . . 25.0 104.99 165.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.97 136.27 55.06 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 116.568 -1.682 . . . . 50.0 108.873 -176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.5 tp -110.29 -19.21 7.04 Favored 'Isoleucine or valine' 0 C--N 1.374 1.639 0 CA-C-O 125.868 2.747 . . . . 25.0 109.81 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.76 150.97 13.13 Favored Glycine 0 N--CA 1.444 -0.773 0 O-C-N 118.268 -2.77 . . . . 25.0 114.562 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . 0.257 . . -143.84 140.96 30.1 Favored 'General case' 0 CA--C 1.569 1.685 1 N-CA-C 98.955 -4.461 . . . . 25.0 98.955 -179.957 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.2 105.11 11.29 Favored Pre-proline 0 CA--C 1.497 -1.078 0 O-C-N 127.208 2.818 . . . . 50.0 103.465 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 61.6 Cg_endo -66.22 167.17 18.98 Favored 'Trans proline' 0 C--O 1.203 -1.225 1 C-N-CA 109.828 -6.315 . . . . 25.0 111.896 166.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -144.01 83.18 1.73 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 118.435 -2.666 . . . . 25.0 111.795 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.93 -17.6 43.06 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 124.675 2.178 . . . . 50.0 113.183 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.01 -168.2 36.57 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 103.581 -3.808 . . . . 25.0 103.581 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 71.09 82.2 Favored Pre-proline 0 C--O 1.181 -2.523 0 CA-C-N 121.534 2.667 . . . . 25.0 114.278 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -67.67 172.06 11.09 Favored 'Trans proline' 0 C--O 1.286 2.906 1 C-N-CA 111.025 -5.517 . . . . 25.0 110.982 155.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.03 -35.76 67.22 Favored 'General case' 0 C--N 1.356 0.89 0 CA-C-O 116.396 -1.764 . . . . 25.0 113.656 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 98.4 p -59.22 -20.21 52.08 Favored 'General case' 0 C--O 1.296 3.536 0 O-C-N 127.532 3.02 . . . . 25.0 115.793 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -105.57 8.22 33.18 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 118.704 2.853 . . . . 25.0 118.704 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -60.19 151.91 25.96 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 125.72 2.676 . . . . 25.0 110.998 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mt -66.46 -27.03 67.49 Favored 'General case' 0 C--O 1.26 1.613 0 CA-C-N 113.202 -1.817 . . . . 75.0 114.56 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.4 m -96.44 145.55 25.56 Favored 'General case' 0 C--O 1.302 3.85 0 O-C-N 119.518 -1.989 . . . . 25.0 105.855 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -131.45 168.32 17.82 Favored 'General case' 0 C--O 1.192 -1.957 0 N-CA-C 116.318 1.97 . . . . 25.0 116.318 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.305 89.9 m-70 -121.3 116.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 121.608 2.004 . . . . 25.0 113.28 168.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mm -122.18 131.79 72.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 C-N-CA 118.745 -1.182 . . . . 25.0 108.981 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -75.78 134.08 40.52 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 107.18 -1.415 . . . . 50.0 107.18 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.04 132.02 22.55 Favored Pre-proline 0 C--O 1.204 -1.309 0 N-CA-C 102.892 -3.003 . . . . 25.0 102.892 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -62.27 143.66 94.34 Favored 'Trans proline' 0 CA--C 1.458 -3.324 1 C-N-CA 113.006 -4.196 . . . . 25.0 118.785 -175.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.73 -22.86 12.86 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 125.447 2.546 . . . . 25.0 114.267 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -77.46 -5.46 49.97 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 118.965 -2.334 . . . . 50.0 112.289 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -145.06 158.09 43.92 Favored 'General case' 0 C--O 1.204 -1.303 0 CA-C-N 112.739 -2.028 . . . . 25.0 112.388 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.2 mp -107.2 152.67 23.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.052 -2.944 . . . . 50.0 103.052 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 158.44 166.63 17.96 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.151 -0.968 . . . . 25.0 114.949 167.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -88.57 136.13 33.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.606 1.335 . . . . 50.0 114.606 166.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.401 ' CD2' HD12 ' A' ' 169' ' ' LEU . 81.8 m-70 -149.45 167.84 25.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 104.213 -2.514 . . . . 25.0 104.213 -159.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.51 131.83 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.985 0 N-CA-C 103.537 -2.764 . . . . 50.0 103.537 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 94.5 mt -98.8 121.17 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 105.925 -1.88 . . . . 25.0 105.925 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.93 138.18 51.12 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 119.904 -1.747 . . . . 50.0 107.799 -175.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.26 145.51 43.64 Favored 'General case' 0 C--O 1.263 1.81 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -133.84 137.3 52.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 114.424 -2.703 . . . . 50.0 110.267 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -115.77 150.5 36.8 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.814 -1.921 . . . . 25.0 105.814 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -112.89 131.74 55.6 Favored 'General case' 0 C--N 1.307 -1.248 1 N-CA-C 99.085 -4.413 . . . . 25.0 99.085 163.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.21 120.82 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 105.046 -2.205 . . . . 50.0 105.046 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.8 -21.3 41.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 118.944 -0.551 . . . . 25.0 111.069 -173.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . 0.304 2.1 p-10 -82.82 -15.13 52.82 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 116.023 1.86 . . . . 25.0 116.023 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.505 ' HG1' ' HE1' ' A' ' 161' ' ' PHE . 39.1 p -112.67 156.58 22.51 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.177 -1.046 . . . . 25.0 108.177 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -90.5 -23.79 20.85 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.638 -1.225 . . . . 25.0 114.064 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -102.0 160.14 14.76 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 115.25 -0.886 . . . . 25.0 111.486 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.82 166.85 22.94 Favored 'General case' 0 C--O 1.253 1.258 0 CA-C-N 113.03 -1.896 . . . . 25.0 112.649 163.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.505 ' HE1' ' HG1' ' A' ' 157' ' ' THR . 52.7 m-85 -129.35 130.83 46.58 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 112.343 -2.208 . . . . 50.0 110.34 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -139.74 136.76 34.49 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 127.207 2.817 . . . . 50.0 108.323 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.62 149.53 20.37 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 106.881 -1.525 . . . . 25.0 106.881 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.9 m -127.51 162.72 32.38 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.595 0 N-CA-C 107.978 -1.119 . . . . 75.0 107.978 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.94 131.44 46.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 105.868 -1.901 . . . . 25.0 105.868 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.55 124.31 38.5 Favored 'General case' 0 CA--C 1.583 2.215 0 O-C-N 126.093 2.121 . . . . 25.0 106.357 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 m -123.46 158.75 28.67 Favored 'Isoleucine or valine' 0 C--O 1.285 2.933 0 C-N-CA 116.186 -2.206 . . . . 50.0 109.221 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -119.44 121.34 39.26 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 101.105 -3.665 . . . . 25.0 101.105 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.401 HD12 ' CD2' ' A' ' 146' ' ' HIS . 77.6 mt -112.28 95.99 5.77 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 105.488 -2.042 . . . . 50.0 105.488 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.8 172.73 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.801 -1.187 . . . . 50.0 113.192 -170.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -66.97 132.81 48.69 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 105.982 -1.859 . . . . 25.0 105.982 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.0 pttp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 115.612 -2.137 . . . . 25.0 110.194 177.546 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 . . . . . 1 N--CA 1.555 4.8 0 CA-C-O 122.761 1.267 . . . . 25.0 107.995 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -121.31 6.33 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.341 -1.409 . . . . 25.0 111.571 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.26 144.33 27.8 Favored 'General case' 0 C--O 1.267 2.023 0 O-C-N 119.196 -2.355 . . . . 50.0 106.438 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -86.86 126.09 40.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 N-CA-C 105.002 -2.221 . . . . 25.0 105.002 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -108.02 -35.31 6.64 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 117.039 -1.864 . . . . 25.0 110.449 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 148.86 57.56 Favored Pre-proline 0 C--O 1.256 1.406 0 N-CA-C 104.967 -2.234 . . . . 25.0 104.967 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -71.43 133.16 27.07 Favored 'Cis proline' 0 C--N 1.359 1.117 0 C-N-CA 132.848 2.437 . . . . 25.0 114.158 2.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.22 -144.12 49.05 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 115.104 0.802 . . . . 25.0 115.104 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -133.72 104.62 6.41 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 105.169 -2.16 . . . . 25.0 105.169 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -69.18 -18.06 63.88 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 117.806 -3.059 . . . . 25.0 109.471 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.19 70.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 116.403 -1.76 . . . . 25.0 111.169 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.56 63.82 Favored 'General case' 0 C--O 1.198 -1.624 0 N-CA-C 106.89 -1.522 . . . . 25.0 106.89 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.485 1.279 0 O-C-N 120.546 -1.346 . . . . 75.0 111.861 -177.758 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 116.86 -1.543 . . . . 25.0 115.111 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.78 -47.27 85.3 Favored 'General case' 0 N--CA 1.421 -1.917 0 O-C-N 126.297 2.248 . . . . 50.0 112.362 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.62 64.03 11.32 Favored Pre-proline 0 CA--C 1.505 -0.755 0 N-CA-C 113.753 1.02 . . . . 25.0 113.753 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.26 -19.87 37.96 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 N-CA-C 117.681 2.146 . . . . 25.0 117.681 -167.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -99.83 6.42 45.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.435 2.013 . . . . 25.0 116.435 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -136.73 38.52 2.62 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.692 1.597 . . . . 25.0 112.216 171.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 tp -77.5 99.32 5.64 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.055 -0.521 . . . . 50.0 110.968 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.28 147.1 52.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.071 -1.455 . . . . 25.0 107.071 -159.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.29 50.6 1.02 Allowed 'General case' 0 CA--C 1.606 3.12 0 N-CA-C 115.437 1.643 . . . . 25.0 115.437 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 45.4 tttt -134.76 -163.1 1.33 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.05 -1.833 . . . . 25.0 106.05 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.451 ' H ' ' HG2' ' A' ' 38' ' ' LYS . 94.0 mttt . . . . . 0 N--CA 1.437 -1.082 0 O-C-N 125.638 1.837 . . . . 25.0 110.679 -168.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.9 mt . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 124.284 1.992 . . . . 50.0 111.428 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -71.12 -40.42 71.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.763 -2.31 . . . . 50.0 104.763 155.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.55 -22.98 47.74 Favored Glycine 0 CA--C 1.499 -0.966 0 O-C-N 118.82 -2.425 . . . . 25.0 114.582 167.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.13 74.6 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 126.069 3.038 . . . . 25.0 113.285 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.96 -33.22 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 117.771 -3.194 . . . . 25.0 105.381 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.13 -14.51 60.98 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 112.65 -2.068 . . . . 75.0 112.956 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.01 -25.97 65.7 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 111.724 -2.489 . . . . 50.0 112.02 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.51 11.27 5.85 Favored 'General case' 0 C--O 1.251 1.155 0 O-C-N 118.807 -2.433 . . . . 25.0 112.756 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -133.06 16.77 4.15 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.05 -1.656 . . . . 25.0 112.457 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -112.4 166.17 11.54 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.286 -0.87 . . . . 25.0 109.345 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.81 -22.6 65.16 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 105.78 -1.933 . . . . 25.0 105.78 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.98 39.64 1.52 Allowed 'General case' 0 C--O 1.168 -3.196 0 C-N-CA 125.55 1.54 . . . . 25.0 110.165 175.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -89.36 91.34 8.7 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-O 124.901 2.286 . . . . 25.0 105.704 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -57.24 139.2 53.43 Favored 'General case' 0 C--N 1.305 -1.34 1 CA-C-N 107.5 -4.409 . . . . 25.0 105.358 172.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -65.56 152.09 44.91 Favored 'General case' 0 C--O 1.286 3.017 0 CA-C-O 126.314 2.959 . . . . 50.0 115.086 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -87.27 134.92 33.49 Favored 'General case' 0 C--O 1.185 -2.318 0 CA-C-N 109.897 -3.32 . . . . 25.0 104.415 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -126.47 134.71 50.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 126.062 2.101 . . . . 25.0 112.883 171.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -93.99 141.25 15.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 tpt -146.3 147.75 31.7 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-O 123.028 1.394 . . . . 25.0 108.739 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 p -82.31 173.61 11.91 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 114.262 -1.335 . . . . 25.0 114.416 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.9 -179.0 35.45 Favored Glycine 0 C--O 1.264 2.019 0 O-C-N 120.053 -1.654 . . . . 25.0 110.526 163.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.76 179.05 32.11 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 106.252 -2.739 . . . . 25.0 106.252 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.75 138.9 39.27 Favored 'General case' 0 C--O 1.257 1.471 0 O-C-N 118.326 -2.867 . . . . 25.0 114.612 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -132.1 160.48 35.84 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 114.044 -1.434 . . . . 25.0 110.803 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -111.52 135.79 51.59 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-O 123.798 1.761 . . . . 25.0 111.597 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -112.97 119.55 38.3 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.79 -1.095 . . . . 50.0 111.518 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.4 m -134.72 129.21 34.36 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 107.275 -1.38 . . . . 25.0 107.275 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -120.77 151.21 39.86 Favored 'General case' 0 C--N 1.313 -1.011 1 N-CA-C 98.617 -4.586 . . . . 25.0 98.617 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -143.66 126.57 16.29 Favored 'General case' 0 C--O 1.263 1.811 0 O-C-N 125.344 1.652 . . . . 25.0 112.397 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -130.3 143.65 50.9 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 118.809 -2.432 . . . . 50.0 109.633 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -61.6 -23.96 66.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 118.522 2.786 . . . . 25.0 118.522 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.05 157.2 78.21 Favored Pre-proline 0 CA--C 1.493 -1.227 0 N-CA-C 101.257 -3.609 . . . . 25.0 101.257 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.26 159.1 11.24 Favored 'Trans proline' 0 N--CA 1.504 2.099 0 N-CA-C 103.003 -3.499 . . . . 25.0 103.003 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -89.83 167.62 12.71 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 102.667 -3.086 . . . . 25.0 102.667 159.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -88.7 117.13 27.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -139.32 156.36 47.08 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 122.613 0.365 . . . . 25.0 110.341 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p -98.83 -48.87 4.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.168 0.987 . . . . 25.0 111.378 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -159.42 160.3 34.68 Favored 'General case' 0 CA--C 1.474 -1.969 0 O-C-N 120.214 -1.553 . . . . 25.0 114.541 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -122.08 144.95 48.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 119.735 1.152 . . . . 25.0 111.221 162.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -122.93 153.56 39.54 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 114.253 -2.784 . . . . 25.0 110.283 -170.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.25 137.56 27.38 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 105.858 -1.904 . . . . 50.0 105.858 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -134.67 156.46 48.72 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 124.56 1.162 . . . . 50.0 110.081 -167.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.451 HG22 HG12 ' A' ' 148' ' ' ILE . 24.2 pt -126.63 162.81 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 124.621 2.153 . . . . 25.0 110.006 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 147' ' ' VAL . 54.8 m -111.9 127.27 55.79 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 118.75 -2.469 . . . . 25.0 108.285 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.449 ' HG3' ' CE3' ' A' ' 104' ' ' TRP . 52.8 pttt -99.01 179.49 4.61 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -164.03 177.13 8.72 Favored 'General case' 0 C--O 1.275 2.433 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.81 26.69 66.46 Favored Glycine 0 C--O 1.252 1.235 1 CA-C-O 129.379 4.877 . . . . 25.0 113.861 -166.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.449 ' CE3' ' HG3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -97.19 150.31 21.04 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 108.83 -3.685 . . . . 25.0 112.95 -173.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 106' ' ' PRO 0.288 9.7 t70 -98.45 141.54 23.1 Favored Pre-proline 0 C--O 1.194 -1.868 0 C-N-CA 127.772 2.429 . . . . 25.0 111.095 -172.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 105' ' ' ASP . 31.3 Cg_exo -67.52 -40.54 10.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 124.776 3.65 . . . . 25.0 121.038 -173.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.67 -29.05 65.27 Favored 'General case' 0 C--O 1.197 -1.704 0 CA-C-O 126.225 2.917 . . . . 75.0 109.312 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.84 161.5 74.47 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 118.484 -2.635 . . . . 25.0 110.31 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.92 17.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.646 2 C-N-CA 127.978 5.785 . . . . 25.0 122.878 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.19 -37.5 15.94 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 116.091 1.885 . . . . 50.0 116.091 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -85.48 -10.66 55.78 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.423 1.638 . . . . 25.0 115.423 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 114' ' ' ASP . 99.4 mtt180 -104.21 -52.81 2.85 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 117.695 2.48 . . . . 25.0 117.695 174.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.67 34.8 0.28 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 127.028 2.705 . . . . 25.0 106.791 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 112' ' ' ARG . 36.0 t70 -63.65 -26.79 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.838 2.055 . . . . 25.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -127.71 145.69 50.82 Favored 'General case' 0 C--N 1.298 -1.674 1 N-CA-C 99.023 -4.436 . . . . 50.0 99.023 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -117.63 130.66 56.51 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 121.414 1.915 . . . . 25.0 110.73 168.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.1 tp -63.87 110.15 1.99 Allowed 'General case' 0 C--O 1.27 2.153 0 CA-C-O 118.311 -0.852 . . . . 50.0 110.467 168.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.6 tt -99.34 -17.85 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.14 166.34 36.35 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 116.319 1.288 . . . . 25.0 116.319 164.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.7 152.18 33.54 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.21 -1.404 . . . . 25.0 107.21 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.96 120.43 15.24 Favored Pre-proline 0 C--O 1.262 1.723 0 O-C-N 125.934 2.021 . . . . 50.0 110.185 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.72 152.67 53.36 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.262 1.276 . . . . 25.0 113.093 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.79 52.29 1.48 Allowed 'General case' 0 C--O 1.245 0.863 0 N-CA-C 105.318 -2.104 . . . . 25.0 105.318 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -83.64 -22.55 32.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.602 -1.629 . . . . 50.0 106.602 -167.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.05 178.89 31.47 Favored Glycine 0 C--O 1.204 -1.738 1 N-CA-C 102.714 -4.154 . . . . 25.0 102.714 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -123.75 56.87 11.27 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 119.434 3.124 . . . . 25.0 119.434 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.6 175.85 10.53 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 O-C-N 118.303 -1.472 . . . . 25.0 108.5 168.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.47 -13.77 43.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 25.0 113.311 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 80.7 p -84.76 -3.83 58.78 Favored 'General case' 0 C--O 1.189 -2.12 0 CA-C-N 119.383 0.992 . . . . 25.0 110.83 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -116.47 26.21 10.06 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 123.973 1.844 . . . . 25.0 110.673 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -68.61 149.97 48.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.825 -1.546 . . . . 25.0 106.825 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.73 -15.11 59.86 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 126.466 2.354 . . . . 75.0 115.781 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.4 t -81.31 123.61 28.67 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 104.223 -2.51 . . . . 25.0 104.223 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -118.71 147.22 44.06 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.664 -1.273 . . . . 25.0 108.047 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -110.53 136.35 49.78 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.9 mm -132.37 128.23 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -78.66 133.53 37.22 Favored 'General case' 0 C--O 1.255 1.365 0 O-C-N 125.696 1.873 . . . . 50.0 111.71 169.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.48 126.18 28.27 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-O 115.22 -2.324 . . . . 25.0 107.218 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.75 151.72 74.36 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 113.563 -3.824 . . . . 25.0 114.619 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -105.11 -8.05 18.7 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.08 -1.873 . . . . 25.0 111.921 -172.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.23 -1.7 24.62 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 126.315 2.259 . . . . 50.0 115.758 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -142.06 165.72 26.67 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 119.409 -2.057 . . . . 25.0 112.596 -172.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 3.8 mp -128.15 147.06 50.54 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 101.184 -3.636 . . . . 50.0 101.184 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.44 174.44 21.56 Favored Glycine 0 CA--C 1.477 -2.326 0 N-CA-C 121.037 3.175 . . . . 25.0 121.037 161.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -82.39 140.48 33.45 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 113.588 -1.306 . . . . 50.0 111.834 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -149.38 165.97 30.46 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.108 -2.182 . . . . 25.0 105.108 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.405 ' H ' ' HB ' ' A' ' 100' ' ' THR . 5.0 t -125.12 141.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.684 0 N-CA-C 103.933 -2.618 . . . . 50.0 103.933 168.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 99' ' ' ILE . 91.0 mt -127.54 132.33 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 116.749 -1.596 . . . . 25.0 109.019 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.53 139.17 44.85 Favored 'General case' 0 C--O 1.263 1.793 0 O-C-N 128.467 3.605 . . . . 50.0 110.55 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.5 116.23 17.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 25.0 112.039 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 t -129.36 127.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 125.089 1.493 . . . . 50.0 108.572 -162.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -119.23 108.98 15.31 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 119.286 0.948 . . . . 25.0 113.027 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.32 116.41 11.62 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 126.762 2.025 . . . . 25.0 109.545 -173.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.4 t -87.68 136.38 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.44 -1.689 . . . . 50.0 106.44 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -95.63 -25.25 16.21 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 115.843 1.794 . . . . 25.0 115.843 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.0 5.65 50.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.082 1.42 . . . . 25.0 113.277 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.9 p -139.6 -177.23 4.85 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 104.179 -2.526 . . . . 25.0 104.179 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.78 -7.23 41.03 Favored 'General case' 0 CA--C 1.481 -1.704 0 O-C-N 125.089 1.493 . . . . 25.0 107.155 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -85.28 176.96 8.01 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 116.565 2.061 . . . . 25.0 116.565 -170.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.91 146.87 28.09 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -78.7 133.91 37.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.22 -1.77 . . . . 50.0 106.22 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -136.58 123.05 20.8 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 126.299 1.839 . . . . 50.0 110.752 -172.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.63 142.67 33.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 103.645 -2.724 . . . . 25.0 103.645 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.96 144.24 24.27 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 102.317 -3.216 . . . . 75.0 102.317 -168.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.2 mt -138.81 122.03 19.02 Favored 'Isoleucine or valine' 0 C--O 1.261 1.706 0 CA-C-O 124.131 1.92 . . . . 25.0 106.162 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -75.59 126.68 31.48 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 112.459 -2.155 . . . . 25.0 106.694 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.84 159.17 39.58 Favored 'Isoleucine or valine' 0 C--O 1.264 1.833 0 O-C-N 117.362 -3.336 . . . . 50.0 116.811 -171.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -133.14 113.65 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 103.953 -2.61 . . . . 25.0 103.953 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.9 mt -116.43 122.5 44.97 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 105.238 -2.134 . . . . 50.0 105.238 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.3 m -135.19 159.83 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 N-CA-C 117.749 2.5 . . . . 50.0 117.749 -172.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -61.36 140.28 58.04 Favored 'General case' 0 C--O 1.189 -2.102 0 O-C-N 121.026 -1.046 . . . . 25.0 110.779 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.9 pttt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 116.266 -1.826 . . . . 25.0 110.52 170.627 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.1 m80 . . . . . 0 N--CA 1.506 2.352 0 CA-C-O 123.733 1.73 . . . . 25.0 109.608 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.7 173.62 42.44 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 127.244 2.355 . . . . 25.0 116.754 -173.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -151.55 164.39 36.94 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-N 119.814 1.807 . . . . 50.0 113.357 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.67 135.24 27.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.647 -1.242 . . . . 25.0 107.647 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -107.89 -36.08 6.47 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 113.378 0.881 . . . . 25.0 113.378 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -148.7 158.84 39.41 Favored Pre-proline 0 C--O 1.286 3.011 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.17 145.26 77.58 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 C-N-CA 133.005 2.502 . . . . 25.0 111.966 -3.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.39 -169.61 52.76 Favored Glycine 0 C--O 1.214 -1.15 0 CA-C-N 113.107 -1.86 . . . . 25.0 111.767 162.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 t -140.89 121.7 14.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.598 1.959 . . . . 25.0 107.025 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.12 -16.8 36.82 Favored 'General case' 0 C--O 1.259 1.59 0 C-N-CA 116.975 -1.89 . . . . 25.0 107.724 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.66 -35.38 70.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 123.453 1.597 . . . . 25.0 110.783 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.28 92.64 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 112.875 -1.966 . . . . 25.0 111.965 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.1 -37.27 86.94 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 113.228 -1.806 . . . . 75.0 114.956 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.8 t -71.07 -16.8 62.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.383 -1.281 . . . . 25.0 113.04 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.5 m -81.13 168.81 18.17 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 -169.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.02 -7.66 31.0 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.872 -1.142 . . . . 25.0 113.336 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.25 -7.66 53.49 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.761 -1.212 . . . . 25.0 110.89 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -52.0 -40.09 60.44 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 105.415 -2.069 . . . . 50.0 105.415 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.54 -74.61 0.02 OUTLIER Glycine 0 N--CA 1.477 1.4 0 N-CA-C 105.753 -2.939 . . . . 25.0 105.753 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -173.49 -33.28 0.01 OUTLIER 'General case' 0 C--O 1.274 2.358 0 C-N-CA 127.274 2.23 . . . . 50.0 109.452 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.22 -17.75 6.06 Favored 'General case' 0 C--N 1.312 -1.049 1 N-CA-C 124.621 5.045 . . . . 50.0 124.621 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -111.68 164.69 12.75 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 108.451 -0.944 . . . . 25.0 108.451 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -164.91 169.98 15.87 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.234 -0.587 . . . . 50.0 111.365 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -153.5 55.8 0.75 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 106.475 -1.676 . . . . 25.0 106.475 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.5 t -66.02 -31.5 72.43 Favored 'General case' 0 N--CA 1.407 -2.597 0 CA-C-O 117.274 -1.346 . . . . 25.0 114.595 -160.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.39 39.65 91.59 Favored Glycine 0 CA--C 1.557 2.703 0 C-N-CA 119.582 -1.294 . . . . 25.0 114.701 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.0 m -53.32 -3.89 0.03 OUTLIER 'General case' 0 CA--C 1.586 2.332 0 CA-C-N 111.21 -2.495 . . . . 25.0 115.446 -168.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.27 -16.94 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 C-N-CA 128.484 2.714 . . . . 50.0 107.52 169.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -75.18 25.24 0.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.643 2.46 . . . . 25.0 117.643 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -63.61 -50.17 70.43 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 120.674 1.579 . . . . 50.0 113.538 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -135.69 42.8 0.78 Allowed Pre-proline 0 N--CA 1.517 2.911 0 N-CA-C 117.347 2.351 . . . . 25.0 117.347 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.43 -15.72 12.36 Favored 'Trans proline' 0 C--N 1.375 1.941 1 C-N-CA 108.82 -6.987 . . . . 25.0 118.324 -170.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -71.7 -39.17 70.38 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -83.86 51.76 2.12 Favored 'General case' 0 C--O 1.266 1.921 0 CA-C-N 113.265 -1.788 . . . . 25.0 112.408 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.4 tp -87.18 111.45 20.99 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.29 1.043 . . . . 50.0 108.325 170.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -78.45 161.78 26.86 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-O 124.869 2.271 . . . . 25.0 110.558 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.69 144.67 50.47 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 104.89 -2.263 . . . . 25.0 104.89 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -135.69 146.25 47.56 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 106.314 -1.735 . . . . 25.0 106.314 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -90.43 145.55 24.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.63 -2.359 . . . . 25.0 104.63 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.6 -151.97 43.85 Favored Glycine 0 C--O 1.198 -2.111 0 N-CA-C 106.347 -2.701 . . . . 25.0 106.347 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . 0.308 42.9 m-85 -135.02 172.01 7.99 Favored Pre-proline 0 C--O 1.249 1.051 0 N-CA-C 102.412 -3.181 . . . . 25.0 102.412 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -76.85 -178.26 23.6 Favored 'Cis proline' 0 N--CA 1.492 1.422 0 O-C-N 119.194 -1.003 . . . . 25.0 111.42 -2.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -122.91 -16.92 6.94 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.631 1.172 . . . . 25.0 111.464 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t 70.4 -61.08 0.48 Allowed 'General case' 0 C--O 1.292 3.293 0 C-N-CA 127.061 2.144 . . . . 25.0 109.844 -171.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.91 -163.29 5.01 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-O 125.088 2.493 . . . . 25.0 111.582 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.57 165.03 32.56 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 CA-C-O 115.845 -1.814 . . . . 25.0 113.797 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.46 135.65 56.6 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.835 1.334 . . . . 25.0 113.848 -172.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -129.02 178.44 6.4 Favored 'General case' 0 C--N 1.306 -1.31 1 N-CA-C 97.134 -5.136 . . . . 25.0 97.134 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.28 21.0 57.86 Favored Glycine 0 CA--C 1.468 -2.86 0 N-CA-C 109.798 -1.321 . . . . 25.0 109.798 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -111.46 22.39 15.15 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.482 0.658 . . . . 25.0 112.316 -169.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mt -70.83 -38.54 73.04 Favored 'Isoleucine or valine' 0 C--O 1.272 2.266 0 O-C-N 120.421 -1.424 . . . . 25.0 113.594 -173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.63 72.14 Favored 'General case' 0 C--O 1.265 1.897 0 CA-C-N 119.997 1.271 . . . . 25.0 112.377 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.0 p -73.15 -9.24 58.51 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 119.755 -1.841 . . . . 25.0 111.312 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.95 27.44 2.41 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 125.833 1.653 . . . . 25.0 115.269 -169.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.7 -31.09 65.41 Favored Glycine 0 C--O 1.246 0.855 0 N-CA-C 105.2 -3.16 . . . . 25.0 105.2 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.86 14.14 59.33 Favored Glycine 0 C--O 1.254 1.388 0 CA-C-N 119.12 1.46 . . . . 25.0 112.988 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.6 mt -125.88 -73.69 0.62 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 116.222 -1.847 . . . . 50.0 111.714 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.75 -32.75 73.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 125.982 2.051 . . . . 50.0 108.726 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.85 -13.28 69.86 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 125.079 2.489 . . . . 25.0 112.094 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.03 0.11 87.88 Favored Glycine 0 CA--C 1.488 -1.644 0 CA-C-N 112.921 -1.639 . . . . 25.0 112.082 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.9 -28.03 39.88 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 O-C-N 121.578 -0.954 . . . . 25.0 110.827 168.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.45 -22.99 61.0 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 117.611 -1.185 . . . . 75.0 112.097 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.17 -23.95 51.52 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.54 1.063 . . . . 50.0 110.116 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -87.02 11.78 12.86 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 125.324 1.64 . . . . 25.0 110.168 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -132.56 23.45 4.36 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.212 1.958 . . . . 25.0 110.636 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.7 t -87.94 155.97 19.58 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 114.496 -1.229 . . . . 25.0 109.487 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.57 -35.73 66.08 Favored 'General case' 0 CA--C 1.484 -1.561 0 O-C-N 120.334 -1.479 . . . . 25.0 112.115 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -79.45 -4.39 50.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.851 2.537 . . . . 25.0 117.851 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -74.95 86.1 2.28 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 111.742 -2.481 . . . . 25.0 113.081 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -76.52 175.77 8.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 109.194 -3.639 . . . . 25.0 111.391 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -75.98 152.81 36.91 Favored 'General case' 0 C--O 1.192 -1.95 0 CA-C-N 112.129 -2.305 . . . . 50.0 115.431 -144.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -75.28 128.48 35.53 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.843 -1.143 . . . . 25.0 109.913 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -84.5 130.55 34.74 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.394 -2.066 . . . . 25.0 108.501 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.17 125.9 44.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mmt -131.01 129.03 41.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 115.651 -2.119 . . . . 25.0 107.559 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.7 p -80.57 173.88 12.16 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 127.713 3.133 . . . . 25.0 107.685 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.91 159.69 46.04 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 117.693 1.837 . . . . 25.0 117.693 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 174.05 25.21 Favored Glycine 0 C--O 1.216 -1.001 0 CA-C-N 112.161 -2.019 . . . . 25.0 112.067 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.51 148.42 31.83 Favored 'General case' 0 CA--C 1.499 -1.0 0 O-C-N 118.045 -3.032 . . . . 25.0 108.845 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.08 154.05 49.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.287 -1.746 . . . . 25.0 106.287 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.9 m -83.64 138.54 33.29 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.597 -1.241 . . . . 25.0 111.761 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . 0.294 71.0 m-85 -124.88 123.85 40.81 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 102.363 -3.199 . . . . 50.0 102.363 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.9 m -139.37 137.78 36.02 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.984 -1.858 . . . . 25.0 105.984 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -120.52 147.07 45.64 Favored 'General case' 0 CA--C 1.466 -2.275 0 CA-C-O 116.288 -1.815 . . . . 25.0 106.612 175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 t -122.26 137.19 54.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.932 1.395 . . . . 25.0 107.368 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.22 158.15 36.4 Favored 'General case' 0 C--O 1.188 -2.132 0 CA-C-O 124.28 1.991 . . . . 50.0 113.311 -172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 p -120.04 16.14 12.46 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 102.964 -2.976 . . . . 25.0 102.964 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.42 125.29 79.18 Favored Pre-proline 0 C--O 1.255 1.366 0 CA-C-O 113.456 -3.164 . . . . 25.0 111.847 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -88.47 -6.5 6.06 Favored 'Trans proline' 0 C--N 1.292 -2.395 0 N-CA-C 108.954 -1.21 . . . . 25.0 108.954 156.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -56.03 139.01 48.16 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.165 -1.38 . . . . 25.0 114.526 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.44 109.28 20.41 Favored 'General case' 0 C--O 1.202 -1.437 0 N-CA-C 114.63 1.344 . . . . 25.0 114.63 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.7 m -66.21 148.44 51.84 Favored 'General case' 0 C--O 1.192 -1.946 0 N-CA-C 106.231 -1.766 . . . . 25.0 106.231 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 p -100.49 -42.06 6.74 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 124.258 1.98 . . . . 25.0 110.09 166.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -164.99 144.2 6.77 Favored 'General case' 0 C--O 1.191 -1.995 0 O-C-N 118.788 -2.445 . . . . 25.0 113.062 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.42 139.64 38.99 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 115.085 -2.646 . . . . 25.0 109.716 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -148.4 152.08 36.38 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.014 -1.678 . . . . 25.0 110.195 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.19 143.56 40.27 Favored 'General case' 0 C--O 1.197 -1.702 0 O-C-N 127.68 3.113 . . . . 50.0 110.9 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.87 166.63 17.12 Favored 'General case' 0 C--O 1.258 1.527 0 N-CA-C 106.39 -1.707 . . . . 50.0 106.39 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 pt -120.99 154.88 24.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 102.694 -3.076 . . . . 25.0 102.694 161.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.5 p -74.97 151.82 38.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.798 -1.189 . . . . 25.0 111.124 163.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -122.29 133.42 54.68 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.216 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.0 157.87 32.36 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 126.429 1.892 . . . . 25.0 108.734 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.87 38.56 7.94 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 118.121 -2.862 . . . . 25.0 118.333 165.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 168.5 9.7 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -144.08 124.29 7.58 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 114.814 -1.085 . . . . 25.0 109.96 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -58.26 -30.08 89.77 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 114.289 -3.341 . . . . 25.0 118.297 172.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.23 1.02 5.27 Favored 'General case' 0 C--O 1.198 -1.634 0 C-N-CA 116.542 -2.063 . . . . 75.0 115.403 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -132.84 173.13 6.25 Favored Pre-proline 0 C--O 1.199 -1.589 0 N-CA-C 104.849 -2.278 . . . . 25.0 104.849 -167.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 27.1 Cg_exo -50.65 20.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.398 2 C-N-CA 129.738 6.959 . . . . 25.0 124.732 173.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -16.71 -49.82 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.017 1 N-CA-C 121.959 4.059 . . . . 50.0 121.959 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -77.58 -8.56 58.03 Favored 'General case' 0 CA--C 1.479 -1.76 1 O-C-N 114.005 -5.434 . . . . 25.0 113.306 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -108.85 -40.73 4.95 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 126.728 2.011 . . . . 25.0 114.76 164.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 109' ' ' PRO . . . -79.27 13.97 1.69 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 127.791 3.182 . . . . 25.0 114.358 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -26.88 67.87 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.481 -0.933 . . . . 25.0 108.481 168.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -137.31 174.14 10.93 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 119.391 3.108 . . . . 50.0 119.391 -171.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -127.8 128.93 46.14 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.566 -1.197 . . . . 25.0 108.265 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 tp -70.16 123.35 21.41 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 103.46 -2.793 . . . . 50.0 103.46 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.9 pt -105.68 -12.93 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.54 1.162 . . . . 25.0 107.937 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.96 154.19 11.68 Favored Glycine 0 CA--C 1.501 -0.81 0 O-C-N 119.117 -2.239 . . . . 25.0 116.791 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.39 139.95 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 126.362 1.86 . . . . 25.0 109.944 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 t -134.69 103.64 11.05 Favored Pre-proline 0 CA--C 1.572 1.8 0 CA-C-O 125.727 2.68 . . . . 50.0 116.863 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.15 157.44 37.97 Favored 'Trans proline' 0 C--O 1.252 1.211 0 O-C-N 115.971 -2.7 . . . . 25.0 108.656 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -82.55 106.48 14.44 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-O 123.917 1.818 . . . . 25.0 110.37 171.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -140.12 -46.53 0.43 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 120.276 3.435 . . . . 50.0 120.276 -174.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 156.17 175.57 27.3 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 105.581 -3.008 . . . . 25.0 105.581 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 p 59.46 162.4 0.1 OUTLIER Pre-proline 0 C--O 1.251 1.176 0 N-CA-C 119.491 3.145 . . . . 25.0 119.491 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.63 1.98 3.87 Favored 'Trans proline' 0 C--N 1.371 1.716 1 C-N-CA 113.147 -4.102 . . . . 25.0 118.591 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -43.12 57.18 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 123.642 1.687 . . . . 25.0 109.877 172.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.1 t -77.46 -26.67 51.65 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.819 -4.301 . . . . 25.0 111.576 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -67.26 -20.86 65.72 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 125.197 2.427 . . . . 25.0 115.614 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -62.31 127.69 32.51 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 112.071 -2.331 . . . . 25.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.5 tp -122.21 4.12 9.78 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.403 -1.702 . . . . 75.0 106.403 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.5 t -128.85 136.36 50.35 Favored 'General case' 0 CA--C 1.47 -2.131 0 N-CA-C 102.442 -3.17 . . . . 25.0 102.442 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -147.88 153.24 38.85 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 106.053 -1.832 . . . . 25.0 106.053 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.823 -1.561 . . . . 25.0 107.925 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.23 129.65 75.43 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-O 113.113 -3.327 . . . . 25.0 108.852 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -73.9 135.51 43.31 Favored 'General case' 0 C--O 1.187 -2.189 0 O-C-N 128.725 3.766 . . . . 50.0 114.173 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.4 mm -113.07 121.67 37.62 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 115.833 -2.032 . . . . 25.0 108.095 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -58.12 147.38 83.65 Favored 'Trans proline' 0 CA--C 1.483 -2.054 1 C-N-CA 112.099 -4.801 . . . . 25.0 114.946 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.08 -11.24 47.68 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 111.557 -2.565 . . . . 25.0 112.555 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -112.19 -9.26 13.94 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 118.818 -1.153 . . . . 50.0 111.464 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -108.99 160.91 15.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 118.921 -2.362 . . . . 25.0 112.387 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 170' ' ' VAL 0.304 2.6 mp -138.95 132.92 31.09 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 128.191 2.596 . . . . 50.0 106.572 178.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.3 148.89 5.25 Favored Glycine 0 C--O 1.272 2.498 0 CA-C-O 127.078 3.599 . . . . 25.0 118.575 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.88 143.78 57.58 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 108.671 -3.765 . . . . 50.0 109.364 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -151.02 165.5 33.59 Favored 'General case' 0 C--O 1.269 2.094 0 N-CA-C 101.561 -3.496 . . . . 25.0 101.561 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.42 136.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 104.243 -2.503 . . . . 50.0 104.243 166.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -78.48 125.96 38.3 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 CA-C-O 114.711 -2.566 . . . . 25.0 106.031 164.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.36 131.62 53.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 103.104 -2.925 . . . . 50.0 103.104 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.29 146.15 44.32 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-O 126.345 2.974 . . . . 25.0 107.003 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -128.27 138.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 119.961 -1.712 . . . . 50.0 107.985 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -138.47 94.56 2.87 Favored 'General case' 0 C--O 1.196 -1.729 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -96.58 146.33 24.92 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-O 126.113 2.863 . . . . 25.0 105.184 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . 0.25 41.3 t -116.82 128.29 74.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 111.16 -2.745 . . . . 50.0 109.196 -169.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.56 -29.63 62.55 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.616 1.966 . . . . 25.0 110.579 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.05 -20.8 60.91 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 114.787 1.402 . . . . 25.0 114.787 -169.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.1 t -151.55 159.15 44.24 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 116.791 -1.576 . . . . 25.0 107.951 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.07 -1.36 28.6 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 117.765 -1.112 . . . . 25.0 112.596 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -103.34 160.57 14.58 Favored 'General case' 0 CA--C 1.569 1.695 0 O-C-N 124.91 1.381 . . . . 25.0 108.463 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.4 -173.89 4.52 Favored 'General case' 0 C--O 1.189 -2.093 0 O-C-N 120.304 -1.497 . . . . 25.0 109.545 -167.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -113.42 148.22 36.28 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.516 -1.661 . . . . 50.0 106.516 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -146.48 118.48 8.22 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.356 -2.461 . . . . 50.0 104.356 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.99 153.29 49.42 Favored 'General case' 0 C--O 1.265 1.899 0 O-C-N 120.734 -1.229 . . . . 25.0 110.063 -164.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.17 152.05 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 125.558 1.786 . . . . 75.0 108.367 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.2 mt -140.57 121.82 14.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.675 0 N-CA-C 105.046 -2.205 . . . . 25.0 105.046 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.47 142.67 44.85 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.522 -1.361 . . . . 25.0 108.632 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.2 163.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 124.903 1.377 . . . . 50.0 109.715 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -133.88 103.56 5.89 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.8 mt -99.73 133.51 43.98 Favored 'General case' 0 C--O 1.16 -3.611 0 N-CA-C 103.289 -2.856 . . . . 50.0 103.289 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 16.0 m -139.17 179.03 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-O 123.743 1.735 . . . . 50.0 111.908 -174.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -64.94 172.21 3.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.748 -2.478 . . . . 25.0 115.969 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 114.784 -2.531 . . . . 25.0 107.985 -177.409 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.511 2.612 0 CA-C-O 123.853 1.787 . . . . 25.0 111.216 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.87 -160.92 30.3 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 111.829 -2.441 . . . . 25.0 118.642 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -156.06 157.34 35.92 Favored 'General case' 0 C--O 1.261 1.683 0 N-CA-C 105.123 -2.177 . . . . 50.0 105.123 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.2 mm -84.09 110.26 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 O-C-N 119.47 -2.018 . . . . 25.0 107.286 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.96 -38.78 20.57 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 123.044 2.657 . . . . 25.0 109.946 170.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.82 149.25 63.82 Favored Pre-proline 0 N--CA 1.518 2.974 0 N-CA-C 104.004 -2.591 . . . . 25.0 104.004 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.07 160.69 93.42 Favored 'Cis proline' 0 C--O 1.252 1.213 0 C-N-CA 129.47 1.029 . . . . 25.0 113.159 -9.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.0 -173.09 52.09 Favored Glycine 0 C--N 1.286 -2.23 0 N-CA-C 117.84 1.896 . . . . 25.0 117.84 155.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 t -153.59 75.96 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 103.009 -2.96 . . . . 25.0 103.009 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -70.55 -7.91 47.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.436 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.28 -40.74 49.16 Favored 'General case' 0 C--O 1.255 1.369 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 161.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.4 67.6 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 114.359 1.244 . . . . 25.0 114.359 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 mt -85.14 -11.15 55.77 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-O 122.743 1.259 . . . . 75.0 113.73 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.8 t -92.34 -25.6 18.47 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 125.768 2.699 . . . . 25.0 113.86 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -70.09 150.23 46.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 119.273 -2.142 . . . . 25.0 110.389 168.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -77.55 6.47 7.08 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.064 1.302 . . . . 25.0 110.398 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.11 -15.96 62.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.066 -1.646 . . . . 25.0 109.517 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -51.58 -18.97 1.29 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 118.069 -2.894 . . . . 50.0 118.329 163.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.55 7.8 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 120.72 3.048 . . . . 25.0 120.72 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 43.52 8.67 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 119.88 3.289 . . . . 50.0 119.88 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 mt -80.53 -41.21 24.6 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 123.92 3.055 . . . . 50.0 106.83 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -147.05 174.85 11.16 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 126.345 2.278 . . . . 25.0 105.472 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.56 160.26 25.63 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-O 123.386 1.565 . . . . 50.0 111.29 162.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -140.87 5.5 1.96 Allowed 'General case' 0 CA--C 1.577 1.993 0 C-N-CA 126.434 1.893 . . . . 25.0 113.041 -171.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -74.31 -43.26 57.47 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 115.404 1.631 . . . . 25.0 115.404 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.73 119.04 1.37 Allowed Glycine 0 CA--C 1.542 1.775 0 N-CA-C 108.728 -1.749 . . . . 25.0 108.728 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.92 -13.03 42.36 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 121.904 -0.762 . . . . 25.0 111.59 -169.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -62.93 -14.63 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.59 -1.263 . . . . 50.0 107.59 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.39 -15.63 0.15 Allowed 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 121.0 3.704 . . . . 25.0 121.0 167.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.3 -34.1 73.31 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-N 114.983 -1.008 . . . . 50.0 109.15 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.02 47.02 0.54 Allowed Pre-proline 0 C--O 1.294 3.447 0 N-CA-C 118.172 2.656 . . . . 25.0 118.172 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.75 -11.37 31.72 Favored 'Trans proline' 0 CA--C 1.487 -1.874 0 C-N-CA 121.372 1.381 . . . . 25.0 111.966 -159.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -116.98 6.75 13.02 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.74 0.7 . . . . 25.0 112.363 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -89.83 55.73 3.26 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 117.906 -2.996 . . . . 25.0 112.17 -171.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.3 mt -103.67 96.08 6.48 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 118.009 -0.996 . . . . 50.0 112.964 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -123.87 157.4 34.28 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 103.721 -2.696 . . . . 25.0 103.721 166.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.84 42.2 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.713 -2.039 . . . . 25.0 110.225 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.02 150.07 47.03 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 121.992 2.178 . . . . 25.0 108.693 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -60.21 155.33 17.72 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.808 0.843 . . . . 25.0 111.605 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.92 99.93 2.26 Favored Glycine 0 C--O 1.198 -2.118 0 N-CA-C 117.493 1.757 . . . . 25.0 117.493 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -125.41 98.55 34.89 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 104.305 -2.48 . . . . 25.0 104.305 171.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -85.72 175.39 31.27 Favored 'Cis proline' 0 N--CA 1.507 2.274 0 CA-C-N 121.635 1.62 . . . . 25.0 113.315 -2.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -64.19 -33.25 75.36 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 113.066 0.765 . . . . 25.0 113.066 -168.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 t 56.58 -113.75 0.78 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 119.471 3.137 . . . . 25.0 119.471 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.67 150.43 51.42 Favored Glycine 0 CA--C 1.485 -1.788 0 CA-C-N 122.331 2.332 . . . . 25.0 109.364 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.51 -31.19 9.15 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 CA-C-N 122.282 3.041 . . . . 25.0 118.586 -166.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . 0.27 . . -66.84 126.4 28.94 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 117.656 2.465 . . . . 25.0 117.656 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -66.77 140.26 57.84 Favored 'General case' 0 CA--C 1.572 1.801 0 O-C-N 120.738 -1.226 . . . . 25.0 113.05 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.21 -10.82 73.56 Favored Glycine 0 C--O 1.295 3.921 0 CA-C-O 121.948 0.749 . . . . 25.0 113.842 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . 0.342 8.4 mm-40 -109.64 -0.46 18.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 121.058 -1.26 . . . . 25.0 113.373 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.12 -45.21 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 N-CA-C 118.451 2.759 . . . . 25.0 118.451 -162.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.09 5.33 11.3 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 124.959 1.304 . . . . 25.0 109.33 173.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -84.62 -13.78 50.61 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 119.137 -2.227 . . . . 25.0 112.335 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 66.89 10.37 7.56 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 128.813 2.845 . . . . 25.0 111.27 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.53 -14.78 80.83 Favored Glycine 0 C--N 1.308 -0.995 0 N-CA-C 116.742 1.457 . . . . 25.0 116.742 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.16 -1.19 82.09 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 112.52 -1.84 . . . . 25.0 113.06 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.4 mt -87.18 99.67 12.11 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-O 126.574 3.083 . . . . 50.0 104.696 172.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -73.69 -24.48 59.96 Favored 'General case' 0 CA--C 1.481 -1.678 1 O-C-N 116.272 -4.018 . . . . 50.0 113.975 -174.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -36.84 80.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-O 124.374 2.097 . . . . 25.0 108.239 167.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.85 -31.28 72.7 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 119.992 -1.887 . . . . 25.0 113.809 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.17 -50.23 65.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 117.582 -3.305 . . . . 25.0 110.432 167.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.98 -26.9 67.04 Favored 'General case' 1 C--O 1.319 4.725 0 CA-C-N 121.593 1.997 . . . . 75.0 107.418 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.11 -29.53 67.61 Favored 'General case' 0 C--O 1.27 2.133 0 C-N-CA 119.997 -0.681 . . . . 50.0 110.121 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -79.11 56.81 2.09 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-O 123.444 1.592 . . . . 25.0 109.391 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -91.94 60.41 3.84 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 118.644 -2.535 . . . . 25.0 106.39 167.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.0 p -146.97 -164.2 1.94 Allowed 'General case' 0 C--O 1.273 2.342 0 CA-C-N 111.303 -2.681 . . . . 25.0 116.633 -164.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.44 -26.92 68.76 Favored 'General case' 0 C--O 1.267 1.981 0 O-C-N 119.604 -1.935 . . . . 25.0 111.17 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -87.35 16.01 5.81 Favored 'General case' 0 C--O 1.264 1.845 0 N-CA-C 116.01 1.856 . . . . 25.0 116.01 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -75.21 89.39 2.53 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 123.879 1.799 . . . . 25.0 108.676 173.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -18.49 142.79 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 108.596 -3.911 . . . . 25.0 121.148 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.13 125.79 26.07 Favored 'General case' 0 N--CA 1.42 -1.949 0 O-C-N 125.459 1.724 . . . . 50.0 111.546 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -117.78 149.74 40.29 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 119.213 3.042 . . . . 25.0 119.213 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -142.61 126.07 16.73 Favored 'General case' 0 CA--C 1.591 2.538 0 N-CA-C 117.276 2.324 . . . . 25.0 117.276 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.54 125.37 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 O-C-N 117.735 -3.103 . . . . 25.0 106.919 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttt -148.06 161.84 40.59 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 102.539 -3.134 . . . . 25.0 102.539 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 64.6 p -88.71 166.67 13.91 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 119.672 -1.893 . . . . 25.0 112.209 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.87 176.41 51.1 Favored Glycine 0 C--O 1.256 1.499 0 C-N-CA 116.792 -2.623 . . . . 25.0 115.704 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.89 -171.79 19.12 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 105.118 -3.193 . . . . 25.0 105.118 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.64 141.1 58.89 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 103.792 -2.67 . . . . 25.0 103.792 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -111.26 144.34 40.59 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 101.814 -3.402 . . . . 25.0 101.814 158.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -126.15 120.83 31.13 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 100.996 -3.705 . . . . 25.0 100.996 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.44 ' CE2' HD12 ' A' ' 136' ' ' ILE . 77.9 m-85 -114.59 119.33 36.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 118.73 -2.481 . . . . 50.0 109.61 -172.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 m -131.61 97.26 4.17 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 100.019 -4.067 . . . . 25.0 100.019 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -112.53 116.28 29.99 Favored 'General case' 1 N--CA 1.539 4.01 0 O-C-N 126.614 2.446 . . . . 25.0 106.657 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . 0.251 2.1 p -127.07 157.33 39.91 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 125.56 1.788 . . . . 25.0 106.228 -162.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -113.52 140.43 48.14 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 127.503 2.321 . . . . 50.0 107.097 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -88.1 -9.59 52.79 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 123.807 1.765 . . . . 25.0 108.773 -169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.94 149.1 38.05 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 101.639 -3.467 . . . . 25.0 101.639 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.68 147.36 75.72 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 118.167 -0.755 . . . . 25.0 113.558 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -141.85 141.83 33.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 117.647 -1.168 . . . . 25.0 110.935 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -80.75 159.58 25.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 117.99 -1.484 . . . . 25.0 113.776 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.9 m -150.48 148.23 28.47 Favored 'General case' 0 C--O 1.208 -1.122 0 C-N-CA 125.903 1.681 . . . . 25.0 109.695 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.7 p -111.21 -29.39 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.583 1.953 . . . . 25.0 112.486 170.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -166.96 158.87 12.84 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.405 1.482 . . . . 25.0 107.777 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -143.74 146.35 33.08 Favored 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 2.2 m-70 -144.48 149.37 35.85 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 120.329 -1.482 . . . . 25.0 110.59 -167.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -130.59 134.7 47.21 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 113.097 -1.865 . . . . 50.0 110.776 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.33 171.09 11.81 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 103.493 -2.78 . . . . 50.0 103.493 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.39 155.95 41.17 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 N-CA-C 103.321 -2.844 . . . . 25.0 103.321 167.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.295 33.5 p -81.52 153.91 26.55 Favored 'General case' 0 CA--C 1.469 -2.173 0 CA-C-O 124.096 1.903 . . . . 25.0 106.925 165.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -87.85 107.99 18.95 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 112.392 -2.185 . . . . 25.0 110.884 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -49.57 117.7 2.37 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 105.696 -1.965 . . . . 25.0 105.696 155.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.66 33.28 34.77 Favored Glycine 0 C--O 1.192 -2.515 0 CA-C-O 117.693 -1.615 . . . . 25.0 115.726 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -51.02 159.83 0.55 Allowed 'General case' 0 C--O 1.259 1.576 0 CA-C-O 122.267 1.032 . . . . 25.0 108.446 169.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -102.9 107.49 55.06 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 102.075 -3.306 . . . . 25.0 102.075 167.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -72.54 -16.34 27.24 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.552 2.168 . . . . 25.0 116.28 -173.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -84.2 -2.61 57.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.392 -1.731 . . . . 75.0 106.873 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -132.48 154.54 81.58 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 103.513 -2.773 . . . . 25.0 103.513 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.381 72.4 Cg_exo -25.64 91.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.285 3 C-N-CA 125.506 4.138 . . . . 25.0 122.529 -167.468 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.42 -15.34 61.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 110.883 -2.871 . . . . 50.0 112.928 -171.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 6.36 11.21 Favored 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 120.027 -1.671 . . . . 25.0 111.866 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -136.62 -46.11 0.6 Allowed 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 118.166 2.654 . . . . 25.0 118.166 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.35 -4.48 53.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.44 1.644 . . . . 25.0 115.44 165.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.61 7.8 16.22 Favored 'General case' 0 C--O 1.274 2.346 0 C-N-CA 125.645 1.578 . . . . 25.0 114.917 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -141.69 166.95 23.34 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 126.041 2.088 . . . . 50.0 106.95 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -134.27 154.41 51.3 Favored 'General case' 0 C--O 1.176 -2.796 0 N-CA-C 105.954 -1.869 . . . . 25.0 105.954 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.32 120.72 38.21 Favored 'General case' 0 CA--C 1.58 2.097 0 O-C-N 120.507 -1.371 . . . . 50.0 112.647 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.292 4.8 tp -98.13 -19.51 5.94 Favored 'Isoleucine or valine' 0 C--O 1.274 2.352 0 C-N-CA 126.738 2.015 . . . . 25.0 106.416 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.77 164.93 26.31 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 113.331 -1.759 . . . . 25.0 117.149 162.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . . . -138.84 157.65 45.66 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 101.531 -3.507 . . . . 25.0 101.531 166.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.9 130.44 13.01 Favored Pre-proline 0 C--O 1.245 0.866 0 N-CA-C 102.832 -3.025 . . . . 50.0 102.832 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.01 168.86 11.92 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 116.847 -1.636 . . . . 25.0 111.898 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -129.76 56.3 1.73 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.9 0.75 . . . . 25.0 109.57 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -123.93 -0.1 8.5 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 124.474 2.083 . . . . 50.0 113.316 -164.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -167.7 -165.72 25.58 Favored Glycine 0 C--O 1.258 1.608 0 N-CA-C 103.919 -3.673 . . . . 25.0 103.919 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.1 t -120.68 69.67 16.9 Favored Pre-proline 0 CA--C 1.556 1.19 0 O-C-N 126.411 1.889 . . . . 25.0 115.318 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.3 178.79 7.2 Favored 'Trans proline' 0 CA--C 1.578 2.682 0 C-N-CA 121.613 1.542 . . . . 25.0 112.618 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.67 71.31 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.36 2.14 2.5 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.992 1.317 . . . . 25.0 114.312 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -70.94 -16.8 62.68 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 124.162 1.934 . . . . 25.0 111.04 170.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -68.24 125.77 27.45 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 103.906 -2.627 . . . . 25.0 103.906 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.8 tp -75.81 -7.14 53.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 118.25 -1.38 . . . . 75.0 113.997 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.9 t -85.23 144.53 28.07 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 104.705 -2.331 . . . . 25.0 104.705 173.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -137.79 135.78 36.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.178 0.806 . . . . 25.0 113.178 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -101.47 128.42 47.69 Favored 'General case' 0 C--O 1.301 3.807 0 CA-C-O 123.272 1.51 . . . . 25.0 108.912 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 82' ' ' PHE . 46.3 mt -118.32 120.98 66.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 116.089 -2.244 . . . . 25.0 108.166 175.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -83.33 117.64 23.14 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 115.255 -2.578 . . . . 50.0 110.019 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.77 97.25 27.59 Favored Pre-proline 0 C--O 1.275 2.424 0 CA-C-O 123.321 1.534 . . . . 25.0 108.686 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 132.96 20.84 Favored 'Trans proline' 0 C--N 1.372 1.771 1 C-N-CA 113.121 -4.119 . . . . 25.0 110.298 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.43 97.06 3.14 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 117.321 -3.362 . . . . 25.0 109.979 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.69 -13.02 30.0 Favored 'General case' 0 C--O 1.267 1.977 0 N-CA-C 104.87 -2.27 . . . . 50.0 104.87 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -106.83 -173.68 2.35 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.643 -1.91 . . . . 25.0 112.82 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.53 129.87 45.05 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.169 -1.582 . . . . 50.0 111.609 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 152.9 -179.95 28.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 124.707 2.282 . . . . 25.0 116.113 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.14 158.84 38.58 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 117.113 -3.581 . . . . 50.0 117.192 -153.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -158.99 168.6 26.32 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 120.579 -1.325 . . . . 25.0 110.292 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.16 135.31 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.065 0 N-CA-C 103.775 -2.676 . . . . 50.0 103.775 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 mt -85.08 134.98 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 100.758 -3.793 . . . . 25.0 100.758 167.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.4 mt -116.5 135.18 54.05 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.387 -2.079 . . . . 50.0 105.387 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.7 136.59 54.94 Favored 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 97.282 -5.081 . . . . 25.0 97.282 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.5 120.44 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 O-C-N 125.491 1.744 . . . . 50.0 108.481 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.89 121.86 35.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.071 1.76 . . . . 25.0 107.881 -175.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -102.77 134.53 46.02 Favored 'General case' 0 N--CA 1.407 -2.625 0 O-C-N 120.413 -1.43 . . . . 25.0 110.346 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.59 99.11 3.65 Favored 'Isoleucine or valine' 0 C--O 1.262 1.747 0 N-CA-C 105.93 -1.878 . . . . 50.0 105.93 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.34 66.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 117.138 -1.825 . . . . 25.0 113.167 -167.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.3 -16.69 55.98 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.379 -1.282 . . . . 25.0 113.13 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.9 p -109.68 164.64 12.35 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 120.15 1.341 . . . . 25.0 109.621 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -81.75 -36.88 28.04 Favored 'General case' 0 C--O 1.285 2.933 0 CA-C-O 123.699 1.714 . . . . 25.0 110.38 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.61 154.38 20.02 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 112.369 -2.196 . . . . 25.0 108.378 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -111.0 158.15 19.12 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 124.941 1.297 . . . . 25.0 111.411 168.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -109.94 142.71 40.91 Favored 'General case' 0 C--O 1.269 2.104 0 O-C-N 119.391 -2.068 . . . . 50.0 109.032 -165.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.16 162.34 41.06 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-O 123.459 1.599 . . . . 50.0 111.872 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -138.86 157.6 45.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.921 -1.112 . . . . 25.0 108.047 166.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.1 133.04 63.2 Favored 'Isoleucine or valine' 0 C--O 1.258 1.53 0 O-C-N 120.117 -1.614 . . . . 75.0 109.363 165.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.2 mt -136.1 119.64 23.71 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 N-CA-C 102.421 -3.177 . . . . 25.0 102.421 -169.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -83.42 133.42 34.92 Favored 'General case' 0 CA--C 1.613 3.376 0 CA-C-O 123.094 1.426 . . . . 25.0 111.241 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.53 144.33 38.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 O-C-N 119.76 -1.838 . . . . 50.0 111.577 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.78 135.14 54.97 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 100.626 -3.842 . . . . 25.0 100.626 167.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 mt -126.36 129.34 48.61 Favored 'General case' 0 C--O 1.294 3.431 0 N-CA-C 104.75 -2.315 . . . . 50.0 104.75 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.01 163.9 30.78 Favored 'Isoleucine or valine' 0 C--O 1.277 2.523 0 N-CA-C 115.714 1.746 . . . . 50.0 115.714 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -71.01 134.36 47.07 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.161 -0.962 . . . . 25.0 111.638 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.657 -1.163 . . . . 25.0 112.826 -173.622 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . 0.259 47.0 p-80 . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 122.897 1.332 . . . . 25.0 109.553 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.52 -165.02 38.85 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-O 116.546 -2.252 . . . . 25.0 114.783 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.71 151.58 33.89 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-N 122.18 2.99 . . . . 50.0 116.056 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 6' ' ' LYS . 43.9 mm -66.78 132.09 32.26 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.722 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.11 39.98 3.42 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 126.4 3.0 . . . . 25.0 107.454 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.577 ' H ' HG22 ' A' ' 4' ' ' ILE . 96.2 mttt 72.09 163.53 0.14 Allowed Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 108.512 -3.949 . . . . 25.0 115.078 169.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.78 122.05 0.42 Allowed 'Cis proline' 0 C--N 1.357 0.98 0 C-N-CA 133.055 2.523 . . . . 25.0 114.14 3.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.47 147.93 13.28 Favored Glycine 0 C--O 1.252 1.238 0 CA-C-N 114.019 -1.446 . . . . 25.0 111.239 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -145.92 134.58 22.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.406 -1.643 . . . . 25.0 108.45 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -75.16 -17.1 60.46 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 117.086 -3.509 . . . . 25.0 111.88 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.78 56.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 116.374 -1.774 . . . . 25.0 107.65 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.72 63.32 Favored 'General case' 1 C--O 1.306 4.054 0 CA-C-N 122.002 2.183 . . . . 25.0 109.642 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.64 -8.42 59.19 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.142 -0.974 . . . . 75.0 110.021 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.1 t -78.32 -15.39 58.78 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 114.358 1.244 . . . . 25.0 114.358 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 t -80.88 137.52 36.16 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 114.77 -1.105 . . . . 25.0 110.048 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.91 -19.42 34.78 Favored 'General case' 0 C--O 1.184 -2.345 0 N-CA-C 105.486 -2.042 . . . . 25.0 105.486 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.89 79.65 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-O 122.8 1.286 . . . . 25.0 113.783 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.27 -25.81 67.35 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.126 -1.609 . . . . 50.0 109.659 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.68 18.48 29.51 Favored Glycine 0 C--O 1.184 -2.977 0 CA-C-N 122.357 2.344 . . . . 25.0 109.493 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.4 t80 57.11 -51.56 0.03 OUTLIER 'General case' 0 C--O 1.204 -1.307 0 C-N-CA 128.732 2.813 . . . . 50.0 114.826 -169.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.6 mt -133.91 10.68 3.94 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.23 1.412 . . . . 50.0 112.46 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -141.59 167.38 22.29 Favored 'General case' 0 C--O 1.19 -2.046 0 N-CA-C 104.165 -2.532 . . . . 25.0 104.165 -173.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.38 169.81 23.38 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 104.235 -2.506 . . . . 50.0 104.235 -172.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -159.19 68.43 0.43 Allowed 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 105.731 -1.951 . . . . 25.0 105.731 -173.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.9 t -69.27 -33.2 72.85 Favored 'General case' 0 C--O 1.183 -2.439 0 N-CA-C 118.22 2.674 . . . . 25.0 118.22 -161.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.55 37.47 35.21 Favored Glycine 0 C--O 1.192 -2.505 0 N-CA-C 119.718 2.647 . . . . 25.0 119.718 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 m -56.32 2.06 0.02 OUTLIER 'General case' 0 C--O 1.268 2.073 1 N-CA-C 122.64 4.311 . . . . 25.0 122.64 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.11 -8.09 5.16 Favored 'Isoleucine or valine' 0 C--O 1.278 2.574 0 N-CA-C 115.847 1.795 . . . . 50.0 115.847 158.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 ptm -52.37 10.83 0.0 OUTLIER 'General case' 0 C--O 1.278 2.578 1 N-CA-C 122.734 4.346 . . . . 25.0 122.734 171.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -57.48 -47.83 80.82 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 120.242 -1.536 . . . . 50.0 113.717 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -149.35 44.66 0.34 Allowed Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 119.733 3.234 . . . . 25.0 119.733 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -79.34 -17.32 11.63 Favored 'Trans proline' 0 C--O 1.272 2.206 0 C-N-CA 115.112 -2.792 . . . . 25.0 114.413 -167.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -92.66 5.77 49.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 116.85 -1.547 . . . . 25.0 112.253 170.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -119.29 16.66 13.11 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 124.983 1.427 . . . . 25.0 111.597 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 mt -73.19 124.85 26.42 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 126.115 1.766 . . . . 50.0 108.361 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.41 164.86 20.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 118.955 -2.341 . . . . 25.0 112.334 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.26 139.02 26.83 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.188 -1.824 . . . . 25.0 111.882 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 82.1 tttt -59.8 137.55 58.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 118.206 -2.809 . . . . 25.0 112.552 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -69.28 159.85 32.32 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.559 -3.213 . . . . 25.0 103.336 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.24 -155.2 24.66 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 113.612 -1.631 . . . . 25.0 114.893 -174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.09 129.22 24.15 Favored Pre-proline 0 N--CA 1.517 2.925 0 CA-C-O 117.642 -1.171 . . . . 25.0 112.296 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.99 178.88 32.75 Favored 'Cis proline' 0 C--O 1.25 1.103 0 CA-C-N 121.706 1.645 . . . . 25.0 110.3 -9.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -156.67 -19.94 0.1 Allowed 'General case' 0 C--O 1.211 -0.964 0 O-C-N 127.447 2.967 . . . . 25.0 116.932 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -49.81 -54.48 18.99 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.02 168.19 51.88 Favored Glycine 0 C--O 1.287 3.465 0 N-CA-C 108.69 -1.764 . . . . 25.0 108.69 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.16 -28.04 13.13 Favored 'Trans proline' 0 C--O 1.266 1.902 0 C-N-CA 122.279 1.986 . . . . 25.0 115.843 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.04 140.78 58.29 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 119.791 -1.818 . . . . 25.0 109.341 -172.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -154.28 144.19 21.8 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 103.681 -2.711 . . . . 25.0 103.681 171.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.45 -24.39 13.87 Favored Glycine 0 N--CA 1.486 2.019 0 CA-C-O 115.789 -2.673 . . . . 25.0 108.324 164.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -134.84 33.55 3.18 Favored 'General case' 0 C--O 1.275 2.427 0 CA-C-N 121.902 2.851 . . . . 25.0 113.429 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.6 mm -69.9 -46.42 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 120.181 -0.608 . . . . 25.0 112.09 -161.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.59 78.38 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.492 -0.883 . . . . 25.0 111.421 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.7 p -79.49 -8.76 59.36 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.163 1.542 . . . . 25.0 115.163 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.03 23.42 11.57 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 125.19 1.556 . . . . 25.0 107.836 -171.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.23 -23.93 73.32 Favored Glycine 1 CA--C 1.581 4.212 0 CA-C-O 115.931 -2.594 . . . . 25.0 113.927 -175.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.58 -13.37 80.25 Favored Glycine 0 N--CA 1.473 1.151 0 N-CA-C 108.43 -1.868 . . . . 25.0 108.43 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.2 mt -104.38 -64.62 1.09 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.916 1.358 . . . . 50.0 112.053 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -68.78 -22.96 64.25 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.547 -0.909 . . . . 50.0 108.547 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -26.43 62.84 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 117.049 -1.973 . . . . 25.0 116.058 166.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.63 -21.22 64.72 Favored Glycine 0 C--O 1.186 -2.855 0 CA-C-O 114.435 -3.425 . . . . 25.0 112.829 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.68 -34.39 23.46 Favored 'Isoleucine or valine' 0 C--O 1.293 3.361 0 CA-C-N 124.147 3.973 . . . . 25.0 112.402 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.72 -18.85 56.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 125.794 1.934 . . . . 75.0 107.51 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.266 4.8 t70 -43.19 -39.77 3.05 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 115.35 1.611 . . . . 50.0 115.35 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -78.05 10.63 2.76 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 116.442 2.015 . . . . 25.0 116.442 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -147.97 47.11 1.08 Allowed 'General case' 0 C--O 1.255 1.395 0 C-N-CA 128.179 2.591 . . . . 25.0 110.269 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 t -144.52 161.19 39.71 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 119.254 3.057 . . . . 25.0 119.254 -166.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -68.21 -17.4 64.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 122.151 2.251 . . . . 25.0 108.907 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -96.54 26.25 4.56 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.322 36.5 ttp180 -78.56 67.79 4.4 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-O 123.491 1.615 . . . . 25.0 110.418 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -61.84 145.39 52.83 Favored 'General case' 0 CA--C 1.454 -2.715 1 CA-C-N 107.191 -4.549 . . . . 25.0 111.745 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.435 ' H ' ' HD1' ' A' ' 71' ' ' PHE . 5.8 p90 -77.17 144.48 38.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.38 -1.736 . . . . 50.0 113.354 -166.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 166' ' ' ASP . 59.8 mttm -107.76 165.53 11.37 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-O 118.311 -0.852 . . . . 25.0 111.541 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.512 ' H ' ' HA ' ' A' ' 167' ' ' VAL . 3.6 m80 -127.72 122.16 32.17 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 126.204 1.802 . . . . 25.0 107.023 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.3 mt -83.7 126.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 103.511 -2.774 . . . . 25.0 103.511 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.8 mtp -138.15 156.4 47.77 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 126.051 2.834 . . . . 25.0 105.013 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.7 p -91.88 166.05 12.93 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.786 -2.302 . . . . 25.0 104.786 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.74 167.85 52.05 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-O 116.793 -2.115 . . . . 25.0 115.213 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.4 171.01 12.95 Favored Glycine 0 CA--C 1.555 2.559 1 N-CA-C 102.906 -4.077 . . . . 25.0 102.906 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 11.7 tt0 -62.92 144.9 56.32 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.572 -1.546 . . . . 25.0 111.258 168.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -136.11 146.75 47.33 Favored 'General case' 0 CA--C 1.445 -3.082 0 O-C-N 119.802 -1.811 . . . . 25.0 107.907 162.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.1 m -101.91 137.27 40.43 Favored 'General case' 0 CA--C 1.468 -2.198 0 C-N-CA 124.907 1.283 . . . . 25.0 109.216 167.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -114.79 140.93 48.52 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.856 -1.778 . . . . 50.0 106.669 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -127.32 136.16 51.54 Favored 'General case' 0 C--O 1.19 -2.059 0 CA-C-O 125.014 2.34 . . . . 25.0 111.109 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -129.99 158.85 38.43 Favored 'General case' 0 C--O 1.28 2.676 1 N-CA-C 97.988 -4.819 . . . . 25.0 97.988 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 t -147.23 155.04 41.73 Favored 'General case' 0 CA--C 1.476 -1.886 0 CA-C-N 119.68 1.127 . . . . 25.0 111.108 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.22 162.26 28.27 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 105.162 -2.162 . . . . 50.0 105.162 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 t -116.51 -9.2 11.45 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-N 120.244 1.383 . . . . 25.0 113.107 167.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.6 31.29 Favored Pre-proline 0 CA--C 1.481 -1.687 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 168.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.01 155.88 61.03 Favored 'Trans proline' 0 CA--C 1.486 -1.887 1 C-N-CA 113.032 -4.179 . . . . 25.0 116.586 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -86.02 156.56 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 104.601 -2.37 . . . . 25.0 104.601 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -80.16 132.22 35.87 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.762 -2.31 . . . . 25.0 104.762 166.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 m -152.48 153.59 33.8 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 116.039 -1.934 . . . . 25.0 109.542 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 p -114.66 -43.27 3.17 Favored 'General case' 0 C--O 1.275 2.43 0 C-N-CA 125.201 1.401 . . . . 25.0 108.76 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -151.16 144.6 24.87 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 117.911 -2.993 . . . . 25.0 110.766 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . 0.262 51.5 p-90 -114.45 150.01 35.4 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 117.902 -1.519 . . . . 25.0 112.403 166.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -136.17 150.28 48.97 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 103.885 -2.635 . . . . 25.0 103.885 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . 0.252 7.1 p90 -147.23 149.4 32.83 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 106.12 -1.808 . . . . 50.0 106.12 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -152.98 163.54 39.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.42 -1.696 . . . . 50.0 106.42 -157.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.02 167.3 20.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 115.529 -2.177 . . . . 25.0 107.657 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.4 p -96.69 157.95 15.66 Favored 'General case' 0 C--O 1.203 -1.373 0 O-C-N 125.718 1.886 . . . . 25.0 109.298 170.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -74.03 92.02 2.11 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 111.292 -2.685 . . . . 25.0 114.274 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.99 113.93 2.11 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 126.457 2.348 . . . . 25.0 114.323 165.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.13 35.47 9.7 Favored Glycine 0 C--O 1.25 1.131 0 CA-C-N 115.05 -0.977 . . . . 25.0 114.097 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 162.4 28.81 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 113.603 -1.299 . . . . 25.0 112.75 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.15 143.83 40.02 Favored Pre-proline 0 C--O 1.194 -1.867 0 CA-C-N 115.518 -0.764 . . . . 25.0 109.394 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.62 -18.18 17.64 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 114.85 -2.967 . . . . 25.0 118.82 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -83.69 9.2 12.26 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 118.779 -2.451 . . . . 75.0 109.172 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -128.0 169.74 11.9 Favored Pre-proline 0 C--O 1.285 2.954 0 N-CA-C 101.74 -3.43 . . . . 25.0 101.74 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -55.66 28.21 0.02 OUTLIER 'Trans proline' 0 C--O 1.243 0.753 1 C-N-CA 129.121 6.547 . . . . 25.0 122.359 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.95 -40.15 66.56 Favored 'General case' 0 C--O 1.197 -1.659 0 CA-C-N 119.773 1.17 . . . . 50.0 112.939 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -85.34 -5.7 59.29 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 115.938 1.829 . . . . 25.0 115.938 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -111.37 -66.54 1.07 Allowed 'General case' 0 CA--C 1.475 -1.937 0 O-C-N 119.978 -1.701 . . . . 25.0 107.927 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.24 54.02 1.2 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.516 2.326 . . . . 25.0 109.251 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . 0.251 9.9 t0 -60.68 -42.24 96.73 Favored 'General case' 0 CA--C 1.596 2.746 0 CA-C-N 110.099 -3.228 . . . . 25.0 110.267 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 126.172 2.17 . . . . 50.0 112.428 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -141.8 129.52 21.62 Favored 'General case' 0 C--O 1.195 -1.774 0 O-C-N 126.364 2.29 . . . . 25.0 112.057 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.06 129.94 41.52 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 115.192 -2.337 . . . . 50.0 110.685 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.4 tt -105.59 -20.5 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 122.114 2.233 . . . . 25.0 106.797 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.65 161.36 27.22 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 120.567 -0.825 . . . . 25.0 114.566 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.5 133.4 14.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 123.0 1.381 . . . . 25.0 111.064 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.76 97.61 38.46 Favored Pre-proline 0 N--CA 1.499 1.982 0 CA-C-N 112.552 -2.113 . . . . 50.0 111.228 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.99 152.73 76.53 Favored 'Trans proline' 0 C--N 1.347 0.479 0 N-CA-C 116.79 1.804 . . . . 25.0 116.79 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -79.09 69.31 5.25 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.702 1.251 . . . . 25.0 111.222 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -74.95 -31.32 61.46 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 119.341 -2.099 . . . . 50.0 113.089 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.17 -5.26 71.53 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-O 117.94 -1.478 . . . . 25.0 113.89 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.0 p -71.7 166.19 42.24 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 126.429 1.899 . . . . 25.0 109.054 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.29 -10.94 26.36 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 116.23 -2.046 . . . . 25.0 117.039 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.4 -30.8 42.56 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 121.616 -0.677 . . . . 25.0 109.21 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 48.0 t -74.87 -44.86 46.7 Favored 'General case' 0 C--O 1.285 2.936 0 CA-C-O 124.141 1.924 . . . . 25.0 108.086 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -64.01 -23.96 67.53 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 111.941 -2.39 . . . . 25.0 113.799 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.25 109.19 12.16 Favored 'General case' 0 CA--C 1.58 2.115 0 O-C-N 124.99 1.431 . . . . 25.0 110.38 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.1 tp -83.35 -33.78 25.76 Favored 'General case' 0 C--O 1.193 -1.901 0 C-N-CA 127.214 2.206 . . . . 75.0 108.17 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -80.36 128.27 33.37 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 115.987 -2.285 . . . . 25.0 108.45 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -124.44 153.86 41.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 125.314 1.634 . . . . 25.0 114.327 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -98.59 148.55 23.67 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.6 mt -142.27 129.2 19.38 Favored 'Isoleucine or valine' 0 C--O 1.264 1.818 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 71.1 t80 -75.95 120.11 20.84 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 120.401 -1.437 . . . . 50.0 113.135 169.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.53 122.81 44.96 Favored Pre-proline 0 C--O 1.206 -1.227 0 N-CA-C 101.918 -3.364 . . . . 25.0 101.918 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -61.43 153.2 67.73 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 123.775 1.408 . . . . 25.0 109.805 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -110.35 -0.09 17.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 119.566 -1.959 . . . . 25.0 112.493 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.91 -8.36 57.33 Favored 'General case' 0 C--O 1.265 1.896 0 N-CA-C 116.583 2.068 . . . . 50.0 116.583 -172.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -133.92 151.38 51.47 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 116.798 2.147 . . . . 25.0 116.798 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 171' ' ' ASN . 90.5 mt -100.0 155.73 17.54 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.56 1.544 . . . . 50.0 107.676 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.17 157.01 10.08 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 123.371 4.108 . . . . 25.0 123.371 172.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 0.1 OUTLIER -80.68 146.0 31.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 123.09 1.424 . . . . 50.0 113.494 -174.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.11 159.14 43.72 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.12 -1.4 . . . . 25.0 109.913 162.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.71 142.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 O-C-N 125.233 1.583 . . . . 50.0 108.156 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 mt -109.85 134.66 51.27 Favored 'Isoleucine or valine' 0 C--O 1.25 1.105 0 CA-C-O 118.201 -0.904 . . . . 25.0 109.76 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.24 155.39 35.96 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 124.913 2.292 . . . . 50.0 108.27 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.6 153.77 48.66 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 118.998 -2.313 . . . . 25.0 109.277 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.86 118.52 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 128.707 2.803 . . . . 50.0 106.29 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -107.63 88.25 2.69 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 126.36 2.287 . . . . 25.0 107.106 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.494 ' HA ' ' HB1' ' A' ' 160' ' ' ALA . 24.6 t70 -77.36 141.69 39.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.158 -1.589 . . . . 25.0 111.832 -163.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.02 123.77 59.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-O 116.991 -1.48 . . . . 50.0 112.464 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.94 20.07 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 120.231 1.378 . . . . 25.0 111.671 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.52 -20.84 65.49 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.8 p -124.51 159.88 29.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.932 1.456 . . . . 25.0 114.932 -173.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.04 -39.7 87.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 116.61 2.078 . . . . 25.0 116.61 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 3.1 m-20 -91.87 160.55 15.24 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 118.508 -0.758 . . . . 25.0 112.299 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 153' ' ' ASP . . . -138.57 159.9 40.93 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 101.221 -3.622 . . . . 25.0 101.221 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -90.99 153.36 20.21 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 124.379 1.071 . . . . 50.0 108.538 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -136.95 164.71 27.7 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.849 -1.94 . . . . 50.0 111.021 164.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.54 133.38 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 111.991 -2.368 . . . . 75.0 115.557 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -135.33 136.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 124.091 1.901 . . . . 25.0 106.413 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 72' ' ' LYS 0.284 22.3 t0 -102.92 150.43 23.53 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 101.246 -3.613 . . . . 25.0 101.246 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 73' ' ' HIS . 27.2 m -144.83 167.07 11.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 116.631 -1.652 . . . . 50.0 107.662 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 10.4 t0 -133.52 132.97 41.59 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.3 mt -126.12 117.12 22.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 107.813 -1.18 . . . . 50.0 107.813 -164.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.0 162.31 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 117.926 2.565 . . . . 50.0 117.926 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.4 ' H ' HD23 ' A' ' 143' ' ' LEU . 7.1 m120 -69.84 160.93 30.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.235 1.814 . . . . 25.0 107.835 166.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.1 mttt . . . . . 0 C--O 1.266 1.953 0 N-CA-C 118.318 2.71 . . . . 25.0 118.318 -176.855 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 51.5 m80 . . . . . 1 N--CA 1.572 5.642 0 CA-C-O 120.832 0.349 . . . . 25.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.01 174.15 36.76 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-O 117.409 -1.773 . . . . 25.0 116.865 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -126.29 171.45 10.93 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 123.436 1.589 . . . . 50.0 107.703 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm -81.73 116.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 O-C-N 120.024 -1.672 . . . . 25.0 108.539 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.05 -40.92 30.06 Favored 'General case' 0 C--O 1.268 2.058 0 CA-C-N 115.424 -0.807 . . . . 25.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -154.55 136.34 9.36 Favored Pre-proline 0 C--O 1.199 -1.599 0 N-CA-C 105.183 -2.154 . . . . 25.0 105.183 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.03 145.61 65.66 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 C-N-CA 130.698 1.541 . . . . 25.0 115.226 -1.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.32 170.31 50.47 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 120.916 -0.659 . . . . 25.0 111.758 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 84.7 p -70.28 162.18 28.96 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.314 2.339 . . . . 25.0 117.314 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -68.71 -3.45 12.16 Favored 'General case' 0 CA--C 1.581 2.16 0 CA-C-N 118.916 0.78 . . . . 25.0 110.471 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.23 -27.71 68.18 Favored 'General case' 0 C--O 1.197 -1.666 0 C-N-CA 118.949 -1.1 . . . . 25.0 110.911 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.82 91.84 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-O 122.962 1.363 . . . . 25.0 108.436 171.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.77 -10.71 59.42 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 124.215 1.959 . . . . 75.0 115.634 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -86.1 -9.57 56.44 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 118.346 -2.721 . . . . 25.0 108.384 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.8 t -65.54 150.09 48.98 Favored 'General case' 0 C--O 1.208 -1.122 0 O-C-N 119.396 -2.065 . . . . 25.0 106.99 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -75.54 -3.35 33.67 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 117.954 2.576 . . . . 25.0 117.954 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.4 -23.65 67.01 Favored 'General case' 0 C--O 1.199 -1.563 0 C-N-CA 125.178 1.391 . . . . 25.0 110.67 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -75.32 3.65 8.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.244 1.942 . . . . 50.0 116.244 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.76 -20.42 1.82 Allowed Glycine 0 C--O 1.255 1.437 0 O-C-N 119.357 -2.089 . . . . 25.0 117.875 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . 0.272 75.3 t80 76.2 -47.58 0.56 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 119.716 3.228 . . . . 50.0 119.716 168.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.9 mt -62.47 -31.06 71.73 Favored 'General case' 0 C--O 1.26 1.609 0 O-C-N 121.316 -0.865 . . . . 50.0 109.205 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -142.5 165.21 28.03 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 118.476 -0.774 . . . . 25.0 112.965 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -163.58 168.97 19.33 Favored 'General case' 0 C--O 1.175 -2.843 0 N-CA-C 105.304 -2.11 . . . . 50.0 105.304 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -152.37 76.07 1.14 Allowed 'General case' 0 C--O 1.193 -1.886 0 N-CA-C 107.902 -1.147 . . . . 25.0 107.902 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -38.11 65.83 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.763 -1.211 . . . . 25.0 114.136 -176.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.01 101.82 0.42 Allowed Glycine 0 CA--C 1.541 1.713 0 N-CA-C 119.467 2.547 . . . . 25.0 119.467 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 m -47.66 -16.15 0.07 Allowed 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 118.574 2.805 . . . . 25.0 118.574 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 70' ' ' TRP . 0.6 OUTLIER -62.98 -18.66 21.82 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.738 0 O-C-N 119.992 -1.692 . . . . 50.0 111.699 178.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -74.55 -17.21 60.77 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.265 1.026 . . . . 25.0 111.905 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -74.55 -50.17 19.07 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.818 -1.537 . . . . 50.0 111.086 -162.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -143.41 63.39 12.49 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.742 -1.224 . . . . 25.0 112.38 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.74 -26.47 38.91 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 115.869 -2.287 . . . . 25.0 114.203 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -60.01 -9.81 3.53 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.024 2.602 . . . . 25.0 118.024 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -74.91 -5.47 43.91 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 116.633 -1.651 . . . . 25.0 113.236 -168.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.0 122.58 25.11 Favored 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 120.6 1.545 . . . . 50.0 112.807 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -136.2 165.17 26.36 Favored 'General case' 0 C--O 1.261 1.691 0 N-CA-C 114.87 1.433 . . . . 25.0 114.87 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.92 143.96 30.83 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 160.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -87.92 158.58 18.65 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 103.514 -2.772 . . . . 25.0 103.514 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -76.74 167.47 21.77 Favored 'General case' 0 C--O 1.29 3.186 0 CA-C-O 123.316 1.531 . . . . 25.0 106.982 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.41 17.25 10.69 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 114.335 -3.48 . . . . 25.0 116.253 -171.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -87.96 152.34 50.83 Favored Pre-proline 0 C--O 1.254 1.331 1 CA-C-N 124.974 4.387 . . . . 25.0 108.853 -172.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.72 -179.66 27.95 Favored 'Cis proline' 0 N--CA 1.471 0.16 0 C-N-CA 134.693 3.205 . . . . 25.0 111.221 -3.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -73.8 -22.24 59.88 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 116.559 -2.057 . . . . 25.0 114.4 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -58.47 -47.73 83.1 Favored 'General case' 0 C--O 1.199 -1.598 0 N-CA-C 118.423 2.749 . . . . 25.0 118.423 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.47 175.48 54.4 Favored Glycine 0 N--CA 1.496 2.699 0 O-C-N 118.872 -2.392 . . . . 25.0 111.887 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.52 165.11 33.5 Favored 'Trans proline' 0 CA--C 1.485 -1.973 0 O-C-N 123.133 1.07 . . . . 25.0 113.356 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.82 39.6 Favored 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 118.041 -1.464 . . . . 25.0 112.613 171.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.32 -176.32 4.78 Favored 'General case' 0 C--N 1.311 -1.078 1 N-CA-C 97.721 -4.918 . . . . 25.0 97.721 162.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.34 -1.49 87.44 Favored Glycine 0 C--O 1.2 -1.977 0 O-C-N 118.244 -2.785 . . . . 25.0 115.542 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -77.23 0.7 20.96 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.978 -1.111 . . . . 25.0 111.987 -169.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.7 mt -72.58 -35.17 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 105.388 -2.078 . . . . 25.0 105.388 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.6 96.43 Favored 'General case' 0 C--O 1.284 2.909 0 N-CA-C 115.606 1.706 . . . . 25.0 115.606 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.4 p -92.2 -9.28 42.86 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.377 -0.374 . . . . 25.0 109.996 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.52 17.8 9.89 Favored 'General case' 0 N--CA 1.514 2.763 0 C-N-CA 128.745 2.818 . . . . 25.0 111.591 -174.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.94 -13.78 80.61 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 114.187 -1.37 . . . . 25.0 110.782 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.11 9.16 31.38 Favored Glycine 0 CA--C 1.556 2.61 0 N-CA-C 107.837 -2.105 . . . . 25.0 107.837 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 60' ' ' GLY . 29.6 mt -123.64 31.13 5.99 Favored 'General case' 0 C--O 1.199 -1.604 0 CA-C-N 113.946 -1.127 . . . . 50.0 112.992 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -69.82 -25.59 63.84 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 101.253 -3.61 . . . . 50.0 101.253 157.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.43 -15.45 80.33 Favored Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.804 -1.553 . . . . 25.0 110.433 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 57' ' ' LEU . . . -66.48 -29.85 75.51 Favored Glycine 0 CA--C 1.493 -1.342 0 O-C-N 126.954 2.208 . . . . 25.0 113.081 -170.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.51 -42.08 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 O-C-N 119.805 -1.997 . . . . 25.0 111.985 174.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.44 -23.94 50.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.83 -1.174 . . . . 75.0 107.83 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.7 -31.2 64.84 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.73 1.252 . . . . 50.0 113.216 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -89.93 35.48 0.85 Allowed 'General case' 0 C--O 1.161 -3.556 0 CA-C-N 114.167 -1.379 . . . . 25.0 111.059 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -159.7 50.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 100.432 -3.914 . . . . 25.0 100.432 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.8 t -140.69 179.58 6.61 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 102.081 -3.303 . . . . 25.0 102.081 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.55 -31.55 65.36 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 123.677 2.944 . . . . 25.0 111.478 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.89 21.59 0.84 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 116.945 -1.503 . . . . 25.0 114.549 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -60.8 90.25 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.809 2.444 . . . . 25.0 106.014 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.491 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -17.25 131.03 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.5 2 CA-C-N 106.614 -4.812 . . . . 25.0 118.806 171.881 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -68.93 142.86 54.61 Favored 'General case' 0 CA--C 1.476 -1.901 0 N-CA-C 117.733 2.494 . . . . 50.0 117.733 -160.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -112.76 147.2 37.37 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.046 1.748 . . . . 25.0 108.496 -166.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -122.84 137.61 54.88 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-O 116.493 -1.718 . . . . 25.0 108.451 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.0 mt -96.47 119.49 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 105.585 -2.006 . . . . 25.0 105.585 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.8 mtp -128.1 174.63 9.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.824 1.249 . . . . 25.0 111.718 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -112.54 171.16 7.69 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.434 1.493 . . . . 25.0 110.147 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.67 170.42 53.21 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 105.997 -2.841 . . . . 25.0 105.997 171.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.14 178.21 15.4 Favored Glycine 0 C--N 1.285 -2.302 2 O-C-N 115.882 -4.305 . . . . 25.0 109.614 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.81 137.32 51.72 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 127.645 2.615 . . . . 25.0 113.651 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -110.74 134.93 52.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 111.765 -2.47 . . . . 25.0 106.189 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -92.18 134.03 35.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 117.56 -3.212 . . . . 25.0 112.948 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.85 127.0 50.03 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 118.829 -2.419 . . . . 50.0 109.371 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.0 m -140.22 126.93 20.43 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.415 -1.328 . . . . 25.0 107.415 -167.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -104.05 162.95 12.72 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 128.938 3.899 . . . . 25.0 109.014 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 t -149.29 146.47 27.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 103.331 -2.84 . . . . 25.0 103.331 165.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.48 143.07 49.46 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 127.123 2.169 . . . . 50.0 111.42 173.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -96.77 -5.16 39.2 Favored 'General case' 0 C--O 1.27 2.169 0 C-N-CA 127.072 2.149 . . . . 25.0 115.173 -168.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.87 137.57 12.59 Favored Pre-proline 0 N--CA 1.481 1.112 0 N-CA-C 103.529 -2.767 . . . . 25.0 103.529 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.5 137.78 61.7 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 115.404 -2.597 . . . . 25.0 116.167 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -148.03 169.2 20.45 Favored 'General case' 0 CA--C 1.557 1.222 1 N-CA-C 99.761 -4.163 . . . . 25.0 99.761 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -111.57 113.11 25.3 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 123.744 1.735 . . . . 25.0 108.402 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.9 m -71.98 136.02 46.62 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 113.094 -1.866 . . . . 25.0 111.847 172.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 -47.13 5.44 Favored 'General case' 0 C--O 1.274 2.376 0 CA-C-O 122.722 1.248 . . . . 25.0 112.624 167.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.24 159.01 44.75 Favored 'General case' 0 C--O 1.219 -0.547 1 O-C-N 116.011 -4.18 . . . . 25.0 102.242 175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -142.06 152.03 42.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 116.821 -1.952 . . . . 25.0 112.604 160.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -129.1 151.58 49.62 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 126.425 1.89 . . . . 25.0 109.771 -156.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.68 147.17 50.05 Favored 'General case' 0 C--O 1.194 -1.834 0 O-C-N 123.498 0.499 . . . . 50.0 111.311 156.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.31 163.02 28.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 104.286 -2.487 . . . . 50.0 104.286 172.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.79 133.55 67.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 163.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -73.48 131.94 42.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 101.88 -3.378 . . . . 25.0 101.88 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -87.27 104.41 16.37 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 125.8 2.714 . . . . 25.0 105.753 -169.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.08 113.25 1.46 Allowed 'General case' 0 C--O 1.279 2.607 0 O-C-N 119.233 -2.167 . . . . 25.0 110.341 153.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.88 40.21 7.72 Favored Glycine 0 C--O 1.181 -3.162 0 C-N-CA 116.912 -2.566 . . . . 25.0 108.837 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -55.87 160.63 2.59 Favored 'General case' 0 CA--C 1.579 2.063 0 O-C-N 120.376 -1.661 . . . . 25.0 109.851 168.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -80.71 117.12 66.46 Favored Pre-proline 0 C--O 1.266 1.933 0 N-CA-C 102.596 -3.113 . . . . 25.0 102.596 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.11 -25.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 N-CA-C 116.36 1.638 . . . . 25.0 116.36 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.33 -6.19 57.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 112.217 -2.265 . . . . 75.0 106.111 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.55 150.9 46.36 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 114.847 -2.501 . . . . 25.0 110.027 -171.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . 0.294 0.0 OUTLIER -2.52 87.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.264 1.794 2 C-N-CA 125.642 4.228 . . . . 25.0 122.698 176.045 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.57 -34.12 72.3 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 110.301 -3.136 . . . . 50.0 109.595 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -87.81 -10.05 52.04 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.695 2.109 . . . . 25.0 116.695 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.84 -38.41 0.64 Allowed 'General case' 0 C--O 1.185 -2.308 0 N-CA-C 121.468 3.877 . . . . 25.0 121.468 -170.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.6 -9.63 59.44 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 117.18 -3.45 . . . . 25.0 111.871 171.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.63 4.98 10.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.378 -0.929 . . . . 25.0 112.849 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.62 167.33 22.18 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.755 0.788 . . . . 50.0 112.782 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -117.73 141.83 47.95 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.193 160.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 tp -67.33 132.09 47.01 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.319 -2.104 . . . . 50.0 105.319 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 tt -110.97 -14.2 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 118.928 2.936 . . . . 25.0 118.928 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.82 165.69 30.9 Favored Glycine 0 C--O 1.212 -1.269 0 CA-C-O 115.217 -2.991 . . . . 25.0 112.43 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.36 21.88 Favored 'General case' 0 N--CA 1.418 -2.054 0 O-C-N 126.025 1.662 . . . . 25.0 108.329 168.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.38 101.02 28.42 Favored Pre-proline 0 C--N 1.312 -1.059 0 C-N-CA 125.473 1.509 . . . . 50.0 111.892 -170.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.64 170.47 8.94 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 115.752 -2.365 . . . . 25.0 113.607 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -97.31 78.27 2.71 Favored 'General case' 0 C--O 1.175 -2.851 0 CA-C-O 115.959 -1.972 . . . . 25.0 108.546 167.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.47 37.47 1.22 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.21 1.481 . . . . 50.0 110.596 -158.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.59 35.01 17.86 Favored Glycine 0 C--O 1.263 1.92 0 N-CA-C 108.834 -1.706 . . . . 25.0 108.834 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.4 m -75.3 147.01 82.27 Favored Pre-proline 0 C--O 1.263 1.796 0 N-CA-C 117.558 2.429 . . . . 25.0 117.558 -154.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.28 177.28 7.48 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 115.564 -2.491 . . . . 25.0 109.267 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.06 6.2 0.99 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.836 2.162 . . . . 25.0 116.836 -167.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.4 p -68.05 -4.44 13.45 Favored 'General case' 0 C--O 1.182 -2.494 0 CA-C-N 114.299 -1.318 . . . . 25.0 109.29 163.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.2 ttp85 -69.88 -16.52 63.25 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 114.154 1.168 . . . . 25.0 114.154 167.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -52.44 133.25 35.35 Favored 'General case' 0 C--O 1.191 -1.995 0 CA-C-O 121.905 0.859 . . . . 25.0 108.732 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -70.66 -13.12 61.95 Favored 'General case' 0 C--O 1.187 -2.197 0 CA-C-O 123.466 1.603 . . . . 75.0 111.504 -161.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.8 t -98.0 141.62 30.74 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 118.487 -2.633 . . . . 25.0 110.405 163.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -132.59 157.16 45.44 Favored 'General case' 0 C--O 1.161 -3.559 0 N-CA-C 103.376 -2.824 . . . . 25.0 103.376 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -120.9 148.45 44.03 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 100.863 -3.754 . . . . 25.0 100.863 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 50.6 mm -129.78 125.69 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -79.76 136.77 36.83 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.94 -0.475 . . . . 50.0 109.853 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.2 mm -125.96 119.76 23.99 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 126.623 2.452 . . . . 25.0 109.403 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.25 159.83 33.02 Favored 'Trans proline' 0 C--N 1.359 1.131 1 C-N-CA 113.288 -4.008 . . . . 25.0 115.353 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.51 43.45 1.1 Allowed 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 122.906 1.336 . . . . 25.0 110.833 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.23 -42.51 99.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 111.089 -2.778 . . . . 50.0 114.351 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -149.47 154.2 38.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.897 1.679 . . . . 25.0 108.742 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.25 154.81 34.9 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.859 -1.534 . . . . 50.0 106.859 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.25 168.02 11.95 Favored Glycine 0 C--N 1.364 2.104 0 O-C-N 126.224 2.202 . . . . 25.0 118.177 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.26 153.52 41.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 117.697 2.48 . . . . 50.0 117.697 -165.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.96 147.09 39.99 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 120.879 -1.138 . . . . 25.0 109.392 160.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.48 133.81 46.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 N-CA-C 103.852 -2.647 . . . . 50.0 103.852 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.81 137.92 31.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 103.962 -2.607 . . . . 25.0 103.962 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.6 mt -122.82 145.77 48.13 Favored 'General case' 0 C--O 1.184 -2.351 0 N-CA-C 104.681 -2.34 . . . . 50.0 104.681 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.22 156.48 44.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 117.983 -1.008 . . . . 25.0 110.344 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.5 132.63 31.63 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 O-C-N 127.715 3.134 . . . . 50.0 105.793 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -105.4 130.69 53.45 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 104.131 -2.544 . . . . 25.0 104.131 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -103.71 126.8 51.08 Favored 'General case' 0 C--O 1.264 1.835 0 O-C-N 118.751 -2.468 . . . . 25.0 104.962 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.06 133.06 64.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 O-C-N 116.656 -3.778 . . . . 50.0 107.823 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.25 -11.73 59.7 Favored 'General case' 0 C--O 1.178 -2.698 0 O-C-N 121.337 -0.852 . . . . 25.0 110.791 -171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -35.53 81.41 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-O 124.078 1.894 . . . . 25.0 114.077 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.2 p -143.79 159.82 41.84 Favored 'General case' 0 C--O 1.274 2.393 0 O-C-N 120.924 -1.11 . . . . 25.0 112.089 -164.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -76.98 -23.98 52.28 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.999 -1.111 . . . . 25.0 107.999 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.49 151.85 45.54 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.041 -0.981 . . . . 25.0 110.85 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -123.9 159.0 30.65 Favored 'General case' 0 C--O 1.27 2.182 0 N-CA-C 102.039 -3.319 . . . . 25.0 102.039 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -111.72 154.41 25.04 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 104.31 -2.478 . . . . 50.0 104.31 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.36 149.48 50.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 110.971 -2.831 . . . . 50.0 106.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -133.74 129.85 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.253 33.9 m -121.73 135.37 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 117.576 -3.203 . . . . 75.0 112.99 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 95.8 mt -135.64 132.59 51.47 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 105.07 -2.196 . . . . 25.0 105.07 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -104.7 141.4 36.53 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 106.118 -1.808 . . . . 25.0 106.118 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.92 149.25 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 107.725 -1.213 . . . . 50.0 107.725 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.42 94.43 4.14 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 118.26 20.96 Favored 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 125.161 1.384 . . . . 50.0 108.333 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.1 m -117.5 157.84 18.47 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-O 124.448 2.071 . . . . 50.0 108.501 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -91.64 162.55 14.45 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 111.252 -2.703 . . . . 25.0 106.401 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 CA--C 1.565 1.548 0 O-C-N 118.742 -2.474 . . . . 25.0 108.166 166.94 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 N--CA 1.517 2.9 0 CA-C-O 123.532 1.634 . . . . 25.0 113.724 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.46 -174.81 24.92 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 125.074 2.486 . . . . 25.0 111.921 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.59 161.95 39.43 Favored 'General case' 0 CA--C 1.47 -2.113 0 CA-C-N 110.77 -2.715 . . . . 50.0 108.891 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 mt -97.8 123.52 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 N-CA-C 103.805 -2.665 . . . . 25.0 103.805 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.35 -38.93 18.22 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 119.609 -1.932 . . . . 25.0 111.383 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -136.45 160.01 68.4 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 118.005 -0.998 . . . . 25.0 110.169 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.13 141.4 62.24 Favored 'Cis proline' 0 CA--C 1.477 -2.327 0 C-N-CA 133.479 2.7 . . . . 25.0 114.386 -1.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.36 -168.66 45.16 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 119.253 2.461 . . . . 25.0 119.253 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t -145.92 156.17 43.35 Favored 'General case' 0 C--O 1.266 1.944 0 CA-C-N 119.196 1.498 . . . . 25.0 107.7 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -79.25 -8.46 59.06 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.87 1.319 . . . . 25.0 109.917 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.47 -29.47 64.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.428 -0.795 . . . . 25.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.13 -27.84 67.65 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 118.686 2.847 . . . . 25.0 118.686 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.31 -21.04 17.46 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 125.903 2.002 . . . . 75.0 111.554 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.1 t -81.46 -19.71 41.81 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 105.745 -1.946 . . . . 25.0 105.745 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.0 t -60.34 151.45 27.75 Favored 'General case' 0 C--O 1.285 2.952 0 O-C-N 118.82 -2.425 . . . . 25.0 111.792 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -65.57 -26.99 68.11 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 118.522 -2.611 . . . . 25.0 110.701 169.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.33 -19.68 63.87 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-O 123.225 1.488 . . . . 25.0 111.965 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -51.55 -17.16 0.75 Allowed 'General case' 0 C--O 1.187 -2.23 0 N-CA-C 114.181 1.178 . . . . 50.0 114.181 168.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.37 2.7 0.8 Allowed Glycine 0 CA--C 1.532 1.126 1 CA-C-O 112.695 -4.392 . . . . 25.0 114.418 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . 0.289 6.9 t80 52.72 27.7 5.55 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 123.9 3.85 . . . . 50.0 116.837 -165.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.9 mt -66.55 -29.76 69.91 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 114.123 1.157 . . . . 50.0 114.123 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 45.05 59.35 3.51 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 126.467 2.354 . . . . 25.0 117.035 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -164.96 161.85 20.22 Favored 'General case' 0 CA--C 1.576 1.949 0 O-C-N 125.478 1.736 . . . . 50.0 111.223 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 52.43 48.19 23.12 Favored 'General case' 0 CA--C 1.567 1.625 1 N-CA-C 122.467 4.247 . . . . 25.0 122.467 171.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.7 -10.43 59.76 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 124.406 1.066 . . . . 25.0 111.811 165.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.09 125.15 4.71 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 120.558 1.526 . . . . 25.0 113.95 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -5.16 2.67 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 115.601 1.704 . . . . 25.0 115.601 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 m -55.59 -18.4 4.54 Favored 'Isoleucine or valine' 0 C--O 1.254 1.331 0 N-CA-C 113.792 1.034 . . . . 50.0 113.792 164.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.0 ptp -54.94 -30.18 58.13 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -101.47 -46.08 5.1 Favored 'General case' 0 CA--C 1.485 -1.529 0 O-C-N 120.908 -1.12 . . . . 50.0 110.452 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -114.3 79.06 4.93 Favored Pre-proline 0 C--O 1.264 1.826 0 N-CA-C 115.654 1.724 . . . . 25.0 115.654 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.18 -20.77 8.35 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 114.958 1.099 . . . . 25.0 114.958 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -127.5 2.36 6.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 120.25 3.426 . . . . 25.0 120.25 -161.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 49.55 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.006 -1.059 . . . . 25.0 108.163 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.59 79.92 8.16 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.42 0.628 . . . . 50.0 111.679 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -135.76 150.98 49.68 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 116.819 -1.563 . . . . 25.0 110.71 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.02 166.52 25.83 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.414 -3.18 . . . . 25.0 102.414 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -93.23 142.56 27.18 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 117.345 -1.742 . . . . 25.0 111.714 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -58.06 146.2 33.81 Favored 'General case' 0 C--O 1.205 -1.272 0 C-N-CA 119.472 -0.891 . . . . 25.0 109.112 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.12 -160.98 53.63 Favored Glycine 0 C--O 1.266 2.151 0 O-C-N 120.133 -1.605 . . . . 25.0 116.182 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -152.27 168.48 11.23 Favored Pre-proline 0 CA--C 1.574 1.867 0 O-C-N 127.101 2.295 . . . . 25.0 108.342 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.96 134.46 2.01 Favored 'Cis proline' 0 C--N 1.39 2.75 1 C-N-CA 137.16 4.233 . . . . 25.0 117.2 -6.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -131.56 -1.3 3.89 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 116.019 1.859 . . . . 25.0 116.019 -163.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 t 62.19 -78.21 0.03 OUTLIER 'General case' 0 C--O 1.194 -1.857 0 N-CA-C 117.645 2.461 . . . . 25.0 117.645 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.63 177.57 26.09 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 117.639 -2.22 . . . . 25.0 110.609 163.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.69 148.71 78.28 Favored 'Trans proline' 0 C--N 1.367 1.501 0 CA-C-N 120.17 1.985 . . . . 25.0 113.85 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.1 151.74 26.88 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-O 124.798 2.237 . . . . 25.0 108.106 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -140.34 176.19 8.97 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 100.218 -3.994 . . . . 25.0 100.218 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.34 34.47 74.67 Favored Glycine 0 N--CA 1.426 -1.998 0 C-N-CA 118.824 -1.655 . . . . 25.0 110.17 -153.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -130.92 54.55 1.9 Allowed 'General case' 0 C--O 1.27 2.145 1 N-CA-C 98.524 -4.621 . . . . 25.0 98.524 -171.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 66.8 mt -74.21 -30.4 26.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 111.545 -2.57 . . . . 25.0 107.849 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.68 -30.73 46.32 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.993 1.849 . . . . 25.0 115.993 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 p -89.46 -5.78 57.04 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.331 -0.856 . . . . 25.0 112.642 168.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.32 13.42 3.99 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 127.047 2.139 . . . . 25.0 111.452 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.92 -33.9 85.41 Favored Glycine 0 CA--C 1.495 -1.219 0 O-C-N 119.21 -2.181 . . . . 25.0 111.377 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.22 -0.67 86.82 Favored Glycine 0 C--O 1.198 -2.121 0 CA-C-N 113.838 -1.181 . . . . 25.0 111.484 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt -112.02 -16.56 13.05 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 114.715 1.376 . . . . 50.0 114.715 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.09 -34.99 69.09 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.775 -1.935 . . . . 50.0 105.775 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -11.3 85.26 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-O 122.805 1.225 . . . . 25.0 110.245 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.6 -29.9 76.21 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 123.85 1.805 . . . . 25.0 114.599 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -74.92 -39.19 44.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 O-C-N 119.986 -1.89 . . . . 25.0 107.111 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -68.88 -27.8 66.12 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 119.269 -2.144 . . . . 75.0 109.783 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 -27.6 67.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.521 -1.362 . . . . 50.0 110.843 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -80.09 3.7 19.53 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 120.574 -1.329 . . . . 25.0 107.641 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -128.45 43.85 3.06 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.122 -2.918 . . . . 25.0 103.122 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 t -134.9 161.14 36.08 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.563 -1.336 . . . . 25.0 109.799 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.17 -29.02 68.41 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-N 114.45 -1.25 . . . . 25.0 111.553 161.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -72.65 0.39 10.77 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.911 1.449 . . . . 25.0 114.911 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -76.13 93.33 3.32 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 103.755 -2.683 . . . . 25.0 103.755 169.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -45.29 153.83 0.2 Allowed 'General case' 0 C--O 1.263 1.791 0 CA-C-N 111.411 -2.631 . . . . 25.0 107.972 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -56.19 136.17 52.93 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 115.247 1.573 . . . . 50.0 115.247 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -94.32 156.24 16.61 Favored 'General case' 0 N--CA 1.528 3.444 0 CA-C-O 117.399 -1.286 . . . . 25.0 112.886 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -153.8 151.95 30.14 Favored 'General case' 0 C--O 1.26 1.65 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 tt -87.43 135.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtp -144.56 -172.76 3.87 Favored 'General case' 0 C--O 1.186 -2.255 0 CA-C-O 123.06 1.409 . . . . 25.0 109.029 -171.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 p -127.37 172.65 10.45 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 104.61 -2.367 . . . . 25.0 104.61 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.61 -178.26 25.2 Favored Glycine 0 CA--C 1.542 1.754 0 O-C-N 124.692 1.245 . . . . 25.0 112.754 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.54 -156.3 30.29 Favored Glycine 0 CA--C 1.559 2.83 0 CA-C-O 115.697 -2.724 . . . . 25.0 111.032 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -72.64 143.33 48.2 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 120.472 3.508 . . . . 25.0 120.472 -171.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -125.5 143.51 50.97 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 101.51 -3.515 . . . . 25.0 101.51 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.7 m -99.11 127.21 45.03 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 105.331 -2.1 . . . . 25.0 105.331 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.61 128.44 55.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 104.191 -2.522 . . . . 50.0 104.191 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.2 m -134.2 109.13 8.67 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 105.4 -2.074 . . . . 25.0 105.4 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -83.31 149.75 26.56 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.641 -1.163 . . . . 25.0 107.896 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.3 t -142.54 122.68 13.76 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 120.922 1.692 . . . . 25.0 109.652 173.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -109.73 143.27 39.76 Favored 'General case' 0 N--CA 1.423 -1.782 0 O-C-N 119.503 -1.998 . . . . 50.0 113.987 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -91.43 -12.67 34.05 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.487 -2.142 . . . . 25.0 110.433 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.18 143.76 25.9 Favored Pre-proline 0 C--O 1.273 2.315 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 168.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.08 140.88 25.75 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 124.078 3.185 . . . . 25.0 117.732 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -138.6 151.4 47.23 Favored 'General case' 0 CA--C 1.55 0.958 1 N-CA-C 97.77 -4.9 . . . . 25.0 97.77 172.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . 0.254 67.2 m-80 -78.68 109.69 13.14 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 121.998 2.181 . . . . 25.0 113.772 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.473 HG21 ' CE3' ' A' ' 95' ' ' TRP . 7.9 m -79.38 135.69 36.77 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 123.684 1.707 . . . . 25.0 109.729 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 155' ' ' ALA . 2.3 p -80.59 -50.11 10.41 Favored 'General case' 0 CA--C 1.571 1.759 0 O-C-N 116.632 -3.792 . . . . 25.0 106.706 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -164.27 173.88 11.79 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 127.084 2.154 . . . . 25.0 113.513 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.473 ' CE3' HG21 ' A' ' 92' ' ' THR . 37.6 p90 -143.32 158.36 43.7 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.098 -1.002 . . . . 25.0 112.767 164.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -133.84 155.25 50.18 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -150.14 149.93 30.95 Favored 'General case' 0 C--O 1.283 2.867 0 CA-C-N 120.789 1.631 . . . . 50.0 114.137 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.64 158.35 44.26 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.632 1.573 . . . . 50.0 109.929 -157.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.22 159.88 13.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 164.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 p -71.82 155.71 40.12 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.648 1.217 . . . . 25.0 110.783 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -124.04 113.07 17.91 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.653 -1.279 . . . . 25.0 113.821 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.08 161.23 8.84 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 114.461 -2.685 . . . . 25.0 110.384 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.1 -0.16 47.74 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 122.827 2.558 . . . . 25.0 115.427 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -59.51 159.05 8.74 Favored 'General case' 0 C--O 1.271 2.199 0 N-CA-C 113.892 1.071 . . . . 25.0 113.892 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -160.77 144.02 9.86 Favored Pre-proline 0 C--O 1.193 -1.916 0 N-CA-C 104.486 -2.412 . . . . 25.0 104.486 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -69.87 -15.94 36.89 Favored 'Trans proline' 0 C--O 1.177 -2.528 0 C-N-CA 114.003 -3.532 . . . . 25.0 119.594 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.84 -21.19 65.2 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.918 1.818 . . . . 75.0 109.131 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -99.47 163.54 18.36 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 103.384 -2.821 . . . . 25.0 103.384 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -32.37 30.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.249 1 C-N-CA 129.759 6.973 . . . . 25.0 121.64 154.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -40.39 60.26 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 115.922 -1.989 . . . . 50.0 114.794 -175.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -75.59 -7.93 55.48 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 116.636 2.087 . . . . 25.0 116.636 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -120.08 -62.55 1.47 Allowed 'General case' 0 C--O 1.198 -1.621 0 O-C-N 121.25 -0.906 . . . . 25.0 112.441 -166.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.51 18.25 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 118.014 2.598 . . . . 25.0 118.014 163.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -65.37 -26.51 68.04 Favored 'General case' 0 CA--C 1.483 -1.602 0 O-C-N 127.116 2.76 . . . . 25.0 109.65 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -141.07 160.52 39.9 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 103.586 -2.746 . . . . 50.0 103.586 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -129.95 135.15 47.99 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 106.65 -1.611 . . . . 25.0 106.65 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.64 145.48 54.78 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 104.173 -2.528 . . . . 50.0 104.173 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.7 tt -128.71 -12.52 2.94 Favored 'Isoleucine or valine' 0 C--O 1.263 1.783 0 CA-C-O 125.848 2.737 . . . . 25.0 112.252 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.75 167.12 37.85 Favored Glycine 0 C--O 1.268 2.234 0 CA-C-O 124.142 1.968 . . . . 25.0 112.266 168.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.84 161.29 40.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 112.991 -1.605 . . . . 25.0 107.968 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.49 111.68 15.16 Favored Pre-proline 0 C--O 1.207 -1.177 0 N-CA-C 104.124 -2.546 . . . . 50.0 104.124 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.4 162.05 36.67 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 117.144 -1.438 . . . . 25.0 110.885 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 129' ' ' SER . 65.6 t-80 -120.11 49.6 1.39 Allowed 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.229 -1.767 . . . . 25.0 106.229 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -76.06 -32.34 59.24 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 112.38 -2.191 . . . . 50.0 110.133 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 172.04 -175.6 45.3 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 119.98 -1.7 . . . . 25.0 115.341 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 57.8 m 72.19 155.72 0.16 Allowed Pre-proline 0 CA--C 1.569 1.698 0 N-CA-C 117.658 2.466 . . . . 25.0 117.658 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.23 -3.33 13.64 Favored 'Trans proline' 0 CA--C 1.572 2.415 0 C-N-CA 115.642 -2.439 . . . . 25.0 113.38 -166.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.25 76.52 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 116.84 2.163 . . . . 25.0 116.84 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 123' ' ' HIS . 83.8 p -80.81 -21.95 40.44 Favored 'General case' 0 C--O 1.273 2.314 0 CA-C-O 124.259 1.981 . . . . 25.0 110.894 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -72.81 -28.55 62.63 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.111 -1.859 . . . . 25.0 111.918 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.55 140.59 39.75 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.709 -3.071 . . . . 25.0 102.709 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mt -103.67 -38.63 7.02 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 124.346 2.022 . . . . 75.0 109.934 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 t -77.36 127.05 31.9 Favored 'General case' 0 N--CA 1.411 -2.421 0 O-C-N 120.361 -1.462 . . . . 25.0 108.392 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -140.04 156.43 46.61 Favored 'General case' 0 CA--C 1.488 -1.442 0 O-C-N 118.937 -2.352 . . . . 25.0 110.607 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -106.1 141.25 37.78 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 125.308 1.63 . . . . 25.0 107.893 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.91 121.13 46.38 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.187 0 C-N-CA 125.944 1.698 . . . . 25.0 109.995 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -82.47 126.14 31.9 Favored 'General case' 0 C--O 1.175 -2.82 0 CA-C-N 121.103 1.774 . . . . 50.0 106.667 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -110.79 123.56 35.22 Favored Pre-proline 0 C--O 1.265 1.879 0 N-CA-C 103.584 -2.747 . . . . 25.0 103.584 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.41 146.17 55.44 Favored 'Trans proline' 0 CA--C 1.585 3.037 0 C-N-CA 116.847 -1.635 . . . . 25.0 115.351 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.1 67.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 125.828 2.727 . . . . 25.0 104.879 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -62.92 -28.6 70.18 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 119.729 -1.857 . . . . 50.0 113.238 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -143.63 158.85 43.36 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.368 -1.716 . . . . 25.0 106.368 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.95 138.56 39.74 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 102.028 -3.323 . . . . 50.0 102.028 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 147.14 177.49 21.71 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 124.992 2.44 . . . . 25.0 116.18 -173.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 137.88 56.6 Favored 'General case' 0 C--O 1.192 -1.953 0 C-N-CA 126.287 1.835 . . . . 50.0 113.443 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -145.96 167.22 23.84 Favored 'General case' 0 C--O 1.255 1.355 0 C-N-CA 126.684 1.994 . . . . 25.0 109.017 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 t -124.16 144.47 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.425 -1.324 . . . . 50.0 107.425 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.16 113.05 43.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.303 -2.851 . . . . 25.0 103.303 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.56 153.06 21.66 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-N 119.029 0.831 . . . . 50.0 110.55 -170.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.52 136.95 23.86 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 120.515 -1.365 . . . . 25.0 109.416 -173.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.56 136.12 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.403 -0.919 . . . . 50.0 112.0 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -118.65 125.62 50.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.181 2.592 . . . . 25.0 104.893 -170.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -113.69 140.98 47.79 Favored 'General case' 0 C--O 1.269 2.109 0 O-C-N 125.679 1.862 . . . . 25.0 108.996 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.3 139.74 26.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 N-CA-C 104.914 -2.254 . . . . 50.0 104.914 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -92.6 -20.44 20.89 Favored 'General case' 0 C--O 1.196 -1.753 0 CA-C-N 112.324 -2.216 . . . . 25.0 112.149 177.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.27 -23.75 54.44 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.905 1.817 . . . . 25.0 115.905 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.2 p -145.3 -179.79 6.88 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 115.6 -2.143 . . . . 25.0 113.245 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -89.01 1.1 56.04 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-O 126.379 2.99 . . . . 25.0 113.014 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.43 158.54 31.26 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 119.781 -1.824 . . . . 25.0 112.739 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.75 159.35 29.99 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -145.42 158.24 43.87 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 124.648 2.166 . . . . 50.0 109.643 172.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -118.47 144.38 46.04 Favored 'General case' 0 C--O 1.193 -1.909 0 CA-C-N 110.824 -2.898 . . . . 50.0 104.101 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -141.51 138.04 32.49 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.312 -1.328 . . . . 25.0 107.886 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.61 156.49 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 120.596 1.543 . . . . 75.0 109.715 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.46 115.16 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.444 1.592 . . . . 25.0 108.322 172.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.18 118.65 22.06 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 117.155 -1.402 . . . . 25.0 108.618 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.88 156.48 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 120.466 1.484 . . . . 50.0 113.45 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -111.7 98.63 7.55 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 103.173 -2.899 . . . . 25.0 103.173 171.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.17 135.02 34.07 Favored 'General case' 0 N--CA 1.499 2.009 1 N-CA-C 99.734 -4.173 . . . . 50.0 99.734 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.01 169.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 119.564 -1.96 . . . . 50.0 113.67 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -59.8 139.42 57.32 Favored 'General case' 0 C--O 1.282 2.791 0 C-N-CA 119.23 -0.988 . . . . 25.0 109.814 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 CA--C 1.577 1.983 0 N-CA-C 115.756 1.762 . . . . 25.0 115.756 177.227 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.882 -1.056 . . . . 25.0 109.245 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.99 170.45 37.66 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 120.764 3.066 . . . . 25.0 120.764 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -136.49 151.79 49.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.818 1.784 . . . . 50.0 115.818 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.28 139.17 20.32 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 101.181 -3.636 . . . . 25.0 101.181 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -112.08 -28.14 8.11 Favored 'General case' 0 C--N 1.362 1.112 0 N-CA-C 113.519 0.933 . . . . 25.0 113.519 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -151.5 140.53 13.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 104.597 -2.371 . . . . 25.0 104.597 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.97 147.27 86.85 Favored 'Cis proline' 0 N--CA 1.499 1.834 0 CA-C-N 119.844 0.98 . . . . 25.0 114.53 -5.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.25 174.25 47.54 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.939 1.936 . . . . 25.0 117.939 161.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -131.62 141.45 49.64 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.472 1.909 . . . . 25.0 107.663 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -58.07 -31.5 67.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 115.105 1.52 . . . . 25.0 115.105 167.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.51 -35.05 70.62 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 125.961 2.038 . . . . 25.0 112.175 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.02 94.66 Favored 'General case' 0 C--O 1.254 1.307 0 O-C-N 121.399 -0.813 . . . . 25.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.23 -16.59 49.03 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.302 -0.999 . . . . 75.0 108.302 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -84.62 -11.74 55.37 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.803 1.241 . . . . 25.0 111.806 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.2 t -65.55 138.84 58.32 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 114.899 1.444 . . . . 25.0 114.899 -173.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -73.96 0.52 13.24 Favored 'General case' 0 C--O 1.177 -2.754 0 O-C-N 117.753 -3.092 . . . . 25.0 114.249 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.85 -36.07 82.72 Favored 'General case' 0 CA--C 1.561 1.384 0 O-C-N 119.315 -2.116 . . . . 25.0 110.262 158.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -69.79 -53.27 19.04 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.502 1.144 . . . . 50.0 110.463 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.16 64.34 2.33 Favored Glycine 0 N--CA 1.501 2.979 0 CA-C-O 126.299 3.166 . . . . 25.0 113.382 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -65.62 -39.06 91.07 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 110.119 -3.041 . . . . 50.0 110.664 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.1 mt -91.12 -40.43 11.6 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 114.858 1.429 . . . . 50.0 114.858 -173.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -152.76 159.68 43.11 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 102.341 -3.207 . . . . 25.0 102.341 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.97 164.14 27.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 104.126 -2.546 . . . . 50.0 104.126 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -150.55 22.04 0.81 Allowed 'General case' 0 CA--C 1.576 1.973 0 O-C-N 125.088 1.493 . . . . 25.0 110.719 -162.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.7 t -61.98 -21.68 65.03 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 119.855 3.28 . . . . 25.0 119.855 -163.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.1 44.25 45.44 Favored Glycine 0 C--O 1.262 1.866 0 C-N-CA 116.211 -2.9 . . . . 25.0 110.683 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.52 -8.52 0.56 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 117.685 2.476 . . . . 25.0 117.685 -159.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.13 -17.55 6.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 O-C-N 121.079 -1.013 . . . . 50.0 109.549 165.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -2.13 0.51 Allowed 'General case' 0 C--O 1.281 2.72 1 O-C-N 115.792 -4.317 . . . . 25.0 117.563 164.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -65.95 -46.75 77.0 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 123.304 2.775 . . . . 50.0 104.784 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.37 73.04 31.25 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 117.529 2.418 . . . . 25.0 117.529 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -71.57 -21.18 26.05 Favored 'Trans proline' 0 C--N 1.393 2.882 0 CA-C-O 122.863 1.11 . . . . 25.0 112.066 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -82.87 -1.22 51.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.345 1.545 . . . . 25.0 112.11 -171.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 t -76.33 -18.0 59.14 Favored 'General case' 0 C--O 1.285 2.961 0 CA-C-N 111.317 -2.674 . . . . 25.0 109.148 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.52 119.22 15.36 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.731 1.605 . . . . 50.0 108.486 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -152.68 176.34 11.86 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 105.151 -2.166 . . . . 25.0 105.151 -172.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.25 144.58 30.87 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 166.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -129.3 145.88 51.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.459 1.481 . . . . 25.0 109.616 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -58.06 160.42 4.89 Favored 'General case' 0 C--O 1.199 -1.595 0 CA-C-N 113.435 -1.712 . . . . 25.0 109.738 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.74 -143.74 29.39 Favored Glycine 0 C--O 1.253 1.309 0 N-CA-C 109.351 -1.5 . . . . 25.0 109.351 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -152.96 161.14 29.86 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 110.816 -2.692 . . . . 25.0 109.957 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -60.8 126.53 3.38 Favored 'Cis proline' 0 CA--C 1.487 -1.851 0 C-N-CA 134.673 3.197 . . . . 25.0 112.386 -2.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -61.98 -34.21 75.73 Favored 'General case' 0 CA--C 1.586 2.355 0 O-C-N 126.244 2.215 . . . . 25.0 108.641 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t 62.38 -81.66 0.02 OUTLIER 'General case' 0 C--O 1.248 0.975 0 O-C-N 125.894 1.996 . . . . 25.0 112.527 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.05 -173.57 15.46 Favored Glycine 0 C--O 1.286 3.364 0 CA-C-O 126.884 3.491 . . . . 25.0 112.904 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -63.84 164.62 21.05 Favored 'Trans proline' 0 C--O 1.258 1.497 0 C-N-CA 123.428 2.752 . . . . 25.0 111.62 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.87 74.01 0.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.976 -1.465 . . . . 25.0 110.719 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -67.72 153.29 44.04 Favored 'General case' 0 C--O 1.289 3.184 0 O-C-N 119.9 -1.75 . . . . 25.0 113.268 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.05 -2.46 69.68 Favored Glycine 0 C--O 1.197 -2.214 0 N-CA-C 117.607 1.803 . . . . 25.0 117.607 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -102.53 40.03 1.42 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.805 1.764 . . . . 25.0 107.549 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 mm -63.18 -46.05 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 120.178 -1.576 . . . . 25.0 110.213 -170.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.1 -28.77 67.63 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 117.674 -1.61 . . . . 25.0 110.59 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.8 p -88.06 -6.15 58.09 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 118.126 -2.859 . . . . 25.0 113.166 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.41 31.82 21.38 Favored 'General case' 0 CA--C 1.459 -2.542 0 C-N-CA 127.683 2.393 . . . . 25.0 111.182 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.01 -12.74 71.87 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.11 -1.619 . . . . 25.0 116.353 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.42 -9.76 22.99 Favored Glycine 0 CA--C 1.5 -0.855 0 O-C-N 121.717 -0.872 . . . . 25.0 112.688 165.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.9 mt -115.29 4.62 14.49 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 115.631 1.715 . . . . 50.0 115.631 -169.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -78.26 -22.77 47.82 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 104.198 -2.519 . . . . 50.0 104.198 152.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.58 -18.6 77.38 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.356 -0.838 . . . . 25.0 111.385 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.3 -34.46 80.36 Favored Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 109.972 -1.251 . . . . 25.0 109.972 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 40.5 mt -61.93 -40.18 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 O-C-N 119.925 -1.926 . . . . 25.0 113.326 -175.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.04 -29.8 68.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 122.585 1.183 . . . . 75.0 109.576 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.66 -36.35 62.82 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 120.287 -1.508 . . . . 50.0 110.118 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -77.92 20.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 114.684 1.365 . . . . 25.0 114.684 166.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -147.12 40.99 1.07 Allowed 'General case' 0 C--O 1.264 1.822 0 CA-C-O 125.691 2.662 . . . . 25.0 110.097 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.3 p -137.63 -177.78 4.95 Favored 'General case' 0 CA--C 1.58 2.119 0 CA-C-N 112.325 -2.216 . . . . 25.0 115.064 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -60.09 -23.69 64.01 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 125.652 2.644 . . . . 25.0 114.789 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -93.03 18.26 9.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 118.894 -2.379 . . . . 25.0 109.599 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -70.12 90.05 0.65 Allowed 'General case' 0 C--O 1.287 3.044 0 CA-C-O 127.681 3.61 . . . . 25.0 108.581 170.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -52.48 160.91 0.76 Allowed 'General case' 0 C--O 1.272 2.241 0 CA-C-N 109.288 -3.596 . . . . 25.0 110.072 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -62.34 142.75 57.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.451 1.1 . . . . 50.0 113.755 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.8 143.58 26.58 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -117.56 125.36 50.69 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-N 123.005 2.639 . . . . 25.0 108.737 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mt -83.49 123.9 39.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 116.332 -0.395 . . . . 25.0 110.864 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 68.7 mtp -138.84 157.44 46.06 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.446 1.117 . . . . 25.0 110.217 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.4 p -89.28 179.25 6.15 Favored 'General case' 0 C--O 1.273 2.32 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.13 -170.1 29.58 Favored Glycine 0 C--O 1.194 -2.364 0 N-CA-C 110.195 -1.162 . . . . 25.0 110.195 163.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.76 179.12 46.22 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 118.736 -1.697 . . . . 25.0 115.978 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.45 149.17 36.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 119.228 -2.336 . . . . 25.0 108.549 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -129.12 157.09 42.74 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.208 -1.814 . . . . 25.0 107.93 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -120.89 157.84 28.96 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 127.078 2.736 . . . . 25.0 110.19 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -143.15 152.45 41.81 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.509 1.124 . . . . 50.0 108.534 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.0 m -137.93 141.93 40.58 Favored 'General case' 0 CA--C 1.426 -3.812 0 C-N-CA 125.304 1.442 . . . . 25.0 107.684 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -135.52 167.92 20.2 Favored 'General case' 0 C--O 1.262 1.741 1 N-CA-C 99.058 -4.423 . . . . 25.0 99.058 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -131.29 146.46 52.31 Favored 'General case' 0 C--O 1.278 2.587 0 N-CA-C 105.24 -2.133 . . . . 25.0 105.24 162.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -95.87 148.01 23.05 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-O 116.834 -1.555 . . . . 50.0 108.706 159.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -103.96 -24.5 13.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.521 1.964 . . . . 25.0 113.809 173.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.25 137.6 52.59 Favored Pre-proline 0 N--CA 1.425 -1.677 0 O-C-N 120.218 -1.551 . . . . 25.0 109.836 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -67.86 135.32 34.95 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 116.661 -1.759 . . . . 25.0 112.684 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -152.39 169.49 22.43 Favored 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.538 -2.023 . . . . 25.0 105.538 -163.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -127.58 96.21 4.47 Favored 'General case' 0 C--O 1.273 2.291 0 CA-C-O 118.186 -0.912 . . . . 25.0 108.961 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.2 m -65.4 143.22 57.87 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 120.943 1.701 . . . . 25.0 108.99 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 p -105.76 -48.79 3.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 116.46 2.022 . . . . 25.0 116.46 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -162.93 172.42 15.11 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 120.703 1.592 . . . . 25.0 110.748 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.28 149.05 32.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.442 1.019 . . . . 25.0 113.445 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -122.73 157.68 31.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 114.388 -2.72 . . . . 25.0 110.884 -170.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.06 128.84 8.64 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 125.32 2.486 . . . . 50.0 109.339 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' A' ' 117' ' ' LEU . 5.8 p90 -142.02 147.17 36.44 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 112.66 -2.064 . . . . 50.0 110.067 -168.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.1 163.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 124.071 0.948 . . . . 25.0 110.387 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 p -62.61 156.51 23.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 116.964 -1.493 . . . . 25.0 111.819 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -91.5 97.95 11.38 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 124.373 2.035 . . . . 25.0 111.404 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -56.86 154.04 9.97 Favored 'General case' 0 C--O 1.187 -2.198 0 O-C-N 117.213 -3.43 . . . . 25.0 113.782 159.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 3.03 50.34 Favored Glycine 0 CA--C 1.545 1.963 0 N-CA-C 120.454 2.941 . . . . 25.0 120.454 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.8 169.17 0.1 Allowed 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.02 1.41 . . . . 25.0 112.611 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.08 130.62 9.4 Favored Pre-proline 0 C--N 1.31 -1.114 0 N-CA-C 102.996 -2.965 . . . . 25.0 102.996 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -59.3 -31.53 95.23 Favored 'Trans proline' 0 C--N 1.373 1.848 0 N-CA-C 116.037 1.514 . . . . 25.0 116.037 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -76.81 -1.74 29.76 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 125.051 1.469 . . . . 75.0 112.186 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -121.15 -176.83 0.43 Allowed Pre-proline 0 CA--C 1.584 2.288 1 N-CA-C 100.053 -4.054 . . . . 25.0 100.053 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -55.49 16.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.477 -2.362 2 C-N-CA 126.754 4.969 . . . . 25.0 123.235 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.97 -39.91 20.79 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 124.828 3.467 . . . . 50.0 119.171 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -77.22 -20.02 55.86 Favored 'General case' 0 C--O 1.194 -1.823 0 O-C-N 120.242 -1.536 . . . . 25.0 110.867 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -91.73 -53.53 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.424 -1.423 . . . . 25.0 112.033 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.4 42.98 0.85 Allowed 'General case' 0 C--N 1.319 -0.76 0 O-C-N 119.343 -2.098 . . . . 25.0 110.527 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.92 -31.37 70.89 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 125.613 1.565 . . . . 25.0 112.434 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 146.13 47.77 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 125.318 2.485 . . . . 50.0 109.46 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -129.89 132.47 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.138 -1.601 . . . . 25.0 107.249 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 98' ' ' TYR . 15.1 tp -73.56 141.04 46.67 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 100.309 -3.96 . . . . 50.0 100.309 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.3 tt -108.12 -14.43 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 25.0 112.035 166.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.42 -173.82 43.16 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 125.893 1.996 . . . . 25.0 114.793 159.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.35 153.7 30.88 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.164 -2.902 . . . . 25.0 103.164 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.17 122.01 5.67 Favored Pre-proline 0 C--O 1.259 1.598 0 CA-C-N 119.777 1.171 . . . . 50.0 108.292 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -75.57 164.06 32.99 Favored 'Trans proline' 0 CA--C 1.494 -1.509 0 C-N-CA 115.991 -2.206 . . . . 25.0 115.312 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -133.82 72.95 1.48 Allowed 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 128.353 2.661 . . . . 25.0 109.941 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -74.76 -24.26 58.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 118.643 2.831 . . . . 50.0 118.643 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -170.58 -92.44 0.08 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 127.723 3.14 . . . . 25.0 109.889 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 t -122.0 61.07 12.95 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 114.237 1.199 . . . . 25.0 114.237 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -86.65 -167.1 0.34 Allowed 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-O 124.047 1.603 . . . . 25.0 111.664 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.86 69.58 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 118.901 -2.375 . . . . 25.0 106.178 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.5 p -79.79 18.88 0.72 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 124.616 2.151 . . . . 25.0 109.314 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -73.39 -27.1 61.29 Favored 'General case' 0 CA--C 1.491 -1.306 0 O-C-N 118.117 -2.865 . . . . 25.0 103.528 168.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.76 134.2 40.51 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 112.954 -1.93 . . . . 25.0 106.235 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 tp -87.65 -28.4 21.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.52 -1.659 . . . . 75.0 106.52 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . 0.281 44.8 t -71.68 139.86 49.39 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.874 -1.766 . . . . 25.0 110.654 173.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -149.39 156.24 41.73 Favored 'General case' 0 C--O 1.273 2.331 0 N-CA-C 106.608 -1.627 . . . . 25.0 106.608 -164.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -97.81 140.53 32.04 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 115.757 -2.068 . . . . 25.0 115.056 170.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.9 mm -127.55 130.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 125.367 1.667 . . . . 25.0 107.624 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -87.96 129.35 35.27 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-O 123.737 1.732 . . . . 50.0 108.259 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.5 mm -107.63 124.75 34.03 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 112.691 -2.05 . . . . 25.0 106.809 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.27 151.44 76.57 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-O 124.498 1.791 . . . . 25.0 107.806 176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -116.73 29.71 7.77 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 111.124 -2.762 . . . . 25.0 112.457 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -75.02 -27.99 60.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.285 -2.234 . . . . 50.0 115.656 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -152.5 164.21 38.04 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 126.026 2.079 . . . . 25.0 106.799 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -83.56 158.75 21.84 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 106.953 -1.499 . . . . 50.0 106.953 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.31 121.99 0.59 Allowed Glycine 0 N--CA 1.481 1.683 0 N-CA-C 117.054 1.582 . . . . 25.0 117.054 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 0.2 OUTLIER -66.04 139.19 58.18 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 114.279 1.214 . . . . 50.0 114.279 -178.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -135.57 168.38 19.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 119.821 -1.799 . . . . 25.0 108.147 -169.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -112.4 139.09 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 102.1 -3.296 . . . . 50.0 102.1 162.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.9 129.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 118.635 0.652 . . . . 25.0 110.801 165.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.46 143.15 48.66 Favored 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 117.087 -1.435 . . . . 50.0 113.59 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.01 160.5 37.55 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 126.143 2.152 . . . . 25.0 111.296 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . 0.288 39.5 t -144.3 125.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.29 1.036 . . . . 50.0 109.088 174.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -104.79 112.3 25.36 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 101.157 -3.645 . . . . 25.0 101.157 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -100.62 133.37 45.18 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.0 129.03 31.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 O-C-N 125.242 1.588 . . . . 50.0 109.834 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.75 -18.45 32.97 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -159.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -86.12 2.79 45.36 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 116.005 1.854 . . . . 25.0 116.005 -172.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 t -143.32 158.69 43.42 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.102 -1.444 . . . . 25.0 107.102 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -82.24 -7.44 59.62 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.327 0.967 . . . . 25.0 110.226 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -86.12 163.72 17.7 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.42 148.98 52.3 Favored 'General case' 0 C--O 1.274 2.357 0 N-CA-C 102.02 -3.326 . . . . 25.0 102.02 164.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -102.73 139.36 38.41 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 106.387 -1.708 . . . . 50.0 106.387 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -116.72 153.12 32.93 Favored 'General case' 0 C--O 1.277 2.502 0 C-N-CA 125.013 1.325 . . . . 50.0 108.499 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.72 138.34 23.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.661 0.743 . . . . 25.0 109.745 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.15 142.27 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 106.489 -1.671 . . . . 75.0 106.489 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.9 mt -136.28 127.09 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 104.166 -2.531 . . . . 25.0 104.166 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.91 145.78 25.33 Favored 'General case' 0 C--O 1.203 -1.353 0 N-CA-C 103.986 -2.598 . . . . 25.0 103.986 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.3 m -149.74 156.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 114.093 1.146 . . . . 50.0 114.093 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 54.1 t0 -121.77 99.87 6.69 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 105.202 -2.147 . . . . 25.0 105.202 172.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.09 121.27 31.26 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.48 -2.785 . . . . 50.0 103.48 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.21 165.79 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 117.099 2.259 . . . . 50.0 117.099 -171.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.64 158.81 15.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt . . . . . 0 C--O 1.261 1.684 0 C-N-CA 119.857 -0.737 . . . . 25.0 112.808 172.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.2 m80 . . . . . 1 N--CA 1.554 4.728 0 CA-C-O 121.705 0.764 . . . . 25.0 111.38 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.73 118.04 0.47 Allowed Glycine 0 CA--C 1.541 1.699 0 O-C-N 117.368 -3.333 . . . . 25.0 107.343 -14.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -130.63 144.82 51.68 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 122.058 2.929 . . . . 50.0 111.209 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.5 mt -99.19 115.43 39.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 101.296 -3.594 . . . . 25.0 101.296 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -88.42 -40.28 13.63 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 125.709 1.88 . . . . 25.0 110.621 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -146.82 145.26 22.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 117.163 2.283 . . . . 25.0 117.163 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.83 149.09 93.44 Favored 'Cis proline' 0 C--O 1.271 2.161 0 CA-C-N 121.161 1.45 . . . . 25.0 115.474 -7.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.21 -168.37 45.18 Favored Glycine 0 N--CA 1.483 1.776 0 O-C-N 126.625 2.453 . . . . 25.0 112.454 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 t -125.91 120.54 30.68 Favored 'General case' 0 C--O 1.266 1.945 0 O-C-N 125.865 1.568 . . . . 25.0 109.794 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -70.11 -35.95 74.5 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.171 -0.678 . . . . 25.0 109.171 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.09 81.97 Favored 'General case' 0 C--O 1.206 -1.231 0 C-N-CA 123.792 0.837 . . . . 25.0 109.84 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.14 -36.51 82.03 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.452 0.908 . . . . 25.0 113.452 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.36 -27.01 65.88 Favored 'General case' 0 C--O 1.182 -2.48 0 O-C-N 125.371 1.669 . . . . 75.0 109.862 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.61 -23.1 46.11 Favored 'General case' 0 CA--C 1.56 1.342 0 O-C-N 124.316 1.01 . . . . 25.0 108.436 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.0 p -82.61 170.98 14.56 Favored 'General case' 0 C--O 1.189 -2.088 0 CA-C-O 123.99 1.852 . . . . 25.0 112.24 -169.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -72.68 -12.62 61.1 Favored 'General case' 0 CA--C 1.554 1.119 0 O-C-N 117.179 -3.451 . . . . 25.0 112.284 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.49 -12.67 60.07 Favored 'General case' 0 CA--C 1.562 1.421 0 O-C-N 120.021 -1.674 . . . . 25.0 112.104 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -52.46 -40.87 62.79 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.305 -1.77 . . . . 50.0 114.184 161.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.24 89.25 0.12 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 103.198 -3.961 . . . . 25.0 103.198 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -47.56 -31.09 4.06 Favored 'General case' 0 C--O 1.269 2.098 0 C-N-CA 127.663 2.385 . . . . 50.0 116.56 -166.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 mt -72.15 -13.99 61.7 Favored 'General case' 0 C--O 1.263 1.784 0 C-N-CA 117.553 -1.659 . . . . 50.0 111.772 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -144.13 158.26 43.82 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.299 0.852 . . . . 25.0 113.299 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -166.95 -178.8 4.38 Favored 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 107.48 -1.304 . . . . 50.0 107.48 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -153.93 48.24 0.64 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 127.387 2.929 . . . . 25.0 106.192 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -142.06 -3.28 1.1 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 118.45 2.759 . . . . 25.0 118.45 -168.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.73 -39.51 91.37 Favored Glycine 0 C--O 1.284 3.245 0 CA-C-N 114.087 -1.415 . . . . 25.0 112.734 -163.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 m -91.4 -32.48 15.63 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-O 127.579 3.562 . . . . 25.0 113.092 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.2 t -65.94 -30.28 49.51 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 111.328 -2.669 . . . . 50.0 113.747 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.5 ptp -68.44 -9.02 45.83 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.2 -50.12 50.3 Favored 'General case' 0 C--O 1.201 -1.449 0 C-N-CA 113.737 -3.185 . . . . 50.0 110.984 175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.98 76.72 27.48 Favored Pre-proline 0 C--O 1.252 1.193 0 O-C-N 120.996 -1.065 . . . . 25.0 110.524 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.68 -21.02 29.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 1 C-N-CA 111.497 -5.202 . . . . 25.0 115.309 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -81.7 2.23 30.64 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 118.94 -2.35 . . . . 25.0 114.362 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 t -118.22 98.95 6.55 Favored 'General case' 0 C--O 1.292 3.303 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.9 mt -126.14 133.52 51.57 Favored 'General case' 0 C--O 1.294 3.399 1 N-CA-C 99.821 -4.14 . . . . 50.0 99.821 157.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -121.83 134.78 54.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 113.975 1.102 . . . . 25.0 113.975 -170.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.24 125.93 32.27 Favored 'General case' 0 C--O 1.198 -1.624 0 C-N-CA 125.335 1.454 . . . . 25.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -113.94 132.27 56.01 Favored 'General case' 0 C--O 1.273 2.3 0 CA-C-N 121.278 1.853 . . . . 25.0 112.778 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -61.56 151.55 32.86 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 126.495 2.372 . . . . 25.0 112.434 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.63 -149.51 38.48 Favored Glycine 0 C--O 1.185 -2.966 0 CA-C-O 119.189 -0.784 . . . . 25.0 114.471 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -102.76 166.3 12.18 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 123.963 0.905 . . . . 25.0 109.93 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.0 -168.73 6.76 Favored 'Cis proline' 0 CA--C 1.552 1.415 0 C-N-CA 132.716 2.382 . . . . 25.0 110.697 3.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -63.07 -42.45 99.66 Favored 'General case' 0 C--O 1.191 -2.005 0 N-CA-C 115.704 1.742 . . . . 25.0 115.704 171.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.72 -95.4 0.05 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-N 114.495 -1.23 . . . . 25.0 113.948 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.34 168.47 11.65 Favored Glycine 0 C--O 1.269 2.287 0 C-N-CA 118.121 -1.99 . . . . 25.0 113.32 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.03 161.81 44.31 Favored 'Trans proline' 0 CA--C 1.492 -1.59 1 C-N-CA 125.489 4.126 . . . . 25.0 114.017 175.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.54 68.71 1.64 Allowed 'General case' 0 C--O 1.261 1.678 0 CA-C-N 113.681 -1.6 . . . . 25.0 111.039 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -151.17 138.47 19.37 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 130.324 3.45 . . . . 25.0 107.245 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.14 79.59 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 119.42 -1.372 . . . . 25.0 111.099 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -122.68 43.74 2.83 Favored 'General case' 0 C--O 1.275 2.428 0 CA-C-O 125.383 2.516 . . . . 25.0 108.862 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.0 mt -82.75 -43.53 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 111.495 -2.593 . . . . 25.0 108.657 -159.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.01 -31.04 68.5 Favored 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 116.744 -1.598 . . . . 25.0 110.637 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.4 t -95.22 -3.71 47.16 Favored 'General case' 0 C--O 1.291 3.251 0 CA-C-O 125.149 2.404 . . . . 25.0 108.369 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.5 25.36 14.43 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 118.886 2.921 . . . . 25.0 118.886 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.38 -21.56 64.4 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 108.006 -2.037 . . . . 25.0 108.006 169.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.41 34.94 2.51 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 120.227 2.851 . . . . 25.0 120.227 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.72 0.19 52.21 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 115.394 1.628 . . . . 50.0 115.394 -170.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -77.18 -11.4 59.81 Favored 'General case' 0 CA--C 1.604 3.053 0 C-N-CA 117.482 -1.687 . . . . 50.0 107.213 161.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.97 69.09 Favored Glycine 0 C--O 1.248 0.971 0 CA-C-O 125.43 2.683 . . . . 25.0 111.828 173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.26 -27.2 70.41 Favored Glycine 0 C--O 1.205 -1.696 0 O-C-N 120.435 -1.627 . . . . 25.0 113.26 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.94 -39.43 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 104.779 -2.304 . . . . 25.0 104.779 -172.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.8 -34.69 78.96 Favored 'General case' 0 CA--C 1.58 2.116 0 O-C-N 124.496 1.123 . . . . 75.0 112.732 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.16 -19.47 33.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 124.228 1.966 . . . . 50.0 115.538 -167.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -77.53 8.57 4.15 Favored 'General case' 0 C--O 1.258 1.552 0 O-C-N 118.307 -2.746 . . . . 25.0 115.945 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -145.01 60.8 1.31 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.828 -1.533 . . . . 25.0 110.601 163.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -130.33 151.41 50.86 Favored 'General case' 0 CA--C 1.599 2.829 0 C-N-CA 119.439 -0.905 . . . . 25.0 111.982 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.6 -26.29 68.62 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 118.018 -2.926 . . . . 25.0 108.547 166.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -93.51 24.92 3.71 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.422 -1.311 . . . . 25.0 111.067 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.91 100.76 0.43 Allowed 'General case' 0 C--O 1.196 -1.749 0 CA-C-O 125.556 2.598 . . . . 25.0 110.557 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -32.73 137.53 0.07 Allowed 'General case' 0 C--N 1.317 -0.824 2 CA-C-N 103.45 -6.25 . . . . 25.0 115.821 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -77.2 128.45 34.4 Favored 'General case' 0 N--CA 1.419 -1.988 0 O-C-N 121.676 -0.64 . . . . 50.0 110.808 -155.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -98.86 147.32 25.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 119.818 3.266 . . . . 25.0 119.818 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -137.81 155.18 49.29 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 102.28 -3.23 . . . . 25.0 102.28 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.0 mt -105.56 126.21 60.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 1 N-CA-C 97.913 -4.847 . . . . 25.0 97.913 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.6 mtp -130.46 140.16 50.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.323 1.049 . . . . 25.0 111.286 -168.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 p -75.44 173.23 11.22 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 116.059 1.874 . . . . 25.0 116.059 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.48 -178.77 48.47 Favored Glycine 0 C--O 1.283 3.182 0 N-CA-C 105.184 -3.166 . . . . 25.0 105.184 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.17 -170.56 31.7 Favored Glycine 2 N--CA 1.389 -4.453 0 CA-C-N 111.313 -2.443 . . . . 25.0 111.314 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 45.5 mt-10 -80.49 136.79 36.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.368 2.084 . . . . 25.0 112.444 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -137.18 161.46 36.1 Favored 'General case' 0 N--CA 1.522 3.16 0 O-C-N 124.939 1.399 . . . . 25.0 108.494 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 m -112.65 130.84 55.9 Favored 'General case' 0 C--O 1.274 2.353 0 CA-C-O 122.438 1.113 . . . . 25.0 109.491 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -118.35 116.99 27.87 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 113.402 -1.727 . . . . 50.0 109.556 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 m -137.36 135.63 37.18 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 114.958 1.466 . . . . 25.0 114.958 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -114.95 161.49 18.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.847 -2.279 . . . . 25.0 104.847 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 t -146.5 147.97 31.73 Favored 'General case' 0 C--O 1.265 1.874 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.44 148.98 32.84 Favored 'General case' 0 CA--C 1.603 3.007 0 O-C-N 118.264 -2.773 . . . . 50.0 106.372 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.5 p -77.76 2.35 17.28 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 118.133 2.642 . . . . 25.0 118.133 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.45 159.54 57.48 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.655 1.182 . . . . 25.0 108.535 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.04 163.82 36.23 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 114.716 -3.056 . . . . 25.0 111.144 171.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -139.03 151.16 46.58 Favored 'General case' 0 C--O 1.183 -2.409 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 163.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.59 121.5 19.82 Favored 'General case' 0 C--O 1.253 1.265 0 CA-C-N 113.424 -1.716 . . . . 25.0 106.624 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.1 m -142.99 138.91 30.38 Favored 'General case' 0 C--N 1.317 -0.832 1 N-CA-C 99.674 -4.195 . . . . 25.0 99.674 -172.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.0 p -78.94 -48.64 14.17 Favored 'General case' 0 C--O 1.272 2.241 0 CA-C-O 124.025 1.869 . . . . 25.0 110.924 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -163.48 175.9 10.28 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.442 -1.411 . . . . 25.0 109.353 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -144.46 154.07 42.55 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 126.085 1.754 . . . . 25.0 108.697 167.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -128.43 160.55 31.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 116.792 -1.575 . . . . 25.0 109.692 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -134.91 148.5 50.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 103.663 -2.717 . . . . 50.0 103.663 162.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -139.2 168.59 19.49 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 103.998 -2.593 . . . . 50.0 103.998 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.4 pt -136.32 160.96 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 104.581 -2.378 . . . . 25.0 104.581 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -123.78 148.33 46.76 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 113.206 -1.815 . . . . 25.0 106.622 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -125.95 93.86 3.94 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 117.893 -1.523 . . . . 25.0 108.07 -172.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.84 165.99 3.67 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 120.114 -1.617 . . . . 25.0 112.757 168.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.82 48.5 Favored Glycine 0 C--O 1.192 -2.52 0 O-C-N 119.811 -1.806 . . . . 25.0 109.822 -171.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.59 159.57 32.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.073 1.416 . . . . 25.0 110.933 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.32 128.8 86.9 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 101.877 -3.379 . . . . 25.0 101.877 170.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 108' ' ' LYS . 72.3 Cg_endo -74.77 -27.06 10.81 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 114.048 -3.501 . . . . 25.0 117.359 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -81.59 1.23 34.75 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.48 1.491 . . . . 75.0 108.575 -165.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 106' ' ' PRO . 25.0 mmtp -118.24 166.53 13.5 Favored Pre-proline 0 CA--C 1.578 2.052 0 O-C-N 127.976 3.297 . . . . 25.0 111.798 -161.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -47.33 30.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.374 2 C-N-CA 130.171 7.247 . . . . 25.0 124.528 174.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -52.28 -27.88 16.83 Favored 'General case' 0 C--O 1.188 -2.178 0 O-C-N 120.141 -1.599 . . . . 50.0 114.835 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -71.57 -14.48 62.1 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 123.706 0.629 . . . . 25.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -116.43 -60.52 1.85 Allowed 'General case' 0 C--O 1.168 -3.235 0 C-N-CA 126.854 2.062 . . . . 25.0 111.817 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.56 -25.37 35.88 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -102.74 28.65 5.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.761 0.791 . . . . 25.0 112.885 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -137.85 151.73 48.36 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.914 -2.625 . . . . 50.0 103.914 156.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -130.01 147.88 51.8 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 119.008 -0.52 . . . . 25.0 111.408 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.8 tp -65.94 136.21 55.78 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 106.28 -1.748 . . . . 50.0 106.28 156.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.53 -15.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 120.24 1.382 . . . . 25.0 107.698 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.8 157.23 15.71 Favored Glycine 0 C--O 1.284 3.279 0 CA-C-O 117.057 -1.968 . . . . 25.0 110.971 163.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.14 150.32 49.55 Favored 'General case' 0 C--O 1.263 1.773 0 CA-C-N 118.067 0.934 . . . . 25.0 112.774 162.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -126.34 111.24 23.56 Favored Pre-proline 0 C--O 1.255 1.382 0 C-N-CA 125.432 1.493 . . . . 50.0 114.997 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -79.31 157.59 26.0 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 114.07 -3.487 . . . . 25.0 119.278 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . 0.279 53.1 t-80 -121.96 65.2 0.91 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 124.292 1.996 . . . . 25.0 107.122 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.15 26.47 8.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 111.624 -2.535 . . . . 50.0 110.458 -166.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.83 57.96 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-O 124.016 1.898 . . . . 25.0 108.806 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.96 160.48 0.65 Allowed Pre-proline 0 C--O 1.266 1.957 0 N-CA-C 118.479 2.77 . . . . 25.0 118.479 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.72 -166.62 0.1 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 123.099 2.533 . . . . 25.0 115.652 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.09 -23.13 7.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.189 1.922 . . . . 25.0 116.189 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.8 p -69.3 -8.44 46.16 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 114.395 1.257 . . . . 25.0 114.395 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -53.67 -29.07 36.88 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 117.217 -1.373 . . . . 25.0 113.811 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . 0.261 85.1 m-20 -68.15 143.59 55.34 Favored 'General case' 0 C--O 1.19 -2.064 0 CA-C-O 123.641 1.686 . . . . 25.0 111.359 -174.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -20.65 66.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.374 1.869 . . . . 75.0 110.073 -170.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.0 t -83.24 127.47 33.66 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.29 1.959 . . . . 25.0 116.29 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -137.45 146.95 44.94 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 124.503 2.097 . . . . 25.0 112.533 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -98.03 129.89 44.87 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.762 -1.211 . . . . 25.0 110.445 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . 0.266 35.9 mm -131.12 120.62 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.81 1.244 . . . . 25.0 107.904 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 89.9 t80 -76.58 126.07 30.34 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.898 -1.519 . . . . 50.0 106.898 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.9 129.08 31.99 Favored Pre-proline 0 C--N 1.364 1.221 0 CA-C-O 115.91 -1.995 . . . . 25.0 109.798 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.14 156.04 47.43 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 116.156 -2.096 . . . . 25.0 110.836 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -109.45 -8.63 15.01 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 126.527 1.931 . . . . 25.0 115.773 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -93.94 -13.58 26.93 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 115.833 1.79 . . . . 50.0 115.833 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.61 163.4 22.83 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.127 1.528 . . . . 25.0 115.127 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.01 146.13 34.41 Favored 'General case' 0 C--O 1.265 1.875 0 O-C-N 124.94 1.4 . . . . 50.0 113.769 158.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.72 158.99 11.21 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 118.826 2.291 . . . . 25.0 118.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -72.79 136.99 45.52 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.975 -1.613 . . . . 50.0 111.149 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -142.87 166.11 25.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.152 -0.476 . . . . 25.0 110.526 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.77 130.95 73.24 Favored 'Isoleucine or valine' 0 C--O 1.267 1.98 0 N-CA-C 101.887 -3.375 . . . . 50.0 101.887 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.3 mt -101.63 123.86 55.04 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.93 1 N-CA-C 98.639 -4.578 . . . . 25.0 98.639 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.497 ' HA ' HG12 ' A' ' 164' ' ' VAL . 4.1 mp -112.38 143.22 43.86 Favored 'General case' 0 C--O 1.189 -2.106 0 N-CA-C 104.527 -2.397 . . . . 50.0 104.527 -173.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.4 34.94 Favored 'General case' 0 CA--C 1.456 -2.65 0 O-C-N 119.87 -1.769 . . . . 25.0 113.097 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.84 125.46 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 CA-C-N 110.143 -3.208 . . . . 50.0 108.489 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -108.06 104.22 13.61 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.873 -1.158 . . . . 25.0 107.873 166.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -78.28 72.74 4.82 Favored 'General case' 0 C--O 1.26 1.653 0 O-C-N 126.267 2.229 . . . . 25.0 106.47 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.64 116.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.773 0 C-N-CA 126.174 1.79 . . . . 50.0 113.374 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.8 -22.31 23.32 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -7.87 0.37 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 119.642 3.201 . . . . 25.0 119.642 171.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.2 p -135.34 165.08 26.27 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 103.089 -2.93 . . . . 25.0 103.089 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -76.97 -41.87 41.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 119.576 -1.953 . . . . 25.0 110.103 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -81.44 168.66 18.08 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 105.098 -2.186 . . . . 25.0 105.098 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -116.34 153.47 31.93 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 102.95 -2.982 . . . . 25.0 102.95 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -97.6 150.05 21.56 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 107.714 -1.217 . . . . 50.0 107.714 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -140.79 162.53 35.2 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 104.957 -2.238 . . . . 50.0 104.957 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 144.64 12.02 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 103.377 -2.823 . . . . 25.0 103.377 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 149' ' ' LEU . 24.0 m -123.38 155.03 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 123.082 1.42 . . . . 75.0 114.6 165.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.46 117.64 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 101.13 -3.656 . . . . 25.0 101.13 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -82.28 127.49 33.26 Favored 'General case' 1 C--O 1.318 4.668 0 CA-C-O 124.614 2.15 . . . . 25.0 106.169 170.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.14 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 116.573 -3.83 . . . . 50.0 115.217 175.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.31 98.18 5.94 Favored 'General case' 0 C--O 1.261 1.692 0 N-CA-C 106.189 -1.782 . . . . 25.0 106.189 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.23 122.74 32.8 Favored 'General case' 0 C--O 1.261 1.695 0 N-CA-C 101.555 -3.498 . . . . 50.0 101.555 -168.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.08 162.57 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 118.607 -2.558 . . . . 50.0 117.366 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -84.63 164.39 18.69 Favored 'General case' 0 C--O 1.282 2.77 0 O-C-N 120.738 -1.226 . . . . 25.0 108.301 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 40.9 pttt . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 116.971 -1.49 . . . . 25.0 108.548 179.072 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 . . . . . 0 C--O 1.262 1.757 0 N-CA-C 113.553 0.946 . . . . 25.0 113.553 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.07 179.44 30.29 Favored Glycine 0 C--O 1.282 3.146 0 CA-C-O 115.706 -2.719 . . . . 25.0 113.844 -172.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.61 153.17 44.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 119.067 1.433 . . . . 50.0 113.033 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 6' ' ' LYS . 19.1 mt -71.03 124.14 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 119.127 -2.233 . . . . 25.0 110.257 -171.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -100.89 11.03 40.4 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 123.516 1.627 . . . . 25.0 109.014 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 4' ' ' ILE . 51.1 mtmt 86.91 159.24 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.679 1 C-N-CA 133.354 4.661 . . . . 25.0 112.529 172.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 139.97 47.87 Favored 'Cis proline' 0 CA--C 1.466 -2.895 0 C-N-CA 132.672 2.363 . . . . 25.0 114.193 2.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.18 69.15 1.21 Allowed Glycine 0 C--N 1.281 -2.496 0 CA-C-N 112.036 -2.347 . . . . 25.0 113.393 165.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -69.86 137.7 51.92 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 125.795 2.712 . . . . 25.0 108.69 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -93.63 -18.8 21.78 Favored 'General case' 0 C--O 1.281 2.759 0 N-CA-C 103.746 -2.686 . . . . 25.0 103.746 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.02 75.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.898 0.856 . . . . 25.0 112.078 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.48 77.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.913 -1.494 . . . . 25.0 110.362 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -85.98 -15.89 40.05 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 113.03 -1.895 . . . . 75.0 109.396 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 t -79.63 -11.46 59.87 Favored 'General case' 0 N--CA 1.416 -2.132 0 C-N-CA 125.991 1.716 . . . . 25.0 114.263 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.5 t -48.91 135.04 16.12 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 125.905 1.682 . . . . 25.0 109.738 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.259 40.8 tt0 -66.54 -20.84 66.12 Favored 'General case' 0 CA--C 1.588 2.418 0 C-N-CA 127.388 2.275 . . . . 25.0 110.045 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.66 -13.48 22.81 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.158 1.54 . . . . 25.0 115.158 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -54.33 -21.87 10.56 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 113.478 0.918 . . . . 50.0 113.478 166.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.97 17.29 0.04 OUTLIER Glycine 0 C--O 1.214 -1.132 0 O-C-N 118.213 -2.804 . . . . 25.0 119.361 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.3 t80 54.26 21.08 2.92 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.733 1.753 . . . . 50.0 115.733 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.18 -34.42 22.08 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.608 -1.933 . . . . 50.0 108.75 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -114.23 176.53 5.0 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 119.505 1.048 . . . . 25.0 108.383 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.56 172.22 8.92 Favored 'General case' 0 N--CA 1.523 3.22 0 CA-C-O 117.114 -1.422 . . . . 50.0 113.527 168.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -35.67 -37.8 0.1 Allowed 'General case' 0 C--O 1.181 -2.549 0 N-CA-C 119.027 2.973 . . . . 25.0 119.027 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -146.36 -21.67 0.43 Allowed 'General case' 0 C--O 1.217 -0.636 0 O-C-N 127.135 2.772 . . . . 25.0 111.531 151.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.53 121.36 2.91 Favored Glycine 0 C--O 1.208 -1.495 0 N-CA-C 106.277 -2.729 . . . . 25.0 106.277 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -7.89 0.39 Allowed 'General case' 0 CA--C 1.574 1.876 1 N-CA-C 122.574 4.287 . . . . 25.0 122.574 -167.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.42 -13.3 8.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 CA-C-N 120.301 1.41 . . . . 50.0 112.382 168.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.9 ptm -53.23 -13.51 0.54 Allowed 'General case' 0 C--O 1.173 -2.928 0 N-CA-C 119.84 3.274 . . . . 25.0 119.84 172.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -64.9 -38.09 89.83 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 115.12 -0.945 . . . . 50.0 110.565 169.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.52 60.81 5.76 Favored Pre-proline 0 C--O 1.275 2.423 0 CA-C-N 115.025 -0.989 . . . . 25.0 112.878 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.19 -22.22 9.96 Favored 'Trans proline' 0 N--CA 1.477 0.546 1 C-N-CA 110.086 -6.143 . . . . 25.0 115.525 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -77.6 -15.39 59.26 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.963 -1.086 . . . . 25.0 111.28 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.4 t -73.66 116.93 14.83 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 118.271 -1.371 . . . . 25.0 111.391 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 162' ' ' TYR . 66.5 mt -118.23 145.55 44.92 Favored 'General case' 0 C--O 1.164 -3.408 0 N-CA-C 104.501 -2.407 . . . . 50.0 104.501 162.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.6 157.88 45.3 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 124.765 2.222 . . . . 25.0 107.984 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.71 155.51 49.02 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 105.161 -2.163 . . . . 25.0 105.161 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.0 156.58 47.93 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 120.986 1.721 . . . . 25.0 110.957 166.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -76.02 157.5 32.94 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 114.657 1.354 . . . . 25.0 114.657 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.39 163.39 13.17 Favored Glycine 0 C--O 1.19 -2.632 0 N-CA-C 105.042 -3.223 . . . . 25.0 105.042 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.1 156.51 72.25 Favored Pre-proline 0 N--CA 1.438 -1.037 0 C-N-CA 128.055 2.542 . . . . 25.0 113.554 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.08 -28.93 5.38 Favored 'Cis proline' 0 C--N 1.371 1.742 0 C-N-CA 130.375 1.406 . . . . 25.0 114.111 -0.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -130.83 10.81 5.11 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-N 120.994 1.725 . . . . 25.0 113.193 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t 61.31 -146.43 0.43 Allowed 'General case' 0 CA--C 1.478 -1.806 0 O-C-N 126.401 2.313 . . . . 25.0 110.271 -168.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.54 -163.44 0.73 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 118.996 -1.574 . . . . 25.0 114.505 169.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.32 169.52 15.28 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 122.502 2.135 . . . . 25.0 113.404 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.16 79.29 0.14 Allowed 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 123.277 1.513 . . . . 25.0 114.854 -170.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -147.03 158.3 43.88 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 96.026 -5.546 . . . . 25.0 96.026 171.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.71 37.19 67.05 Favored Glycine 0 C--O 1.273 2.59 0 N-CA-C 109.793 -1.323 . . . . 25.0 109.793 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -97.12 21.34 9.97 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.889 1.276 . . . . 25.0 108.808 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.1 mt -75.15 -44.75 43.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.25 -1.018 . . . . 25.0 108.25 -166.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.36 -31.1 72.17 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 119.565 -1.96 . . . . 25.0 110.847 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.6 p -82.08 7.94 12.07 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.973 1.842 . . . . 25.0 115.973 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.22 10.0 0.03 OUTLIER 'General case' 0 C--O 1.26 1.639 0 N-CA-C 116.547 2.055 . . . . 25.0 116.547 -167.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.92 -40.54 98.51 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 122.285 2.312 . . . . 25.0 108.955 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.65 -2.03 79.3 Favored Glycine 0 CA--C 1.568 3.354 0 C-N-CA 119.408 -1.377 . . . . 25.0 114.354 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.2 mt -112.15 -23.51 10.39 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 117.668 -1.158 . . . . 50.0 114.005 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -71.56 -36.5 70.94 Favored 'General case' 0 C--O 1.262 1.713 0 N-CA-C 106.902 -1.518 . . . . 50.0 106.902 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.19 -16.52 78.61 Favored Glycine 1 C--O 1.156 -4.726 0 CA-C-O 123.362 1.535 . . . . 25.0 115.082 171.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.38 -17.01 73.98 Favored Glycine 0 C--N 1.307 -1.07 0 O-C-N 118.916 -2.52 . . . . 25.0 112.02 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -77.63 -34.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.53 0 N-CA-C 106.23 -1.767 . . . . 25.0 106.23 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.18 -23.0 57.65 Favored 'General case' 0 C--O 1.27 2.149 0 O-C-N 119.268 -2.145 . . . . 75.0 107.746 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -73.22 -8.2 54.79 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 113.566 -1.652 . . . . 50.0 112.726 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -77.36 7.7 5.01 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 124.378 2.037 . . . . 25.0 113.485 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -131.26 34.35 4.01 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.294 -1.373 . . . . 25.0 107.294 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 t -142.58 157.73 44.4 Favored 'General case' 0 C--O 1.252 1.229 0 O-C-N 119.954 -1.716 . . . . 25.0 111.656 -164.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.41 -25.08 66.96 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-O 122.466 1.126 . . . . 25.0 109.694 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.09 13.66 16.26 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.062 2.545 . . . . 25.0 108.173 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -76.41 99.62 4.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.313 -2.847 . . . . 25.0 103.313 167.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -46.72 145.13 2.03 Favored 'General case' 0 C--N 1.309 -1.155 1 CA-C-N 107.105 -4.589 . . . . 25.0 113.597 166.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -80.03 147.8 31.35 Favored 'General case' 0 C--O 1.21 -0.998 0 CA-C-O 115.626 -2.13 . . . . 50.0 110.4 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.91 101.66 13.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 126.246 2.216 . . . . 25.0 107.354 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -73.28 119.39 17.45 Favored 'General case' 0 C--O 1.284 2.911 0 N-CA-C 107.048 -1.464 . . . . 25.0 107.048 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.7 mt -81.53 130.97 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.0 ttt -147.82 134.55 19.98 Favored 'General case' 0 C--O 1.178 -2.695 0 N-CA-C 107.893 -1.151 . . . . 25.0 107.893 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 p -79.72 150.27 30.9 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.524 -2.398 . . . . 25.0 104.524 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.93 163.23 37.77 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 119.793 2.677 . . . . 25.0 119.793 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.75 -177.92 18.49 Favored Glycine 0 C--O 1.27 2.402 0 N-CA-C 105.998 -2.841 . . . . 25.0 105.998 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 9.3 pt-20 -82.48 152.24 26.16 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 125.437 2.542 . . . . 25.0 106.307 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.94 154.28 51.16 Favored 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 118.334 -2.729 . . . . 25.0 105.603 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.3 m -117.88 131.79 56.5 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 103.15 -2.907 . . . . 25.0 103.15 163.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -115.64 141.54 47.93 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.352 -1.351 . . . . 50.0 107.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -139.41 129.18 24.71 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 113.043 -1.889 . . . . 25.0 111.907 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -131.59 162.58 30.0 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 101.655 -3.461 . . . . 25.0 101.655 -174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.4 p -132.46 140.01 48.22 Favored 'General case' 0 CA--C 1.488 -1.417 0 O-C-N 121.597 -0.689 . . . . 25.0 111.748 156.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.447 ' CD2' ' HE1' ' A' ' 90' ' ' HIS . 76.4 m-85 -79.74 154.75 28.33 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.035 -1.469 . . . . 50.0 107.035 164.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.9 t -91.96 -19.72 22.13 Favored 'General case' 0 C--O 1.257 1.449 0 N-CA-C 106.762 -1.57 . . . . 25.0 106.762 -165.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.95 139.39 13.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 CA-C-O 117.305 -1.331 . . . . 25.0 109.12 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.85 131.86 34.8 Favored 'Trans proline' 0 CA--C 1.599 3.729 0 C-N-CA 115.461 -2.56 . . . . 25.0 111.225 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.447 ' HE1' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -153.16 160.43 42.85 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -81.61 161.48 23.47 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 116.048 1.87 . . . . 25.0 116.048 -158.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.416 HG21 ' HE3' ' A' ' 95' ' ' TRP . 53.1 m -154.97 134.96 12.97 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.332 -1.358 . . . . 25.0 107.332 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.1 p -91.52 -41.22 10.93 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.49 -1.67 . . . . 25.0 106.49 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -161.39 172.53 16.37 Favored 'General case' 0 C--O 1.281 2.732 0 N-CA-C 104.95 -2.241 . . . . 25.0 104.95 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.416 ' HE3' HG21 ' A' ' 92' ' ' THR . 3.5 p90 -144.53 152.52 40.69 Favored 'General case' 0 C--O 1.258 1.533 0 N-CA-C 114.477 1.288 . . . . 25.0 114.477 167.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -128.98 142.25 50.99 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.385 -1.293 . . . . 25.0 110.59 -167.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.74 144.19 47.38 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-N 120.276 1.398 . . . . 50.0 107.556 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.3 167.57 20.47 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 105.61 -1.996 . . . . 50.0 105.61 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.3 pt -129.6 147.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 105.42 -2.067 . . . . 25.0 105.42 172.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.6 p -77.79 154.89 31.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 117.739 -1.124 . . . . 25.0 109.565 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -144.86 80.09 1.61 Allowed 'General case' 0 C--O 1.239 0.545 0 N-CA-C 117.411 2.374 . . . . 25.0 117.411 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -47.24 157.72 0.18 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 125.411 2.529 . . . . 25.0 115.124 167.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.95 32.71 23.05 Favored Glycine 0 C--O 1.204 -1.767 0 C-N-CA 116.985 -2.531 . . . . 25.0 112.108 167.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -60.66 159.41 10.83 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.989 1.848 . . . . 25.0 115.989 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -74.82 134.34 75.35 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.126 -1.435 . . . . 25.0 107.126 162.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.23 -26.5 49.26 Favored 'Trans proline' 0 C--N 1.362 1.26 0 N-CA-C 120.164 3.102 . . . . 25.0 120.164 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.18 -6.5 58.59 Favored 'General case' 0 C--O 1.191 -1.994 0 C-N-CA 116.96 -1.896 . . . . 75.0 110.198 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -66.27 157.6 80.9 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 111.684 -2.507 . . . . 25.0 110.913 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.14 51.16 1.29 Allowed 'Trans proline' 0 C--N 1.37 1.668 1 N-CA-C 122.829 4.126 . . . . 25.0 122.829 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -2.45 -66.31 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 1 C-N-CA 132.092 4.157 . . . . 50.0 118.968 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -72.34 -8.6 55.8 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 122.189 2.268 . . . . 25.0 114.652 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 -55.4 2.58 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 124.523 1.129 . . . . 25.0 109.32 165.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.85 -25.69 1.39 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 117.323 2.342 . . . . 25.0 117.323 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -82.96 8.45 12.64 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.27 160.57 39.85 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 119.938 -1.726 . . . . 50.0 108.49 159.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -144.44 134.37 23.89 Favored 'General case' 0 C--O 1.182 -2.5 0 N-CA-C 105.821 -1.918 . . . . 25.0 105.821 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.41 132.57 50.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.678 1.191 . . . . 50.0 111.358 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.8 tt -111.15 -18.15 7.85 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 N-CA-C 106.224 -1.769 . . . . 25.0 106.224 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.29 156.03 13.11 Favored Glycine 0 C--N 1.306 -1.095 0 O-C-N 120.542 -1.349 . . . . 25.0 113.085 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.14 139.41 24.61 Favored 'General case' 0 C--O 1.266 1.943 0 CA-C-O 123.769 1.747 . . . . 25.0 107.065 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -128.81 107.21 18.44 Favored Pre-proline 0 C--O 1.255 1.381 0 CA-C-N 114.63 -1.168 . . . . 50.0 110.056 -170.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.95 164.52 31.49 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 113.331 -3.979 . . . . 25.0 115.038 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -139.98 2.98 1.98 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 118.058 2.614 . . . . 25.0 118.058 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -90.29 -24.92 20.77 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 107.637 -1.246 . . . . 50.0 107.637 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.62 160.93 27.43 Favored Glycine 0 C--N 1.352 1.437 1 N-CA-C 95.207 -7.157 . . . . 25.0 95.207 155.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.5 t -154.8 149.11 19.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 120.543 2.171 . . . . 25.0 112.706 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.03 -178.03 3.59 Favored 'Trans proline' 0 N--CA 1.436 -1.86 0 C-N-CA 114.866 -2.956 . . . . 25.0 111.008 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -15.8 5.37 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 118.474 -2.641 . . . . 25.0 115.496 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.53 4.02 0.43 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.103 1.89 . . . . 25.0 116.103 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -57.47 -33.54 68.08 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 127.108 2.163 . . . . 25.0 115.05 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -48.57 131.37 17.5 Favored 'General case' 0 C--O 1.18 -2.592 0 CA-C-N 119.367 0.985 . . . . 25.0 113.201 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.3 tp -65.86 -29.9 70.42 Favored 'General case' 0 C--O 1.268 2.077 0 CA-C-O 122.017 0.913 . . . . 75.0 113.355 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 132.5 47.46 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 121.748 -0.595 . . . . 25.0 110.67 166.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -153.84 161.05 42.36 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.597 1.665 . . . . 25.0 110.559 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -112.12 137.52 50.07 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.518 1.303 . . . . 25.0 114.518 -172.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.3 mt -132.53 133.23 59.89 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 102.956 -2.979 . . . . 25.0 102.956 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 73.5 t80 -101.0 134.19 44.36 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 105.716 -1.957 . . . . 50.0 105.716 173.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.4 mm -125.17 110.38 26.85 Favored Pre-proline 0 C--O 1.2 -1.509 0 N-CA-C 102.127 -3.286 . . . . 25.0 102.127 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.25 149.83 70.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 115.101 -2.799 . . . . 25.0 109.854 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -92.51 47.07 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.77 -14.69 60.74 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 118.791 -2.443 . . . . 50.0 114.487 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -166.44 169.45 13.89 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 103.946 -2.613 . . . . 25.0 103.946 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.6 pt? -98.15 152.57 19.22 Favored 'General case' 0 C--O 1.281 2.741 0 N-CA-C 100.459 -3.904 . . . . 50.0 100.459 163.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.24 164.19 17.72 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-O 123.386 1.548 . . . . 25.0 111.163 -171.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.91 157.65 45.06 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 117.105 -3.585 . . . . 50.0 116.844 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -158.42 175.94 13.07 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 100.652 -3.833 . . . . 25.0 100.652 170.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.75 146.92 6.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 123.449 0.7 . . . . 50.0 111.726 167.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.94 128.39 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 O-C-N 119.329 -2.107 . . . . 25.0 106.252 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -115.7 153.77 30.75 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 115.683 -2.103 . . . . 50.0 106.531 -167.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.49 44.2 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 121.48 1.945 . . . . 25.0 114.536 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.41 135.44 57.84 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.714 0 C-N-CA 125.028 1.331 . . . . 50.0 111.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -115.77 137.8 51.74 Favored 'General case' 0 C--O 1.277 2.543 0 C-N-CA 127.583 2.353 . . . . 25.0 107.273 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -118.0 144.82 45.22 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 103.269 -2.863 . . . . 25.0 103.269 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.33 113.27 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 105.538 -2.023 . . . . 50.0 105.538 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.0 -14.29 62.29 Favored 'General case' 0 C--O 1.262 1.728 0 N-CA-C 115.255 1.576 . . . . 25.0 115.255 -167.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -71.3 -25.09 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 126.39 2.306 . . . . 25.0 111.16 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.9 p -120.13 165.45 14.75 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 112.272 -2.24 . . . . 25.0 111.819 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -100.7 -9.79 21.49 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 123.808 1.766 . . . . 25.0 107.374 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -78.66 159.42 28.03 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 113.121 -1.854 . . . . 25.0 112.841 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.44 148.58 42.95 Favored 'General case' 0 CA--C 1.557 1.242 1 N-CA-C 98.837 -4.505 . . . . 25.0 98.837 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -126.67 139.48 53.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.276 -1.379 . . . . 50.0 107.276 -165.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 35' ' ' LEU . 75.7 m-85 -140.19 159.46 42.13 Favored 'General case' 0 C--O 1.203 -1.365 0 O-C-N 126.427 2.329 . . . . 50.0 110.404 -166.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -148.38 161.83 40.79 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.206 1.402 . . . . 25.0 111.816 166.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.52 130.6 50.43 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.178 0 N-CA-C 106.207 -1.775 . . . . 75.0 106.207 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -126.92 120.8 56.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.772 -1.566 . . . . 25.0 106.772 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -91.12 145.49 24.64 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 107.445 -1.316 . . . . 25.0 107.445 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.42 163.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 C-N-CA 127.187 2.195 . . . . 50.0 112.903 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.58 108.57 6.02 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 127.235 2.214 . . . . 25.0 109.701 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.33 116.49 30.45 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 102.867 -3.012 . . . . 50.0 102.867 -161.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 31.8 m -125.18 167.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.127 -1.029 . . . . 50.0 113.015 -156.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.88 155.03 31.2 Favored 'General case' 0 C--O 1.263 1.766 0 O-C-N 124.715 1.259 . . . . 25.0 108.277 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 C--O 1.249 1.059 0 CA-C-N 113.672 -1.603 . . . . 25.0 106.825 -177.346 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.527 -1.702 . . . . 25.0 113.252 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.53 166.72 39.14 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 117.155 -2.45 . . . . 25.0 116.658 -170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.81 173.35 13.83 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 106.681 -1.6 . . . . 50.0 106.681 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.0 121.96 54.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 N-CA-C 102.897 -3.001 . . . . 25.0 102.897 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.6 -41.81 16.03 Favored 'General case' 0 C--O 1.18 -2.569 0 C-N-CA 127.631 2.372 . . . . 25.0 113.837 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -152.7 155.74 32.69 Favored Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 105.838 -1.912 . . . . 25.0 105.838 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -60.51 139.18 23.0 Favored 'Cis proline' 0 C--N 1.358 1.028 0 C-N-CA 132.291 2.204 . . . . 25.0 116.209 3.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.58 -177.17 54.41 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 122.639 1.133 . . . . 25.0 114.123 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -123.08 103.01 8.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 125.129 2.395 . . . . 25.0 107.548 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -58.77 -27.83 65.35 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 119.861 -1.774 . . . . 25.0 112.988 167.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.79 73.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 122.902 1.334 . . . . 25.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.86 73.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 122.058 0.932 . . . . 25.0 108.857 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.5 -17.5 64.19 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 127.192 2.197 . . . . 75.0 109.721 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.15 -20.94 26.29 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 108.49 -0.93 . . . . 25.0 108.49 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.0 t -80.47 121.75 26.13 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 116.518 -1.706 . . . . 25.0 110.026 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.4 -29.7 69.28 Favored 'General case' 0 C--O 1.195 -1.806 0 CA-C-N 121.994 2.179 . . . . 25.0 107.64 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.76 71.77 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 115.863 1.801 . . . . 25.0 115.863 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.49 -22.29 62.67 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 109.531 -0.544 . . . . 50.0 109.531 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.43 27.37 8.49 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 109.963 -1.255 . . . . 25.0 109.963 172.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.5 t80 60.51 -51.52 0.09 Allowed 'General case' 0 C--O 1.27 2.17 0 C-N-CA 128.952 2.901 . . . . 50.0 117.606 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 23.0 mt -123.64 -10.44 7.85 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.254 -1.529 . . . . 50.0 113.838 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -128.87 157.66 40.92 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 116.374 1.991 . . . . 25.0 116.374 -154.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -155.74 157.69 36.96 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 125.099 2.381 . . . . 50.0 109.232 -172.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -143.85 31.16 1.29 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.724 -2.035 . . . . 25.0 114.104 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -20.53 61.25 Favored 'General case' 0 C--O 1.267 1.996 0 CA-C-N 113.37 -1.741 . . . . 25.0 113.426 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.07 138.82 8.43 Favored Glycine 0 CA--C 1.473 -2.575 0 N-CA-C 104.08 -3.608 . . . . 25.0 104.08 -171.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.1 p -57.6 -7.28 0.62 Allowed 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 114.632 1.345 . . . . 25.0 114.632 175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 28' ' ' VAL . 3.2 t -58.78 -30.93 43.55 Favored 'Isoleucine or valine' 0 C--O 1.262 1.732 0 C-N-CA 127.434 2.294 . . . . 50.0 109.498 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -61.63 1.65 0.23 Allowed 'General case' 0 C--O 1.255 1.372 0 N-CA-C 118.811 2.893 . . . . 25.0 118.811 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -66.82 -41.29 87.73 Favored 'General case' 0 C--O 1.267 1.974 0 C-N-CA 124.104 0.961 . . . . 50.0 111.321 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.94 56.68 8.23 Favored Pre-proline 0 C--O 1.249 1.051 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.05 -20.89 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.318 0 N-CA-C 120.555 3.252 . . . . 25.0 120.555 -167.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -94.33 -2.85 51.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 116.849 -1.94 . . . . 25.0 113.179 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 t -77.09 87.25 3.58 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 122.191 0.996 . . . . 25.0 111.164 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.13 80.05 1.33 Allowed 'General case' 0 C--O 1.252 1.194 0 N-CA-C 107.729 -1.212 . . . . 50.0 107.729 -167.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -141.2 135.7 31.03 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 121.147 1.794 . . . . 25.0 114.43 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.68 166.11 31.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.044 -2.576 . . . . 25.0 104.044 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -84.93 146.56 27.19 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -58.96 147.3 34.78 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.647 1.179 . . . . 25.0 111.319 170.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.73 -156.15 13.45 Favored Glycine 0 N--CA 1.414 -2.808 0 CA-C-O 124.752 2.307 . . . . 25.0 111.37 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -129.76 168.1 17.81 Favored Pre-proline 0 C--O 1.264 1.86 0 CA-C-N 109.921 -3.139 . . . . 25.0 103.904 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -13.02 15.74 Favored 'Cis proline' 0 CA--C 1.555 1.527 0 N-CA-C 121.255 3.521 . . . . 25.0 121.255 -8.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 87.24 -34.96 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 124.971 1.308 . . . . 25.0 110.102 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -78.24 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.24 1.416 . . . . 25.0 108.542 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.99 163.98 52.0 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 119.289 -2.132 . . . . 25.0 110.181 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.6 -23.2 27.23 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 113.399 -3.934 . . . . 25.0 117.305 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.13 113.17 7.06 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 104.566 -2.383 . . . . 25.0 104.566 168.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.83 128.6 12.46 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 126.523 1.929 . . . . 25.0 114.597 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.83 -28.83 0.23 Allowed Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 120.603 3.001 . . . . 25.0 120.603 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -96.4 39.02 1.17 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 104.545 -2.391 . . . . 25.0 104.545 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.1 -47.34 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.559 0.744 . . . . 25.0 109.974 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.95 73.82 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.603 1.705 . . . . 25.0 115.603 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.4 p -91.97 -11.45 36.07 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.53 1.532 . . . . 25.0 113.7 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.57 31.82 21.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 112.247 -2.252 . . . . 25.0 112.818 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -20.47 76.45 Favored Glycine 0 C--O 1.267 2.182 0 C-N-CA 118.329 -1.891 . . . . 25.0 116.647 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.8 8.0 76.71 Favored Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 119.817 1.809 . . . . 25.0 112.32 173.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 mt -117.51 -172.84 2.31 Favored 'General case' 0 C--O 1.278 2.595 0 C-N-CA 126.679 1.992 . . . . 50.0 110.371 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -66.68 -14.04 62.0 Favored 'General case' 0 C--O 1.175 -2.824 0 C-N-CA 118.635 -1.226 . . . . 50.0 113.512 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.51 73.13 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 106.973 -2.451 . . . . 25.0 106.973 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.14 -11.26 84.58 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 124.461 2.145 . . . . 25.0 117.283 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -79.77 -32.19 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.375 0 CA-C-O 125.891 2.758 . . . . 25.0 107.126 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.48 -17.55 51.29 Favored 'General case' 0 CA--C 1.468 -2.181 0 CA-C-N 113.267 -1.788 . . . . 75.0 109.41 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.15 2.53 2.11 Favored 'General case' 0 C--O 1.197 -1.662 0 CA-C-O 123.928 1.823 . . . . 50.0 115.832 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -85.52 40.98 0.87 Allowed 'General case' 0 C--O 1.263 1.788 0 O-C-N 120.285 -1.509 . . . . 25.0 107.998 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.47 49.25 0.48 Allowed 'General case' 0 C--O 1.262 1.757 0 N-CA-C 105.847 -1.909 . . . . 25.0 105.847 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.8 t -147.01 157.3 43.58 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 126.747 2.019 . . . . 25.0 108.194 -162.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -31.41 67.46 Favored 'General case' 0 C--O 1.261 1.687 0 N-CA-C 102.177 -3.268 . . . . 25.0 102.177 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -88.19 21.11 2.91 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 120.308 -0.557 . . . . 25.0 109.671 -171.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -68.62 98.53 0.89 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 125.602 2.62 . . . . 25.0 103.946 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -33.78 144.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 1 CA-C-N 105.865 -5.152 . . . . 25.0 113.416 165.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -66.94 134.49 52.11 Favored 'General case' 0 C--O 1.263 1.767 0 O-C-N 125.233 1.583 . . . . 50.0 107.098 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -80.57 153.65 27.94 Favored 'General case' 0 CA--C 1.483 -1.598 0 O-C-N 120.589 -1.32 . . . . 25.0 110.481 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -136.93 143.3 42.83 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 117.29 2.33 . . . . 25.0 117.29 157.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.84 134.27 39.82 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.705 0 N-CA-C 105.406 -2.072 . . . . 25.0 105.406 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 66.3 mtm -144.32 146.92 32.87 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 118.624 -2.547 . . . . 25.0 105.895 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 p -86.58 171.55 10.94 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 124.143 1.925 . . . . 25.0 108.079 168.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.26 -173.77 17.09 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 124.455 2.142 . . . . 25.0 115.502 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.84 -176.7 38.03 Favored Glycine 0 C--O 1.266 2.106 0 N-CA-C 108.006 -2.038 . . . . 25.0 108.006 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 68.1 mm-40 -66.55 149.37 50.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 116.344 -1.789 . . . . 25.0 110.843 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -147.24 137.43 23.26 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 126.679 2.487 . . . . 25.0 105.675 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -93.61 105.96 17.97 Favored 'General case' 0 CA--C 1.479 -1.774 0 O-C-N 126.532 2.395 . . . . 25.0 105.152 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -76.64 142.23 40.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 103.061 -2.94 . . . . 50.0 103.061 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -136.46 103.28 5.21 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 118.385 -2.697 . . . . 25.0 106.75 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -100.78 126.7 47.37 Favored 'General case' 0 C--O 1.177 -2.754 0 N-CA-C 102.688 -3.079 . . . . 25.0 102.688 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -123.33 120.63 33.63 Favored 'General case' 0 C--O 1.175 -2.818 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -113.5 153.76 28.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.905 -1.498 . . . . 50.0 109.022 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 t -116.31 8.24 14.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 126.573 2.421 . . . . 25.0 113.271 174.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.91 119.39 25.86 Favored Pre-proline 0 C--N 1.349 0.586 0 C-N-CA 128.084 2.554 . . . . 25.0 111.451 -167.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -68.6 -37.94 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 124.922 2.011 . . . . 25.0 116.11 160.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.433 ' HD1' HG13 ' A' ' 154' ' ' VAL . 12.9 p80 -68.28 139.56 55.96 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 123.224 1.488 . . . . 25.0 110.857 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -78.68 129.74 35.06 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 112.887 -1.96 . . . . 25.0 113.479 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 154' ' ' VAL . 31.9 p -93.05 164.02 13.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.067 -1.646 . . . . 25.0 108.918 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -96.7 -49.94 4.89 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 120.698 -1.251 . . . . 25.0 110.185 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -166.46 170.88 12.45 Favored 'General case' 0 C--O 1.262 1.738 0 CA-C-O 118.354 -0.831 . . . . 25.0 110.758 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -144.13 153.06 41.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.096 -0.954 . . . . 25.0 109.315 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -131.16 142.59 50.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.832 -2.655 . . . . 25.0 103.832 -164.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -142.36 135.44 28.61 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 117.512 -3.242 . . . . 50.0 113.002 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 117' ' ' LEU . 14.5 p90 -146.38 167.16 24.28 Favored 'General case' 0 C--O 1.163 -3.495 0 O-C-N 119.546 -1.971 . . . . 50.0 111.105 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -120.1 173.97 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 125.933 2.02 . . . . 25.0 113.369 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -135.56 154.12 51.47 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 124.063 0.852 . . . . 25.0 112.711 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -137.81 100.77 4.27 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.388 1.625 . . . . 25.0 115.388 -165.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -42.86 162.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 120.73 3.604 . . . . 25.0 120.73 157.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.1 28.5 Favored Glycine 0 N--CA 1.488 2.113 0 CA-C-O 126.056 3.031 . . . . 25.0 107.763 165.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -67.62 160.89 26.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.06 -2.07 . . . . 25.0 114.067 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.02 111.75 20.43 Favored Pre-proline 0 C--O 1.194 -1.816 0 N-CA-C 107.127 -1.434 . . . . 25.0 107.127 155.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -64.35 -24.48 64.59 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 C-N-CA 123.671 2.914 . . . . 25.0 114.855 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.23 -15.99 50.5 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.379 1.049 . . . . 75.0 113.195 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -71.88 161.79 76.8 Favored Pre-proline 0 N--CA 1.483 1.199 0 CA-C-O 116.884 -1.531 . . . . 25.0 108.584 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -54.08 31.16 0.02 OUTLIER 'Trans proline' 0 CA--C 1.574 2.485 2 C-N-CA 126.302 4.668 . . . . 25.0 122.66 160.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -8.9 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 1 N-CA-C 122.386 4.217 . . . . 50.0 122.386 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.52 -16.83 64.44 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 117.118 -3.489 . . . . 25.0 109.586 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.26 -57.33 2.29 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 126.033 2.083 . . . . 25.0 106.955 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.76 -24.63 66.95 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.536 1.773 . . . . 25.0 115.299 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -69.88 -4.69 21.48 Favored 'General case' 0 C--O 1.198 -1.634 0 CA-C-O 116.513 -1.708 . . . . 25.0 114.903 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -118.32 150.29 39.75 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 122.807 2.549 . . . . 50.0 110.011 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.81 149.64 38.9 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 119.823 -1.798 . . . . 25.0 111.382 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 98' ' ' TYR . 21.1 tp -76.44 123.84 26.64 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 116.054 -1.927 . . . . 50.0 108.93 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.0 tt -95.29 -11.68 8.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.83 173.5 33.53 Favored Glycine 0 C--O 1.19 -2.633 0 N-CA-C 116.645 1.418 . . . . 25.0 116.645 164.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -157.32 132.12 8.73 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.344 -1.428 . . . . 25.0 111.295 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.44 130.32 18.02 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 105.033 -2.21 . . . . 50.0 105.033 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -82.56 163.87 16.56 Favored 'Trans proline' 0 C--N 1.372 1.769 0 CA-C-O 124.83 1.929 . . . . 25.0 116.229 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -82.87 136.05 34.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 113.732 -1.576 . . . . 25.0 108.426 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.7 32.14 11.5 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.9 1.68 . . . . 50.0 111.008 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.28 165.11 43.64 Favored Glycine 0 N--CA 1.425 -2.088 0 O-C-N 119.502 -1.999 . . . . 25.0 108.625 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 t -66.17 -38.31 21.4 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-O 116.241 -1.838 . . . . 25.0 112.872 -173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.24 160.94 23.19 Favored 'Trans proline' 0 C--N 1.38 2.231 1 C-N-CA 108.351 -7.299 . . . . 25.0 107.874 -170.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.37 -26.1 11.5 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 126.876 3.227 . . . . 25.0 114.08 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -66.91 2.83 1.26 Allowed 'General case' 0 CA--C 1.512 -0.49 1 N-CA-C 122.615 4.302 . . . . 25.0 122.615 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.03 5.48 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 121.438 3.866 . . . . 25.0 121.438 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.25 141.5 41.7 Favored 'General case' 0 C--O 1.276 2.499 0 N-CA-C 121.55 3.907 . . . . 25.0 121.55 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.18 -25.72 63.57 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 106.589 -1.634 . . . . 75.0 106.589 -165.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 t -90.37 127.79 36.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 O-C-N 117.819 -3.051 . . . . 25.0 110.583 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -125.64 155.44 40.81 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 117.014 2.227 . . . . 25.0 117.014 164.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -79.72 125.63 29.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 113.139 -3.315 . . . . 25.0 108.304 169.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.7 mm -124.38 129.03 74.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 123.582 2.901 . . . . 25.0 105.968 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 79.0 t80 -81.59 127.2 32.62 Favored 'General case' 0 C--O 1.276 2.462 0 O-C-N 120.472 -1.393 . . . . 50.0 113.399 177.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.64 116.27 61.3 Favored Pre-proline 0 CA--C 1.515 -0.4 0 C-N-CA 130.768 3.627 . . . . 25.0 105.842 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.57 158.3 58.26 Favored 'Trans proline' 0 C--O 1.193 -1.728 1 C-N-CA 111.925 -4.916 . . . . 25.0 115.848 175.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -115.86 9.26 14.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.268 1.509 . . . . 25.0 109.427 -170.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.23 -8.66 57.55 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.113 2.264 . . . . 50.0 117.113 -171.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -146.5 170.21 17.35 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.274 -2.491 . . . . 25.0 104.274 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.1 pt? -111.99 131.68 55.25 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 101.269 -3.604 . . . . 50.0 101.269 160.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -176.08 164.4 34.37 Favored Glycine 0 C--N 1.302 -1.357 0 CA-C-O 124.756 2.309 . . . . 25.0 113.649 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.15 139.75 34.17 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.569 -1.548 . . . . 50.0 111.125 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -154.69 159.62 40.86 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 104.884 -2.265 . . . . 25.0 104.884 -171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.54 134.54 66.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 113.781 -3.009 . . . . 50.0 112.839 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.6 mt -110.01 130.18 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 O-C-N 127.453 2.97 . . . . 25.0 106.553 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.51 143.18 50.8 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 103.324 -2.843 . . . . 50.0 103.324 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.61 153.1 49.94 Favored 'General case' 0 C--O 1.257 1.455 0 N-CA-C 104.723 -2.325 . . . . 25.0 104.723 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.82 135.66 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-N 113.7 -1.591 . . . . 50.0 107.258 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.49 124.97 31.26 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-N 119.782 1.174 . . . . 25.0 110.067 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 143.58 34.31 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 125.274 1.609 . . . . 25.0 112.853 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.433 HG13 ' HD1' ' A' ' 90' ' ' HIS . 39.0 t -99.32 135.19 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 123.901 1.81 . . . . 50.0 111.159 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 -34.14 20.81 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.3 -1.5 . . . . 25.0 111.691 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -72.96 -17.59 61.46 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 124.872 1.358 . . . . 25.0 110.32 -171.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 p -146.06 179.26 7.61 Favored 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 109.204 -0.665 . . . . 25.0 109.204 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -87.02 9.98 17.89 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-O 122.571 1.177 . . . . 25.0 111.873 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -73.6 150.78 41.16 Favored 'General case' 0 C--O 1.281 2.733 0 CA-C-O 123.118 1.437 . . . . 25.0 110.291 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.33 160.16 43.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 103.017 -2.957 . . . . 25.0 103.017 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -145.23 173.78 11.65 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.022 -1.844 . . . . 50.0 106.022 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.48 149.07 46.54 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 105.588 -2.005 . . . . 50.0 105.588 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.67 145.2 42.35 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 121.409 1.913 . . . . 25.0 108.192 -173.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.6 p -141.64 145.33 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 CA-C-N 119.399 1.0 . . . . 75.0 111.929 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.11 134.41 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 103.65 -2.722 . . . . 25.0 103.65 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.53 135.25 33.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.899 -1.046 . . . . 25.0 110.767 169.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.41 133.2 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 119.398 -2.064 . . . . 50.0 111.758 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -106.45 89.96 3.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 102.353 -3.203 . . . . 25.0 102.353 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.48 118.97 32.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.578 -1.646 . . . . 50.0 107.007 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 5.1 m -120.38 157.61 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 123.989 1.852 . . . . 50.0 114.21 -170.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -74.23 143.83 44.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 100.38 -3.933 . . . . 25.0 100.38 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 CA--C 1.55 0.97 0 C-N-CA 126.768 2.027 . . . . 25.0 108.521 -175.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 123.279 1.514 . . . . 25.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.43 -149.13 28.63 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 117.477 1.751 . . . . 25.0 117.477 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.19 133.68 40.2 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.121 1.368 . . . . 50.0 108.726 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.71 120.85 35.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 119.809 1.186 . . . . 25.0 108.268 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -98.2 -29.46 13.2 Favored 'General case' 0 C--O 1.281 2.733 0 C-N-CA 125.079 1.352 . . . . 25.0 112.816 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -153.31 146.79 18.12 Favored Pre-proline 0 CA--C 1.559 1.298 1 N-CA-C 98.742 -4.54 . . . . 25.0 98.742 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.38 131.11 8.81 Favored 'Cis proline' 0 C--N 1.311 -1.436 0 C-N-CA 131.058 1.691 . . . . 25.0 115.743 15.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.47 177.29 44.39 Favored Glycine 0 C--O 1.192 -2.494 0 N-CA-C 118.632 2.213 . . . . 25.0 118.632 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -103.58 125.65 50.24 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 105.201 -2.148 . . . . 25.0 105.201 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -61.93 -34.0 75.29 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 123.789 0.681 . . . . 25.0 109.74 170.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.09 -33.13 73.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 116.718 -1.993 . . . . 25.0 111.284 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.69 78.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.248 -0.908 . . . . 25.0 111.665 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mp -80.12 -30.65 39.08 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-O 122.277 1.037 . . . . 75.0 111.362 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -65.28 -25.49 67.67 Favored 'General case' 0 C--O 1.269 2.087 0 O-C-N 121.517 -0.739 . . . . 25.0 111.288 172.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.5 t -70.45 140.75 52.04 Favored 'General case' 0 CA--C 1.47 -2.116 0 O-C-N 119.159 -2.213 . . . . 25.0 105.495 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -66.45 -11.35 51.58 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 116.557 -1.687 . . . . 25.0 110.717 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.41 -37.6 85.58 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 120.863 1.665 . . . . 25.0 109.634 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -79.54 -38.47 34.12 Favored 'General case' 0 C--O 1.208 -1.086 0 O-C-N 120.652 -1.28 . . . . 50.0 111.074 169.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.06 17.91 9.8 Favored Glycine 0 C--N 1.362 1.988 0 N-CA-C 116.419 1.328 . . . . 25.0 116.419 -152.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -59.21 -41.69 89.2 Favored 'General case' 0 C--O 1.176 -2.788 0 O-C-N 120.054 -1.85 . . . . 50.0 114.77 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.06 -15.2 62.96 Favored 'General case' 0 CA--C 1.467 -2.22 0 O-C-N 118.631 -2.543 . . . . 50.0 115.959 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -109.99 175.54 5.4 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 124.604 1.162 . . . . 25.0 111.753 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mp -55.81 151.96 10.52 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 119.568 -1.957 . . . . 50.0 115.449 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -35.7 -43.12 0.27 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.41 3.115 . . . . 25.0 119.41 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 t -146.45 6.53 0.97 Allowed 'General case' 0 C--O 1.257 1.448 0 N-CA-C 117.143 2.275 . . . . 25.0 117.143 -169.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.52 82.62 0.22 Allowed Glycine 0 C--O 1.17 -3.845 0 CA-C-O 118.383 -1.232 . . . . 25.0 112.739 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.72 -10.89 0.12 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 118.174 2.657 . . . . 25.0 118.174 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 p -58.01 -22.2 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-N 120.634 1.561 . . . . 50.0 109.597 172.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -47.02 -22.45 0.34 Allowed 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 123.868 1.794 . . . . 25.0 115.741 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -62.5 -40.15 95.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.407 1.632 . . . . 50.0 115.407 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -143.12 46.18 0.67 Allowed Pre-proline 0 CA--C 1.473 -2.009 0 N-CA-C 119.044 2.979 . . . . 25.0 119.044 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.35 -30.7 29.73 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 O-C-N 116.918 -2.201 . . . . 25.0 113.513 -167.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -77.89 -1.07 29.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.374 1.99 . . . . 25.0 116.374 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.5 16.69 3.0 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 121.122 3.749 . . . . 25.0 121.122 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.78 114.64 18.85 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 125.39 2.519 . . . . 50.0 110.819 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -99.2 162.43 13.06 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 117.633 -3.167 . . . . 25.0 110.822 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.87 14.97 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.72 1.263 . . . . 25.0 112.388 -172.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -92.35 -172.61 3.15 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.401 1.572 . . . . 25.0 109.792 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.34 138.25 17.15 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 105.388 -2.078 . . . . 25.0 105.388 172.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.86 -5.8 0.53 Allowed Glycine 0 C--O 1.195 -2.312 0 O-C-N 128.042 3.339 . . . . 25.0 111.761 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -65.83 138.98 96.68 Favored Pre-proline 0 N--CA 1.477 0.914 0 CA-C-O 115.074 -2.393 . . . . 25.0 109.212 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.51 115.68 2.91 Favored 'Cis proline' 0 C--O 1.2 -1.405 0 O-C-N 125.966 2.561 . . . . 25.0 111.418 -2.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -60.14 -26.96 66.67 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 117.815 2.524 . . . . 25.0 117.815 -165.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.86 -39.3 53.46 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 116.985 2.216 . . . . 25.0 116.985 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.06 179.72 38.37 Favored Glycine 0 CA--C 1.563 3.063 0 O-C-N 120.539 -1.351 . . . . 25.0 113.803 -172.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -63.25 165.55 16.95 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 123.3 2.666 . . . . 25.0 106.028 166.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.99 133.55 32.63 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 119.416 3.117 . . . . 25.0 119.416 -166.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -64.08 150.92 44.46 Favored 'General case' 0 C--O 1.272 2.258 0 CA-C-N 114.447 -1.251 . . . . 25.0 109.464 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.97 -1.9 78.63 Favored Glycine 0 C--O 1.196 -2.23 1 CA-C-O 113.268 -4.073 . . . . 25.0 109.801 175.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -129.98 9.47 5.33 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 120.836 2.318 . . . . 25.0 108.574 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.49 -36.91 43.14 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.217 0 C-N-CA 124.648 1.179 . . . . 25.0 110.329 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.34 -48.36 23.42 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 120.945 -1.097 . . . . 25.0 112.142 -175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.5 p -136.12 -5.6 2.11 Favored 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 118.129 2.64 . . . . 25.0 118.129 -168.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 41.32 38.77 0.85 Allowed 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 126.98 2.112 . . . . 25.0 114.763 -163.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.37 -29.99 70.31 Favored Glycine 0 C--O 1.213 -1.184 0 O-C-N 120.621 -1.299 . . . . 25.0 109.951 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.02 -19.35 71.75 Favored Glycine 0 CA--C 1.553 2.458 0 O-C-N 120.95 -1.324 . . . . 25.0 116.171 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 60' ' ' GLY . 46.7 mt -112.73 -12.41 13.37 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 117.426 2.38 . . . . 50.0 117.426 173.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.83 -36.45 70.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 104.465 -2.42 . . . . 50.0 104.465 161.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.25 -20.62 75.24 Favored Glycine 0 C--O 1.269 2.285 0 CA-C-O 126.009 3.005 . . . . 25.0 108.53 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 57' ' ' LEU . . . -64.52 -20.17 65.48 Favored Glycine 0 C--O 1.197 -2.214 0 O-C-N 116.841 -3.741 . . . . 25.0 115.189 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.8 mt -71.8 -46.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 111.793 -2.203 . . . . 25.0 105.645 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.96 -17.52 57.09 Favored 'General case' 0 CA--C 1.574 1.877 0 O-C-N 118.892 -2.38 . . . . 75.0 116.582 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -66.4 -29.25 69.37 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 123.805 1.764 . . . . 50.0 110.467 167.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.64 24.52 1.21 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.975 2.321 . . . . 25.0 113.983 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.6 48.78 1.43 Allowed 'General case' 0 C--O 1.25 1.114 0 O-C-N 119.52 -1.988 . . . . 25.0 110.951 157.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.271 13.7 t -133.56 174.94 9.89 Favored 'General case' 0 C--O 1.216 -0.702 0 O-C-N 125.365 1.666 . . . . 25.0 111.642 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.68 -17.39 59.97 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 123.849 1.785 . . . . 25.0 107.877 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -89.69 32.38 0.89 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 112.43 -2.168 . . . . 25.0 112.041 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -81.84 84.63 6.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 125.258 2.456 . . . . 25.0 116.354 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -40.06 150.83 0.05 Allowed 'General case' 0 C--O 1.292 3.293 1 CA-C-N 107.438 -4.437 . . . . 25.0 113.077 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -66.32 152.35 45.16 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 105.507 -2.034 . . . . 50.0 105.507 -167.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.51 151.48 27.52 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.79 132.39 28.81 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 117.321 2.341 . . . . 25.0 117.321 168.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -90.0 133.98 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 117.409 -1.281 . . . . 25.0 108.936 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.4 ttt -150.02 142.65 24.54 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 120.359 1.436 . . . . 25.0 111.189 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.459 HG22 HG23 ' A' ' 170' ' ' VAL . 32.2 p -79.35 166.95 21.53 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.285 0.846 . . . . 25.0 113.285 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 147.73 45.45 Favored Glycine 0 C--O 1.257 1.578 0 O-C-N 118.535 -2.603 . . . . 25.0 114.002 172.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.99 -166.04 33.38 Favored Glycine 0 CA--C 1.572 3.599 0 O-C-N 119.693 -2.063 . . . . 25.0 108.658 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -65.44 136.94 57.09 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.13 -1.806 . . . . 25.0 109.848 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -121.15 148.96 43.51 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 103.45 -2.796 . . . . 25.0 103.45 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -122.39 126.2 47.5 Favored 'General case' 0 C--O 1.201 -1.463 0 C-N-CA 124.807 1.243 . . . . 25.0 107.652 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -116.9 79.38 1.32 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 103.535 -2.765 . . . . 50.0 103.535 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -82.95 101.31 10.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.635 -1.166 . . . . 25.0 108.504 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -106.96 137.4 45.1 Favored 'General case' 0 CA--C 1.556 1.187 1 N-CA-C 99.708 -4.182 . . . . 25.0 99.708 173.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 t -151.13 143.46 24.17 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 123.787 1.756 . . . . 25.0 113.671 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -143.11 170.32 15.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 117.791 -1.1 . . . . 50.0 108.593 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . 0.287 9.1 t -72.13 -30.66 65.25 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 124.681 2.182 . . . . 25.0 112.737 175.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.47 152.81 69.79 Favored Pre-proline 0 C--O 1.262 1.721 0 O-C-N 116.78 -3.7 . . . . 25.0 109.062 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.46 161.45 42.38 Favored 'Trans proline' 0 C--O 1.282 2.677 0 C-N-CA 115.61 -2.46 . . . . 25.0 108.52 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -126.06 162.33 25.56 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 117.557 -3.215 . . . . 25.0 112.905 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.41 124.98 23.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 105.026 -2.213 . . . . 25.0 105.026 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -147.12 150.84 35.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 169.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.0 p -94.53 -31.14 14.05 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 120.447 1.476 . . . . 25.0 109.442 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . 0.261 7.2 tt0 -158.54 160.88 37.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 118.604 0.638 . . . . 25.0 109.396 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -142.91 148.93 37.75 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 123.784 1.754 . . . . 25.0 106.815 166.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.96 151.8 51.17 Favored 'General case' 0 C--N 1.27 -2.876 0 O-C-N 119.089 -2.257 . . . . 25.0 108.871 -169.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.21 130.07 45.83 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 105.104 -2.184 . . . . 50.0 105.104 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.43 155.83 23.57 Favored 'General case' 0 C--O 1.182 -2.468 0 CA-C-N 111.857 -2.428 . . . . 50.0 104.512 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.1 pt -134.62 155.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-N 112.129 -2.305 . . . . 25.0 112.291 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 p -70.63 156.88 38.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 124.523 2.106 . . . . 25.0 115.108 168.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -130.68 95.43 3.85 Favored 'General case' 0 C--O 1.188 -2.132 0 O-C-N 116.988 -3.57 . . . . 25.0 114.922 173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -68.9 157.07 37.37 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 107.869 -1.16 . . . . 25.0 107.869 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.55 37.75 89.9 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-O 126.077 3.043 . . . . 25.0 110.985 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -67.16 159.84 28.09 Favored 'General case' 0 C--O 1.267 1.987 0 CA-C-O 125.686 2.66 . . . . 25.0 110.777 -171.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -67.46 123.89 87.79 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-N 111.958 -2.383 . . . . 25.0 107.279 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.53 -17.67 20.63 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 117.923 2.24 . . . . 25.0 117.923 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.71 8.44 39.22 Favored 'General case' 0 C--O 1.253 1.252 0 O-C-N 119.696 -1.877 . . . . 75.0 108.407 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -122.18 162.42 37.62 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 112.203 -2.271 . . . . 25.0 114.596 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.88 95.0 1.06 Allowed 'Trans proline' 0 CA--C 1.463 -3.04 0 N-CA-C 117.052 1.905 . . . . 25.0 117.052 -168.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -21.34 -60.76 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 127.064 2.146 . . . . 50.0 116.355 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -77.47 3.33 13.68 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 119.1 -2.25 . . . . 25.0 113.735 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.258 84.2 mtt180 -119.99 -42.19 2.61 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 127.422 2.289 . . . . 25.0 110.868 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.93 -15.74 5.47 Favored 'General case' 0 C--O 1.283 2.84 0 O-C-N 119.812 -1.805 . . . . 25.0 111.833 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -98.58 17.02 20.09 Favored 'General case' 0 C--O 1.271 2.192 0 N-CA-C 118.639 2.829 . . . . 25.0 118.639 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -144.85 161.28 39.67 Favored 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 118.762 -1.175 . . . . 50.0 107.898 168.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.79 158.59 43.84 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.71 137.74 35.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.049 -1.834 . . . . 50.0 106.049 164.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.287 16.7 tt -94.98 -26.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 116.268 -1.825 . . . . 25.0 111.964 169.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.92 156.12 13.65 Favored Glycine 0 N--CA 1.432 -1.58 0 O-C-N 124.893 1.371 . . . . 25.0 112.345 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.26 143.01 50.24 Favored 'General case' 0 N--CA 1.394 -3.251 0 CA-C-O 124.442 2.067 . . . . 25.0 108.351 170.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.4 96.53 48.06 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.325 -1.307 . . . . 50.0 108.173 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.97 159.23 50.84 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 114.056 -3.496 . . . . 25.0 110.601 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -139.91 47.74 1.82 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 115.629 1.715 . . . . 25.0 115.629 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -112.19 -24.86 9.6 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.767 -2.015 . . . . 50.0 107.143 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -160.89 40.21 0.43 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-O 124.925 2.403 . . . . 25.0 113.427 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -81.28 146.96 59.26 Favored Pre-proline 0 C--O 1.273 2.317 0 O-C-N 119.392 -2.24 . . . . 25.0 108.304 -154.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.57 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.768 1 C-N-CA 126.021 4.481 . . . . 25.0 107.031 169.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.6 -18.52 0.26 Allowed 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 121.081 3.734 . . . . 25.0 121.081 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 56.8 p -52.5 -9.41 0.11 Allowed 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 121.728 2.058 . . . . 25.0 114.582 162.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -60.03 -16.16 28.74 Favored 'General case' 0 N--CA 1.522 3.161 0 O-C-N 117.661 -3.149 . . . . 25.0 113.192 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.66 136.08 50.68 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 104.389 -2.449 . . . . 25.0 104.389 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -69.23 -24.83 64.06 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.504 -1.372 . . . . 75.0 111.196 -165.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.4 t -85.41 136.48 33.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 113.834 -1.53 . . . . 25.0 110.395 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.08 156.58 42.58 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 104.729 -2.323 . . . . 25.0 104.729 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -108.4 119.51 39.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 115.164 -2.351 . . . . 25.0 105.624 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.8 mm -118.42 119.23 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.312 0 C-N-CA 125.384 1.474 . . . . 25.0 111.19 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -77.16 133.77 38.86 Favored 'General case' 0 C--O 1.269 2.101 0 N-CA-C 105.022 -2.214 . . . . 50.0 105.022 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.3 mt -134.86 119.67 13.85 Favored Pre-proline 0 C--N 1.361 1.102 0 CA-C-O 122.908 1.337 . . . . 25.0 108.267 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.83 159.08 13.98 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 116.718 -1.721 . . . . 25.0 112.512 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 169' ' ' LEU . 11.5 tp10 -153.95 115.92 4.27 Favored 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.923 1.823 . . . . 25.0 115.923 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -105.95 -4.04 21.05 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 113.77 -1.559 . . . . 50.0 115.062 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -118.02 166.51 12.44 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 117.277 -3.389 . . . . 25.0 110.492 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.9 mp -116.55 136.6 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.947 -2.612 . . . . 50.0 103.947 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.97 174.18 25.47 Favored Glycine 0 C--N 1.306 -1.085 0 N-CA-C 119.913 2.725 . . . . 25.0 119.913 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.31 142.19 27.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.588 1.555 . . . . 50.0 108.268 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -146.25 162.73 37.44 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 104.672 -2.344 . . . . 25.0 104.672 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.9 t -127.64 136.81 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 123.828 3.013 . . . . 50.0 112.598 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 76.9 mt -104.02 118.58 51.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.642 0 N-CA-C 105.439 -2.06 . . . . 25.0 105.439 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.5 130.76 44.55 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.417 2.056 . . . . 50.0 108.882 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -110.51 127.53 55.21 Favored 'General case' 0 C--O 1.246 0.902 0 O-C-N 120.145 -1.597 . . . . 25.0 109.704 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.87 132.73 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 O-C-N 126.083 2.114 . . . . 50.0 114.673 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 119.52 31.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.69 1.596 . . . . 25.0 109.304 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.42 72.08 4.42 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 126.294 2.246 . . . . 25.0 107.875 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.46 98.97 2.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.533 0 C-N-CA 117.51 -1.676 . . . . 50.0 111.164 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.68 -16.45 64.15 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.756 1.265 . . . . 25.0 113.804 -165.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -60.89 -32.99 72.42 Favored 'General case' 0 CA--C 1.601 2.913 0 CA-C-N 113.763 -1.562 . . . . 25.0 112.145 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.0 t -123.92 158.69 31.38 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.475 1.734 . . . . 25.0 110.019 -166.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -74.41 -23.73 58.99 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.18 165.05 7.74 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.751 1.019 . . . . 25.0 113.751 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.96 178.44 6.67 Favored 'General case' 0 C--O 1.209 -1.053 1 N-CA-C 98.25 -4.722 . . . . 25.0 98.25 175.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -126.22 130.43 50.93 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.891 -3.744 . . . . 50.0 100.891 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -135.33 138.67 43.63 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 126.15 1.78 . . . . 50.0 111.529 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -160.58 175.52 12.6 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 104.848 -2.278 . . . . 25.0 104.848 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 148' ' ' ILE . 26.5 m -135.86 164.63 31.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 125.158 1.536 . . . . 75.0 107.392 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.0 mm -133.65 120.48 37.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 112.721 -2.036 . . . . 25.0 105.6 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -88.64 124.95 34.57 Favored 'General case' 0 C--O 1.262 1.753 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.518 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.68 158.1 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 117.077 2.251 . . . . 50.0 117.077 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.7 124.92 30.8 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 101.901 -3.37 . . . . 25.0 101.901 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 140' ' ' GLU . 84.2 mt -114.07 130.53 56.56 Favored 'General case' 0 C--O 1.204 -1.34 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 -174.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.459 HG23 HG22 ' A' ' 76' ' ' THR . 27.6 m -124.95 158.1 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 116.223 1.934 . . . . 50.0 116.223 -173.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.7 132.38 35.18 Favored 'General case' 0 CA--C 1.585 2.311 0 O-C-N 125.842 1.964 . . . . 25.0 108.831 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.4 pttt . . . . . 0 CA--C 1.552 1.055 0 CA-C-O 118.235 -0.888 . . . . 25.0 110.884 -167.669 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.672 0.749 . . . . 25.0 111.349 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.35 179.71 27.32 Favored Glycine 0 C--O 1.267 2.203 0 C-N-CA 117.794 -2.146 . . . . 25.0 116.956 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -152.37 153.96 34.66 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.096 -2.414 . . . . 50.0 111.351 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -74.71 133.49 31.42 Favored 'Isoleucine or valine' 0 C--O 1.258 1.518 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 -163.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -120.29 -30.32 4.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.421 -1.312 . . . . 25.0 111.768 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG2' HG22 ' A' ' 83' ' ' THR . 19.0 pttt -146.72 162.46 33.63 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 123.568 1.651 . . . . 25.0 107.148 151.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.69 148.95 87.33 Favored 'Cis proline' 0 N--CA 1.494 1.531 0 CA-C-O 123.439 1.35 . . . . 25.0 112.219 6.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.39 -175.69 52.55 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-O 126.013 3.007 . . . . 25.0 115.995 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.3 t -117.4 102.03 8.89 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 111.851 -2.175 . . . . 25.0 108.913 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -57.74 -31.93 66.95 Favored 'General case' 0 C--O 1.181 -2.533 0 O-C-N 123.784 0.678 . . . . 25.0 111.472 -169.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.67 65.58 Favored 'General case' 0 CA--C 1.558 1.269 0 O-C-N 118.365 -2.709 . . . . 25.0 111.925 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.11 -22.12 55.89 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.613 -1.625 . . . . 25.0 106.613 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt -74.83 -33.31 62.15 Favored 'General case' 0 C--O 1.257 1.491 0 N-CA-C 114.049 1.129 . . . . 75.0 114.049 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.51 -49.74 14.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.881 -1.054 . . . . 25.0 113.522 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.5 m -61.63 163.15 7.44 Favored 'General case' 0 N--CA 1.512 2.644 0 C-N-CA 126.927 2.091 . . . . 25.0 114.328 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -68.62 -47.67 66.06 Favored 'General case' 0 C--O 1.287 3.041 0 CA-C-N 114.432 -1.258 . . . . 25.0 112.838 -167.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.38 -38.38 0.01 OUTLIER 'General case' 0 C--O 1.201 -1.465 0 O-C-N 125.65 1.844 . . . . 25.0 111.859 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -89.54 17.73 6.07 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 125.962 1.705 . . . . 50.0 113.082 -152.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.4 29.75 15.89 Favored Glycine 0 CA--C 1.457 -3.559 0 CA-C-O 113.655 -3.858 . . . . 25.0 114.138 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . 0.26 36.4 t80 31.65 47.66 0.07 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 126.462 1.919 . . . . 50.0 115.145 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.48 -27.29 56.04 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 104.704 -2.332 . . . . 50.0 104.704 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -123.7 160.53 27.01 Favored 'General case' 0 C--O 1.297 3.601 0 N-CA-C 108.723 -0.843 . . . . 25.0 108.723 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.56 164.02 27.22 Favored 'General case' 0 CA--C 1.496 -1.097 0 O-C-N 126.157 2.161 . . . . 50.0 107.103 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -179.3 -23.85 0.0 OUTLIER 'General case' 0 C--O 1.27 2.14 0 C-N-CA 124.547 1.139 . . . . 25.0 113.568 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 t -96.66 -6.11 37.35 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 119.508 3.151 . . . . 25.0 119.508 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 29' ' ' MET . . . 94.31 127.41 4.87 Favored Glycine 0 CA--C 1.486 -1.749 0 N-CA-C 108.088 -2.005 . . . . 25.0 108.088 -175.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -60.46 -15.89 31.17 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 113.9 -1.15 . . . . 25.0 112.901 -172.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.37 -20.96 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 O-C-N 124.158 0.911 . . . . 50.0 110.005 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 23.1 ptm -53.82 -22.28 9.29 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.849 0.859 . . . . 25.0 112.86 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.91 -53.72 55.03 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 118.271 -2.768 . . . . 50.0 111.595 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.93 67.83 41.89 Favored Pre-proline 0 CA--C 1.566 1.58 0 O-C-N 118.88 -2.387 . . . . 25.0 115.813 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.07 -11.49 22.02 Favored 'Trans proline' 0 C--O 1.206 -1.086 0 C-N-CA 124.449 3.433 . . . . 25.0 117.252 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 -8.15 30.21 Favored 'General case' 0 C--O 1.159 -3.663 0 N-CA-C 114.244 1.201 . . . . 25.0 114.244 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -70.44 50.83 0.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 119.412 3.115 . . . . 25.0 119.412 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.15 132.82 46.43 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.198 -1.408 . . . . 50.0 107.198 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 161.92 19.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 120.719 1.6 . . . . 25.0 110.615 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.2 41.42 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-O 115.499 -2.191 . . . . 25.0 108.272 161.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -112.43 142.99 44.3 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-N 121.962 2.164 . . . . 25.0 113.389 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -76.82 150.22 36.14 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 117.987 -2.946 . . . . 25.0 104.487 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.21 148.86 6.23 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 106.242 -2.743 . . . . 25.0 106.242 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -134.82 146.1 57.44 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 117.959 -1.019 . . . . 25.0 111.526 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.85 -19.31 7.27 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 121.299 -2.375 . . . . 25.0 113.547 -8.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -144.5 -27.48 0.5 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 116.982 -1.887 . . . . 25.0 113.248 160.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 51.49 -87.94 0.01 OUTLIER 'General case' 0 C--O 1.246 0.894 0 O-C-N 119.603 -1.935 . . . . 25.0 113.278 -167.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.24 -172.26 18.5 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 109.569 -1.412 . . . . 25.0 109.569 175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -64.69 157.62 54.86 Favored 'Trans proline' 0 CA--C 1.554 1.509 0 CA-C-N 121.208 2.504 . . . . 25.0 116.794 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.64 91.9 0.83 Allowed 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 114.074 1.138 . . . . 25.0 114.074 -174.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -123.19 158.58 30.49 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 101.183 -3.636 . . . . 25.0 101.183 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.58 11.79 60.3 Favored Glycine 0 N--CA 1.48 1.604 0 O-C-N 128.637 3.71 . . . . 25.0 110.094 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -73.61 -22.79 59.91 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 118.669 2.84 . . . . 25.0 118.669 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 mm -86.79 -36.92 10.76 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.307 0 CA-C-N 114.026 -1.443 . . . . 25.0 108.597 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.67 86.98 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 118.204 -1.398 . . . . 25.0 113.589 170.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.0 p -70.29 -6.41 34.77 Favored 'General case' 0 C--O 1.184 -2.376 0 O-C-N 123.723 0.64 . . . . 25.0 112.332 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.282 . . 47.86 24.34 0.57 Allowed 'General case' 0 C--O 1.251 1.141 1 N-CA-C 125.992 5.553 . . . . 25.0 125.992 -173.228 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.49 -21.14 52.54 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 113.311 -1.768 . . . . 25.0 113.561 168.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.36 15.99 58.38 Favored Glycine 0 CA--C 1.474 -2.475 0 CA-C-O 116.078 -2.512 . . . . 25.0 116.904 -173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.13 -19.77 39.36 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 122.295 3.048 . . . . 50.0 117.509 -161.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.34 -25.75 46.55 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.325 -2.843 . . . . 50.0 103.325 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.82 -17.92 62.52 Favored Glycine 0 C--O 1.209 -1.445 0 CA-C-O 125.286 2.604 . . . . 25.0 112.578 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.9 -25.28 71.89 Favored Glycine 0 CA--C 1.561 2.948 0 O-C-N 118.684 -2.656 . . . . 25.0 111.821 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.23 -38.03 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.14 -32.53 63.2 Favored 'General case' 0 C--O 1.198 -1.615 0 N-CA-C 104.95 -2.241 . . . . 75.0 104.95 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -68.47 -34.82 76.61 Favored 'General case' 0 C--O 1.264 1.834 0 N-CA-C 116.807 2.151 . . . . 50.0 116.807 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -76.65 16.42 0.51 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 125.789 2.709 . . . . 25.0 114.687 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -126.38 82.64 2.09 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 101.946 -3.353 . . . . 25.0 101.946 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -163.39 166.18 23.16 Favored 'General case' 0 CA--C 1.479 -1.784 0 O-C-N 123.636 0.585 . . . . 25.0 111.839 -173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -66.46 -29.43 69.56 Favored 'General case' 0 C--O 1.196 -1.754 0 O-C-N 117.448 -3.282 . . . . 25.0 109.977 171.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -82.04 21.88 0.84 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 112.876 -1.966 . . . . 25.0 112.66 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -74.0 97.34 2.83 Favored 'General case' 0 C--O 1.171 -3.054 0 CA-C-O 127.312 3.434 . . . . 25.0 109.649 158.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.1 p90 -29.64 135.41 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.375 1 CA-C-N 107.502 -4.408 . . . . 25.0 112.393 160.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -63.5 152.34 38.77 Favored 'General case' 0 C--O 1.268 2.037 0 N-CA-C 116.302 1.964 . . . . 50.0 116.302 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -101.56 162.01 13.22 Favored 'General case' 0 CA--C 1.479 -1.773 0 CA-C-N 113.513 -1.676 . . . . 25.0 111.576 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -153.47 146.41 24.47 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 124.472 1.109 . . . . 25.0 109.813 164.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.37 135.16 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 106.412 -1.699 . . . . 25.0 106.412 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 48.1 mtp -137.52 158.28 44.72 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 109.095 -0.706 . . . . 25.0 109.095 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.3 p -120.2 167.02 12.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.41 -164.98 40.36 Favored Glycine 0 C--O 1.266 2.105 0 C-N-CA 119.821 -1.181 . . . . 25.0 111.819 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.85 -173.66 32.24 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 120.573 -0.823 . . . . 25.0 111.104 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -82.02 141.71 32.99 Favored 'General case' 0 C--O 1.28 2.695 0 CA-C-O 124.071 1.891 . . . . 25.0 110.752 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.51 143.33 39.49 Favored 'General case' 0 C--O 1.19 -2.074 0 N-CA-C 104.133 -2.543 . . . . 25.0 104.133 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -98.56 126.14 44.04 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.273 -1.751 . . . . 25.0 106.273 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -110.85 150.73 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 116.179 -1.867 . . . . 50.0 106.154 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.449 HG22 ' HG2' ' A' ' 6' ' ' LYS . 3.3 t -153.3 159.61 42.56 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 117.632 -1.175 . . . . 25.0 114.129 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -138.07 171.58 14.2 Favored 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.872 -3.01 . . . . 25.0 102.872 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 p -135.3 154.75 51.43 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.121 1.513 . . . . 25.0 107.94 153.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -94.02 154.2 17.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.902 0.858 . . . . 50.0 109.043 169.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.1 p -85.29 -27.02 26.24 Favored 'General case' 0 C--O 1.172 -2.98 0 O-C-N 120.396 -1.44 . . . . 25.0 111.691 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.67 141.66 13.89 Favored Pre-proline 0 CA--C 1.48 -1.739 0 N-CA-C 102.408 -3.182 . . . . 25.0 102.408 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.49 162.84 35.27 Favored 'Trans proline' 0 C--N 1.373 1.843 0 CA-C-O 123.507 1.378 . . . . 25.0 113.76 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.88 148.12 41.58 Favored 'General case' 0 CA--C 1.471 -2.059 0 CA-C-N 112.963 -1.926 . . . . 25.0 106.471 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -81.76 96.95 7.74 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 112.161 -2.291 . . . . 25.0 108.731 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.6 m -83.98 127.7 34.05 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 116.446 2.017 . . . . 25.0 116.446 -170.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 p -87.83 -42.27 12.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 118.335 -1.346 . . . . 25.0 110.486 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -168.29 168.21 11.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.068 -1.424 . . . . 25.0 109.866 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -140.66 164.65 29.6 Favored 'General case' 0 C--O 1.261 1.661 0 CA-C-N 123.199 2.727 . . . . 25.0 110.96 164.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -139.89 159.77 41.43 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 115.092 -2.385 . . . . 25.0 112.217 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.89 145.0 24.58 Favored 'General case' 0 C--O 1.246 0.901 0 O-C-N 124.951 1.407 . . . . 50.0 111.986 169.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 117' ' ' LEU . 58.9 m-85 -139.57 169.77 17.14 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 105.56 -2.015 . . . . 50.0 105.56 -172.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 pt -125.38 152.63 32.25 Favored 'Isoleucine or valine' 0 C--O 1.261 1.68 0 CA-C-O 123.791 1.758 . . . . 25.0 106.895 162.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.94 143.32 29.91 Favored 'General case' 0 C--N 1.387 2.206 0 N-CA-C 100.49 -3.892 . . . . 25.0 100.49 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -101.17 133.16 46.14 Favored 'General case' 0 C--O 1.183 -2.416 1 N-CA-C 100.085 -4.042 . . . . 25.0 100.085 -172.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -146.05 151.65 38.08 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 -163.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.21 37.13 9.25 Favored Glycine 0 C--O 1.202 -1.893 0 CA-C-O 125.087 2.493 . . . . 25.0 110.428 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -65.56 157.58 29.37 Favored 'General case' 0 CA--C 1.462 -2.413 0 C-N-CA 126.874 2.07 . . . . 25.0 114.908 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.97 123.05 89.15 Favored Pre-proline 0 CA--C 1.501 -0.942 1 O-C-N 115.438 -4.539 . . . . 25.0 108.937 155.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.77 -24.66 72.6 Favored 'Trans proline' 0 CA--C 1.499 -1.267 0 C-N-CA 115.017 -2.856 . . . . 25.0 117.102 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.96 -6.06 49.16 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 124.221 1.962 . . . . 75.0 113.854 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -56.1 161.95 3.34 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-N 112.663 -2.062 . . . . 25.0 112.254 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -77.55 70.37 6.9 Favored 'Trans proline' 0 C--O 1.175 -2.671 0 CA-C-O 125.972 2.405 . . . . 25.0 113.696 161.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 mt -46.63 -40.66 13.41 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 110.16 -3.2 . . . . 50.0 113.808 -168.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.79 -13.04 61.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 123.233 2.742 . . . . 25.0 115.42 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -117.78 -41.89 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 127.112 2.758 . . . . 25.0 111.627 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.22 -18.07 65.01 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 114.138 1.162 . . . . 25.0 114.138 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.35 33.45 1.4 Allowed 'General case' 0 C--N 1.316 -0.873 0 O-C-N 119.945 -1.722 . . . . 25.0 115.184 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -141.52 145.74 35.52 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.642 1.177 . . . . 50.0 108.538 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.45 142.61 50.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 115.309 1.596 . . . . 25.0 115.309 163.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 98' ' ' TYR . 41.5 tp -77.76 137.96 38.74 Favored 'General case' 0 C--N 1.319 -0.753 1 N-CA-C 99.426 -4.287 . . . . 50.0 99.426 179.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.1 tt -124.52 -5.32 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 O-C-N 126.726 2.516 . . . . 25.0 108.902 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.12 170.31 37.28 Favored Glycine 0 C--O 1.273 2.576 0 N-CA-C 118.277 2.071 . . . . 25.0 118.277 154.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.99 145.6 24.24 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 123.449 1.595 . . . . 25.0 108.243 170.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -118.96 100.63 50.67 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 120.899 -1.125 . . . . 50.0 111.049 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.19 172.81 15.41 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 122.615 2.21 . . . . 25.0 108.398 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -133.88 48.17 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 112.819 -1.991 . . . . 25.0 108.358 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.7 -11.77 59.83 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 117.239 -1.784 . . . . 50.0 109.131 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 143.1 -171.79 24.84 Favored Glycine 0 C--N 1.294 -1.803 0 CA-C-O 116.927 -2.041 . . . . 25.0 113.091 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.0 154.27 0.12 Allowed Pre-proline 0 N--CA 1.428 -1.525 0 C-N-CA 129.127 2.971 . . . . 25.0 115.75 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.27 10.33 3.75 Favored 'Trans proline' 0 C--O 1.182 -2.277 1 C-N-CA 112.524 -4.517 . . . . 25.0 117.681 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.78 -25.92 62.21 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 119.711 -1.868 . . . . 25.0 109.165 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 81.3 p -71.61 -19.0 62.18 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 123.917 1.817 . . . . 25.0 111.67 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -72.46 -23.92 61.12 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 111.416 -2.629 . . . . 25.0 109.609 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.62 109.87 5.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 119.282 -2.136 . . . . 25.0 110.444 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.7 -36.22 14.46 Favored 'General case' 0 C--O 1.278 2.58 0 O-C-N 119.358 -2.088 . . . . 75.0 109.312 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.7 t -73.73 131.66 41.83 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.176 0.99 . . . . 25.0 110.085 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.08 161.14 38.34 Favored 'General case' 0 C--O 1.275 2.429 0 CA-C-O 121.85 0.833 . . . . 25.0 109.293 -173.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -109.11 131.75 54.77 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.153 -0.931 . . . . 25.0 108.587 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.14 117.79 38.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -75.66 134.5 40.57 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 125.583 1.802 . . . . 50.0 106.971 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 18.1 mt -125.72 119.3 24.31 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 103.041 -2.948 . . . . 25.0 103.041 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.2 153.26 67.08 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 124.007 1.53 . . . . 25.0 112.361 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -104.29 50.98 0.78 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.201 1.477 . . . . 25.0 109.692 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.55 -35.4 75.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 118.606 2.817 . . . . 50.0 118.606 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -155.47 166.64 32.93 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.602 1.961 . . . . 25.0 112.861 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.6 mp -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 115.993 -0.549 . . . . 50.0 111.148 165.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 141.08 165.06 10.18 Favored Glycine 0 C--O 1.187 -2.842 0 C-N-CA 118.122 -1.99 . . . . 25.0 114.779 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.59 145.51 47.32 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 119.181 3.03 . . . . 50.0 119.181 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -142.9 157.37 44.65 Favored 'General case' 0 C--O 1.201 -1.478 0 N-CA-C 102.883 -3.006 . . . . 25.0 102.883 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.15 135.87 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 104.512 -2.403 . . . . 50.0 104.512 164.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.79 123.58 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 93.128 -6.619 . . . . 25.0 93.128 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 mp -106.29 145.03 32.14 Favored 'General case' 0 C--O 1.185 -2.292 0 C-N-CA 124.021 0.929 . . . . 50.0 109.647 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.36 45.88 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 115.971 -1.966 . . . . 25.0 113.619 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.52 128.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.265 1.911 0 O-C-N 125.006 1.442 . . . . 50.0 111.059 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -118.82 119.55 34.71 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 116.766 -1.588 . . . . 25.0 109.02 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -92.35 135.6 33.89 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 103.704 -2.702 . . . . 25.0 103.704 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.6 t -118.46 126.81 75.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 104.154 -2.536 . . . . 50.0 104.154 -172.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.42 -16.97 63.0 Favored 'General case' 0 CA--C 1.476 -1.901 1 O-C-N 116.051 -4.156 . . . . 25.0 115.936 -166.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.19 -28.13 53.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 128.172 2.589 . . . . 25.0 112.753 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.3 p -134.75 164.8 26.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 116.775 2.139 . . . . 25.0 116.775 -158.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -95.1 -15.96 22.99 Favored 'General case' 0 C--O 1.184 -2.357 0 CA-C-O 124.47 2.081 . . . . 25.0 113.092 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -66.83 155.04 39.35 Favored 'General case' 0 C--O 1.287 3.04 0 O-C-N 118.86 -2.4 . . . . 25.0 111.084 155.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.82 140.74 22.84 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 103.354 -2.832 . . . . 25.0 103.354 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -83.78 165.67 18.64 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 105.119 -2.178 . . . . 50.0 105.119 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.12 160.58 43.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.853 -1.521 . . . . 50.0 109.241 164.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -147.65 154.2 40.32 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 116.787 -1.578 . . . . 25.0 110.416 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.5 m -138.85 128.28 31.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.56 -2.015 . . . . 75.0 105.56 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.8 mt -132.53 126.97 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.135 0 N-CA-C 106.262 -1.755 . . . . 25.0 106.262 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.97 135.3 33.72 Favored 'General case' 0 C--N 1.311 -1.086 1 O-C-N 115.773 -4.329 . . . . 25.0 108.813 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.86 134.96 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 O-C-N 117.246 -3.409 . . . . 50.0 102.802 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.42 99.11 12.02 Favored 'General case' 0 CA--C 1.554 1.102 0 O-C-N 119.769 -1.832 . . . . 25.0 106.192 171.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.33 128.43 35.49 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 121.696 2.044 . . . . 50.0 110.499 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.11 168.25 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . 0.312 26.1 t30 -83.07 146.82 28.49 Favored 'General case' 0 N--CA 1.385 -3.703 0 N-CA-C 106.775 -1.565 . . . . 25.0 106.775 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 CA--C 1.482 -1.651 0 CA-C-N 121.727 2.058 . . . . 25.0 110.042 170.757 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 161' ' ' PHE . 76.5 m80 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 125.118 2.389 . . . . 25.0 109.669 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.37 -161.38 14.22 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 112.712 -2.04 . . . . 25.0 108.257 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -149.96 162.71 39.82 Favored 'General case' 0 C--O 1.27 2.166 0 CA-C-N 114.138 -1.031 . . . . 50.0 110.703 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mm -85.16 139.14 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 O-C-N 125.554 1.784 . . . . 25.0 111.543 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.73 39.21 3.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 103.912 -2.625 . . . . 25.0 103.912 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 75.92 146.43 0.11 Allowed Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 127.451 2.3 . . . . 25.0 114.161 171.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.68 147.55 15.61 Favored 'Cis proline' 0 CA--C 1.491 -1.635 0 O-C-N 118.252 -1.499 . . . . 25.0 114.865 -18.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.07 33.38 6.04 Favored Glycine 0 C--O 1.187 -2.836 0 C-N-CA 124.867 1.222 . . . . 25.0 111.668 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.6 t -75.73 138.75 41.47 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 118.951 1.375 . . . . 25.0 108.266 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -85.39 -18.18 34.46 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 123.618 1.675 . . . . 25.0 106.568 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.79 80.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.12 -14.66 60.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.53 -0.731 . . . . 25.0 110.288 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.1 mt -92.18 -21.45 20.37 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 104.15 -2.537 . . . . 75.0 104.15 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.88 -25.29 21.07 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.109 -1.441 . . . . 25.0 107.109 -175.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.1 t -62.63 112.25 2.42 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 116.853 2.168 . . . . 25.0 116.853 173.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -73.36 -31.84 64.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.295 1.438 . . . . 25.0 107.213 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.79 92.03 Favored 'General case' 0 CA--C 1.581 2.166 0 O-C-N 120.836 -1.165 . . . . 25.0 110.209 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -47.89 -44.83 29.95 Favored 'General case' 0 C--O 1.275 2.445 0 N-CA-C 117.818 2.525 . . . . 50.0 117.818 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.68 19.86 32.79 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 104.111 -3.596 . . . . 25.0 104.111 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.8 t80 45.42 -50.55 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 121.727 3.973 . . . . 50.0 121.727 -165.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.71 -7.2 10.56 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.804 1.288 . . . . 50.0 112.701 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -122.97 153.86 39.19 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 117.65 -1.167 . . . . 25.0 108.448 -166.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -161.47 167.64 25.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.075 -2.195 . . . . 50.0 105.075 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.64 42.06 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 127.177 2.798 . . . . 25.0 117.435 -162.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -67.8 -22.92 65.16 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.375 0.88 . . . . 25.0 113.375 -166.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.82 95.01 1.05 Allowed Glycine 0 C--O 1.189 -2.687 0 C-N-CA 119.518 -1.325 . . . . 25.0 112.924 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 m -68.04 -9.28 44.66 Favored 'General case' 0 C--O 1.256 1.399 0 N-CA-C 114.544 1.313 . . . . 25.0 114.544 -171.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.65 -13.0 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 115.219 1.563 . . . . 50.0 115.219 169.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.5 ptm -70.11 18.39 0.05 Allowed 'General case' 0 C--O 1.199 -1.572 0 N-CA-C 120.718 3.599 . . . . 25.0 120.718 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.27 -43.29 95.3 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 119.172 -2.205 . . . . 50.0 112.162 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -145.05 62.6 9.22 Favored Pre-proline 0 C--O 1.275 2.415 0 N-CA-C 113.394 0.887 . . . . 25.0 113.394 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -15.64 47.03 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 116.325 -1.983 . . . . 25.0 112.817 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -66.06 -18.69 65.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.765 -1.835 . . . . 25.0 115.741 170.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -77.95 -4.42 46.83 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.584 0.707 . . . . 25.0 112.016 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.1 94.47 1.92 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 120.806 -1.184 . . . . 50.0 112.687 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -120.73 162.26 20.03 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 119.208 3.04 . . . . 25.0 119.208 -174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . . . -136.25 170.94 15.22 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 104.804 -2.295 . . . . 25.0 104.804 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -122.96 141.37 52.01 Favored 'General case' 0 C--O 1.275 2.42 0 O-C-N 124.89 1.369 . . . . 25.0 108.657 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -72.91 156.18 39.13 Favored 'General case' 0 C--O 1.197 -1.701 0 O-C-N 125.544 1.778 . . . . 25.0 109.142 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.58 -166.16 25.64 Favored Glycine 0 C--O 1.205 -1.663 0 N-CA-C 109.555 -1.418 . . . . 25.0 109.555 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -132.02 139.2 34.27 Favored Pre-proline 0 CA--C 1.573 1.859 0 O-C-N 128.072 2.866 . . . . 25.0 106.773 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.55 162.46 88.65 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 121.13 1.439 . . . . 25.0 114.867 -0.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -165.28 -2.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 117.371 2.36 . . . . 25.0 117.371 -168.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -32.12 -65.5 0.14 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 117.555 2.428 . . . . 25.0 117.555 -170.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.78 176.22 46.24 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 116.686 1.434 . . . . 25.0 116.686 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.64 -27.73 12.49 Favored 'Trans proline' 0 C--O 1.272 2.221 0 CA-C-O 118.666 -0.639 . . . . 25.0 113.006 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.26 156.5 20.24 Favored 'General case' 0 CA--C 1.479 -1.756 0 C-N-CA 124.634 1.173 . . . . 25.0 111.344 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -148.89 152.54 36.6 Favored 'General case' 0 C--O 1.26 1.606 0 N-CA-C 107.195 -1.409 . . . . 25.0 107.195 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.68 -21.27 33.81 Favored Glycine 0 C--O 1.215 -1.06 0 CA-C-O 117.118 -1.935 . . . . 25.0 115.352 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -135.48 47.22 2.31 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 127.237 2.215 . . . . 25.0 110.339 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.5 mm -72.73 -38.4 57.95 Favored 'Isoleucine or valine' 1 C--O 1.306 4.038 0 CA-C-N 114.146 -1.388 . . . . 25.0 110.602 -168.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.59 69.21 Favored 'General case' 0 C--O 1.167 -3.258 0 N-CA-C 116.276 1.954 . . . . 25.0 116.276 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.8 p -87.72 -4.57 58.9 Favored 'General case' 0 CA--C 1.565 1.537 0 O-C-N 119.552 -1.967 . . . . 25.0 112.796 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.45 37.03 11.11 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 119.861 1.21 . . . . 25.0 110.703 -169.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.49 -18.63 78.95 Favored Glycine 0 N--CA 1.412 -2.939 0 O-C-N 119.831 -1.793 . . . . 25.0 114.401 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.21 -2.21 89.33 Favored Glycine 0 C--O 1.26 1.758 0 CA-C-O 116.979 -2.011 . . . . 25.0 111.797 166.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 mt -111.42 -54.94 2.56 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 116.999 2.222 . . . . 50.0 116.999 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -74.99 -24.95 58.51 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 112.681 -2.054 . . . . 50.0 110.769 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.32 59.89 Favored Glycine 0 C--O 1.2 -2.002 0 O-C-N 127.294 2.871 . . . . 25.0 109.025 173.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.02 -30.45 78.03 Favored Glycine 0 C--N 1.358 1.797 0 N-CA-C 116.728 1.451 . . . . 25.0 116.728 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -80.41 -39.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.246 -2.502 . . . . 25.0 104.246 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.63 -27.4 66.85 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 126.631 1.973 . . . . 75.0 111.63 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.14 -10.45 59.77 Favored 'General case' 0 C--O 1.182 -2.456 0 O-C-N 121.169 -0.957 . . . . 50.0 109.469 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.71 -12.52 60.74 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 127.259 3.409 . . . . 25.0 112.979 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -148.55 69.15 1.09 Allowed 'General case' 0 C--O 1.277 2.501 0 CA-C-N 111.42 -2.627 . . . . 25.0 109.047 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.0 t -143.29 155.53 44.49 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 116.834 -1.555 . . . . 25.0 108.928 -170.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -55.0 -32.57 61.89 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 121.276 1.853 . . . . 25.0 114.624 158.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.53 -34.91 67.89 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 115.303 1.594 . . . . 25.0 115.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.314 24.8 ttp180 0.42 73.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.448 2.699 . . . . 25.0 116.458 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.16 149.3 45.66 Favored 'General case' 0 C--O 1.208 -1.112 1 CA-C-N 107.871 -4.24 . . . . 25.0 107.546 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -74.92 142.43 44.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.114 1.766 . . . . 50.0 114.139 -146.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -120.69 153.72 36.54 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 125.222 1.409 . . . . 25.0 111.107 -172.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -135.01 176.76 8.36 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 102.905 -2.998 . . . . 25.0 102.905 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -124.01 139.65 49.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 168.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . 0.267 60.6 mtp -143.94 171.24 14.52 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.683 1.128 . . . . 25.0 109.396 175.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.7 p -103.12 165.7 10.87 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.127 -1.608 . . . . 25.0 113.201 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.15 179.32 48.07 Favored Glycine 0 C--O 1.256 1.475 0 O-C-N 119.347 -2.096 . . . . 25.0 114.068 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.31 168.02 29.02 Favored Glycine 0 CA--C 1.542 1.757 0 CA-C-O 123.511 1.617 . . . . 25.0 112.849 -168.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.4 127.64 33.74 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.158 -2.217 . . . . 25.0 115.935 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.97 156.84 37.42 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m -103.72 141.04 36.76 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 112.37 -2.195 . . . . 25.0 108.904 166.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -123.66 149.08 45.86 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 115.695 -2.098 . . . . 50.0 105.606 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.8 m -132.25 138.19 47.81 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.373 -1.343 . . . . 25.0 107.373 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.84 161.04 24.81 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 103.02 -2.956 . . . . 25.0 103.02 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.0 t -140.16 137.11 34.15 Favored 'General case' 0 C--O 1.263 1.774 0 N-CA-C 106.799 -1.556 . . . . 25.0 106.799 160.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.36 125.76 50.7 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.569 1.548 . . . . 50.0 109.95 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -125.65 6.78 7.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 119.52 3.156 . . . . 25.0 119.52 -156.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . 0.313 . . -57.75 -63.38 3.89 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 114.512 -2.661 . . . . 25.0 117.111 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.29 176.86 37.44 Favored 'Cis proline' 0 CA--C 1.538 0.691 1 C-N-CA 136.676 4.032 . . . . 25.0 111.678 -9.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -131.02 164.35 25.6 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 102.84 -3.022 . . . . 25.0 102.84 165.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -89.11 150.04 22.91 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 105.125 -2.176 . . . . 25.0 105.125 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.4 m -137.84 134.82 35.58 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 107.733 -1.21 . . . . 25.0 107.733 -159.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 p -98.98 -34.27 10.5 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 117.437 -1.705 . . . . 25.0 110.978 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -156.03 151.22 26.6 Favored 'General case' 0 C--O 1.194 -1.841 0 C-N-CA 128.425 2.69 . . . . 25.0 111.492 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -137.96 136.27 36.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 119.452 -2.03 . . . . 25.0 108.459 150.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -142.72 163.43 32.84 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 117.861 -1.536 . . . . 25.0 111.701 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -149.43 141.29 23.7 Favored 'General case' 0 C--O 1.261 1.699 0 O-C-N 125.276 1.61 . . . . 50.0 114.259 -164.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -121.36 165.28 15.76 Favored 'General case' 0 C--O 1.183 -2.417 0 C-N-CA 126.535 1.934 . . . . 50.0 106.605 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.5 pt -127.3 159.69 37.28 Favored 'Isoleucine or valine' 0 C--O 1.261 1.681 0 CA-C-N 111.936 -2.393 . . . . 25.0 106.95 168.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.9 p -102.78 165.89 10.8 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 124.425 2.059 . . . . 25.0 105.699 156.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -105.63 -177.14 3.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 112.322 -2.217 . . . . 25.0 107.121 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -163.31 167.03 22.39 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.08 64.27 3.22 Favored Glycine 0 C--O 1.274 2.633 0 O-C-N 119.822 -1.798 . . . . 25.0 113.092 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.12 171.18 14.42 Favored 'General case' 0 C--O 1.193 -1.904 0 N-CA-C 116.38 1.993 . . . . 25.0 116.38 -166.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -85.39 110.92 32.89 Favored Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-O 117.1 -1.428 . . . . 25.0 110.974 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -57.99 -21.56 50.63 Favored 'Trans proline' 0 N--CA 1.447 -1.25 1 N-CA-C 123.68 4.454 . . . . 25.0 123.68 174.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.251 23.7 t70 -71.45 -17.83 62.35 Favored 'General case' 0 C--O 1.264 1.852 0 C-N-CA 116.151 -2.22 . . . . 75.0 114.032 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -72.01 161.12 80.52 Favored Pre-proline 0 C--N 1.38 1.921 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -41.01 22.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.542 2 C-N-CA 129.403 6.735 . . . . 25.0 124.373 161.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 53.7 mt -51.93 -35.57 46.17 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 116.507 -3.871 . . . . 50.0 116.991 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -68.11 -7.96 34.21 Favored 'General case' 0 C--O 1.198 -1.617 0 N-CA-C 115.046 1.499 . . . . 25.0 115.046 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -127.8 -60.3 1.17 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.453 -0.794 . . . . 25.0 110.074 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.1 -22.49 62.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 116.443 -1.741 . . . . 25.0 112.634 -168.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.8 20.8 18.07 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 127.042 2.713 . . . . 25.0 113.194 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -110.34 127.73 55.2 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 103.084 -2.932 . . . . 50.0 103.084 158.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.46 122.86 20.71 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.036 -1.865 . . . . 25.0 110.891 -169.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -62.25 117.62 6.32 Favored 'General case' 0 C--O 1.2 -1.522 0 N-CA-C 102.547 -3.131 . . . . 50.0 102.547 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.95 -11.14 9.3 Favored 'Isoleucine or valine' 0 C--O 1.265 1.919 0 CA-C-O 122.729 1.252 . . . . 25.0 112.594 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 174.83 30.1 Favored Glycine 0 C--N 1.365 2.192 0 N-CA-C 117.644 1.817 . . . . 25.0 117.644 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.81 155.13 43.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 128.612 3.183 . . . . 25.0 111.788 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.82 89.84 48.14 Favored Pre-proline 0 C--O 1.265 1.885 0 C-N-CA 128.682 2.793 . . . . 50.0 104.22 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.05 161.24 29.77 Favored 'Trans proline' 0 C--O 1.195 -1.674 1 C-N-CA 111.904 -4.93 . . . . 25.0 111.982 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -79.8 115.41 19.38 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.346 -1.741 . . . . 25.0 109.005 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -128.09 -8.11 5.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.147 1.339 . . . . 50.0 113.661 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.34 -15.67 62.82 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 115.762 1.065 . . . . 25.0 115.762 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.8 t -66.93 153.1 95.0 Favored Pre-proline 0 N--CA 1.492 1.652 1 N-CA-C 99.736 -4.172 . . . . 25.0 99.736 163.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.99 18.42 0.31 Allowed 'Trans proline' 0 CA--C 1.509 -0.76 0 N-CA-C 116.231 1.589 . . . . 25.0 116.231 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -31.87 68.04 Favored 'General case' 0 C--O 1.262 1.752 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 154.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.1 m -76.02 -25.23 55.5 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-O 116.534 -1.698 . . . . 25.0 106.523 -172.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -82.6 -0.46 47.06 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 121.341 1.882 . . . . 25.0 115.851 176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -81.95 84.66 6.87 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.862 -1.135 . . . . 25.0 113.937 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.1 3.94 54.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.755 -1.566 . . . . 75.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.0 t -104.48 122.61 45.89 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 119.85 -1.781 . . . . 25.0 115.402 162.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -148.76 137.48 21.35 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.765 -1.569 . . . . 25.0 106.765 -154.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -84.34 132.67 34.58 Favored 'General case' 0 C--O 1.267 2.012 0 C-N-CA 126.022 1.729 . . . . 25.0 114.946 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.4 mt -131.06 124.82 56.62 Favored 'Isoleucine or valine' 0 C--O 1.262 1.754 0 O-C-N 119.739 -1.851 . . . . 25.0 107.445 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -77.67 126.03 30.25 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 112.913 0.708 . . . . 50.0 112.913 167.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.96 128.66 25.72 Favored Pre-proline 0 C--O 1.248 0.989 0 N-CA-C 102.476 -3.157 . . . . 25.0 102.476 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.99 157.96 53.52 Favored 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 112.587 -4.475 . . . . 25.0 112.658 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -101.34 36.87 1.9 Allowed 'General case' 0 C--O 1.211 -0.924 0 O-C-N 120.461 -1.399 . . . . 25.0 110.628 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -65.81 -46.65 77.84 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 119.765 3.246 . . . . 50.0 119.765 -167.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -150.9 173.32 14.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.213 2.205 . . . . 25.0 105.775 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 6.1 mp -84.83 169.0 14.59 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 101.497 -3.52 . . . . 50.0 101.497 170.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.78 176.53 22.35 Favored Glycine 0 CA--C 1.476 -2.362 0 CA-C-O 126.441 3.245 . . . . 25.0 113.014 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 24.4 p90 -93.17 163.98 13.42 Favored 'General case' 0 C--O 1.271 2.187 0 O-C-N 117.399 -3.413 . . . . 50.0 112.241 -164.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -162.16 173.44 14.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 127.442 2.297 . . . . 25.0 107.7 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.52 143.1 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.792 1.178 . . . . 50.0 113.894 174.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.0 mt -103.88 135.96 39.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 101.635 -3.469 . . . . 25.0 101.635 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -125.8 148.97 48.96 Favored 'General case' 0 C--O 1.187 -2.223 0 O-C-N 117.909 -2.995 . . . . 50.0 107.963 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.16 161.52 37.68 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 116.224 -1.846 . . . . 25.0 113.321 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.61 119.96 3.81 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 O-C-N 125.787 1.93 . . . . 50.0 106.162 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.13 117.63 31.76 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 127.169 2.188 . . . . 25.0 112.457 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.88 111.29 23.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 104.144 -2.539 . . . . 25.0 104.144 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.0 t -84.33 124.87 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.145 0 CA-C-O 124.118 1.913 . . . . 50.0 109.63 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.69 -24.13 62.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.107 -1.621 . . . . 25.0 111.309 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.09 -17.11 58.92 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 117.094 -1.842 . . . . 25.0 114.493 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.0 p -125.53 156.68 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 119.279 -2.138 . . . . 25.0 113.911 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.73 -29.61 69.63 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-O 122.641 1.21 . . . . 25.0 110.274 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -79.55 161.4 26.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 119.194 -2.191 . . . . 25.0 115.062 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . . . -133.7 167.13 21.08 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 114.691 -1.141 . . . . 25.0 108.736 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 1' ' ' HIS . 63.2 m-85 -115.94 144.66 43.76 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.976 -1.12 . . . . 50.0 107.976 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -122.33 155.88 35.07 Favored 'General case' 0 C--O 1.242 0.707 0 O-C-N 125.84 1.963 . . . . 50.0 107.402 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -126.8 151.9 47.67 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.763 -1.562 . . . . 25.0 108.939 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.71 135.55 50.99 Favored 'Isoleucine or valine' 0 C--O 1.268 2.065 0 N-CA-C 105.91 -1.885 . . . . 75.0 105.91 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.6 mt -139.56 106.96 2.83 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 N-CA-C 105.642 -1.984 . . . . 25.0 105.642 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -84.71 131.41 34.58 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 120.247 -1.533 . . . . 25.0 113.837 174.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.74 142.4 43.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 120.307 -1.496 . . . . 50.0 113.061 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 45.3 t0 -83.9 132.36 34.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 116.497 -1.716 . . . . 25.0 107.581 167.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.1 mt -126.4 131.51 51.72 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 103.146 -2.909 . . . . 50.0 103.146 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.3 m -135.0 171.51 17.58 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 105.683 -1.969 . . . . 50.0 105.683 -171.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.35 146.27 32.98 Favored 'General case' 0 C--O 1.283 2.844 0 O-C-N 120.972 -1.08 . . . . 25.0 111.575 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt . . . . . 0 C--O 1.289 3.17 0 CA-C-O 116.173 -1.87 . . . . 25.0 112.114 178.724 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.6 m80 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 118.228 -0.892 . . . . 25.0 108.666 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.67 -154.06 10.65 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 118.046 -2.026 . . . . 25.0 116.134 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.19 170.12 20.22 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 125.237 2.446 . . . . 50.0 105.956 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.7 mt -84.34 126.51 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 O-C-N 118.915 -2.366 . . . . 25.0 113.509 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -92.88 -28.3 16.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 116.204 1.927 . . . . 25.0 116.204 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -145.92 122.33 5.87 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 105.729 -1.952 . . . . 25.0 105.729 168.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.29 133.06 10.53 Favored 'Cis proline' 0 C--O 1.197 -1.551 0 C-N-CA 130.543 1.476 . . . . 25.0 113.116 -2.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.62 -88.99 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.805 -1.543 . . . . 25.0 116.146 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -54.5 134.4 46.23 Favored 'General case' 0 C--O 1.262 1.724 0 N-CA-C 114.811 1.412 . . . . 25.0 114.811 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 ttt-85 -118.86 -32.19 4.57 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 112.481 -2.145 . . . . 25.0 114.405 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 14' ' ' CYS . . . -70.47 -24.06 62.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 116.788 2.144 . . . . 25.0 116.788 -172.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.19 60.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 124.437 2.065 . . . . 25.0 111.191 174.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 13' ' ' LEU . 23.2 mt -80.05 -31.17 39.5 Favored 'General case' 0 N--CA 1.492 1.642 1 O-C-N 115.572 -4.455 . . . . 75.0 109.67 179.158 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -60.85 -26.38 67.32 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 111.361 -2.654 . . . . 25.0 116.796 173.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 t -50.85 147.83 4.62 Favored 'General case' 0 C--O 1.283 2.842 0 CA-C-N 114.227 -1.351 . . . . 25.0 114.218 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -72.21 0.19 10.44 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 126.868 2.605 . . . . 25.0 113.302 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.45 4.74 1.63 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.557 1.17 . . . . 25.0 114.043 174.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -57.58 -27.65 62.9 Favored 'General case' 0 C--O 1.202 -1.431 0 O-C-N 118.906 -2.371 . . . . 50.0 113.478 152.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.02 20.4 0.1 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 116.324 1.29 . . . . 25.0 116.324 169.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 58.85 7.8 0.85 Allowed 'General case' 0 C--N 1.387 2.219 0 N-CA-C 117.016 2.228 . . . . 50.0 117.016 156.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.0 mt -74.09 -37.42 64.18 Favored 'General case' 0 C--O 1.286 2.987 0 O-C-N 121.309 -0.87 . . . . 50.0 109.719 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -152.87 177.95 10.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 128.039 2.536 . . . . 25.0 111.641 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.82 157.34 12.43 Favored 'General case' 0 C--O 1.255 1.381 0 N-CA-C 116.509 2.04 . . . . 50.0 116.509 161.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -138.8 14.24 2.69 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 110.965 -2.834 . . . . 25.0 113.271 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -85.72 -43.61 13.24 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 111.968 -2.378 . . . . 25.0 111.16 -164.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.19 72.73 1.22 Allowed Glycine 0 CA--C 1.493 -1.343 0 CA-C-O 116.113 -2.493 . . . . 25.0 116.345 -169.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 m -57.94 -10.69 1.89 Allowed 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 120.387 2.093 . . . . 25.0 114.728 -166.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.68 -10.56 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-N 119.301 0.955 . . . . 50.0 109.733 169.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -45.36 -18.91 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 117.681 2.474 . . . . 25.0 117.681 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -63.65 -38.44 91.14 Favored 'General case' 0 N--CA 1.432 -1.329 0 O-C-N 119.484 -2.01 . . . . 50.0 106.639 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.37 48.83 0.56 Allowed Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.371 1.248 . . . . 25.0 114.371 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.24 -19.99 21.83 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 O-C-N 116.571 -2.384 . . . . 25.0 117.449 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -83.83 -2.45 56.4 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 117.007 -1.473 . . . . 25.0 109.616 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.694 2.497 . . . . 25.0 113.722 -171.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.96 151.21 31.77 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 118.021 -2.925 . . . . 50.0 105.913 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -140.01 160.9 38.87 Favored 'General case' 0 C--O 1.186 -2.239 0 O-C-N 120.271 -1.518 . . . . 25.0 113.625 -170.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.79 149.8 35.01 Favored 'General case' 0 C--O 1.261 1.662 1 N-CA-C 99.912 -4.107 . . . . 25.0 99.912 163.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 82.0 tttt -91.33 146.16 24.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 105.06 -2.2 . . . . 25.0 105.06 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -76.98 162.97 27.14 Favored 'General case' 0 CA--C 1.579 2.075 0 O-C-N 126.382 2.301 . . . . 25.0 110.587 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.66 -176.73 16.76 Favored Glycine 0 CA--C 1.472 -2.623 1 N-CA-C 102.78 -4.128 . . . . 25.0 102.78 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -61.54 142.97 93.9 Favored Pre-proline 0 N--CA 1.395 -3.178 0 CA-C-N 120.618 2.209 . . . . 25.0 110.782 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -86.35 23.89 17.38 Favored 'Cis proline' 0 C--O 1.174 -2.684 1 C-N-CA 136.612 4.005 . . . . 25.0 120.475 -4.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -52.59 -34.4 50.53 Favored 'General case' 0 C--O 1.261 1.663 1 N-CA-C 122.686 4.328 . . . . 25.0 122.686 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -57.52 -38.15 74.18 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 118.69 -2.506 . . . . 25.0 114.675 167.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.34 -176.62 19.94 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.778 -1.101 . . . . 25.0 111.698 -174.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.4 168.09 23.39 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 CA-C-O 125.836 2.349 . . . . 25.0 110.795 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.95 94.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 119.772 3.249 . . . . 25.0 119.772 -168.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -119.25 166.12 13.38 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 123.765 1.745 . . . . 25.0 106.304 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.46 11.63 56.89 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-N 113.896 -1.502 . . . . 25.0 113.667 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -116.4 -11.78 11.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 116.248 1.944 . . . . 25.0 116.248 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.4 mt -67.78 -37.84 79.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.562 -0.903 . . . . 25.0 108.562 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.54 -10.3 24.98 Favored 'General case' 0 C--O 1.262 1.724 0 N-CA-C 116.102 1.89 . . . . 25.0 116.102 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.7 p -113.37 -3.34 13.79 Favored 'General case' 0 C--O 1.184 -2.35 0 C-N-CA 125.797 1.639 . . . . 25.0 113.069 172.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.48 43.51 23.69 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.751 1.22 . . . . 25.0 113.252 -161.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.48 -7.87 64.68 Favored Glycine 0 C--O 1.203 -1.828 0 CA-C-N 113.902 -1.499 . . . . 25.0 111.342 158.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.16 23.56 11.12 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 125.267 1.413 . . . . 25.0 113.69 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.6 mt -88.51 34.66 0.76 Allowed 'General case' 0 C--O 1.251 1.133 0 CA-C-O 116.624 -1.655 . . . . 50.0 111.86 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -63.66 -25.96 68.45 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 107.007 -1.479 . . . . 50.0 107.007 142.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.86 -10.02 85.05 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 119.769 -1.832 . . . . 25.0 115.477 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.34 -2.31 47.97 Favored Glycine 0 C--O 1.286 3.386 0 N-CA-C 118.418 2.127 . . . . 25.0 118.418 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -63.2 -41.19 91.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 123.378 1.561 . . . . 25.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.04 -28.58 62.42 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 114.087 -1.415 . . . . 75.0 110.933 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -109.89 21.98 16.2 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-O 124.086 1.898 . . . . 50.0 113.971 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -75.84 41.72 0.22 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 120.991 3.7 . . . . 25.0 120.991 -170.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -138.12 45.6 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.767 -1.938 . . . . 25.0 105.767 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -143.31 -172.87 3.79 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 123.634 1.683 . . . . 25.0 110.784 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -61.48 -22.01 64.7 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.393 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -77.01 2.82 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 119.699 -1.876 . . . . 25.0 112.507 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -87.69 84.11 7.11 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 128.183 3.849 . . . . 25.0 112.918 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 148.87 34.78 Favored 'General case' 0 C--N 1.287 -2.117 1 CA-C-N 106.008 -5.087 . . . . 25.0 111.395 156.1 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -75.87 147.36 39.11 Favored 'General case' 0 C--O 1.188 -2.162 0 N-CA-C 105.911 -1.885 . . . . 50.0 105.911 -174.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HE3' ' CG ' ' A' ' 145' ' ' TYR . 24.3 mtpt -84.12 121.34 27.32 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 174.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -73.59 119.73 18.21 Favored 'General case' 0 CA--C 1.461 -2.477 0 C-N-CA 116.412 -2.115 . . . . 25.0 106.535 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.25 129.54 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 103.735 -2.691 . . . . 25.0 103.735 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 98.7 mmm -140.57 150.76 44.07 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 104.476 -2.416 . . . . 25.0 104.476 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -88.31 176.97 6.98 Favored 'General case' 0 C--O 1.262 1.763 0 N-CA-C 104.451 -2.425 . . . . 25.0 104.451 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.24 174.1 34.84 Favored Glycine 1 C--O 1.158 -4.628 0 N-CA-C 107.079 -2.409 . . . . 25.0 107.079 171.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.72 178.76 47.84 Favored Glycine 0 C--O 1.201 -1.911 0 C-N-CA 126.543 2.02 . . . . 25.0 112.851 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -72.81 141.37 48.02 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 114.417 -2.706 . . . . 25.0 114.006 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -132.6 156.55 46.68 Favored 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 105.974 -1.861 . . . . 25.0 105.974 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.4 m -89.18 107.59 19.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.741 -3.059 . . . . 25.0 102.741 -172.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.83 115.31 27.99 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 106.436 -1.69 . . . . 50.0 106.436 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.4 m -133.01 132.4 41.83 Favored 'General case' 0 C--O 1.267 1.976 0 N-CA-C 108.501 -0.926 . . . . 25.0 108.501 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -117.48 170.06 9.03 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 106.106 -1.812 . . . . 25.0 106.106 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -140.31 146.73 38.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.976 -2.601 . . . . 25.0 103.976 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.72 147.3 46.09 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 113.773 -1.558 . . . . 50.0 113.06 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 t -61.24 -23.39 65.6 Favored 'General case' 0 C--O 1.26 1.633 0 O-C-N 125.748 1.905 . . . . 25.0 113.714 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.19 32.06 Favored Pre-proline 0 CA--C 1.497 -1.082 0 N-CA-C 103.6 -2.741 . . . . 25.0 103.6 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -64.45 166.2 18.07 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 113.656 -3.762 . . . . 25.0 111.77 164.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -129.06 147.17 50.9 Favored 'General case' 0 C--O 1.197 -1.696 0 O-C-N 126.21 2.194 . . . . 25.0 106.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.76 125.71 25.66 Favored 'General case' 0 C--O 1.186 -2.256 0 O-C-N 126.051 2.095 . . . . 25.0 106.498 165.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.3 m -129.43 145.21 51.45 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 124.917 1.287 . . . . 25.0 109.921 -172.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -105.79 -48.95 3.51 Favored 'General case' 0 CA--C 1.624 3.815 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 41.9 tt0 -152.51 160.48 43.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.295 -2.483 . . . . 25.0 104.295 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -143.21 141.02 30.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.07 -1.423 . . . . 25.0 110.637 161.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.56 163.64 32.62 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.177 -0.952 . . . . 25.0 113.123 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -136.99 149.34 47.45 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 117.713 2.486 . . . . 50.0 117.713 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -127.87 164.8 21.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.596 1.558 . . . . 50.0 112.851 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.8 pt -127.78 152.35 35.75 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-N 113.93 -1.486 . . . . 25.0 109.254 173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.3 p -94.16 164.14 13.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 102.919 -2.993 . . . . 25.0 102.919 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -73.58 136.43 43.98 Favored 'General case' 0 C--O 1.185 -2.318 0 O-C-N 119.808 -1.808 . . . . 25.0 111.995 -163.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -71.88 114.51 10.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 119.162 -2.211 . . . . 25.0 108.53 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.6 47.97 3.58 Favored Glycine 0 C--O 1.277 2.792 0 CA-C-N 120.857 1.662 . . . . 25.0 110.393 -172.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.4 160.89 12.57 Favored 'General case' 0 CA--C 1.593 2.616 0 N-CA-C 107.186 -1.412 . . . . 25.0 107.186 -170.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -132.67 105.29 12.96 Favored Pre-proline 0 C--O 1.275 2.421 0 O-C-N 126.119 2.137 . . . . 25.0 107.142 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.97 -11.31 25.44 Favored 'Trans proline' 0 C--N 1.371 1.745 0 N-CA-C 116.872 1.835 . . . . 25.0 116.872 -174.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.85 -10.46 53.19 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.12 1.155 . . . . 75.0 114.12 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -89.25 175.53 3.88 Favored Pre-proline 0 C--O 1.215 -0.747 0 C-N-CA 126.961 2.104 . . . . 25.0 113.211 -176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -19.66 37.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 1 C-N-CA 134.626 10.218 . . . . 25.0 120.124 121.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.69 -36.02 23.69 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 129.571 3.149 . . . . 50.0 111.33 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.46 -5.72 58.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 119.887 -1.758 . . . . 25.0 110.942 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -130.26 -72.01 0.58 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.306 1.965 . . . . 25.0 116.306 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.75 -0.89 25.43 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 122.975 2.625 . . . . 25.0 114.274 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -75.64 -23.63 56.34 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.593 1.088 . . . . 25.0 111.337 163.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.27 154.79 21.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.969 -1.493 . . . . 50.0 106.969 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.58 158.22 40.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.312 -2.477 . . . . 25.0 104.312 159.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.3 tp -87.81 128.79 35.33 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 102.616 -3.105 . . . . 50.0 102.616 158.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.97 -21.77 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 106.926 -1.509 . . . . 25.0 106.926 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.91 164.56 30.41 Favored Glycine 0 C--O 1.202 -1.89 0 CA-C-N 119.719 1.145 . . . . 25.0 113.082 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.4 42.21 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 106.0 -1.852 . . . . 25.0 106.0 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.68 95.4 17.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-N 112.251 -2.25 . . . . 50.0 108.736 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 97.1 Cg_endo -74.61 166.34 29.58 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 121.391 1.394 . . . . 25.0 109.87 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -124.32 140.59 52.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.197 -1.408 . . . . 25.0 107.197 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.3 -11.73 5.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 115.449 1.648 . . . . 50.0 115.449 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.03 -9.07 33.75 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 126.44 1.972 . . . . 25.0 110.892 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.6 p -74.46 154.27 87.81 Favored Pre-proline 0 C--O 1.197 -1.659 0 N-CA-C 100.827 -3.768 . . . . 25.0 100.827 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.39 25.53 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 117.202 -1.399 . . . . 25.0 113.932 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.55 -16.29 60.28 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 118.808 -2.433 . . . . 25.0 108.171 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.1 p -69.57 -13.97 62.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.667 -1.606 . . . . 25.0 113.659 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.92 -28.79 69.18 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.067 -0.97 . . . . 25.0 111.54 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -68.12 88.89 0.3 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.62 0.724 . . . . 25.0 109.979 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.6 tp -92.39 -27.6 17.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 126.412 3.006 . . . . 75.0 107.485 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.4 t -81.41 123.72 28.81 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 110.724 -2.944 . . . . 25.0 107.647 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -129.63 135.68 48.83 Favored 'General case' 0 CA--C 1.572 1.801 0 O-C-N 124.959 1.412 . . . . 25.0 108.841 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -69.78 130.53 42.56 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 116.233 -1.841 . . . . 25.0 106.117 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.8 mm -128.7 118.33 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.953 0 CA-C-N 121.058 1.754 . . . . 25.0 112.274 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -67.49 129.85 41.19 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 115.654 1.724 . . . . 50.0 115.654 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.26 118.4 44.01 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 118.1 -2.875 . . . . 25.0 107.555 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.34 146.41 45.14 Favored 'Trans proline' 0 CA--C 1.483 -2.06 0 C-N-CA 115.216 -2.723 . . . . 25.0 116.417 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -87.73 53.88 2.93 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 123.297 1.522 . . . . 25.0 108.05 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -84.33 -30.87 25.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 120.002 3.334 . . . . 50.0 120.002 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -152.22 177.96 9.99 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 114.047 -2.882 . . . . 25.0 104.505 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 mp -113.67 126.46 55.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 104.567 -2.383 . . . . 50.0 104.567 160.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.78 170.12 32.16 Favored Glycine 0 CA--C 1.473 -2.539 0 C-N-CA 118.148 -1.977 . . . . 25.0 114.533 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.444 ' CG ' ' HE3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -112.86 135.61 53.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.36 1.464 . . . . 50.0 112.462 -168.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -147.0 167.69 23.39 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 125.349 1.656 . . . . 25.0 113.449 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.4 t -85.2 158.87 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 126.896 2.623 . . . . 50.0 104.559 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.8 mt -129.24 136.16 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 N-CA-C 103.43 -2.804 . . . . 25.0 103.43 162.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.34 153.03 39.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 104.741 -2.318 . . . . 50.0 104.741 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.61 157.4 45.52 Favored 'General case' 0 C--O 1.184 -2.371 0 CA-C-N 121.632 2.015 . . . . 25.0 106.61 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.52 134.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 126.832 2.583 . . . . 50.0 110.405 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -124.17 119.68 30.1 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 120.792 1.633 . . . . 25.0 108.084 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -84.4 89.13 7.33 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 119.563 -1.96 . . . . 25.0 111.461 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.67 103.65 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 113.23 -1.805 . . . . 50.0 106.5 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.12 -18.89 64.76 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 113.793 -1.549 . . . . 25.0 114.26 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.68 -26.35 66.99 Favored 'General case' 0 C--O 1.254 1.312 0 N-CA-C 119.178 3.029 . . . . 25.0 119.178 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 45.7 p -115.24 158.45 22.3 Favored 'General case' 0 C--O 1.262 1.725 0 N-CA-C 114.796 1.406 . . . . 25.0 114.796 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -28.15 27.81 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 106.918 -1.512 . . . . 25.0 106.918 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 86.1 m-20 -66.7 157.89 31.53 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 124.615 2.15 . . . . 25.0 111.416 160.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.49 155.45 42.27 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 101.954 -3.35 . . . . 25.0 101.954 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -111.53 153.35 26.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.072 2.107 . . . . 50.0 115.905 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -142.59 152.1 42.2 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 124.019 1.866 . . . . 50.0 106.74 -162.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -155.38 149.26 25.49 Favored 'General case' 0 C--O 1.19 -2.068 0 O-C-N 120.043 -1.661 . . . . 25.0 111.534 167.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.81 127.5 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 125.269 1.606 . . . . 75.0 112.556 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 152.77 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-N 121.835 2.107 . . . . 25.0 108.676 172.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -88.93 156.82 18.67 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 118.94 2.941 . . . . 25.0 118.94 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.1 169.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 102.695 -3.076 . . . . 50.0 102.695 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -132.66 122.61 24.92 Favored 'General case' 0 C--O 1.258 1.505 0 N-CA-C 103.03 -2.952 . . . . 25.0 103.03 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.68 119.4 34.35 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 122.07 2.214 . . . . 50.0 106.329 -164.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.59 -175.65 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.268 2.063 0 CA-C-O 122.408 1.099 . . . . 50.0 113.359 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.97 151.49 43.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.634 1.716 . . . . 25.0 115.634 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 79.7 mttt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 121.586 1.994 . . . . 25.0 115.319 176.171 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.44 ' HA ' ' CE3' ' A' ' 152' ' ' TRP . 24.0 p-80 . . . . . 0 C--O 1.293 3.366 0 CA-C-O 117.995 -1.002 . . . . 25.0 112.233 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.25 -124.02 31.0 Favored Glycine 0 CA--C 1.489 -1.579 0 CA-C-O 118.482 -1.177 . . . . 25.0 112.297 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -113.58 164.18 13.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 126.549 1.97 . . . . 50.0 110.97 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.4 mt -96.1 120.53 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 N-CA-C 102.972 -2.973 . . . . 25.0 102.972 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -91.72 -34.02 14.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 117.575 -1.202 . . . . 25.0 108.256 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.52 133.17 13.55 Favored Pre-proline 0 C--N 1.309 -1.185 0 C-N-CA 124.382 1.073 . . . . 25.0 110.097 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.57 144.77 80.83 Favored 'Cis proline' 0 C--O 1.249 1.033 0 CA-C-O 123.625 1.427 . . . . 25.0 109.39 -3.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.04 133.29 10.33 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 113.761 -1.563 . . . . 25.0 110.75 169.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 35.13 0.8 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.159 1.48 . . . . 25.0 108.699 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -65.16 -26.33 68.12 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 116.071 -1.919 . . . . 25.0 112.778 -166.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.74 57.29 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 122.224 2.284 . . . . 25.0 109.189 -175.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.35 97.13 Favored 'General case' 0 C--O 1.274 2.385 0 CA-C-N 114.641 -1.163 . . . . 25.0 112.574 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.1 mt -66.84 -34.25 77.39 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.31 0.576 . . . . 75.0 109.994 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 t -65.22 -26.36 68.09 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 123.006 1.384 . . . . 25.0 113.36 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -64.53 132.73 50.73 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 119.577 -1.952 . . . . 25.0 110.355 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -67.65 -27.15 66.63 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.43 -25.16 36.38 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-O 122.368 1.08 . . . . 25.0 110.827 -167.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -54.81 -41.38 70.55 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 114.31 1.226 . . . . 50.0 114.31 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.1 19.57 22.61 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 108.602 -1.799 . . . . 25.0 108.602 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.4 t80 37.54 -49.01 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.786 1 N-CA-C 127.677 6.177 . . . . 50.0 127.677 -159.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.8 mt -108.6 15.91 23.37 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.172 0.589 . . . . 50.0 112.398 -174.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -75.45 159.58 31.2 Favored 'General case' 0 C--O 1.185 -2.302 0 N-CA-C 116.019 1.859 . . . . 25.0 116.019 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 mp -62.49 171.48 1.94 Allowed 'General case' 0 C--O 1.254 1.311 0 O-C-N 124.277 0.985 . . . . 50.0 111.453 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -71.18 -18.44 62.49 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 115.711 -2.396 . . . . 25.0 113.39 -159.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.9 t -141.26 -15.95 0.85 Allowed 'General case' 0 C--O 1.288 3.098 0 C-N-CA 119.383 -0.927 . . . . 25.0 113.47 161.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.13 59.06 1.7 Allowed Glycine 0 CA--C 1.543 1.823 0 CA-C-O 116.207 -2.44 . . . . 25.0 116.024 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.415 ' HA ' ' HG2' ' A' ' 29' ' ' MET . 2.7 m -54.67 -2.19 0.03 OUTLIER 'General case' 0 C--O 1.27 2.159 0 N-CA-C 120.447 3.499 . . . . 25.0 120.447 -176.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.2 p -56.4 -23.02 15.79 Favored 'Isoleucine or valine' 0 C--O 1.258 1.548 0 N-CA-C 105.349 -2.093 . . . . 50.0 105.349 162.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.415 ' HG2' ' HA ' ' A' ' 27' ' ' SER . 27.2 ptt? -62.26 -7.42 4.23 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 115.532 1.679 . . . . 25.0 115.532 175.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -62.64 -44.69 95.63 Favored 'General case' 0 C--O 1.286 3.024 0 N-CA-C 119.482 3.142 . . . . 50.0 119.482 -166.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.256 11.9 pt-20 -142.17 62.38 13.7 Favored Pre-proline 0 C--O 1.258 1.508 0 N-CA-C 117.018 2.229 . . . . 25.0 117.018 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.8 -21.78 37.81 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 117.049 -1.501 . . . . 25.0 113.408 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -71.61 -14.28 62.02 Favored 'General case' 0 C--O 1.261 1.697 0 O-C-N 119.537 -1.977 . . . . 25.0 115.482 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 m -85.4 2.38 44.63 Favored 'General case' 0 C--O 1.285 2.933 0 O-C-N 119.934 -1.729 . . . . 25.0 115.373 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.2 150.58 48.9 Favored 'General case' 0 C--O 1.273 2.337 0 N-CA-C 104.267 -2.494 . . . . 50.0 104.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -132.14 162.16 31.55 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.53 1.932 . . . . 25.0 108.016 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.61 178.4 9.37 Favored 'General case' 0 C--O 1.184 -2.372 0 CA-C-O 124.33 2.014 . . . . 25.0 110.743 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.86 175.64 5.63 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 115.851 1.797 . . . . 25.0 115.851 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 95.3 mttt -57.68 144.15 38.92 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 120.159 -1.588 . . . . 25.0 114.812 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.4 -17.99 27.45 Favored Glycine 0 N--CA 1.479 1.546 0 C-N-CA 118.071 -2.014 . . . . 25.0 112.123 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -69.72 135.04 88.05 Favored Pre-proline 0 C--O 1.261 1.666 0 CA-C-N 118.341 1.071 . . . . 25.0 113.738 -166.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.86 121.01 1.24 Allowed 'Cis proline' 0 C--O 1.269 2.029 0 C-N-CA 134.062 2.942 . . . . 25.0 117.816 -18.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -59.13 -21.64 59.62 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 117.991 2.589 . . . . 25.0 117.991 -166.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 t -46.65 -50.02 18.33 Favored 'General case' 1 C--O 1.151 -4.094 0 N-CA-C 118.176 2.658 . . . . 25.0 118.176 177.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.67 -173.25 30.53 Favored Glycine 0 C--N 1.359 1.835 0 N-CA-C 119.457 2.543 . . . . 25.0 119.457 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.68 -178.52 4.7 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 121.879 1.719 . . . . 25.0 116.398 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.64 134.11 54.3 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 116.537 2.051 . . . . 25.0 116.537 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -84.53 139.83 31.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.829 -1.532 . . . . 25.0 109.676 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.96 1.59 76.15 Favored Glycine 0 C--O 1.259 1.708 0 CA-C-O 124.397 2.11 . . . . 25.0 115.67 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -72.74 -17.77 61.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 117.803 -1.559 . . . . 25.0 111.926 -174.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.5 mm -74.78 -40.66 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 1 O-C-N 115.274 -4.641 . . . . 25.0 107.815 172.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.93 -29.48 66.65 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 119.166 -2.209 . . . . 25.0 115.496 -172.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.6 p -78.95 -11.68 60.01 Favored 'General case' 0 C--O 1.204 -1.338 0 O-C-N 125.585 1.803 . . . . 25.0 110.358 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.49 20.36 12.13 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 127.696 2.399 . . . . 25.0 115.552 -170.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.99 -23.38 77.98 Favored Glycine 0 C--O 1.261 1.795 0 C-N-CA 126.129 1.824 . . . . 25.0 112.699 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.49 8.34 68.96 Favored Glycine 0 C--O 1.254 1.368 0 C-N-CA 125.411 1.482 . . . . 25.0 109.43 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.4 mt -132.71 -176.94 4.27 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 128.214 2.605 . . . . 50.0 106.523 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.01 -14.6 60.83 Favored 'General case' 0 C--O 1.271 2.205 0 N-CA-C 114.824 1.416 . . . . 50.0 114.824 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.41 -22.27 63.27 Favored Glycine 0 C--O 1.274 2.633 0 N-CA-C 110.028 -1.229 . . . . 25.0 110.028 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -13.01 83.67 Favored Glycine 0 C--O 1.268 2.258 0 O-C-N 119.391 -2.241 . . . . 25.0 110.829 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -38.04 66.44 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 O-C-N 117.461 -3.376 . . . . 25.0 105.964 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.64 -32.32 73.76 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.516 -1.365 . . . . 75.0 111.317 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.22 -15.3 61.44 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 119.973 -1.704 . . . . 50.0 111.025 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.26 87.3 mt-30 -92.83 17.76 10.02 Favored 'General case' 0 C--O 1.192 -1.948 0 O-C-N 120.095 -1.628 . . . . 25.0 114.997 168.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -137.71 49.7 1.97 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.631 -1.988 . . . . 25.0 105.631 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -157.85 179.31 9.32 Favored 'General case' 0 C--O 1.261 1.669 1 N-CA-C 100.094 -4.039 . . . . 25.0 100.094 -170.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -47.74 -32.11 5.53 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 117.949 2.574 . . . . 25.0 117.949 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.41 29.53 1.68 Allowed 'General case' 0 C--O 1.253 1.282 0 CA-C-N 121.357 1.89 . . . . 25.0 107.477 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -83.32 78.81 9.57 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 123.967 1.841 . . . . 25.0 107.714 153.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -56.67 158.87 4.25 Favored 'General case' 0 C--O 1.29 3.196 0 CA-C-N 111.15 -2.75 . . . . 25.0 112.781 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -65.94 157.8 29.76 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-N 113.563 -1.653 . . . . 50.0 107.329 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -108.7 144.57 36.32 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 123.676 1.703 . . . . 25.0 108.137 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -139.79 152.82 46.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.625 -1.625 . . . . 25.0 109.735 162.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.7 mt -85.62 136.38 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.591 1.541 . . . . 25.0 107.998 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.6 ttt -137.31 144.8 42.79 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 171.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.298 12.1 p -79.43 173.43 12.59 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 120.373 -1.454 . . . . 25.0 113.209 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.5 -163.76 8.67 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.203 -1.475 . . . . 25.0 111.743 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.6 -172.72 36.19 Favored Glycine 0 N--CA 1.486 1.976 0 O-C-N 119.572 -2.134 . . . . 25.0 113.017 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -77.56 142.55 38.95 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 117.609 2.448 . . . . 25.0 117.609 169.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -137.86 165.88 25.39 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 105.763 -1.94 . . . . 25.0 105.763 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.7 m -118.46 120.25 36.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.956 -1.868 . . . . 25.0 105.956 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.52 141.71 47.7 Favored 'General case' 0 C--O 1.17 -3.111 0 N-CA-C 105.279 -2.119 . . . . 50.0 105.279 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 m -136.84 140.29 42.31 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 116.116 -1.897 . . . . 25.0 113.689 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 143.52 51.22 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 122.367 2.349 . . . . 25.0 109.688 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -149.08 144.57 26.76 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 127.157 3.36 . . . . 25.0 108.393 -170.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -142.54 151.98 42.16 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-N 111.845 -2.434 . . . . 50.0 112.718 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.0 t -73.64 -9.09 58.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 O-C-N 125.678 1.861 . . . . 25.0 113.634 -169.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.96 159.71 67.44 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 117.064 -3.523 . . . . 25.0 103.833 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -73.14 139.7 29.94 Favored 'Trans proline' 0 C--N 1.307 -1.654 1 C-N-CA 111.761 -5.026 . . . . 25.0 110.301 166.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 2.486 47.9 p-80 73.12 12.79 4.91 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 123.308 2.777 . . . . 25.0 116.611 -5.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -65.58 115.89 6.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 118.442 -1.303 . . . . 25.0 113.256 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.0 t -75.73 160.26 30.22 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.084 -1.446 . . . . 25.0 112.071 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 90.3 p -111.51 -26.37 9.1 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 118.246 0.475 . . . . 25.0 110.87 163.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 61.8 tt0 -168.6 150.56 4.97 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 103.013 -2.958 . . . . 25.0 103.013 168.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -136.73 160.54 38.52 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-O 116.921 -1.514 . . . . 25.0 107.589 166.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 6.2 m-70 -142.53 162.43 35.49 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.241 -1.763 . . . . 25.0 106.241 -163.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.27 127.63 45.9 Favored 'General case' 0 C--O 1.274 2.345 0 N-CA-C 103.953 -2.61 . . . . 50.0 103.953 158.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -117.61 149.91 39.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 118.17 -2.831 . . . . 50.0 107.898 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.8 pt -120.64 153.37 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 119.463 1.029 . . . . 25.0 112.626 168.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 p -71.54 147.34 47.79 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 105.743 -1.947 . . . . 25.0 105.743 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -95.88 84.79 3.93 Favored 'General case' 0 C--O 1.191 -1.987 0 CA-C-O 123.103 1.43 . . . . 25.0 109.577 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -49.83 155.29 0.89 Allowed 'General case' 0 C--N 1.354 0.777 0 N-CA-C 117.0 2.222 . . . . 25.0 117.0 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 15.56 76.98 Favored Glycine 0 C--O 1.266 2.129 0 CA-C-O 126.551 3.306 . . . . 25.0 120.889 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 179.2 2.83 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.35 -1.925 . . . . 25.0 113.759 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.93 142.43 11.74 Favored Pre-proline 0 CA--C 1.492 -1.255 0 O-C-N 126.38 2.3 . . . . 25.0 106.333 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -60.41 -22.74 72.6 Favored 'Trans proline' 0 CA--C 1.592 3.42 0 N-CA-C 117.677 2.145 . . . . 25.0 117.677 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 116.399 -2.12 . . . . 75.0 110.709 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -108.09 170.95 4.98 Favored Pre-proline 0 CA--C 1.599 2.856 0 C-N-CA 129.751 3.221 . . . . 25.0 103.272 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.33 16.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.393 1 N-CA-C 122.767 4.103 . . . . 25.0 122.767 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.66 -40.4 69.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 117.172 2.286 . . . . 50.0 117.172 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -75.36 -6.84 52.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 126.287 2.242 . . . . 25.0 114.401 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -116.26 -59.69 1.95 Allowed 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 127.259 2.224 . . . . 25.0 114.49 -171.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -141.67 29.6 1.73 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 123.469 1.604 . . . . 25.0 111.794 -159.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.89 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 111.763 -2.471 . . . . 25.0 116.985 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -129.29 166.21 19.9 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 123.157 2.708 . . . . 50.0 112.457 172.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.07 143.25 49.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 101.289 -3.597 . . . . 25.0 101.289 163.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 tp -86.3 120.94 28.19 Favored 'General case' 0 C--O 1.182 -2.482 0 O-C-N 127.507 3.004 . . . . 50.0 108.701 166.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.8 tt -101.93 -8.29 9.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 121.536 1.971 . . . . 25.0 110.172 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.65 154.55 9.64 Favored Glycine 0 C--O 1.207 -1.592 0 C-N-CA 116.086 -2.959 . . . . 25.0 113.791 165.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . . . -144.55 145.85 32.04 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 122.999 3.399 . . . . 25.0 104.839 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.44 105.79 30.54 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-O 117.067 -1.444 . . . . 50.0 114.104 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 42.5 Cg_endo -77.48 164.59 28.4 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 C-N-CA 115.809 -2.327 . . . . 25.0 115.436 172.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -74.22 112.76 10.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.666 -1.976 . . . . 25.0 105.666 167.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.66 -18.4 1.91 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 119.379 -2.076 . . . . 50.0 116.335 -165.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.63 16.65 33.32 Favored Glycine 0 N--CA 1.466 0.673 0 O-C-N 119.917 -1.739 . . . . 25.0 114.371 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -55.54 162.33 2.49 Favored Pre-proline 0 CA--C 1.568 1.661 0 O-C-N 125.664 1.45 . . . . 25.0 113.72 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -66.31 176.25 4.19 Favored 'Trans proline' 0 C--O 1.276 2.412 0 CA-C-O 123.452 1.355 . . . . 25.0 112.065 166.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.85 -12.44 0.31 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 119.585 3.18 . . . . 25.0 119.585 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 p -69.44 -0.57 6.68 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 120.131 -1.605 . . . . 25.0 111.737 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.27 4.85 7.93 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 117.587 2.439 . . . . 25.0 117.587 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -61.03 164.68 4.78 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.347 1.546 . . . . 25.0 114.157 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.8 30.61 0.11 Allowed 'General case' 0 N--CA 1.516 2.829 0 O-C-N 119.256 -2.153 . . . . 75.0 113.287 -171.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.4 t -113.8 149.72 34.53 Favored 'General case' 0 C--O 1.262 1.737 0 N-CA-C 103.232 -2.877 . . . . 25.0 103.232 170.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -146.27 142.56 28.45 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 123.87 0.868 . . . . 25.0 109.318 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -75.39 135.69 40.79 Favored 'General case' 0 C--O 1.172 -3.023 0 N-CA-C 105.592 -2.003 . . . . 25.0 105.592 162.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.9 129.82 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 104.776 -2.305 . . . . 25.0 104.776 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -90.49 135.08 33.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 112.672 -2.058 . . . . 50.0 112.036 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.04 108.74 41.89 Favored Pre-proline 0 C--N 1.307 -1.245 0 O-C-N 119.678 -1.889 . . . . 25.0 108.427 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.82 136.86 21.37 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 O-C-N 117.033 -2.141 . . . . 25.0 114.456 164.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -150.86 101.82 2.93 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.162 -0.961 . . . . 25.0 109.273 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -105.56 10.55 33.05 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 126.943 2.097 . . . . 50.0 108.632 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -132.87 -176.83 4.24 Favored 'General case' 0 C--O 1.21 -0.98 0 O-C-N 119.174 -2.204 . . . . 25.0 110.304 -173.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.44 148.99 51.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 103.443 -2.799 . . . . 50.0 103.443 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 145.62 174.42 17.79 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 121.206 3.243 . . . . 25.0 121.206 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -75.12 135.72 41.13 Favored 'General case' 0 C--O 1.279 2.614 0 N-CA-C 116.122 1.897 . . . . 50.0 116.122 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -139.82 172.78 12.28 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 103.631 -2.729 . . . . 25.0 103.631 174.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.0 t -123.18 148.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 103.455 -2.794 . . . . 50.0 103.455 166.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.5 mt -115.66 137.86 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 1 N-CA-C 98.647 -4.575 . . . . 25.0 98.647 172.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.54 129.48 55.37 Favored 'General case' 0 C--O 1.187 -2.193 0 CA-C-N 119.172 0.896 . . . . 50.0 113.024 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.18 135.0 45.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.521 -1.362 . . . . 25.0 111.502 -173.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 69.2 t -124.96 137.37 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.972 0 N-CA-C 103.033 -2.951 . . . . 50.0 103.033 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.44 ' CE3' ' HA ' ' A' ' 1' ' ' HIS . 2.7 t90 -140.03 112.57 7.89 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.092 -2.558 . . . . 25.0 104.092 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.5 140.56 32.57 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 100.533 -3.877 . . . . 25.0 100.533 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.51 157.16 34.97 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 CA-C-O 122.715 1.245 . . . . 50.0 107.807 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.79 -24.36 36.01 Favored 'General case' 0 C--O 1.199 -1.595 0 CA-C-N 115.042 -0.981 . . . . 25.0 108.86 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -67.16 -35.48 79.77 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 115.17 1.544 . . . . 25.0 115.17 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 t -135.29 159.05 42.78 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 115.066 -2.397 . . . . 25.0 107.899 -166.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.02 -27.03 41.26 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 120.873 1.669 . . . . 25.0 113.914 162.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 96.7 m-20 -73.04 163.16 28.57 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.531 -1.356 . . . . 25.0 110.861 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.81 -176.19 3.77 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 104.597 -2.372 . . . . 25.0 104.597 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.79 146.53 47.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.772 -0.825 . . . . 50.0 108.772 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -134.56 135.62 42.41 Favored 'General case' 0 C--O 1.172 -2.98 0 CA-C-O 115.377 -2.249 . . . . 50.0 106.535 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -144.93 172.08 13.55 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 121.371 1.896 . . . . 25.0 107.735 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 147.53 32.06 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 O-C-N 120.047 -1.658 . . . . 75.0 107.344 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.4 mm -130.15 122.42 53.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 103.429 -2.804 . . . . 25.0 103.429 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -87.11 123.76 32.52 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.217 -2.142 . . . . 25.0 105.217 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.13 155.14 38.03 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.656 -1.278 . . . . 50.0 112.765 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -116.31 130.45 56.78 Favored 'General case' 0 N--CA 1.436 -1.144 1 N-CA-C 96.279 -5.452 . . . . 25.0 96.279 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.2 mt -123.8 128.78 50.04 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 115.781 -2.057 . . . . 50.0 106.693 -171.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.17 159.0 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 O-C-N 127.101 2.75 . . . . 50.0 112.09 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -70.22 131.52 44.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 117.987 -2.945 . . . . 25.0 108.138 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.4 pttt . . . . . 0 C--O 1.28 2.685 0 N-CA-C 120.464 3.505 . . . . 25.0 120.464 -171.286 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.406 ' HB3' HE22 ' A' ' 33' ' ' GLN . 72.8 m80 . . . . . 0 N--CA 1.517 2.89 0 N-CA-C 112.667 0.617 . . . . 25.0 112.667 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.7 -146.99 4.46 Favored Glycine 0 C--O 1.253 1.294 0 CA-C-O 114.393 -3.448 . . . . 25.0 118.742 -162.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.3 168.95 23.19 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 122.285 3.043 . . . . 50.0 105.941 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.11 121.73 41.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 103.998 -2.593 . . . . 25.0 103.998 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -83.05 -36.45 24.92 Favored 'General case' 0 C--O 1.262 1.734 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -172.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -160.89 159.98 25.08 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-O 113.634 -3.079 . . . . 25.0 106.352 -175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -78.09 137.52 46.9 Favored 'Cis proline' 0 C--O 1.206 -1.112 0 O-C-N 124.721 1.906 . . . . 25.0 107.195 1.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.26 -171.98 44.74 Favored Glycine 0 CA--C 1.454 -3.725 0 CA-C-N 114.811 -1.086 . . . . 25.0 110.51 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.1 p -145.75 158.34 43.86 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 119.644 1.722 . . . . 25.0 107.003 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -82.47 -24.41 34.23 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 118.764 -1.174 . . . . 25.0 111.429 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.17 79.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.134 0.974 . . . . 25.0 111.648 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.15 -31.94 69.43 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 119.3 0.954 . . . . 25.0 113.477 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 mt -85.99 -24.23 26.55 Favored 'General case' 0 C--O 1.192 -1.938 0 C-N-CA 124.261 1.025 . . . . 75.0 113.514 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.0 t -65.96 -32.03 73.28 Favored 'General case' 0 C--O 1.205 -1.281 0 O-C-N 125.348 1.655 . . . . 25.0 111.37 173.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -58.83 147.53 33.27 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.16 -1.382 . . . . 25.0 114.306 172.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.79 -11.53 58.95 Favored 'General case' 0 C--O 1.187 -2.21 0 C-N-CA 118.856 -1.137 . . . . 25.0 111.529 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . . . -52.62 -24.78 9.03 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 118.927 2.936 . . . . 25.0 118.927 -167.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.13 -28.34 51.97 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 115.74 1.756 . . . . 50.0 115.74 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.58 -26.93 0.07 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 117.927 1.931 . . . . 25.0 117.927 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.475 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 94.5 m-85 50.15 26.27 2.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 119.455 -2.203 . . . . 50.0 112.089 -170.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.4 mt -86.02 -37.83 18.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 118.302 -2.749 . . . . 50.0 107.134 -173.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -171.13 170.21 6.21 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 115.125 -2.369 . . . . 25.0 109.529 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mp -69.45 151.16 46.42 Favored 'General case' 0 C--O 1.263 1.81 0 CA-C-N 121.314 1.87 . . . . 50.0 109.941 175.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -150.81 30.03 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 113.598 -1.637 . . . . 25.0 108.98 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.4 t -70.12 -36.9 75.13 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.377 1.084 . . . . 25.0 112.156 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.95 97.61 0.18 Allowed Glycine 0 C--N 1.285 -2.298 0 C-N-CA 117.332 -2.366 . . . . 25.0 116.767 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.2 m -54.64 -8.5 0.24 Allowed 'General case' 0 C--O 1.249 1.056 0 C-N-CA 126.68 1.992 . . . . 25.0 115.354 -171.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.26 -18.05 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 N-CA-C 115.15 1.537 . . . . 50.0 115.15 161.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -48.4 -16.74 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 1 N-CA-C 122.437 4.236 . . . . 25.0 122.437 177.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -63.87 -41.55 97.74 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 114.43 1.27 . . . . 50.0 114.43 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -153.94 53.74 0.99 Allowed Pre-proline 0 C--O 1.274 2.394 0 O-C-N 120.119 -1.613 . . . . 25.0 110.539 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.01 -33.17 42.52 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 O-C-N 118.311 -1.468 . . . . 25.0 113.757 -165.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.406 HE22 ' HB3' ' A' ' 1' ' ' HIS . 3.7 pp0? -67.13 -1.33 4.17 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 117.319 2.34 . . . . 25.0 117.319 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -82.81 55.39 3.02 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.94 1.696 . . . . 25.0 113.601 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.72 135.26 33.72 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 123.24 1.495 . . . . 50.0 107.004 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.21 149.86 39.7 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 125.663 2.649 . . . . 25.0 105.424 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.11 12.48 Favored 'General case' 0 C--O 1.259 1.587 0 N-CA-C 102.329 -3.211 . . . . 25.0 102.329 164.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -100.15 168.59 9.72 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.616 2.08 . . . . 25.0 116.616 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -54.0 144.63 18.63 Favored 'General case' 0 N--CA 1.402 -2.858 0 CA-C-O 123.372 1.558 . . . . 25.0 111.512 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.53 166.91 38.13 Favored Glycine 0 C--O 1.255 1.443 1 N-CA-C 99.406 -5.478 . . . . 25.0 99.406 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -142.31 149.21 50.72 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 113.267 -1.467 . . . . 25.0 113.156 -173.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.74 108.7 0.34 Allowed 'Cis proline' 0 CA--C 1.552 1.394 0 C-N-CA 129.639 1.099 . . . . 25.0 112.512 -28.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -22.12 66.79 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 117.427 -3.295 . . . . 25.0 114.628 -167.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -43.23 99.26 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 119.512 1.051 . . . . 25.0 111.671 168.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.68 -156.23 6.9 Favored Glycine 0 N--CA 1.477 1.413 0 O-C-N 124.296 0.998 . . . . 25.0 111.866 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.86 162.35 35.35 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 CA-C-N 118.603 1.201 . . . . 25.0 114.26 -168.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.62 125.13 21.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 126.95 2.657 . . . . 25.0 112.887 -162.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -136.93 159.59 41.41 Favored 'General case' 0 CA--C 1.499 -1.009 1 N-CA-C 98.537 -4.616 . . . . 25.0 98.537 169.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.87 -14.01 59.66 Favored Glycine 0 C--O 1.22 -0.722 0 CA-C-O 125.17 2.539 . . . . 25.0 114.302 171.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -96.81 12.89 30.48 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 119.668 -2.078 . . . . 25.0 112.896 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.85 -57.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.97 -1.122 . . . . 25.0 107.97 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.27 79.0 Favored 'General case' 0 CA--C 1.591 2.557 0 CA-C-O 122.574 1.178 . . . . 25.0 110.85 -172.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.6 p -76.19 -12.45 60.1 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 117.04 -3.538 . . . . 25.0 112.158 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.22 22.59 10.85 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 111.888 -2.415 . . . . 25.0 113.31 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.78 -2.48 75.39 Favored Glycine 0 C--O 1.184 -3.008 0 CA-C-O 127.241 3.689 . . . . 25.0 112.519 -173.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.3 -3.26 69.74 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 108.32 -1.912 . . . . 25.0 108.32 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -84.87 118.01 24.24 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 119.446 1.623 . . . . 50.0 108.045 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -76.05 -21.47 56.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.215 -1.394 . . . . 50.0 107.645 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 -20.6 58.75 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 104.347 -3.501 . . . . 25.0 104.347 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.13 -20.87 71.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 111.471 -2.365 . . . . 25.0 112.122 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.71 -37.31 23.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 118.208 -1.397 . . . . 25.0 113.809 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.0 -34.67 75.66 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 119.751 -1.843 . . . . 75.0 111.687 172.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.54 -5.56 56.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.463 2.554 . . . . 50.0 110.065 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -81.97 75.43 8.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 113.716 -1.584 . . . . 25.0 111.01 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -128.2 44.28 2.98 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 127.295 2.238 . . . . 25.0 105.817 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.0 t -127.32 -166.56 1.62 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.3 -3.222 . . . . 25.0 102.3 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.79 -17.62 64.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 117.673 2.471 . . . . 25.0 117.673 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.47 24.3 7.52 Favored 'General case' 0 CA--C 1.595 2.686 0 CA-C-O 124.557 2.122 . . . . 25.0 109.978 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -87.31 102.25 14.33 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 126.742 3.163 . . . . 25.0 109.047 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -35.59 143.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.482 2 CA-C-N 102.415 -6.721 . . . . 25.0 112.146 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -70.92 152.84 43.23 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 115.323 1.601 . . . . 50.0 115.323 -173.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -95.35 152.73 18.13 Favored 'General case' 0 CA--C 1.587 2.38 0 O-C-N 121.353 -0.842 . . . . 25.0 109.85 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.12 148.61 49.83 Favored 'General case' 0 C--O 1.198 -1.658 0 CA-C-N 120.83 1.65 . . . . 25.0 109.156 169.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.7 mt -107.7 134.08 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 122.926 2.603 . . . . 25.0 111.952 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 85.1 mmm -144.22 169.97 16.87 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.203 -1.777 . . . . 25.0 106.203 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -90.98 172.09 8.82 Favored 'General case' 0 CA--C 1.446 -3.032 0 CA-C-O 116.056 -1.926 . . . . 25.0 111.606 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.98 173.46 9.66 Favored Glycine 0 CA--C 1.495 -1.176 0 O-C-N 124.94 1.4 . . . . 25.0 112.792 165.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.62 163.99 29.26 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 117.127 -2.463 . . . . 25.0 107.86 -171.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.38 155.18 28.51 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 120.291 -1.711 . . . . 25.0 109.168 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -145.5 160.67 41.27 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 103.049 -2.945 . . . . 25.0 103.049 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -125.9 130.71 51.84 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 -171.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.79 116.53 25.39 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 102.078 -3.305 . . . . 50.0 102.078 -165.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 133' ' ' SER . 60.9 m -115.63 131.97 56.77 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 102.867 -3.012 . . . . 25.0 102.867 -167.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -119.1 153.07 35.39 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.215 -2.513 . . . . 25.0 104.215 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 t -144.0 147.94 34.58 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -133.41 147.12 51.74 Favored 'General case' 0 C--O 1.266 1.954 0 O-C-N 127.743 3.152 . . . . 50.0 113.665 176.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.2 t -71.23 -20.82 62.2 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 116.341 1.978 . . . . 25.0 116.341 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.34 145.79 56.78 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 121.849 0.833 . . . . 25.0 112.722 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.87 160.51 49.44 Favored 'Trans proline' 0 CA--C 1.488 -1.789 1 C-N-CA 112.056 -4.83 . . . . 25.0 111.791 169.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -135.18 155.29 50.93 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 125.131 1.372 . . . . 25.0 109.922 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.96 155.29 40.8 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.239 -1.393 . . . . 25.0 107.239 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -140.53 150.97 44.37 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 117.498 -1.681 . . . . 25.0 110.445 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.6 p -112.58 -38.85 4.5 Favored 'General case' 0 CA--C 1.484 -1.569 0 O-C-N 120.68 -1.262 . . . . 25.0 109.385 164.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 17.0 tt0 -150.8 154.13 36.72 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 104.559 -2.386 . . . . 25.0 104.559 169.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -139.74 153.17 47.13 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 117.031 -1.867 . . . . 25.0 108.327 158.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -134.26 154.65 51.16 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 112.616 -2.084 . . . . 25.0 109.901 -157.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 147.0 50.03 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.381 -3.562 . . . . 50.0 101.381 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.75 158.86 43.44 Favored 'General case' 0 C--O 1.184 -2.35 0 CA-C-N 114.001 -1.454 . . . . 50.0 109.056 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 pt -135.91 149.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 106.124 -1.806 . . . . 25.0 106.124 168.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -76.05 137.19 40.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 164.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -86.17 98.15 10.74 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 126.423 1.889 . . . . 25.0 110.452 -164.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -59.65 150.23 28.15 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 119.773 1.17 . . . . 25.0 113.41 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.77 67.1 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 108.906 -1.677 . . . . 25.0 108.906 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -55.77 166.83 0.64 Allowed 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 125.937 1.695 . . . . 25.0 113.71 172.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.01 123.45 6.12 Favored Pre-proline 0 C--O 1.186 -2.26 0 N-CA-C 102.969 -2.974 . . . . 25.0 102.969 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.14 -15.55 39.5 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.383 1.388 . . . . 25.0 114.846 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.56 -6.59 51.04 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 117.526 -3.234 . . . . 75.0 115.458 173.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.09 166.66 15.21 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 101.409 -3.552 . . . . 25.0 101.409 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -43.56 7.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.698 1 C-N-CA 134.179 9.919 . . . . 25.0 120.308 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.28 -26.36 7.22 Favored 'General case' 0 CA--C 1.598 2.794 0 O-C-N 119.599 -1.938 . . . . 50.0 115.667 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -75.96 -2.5 30.73 Favored 'General case' 0 CA--C 1.482 -1.639 1 O-C-N 115.82 -4.3 . . . . 25.0 113.481 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -126.76 -44.61 1.65 Allowed 'General case' 0 CA--C 1.457 -2.61 0 N-CA-C 114.208 1.188 . . . . 25.0 114.208 171.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.38 32.03 0.34 Allowed 'General case' 0 C--O 1.193 -1.872 0 O-C-N 127.938 3.274 . . . . 25.0 112.051 172.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.11 -32.92 73.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 123.708 1.718 . . . . 25.0 113.107 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -103.94 156.54 17.76 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.385 -2.82 . . . . 50.0 103.385 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.95 139.05 50.14 Favored 'General case' 0 C--O 1.27 2.157 0 N-CA-C 102.911 -2.996 . . . . 25.0 102.911 151.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.99 111.84 5.97 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 125.169 1.388 . . . . 50.0 107.517 154.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.42 -16.01 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 O-C-N 125.982 2.051 . . . . 25.0 110.266 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.01 174.41 44.3 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 122.074 2.216 . . . . 25.0 110.383 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -160.45 147.49 15.82 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 114.487 1.292 . . . . 25.0 114.487 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.63 110.28 18.99 Favored Pre-proline 0 CA--C 1.593 2.623 0 C-N-CA 126.209 1.804 . . . . 50.0 108.964 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 89.0 Cg_endo -88.07 161.6 7.25 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 N-CA-C 116.563 1.717 . . . . 25.0 116.563 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -78.26 115.42 17.97 Favored 'General case' 0 CA--C 1.469 -2.137 1 N-CA-C 99.907 -4.108 . . . . 25.0 99.907 171.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -102.3 -14.61 16.89 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.355 -0.839 . . . . 50.0 111.512 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.45 -23.0 2.7 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 105.273 -3.131 . . . . 25.0 105.273 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -78.88 148.02 71.48 Favored Pre-proline 0 C--O 1.266 1.937 0 N-CA-C 104.646 -2.353 . . . . 25.0 104.646 155.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -58.67 147.26 88.49 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 106.476 -2.163 . . . . 25.0 106.476 174.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.34 -19.26 46.89 Favored 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 64.4 p -83.35 6.19 20.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 125.778 1.924 . . . . 25.0 110.491 -176.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -55.06 -43.98 74.33 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 120.047 1.294 . . . . 25.0 113.871 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -110.3 98.43 7.67 Favored 'General case' 0 C--O 1.256 1.445 0 CA-C-O 116.676 -1.63 . . . . 25.0 108.694 166.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.7 tp -85.66 -11.37 53.99 Favored 'General case' 0 C--O 1.288 3.082 0 O-C-N 125.779 1.925 . . . . 75.0 110.626 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 83' ' ' THR . 29.3 t -103.92 138.25 40.76 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -143.06 148.24 36.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.138 1.336 . . . . 25.0 111.715 -164.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -103.6 150.13 24.25 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 125.87 1.981 . . . . 25.0 109.82 -170.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -141.1 127.48 20.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.261 -1.755 . . . . 25.0 106.261 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -84.86 126.93 33.89 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 119.215 0.916 . . . . 50.0 109.009 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -101.38 121.46 51.56 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 106.639 -1.615 . . . . 25.0 106.639 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -67.09 150.57 82.34 Favored 'Trans proline' 0 N--CA 1.481 0.793 1 C-N-CA 113.201 -4.066 . . . . 25.0 116.444 170.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.27 31.37 1.14 Allowed 'General case' 0 CA--C 1.573 1.861 0 CA-C-N 115.512 -0.767 . . . . 25.0 111.816 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.43 -44.77 70.66 Favored 'General case' 1 N--CA 1.545 4.277 0 O-C-N 120.883 -1.136 . . . . 50.0 114.021 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -152.14 166.92 30.16 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.816 0.672 . . . . 25.0 112.816 -170.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mp -83.83 149.22 26.54 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.785 -1.191 . . . . 50.0 107.785 167.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.05 -178.43 19.83 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-O 121.999 0.777 . . . . 25.0 114.962 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -120.42 159.35 25.28 Favored 'General case' 0 C--O 1.197 -1.705 0 N-CA-C 117.485 2.402 . . . . 50.0 117.485 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -160.62 163.41 32.62 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 165.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.55 137.97 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.562 0 C-N-CA 124.299 1.04 . . . . 50.0 112.918 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.64 129.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 C-N-CA 125.085 1.354 . . . . 25.0 109.734 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.79 151.91 35.5 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 126.06 2.1 . . . . 50.0 113.881 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.05 51.37 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 104.463 -2.421 . . . . 25.0 104.463 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 162' ' ' TYR . 58.4 t -135.4 131.34 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 126.345 2.278 . . . . 50.0 107.259 -174.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -124.06 128.05 48.76 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 122.619 1.199 . . . . 25.0 108.592 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.73 144.65 34.55 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 123.502 1.62 . . . . 25.0 110.363 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.88 125.36 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 127.449 2.3 . . . . 50.0 111.744 -169.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.49 62.67 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 103.239 -2.874 . . . . 25.0 103.239 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.3 -12.59 60.58 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 117.621 2.452 . . . . 25.0 117.621 -173.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 34.0 p -133.26 148.38 51.97 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 120.395 -1.441 . . . . 25.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -81.94 -25.21 35.07 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.9 0.88 . . . . 25.0 109.749 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.77 153.25 26.59 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 121.224 -0.922 . . . . 25.0 109.991 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.6 147.66 51.42 Favored 'General case' 0 C--O 1.175 -2.855 0 N-CA-C 105.465 -2.05 . . . . 25.0 105.465 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -120.73 137.29 54.57 Favored 'General case' 0 CA--C 1.479 -1.779 0 C-N-CA 117.996 -1.482 . . . . 50.0 112.21 -158.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.417 ' CD2' HG22 ' A' ' 151' ' ' VAL . 7.8 m-85 -128.96 148.11 50.91 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.691 1.997 . . . . 50.0 114.92 -168.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -139.11 135.93 34.63 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 105.85 -1.907 . . . . 25.0 105.85 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.6 130.97 17.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.463 0 N-CA-C 114.578 1.325 . . . . 75.0 114.578 -169.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.47 123.76 55.91 Favored 'Isoleucine or valine' 0 C--O 1.273 2.32 0 O-C-N 124.728 1.267 . . . . 25.0 111.669 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.5 124.04 26.48 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.95 139.63 49.16 Favored 'Isoleucine or valine' 0 C--O 1.271 2.22 0 CA-C-O 125.311 2.481 . . . . 50.0 109.344 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -117.3 121.34 40.87 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 102.691 -3.077 . . . . 25.0 102.691 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 44.7 mt -131.27 120.42 23.17 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.803 -1.184 . . . . 50.0 107.803 -158.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.4 m -125.68 171.23 14.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 117.618 2.451 . . . . 50.0 117.618 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -74.11 159.59 32.39 Favored 'General case' 0 C--O 1.258 1.522 0 O-C-N 120.772 -1.205 . . . . 25.0 109.574 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.4 mttt . . . . . 0 C--O 1.259 1.568 0 O-C-N 126.821 2.576 . . . . 25.0 109.433 -177.545 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 . . . . . 0 C--O 1.267 1.997 0 CA-C-O 122.49 1.138 . . . . 25.0 111.638 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.76 -174.08 20.18 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-O 114.301 -3.499 . . . . 25.0 118.158 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.39 143.78 47.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 121.674 2.737 . . . . 50.0 107.141 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.5 mt -73.32 140.23 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 102.756 -3.053 . . . . 25.0 102.756 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -135.16 48.21 2.28 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 126.248 2.928 . . . . 25.0 113.834 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 mttt 75.65 163.19 0.14 Allowed Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 109.913 -3.312 . . . . 25.0 113.062 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.58 131.65 22.09 Favored 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 134.665 3.194 . . . . 25.0 108.693 7.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.54 154.5 17.87 Favored Glycine 0 C--O 1.282 3.133 0 N-CA-C 110.716 -0.953 . . . . 25.0 110.716 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 t -152.71 132.7 13.37 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.879 0.987 . . . . 25.0 111.449 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -85.83 -19.79 30.11 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.84 81.6 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 117.774 -1.57 . . . . 25.0 113.228 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.85 -22.67 59.68 Favored 'General case' 0 C--O 1.269 2.117 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -90.25 -8.86 49.93 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.867 1.803 . . . . 75.0 115.867 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -45.98 -40.43 10.4 Favored 'General case' 0 C--O 1.189 -2.082 0 CA-C-N 112.566 -2.106 . . . . 25.0 113.485 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.0 p -68.41 175.14 3.53 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 118.748 2.87 . . . . 25.0 118.748 -160.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.34 -15.41 1.61 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.511 1.925 . . . . 25.0 113.916 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 -19.63 52.06 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -65.91 -3.14 4.65 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 117.258 -3.401 . . . . 50.0 116.228 169.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.29 -28.05 1.53 Allowed Glycine 0 CA--C 1.561 2.927 0 N-CA-C 117.909 1.923 . . . . 25.0 117.909 173.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.8 t80 60.88 25.9 15.82 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 123.613 1.673 . . . . 50.0 109.951 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.2 mt -93.13 -29.19 15.88 Favored 'General case' 0 C--O 1.191 -1.998 0 CA-C-N 114.775 -1.102 . . . . 50.0 112.082 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -137.09 170.86 15.39 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 102.401 -3.185 . . . . 25.0 102.401 -171.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -56.12 156.13 5.84 Favored 'General case' 0 C--O 1.193 -1.884 0 O-C-N 125.344 1.653 . . . . 50.0 109.029 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -100.43 25.24 7.88 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 117.137 -3.477 . . . . 25.0 115.134 -141.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.34 -41.49 0.3 Allowed 'General case' 0 C--O 1.266 1.972 0 CA-C-O 118.573 -0.727 . . . . 25.0 112.582 173.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.25 121.71 4.85 Favored Glycine 0 C--O 1.201 -1.964 0 C-N-CA 118.386 -1.864 . . . . 25.0 110.403 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -54.32 -23.44 15.28 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 119.042 2.978 . . . . 25.0 119.042 -165.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -64.01 -15.79 17.61 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 CA-C-O 118.354 -0.831 . . . . 50.0 112.789 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm -37.3 -15.09 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.535 1 N-CA-C 124.284 4.92 . . . . 25.0 124.284 172.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -71.13 -46.87 60.77 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 116.301 -3.999 . . . . 50.0 114.547 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB2' HE22 ' A' ' 33' ' ' GLN . 7.1 pt-20 -145.69 60.57 6.74 Favored Pre-proline 0 C--O 1.2 -1.505 0 CA-C-O 124.646 2.165 . . . . 25.0 112.834 169.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.13 -10.89 28.22 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 117.279 -1.348 . . . . 25.0 113.647 -166.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.496 HE22 ' HB2' ' A' ' 31' ' ' GLU . 2.8 pm0 -78.8 -15.13 58.79 Favored 'General case' 0 C--O 1.189 -2.08 0 C-N-CA 126.925 2.09 . . . . 25.0 111.641 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -122.55 141.87 51.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 113.43 0.9 . . . . 25.0 113.43 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.2 109.13 20.82 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 124.667 2.175 . . . . 50.0 105.234 156.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.86 151.14 25.29 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.402 -2.074 . . . . 25.0 105.402 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.91 170.62 15.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 123.526 1.631 . . . . 25.0 107.956 169.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -136.76 147.29 46.59 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 119.24 -2.163 . . . . 25.0 108.222 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -76.64 135.94 39.15 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 104.654 -2.35 . . . . 25.0 104.654 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.09 164.61 24.07 Favored Glycine 0 C--O 1.202 -1.899 0 O-C-N 118.514 -2.616 . . . . 25.0 114.357 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -143.63 152.85 57.36 Favored Pre-proline 0 C--O 1.193 -1.878 0 O-C-N 119.144 -2.386 . . . . 25.0 116.142 -168.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -68.15 -15.73 10.03 Favored 'Cis proline' 0 C--O 1.272 2.188 0 CA-C-O 114.892 -2.212 . . . . 25.0 117.227 0.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -145.21 19.94 1.57 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 122.239 2.291 . . . . 25.0 116.77 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t 63.34 -171.16 0.17 Allowed 'General case' 0 N--CA 1.529 3.479 0 CA-C-N 113.503 -1.681 . . . . 25.0 111.642 -168.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.18 -68.48 1.64 Allowed Glycine 0 C--O 1.204 -1.774 0 CA-C-O 115.409 -2.884 . . . . 25.0 116.971 -166.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -63.0 170.44 7.5 Favored 'Trans proline' 0 CA--C 1.495 -1.426 1 C-N-CA 128.589 6.192 . . . . 25.0 111.568 148.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.41 68.23 0.13 Allowed 'General case' 0 C--O 1.269 2.095 0 O-C-N 118.195 -2.816 . . . . 25.0 112.56 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -78.07 161.85 27.13 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 125.68 1.592 . . . . 25.0 111.946 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.73 72.98 Favored Glycine 0 C--O 1.2 -1.994 0 CA-C-O 124.503 2.168 . . . . 25.0 116.678 -167.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -69.77 -23.73 63.41 Favored 'General case' 0 CA--C 1.556 1.181 0 O-C-N 119.645 -2.091 . . . . 25.0 109.485 -172.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.486 HG23 HD21 ' A' ' 57' ' ' LEU . 92.9 mt -83.86 -27.62 7.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 103.152 -2.907 . . . . 25.0 103.152 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.45 -26.29 59.95 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 118.39 -2.694 . . . . 25.0 110.35 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -92.2 -0.44 57.42 Favored 'General case' 0 N--CA 1.527 3.4 0 CA-C-O 124.157 1.932 . . . . 25.0 111.635 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 48.62 13.27 0.05 OUTLIER 'General case' 0 CA--C 1.587 2.373 0 CA-C-N 112.096 -2.32 . . . . 25.0 117.198 -156.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.88 -40.09 89.37 Favored Glycine 0 C--N 1.305 -1.181 0 CA-C-O 127.232 3.684 . . . . 25.0 110.31 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.82 9.84 54.52 Favored Glycine 0 C--O 1.185 -2.943 0 CA-C-N 111.114 -2.543 . . . . 25.0 112.347 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.486 HD21 HG23 ' A' ' 51' ' ' ILE . 16.2 mt -116.05 -12.5 11.29 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 126.284 2.945 . . . . 50.0 112.8 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -74.98 -33.53 61.89 Favored 'General case' 0 C--O 1.265 1.877 0 CA-C-O 126.471 3.034 . . . . 50.0 105.456 154.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.5 -17.28 78.96 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-O 124.762 2.312 . . . . 25.0 110.191 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.88 -22.45 75.66 Favored Glycine 0 C--O 1.208 -1.512 0 CA-C-O 124.041 1.912 . . . . 25.0 112.66 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.16 -41.35 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 118.677 -2.661 . . . . 25.0 109.398 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.7 mt -72.21 -26.48 62.06 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 119.971 3.323 . . . . 75.0 119.971 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -66.5 -28.05 68.26 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.61 -1.255 . . . . 50.0 107.61 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -78.77 6.97 7.76 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 123.819 0.699 . . . . 25.0 111.31 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -126.15 39.64 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 104.306 -2.479 . . . . 25.0 104.306 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.2 t -154.98 169.44 24.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.264 -1.523 . . . . 25.0 107.544 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.73 -14.63 63.15 Favored 'General case' 0 C--O 1.182 -2.471 0 CA-C-O 124.745 2.212 . . . . 25.0 109.245 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -86.06 20.18 2.38 Favored 'General case' 0 N--CA 1.422 -1.852 0 O-C-N 119.03 -2.294 . . . . 25.0 112.319 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.92 96.91 2.18 Favored 'General case' 0 C--O 1.263 1.802 0 CA-C-O 124.803 2.24 . . . . 25.0 105.589 163.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -44.71 146.0 0.83 Allowed 'General case' 0 C--O 1.275 2.395 1 CA-C-N 106.598 -4.819 . . . . 25.0 109.74 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -79.78 132.34 36.13 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 119.681 -1.887 . . . . 50.0 112.037 -157.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.05 155.83 16.9 Favored 'General case' 0 C--N 1.365 1.256 0 CA-C-N 112.333 -2.212 . . . . 25.0 112.17 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -152.44 141.25 21.03 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.032 -1.467 . . . . 25.0 113.841 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.28 129.9 39.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.78 0 C-N-CA 117.045 -1.862 . . . . 25.0 106.611 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' A' ' 169' ' ' LEU . 26.4 ttt -139.92 157.77 45.15 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 121.177 1.808 . . . . 25.0 107.452 164.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 p -68.02 162.74 23.83 Favored 'General case' 0 CA--C 1.584 2.275 0 O-C-N 117.911 -2.993 . . . . 25.0 109.214 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.95 -156.27 3.38 Favored Glycine 0 C--O 1.209 -1.463 1 O-C-N 115.928 -4.232 . . . . 25.0 113.485 164.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 -173.38 38.02 Favored Glycine 0 C--O 1.192 -2.495 0 O-C-N 121.322 -1.105 . . . . 25.0 111.5 -165.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.62 133.15 51.66 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 120.491 2.145 . . . . 25.0 114.089 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -120.16 133.2 55.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.767 -1.568 . . . . 25.0 106.767 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.1 m -115.54 89.62 3.14 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 120.695 1.589 . . . . 25.0 111.573 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -74.4 117.7 16.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.618 0.767 . . . . 50.0 109.981 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -123.99 145.02 49.47 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.372 -2.084 . . . . 25.0 105.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -127.8 159.24 35.44 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 102.225 -3.25 . . . . 25.0 102.225 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.3 p -134.91 163.1 30.6 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 127.704 3.128 . . . . 25.0 108.245 166.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.36 137.9 52.89 Favored 'General case' 0 N--CA 1.496 1.863 1 N-CA-C 96.768 -5.271 . . . . 50.0 96.768 164.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.4 t -74.51 -20.68 59.89 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 116.031 -2.268 . . . . 25.0 105.713 -165.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.16 157.58 77.68 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 103.038 -2.949 . . . . 25.0 103.038 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.29 143.16 27.86 Favored 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 109.95 -6.233 . . . . 25.0 112.018 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -118.03 152.65 35.11 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.833 -2.284 . . . . 25.0 104.833 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.57 160.54 32.51 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.67 147.05 24.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 127.867 2.467 . . . . 25.0 113.389 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -108.64 -27.94 9.55 Favored 'General case' 0 C--O 1.26 1.617 0 N-CA-C 114.535 1.309 . . . . 25.0 114.535 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -174.43 173.74 2.9 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.054 -2.573 . . . . 25.0 104.054 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -153.24 169.43 23.06 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.982 -0.747 . . . . 25.0 108.982 163.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -145.01 151.79 39.12 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 114.434 -2.698 . . . . 25.0 106.764 -169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.88 147.18 21.22 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 124.737 2.208 . . . . 50.0 112.982 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -132.08 165.09 24.81 Favored 'General case' 1 C--O 1.306 4.059 0 CA-C-N 114.324 -1.307 . . . . 50.0 107.661 -162.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.4 pt -125.94 157.0 36.11 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.676 0 N-CA-C 101.311 -3.589 . . . . 25.0 101.311 161.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 115' ' ' PHE . 34.9 p -76.3 150.15 36.98 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.346 -1.724 . . . . 25.0 106.346 169.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -143.49 76.85 1.54 Allowed 'General case' 0 N--CA 1.423 -1.791 0 O-C-N 120.641 -1.287 . . . . 25.0 108.221 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -56.44 153.45 9.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.11 -1.859 . . . . 25.0 112.851 167.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.73 37.77 22.08 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 116.79 -2.116 . . . . 25.0 109.774 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -64.5 157.22 27.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 126.598 1.999 . . . . 25.0 110.949 163.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -59.22 133.81 87.92 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 108.221 -1.029 . . . . 25.0 108.221 158.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.33 -36.14 98.9 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 N-CA-C 117.456 2.06 . . . . 25.0 117.456 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.66 -19.8 62.72 Favored 'General case' 0 C--O 1.267 1.994 0 N-CA-C 116.889 2.181 . . . . 75.0 116.889 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -58.16 159.08 11.88 Favored Pre-proline 0 C--O 1.205 -1.27 0 CA-C-N 113.13 -1.85 . . . . 25.0 110.231 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.45 23.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.193 -1.774 2 C-N-CA 127.128 5.219 . . . . 25.0 125.08 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 tp 14.79 -56.87 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.244 1 N-CA-C 125.56 5.393 . . . . 50.0 125.56 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -69.24 -31.54 70.17 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -96.72 -46.5 6.26 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.624 -1.626 . . . . 25.0 110.517 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.79 -3.78 1.75 Allowed 'General case' 0 C--O 1.206 -1.19 0 C-N-CA 118.82 -1.152 . . . . 25.0 113.058 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.7 -26.35 68.34 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 115.471 1.656 . . . . 25.0 115.471 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 29.8 p90 -127.51 153.23 46.59 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.207 -2.146 . . . . 50.0 105.207 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -126.68 130.61 50.74 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 111.877 -2.419 . . . . 25.0 111.258 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.18 111.44 3.43 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 105.508 -2.034 . . . . 50.0 105.508 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.9 tt -86.73 -20.24 7.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.444 -1.317 . . . . 25.0 107.444 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 175.7 166.55 33.39 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.748 -1.22 . . . . 25.0 113.555 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.92 155.36 41.5 Favored 'General case' 0 C--O 1.181 -2.516 0 N-CA-C 104.124 -2.547 . . . . 25.0 104.124 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.3 107.12 17.6 Favored Pre-proline 0 C--O 1.271 2.213 0 N-CA-C 106.828 -1.545 . . . . 50.0 106.828 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.33 162.05 28.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 N-CA-C 107.553 -1.749 . . . . 25.0 107.553 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -139.66 63.01 1.5 Allowed 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 119.544 -0.862 . . . . 25.0 110.542 -170.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.15 -16.9 0.83 Allowed 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.533 1.679 . . . . 50.0 115.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -164.75 21.58 0.14 Allowed Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 125.412 1.482 . . . . 25.0 116.681 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.63 162.06 73.35 Favored Pre-proline 0 CA--C 1.556 1.201 0 O-C-N 124.88 0.988 . . . . 25.0 113.437 -174.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.29 -170.01 0.53 Allowed 'Trans proline' 0 C--O 1.264 1.808 0 CA-C-O 117.822 -0.991 . . . . 25.0 113.987 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.42 4.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 1 N-CA-C 122.027 4.084 . . . . 25.0 122.027 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 p -57.66 -17.6 15.73 Favored 'General case' 0 C--O 1.187 -2.224 0 CA-C-N 115.921 -0.582 . . . . 25.0 110.284 161.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -63.9 -16.71 62.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.183 0.809 . . . . 25.0 113.183 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -60.72 129.83 43.46 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 117.821 -1.085 . . . . 25.0 109.471 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.49 -5.01 17.06 Favored 'General case' 0 C--O 1.283 2.86 0 N-CA-C 120.357 3.465 . . . . 75.0 120.357 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.4 t -86.51 127.18 34.85 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 126.039 1.736 . . . . 25.0 109.141 160.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -134.67 130.13 35.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 118.921 2.934 . . . . 25.0 118.921 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -92.07 129.22 38.07 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.174 -1.375 . . . . 25.0 113.573 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.5 mt -121.09 124.03 71.29 Favored 'Isoleucine or valine' 0 C--O 1.271 2.194 0 N-CA-C 105.605 -1.998 . . . . 25.0 105.605 169.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -75.84 137.09 40.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.003 -2.221 . . . . 50.0 105.003 165.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mm -115.28 129.78 24.81 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 101.763 -3.421 . . . . 25.0 101.763 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.74 140.63 68.58 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 116.372 -1.952 . . . . 25.0 109.415 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -108.66 2.92 22.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.31 -23.71 32.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.517 2.043 . . . . 50.0 116.517 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -143.49 155.1 44.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 114.768 -2.539 . . . . 25.0 107.512 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.5 pt? -75.22 164.56 26.34 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 125.808 1.943 . . . . 50.0 109.605 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 175.81 135.28 2.09 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 108.12 -1.992 . . . . 25.0 108.12 170.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -115.3 148.53 39.1 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 124.973 1.309 . . . . 50.0 111.396 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -161.04 161.88 31.52 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 116.569 -1.681 . . . . 25.0 107.471 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.9 t -91.01 158.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 101.664 -3.458 . . . . 50.0 101.664 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.77 135.78 49.97 Favored 'Isoleucine or valine' 0 C--O 1.28 2.671 1 N-CA-C 98.048 -4.797 . . . . 25.0 98.048 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.26 148.2 48.77 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 103.749 -2.685 . . . . 50.0 103.749 168.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.09 153.0 41.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.588 -0.695 . . . . 25.0 110.718 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.9 140.64 46.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.625 0 C-N-CA 123.067 0.547 . . . . 50.0 111.304 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.19 133.76 45.83 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.788 1.235 . . . . 25.0 112.574 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.96 133.29 55.6 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.338 1.055 . . . . 25.0 112.663 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.9 t -131.64 111.87 19.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 102.119 -3.289 . . . . 50.0 102.119 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.62 -24.86 53.37 Favored 'General case' 0 C--O 1.17 -3.091 0 CA-C-O 117.753 -1.118 . . . . 25.0 108.288 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.98 -19.27 65.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 124.477 2.084 . . . . 25.0 115.858 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.7 p -118.82 150.83 39.16 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.151 -1.84 . . . . 25.0 114.202 -173.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -78.55 -25.55 45.47 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.344 -1.753 . . . . 25.0 109.974 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -63.33 152.22 38.55 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 118.611 -1.236 . . . . 25.0 114.133 163.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.88 158.34 44.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 105.588 -2.005 . . . . 25.0 105.588 174.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -131.36 146.06 52.11 Favored 'General case' 0 C--O 1.29 3.206 0 O-C-N 118.618 -2.551 . . . . 50.0 114.78 -170.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.01 170.54 15.83 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 102.466 -3.161 . . . . 50.0 102.466 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -164.34 167.36 19.86 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.977 -2.231 . . . . 25.0 104.977 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.2 p -145.32 134.99 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.935 -1.135 . . . . 75.0 107.935 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -141.85 146.26 23.14 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 101.972 -3.344 . . . . 25.0 101.972 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -122.17 152.18 40.21 Favored 'General case' 0 C--O 1.264 1.827 0 CA-C-N 121.072 1.76 . . . . 25.0 108.002 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.66 153.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.76 0 N-CA-C 110.185 -0.302 . . . . 50.0 110.185 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -131.79 94.52 3.52 Favored 'General case' 0 C--O 1.264 1.857 0 N-CA-C 101.401 -3.555 . . . . 25.0 101.401 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 75' ' ' MET . 53.3 mt -102.49 111.77 24.22 Favored 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 120.34 -1.475 . . . . 50.0 114.446 -170.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 33.5 m -128.11 173.71 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.964 2.579 . . . . 50.0 117.964 -153.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.37 147.13 23.65 Favored 'General case' 0 CA--C 1.494 -1.203 1 N-CA-C 99.541 -4.244 . . . . 25.0 99.541 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 C--O 1.269 2.088 0 N-CA-C 116.036 1.865 . . . . 25.0 116.036 169.206 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 N--CA 1.534 3.748 0 CA-C-O 123.846 1.784 . . . . 25.0 113.33 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 33' ' ' GLN . . . -144.21 -32.44 0.09 OUTLIER Glycine 0 C--O 1.27 2.384 0 C-N-CA 127.632 2.539 . . . . 25.0 111.052 169.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.08 140.13 53.34 Favored 'General case' 0 CA--C 1.482 -1.643 0 C-N-CA 125.637 1.575 . . . . 50.0 109.8 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.5 mt -103.76 122.04 55.96 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 N-CA-C 100.703 -3.814 . . . . 25.0 100.703 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -92.63 -40.56 10.68 Favored 'General case' 0 C--O 1.182 -2.486 0 CA-C-N 119.14 0.882 . . . . 25.0 112.66 -173.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -144.82 154.41 55.35 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 115.887 -2.006 . . . . 25.0 106.634 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.65 136.45 45.14 Favored 'Cis proline' 0 N--CA 1.476 0.478 0 CA-C-N 121.909 1.718 . . . . 25.0 109.059 0.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.74 -162.44 38.29 Favored Glycine 0 C--O 1.214 -1.113 0 N-CA-C 120.082 2.793 . . . . 25.0 120.082 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -114.51 116.0 28.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.487 1.644 . . . . 25.0 111.282 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -73.11 -23.24 60.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.123 0.874 . . . . 25.0 109.588 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.47 72.63 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.234 1.814 . . . . 25.0 106.297 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.38 -37.95 68.22 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 124.216 0.947 . . . . 25.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -94.66 -32.2 13.49 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.803 0.689 . . . . 75.0 110.638 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 25' ' ' CYS . 11.0 t -74.21 -23.31 59.17 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 119.665 -1.897 . . . . 25.0 115.96 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.442 ' HB2' ' H ' ' A' ' 17' ' ' ALA . 72.3 p -94.47 155.94 16.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 123.876 1.798 . . . . 25.0 108.244 -164.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.25 61.8 mt-10 -89.76 -13.12 37.43 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.497 -2.038 . . . . 25.0 105.497 166.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' H ' ' HB2' ' A' ' 15' ' ' SER . . . -64.92 -36.88 85.79 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -174.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -56.28 -49.08 75.27 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 115.602 1.704 . . . . 50.0 115.602 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.78 -0.96 0.64 Allowed Glycine 0 C--N 1.308 -0.993 0 N-CA-C 118.743 2.257 . . . . 25.0 118.743 -167.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.4 t80 59.26 -46.79 0.07 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 120.016 3.339 . . . . 50.0 120.016 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.06 -19.36 61.19 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 123.731 2.969 . . . . 50.0 115.551 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -149.27 175.56 11.3 Favored 'General case' 0 CA--C 1.499 -0.994 1 N-CA-C 100.064 -4.05 . . . . 25.0 100.064 -171.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.81 170.77 18.93 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 103.132 -2.914 . . . . 50.0 103.132 170.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -147.38 70.9 1.19 Allowed 'General case' 0 C--N 1.319 -0.726 0 O-C-N 118.698 -2.501 . . . . 25.0 108.598 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -131.91 -19.05 2.62 Favored 'General case' 0 C--O 1.193 -1.88 0 CA-C-N 112.208 -2.269 . . . . 25.0 113.997 -175.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.76 -107.52 1.32 Allowed Glycine 0 C--O 1.211 -1.342 0 CA-C-O 123.163 1.424 . . . . 25.0 115.091 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -96.27 -29.08 14.21 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 112.483 -1.859 . . . . 25.0 111.309 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.49 -28.57 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 CA-C-N 115.457 -0.792 . . . . 50.0 111.668 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.3 ptt? -62.61 -23.09 66.86 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 114.601 1.334 . . . . 25.0 114.601 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -88.15 -37.83 15.85 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.291 -1.364 . . . . 50.0 111.319 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.51 48.02 0.25 Allowed Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 115.978 1.844 . . . . 25.0 115.978 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.16 -19.49 34.14 Favored 'Trans proline' 0 CA--C 1.569 2.261 1 C-N-CA 110.915 -5.59 . . . . 25.0 116.621 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.459 ' HB3' ' HA2' ' A' ' 2' ' ' GLY 0.266 12.2 pt20 -109.15 -20.88 12.83 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.846 1.203 . . . . 25.0 113.911 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.1 p -96.58 22.45 8.02 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.297 1.046 . . . . 25.0 113.755 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.97 44.47 0.03 OUTLIER 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.669 1.988 . . . . 50.0 115.485 -172.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 161' ' ' PHE . 47.0 mt-10 -71.77 156.63 39.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 120.766 3.617 . . . . 25.0 120.766 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.72 58.3 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 117.651 -1.166 . . . . 25.0 113.976 170.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 31.7 tttm -151.71 -164.23 1.93 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.831 3.014 . . . . 25.0 109.435 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.544 ' H ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 mttt -65.21 159.38 23.78 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 113.508 -1.678 . . . . 25.0 109.862 -170.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.38 169.97 39.38 Favored Glycine 0 C--N 1.359 1.819 0 CA-C-O 118.41 -1.217 . . . . 25.0 116.082 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -115.02 97.14 47.17 Favored Pre-proline 0 CA--C 1.583 2.247 0 O-C-N 125.962 1.625 . . . . 25.0 114.643 -176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.4 177.33 33.47 Favored 'Cis proline' 0 CA--C 1.547 1.129 0 C-N-CA 132.783 2.41 . . . . 25.0 109.429 -8.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -75.55 -29.97 59.57 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 118.608 2.818 . . . . 25.0 118.608 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t 56.4 -60.65 0.02 OUTLIER 'General case' 0 C--O 1.175 -2.83 0 C-N-CA 131.488 3.915 . . . . 25.0 118.039 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.65 176.53 35.56 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-O 114.221 -3.544 . . . . 25.0 113.96 -176.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.08 168.8 18.06 Favored 'Trans proline' 0 C--O 1.258 1.492 1 C-N-CA 129.629 6.886 . . . . 25.0 109.679 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.69 136.34 57.66 Favored 'General case' 0 C--O 1.203 -1.392 0 N-CA-C 107.735 -1.209 . . . . 25.0 107.735 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -82.01 130.14 34.99 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 119.077 -2.264 . . . . 25.0 107.692 -166.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.75 3.82 6.31 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 113.557 -3.913 . . . . 25.0 115.571 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 42.08 39.4 1.34 Allowed 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.143 1.972 . . . . 25.0 108.899 -168.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.4 mt -72.5 -41.42 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 119.262 -2.149 . . . . 25.0 110.605 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.7 81.79 Favored 'General case' 0 C--O 1.26 1.641 0 N-CA-C 114.425 1.268 . . . . 25.0 114.425 -168.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.0 p -87.67 -15.94 35.77 Favored 'General case' 0 C--O 1.263 1.816 0 O-C-N 123.887 0.742 . . . . 25.0 109.265 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.06 -16.62 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 121.571 3.915 . . . . 25.0 121.571 165.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.08 -25.23 76.08 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-O 122.186 0.881 . . . . 25.0 111.574 172.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.67 -11.75 66.15 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 113.746 -1.227 . . . . 25.0 115.916 166.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.7 mt -85.01 -20.92 29.76 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 119.084 -2.421 . . . . 50.0 113.303 172.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 -35.79 32.92 Favored 'General case' 0 CA--C 1.586 2.337 0 N-CA-C 101.343 -3.577 . . . . 50.0 101.343 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.56 63.74 Favored Glycine 0 C--O 1.268 2.245 0 CA-C-N 114.014 -1.448 . . . . 25.0 113.07 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.66 77.56 Favored Glycine 0 C--O 1.201 -1.914 0 CA-C-N 119.058 1.429 . . . . 25.0 110.938 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -65.55 -43.57 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 106.885 -1.524 . . . . 25.0 106.885 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.12 -24.21 59.41 Favored 'General case' 0 C--O 1.172 -3.014 0 N-CA-C 107.686 -1.227 . . . . 75.0 107.686 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.69 -21.39 60.26 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 123.777 1.751 . . . . 50.0 111.171 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -103.95 16.35 26.5 Favored 'General case' 0 C--O 1.183 -2.441 0 O-C-N 118.213 -2.804 . . . . 25.0 108.37 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -128.95 49.73 2.2 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 102.303 -3.221 . . . . 25.0 102.303 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -152.5 -179.67 7.79 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 100.525 -3.88 . . . . 25.0 100.525 -162.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -66.8 -17.61 64.96 Favored 'General case' 0 CA--C 1.592 2.587 0 C-N-CA 117.651 -1.62 . . . . 25.0 114.413 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -94.68 48.77 1.22 Allowed 'General case' 0 CA--C 1.556 1.21 0 O-C-N 120.203 -1.561 . . . . 25.0 108.317 165.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -85.32 98.98 10.84 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 100.191 -4.003 . . . . 25.0 100.191 156.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -65.6 163.06 16.98 Favored 'General case' 0 C--O 1.256 1.43 1 CA-C-N 106.583 -4.826 . . . . 25.0 110.703 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -59.52 146.29 41.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 120.016 1.28 . . . . 50.0 112.366 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -129.33 154.4 46.92 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -139.77 150.72 45.09 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 118.282 -0.866 . . . . 25.0 112.038 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.98 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.127 0 CA-C-O 123.789 1.757 . . . . 25.0 110.561 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 30.6 mtm -147.0 172.0 14.39 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 120.147 -1.596 . . . . 25.0 113.493 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.1 p -71.53 165.21 24.35 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 105.071 -2.196 . . . . 25.0 105.071 168.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.06 176.62 53.11 Favored Glycine 0 C--N 1.309 -0.932 0 N-CA-C 106.378 -2.689 . . . . 25.0 106.378 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.94 -170.15 20.17 Favored Glycine 0 C--O 1.266 2.113 0 CA-C-N 120.342 2.071 . . . . 25.0 113.815 -170.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -74.68 137.39 42.11 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 112.922 -1.639 . . . . 25.0 109.852 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -127.62 159.1 35.69 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.719 1.208 . . . . 25.0 111.158 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.3 m -117.89 142.04 47.77 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 106.31 -1.737 . . . . 25.0 106.31 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -125.96 114.72 18.86 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 102.687 -3.079 . . . . 50.0 102.687 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 m -129.87 117.68 20.54 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.706 -1.588 . . . . 25.0 112.524 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . 0.308 0.8 OUTLIER -111.51 136.61 50.45 Favored 'General case' 0 C--O 1.3 3.717 0 N-CA-C 101.353 -3.573 . . . . 25.0 101.353 171.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -148.88 160.29 43.39 Favored 'General case' 0 C--O 1.181 -2.54 0 O-C-N 125.59 1.806 . . . . 25.0 108.887 -167.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.04 170.32 16.2 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.852 -1.067 . . . . 50.0 109.288 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.9 t -64.76 -25.42 67.92 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.907 -1.044 . . . . 25.0 111.45 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.34 153.23 74.54 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 125.096 1.497 . . . . 25.0 111.129 -171.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.99 169.39 20.61 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 117.331 -1.313 . . . . 25.0 112.53 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.258 3.2 m80 -127.09 161.51 28.26 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 103.81 -2.663 . . . . 25.0 103.81 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -81.86 57.93 3.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.091 0.956 . . . . 25.0 109.642 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 154' ' ' VAL . 4.5 m -66.98 144.5 56.17 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 127.022 2.702 . . . . 25.0 108.878 -178.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -117.37 -32.05 5.07 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 126.478 2.361 . . . . 25.0 109.822 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 50.3 tt0 -165.59 154.68 12.02 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 124.755 1.222 . . . . 25.0 109.471 -170.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -141.74 164.56 29.88 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 145.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.33 36.4 m-70 -131.9 145.06 51.3 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 126.588 1.955 . . . . 25.0 107.776 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -139.54 148.34 42.46 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-O 122.713 1.244 . . . . 50.0 111.286 170.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.46 162.05 30.05 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 109.679 -3.418 . . . . 50.0 111.042 -164.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.2 151.05 33.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 102.25 -3.241 . . . . 25.0 102.25 176.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 114' ' ' ASP . 71.6 m -82.32 113.88 20.41 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 125.883 1.989 . . . . 25.0 109.893 157.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -83.38 94.33 7.94 Favored 'General case' 0 C--O 1.195 -1.811 0 CA-C-N 120.209 1.368 . . . . 25.0 109.57 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -61.76 161.19 10.51 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 124.671 1.188 . . . . 25.0 111.923 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.42 28.15 Favored Glycine 0 CA--C 1.497 -1.048 0 C-N-CA 119.0 -1.571 . . . . 25.0 116.504 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.21 159.89 32.18 Favored 'General case' 0 CA--C 1.581 2.145 0 C-N-CA 119.592 -0.843 . . . . 25.0 111.426 -171.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -71.31 117.1 53.74 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 102.377 -3.194 . . . . 25.0 102.377 149.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.81 -22.22 37.05 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 125.282 3.988 . . . . 25.0 117.525 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -75.08 -13.84 60.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.387 -1.446 . . . . 75.0 109.934 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.253 95.9 mttt -117.11 165.3 15.84 Favored Pre-proline 0 C--O 1.2 -1.504 2 N-CA-C 99.202 -4.37 . . . . 25.0 99.202 -171.75 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 3.38 14.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 2 C-N-CA 135.44 10.76 . . . . 25.0 127.967 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.1 tt -46.66 -43.53 17.69 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-O 115.616 -2.135 . . . . 50.0 113.768 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -75.39 -2.58 29.19 Favored 'General case' 0 C--O 1.169 -3.163 0 O-C-N 125.195 1.56 . . . . 25.0 113.207 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -121.94 -51.85 2.0 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 122.799 1.285 . . . . 25.0 112.155 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.55 -26.53 3.57 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 112.653 -2.067 . . . . 25.0 115.095 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.47 ' HA ' HG23 ' A' ' 100' ' ' THR . 20.2 t0 -80.35 -7.78 59.22 Favored 'General case' 0 C--O 1.28 2.676 0 CA-C-N 113.489 -1.687 . . . . 25.0 111.04 -176.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -141.64 47.56 1.66 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 118.236 -2.79 . . . . 50.0 106.631 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.8 122.45 29.15 Favored 'General case' 0 CA--C 1.558 1.286 0 O-C-N 118.143 -2.848 . . . . 25.0 111.5 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.6 tp -60.72 125.96 25.64 Favored 'General case' 0 C--O 1.266 1.94 0 N-CA-C 114.174 1.176 . . . . 50.0 114.174 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.7 tt -108.21 -22.4 5.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 116.799 -1.572 . . . . 25.0 106.999 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.12 -179.43 44.74 Favored Glycine 0 C--N 1.371 2.488 0 C-N-CA 118.746 -1.692 . . . . 25.0 116.193 161.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -146.59 153.99 40.98 Favored 'General case' 0 C--O 1.286 3.023 0 CA-C-O 123.279 1.514 . . . . 25.0 107.333 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.2 t -132.46 86.49 45.14 Favored Pre-proline 0 CA--C 1.62 3.648 0 N-CA-C 103.608 -2.738 . . . . 50.0 103.608 -173.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 71.9 Cg_endo -71.18 154.33 61.98 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 115.234 -2.711 . . . . 25.0 112.259 171.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -144.59 96.44 2.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.37 1.618 . . . . 25.0 115.37 -157.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.34 -7.25 16.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.57 -1.65 . . . . 50.0 114.722 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.41 -171.1 42.1 Favored Glycine 0 C--O 1.283 3.194 1 N-CA-C 101.969 -4.452 . . . . 25.0 101.969 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.4 m -126.42 75.11 73.89 Favored Pre-proline 0 N--CA 1.508 2.439 0 N-CA-C 115.193 1.553 . . . . 25.0 115.193 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.3 170.19 17.81 Favored 'Trans proline' 0 C--O 1.213 -0.759 1 C-N-CA 111.984 -4.877 . . . . 25.0 106.208 150.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.76 67.02 Favored 'General case' 0 CA--C 1.573 1.842 0 O-C-N 119.373 -2.079 . . . . 25.0 115.567 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 95.5 p -68.02 -22.89 64.96 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 120.93 1.696 . . . . 25.0 114.407 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -111.97 19.59 17.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 127.039 2.712 . . . . 25.0 111.974 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -55.59 148.82 15.06 Favored 'General case' 0 N--CA 1.513 2.681 0 CA-C-O 122.82 1.295 . . . . 25.0 108.404 168.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tp -64.65 -36.4 84.14 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 111.483 -2.599 . . . . 75.0 110.795 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.7 t -91.81 153.76 19.36 Favored 'General case' 0 C--O 1.285 2.946 0 N-CA-C 104.12 -2.548 . . . . 25.0 104.12 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -147.41 164.63 32.72 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 112.82 0.674 . . . . 25.0 112.82 170.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -113.59 148.9 35.34 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 104.471 -2.418 . . . . 25.0 104.471 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -133.03 124.5 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 105.645 -1.983 . . . . 25.0 105.645 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . 0.254 70.0 t80 -90.91 132.75 35.74 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.124 -2.86 . . . . 50.0 109.039 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.6 mm -131.63 124.4 19.93 Favored Pre-proline 0 C--O 1.268 2.059 0 N-CA-C 103.254 -2.869 . . . . 25.0 103.254 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.19 165.89 29.96 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 114.51 -3.193 . . . . 25.0 116.697 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.53 39.35 1.06 Allowed 'General case' 0 C--O 1.295 3.46 0 CA-C-O 125.853 2.74 . . . . 25.0 111.27 175.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.86 -20.17 59.85 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 115.64 1.719 . . . . 50.0 115.64 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -148.92 170.32 18.56 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.63 139.46 38.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 101.631 -3.47 . . . . 50.0 101.631 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.13 176.67 20.19 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 118.328 -1.891 . . . . 25.0 115.47 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -81.86 146.25 29.95 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 117.985 2.587 . . . . 50.0 117.985 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -138.93 113.75 9.21 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.916 2.01 . . . . 25.0 111.138 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.76 130.87 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 CA-C-O 116.176 -1.869 . . . . 50.0 108.625 -172.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.48 132.15 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 124.031 1.872 . . . . 25.0 109.907 167.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HG ' HG23 ' A' ' 164' ' ' VAL . 3.1 mp -118.04 138.59 52.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 102.868 -3.012 . . . . 50.0 102.868 -175.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.39 144.61 29.85 Favored 'General case' 0 C--O 1.29 3.187 0 O-C-N 119.826 -1.796 . . . . 25.0 111.835 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 79.8 t -124.67 135.14 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 102.728 -3.064 . . . . 50.0 102.728 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -135.26 114.83 12.66 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 125.428 1.705 . . . . 25.0 112.079 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -112.18 128.84 56.35 Favored 'General case' 0 C--O 1.284 2.885 0 O-C-N 123.872 0.732 . . . . 25.0 111.687 -162.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 79.6 t -121.7 119.07 57.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 115.823 -2.037 . . . . 50.0 107.319 -169.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.71 -13.36 31.55 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 119.719 3.229 . . . . 25.0 119.719 -166.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -76.36 -18.65 58.78 Favored 'General case' 0 C--O 1.253 1.263 0 O-C-N 120.268 -1.52 . . . . 25.0 112.348 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -112.25 153.4 27.19 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 119.951 -1.718 . . . . 25.0 111.751 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -78.11 -28.2 48.56 Favored 'General case' 0 C--O 1.28 2.673 0 N-CA-C 103.161 -2.904 . . . . 25.0 103.161 171.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.08 179.34 3.34 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 119.177 -2.202 . . . . 25.0 113.23 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.57 151.56 36.49 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 125.84 1.656 . . . . 25.0 108.584 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 84.2 m-85 -95.25 150.22 20.47 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 126.023 2.077 . . . . 50.0 111.778 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -133.56 130.7 38.79 Favored 'General case' 0 C--O 1.284 2.872 0 CA-C-N 114.741 -1.118 . . . . 50.0 108.205 -169.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.0 156.87 45.45 Favored 'General case' 0 C--O 1.267 1.988 0 CA-C-N 119.65 1.114 . . . . 25.0 112.22 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.412 HG23 ' HG ' ' A' ' 149' ' ' LEU . 6.6 p -146.8 127.94 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 107.631 -1.248 . . . . 75.0 107.631 -171.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.58 137.04 57.82 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 N-CA-C 107.465 -1.309 . . . . 25.0 107.465 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.67 126.95 50.18 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 123.648 0.593 . . . . 25.0 110.941 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.36 132.99 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 122.914 1.34 . . . . 50.0 111.697 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -96.23 113.42 25.01 Favored 'General case' 0 C--O 1.204 -1.339 0 N-CA-C 104.625 -2.361 . . . . 25.0 104.625 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 87.3 mt -110.36 110.71 21.6 Favored 'General case' 0 CA--C 1.476 -1.896 0 CA-C-N 112.807 -1.997 . . . . 50.0 110.202 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.7 m -132.93 154.57 39.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-O 124.564 2.126 . . . . 50.0 112.615 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -59.11 126.38 27.46 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.0 pttp . . . . . 0 C--O 1.263 1.801 0 CA-C-O 116.061 -1.924 . . . . 25.0 108.53 179.045 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 118.996 -0.526 . . . . 25.0 111.217 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.65 173.64 42.03 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 120.482 1.492 . . . . 25.0 115.341 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -129.21 135.73 49.2 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 125.165 1.386 . . . . 50.0 112.746 -156.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.5 mt -89.57 121.53 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 119.229 -2.169 . . . . 25.0 111.151 -171.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -101.22 16.48 25.37 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.862 1.265 . . . . 25.0 110.245 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 64.87 166.27 0.11 Allowed Pre-proline 0 CA--C 1.594 2.652 0 C-N-CA 128.195 2.598 . . . . 25.0 111.14 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.55 141.3 45.07 Favored 'Cis proline' 0 C--O 1.204 -1.225 0 C-N-CA 132.621 2.342 . . . . 25.0 111.709 13.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.94 91.53 1.61 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 117.272 1.669 . . . . 25.0 117.272 168.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 t -75.63 144.44 41.71 Favored 'General case' 0 C--O 1.275 2.423 0 CA-C-O 123.183 1.468 . . . . 25.0 110.921 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -107.23 -22.93 12.44 Favored 'General case' 0 CA--C 1.581 2.138 0 CA-C-N 113.721 -1.581 . . . . 25.0 109.724 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.39 89.71 Favored 'General case' 0 C--O 1.264 1.856 0 CA-C-O 117.398 -1.287 . . . . 25.0 108.792 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -29.14 70.57 Favored 'General case' 0 C--O 1.279 2.656 0 O-C-N 125.764 1.915 . . . . 25.0 115.389 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt -80.98 -21.55 40.22 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 120.433 -1.417 . . . . 75.0 109.575 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -11.09 59.68 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 116.334 1.976 . . . . 25.0 116.334 174.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.8 t -65.6 165.7 11.92 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 114.913 1.449 . . . . 25.0 114.913 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.18 -24.51 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 1 N-CA-C 124.498 4.999 . . . . 25.0 124.498 -169.343 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.63 -20.19 66.21 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.705 1.602 . . . . 25.0 110.404 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -52.78 -18.91 2.1 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 117.685 2.476 . . . . 50.0 117.685 165.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.43 7.65 0.21 Allowed Glycine 0 C--O 1.211 -1.3 0 N-CA-C 122.888 3.915 . . . . 25.0 122.888 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 49.86 0.47 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 131.047 3.739 . . . . 50.0 117.584 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.6 mt -94.6 -12.14 28.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 118.251 -2.78 . . . . 50.0 116.156 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -132.77 -171.98 2.8 Favored 'General case' 0 C--O 1.182 -2.479 0 O-C-N 121.782 -0.573 . . . . 25.0 109.671 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mp -65.57 159.68 24.11 Favored 'General case' 0 C--O 1.245 0.855 0 O-C-N 120.541 -1.349 . . . . 50.0 114.095 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -78.56 2.38 19.42 Favored 'General case' 0 C--O 1.191 -1.991 0 C-N-CA 125.909 1.683 . . . . 25.0 112.274 -169.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -147.93 -38.81 0.18 Allowed 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 119.355 -0.938 . . . . 25.0 111.083 138.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.64 131.0 5.68 Favored Glycine 0 C--O 1.267 2.207 0 N-CA-C 106.058 -2.817 . . . . 25.0 106.058 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 m -52.05 -12.33 0.22 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.864 3.283 . . . . 25.0 119.864 -174.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.94 -4.85 6.24 Favored 'Isoleucine or valine' 0 C--O 1.256 1.396 0 O-C-N 118.553 -2.592 . . . . 50.0 112.116 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.9 ptm -55.48 -10.07 0.58 Allowed 'General case' 0 C--O 1.257 1.452 0 N-CA-C 115.62 1.711 . . . . 25.0 115.62 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -64.58 -38.16 90.03 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.653 2.094 . . . . 50.0 116.653 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -147.41 64.26 8.54 Favored Pre-proline 0 C--O 1.262 1.76 0 CA-C-O 118.353 -0.832 . . . . 25.0 109.558 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 -21.67 12.96 Favored 'Trans proline' 0 N--CA 1.486 1.063 1 C-N-CA 110.775 -5.683 . . . . 25.0 117.537 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -72.48 -20.75 61.32 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 114.485 -2.674 . . . . 25.0 112.698 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.7 t -79.54 112.7 17.04 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 124.802 2.239 . . . . 25.0 109.615 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 mt -106.89 91.41 3.65 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 109.139 -3.664 . . . . 50.0 104.14 163.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.04 161.72 28.4 Favored 'General case' 0 CA--C 1.457 -2.618 0 C-N-CA 118.074 -1.45 . . . . 25.0 112.732 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.15 166.32 25.01 Favored 'General case' 0 C--O 1.187 -2.201 0 N-CA-C 102.674 -3.084 . . . . 25.0 102.674 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -130.12 140.49 50.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -73.09 170.05 15.73 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.098 0.874 . . . . 25.0 109.296 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.51 168.2 40.11 Favored Glycine 0 CA--C 1.557 2.712 0 CA-C-O 122.895 1.275 . . . . 25.0 113.367 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.75 167.43 10.17 Favored Pre-proline 0 C--O 1.26 1.632 0 N-CA-C 103.399 -2.815 . . . . 25.0 103.399 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.34 -56.75 0.14 OUTLIER 'Cis proline' 0 C--O 1.199 -1.429 0 C-N-CA 130.449 1.437 . . . . 25.0 112.173 -1.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.41 ' H ' ' H ' ' A' ' 44' ' ' SER . 14.1 p80 -147.81 -31.76 0.29 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 124.041 1.877 . . . . 25.0 111.336 132.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.41 ' H ' ' H ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER 68.11 -53.62 0.52 Allowed 'General case' 0 C--O 1.274 2.355 0 N-CA-C 118.239 2.681 . . . . 25.0 118.239 -174.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.76 -157.5 4.77 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 105.736 -2.946 . . . . 25.0 105.736 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.33 170.68 12.93 Favored 'Trans proline' 0 C--N 1.331 -0.357 0 O-C-N 123.935 1.492 . . . . 25.0 109.926 -172.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.85 109.5 0.58 Allowed 'General case' 0 C--O 1.179 -2.634 0 N-CA-C 114.541 1.311 . . . . 25.0 114.541 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -119.18 170.29 9.21 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 118.24 -2.788 . . . . 25.0 108.796 -174.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.7 -5.64 77.53 Favored Glycine 0 C--O 1.268 2.269 0 CA-C-N 112.126 -2.306 . . . . 25.0 115.296 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -87.72 -28.07 21.99 Favored 'General case' 0 N--CA 1.414 -2.227 0 O-C-N 125.249 1.205 . . . . 25.0 107.858 -169.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.2 mt -73.46 -32.2 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.646 0 CA-C-O 116.856 -1.545 . . . . 25.0 108.492 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.7 -24.78 67.07 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 116.838 2.162 . . . . 25.0 116.838 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.4 p -100.19 5.86 44.76 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 124.291 0.994 . . . . 25.0 109.68 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.98 14.99 0.22 Allowed 'General case' 0 C--O 1.182 -2.457 0 C-N-CA 128.647 2.779 . . . . 25.0 117.235 -167.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.94 -34.79 90.89 Favored Glycine 0 C--O 1.257 1.591 0 O-C-N 120.38 -1.45 . . . . 25.0 109.606 169.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.87 -12.88 68.54 Favored Glycine 0 C--O 1.253 1.34 0 CA-C-O 116.458 -2.301 . . . . 25.0 112.081 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . 0.273 59.0 mt -110.23 -12.46 14.46 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.533 1.666 . . . . 50.0 112.677 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -82.96 -40.13 20.45 Favored 'General case' 0 C--N 1.301 -1.534 1 N-CA-C 99.359 -4.311 . . . . 50.0 99.359 171.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.77 -16.41 80.34 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 126.661 3.367 . . . . 25.0 110.522 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.97 -23.33 72.75 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 110.116 -3.042 . . . . 25.0 112.323 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.8 -39.19 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 122.136 2.968 . . . . 25.0 109.217 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -73.83 -29.64 62.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 116.667 2.099 . . . . 75.0 116.667 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -66.97 -28.03 67.94 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 126.881 2.073 . . . . 50.0 110.705 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -91.56 39.3 1.0 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.722 -1.127 . . . . 25.0 110.924 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -136.31 59.68 1.7 Allowed 'General case' 0 C--N 1.281 -2.37 0 O-C-N 125.667 1.854 . . . . 25.0 107.335 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.9 p -169.21 168.28 9.89 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 113.255 -1.793 . . . . 25.0 106.756 -156.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.61 -20.45 60.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 126.869 2.605 . . . . 25.0 109.011 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -84.46 8.74 15.4 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 126.852 2.595 . . . . 25.0 115.614 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -68.79 86.54 0.33 Allowed 'General case' 0 C--O 1.271 2.209 0 CA-C-O 124.721 2.2 . . . . 25.0 107.247 163.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -40.09 148.44 0.08 Allowed 'General case' 0 N--CA 1.426 -1.648 1 CA-C-N 108.242 -4.072 . . . . 25.0 117.242 169.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -74.47 138.95 43.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 123.978 1.847 . . . . 50.0 111.799 -166.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -77.23 154.29 33.17 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 112.207 -2.269 . . . . 25.0 107.798 157.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -132.83 126.5 32.43 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.545 -3.872 . . . . 25.0 100.545 157.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -97.69 116.57 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 105.43 -2.063 . . . . 25.0 105.43 -166.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.9 ttt -132.88 154.27 50.54 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 119.788 -1.82 . . . . 25.0 109.838 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 p -74.79 158.19 33.9 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.66 -177.63 18.95 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 116.221 1.248 . . . . 25.0 116.221 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.61 -167.11 23.68 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 119.24 -1.457 . . . . 25.0 114.788 -174.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -71.24 135.76 47.64 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.997 -1.296 . . . . 25.0 108.764 163.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -134.63 140.65 46.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-O 116.122 -1.894 . . . . 25.0 112.114 -166.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.9 m -124.38 131.74 53.51 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.874 1.358 . . . . 25.0 111.264 171.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -112.67 124.74 53.23 Favored 'General case' 0 CA--C 1.605 3.06 1 N-CA-C 100.133 -4.025 . . . . 50.0 100.133 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.2 m -124.89 129.54 50.59 Favored 'General case' 0 C--O 1.273 2.297 0 CA-C-O 126.24 2.924 . . . . 25.0 111.864 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -123.39 155.84 36.6 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 111.35 -2.659 . . . . 25.0 108.38 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 45.4 p -125.02 143.84 50.7 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 104.382 -2.451 . . . . 25.0 104.382 170.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.36 150.26 28.3 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 104.537 -2.394 . . . . 50.0 104.537 165.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.5 t -76.07 -38.28 57.25 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 124.456 2.074 . . . . 25.0 110.229 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.79 137.69 11.29 Favored Pre-proline 0 N--CA 1.482 1.129 1 N-CA-C 96.18 -5.489 . . . . 25.0 96.18 165.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.06 172.47 16.3 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 CA-C-N 120.9 1.357 . . . . 25.0 112.902 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.344 30.9 m-70 -93.87 159.18 15.3 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 118.029 -2.919 . . . . 25.0 104.726 167.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -60.64 125.8 25.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 117.311 2.337 . . . . 25.0 117.311 167.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.9 m -139.26 134.59 32.85 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 106.721 -1.585 . . . . 25.0 106.721 -160.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.3 p -91.65 -29.02 17.11 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.907 1.337 . . . . 25.0 109.542 -171.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -172.64 171.57 4.47 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 116.421 -1.752 . . . . 25.0 108.292 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.434 ' CZ3' ' CD2' ' A' ' 123' ' ' HIS . 26.9 p90 -153.06 158.54 42.1 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-O 117.018 -1.468 . . . . 25.0 111.528 166.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.415 ' HD2' ' HB ' ' A' ' 151' ' ' VAL 0.253 8.3 m-70 -139.96 144.37 37.01 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.011 1.278 . . . . 25.0 114.12 -167.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -123.72 137.95 54.61 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 121.209 1.822 . . . . 50.0 112.768 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -140.54 166.79 23.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.301 -1.74 . . . . 50.0 106.301 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.4 pt -134.68 166.15 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -83.17 150.93 25.94 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.168 0.44 . . . . 25.0 111.5 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -99.52 162.65 12.9 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 -166.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -163.88 168.46 19.46 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 100.477 -3.898 . . . . 25.0 100.477 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.38 60.32 3.07 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 103.763 -3.735 . . . . 25.0 103.763 -174.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -146.5 171.67 14.71 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 114.776 -2.535 . . . . 25.0 112.476 -169.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.64 135.93 11.08 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 122.99 2.632 . . . . 25.0 104.576 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -64.04 -16.4 54.69 Favored 'Trans proline' 0 C--O 1.191 -1.868 1 N-CA-C 125.04 4.977 . . . . 25.0 125.04 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -78.49 -1.79 35.46 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 117.061 -3.524 . . . . 75.0 112.284 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -130.93 165.18 36.83 Favored Pre-proline 0 N--CA 1.406 -2.64 1 N-CA-C 100.19 -4.004 . . . . 25.0 100.19 -166.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -47.94 24.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 2 C-N-CA 127.703 5.602 . . . . 25.0 122.908 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -41.97 -39.28 1.83 Allowed 'General case' 0 CA--C 1.599 2.848 0 N-CA-C 120.059 3.355 . . . . 50.0 120.059 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -93.79 -10.75 33.12 Favored 'General case' 0 C--O 1.262 1.725 0 CA-C-N 120.041 1.292 . . . . 25.0 112.237 -176.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -107.2 -45.32 4.14 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.601 1.191 . . . . 25.0 110.763 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.17 37.7 0.78 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.838 -1.541 . . . . 25.0 106.838 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.15 -20.73 64.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 125.478 2.561 . . . . 25.0 112.297 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.16 157.24 47.1 Favored 'General case' 0 CA--C 1.594 2.668 0 C-N-CA 126.366 1.866 . . . . 50.0 106.208 165.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -141.27 144.22 34.53 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 125.179 1.549 . . . . 25.0 108.756 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.88 135.89 57.92 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 123.303 1.525 . . . . 50.0 111.074 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.266 2.4 tt -107.29 -26.51 3.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 103.698 -2.704 . . . . 25.0 103.698 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.54 171.68 38.29 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 123.396 1.553 . . . . 25.0 113.571 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.45 147.29 26.08 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.15 119.43 27.65 Favored Pre-proline 0 N--CA 1.484 1.254 0 N-CA-C 105.633 -1.988 . . . . 50.0 105.633 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.09 167.08 16.26 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 N-CA-C 102.585 -3.659 . . . . 25.0 102.585 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.434 ' CD2' ' CZ3' ' A' ' 95' ' ' TRP . 12.4 t-80 -136.2 61.87 1.63 Allowed 'General case' 0 C--O 1.261 1.703 0 N-CA-C 117.515 2.413 . . . . 25.0 117.515 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.43 -25.88 1.14 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 118.973 2.953 . . . . 50.0 118.973 165.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -162.12 12.95 0.12 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 119.713 -1.867 . . . . 25.0 114.581 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.81 170.1 5.56 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 118.976 2.954 . . . . 25.0 118.976 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.54 -166.16 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 120.734 0.956 . . . . 25.0 113.628 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.18 -1.88 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 119.269 3.063 . . . . 25.0 119.269 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.1 p -60.78 -21.45 63.09 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.741 -1.118 . . . . 25.0 113.391 168.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -71.71 -5.03 30.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 117.443 2.386 . . . . 25.0 117.443 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -65.62 133.31 50.87 Favored 'General case' 0 C--O 1.267 2.002 0 O-C-N 120.433 -1.417 . . . . 25.0 108.259 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.73 -30.96 66.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 124.777 2.227 . . . . 75.0 110.774 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.7 t -62.8 127.71 32.51 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 105.337 -2.097 . . . . 25.0 105.337 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.13 134.5 29.72 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 117.593 2.442 . . . . 25.0 117.593 -172.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -94.86 145.0 25.2 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 113.978 -1.464 . . . . 25.0 107.565 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -136.46 125.13 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.356 -2.09 . . . . 25.0 105.356 159.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -71.92 133.97 45.72 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 123.001 2.637 . . . . 50.0 109.062 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.52 110.54 44.74 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -65.88 154.38 74.17 Favored 'Trans proline' 0 N--CA 1.53 3.669 1 C-N-CA 112.309 -4.661 . . . . 25.0 114.053 172.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -91.69 53.52 2.26 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 115.757 -2.377 . . . . 25.0 112.029 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.5 -25.61 38.66 Favored 'General case' 0 C--O 1.261 1.679 0 N-CA-C 114.541 1.312 . . . . 50.0 114.541 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -155.26 173.29 16.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 119.139 0.881 . . . . 25.0 109.643 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.1 pt? -110.97 139.84 45.99 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 104.472 -2.418 . . . . 50.0 104.472 166.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 160.03 167.86 21.19 Favored Glycine 0 C--O 1.294 3.897 0 O-C-N 119.819 -1.801 . . . . 25.0 113.714 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -102.38 139.87 37.42 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 127.166 2.187 . . . . 50.0 111.401 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -156.27 165.24 36.94 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 103.169 -2.9 . . . . 25.0 103.169 166.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.51 161.77 3.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 CA-C-N 120.754 1.615 . . . . 50.0 111.102 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.38 126.77 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 N-CA-C 100.701 -3.814 . . . . 25.0 100.701 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.5 mt -103.81 154.59 19.42 Favored 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 120.555 1.525 . . . . 50.0 108.414 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.1 157.98 43.45 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 119.675 1.125 . . . . 25.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 162' ' ' TYR . 58.8 t -131.09 134.02 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 105.007 -2.22 . . . . 50.0 105.007 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.75 108.09 10.44 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 105.041 -2.207 . . . . 25.0 105.041 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -86.37 95.4 9.65 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 125.325 2.488 . . . . 25.0 106.178 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.83 120.01 23.47 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.12 0 CA-C-N 113.56 -1.654 . . . . 50.0 107.396 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.76 -13.48 42.24 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.698 1.37 . . . . 25.0 114.698 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.95 -23.66 67.43 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.595 2.072 . . . . 25.0 116.595 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.5 p -138.03 158.03 45.15 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 110.875 -2.875 . . . . 25.0 107.218 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -75.18 -17.35 60.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 123.091 1.424 . . . . 25.0 111.547 164.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -69.72 154.84 41.42 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 162.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.09 178.52 7.32 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 100.55 -3.87 . . . . 25.0 100.55 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -124.0 153.97 40.51 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 125.919 2.012 . . . . 50.0 112.28 171.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.426 ' CD2' HG22 ' A' ' 151' ' ' VAL . 11.1 m-85 -123.13 159.75 27.9 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 105.993 -1.854 . . . . 50.0 105.993 158.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -154.62 152.04 29.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 120.642 1.565 . . . . 25.0 108.31 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . 0.282 1.1 p -133.91 136.44 53.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.958 1.361 . . . . 75.0 112.567 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.14 125.62 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.329 -1.36 . . . . 25.0 107.329 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.58 136.45 32.99 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 104.98 -2.23 . . . . 25.0 104.98 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 m -132.79 160.27 42.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 125.241 2.448 . . . . 50.0 110.026 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -130.96 111.74 12.33 Favored 'General case' 0 C--O 1.275 2.397 0 N-CA-C 104.233 -2.506 . . . . 25.0 104.233 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.7 mt -119.26 117.47 28.68 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 100.791 -3.781 . . . . 50.0 100.791 -167.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 19.2 m -115.22 170.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 116.889 2.181 . . . . 50.0 116.889 -167.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -78.91 151.57 31.65 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.9 tptt . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 115.574 -2.155 . . . . 25.0 111.971 178.271 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 . . . . . 0 N--CA 1.51 2.558 0 CA-C-O 120.573 0.225 . . . . 25.0 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.39 -160.01 30.15 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-O 116.812 -2.104 . . . . 25.0 117.027 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -129.87 156.54 44.22 Favored 'General case' 0 C--O 1.253 1.267 0 C-N-CA 126.921 2.088 . . . . 50.0 113.377 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -95.3 125.54 47.97 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 101.418 -3.549 . . . . 25.0 101.418 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -89.74 -40.48 12.48 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 113.706 -1.588 . . . . 25.0 113.738 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -148.54 150.55 34.06 Favored Pre-proline 0 CA--C 1.549 0.918 1 N-CA-C 99.532 -4.248 . . . . 25.0 99.532 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.44 139.13 59.72 Favored 'Cis proline' 0 N--CA 1.442 -1.529 0 CA-C-N 120.676 1.277 . . . . 25.0 113.604 1.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.89 -154.93 49.03 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 117.458 1.743 . . . . 25.0 117.458 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -137.33 114.66 10.95 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 125.319 1.448 . . . . 25.0 109.48 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -67.62 -24.51 65.48 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 123.896 1.808 . . . . 25.0 114.452 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.15 -30.75 71.29 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 118.139 -2.85 . . . . 25.0 114.536 171.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.36 90.44 Favored 'General case' 0 C--O 1.192 -1.946 0 CA-C-O 125.82 2.724 . . . . 25.0 110.323 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.43 -17.22 49.61 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 112.394 -2.185 . . . . 75.0 108.487 -169.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 t -67.98 -13.67 62.36 Favored 'General case' 0 C--O 1.186 -2.283 0 O-C-N 123.991 0.807 . . . . 25.0 111.131 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.9 t -63.0 156.42 24.68 Favored 'General case' 0 CA--C 1.603 3.019 0 N-CA-C 114.102 1.149 . . . . 25.0 114.102 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -74.89 -33.59 62.07 Favored 'General case' 0 C--O 1.196 -1.719 0 CA-C-N 114.853 -1.067 . . . . 25.0 110.31 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.23 -35.17 79.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.149 1.907 . . . . 25.0 116.149 172.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -61.26 -47.88 83.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.711 1.745 . . . . 50.0 115.711 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.64 72.6 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 109.834 -1.306 . . . . 25.0 109.834 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.0 t80 147.19 -56.81 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 111.697 -2.251 . . . . 50.0 109.558 159.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.11 -20.37 8.06 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 119.425 3.12 . . . . 50.0 119.425 161.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -143.03 150.64 39.85 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 -167.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.26 2.0 pt? -78.95 155.86 28.77 Favored 'General case' 0 C--O 1.206 -1.202 0 C-N-CA 119.589 -0.844 . . . . 50.0 110.993 -166.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -136.89 64.69 1.53 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 100.313 -3.958 . . . . 25.0 100.313 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.7 t -153.1 -59.0 0.14 Allowed 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 127.25 2.843 . . . . 25.0 110.955 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.18 -76.93 2.14 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 127.237 2.351 . . . . 25.0 117.332 169.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 m -115.78 -2.97 12.27 Favored 'General case' 0 C--O 1.185 -2.332 0 N-CA-C 117.961 2.578 . . . . 25.0 117.961 -173.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -58.49 -45.58 90.03 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.392 0 CA-C-O 124.001 1.858 . . . . 50.0 112.692 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -69.82 -2.92 13.52 Favored 'General case' 0 CA--C 1.503 -0.852 1 N-CA-C 122.17 4.137 . . . . 25.0 122.17 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.58 -50.77 16.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 124.956 2.312 . . . . 50.0 108.006 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -131.43 82.65 61.37 Favored Pre-proline 0 N--CA 1.511 2.606 0 CA-C-N 113.073 -1.876 . . . . 25.0 106.177 167.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.49 -16.86 54.85 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 116.273 -2.018 . . . . 25.0 116.105 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.45 -51.78 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.7 t -84.55 46.02 1.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 118.462 -2.649 . . . . 25.0 113.844 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.45 129.69 39.91 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-O 125.053 2.359 . . . . 50.0 105.475 173.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.41 146.27 42.63 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.014 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.82 41.37 0.67 Allowed 'General case' 0 C--O 1.193 -1.885 0 CA-C-O 124.379 2.038 . . . . 25.0 113.299 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -142.87 -73.84 0.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 118.811 -2.431 . . . . 25.0 112.889 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.93 177.38 8.81 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.728 1.611 . . . . 25.0 111.669 -165.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.4 28.02 6.96 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 124.733 1.271 . . . . 25.0 113.887 -169.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -71.55 151.69 93.78 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 108.297 -1.001 . . . . 25.0 108.297 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.38 124.63 6.97 Favored 'Cis proline' 0 C--N 1.368 1.578 0 C-N-CA 130.776 1.574 . . . . 25.0 111.641 -15.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -72.18 -18.85 61.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.277 -1.514 . . . . 25.0 111.413 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m 73.76 -45.36 0.6 Allowed 'General case' 0 C--N 1.363 1.157 0 C-N-CA 127.93 2.492 . . . . 25.0 116.24 174.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.92 -178.73 27.66 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 114.943 -3.143 . . . . 25.0 111.649 167.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.15 149.47 91.35 Favored 'Trans proline' 0 CA--C 1.59 3.309 0 CA-C-N 122.125 2.962 . . . . 25.0 110.058 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.86 132.74 32.1 Favored 'General case' 0 N--CA 1.507 2.398 0 C-N-CA 128.115 2.566 . . . . 25.0 116.411 -167.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.11 120.91 13.55 Favored 'General case' 0 C--O 1.256 1.399 0 CA-C-O 117.841 -1.076 . . . . 25.0 113.474 -169.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.14 -13.4 50.11 Favored Glycine 0 CA--C 1.486 -1.773 0 O-C-N 126.777 2.548 . . . . 25.0 117.497 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 42.34 40.44 1.82 Allowed 'General case' 0 C--O 1.247 0.956 0 C-N-CA 130.024 3.33 . . . . 25.0 113.782 -175.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.1 mt -65.21 -29.13 46.36 Favored 'Isoleucine or valine' 0 C--O 1.256 1.416 0 CA-C-N 113.512 -1.676 . . . . 25.0 112.605 -162.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.66 79.8 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 115.009 1.485 . . . . 25.0 115.009 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.6 p -141.15 -9.82 0.99 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 119.677 -1.889 . . . . 25.0 114.616 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 49.63 25.94 1.62 Allowed 'General case' 0 CA--C 1.577 2.014 0 C-N-CA 124.978 1.311 . . . . 25.0 113.012 -166.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.32 -29.64 71.79 Favored Glycine 0 C--O 1.237 0.305 0 CA-C-N 119.83 1.195 . . . . 25.0 112.67 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.08 -16.31 68.51 Favored Glycine 0 C--O 1.263 1.911 0 O-C-N 120.327 -1.69 . . . . 25.0 111.65 171.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mt -113.44 48.14 1.08 Allowed 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 118.436 2.754 . . . . 50.0 118.436 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -70.97 -26.1 63.01 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.346 -3.205 . . . . 50.0 102.346 148.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.04 -16.68 68.91 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 119.881 -1.762 . . . . 25.0 109.003 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.95 -23.53 77.69 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 119.997 -1.097 . . . . 25.0 114.092 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.48 -44.41 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 117.012 -1.875 . . . . 25.0 109.519 165.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.11 1.02 2.24 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 126.235 2.921 . . . . 75.0 118.624 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.78 -14.93 60.78 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 112.262 -2.245 . . . . 50.0 110.721 170.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -72.74 5.15 3.35 Favored 'General case' 0 CA--C 1.485 -1.557 0 O-C-N 116.631 -3.793 . . . . 25.0 116.733 173.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -122.62 67.31 0.95 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 125.919 1.687 . . . . 25.0 107.258 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -147.18 151.24 36.43 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 117.192 2.293 . . . . 25.0 117.192 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -72.28 -30.22 64.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 118.246 -2.784 . . . . 25.0 109.02 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -106.02 31.36 5.14 Favored 'General case' 0 C--O 1.176 -2.776 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -78.46 101.71 7.45 Favored 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 97.859 -4.867 . . . . 25.0 97.859 164.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -43.15 155.96 0.05 Allowed 'General case' 0 C--O 1.262 1.714 0 CA-C-N 110.023 -3.262 . . . . 25.0 115.468 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -58.86 144.73 43.45 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 127.043 3.306 . . . . 50.0 117.076 -167.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -82.96 153.78 24.85 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 117.714 2.487 . . . . 25.0 117.714 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -152.35 156.52 39.74 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 117.981 -2.949 . . . . 25.0 109.138 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.2 tt -132.58 139.75 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 106.367 -1.716 . . . . 25.0 106.367 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtt -152.87 151.8 30.81 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 120.087 1.312 . . . . 25.0 110.255 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.5 p -84.55 176.68 8.46 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.071 -0.714 . . . . 25.0 109.071 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.65 168.8 53.86 Favored Glycine 0 C--O 1.209 -1.439 0 C-N-CA 120.825 -0.702 . . . . 25.0 112.065 168.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.62 174.26 15.56 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.472 -1.823 . . . . 25.0 110.687 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -71.06 134.04 46.77 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.279 -0.968 . . . . 25.0 111.807 162.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -133.73 147.35 51.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.131 -0.94 . . . . 25.0 110.77 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m -85.62 136.09 33.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 124.274 1.03 . . . . 25.0 110.597 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.42 134.81 49.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.067 -1.827 . . . . 50.0 106.067 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.4 m -114.66 120.93 41.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -120.27 149.02 42.96 Favored 'General case' 0 C--O 1.263 1.803 0 CA-C-O 118.288 -0.863 . . . . 25.0 109.446 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 t -143.35 158.18 43.85 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.275 1.852 . . . . 25.0 109.871 -171.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -86.15 147.93 25.91 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 104.443 -2.429 . . . . 50.0 104.443 161.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.7 t -110.41 -18.28 13.27 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 103.711 -2.7 . . . . 25.0 103.711 162.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 147.04 54.14 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 101.117 -3.66 . . . . 25.0 101.117 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.35 151.54 84.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 117.887 -0.942 . . . . 25.0 113.579 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -129.1 178.49 6.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 100.762 -3.792 . . . . 25.0 100.762 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -118.56 84.84 2.25 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.938 1.695 . . . . 25.0 107.007 157.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -75.56 149.52 38.31 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 103.233 -2.877 . . . . 25.0 103.233 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 p -106.16 -30.32 9.3 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-N 120.713 1.597 . . . . 25.0 114.56 168.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 51.2 tt0 -164.21 158.34 18.92 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 118.614 -2.554 . . . . 25.0 104.674 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -149.69 162.04 41.01 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 120.167 -1.583 . . . . 25.0 110.156 163.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -128.79 156.58 43.35 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 127.009 2.124 . . . . 25.0 110.738 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -147.7 149.76 33.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 124.693 2.187 . . . . 50.0 105.959 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -146.3 168.6 20.68 Favored 'General case' 0 CA--C 1.501 -0.914 1 N-CA-C 98.813 -4.514 . . . . 50.0 98.813 -154.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.1 pt -134.51 158.0 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 117.07 -1.443 . . . . 25.0 108.693 162.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.451 HG23 ' HA ' ' A' ' 114' ' ' ASP . 49.9 m -95.14 133.32 39.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 125.525 1.766 . . . . 25.0 110.592 172.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -76.87 135.77 38.85 Favored 'General case' 0 C--O 1.297 3.563 0 CA-C-N 122.328 2.331 . . . . 25.0 109.998 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.32 164.71 26.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 103.999 -2.593 . . . . 25.0 103.999 171.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.33 3.24 65.21 Favored Glycine 0 C--O 1.276 2.739 0 N-CA-C 117.333 1.693 . . . . 25.0 117.333 169.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.87 176.97 5.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.711 1.004 . . . . 25.0 113.711 -174.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.56 138.04 11.38 Favored Pre-proline 0 C--O 1.194 -1.847 0 CA-C-O 116.188 -1.863 . . . . 25.0 109.944 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.51 -21.23 46.66 Favored 'Trans proline' 0 C--O 1.286 2.912 0 N-CA-C 117.983 2.263 . . . . 25.0 117.983 -174.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.53 3.13 12.0 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 118.977 -2.327 . . . . 75.0 113.198 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -129.38 174.04 5.02 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 100.615 -3.846 . . . . 25.0 100.615 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.6 21.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 N-CA-C 122.138 3.861 . . . . 25.0 122.138 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 tt -38.84 -33.74 0.12 Allowed 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.755 2.132 . . . . 50.0 116.755 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.28 -5.44 59.18 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 116.593 2.072 . . . . 25.0 116.593 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -116.15 -43.11 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 123.654 1.693 . . . . 25.0 110.105 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.2 4.77 1.14 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 113.315 -1.766 . . . . 25.0 112.883 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.451 ' HA ' HG23 ' A' ' 100' ' ' THR . 26.2 t0 -70.63 -14.92 62.66 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 119.571 -0.852 . . . . 25.0 108.837 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.73 106.74 8.91 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -109.09 120.16 41.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 104.99 -2.226 . . . . 25.0 104.99 165.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.97 136.27 55.06 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 116.568 -1.682 . . . . 50.0 108.873 -176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.5 tp -110.29 -19.21 7.04 Favored 'Isoleucine or valine' 0 C--N 1.374 1.639 0 CA-C-O 125.868 2.747 . . . . 25.0 109.81 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.76 150.97 13.13 Favored Glycine 0 N--CA 1.444 -0.773 0 O-C-N 118.268 -2.77 . . . . 25.0 114.562 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . 0.257 . . -143.84 140.96 30.1 Favored 'General case' 0 CA--C 1.569 1.685 1 N-CA-C 98.955 -4.461 . . . . 25.0 98.955 -179.957 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.2 105.11 11.29 Favored Pre-proline 0 CA--C 1.497 -1.078 0 O-C-N 127.208 2.818 . . . . 50.0 103.465 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 61.6 Cg_endo -66.22 167.17 18.98 Favored 'Trans proline' 0 C--O 1.203 -1.225 1 C-N-CA 109.828 -6.315 . . . . 25.0 111.896 166.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -144.01 83.18 1.73 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 118.435 -2.666 . . . . 25.0 111.795 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.93 -17.6 43.06 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 124.675 2.178 . . . . 50.0 113.183 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.01 -168.2 36.57 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 103.581 -3.808 . . . . 25.0 103.581 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 71.09 82.2 Favored Pre-proline 0 C--O 1.181 -2.523 0 CA-C-N 121.534 2.667 . . . . 25.0 114.278 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -67.67 172.06 11.09 Favored 'Trans proline' 0 C--O 1.286 2.906 1 C-N-CA 111.025 -5.517 . . . . 25.0 110.982 155.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.03 -35.76 67.22 Favored 'General case' 0 C--N 1.356 0.89 0 CA-C-O 116.396 -1.764 . . . . 25.0 113.656 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 98.4 p -59.22 -20.21 52.08 Favored 'General case' 0 C--O 1.296 3.536 0 O-C-N 127.532 3.02 . . . . 25.0 115.793 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -105.57 8.22 33.18 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 118.704 2.853 . . . . 25.0 118.704 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -60.19 151.91 25.96 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 125.72 2.676 . . . . 25.0 110.998 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mt -66.46 -27.03 67.49 Favored 'General case' 0 C--O 1.26 1.613 0 CA-C-N 113.202 -1.817 . . . . 75.0 114.56 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.4 m -96.44 145.55 25.56 Favored 'General case' 0 C--O 1.302 3.85 0 O-C-N 119.518 -1.989 . . . . 25.0 105.855 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -131.45 168.32 17.82 Favored 'General case' 0 C--O 1.192 -1.957 0 N-CA-C 116.318 1.97 . . . . 25.0 116.318 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.305 89.9 m-70 -121.3 116.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 121.608 2.004 . . . . 25.0 113.28 168.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mm -122.18 131.79 72.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 C-N-CA 118.745 -1.182 . . . . 25.0 108.981 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -75.78 134.08 40.52 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 107.18 -1.415 . . . . 50.0 107.18 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.04 132.02 22.55 Favored Pre-proline 0 C--O 1.204 -1.309 0 N-CA-C 102.892 -3.003 . . . . 25.0 102.892 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -62.27 143.66 94.34 Favored 'Trans proline' 0 CA--C 1.458 -3.324 1 C-N-CA 113.006 -4.196 . . . . 25.0 118.785 -175.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.73 -22.86 12.86 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 125.447 2.546 . . . . 25.0 114.267 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -77.46 -5.46 49.97 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 118.965 -2.334 . . . . 50.0 112.289 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -145.06 158.09 43.92 Favored 'General case' 0 C--O 1.204 -1.303 0 CA-C-N 112.739 -2.028 . . . . 25.0 112.388 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.2 mp -107.2 152.67 23.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.052 -2.944 . . . . 50.0 103.052 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 158.44 166.63 17.96 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.151 -0.968 . . . . 25.0 114.949 167.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -88.57 136.13 33.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.606 1.335 . . . . 50.0 114.606 166.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.401 ' CD2' HD12 ' A' ' 169' ' ' LEU . 81.8 m-70 -149.45 167.84 25.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 104.213 -2.514 . . . . 25.0 104.213 -159.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.51 131.83 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.985 0 N-CA-C 103.537 -2.764 . . . . 50.0 103.537 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 94.5 mt -98.8 121.17 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 105.925 -1.88 . . . . 25.0 105.925 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.93 138.18 51.12 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 119.904 -1.747 . . . . 50.0 107.799 -175.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.26 145.51 43.64 Favored 'General case' 0 C--O 1.263 1.81 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.3 t -133.84 137.3 52.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 114.424 -2.703 . . . . 50.0 110.267 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -115.77 150.5 36.8 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.814 -1.921 . . . . 25.0 105.814 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -112.89 131.74 55.6 Favored 'General case' 0 C--N 1.307 -1.248 1 N-CA-C 99.085 -4.413 . . . . 25.0 99.085 163.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.21 120.82 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 105.046 -2.205 . . . . 50.0 105.046 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.8 -21.3 41.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 118.944 -0.551 . . . . 25.0 111.069 -173.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . 0.304 2.1 p-10 -82.82 -15.13 52.82 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 116.023 1.86 . . . . 25.0 116.023 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.505 ' HG1' ' HE1' ' A' ' 161' ' ' PHE . 39.1 p -112.67 156.58 22.51 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.177 -1.046 . . . . 25.0 108.177 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -90.5 -23.79 20.85 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.638 -1.225 . . . . 25.0 114.064 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -102.0 160.14 14.76 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 115.25 -0.886 . . . . 25.0 111.486 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.82 166.85 22.94 Favored 'General case' 0 C--O 1.253 1.258 0 CA-C-N 113.03 -1.896 . . . . 25.0 112.649 163.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.505 ' HE1' ' HG1' ' A' ' 157' ' ' THR . 52.7 m-85 -129.35 130.83 46.58 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 112.343 -2.208 . . . . 50.0 110.34 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -139.74 136.76 34.49 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 127.207 2.817 . . . . 50.0 108.323 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.62 149.53 20.37 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 106.881 -1.525 . . . . 25.0 106.881 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.9 m -127.51 162.72 32.38 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.595 0 N-CA-C 107.978 -1.119 . . . . 75.0 107.978 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.94 131.44 46.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 105.868 -1.901 . . . . 25.0 105.868 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.55 124.31 38.5 Favored 'General case' 0 CA--C 1.583 2.215 0 O-C-N 126.093 2.121 . . . . 25.0 106.357 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 m -123.46 158.75 28.67 Favored 'Isoleucine or valine' 0 C--O 1.285 2.933 0 C-N-CA 116.186 -2.206 . . . . 50.0 109.221 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -119.44 121.34 39.26 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 101.105 -3.665 . . . . 25.0 101.105 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.401 HD12 ' CD2' ' A' ' 146' ' ' HIS . 77.6 mt -112.28 95.99 5.77 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 105.488 -2.042 . . . . 50.0 105.488 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.8 172.73 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.801 -1.187 . . . . 50.0 113.192 -170.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -66.97 132.81 48.69 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 105.982 -1.859 . . . . 25.0 105.982 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.0 pttp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 115.612 -2.137 . . . . 25.0 110.194 177.546 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 . . . . . 1 N--CA 1.555 4.8 0 CA-C-O 122.761 1.267 . . . . 25.0 107.995 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -121.31 6.33 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.341 -1.409 . . . . 25.0 111.571 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.26 144.33 27.8 Favored 'General case' 0 C--O 1.267 2.023 0 O-C-N 119.196 -2.355 . . . . 50.0 106.438 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -86.86 126.09 40.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 N-CA-C 105.002 -2.221 . . . . 25.0 105.002 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -108.02 -35.31 6.64 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 117.039 -1.864 . . . . 25.0 110.449 -169.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 148.86 57.56 Favored Pre-proline 0 C--O 1.256 1.406 0 N-CA-C 104.967 -2.234 . . . . 25.0 104.967 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -71.43 133.16 27.07 Favored 'Cis proline' 0 C--N 1.359 1.117 0 C-N-CA 132.848 2.437 . . . . 25.0 114.158 2.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.22 -144.12 49.05 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 115.104 0.802 . . . . 25.0 115.104 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -133.72 104.62 6.41 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 105.169 -2.16 . . . . 25.0 105.169 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -69.18 -18.06 63.88 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 117.806 -3.059 . . . . 25.0 109.471 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.04 -30.19 70.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 116.403 -1.76 . . . . 25.0 111.169 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.56 63.82 Favored 'General case' 0 C--O 1.198 -1.624 0 N-CA-C 106.89 -1.522 . . . . 25.0 106.89 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.61 -28.97 59.07 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.546 -1.346 . . . . 75.0 111.861 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.5 t -72.87 -36.78 67.46 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 112.76 -2.018 . . . . 25.0 113.502 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 p -56.02 148.55 17.33 Favored 'General case' 0 C--O 1.273 2.331 0 N-CA-C 119.375 3.102 . . . . 25.0 119.375 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.62 -37.09 72.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.464 -0.773 . . . . 25.0 110.627 169.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.5 -6.01 37.33 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.816 0.846 . . . . 25.0 111.875 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -58.58 -37.79 76.54 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 123.025 1.393 . . . . 50.0 109.911 170.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.88 -1.33 0.72 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 122.571 3.788 . . . . 25.0 122.571 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 43.71 16.3 0.01 OUTLIER 'General case' 0 C--O 1.29 3.234 0 N-CA-C 121.523 3.897 . . . . 50.0 121.523 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.1 mt -121.74 -36.89 2.95 Favored 'General case' 0 N--CA 1.517 2.906 0 O-C-N 120.782 -1.199 . . . . 50.0 110.45 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -149.1 -168.37 3.09 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 120.412 -1.43 . . . . 25.0 111.701 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -168.27 157.64 9.39 Favored 'General case' 0 C--O 1.209 -1.069 0 O-C-N 127.926 3.266 . . . . 50.0 108.894 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -160.47 45.6 0.21 Allowed 'General case' 0 N--CA 1.517 2.912 1 CA-C-O 129.395 4.426 . . . . 25.0 114.539 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.8 t -87.46 -5.63 58.74 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 117.843 -3.036 . . . . 25.0 113.166 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.79 -35.74 87.51 Favored Glycine 0 C--O 1.179 -3.339 0 N-CA-C 119.239 2.456 . . . . 25.0 119.239 -158.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 m -83.45 -12.69 56.07 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 121.859 2.83 . . . . 25.0 110.579 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -89.61 -45.77 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.522 0 N-CA-C 105.022 -2.214 . . . . 50.0 105.022 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.3 ptm -76.13 -7.28 54.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 117.783 -3.073 . . . . 25.0 115.111 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.78 -47.27 85.3 Favored 'General case' 0 N--CA 1.421 -1.917 0 O-C-N 126.297 2.248 . . . . 50.0 112.362 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.62 64.03 11.32 Favored Pre-proline 0 CA--C 1.505 -0.755 0 N-CA-C 113.753 1.02 . . . . 25.0 113.753 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.26 -19.87 37.96 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 N-CA-C 117.681 2.146 . . . . 25.0 117.681 -167.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -99.83 6.42 45.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.435 2.013 . . . . 25.0 116.435 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -136.73 38.52 2.62 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.692 1.597 . . . . 25.0 112.216 171.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 tp -77.5 99.32 5.64 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.055 -0.521 . . . . 50.0 110.968 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.28 147.1 52.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.071 -1.455 . . . . 25.0 107.071 -159.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.29 50.6 1.02 Allowed 'General case' 0 CA--C 1.606 3.12 0 N-CA-C 115.437 1.643 . . . . 25.0 115.437 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HG2' ' H ' ' A' ' 39' ' ' LYS . 45.4 tttt -134.76 -163.1 1.33 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.05 -1.833 . . . . 25.0 106.05 175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HA ' ' CE1' ' A' ' 43' ' ' HIS . 94.0 mttt -68.76 163.74 23.38 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 125.638 1.837 . . . . 25.0 110.679 -168.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.07 178.22 47.38 Favored Glycine 0 N--CA 1.439 -1.126 1 CA-C-O 112.158 -4.69 . . . . 25.0 103.986 176.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -127.02 104.59 22.74 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 121.275 2.538 . . . . 25.0 110.434 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.89 158.17 85.2 Favored 'Cis proline' 0 C--O 1.259 1.569 0 C-N-CA 134.078 2.949 . . . . 25.0 112.451 2.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.452 ' CE1' ' HA ' ' A' ' 39' ' ' LYS . 41.5 t60 -65.58 -32.9 74.73 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 121.619 2.009 . . . . 25.0 107.019 -172.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t 76.28 -71.7 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.767 1.627 . . . . 25.0 114.012 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.78 -175.17 27.48 Favored Glycine 0 N--CA 1.484 1.847 0 CA-C-O 124.208 2.005 . . . . 25.0 109.514 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.95 -172.0 1.13 Allowed 'Trans proline' 0 N--CA 1.514 2.712 0 O-C-N 119.48 -0.853 . . . . 25.0 113.421 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.71 133.74 55.92 Favored 'General case' 0 CA--C 1.555 1.163 0 O-C-N 118.266 -2.771 . . . . 25.0 109.353 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -66.9 121.11 14.78 Favored 'General case' 1 C--O 1.314 4.482 0 N-CA-C 118.628 2.825 . . . . 25.0 118.628 -173.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.12 1.71 88.15 Favored Glycine 0 C--O 1.25 1.119 0 CA-C-O 115.91 -2.605 . . . . 25.0 111.863 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 36.95 38.32 0.09 Allowed 'General case' 0 CA--C 1.568 1.642 0 O-C-N 126.757 2.092 . . . . 25.0 115.887 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.9 mt -69.45 -40.07 79.42 Favored 'Isoleucine or valine' 0 C--O 1.263 1.779 0 CA-C-N 114.91 -1.041 . . . . 25.0 108.77 -160.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.91 -48.73 79.01 Favored 'General case' 0 C--O 1.185 -2.295 0 O-C-N 119.309 -2.119 . . . . 25.0 113.713 -169.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 t -108.66 -22.49 12.23 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 125.017 1.448 . . . . 25.0 109.948 -167.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.269 . . 59.66 9.8 1.74 Allowed 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 117.348 2.351 . . . . 25.0 117.348 -171.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.82 -20.39 73.71 Favored Glycine 0 C--O 1.258 1.647 0 O-C-N 118.651 -2.53 . . . . 25.0 107.483 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.1 -17.2 69.65 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 122.407 3.723 . . . . 25.0 122.407 164.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.9 mt -110.96 -20.19 12.52 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 124.284 1.992 . . . . 50.0 111.428 -172.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -71.12 -40.42 71.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.763 -2.31 . . . . 50.0 104.763 155.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.55 -22.98 47.74 Favored Glycine 0 CA--C 1.499 -0.966 0 O-C-N 118.82 -2.425 . . . . 25.0 114.582 167.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.13 74.6 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 126.069 3.038 . . . . 25.0 113.285 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.96 -33.22 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 117.771 -3.194 . . . . 25.0 105.381 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.13 -14.51 60.98 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 112.65 -2.068 . . . . 75.0 112.956 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.01 -25.97 65.7 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 111.724 -2.489 . . . . 50.0 112.02 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.51 11.27 5.85 Favored 'General case' 0 C--O 1.251 1.155 0 O-C-N 118.807 -2.433 . . . . 25.0 112.756 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -133.06 16.77 4.15 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.05 -1.656 . . . . 25.0 112.457 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -112.4 166.17 11.54 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.286 -0.87 . . . . 25.0 109.345 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.81 -22.6 65.16 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 105.78 -1.933 . . . . 25.0 105.78 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.98 39.64 1.52 Allowed 'General case' 0 C--O 1.168 -3.196 0 C-N-CA 125.55 1.54 . . . . 25.0 110.165 175.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -89.36 91.34 8.7 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-O 124.901 2.286 . . . . 25.0 105.704 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -57.24 139.2 53.43 Favored 'General case' 0 C--N 1.305 -1.34 1 CA-C-N 107.5 -4.409 . . . . 25.0 105.358 172.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -65.56 152.09 44.91 Favored 'General case' 0 C--O 1.286 3.017 0 CA-C-O 126.314 2.959 . . . . 50.0 115.086 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -87.27 134.92 33.49 Favored 'General case' 0 C--O 1.185 -2.318 0 CA-C-N 109.897 -3.32 . . . . 25.0 104.415 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -126.47 134.71 50.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 126.062 2.101 . . . . 25.0 112.883 171.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -93.99 141.25 15.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 tpt -146.3 147.75 31.7 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-O 123.028 1.394 . . . . 25.0 108.739 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 p -82.31 173.61 11.91 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 114.262 -1.335 . . . . 25.0 114.416 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.9 -179.0 35.45 Favored Glycine 0 C--O 1.264 2.019 0 O-C-N 120.053 -1.654 . . . . 25.0 110.526 163.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.76 179.05 32.11 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 106.252 -2.739 . . . . 25.0 106.252 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.75 138.9 39.27 Favored 'General case' 0 C--O 1.257 1.471 0 O-C-N 118.326 -2.867 . . . . 25.0 114.612 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -132.1 160.48 35.84 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 114.044 -1.434 . . . . 25.0 110.803 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -111.52 135.79 51.59 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-O 123.798 1.761 . . . . 25.0 111.597 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -112.97 119.55 38.3 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.79 -1.095 . . . . 50.0 111.518 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.4 m -134.72 129.21 34.36 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 107.275 -1.38 . . . . 25.0 107.275 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -120.77 151.21 39.86 Favored 'General case' 0 C--N 1.313 -1.011 1 N-CA-C 98.617 -4.586 . . . . 25.0 98.617 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -143.66 126.57 16.29 Favored 'General case' 0 C--O 1.263 1.811 0 O-C-N 125.344 1.652 . . . . 25.0 112.397 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -130.3 143.65 50.9 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 118.809 -2.432 . . . . 50.0 109.633 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -61.6 -23.96 66.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 118.522 2.786 . . . . 25.0 118.522 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.05 157.2 78.21 Favored Pre-proline 0 CA--C 1.493 -1.227 0 N-CA-C 101.257 -3.609 . . . . 25.0 101.257 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.26 159.1 11.24 Favored 'Trans proline' 0 N--CA 1.504 2.099 0 N-CA-C 103.003 -3.499 . . . . 25.0 103.003 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -89.83 167.62 12.71 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 102.667 -3.086 . . . . 25.0 102.667 159.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -88.7 117.13 27.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -139.32 156.36 47.08 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 122.613 0.365 . . . . 25.0 110.341 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p -98.83 -48.87 4.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.168 0.987 . . . . 25.0 111.378 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -159.42 160.3 34.68 Favored 'General case' 0 CA--C 1.474 -1.969 0 O-C-N 120.214 -1.553 . . . . 25.0 114.541 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -122.08 144.95 48.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 119.735 1.152 . . . . 25.0 111.221 162.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -122.93 153.56 39.54 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 114.253 -2.784 . . . . 25.0 110.283 -170.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.25 137.56 27.38 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 105.858 -1.904 . . . . 50.0 105.858 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -134.67 156.46 48.72 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 124.56 1.162 . . . . 50.0 110.081 -167.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.451 HG22 HG12 ' A' ' 148' ' ' ILE . 24.2 pt -126.63 162.81 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 124.621 2.153 . . . . 25.0 110.006 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 147' ' ' VAL . 54.8 m -111.9 127.27 55.79 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 118.75 -2.469 . . . . 25.0 108.285 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.449 ' HG3' ' CE3' ' A' ' 104' ' ' TRP . 52.8 pttt -99.01 179.49 4.61 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -164.03 177.13 8.72 Favored 'General case' 0 C--O 1.275 2.433 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.81 26.69 66.46 Favored Glycine 0 C--O 1.252 1.235 1 CA-C-O 129.379 4.877 . . . . 25.0 113.861 -166.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.449 ' CE3' ' HG3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -97.19 150.31 21.04 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 108.83 -3.685 . . . . 25.0 112.95 -173.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 106' ' ' PRO 0.288 9.7 t70 -98.45 141.54 23.1 Favored Pre-proline 0 C--O 1.194 -1.868 0 C-N-CA 127.772 2.429 . . . . 25.0 111.095 -172.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 105' ' ' ASP . 31.3 Cg_exo -67.52 -40.54 10.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 124.776 3.65 . . . . 25.0 121.038 -173.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.67 -29.05 65.27 Favored 'General case' 0 C--O 1.197 -1.704 0 CA-C-O 126.225 2.917 . . . . 75.0 109.312 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.84 161.5 74.47 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 118.484 -2.635 . . . . 25.0 110.31 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.92 17.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.646 2 C-N-CA 127.978 5.785 . . . . 25.0 122.878 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.19 -37.5 15.94 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 116.091 1.885 . . . . 50.0 116.091 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -85.48 -10.66 55.78 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.423 1.638 . . . . 25.0 115.423 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 114' ' ' ASP . 99.4 mtt180 -104.21 -52.81 2.85 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 117.695 2.48 . . . . 25.0 117.695 174.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.67 34.8 0.28 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 127.028 2.705 . . . . 25.0 106.791 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 112' ' ' ARG . 36.0 t70 -63.65 -26.79 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.838 2.055 . . . . 25.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -127.71 145.69 50.82 Favored 'General case' 0 C--N 1.298 -1.674 1 N-CA-C 99.023 -4.436 . . . . 50.0 99.023 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -117.63 130.66 56.51 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 121.414 1.915 . . . . 25.0 110.73 168.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.1 tp -63.87 110.15 1.99 Allowed 'General case' 0 C--O 1.27 2.153 0 CA-C-O 118.311 -0.852 . . . . 50.0 110.467 168.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.6 tt -99.34 -17.85 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.14 166.34 36.35 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 116.319 1.288 . . . . 25.0 116.319 164.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.7 152.18 33.54 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.21 -1.404 . . . . 25.0 107.21 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.96 120.43 15.24 Favored Pre-proline 0 C--O 1.262 1.723 0 O-C-N 125.934 2.021 . . . . 50.0 110.185 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.72 152.67 53.36 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.262 1.276 . . . . 25.0 113.093 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.79 52.29 1.48 Allowed 'General case' 0 C--O 1.245 0.863 0 N-CA-C 105.318 -2.104 . . . . 25.0 105.318 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -83.64 -22.55 32.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.602 -1.629 . . . . 50.0 106.602 -167.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.05 178.89 31.47 Favored Glycine 0 C--O 1.204 -1.738 1 N-CA-C 102.714 -4.154 . . . . 25.0 102.714 -174.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -123.75 56.87 11.27 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 119.434 3.124 . . . . 25.0 119.434 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.6 175.85 10.53 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 O-C-N 118.303 -1.472 . . . . 25.0 108.5 168.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.47 -13.77 43.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 25.0 113.311 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 80.7 p -84.76 -3.83 58.78 Favored 'General case' 0 C--O 1.189 -2.12 0 CA-C-N 119.383 0.992 . . . . 25.0 110.83 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -116.47 26.21 10.06 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 123.973 1.844 . . . . 25.0 110.673 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -68.61 149.97 48.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.825 -1.546 . . . . 25.0 106.825 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.73 -15.11 59.86 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 126.466 2.354 . . . . 75.0 115.781 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.4 t -81.31 123.61 28.67 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 104.223 -2.51 . . . . 25.0 104.223 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -118.71 147.22 44.06 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.664 -1.273 . . . . 25.0 108.047 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -110.53 136.35 49.78 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.9 mm -132.37 128.23 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -78.66 133.53 37.22 Favored 'General case' 0 C--O 1.255 1.365 0 O-C-N 125.696 1.873 . . . . 50.0 111.71 169.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.48 126.18 28.27 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-O 115.22 -2.324 . . . . 25.0 107.218 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.75 151.72 74.36 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 113.563 -3.824 . . . . 25.0 114.619 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -105.11 -8.05 18.7 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.08 -1.873 . . . . 25.0 111.921 -172.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.23 -1.7 24.62 Favored 'General case' 0 C--O 1.186 -2.255 0 O-C-N 126.315 2.259 . . . . 50.0 115.758 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -142.06 165.72 26.67 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 119.409 -2.057 . . . . 25.0 112.596 -172.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 3.8 mp -128.15 147.06 50.54 Favored 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 101.184 -3.636 . . . . 50.0 101.184 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.44 174.44 21.56 Favored Glycine 0 CA--C 1.477 -2.326 0 N-CA-C 121.037 3.175 . . . . 25.0 121.037 161.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -82.39 140.48 33.45 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 113.588 -1.306 . . . . 50.0 111.834 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -149.38 165.97 30.46 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.108 -2.182 . . . . 25.0 105.108 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.405 ' H ' ' HB ' ' A' ' 100' ' ' THR . 5.0 t -125.12 141.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.684 0 N-CA-C 103.933 -2.618 . . . . 50.0 103.933 168.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 99' ' ' ILE . 91.0 mt -127.54 132.33 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 116.749 -1.596 . . . . 25.0 109.019 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.53 139.17 44.85 Favored 'General case' 0 C--O 1.263 1.793 0 O-C-N 128.467 3.605 . . . . 50.0 110.55 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.5 116.23 17.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 25.0 112.039 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 t -129.36 127.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 125.089 1.493 . . . . 50.0 108.572 -162.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -119.23 108.98 15.31 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 119.286 0.948 . . . . 25.0 113.027 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.32 116.41 11.62 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 126.762 2.025 . . . . 25.0 109.545 -173.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.4 t -87.68 136.38 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.44 -1.689 . . . . 50.0 106.44 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -95.63 -25.25 16.21 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 115.843 1.794 . . . . 25.0 115.843 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.0 5.65 50.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.082 1.42 . . . . 25.0 113.277 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.9 p -139.6 -177.23 4.85 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 104.179 -2.526 . . . . 25.0 104.179 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.78 -7.23 41.03 Favored 'General case' 0 CA--C 1.481 -1.704 0 O-C-N 125.089 1.493 . . . . 25.0 107.155 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -85.28 176.96 8.01 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 116.565 2.061 . . . . 25.0 116.565 -170.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.91 146.87 28.09 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -78.7 133.91 37.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.22 -1.77 . . . . 50.0 106.22 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -136.58 123.05 20.8 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 126.299 1.839 . . . . 50.0 110.752 -172.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.63 142.67 33.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 103.645 -2.724 . . . . 25.0 103.645 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.96 144.24 24.27 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 102.317 -3.216 . . . . 75.0 102.317 -168.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.2 mt -138.81 122.03 19.02 Favored 'Isoleucine or valine' 0 C--O 1.261 1.706 0 CA-C-O 124.131 1.92 . . . . 25.0 106.162 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -75.59 126.68 31.48 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 112.459 -2.155 . . . . 25.0 106.694 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.84 159.17 39.58 Favored 'Isoleucine or valine' 0 C--O 1.264 1.833 0 O-C-N 117.362 -3.336 . . . . 50.0 116.811 -171.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -133.14 113.65 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 103.953 -2.61 . . . . 25.0 103.953 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.9 mt -116.43 122.5 44.97 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 105.238 -2.134 . . . . 50.0 105.238 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.3 m -135.19 159.83 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.396 0 N-CA-C 117.749 2.5 . . . . 50.0 117.749 -172.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -61.36 140.28 58.04 Favored 'General case' 0 C--O 1.189 -2.102 0 O-C-N 121.026 -1.046 . . . . 25.0 110.779 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.9 pttt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 116.266 -1.826 . . . . 25.0 110.52 170.627 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_